Citrus Sinensis ID: 042216

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------
Protein Sequence
DSPSPYYTPTEITFVACGWLGNISAHGQTWAGDVSSQYSPLGHQQSTISKKPREPPYSASRLSHSQFTYTFNVTPGQKFIRLHFYSTSYSGFNISSAFFSVKANSFTLVNNFSASFAPDDTFFKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYYTATDDQRLEFVGEGSQFSILNSNALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDARPSALPVNTTIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRLHFCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGSKSDVKKQNLSIALHPAPRWRTKYSDSILNGIEIFKVDNNGSLAGPNPYPTVSQASSFGTRSPQQSTKAKNNRPRMLGIVGVVASGLVVLFIVFLLISRRAVMKEAKSRGPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEKSMIAHP
Secondary Structure (PSIPRED)
ccccccccccccEEEcccccccccccccEEEcccccccccccccccccccccccccccEEEEEccccEEEEEEccccEEEEEEEEccccccccccccEEEEEEccEEEEccccccccccccEEEEEEEEEccccccEEEEEEccccccccEEEEEEEEEEEccccccccccccccccccccccccccccccccEEEEEEEcccccccccccccccEEcccccccccccccccccccccEEEEccccccccccHHHHHHHHHccccccccccccEEEEEEEcccccEEEEEEEEcEEccccccccEEEEEEEcccEEccccHHHHHcccccccEEEEEEEEEccccccccccEEEEEEEccccccccccccccccEEEEEccccccccccccccccccccccccccccccccccccccEEEEEEEEEHHHHHHHHHHHEEEccccccccccccccccccccccccccHHHHHHHHcccccccccEEccccEEEEEEEcccccEEEEEEcccccccHHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEccccccHHHHccccccccccHHHHHHHHHHHHHHHHHHccccccccEEEccccccccccccccccccccccccccccccccEEEEEEccccccccHHHHHccccccccccccHHHHHHHHHcccccccccccccccHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHcccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccEEEEccccccccccccEEEEcccccccccccccccccccccccccEEEEEEccccEEEEEcccccEEEEEEEEEcccccccccccEEEEEcccEEEEccccccccccccEEEEEEEEccccccEEEEEEEccccccccEEEEEEEEEEEcccccccccccccccccccccccccccccccEEEEEEEEcccccccccccccccEEEccccccccccccccccccccEEEcccccccccccHHHHHHHHHccccccccccEEEEEEEEcccccEEEEEEEEEEEEccccccccEEEEEEEEccEEcccccHHHHccccccEEEEEEEEEEcccccccccEEEEEEccccccccccccccccccEEEEEcccccccccccccccccccccccccccccccccccHHHEHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccEEcHHHHHHHHccccHccEEEccccccEEEEEEcccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHEEEcccccccEEEEEHHHccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHcccccEEEEEcccccHEEEcccccHEEcccccccccccccccEEEEEEEcccccccHHHHHHHccccccHHHHHHHEHHHHHcccccccccccHHHHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHHHHHcccccccccc
Coil and Loop (DISEMBL)
dspspyytpteitFVACGwlgnisahgqtwagdvssqysplghqqstiskkpreppysasrlshsqftytfnvtpgqkfiRLHFystsysgfnissAFFSVKansftlvnnfsasfapddtfFKEFCinvpedqrslsitftpspdyqdsyaFINGIELVSMplnlyytatddqrlefvgegsqfsilnsNALETLYRINvggsfispqmdtgmyrtwiaddgyvtdarpsalpvnTTIVLRFSRilnfsaplaVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRLHFcefqsevtEEGDRVFKIYLANLTAEDVADVIAwsggngvpeyRDYAVAIgsksdvkkqnlsialhpaprwrtkysDSILNGIEifkvdnngslagpnpyptvsqassfgtrspqqstkaknnrprmLGIVGVVASGLVVLFIVFLLISRRAVMKEaksrgpasslpsdlctqFSISEIKEATKDFNNLLIigrggfgnvykgflngdstpvaikrlnpgsqqgaLEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARgtlrdhlynndnpplpwdrrLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAkvsdfglckfgpnfskthvstqvkgsigyldpeyYRLQLLTEKSDVYSFGVVLLEVLcarppilrtgdkkqVNLAVWATECyrngkigdiidpflkgnappvcLNQFVEVAMSCvnddrirrpsmsdVVWGLEFVFQLLRESSeksmiahp
Flexible Loop (DISEMBL)
dspspyytPTEITFVACGWLGNISAHGQTWAGDVSSQYSPLGHQQSTISKKPREPPYSASRLSHSQFTYTFNVTPGQKFIRLHFYSTSYSGFNISSAFFSVKANSFTLVNNFSASFAPDDTFFKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYYTATDDQRLEFVGEGSQFSILNSNALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDARPSALPVNTTIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRLHFCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGSKSDVKKQnlsialhpaprwrtKYSDSILNGIEIFKVDNNGSLAGPNPYPTVSQASSFGTRSPQqstkaknnrprMLGIVGVVASGLVVLFIVFLLISRRAVMKEAksrgpasslpsdlCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHtgaskviihRDVKTTNILLDEEWVAKVSDFGLCKFgpnfskthvstqvkgsigYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCarppilrtgdkkqvnlAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLlresseksmiahp
Low Complexity Region (SEG)
DSPSPYYTPTEITFVACGWLGNISAHGQTWAGDVSSQYSPLGHQQSTISKKPREPPYSASRLSHSQFTYTFNVTPGQKFIRLHFYSTSYSGFNISSAFFSVKANSFTLVNNFSASFAPDDTFFKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYYTATDDQRLEFVGEGSQFSILNSNALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDARPSALPVNTTIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRLHFCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGSKSDVKKQNLSIALHPAPRWRTKYSDSILNGIEIFKVDNNGSLAGPNPYPTVSQASSFGTRSPQQSTKAKNNRPRMLGIVGVVASGlvvlfivflliSRRAVMKEAKSRGPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEKSMIAHP
Disordered region (IsUnstruct)
*****YYTPTEITFVACGWLGNISAHGQTWAGD********************************QFTYTFNVTPGQKFIRLHFYSTSYSGFNISSAFFSVKANSFTLVNNFSASFAPDDTFFKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYYTATDDQRLEFVGEGSQFSILNSNALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDARPSALPVNTTIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRLHFCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGSKSDVKKQNLSIALHPAPRWRTKYSDSILNGIEIFKVDN************************************MLGIVGVVASGLVVLFIVFLLISRRAV****************LCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL************
Disordered Region (DISOPRED)
***SPYYTPTEITFVACGWLGNISAHGQTWAGDVS*********************YSASRLSHSQFTYTFNVTPGQKFIRLHFYSTSYSGFNISSAFFSVKANSFTLVNNFSASFAPDDTFFKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYYTATDDQRLEFVGEGSQFSILNSNALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDARPSALPVNTTIVLRFSRILNFSAPLAVYRTART*******NEQYNLTWEFQVDSGFIYFVRLHFCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGSKSDVKKQNLSIALHPAPRWRTKYSDSILNGIEIFKVD***********************************PRMLGIVGVVASGLVVLFIVFLLISR**********************QFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL*******A*EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF*****************
Disordered Region (DISEMBL)
DSPSPYYTPTEITFVACGWLGNISAHGQTWAGDVSS*************************LSHSQFTYTFNVTPGQKFIRLHFYSTSYSGFNISSAFFSVKANSFTLVNNFSASFAPDDTFFKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYYTATDDQRLEFVGEGSQFSILNSNALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDARPSALPVNTTIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRLHFCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGSKSDVKKQNLSIALHPAPRWRTKYSDSILNGIEIFKVDNNGSLAGPNPYPT********************NRPRMLGIVGVVASGLVVLFIVFLLISRRAVM**************DLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRES*********
Disordered Region (DISPRO)
*****YYTPTEITFVACGWLGN*S**GQTWA*********************REPPYSASRLSHSQFTYTFNVTPGQKFIRLHFYSTSYSGFNISSAFFSVKANSFTLVNNFSASFAPDDTFFKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYYTATDDQRLEFVGEGSQFSILNSNALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDARPSALPVNTTIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRLHFCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGSKSDVKKQNLSIALHPAPRWRTKYSDSILNGIEIFKVDNNGSLAGPNPYPT*******************NNRPRMLGIVGVVASGLVVLFIVFLLISRRAV**************SDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRES*********
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
DSPSPYYTPTEITFVACGWLGNISAHGQTWAGDVSSQYSPLGHQQSTISKKPREPPYSASRLSHSQFTYTFNVTPGQKFIRLHFYSTSYSGFNISSAFFSVKANSFTLVNNFSASFAPDDTFFKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYYTATDDQRLEFVGEGSQFSILNSNALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDARPSALPVNTTIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRLHFCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGSKSDVKKQNLSIALHPAPRWRTKYSDSILNGIEIFKVDNNGSLAGPNPYPTVSQASSFGTRSPQQSTKAKNNRPRMLGIVGVVASGLVVLFIVFLLISRRAVMKEAKSRGPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEKSMIAHP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	767	2.2.26 [Sep-21-2011]
Q9SCZ4	895	Receptor-like protein kin	yes	no	0.972	0.833	0.488	0.0
Q9FID8	873	Putative receptor-like pr	no	no	0.958	0.841	0.468	0.0
Q9FID9	880	Probable receptor-like pr	no	no	0.963	0.839	0.448	1e-175
Q3E8W4	858	Receptor-like protein kin	no	no	0.904	0.808	0.450	1e-174
Q9SR05	850	Receptor-like protein kin	no	no	0.885	0.798	0.441	1e-171
Q9SA72	849	Probable receptor-like pr	no	no	0.923	0.833	0.390	1e-143
Q9FN92	829	Probable receptor-like pr	no	no	0.925	0.856	0.391	1e-137
Q9SJT0	871	Probable receptor-like pr	no	no	0.925	0.815	0.390	1e-135
Q9LX66	830	Receptor-like protein kin	no	no	0.928	0.857	0.388	1e-134
Q9T020	878	Probable receptor-like pr	no	no	0.864	0.755	0.406	1e-134

>sp|Q9SCZ4|FERON_ARATH Receptor-like protein kinase FERONIA OS=Arabidopsis thaliana GN=FER PE=1 SV=1

 Score =  703 bits (1814), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 391/801 (48%), Positives = 499/801 (62%), Gaps = 55/801 (6%)

Query: 7   YTPTEITFVACGWLGN--ISAHGQTWAGDVSSQY----SPLGHQQSTISKKPREP--PYS 58
           Y+PTE   + CG   +       + W  DV S++    S        +++ P  P  PY 
Sbjct: 30  YSPTEKILLNCGGGASNLTDTDNRIWISDVKSKFLSSSSEDSKTSPALTQDPSVPEVPYM 89

Query: 59  ASRLSHSQFTYTFNVTPGQKFIRLHFYSTSYSGFNISSAFFSVKANSFTLVNNFSASFAP 118
            +R+  S FTYTF V  G+KF+RL+FY  SY G N +++ FSV    +TL+ NFSAS   
Sbjct: 90  TARVFRSPFTYTFPVASGRKFVRLYFYPNSYDGLNATNSLFSVSFGPYTLLKNFSASQTA 149

Query: 119 DDTFF----KEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYYTATDDQ 174
           +   +    KEF +NV  +  +L++TFTP     ++YAF+NGIE+ SMP ++Y  ++ D 
Sbjct: 150 EALTYAFIIKEFVVNV--EGGTLNMTFTPESAPSNAYAFVNGIEVTSMP-DMY--SSTDG 204

Query: 175 RLEFVGEGSQFSILNSNALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDAR---PS 231
            L  VG     +I NS ALE +YR+NVGG+ ISP  DTG+YR+W  D  Y+  A    P 
Sbjct: 205 TLTMVGSSGSVTIDNSTALENVYRLNVGGNDISPSADTGLYRSWYDDQPYIFGAGLGIPE 264

Query: 232 ALPVNTTIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRLH 291
               N TI    +    + AP+ VY TAR+MG    IN  YNLTW F +DSGF Y VRLH
Sbjct: 265 TADPNMTIKYP-TGTPTYVAPVDVYSTARSMGPTAQINLNYNLTWIFSIDSGFTYLVRLH 323

Query: 292 FCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGSKSDVKKQN 351
           FCE  S +T+   RVF IYL N TAE  ADVIAW+  NGVP ++DY V         +Q+
Sbjct: 324 FCEVSSNITKINQRVFTIYLNNQTAEPEADVIAWTSSNGVPFHKDYVV--NPPEGNGQQD 381

Query: 352 LSIALHPAPRWRTKYSDSILNGIEIFKVD-NNGSLAGPNPY--PTVSQASSFGTRSPQQS 408
           L +ALHP P  + +Y DS+LNG+EIFK++ ++G+LAG NP   P V+   S   R   + 
Sbjct: 382 LWLALHPNPVNKPEYYDSLLNGVEIFKMNTSDGNLAGTNPIPGPQVTADPSKVLRPTTRK 441

Query: 409 TKAKNNRPRMLGIVGVVASGLVVLFIVFLLISRR------------------AVMKEAKS 450
           +K+            VV + L++ F VF    RR                  ++   + S
Sbjct: 442 SKSNTAIIAGAASGAVVLA-LIIGFCVFGAYRRRKRGDYQPASDATSGWLPLSLYGNSHS 500

Query: 451 RGP---------ASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDST 501
            G          ASSLPS+LC  FS +EIK ATK+F+   ++G GGFG VY+G ++G +T
Sbjct: 501 AGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATKNFDESRVLGVGGFGKVYRGEIDGGTT 560

Query: 502 PVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRD 561
            VAIKR NP S+QG  EFQTEI MLS+LR+ HLVSLIGYC ++ +MILVYDYMA GT+R+
Sbjct: 561 KVAIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAHGTMRE 620

Query: 562 HLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDF 621
           HLY   NP LPW +RL+ICIGAAR LHYLHTGA   IIHRDVKTTNILLDE+WVAKVSDF
Sbjct: 621 HLYKTQNPSLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDF 680

Query: 622 GLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILR 681
           GL K GP    THVST VKGS GYLDPEY+R Q LTEKSDVYSFGVVL E LCARP +  
Sbjct: 681 GLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEALCARPALNP 740

Query: 682 TGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSM 741
           T  K+QV+LA WA  CY+ G +  I+DP+LKG   P C  +F E AM CV D  I RPSM
Sbjct: 741 TLAKEQVSLAEWAPYCYKKGMLDQIVDPYLKGKITPECFKKFAETAMKCVLDQGIERPSM 800

Query: 742 SDVVWGLEFVFQLLRESSEKS 762
            DV+W LEF  Q L+ES+E++
Sbjct: 801 GDVLWNLEFALQ-LQESAEEN 820

Receptor-like protein kinase that mediates the female control of male gamete delivery during fertilization, including growth cessation of compatible pollen tubes ensuring a reproductive isolation barriers. Required for cell elongation during vegetative growth, mostly in a brassinosteroids- (BR-) independent manner.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FID8|Y5900_ARATH Putative receptor-like protein kinase At5g39000 OS=Arabidopsis thaliana GN=At5g39000 PE=3 SV=1

 Score =  659 bits (1701), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 376/803 (46%), Positives = 498/803 (62%), Gaps = 68/803 (8%)

Query: 7   YTPTEITFVACG-WLGNISAHGQTWAGD---------VSSQYSP-LGHQQSTISKKPREP 55
           Y PT++    CG    N+   G+ W  +         V++ ++    +Q+S +S    + 
Sbjct: 26  YEPTDVFLFNCGDTSNNVDVSGRNWTAENQKILSSNLVNASFTAQASYQESGVS----QI 81

Query: 56  PYSASRLSHSQFTYTFNVTPGQKFIRLHFYSTSY-SGFNISSAFFSVKANSFTLVNNFSA 114
           PY  +R+  S+FTY+F VTPG  F+RL+FY T Y S FN   +FFSVK N FTL+NNFSA
Sbjct: 82  PYMTARIFRSEFTYSFPVTPGSNFLRLYFYPTRYGSQFNAVKSFFSVKVNGFTLLNNFSA 141

Query: 115 SFA-----PDDTFF-KEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYY 168
                   P   F  KEF I V    ++L++TFTPS    DS AF+NGIE+VS+P   Y 
Sbjct: 142 DLTVKASKPQTEFIIKEFIIPV---YQTLNLTFTPS---LDSLAFVNGIEIVSIPNRFYS 195

Query: 169 TATDDQRLEFVGEGSQFSILNSNALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDA 228
               D  +  VG    F I NS A ET+YR+NVGG  +    D+GM+R W++DD  +   
Sbjct: 196 KGGFDDVITNVGSSVDFHIENSTAFETVYRLNVGGKTVG---DSGMFRRWVSDDEIILSE 252

Query: 229 RPSALPVNTTIVLRFS-RILNFSAPLAVYRTARTMG----LDKNINEQYNLTWEFQVDSG 283
                P+   I + ++ +  ++ AP  VY T+R+MG     ++N+N  +NLTW F VD+G
Sbjct: 253 SSGISPIVPDIKINYTEKTPSYVAPDDVYATSRSMGNADHPEQNLN--FNLTWLFTVDAG 310

Query: 284 FIYFVRLHFCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGS 343
           F Y VRLHFCE  SEV +EG RVF I++ N TA    DV   SGG+ +P Y DY V  GS
Sbjct: 311 FSYLVRLHFCETLSEVNKEGQRVFSIFIENQTATLEMDVFRMSGGSWIPMYLDYTVIAGS 370

Query: 344 KSDVKKQNLSIALHPAPRWRTKYSDSILNGIEIFKV-DNNGSLAGPNPYPTVSQASSFGT 402
            S  ++ +L + LHP      KY D+ILNG+EI K+ D +G+LAGPNP P VS       
Sbjct: 371 GSG-RRHDLRLDLHPLVSINPKYYDAILNGVEILKMNDPDGNLAGPNPDPLVSP-----D 424

Query: 403 RSPQQST-KAKNNRPRMLGIVGVVASGLVVL--FIVFLLISRRAVM-------------- 445
             P ++T + + N+  +L I   V   LVVL  F+V +L+  +                 
Sbjct: 425 LIPNRATPRIRKNKSHILPITLAVVGSLVVLAMFVVGVLVIMKKKKKSKPSTNSSWCPLP 484

Query: 446 --KEAKSRGPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPV 503
              ++ +  PA SLP+DLC +FSI EIK AT DF + LIIG GGFG+VYKG ++G +T V
Sbjct: 485 HGTDSTNTKPAKSLPADLCRRFSIFEIKSATNDFEDKLIIGVGGFGSVYKGQIDGGATLV 544

Query: 504 AIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL 563
           A+KRL   S QGA EF+TE+ MLS+LR++HLVSLIGYC++D +M+LVY+YM  GTL+DHL
Sbjct: 545 AVKRLEITSNQGAKEFETELEMLSKLRHVHLVSLIGYCDEDNEMVLVYEYMPHGTLKDHL 604

Query: 564 YNND---NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSD 620
           +  D   +PPL W RRL+ICIGAAR L YLHTGA   IIHRD+KTTNILLDE +V KVSD
Sbjct: 605 FRRDKTSDPPLSWKRRLEICIGAARGLQYLHTGAKYTIIHRDIKTTNILLDENFVTKVSD 664

Query: 621 FGLCKFGP-NFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPI 679
           FGL + GP + S+THVST VKG+ GYLDPEYYR Q+LTEKSDVYSFGVVLLEVLC RP  
Sbjct: 665 FGLSRVGPTSASQTHVSTVVKGTFGYLDPEYYRRQVLTEKSDVYSFGVVLLEVLCCRPIR 724

Query: 680 LRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRP 739
           +++   +Q +L  W    YR G +  IID  L  +     L +F E+A+ CV D  + RP
Sbjct: 725 MQSVPPEQADLIRWVKSNYRRGTVDQIIDSDLSADITSTSLEKFCEIAVRCVQDRGMERP 784

Query: 740 SMSDVVWGLEFVFQLLRESSEKS 762
            M+DVVW LEF  QL   + +K+
Sbjct: 785 PMNDVVWALEFALQLHETAKKKN 807

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FID9|Y5389_ARATH Probable receptor-like protein kinase At5g38990 OS=Arabidopsis thaliana GN=At5g38990 PE=2 SV=1

 Score =  616 bits (1589), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 363/809 (44%), Positives = 480/809 (59%), Gaps = 70/809 (8%)

Query: 7   YTPTEITFVACG-WLGNISAHGQTW-----------AGDVSSQYSPLGHQQSTISKKPRE 54
           Y PT++  + CG    N+   G+ W           A D +S  S   +Q+S I     +
Sbjct: 23  YEPTDVFLINCGDTSNNMDYSGRNWTTENPKFMSSNAVDDASFTSSASYQESGIP----Q 78

Query: 55  PPYSASRLSHSQFTYTFNVTPGQKFIRLHFYSTSY-SGFNISSAFFSVKANSFTLVNNFS 113
            PY  +R+    FTY+F V+PG KF+RL+FY T Y S F+   +FFSV  N FTL++NFS
Sbjct: 79  VPYLKARIFRYDFTYSFPVSPGWKFLRLYFYPTRYGSDFDAVKSFFSVNVNRFTLLHNFS 138

Query: 114 --ASFAPDDTFFKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYYTAT 171
             AS     +  KEF + V    ++L +TFTPSP+   S AF+NGIE++SMP   Y    
Sbjct: 139 VKASIPESSSLIKEFIVPV---NQTLDLTFTPSPN---SLAFVNGIEIISMPDRFYSKGG 192

Query: 172 DDQRLEFVGEGSQFSILNSNALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDARPS 231
            D  +  VG    F I NS A ET+YR+NVGG  +    D+GM+R W++D+G++      
Sbjct: 193 FDDVVRNVGRDVDFEIDNSTAFETVYRVNVGGKVVGDVGDSGMFRRWLSDEGFLLGINSG 252

Query: 232 ALPVNTTIVLRFS-RILNFSAPLAVYRTARTMGLDKN--INEQYNLTWEFQVDSGFIYFV 288
           A+P  T + + ++ +   + AP  VY T R MG   +  +N  +NLTW F+VD+GF Y V
Sbjct: 253 AIPNITGVKINYTDKTPAYVAPEDVYTTCRLMGNKDSPELNLNFNLTWLFEVDAGFAYIV 312

Query: 289 RLHFCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGSKSDVK 348
           RLHFCE Q EV + GDRVF I+     A    DV   SGG  +P Y D+ V + +    +
Sbjct: 313 RLHFCETQPEVNKTGDRVFSIFFGYQLAMREMDVFRLSGGFRLPMYLDFKVLVDADGTSQ 372

Query: 349 KQNLSIALHPAPRWRTKYSDSILNGIEIFKVDN-NGSLAGPNPYPTVSQASSFGTRSPQQ 407
           + +L + L P       Y D+IL+G+EI K+ N +G+LAG NP P +S         PQ 
Sbjct: 373 RPSLRVDLTPYKEDYPTYYDAILSGVEILKLSNSDGNLAGLNPIPQLSPP-------PQS 425

Query: 408 ST--KAKNNRPRMLGIVGVVASGLVVLFIVFLLISRRAVMKEAKSR-------------- 451
            T  K K     +L I+  V    V L    L++    + ++ KS               
Sbjct: 426 ITPLKGKGKSSHVLPIIIAVVGSAVALAFFVLVVVLVVMKRKKKSNESSVDTTNKPSTNS 485

Query: 452 --GP------------ASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLN 497
             GP            ASSLPSDLC +FSI EIK AT DF   LIIG GGFG+VYKG ++
Sbjct: 486 SWGPLLHGTGSTNTKSASSLPSDLCRRFSIYEIKSATNDFEEKLIIGVGGFGSVYKGRID 545

Query: 498 GDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARG 557
           G +T VA+KRL   S QGA EF TE+ MLS+LR++HLVSLIGYC+DD +M+LVY+YM  G
Sbjct: 546 GGATLVAVKRLEITSNQGAKEFDTELEMLSKLRHVHLVSLIGYCDDDNEMVLVYEYMPHG 605

Query: 558 TLRDHLYNND---NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW 614
           TL+DHL+  D   +PPL W RRL+ICIGAAR L YLHTGA   IIHRD+KTTNILLDE +
Sbjct: 606 TLKDHLFRRDKASDPPLSWKRRLEICIGAARGLQYLHTGAKYTIIHRDIKTTNILLDENF 665

Query: 615 VAKVSDFGLCKFGP-NFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
           VAKVSDFGL + GP + S+THVST VKG+ GYLDPEYYR Q+LTEKSDVYSFGVVLLEVL
Sbjct: 666 VAKVSDFGLSRVGPTSASQTHVSTVVKGTFGYLDPEYYRRQILTEKSDVYSFGVVLLEVL 725

Query: 674 CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVND 733
           C RP  +++   +Q +L  W    +    +  IID  L  +     + +F E+A+ CV D
Sbjct: 726 CCRPIRMQSVPPEQADLIRWVKSNFNKRTVDQIIDSDLTADITSTSMEKFCEIAIRCVQD 785

Query: 734 DRIRRPSMSDVVWGLEFVFQLLRESSEKS 762
             + RP M+DVVW LEF  QL   + +K+
Sbjct: 786 RGMERPPMNDVVWALEFALQLHETAKKKN 814

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q3E8W4|ANX2_ARATH Receptor-like protein kinase ANXUR2 OS=Arabidopsis thaliana GN=ANX2 PE=2 SV=1

 Score =  611 bits (1575), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 338/751 (45%), Positives = 462/751 (61%), Gaps = 57/751 (7%)

Query: 56  PYSASRLSHSQFTYTFNVTPGQK-FIRLHFYSTSYSGFNISSAFFSVKANSFTLVNNFSA 114
           PY  SR+  +  TY   V   ++  +RLHFY ++Y+G NI  ++FSV AN  TL++NFSA
Sbjct: 77  PYMTSRIFTAPATYEIPVKGDKRHMLRLHFYPSTYTGLNILDSYFSVAANDLTLLSNFSA 136

Query: 115 SFA----PDDTFFKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYYTA 170
           +            +E+ +  P ++  LSI FTPS  +  ++AFINGIE++ MP  L+ TA
Sbjct: 137 AITCQALTQAYLVREYSL-APSEKDVLSIIFTPSDKHPKAFAFINGIEVIPMP-ELFDTA 194

Query: 171 TDDQRLEFVGEGSQFSILNSNALETLYRINVGGSFISPQMDTG-MYRTWIADDGYVTDAR 229
           +       VG   Q S   +  L+T++R+NVGG  I    D+G + RTW  D  Y+  A 
Sbjct: 195 S------LVGFSDQTSDTKTANLQTMFRLNVGGQDIPGSQDSGGLTRTWYNDAPYIFSAG 248

Query: 230 PS-ALPVNTTIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFV 288
               L  +    + + ++   +AP  VY+TAR+ G + +IN + NLTW FQVD+ F Y +
Sbjct: 249 LGVTLQASNNFRIDYQKMPVSTAPADVYKTARSQGPNGDINMKSNLTWMFQVDTNFTYIM 308

Query: 289 RLHFCEFQSEVTEEGDRVFKIYLANLTAE---DVADVIAWSGGNGVPEYRDYAVAIGSKS 345
           RLHFCEFQ  + +   +VF I++ N TA+   + AD++ W+GG G+P Y+DYA+ + + +
Sbjct: 309 RLHFCEFQ--LAKINQKVFNIFINNRTAQGDTNPADILGWTGGKGIPTYKDYAIYVDANT 366

Query: 346 DVKKQNLSIALHPAPRWRTKYSDSILNGIEIFKVDNNGSLAGPNPYPTVSQASSFGTRSP 405
               + +S+ + P+   + +Y DS LNG+EIFK+D   +LAGPNP P+  QA+    +  
Sbjct: 367 GGGGEEISLQMTPSTFGQPEYYDSQLNGLEIFKIDTMKNLAGPNPKPSPMQANEDVKKDF 426

Query: 406 QQSTKAKNNRPRMLGIVGVVASGLVVLF--IVFLLISRRAVMKEAKSRGPA--------- 454
           Q     K     ++G  G VA+   VLF  + F +  R+     + S   +         
Sbjct: 427 QGD---KRITAFVIGSAGGVAA---VLFCALCFTMYQRKRKFSGSDSHTSSWLPIYGNSH 480

Query: 455 ------------------SSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFL 496
                             S+L + LC +FS+SEIK  T +F+   +IG GGFG VYKG +
Sbjct: 481 TSATKSTISGKSNNGSHLSNLAAGLCRRFSLSEIKHGTHNFDESNVIGVGGFGKVYKGVI 540

Query: 497 NGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMAR 556
           +G  T VAIK+ NP S+QG  EF+TEI +LS+LR+ HLVSLIGYC++ G+M L+YDYM+ 
Sbjct: 541 DG-GTKVAIKKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDEGGEMCLIYDYMSL 599

Query: 557 GTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVA 616
           GTLR+HLYN   P L W RRL+I IGAAR LHYLHTGA   IIHRDVKTTNILLDE WVA
Sbjct: 600 GTLREHLYNTKRPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVA 659

Query: 617 KVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           KVSDFGL K GPN +  HV+T VKGS GYLDPEY+R Q LTEKSDVYSFGVVL EVLCAR
Sbjct: 660 KVSDFGLSKTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 719

Query: 677 PPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRI 736
           P +  +  K+QV+L  WA  C R G + DIIDP LKG   P CL +F + A  C++D  +
Sbjct: 720 PALNPSLSKEQVSLGDWAMNCKRKGTLEDIIDPNLKGKINPECLKKFADTAEKCLSDSGL 779

Query: 737 RRPSMSDVVWGLEFVFQLLRESSEKSMIAHP 767
            RP+M DV+W LEF  Q L+E+++ S    P
Sbjct: 780 DRPTMGDVLWNLEFALQ-LQETADGSRHRTP 809

Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SR05|ANX1_ARATH Receptor-like protein kinase ANXUR1 OS=Arabidopsis thaliana GN=ANX1 PE=2 SV=1

 Score =  603 bits (1555), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 326/738 (44%), Positives = 450/738 (60%), Gaps = 59/738 (7%)

Query: 56  PYSASRLSHSQFTYTFNVTPGQK-FIRLHFYSTSYSGFNISSAFFSVKANSFTLVNNFSA 114
           PY  +R+  +  TY   +   ++  +RL+FY ++Y+G NIS+++F+V+AN  TL++NFSA
Sbjct: 76  PYMTARIFTAPATYEIPIKGDKRHLLRLYFYPSTYTGLNISNSYFTVEANDVTLLSNFSA 135

Query: 115 SFA----PDDTFFKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYYTA 170
           +            KE+ +  P D+  LSI FTPS  Y+D++AFINGIE++ MP  L+ TA
Sbjct: 136 AITCQALTQAYLVKEYSL-APTDKDVLSIKFTPSDKYRDAFAFINGIEVIQMP-ELFDTA 193

Query: 171 TDDQRLEFVGEGSQFSILNSNALETLYRINVGGSFISPQMDTG-MYRTWIADDGYVTDAR 229
                   VG   Q     +  L++++R+NVGG  I    D+G + RTW  D  Y+  A 
Sbjct: 194 A------LVGFTDQTMDAKTANLQSMFRLNVGGQDIPGSQDSGGLTRTWYNDAPYIFSAG 247

Query: 230 PS-ALPVNTTIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFV 288
               L  +    + +  +    AP  +Y+TAR+ G + +IN + NLTW FQ+D  F Y +
Sbjct: 248 LGVTLQASNNFRINYQNMPVSIAPADIYKTARSQGPNGDINLKSNLTWMFQIDKNFTYIL 307

Query: 289 RLHFCEFQSEVTEEGDRVFKIYLANLTAE---DVADVIAWSGGNGVPEYRDYAVAIGSKS 345
           RLHFCEFQ  +++   +VF IY+ N TA+     AD+I W+G  G+P Y+DYA+ + + +
Sbjct: 308 RLHFCEFQ--LSKINQKVFNIYINNRTAQADTTPADIIGWTGEKGIPMYKDYAIYVDANN 365

Query: 346 DVKKQNLSIALHPAPRWRTKYSDSILNGIEIFKVDNNGSLAGPNPYPTVSQASSFGTRSP 405
               + +++ + P+   + +Y DS LNG+EIFK+D   +LAGPNP P+  QA        
Sbjct: 366 G--GEEITLQMTPSTFGQPEYYDSSLNGLEIFKMDTMKNLAGPNPEPSPMQAE------- 416

Query: 406 QQSTKAKNNRPRMLGIVGVVASGLVVLFIVFLLI-------------------------- 439
           ++  K   N  R   I+G     L VL                                 
Sbjct: 417 EEVKKEFKNEKRHAFIIGSAGGVLAVLIGALCFTAYKKKQGYQGGDSHTSSWLPIYGNST 476

Query: 440 ---SRRAVMKEAKSRGPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFL 496
              ++  +  ++ +    S+L + LC +FS+ EIK  T++F++  +IG GGFG VYKG +
Sbjct: 477 TSGTKSTISGKSNNGSHLSNLAAGLCRRFSLPEIKHGTQNFDDSNVIGVGGFGKVYKGVI 536

Query: 497 NGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMAR 556
           +G +T VA+K+ NP S+QG  EF+TEI +LS+LR+ HLVSLIGYC++ G+M LVYDYMA 
Sbjct: 537 DG-TTKVAVKKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDEGGEMCLVYDYMAF 595

Query: 557 GTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVA 616
           GTLR+HLYN   P L W RRL+I IGAAR LHYLHTGA   IIHRDVKTTNIL+DE WVA
Sbjct: 596 GTLREHLYNTKKPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNILVDENWVA 655

Query: 617 KVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           KVSDFGL K GPN +  HV+T VKGS GYLDPEY+R Q LTEKSDVYSFGVVL E+LCAR
Sbjct: 656 KVSDFGLSKTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCAR 715

Query: 677 PPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRI 736
           P +  +  K+QV+L  WA  C R G + DIIDP LKG     CL +F + A  C+ND  +
Sbjct: 716 PALNPSLPKEQVSLGDWAMNCKRKGNLEDIIDPNLKGKINAECLKKFADTAEKCLNDSGL 775

Query: 737 RRPSMSDVVWGLEFVFQL 754
            RP+M DV+W LEF  QL
Sbjct: 776 ERPTMGDVLWNLEFALQL 793

Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1

 Score =  508 bits (1309), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 311/796 (39%), Positives = 437/796 (54%), Gaps = 88/796 (11%)

Query: 14  FVACGWLGNISAHGQTWAGDVSSQYSPLGHQQSTISKKPREPP------YSASRLSHSQF 67
            V CG        G+TW GD+S   S        I+    +        Y  +R+  +  
Sbjct: 34  LVDCGSNATTEVDGRTWVGDLSPNKSVTLQGFDAITASTSKGSSVYAEIYKTARVFDAVL 93

Query: 68  TYTFN-VTPGQKFIRLHFYSTSYSGFNISSAFFSVKANSFTLVNNF-------------- 112
            YTF  +T G  F+RLHF   +    N++ + FSV A+   L+ +               
Sbjct: 94  NYTFEGITQGNYFVRLHFSPFAIENHNVNESSFSVFADGLRLMLDINIAGEIAHKNLILE 153

Query: 113 -SASFAPDDTFFKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYYTAT 171
            +   A   +  KEF +  P     L ++F P    + S+ F+N IE+VS+   L+    
Sbjct: 154 STGHNATASSLVKEFLL--PTGPGKLVLSFIPE---KGSFGFVNAIEIVSVDDKLF---- 204

Query: 172 DDQRLEFVGEGSQFSI-LNSNALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDARP 230
             + +  VG GS+  + L    +ET+YR+NVGG  + P  D  +YRTW  D  Y+     
Sbjct: 205 -KESVTKVG-GSEVELGLGGRGIETMYRLNVGGPKLGPSKDLKLYRTWETDLSYMVIENA 262

Query: 231 SALPVNTTIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRL 290
                N++ +       +  APL VY TAR M   + + +++N++W+F+VD  F Y VRL
Sbjct: 263 GVEVKNSSNITYALADDSPVAPLLVYETARMMSNTEVLEKRFNISWKFEVDPNFDYLVRL 322

Query: 291 HFCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGSKSDVKKQ 350
           HFCE    V ++  R+F+IY+ N TA    D+ A +GG     Y+DY   + SK+DV   
Sbjct: 323 HFCELL--VDKQNQRIFRIYINNQTAAGNFDIFAHAGGKNKGIYQDYLDPVSSKNDV--- 377

Query: 351 NLSIALHPAPRWRTKYSDSILNGIEIFKVDNNGSLAGPNPYPTVSQASSFGTRSPQQSTK 410
            L I L P         D++L+G+EIFK+  NG+LA    + +   + S           
Sbjct: 378 -LWIQLGPDSSVGAS-GDALLSGLEIFKLSKNGNLAHLIRFDSTGHSVS----------- 424

Query: 411 AKNNRPRMLGIVGVVASGLVVLFIVFLLI-------SRRAVMKEAKSRGPA--------- 454
             +++ R++ I  V A   +++F VFL I        RR+   E+K+  P          
Sbjct: 425 --DSKMRIIWI-SVGAGIAIIIFFVFLGILVVCLCKKRRSKSDESKNNPPGWRPLFLHVN 481

Query: 455 ----------------SSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNG 498
                           +   S +  +F+++EI+ ATK+F++ L IG GGFG VY+G L  
Sbjct: 482 NSTANAKATGGSLRLNTLAASTMGRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELE- 540

Query: 499 DSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGT 558
           D T +AIKR  P SQQG  EF+TEI MLS+LR+ HLVSLIG+C++  +MILVY+YMA GT
Sbjct: 541 DGTLIAIKRATPHSQQGLAEFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGT 600

Query: 559 LRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKV 618
           LR HL+ ++ PPL W +RL+ CIG+AR LHYLHTG+ + IIHRDVKTTNILLDE +VAK+
Sbjct: 601 LRSHLFGSNLPPLSWKQRLEACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKM 660

Query: 619 SDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           SDFGL K GP+   THVST VKGS GYLDPEY+R Q LTEKSDVYSFGVVL E +CAR  
Sbjct: 661 SDFGLSKAGPSMDHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAV 720

Query: 679 ILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRR 738
           I  T  K Q+NLA WA    +   +  IID  L+GN  P  L ++ E+A  C+ D+   R
Sbjct: 721 INPTLPKDQINLAEWALSWQKQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNR 780

Query: 739 PSMSDVVWGLEFVFQL 754
           P M +V+W LE+V Q+
Sbjct: 781 PMMGEVLWSLEYVLQI 796

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FN92|Y5597_ARATH Probable receptor-like protein kinase At5g59700 OS=Arabidopsis thaliana GN=At5g59700 PE=1 SV=1

 Score =  488 bits (1257), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 302/772 (39%), Positives = 425/772 (55%), Gaps = 62/772 (8%)

Query: 7   YTPTEITFVACGWLGNISAHGQTWAGD--VSSQYSPLGHQQSTISKKPREPPYSASRLSH 64
           Y P +   + CG   N++   + +  D   S+  +      +  ++      Y  +R+  
Sbjct: 25  YVPVDNYLINCGSSTNVTVTSRVFISDNLASNFLTSPNEILAASNRNSNSDIYQTARIFT 84

Query: 65  SQFTYTFNVTPGQKFIRLHFYSTSYSGFNISSAFFSVKANSFTLVNNFSASFAPDDTFFK 124
               Y F+V  G+ +IRLHF    Y  F + SA FSV + +  L+++F+ S        K
Sbjct: 85  GISKYRFSVARGRHWIRLHFNPFQYQNFQMVSAKFSVSSETHVLLSDFTVS----SRVMK 140

Query: 125 EFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYYTATDDQRLEFVGEGSQ 184
           E+ +NV  D   L +TFTPS    DS+AF+N +E+VS+P  L+   + D    F G   +
Sbjct: 141 EYSLNVATDH--LELTFTPS---GDSFAFLNALEVVSVPDTLF---SGDP--SFAGSPGK 190

Query: 185 FSILNSNALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDARPSALPVNTTIVLRFS 244
           F  L+  ALET+YR+N+GG  ++P  DT + R W  D  ++ +     L  + + +    
Sbjct: 191 FQGLSWQALETVYRVNMGGPRVTPSNDT-LSRIWEPDSEFLVEKN---LVKSVSKIASVD 246

Query: 245 RILNF----SAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRLHFCEFQSEVT 300
            +  F    +AP  VY T   M    N +  +N+TW+F VD GF YF+R HFC+  S+  
Sbjct: 247 YVPGFATEETAPRTVYGTCTEMNSADNPSSNFNVTWDFDVDPGFQYFLRFHFCDIVSKAL 306

Query: 301 EEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEY-RDYAVAIGSKSDVKKQNLSIALHPA 359
            +    F +Y+ ++   +  D+ ++        Y  D+    GS    K+  +SI     
Sbjct: 307 NQ--LYFNLYVDSMDVVENLDLSSYLSNTLSGAYAMDFVT--GSAKLTKRIRVSIGRSSV 362

Query: 360 PRWRTKYSDSILNGIEIFKVDNNGSLAGPNPYPTVSQASSFGTRSPQ-QSTKAKNNRPRM 418
               T Y  +ILNG+EI K++N+ S              S GT  P   S+  K N   +
Sbjct: 363 ---HTDYPTAILNGLEIMKMNNSKS------------QLSIGTFLPSGSSSTTKKNVGMI 407

Query: 419 LGIVGVVASGLVVLFIVFLLISRRAVMKEAKSR----------------GPASSLPSDLC 462
           +G+       LVVL   F+L  +R   ++  S+                   +S+ S+  
Sbjct: 408 IGLTIGSLLALVVLGGFFVLYKKRGRDQDGNSKTWIPLSSNGTTSSSNGTTLASIASNSS 467

Query: 463 TQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTE 522
            +  +  +KEAT  F+    IG GGFG VYKG L+ D T VA+KR NP SQQG  EF+TE
Sbjct: 468 YRIPLVAVKEATNSFDENRAIGVGGFGKVYKGELH-DGTKVAVKRANPKSQQGLAEFRTE 526

Query: 523 IGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
           I MLSQ R+ HLVSLIGYC+++ +MILVY+YM  GTL+ HLY +    L W +RL+ICIG
Sbjct: 527 IEMLSQFRHRHLVSLIGYCDENNEMILVYEYMENGTLKSHLYGSGLLSLSWKQRLEICIG 586

Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS 642
           +AR LHYLHTG +K +IHRDVK+ NILLDE  +AKV+DFGL K GP   +THVST VKGS
Sbjct: 587 SARGLHYLHTGDAKPVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGS 646

Query: 643 IGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK 702
            GYLDPEY+R Q LTEKSDVYSFGVV+ EVLCARP I  T  ++ VNLA WA +  + G+
Sbjct: 647 FGYLDPEYFRRQQLTEKSDVYSFGVVMFEVLCARPVIDPTLTREMVNLAEWAMKWQKKGQ 706

Query: 703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
           +  IIDP L+G   P  L +F E    C+ D  + RPSM DV+W LE+  QL
Sbjct: 707 LEHIIDPSLRGKIRPDSLRKFGETGEKCLADYGVDRPSMGDVLWNLEYALQL 758

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SJT0|Y2214_ARATH Probable receptor-like protein kinase At2g21480 OS=Arabidopsis thaliana GN=At2g21480 PE=3 SV=1

 Score =  483 bits (1243), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 312/798 (39%), Positives = 433/798 (54%), Gaps = 88/798 (11%)

Query: 2   SPSPYYTPTEITFVACGWLGNI-SAHGQTWAGDVSSQYSPLGHQQSTISKKPRE----PP 56
           SP+  + P +   + CG   +  +  G+ +  D  +           +S  P +    P 
Sbjct: 46  SPTAGFKPADDILIDCGSKSSTKTPEGRVFKSDSETVQYIEAKDDIQVSAPPSDKLPSPI 105

Query: 57  YSASRLSHSQFTYTFNVT-PGQKFIRLHFYSTSYSGFNISSAFFSVKANSFTLVNNFSAS 115
           Y  +++   +  Y F++T PG  ++RLHF++     F++  A FSV    + L++NF  S
Sbjct: 106 YLTAKIFREEAIYKFHLTRPGWHWVRLHFFAFPNDKFDLQQATFSVLTEKYVLLHNFKLS 165

Query: 116 FAPDD---TFFKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYYTATD 172
              +D   T  KE+ +N+ + Q   ++ F P    + S AFINGIELVS P  L    +D
Sbjct: 166 NDNNDSQATVQKEYLLNMTDAQ--FALRFKP---MKGSAAFINGIELVSAPDELI---SD 217

Query: 173 DQRLEFVGEGSQFSILNSNALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDARPSA 232
                F   G  FS L+  A +++YR+NVGG  I+PQ DT + RTW  D  Y+ D   + 
Sbjct: 218 AGTSLFPVNG--FSGLSDYAYQSVYRVNVGGPLITPQNDT-LGRTWTPDKEYLKDENLAK 274

Query: 233 -LPVNTTIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRLH 291
            +  N T ++    +    AP  VY T   M   + I+  +N+TW F  +  F YF+RLH
Sbjct: 275 DVKTNPTAIIYPPGVTPLIAPQTVYATGAEMADSQTIDPNFNVTWNFPSNPSFHYFIRLH 334

Query: 292 FCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGSKSDVKKQN 351
           FC+  S+     D  F +Y+   TA    D+   +G    P Y+D  V     S +    
Sbjct: 335 FCDIISKSLN--DLYFNVYINGKTAISGLDLSTVAGDLSAPYYKDIVV----NSTLMTSE 388

Query: 352 LSIALHPAPRWRTKYSDSILNGIEIFKVDNN-GSLAGPNPYPTVSQASSFGTRSPQQSTK 410
           L + + P     T   ++ILNG+E+ K+ N+  SL G            FG    + S  
Sbjct: 389 LQVQIGPMGE-DTGKKNAILNGVEVLKMSNSVNSLDG-----------EFGVDGQRAS-- 434

Query: 411 AKNNRPRMLGIVGVVAS-GLVVLFIVFLLISRRAVMKEAKSR------------------ 451
                   +G  G+VA+ G V++F  F+ +   A++ + K R                  
Sbjct: 435 --------MGKQGMVATAGFVMMFGAFVGLG--AMVYKWKKRPQDWQKRNSFSSWLLPIH 484

Query: 452 -GPASSLPSD--------------LCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFL 496
            G ++ + S               L   FS+SE++E TK+F+   IIG GGFGNVY G +
Sbjct: 485 AGDSTFMTSKTGSHKSNLYNSALGLGRYFSLSELQEVTKNFDASEIIGVGGFGNVYIGTI 544

Query: 497 NGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMAR 556
           + D T VAIKR NP S+QG  EF TEI MLS+LR+ HLVSLIGYC+++ +MILVY+YM+ 
Sbjct: 545 D-DGTQVAIKRGNPQSEQGITEFHTEIQMLSKLRHRHLVSLIGYCDENAEMILVYEYMSN 603

Query: 557 GTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVA 616
           G  RDHLY  +  PL W +RL+ICIGAAR LHYLHTG ++ IIHRDVK+TNILLDE  VA
Sbjct: 604 GPFRDHLYGKNLSPLTWKQRLEICIGAARGLHYLHTGTAQGIIHRDVKSTNILLDEALVA 663

Query: 617 KVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           KV+DFGL K    F + HVST VKGS GYLDPEY+R Q LT+KSDVYSFGVVLLE LCAR
Sbjct: 664 KVADFGLSK-DVAFGQNHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCAR 722

Query: 677 PPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRI 736
           P I     ++QVNLA WA    + G +  IIDP L G   P  + +F E A  C+ D  +
Sbjct: 723 PAINPQLPREQVNLAEWAMLWKQKGLLEKIIDPHLVGAVNPESMKKFAEAAEKCLADYGV 782

Query: 737 RRPSMSDVVWGLEFVFQL 754
            RP+M DV+W LE+  QL
Sbjct: 783 DRPTMGDVLWNLEYALQL 800

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1

 Score =  480 bits (1236), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 300/773 (38%), Positives = 434/773 (56%), Gaps = 61/773 (7%)

Query: 7   YTPTEITFVACGWLGNISAHGQTWAGDVSSQYSPLGHQQ--STISKKPREPPYSASRLSH 64
           +TP +   + CG   N +  G+ +  D  S       ++  +++        Y  +R+  
Sbjct: 25  FTPVDNYLINCGSPTNGTLMGRIFLSDKLSSKLLTSSKEILASVGGNSGSDIYHTARVFT 84

Query: 65  SQFTYTFNVTPGQKFIRLHFYSTSYSGFNISSAFFSVKANSFTLVNNFSASFAPDDTFFK 124
              +Y F+VT G+ ++RL+F    Y  F + SA F+V + S  L+++F+ +        K
Sbjct: 85  EVSSYKFSVTRGRHWVRLYFNPFDYQNFKMGSAKFAVSSQSHVLLSDFTVT---SSKVVK 141

Query: 125 EFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYYTATDDQRLEFVGEGSQ 184
           E+ +NV  +   L +TFTPS     S+AF+N IE++S+P  L    T   R  FVG  +Q
Sbjct: 142 EYSLNVTTND--LVLTFTPS---SGSFAFVNAIEVISIPDTL---ITGSPR--FVGNPAQ 191

Query: 185 FSILNSNALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDAR-PSALPVNTTIVLRF 243
           F  ++   LET++R+N+GG  ++   DT + RTW+ D  ++ +     ++   +T+    
Sbjct: 192 FPDMSMQGLETIHRVNMGGPLVASNNDT-LTRTWVPDSEFLLEKNLAKSMSKFSTVNFVP 250

Query: 244 SRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRLHFCEFQSEVTEEG 303
                 SAP  VY +   M    N N  +N+TWEF VD GF Y+ R HFC+  S    + 
Sbjct: 251 GYATEDSAPRTVYGSCTEMNSADNPNSIFNVTWEFDVDPGFQYYFRFHFCDIVSLSLNQ- 309

Query: 304 DRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGSKSDVKKQNLSIALHPAPRWR 363
              F +Y+ ++ A    D+           Y    V    K   K   + +++ P+    
Sbjct: 310 -LYFNLYVDSMVAATDIDLSTLVDNTLAGAYSMDFVTQTPKGSNK---VRVSIGPS-TVH 364

Query: 364 TKYSDSILNGIEIFKVDNN-GSLAGPNPYPTVSQASSFGTRSPQQSTKAKNNRPRMLGIV 422
           T Y ++I+NG+EI K++N+ G L             S GT  P  S+ +K+N   ++G  
Sbjct: 365 TDYPNAIVNGLEIMKMNNSKGQL-------------STGTFVPGSSSSSKSNLGLIVG-- 409

Query: 423 GVVASGLVVLFI--VFLLISRRAVMKEAKSRG--PASSLPSDLCTQFS------------ 466
             + S L V+F+   F+L  +R   ++  S+   P S   + + +++S            
Sbjct: 410 SAIGSLLAVVFLGSCFVLYKKRKRGQDGHSKTWMPFSINGTSMGSKYSNGTTLTSITTNA 469

Query: 467 -----ISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT 521
                 + +K+AT +F+    IG GGFG VYKG LN D T VA+KR NP SQQG  EF+T
Sbjct: 470 NYRIPFAAVKDATNNFDESRNIGVGGFGKVYKGELN-DGTKVAVKRGNPKSQQGLAEFRT 528

Query: 522 EIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICI 581
           EI MLSQ R+ HLVSLIGYC+++ +MIL+Y+YM  GT++ HLY +  P L W +RL+ICI
Sbjct: 529 EIEMLSQFRHRHLVSLIGYCDENNEMILIYEYMENGTVKSHLYGSGLPSLTWKQRLEICI 588

Query: 582 GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG 641
           GAAR LHYLHTG SK +IHRDVK+ NILLDE ++AKV+DFGL K GP   +THVST VKG
Sbjct: 589 GAARGLHYLHTGDSKPVIHRDVKSANILLDENFMAKVADFGLSKTGPELDQTHVSTAVKG 648

Query: 642 SIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG 701
           S GYLDPEY+R Q LT+KSDVYSFGVVL EVLCARP I  T  ++ VNLA WA +  + G
Sbjct: 649 SFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQKKG 708

Query: 702 KIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
           ++  IID  L+GN  P  L +F E    C+ D  + RPSM DV+W LE+  QL
Sbjct: 709 QLDQIIDQSLRGNIRPDSLRKFAETGEKCLADYGVDRPSMGDVLWNLEYALQL 761

Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9T020|Y4391_ARATH Probable receptor-like protein kinase At4g39110 OS=Arabidopsis thaliana GN=At4g39110 PE=1 SV=1

 Score =  478 bits (1230), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 303/746 (40%), Positives = 414/746 (55%), Gaps = 83/746 (11%)

Query: 49  SKKPREPPYSASRLSHSQFTYTFNVT-PGQKFIRLHFYSTSYSGFNISSAFFSVKANSFT 107
           S K   P Y  +R+   + TY F++T PG  ++RLHF +     F++  A FSV    + 
Sbjct: 99  SDKVASPIYLTARIFREEATYKFHLTRPGWHWVRLHFLAFPNDKFDLQQATFSVLTEKYV 158

Query: 108 LVNNFSASFAPDDT---FFKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPL 164
           L++NF  S   +D+     KE+ +N+ + Q   ++ F P    + S AFIN IE+VS P 
Sbjct: 159 LLHNFKISNNNNDSQAAVQKEYLVNMTDAQ--FALRFRP---MKSSAAFINAIEVVSAPD 213

Query: 165 NLYYTATDDQRLEFVGEGSQFSILNSNALETLYRINVGGSFISPQMDTGMYRTWIADDGY 224
            L    +D     F   G  FS L+  A +++YR+NVGG  I PQ DT + RTWI D  +
Sbjct: 214 ELI---SDSGTALFPVIG--FSGLSDYAYQSVYRVNVGGPLIMPQNDT-LGRTWIPDKEF 267

Query: 225 VTDARPSALPVNTTIVLRFS-RILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSG 283
           + D   +     T   +++   +    AP  VY TA  M     I+  +N++W F  +  
Sbjct: 268 LKDENLAKDVKTTPSAIKYPPEVTPLIAPQTVYATAVEMANSLTIDPNFNVSWNFPSNPS 327

Query: 284 FIYFVRLHFCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGS 343
           F Y +RLHFC+  S+     D  F +Y+   TA    D+   +G    P Y+D  V    
Sbjct: 328 FNYLIRLHFCDIVSKSLN--DLYFNVYINGKTAISGLDLSTVAGNLAAPYYKDIVV---- 381

Query: 344 KSDVKKQNLSIALHPAPRWRTKYSDSILNGIEIFKVDNN-GSLAGPNPYPTVSQASSFGT 402
            + +    L + + P     T   ++ILNG+E+ K+ N+  SL G            FG 
Sbjct: 382 NATLMGPELQVQIGPMGE-DTGTKNAILNGVEVLKMSNSVNSLDG-----------EFGV 429

Query: 403 RSPQQSTKAKNNRPRMLGIVGVVAS-GLVVLFIVFLLISRRAVMKEAKSR---------- 451
                     + R   +G  G+VA+ G V++F  F  I   A++ + K R          
Sbjct: 430 ----------DGRTTGMGKHGMVATAGFVMMFGAF--IGLGAMVYKWKKRPQDWQKRNSF 477

Query: 452 ---------GPASSLPSDLCTQ--------------FSISEIKEATKDFNNLLIIGRGGF 488
                    G ++ + S   +Q              FS+SE++EATK+F    IIG GGF
Sbjct: 478 SSWLLPIHAGDSTFMTSKGGSQKSNFYNSTLGLGRYFSLSELQEATKNFEASQIIGVGGF 537

Query: 489 GNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMI 548
           GNVY G L+ D T VA+KR NP S+QG  EFQTEI MLS+LR+ HLVSLIGYC+++ +MI
Sbjct: 538 GNVYIGTLD-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMI 596

Query: 549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNI 608
           LVY++M+ G  RDHLY  +  PL W +RL+ICIG+AR LHYLHTG ++ IIHRDVK+TNI
Sbjct: 597 LVYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGSARGLHYLHTGTAQGIIHRDVKSTNI 656

Query: 609 LLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVV 668
           LLDE  VAKV+DFGL K    F + HVST VKGS GYLDPEY+R Q LT+KSDVYSFGVV
Sbjct: 657 LLDEALVAKVADFGLSK-DVAFGQNHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVV 715

Query: 669 LLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAM 728
           LLE LCARP I     ++QVNLA WA +  R G +  IIDP L G   P  + +F E A 
Sbjct: 716 LLEALCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLAGTINPESMKKFAEAAE 775

Query: 729 SCVNDDRIRRPSMSDVVWGLEFVFQL 754
            C+ D  + RP+M DV+W LE+  QL
Sbjct: 776 KCLEDYGVDRPTMGDVLWNLEYALQL 801

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	767
296082193	932	unnamed protein product [Vitis vinifera]	0.984	0.810	0.569	0.0
359488516	1393	PREDICTED: receptor-like protein kinase	0.975	0.536	0.577	0.0
359488520	894	PREDICTED: receptor-like protein kinase	0.979	0.840	0.565	0.0
255580328	904	kinase, putative [Ricinus communis] gi|2	0.970	0.823	0.544	0.0
359488514	863	PREDICTED: receptor-like protein kinase	0.946	0.841	0.539	0.0
449438965	910	PREDICTED: receptor-like protein kinase	0.977	0.824	0.519	0.0
449476522	910	PREDICTED: LOW QUALITY PROTEIN: receptor	0.977	0.824	0.517	0.0
449476518	892	PREDICTED: receptor-like protein kinase	0.979	0.841	0.517	0.0
449438963	892	PREDICTED: receptor-like protein kinase	0.979	0.841	0.517	0.0
147778506	827	hypothetical protein VITISV_015218 [Viti	0.899	0.834	0.511	0.0

>gi|296082193|emb|CBI21198.3| unnamed protein product [Vitis vinifera]

 Score =  870 bits (2248), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 454/797 (56%), Positives = 559/797 (70%), Gaps = 42/797 (5%)

Query: 1   DSPSPYYTPTEITFVACGWLGNISA-HGQTWAGDVSSQYSPLGHQQSTISKKPREP---- 55
           DSP P Y PT+I  V CG  GN+ A   + W GD +S++S +   +++I  K  +     
Sbjct: 56  DSP-PLYNPTDIYTVDCGASGNLKAWDNRIWIGDTNSRFSLIEKNKASIISKAAKTSPSV 114

Query: 56  ---PYSASRLSHSQFTYTFNVTPGQKFIRLHFYSTSYSGFNISSAFFSVKANSFTLVNNF 112
              P++ +RLS  QF Y F VT GQKFIRLHFY +S +GF+ S AFFSVK   +TL+NNF
Sbjct: 115 DPVPFATARLSRFQFAYIFPVTTGQKFIRLHFYPSSVAGFDRSKAFFSVKIGGYTLLNNF 174

Query: 113 SASFAPD----DTFFKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYY 168
           SA+ A D    +T  KEFC+NV +  + L+ITFTP+    D+YAFINGIE+VSMP  LYY
Sbjct: 175 SAALAADAHGDETVSKEFCVNVKQGDQMLNITFTPTASDPDAYAFINGIEIVSMPDYLYY 234

Query: 169 TATDDQRLEFVGE-GSQFSILNSNALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTD 227
           T+  +  ++F+G+  + F +   +ALE +YR+NVGG  +SP  DTGM+RTW ADD Y   
Sbjct: 235 TSPQNGGIQFIGQKNNSFFVETDHALENVYRLNVGGKSLSPTDDTGMFRTWDADDEYC-- 292

Query: 228 ARPSALPVNTTIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYF 287
            + + +P NT+I L+F++I N++APL VYRTARTMG +K  N  YNLTW   VDSGF Y 
Sbjct: 293 VKLAFVPANTSINLKFTQIPNYTAPLDVYRTARTMGNNKTENMGYNLTWFLPVDSGFSYL 352

Query: 288 VRLHFCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGSKSDV 347
           +RLHFCEFQ E+ E+ DR F I +AN TAE+ ADVI WS GNGVP Y+DY V + S+   
Sbjct: 353 LRLHFCEFQPEIQEQHDREFAIIIANQTAENHADVITWSTGNGVPIYKDYGVMMPSQGSN 412

Query: 348 KKQNLSIALHPAPRWRTKYSDSILNGIEIFKVDN-NGSLAGPNPYPTVSQASSFGTRSPQ 406
           KKQNL I LHP P   T Y+D+ILNGIE+FK+ N   SLAGPNP P+ + A         
Sbjct: 413 KKQNLYIQLHPNPDSETVYNDAILNGIELFKLSNPEKSLAGPNPDPSEAPAPPPPV---- 468

Query: 407 QSTKAKNNRPRMLGIVGVVASGLVVLFIVFLLI---SRRAVMKEAKSRGP---------- 453
           QST  K N+ +++ I G V +GL+ L ++ L I    RR    E    G           
Sbjct: 469 QSTSPKRNKTKLIAIAGSVVAGLIALSVIVLFIVWRGRRVRDSEPSDGGSWWGQFSYTSV 528

Query: 454 ------ASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKR 507
                  SSLPSDLC  F++ E+K AT +F+ + IIG GGFGNVYKG++NG +TPVAIKR
Sbjct: 529 KSTKTSRSSLPSDLCRHFTLQEVKVATNNFDQVFIIGVGGFGNVYKGYINGGTTPVAIKR 588

Query: 508 LNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNND 567
           LNP SQQGA EFQTEI MLSQLR+LHLVSLIGYCNDD +MILVYDYMA GTLRDHLY  D
Sbjct: 589 LNPESQQGAQEFQTEIEMLSQLRHLHLVSLIGYCNDDREMILVYDYMAHGTLRDHLYKTD 648

Query: 568 NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG 627
           NPPL W +RL+ICIGAAR LHYLHTG    IIHRDVKTTNILLDE+WVAKVSDFGL K G
Sbjct: 649 NPPLSWKQRLEICIGAARGLHYLHTGVKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKMG 708

Query: 628 P-NFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKK 686
           P + S  HVST VKGS GYLDPEYYR Q LTEKSDVYSFGVVL EVLCARPP+ +T +K+
Sbjct: 709 PTSMSNAHVSTVVKGSFGYLDPEYYRRQQLTEKSDVYSFGVVLFEVLCARPPLNQTVEKE 768

Query: 687 QVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW 746
           +V+LA WA  CYR+GK+  I+DPFLKG   P CL +F E+A+SC+ D  I RPSMSDVVW
Sbjct: 769 RVSLAQWAPACYRDGKLEQIVDPFLKGKIAPDCLQKFGEIAVSCLQDQGIERPSMSDVVW 828

Query: 747 GLEFVFQLLRESSEKSM 763
           GL+F  Q L+ES+E+ M
Sbjct: 829 GLQFAMQ-LQESAEQEM 844

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359488516|ref|XP_003633769.1| PREDICTED: receptor-like protein kinase FERONIA-like [Vitis vinifera]

 Score =  868 bits (2242), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 455/788 (57%), Positives = 554/788 (70%), Gaps = 40/788 (5%)

Query: 7    YTPTEITFVACGWLGNISAHGQTWAGDVSSQYSPLGHQQ-STISKKPREP----PYSASR 61
            YTPTE   + CG   N  A  + W GDV S++SP    + ST S    +P    PYS +R
Sbjct: 536  YTPTENFAINCGSAENWQALARNWTGDVDSKFSPSEKGELSTTSLAAEQPFESFPYSTAR 595

Query: 62   LSHSQFTYTFNVTPGQKFIRLHFYSTSYSGFNISSAFFSVK-ANSFTLVNNFSASFAPDD 120
            LS ++FTY+F +T GQK+IRLHFY +SY  F+ S AFFSVK    +TL++NFSA+ A +D
Sbjct: 596  LSRNEFTYSFPLTAGQKYIRLHFYPSSYGEFDRSKAFFSVKTGGGYTLLSNFSAALAAED 655

Query: 121  ----TFFKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYYTATDDQRL 176
                T  +EFCIN  E+   L+ITFTP+    D+YAFINGIE+VSMP NLYYTA D    
Sbjct: 656  IQKETIVREFCINFNEEGEKLNITFTPTAG-ADAYAFINGIEIVSMPDNLYYTAQDGG-F 713

Query: 177  EFVGEGSQFSILNSNALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDARPSALPVN 236
            +F+G+ + F +   +ALE +YR+NVGG  +SP  DTGM+RTW ADD Y    + + +P N
Sbjct: 714  QFIGQQNSFFVETDHALENVYRLNVGGKSLSPTDDTGMFRTWDADDEYC--VKLAFVPAN 771

Query: 237  TTIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRLHFCEFQ 296
            T+I L+F++I N++APL VYRTARTMG +K  N  YNLTW   VDSGF Y +RLHFCEFQ
Sbjct: 772  TSINLKFTQIPNYTAPLDVYRTARTMGNNKTENMGYNLTWFLPVDSGFSYLLRLHFCEFQ 831

Query: 297  SEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGSKSDVKKQNLSIAL 356
             E+ E+ DR F I +AN TAE+ ADVI WS GNGVP Y+DY V + S+   KKQNL I L
Sbjct: 832  PEIQEQHDREFAIIIANQTAENHADVITWSTGNGVPIYKDYGVMMPSQGSNKKQNLYIQL 891

Query: 357  HPAPRWRTKYSDSILNGIEIFKVDN-NGSLAGPNPYPTVSQASSFGTRSPQQSTKAKNNR 415
            HP P   T Y+D+ILNGIE+FK+ N   SLAGPNP P+ + A         QST  K N+
Sbjct: 892  HPNPDSETVYNDAILNGIELFKLSNPEKSLAGPNPDPSEAPAPPPPV----QSTSPKRNK 947

Query: 416  PRMLGIVGVVASGLVVLFIVFLLI---SRRAVMKEAKSRGP----------------ASS 456
             +++ I G V +GL+ L ++ L I    RR    E    G                  SS
Sbjct: 948  TKLIAIAGSVVAGLIALSVIVLFIVWRGRRVRDSEPSDGGSWWGQFSYTSVKSTKTSRSS 1007

Query: 457  LPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA 516
            LPSDLC  F++ E+K AT +F+ + IIG GGFGNVYKG++NG +TPVAIKRLNP SQQGA
Sbjct: 1008 LPSDLCRHFTLQEVKVATNNFDQVFIIGVGGFGNVYKGYINGGTTPVAIKRLNPESQQGA 1067

Query: 517  LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRR 576
             EFQTEI MLSQLR+LHLVSLIGYCNDD +MILVYDYMA GTLRDHLY  DNPPL W +R
Sbjct: 1068 QEFQTEIEMLSQLRHLHLVSLIGYCNDDREMILVYDYMAHGTLRDHLYKTDNPPLSWKQR 1127

Query: 577  LKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP-NFSKTHV 635
            L+ICIGAAR LHYLHTG    IIHRDVKTTNILLDE+WVAKVSDFGL K GP + S  HV
Sbjct: 1128 LEICIGAARGLHYLHTGVKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKMGPTSMSNAHV 1187

Query: 636  STQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWAT 695
            ST VKGS GYLDPEYYR Q LTEKSDVYSFGVVL EVLCARPP+ +T +K++V+LA WA 
Sbjct: 1188 STVVKGSFGYLDPEYYRRQQLTEKSDVYSFGVVLFEVLCARPPLNQTVEKERVSLAQWAP 1247

Query: 696  ECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL 755
             CYR+GK+  I+DPFLKG   P CL +F E+A+SC+ D  I RPSMSDVVWGL+F  Q L
Sbjct: 1248 ACYRDGKLEQIVDPFLKGKIAPDCLQKFGEIAVSCLQDQGIERPSMSDVVWGLQFAMQ-L 1306

Query: 756  RESSEKSM 763
            +ES+E+ M
Sbjct: 1307 QESAEQEM 1314

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359488520|ref|XP_003633771.1| PREDICTED: receptor-like protein kinase FERONIA-like [Vitis vinifera]

 Score =  861 bits (2224), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 447/790 (56%), Positives = 553/790 (70%), Gaps = 39/790 (4%)

Query: 3   PSPYYTPTEITFVACGWLGNISAHGQTWAGDVSSQYSPLGHQQSTISKKPREPP-----Y 57
           P   YTPTE   + CG   N    G+ W GDV S++SPL   + + + +  +P      Y
Sbjct: 32  PIAGYTPTENFAINCGSSENWQDLGRNWTGDVGSKFSPLEKGKLSTTSQADKPSSSSVLY 91

Query: 58  SASRLSHSQFTYTFNVTPGQKFIRLHFYSTSYSGFNISSAFFSVK-ANSFTLVNNFSASF 116
           S +RLS  +FTY+F +T GQKFIRLHFY +SY  F+ S AFFSVK    +TL++NFSA+ 
Sbjct: 92  STARLSRYEFTYSFPLTAGQKFIRLHFYPSSYGEFDGSKAFFSVKTGGGYTLLSNFSAAL 151

Query: 117 APDD----TFFKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYYTATD 172
           A +D    T  +EFCI   E+   L+ITFTP+    D+YAFINGIE+VSMP +LYY++  
Sbjct: 152 AAEDLQKETIVREFCIYFNEEGGKLNITFTPTAA-ADAYAFINGIEIVSMPNDLYYSSPQ 210

Query: 173 DQRLEFVGEGSQFSILNSNALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDARPSA 232
           D   + +G+ + F I    ALE +YR+NVG  ++S + DTGM+RTW  DD Y    + + 
Sbjct: 211 DVGFQLIGQQNSFRIETDYALEMVYRLNVGMQYVSAKDDTGMFRTWDMDDDYC--MKLAF 268

Query: 233 LPVNTTIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRLHF 292
           +P NT+I L+F++I N++AP  VYRTARTMG +K  N  YNLTW   VDSGF Y +RLHF
Sbjct: 269 VPANTSINLKFTKIPNYTAPHDVYRTARTMGNNKTENMGYNLTWVLPVDSGFYYLIRLHF 328

Query: 293 CEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGSKSDVKKQNL 352
           CEFQ E+ ++ DR F I++AN TAE+ ADVI WSGGNGVP YRDY V + S+   KKQNL
Sbjct: 329 CEFQPEIQQQHDREFTIFIANQTAENHADVITWSGGNGVPIYRDYGVMMPSQGSNKKQNL 388

Query: 353 SIALHPAPRWRTKYSDSILNGIEIFKVDN-NGSLAGPNPYPTVSQASSFGTRSPQQSTKA 411
            I LHP P + T Y+D+ILNGIE+FK+ N   SLAGPNP P+ + A         QST  
Sbjct: 389 YIQLHPNPDYETVYNDAILNGIELFKLSNPEKSLAGPNPDPSEAPAPPPPV----QSTSP 444

Query: 412 KNNRPRMLGIVGVVASGLVVLFIVFLLI---SRRAVMKEAKSRGP--------------- 453
           K+N+ +++ I G V +GL+ L ++ L I    RR    E    G                
Sbjct: 445 KSNKTKLIAIAGSVVAGLIALSVIALFIVWRGRRVRDSEPSDGGSWWGQFSYTSVKSTKT 504

Query: 454 -ASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS 512
             SSLPSDLC  F++ EIK AT +F+N+ IIG GGFGNVYKG++NG +TPVAIKRLNP S
Sbjct: 505 SRSSLPSDLCRLFTLQEIKVATNNFDNVFIIGVGGFGNVYKGYINGGTTPVAIKRLNPES 564

Query: 513 QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLP 572
           QQGA EFQTEI MLSQLR+LHLVSLIGYCNDD +MILVYDYMA GTLRDHLY  DNPPL 
Sbjct: 565 QQGAQEFQTEIEMLSQLRHLHLVSLIGYCNDDREMILVYDYMAHGTLRDHLYKTDNPPLS 624

Query: 573 WDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP-NFS 631
           W +RL+ICIGAAR LHYLHTG    IIHRDVKTTNILLDE+WVAKVSDFGL K GP + S
Sbjct: 625 WKQRLEICIGAARGLHYLHTGVKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKMGPTSMS 684

Query: 632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLA 691
             HVST VKGS GYLDPEYYR Q LTEKSDVYSFGVVL EVLCARPP+ +T +K++V+LA
Sbjct: 685 NAHVSTVVKGSFGYLDPEYYRRQQLTEKSDVYSFGVVLFEVLCARPPLNQTVEKERVSLA 744

Query: 692 VWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV 751
            WA  CYR+GK+  I+DPFLKG   P CL +F E+A+SC+ D  I RPSM+DVVWGL+F 
Sbjct: 745 QWAPSCYRDGKLEQIVDPFLKGKIAPDCLQKFGEIAVSCLQDQGIERPSMTDVVWGLQFA 804

Query: 752 FQLLRESSEK 761
            Q L+ES+E+
Sbjct: 805 MQ-LQESAEQ 813

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255580328|ref|XP_002530992.1| kinase, putative [Ricinus communis] gi|223529419|gb|EEF31380.1| kinase, putative [Ricinus communis]

 Score =  821 bits (2120), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 428/786 (54%), Positives = 538/786 (68%), Gaps = 42/786 (5%)

Query: 4   SPYYTPTEITFVACGWLGN-ISAHGQTWAGDVS------SQYSPLGHQQSTISKKPREPP 56
           SP Y P +   + CG   N    + + W  D +      +  +PL   +S   K     P
Sbjct: 41  SPLYIPLDNIALDCGSPSNGPDMNHRNWIADTNFFDLQHNASTPLQANESASRKGLDSVP 100

Query: 57  YSASRLSHSQFTYTFNVT-PGQKFIRLHFYSTSYSGFNISSAFFSVKANSFTLVNNFSAS 115
           Y+ +RLS SQFTY+F +T  G KF+RL+FY  SYS F++S+A+FSV+A  +TL++NFS+ 
Sbjct: 101 YATARLSFSQFTYSFPITTAGPKFVRLYFYPASYSDFDMSNAYFSVQAGRYTLLSNFSSV 160

Query: 116 FAPDDT----FFKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYYTAT 171
               +     F KEFC+NV E Q  L++TFTP+P+  D+YAFINGIE+VSMP NLYY+A 
Sbjct: 161 LHSKNLSLPGFVKEFCLNVEEGQNLLNLTFTPTPNMPDAYAFINGIEIVSMPANLYYSAE 220

Query: 172 DDQRLEFVGEGSQFSILNSN-ALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDARP 230
           +D     VG  +    + SN AL+ +YRINVGG  +SPQ DTGM+R+W  D  Y+     
Sbjct: 221 NDVGFPSVGSLNSVMRIESNIALQLMYRINVGGQSVSPQNDTGMFRSWDGDTDYIILESQ 280

Query: 231 SALPVNTTIVLRF-SRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVR 289
           SAL  N    L++   I  +SAP  VY T+R MGL+  INE++NLTW+FQVDS FIY VR
Sbjct: 281 SALAHNNVTQLKYRDNITRYSAPDEVYNTSRMMGLNATINEKHNLTWQFQVDSDFIYLVR 340

Query: 290 LHFCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGSKSDVKK 349
            +FCEF   +T++GDRVF IY+AN TAED ADVI WSGGNG+P Y+DYAV +  K   K 
Sbjct: 341 FYFCEFYPPITQKGDRVFLIYMANQTAEDYADVIEWSGGNGIPVYKDYAVKMEPKGSEKF 400

Query: 350 QNLSIALHPAPRWRTKYSDSILNGIEIFKVDNNGSLAGPNPYPTVSQASSFGTRSPQQST 409
           Q L+IALHP P  RT+ + +ILNG+EIFK+  + +LA PNP   +S   S  T  P+ S 
Sbjct: 401 QKLAIALHPKPEDRTRAASAILNGLEIFKLSVSDNLASPNPDIPLSNTPSAATPIPKSS- 459

Query: 410 KAKNNRPRMLGIVGVVASGLVVLFIVFLLISRR--------------------AVMKEAK 449
             K+N   ++G  G VA  + +  ++F +  RR                    A  K AK
Sbjct: 460 --KSNISAIIG--GAVAGFVALSLLLFFIYWRRSKSKQSGFNDGASRLDQFSTASTKSAK 515

Query: 450 SRGPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLN 509
           ++G  S+LPSDLC +FS+ EIKEAT +F+++ IIG GGFGNVY+G +N  +  VAIKRLN
Sbjct: 516 TQG--STLPSDLCRRFSLPEIKEATNNFDSVFIIGVGGFGNVYRGLINDGAVTVAIKRLN 573

Query: 510 PGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNP 569
           PGS+QGA EF+TEI MLSQLRYLHLVSLIGYC +D +MILVYDYMARGTLRDHLY  DNP
Sbjct: 574 PGSEQGAHEFKTEIEMLSQLRYLHLVSLIGYCYEDNEMILVYDYMARGTLRDHLYKTDNP 633

Query: 570 PLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP- 628
           PL W +RL+ICIGAAR L YLH+GA   IIHRDVKTTNILLDE+W AKVSDFGL K GP 
Sbjct: 634 PLTWIQRLEICIGAARGLQYLHSGAKNTIIHRDVKTTNILLDEKWAAKVSDFGLSKVGPS 693

Query: 629 NFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQV 688
           + SK H+ST VKGS GYLDPEYYRLQ LTEKSDVYSFGVVL EVL ARPP+ ++   K V
Sbjct: 694 SMSKPHISTVVKGSFGYLDPEYYRLQRLTEKSDVYSFGVVLFEVLSARPPVSKSSFNKPV 753

Query: 689 NLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGL 748
           +LA WA +CYR G + DI+DP LKG   P CL +F E+A+SC+ D+ + RPSMSDVVWGL
Sbjct: 754 SLAEWARQCYRKGTLDDIVDPHLKGKIAPDCLKKFFELAVSCLLDNGMDRPSMSDVVWGL 813

Query: 749 EFVFQL 754
           EF  QL
Sbjct: 814 EFALQL 819

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359488514|ref|XP_003633768.1| PREDICTED: receptor-like protein kinase FERONIA-like [Vitis vinifera]

 Score =  818 bits (2112), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 426/790 (53%), Positives = 536/790 (67%), Gaps = 64/790 (8%)

Query: 7   YTPTEITFVACGWLGNISAHGQTWAGDVSSQYSPLGHQQSTISKKPREP----PYSASRL 62
           Y PTE   + CG  GN    G+ W GD+ S++SPL +  ST S     P    PYS +RL
Sbjct: 38  YNPTENFAINCGSSGNSQELGRNWMGDIDSKFSPLENGTSTTSSADEPPFLSVPYSTARL 97

Query: 63  SHSQFTYTFNVTPGQKFIRLHFYSTSYSG-FNISSAFFSVK-ANSFTLVNNFSASFAPD- 119
           S  +FTY+F +T GQK+IRLHF+ + Y G F+ S+A FSVK    +TL++NFS +   D 
Sbjct: 98  SRYEFTYSFPLTAGQKYIRLHFHPSLYVGEFDRSTAIFSVKTGGGYTLLSNFSGALVADS 157

Query: 120 ----DTFFKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYYTATDDQR 175
               +   KEFCIN  E+   L+ITF P+    D+YAFINGIE+VSMP NLYYTA D   
Sbjct: 158 DLGKEKILKEFCINFNEEGEKLNITFAPTAGV-DAYAFINGIEIVSMPDNLYYTAQDGG- 215

Query: 176 LEFVGEGSQFSILNSNALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDARPSALPV 235
            +F+G+ + F +   +ALE LYR+NVGG  + P  DTGM+RTW AD  Y+   + + +PV
Sbjct: 216 FKFIGQQNSFFVETDHALENLYRLNVGGKSLLPMDDTGMFRTWDADYEYL--PKLAFVPV 273

Query: 236 NTTIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRLHFCEF 295
           N +I L+F++I N++APL VYRTARTMG +K  N  YNLTW   VDSGF Y +RLHFCEF
Sbjct: 274 NGSITLKFTQIPNYAAPLDVYRTARTMGNNKTENMGYNLTWSLPVDSGFSYLLRLHFCEF 333

Query: 296 QSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGSKSDVKKQNLSIA 355
           Q E+ E+ DR F I++AN TAE+ ADVI WSGGNGVP YRDY V + S+   KKQ L I 
Sbjct: 334 QPEIQEQQDREFTIFIANQTAENHADVIKWSGGNGVPIYRDYGVMMPSQGSNKKQKLYIQ 393

Query: 356 LHPAPRWRTKYSDSILNGIEIFKVDNNGSLAGPNPYPTVSQASSFGTRSPQQSTKAKNNR 415
           LHP P + T Y+D+ILNGIE+FK+ N      PNP               QQ T  ++N+
Sbjct: 394 LHPNPDYETVYNDAILNGIELFKLIN------PNP--------------DQQPTSRESNK 433

Query: 416 PRMLGIVGVVASGLVVLFIVFLLISRRAVMKEAKSRGPA--------------------- 454
            +++ I G V  GLV + +++  +    V +  ++R P+                     
Sbjct: 434 MKLVAITGGVVCGLVAVSVLYFFV----VHQMKRNRDPSLRDGALWWGPVFYILGTSTET 489

Query: 455 --SSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS 512
             SSL SDL   FS+ +IK ATK+F+   I+G GGFGNVYKG+++G +TPVAIKRLNP S
Sbjct: 490 HRSSLTSDLSHHFSLQDIKTATKNFDKGYIVGEGGFGNVYKGYISGGTTPVAIKRLNPES 549

Query: 513 QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLP 572
           QQGA EF TEI MLSQLR++HLVSLIGYCN   +MILVY+YMA G LRDHLYN DNPPLP
Sbjct: 550 QQGAHEFMTEIEMLSQLRHIHLVSLIGYCNHKREMILVYEYMANGNLRDHLYNTDNPPLP 609

Query: 573 WDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP-NFS 631
           W +RL+ICIGAAR LHYLH G  K IIHRDVKTTNILLD +WVAKVSDFGL K  P + +
Sbjct: 610 WTQRLQICIGAARGLHYLHAGVKKTIIHRDVKTTNILLDHKWVAKVSDFGLSKMSPTSVA 669

Query: 632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLA 691
             H+ST VKGS GYLDPEY+R Q L EKSDVYSFGVVL EVLCARPP+ +TG+++Q  LA
Sbjct: 670 NAHISTVVKGSFGYLDPEYFRFQRLNEKSDVYSFGVVLFEVLCARPPVNQTGEEEQAGLA 729

Query: 692 VWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV 751
            WA   Y+NGK+ +IIDP L+G   P+CL ++ EVA+SCV D RI+RPSMSDVV GLE  
Sbjct: 730 HWAVTSYKNGKLEEIIDPHLEGKIAPMCLEKYGEVAVSCVLDQRIKRPSMSDVVRGLELA 789

Query: 752 FQLLRESSEK 761
            + L+ES+EK
Sbjct: 790 LE-LQESTEK 798

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449438965|ref|XP_004137258.1| PREDICTED: receptor-like protein kinase FERONIA-like [Cucumis sativus]

 Score =  793 bits (2049), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 422/813 (51%), Positives = 542/813 (66%), Gaps = 63/813 (7%)

Query: 4   SPYYTPTEITFVACGWLGNISA---HGQTWAGDVSSQYSPLGHQQSTISKKPREP----- 55
           S +Y P +   + CG   N+S+   + + W GD+ S+Y P  HQQ+  S   +       
Sbjct: 30  SSFYEPIDNITLDCGSDANLSSFYENDRIWVGDIDSKYFPSDHQQNGASMTSKADAQSTS 89

Query: 56  ----PYSASRLSHSQFTYTFNVTPGQKFIRLHFYSTSYSGFNISSAFFSVKANSFTLVNN 111
               PY  +RLS SQFTY+F VTPGQKFIRL+FYS +Y  F+ S A FSV+A  FTL+ +
Sbjct: 90  VTTVPYMTARLSRSQFTYSFPVTPGQKFIRLYFYSANYQQFDRSKAVFSVRAGLFTLLRD 149

Query: 112 FSASFAPDDTF----FKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLY 167
           F+ S   D +F    F+EFC++V E+   L++TFTP+   QDSYAFI+GIE+VSMP NLY
Sbjct: 150 FNTSVNADASFNNEIFREFCVHVGENDPKLNLTFTPTN--QDSYAFISGIEIVSMPTNLY 207

Query: 168 YTATD-----DQRLEFVGEGSQF-SILNSNALETLYRINVGGSFISPQMDTGMYRTWIAD 221
           YT  +      + L+ VG+ ++F  I N  +LE +YRIN+ G F+SP  DTGM+RTW  D
Sbjct: 208 YTPLELNDEGGRGLKQVGQNNKFFPIENYTSLEMVYRINIAGKFLSPMEDTGMFRTWY-D 266

Query: 222 DGYVTDARP-----SALPVNTTIVLRFS-RILNFSAPLAVYRTARTMGLDKNINEQYNLT 275
           +       P      A P N++I L +S ++  ++AP  VYRTARTMG +   N++YNLT
Sbjct: 267 EEVSNFLEPFTGNYDARPANSSIKLNYSSKVPAYTAPEDVYRTARTMGPNTTENKRYNLT 326

Query: 276 WEFQVDSGFIYFVRLHFCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYR 335
           WEF +D GF+Y +RLHFCEFQ E+    DRVF IY+ +   E  ADV  W+GG G+P  R
Sbjct: 327 WEFPIDPGFLYMIRLHFCEFQEEINSTEDRVFLIYIRDTMVEQSADVFRWAGGGGIPYRR 386

Query: 336 DYAVAIGSKSDVKKQNLSIALHPAPR-WRTKYSDSILNGIEIFKV-DNNGSLAGPNPYPT 393
           DY + + SK+D KK NLS+ L   P   +T+Y++ ILNGIEIFK+ D++G+L G NP P 
Sbjct: 387 DYVLLV-SKNDKKKVNLSVTLQANPDDSKTRYTNVILNGIEIFKLNDSDGNLGGQNPDPL 445

Query: 394 -VSQASSFGTRSPQQSTKAKNNRPRMLGIVGVVASGLVVLFIV----FLLISRRAVMKEA 448
             +Q  S     P+  +K    R +M  I+  +  G VV  I+    F++  R+  M ++
Sbjct: 446 PTTQTQSLP--PPKDHSK----RSKMAAIIIPIVVGGVVAMILAMGLFVIRQRKTFMDQS 499

Query: 449 KSRGPA-----------------SSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNV 491
            S G +                 S+LPSDLC  FS++EIK ATK+F++  IIG GGFGNV
Sbjct: 500 SSDGTSWWALYSISTNKSSKSRNSNLPSDLCRYFSLAEIKAATKNFDDNFIIGVGGFGNV 559

Query: 492 YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY 551
           YKG+++  +T VAIKRL PGS+QGA EF+TEI MLSQLR+LHLVSLIGYCND  +MILVY
Sbjct: 560 YKGYVDDGATQVAIKRLKPGSKQGAHEFKTEIEMLSQLRHLHLVSLIGYCNDGNEMILVY 619

Query: 552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD 611
           DYM+ GTLR+HLY +D  PL W +RL+ICIGAA+ LHYLHTGA   IIHRDVKTTNILLD
Sbjct: 620 DYMSHGTLRNHLYGDDEQPLTWKQRLQICIGAAKGLHYLHTGAKHTIIHRDVKTTNILLD 679

Query: 612 EEWVAKVSDFGLCKFGP-NFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLL 670
           E+WVAKVSDFGL K GP + SK H+ST VKGS GYLDPEYYR Q LTEKSDVYSFGVVL 
Sbjct: 680 EKWVAKVSDFGLSKVGPTDMSKAHISTVVKGSFGYLDPEYYRRQQLTEKSDVYSFGVVLC 739

Query: 671 EVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSC 730
           EVLCARPP++R  DKKQV LA W   C R+  I  IIDP +K    P CL +F+E+A+ C
Sbjct: 740 EVLCARPPLMRLTDKKQVYLAEWVRRCNRDNTIAQIIDPNIKNEISPECLRKFIEIAVRC 799

Query: 731 VNDDRIRRPSMSDVVWGLEFVFQLLRESSEKSM 763
           + DD I RPSM+DVVWGLEF  QL   S +K +
Sbjct: 800 IQDDGINRPSMNDVVWGLEFAVQLQEASKKKEV 832

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449476522|ref|XP_004154760.1| PREDICTED: LOW QUALITY PROTEIN: receptor-like protein kinase FERONIA-like [Cucumis sativus]

 Score =  792 bits (2046), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 421/813 (51%), Positives = 543/813 (66%), Gaps = 63/813 (7%)

Query: 4   SPYYTPTEITFVACGWLGNISA---HGQTWAGDVSSQYSPLGHQQSTISKKPREP----- 55
           S +Y P +   + CG   N+S+   + + W GD+ S+Y P  HQQ+  S   +       
Sbjct: 30  SSFYEPIDNITLDCGSDANLSSFYENDRIWVGDIDSKYFPSDHQQNGASMTSKADAQSTS 89

Query: 56  ----PYSASRLSHSQFTYTFNVTPGQKFIRLHFYSTSYSGFNISSAFFSVKANSFTLVNN 111
               PY  +RLS SQFTY+F VTPGQKFIRL+FYS +Y  F+ S A FSV+A  FTL+ +
Sbjct: 90  VTTVPYMTARLSRSQFTYSFPVTPGQKFIRLYFYSANYQQFDRSKAVFSVRAGLFTLLRD 149

Query: 112 FSASFAPDDTF----FKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLY 167
           F+ S   D +F    F+EFC++V E+   L++TFTP+   QDSYAFI+GIE+VSMP NLY
Sbjct: 150 FNTSVNADASFNNEIFREFCVHVGENDPKLNLTFTPTN--QDSYAFISGIEIVSMPTNLY 207

Query: 168 YTATD-----DQRLEFVGEGSQF-SILNSNALETLYRINVGGSFISPQMDTGMYRTWIAD 221
           YT  +      + L+ VG+ ++F  I N  +LE +YRIN+ G F+SP  DTGM+RTW  D
Sbjct: 208 YTPLELNDEGGRGLKQVGQNNKFFPIENYTSLEMVYRINIAGKFLSPMEDTGMFRTWY-D 266

Query: 222 DGYVTDARP-----SALPVNTTIVLRFS-RILNFSAPLAVYRTARTMGLDKNINEQYNLT 275
           +       P      A P N++I L +S ++  ++AP  VYRTARTMG +   N++YNLT
Sbjct: 267 EEVSNFLEPFTGNYDARPANSSIKLNYSSKVPAYTAPEDVYRTARTMGPNTTENKRYNLT 326

Query: 276 WEFQVDSGFIYFVRLHFCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYR 335
           WEF +D GF+Y +RLHFCEFQ E+    DRVF IY+ +   E  ADV  W+GG G+P  R
Sbjct: 327 WEFPIDPGFLYMIRLHFCEFQEEINSTEDRVFLIYIRDTMVEQSADVFRWAGGGGIPYRR 386

Query: 336 DYAVAIGSKSDVKKQNLSIALHPAPR-WRTKYSDSILNGIEIFKV-DNNGSLAGPNPYPT 393
           DY + + SK+D KK NLS+ L   P   +T+Y++ ILNGIEIFK+ D++G+L G NP P 
Sbjct: 387 DYVLLV-SKNDKKKVNLSVTLQANPDDSKTRYTNVILNGIEIFKLNDSDGNLGGQNPDPL 445

Query: 394 -VSQASSFGTRSPQQSTKAKNNRPRMLGIVGVVASGLVVLFIV----FLLISRRAVMKEA 448
             +Q  S     P+  +K    R +M  I+  +  G VV  I+    F++  R+  M ++
Sbjct: 446 PTTQTQSLP--PPKDHSK----RSKMAAIIIPIVVGGVVAMILAMGLFVIRQRKTFMDQS 499

Query: 449 KSRGPA-----------------SSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNV 491
            S G +                 S+LPSDLC  FS++EIK ATK+F++  IIG GGFGNV
Sbjct: 500 SSDGTSWWALYSISTNKSSKSRNSNLPSDLCRYFSLAEIKAATKNFDDNFIIGVGGFGNV 559

Query: 492 YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY 551
           YKG+++  +T VAIKRL PGS+QGA EF+TEI MLSQLR+LHLVSLIGYCND  +MILVY
Sbjct: 560 YKGYVDDGATQVAIKRLKPGSKQGAHEFKTEIEMLSQLRHLHLVSLIGYCNDGNEMILVY 619

Query: 552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD 611
           DYM+ GTLR+HLY +D  PL W +RL+ICIGAA+ LHYLHTGA   IIHRDVKTTNILLD
Sbjct: 620 DYMSHGTLRNHLYGDDEQPLTWKQRLQICIGAAKGLHYLHTGAKHTIIHRDVKTTNILLD 679

Query: 612 EEWVAKVSDFGLCKFGP-NFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLL 670
           E+WVAKVSDFGL K GP + SK H+ST VKGS GYLDPEYYR Q LTEKSDVYSFGVVL 
Sbjct: 680 EKWVAKVSDFGLSKVGPTDMSKAHISTVVKGSFGYLDPEYYRRQQLTEKSDVYSFGVVLC 739

Query: 671 EVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSC 730
           EVLCARPP++R  DKKQV LA W   C R+ ++  IIDP +K    P CL +F+E+A+ C
Sbjct: 740 EVLCARPPLMRLTDKKQVYLAEWVRRCNRDNRLXQIIDPNIKNEISPECLRKFIEIAVRC 799

Query: 731 VNDDRIRRPSMSDVVWGLEFVFQLLRESSEKSM 763
           + DD I RPSM+DVVWGLEF  QL   S +K +
Sbjct: 800 IQDDGINRPSMNDVVWGLEFAVQLQEASKKKEV 832

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449476518|ref|XP_004154759.1| PREDICTED: receptor-like protein kinase FERONIA-like [Cucumis sativus]

 Score =  773 bits (1997), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 415/802 (51%), Positives = 531/802 (66%), Gaps = 51/802 (6%)

Query: 1   DSPSPYYTPTEITFVACGWLGNISAHGQT--WAGDVSSQYSP---------LGHQQSTIS 49
           DSP+ Y  P +   + CG    +SA G    W GDV S++ P         +  Q  T S
Sbjct: 28  DSPASY-KPIDDILLNCGTSETLSASGDNRPWTGDVQSKFFPSDFHQNRASVTSQADTQS 86

Query: 50  KKPREPPYSASRLSHSQFTYTFNVTPGQKFIRLHFYSTSYSGFNISSAFFSVKANSF-TL 108
             P   PYS +RLSHS FTY+F V+PG KFIRL+FYS  Y  F+   A FSVK  S  TL
Sbjct: 87  SSPNVVPYSTARLSHSNFTYSFPVSPGPKFIRLYFYSAFYLNFDRYKAVFSVKTTSMHTL 146

Query: 109 VNNFSASFAPDD------TFFKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSM 162
           ++NF+AS   D       T  +EFC+   E+ + L+ITF+P+   QDSYAFINGIE+VSM
Sbjct: 147 LSNFNASVNADASDLNSPTITREFCVYTDENDQMLNITFSPTN--QDSYAFINGIEIVSM 204

Query: 163 PLNLYYTATDDQRLEFVGEGSQF-SILNSNALETLYRINVGGSFISPQMDTGMYRTWIAD 221
           PL+LYYT     RL+ V + +QF  + N+ +LE +YR+N+GG+ IS   DTGM+RTW  +
Sbjct: 205 PLDLYYTP----RLKLVDQNNQFIQVGNNTSLEMVYRMNIGGNTISSGEDTGMFRTWAEE 260

Query: 222 DGYVTDARPSALPVNTTIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVD 281
             Y+ D    A P N +I L +     ++AP  VYRTARTMG +  +N+ YNLTWE+ VD
Sbjct: 261 SNYMNDYVADARPANLSIQLNYIERQPYTAPENVYRTARTMGPNSTLNKNYNLTWEYPVD 320

Query: 282 SGFIYFVRLHFCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAI 341
            GF Y +RLHFCEFQ+E+T  GDRVF IY+ + TAE+  DV   + G   P Y DY V +
Sbjct: 321 PGFYYMIRLHFCEFQAEITAAGDRVFLIYIKDATAEESFDVFQKARGKYNPIYEDYGVFV 380

Query: 342 GSKSDVKKQNLSIALHPAPRWR-TKYSDSILNGIEIFKV-DNNGSLAGPNPYPTVSQASS 399
            +KS+ KK NLS+ L P P    T++S+ ILNG+EIFK+ D NG+L G NP P  +Q  S
Sbjct: 381 -TKSNQKKVNLSVKLRPNPNDDLTRFSNVILNGVEIFKLNDTNGNLGGQNPDPPPTQ--S 437

Query: 400 FGTRSPQQSTKAKNNRPRMLGIVGVVASGLVVLFIVFLLISRRAVM-KEAKSRGPA---- 454
               +PQ +  + N +   + I  V+   + +L +  L   RR  +  +A S G +    
Sbjct: 438 LPPSTPQMNNDSSNTKIVAIVIPVVIGVVVAILALGLLFFRRRRTLTDQASSDGTSWWAP 497

Query: 455 -------------SSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDST 501
                        S+LPSDLC  FS+ EIK ATK+F+++ IIG GGFGNVYKG+++  +T
Sbjct: 498 FSTSTNKTSKTRNSNLPSDLCRYFSLGEIKAATKNFDDVFIIGVGGFGNVYKGYIDDGAT 557

Query: 502 PVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRD 561
            VAIKRL PGS+QGA EF+TEI MLSQLR+LHLVSLIGYCND  +MILVY+YM+ GTLR 
Sbjct: 558 QVAIKRLKPGSKQGAHEFKTEIEMLSQLRHLHLVSLIGYCNDGNEMILVYEYMSHGTLRS 617

Query: 562 HLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDF 621
           HLY ND  PL W++RL+IC+GAA+ LHYLHTGA+  IIHRDVKTTNILLDE+W+AKVSDF
Sbjct: 618 HLYGNDEQPLTWNQRLQICVGAAKGLHYLHTGANHTIIHRDVKTTNILLDEKWIAKVSDF 677

Query: 622 GLCKFGP-NFS-KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPI 679
           GL K GP N S  TH+ST VKGS GYLDPEYYR Q LTEKSDVYSFGVVL EVLCARPP+
Sbjct: 678 GLSKVGPANMSNNTHISTVVKGSFGYLDPEYYRRQQLTEKSDVYSFGVVLCEVLCARPPL 737

Query: 680 LRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRP 739
           +R+ +KK+V LA W  +C+R   +   ID  +K    P CL +F+E+A+SCV DD ++RP
Sbjct: 738 VRSAEKKEVYLAEWVRQCHRKNTVAQTIDENVKNEISPECLRKFIEIAVSCVEDDGVKRP 797

Query: 740 SMSDVVWGLEFVFQLLRESSEK 761
            M DVVWGLEF  QL   S +K
Sbjct: 798 PMKDVVWGLEFALQLQEASKKK 819

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449438963|ref|XP_004137257.1| PREDICTED: receptor-like protein kinase FERONIA-like [Cucumis sativus]

 Score =  773 bits (1997), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 415/802 (51%), Positives = 531/802 (66%), Gaps = 51/802 (6%)

Query: 1   DSPSPYYTPTEITFVACGWLGNISAHGQT--WAGDVSSQYSP---------LGHQQSTIS 49
           DSP+ Y  P +   + CG    +SA G    W GDV S++ P         +  Q  T S
Sbjct: 28  DSPASY-KPIDDILLNCGTSETLSASGDNRPWTGDVQSKFFPSDFHQNRASVTSQADTQS 86

Query: 50  KKPREPPYSASRLSHSQFTYTFNVTPGQKFIRLHFYSTSYSGFNISSAFFSVKANSF-TL 108
             P   PYS +RLSHS FTY+F V+PG KFIRL+FYS  Y  F+   A FSVK  S  TL
Sbjct: 87  SSPNVVPYSTARLSHSNFTYSFPVSPGPKFIRLYFYSAFYLNFDRYKAVFSVKTTSMHTL 146

Query: 109 VNNFSASFAPDD------TFFKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSM 162
           ++NF+AS   D       T  +EFC+   E+ + L+ITF+P+   QDSYAFINGIE+VSM
Sbjct: 147 LSNFNASVNADASDLNSPTITREFCVYTDENDQMLNITFSPTN--QDSYAFINGIEIVSM 204

Query: 163 PLNLYYTATDDQRLEFVGEGSQF-SILNSNALETLYRINVGGSFISPQMDTGMYRTWIAD 221
           PL+LYYT     RL+ V + +QF  + N+ +LE +YR+N+GG+ IS   DTGM+RTW  +
Sbjct: 205 PLDLYYTP----RLKLVDQNNQFIQVGNNTSLEMVYRMNIGGNTISSGEDTGMFRTWAEE 260

Query: 222 DGYVTDARPSALPVNTTIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVD 281
             Y+ D    A P N +I L +     ++AP  VYRTARTMG +  +N+ YNLTWE+ VD
Sbjct: 261 SNYMNDYVADARPANLSIQLNYIERQPYTAPENVYRTARTMGPNSTLNKNYNLTWEYPVD 320

Query: 282 SGFIYFVRLHFCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAI 341
            GF Y +RLHFCEFQ+E+T  GDRVF IY+ + TAE+  DV   + G   P Y DY V +
Sbjct: 321 PGFYYMIRLHFCEFQAEITAAGDRVFLIYIKDATAEESFDVFQKARGKYNPIYEDYGVFV 380

Query: 342 GSKSDVKKQNLSIALHPAPRWR-TKYSDSILNGIEIFKV-DNNGSLAGPNPYPTVSQASS 399
            +KS+ KK NLS+ L P P    T++S+ ILNG+EIFK+ D NG+L G NP P  +Q  S
Sbjct: 381 -TKSNQKKVNLSVKLRPNPNDDLTRFSNVILNGVEIFKLNDTNGNLGGQNPDPPPTQ--S 437

Query: 400 FGTRSPQQSTKAKNNRPRMLGIVGVVASGLVVLFIVFLLISRRAVM-KEAKSRGPA---- 454
               +PQ +  + N +   + I  V+   + +L +  L   RR  +  +A S G +    
Sbjct: 438 LPPSTPQMNNDSSNTKIVAIVIPVVIGVVVAILALGLLFFRRRRTLTDQASSDGTSWWAP 497

Query: 455 -------------SSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDST 501
                        S+LPSDLC  FS+ EIK ATK+F+++ IIG GGFGNVYKG+++  +T
Sbjct: 498 FSTSTNKTSKTRNSNLPSDLCRYFSLGEIKAATKNFDDVFIIGVGGFGNVYKGYIDDGAT 557

Query: 502 PVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRD 561
            VAIKRL PGS+QGA EF+TEI MLSQLR+LHLVSLIGYCND  +MILVY+YM+ GTLR 
Sbjct: 558 QVAIKRLKPGSKQGAHEFKTEIEMLSQLRHLHLVSLIGYCNDGNEMILVYEYMSHGTLRS 617

Query: 562 HLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDF 621
           HLY ND  PL W++RL+IC+GAA+ LHYLHTGA+  IIHRDVKTTNILLDE+W+AKVSDF
Sbjct: 618 HLYGNDEQPLTWNQRLQICVGAAKGLHYLHTGANHTIIHRDVKTTNILLDEKWIAKVSDF 677

Query: 622 GLCKFGP-NFS-KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPI 679
           GL K GP N S  TH+ST VKGS GYLDPEYYR Q LTEKSDVYSFGVVL EVLCARPP+
Sbjct: 678 GLSKVGPANMSNNTHISTVVKGSFGYLDPEYYRRQQLTEKSDVYSFGVVLCEVLCARPPL 737

Query: 680 LRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRP 739
           +R+ +KK+V LA W  +C+R   +   ID  +K    P CL +F+E+A+SCV DD ++RP
Sbjct: 738 VRSAEKKEVYLAEWVRQCHRKNTVAQTIDKNVKNEISPECLRKFIEIAVSCVEDDGVKRP 797

Query: 740 SMSDVVWGLEFVFQLLRESSEK 761
            M DVVWGLEF  QL   S +K
Sbjct: 798 PMKDVVWGLEFALQLQEASKKK 819

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147778506|emb|CAN76103.1| hypothetical protein VITISV_015218 [Vitis vinifera]

 Score =  759 bits (1961), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 404/790 (51%), Positives = 509/790 (64%), Gaps = 100/790 (12%)

Query: 7   YTPTEITFVACGWLGNISAHGQTWAGDVSSQYSPLGHQQSTISKKPREP----PYSASRL 62
           Y PTE   + CG  GN    G+ W GD+ S++SPL +  ST S     P    PYS +RL
Sbjct: 38  YNPTENFAINCGSSGNSQELGRNWMGDIDSKFSPLENGTSTTSSADEPPFLSVPYSTARL 97

Query: 63  SHSQFTYTFNVTPGQKFIRLHFYSTSYSG-FNISSAFFSVK-ANSFTLVNNFSASFAPD- 119
           S  +FTY+F +T GQK+IRLHF+ + Y G F+ S+A FSVK    +TL++NFS +   D 
Sbjct: 98  SRYEFTYSFPLTAGQKYIRLHFHPSLYVGEFDRSTAIFSVKTGGGYTLLSNFSGALVADS 157

Query: 120 ----DTFFKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYYTATDDQR 175
               +   KEFCIN  E+   L+ITF P+    D+YAFINGIE+VSMP NLYYTA  D  
Sbjct: 158 DLGKEKILKEFCINFNEEGEKLNITFAPTAGV-DAYAFINGIEIVSMPDNLYYTAPQDGG 216

Query: 176 LEFVGEGSQFSILNSNALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDARPSALPV 235
            +F+G+ + F +   +ALE LYR+NVGG  + P  DTGM+RTW AD  Y+   + + +PV
Sbjct: 217 FKFIGQQNSFFVETDHALENLYRLNVGGKSLLPMDDTGMFRTWDADYEYL--PKLAFVPV 274

Query: 236 NTTIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRLHFCEF 295
           N +I L+F++I N++APL VYRTARTMG +K  N  YNLTW   VDSGF Y +RLHFCEF
Sbjct: 275 NGSITLKFTQIPNYAAPLDVYRTARTMGNNKTENMGYNLTWSLPVDSGFSYLLRLHFCEF 334

Query: 296 QSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGSKSDVKKQNLSIA 355
           Q E+ E+ DR F I++AN TAE+ ADVI WSGGNGVP YRDY                  
Sbjct: 335 QPEIQEQQDREFTIFIANQTAENHADVIKWSGGNGVPIYRDYG----------------- 377

Query: 356 LHPAPRWRTKYSDSILNGIEIFKVDNNGSLAGPNPYPTVSQASSFGTRSPQQSTKAKNNR 415
                               +FK+ N      PN                QQ T  ++N+
Sbjct: 378 --------------------LFKLIN------PN--------------XDQQPTSRESNK 397

Query: 416 PRMLGIVGVVASGLVVLFIVFLLISRRAVMKEAKSRGPA--------------------- 454
            +++ I G V  GLV + +++  +    V +  ++R P+                     
Sbjct: 398 MKLVAITGGVVCGLVAVSVLYFFV----VHQMKRNRDPSLRDGALWWGPVFYILGTSTET 453

Query: 455 --SSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS 512
             SSL SDL   FS+ +IK ATK+F+   I+G GGFGNVYKG+++G +TPVAIKRLNP S
Sbjct: 454 HRSSLTSDLSHHFSLQDIKTATKNFDKGYIVGEGGFGNVYKGYISGGTTPVAIKRLNPES 513

Query: 513 QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLP 572
           QQGA EF TEI MLSQLR++HLVSLIGYCN   +MILVY+YMA G LRDHLYN DNPPLP
Sbjct: 514 QQGAHEFMTEIEMLSQLRHIHLVSLIGYCNHKREMILVYEYMANGNLRDHLYNTDNPPLP 573

Query: 573 WDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP-NFS 631
           W +RL+ICIGAAR LHYLH G  K IIHRDVKTTNILLD +WVAKVSDFGL K  P + +
Sbjct: 574 WTQRLQICIGAARGLHYLHAGVKKTIIHRDVKTTNILLDHKWVAKVSDFGLSKMSPTSVA 633

Query: 632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLA 691
             H+ST VKGS GYLDPEY+R Q L EKSDVYSFGVVL EVLCARPP+ +TG+++Q  LA
Sbjct: 634 NAHISTVVKGSFGYLDPEYFRFQRLNEKSDVYSFGVVLFEVLCARPPVNQTGEEEQAGLA 693

Query: 692 VWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV 751
            WA   Y+NGK+ +IIDP L+G   P+CL ++ E A+SCV D RI+RPSMSDVV GLE  
Sbjct: 694 HWAVTSYKNGKLEEIIDPHLEGKIAPMCLEKYGEXAVSCVLDQRIKRPSMSDVVRGLELA 753

Query: 752 FQLLRESSEK 761
            + L+ES+EK
Sbjct: 754 LE-LQESTEK 762

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	767
TAIR|locus:2081895	895	FER "FERONIA" [Arabidopsis tha	0.401	0.344	0.653	9.3e-189
TAIR|locus:2152312	880	AT5G38990 [Arabidopsis thalian	0.400	0.348	0.602	4.4e-167
TAIR|locus:2177202	873	AT5G39000 [Arabidopsis thalian	0.915	0.804	0.476	5.7e-162
TAIR|locus:2148830	858	ANX2 "ANXUR2" [Arabidopsis tha	0.398	0.356	0.613	6.6e-162
TAIR|locus:2084953	850	ANX1 "ANXUR1" [Arabidopsis tha	0.396	0.357	0.607	1.4e-159
TAIR|locus:2151349	855	THE1 "THESEUS1" [Arabidopsis t	0.383	0.343	0.6	1.8e-133
TAIR|locus:2204564	849	HERK2 "hercules receptor kinas	0.384	0.347	0.581	3.7e-133
TAIR|locus:2136338	878	AT4G39110 [Arabidopsis thalian	0.375	0.328	0.603	5.5e-128
TAIR|locus:2163158	842	AT5G61350 [Arabidopsis thalian	0.408	0.371	0.549	1.7e-126
TAIR|locus:2174249	829	AT5G59700 [Arabidopsis thalian	0.925	0.856	0.391	6.1e-126

TAIR|locus:2081895 FER "FERONIA" [Arabidopsis thaliana (taxid:3702)]

 Score = 1056 (376.8 bits), Expect = 9.3e-189, Sum P(2) = 9.3e-189
 Identities = 202/309 (65%), Positives = 237/309 (76%)

Query:   454 ASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ 513
             ASSLPS+LC  FS +EIK ATK+F+   ++G GGFG VY+G ++G +T VAIKR NP S+
Sbjct:   513 ASSLPSNLCRHFSFAEIKAATKNFDESRVLGVGGFGKVYRGEIDGGTTKVAIKRGNPMSE 572

Query:   514 QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPW 573
             QG  EFQTEI MLS+LR+ HLVSLIGYC ++ +MILVYDYMA GT+R+HLY   NP LPW
Sbjct:   573 QGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAHGTMREHLYKTQNPSLPW 632

Query:   574 DRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT 633
              +RL+ICIGAAR LHYLHTGA   IIHRDVKTTNILLDE+WVAKVSDFGL K GP    T
Sbjct:   633 KQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHT 692

Query:   634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVW 693
             HVST VKGS GYLDPEY+R Q LTEKSDVYSFGVVL E LCARP +  T  K+QV+LA W
Sbjct:   693 HVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEALCARPALNPTLAKEQVSLAEW 752

Query:   694 ATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
             A  CY+ G +  I+DP+LKG   P C  +F E AM CV D  I RPSM DV+W LEF  Q
Sbjct:   753 APYCYKKGMLDQIVDPYLKGKITPECFKKFAETAMKCVLDQGIERPSMGDVLWNLEFALQ 812

Query:   754 LLRESSEKS 762
             L +ES+E++
Sbjct:   813 L-QESAEEN 820

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0016020 "membrane" evidence=IDA

GO:0010483 "pollen tube reception" evidence=IMP

GO:0043680 "filiform apparatus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009791 "post-embryonic development" evidence=IMP

GO:0050832 "defense response to fungus" evidence=IMP

GO:0009506 "plasmodesma" evidence=IDA

GO:0000902 "cell morphogenesis" evidence=RCA

GO:0006007 "glucose catabolic process" evidence=RCA

GO:0006096 "glycolysis" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006972 "hyperosmotic response" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0010193 "response to ozone" evidence=RCA

GO:0016049 "cell growth" evidence=RCA

GO:0030244 "cellulose biosynthetic process" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048193 "Golgi vesicle transport" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2152312 AT5G38990 [Arabidopsis thaliana (taxid:3702)]

 Score = 948 (338.8 bits), Expect = 4.4e-167, Sum P(2) = 4.4e-167
 Identities = 188/312 (60%), Positives = 230/312 (73%)

Query:   454 ASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ 513
             ASSLPSDLC +FSI EIK AT DF   LIIG GGFG+VYKG ++G +T VA+KRL   S 
Sbjct:   502 ASSLPSDLCRRFSIYEIKSATNDFEEKLIIGVGGFGSVYKGRIDGGATLVAVKRLEITSN 561

Query:   514 QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNND---NPP 570
             QGA EF TE+ MLS+LR++HLVSLIGYC+DD +M+LVY+YM  GTL+DHL+  D   +PP
Sbjct:   562 QGAKEFDTELEMLSKLRHVHLVSLIGYCDDDNEMVLVYEYMPHGTLKDHLFRRDKASDPP 621

Query:   571 LPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP-N 629
             L W RRL+ICIGAAR L YLHTGA   IIHRD+KTTNILLDE +VAKVSDFGL + GP +
Sbjct:   622 LSWKRRLEICIGAARGLQYLHTGAKYTIIHRDIKTTNILLDENFVAKVSDFGLSRVGPTS 681

Query:   630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVN 689
              S+THVST VKG+ GYLDPEYYR Q+LTEKSDVYSFGVVLLEVLC RP  +++   +Q +
Sbjct:   682 ASQTHVSTVVKGTFGYLDPEYYRRQILTEKSDVYSFGVVLLEVLCCRPIRMQSVPPEQAD 741

Query:   690 LAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
             L  W    +    +  IID  L  +     + +F E+A+ CV D  + RP M+DVVW LE
Sbjct:   742 LIRWVKSNFNKRTVDQIIDSDLTADITSTSMEKFCEIAIRCVQDRGMERPPMNDVVWALE 801

Query:   750 FVFQLLRESSEK 761
             F  QL  E+++K
Sbjct:   802 FALQL-HETAKK 812

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2177202 AT5G39000 [Arabidopsis thaliana (taxid:3702)]

 Score = 1577 (560.2 bits), Expect = 5.7e-162, P = 5.7e-162
 Identities = 357/750 (47%), Positives = 466/750 (62%)

Query:    43 HQQSTISKKPREPPYSASRLSHSQFTYTFNVTPGQKFIRLHFYSTSY-SGFNISSAFFSV 101
             +Q+S +S    + PY  +R+  S+FTY+F VTPG  F+RL+FY T Y S FN   +FFSV
Sbjct:    73 YQESGVS----QIPYMTARIFRSEFTYSFPVTPGSNFLRLYFYPTRYGSQFNAVKSFFSV 128

Query:   102 KANSFTLVNNFSASFA-----PDDTFF-KEFCINVPEDQRSLSITFTPSPDYQDSYAFIN 155
             K N FTL+NNFSA        P   F  KEF I V    ++L++TFTPS    DS AF+N
Sbjct:   129 KVNGFTLLNNFSADLTVKASKPQTEFIIKEFIIPV---YQTLNLTFTPS---LDSLAFVN 182

Query:   156 GIELVSMPLNLYYTATDDQRLEFVGEGSQFSILNSNALETLYRINVGGSFISPQMDTGMY 215
             GIE+VS+P   Y     D  +  VG    F I NS A ET+YR+NVGG  +         
Sbjct:   183 GIEIVSIPNRFYSKGGFDDVITNVGSSVDFHIENSTAFETVYRLNVGGKTVGDS--GMFR 240

Query:   216 RTWIADDGYVTDARPSALPVNTTIVLRFSRILNFSAPLAVYRTARTMGL----DKNINEQ 271
             R    D+  ++++   +  V    +    +  ++ AP  VY T+R+MG     ++N+N  
Sbjct:   241 RWVSDDEIILSESSGISPIVPDIKINYTEKTPSYVAPDDVYATSRSMGNADHPEQNLN-- 298

Query:   272 YNLTWEFQVDSGFIYFVRLHFCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGV 331
             +NLTW F VD+GF Y VRLHFCE  SEV +EG RVF I++ N TA    DV   SGG+ +
Sbjct:   299 FNLTWLFTVDAGFSYLVRLHFCETLSEVNKEGQRVFSIFIENQTATLEMDVFRMSGGSWI 358

Query:   332 PEYRDYAVAIGSKSDVKKQNLSIALHPAPRWRTKYSDSILNGIEIFKV-DNNGSLAGPNP 390
             P Y DY V  GS S  ++ +L + LHP      KY D+ILNG+EI K+ D +G+LAGPNP
Sbjct:   359 PMYLDYTVIAGSGSG-RRHDLRLDLHPLVSINPKYYDAILNGVEILKMNDPDGNLAGPNP 417

Query:   391 YPTVSQASSFGTRSPQQSTKAKNN-RPRMLGIVGVVASGXXXXXXXXXXXSRRAVMK--- 446
              P VS       R+  +  K K++  P  L +VG +               ++   K   
Sbjct:   418 DPLVSP-DLIPNRATPRIRKNKSHILPITLAVVGSLVVLAMFVVGVLVIMKKKKKSKPST 476

Query:   447 -----------EAKSRGPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGF 495
                        ++ +  PA SLP+DLC +FSI EIK AT DF + LIIG GGFG+VYKG 
Sbjct:   477 NSSWCPLPHGTDSTNTKPAKSLPADLCRRFSIFEIKSATNDFEDKLIIGVGGFGSVYKGQ 536

Query:   496 LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMA 555
             ++G +T VA+KRL   S QGA EF+TE+ MLS+LR++HLVSLIGYC++D +M+LVY+YM 
Sbjct:   537 IDGGATLVAVKRLEITSNQGAKEFETELEMLSKLRHVHLVSLIGYCDEDNEMVLVYEYMP 596

Query:   556 RGTLRDHLYNND---NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE 612
              GTL+DHL+  D   +PPL W RRL+ICIGAAR L YLHTGA   IIHRD+KTTNILLDE
Sbjct:   597 HGTLKDHLFRRDKTSDPPLSWKRRLEICIGAARGLQYLHTGAKYTIIHRDIKTTNILLDE 656

Query:   613 EWVAKVSDFGLCKFGP-NFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLE 671
              +V KVSDFGL + GP + S+THVST VKG+ GYLDPEYYR Q+LTEKSDVYSFGVVLLE
Sbjct:   657 NFVTKVSDFGLSRVGPTSASQTHVSTVVKGTFGYLDPEYYRRQVLTEKSDVYSFGVVLLE 716

Query:   672 VLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCV 731
             VLC RP  +++   +Q +L  W    YR G +  IID  L  +     L +F E+A+ CV
Sbjct:   717 VLCCRPIRMQSVPPEQADLIRWVKSNYRRGTVDQIIDSDLSADITSTSLEKFCEIAVRCV 776

Query:   732 NDDRIRRPSMSDVVWGLEFVFQLLRESSEK 761
              D  + RP M+DVVW LEF  QL  E+++K
Sbjct:   777 QDRGMERPPMNDVVWALEFALQL-HETAKK 805

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2148830 ANX2 "ANXUR2" [Arabidopsis thaliana (taxid:3702)]

 Score = 978 (349.3 bits), Expect = 6.6e-162, Sum P(2) = 6.6e-162
 Identities = 189/308 (61%), Positives = 230/308 (74%)

Query:   455 SSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ 514
             S+L + LC +FS+SEIK  T +F+   +IG GGFG VYKG ++G  T VAIK+ NP S+Q
Sbjct:   499 SNLAAGLCRRFSLSEIKHGTHNFDESNVIGVGGFGKVYKGVIDG-GTKVAIKKSNPNSEQ 557

Query:   515 GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD 574
             G  EF+TEI +LS+LR+ HLVSLIGYC++ G+M L+YDYM+ GTLR+HLYN   P L W 
Sbjct:   558 GLNEFETEIELLSRLRHKHLVSLIGYCDEGGEMCLIYDYMSLGTLREHLYNTKRPQLTWK 617

Query:   575 RRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH 634
             RRL+I IGAAR LHYLHTGA   IIHRDVKTTNILLDE WVAKVSDFGL K GPN +  H
Sbjct:   618 RRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMNGGH 677

Query:   635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWA 694
             V+T VKGS GYLDPEY+R Q LTEKSDVYSFGVVL EVLCARP +  +  K+QV+L  WA
Sbjct:   678 VTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNPSLSKEQVSLGDWA 737

Query:   695 TECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
               C R G + DIIDP LKG   P CL +F + A  C++D  + RP+M DV+W LEF  QL
Sbjct:   738 MNCKRKGTLEDIIDPNLKGKINPECLKKFADTAEKCLSDSGLDRPTMGDVLWNLEFALQL 797

Query:   755 LRESSEKS 762
              +E+++ S
Sbjct:   798 -QETADGS 804

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009860 "pollen tube growth" evidence=IGI

GO:0016324 "apical plasma membrane" evidence=IDA

GO:0090404 "pollen tube tip" evidence=IDA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2084953 ANX1 "ANXUR1" [Arabidopsis thaliana (taxid:3702)]

 Score = 972 (347.2 bits), Expect = 1.4e-159, Sum P(2) = 1.4e-159
 Identities = 186/306 (60%), Positives = 230/306 (75%)

Query:   455 SSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ 514
             S+L + LC +FS+ EIK  T++F++  +IG GGFG VYKG ++G +T VA+K+ NP S+Q
Sbjct:   495 SNLAAGLCRRFSLPEIKHGTQNFDDSNVIGVGGFGKVYKGVIDG-TTKVAVKKSNPNSEQ 553

Query:   515 GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD 574
             G  EF+TEI +LS+LR+ HLVSLIGYC++ G+M LVYDYMA GTLR+HLYN   P L W 
Sbjct:   554 GLNEFETEIELLSRLRHKHLVSLIGYCDEGGEMCLVYDYMAFGTLREHLYNTKKPQLTWK 613

Query:   575 RRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH 634
             RRL+I IGAAR LHYLHTGA   IIHRDVKTTNIL+DE WVAKVSDFGL K GPN +  H
Sbjct:   614 RRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNILVDENWVAKVSDFGLSKTGPNMNGGH 673

Query:   635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWA 694
             V+T VKGS GYLDPEY+R Q LTEKSDVYSFGVVL E+LCARP +  +  K+QV+L  WA
Sbjct:   674 VTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPSLPKEQVSLGDWA 733

Query:   695 TECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
               C R G + DIIDP LKG     CL +F + A  C+ND  + RP+M DV+W LEF  QL
Sbjct:   734 MNCKRKGNLEDIIDPNLKGKINAECLKKFADTAEKCLNDSGLERPTMGDVLWNLEFALQL 793

Query:   755 LRESSE 760
              +E+++
Sbjct:   794 -QETAD 798

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009860 "pollen tube growth" evidence=IGI;RCA

GO:0016324 "apical plasma membrane" evidence=IDA

GO:0090404 "pollen tube tip" evidence=IDA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2151349 THE1 "THESEUS1" [Arabidopsis thaliana (taxid:3702)]

 Score = 892 (319.1 bits), Expect = 1.8e-133, Sum P(2) = 1.8e-133
 Identities = 177/295 (60%), Positives = 211/295 (71%)

Query:   465 FSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIG 524
             F   EI +AT  F+   ++G GGFG VYKG L  D T VA+KR NP S+QG  EF+TEI 
Sbjct:   498 FMFQEIMDATNKFDESSLLGVGGFGRVYKGTLE-DGTKVAVKRGNPRSEQGMAEFRTEIE 556

Query:   525 MLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAA 584
             MLS+LR+ HLVSLIGYC++  +MILVY+YMA G LR HLY  D PPL W +RL+ICIGAA
Sbjct:   557 MLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGADLPPLSWKQRLEICIGAA 616

Query:   585 RALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG 644
             R LHYLHTGAS+ IIHRDVKTTNILLDE  VAKV+DFGL K GP+  +THVST VKGS G
Sbjct:   617 RGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVADFGLSKTGPSLDQTHVSTAVKGSFG 676

Query:   645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG 704
             YLDPEY+R Q LTEKSDVYSFGVVL+EVLC RP +     ++QVN+A WA    + G + 
Sbjct:   677 YLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLPREQVNIAEWAMAWQKKGLLD 736

Query:   705 DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESS 759
              I+D  L G   P  L +F E A  C+ +  + RPSM DV+W LE+  QL   SS
Sbjct:   737 QIMDSNLTGKVNPASLKKFGETAEKCLAEYGVDRPSMGDVLWNLEYALQLEETSS 791

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI

GO:0009791 "post-embryonic development" evidence=IGI

GO:0051510 "regulation of unidimensional cell growth" evidence=IGI;RCA

GO:0009741 "response to brassinosteroid stimulus" evidence=IGI

GO:0009826 "unidimensional cell growth" evidence=IGI

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2204564 HERK2 "hercules receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 879 (314.5 bits), Expect = 3.7e-133, Sum P(2) = 3.7e-133
 Identities = 172/296 (58%), Positives = 217/296 (73%)

Query:   459 SDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE 518
             S +  +F+++EI+ ATK+F++ L IG GGFG VY+G L  D T +AIKR  P SQQG  E
Sbjct:   502 STMGRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELE-DGTLIAIKRATPHSQQGLAE 560

Query:   519 FQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK 578
             F+TEI MLS+LR+ HLVSLIG+C++  +MILVY+YMA GTLR HL+ ++ PPL W +RL+
Sbjct:   561 FETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLPPLSWKQRLE 620

Query:   579 ICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ 638
              CIG+AR LHYLHTG+ + IIHRDVKTTNILLDE +VAK+SDFGL K GP+   THVST 
Sbjct:   621 ACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGPSMDHTHVSTA 680

Query:   639 VKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECY 698
             VKGS GYLDPEY+R Q LTEKSDVYSFGVVL E +CAR  I  T  K Q+NLA WA    
Sbjct:   681 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINLAEWALSWQ 740

Query:   699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             +   +  IID  L+GN  P  L ++ E+A  C+ D+   RP M +V+W LE+V Q+
Sbjct:   741 KQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSLEYVLQI 796

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IGI

GO:0009826 "unidimensional cell growth" evidence=IGI

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2136338 AT4G39110 [Arabidopsis thaliana (taxid:3702)]

 Score = 878 (314.1 bits), Expect = 5.5e-128, Sum P(2) = 5.5e-128
 Identities = 175/290 (60%), Positives = 213/290 (73%)

Query:   465 FSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIG 524
             FS+SE++EATK+F    IIG GGFGNVY G L+ D T VA+KR NP S+QG  EFQTEI 
Sbjct:   514 FSLSELQEATKNFEASQIIGVGGFGNVYIGTLD-DGTKVAVKRGNPQSEQGITEFQTEIQ 572

Query:   525 MLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAA 584
             MLS+LR+ HLVSLIGYC+++ +MILVY++M+ G  RDHLY  +  PL W +RL+ICIG+A
Sbjct:   573 MLSKLRHRHLVSLIGYCDENSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGSA 632

Query:   585 RALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG 644
             R LHYLHTG ++ IIHRDVK+TNILLDE  VAKV+DFGL K    F + HVST VKGS G
Sbjct:   633 RGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSK-DVAFGQNHVSTAVKGSFG 691

Query:   645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG 704
             YLDPEY+R Q LT+KSDVYSFGVVLLE LCARP I     ++QVNLA WA +  R G + 
Sbjct:   692 YLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMQWKRKGLLE 751

Query:   705 DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
              IIDP L G   P  + +F E A  C+ D  + RP+M DV+W LE+  QL
Sbjct:   752 KIIDPHLAGTINPESMKKFAEAAEKCLEDYGVDRPTMGDVLWNLEYALQL 801

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

GO:0030048 "actin filament-based movement" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2163158 AT5G61350 [Arabidopsis thaliana (taxid:3702)]

 Score = 835 (299.0 bits), Expect = 1.7e-126, Sum P(2) = 1.7e-126
 Identities = 177/322 (54%), Positives = 224/322 (69%)

Query:   446 KEAKSRGPASSLPSD-LCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVA 504
             K++KS G +S   +  L   F  +E++ AT++F+   + G GGFG VY G ++G  T VA
Sbjct:   493 KKSKSNGFSSFFSNQGLGRYFPFTELQTATQNFDENAVCGVGGFGKVYIGEIDG-GTQVA 551

Query:   505 IKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY 564
             IKR +  S+QG  EFQTEI MLS+LR+ HLVSLIG+C+++ +MILVY+YM+ G LRDHLY
Sbjct:   552 IKRGSQSSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDENKEMILVYEYMSNGPLRDHLY 611

Query:   565 N---NDNPPLP---WDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKV 618
                 ND  P+P   W +RL+ICIG+AR LHYLHTGA++ IIHRDVKTTNILLDE  VAKV
Sbjct:   612 GSKENDPNPIPTLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKV 671

Query:   619 SDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
             SDFGL K  P   + HVST VKGS GYLDPEY+R Q LT+KSDVYSFGVVL EVLCARP 
Sbjct:   672 SDFGLSKDAP-MDEGHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPV 730

Query:   679 ILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRR 738
             I     ++QVNLA +A   +R G +  IIDP + G      L +FVE A  C+ +  + R
Sbjct:   731 INPQLPREQVNLAEYAMNLHRKGMLEKIIDPKIVGTISKGSLRKFVEAAEKCLAEYGVDR 790

Query:   739 PSMSDVVWGLEFVFQLLRESSE 760
             P M DV+W LE+  QL   S++
Sbjct:   791 PGMGDVLWNLEYALQLQEASAQ 812

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2174249 AT5G59700 [Arabidopsis thaliana (taxid:3702)]

 Score = 1237 (440.5 bits), Expect = 6.1e-126, P = 6.1e-126
 Identities = 302/772 (39%), Positives = 423/772 (54%)

Query:     7 YTPTEITFVACGWLGNISAHGQTWAGD-VSSQYSPLGHQQSTISKKPREPP-YSASRLSH 64
             Y P +   + CG   N++   + +  D ++S +    ++    S +      Y  +R+  
Sbjct:    25 YVPVDNYLINCGSSTNVTVTSRVFISDNLASNFLTSPNEILAASNRNSNSDIYQTARIFT 84

Query:    65 SQFTYTFNVTPGQKFIRLHFYSTSYSGFNISSAFFSVKANSFTLVNNFSASFAPDDTFFK 124
                 Y F+V  G+ +IRLHF    Y  F + SA FSV + +  L+++F+ S        K
Sbjct:    85 GISKYRFSVARGRHWIRLHFNPFQYQNFQMVSAKFSVSSETHVLLSDFTVS----SRVMK 140

Query:   125 EFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYYTATDDQRLEFVGEGSQ 184
             E+ +NV  D   L +TFTPS D   S+AF+N +E+VS+P  L+   + D    F G   +
Sbjct:   141 EYSLNVATDH--LELTFTPSGD---SFAFLNALEVVSVPDTLF---SGDP--SFAGSPGK 190

Query:   185 FSILNSNALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDARPSALPVNTTIVLRFS 244
             F  L+  ALET+YR+N+GG  ++P  DT + R W  D  ++ +     L  + + +    
Sbjct:   191 FQGLSWQALETVYRVNMGGPRVTPSNDT-LSRIWEPDSEFLVEKN---LVKSVSKIASVD 246

Query:   245 RILNFS----APLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRLHFCEFQSEVT 300
              +  F+    AP  VY T   M    N +  +N+TW+F VD GF YF+R HFC+  S+  
Sbjct:   247 YVPGFATEETAPRTVYGTCTEMNSADNPSSNFNVTWDFDVDPGFQYFLRFHFCDIVSKAL 306

Query:   301 EEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYR-DYAVAIGSKSDVKKQNLSIALHPA 359
              +    F +Y+ ++   +  D+ ++        Y  D+    GS    K+  +SI     
Sbjct:   307 NQ--LYFNLYVDSMDVVENLDLSSYLSNTLSGAYAMDFVT--GSAKLTKRIRVSIGRSSV 362

Query:   360 PRWRTKYSDSILNGIEIFKVDNNGSLAGPNPYPTVSQASSFGTRSPQ-QSTKAKNNRPRM 418
                 T Y  +ILNG+EI K++N+ S              S GT  P   S+  K N   +
Sbjct:   363 ---HTDYPTAILNGLEIMKMNNSKSQL------------SIGTFLPSGSSSTTKKNVGMI 407

Query:   419 LGI-VG----VVASGXXXXXXXXXXXSRRAVMKE---AKSRGPASS--------LPSDLC 462
             +G+ +G    +V  G            +    K      S G  SS        + S+  
Sbjct:   408 IGLTIGSLLALVVLGGFFVLYKKRGRDQDGNSKTWIPLSSNGTTSSSNGTTLASIASNSS 467

Query:   463 TQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTE 522
              +  +  +KEAT  F+    IG GGFG VYKG L+ D T VA+KR NP SQQG  EF+TE
Sbjct:   468 YRIPLVAVKEATNSFDENRAIGVGGFGKVYKGELH-DGTKVAVKRANPKSQQGLAEFRTE 526

Query:   523 IGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
             I MLSQ R+ HLVSLIGYC+++ +MILVY+YM  GTL+ HLY +    L W +RL+ICIG
Sbjct:   527 IEMLSQFRHRHLVSLIGYCDENNEMILVYEYMENGTLKSHLYGSGLLSLSWKQRLEICIG 586

Query:   583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS 642
             +AR LHYLHTG +K +IHRDVK+ NILLDE  +AKV+DFGL K GP   +THVST VKGS
Sbjct:   587 SARGLHYLHTGDAKPVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGS 646

Query:   643 IGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK 702
              GYLDPEY+R Q LTEKSDVYSFGVV+ EVLCARP I  T  ++ VNLA WA +  + G+
Sbjct:   647 FGYLDPEYFRRQQLTEKSDVYSFGVVMFEVLCARPVIDPTLTREMVNLAEWAMKWQKKGQ 706

Query:   703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             +  IIDP L+G   P  L +F E    C+ D  + RPSM DV+W LE+  QL
Sbjct:   707 LEHIIDPSLRGKIRPDSLRKFGETGEKCLADYGVDRPSMGDVLWNLEYALQL 758

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0007062 "sister chromatid cohesion" evidence=RCA

GO:0007131 "reciprocal meiotic recombination" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0033044 "regulation of chromosome organization" evidence=RCA

GO:0042138 "meiotic DNA double-strand break formation" evidence=RCA

GO:0045132 "meiotic chromosome segregation" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9SCZ4	FERON_ARATH	2, ., 7, ., 1, 1, ., 1	0.4881	0.9726	0.8335	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	767
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-51
pfam12819	335	pfam12819, Malectin_like, Carbohydrate-binding pro	3e-51
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-50
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-50
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-50
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-49
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-41
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-39
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-38
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	8e-37
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-32
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-29
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-29
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-28
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-28
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-28
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-27
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-27
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	8e-27
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-26
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-25
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-25
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-25
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-24
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-24
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-23
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-23
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-23
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-22
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-22
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-22
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-22
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	9e-22
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-21
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-21
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-21
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-21
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-21
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-21
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-21
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-20
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-20
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-19
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-19
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-19
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-19
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-18
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-18
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-18
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-18
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-18
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-18
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	7e-18
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-17
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-17
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-17
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-17
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-17
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-17
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-17
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-16
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-16
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-16
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-16
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	6e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-16
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	9e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	9e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-15
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-15
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-15
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	5e-15
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-15
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-15
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-14
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-14
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-14
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-14
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-14
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-13
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-13
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-13
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	6e-13
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	8e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-12
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-12
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-12
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-12
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-10
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-10
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	7e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-09
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-09
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-09
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-08
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-08
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	5e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-08
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	9e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	9e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-07
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-07
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-07
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-07
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	9e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-06
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-05
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	8e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	9e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	5e-04
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	5e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-04
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	8e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-04
pfam11721	164	pfam11721, Malectin, Di-glucose binding within end	0.001
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	0.002
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.003

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  179 bits (457), Expect = 2e-51
 Identities = 81/271 (29%), Positives = 125/271 (46%), Gaps = 28/271 (10%)

Query: 482 IIGRGGFGNVYKGFLNGDS----TPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVS 536
            +G G FG VYKG L G        VA+K L   + +  + EF  E  ++ +L + ++V 
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           L+G C ++  +++V +YM  G L D+L  N    L     L   +  AR + YL    SK
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SK 122

Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
             IHRD+   N L+ E  V K+SDFGL +   +    +     K  I ++ PE  +    
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYKVKGGKLPIRWMAPESLKEGKF 181

Query: 657 TEKSDVYSFGVVLLEV--LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
           T KSDV+SFGV+L E+  L   P            +  +  + YR  K            
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPY----PGMSNAEVLEYLKKGYRLPK------------ 225

Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
            PP C  +  ++ + C  +D   RP+ S++V
Sbjct: 226 -PPNCPPELYKLMLQCWAEDPEDRPTFSELV 255

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER

 Score =  181 bits (462), Expect = 3e-51
 Identities = 91/365 (24%), Positives = 132/365 (36%), Gaps = 62/365 (16%)

Query: 29  TWAGDVSSQYSPLGHQ-QSTISKKPREPPYSASRL--SHSQFTYTFNVTPGQK---FIRL 82
           TW  D     +          S      PY   R      +  YT  VTPG+     IR 
Sbjct: 19  TWVSDAGFIDTGKSGNISKENSSSFLSKPYKTLRSFPDGKRNCYTLPVTPGKGTKYLIRA 78

Query: 83  HFYSTSYSGFNISSAFFSVKANSFTLVNNFS------ASFAPDDTFFKEFCINVPEDQRS 136
            F   +Y G N  S+       SF L    +       S    D+  KE+ I+V +   +
Sbjct: 79  TFLYGNYDGLNSVSS-----PPSFDLYLGVNLWTTVNLSNDSGDSVVKEYIIHVTKS-DT 132

Query: 137 LSITFTPSPDYQDSYAFINGIELVSMPLNLYYTATDDQRLEFVGEGSQFSILNSNALETL 196
           LS+    +        FI+ +EL  +P +LY ++                   S AL+ +
Sbjct: 133 LSVCLVNT---GTGTPFISALELRPLPDSLYPSSG-----------------GSQALKLV 172

Query: 197 YRINVG--GSFISPQMDTGMYRTWIADDGYVTDARPSALPVNTTIVLRFSRILNFSAPLA 254
            R+N G     I    D    R W            S +  + ++ +  +       P A
Sbjct: 173 ARLNFGGSEGTIRYPDDV-YDRIWEPFFSSPGW---SQISTSLSVDISSNNAPYI-PPSA 227

Query: 255 VYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRLHFCEFQSEVTEEGDRVFKIYLANL 314
           V +TA T     N +   N TW+  VD  F Y+V LHF E QS  T    R F IY+   
Sbjct: 228 VLQTAVTPT---NASAPLNFTWDL-VDPNFEYYVYLHFAEIQSLET----REFDIYINGK 279

Query: 315 TAEDVADVIAWSGGNGVPEYRDYAVAIGSKSDVKKQNLSIALHPAPRWRTKYSDSILNGI 374
           T         + G +    Y D+ V +          L+I+L P           +LN +
Sbjct: 280 TVYGDVS-PKYLGTDTGALYLDFPVNVSGGG-----LLNISLVPTSGSTL---PPLLNAL 330

Query: 375 EIFKV 379
           EIFKV
Sbjct: 331 EIFKV 335

Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  175 bits (445), Expect = 3e-50
 Identities = 68/192 (35%), Positives = 93/192 (48%), Gaps = 9/192 (4%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLIGYC 541
           +G GGFG VY          VAIK +        LE    EI +L +L + ++V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
            D+  + LV +Y   G+L+D L  N    L  D  L+I +     L YLH   S  IIHR
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKEN-EGKLSEDEILRILLQILEGLEYLH---SNGIIHR 116

Query: 602 DVKTTNILLDE-EWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR-LQLLTEK 659
           D+K  NILLD      K++DFGL K   +         + G+  Y+ PE        +EK
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 660 SDVYSFGVVLLE 671
           SD++S GV+L E
Sbjct: 175 SDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  176 bits (448), Expect = 4e-50
 Identities = 81/274 (29%), Positives = 125/274 (45%), Gaps = 29/274 (10%)

Query: 482 IIGRGGFGNVYKGFLNGDST----PVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVS 536
            +G G FG VYKG L G        VA+K L   + +  + EF  E  ++ +L + ++V 
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           L+G C ++  + +V +YM  G L  +L  N  P L     L   +  AR + YL    SK
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR-PKLSLSDLLSFALQIARGMEYLE---SK 121

Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
             IHRD+   N L+ E  V K+SDFGL +   +    +     K  I ++ PE  +    
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYRKRGGKLPIRWMAPESLKEGKF 180

Query: 657 TEKSDVYSFGVVLLEV--LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
           T KSDV+SFGV+L E+  L  +P            +  +    YR  +            
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQPY----PGMSNEEVLEYLKNGYRLPQ------------ 224

Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGL 748
            PP C  +  ++ + C  +D   RP+ S++V  L
Sbjct: 225 -PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  176 bits (448), Expect = 4e-50
 Identities = 83/277 (29%), Positives = 130/277 (46%), Gaps = 33/277 (11%)

Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSL 537
            +G G FG VYKG L   +G +T VA+K L   + +    +F  E  ++ +L + ++V L
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHL-------YNNDNPPLPWDRRLKICIGAARALHYL 590
           +G C ++  + LV +YM  G L D+L        + +   L     L   I  A+ + YL
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121

Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
               SK  +HRD+   N L+ E+ V K+SDFGL +   +       T  K  I ++ PE 
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178

Query: 651 YRLQLLTEKSDVYSFGVVLLEV--LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID 708
            +  + T KSDV+SFGV+L E+  L A P            +  +  + YR  K      
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATP----YPGLSNEEVLEYLRKGYRLPK------ 228

Query: 709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
                  P  C ++  E+ +SC   D   RP+ S++V
Sbjct: 229 -------PEYCPDELYELMLSCWQLDPEDRPTFSELV 258

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  174 bits (444), Expect = 1e-49
 Identities = 81/273 (29%), Positives = 124/273 (45%), Gaps = 34/273 (12%)

Query: 483 IGRGGFGNVYKGFLNGDS----TPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G FG VYKG L GD     T VA+K L  G S++   EF  E  ++ +L + ++V L
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
           +G C     + +V +YM  G L D L  +    L     L++ +  A+ + YL    SK 
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHG-EKLTLKDLLQMALQIAKGMEYLE---SKN 122

Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLT 657
            +HRD+   N L+ E  V K+SDFGL +              K  I ++ PE  +    T
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT 182

Query: 658 EKSDVYSFGVVLLEV--LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN- 714
            KSDV+SFGV+L E+  L  +P                    Y      ++++    G  
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEQP--------------------YPGMSNEEVLELLEDGYR 222

Query: 715 --APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
              P  C ++  E+ + C   D   RP+ S++V
Sbjct: 223 LPRPENCPDELYELMLQCWAYDPEDRPTFSELV 255

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  152 bits (386), Expect = 1e-41
 Identities = 65/203 (32%), Positives = 94/203 (46%), Gaps = 9/203 (4%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLV 535
           +  L  +G G FG VY          VAIK +     +   E    EI +L +L++ ++V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
            L     D+ ++ LV +Y   G L D L       L  D           AL YLH   S
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLH---S 115

Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
           K I+HRD+K  NILLDE+   K++DFGL +           T   G+  Y+ PE    + 
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQ---LDPGEKLTTFVGTPEYMAPEVLLGKG 172

Query: 656 LTEKSDVYSFGVVLLEVLCARPP 678
             +  D++S GV+L E+L  +PP
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  146 bits (370), Expect = 2e-39
 Identities = 85/269 (31%), Positives = 125/269 (46%), Gaps = 24/269 (8%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--QGALEFQTEIGMLSQLRYLHLVSLIG 539
            +G G FG VYK    G    VA+K L   S+  +     + EI +L +L + ++V LI 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
              D   + LV +Y   G L D+L  +   PL  D   KI +   R L YLH   S  II
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLH---SNGII 120

Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL-TE 658
           HRD+K  NILLDE  V K++DFGL K     S + ++T V G+  Y+ PE          
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGYGP 178

Query: 659 KSDVYSFGVVLLEVLCARPP--ILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP 716
           K DV+S GV+L E+L  +PP       D+ Q+          R      +     K ++ 
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENILDQLQL---------IRRILGPPLEFDEPKWSSG 229

Query: 717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
                  ++    C+N D  +RP+  +++
Sbjct: 230 SEEAKDLIK---KCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  143 bits (362), Expect = 3e-38
 Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 9/201 (4%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIK--RLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           ++GRG FG+VY          +A+K   L+  S++     + EI +LS L++ ++V   G
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66

Query: 540 -YCNDDGQMILVY-DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
              +++   + ++ +Y++ G+L   L      P P  R+    I     L YLH   S  
Sbjct: 67  SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI--LEGLAYLH---SNG 121

Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLT 657
           I+HRD+K  NIL+D + V K++DFG  K   +      +  V+G+  ++ PE  R +   
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181

Query: 658 EKSDVYSFGVVLLEVLCARPP 678
             +D++S G  ++E+   +PP
Sbjct: 182 RAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  138 bits (350), Expect = 8e-37
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 11/205 (5%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV 535
            F  L  IG+GGFG VYK         VAIK +   S++   +   EI +L + ++ ++V
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 536 SLIG--YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
              G     D+  +++  ++ + G+L+D L  + N  L   +   +C    + L YLH  
Sbjct: 61  KYYGSYLKKDELWIVM--EFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYLH-- 115

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
            S  IIHRD+K  NILL  +   K+ DFGL       S T     + G+  ++ PE    
Sbjct: 116 -SNGIIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVING 171

Query: 654 QLLTEKSDVYSFGVVLLEVLCARPP 678
           +    K+D++S G+  +E+   +PP
Sbjct: 172 KPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  125 bits (317), Expect = 2e-32
 Identities = 78/262 (29%), Positives = 120/262 (45%), Gaps = 34/262 (12%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           IG+G FG+V  G   G    VA+K L       A  F  E  +++ LR+ +LV L+G   
Sbjct: 14  IGKGEFGDVMLGDYRGQK--VAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
               + +V +YMA+G+L D+L +     +   ++L   +     + YL     K  +HRD
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRD 127

Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N+L+ E+ VAKVSDFGL K     S+   S   K  + +  PE  R +  + KSDV
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK---EASQGQDSG--KLPVKWTAPEALREKKFSTKSDV 182

Query: 663 YSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG---NAPPV 718
           +SFG++L E+    R P  R                     + D++    KG    AP  
Sbjct: 183 WSFGILLWEIYSFGRVPYPRIP-------------------LKDVVPHVEKGYRMEAPEG 223

Query: 719 CLNQFVEVAMSCVNDDRIRRPS 740
           C  +  +V   C   D  +RP+
Sbjct: 224 CPPEVYKVMKDCWELDPAKRPT 245

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  117 bits (297), Expect = 1e-29
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 13/202 (6%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKR--LNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGY 540
           IG+G FG VY      D     +K   L+  S++   +   E+ +L +L + +++     
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67

Query: 541 CNDDGQMILVYDYMARGTLRDHL--YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVI 598
             + G++ +V +Y   G L   +     +  P P ++ L   +    AL YLH   S+ I
Sbjct: 68  FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKI 124

Query: 599 IHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT--HVSTQVKGSIGYLDPEYYRLQLL 656
           +HRD+K  NI L    + K+ DFG+ K     S T     T V G+  YL PE  + +  
Sbjct: 125 LHRDIKPQNIFLTSNGLVKLGDFGISKV---LSSTVDLAKTVV-GTPYYLSPELCQNKPY 180

Query: 657 TEKSDVYSFGVVLLEVLCARPP 678
             KSD++S G VL E+   + P
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  116 bits (292), Expect = 5e-29
 Identities = 86/286 (30%), Positives = 135/286 (47%), Gaps = 42/286 (14%)

Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSL 537
           +IG+G FG VY G L   +G     A+K LN  +    +E F  E  ++    + +++SL
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 538 IGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG----AARALHYLHT 592
           +G C   +G  ++V  YM  G LR+ + +  + P      +K  IG     A+ + YL  
Sbjct: 62  LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP-----TVKDLIGFGLQVAKGMEYL-- 114

Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEY 650
            ASK  +HRD+   N +LDE +  KV+DFGL +  +   +   H  T  K  + ++  E 
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173

Query: 651 YRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
            + Q  T KSDV+SFGV+L E++    PP                   Y +    DI   
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMTRGAPP-------------------YPDVDSFDITVY 214

Query: 710 FLKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF 752
            L+G     P  C +   EV +SC +     RP+ S++V  +E +F
Sbjct: 215 LLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  115 bits (290), Expect = 1e-28
 Identities = 78/289 (26%), Positives = 126/289 (43%), Gaps = 37/289 (12%)

Query: 483 IGRGGFGNVYKGFL--NGDST--PVAIKRLNP-GSQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G FG V        GD+T   VA+K LN  G +Q   +F+ EI +L  L + ++V  
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 538 IGYCNDDGQMI--LVYDYMARGTLRDHL----YNNDNPPLPWDRRLKICIGAARALHYLH 591
            G C   G     L+ +Y+  G+LRD+L       +   L     L       + + YL 
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRL-----LLFSSQICKGMDYLG 126

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS-IGYLDPEY 650
              S+  IHRD+   NIL++ E + K+SDFGL K  P     +   +   S I +  PE 
Sbjct: 127 ---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183

Query: 651 YRLQLLTEKSDVYSFGVVLLEVL------CARPP--ILRTGDKKQVNLAVWATECYRNGK 702
            R    +  SDV+SFGV L E+        + P   +   G  +   +     E  + G+
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243

Query: 703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV 751
                    +   PP C ++  ++   C   +   RPS +D++  ++ +
Sbjct: 244 ---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  117 bits (293), Expect = 3e-28
 Identities = 82/283 (28%), Positives = 120/283 (42%), Gaps = 23/283 (8%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE---FQTEIGMLSQLRYL 532
            +  L  +G G FG VY      D   VA+K L    +  + E   F  EI +L+ L + 
Sbjct: 1   SYRILRKLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 533 -HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNP-PLPWDRRLKICIGAARALHYL 590
            ++V L  +  D+G + LV +Y+  G+L D L       PL     L I      AL YL
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 591 HTGASKVIIHRDVKTTNILLDEE-WVAKVSDFGLCKF----GPNFSKTHVSTQVKGSIGY 645
           H   SK IIHRD+K  NILLD +  V K+ DFGL K     G   S   + +   G+ GY
Sbjct: 118 H---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 646 LDPEYYRLQLL---TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK 702
           + PE      L   +  SD++S G+ L E+L   PP     +    +  +   +      
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL---KIILELP 231

Query: 703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
              +  P    N P +      ++    +  D   R S S  +
Sbjct: 232 TPSLASPLSPSN-PELISKAASDLLKKLLAKDPKNRLSSSSDL 273

Length = 384

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  113 bits (284), Expect = 7e-28
 Identities = 78/273 (28%), Positives = 121/273 (44%), Gaps = 33/273 (12%)

Query: 482 IIGRGGFGNVYKGFLNGDSTP---VAIKRLNPGSQQGA-LEFQTEIGMLSQLRYLHLVSL 537
           +IG G FG V +G L         VAIK L  GS     L+F TE  ++ Q  + +++ L
Sbjct: 11  VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G       ++++ +YM  G+L   L  ND       + + +  G A  + YL   +   
Sbjct: 71  EGVVTKSRPVMIITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGIASGMKYL---SEMN 126

Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLT 657
            +HRD+   NIL++   V KVSDFGL +   +   T+ +   K  I +  PE    +  T
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT 186

Query: 658 EKSDVYSFGVVLLEVLC--ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN- 714
             SDV+SFG+V+ EV+    RP                    Y +    D+I     G  
Sbjct: 187 SASDVWSFGIVMWEVMSYGERP--------------------YWDMSNQDVIKAVEDGYR 226

Query: 715 -APPV-CLNQFVEVAMSCVNDDRIRRPSMSDVV 745
             PP+ C +   ++ + C   DR  RP+ S +V
Sbjct: 227 LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIV 259

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  111 bits (279), Expect = 3e-27
 Identities = 71/269 (26%), Positives = 122/269 (45%), Gaps = 25/269 (9%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V++G  N  +TPVA+K L PG+     +F  E  ++ +LR+  L+ L   C 
Sbjct: 14  LGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + +V + M  G+L ++L       L   + + +    A  + YL    ++  IHRD
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128

Query: 603 VKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSD 661
           +   N+L+ E  + KV+DFGL +    +  +       K  I +  PE       + KSD
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGA--KFPIKWTAPEAALYNRFSIKSD 186

Query: 662 VYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCL 720
           V+SFG++L E++   R P                     N ++   +D   +   PP C 
Sbjct: 187 VWSFGILLTEIVTYGRMPY----------------PGMTNAEVLQQVDQGYRMPCPPGCP 230

Query: 721 NQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
            +  ++ + C  +D   RP+   + W LE
Sbjct: 231 KELYDIMLDCWKEDPDDRPTFETLQWKLE 259

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  110 bits (276), Expect = 6e-27
 Identities = 83/292 (28%), Positives = 121/292 (41%), Gaps = 45/292 (15%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGAL--EFQTEIGMLSQLRYLH 533
           DF  L  IG+G FG V+K     D    A+K+++          E   E  +L++L   +
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           ++       D G++ +V +Y   G L   L      PLP D+  +  I     L +LH  
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH-- 118

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGP--NFSKTHVSTQVKGSIGYLDPEY 650
            SK I+HRD+K+ N+ LD     K+ D G+ K      NF+ T V T       YL PE 
Sbjct: 119 -SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPY-----YLSPEL 172

Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF 710
              +   EKSDV++ GVVL E    + P                   +     G +I   
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHP-------------------FDANNQGALILKI 213

Query: 711 LKGNAPPVCL---NQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESS 759
           ++G  PPV      Q  ++   C+  D  +RP            FQLLR  S
Sbjct: 214 IRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPD----------TFQLLRNPS 255

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  110 bits (275), Expect = 8e-27
 Identities = 89/282 (31%), Positives = 133/282 (47%), Gaps = 36/282 (12%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL-NPGSQQGALEFQTEIGMLSQLRYLH 533
           K+   L  IG+G FG+V  G   G    VA+K + N  + Q    F  E  +++QLR+ +
Sbjct: 6   KELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIKNDATAQA---FLAEASVMTQLRHSN 60

Query: 534 LVSLIGY-CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           LV L+G    + G + +V +YMA+G+L D+L +     L  D  LK  +    A+ YL  
Sbjct: 61  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE- 119

Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ--VKGSIGYLDPEY 650
             +   +HRD+   N+L+ E+ VAKVSDFGL       +K   STQ   K  + +  PE 
Sbjct: 120 --ANNFVHRDLAARNVLVSEDNVAKVSDFGL-------TKEASSTQDTGKLPVKWTAPEA 170

Query: 651 YRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
            R +  + KSDV+SFG++L E+    R P  R   K  V                  ++ 
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR----------------VEK 214

Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV 751
             K +AP  C     +V   C + D   RPS   +   LE +
Sbjct: 215 GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 6e-26
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 19/204 (9%)

Query: 482 IIGRGGFGNVYKGFLNGDS-TPVAIKRLNP-GSQQGAL-EFQTEIGMLSQLRYLHLVSLI 538
           +IGRG FG VYKG LN ++   VAIK+++    ++ AL     EI +L  L++ ++V  I
Sbjct: 7   LIGRGAFGVVYKG-LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAA---RALHYLHTGAS 595
           G       + ++ +Y   G+LR  +      P P      + +      + L YLH    
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFG--PFP---ESLVAVYVYQVLQGLAYLHE--- 117

Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHV-STQVKGSIGYLDPEYYRLQ 654
           + +IHRD+K  NIL  ++ V K++DFG+       +        V G+  ++ PE   + 
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVAT---KLNDVSKDDASVVGTPYWMAPEVIEMS 174

Query: 655 LLTEKSDVYSFGVVLLEVLCARPP 678
             +  SD++S G  ++E+L   PP
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  105 bits (263), Expect = 3e-25
 Identities = 74/271 (27%), Positives = 126/271 (46%), Gaps = 28/271 (10%)

Query: 482 IIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           +IG G FG V++G L         VAIK L PG +++   +F +E  ++ Q  + +++ L
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G        +++ +YM  G L  +L ++D     + + + +  G A  + YL   +   
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY-QLVGMLRGIAAGMKYL---SDMN 127

Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK-THVSTQVKGSIGYLDPEYYRLQLL 656
            +HRD+   NIL++     KVSDFGL +   +  + T+ ++  K  I +  PE    +  
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187

Query: 657 TEKSDVYSFGVVLLEVLC--ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
           T  SDV+SFG+V+ EV+    RP               W      N ++   I+   +  
Sbjct: 188 TSASDVWSFGIVMWEVMSFGERP--------------YWDMS---NHEVMKAINDGFRLP 230

Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           AP  C +   ++ + C   DR RRP   D+V
Sbjct: 231 APMDCPSAVYQLMLQCWQQDRARRPRFVDIV 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  105 bits (263), Expect = 6e-25
 Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 35/215 (16%)

Query: 483 IGRGGFGNVYKGFL-----NGDSTPVAIKRLNPGSQQGA-LEFQTEIGMLSQLRYLHLVS 536
           +G G FG V+ G         D   VA+K L   +   A  +F+ E  +L+  ++ ++V 
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 537 LIGYCNDDGQMILVYDYMARGT----LRDH------LYNNDNPPLPWDRR--LKICIGAA 584
             G C +    I+V++YM  G     LR H      L + D+P         L+I +  A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 585 RALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST---QVKG 641
             + YL   AS+  +HRD+ T N L+  + V K+ DFG+       S+   +T   +V G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGM-------SRDVYTTDYYRVGG 182

Query: 642 S----IGYLDPEYYRLQLLTEKSDVYSFGVVLLEV 672
                I ++ PE    +  T +SDV+SFGVVL E+
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 8e-25
 Identities = 63/191 (32%), Positives = 99/191 (51%), Gaps = 8/191 (4%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+ G  NG +T VA+K L PG+      F  E  ++ +LR+  LV L   C+
Sbjct: 14  LGAGQFGEVWMGTWNG-TTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V +YM++G+L D L + +   L   + + +    A  + YL    S+  IHRD
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRD 128

Query: 603 VKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSD 661
           +   NIL+ E  V K++DFGL +    +          K  I +  PE       T KSD
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDEYTAREGA--KFPIKWTAPEAANYGRFTIKSD 186

Query: 662 VYSFGVVLLEV 672
           V+SFG++L E+
Sbjct: 187 VWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  103 bits (258), Expect = 2e-24
 Identities = 59/192 (30%), Positives = 94/192 (48%), Gaps = 10/192 (5%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V++G L  +   VAIK L         +FQ E+  L +LR+ HL+SL   C+
Sbjct: 14  LGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72

Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
               + ++ + M +G+L   L + +   LP    + +    A  + YL     +  IHRD
Sbjct: 73  VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRD 129

Query: 603 VKTTNILLDEEWVAKVSDFGLCKF--GPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKS 660
           +   NIL+ E+ V KV+DFGL +      +  +      K    +  PE       + KS
Sbjct: 130 LAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK----WTAPEAASHGTFSTKS 185

Query: 661 DVYSFGVVLLEV 672
           DV+SFG++L E+
Sbjct: 186 DVWSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 6e-24
 Identities = 77/268 (28%), Positives = 125/268 (46%), Gaps = 31/268 (11%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKR----LNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           IG+G FG+VYKG L   +T VA+K     L P  ++   +F  E  +L Q  + ++V LI
Sbjct: 3   IGKGNFGDVYKGVLK-GNTEVAVKTCRSTLPPDLKR---KFLQEAEILKQYDHPNIVKLI 58

Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVI 598
           G C     + +V + +  G+L   L    N  L   + L++ + AA  + YL    SK  
Sbjct: 59  GVCVQKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLE---SKNC 114

Query: 599 IHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
           IHRD+   N L+ E  V K+SDFG+ +   G  ++ +    Q+   I +  PE       
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRY 172

Query: 657 TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP 716
           T +SDV+S+G++L E           GD     ++        N +  + I+   +  AP
Sbjct: 173 TSESDVWSYGILLWE-------TFSLGDTPYPGMS--------NQQTRERIESGYRMPAP 217

Query: 717 PVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
            +C  +   + + C   D   RPS S++
Sbjct: 218 QLCPEEIYRLMLQCWAYDPENRPSFSEI 245

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  100 bits (250), Expect = 2e-23
 Identities = 74/250 (29%), Positives = 104/250 (41%), Gaps = 38/250 (15%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT------EIGMLSQLR 530
           F  L +IG+G FG V            A+K +N   +Q  +E  +      E  +L +L 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMN---KQKCVEKGSVRNVLNERRILQELN 58

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR----- 585
           +  LV+L     D+  M LV D +  G LR HL           +++K      +     
Sbjct: 59  HPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL----------SQKVKFSEEQVKFWICE 108

Query: 586 ---ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL-CKFGPNFSKTHVSTQVKG 641
              AL YLH   SK IIHRD+K  NILLDE+    ++DF +  K  P+   T  S    G
Sbjct: 109 IVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS----G 161

Query: 642 SIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP---ILRTGDKKQVNLAVWATECY 698
           + GY+ PE    Q  +   D +S GV   E L  + P     RT   +       A   Y
Sbjct: 162 TPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLY 221

Query: 699 RNGKIGDIID 708
                 + ID
Sbjct: 222 PATWSTEAID 231

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  100 bits (250), Expect = 3e-23
 Identities = 88/293 (30%), Positives = 139/293 (47%), Gaps = 49/293 (16%)

Query: 483 IGRGGFGNVYKGFLN--GDSTP--VAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+G FG+V     +   D+T   VA+K+L   + +   +F+ EI +L  L++ ++V   
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 539 GYCNDDGQ--MILVYDYMARGTLRDHLYNN----DNPPL---PWDRRLKICIGAARALHY 589
           G C   G+  + LV +Y+  G+LRD+L  +    D+  L         +IC G    + Y
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYAS----QICKG----MEY 123

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS-IGYLDP 648
           L    SK  +HRD+ T NIL++ E   K+ DFGL K  P   + +   +   S I +  P
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAP 180

Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVL--CAR---PPIL---RTGDKKQVNLAVWATECYRN 700
           E       +  SDV+SFGVVL E+     +   PP       G+ KQ  + V+       
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVY------- 233

Query: 701 GKIGDIIDPFLKGN----APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
                +I+  LK N    APP C  +   +   C N+D  +RPS S++   +E
Sbjct: 234 ----HLIE-LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 99.6 bits (249), Expect = 5e-23
 Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 9/209 (4%)

Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH 533
            + + NL  IG G  G VYK         VAIK++    Q   L    EI ++   ++ +
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPN 76

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           +V          ++ +V +YM  G+L D +  N    +   +   +C    + L YLH  
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH-- 133

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
            S+ +IHRD+K+ NILL ++   K++DFG   +     SK +  + V G+  ++ PE  +
Sbjct: 134 -SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN--SVV-GTPYWMAPEVIK 189

Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPILR 681
            +    K D++S G++ +E+    PP LR
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEPPYLR 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 97.9 bits (244), Expect = 1e-22
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 17/206 (8%)

Query: 480 LLIIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLH 533
           +  +GRG FG V+     G       T V +K L     +    EF+ E+ M  +L + +
Sbjct: 10  ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKN 69

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHL-------YNNDNPPLPWDRRLKICIGAARA 586
           +V L+G C +     ++ +Y   G L+  L            PPL   +++ +C   A  
Sbjct: 70  VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129

Query: 587 LHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL 646
           + +L        +HRD+   N L+  +   KVS   L K   N S+ +        + +L
Sbjct: 130 MDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYN-SEYYKLRNALIPLRWL 185

Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEV 672
            PE  +    + KSDV+SFGV++ EV
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 76/275 (27%), Positives = 121/275 (44%), Gaps = 37/275 (13%)

Query: 482 IIGRGGFGNVYKGF----LNGDSTPVAIKRL-NPGSQQGALEFQTEIGMLSQLRYLHLVS 536
           ++G G FG VYKG           PVAIK L    S +   E   E  +++ + + H+V 
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHTGAS 595
           L+G C    Q+ L+   M  G L D++ N+ DN  +     L  C+  A+ + YL     
Sbjct: 74  LLGICLSS-QVQLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLE---E 127

Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
           K ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E    ++
Sbjct: 128 KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI 187

Query: 656 LTEKSDVYSFGVVLLEVLC--ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
            T KSDV+S+GV + E++   A+P                    Y      +I D   KG
Sbjct: 188 YTHKSDVWSYGVTVWELMTFGAKP--------------------YEGIPAVEIPDLLEKG 227

Query: 714 N---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
                PP+C      V + C   D   RP+  +++
Sbjct: 228 ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 68/216 (31%), Positives = 104/216 (48%), Gaps = 35/216 (16%)

Query: 483 IGRGGFGNVYKGFLNGDS-----TPVAIKRL----NPGSQQGALEFQTEIGMLSQLRYLH 533
           +G G FG VYKG L G +     T VAIK L     P  QQ   EF+ E  ++S L++ +
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ---EFRQEAELMSDLQHPN 69

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNN---DNP-----------PLPWDRRLKI 579
           +V L+G C  +    ++++Y+A G L + L  N    +             L     L I
Sbjct: 70  IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129

Query: 580 CIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
            I  A  + YL   +S   +HRD+   N L+ E    K+SDFGL +   +     V ++ 
Sbjct: 130 AIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 640 KGSIGYLDPE---YYRLQLLTEKSDVYSFGVVLLEV 672
              + ++ PE   Y +    T +SD++SFGVVL E+
Sbjct: 187 LLPVRWMPPEAILYGK---FTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 55/195 (28%), Positives = 84/195 (43%), Gaps = 9/195 (4%)

Query: 483 IGRGGFGNVYKG---FLNGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSLI 538
           +G G FG V +G      G   PVA+K L        + +F  E  ++  L + +L+ L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVI 598
           G       +++V +    G+L D L  +              +  A  + YL    SK  
Sbjct: 63  GVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRF 118

Query: 599 IHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST-QVKGSIGYLDPEYYRLQLLT 657
           IHRD+   NILL  +   K+ DFGL +  P     +V    +K    +  PE  R +  +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178

Query: 658 EKSDVYSFGVVLLEV 672
             SDV+ FGV L E+
Sbjct: 179 HASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 96.2 bits (240), Expect = 4e-22
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 32/216 (14%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIK--RLNPGSQQGALEFQTEIGMLSQLRYL 532
           + F+ L  +G G +G+VYK         VAIK   +    Q    E   EI +L Q    
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ----EIIKEISILKQCDSP 58

Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V   G    +  + +V +Y   G++ D +    N  L  +    I     + L YLH 
Sbjct: 59  YIVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLTEEEIAAILYQTLKGLEYLH- 116

Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS-------IG- 644
             S   IHRD+K  NILL+EE  AK++DFG            VS Q+  +       IG 
Sbjct: 117 --SNKKIHRDIKAGNILLNEEGQAKLADFG------------VSGQLTDTMAKRNTVIGT 162

Query: 645 --YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
             ++ PE  +      K+D++S G+  +E+   +PP
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 95.6 bits (238), Expect = 7e-22
 Identities = 64/190 (33%), Positives = 95/190 (50%), Gaps = 7/190 (3%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+ G   G    VAIK +  G+     +F  E  ++ +L + +LV L G C 
Sbjct: 12  LGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSED-DFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
               + +V +YMA G L ++L       L  +  L +C     A+ YL    S   IHRD
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAMEYLE---SNGFIHRD 125

Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E+ V KVSDFGL ++  +   T  S   K  + +  PE +     + KSDV
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDV 184

Query: 663 YSFGVVLLEV 672
           +SFGV++ EV
Sbjct: 185 WSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 95.4 bits (237), Expect = 7e-22
 Identities = 63/190 (33%), Positives = 95/190 (50%), Gaps = 7/190 (3%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           IG G FG V+ G+       VAIK +  G+     +F  E  ++ +L +  LV L G C 
Sbjct: 12  IGSGQFGLVWLGYWLEK-RKVAIKTIREGAMSEE-DFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           +   + LV+++M  G L D+L          +  L +C+     + YL    S  +IHRD
Sbjct: 70  ERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRD 125

Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  V KVSDFG+ +F  +   T  ST  K  + +  PE +     + KSDV
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSKSDV 184

Query: 663 YSFGVVLLEV 672
           +SFGV++ EV
Sbjct: 185 WSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 94.9 bits (237), Expect = 9e-22
 Identities = 61/199 (30%), Positives = 90/199 (45%), Gaps = 10/199 (5%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEF-QTEIGMLSQLRYLHLVSLIG 539
           +G+G FG V            A+K L      ++  +E   TE  +LS++ +  +V L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
               + ++ LV +Y   G L  HL           R     I    AL YLH   S  II
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEI--VLALEYLH---SLGII 115

Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEK 659
           +RD+K  NILLD +   K++DFGL K     S+   +    G+  YL PE    +   + 
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173

Query: 660 SDVYSFGVVLLEVLCARPP 678
            D +S GV+L E+L  +PP
Sbjct: 174 VDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 71/270 (26%), Positives = 112/270 (41%), Gaps = 30/270 (11%)

Query: 483 IGRGGFGNVYKGFL---NGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G G FG+V KG     +G    VA+K L       G  EF  E  +++QL +  +V LI
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVI 598
           G C  +  ++LV +    G L  +L       +P     ++    A  + YL    SK  
Sbjct: 63  GVCKGE-PLMLVMELAPLGPLLKYL--KKRREIPVSDLKELAHQVAMGMAYLE---SKHF 116

Query: 599 IHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLT 657
           +HRD+   N+LL     AK+SDFG+ +  G        +T  +  + +  PE       +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176

Query: 658 EKSDVYSFGVVLLEVLC--ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNA 715
            KSDV+S+GV L E     A+P     G+ K   +        R  +             
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKP----YGEMKGAEVIAMLESGERLPR------------- 219

Query: 716 PPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           P  C  +   + +SC       RP+ S++ 
Sbjct: 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELE 249

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 95.5 bits (237), Expect = 1e-21
 Identities = 77/294 (26%), Positives = 123/294 (41%), Gaps = 40/294 (13%)

Query: 483 IGRGGFGNV-----YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G FG V     Y      D   VA+K L   S     +F  E  +L+ L++ H+V  
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 538 IGYCNDDGQMILVYDYMARGT----LRDH-----LYNNDNPP--LPWDRRLKICIGAARA 586
            G C +   +I+V++YM  G     LR H     L    N P  L   + L I    A  
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 587 LHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL 646
           + YL   AS+  +HRD+ T N L+ E  + K+ DFG+ +   +     V       I ++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGD 705
            PE    +  T +SDV+S GVVL E+    + P  +  + + +       EC   G++  
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI-------ECITQGRV-- 240

Query: 706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESS 759
                     P  C  +  ++ + C      R P M   +  +  + Q L ++S
Sbjct: 241 -------LQRPRTCPKEVYDLMLGCWQ----REPHMRLNIKEIHSLLQNLAKAS 283

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 17/221 (7%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH-- 533
           D   + ++G+G  G VYK          A+K+++        EF+ ++  L +L+ L   
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQL--LRELKTLRSC 56

Query: 534 ----LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
               +V   G    +G++ +V +YM  G+L D L       +P      I     + L Y
Sbjct: 57  ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLK--KVGKIPEPVLAYIARQILKGLDY 114

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           LHT   + IIHRD+K +N+L++ +   K++DFG+ K   N +    +T V G++ Y+ PE
Sbjct: 115 LHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN-TLDQCNTFV-GTVTYMSPE 170

Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL 690
             + +  +  +D++S G+ LLE    + P L  G      L
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL 211

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =   99 bits (249), Expect = 1e-21
 Identities = 88/306 (28%), Positives = 144/306 (47%), Gaps = 31/306 (10%)

Query: 459 SDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE 518
           S +    +I++I  + K+ N   +I RG  G  YKG    +     +K +N  +      
Sbjct: 677 SKVSKSITINDILSSLKEEN---VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP--- 730

Query: 519 FQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK 578
             +EI  + +L++ ++V LIG C  +    L+++Y+    L + L N     L W+RR K
Sbjct: 731 -SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRK 784

Query: 579 ICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ 638
           I IG A+AL +LH   S  ++  ++    I++D +         L    P    T     
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH-----LRLSLPGLLCTDTKCF 839

Query: 639 VKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVN--LAVWATE 696
           +  S  Y+ PE    + +TEKSD+Y FG++L+E+L  + P      +  V+  +  WA  
Sbjct: 840 I--SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP---ADAEFGVHGSIVEWARY 894

Query: 697 CYRNGKIGDIIDPFLKGNAPPVCLNQFVEV---AMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           CY +  +   IDP ++G+   V  N+ VEV   A+ C   D   RP  +DV+  LE    
Sbjct: 895 CYSDCHLDMWIDPSIRGDV-SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA-- 951

Query: 754 LLRESS 759
             R SS
Sbjct: 952 -SRSSS 956

Length = 968

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 33/218 (15%)

Query: 483 IGRGGFGNVYKGFLNGDS-----TPVAIKRLNPGSQQGA-LEFQTEIGMLSQLRYLHLVS 536
           +G+G FG VY+G   G       T VAIK +N  +     +EF  E  ++ +    H+V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHL--------YNNDNPPLPWDRRLKICIGAARALH 588
           L+G  +     ++V + MA+G L+ +L         N    P    + +++    A  + 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYL 646
           YL   A+K  +HRD+   N ++ E+   K+ DFG+ +  +  ++ +       KG  G L
Sbjct: 134 YL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR-------KGGKGLL 183

Query: 647 -----DPEYYRLQLLTEKSDVYSFGVVLLEV--LCARP 677
                 PE  +  + T KSDV+SFGVVL E+  L  +P
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 93.5 bits (232), Expect = 3e-21
 Identities = 81/281 (28%), Positives = 123/281 (43%), Gaps = 41/281 (14%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
           IIG G FG V +G   G    V   + +  +Q     F  E  ++++L + +LV L+G  
Sbjct: 13  IIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQA----FLEETAVMTKLHHKNLVRLLGVI 68

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
             +G  I V + M++G L + L       +   + L+  +  A  + YL    SK ++HR
Sbjct: 69  LHNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHR 124

Query: 602 DVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSD 661
           D+   NIL+ E+ VAKVSDFGL + G            K  + +  PE  + +  + KSD
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDN-----SKLPVKWTAPEALKHKKFSSKSD 179

Query: 662 VYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCL 720
           V+S+GV+L EV    R P  +   K+         EC   G     ++P      P  C 
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKGY---RMEP------PEGCP 223

Query: 721 NQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEK 761
                +  SC   +  +RPS           F  LRE  EK
Sbjct: 224 ADVYVLMTSCWETEPKKRPS-----------FHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 93.0 bits (231), Expect = 5e-21
 Identities = 63/195 (32%), Positives = 102/195 (52%), Gaps = 9/195 (4%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           ++GRG FG V+      D   V IK++     ++   L  Q E  +L  L + +++    
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
              +D  +++V +Y   GTL +++    N  L  D  L   +    ALH++HT   K+I+
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLIL 123

Query: 600 HRDVKTTNILLDE-EWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTE 658
           HRD+KT NILLD+ + V K+ DFG+ K     SK+   T V G+  Y+ PE    +   +
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILS--SKSKAYT-VVGTPCYISPELCEGKPYNQ 180

Query: 659 KSDVYSFGVVLLEVL 673
           KSD+++ G VL E+ 
Sbjct: 181 KSDIWALGCVLYELA 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 93.5 bits (232), Expect = 5e-21
 Identities = 70/281 (24%), Positives = 118/281 (41%), Gaps = 38/281 (13%)

Query: 483 IGRGGFGNVYKG-----FLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G FG V+           D   VA+K L   S+    +FQ E  +L+ L++ H+V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNN-----------DNP--PLPWDRRLKICIGAA 584
            G C +   +++V++YM  G L   L ++           D     L   + L I    A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 585 RALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG 644
             + YL   AS   +HRD+ T N L+ +  V K+ DFG+ +   +     V  +    I 
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKI 703
           ++ PE    +  T +SD++SFGVVL E+    + P  +  + +       A EC   G+ 
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-------AIECITQGR- 241

Query: 704 GDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
                   +   P  C  +   +   C   +  +R  + D+
Sbjct: 242 --------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 6e-21
 Identities = 62/215 (28%), Positives = 92/215 (42%), Gaps = 29/215 (13%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEF-QTEIGMLSQLRYLH 533
           + F  L  IG+G FG VYK      +  VAIK ++    +  +E  Q EI  LSQ R  +
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           +    G      ++ ++ +Y   G+  D L       L       I       L YLH  
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLH-- 115

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK----------GSI 643
             +  IHRD+K  NILL EE   K++DFG            VS Q+           G+ 
Sbjct: 116 -EEGKIHRDIKAANILLSEEGDVKLADFG------------VSGQLTSTMSKRNTFVGTP 162

Query: 644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            ++ PE  +     EK+D++S G+  +E+    PP
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 69/273 (25%), Positives = 118/273 (43%), Gaps = 26/273 (9%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHRD
Sbjct: 73  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 129

Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDV 188

Query: 663 YSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG---NAPPVC 719
           ++FGV+L E+                  A +    Y    +  + +   KG     P  C
Sbjct: 189 WAFGVLLWEI------------------ATYGMSPYPGIDLSQVYELLEKGYRMERPEGC 230

Query: 720 LNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF 752
             +  E+  +C   +   RPS +++    E +F
Sbjct: 231 PPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 60/191 (31%), Positives = 94/191 (49%), Gaps = 7/191 (3%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+ G+ NG  T VAIK L  GS      F  E  ++ QL++  LV L     
Sbjct: 14  LGAGQFGEVWMGYYNG-HTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ +YM  G+L D L   +   L  ++ + +    A  + ++     K  IHRD
Sbjct: 72  QE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRD 127

Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ E    K++DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDV 186

Query: 663 YSFGVVLLEVL 673
           +SFG++L E++
Sbjct: 187 WSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 24/218 (11%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQ--TEIGMLSQLRYLH 533
           D+  L  IG+G FG V K     D   +  K ++ G+     + Q  +E+ +L +L++ +
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60

Query: 534 LVSLIGYCN-----DDGQMILVYDYMARGTLRDHL--YNNDNPPLPWDRRLKICIGAARA 586
           +V    Y +      +  + +V +Y   G L   +     +   +  +   +I      A
Sbjct: 61  IV---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA 117

Query: 587 LHYLHTG--ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN---FSKTHVSTQVKG 641
           L+  H        ++HRD+K  NI LD     K+ DFGL K   +   F+KT+V T    
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPY-- 175

Query: 642 SIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCA-RPP 678
              Y+ PE        EKSD++S G ++ E LCA  PP
Sbjct: 176 ---YMSPEQLNHMSYDEKSDIWSLGCLIYE-LCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 75/289 (25%), Positives = 133/289 (46%), Gaps = 39/289 (13%)

Query: 482 IIGRGGFGNVYKGFLNGDSTP-----VAIKRL-NPGSQQGALEFQTEIGMLSQL-RYLHL 534
            +G G FG V K    G   P     VA+K L +  +++   +  +E+ M+  + ++ ++
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHL--------YNNDNPPLPWDRRLK------IC 580
           ++L+G C  +G + +V +Y A G LRD L        Y + + P P +  L         
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 581 IGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK 640
              AR + +L   ASK  IHRD+   N+L+ E+ V K++DFGL +   +      +T  +
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 641 GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRN 700
             + ++ PE    ++ T +SDV+SFGV+L E       I   G      + V   E ++ 
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWE-------IFTLGGSPYPGIPVE--ELFKL 246

Query: 701 GKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
            K G  ++       P  C  +   +   C ++   +RP+   +V  L+
Sbjct: 247 LKEGYRMEK------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 91.6 bits (227), Expect = 2e-20
 Identities = 69/279 (24%), Positives = 121/279 (43%), Gaps = 31/279 (11%)

Query: 474 TKDFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRL-NPGSQQGALEFQTEIGMLSQ 528
             +   L ++G G FG V+KG     GDS   PVAIK + +   +Q   E    +  +  
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65

Query: 529 LRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALH 588
           L + ++V L+G C     + LV      G+L DH+  + +   P  R L  C+  A+ ++
Sbjct: 66  LDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDP-QRLLNWCVQIAKGMY 123

Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           YL       ++HR++   NILL  + + +++DFG+        K +  ++ K  I ++  
Sbjct: 124 YLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180

Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID 708
           E       T +SDV+S+GV + E++                   +  E Y   +  ++ D
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMM------------------SYGAEPYAGMRPHEVPD 222

Query: 709 PFLKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
              KG     P +C      V + C   D   RP+  ++
Sbjct: 223 LLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKEL 261

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 90.9 bits (225), Expect = 3e-20
 Identities = 58/191 (30%), Positives = 98/191 (51%), Gaps = 6/191 (3%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+ G+ N +ST VA+K L PG+      F  E  ++  L++  LV L     
Sbjct: 14  LGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ +YMA+G+L D L +++   +   + +      A  + Y+     K  IHRD
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 128

Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  N+L+ E  + K++DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDV 187

Query: 663 YSFGVVLLEVL 673
           +SFG++L E++
Sbjct: 188 WSFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 90.2 bits (224), Expect = 5e-20
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 10/196 (5%)

Query: 482 IIGRGGFGNVYKGF---LNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSL 537
            IG G FG+VY+G       +   VA+K     +     E F  E  ++ Q  + H+V L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
           IG   ++  + +V +    G LR +L  N    L     +      + AL YL    SK 
Sbjct: 73  IGVITEN-PVWIVMELAPLGELRSYLQVNKYS-LDLASLILYSYQLSTALAYLE---SKR 127

Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLT 657
            +HRD+   N+L+      K+ DFGL ++  + S    S   K  I ++ PE    +  T
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASK-GKLPIKWMAPESINFRRFT 186

Query: 658 EKSDVYSFGVVLLEVL 673
             SDV+ FGV + E+L
Sbjct: 187 SASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 89.2 bits (221), Expect = 1e-19
 Identities = 73/279 (26%), Positives = 119/279 (42%), Gaps = 34/279 (12%)

Query: 482 IIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           +IG G FG V +G L         VAIK L  G +++   +F +E  ++ Q  + +++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDN--PPLPWDRRLKICIGAARALHYLHTGAS 595
            G       ++++ ++M  G L   L  ND     +     L+   G A  + YL   + 
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYL---SE 124

Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS---IGYLDPEYYR 652
              +HRD+   NIL++   V KVSDFGL +F  + +     T   G    I +  PE   
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 653 LQLLTEKSDVYSFGVVLLEVLC--ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF 710
            +  T  SDV+S+G+V+ EV+    RP               W      N  + + I+  
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERP--------------YWDMS---NQDVINAIEQD 227

Query: 711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
            +   P  C     ++ + C   DR  RP    +V  L+
Sbjct: 228 YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 56/204 (27%), Positives = 88/204 (43%), Gaps = 14/204 (6%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIK--RLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGY 540
           IG G FG VY          +A+K  R+     +   E   E+ +L  L++ +LV   G 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 541 CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIH 600
                ++ +  +Y + GTL + L +         R   + +     L YLH   S  I+H
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLH---SHGIVH 122

Query: 601 RDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG---YLDPEYYRLQLLT 657
           RD+K  NI LD   V K+ DFG      N + T +  +V+   G   Y+ PE        
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKN-NTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181

Query: 658 EK---SDVYSFGVVLLEVLCARPP 678
                +D++S G V+LE+   + P
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 88.6 bits (220), Expect = 3e-19
 Identities = 78/298 (26%), Positives = 126/298 (42%), Gaps = 56/298 (18%)

Query: 483 IGRGGFGNVY------------KGFLNGDS----TPVAIKRLNPGSQQGAL-EFQTEIGM 525
           +G G FG V+            K F   D+      VA+K L P +   A  +F  E+ +
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 526 LSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY---------NNDNPPLPWDRR 576
           LS+L   ++  L+G C  D  + ++ +YM  G L   L            ++  L +   
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132

Query: 577 LKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTH 634
           L +    A  + YL    S   +HRD+ T N L+ + +  K++DFG+ +  +  ++ +  
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR-- 187

Query: 635 VSTQVKGS----IGYLDPEYYRLQLLTEKSDVYSFGVVLLEV--LCARPPILRTGDKKQV 688
               V+G     I ++  E   L   T KSDV++FGV L E+  LC   P     D +QV
Sbjct: 188 ----VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-QQV 242

Query: 689 --NLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
             N    A   +R+     I  P      PP C     E+ + C   D   RP+  ++
Sbjct: 243 IEN----AGHFFRDDG-RQIYLP-----RPPNCPKDIYELMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 88.5 bits (219), Expect = 3e-19
 Identities = 71/282 (25%), Positives = 121/282 (42%), Gaps = 39/282 (13%)

Query: 483 IGRGGFGNV-----YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G FG V     Y      D   VA+K L   +     +FQ E  +L+ L++ H+V  
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNN--------DNPP------LPWDRRLKICIGA 583
            G C D   +I+V++YM  G L   L  +        D  P      L   + L I    
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSI 643
           A  + YL   AS+  +HRD+ T N L+    + K+ DFG+ +   +     V       I
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGK 702
            ++ PE    +  T +SDV+SFGV+L E+    + P  +  + + +       EC   G+
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI-------ECITQGR 242

Query: 703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
           + +          P VC  +  ++ + C   +  +R ++ ++
Sbjct: 243 VLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 87.4 bits (216), Expect = 3e-19
 Identities = 76/268 (28%), Positives = 121/268 (45%), Gaps = 30/268 (11%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKR----LNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           IGRG FG V+ G L  D+TPVA+K     L P  +    +F  E  +L Q  + ++V LI
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA---KFLQEARILKQYSHPNIVRLI 59

Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVI 598
           G C     + +V + +  G     L   + P L     +++   AA  + YL    SK  
Sbjct: 60  GVCTQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLE---SKHC 115

Query: 599 IHRDVKTTNILLDEEWVAKVSDFGLCKFGPN--FSKTHVSTQVKGSIGYLDPEYYRLQLL 656
           IHRD+   N L+ E+ V K+SDFG+ +   +  ++ T    Q+   + +  PE       
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRY 173

Query: 657 TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP 716
           + +SDV+SFG++L E           G     NL+        N +  + I+  ++   P
Sbjct: 174 SSESDVWSFGILLWEA-------FSLGAVPYANLS--------NQQTREAIEQGVRLPCP 218

Query: 717 PVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
            +C +    +   C   D  +RPS S V
Sbjct: 219 ELCPDAVYRLMERCWEYDPGQRPSFSTV 246

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 87.5 bits (217), Expect = 4e-19
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 28/209 (13%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ----QGAL-EFQTEIGMLSQLRYLHLVSL 537
           +G G FG+VY+G    D    A+K ++        Q A+ + + EI +LS+L++ ++V  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL--KICIGAARALHYLHTGAS 595
           +G   ++  + +  + +  G+L   L    + P P  R    +I +G    L YLH    
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLH---D 120

Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-----VKGSIGYLDPEY 650
           +  +HRD+K  NIL+D   V K++DFG+ K         V         KGS  ++ PE 
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYWMAPEV 172

Query: 651 YRLQ-LLTEKSDVYSFGVVLLEVLCARPP 678
              Q      +D++S G  +LE+   +PP
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 87.2 bits (216), Expect = 6e-19
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 23/215 (10%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G+GGFG V    +       A K+L+         +Q AL    E  +L ++    +VS
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMAL---NEKKILEKVSSRFIVS 57

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL----KICIGAARALHYLHT 592
           L         + LV   M  G L+ H+YN   P  P  R +    +I  G    L +LH 
Sbjct: 58  LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLH- 112

Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
              + I++RD+K  N+LLD+    ++SD GL        K        G+ GY+ PE  +
Sbjct: 113 --QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQ 167

Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
            ++     D ++ G  L E++  R P  +  +K +
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 87.6 bits (217), Expect = 7e-19
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 33/218 (15%)

Query: 483 IGRGGFGNVYK----GFLNG-DSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVS 536
           IG+G FG V++    G L     T VA+K L    S     +FQ E  ++++  + ++V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNN------------------DNPPLPWDRRLK 578
           L+G C     M L+++YMA G L + L +                      PLP     +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 579 ICIGA--ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTH 634
           +CI    A  + YL   + +  +HRD+ T N L+ E  V K++DFGL +  +  ++ K  
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEV 672
            +  +   I ++ PE       T +SDV+++GVVL E+
Sbjct: 190 ENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 86.3 bits (214), Expect = 8e-19
 Identities = 69/281 (24%), Positives = 120/281 (42%), Gaps = 43/281 (15%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLH 533
           DF  L  +G+G +G+VYK     D+   A+K ++ G  SQ+   +   EI +L+ + + +
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNP--PLPWDRRLKICIGAARALHYLH 591
           ++S      D  ++ +V +Y   G L   +         +P     +I I   R L  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDPEY 650
               + I+HRD+K+ NILL    + K+ D G+ K    N +KT + T       Y+ PE 
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH-----YMAPEV 172

Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK-IGDIIDP 709
           ++ +  + KSD++S G +L E+    PP                       + + D+   
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFAPPF--------------------EARSMQDLRYK 212

Query: 710 FLKGNAPPVC------LNQFVEVAMSCVNDDRIRRPSMSDV 744
             +G  PP+       L  F+    S +      RP+   +
Sbjct: 213 VQRGKYPPIPPIYSQDLQNFI---RSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 87.0 bits (216), Expect = 9e-19
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 16/207 (7%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLRYLHL 534
           +  L  IG G +G VYK         VAIK++    +   +      EI +L +L + ++
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           + L+      G + LV+++M        L  +    LP            + L + H   
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDTDLY--KLIKDRQRGLPESLIKSYLYQLLQGLAFCH--- 115

Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSK-TH-VSTQVKGSIGYLDPE-Y 650
           S  I+HRD+K  N+L++ E V K++DFGL + FG      TH V T+      Y  PE  
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELL 170

Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARP 677
              +  +   D++S G +  E+L  RP
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRP 197

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 86.1 bits (213), Expect = 1e-18
 Identities = 70/264 (26%), Positives = 115/264 (43%), Gaps = 24/264 (9%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+ G        VAIK +N G+     +F  E  ++ +L +  LV L G C 
Sbjct: 12  LGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEE-DFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
               + +V ++M  G L ++L       L  D  L +C      + YL   +    IHRD
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGMEYLERNS---FIHRD 125

Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+    V KVSDFG+ ++  +   T  S+  K  + +  PE +     + KSDV
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKSDV 184

Query: 663 YSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLN 721
           +SFGV++ EV    + P  +  + + V +       YR                P +   
Sbjct: 185 WSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR----------------PKLASM 228

Query: 722 QFVEVAMSCVNDDRIRRPSMSDVV 745
              EV  SC ++    RP+ ++++
Sbjct: 229 TVYEVMYSCWHEKPEGRPTFAELL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 74/280 (26%), Positives = 127/280 (45%), Gaps = 49/280 (17%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKR------LNPGSQQGALEFQTEIGMLSQLRYLHLVS 536
           IG+G F  VYK     D   VA+K+      ++  ++Q  L+   EI +L QL + +++ 
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK---EIDLLKQLDHPNVIK 66

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHL--YNNDNPPLP----WDRRLKICIGAARALHYL 590
            +    ++ ++ +V +    G L   +  +      +P    W   +++C     AL ++
Sbjct: 67  YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEHM 122

Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS-KTHVSTQVKGSIGYLDPE 649
           H   SK I+HRD+K  N+ +    V K+ D GL +F   FS KT  +  + G+  Y+ PE
Sbjct: 123 H---SKRIMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAAHSLVGTPYYMSPE 176

Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
                    KSD++S G +L E+   + P    GDK  +NL               +   
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPF--YGDK--MNLY-------------SLCKK 219

Query: 710 FLKGNAPPVCLNQFVE-----VAMSCVNDDRIRRPSMSDV 744
             K + PP+  + + E     V+  C+N D  +RP +S V
Sbjct: 220 IEKCDYPPLPADHYSEELRDLVSR-CINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 21/206 (10%)

Query: 483 IGRGGFGNVYKG---FLNGDSTP--VAIKRL-NPGSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G G FG VY+G     +GD+    VA+K L    S+Q   +F  E  ++S+  + ++V 
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNN----DNP-PLPWDRRLKICIGAARALHYLH 591
           LIG   +     ++ + MA G L+  L  N    + P  L     L      A+   YL 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 592 TGASKVIIHRDVKTTNILLDEEW---VAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYL 646
                  IHRD+   N LL  +    VAK++DFG+ +  +  ++ +      +   I ++
Sbjct: 134 ---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML--PIKWM 188

Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEV 672
            PE +   + T K+DV+SFGV+L E+
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 61/191 (31%), Positives = 98/191 (51%), Gaps = 7/191 (3%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G+G FG V+ G  NG +T VAIK L PG+      F  E  ++ +LR+  LV L    +
Sbjct: 14  LGQGCFGEVWMGTWNG-TTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V ++M +G+L D L   D   L   + + +    A  + Y+        IHRD
Sbjct: 72  EE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127

Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ +  V K++DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 663 YSFGVVLLEVL 673
           +SFG++L E++
Sbjct: 187 WSFGILLTELV 197

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 85.1 bits (210), Expect = 3e-18
 Identities = 60/191 (31%), Positives = 99/191 (51%), Gaps = 7/191 (3%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+ G  NG +T VA+K L PG+      F  E  ++ +LR+  LV L    +
Sbjct: 14  LGNGQFGEVWMGTWNG-NTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V +YM++G+L D L + +   L     + +    A  + Y+        IHRD
Sbjct: 72  EE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 127

Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +++ NIL+ +  V K++DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 663 YSFGVVLLEVL 673
           +SFG++L E++
Sbjct: 187 WSFGILLTELV 197

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 84.3 bits (208), Expect = 4e-18
 Identities = 73/269 (27%), Positives = 121/269 (44%), Gaps = 32/269 (11%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGY 540
           ++G+G FG V+KG L  D TPVA+K       Q+  ++F +E  +L Q  + ++V LIG 
Sbjct: 2   LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 541 CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIH 600
           C     + +V + +  G     L    +  L   + +K  + AA  + YL    SK  IH
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKDE-LKTKQLVKFALDAAAGMAYLE---SKNCIH 116

Query: 601 RDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG-SIGYLDPEYYRLQLLTEK 659
           RD+   N L+ E  V K+SDFG+ +        + S+ +K   I +  PE       + +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174

Query: 660 SDVYSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNA 715
           SDV+S+G++L E     +C  P +     ++QV       + YR              + 
Sbjct: 175 SDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE------KGYRM-------------SC 215

Query: 716 PPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
           P  C +   +V   C +     RP  S++
Sbjct: 216 PQKCPDDVYKVMQRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 85.4 bits (211), Expect = 4e-18
 Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 26/214 (12%)

Query: 483 IGRGGFGNVYKGFLNG-------DSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V      G         T VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHL-----------YNNDNPP---LPWDRRLKI 579
           +++L+G C  DG + ++ +Y ++G LR++L           YN    P   L +   +  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 580 CIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   ASK  IHRD+   N+L+ E+ V K++DFGL +   +      +T  
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
           +  + ++ PE    ++ T +SDV+SFGV+L E+ 
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 85.0 bits (210), Expect = 4e-18
 Identities = 66/203 (32%), Positives = 98/203 (48%), Gaps = 22/203 (10%)

Query: 483 IGRGGFGNV--YKGFLNGDSTP--VAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G FG V  Y      D T   VA+K L     QQ    ++ EI +L  L + ++V  
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 538 IGYCNDDGQMI--LVYDYMARGTLRDHLYNNDNPPLPWDRRL----KICIGAARALHYLH 591
            G C++ G     L+ +Y+  G+LRD+L  +    L   + L    +IC G A    YLH
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMA----YLH 124

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH-VSTQVKGSIGYLDPEY 650
              S+  IHRD+   N+LLD + + K+ DFGL K  P   + + V       + +   E 
Sbjct: 125 ---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181

Query: 651 YRLQLLTEKSDVYSFGVVLLEVL 673
            +    +  SDV+SFGV L E+L
Sbjct: 182 LKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 84.5 bits (209), Expect = 4e-18
 Identities = 66/198 (33%), Positives = 97/198 (48%), Gaps = 7/198 (3%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           KD   L  +G G FG V  G   G    VAIK +  GS     EF  E  ++ +L +  L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSED-EFIEEAKVMMKLSHEKL 61

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           V L G C     + +V +YM+ G L ++L  +     P  + L++C      + YL    
Sbjct: 62  VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQP-SQLLEMCKDVCEGMAYLE--- 117

Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
           SK  IHRD+   N L+D++   KVSDFGL ++  +   T  S   K  + +  PE     
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLLYS 176

Query: 655 LLTEKSDVYSFGVVLLEV 672
             + KSDV++FGV++ EV
Sbjct: 177 KFSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 83.9 bits (208), Expect = 7e-18
 Identities = 64/223 (28%), Positives = 94/223 (42%), Gaps = 42/223 (18%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIK--RLNPGSQQGALEFQTEIGMLSQLRYL 532
            D   L  +G G  G V K         +A+K  RL           Q +I  L +L  L
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-----AIQKQI--LRELDIL 53

Query: 533 H------LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARA 586
           H      +V   G   ++G + +  +YM  G+L D +       +P     KI +   + 
Sbjct: 54  HKCNSPYIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKG 112

Query: 587 LHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG-- 644
           L YLH      IIHRDVK +NIL++     K+ DFG            VS Q+  S+   
Sbjct: 113 LTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKT 158

Query: 645 ------YLDPEYYRLQLL--TEKSDVYSFGVVLLEVLCARPPI 679
                 Y+ PE  R+Q    + KSD++S G+ L+E+   R P 
Sbjct: 159 FVGTSSYMAPE--RIQGNDYSVKSDIWSLGLSLIELATGRFPY 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 84.7 bits (209), Expect = 7e-18
 Identities = 73/295 (24%), Positives = 134/295 (45%), Gaps = 41/295 (13%)

Query: 483 IGRGGFGNVYKGFLNG-------DSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V      G       ++  VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHL---------YNND-----NPPLPWDRRLKI 579
           +++L+G C  DG + ++ +Y ++G LR++L         Y+ D     +  + +   +  
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 580 CIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   AS+  IHRD+   N+L+ E  V K++DFGL +   N      +T  
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV++ E       I   G      + V   E ++
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYPGIPV--EELFK 250

Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             K G  +D       P  C N+   +   C +     RP+   +V  L+ +  L
Sbjct: 251 LLKEGHRMD------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 83.9 bits (207), Expect = 7e-18
 Identities = 62/190 (32%), Positives = 97/190 (51%), Gaps = 7/190 (3%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G+G FG V+ G  NG +T VAIK L PG+      F  E  ++ +LR+  LV L    +
Sbjct: 14  LGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V +YM++G+L D L       L   + + +    A  + Y+        +HRD
Sbjct: 72  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127

Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ E  V KV+DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 663 YSFGVVLLEV 672
           +SFG++L E+
Sbjct: 187 WSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 84.0 bits (207), Expect = 9e-18
 Identities = 78/276 (28%), Positives = 126/276 (45%), Gaps = 37/276 (13%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLV 535
           F  L  IG+G FG V+KG  N     VAIK ++    +  +E  Q EI +LSQ    ++ 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
              G    D ++ ++ +Y+  G+  D L   +  PL   +   I     + L YLH   S
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLH---S 119

Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK-----GSIGYLDPEY 650
           +  IHRD+K  N+LL E    K++DFG+       +     TQ+K     G+  ++ PE 
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGV-------AGQLTDTQIKRNTFVGTPFWMAPEV 172

Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF 710
            +      K+D++S G+  +E+    PP       K + L            I     P 
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL------------IPKNNPPT 220

Query: 711 LKGN-APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           L+GN + P  L +FVE   +C+N +   RP+  +++
Sbjct: 221 LEGNYSKP--LKEFVE---ACLNKEPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 83.0 bits (205), Expect = 2e-17
 Identities = 53/207 (25%), Positives = 99/207 (47%), Gaps = 14/207 (6%)

Query: 482 IIGRGGFGNVYKGFLN-GDSTPVAIKRLNPGSQQGA----LEFQTEIGMLSQLRYLHLVS 536
           ++G+G +G VY G  N G    V    L+  +   A     + Q E+ +L  L+++++V 
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
            +G C DD  + +  +++  G++   L  N   PLP     K        + YLH   + 
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVAYLH---NN 121

Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFG----LCKFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
            ++HRD+K  N++L    + K+ DFG    L   G + + +++   + G+  ++ PE   
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181

Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPI 679
                 KSD++S G  + E+   +PP+
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 70/287 (24%), Positives = 127/287 (44%), Gaps = 41/287 (14%)

Query: 482 IIGRGGFGNVYKGFLNGDSTP---VAIK--RLNPGSQQGALEFQTEIGMLSQLRYLHLVS 536
           I+G G FG+V +G L+ D      VA+K  +L+  +     EF +E   +    + +++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 537 LIGYC---NDDGQM---ILVYDYMARGTLRDHLYNN---DNPP-LPWDRRLKICIGAARA 586
           LIG C   +   ++   +++  +M  G L   L  +     P  LP    LK  +  A  
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 587 LHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVKGSI 643
           + YL   +++  IHRD+   N +L E+    V+DFGL K    G  + +  ++   K  +
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA---KMPV 179

Query: 644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGK 702
            ++  E    ++ T KSDV++FGV + E+    + P     + +  +         R+G 
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY-------LRHGN 232

Query: 703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
                    +   P  CL++  ++  SC   D   RP+ + +   LE
Sbjct: 233 ---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 83.5 bits (206), Expect = 3e-17
 Identities = 61/214 (28%), Positives = 109/214 (50%), Gaps = 26/214 (12%)

Query: 483 IGRGGFGNVYKGFLNG-------DSTPVAIKRL-NPGSQQGALEFQTEIGMLSQL-RYLH 533
           +G G FG V      G           VA+K L +  + +   +  +E+ M+  + ++ +
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHL---------YNNDNPPLPWD----RRLKIC 580
           +++L+G C  DG + ++ +Y ++G LR++L         Y+ D   LP +    + L  C
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   AS+  IHRD+   N+L+ E+ V K++DFGL +   N      +T  
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
           +  + ++ PE    ++ T +SDV+SFGV+L E+ 
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 82.8 bits (204), Expect = 3e-17
 Identities = 75/272 (27%), Positives = 121/272 (44%), Gaps = 33/272 (12%)

Query: 482 IIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLRYLHLVS 536
           ++G G FG VYKG     G++   PVAIK LN  +   A +EF  E  +++ + + HLV 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
           L+G C     + LV   M  G L D+++ + DN  +     L  C+  A+ + YL     
Sbjct: 74  LLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDN--IGSQLLLNWCVQIAKGMMYLE---E 127

Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
           + ++HRD+   N+L+      K++DFGL +      K + +   K  I ++  E    + 
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 187

Query: 656 LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN- 714
            T +SDV+S+GV + E                  L  +  + Y      +I D   KG  
Sbjct: 188 FTHQSDVWSYGVTIWE------------------LMTFGGKPYDGIPTREIPDLLEKGER 229

Query: 715 --APPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
              PP+C      V + C   D   RP   ++
Sbjct: 230 LPQPPICTIDVYMVMVKCWMIDADSRPKFKEL 261

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 82.9 bits (205), Expect = 3e-17
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 17/207 (8%)

Query: 478 NNLL---IIGRGGFGNVYKGFLNG-----DSTPVAIKRLNP---GSQQGALEFQTEIGML 526
           NNL     +G G FG V +    G         VA+K L P    S++ AL   +E+ ++
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREAL--MSELKIM 92

Query: 527 SQL-RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR 585
           S L  + ++V+L+G C   G ++++ +Y   G L + L       L  +  L      A+
Sbjct: 93  SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152

Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            + +L   ASK  IHRD+   N+LL    + K+ DFGL +   N S   V    +  + +
Sbjct: 153 GMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209

Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLEV 672
           + PE     + T +SDV+S+G++L E+
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 82.3 bits (203), Expect = 3e-17
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 31/220 (14%)

Query: 482 IIGRGGFGNVYKGF---LNGDS--TPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLV 535
            +G G FG V K     L G +  T VA+K L   +    L +  +E  +L Q+ + H++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHL----------------------YNNDNPPLPW 573
            L G C+ DG ++L+ +Y   G+LR  L                       N D   L  
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 574 DRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT 633
              +      +R + YL   A   ++HRD+   N+L+ E    K+SDFGL +        
Sbjct: 127 GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183

Query: 634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
              ++ +  + ++  E     + T +SDV+SFGV+L E++
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 81.7 bits (202), Expect = 4e-17
 Identities = 65/268 (24%), Positives = 118/268 (44%), Gaps = 27/268 (10%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           ++G+G FG         D + V  K +N    S++   +   EI +LS L++ ++++   
Sbjct: 7   VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
           +  DD  +++  +Y   GTL D +          +  L        A+ Y+H      I+
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGIL 123

Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTE 658
           HRD+KT NI L +  + K+ DFG+ K  G   S+  ++  V G+  Y+ PE  +      
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILG---SEYSMAETVVGTPYYMSPELCQGVKYNF 180

Query: 659 KSDVYSFGVVLLEVLCARPPILRTGD-KKQVNLAVWATECYRNGKIGDIIDPFLKGNAPP 717
           KSD+++ G VL E+L  +    RT D    +NL V   +         ++  +       
Sbjct: 181 KSDIWALGCVLYELLTLK----RTFDATNPLNLVVKIVQGNYT----PVVSVYSSE---- 228

Query: 718 VCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
                 + +  S +  D  +RP+  +V+
Sbjct: 229 -----LISLVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 82.0 bits (202), Expect = 4e-17
 Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 21/206 (10%)

Query: 483 IGRGGFGNVYKGFLNG-----DSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G+G FG VY+G   G       T VAIK +N   S +  +EF  E  ++ +    H+V 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYN-----NDNP---PLPWDRRLKICIGAARALH 588
           L+G  +     +++ + M RG L+ +L +      +NP   P    + +++    A  + 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYL 646
           YL+  A+K  +HRD+   N ++ E++  K+ DFG+ +    +   +     KG   + ++
Sbjct: 134 YLN--ANK-FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWM 188

Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEV 672
            PE  +  + T  SDV+SFGVVL E+
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 81.8 bits (202), Expect = 4e-17
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 21/211 (9%)

Query: 482 IIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGS-------QQGALE-FQTEIGMLSQLRY 531
           +IG+G +G VY       G+   V    L           Q+  ++  ++EI  L  L +
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHL--YNNDNPPLPWDRRLKICIGAARALHY 589
           L++V  +G+   +  + +  +Y+  G++   L  Y      L      ++  G    L Y
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG----LAY 123

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           LH   SK I+HRD+K  N+L+D + + K+SDFG+ K   +      +  ++GS+ ++ PE
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180

Query: 650 YYRL--QLLTEKSDVYSFGVVLLEVLCARPP 678
                 Q  + K D++S G V+LE+   R P
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 82.0 bits (202), Expect = 6e-17
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 24/210 (11%)

Query: 482 IIGRGGFGNVYKGFL--NGDSTPVAIKRLNP-GSQQGALEFQTEIGMLSQL-RYLHLVSL 537
           +IG G FG V +  +  +G     AIK L    S+    +F  E+ +L +L  + ++++L
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNN---DNPP-----------LPWDRRLKICIGA 583
           +G C + G + +  +Y   G L D L  +   +  P           L   + L+     
Sbjct: 69  LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128

Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSI 643
           A  + YL   + K  IHRD+   N+L+ E   +K++DFGL +    + K    T  +  +
Sbjct: 129 ATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK---KTMGRLPV 182

Query: 644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
            ++  E     + T KSDV+SFGV+L E++
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 81.1 bits (200), Expect = 7e-17
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 14/206 (6%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIK-----RLNPGSQQGALE-FQTEIGMLSQLRYLHLV 535
            +G G F + Y+       T +A+K     R     Q+  +E  + EI ++++L + H++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
            ++G   +D    L  ++MA G++   L             +       R L YLH    
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLH---E 121

Query: 596 KVIIHRDVKTTNILLDEE-WVAKVSDFGLC-KFGPNFSKT-HVSTQVKGSIGYLDPEYYR 652
             IIHRDVK  N+L+D      +++DFG   +     +       Q+ G+I ++ PE  R
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181

Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPP 678
            +      DV+S G V++E+  A+PP
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 81.5 bits (201), Expect = 8e-17
 Identities = 70/269 (26%), Positives = 122/269 (45%), Gaps = 36/269 (13%)

Query: 498 GDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMAR 556
           G    VA+K L P + + A  +F  E+ +LS+L+  +++ L+G C D+  + ++ +YM  
Sbjct: 44  GRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMEN 103

Query: 557 GTLRDHLYN--------NDNPPLPWDRR---------LKICIGAARALHYLHTGASKVII 599
           G L   L +        N N  +P             L + +  A  + YL   +S   +
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFV 160

Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLT 657
           HRD+ T N L+ E    K++DFG+ +  +  ++ +  +  +    I ++  E   +   T
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR--IQGRAVLPIRWMAWECILMGKFT 218

Query: 658 EKSDVYSFGVVLLEVL--CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNA 715
             SDV++FGV L E+L  C   P     D++ +     A E +R+         +L    
Sbjct: 219 TASDVWAFGVTLWEILMLCKEQPYGELTDEQVIEN---AGEFFRDQG----RQVYL--FR 269

Query: 716 PPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
           PP C     E+ + C + D   RPS SD+
Sbjct: 270 PPPCPQGLYELMLQCWSRDCRERPSFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 81.6 bits (201), Expect = 8e-17
 Identities = 76/287 (26%), Positives = 129/287 (44%), Gaps = 43/287 (14%)

Query: 483 IGRGGFGNVY----KGFLN--GDSTP--------VAIKRLNPGSQQGAL-EFQTEIGMLS 527
           +G G FG V+    +G     G+  P        VA+K L     + A  +F  EI ++S
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 528 QLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL----------YNNDNPPLPWDRRL 577
           +L+  +++ L+G C  D  + ++ +YM  G L   L          + N+ P +     L
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 578 KICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST 637
            + +  A  + YL   AS   +HRD+ T N L+   +  K++DFG+ +    +S  +   
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR--NLYSGDYYRI 187

Query: 638 QVKG--SIGYLDPEYYRLQLLTEKSDVYSFGVVLLEV--LCARPPILRTGDKKQVNLAVW 693
           Q +    I ++  E   L   T  SDV++FGV L E+  LC   P     D++ +     
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN--- 244

Query: 694 ATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPS 740
             E +RN   G  I  +L  +  P+C +   ++ M C + D   RP+
Sbjct: 245 TGEFFRNQ--GRQI--YL--SQTPLCPSPVFKLMMRCWSRDIKDRPT 285

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 80.7 bits (199), Expect = 1e-16
 Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 16/211 (7%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           +G+GGFG V    +       A K+LN      ++G      E  +L+++    +VSL  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNND--NPPLPWDRRLKICIGAARALHYLHTGASKV 597
                  + LV   M  G LR H+YN D  NP  P  R           L +LH    + 
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117

Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLC---KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
           II+RD+K  N+LLD +   ++SD GL    K G + +K +      G+ G++ PE  + +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTPGFMAPELLQGE 172

Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDK 685
                 D ++ GV L E++ AR P    G+K
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPFRARGEK 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 22/212 (10%)

Query: 482 IIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQG---------ALEFQTEIGMLSQLR 530
           +IG G FG+VY G    +G+   V    L   S            AL    EI +L +L+
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDAL--AREIALLKELQ 64

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + ++V  +G   D   + +  +Y+  G++   L N         R     I   + L+YL
Sbjct: 65  HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI--LKGLNYL 122

Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQ---VKGSIGYL 646
           H   ++ IIHRD+K  NIL+D +   K+SDFG+  K   N   T  +     ++GS+ ++
Sbjct: 123 H---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179

Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            PE  +    T K+D++S G +++E+L  + P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 20/210 (9%)

Query: 481 LIIGRGGFGNVYKGFLN---GDST---PVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLH 533
             +G G FG VY+G      G  +    VA+K L  G+  Q   EF  E  ++S   + +
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTL----RDHLYNNDNPP-LPWDRRLKICIGAARALH 588
           +V L+G C  +    ++ + M  G L    RD       PP L     L IC+  A+   
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 589 YLHTGASKVIIHRDVKTTNILLDEEW-----VAKVSDFGLCKFGPNFSKTHVSTQVKGSI 643
           YL        IHRD+   N L+ E+      V K+ DFGL +            +    +
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
            ++ PE       T +SDV+SFGV++ E+L
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 19/207 (9%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLN--PGSQQGALEFQT---EIGMLSQLRYLHLVS 536
           ++G+G FG VY  +       +A+K++   P S +   E      EI +L  L++  +V 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYN----NDNPPLPWDRRLKICIGAARALHYLHT 592
             G   DD  + +  +YM  G+++D L       +     + R++         + YLH 
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI------LEGVEYLH- 121

Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDPEYY 651
             S +I+HRD+K  NIL D     K+ DFG  K      S       V G+  ++ PE  
Sbjct: 122 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179

Query: 652 RLQLLTEKSDVYSFGVVLLEVLCARPP 678
             +    K+DV+S G  ++E+L  +PP
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 13/200 (6%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLRYLHLVSLIGY 540
           IG G  G V+K         VA+K++     +G +  Q   EI  L   ++ ++V L+  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 541 CNDDGQMILVYDYMARGTLRDHLYNNDNP-PLPWDRRLKICIGAARALHYLHTGASKVII 599
                  +LV +YM    L + L + + P P    +     +   + + Y+H   +  I+
Sbjct: 68  FPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRML--LKGVAYMH---ANGIM 121

Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDPE-YYRLQLLT 657
           HRD+K  N+L+  + V K++DFGL + F     + + S QV  +  Y  PE  Y  +   
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY-SHQV-ATRWYRAPELLYGARKYD 179

Query: 658 EKSDVYSFGVVLLEVLCARP 677
              D+++ G +  E+L   P
Sbjct: 180 PGVDLWAVGCIFAELLNGSP 199

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 76/280 (27%), Positives = 120/280 (42%), Gaps = 45/280 (16%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLV 535
           F  L  IG+G FG VYKG  N     VAIK ++    +  +E  Q EI +LSQ    ++ 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
              G      ++ ++ +Y+  G+  D L      PL       I     + L YLH   S
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLH---S 119

Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK-----GSIGYLDPEY 650
           +  IHRD+K  N+LL E+   K++DFG+       +     TQ+K     G+  ++ PE 
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGV-------AGQLTDTQIKRNTFVGTPFWMAPEV 172

Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF 710
            +      K+D++S G+  +E+    PP                     N  +  +   F
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPP---------------------NSDLHPMRVLF 211

Query: 711 L-KGNAPPVCLNQ----FVEVAMSCVNDDRIRRPSMSDVV 745
           L   N+PP    Q    F E   +C+N D   RP+  +++
Sbjct: 212 LIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 78.6 bits (194), Expect = 6e-16
 Identities = 63/306 (20%), Positives = 129/306 (42%), Gaps = 46/306 (15%)

Query: 460 DLCTQFSISEIKE-ATKDFN--NLLIIGRGGFGNVYKGFLNGDSTPVAIKRL---NPGSQ 513
           ++ T+  I++IK   + D +    ++I      ++YKG  N     V I+     + G +
Sbjct: 2   NIITRSYINDIKCIESDDIDKYTSVLIKENDQNSIYKGIFNN--KEVIIRTFKKFHKGHK 59

Query: 514 QGALEFQTEIGMLSQLRYLHLVSLIGY----CNDDGQMILVYDYMARGTLRDHLYNNDNP 569
                 + EI  L ++   +++ + G+     +D  ++ L+ +Y  RG LR+ L    + 
Sbjct: 60  VLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD- 118

Query: 570 PLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN 629
            L +  +L + I   + L+ L+   +K   ++++ + + L+ E +  K+   GL K   +
Sbjct: 119 -LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSS 175

Query: 630 FSKTHVSTQVKGSIGYLDPEYYR--LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
               +V+  V     Y   +         T K D+YS GVVL E+   + P         
Sbjct: 176 PPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIP--------- 221

Query: 688 VNLAVWATECYRNGKIGDIIDPFLKGNA----PPVCLNQFVEVAMSCVNDDRIRRPSMSD 743
                     + N    +I D  +  N     P  C  +   +  +C + D I+RP++ +
Sbjct: 222 ----------FENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKE 271

Query: 744 VVWGLE 749
           +++ L 
Sbjct: 272 ILYNLS 277

Length = 283

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 78.9 bits (194), Expect = 6e-16
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 24/210 (11%)

Query: 482 IIGRGGFGNVYKGFLNGDS--TPVAIKRLNP-GSQQGALEFQTEIGMLSQL-RYLHLVSL 537
           +IG G FG V K  +  D      AIKR+    S+    +F  E+ +L +L  + ++++L
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLY--------------NNDNPPLPWDRRLKICIGA 583
           +G C   G + L  +Y   G L D L               N+    L   + L      
Sbjct: 74  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133

Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSI 643
           AR + YL   + K  IHRD+   NIL+ E +VAK++DFGL +    + K    T  +  +
Sbjct: 134 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPV 187

Query: 644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
            ++  E     + T  SDV+S+GV+L E++
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 78.4 bits (194), Expect = 7e-16
 Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 21/211 (9%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQT--EIGMLSQLR 530
            DF  +  +G G FG V      G     A+K L+     +   +E     E  +L  +R
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVE-HVLNEKRILQSIR 59

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR---AL 587
           +  LV+L G   DD  + LV +Y+  G L  HL  +   P P          AA+   AL
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPV-----ARFYAAQVVLAL 114

Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
            YLH   S  I++RD+K  N+LLD +   K++DFG  K     + T     + G+  YL 
Sbjct: 115 EYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT-----LCGTPEYLA 166

Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           PE    +   +  D ++ G+++ E+L   PP
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 78.0 bits (193), Expect = 9e-16
 Identities = 60/230 (26%), Positives = 99/230 (43%), Gaps = 35/230 (15%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEF-QTEIGMLSQLRY 531
            DF    IIG G F  V        +   AIK L+     ++  +++ + E  +L++L  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 532 LH--LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR---A 586
            H  ++ L     D+  +  V +Y   G L  ++    +      R       AA    A
Sbjct: 61  -HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFY-----AAEILLA 114

Query: 587 LHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN--------------FSK 632
           L YLH   SK IIHRD+K  NILLD++   K++DFG  K                   S+
Sbjct: 115 LEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 633 THVSTQVKGS-IG---YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
              + +   S +G   Y+ PE    +   + SD+++ G ++ ++L  +PP
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 78.2 bits (192), Expect = 9e-16
 Identities = 70/275 (25%), Positives = 128/275 (46%), Gaps = 22/275 (8%)

Query: 466 SISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM 525
           SI  + +  K +     IG+G  G VY          VAI+++N   Q        EI +
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70

Query: 526 LSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR 585
           + + +  ++V+ +       ++ +V +Y+A G+L D +       +   +   +C    +
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQ 127

Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIG 644
           AL +LH   S  +IHRD+K+ NILL  +   K++DFG C +  P  SK    + + G+  
Sbjct: 128 ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPY 181

Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL-AVWATECYRN-GK 702
           ++ PE    +    K D++S G++ +E++   PP L     + + L A   T   +N  K
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241

Query: 703 IGDIIDPFL----------KGNAPPVCLNQFVEVA 727
           +  I   FL          +G+A  +  +QF+++A
Sbjct: 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 14/218 (6%)

Query: 466 SISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM 525
           +I  I +  K +     IG+G  G V+          VAIK++N   Q        EI +
Sbjct: 10  TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69

Query: 526 LSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNN--DNPPLPWDRRLKICIGA 583
           + +L+  ++V+ +       ++ +V +Y+A G+L D +     D   +       +C   
Sbjct: 70  MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIA-----AVCREC 124

Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGS 642
            +AL +LH   +  +IHRD+K+ N+LL  +   K++DFG C +  P  SK   ST V G+
Sbjct: 125 LQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--STMV-GT 178

Query: 643 IGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPIL 680
             ++ PE    +    K D++S G++ +E++   PP L
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 29/209 (13%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           IG G +G+VYK         VAIK +           Q EI ML + R+ ++V+  G   
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
              ++ +V +Y   G+L+D +Y     PL   +   +C    + L YLH       IHRD
Sbjct: 71  RRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRD 126

Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG----------YLDPEYYR 652
           +K  NILL E+   K++DFG            VS Q+  +I           ++ PE   
Sbjct: 127 IKGANILLTEDGDVKLADFG------------VSAQLTATIAKRKSFIGTPYWMAPEVAA 174

Query: 653 LQLL---TEKSDVYSFGVVLLEVLCARPP 678
           ++       K D+++ G+  +E+   +PP
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 78.1 bits (192), Expect = 1e-15
 Identities = 54/214 (25%), Positives = 108/214 (50%), Gaps = 26/214 (12%)

Query: 483 IGRGGFGNVYKGFLNG-------DSTPVAIKRL-NPGSQQGALEFQTEIGMLSQL-RYLH 533
           +G G FG V +    G        +  VA+K L +  + +   +  +E+ ++  + ++ +
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHL---------YNNDNPPLPWD----RRLKIC 580
           +++L+G C  +G + ++ +Y A+G LR+ L         Y  D   +P +    + L  C
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL    S+  IHRD+   N+L+ E+ V K++DFGL +   +      ++  
Sbjct: 140 AYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
           +  + ++ PE    ++ T +SDV+SFG+++ E+ 
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIF 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 81.0 bits (200), Expect = 1e-15
 Identities = 53/188 (28%), Positives = 90/188 (47%), Gaps = 19/188 (10%)

Query: 503 VAIKRLNPGSQQGALE---FQTEIGMLSQLRYLHLVSLI--GYCNDDGQMILVYDYMARG 557
           VAIK L   + +   +   F+ E  + ++L + ++V+L+  G     G +  V++Y+   
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGR 64

Query: 558 TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL---DEEW 614
           TLR+ L  +    LP     ++ +    AL   H      I+HRD+K  NI++       
Sbjct: 65  TLREVLAADG--ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRP 119

Query: 615 VAKVSDFGLCKFGPNFSKTHV-----STQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVL 669
            AKV DFG+    P      V     +T+V G+  Y  PE  R + +T  SD+Y++G++ 
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179

Query: 670 LEVLCARP 677
           LE L  + 
Sbjct: 180 LECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLV 535
           F  L  IG+G FG V+KG  N     VAIK ++    +  +E  Q EI +LSQ    ++ 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
              G      ++ ++ +Y+  G+  D L             LK  +   + L YLH   S
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLH---S 119

Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK-----GSIGYLDPEY 650
           +  IHRD+K  N+LL E+   K++DFG+       +     TQ+K     G+  ++ PE 
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGV-------AGQLTDTQIKRNTFVGTPFWMAPEV 172

Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            +      K+D++S G+  +E+    PP
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 70/269 (26%), Positives = 119/269 (44%), Gaps = 24/269 (8%)

Query: 482 IIGRGGFGNVYKGFLNGDS---TPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           +IG G FG V  G L        PVAIK L  G +++   +F +E  ++ Q  + +++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G       +++V +YM  G+L   L  +D       + + +  G A  + YL   +   
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ-FTVIQLVGMLRGIASGMKYL---SDMG 126

Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
            +HRD+   NIL++   V KVSDFGL +    +    + +   K  I +  PE    +  
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186

Query: 657 TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP 716
           T  SDV+S+G+V+ EV       +  G++    ++        N  +   I+   +  AP
Sbjct: 187 TSASDVWSYGIVMWEV-------MSYGERPYWEMS--------NQDVIKAIEEGYRLPAP 231

Query: 717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
             C     ++ + C   DR  RP    +V
Sbjct: 232 MDCPAALHQLMLDCWQKDRNERPKFEQIV 260

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 76.9 bits (189), Expect = 2e-15
 Identities = 75/292 (25%), Positives = 124/292 (42%), Gaps = 47/292 (16%)

Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVS 536
           ++G+G FG+V +  L   +G    VA+K L     S     EF  E   + +  + +++ 
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 537 LIG---YCNDDGQM---ILVYDYMARGTLRDHLYNN---DNP-PLPWDRRLKICIGAARA 586
           LIG        G++   +++  +M  G L   L  +   + P  LP    ++  I  A  
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 587 LHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVKGSI 643
           + YL   +SK  IHRD+   N +L+E     V+DFGL K    G  + +   S   K  +
Sbjct: 126 MEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS---KLPV 179

Query: 644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGK 702
            +L  E     + T  SDV++FGV + E++   + P                   Y   +
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP-------------------YAGVE 220

Query: 703 IGDIIDPFLKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV 751
             +I +  +KGN    PP CL    E+   C + +   RPS   +   LE +
Sbjct: 221 NSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 40/279 (14%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLV 535
           +  L +IGRG +G VY+G        VA+K +N  +    + + Q E+ +LSQLR     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 536 SLIGY--CNDDG-QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAA-----RAL 587
           ++  Y      G ++ ++ +Y   G++R  +        P   +    I         AL
Sbjct: 63  NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM-----KAGPIAEK---YISVIIREVLVAL 114

Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL-CKFGPNFSKTHVSTQVKGSIGYL 646
            Y+H      +IHRD+K  NIL+      K+ DFG+      N SK   ST V G+  ++
Sbjct: 115 KYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR--STFV-GTPYWM 168

Query: 647 DPEYYR-LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD 705
            PE     +    K+D++S G+ + E+    PP       + + L            I  
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML------------IPK 216

Query: 706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
              P L+ N     L +FV    +C++++   R S  ++
Sbjct: 217 SKPPRLEDNGYSKLLREFV---AACLDEEPKERLSAEEL 252

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 77.1 bits (189), Expect = 2e-15
 Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 10/216 (4%)

Query: 466 SISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM 525
           SI  + +  K +     IG+G  G VY          VAIK++N   Q        EI +
Sbjct: 10  SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILV 69

Query: 526 LSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR 585
           + + +  ++V+ +       ++ +V +Y+A G+L D +       +   +   +C    +
Sbjct: 70  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQ 126

Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIG 644
           AL +LH   S  +IHRD+K+ NILL  +   K++DFG C +  P  SK   ST V G+  
Sbjct: 127 ALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMV-GTPY 180

Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPIL 680
           ++ PE    +    K D++S G++ +E++   PP L
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 77.2 bits (190), Expect = 3e-15
 Identities = 67/217 (30%), Positives = 99/217 (45%), Gaps = 21/217 (9%)

Query: 471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQ---TEIGMLS 527
            +  K F +L  IG G FG VY       +  VAIK+++   +Q   ++Q    E+  L 
Sbjct: 11  DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 528 QLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARAL 587
           QLR+ + +   G    +    LV +Y   G+  D +      PL       IC GA + L
Sbjct: 71  QLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASD-ILEVHKKPLQEVEIAAICHGALQGL 128

Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFG---LCKFGPNFSKT--HVSTQVKGS 642
            YLH   S   IHRD+K  NILL E    K++DFG   L     +F  T   ++ +V   
Sbjct: 129 AYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEV--- 182

Query: 643 IGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPI 679
           I  +D   Y       K DV+S G+  +E+   +PP+
Sbjct: 183 ILAMDEGQY-----DGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 76.4 bits (188), Expect = 3e-15
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 19/214 (8%)

Query: 483 IGRGGFGNVYK-GFLNGDSTPVAIKRL---NPGSQQGALEFQTEIGML--------SQLR 530
           +G G FG VYK    N     +A+K +   NP   +   E    IG +         QLR
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL--YNNDNPPLPWDRRLKICIGAARALH 588
           + ++V       ++ ++ +V D +    L +H             +R   I +    AL 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           YLH    K I+HRD+   NI+L E+    ++DFGL K     SK    T V G+I Y  P
Sbjct: 128 YLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGTILYSCP 182

Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRT 682
           E  + +   EK+DV++FG +L ++   +PP   T
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 76.2 bits (187), Expect = 5e-15
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 23/207 (11%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG VYK          A K +   S++   ++  EI +L+   + ++V L+G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK------ICIGAARALHYLHTGASK 596
            DG++ ++ ++   G +       D   L  DR L       IC     AL YLH   S 
Sbjct: 80  WDGKLWIMIEFCPGGAV-------DAIMLELDRGLTEPQIQVICRQMLEALQYLH---SM 129

Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
            IIHRD+K  N+LL  +   K++DFG+     N           G+  ++ PE    + +
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187

Query: 657 TE-----KSDVYSFGVVLLEVLCARPP 678
            +     K+D++S G+ L+E+    PP
Sbjct: 188 KDTPYDYKADIWSLGITLIEMAQIEPP 214

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 76.1 bits (187), Expect = 5e-15
 Identities = 63/217 (29%), Positives = 108/217 (49%), Gaps = 12/217 (5%)

Query: 466 SISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM 525
           +I  + +  K +     IG+G  G VY          VAIK++N   Q        EI +
Sbjct: 10  TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILV 69

Query: 526 LSQLRYLHLVS-LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAA 584
           + + ++ ++V+ L  Y   D ++ +V +Y+A G+L D +       +   +   +C    
Sbjct: 70  MRENKHPNIVNYLDSYLVGD-ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECL 125

Query: 585 RALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSI 643
           +AL +LH   S  +IHRD+K+ NILL  +   K++DFG C +  P  SK   ST V G+ 
Sbjct: 126 QALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMV-GTP 179

Query: 644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPIL 680
            ++ PE    +    K D++S G++ +E++   PP L
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 76.0 bits (188), Expect = 5e-15
 Identities = 60/235 (25%), Positives = 99/235 (42%), Gaps = 67/235 (28%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP-----GSQQGALEFQTEIGMLSQLRY 531
           +  +  IG G +G VYK         VA+K++       G    A+    EI +L +LR+
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR---EIKLLQKLRH 57

Query: 532 LHLVSLIGYC--NDDGQMILVYDYMARGTLRDH-----LYNNDNPPLPWDRRLKICIGAA 584
            ++V L         G + +V++YM      DH     L + +         +K      
Sbjct: 58  PNIVRLKEIVTSKGKGSIYMVFEYM------DHDLTGLLDSPE---------VKFTESQI 102

Query: 585 R--------ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH-- 634
           +         L YLH   S  I+HRD+K +NIL++ + V K++DFGL +    ++K +  
Sbjct: 103 KCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARP---YTKRNSA 156

Query: 635 -----VSTQVKGSIGYLDPEYYRLQLL------TEKSDVYSFGVVLLEVLCARPP 678
                V T     + Y  PE     LL        + D++S G +L E+   +P 
Sbjct: 157 DYTNRVIT-----LWYRPPE-----LLLGATRYGPEVDMWSVGCILAELFLGKPI 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 75.2 bits (185), Expect = 5e-15
 Identities = 76/284 (26%), Positives = 116/284 (40%), Gaps = 52/284 (18%)

Query: 483 IGRGGFGNVYKGFL--NGDS--------TPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL 532
           +G+G F N+YKG L    D           V +K L     + +L F     ++SQL + 
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD-HRDSLAFFETASLMSQLSHK 61

Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLH 591
           HLV L G C  D   I+V +Y+  G L   L+   +N  L W  +L +    A ALHYL 
Sbjct: 62  HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118

Query: 592 TGASKVIIHRDVKTTNILL-----DEEWV--AKVSDFGLCKFGPNFSKTHVSTQVKGS-I 643
               K ++H +V   NIL+     +E +V   K+SD       P    T +S + +   I
Sbjct: 119 ---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD-------PGIPITVLSREERVERI 168

Query: 644 GYLDPEYYR--LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG 701
            ++ PE  R     LT  +D +SFG  LLE+       L T    +          Y++ 
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE------KERFYQDQ 222

Query: 702 KIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
               + D             +   +   C   D  +RPS   ++
Sbjct: 223 HRLPMPD-----------CAELANLINQCWTYDPTKRPSFRAIL 255

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 76.2 bits (187), Expect = 6e-15
 Identities = 69/279 (24%), Positives = 119/279 (42%), Gaps = 33/279 (11%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDS----TPVAIKRLNPG-SQQGALEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG    +      PVAIK L    S +   E   E  +++ + 
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN    +   L  C+  A+ ++Y
Sbjct: 68  NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQIAKGMNY 124

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 125 LE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181

Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E                  L  + ++ Y      +I   
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWE------------------LMTFGSKPYDGIPASEISSI 223

Query: 710 FLKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
             KG     PP+C      + + C   D   RP   +++
Sbjct: 224 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 75.5 bits (185), Expect = 6e-15
 Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 24/210 (11%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPV--AIKRLNP-GSQQGALEFQTEIGMLSQL-RYLHLVSL 537
           +IG G FG V K  +  D   +  AIKR+    S+    +F  E+ +L +L  + ++++L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNN---DNPP-----------LPWDRRLKICIGA 583
           +G C   G + L  +Y   G L D L  +   +  P           L   + L      
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSI 643
           AR + YL   + K  IHRD+   NIL+ E +VAK++DFGL +    + K    T  +  +
Sbjct: 122 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPV 175

Query: 644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
            ++  E     + T  SDV+S+GV+L E++
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 75.4 bits (185), Expect = 6e-15
 Identities = 73/267 (27%), Positives = 118/267 (44%), Gaps = 23/267 (8%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQ---TEIGMLSQLRYLHLVSLIG 539
           IGRG F  VY+     D  PVA+K++       A        EI +L QL + +++    
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 540 YCNDDGQMILVYDYMARGTLRDHL--YNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
              +D ++ +V +    G L   +  +      +P     K  +    AL ++H   S+ 
Sbjct: 70  SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRR 126

Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLT 657
           ++HRD+K  N+ +    V K+ D GL +F    SKT  +  + G+  Y+ PE        
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPERIHENGYN 184

Query: 658 EKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPP 717
            KSD++S G +L E+   + P    GDK  +NL    + C    KI     P L  +   
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFY--GDK--MNL---YSLC---KKIEQCDYPPLPSDHYS 234

Query: 718 VCLNQFVEVAMSCVNDDRIRRPSMSDV 744
             L Q V +   C+N D  +RP ++ V
Sbjct: 235 EELRQLVNM---CINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 75.6 bits (187), Expect = 7e-15
 Identities = 65/221 (29%), Positives = 100/221 (45%), Gaps = 42/221 (19%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRL-----NPGSQQGALEFQTEIGMLSQLRYLHLVS 536
            +G G +G VYK         VA+K++       G    AL    EI +L +L++ ++V 
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR---EISLLKELKHPNIVK 62

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAA--RALHYLHTGA 594
           L+   + + ++ LV++Y     L+ +L   D  P P    L   I     R L Y H   
Sbjct: 63  LLDVIHTERKLYLVFEYCDM-DLKKYL---DKRPGPLSPNLIKSIMYQLLRGLAYCH--- 115

Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSK-TH-VSTQVKGSIGYLDPEYY 651
           S  I+HRD+K  NIL++ + V K++DFGL + FG      TH V T            +Y
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTL-----------WY 164

Query: 652 R---LQLLTEKS-----DVYSFGVVLLEVLCARPPILRTGD 684
           R   + LL  K      D++S G +  E +    P+   GD
Sbjct: 165 RAPEI-LLGSKHYSTAVDIWSVGCIFAE-MITGKPLFP-GD 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 75.7 bits (187), Expect = 7e-15
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE---FQT--EIGMLSQLRYLHLVSL 537
           +G G +  VYK         VAIK++  G ++ A +   F    EI +L +L++ +++ L
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPL-PWDRR---LKICIGAARALHYLHTG 593
           +        + LV+++M    L   +  + +  L P D +   L       R L YLH  
Sbjct: 68  LDVFGHKSNINLVFEFME-TDLE-KVIKDKSIVLTPADIKSYMLMTL----RGLEYLH-- 119

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
            S  I+HRD+K  N+L+  + V K++DFGL +   +     ++ QV  +  Y  PE    
Sbjct: 120 -SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS-PNRKMTHQVV-TRWYRAPEL--- 173

Query: 654 QLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
            L   +      D++S G +  E L  R P L
Sbjct: 174 -LFGARHYGVGVDMWSVGCIFAE-LLLRVPFL 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 75.4 bits (185), Expect = 7e-15
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 16/201 (7%)

Query: 483 IGRGGFGNV----YKGFLNGDST--PVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLV 535
           +G G FG V    Y     GD+T   VA+K L P S    + + + EI +L  L + ++V
Sbjct: 12  LGEGHFGKVELCRYDP--EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 536 SLIGYCNDDG--QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
              G C +DG   + L+ +++  G+L+++L  N N  +   ++LK  +   + + YL   
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYL--- 125

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDPEYYR 652
            S+  +HRD+   N+L++ E   K+ DFGL K    +     V   +   + +  PE   
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 653 LQLLTEKSDVYSFGVVLLEVL 673
                  SDV+SFGV L E+L
Sbjct: 186 QSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 75.1 bits (184), Expect = 7e-15
 Identities = 55/191 (28%), Positives = 94/191 (49%), Gaps = 7/191 (3%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+    N   T VA+K + PGS      F  E  ++  L++  LV L     
Sbjct: 14  LGAGQFGEVWMATYN-KHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ ++MA+G+L D L +++    P  + +      A  + ++     +  IHRD
Sbjct: 72  KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRD 127

Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+    V K++DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDV 186

Query: 663 YSFGVVLLEVL 673
           +SFG++L+E++
Sbjct: 187 WSFGILLMEIV 197

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.1 bits (184), Expect = 8e-15
 Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 23/210 (10%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRL--NPGSQQGALE---FQTEIGMLSQLRYLHLVS 536
           ++GRG FG VY  +       +A+K++  +P SQ+ + E    + EI +L  LR+  +V 
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 537 LIGYCNDDGQ--MILVYDYMARGTLRDHLYN----NDNPPLPWDRRLKICIGAARALHYL 590
             G   D  +  + +  +YM  G+++D L       +N    + R++       + + YL
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI------LQGVSYL 122

Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN--FSKTHVSTQVKGSIGYLDP 648
           H   S +I+HRD+K  NIL D     K+ DFG  K       S T + + V G+  ++ P
Sbjct: 123 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMSP 178

Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           E    +    K+DV+S    ++E+L  +PP
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 75.5 bits (186), Expect = 8e-15
 Identities = 59/213 (27%), Positives = 89/213 (41%), Gaps = 32/213 (15%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIK----RLNPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
            +G G  G+V K  L       A+K      NP  Q+  L    E+ +    +  ++V  
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR---ELEINKSCKSPYIVKY 64

Query: 538 IGYCND--DGQMILVYDYMARGTLRDHLYNN--------DNPPLPWDRRLKICIGAARAL 587
            G   D     + +  +Y   G+L D +Y              L      KI     + L
Sbjct: 65  YGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVL-----GKIAESVLKGL 118

Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYL 646
            YLH   S+ IIHRD+K +NILL  +   K+ DFG+  +   + + T   T       Y+
Sbjct: 119 SYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSF-----YM 170

Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPI 679
            PE  + +  +  SDV+S G+ LLEV   R P 
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 74.7 bits (183), Expect = 9e-15
 Identities = 71/271 (26%), Positives = 119/271 (43%), Gaps = 31/271 (11%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQ---TEIGMLSQLRYLHLVSLIG 539
           IGRG F  VY+     D  PVA+K++       A   Q    EI +L QL + +++  + 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 540 YCNDDGQMILVYDYMARGTLRDHL--YNNDNPPLP----WDRRLKICIGAARALHYLHTG 593
              +D ++ +V +    G L   +  +      +P    W   +++C     A+ ++H  
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEHMH-- 123

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
            S+ ++HRD+K  N+ +    V K+ D GL +F    SKT  +  + G+  Y+ PE    
Sbjct: 124 -SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPERIHE 180

Query: 654 QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
                KSD++S G +L E+   + P    GDK  +NL    + C    KI     P L  
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFY--GDK--MNL---FSLCQ---KIEQCDYPPLPT 230

Query: 714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
                   +  E+   C+  D  +RP +  V
Sbjct: 231 EHYS---EKLRELVSMCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 75.5 bits (186), Expect = 1e-14
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 11/201 (5%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEF-QTEIGMLSQL-RYLHLVSL 537
           ++G+G FG V    L G     A+K L      Q   +E   TE  +L+   ++  L  L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
                   ++  V +Y+  G L  H+  +     P  R     I     L +LH    + 
Sbjct: 62  HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEI--VLGLQFLH---ERG 116

Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLT 657
           II+RD+K  N+LLD E   K++DFG+CK G     T  ++   G+  Y+ PE    Q   
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQPYG 174

Query: 658 EKSDVYSFGVVLLEVLCARPP 678
              D ++ GV+L E+L  + P
Sbjct: 175 PAVDWWALGVLLYEMLAGQSP 195

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 27/213 (12%)

Query: 483 IGRGGFGNVYKG--FLNG--DSTPVAIKRL-NPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G   FG +YKG  +L G   +  VAIK L +  + Q   EFQ E  ++++L + ++V L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNND---------------NPPLPWDRRLKICIG 582
           +G    +  + ++++Y+ +G L + L                      L     L I I 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVK 640
            A  + YL   +S   +H+D+   NIL+ E+   K+SD GL +  +  ++ +    + + 
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL- 188

Query: 641 GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
             I ++ PE       +  SD++SFGVVL E+ 
Sbjct: 189 -PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 75.2 bits (185), Expect = 1e-14
 Identities = 70/205 (34%), Positives = 94/205 (45%), Gaps = 19/205 (9%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIG--------MLSQLRYLH 533
           +IG+G FG V       D    A+K L    Q+ A+  + E          +L  +++  
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVL----QKKAILKKKEQKHIMAERNVLLKNVKHPF 57

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           LV L        ++  V DY+  G L  HL    + P P  R     I  A AL YLH  
Sbjct: 58  LVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEI--ASALGYLH-- 113

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
            S  II+RD+K  NILLD +    ++DFGLCK G   SKT  ++   G+  YL PE  R 
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRK 170

Query: 654 QLLTEKSDVYSFGVVLLEVLCARPP 678
           Q      D +  G VL E+L   PP
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 67/270 (24%), Positives = 106/270 (39%), Gaps = 32/270 (11%)

Query: 483 IGRGGFGNVYKGFLNGDST--PVAIKRLNPGSQQGAL--EFQTEIGMLSQLRYLHLVSLI 538
           +G G FG V KG      +   VA+K L   +   AL  E   E  ++ QL   ++V +I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVI 598
           G C  +  M LV +    G L   L  N +  +      ++    +  + YL        
Sbjct: 63  GICEAESWM-LVMELAELGPLNKFLQKNKH--VTEKNITELVHQVSMGMKYLEETN---F 116

Query: 599 IHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLT 657
           +HRD+   N+LL  +  AK+SDFGL K  G + +     T  K  + +  PE       +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 658 EKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG---N 714
            KSDV+SFGV++ E                     +  + Y+  K  ++      G    
Sbjct: 177 SKSDVWSFGVLMWEAFS------------------YGQKPYKGMKGNEVTQMIESGERME 218

Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
            P  C  +  ++   C       RP  + V
Sbjct: 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVV 248

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 73.8 bits (181), Expect = 3e-14
 Identities = 60/218 (27%), Positives = 108/218 (49%), Gaps = 22/218 (10%)

Query: 472 EATKDFNNLLI-IGRGGFGNVYKG----FLNGD-STPVAIKRLN-PGSQQGALEFQTEIG 524
           E +++   LL  +G+G FG VY+G     + G+  T VA+K +N   S +  +EF  E  
Sbjct: 2   EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61

Query: 525 MLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-------NNDNPPLPWDRRL 577
           ++      H+V L+G  +     ++V + MA G L+ +L        NN   P P  + +
Sbjct: 62  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121

Query: 578 -KICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVS 636
            ++    A  + YL+   +K  +HRD+   N ++  ++  K+ DFG+ +    +   +  
Sbjct: 122 IQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR 176

Query: 637 TQVKG--SIGYLDPEYYRLQLLTEKSDVYSFGVVLLEV 672
              KG   + ++ PE  +  + T  SD++SFGVVL E+
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 73.4 bits (181), Expect = 3e-14
 Identities = 62/208 (29%), Positives = 93/208 (44%), Gaps = 20/208 (9%)

Query: 483 IGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQ---TEIGMLSQLRYLHLVSL 537
           I +G +G V+  K    GD    AIK +         +     TE  +LSQ +  ++V L
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGA-ARALHYLHTGASK 596
                    + LV +Y+  G L   L N  +     +   +I I     AL YLH   S 
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLD---EDVARIYIAEIVLALEYLH---SN 112

Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVS------TQVKGSIGYLDPEY 650
            IIHRD+K  NIL+D     K++DFGL K G    + +++       ++ G+  Y+ PE 
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPP 678
              Q  ++  D +S G +L E L   PP
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 78/298 (26%), Positives = 124/298 (41%), Gaps = 49/298 (16%)

Query: 483 IGRGGFGNVYKGFLNGDST--PVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G G FG+V +G LN D +   VA+K +     ++    +F +E   + +  + +++ LI
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 539 GYCNDDGQM------ILVYDYMARGTLRDHLYNN---DNPP-LPWDRRLKICIGAARALH 588
           G C    +       +++  +M  G L   L  +   D P  LP    +K     A  + 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           YL   +SK  IHRD+   N +L+E     V+DFGL K   N          K  + ++  
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID 708
           E    ++ T KSDV+SFGV + E+                  A      Y   +  +I D
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI------------------ATRGQTPYPGVENSEIYD 225

Query: 709 PFLKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEKSM 763
              +GN    PP CL+    +  SC   +   RPS           F+ LR   EK++
Sbjct: 226 YLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPS-----------FETLRCELEKAL 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 72.7 bits (178), Expect = 5e-14
 Identities = 54/196 (27%), Positives = 98/196 (50%), Gaps = 8/196 (4%)

Query: 480 LLIIGRGGFGNVYKGFLNGDSTPVAIKRLN--PGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           + ++G+G +G V       D     IK+LN    S++     + E  +LSQL++ ++V+ 
Sbjct: 5   VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 538 I-GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
              +  +DG + +V  +   G L   L       LP ++ ++  +  A AL YLH    K
Sbjct: 65  RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EK 121

Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
            I+HRD+KT N+ L    + KV D G+ +   N  +  +++ + G+  Y+ PE +  +  
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCDMASTLIGTPYYMSPELFSNKPY 179

Query: 657 TEKSDVYSFGVVLLEV 672
             KSDV++ G  + E+
Sbjct: 180 NYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 72.8 bits (179), Expect = 6e-14
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 18/208 (8%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE--FQTEIGMLSQLRYLHL 534
           + NL ++G G +G V K         VAIK+         ++     EI ML QLR+ +L
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           V+LI       ++ LV++++   T+ D L    N  L   R  K      R + + H   
Sbjct: 63  VNLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNG-LDESRVRKYLFQILRGIEFCH--- 117

Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF--GPNFSKT-HVSTQVKGSIGYL--DPE 649
           S  IIHRD+K  NIL+ +  V K+ DFG  +    P    T +V+T+   +   L  D +
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177

Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARP 677
           Y R        D+++ G ++ E+L   P
Sbjct: 178 YGR------AVDIWAVGCLVTEMLTGEP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 73.5 bits (181), Expect = 6e-14
 Identities = 63/240 (26%), Positives = 91/240 (37%), Gaps = 47/240 (19%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG----SQQGALEFQTEIGMLSQLR 530
            DF  + +IGRG FG V+           A+K L         Q A   + E  +L+   
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADAD 59

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL--KICIGAARALH 588
              +V L     D+  + LV +YM  G L + L   D  P    R    ++ +    AL 
Sbjct: 60  SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVL----ALD 115

Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK-------- 640
            +H       IHRD+K  NIL+D +   K++DFGLCK     +K                
Sbjct: 116 SVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCK---KMNKAKDREYYLNDSHNLLF 169

Query: 641 ----------------------GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
                                 G+  Y+ PE  R      + D +S GV+L E+L   PP
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 72.0 bits (177), Expect = 8e-14
 Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 22/216 (10%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEF-QTEIGMLSQLRYLH 533
            D+  + +IG G    VY      ++  VAIKR++    Q +++  + E+  +SQ  + +
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRD---HLYNNDNPPLPWDRRLKICIGAA-----R 585
           +V          ++ LV  Y++ G+L D     Y                I        +
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEA-------IIATVLKEVLK 113

Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL--CKFGPNFSKTHVSTQVKGSI 643
            L YLH+      IHRD+K  NILL E+   K++DFG+             V     G+ 
Sbjct: 114 GLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170

Query: 644 GYLDPE-YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            ++ PE   ++     K+D++SFG+  +E+     P
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 71.5 bits (176), Expect = 9e-14
 Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 17/202 (8%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN-----PGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G GGFG V    +   +   A+K +         QQ  +  + EI  L +  +  +V L
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEI--LEECNHPFIVKL 58

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAA-RALHYLHTGASK 596
                D   + ++ +Y   G L   L +        +   +  I     A  YLH   ++
Sbjct: 59  YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD---EYTARFYIACVVLAFEYLH---NR 112

Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
            II+RD+K  N+LLD     K+ DFG  K   +  KT   T   G+  Y+ PE    +  
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIILNKGY 169

Query: 657 TEKSDVYSFGVVLLEVLCARPP 678
               D +S G++L E+L  RPP
Sbjct: 170 DFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 23/207 (11%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI-GYC 541
           +G G FG VYK          A K +   S++   +F  EI +LS+ ++ ++V L   Y 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
            ++   IL+ ++   G L D +       L   +   +C     AL++LH   S  +IHR
Sbjct: 73  YENKLWILI-EFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHR 127

Query: 602 DVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK-----GSIGYLDPEY-----Y 651
           D+K  NILL  +   K++DFG+       S  + ST  K     G+  ++ PE      +
Sbjct: 128 DLKAGNILLTLDGDVKLADFGV-------SAKNKSTLQKRDTFIGTPYWMAPEVVACETF 180

Query: 652 RLQLLTEKSDVYSFGVVLLEVLCARPP 678
           +      K+D++S G+ L+E+    PP
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 23/210 (10%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRL--NPGSQQGALE---FQTEIGMLSQLRYLHLVS 536
           ++G+G FG VY  +       +A+K++  +P S + + E    + EI +L  L +  +V 
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 537 LIGYCNDDGQMIL--VYDYMARGTLRDHLYN----NDNPPLPWDRRLKICIGAARALHYL 590
             G   D  +  L    ++M  G+++D L +     +N    + R++         + YL
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI------LEGVSYL 122

Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN--FSKTHVSTQVKGSIGYLDP 648
           H   S +I+HRD+K  NIL D     K+ DFG  K       S T + + V G+  ++ P
Sbjct: 123 H---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSP 178

Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           E    +    K+D++S G  ++E+L  +PP
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 13/204 (6%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLN----PGSQQGALEFQTEIGMLSQLRYL 532
           +  +  IG G FG +Y      DS    IK ++    P  ++ A   + E+ +L+++++ 
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEA--SKKEVILLAKMKHP 59

Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V+      ++G++ +V +Y   G L   +          D+ L   +  +  L ++H 
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH- 118

Query: 593 GASKVIIHRDVKTTNILLDEE-WVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
              + I+HRD+K+ NI L +   VAK+ DFG+ +   +     ++    G+  YL PE  
Sbjct: 119 --DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SMELAYTCVGTPYYLSPEIC 174

Query: 652 RLQLLTEKSDVYSFGVVLLEVLCA 675
           + +    K+D++S G VL E LC 
Sbjct: 175 QNRPYNNKTDIWSLGCVLYE-LCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 73.8 bits (181), Expect = 1e-13
 Identities = 62/248 (25%), Positives = 102/248 (41%), Gaps = 29/248 (11%)

Query: 453 PASSLPSDLCTQFSIS------EIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIK 506
              ++   +C  F  +        KE  K +    ++G G  G V       D  P A+K
Sbjct: 4   SGDAMIGRVCRTFPDTFAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVK 63

Query: 507 --RLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD------------GQMILVYD 552
              +   S+      Q E+  L    +  +V     C++D              + LV D
Sbjct: 64  VVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK----CHEDFAKKDPRNPENVLMIALVLD 119

Query: 553 YMARGTLRDHLYNNDNPPLPWDRRLK--ICIGAARALHYLHTGASKVIIHRDVKTTNILL 610
           Y   G LR  + +       +       + I    A+H++H   SK +IHRD+K+ NILL
Sbjct: 120 YANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILL 176

Query: 611 DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLL 670
               + K+ DFG  K         V     G+  Y+ PE +R +  ++K+D++S GV+L 
Sbjct: 177 CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLY 236

Query: 671 EVLCARPP 678
           E+L  + P
Sbjct: 237 ELLTLKRP 244

Length = 496

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 72.3 bits (177), Expect = 1e-13
 Identities = 65/203 (32%), Positives = 92/203 (45%), Gaps = 15/203 (7%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-----SQQGALEFQTEIGMLSQLRYLHLVS 536
           +IG+G FG V       D    A+K L         +Q  +  +  + +L  +++  LV 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVG 60

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGA-ARALHYLHTGAS 595
           L        ++  V D++  G L  HL    + P P   R +      A AL YLH   S
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP---RARFYAAEIASALGYLH---S 114

Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
             I++RD+K  NILLD +    ++DFGLCK G   S T  +T   G+  YL PE  R Q 
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRKQP 172

Query: 656 LTEKSDVYSFGVVLLEVLCARPP 678
                D +  G VL E+L   PP
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 31/215 (14%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL-----NPGSQQGALEFQTEIGMLSQLRY 531
           +  L ++G G +G V K         VAIK+      +   ++ AL    E+ +L QLR+
Sbjct: 3   YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR---EVKVLRQLRH 59

Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
            ++V+L       G++ LV++Y+ R TL + L  +    LP D          +A+ Y H
Sbjct: 60  ENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGG-LPPDAVRSYIWQLLQAIAYCH 117

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF---GPNFSKT-HVSTQVKGSIGYLD 647
              S  IIHRD+K  NIL+ E  V K+ DFG  +     P    T +V+T+      Y  
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR-----WYRA 169

Query: 648 PEYYRLQLLTEKS-----DVYSFGVVLLEVLCARP 677
           PE     L+ + +     DV++ G ++ E+L   P
Sbjct: 170 PEL----LVGDTNYGKPVDVWAIGCIMAELLDGEP 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 71.1 bits (174), Expect = 2e-13
 Identities = 68/274 (24%), Positives = 111/274 (40%), Gaps = 38/274 (13%)

Query: 482 IIGRGGFGNVYKGFLNGDST---PVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           I+G G FG + +G L   S    PVAI  L  G S +    F  E   L Q  + ++V L
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G       M++V +YM+ G L   L  ++   L   + + +  G A  + YL   +   
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ-LVAGQLMGMLPGLASGMKYL---SEMG 127

Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS--IGYLDPEYYRLQL 655
            +H+ +    +L++ + V K+S F             + T + G   + +  PE  +   
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184

Query: 656 LTEKSDVYSFGVVLLEVLC--ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
            +  SDV+SFG+V+ EV+    RP                    Y +    D+I     G
Sbjct: 185 FSSASDVWSFGIVMWEVMSYGERP--------------------YWDMSGQDVIKAVEDG 224

Query: 714 ---NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
               AP  C N   ++ + C   +R  RP  S +
Sbjct: 225 FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQI 258

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 60/238 (25%), Positives = 95/238 (39%), Gaps = 52/238 (21%)

Query: 471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
            + T  F  + +IG G +G VYK         VAIK ++    +   E + E  +L   +
Sbjct: 2   PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE-EIKEEYNILR--K 58

Query: 531 YLHLVSLIGY---------CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK--- 578
           Y +  ++  +           +D Q+ LV +    G++ D L           +RLK   
Sbjct: 59  YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKG---LRKKGKRLKEEW 114

Query: 579 ---ICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHV 635
              I     R L YLH      +IHRD+K  NILL +    K+ DFG            V
Sbjct: 115 IAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG------------V 159

Query: 636 STQVKGSIG----------YLDPE-----YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           S Q+  ++G          ++ PE              +SDV+S G+  +E+   +PP
Sbjct: 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 70.9 bits (173), Expect = 2e-13
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 17/207 (8%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRL--NPGSQQGALE---FQTEIGMLSQLRYLHLVS 536
           ++G+G FG VY  +       +A K++  +P S + + E    + EI +L  L++  +V 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 537 LIGYCNDDGQ--MILVYDYMARGTLRDHL--YNNDNPPLPWDRRLKICIGAARALHYLHT 592
             G   D  +  + +  +YM  G+++D L  Y      +      +I  G    + YLH 
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEG----MSYLH- 123

Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYY 651
             S +I+HRD+K  NIL D     K+ DFG  K       +    + V G+  ++ PE  
Sbjct: 124 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181

Query: 652 RLQLLTEKSDVYSFGVVLLEVLCARPP 678
             +    K+DV+S G  ++E+L  +PP
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 69.6 bits (170), Expect = 5e-13
 Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 9/195 (4%)

Query: 483 IGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSLIG 539
           +G G FG V KG   +      VAIK L   +++    E   E  ++ QL   ++V +IG
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
            C  +  M+++   MA G   +   +     +     +++    +  + YL     K  +
Sbjct: 63  VCEAEALMLVME--MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117

Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTE 658
           HRD+   N+LL  +  AK+SDFGL K  G + S     +  K  + +  PE    +  + 
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177

Query: 659 KSDVYSFGVVLLEVL 673
           +SDV+S+G+ + E  
Sbjct: 178 RSDVWSYGITMWEAF 192

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 69.7 bits (170), Expect = 5e-13
 Identities = 67/277 (24%), Positives = 117/277 (42%), Gaps = 29/277 (10%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDS----TPVAIKRLNPG-SQQGALEFQTEIGMLSQLR 530
           +   + ++G G FG VYKG    D      PVAIK L    S +   E   E  +++ + 
Sbjct: 8   ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
             ++  L+G C     + LV   M  G L D++  N +     D  L  C+  A+ + YL
Sbjct: 68  SPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDL-LNWCVQIAKGMSYL 125

Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
                  ++HRD+   N+L+      K++DFGL +        + +   K  I ++  E 
Sbjct: 126 E---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182

Query: 651 YRLQLLTEKSDVYSFGVVLLEVLC--ARPPILRTGDKKQVNLAVWATECYRNGKIGDIID 708
              +  T +SDV+S+GV + E++   A+P                  +     +I D+++
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKP-----------------YDGIPAREIPDLLE 225

Query: 709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
              +   PP+C      + + C   D   RP   ++V
Sbjct: 226 KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 262

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 69.1 bits (169), Expect = 6e-13
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 16/203 (7%)

Query: 483 IGRGGFGNVYKGFLN--GD-----STPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV 535
           +G+G F  ++KG     GD      T V +K L+   +  +  F     M+SQL + HLV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNP-PLPWDRRLKICIGAARALHYLHTGA 594
              G C    + I+V +Y+  G+L  +L  N N   + W  +L++    A ALH+L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE--- 117

Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQV-KGSIGYLDPEYYR 652
            K + H +V   N+LL  E   K  +    K   P  S T +  ++    I ++ PE   
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIE 177

Query: 653 -LQLLTEKSDVYSFGVVLLEVLC 674
             Q L+  +D +SFG  L E+  
Sbjct: 178 NPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 69.4 bits (170), Expect = 7e-13
 Identities = 57/214 (26%), Positives = 104/214 (48%), Gaps = 30/214 (14%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV 535
             +N + IG G  G V           VA+K+++   QQ       E+ ++   ++ ++V
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79

Query: 536 SLIG-YCNDDGQMILVYDYMARGTLRD---HLYNNDNPPLPWDRRLKICIGAARALHYLH 591
            +   Y   D ++ +V +++  G L D   H   N+      ++   +C+   +AL +LH
Sbjct: 80  EMYSSYLVGD-ELWVVMEFLEGGALTDIVTHTRMNE------EQIATVCLAVLKALSFLH 132

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV---KGSIG---Y 645
              ++ +IHRD+K+ +ILL  +   K+SDFG C          VS +V   K  +G   +
Sbjct: 133 ---AQGVIHRDIKSDSILLTSDGRVKLSDFGFC--------AQVSKEVPRRKSLVGTPYW 181

Query: 646 LDPEYY-RLQLLTEKSDVYSFGVVLLEVLCARPP 678
           + PE   RL   TE  D++S G++++E++   PP
Sbjct: 182 MAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 69.3 bits (170), Expect = 7e-13
 Identities = 64/239 (26%), Positives = 97/239 (40%), Gaps = 44/239 (18%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRL---NPGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           IGRG FG V K       T +A+KR+       +Q  L    ++ M S     ++V   G
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-DCPYIVKFYG 70

Query: 540 YCNDDGQMILVYDYMARGTLRDHLY----NNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
               +G   +  + M      D  Y          +P +   KI +   +AL+YL     
Sbjct: 71  ALFREGDCWICMELMD--ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK 128

Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
             IIHRDVK +NILLD     K+ DFG+  +   + +KT  +    G   Y+ PE  R+ 
Sbjct: 129 --IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA----GCRPYMAPE--RID 180

Query: 655 LLTE-----KSDVYSFGVVLLEVLCAR--------------------PPILRTGDKKQV 688
                    +SDV+S G+ L EV   +                    PPIL   ++++ 
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREF 239

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 69.7 bits (171), Expect = 8e-13
 Identities = 64/217 (29%), Positives = 94/217 (43%), Gaps = 27/217 (12%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL-- 532
            D  NL  IG G  G VYK         +A+K++    + G  E    I M   L  +  
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKEENKRILM--DLDVVLK 69

Query: 533 -----HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARAL 587
                ++V   GY   D  + +  + M+  T  D L      P+P D   K+ +   +AL
Sbjct: 70  SHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKAL 127

Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
           HYL       +IHRDVK +NILLD     K+ DFG+     + SK    T+  G   Y+ 
Sbjct: 128 HYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVD-SKAK--TRSAGCAAYMA 182

Query: 648 PEYYRLQLLTEK------SDVYSFGVVLLEVLCARPP 678
           PE  R+            +DV+S G+ L+E+   + P
Sbjct: 183 PE--RIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 69.7 bits (171), Expect = 8e-13
 Identities = 67/217 (30%), Positives = 92/217 (42%), Gaps = 32/217 (14%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE----------FQTEIGML 526
           F  L ++GRG FG V            AIK L  G      E          F+T     
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFET----A 56

Query: 527 SQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARA 586
           +  R+  LV+L      +  +  V +Y A G L  H++  D    P       C+     
Sbjct: 57  NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACV--VLG 113

Query: 587 LHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL 646
           L YLH      I++RD+K  N+LLD E   K++DFGLCK G  F     ST   G+  +L
Sbjct: 114 LQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-TST-FCGTPEFL 168

Query: 647 DPEYYRLQLLTEKS-----DVYSFGVVLLEVLCARPP 678
            PE     +LTE S     D +  GV++ E+L    P
Sbjct: 169 APE-----VLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 69.6 bits (170), Expect = 1e-12
 Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 13/202 (6%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-----QQGALEFQTEIGMLSQLRYLHLVS 536
           +IG+G FG V       D +  A+K L   +     +Q  +  +  + +L  L++  LV 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVG 60

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           L        ++  V DY+  G L  HL        P  R     +  A A+ YLH   S 
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEV--ASAIGYLH---SL 115

Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
            II+RD+K  NILLD +    ++DFGLCK G    +T  ++   G+  YL PE  R +  
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKEPY 173

Query: 657 TEKSDVYSFGVVLLEVLCARPP 678
               D +  G VL E+L   PP
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 25/212 (11%)

Query: 483 IGRGGFGNVYKGFLNGDSTP------VAIKRLNPGSQQGAL--EFQTEIGMLSQLRYLHL 534
           +G   FG VYKG L G + P      VAIK L   ++ G L  EF+ E  M S+L++ ++
Sbjct: 13  LGEDRFGKVYKGHLFG-TAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNI 70

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLY----NNDNPPLPWDRRLKICIGAARALHYL 590
           V L+G    +  + +++ Y +   L + L     ++D      D+ +K  +  A  +H +
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 591 HTGASKV-------IIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKG 641
              A+ +       ++H+D+ T N+L+ ++   K+SD GL +  +  ++ K   ++ +  
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL-- 188

Query: 642 SIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
            I ++ PE       +  SD++S+GVVL EV 
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 17/209 (8%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLH 533
           F    ++G+GGFG V    +       A KRL       ++G      E  +L ++    
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL----KICIGAARALHY 589
           +V+L         + LV   M  G L+ H+YN  NP    +R L    +I  G    L  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG----LED 117

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           LH    +  ++RD+K  NILLD+    ++SD GL    P      +  +V G++GY+ PE
Sbjct: 118 LH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIP--EGESIRGRV-GTVGYMAPE 171

Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               Q  T   D +  G ++ E++  + P
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 67.2 bits (164), Expect = 3e-12
 Identities = 51/199 (25%), Positives = 91/199 (45%), Gaps = 19/199 (9%)

Query: 483 IGRGGFGNVYKGFLNGDST--------PVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           IG G FG   K  L              + I +++P  ++   E + E+ +LS +++ ++
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNI 61

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           V       ++G + +V DY   G L   +        P D+ L   +    AL ++H   
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH--- 118

Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
            + I+HRD+K+ NI L ++   K+ DFG+ +     S   ++    G+  YL PE    +
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN--STVELARTCIGTPYYLSPEICENR 176

Query: 655 LLTEKSDVYSFGVVLLEVL 673
               KSD+++ G VL E+ 
Sbjct: 177 PYNNKSDIWALGCVLYEMC 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 67.5 bits (165), Expect = 5e-12
 Identities = 66/212 (31%), Positives = 97/212 (45%), Gaps = 21/212 (9%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALE-FQTEIGMLSQLRYL 532
           DFN L+++G+G FG V      G     AIK L      Q   +E    E  +L+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 533 H-LVSLIGYCNDDGQMILVYDYMARGTLRDHL--YNNDNPPLPWDRRLKICIGAARALHY 589
             L  L        ++  V +Y+  G L  H+        P       +I IG    L +
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG----LFF 116

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVKGSIGYL 646
           LH   SK II+RD+K  N++LD E   K++DFG+CK   FG   ++T       G+  Y+
Sbjct: 117 LH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-----GTPDYI 168

Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            PE    Q   +  D ++FGV+L E+L  +PP
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 67.4 bits (165), Expect = 5e-12
 Identities = 65/209 (31%), Positives = 91/209 (43%), Gaps = 17/209 (8%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQ---TEIGMLSQLRY 531
           KDF  L  +G+GG+G V+          VA+KR+         E +   TE  +L+  + 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKIC--IGAARALHY 589
             LV L+    DD  + L  +Y+  G  R  L NN         R  +     A  ALH 
Sbjct: 61  EWLVKLLYAFQDDEYLYLAMEYVPGGDFRT-LLNNLGVLSEDHARFYMAEMFEAVDALHE 119

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L        IHRD+K  N L+D     K++DFGL K    ++ + V     GS  Y+ PE
Sbjct: 120 LG------YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GSPDYMAPE 168

Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
             R +      D +S G +L E LC  PP
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 67.7 bits (165), Expect = 5e-12
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)

Query: 469 EIKEATKDFNNLLIIGRGGFGNVYKG-FLNGDSTPVAIKRLNPGS---QQGALEFQTEIG 524
           + K   +DFN +  +G G FG V    + N D  PVAIKR        Q+      +E  
Sbjct: 24  KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERK 83

Query: 525 MLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAA 584
           +L+ + +   V+L G   D+  + LV +++  G     L  N     P D     C  AA
Sbjct: 84  ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR--FPNDVG---CFYAA 138

Query: 585 RALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG 644
           + +       S  I++RD+K  N+LLD++   K++DFG  K     + T   T       
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGT------- 191

Query: 645 YLDPEYYRLQLLT-----EKSDVYSFGVVLLEVLCARPP 678
              PEY   ++L      + +D ++ G+ + E+L   PP
Sbjct: 192 ---PEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 66.4 bits (162), Expect = 6e-12
 Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 15/214 (7%)

Query: 478 NNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
              +++G+G +G VY          +AIK +     +       EI + S L++ ++V  
Sbjct: 11  GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQY 70

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAA--RALHYLHTGAS 595
           +G  +++G   +  + +  G+L   L  +   PL  + +  I         L YLH    
Sbjct: 71  LGSDSENGFFKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---D 126

Query: 596 KVIIHRDVKTTNILLDE-EWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEY-- 650
             I+HRD+K  N+L++    V K+SDFG  K   G N      +    G++ Y+ PE   
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN----PCTETFTGTLQYMAPEVID 182

Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGD 684
              +     +D++S G  ++E+   +PP +  G+
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 66.6 bits (162), Expect = 7e-12
 Identities = 64/237 (27%), Positives = 102/237 (43%), Gaps = 42/237 (17%)

Query: 467 ISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGML 526
           +S +++    F  + ++G G +G VYKG         AIK ++  ++    E + EI ML
Sbjct: 8   LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEINML 66

Query: 527 SQLRYLHLVSLIGY---------CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL 577
              +Y H  ++  Y            D Q+ LV ++   G++ D + N     L  D   
Sbjct: 67  K--KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA 124

Query: 578 KICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST 637
            IC    R L +LH  A KVI HRD+K  N+LL E    K+ DFG            VS 
Sbjct: 125 YICREILRGLAHLH--AHKVI-HRDIKGQNVLLTENAEVKLVDFG------------VSA 169

Query: 638 QVKGSIG----------YLDPEYYRLQ-----LLTEKSDVYSFGVVLLEVLCARPPI 679
           Q+  ++G          ++ PE              +SD++S G+  +E+    PP+
Sbjct: 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 66.4 bits (162), Expect = 8e-12
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 10/158 (6%)

Query: 522 EIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICI 581
           E+ ++ + R  ++VS  G   ++  + +  ++M  G+L D +Y    P +P +   KI +
Sbjct: 53  ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGP-IPVEILGKIAV 110

Query: 582 GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVK 640
                L YL+      I+HRD+K +NIL++     K+ DFG+     N  + T V T   
Sbjct: 111 AVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTST- 167

Query: 641 GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               Y+ PE  +    T KSDV+S G+ ++E+   + P
Sbjct: 168 ----YMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 66.4 bits (163), Expect = 1e-11
 Identities = 59/237 (24%), Positives = 92/237 (38%), Gaps = 69/237 (29%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT---------EIGMLS 527
           +  L  IG G +G V           VAIK+++         F           EI +L 
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLR 54

Query: 528 QLRYLHLVSLI-----GYCNDDGQMILVYDYM---------ARGTLR-DH----LYNNDN 568
            LR+ +++ L+         D   + +V + M         +   L  DH    LY    
Sbjct: 55  HLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQ--- 111

Query: 569 PPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG 627
                     I     R L YLH   S  +IHRD+K +NIL++     K+ DFGL +   
Sbjct: 112 ----------IL----RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154

Query: 628 PNFSKTHVSTQVKGSIGYLDPEYYR---LQLL----TEKSDVYSFGVVLLEVLCARP 677
           P+  +    T+      Y+   +YR   L L     T+  D++S G +  E+L  +P
Sbjct: 155 PDEDEKGFLTE------YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 19/210 (9%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLH 533
           F +  ++G+GGFG V    +       A K+L       ++G      E  +L ++    
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 534 LVSLI-GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL----KICIGAARALH 588
           +VSL   Y   D  + LV   M  G L+ H+YN  NP    +R +    +I  G    L 
Sbjct: 62  VVSLAYAYETKDA-LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG----LE 116

Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
            LH    + I++RD+K  NILLD+    ++SD GL    P      +  +V G++GY+ P
Sbjct: 117 DLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAP 170

Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           E  + +  T   D +  G ++ E++  + P
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 28/212 (13%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVS 536
            ++ + IG G  G V           VA+K+++   QQ       E+ ++    + ++V 
Sbjct: 24  LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVD 83

Query: 537 LIGYCNDDGQMILVYDYMARGTLRD---HLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           +        ++ +V +++  G L D   H   N+      ++   +C+   RAL YLH  
Sbjct: 84  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------EQIATVCLSVLRALSYLHNQ 137

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK------GSIGYLD 647
               +IHRD+K+ +ILL  +   K+SDFG C          VS +V       G+  ++ 
Sbjct: 138 G---VIHRDIKSDSILLTSDGRIKLSDFGFC--------AQVSKEVPKRKSLVGTPYWMA 186

Query: 648 PEYY-RLQLLTEKSDVYSFGVVLLEVLCARPP 678
           PE   RL   TE  D++S G++++E++   PP
Sbjct: 187 PEVISRLPYGTE-VDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 23/207 (11%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALE-FQTEIGMLSQLRYLHLVSLI 538
           ++G+G FG V    L       A+K L      Q   +E   TE  +LS  R    ++ +
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 539 GYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL---KICIGAAR---ALHYLH 591
             C     ++  V +++  G L  H+  +        RR    +    AA    AL +LH
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDLMFHIQKS--------RRFDEARARFYAAEITSALMFLH 113

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               K II+RD+K  N+LLD E   K++DFG+CK G    KT  ++   G+  Y+ PE  
Sbjct: 114 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEIL 168

Query: 652 RLQLLTEKSDVYSFGVVLLEVLCARPP 678
           +  L     D ++ GV+L E+LC   P
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 17/209 (8%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLH 533
           F    ++G+GGFG V    +       A K+L       ++G      E  +L ++    
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL----KICIGAARALHY 589
           +VSL         + LV   M  G L+ H+Y+         R +    +IC G    L  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LED 117

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           LH    + I++RD+K  NILLD+    ++SD GL    P      +  +V G++GY+ PE
Sbjct: 118 LH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVP--EGQTIKGRV-GTVGYMAPE 171

Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
             + +  T   D ++ G +L E++  + P
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 62/204 (30%), Positives = 90/204 (44%), Gaps = 17/204 (8%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQ-------LRYLHL 534
           +IG+G FG V       +    A+K L    ++  L+ + E  ++S+       +++  L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQ---KKAILKKKEEKHIMSERNVLLKNVKHPFL 58

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           V L        ++  V DY+  G L  HL        P  R     I  A AL YLH   
Sbjct: 59  VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI--ASALGYLH--- 113

Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
           S  I++RD+K  NILLD +    ++DFGLCK   N      ++   G+  YL PE    Q
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQ 171

Query: 655 LLTEKSDVYSFGVVLLEVLCARPP 678
                 D +  G VL E+L   PP
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 21/212 (9%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQ---TEIGMLSQLRYLH 533
           F  L  IG G FG VY    +  +  VA+K+++   +Q   ++Q    E+  L QL++ +
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
            +   G    +    LV +Y   G+  D L      PL       I  GA + L YLH  
Sbjct: 83  TIEYKGCYLKEHTAWLVMEY-CLGSASD-LLEVHKKPLQEVEIAAITHGALQGLAYLH-- 138

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
            S  +IHRD+K  NILL E    K++DFG      + SK+  +    G+  ++ PE   +
Sbjct: 139 -SHNMIHRDIKAGNILLTEPGQVKLADFG------SASKSSPANSFVGTPYWMAPEV--I 189

Query: 654 QLLTE-----KSDVYSFGVVLLEVLCARPPIL 680
             + E     K DV+S G+  +E+   +PP+ 
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLF 221

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 32/209 (15%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRL-----NPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           IG G +G V+K         VAIK+      +P  ++ AL    EI ML QL++ +LV+L
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR---EIRMLKQLKHPNLVNL 65

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
           I       ++ LV++Y    T+ + L  N    +P     KI     +A+++ H      
Sbjct: 66  IEVFRRKRKLHLVFEYCDH-TVLNELEKNPRG-VPEHLIKKIIWQTLQAVNFCH---KHN 120

Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKF--GPNFSKT-HVSTQVKGSIGYLDPEYYRLQ 654
            IHRDVK  NIL+ ++   K+ DFG  +   GP    T +V+T+      Y  PE     
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPE----- 170

Query: 655 LLTEKS------DVYSFGVVLLEVLCARP 677
           LL   +      DV++ G V  E+L  +P
Sbjct: 171 LLVGDTQYGPPVDVWAIGCVFAELLTGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (158), Expect = 4e-11
 Identities = 68/245 (27%), Positives = 97/245 (39%), Gaps = 28/245 (11%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIG--------MLSQLRYLHL 534
           IG+G FG VY+          A+K L+        E    IG        +L +  ++  
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFI-- 58

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGA-ARALHYLHTG 593
           V L      D  + LV DYM+ G L  HL          + R K  I     AL +LH  
Sbjct: 59  VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS---EDRAKFYIAELVLALEHLHKY 115

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
               I++RD+K  NILLD      + DFGL K   N +    +    G+  YL PE    
Sbjct: 116 D---IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEV--- 167

Query: 654 QLLTEKS-----DVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID 708
            LL EK      D +S GV++ E+ C   P      ++      +    +    + D   
Sbjct: 168 -LLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGR 226

Query: 709 PFLKG 713
            F+KG
Sbjct: 227 QFVKG 231

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 11/201 (5%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG VYK          A K ++  S++   ++  EI +L+   + ++V L+    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ ++ A G + D +      PL   +   +C     AL+YLH      IIHRD
Sbjct: 73  YENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRD 128

Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTE---- 658
           +K  NIL   +   K++DFG+     N           G+  ++ PE    +   +    
Sbjct: 129 LKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 186

Query: 659 -KSDVYSFGVVLLEVLCARPP 678
            K+DV+S G+ L+E+    PP
Sbjct: 187 YKADVWSLGITLIEMAQIEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 64.8 bits (158), Expect = 4e-11
 Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 5/93 (5%)

Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L +LH    K II+RD+K  N+LLD++   K++DFG+CK   N      ++   G+  Y
Sbjct: 108 GLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162

Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           + PE  + Q   E  D +SFGV+L E+L  + P
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 64.2 bits (156), Expect = 5e-11
 Identities = 61/257 (23%), Positives = 115/257 (44%), Gaps = 30/257 (11%)

Query: 503 VAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRD 561
           VA+K L   + + A  +F  EI ++S+L+  +++ L+  C     + ++ +YM  G L  
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 562 HL---------YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE 612
            L            D   + +   + +    A  + YL   +S   +HRD+ T N L+ +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGK 165

Query: 613 EWVAKVSDFGLCKFGPN-FSKTHVSTQVKG--SIGYLDPEYYRLQLLTEKSDVYSFGVVL 669
            +  K++DFG+ +   N +S  +   Q +    I ++  E   L   T  SDV++FGV L
Sbjct: 166 NYTIKIADFGMSR---NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTL 222

Query: 670 LEVL--CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVA 727
            E+L  C   P  +  D++ +       E +R+     +  P      P +C +   ++ 
Sbjct: 223 WEILTLCKEQPYSQLSDEQVIEN---TGEFFRDQG-RQVYLP-----KPALCPDSLYKLM 273

Query: 728 MSCVNDDRIRRPSMSDV 744
           +SC   +   RPS  ++
Sbjct: 274 LSCWRRNAKERPSFQEI 290

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 54/225 (24%), Positives = 103/225 (45%), Gaps = 34/225 (15%)

Query: 471 KEATKDFNNLLIIGRGGFGNVYKG--FLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQ 528
           +   +DF  +  IG G +G+VYK      G+   + + +L PG     +  Q EI M+  
Sbjct: 5   RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVV--QQEIIMMKD 62

Query: 529 LRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALH 588
            ++ ++V+  G      ++ +  ++   G+L+D +Y+   P L   +   +     + L+
Sbjct: 63  CKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGP-LSESQIAYVSRETLQGLY 120

Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG---- 644
           YLH   SK  +HRD+K  NILL +    K++DFG            VS Q+  +I     
Sbjct: 121 YLH---SKGKMHRDIKGANILLTDNGHVKLADFG------------VSAQITATIAKRKS 165

Query: 645 ------YLDPEYYRLQL---LTEKSDVYSFGVVLLEVLCARPPIL 680
                 ++ PE   ++      +  D+++ G+  +E+   +PP+ 
Sbjct: 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 64.8 bits (158), Expect = 6e-11
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 16/223 (7%)

Query: 466 SISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE---FQTE 522
            I++++   +DF+ + +IGRG FG V            A+K L+        +   F  E
Sbjct: 34  KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 523 IGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
             +++      +V L     DD  + +V +YM  G L + + N D P   W R     + 
Sbjct: 94  RDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-KWARFYTAEV- 151

Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKG 641
              AL  +H   S   IHRDVK  N+LLD+    K++DFG C K   N       T V G
Sbjct: 152 -VLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN-GMVRCDTAV-G 205

Query: 642 SIGYLDPEYYRLQLLT----EKSDVYSFGVVLLEVLCARPPIL 680
           +  Y+ PE  + Q        + D +S GV L E+L    P  
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 50/211 (23%), Positives = 98/211 (46%), Gaps = 26/211 (12%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVS 536
            +N + IG G  G V    +      VA+K+++   QQ       E+ ++   ++ ++V 
Sbjct: 22  LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81

Query: 537 LIGYCNDDGQMILVYDYMARGTLRD---HLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           +        ++ +V +++  G L D   H   N+      ++   +C+   +AL  LH  
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------EQIAAVCLAVLKALSVLH-- 133

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK------GSIGYLD 647
            ++ +IHRD+K+ +ILL  +   K+SDFG C          VS +V       G+  ++ 
Sbjct: 134 -AQGVIHRDIKSDSILLTHDGRVKLSDFGFC--------AQVSKEVPRRKSLVGTPYWMA 184

Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           PE         + D++S G++++E++   PP
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 63.7 bits (155), Expect = 7e-11
 Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 20/224 (8%)

Query: 476 DFNNLLIIGRGGFGNVY---KGFLNGDSTPVAIKRLNPGS----QQGALEFQTEIGMLSQ 528
           +F  L ++G G +G V+   K   +      A+K L   +     + A   +TE  +L  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 529 LRYL-HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGA-ARA 586
           +R    LV+L      D ++ L+ DY+  G L  HLY  ++        +++ I     A
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE---SEVRVYIAEIVLA 117

Query: 587 LHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGY 645
           L +LH      II+RD+K  NILLD E    ++DFGL K F     +   +    G+I Y
Sbjct: 118 LDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE--EEERAYSFCGTIEY 172

Query: 646 LDPEYYRLQLLTEKS--DVYSFGVVLLEVLCARPPILRTGDKKQ 687
           + PE  R          D +S GV+  E+L    P    G++  
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS 216

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 63.6 bits (155), Expect = 7e-11
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 22/215 (10%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL--NPGSQ-QGALEFQTEIGMLSQLRYL 532
           D   +  +GRG +G V K       T +A+KR+     SQ Q  L    +I M S     
Sbjct: 2   DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSV-DCP 60

Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPP---LPWDRRLKICIGAARALHY 589
           + V+  G    +G + +  + M   T  D  Y         +P D   KI +   +AL Y
Sbjct: 61  YTVTFYGALFREGDVWICMEVMD--TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           LH+  S  +IHRDVK +N+L++     K+ DFG+         +   T   G   Y+ PE
Sbjct: 119 LHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKPYMAPE 173

Query: 650 YYRLQLLTE------KSDVYSFGVVLLEVLCARPP 678
             R+           KSDV+S G+ ++E+   R P
Sbjct: 174 --RINPELNQKGYDVKSDVWSLGITMIELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 63.5 bits (154), Expect = 7e-11
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 17/216 (7%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLH 533
           F +  ++G+GGFG V    +       A K+L       ++G      E  +L ++    
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL----KICIGAARALHY 589
           +VSL         + LV   M  G L+ H+YN  NP     R +    ++C G    L  
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG----LED 117

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + I++RD+K  NILLD+    ++SD GL    P      V  +V G++GY+ PE
Sbjct: 118 LQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPE 171

Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDK 685
               +  T   D +  G ++ E++  + P  +  ++
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 63.4 bits (155), Expect = 8e-11
 Identities = 47/155 (30%), Positives = 78/155 (50%), Gaps = 16/155 (10%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLN-PGSQQGALEFQT--EIGMLSQL-RYLH--LV 535
            IG G +G VYK         VA+K++  P S++G +   T  EI +L QL  + H  +V
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG-IPLSTLREIALLKQLESFEHPNIV 64

Query: 536 SLIGYC---NDDGQMI--LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
            L+  C     D ++   LV++++ +  L  +L     P LP +    +     R + +L
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFL 123

Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK 625
           H+     I+HRD+K  NIL+  +   K++DFGL +
Sbjct: 124 HSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 8e-11
 Identities = 62/228 (27%), Positives = 96/228 (42%), Gaps = 40/228 (17%)

Query: 477 FNNLLIIGRGGFGNVYKGFL--NGDSTPVAIKRLNPGSQQGALEFQT---EIGMLSQLRY 531
           +     IGRG +G VYK       D    AIK+     +Q     Q+   EI +L +L++
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 532 LHLVSLIGYC--NDDGQMILVYDYMAR---GTLRDHLYNNDNPPLPWDRRLK-----ICI 581
            ++VSL+     + D  + L++DY        ++ H        +P    +K     I  
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFH-RQAKRVSIP-PSMVKSLLWQILN 119

Query: 582 GAARALHYLHTGASKVIIHRDVKTTNILL----DEEWVAKVSDFGLCKFGPNFSKTHVS- 636
           G    +HYLH   S  ++HRD+K  NIL+     E  V K+ D GL +      K     
Sbjct: 120 G----VHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172

Query: 637 TQVKGSIGYLDPEYYRLQLL------TEKSDVYSFGVVLLEVLCARPP 678
             V  +I Y  PE     LL      T+  D+++ G +  E+L   P 
Sbjct: 173 DPVVVTIWYRAPE-----LLLGARHYTKAIDIWAIGCIFAELLTLEPI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 63.6 bits (154), Expect = 9e-11
 Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 10/212 (4%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLI 538
           ++G+G FG V            A+K L      ++       TE  +L   R+  L SL 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVI 598
                  ++  V +Y+  G L  HL  +       DR          AL YLH+G    I
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHL--SRERVFSEDRTRFYGAEIVSALDYLHSGK---I 116

Query: 599 IHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTE 658
           ++RD+K  N++LD++   K++DFGLCK G   + T  +    G+  YL PE         
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDNDYGR 174

Query: 659 KSDVYSFGVVLLEVLCARPPILRTGDKKQVNL 690
             D +  GVV+ E++C R P      +K   L
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 63.5 bits (154), Expect = 9e-11
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 17/210 (8%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALE---FQTEIGMLSQLR 530
           DFN L+++G+G FG V      G     AIK L      Q   +E    +  +  LS  +
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG-K 59

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYN--NDNPPLPWDRRLKICIGAARALH 588
              L  L        ++  V +Y+  G L   +        P       +I IG    L 
Sbjct: 60  PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG----LF 115

Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           +LH   SK II+RD+K  N++LD E   K++DFG+CK   N      +    G+  Y+ P
Sbjct: 116 FLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAP 170

Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           E    Q   +  D ++FGV+L E+L  + P
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 63.4 bits (154), Expect = 1e-10
 Identities = 60/203 (29%), Positives = 90/203 (44%), Gaps = 15/203 (7%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQ----LRYLHLVSL 537
           ++G+G FG V+   L G +   AIK L        ++   E  M+ +    L + H    
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALK--KDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 538 IGYC--NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
             YC       +  V +Y+  G L  H+ +     LP  R           L +LH   S
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLP--RATFYAAEIICGLQFLH---S 114

Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
           K I++RD+K  NILLD +   K++DFG+CK   N      +    G+  Y+ PE    Q 
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQK 172

Query: 656 LTEKSDVYSFGVVLLEVLCARPP 678
                D +SFGV+L E+L  + P
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 54/218 (24%), Positives = 102/218 (46%), Gaps = 20/218 (9%)

Query: 471 KEATKDFNNLLIIGRGGFGNVYKG--FLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQ 528
           +    D+  +  +G G +G+VYK      G+   V I +L PG     +  Q EI M+ +
Sbjct: 5   RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLI--QQEIFMVKE 62

Query: 529 LRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALH 588
            ++ ++V+  G      ++ +  +Y   G+L+D +Y+   P L   +   +C    + L 
Sbjct: 63  CKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGP-LSELQIAYVCRETLQGLA 120

Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG---Y 645
           YLH+      +HRD+K  NILL +    K++DFG+         T    + K  IG   +
Sbjct: 121 YLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAA-----KITATIAKRKSFIGTPYW 172

Query: 646 LDPEYYRLQL---LTEKSDVYSFGVVLLEVLCARPPIL 680
           + PE   ++      +  D+++ G+  +E+   +PP+ 
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 12/207 (5%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHL 534
            +N L ++G G FG              A+K +  P S     + + E  +L+++++ ++
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           V+       DG + +V +Y   G L   +        P D  L+  +     + ++H   
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH--- 117

Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN---FSKTHVSTQVKGSIGYLDPEYY 651
            K ++HRD+K+ NI L +    K+ DFG  +   +   ++ T+V T       Y+ PE +
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPY-----YVPPEIW 172

Query: 652 RLQLLTEKSDVYSFGVVLLEVLCARPP 678
                  KSD++S G +L E+   + P
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 60/242 (24%), Positives = 107/242 (44%), Gaps = 50/242 (20%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLRYL 532
            +F  L  IG G +G VY+         VA+K++   +++  +   +  EI +L  LR+ 
Sbjct: 7   TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66

Query: 533 HLVSL---------------IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL 577
           ++V L               + YC  D         +A       L +N   P    +  
Sbjct: 67  NIVELKEVVVGKHLDSIFLVMEYCEQD---------LAS------LLDNMPTPFSESQVK 111

Query: 578 KICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVS 636
            + +   R L YLH      IIHRD+K +N+LL ++   K++DFGL + +G       ++
Sbjct: 112 CLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL--PAKPMT 166

Query: 637 TQVKGSIGYLDPEYYRLQLL------TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL 690
            +V  ++ Y  PE     LL      T   D+++ G +L E+L  +P +    + +Q++L
Sbjct: 167 PKVV-TLWYRAPE-----LLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL 220

Query: 691 AV 692
            +
Sbjct: 221 II 222

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 63.9 bits (155), Expect = 1e-10
 Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 14/219 (6%)

Query: 467 ISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEI 523
           I +++   +D++ + +IGRG FG V            A+K L+      +  +  F  E 
Sbjct: 35  IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 524 GMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGA 583
            +++      +V L     DD  + +V +YM  G L + + N D P   W +     +  
Sbjct: 95  DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAKFYTAEV-- 151

Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSI 643
             AL  +H   S  +IHRDVK  N+LLD+    K++DFG C            T V G+ 
Sbjct: 152 VLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTP 207

Query: 644 GYLDPEYYRLQ----LLTEKSDVYSFGVVLLEVLCARPP 678
            Y+ PE  + Q        + D +S GV L E+L    P
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 63.2 bits (153), Expect = 1e-10
 Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQ---TEIGMLSQLRY 531
           K F +L  IG G FG VY       +  VAIK+++   +Q   ++Q    E+  L ++++
Sbjct: 25  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84

Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
            + +   G    +    LV +Y   G+  D L      PL       I  GA + L YLH
Sbjct: 85  PNSIEYKGCYLREHTAWLVMEY-CLGSASD-LLEVHKKPLQEVEIAAITHGALQGLAYLH 142

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
              S  +IHRD+K  NILL E    K++DFG      + S    +    G+  ++ PE  
Sbjct: 143 ---SHNMIHRDIKAGNILLTEPGQVKLADFG------SASIASPANSFVGTPYWMAPEV- 192

Query: 652 RLQLLTE-----KSDVYSFGVVLLEVLCARPPIL 680
            +  + E     K DV+S G+  +E+   +PP+ 
Sbjct: 193 -ILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 225

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 21/214 (9%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQ---TEIGMLSQLRY 531
           K F++L  IG G FG VY      +S  VAIK+++   +Q   ++Q    E+  L +LR+
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
            + +   G    +    LV +Y   G+  D L      PL       +  GA + L YLH
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEY-CLGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLH 132

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
              S  +IHRDVK  NILL E  + K+ DFG      + S    +    G+  ++ PE  
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFG------SASIMAPANXFVGTPYWMAPEV- 182

Query: 652 RLQLLTE-----KSDVYSFGVVLLEVLCARPPIL 680
            +  + E     K DV+S G+  +E+   +PP+ 
Sbjct: 183 -ILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 11/158 (6%)

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDR--RLKICIGAARALHYLH 591
           LV L        ++ LV +Y+  G L  H+      P    R    +ICI    AL++LH
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICI----ALNFLH 113

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               + II+RD+K  N+LLD +   K++D+G+CK G     T  ++   G+  Y+ PE  
Sbjct: 114 ---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEIL 168

Query: 652 RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVN 689
           R +      D ++ GV++ E++  R P     D   +N
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN 206

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 42/227 (18%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVS 536
           F  + ++G G +G VYKG         AIK ++    +   E + EI ML   +Y H  +
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-EIKQEINMLK--KYSHHRN 64

Query: 537 LIGYCND---------DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARAL 587
           +  Y            D Q+ LV ++   G++ D + N     L  +    IC    R L
Sbjct: 65  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124

Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG--- 644
            +LH      +IHRD+K  N+LL E    K+ DFG            VS Q+  ++G   
Sbjct: 125 SHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFG------------VSAQLDRTVGRRN 169

Query: 645 -------YLDPEYYRLQLLTE-----KSDVYSFGVVLLEVLCARPPI 679
                  ++ PE        +     KSD++S G+  +E+    PP+
Sbjct: 170 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 34/93 (36%), Positives = 50/93 (53%), Gaps = 5/93 (5%)

Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
           AL YLH   S  +++RD+K  N++LD++   K++DFGLCK G +   T       G+  Y
Sbjct: 107 ALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEY 161

Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           L PE           D +  GVV+ E++C R P
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 28/222 (12%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPV-AIKRLNPGS---QQG---ALEFQTEIGMLSQLRYLHL 534
           IIGRGGFG VY G    D+  + A+K L+      +QG   AL  +  + ++S      +
Sbjct: 1   IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL---KICIGAARALHYLH 591
           V +    +   ++  + D M  G L  HL +        + R    +I +G    L ++H
Sbjct: 60  VCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFSEKEMRFYATEIILG----LEHMH 114

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGL-CKFGPNFSKTHVSTQVKGSIGYLDPEY 650
              ++ +++RD+K  NILLDE    ++SD GL C F     K H S    G+ GY+ PE 
Sbjct: 115 ---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASV---GTHGYMAPEV 166

Query: 651 YRLQLLTEKS-DVYSFGVVLLEVLCARPPIL--RTGDKKQVN 689
            +     + S D +S G +L ++L    P    +T DK +++
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 208

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 15/202 (7%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G+GGFG V    +       A K+L+         ++ AL  + EI  L ++    +V+
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMAL-LEKEI--LEKVNSPFIVN 57

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           L         + LV   M  G L+ H+YN     L  +R +         + +LH   S 
Sbjct: 58  LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SM 114

Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
            I++RD+K  N+LLD++   ++SD GL     +       TQ  G+ GY+ PE  + +  
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPY 171

Query: 657 TEKSDVYSFGVVLLEVLCARPP 678
           +   D ++ G  + E++  R P
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 62.5 bits (152), Expect = 3e-10
 Identities = 74/300 (24%), Positives = 125/300 (41%), Gaps = 40/300 (13%)

Query: 453 PASSLPSDLCTQFSISEIKEATKDFNNLL---IIGRGGFGNVYKGFLNGDSTPVAIKRLN 509
           P+SS  S   +  S S    A K  + L     IG G  G VYK          A+K + 
Sbjct: 50  PSSSSSSSSSSSASGSAPS-AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIY 108

Query: 510 PGSQQGALEFQT--EIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNND 567
            G+ +  +  Q   EI +L  + + ++V      + +G++ ++ ++M  G+L    +  D
Sbjct: 109 -GNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT-HIAD 166

Query: 568 NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG 627
              L  D   +I  G    + YLH    + I+HRD+K +N+L++     K++DFG+ +  
Sbjct: 167 EQFLA-DVARQILSG----IAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI- 217

Query: 628 PNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEK-----SDVYSFGVVLLEVLCARPP--IL 680
              +    ++ V G+I Y+ PE     L          D++S GV +LE    R P  + 
Sbjct: 218 LAQTMDPCNSSV-GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276

Query: 681 RTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPS 740
           R GD   +  A+    C           P     AP     +F      C+  +  +R S
Sbjct: 277 RQGDWASLMCAI----CMS--------QP---PEAPATASREFRHFISCCLQREPAKRWS 321

Length = 353

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 29/210 (13%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL-------HL 534
           ++G+G FG V    L G     A+K L        ++   E  M+ + R L        L
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALK--KDVVLIDDDVECTMVEK-RVLALAWENPFL 58

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR---ALHYLH 591
             L         +  V +++  G L  H+ +     L      +    AA     L +LH
Sbjct: 59  THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL-----YRATFYAAEIVCGLQFLH 113

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVKGSIGYLDP 648
              SK II+RD+K  N++LD +   K++DFG+CK   FG N + T       G+  Y+ P
Sbjct: 114 ---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-----GTPDYIAP 165

Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           E  +    T   D +SFGV+L E+L  + P
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 61.8 bits (150), Expect = 4e-10
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 19/202 (9%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQ------TEIGMLSQLRYLHLVS 536
           +G G FG V      G     AIK L    ++  L+ +       E  +L +L +  +V+
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLK---KREILKMKQVQHVAQEKSILMELSHPFIVN 82

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           ++    D+ ++  + +++  G L  HL        P D           A  YLH   SK
Sbjct: 83  MMCSFQDENRVYFLLEFVVGGELFTHLRKAGR--FPNDVAKFYHAELVLAFEYLH---SK 137

Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
            II+RD+K  N+LLD +   KV+DFG  K  P+ + T     + G+  YL PE  + +  
Sbjct: 138 DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LCGTPEYLAPEVIQSKGH 192

Query: 657 TEKSDVYSFGVVLLEVLCARPP 678
            +  D ++ GV+L E +   PP
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 61.4 bits (149), Expect = 5e-10
 Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 5/93 (5%)

Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
           AL +LH      +I+RD+K  NILLD E   K++DFG+CK G     T  +T   G+  Y
Sbjct: 108 ALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDY 162

Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           + PE  +        D ++ GV++ E++  +PP
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 61.4 bits (149), Expect = 6e-10
 Identities = 62/226 (27%), Positives = 105/226 (46%), Gaps = 32/226 (14%)

Query: 480 LLIIGRGGFGNVYK-GFLNGDSTP--VAIKRLNPG----SQQGALEFQTEIGMLSQLRYL 532
           L ++G+GG+G V++   + G  T    A+K L       +Q+     + E  +L  +++ 
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKI------CIGAAR- 585
            +V LI      G++ L+ +Y++ G L  HL            R  I      C   +  
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHL-----------EREGIFMEDTACFYLSEI 109

Query: 586 --ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSI 643
             AL +LH    + II+RD+K  NILLD +   K++DFGLCK   +  +  V+    G+I
Sbjct: 110 SLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTI 164

Query: 644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVN 689
            Y+ PE        +  D +S G ++ ++L   PP      KK ++
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID 210

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 61.0 bits (148), Expect = 6e-10
 Identities = 38/95 (40%), Positives = 55/95 (57%), Gaps = 5/95 (5%)

Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSI 643
           A AL +LH+     II+RD+K  NILLDEE   K++DFGL K   +  K   S    G++
Sbjct: 108 ALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTV 162

Query: 644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            Y+ PE    +  T+ +D +SFGV++ E+L    P
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 60.4 bits (146), Expect = 7e-10
 Identities = 62/235 (26%), Positives = 103/235 (43%), Gaps = 29/235 (12%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLRYL---HLVSL 537
           IG G +G VYK         VA+K +   + +  L   T  E+ +L +L      ++V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 538 IGYC-----NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           +  C     + + ++ LV++++ +  LR +L     P LP +    +     R L +LH 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
                I+HRD+K  NIL+      K++DFGL +    +S     T V  ++ Y  PE   
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLWYRAPEVLL 180

Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDII 707
                   D++S G +  E+   +P  L  G+ +   L          GKI D+I
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFRRKP--LFCGNSEADQL----------GKIFDLI 223

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 60.8 bits (147), Expect = 7e-10
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 15/209 (7%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALE-FQTEIGMLSQLRYL 532
           DFN L+++G+G FG V      G     AIK L      Q   +E    E  +L+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 533 HLVSLIGYC-NDDGQMILVYDYMARGTLRDHLYN--NDNPPLPWDRRLKICIGAARALHY 589
             ++ +  C     ++  V +Y+  G L  H+        P       +I +G    L +
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG----LFF 116

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           LH    + II+RD+K  N++LD E   K++DFG+CK   +      +    G+  Y+ PE
Sbjct: 117 LH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPE 171

Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               Q   +  D +++GV+L E+L  +PP
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 60.8 bits (147), Expect = 7e-10
 Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 11/201 (5%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP---GSQQGALEFQTEIGMLSQL-RYLHLVSL 537
           +IGRG +  V    L       A+K +        +     QTE  +  Q   +  LV L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
                 + ++  V +Y+  G L  H+      P    R     I  + AL+YLH    + 
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI--SLALNYLH---ERG 116

Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLT 657
           II+RD+K  N+LLD E   K++D+G+CK G     T  ++   G+  Y+ PE  R +   
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYG 174

Query: 658 EKSDVYSFGVVLLEVLCARPP 678
              D ++ GV++ E++  R P
Sbjct: 175 FSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 61.0 bits (148), Expect = 9e-10
 Identities = 47/125 (37%), Positives = 59/125 (47%), Gaps = 17/125 (13%)

Query: 570 PLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFG-LCKFGP 628
           PLP ++ + I      AL YLH    + IIHRDVKT NI LDE   A + DFG  CK   
Sbjct: 181 PLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD- 236

Query: 629 NFSKTHVST-QVKGSIGYLD---PEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGD 684
                H  T Q  G  G L+   PE   L     K+D++S G+VL E+      +     
Sbjct: 237 ----AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLF---- 288

Query: 685 KKQVN 689
            KQV 
Sbjct: 289 GKQVK 293

Length = 392

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 15/203 (7%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEF---QTEIGMLSQL-RYLHLVSL 537
           +IGRG +  V    L       A+K +         +    QTE  +      +  LV L
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDR--RLKICIGAARALHYLHTGAS 595
                 + ++  V ++++ G L  H+      P    R    +I +    AL++LH    
Sbjct: 62  HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISL----ALNFLH---E 114

Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
           + II+RD+K  N+LLD E   K++D+G+CK G        ++   G+  Y+ PE  R + 
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--IRPGDTTSTFCGTPNYIAPEILRGED 172

Query: 656 LTEKSDVYSFGVVLLEVLCARPP 678
                D ++ GV++ E++  R P
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 35/222 (15%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLRYLHL 534
           F+ +  IG G +G VYK         VA+K++   +++         EI +L QL + ++
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 535 VSL----------IGYCNDDGQMILVYDYMAR---GTLRDHLYN-NDNPPLPWDRRLKIC 580
           V+L          + +  D G   LV++YM     G L   L + +++    + ++L   
Sbjct: 69  VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL--- 125

Query: 581 IGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK 640
                 L+Y H    K  +HRD+K +NILL+ +   K++DFGL +   +      + +V 
Sbjct: 126 ---LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179

Query: 641 GSIGYLDPEYYRLQLLTEKS-----DVYSFGVVLLEVLCARP 677
            ++ Y  PE     LL E+      DV+S G +L E+   +P
Sbjct: 180 -TLWYRPPEL----LLGEERYGPAIDVWSCGCILGELFTKKP 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 32/213 (15%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIK--RLNPGSQQGALEFQTEIGMLSQLRYLH------L 534
           +G+G +G+VYK         +A+K  RL        L+      ++ +L  LH      +
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLE-------LDESKFNQIIMELDILHKAVSPYI 61

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPP--LPWDRRLKICIGAARALHYLHT 592
           V   G    +G + +  +YM  G+L D LY        +P D   +I     + L +L  
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120

Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYLDPEYY 651
             +  IIHRDVK TN+L++     K+ DFG+      + +KT++  Q      Y+ PE  
Sbjct: 121 EHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQ-----SYMAPERI 173

Query: 652 RLQ------LLTEKSDVYSFGVVLLEVLCARPP 678
           +          T +SDV+S G+ +LE+   R P
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 62/226 (27%), Positives = 107/226 (47%), Gaps = 29/226 (12%)

Query: 476 DFNNLLIIGRGGFGNVY--KGFLNGDSTPV-AIKRLNPGS----QQGALEFQTEIGMLSQ 528
           +F  L ++G G +G V+  +     D+  + A+K L   +     +     +TE  +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 529 LRYL-HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAA-RA 586
           +R    LV+L      + ++ L+ DY++ G +  HLY  DN     +  ++   G    A
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS---EDEVRFYSGEIILA 117

Query: 587 LHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK------ 640
           L +LH      I++RD+K  NILLD E    ++DFGL       SK  +S + +      
Sbjct: 118 LEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGL-------SKEFLSEEKERTYSFC 167

Query: 641 GSIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPPILRTGDK 685
           G+I Y+ PE  R +    K+ D +S G+++ E+L    P    G++
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER 213

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 64/245 (26%), Positives = 112/245 (45%), Gaps = 29/245 (11%)

Query: 464 QFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-- 521
           Q+      E +K +  L  IG+G FG V+K         VA+K++   +++         
Sbjct: 2   QYEFPFCDEVSK-YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR 60

Query: 522 EIGMLSQLRYLHLVSLIGYC--------NDDGQMILVYDYMARGTLRDHLYNNDNPPLPW 573
           EI +L  L++ ++V+LI  C           G   LV+++         L +N N     
Sbjct: 61  EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAG--LLSNKNVKFTL 118

Query: 574 DRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFS 631
               K+       L+Y+H   +K I+HRD+K  NIL+ ++ + K++DFGL + F     S
Sbjct: 119 SEIKKVMKMLLNGLYYIHR--NK-ILHRDMKAANILITKDGILKLADFGLARAFSLSKNS 175

Query: 632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPILR-TGDK 685
           K +  T    ++ Y  PE     LL E+      D++  G ++ E +  R PI++   ++
Sbjct: 176 KPNRYTNRVVTLWYRPPEL----LLGERDYGPPIDMWGAGCIMAE-MWTRSPIMQGNTEQ 230

Query: 686 KQVNL 690
            Q+ L
Sbjct: 231 HQLTL 235

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 58/225 (25%), Positives = 89/225 (39%), Gaps = 46/225 (20%)

Query: 472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQL 529
           E T  + +L  +G G FG V           VAIK++        L  +T  E+ +L  L
Sbjct: 7   EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL 66

Query: 530 RYLHLVSL----IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK------I 579
           R+ +++SL    I    D      +Y           L   D   L   R L+       
Sbjct: 67  RHENIISLSDIFISPLED------IY-------FVTELLGTDLHRLLTSRPLEKQFIQYF 113

Query: 580 CIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
                R L Y+H+     ++HRD+K +NIL++E    K+ DFGL +            Q 
Sbjct: 114 LYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR-----------IQD 159

Query: 640 KGSIGYLDPEYYRL-------QLLTEKSDVYSFGVVLLEVLCARP 677
               GY+   YYR        Q    + D++S G +  E+L  +P
Sbjct: 160 PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 49/208 (23%), Positives = 93/208 (44%), Gaps = 20/208 (9%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVS 536
             N + IG G  G V           VA+K ++   QQ       E+ ++   ++ ++V 
Sbjct: 23  LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVE 82

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           +        ++ ++ +++  G L D +       L  ++   +C    +AL YLH   S+
Sbjct: 83  MYKSYLVGEELWVLMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQALCYLH---SQ 136

Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK------GSIGYLDPEY 650
            +IHRD+K+ +ILL  +   K+SDFG C          +S  V       G+  ++ PE 
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFC--------AQISKDVPKRKSLVGTPYWMAPEV 188

Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPP 678
                   + D++S G++++E++   PP
Sbjct: 189 ISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 59/236 (25%), Positives = 103/236 (43%), Gaps = 30/236 (12%)

Query: 483 IGRGGFGNVYKGF-LNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLR---YLHLVS 536
           IG G +G V+K   L      VA+KR+   + +  +   T  E+ +L  L    + ++V 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 537 LIGYC-----NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
           L   C     + + ++ LV++++ +  L  +L     P +P +    +     R L +LH
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
              S  ++HRD+K  NIL+      K++DFGL +    +S     T V  ++ Y  PE  
Sbjct: 128 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPEVL 181

Query: 652 RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDII 707
                    D++S G +  E+   +P    + D  Q+            GKI D+I
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL------------GKILDVI 225

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 23/211 (10%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYL 532
           D   +  +G G FG V+           A+K +        +       E  +L ++ + 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYN----NDNPPLPWDRRLKICIGAARALH 588
            ++ L    +D   + ++ +Y+  G L  +L N    +++  L +   + +C     AL 
Sbjct: 62  FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI-VC-----ALE 115

Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST-QVKGSIGYLD 647
           YLH   SK I++RD+K  NILLD+E   K++DFG  K      K    T  + G+  YL 
Sbjct: 116 YLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTLCGTPEYLA 166

Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           PE  + +   +  D ++ G+++ E+L   PP
Sbjct: 167 PEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 43/221 (19%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRL-----NPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           IG G +G VYK         VA+K++     + G    A+    EI +L +L + ++V L
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR---EISLLKELNHPNIVRL 63

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL------KICIGAARALHYLH 591
           +   + + ++ LV++++    L+ ++  + +P    D  L      ++     + + Y H
Sbjct: 64  LDVVHSENKLYLVFEFLDL-DLKKYM--DSSPLTGLDPPLIKSYLYQLL----QGIAYCH 116

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH-VSTQVKGSIGYLDP 648
              S  ++HRD+K  N+L+D E   K++DFGL + FG P  + TH V T     + Y  P
Sbjct: 117 ---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVT-----LWYRAP 168

Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPILRTGD 684
           E     LL  +      D++S G +  E++  RP  L  GD
Sbjct: 169 EI----LLGSRQYSTPVDIWSIGCIFAEMVNRRP--LFPGD 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 62/219 (28%), Positives = 94/219 (42%), Gaps = 14/219 (6%)

Query: 467 ISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEI 523
           I +++   +D+  + +IGRG FG V            A+K L+      +  +  F  E 
Sbjct: 35  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 524 GMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGA 583
            +++      +V L     DD  + +V +YM  G L + + N D P   W R     +  
Sbjct: 95  DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEV-- 151

Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSI 643
             AL  +H   S   IHRDVK  N+LLD+    K++DFG C            T V G+ 
Sbjct: 152 VLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTP 207

Query: 644 GYLDPEYYRLQ----LLTEKSDVYSFGVVLLEVLCARPP 678
            Y+ PE  + Q        + D +S GV L E+L    P
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 15/200 (7%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA-LEFQTEIGMLSQLRYLHLVSLIGYC 541
           +G G +  V+KG        VA+K +    ++GA      E+ +L  L++ ++V+L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICI-GAARALHYLHTGASKVIIH 600
           + +  + LV++Y+    L+ +L N  N  L     +KI +    R L Y H    + I+H
Sbjct: 73  HTERCLTLVFEYL-DSDLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCH---KRKILH 126

Query: 601 RDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKS 660
           RD+K  N+L++E+   K++DFGL +     +KT+ +  V  ++ Y  P+   L   TE S
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDV--LLGSTEYS 182

Query: 661 ---DVYSFGVVLLEVLCARP 677
              D++  G +L E+   RP
Sbjct: 183 TPIDMWGVGCILYEMATGRP 202

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 34/93 (36%), Positives = 50/93 (53%), Gaps = 5/93 (5%)

Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
           AL YLH   S+ +++RD+K  N++LD++   K++DFGLCK G   S         G+  Y
Sbjct: 107 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEY 161

Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           L PE           D +  GVV+ E++C R P
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 36/105 (34%), Positives = 54/105 (51%), Gaps = 4/105 (3%)

Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
           AL YLH  + K +++RD+K  N++LD++   K++DFGLCK G     T  +    G+  Y
Sbjct: 107 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEY 162

Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL 690
           L PE           D +  GVV+ E++C R P      +K   L
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 58.9 bits (143), Expect = 3e-09
 Identities = 58/207 (28%), Positives = 84/207 (40%), Gaps = 28/207 (13%)

Query: 483 IGR----GGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA--LEFQTEIGMLSQLRYLHLVS 536
           IG+        ++ K       T VA+K++N  S         Q EI    QL++ +++ 
Sbjct: 6   IGKCFEDLMIVHLAKHKPTN--TLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICI---GAARALHYLHTG 593
            +     D ++ +V   MA G+  D L  +    LP    L I         AL Y+H  
Sbjct: 64  YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP---ELAIAFILKDVLNALDYIH-- 118

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLC----KFGPNFSKTHVSTQVKGSIG---YL 646
            SK  IHR VK ++ILL  +    +S         K G      H     K S+    +L
Sbjct: 119 -SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP--KSSVKNLPWL 175

Query: 647 DPE--YYRLQLLTEKSDVYSFGVVLLE 671
            PE     LQ   EKSD+YS G+   E
Sbjct: 176 SPEVLQQNLQGYNEKSDIYSVGITACE 202

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 70/229 (30%), Positives = 106/229 (46%), Gaps = 42/229 (18%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPV-AIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSL 537
           IIGRGGFG VY G    D+  + A+K L+      +QG      E  MLS      LVS 
Sbjct: 1   IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVS- 52

Query: 538 IGYC----------NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL---KICIGAA 584
            G C          +   ++  + D M  G L  HL +        + R    +I +G  
Sbjct: 53  TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAEIILG-- 109

Query: 585 RALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL-CKFGPNFSKTHVSTQVKGSI 643
             L ++H   ++ +++RD+K  NILLDE    ++SD GL C F     K H S    G+ 
Sbjct: 110 --LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASV---GTH 159

Query: 644 GYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPPI--LRTGDKKQVN 689
           GY+ PE  +  +  + S D +S G +L ++L    P    +T DK +++
Sbjct: 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 208

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 58.0 bits (140), Expect = 4e-09
 Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 21/203 (10%)

Query: 483 IGRGGFGNVY----KGFLNGDSTPV----AIKRLNPG-SQQGALEFQTEIGMLSQLRYLH 533
           +G+G FG VY    K  +  +   V     +  LNP  + Q   E Q    +LS+L +  
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQ----LLSKLDHPA 63

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHL--YNNDNPPLPWDRRLKICIGAARALHYLH 591
           +V       +     ++ +Y     L   L    +    L  ++  +  I     +HY+H
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               + I+HRD+K  NI L    + K+ DFG+ +         ++T   G+  Y+ PE  
Sbjct: 124 Q---RRILHRDLKAKNIFLKNNLL-KIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEAL 177

Query: 652 RLQLLTEKSDVYSFGVVLLEVLC 674
           + Q    KSD++S G +L E+ C
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCC 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 51/203 (25%), Positives = 83/203 (40%), Gaps = 21/203 (10%)

Query: 483 IGRGGFGNVY--KGFLNGDSTPV-AIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           I +G FG+VY  K    GD   +  +K+ +  ++      + E  ++        V+ + 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 540 YCNDDGQ-MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR---ALHYLHTGAS 595
           Y       + LV +Y+  G     +      P  W          A     +  LH    
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDW-----AKQYIAEVVLGVEDLH---Q 115

Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
           + IIHRD+K  N+L+D+    K++DFGL + G        + +  G+  YL PE      
Sbjct: 116 RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVG 169

Query: 656 LTEKSDVYSFGVVLLEVLCARPP 678
             + SD +S G V+ E L   PP
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 60.2 bits (146), Expect = 4e-09
 Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 31/233 (13%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGAL---EFQTEIGMLSQLRYLHLVSLI 538
           +IG+GG G VY  +    S  VA+K++     +  L    F  E  + + L +  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGA--------ARALHY 589
             C+D   +     Y+   TL+  L +      L  +   K  +GA           + Y
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF----------------GPNFSKT 633
           +H   SK ++HRD+K  NILL       + D+G   F                   +S  
Sbjct: 129 VH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185

Query: 634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKK 686
            +  ++ G+  Y+ PE       +E +D+Y+ GV+L ++L    P  R   +K
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238

Length = 932

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 58.5 bits (142), Expect = 4e-09
 Identities = 68/253 (26%), Positives = 103/253 (40%), Gaps = 55/253 (21%)

Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKR-LNPGSQQGA-LEFQTEIGMLSQLR 530
             +D+  L  +G G FG VYK         VA+K+ L    + G  +    EI +L +L+
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65

Query: 531 YLHLVSLI--------GYCNDDGQMILVYDYMARGTLRDH-----LYNND---NPPLPWD 574
           + ++V LI              G + +V  YM      DH     L N            
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM------DHDLSGLLENPSVKLTESQIKC 119

Query: 575 RRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSK 632
             L++  G    ++YLH      I+HRD+K  NIL+D + + K++DFGL +   GP    
Sbjct: 120 YMLQLLEG----INYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGP---- 168

Query: 633 THVSTQVKGSIGYLDPEY--------YRLQ--LLTEKS-----DVYSFGVVLLEVLCARP 677
                  KG  G    +Y        YR    LL E+      D++  G V  E+   RP
Sbjct: 169 ---PPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRP 225

Query: 678 PILRTGDKKQVNL 690
            +    D  Q++L
Sbjct: 226 ILQGKSDIDQLHL 238

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 70/300 (23%), Positives = 112/300 (37%), Gaps = 67/300 (22%)

Query: 486 GGFGNVYKGFLN----GDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLIGY 540
           G FG ++ G L     G    V +K +   + +  +     E  +L  L + +++ ++  
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76

Query: 541 CNDDGQMILV-YDYMARGTLRDHLYNNDNPPLPWDRRLK------ICIGAARALHYLHTG 593
           C +DG+   V Y YM  G L+  L           + L       + I  A  + YLH  
Sbjct: 77  CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH-- 134

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---------FGPNFSKTHVSTQVKGSIG 644
             + +IH+D+   N ++DEE   K++D  L +          G N ++          + 
Sbjct: 135 -KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR---------PVK 184

Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG 704
           ++  E    +  +  SDV+SFGV+L E                  L       Y      
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWE------------------LMTLGQTPYVE---- 222

Query: 705 DIIDPF------LKG---NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGL-EFVFQL 754
             IDPF        G     P  C ++   V   C   D   RPS S +V  L +F  QL
Sbjct: 223 --IDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 57.6 bits (139), Expect = 5e-09
 Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 36/213 (16%)

Query: 483 IGRGGFGNVYKGFLNGDS------------TPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           +GRG    +Y G LN                 V +K L+P  +  +L F     M+ Q+ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPL--PWDRRLKICIGAARALH 588
           + H+V L G C  D + I+V +++  G L D   +  +  L  PW  + K+    A AL 
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPL-DLFMHRKSDVLTTPW--KFKVAKQLASALS 119

Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWV-------AKVSDFGLCKFGPNFSKTHVSTQVK- 640
           YL     K ++H +V T NILL  E +        K+SD       P    T +S Q   
Sbjct: 120 YLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSD-------PGIPITVLSRQECV 169

Query: 641 GSIGYLDPEYYR-LQLLTEKSDVYSFGVVLLEV 672
             I ++ PE     + L+  +D +SFG  L E+
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 21/203 (10%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA-LEFQTEIGMLSQLRYLHLVSLIGYC 541
           +G G +  V+KG        VA+K +    ++GA      E+ +L  L++ ++V+L    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICI-GAARALHYLHTGASKVIIH 600
           + D  + LV++Y+ +   +   Y +D   +     +KI +    R L Y H    + ++H
Sbjct: 74  HTDKSLTLVFEYLDKDLKQ---YMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLH 127

Query: 601 RDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY------YRLQ 654
           RD+K  N+L++E    K++DFGL +     +KT+ +  V  ++ Y  P+       Y  Q
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYSTQ 185

Query: 655 LLTEKSDVYSFGVVLLEVLCARP 677
           +     D++  G +  E+   RP
Sbjct: 186 I-----DMWGVGCIFFEMASGRP 203

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 58.3 bits (141), Expect = 6e-09
 Identities = 38/107 (35%), Positives = 58/107 (54%), Gaps = 3/107 (2%)

Query: 566 NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK 625
            D+ PL  D  L+     A+ + +L   ASK  IHRDV   N+LL +  VAK+ DFGL +
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260

Query: 626 FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEV 672
              N S   V    +  + ++ PE     + T +SDV+S+G++L E+
Sbjct: 261 DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 57.8 bits (139), Expect = 8e-09
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 15/214 (7%)

Query: 469 EIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGML 526
           E+K+   DF  +  +G G  G V K   +  S  +  ++L     + A+  Q   E+ +L
Sbjct: 1   ELKD--DDFERISELGAGNGGVVTK-VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL 57

Query: 527 SQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARA 586
            +    ++V   G    DG++ +  ++M  G+L   L   +   +P +   K+ I   R 
Sbjct: 58  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRG 115

Query: 587 LHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGY 645
           L YL       I+HRDVK +NIL++     K+ DFG+  +   + + + V T+      Y
Sbjct: 116 LAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SY 168

Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPI 679
           + PE  +    + +SD++S G+ L+E+   R PI
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 57.3 bits (138), Expect = 8e-09
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 12/205 (5%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLRYLHL 534
           F  L ++G G +G V K         VAIK+     +   ++  T  E+ ML  L+  ++
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           V L       G++ LV++Y+ +  L + L    N   P ++         +A+H+ H   
Sbjct: 63  VELKEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPP-EKVRSYIYQLIKAIHWCHKND 120

Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVS--TQVKGSIGYLDPEYYR 652
              I+HRD+K  N+L+    V K+ DFG   F  N S+   +  T+   +  Y  PE   
Sbjct: 121 ---IVHRDIKPENLLISHNDVLKLCDFG---FARNLSEGSNANYTEYVATRWYRSPELLL 174

Query: 653 LQLLTEKSDVYSFGVVLLEVLCARP 677
                +  D++S G +L E+   +P
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 57.4 bits (139), Expect = 8e-09
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 43/222 (19%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEI--GMLSQLRYLH 533
           DF  L  +G G  G V K         +A K ++       LE +  I   ++ +L+ LH
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIH-------LEIKPAIRNQIIRELKVLH 54

Query: 534 ------LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARAL 587
                 +V   G    DG++ +  ++M  G+L   L      P     ++ I +   R L
Sbjct: 55  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV--LRGL 112

Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG--- 644
            YL       I+HRDVK +NIL++     K+ DFG            VS Q+  S+    
Sbjct: 113 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFG------------VSGQLIDSMANSF 158

Query: 645 -----YLDPEYYRLQ--LLTEKSDVYSFGVVLLEVLCARPPI 679
                Y+ PE  RLQ    T +SD++S G+ L+E+   R PI
Sbjct: 159 VGTRSYMSPE--RLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 57.4 bits (138), Expect = 1e-08
 Identities = 63/220 (28%), Positives = 90/220 (40%), Gaps = 29/220 (13%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE---FQTEIGMLSQLRY 531
           +DF  L +IGRG FG V    L       A+K LN        E   F+ E  +L     
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDR------RLKICIGAAR 585
             + +L     D+  + LV DY   G L   L   ++  LP D        + I I +  
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVH 119

Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            LHY         +HRD+K  NIL+D     +++DFG C           S  V G+  Y
Sbjct: 120 QLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDY 169

Query: 646 LDPEYYRLQLLTE-------KSDVYSFGVVLLEVLCARPP 678
           + PE   LQ + +       + D +S GV + E+L    P
Sbjct: 170 ISPEI--LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 51/202 (25%), Positives = 98/202 (48%), Gaps = 19/202 (9%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA-LEFQTEIGMLSQLRYLHLVSLIGYC 541
           +G G +  VYKG        VA+K +    ++GA      E+ +L  L++ ++V+L    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
           + +  + LV++Y+ +  L+ +L +  N     + +L       R L+Y H    + ++HR
Sbjct: 74  HTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKL-FLFQLLRGLNYCH---RRKVLHR 128

Query: 602 DVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY------YRLQL 655
           D+K  N+L++E    K++DFGL +     +KT+ +  V  ++ Y  P+       Y  Q+
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYSTQI 186

Query: 656 LTEKSDVYSFGVVLLEVLCARP 677
                D++  G +  E+   RP
Sbjct: 187 -----DMWGVGCIFYEMSTGRP 203

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 38/121 (31%), Positives = 55/121 (45%), Gaps = 13/121 (10%)

Query: 556 RGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV 615
              L  +L     P LP D+ L I       L YLH   ++ IIHRDVKT NI +++   
Sbjct: 140 SSDLYTYLTKRSRP-LPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQ 195

Query: 616 AKVSDFGLCKF---GPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEV 672
             + D G  +F    P F        + G++    PE         K+D++S G+VL E+
Sbjct: 196 VCIGDLGAAQFPVVAPAF------LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249

Query: 673 L 673
           L
Sbjct: 250 L 250

Length = 357

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 57.2 bits (138), Expect = 2e-08
 Identities = 44/166 (26%), Positives = 76/166 (45%), Gaps = 17/166 (10%)

Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSI 643
           A+ + +L   ASK  IHRD+   NILL    + K+ DFGL +   N S   V    +  +
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280

Query: 644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKI 703
            ++ PE     + T +SDV+S+G++L E       I   G      + V       + K 
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWE-------IFSLGSSPYPGMPV-------DSKF 326

Query: 704 GDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
             +I    +  +P    ++  ++  SC + D ++RP+   +V  +E
Sbjct: 327 YKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 56.8 bits (137), Expect = 2e-08
 Identities = 36/99 (36%), Positives = 55/99 (55%), Gaps = 11/99 (11%)

Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVK 640
           AR + +L   AS+  IHRD+   NILL E  V K+ DFGL +     P++ +       +
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR---KGDAR 236

Query: 641 GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEV--LCARP 677
             + ++ PE    ++ T +SDV+SFGV+L E+  L A P
Sbjct: 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 57.5 bits (139), Expect = 2e-08
 Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 21/165 (12%)

Query: 216 RTWIADDGYVTDARPSALPVNT-TIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYNL 274
           R W     + +    S   ++T  ++ + S   NF  P ++Y++A       + + Q +L
Sbjct: 218 RFWNRMQTFGSG---SDQAISTENVIKKASNAPNFY-PESLYQSALV-----STDTQPDL 268

Query: 275 TWEFQVDSGFIYFVRLHFCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEY 334
           ++   VD    Y V LHF E  + +T EG RVF + +   TA    D++  SG       
Sbjct: 269 SYTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGE------ 322

Query: 335 RDYAVAIGSKSDVKKQNLSIALHPAPRWRTKYSDSILNGIEIFKV 379
           R  A+ +     V  + L+I L P      K + +I+N IE+F++
Sbjct: 323 RYTALVLNKTVAVSGRTLTIVLQP-----KKGTHAIINAIEVFEI 362

Length = 623

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 52/181 (28%), Positives = 81/181 (44%), Gaps = 34/181 (18%)

Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVK 640
           AR + +L   AS+  IHRD+   NILL E  V K+ DFGL +     P++ +       K
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR-------K 233

Query: 641 GS----IGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATE 696
           GS    + ++ PE    ++ T +SDV+SFGV+L E       I   G      + +    
Sbjct: 234 GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWE-------IFSLGASPYPGVQINEEF 286

Query: 697 CYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLR 756
           C R       +    +  AP     +   + ++C   D   RP+ S +V   E +  LL+
Sbjct: 287 CQR-------LKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALV---EILGDLLQ 336

Query: 757 E 757
           E
Sbjct: 337 E 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 56.0 bits (135), Expect = 3e-08
 Identities = 57/221 (25%), Positives = 89/221 (40%), Gaps = 30/221 (13%)

Query: 475 KDFNNLLIIGRGGFGNVY--KGFLNGDSTPV-AIKRLNPGSQQGALEFQTEIGMLSQLRY 531
           KDF+   ++GRG FG V   +    GD   +  +K+    +Q+    F+ E  +LS    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGA--ARALHY 589
             +  L     D   + LV +Y   G L   L   ++    +D  +     A    A+H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ---FDEDMAQFYLAELVLAIHS 117

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFG----LCKFGPNFSKTHVSTQVKGSIGY 645
           +H       +HRD+K  N+L+D     K++DFG    L       SK  V T       Y
Sbjct: 118 VHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTP-----DY 169

Query: 646 LDPEYYRLQLLTEKS--------DVYSFGVVLLEVLCARPP 678
           + PE   L  +            D +S GV+  E++  R P
Sbjct: 170 IAPEV--LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 49/215 (22%), Positives = 84/215 (39%), Gaps = 28/215 (13%)

Query: 483 IGRGGFGNVYKGFLNG--DSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIG 539
           IG G FG V  G  +       V +K L   +     L F  E+    +L + +++  +G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNN------DNPPLPWDRRLKICIGAARALHYLHTG 593
            C +    +LV ++   G L+++L +N              R           LH     
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGL--CKFGPNFSKTHVSTQVKGSIGYLDPEY- 650
                IH D+   N  L  +   K+ D+GL   ++  ++  T     V   + +L PE  
Sbjct: 121 ----FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV--PLRWLAPELV 174

Query: 651 --YRLQLL----TEKSDVYSFGVVLLEV--LCARP 677
                 LL    T+KS+++S GV + E+     +P
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 13/207 (6%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLRYLH 533
           DF  +  +G G  G V+K   +  S  +  ++L     + A+  Q   E+ +L +    +
Sbjct: 6   DFEKISELGAGNGGVVFK-VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           +V   G    DG++ +  ++M  G+L   L       +P     K+ I   + L YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLRE- 121

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
               I+HRDVK +NIL++     K+ DFG+  +   + + + V T+      Y+ PE  +
Sbjct: 122 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQ 175

Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPI 679
               + +SD++S G+ L+E+   R PI
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 63/216 (29%), Positives = 93/216 (43%), Gaps = 23/216 (10%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE---FQTEIGMLSQLRYL 532
           DF  + +IGRG FG V    +       A+K LN        E   F+ E  +L      
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61

Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD-RRLKIC--IGAARALHY 589
            + +L     D+  + LV DY   G L   L   ++  LP D  R  I   + A  ++H 
Sbjct: 62  WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHSIHQ 120

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           LH       +HRD+K  N+LLD     +++DFG C    N   T  S+   G+  Y+ PE
Sbjct: 121 LH------YVHRDIKPDNVLLDMNGHIRLADFGSC-LKMNQDGTVQSSVAVGTPDYISPE 173

Query: 650 YYRLQLLTE-------KSDVYSFGVVLLEVLCARPP 678
              LQ + +       + D +S GV + E+L    P
Sbjct: 174 I--LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 50/220 (22%), Positives = 102/220 (46%), Gaps = 15/220 (6%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           F  L  +G G +  VYKG        VA+K ++  +++G       EI ++ +L++ ++V
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61

Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNP-PLPWDRRLKICIGAARALHYLHTGA 594
            L    + + +++LV++YM    L+ ++  +     L  +          + + + H   
Sbjct: 62  RLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR 120

Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG---PNFSKTHVSTQVKGSIGYLDPEY 650
              ++HRD+K  N+L+++    K++DFGL + FG     FS   V+   +     L    
Sbjct: 121 ---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177

Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL 690
           Y     +   D++S G ++ E++  RP    T ++ Q+  
Sbjct: 178 Y-----STSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLK 212

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 55.3 bits (134), Expect = 4e-08
 Identities = 54/211 (25%), Positives = 102/211 (48%), Gaps = 34/211 (16%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRL-NPGSQQG----ALEFQTEIGMLSQLRYLHLVSL 537
           I  G +G VY+         VA+K+L     ++G    +L    EI +L +L++ ++V++
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR---EINILLKLQHPNIVTV 69

Query: 538 --IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRR---LKICIGAARALHYLHT 592
             +   ++  ++ +V +Y+    L+  +     P L  + +   L++       + +LH 
Sbjct: 70  KEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLL----SGVAHLH- 123

Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYLDPEYY 651
                I+HRD+KT+N+LL+   + K+ DFGL  ++G   S     TQ+  ++ Y  PE  
Sbjct: 124 --DNWILHRDLKTSNLLLNNRGILKICDFGLAREYG---SPLKPYTQLVVTLWYRAPEL- 177

Query: 652 RLQLLTEKS-----DVYSFGVVLLEVLCARP 677
              LL  K      D++S G +  E+L  +P
Sbjct: 178 ---LLGAKEYSTAIDMWSVGCIFAELLTKKP 205

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 54.5 bits (131), Expect = 5e-08
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 44/223 (19%)

Query: 483 IGRGGFGNVYKGFL------------------------NGDSTPVAIKRLNPGSQQGALE 518
           +G+G   N+Y G L                        NG    V +K L+P  +  AL 
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 519 FQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK 578
           F     ++SQ+ ++HL  + G C    + I+V +++  G L D     +   +P   ++ 
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAWKIT 121

Query: 579 ICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVA-------KVSDFGLCKFGPNFS 631
           +    A AL YL     K ++H +V   NILL    +A       K+SD       P  S
Sbjct: 122 VAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSD-------PGVS 171

Query: 632 KTHVSTQVK-GSIGYLDPEYYR-LQLLTEKSDVYSFGVVLLEV 672
            T +S + +   I ++ PE       L+  +D +SFG  LLE+
Sbjct: 172 FTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 54.9 bits (132), Expect = 5e-08
 Identities = 34/93 (36%), Positives = 46/93 (49%), Gaps = 5/93 (5%)

Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
           AL  LH      +I+RD+K  NILLD +    + DFGLCK   N      +    G+  Y
Sbjct: 105 ALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEY 159

Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           L PE       T+  D ++ GV+L E+L   PP
Sbjct: 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 54.6 bits (131), Expect = 7e-08
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 37/219 (16%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIG-- 539
           IG+G +G VYK     D +  A+K L+P S     E + E  +L  L  + ++V   G  
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 540 YCNDD---GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK------ICIGAARALHYL 590
           Y  D    GQ+ LV +    G++ + +       L   +RL       I  GA   L +L
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKG----LLICGQRLDEAMISYILYGALLGLQHL 144

Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK-----GSIGY 645
           H      IIHRDVK  NILL  E   K+ DFG+       S    ST+++     G+  +
Sbjct: 145 HNNR---IIHRDVKGNNILLTTEGGVKLVDFGV-------SAQLTSTRLRRNTSVGTPFW 194

Query: 646 LDPEYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPI 679
           + PE    +   + S     DV+S G+  +E+    PP+
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 54.4 bits (131), Expect = 7e-08
 Identities = 59/221 (26%), Positives = 89/221 (40%), Gaps = 25/221 (11%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQ-----TEIGMLSQLR 530
           DF  + +I  G +G VY           A+K++N   Q   L  Q      E  +L+   
Sbjct: 2   DFETIKLISNGAYGAVYLVRHKETRQRFAMKKIN--KQNLILRNQIQQVFVERDILTFAE 59

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              +VS+         + +V +Y+  G     L N     LP D           AL YL
Sbjct: 60  NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYL 117

Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-----PNFSKTHVST-------- 637
           H   +  I+HRD+K  N+L+      K++DFGL K G      N  + H+          
Sbjct: 118 H---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK 174

Query: 638 QVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           QV G+  Y+ PE    Q   +  D ++ G++L E L    P
Sbjct: 175 QVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 54.6 bits (132), Expect = 7e-08
 Identities = 54/237 (22%), Positives = 93/237 (39%), Gaps = 65/237 (27%)

Query: 472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLN-PGSQQGALEFQT--------- 521
           E    + NL  +G G +G V   F       VAIK+L+ P        FQ+         
Sbjct: 12  EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP--------FQSAIHAKRTYR 63

Query: 522 EIGMLSQLRYLHLVSLIG-YCNDDG-----QMILVYDYMAR---GTLRDHLYNNDNPPLP 572
           E+ +L  + + +++ L+  +           + LV   M       ++    ++D     
Sbjct: 64  ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDD----- 118

Query: 573 WDRRLKICIGA---ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN 629
                 I        R L Y+H   S  IIHRD+K +NI ++E+   K+ DFGL +    
Sbjct: 119 -----HIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR---- 166

Query: 630 FSKTHVSTQVKGSIG---YLDPE------YYRLQLLTEKSDVYSFGVVLLEVLCARP 677
               H   ++ G +    Y  PE      +Y      +  D++S G ++ E+L  + 
Sbjct: 167 ----HTDDEMTGYVATRWYRAPEIMLNWMHY-----NQTVDIWSVGCIMAELLTGKT 214

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 54.6 bits (131), Expect = 9e-08
 Identities = 55/229 (24%), Positives = 96/229 (41%), Gaps = 40/229 (17%)

Query: 466 SISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQG--ALEFQTEI 523
           +I E+ +  +D   L  +G G +G V           VAIK+L    Q    A     E+
Sbjct: 9   TIWEVPDRYRD---LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYREL 65

Query: 524 GMLSQLRYLHLVSLIGYCNDDGQM------ILVYDYMAR--GTLRDHLYNNDNPPLPWDR 575
            +L  +++ +++ L+     D  +       LV  +M    G L  H        L  DR
Sbjct: 66  RLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH------EKLSEDR 119

Query: 576 RLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHV 635
              +     + L Y+H      IIHRD+K  N+ ++E+   K+ DFGL +          
Sbjct: 120 IQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR--------QT 168

Query: 636 STQVKGSIGYLDPEYYRLQLL-------TEKSDVYSFGVVLLEVLCARP 677
            +++    GY+   +YR   +       T+  D++S G ++ E+L  +P
Sbjct: 169 DSEMT---GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 55.0 bits (132), Expect = 9e-08
 Identities = 42/165 (25%), Positives = 79/165 (47%), Gaps = 13/165 (7%)

Query: 520 QTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRR--- 576
           ++E+  L+   +  +V        D +++L+ +Y + G L   +       LP+      
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172

Query: 577 ---LKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT 633
               +I +    AL  +H   S+ ++HRD+K+ NI L    + K+ DFG  K   +    
Sbjct: 173 LLFYQIVL----ALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225

Query: 634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            V++   G+  YL PE +  +  ++K+D++S GV+L E+L    P
Sbjct: 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 54.9 bits (132), Expect = 1e-07
 Identities = 45/156 (28%), Positives = 71/156 (45%), Gaps = 12/156 (7%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRY 531
           ++F  +  I RG FG VY G    +S   A+K +      ++    + Q E   L+  + 
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63

Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRD--HLYNNDNPPLPWDRRLKICIGAARALHY 589
             +V L         + LV +Y+  G ++   H+Y   +  +     +K     A AL Y
Sbjct: 64  PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA----VKYISEVALALDY 119

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK 625
           LH      IIHRD+K  N+L+  E   K++DFGL K
Sbjct: 120 LHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 38/128 (29%), Positives = 59/128 (46%), Gaps = 13/128 (10%)

Query: 551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL 610
           Y   A    R     N++P L +   +      A  + +L   ASK  +HRD+   N+L+
Sbjct: 216 YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLI 272

Query: 611 DEEWVAKVSDFGLCKFGPNFSKTHVSTQV-KGS----IGYLDPEYYRLQLLTEKSDVYSF 665
            E  + K+ DFGL +          S  + KGS    + ++ PE     L T  SDV+SF
Sbjct: 273 CEGKLVKICDFGLAR-----DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSF 327

Query: 666 GVVLLEVL 673
           G++L E+ 
Sbjct: 328 GILLWEIF 335

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 59/222 (26%), Positives = 105/222 (47%), Gaps = 30/222 (13%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLRYLH 533
           D+  +  IG G +G VYKG        VA+K++   S++  +      EI +L +L++ +
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT- 592
           +V L      + ++ L++++++   L+ +L       LP  + +     A     YL+  
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSM-DLKKYL-----DSLPKGQYMD----AELVKSYLYQI 110

Query: 593 ------GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH-VSTQVKGSI 643
                   S+ ++HRD+K  N+L+D + V K++DFGL + FG P    TH V T     +
Sbjct: 111 LQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVT-----L 165

Query: 644 GYLDPEYYR-LQLLTEKSDVYSFGVVLLEVLCARPPILRTGD 684
            Y  PE        +   D++S G +  E+   +P  L  GD
Sbjct: 166 WYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKP--LFHGD 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 35/99 (35%), Positives = 55/99 (55%), Gaps = 11/99 (11%)

Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVK 640
           A+ + +L   AS+  IHRD+   NILL E  V K+ DFGL +     P++ +       +
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR---KGDAR 242

Query: 641 GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEV--LCARP 677
             + ++ PE    ++ T +SDV+SFGV+L E+  L A P
Sbjct: 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 53.0 bits (128), Expect = 3e-07
 Identities = 19/41 (46%), Positives = 30/41 (73%), Gaps = 3/41 (7%)

Query: 585 RALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK 625
           +AL Y+H+G    +IHRD+K +NILL+ +   K++DFGL +
Sbjct: 118 KALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 22/223 (9%)

Query: 476 DFNNLLIIGRGGFGNVY--KGFLNGDSTPV-AIKRLNPGS----QQGALEFQTEIGMLSQ 528
           +F  L ++G G +G V+  +     DS  + A+K L   +     +     +TE  +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 529 LRYL-HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGA-ARA 586
           +R    LV+L      D ++ L+ DY+  G L  HL   +      ++ ++I  G    A
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLA 117

Query: 587 LHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF--SKTHVSTQVKGSIG 644
           L +LH      II+RD+K  NILLD      ++DFGL K    F   +   +    G+I 
Sbjct: 118 LEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK---EFHEDEVERAYSFCGTIE 171

Query: 645 YLDPEYYR-LQLLTEKS-DVYSFGVVLLEVLCARPPILRTGDK 685
           Y+ P+  R      +K+ D +S GV++ E+L    P    G+K
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK 214

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 29/213 (13%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIK--RLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           F  +  IG G +G VYK         VA+K  RL+  ++        EI +L +L + ++
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPP--LPWDRRLKICIGAARALHYLHT 592
           V L+   + + ++ LV++++ +   +   + + +P   +P            + L + H 
Sbjct: 62  VKLLDVIHTENKLYLVFEFLHQDLKK---FMDASPLSGIPLPLIKSYLFQLLQGLAFCH- 117

Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH-VSTQVKGSIGYLDPE 649
             S  ++HRD+K  N+L++ E   K++DFGL + FG P  + TH V T     + Y  PE
Sbjct: 118 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT-----LWYRAPE 170

Query: 650 ------YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
                 YY     +   D++S G +  E++  R
Sbjct: 171 ILLGCKYY-----STAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 36/218 (16%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRL-----NPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           IG G +G VYK      +  +A+K++     + G    A+    EI +L ++++ ++V L
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR---EISLLKEMQHGNIVRL 66

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL--KICIGAARALHYLHTGAS 595
               + + ++ LV++Y+    L+ H+  + +P    + RL         R + Y H   S
Sbjct: 67  QDVVHSEKRLYLVFEYLDL-DLKKHM--DSSPDFAKNPRLIKTYLYQILRGIAYCH---S 120

Query: 596 KVIIHRDVKTTNILLDEEWVA-KVSDFGLCK-FG-PNFSKTH-VSTQVKGSIGYLDPEYY 651
             ++HRD+K  N+L+D    A K++DFGL + FG P  + TH V T     + Y  PE  
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVT-----LWYRAPEI- 174

Query: 652 RLQLLTEKS-----DVYSFGVVLLEVLCARPPILRTGD 684
              LL  +      D++S G +  E++  +P  L  GD
Sbjct: 175 ---LLGSRHYSTPVDIWSVGCIFAEMVNQKP--LFPGD 207

Length = 294

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 58/226 (25%), Positives = 106/226 (46%), Gaps = 15/226 (6%)

Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLR 530
           A   + NL  +G G +  VYKG    +   VA+K ++  +++G + F    E  +L  L+
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLK 61

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + ++V L    +    +  V++YM    L  ++  +     P++ RL       R L Y+
Sbjct: 62  HANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYI 119

Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
           H    + I+HRD+K  N+L+      K++DFGL +     S+T+ S  V  ++ Y  P+ 
Sbjct: 120 H---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDV 174

Query: 651 YRLQLLTEKS---DVYSFGVVLLEVLCARPPILRTGDKKQVNLAVW 693
             L   T+ S   D++  G + +E+L  +P      D  +    +W
Sbjct: 175 --LLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 51.9 bits (125), Expect = 4e-07
 Identities = 55/219 (25%), Positives = 88/219 (40%), Gaps = 52/219 (23%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGALEFQTEIGMLSQLRY----LHLVS 536
           IG G F  V K          AIK +     S +     + EI  L +L      L L+ 
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILRLIE 65

Query: 537 LIGYCNDDGQMILV--------YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALH 588
           ++ +    G++ LV        Y+ +     +         PLP  R         ++L 
Sbjct: 66  VL-FDRKTGRLALVFELMDMNLYELI-----KGRKR-----PLPEKRVKSYMYQLLKSLD 114

Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK----THVSTQVKGSIG 644
           ++H      I HRD+K  NIL+ ++ + K++DFG C+    +SK     ++ST+      
Sbjct: 115 HMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYISTR-----W 163

Query: 645 YLDPE------YYRLQLLTEKSDVYSFGVVLLEVLCARP 677
           Y  PE      YY       K D+++ G V  E+L   P
Sbjct: 164 YRAPECLLTDGYY-----GPKMDIWAVGCVFFEILSLFP 197

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 4e-07
 Identities = 55/225 (24%), Positives = 91/225 (40%), Gaps = 43/225 (19%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQG-ALEFQTEIGMLSQLRYLH 533
             + NL  IG G +G V           VAIK+++P   Q        EI +L + ++ +
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 534 LVSL--------IGYCNDDGQMILVYDYMARG---TLRDHLYNNDNPPLPWDRRLKICI- 581
           ++ +            ND   + +V + M       ++    +ND+          I   
Sbjct: 65  IIGILDIIRPPSFESFND---VYIVQELMETDLYKLIKTQHLSNDH----------IQYF 111

Query: 582 --GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
                R L Y+H   S  ++HRD+K +N+LL+     K+ DFGL +        H  T  
Sbjct: 112 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR---IADPEHDHTG- 164

Query: 640 KGSIGYLDPEYYRLQ--LLTEKS-----DVYSFGVVLLEVLCARP 677
                Y+   +YR    +L  K      D++S G +L E+L  RP
Sbjct: 165 -FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 51.6 bits (124), Expect = 8e-07
 Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 27/174 (15%)

Query: 475 KDFNNLLIIGRGGFGNV--YKGFLNGDSTPVAIKRLNPGS----QQGALEFQTEIGMLSQ 528
            DF ++ +IGRG FG V   +    G     A+K+L        +Q A   + E  +L++
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHI--YAMKKLRKSEMLEKEQVA-HVRAERDILAE 57

Query: 529 LRYLHLVSLIGYCN--DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDR-RLKI--CIGA 583
                +V L  Y +  D+  + L+ +Y+  G +   L   D      +  R  I   I A
Sbjct: 58  ADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDT--FTEEETRFYIAETILA 113

Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST 637
             ++H L        IHRD+K  N+LLD +   K+SDFGLC       K+H + 
Sbjct: 114 IDSIHKLG------YIHRDIKPDNLLLDAKGHIKLSDFGLCT---GLKKSHRTE 158

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 48.9 bits (117), Expect = 9e-07
 Identities = 31/146 (21%), Positives = 54/146 (36%), Gaps = 16/146 (10%)

Query: 486 GGFGN-VYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-YLHLV-SLIGYCN 542
           GG  N VY   L        +K      ++   + + E+ +L  L      V  ++    
Sbjct: 8   GGLTNRVYL--LGTKDEDYVLKINPS--REKGADREREVAILQLLARKGLPVPKVLASGE 63

Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            DG   L+ +++  G   D +   +           I    A  L  LH     V+ H D
Sbjct: 64  SDGWSYLLMEWIE-GETLDEVSEEEKE--------DIAEQLAELLAKLHQLPLLVLCHGD 114

Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGP 628
           +   NIL+D+  +  + D+    +GP
Sbjct: 115 LHPGNILVDDGKILGIIDWEYAGYGP 140

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 22/212 (10%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIK----RLNPGSQQGALEFQTEIGMLSQLR 530
           +D     I+G G  G VYK +       +A+K     +    Q+   +  +E+ +L +  
Sbjct: 1   QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK---QIMSELEILYKCD 57

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
             +++   G    + ++ +  ++M  G+L   +Y      +P     +I +   + L YL
Sbjct: 58  SPYIIGFYGAFFVENRISICTEFMDGGSL--DVYRK----IPEHVLGRIAVAVVKGLTYL 111

Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKGSIGYLDPE 649
               S  I+HRDVK +N+L++     K+ DFG+     N  +KT+V T       Y+ PE
Sbjct: 112 W---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTN-----AYMAPE 163

Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILR 681
               +     SDV+S G+  +E+   R P  +
Sbjct: 164 RISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 33/213 (15%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
           IIG G FG VY+      S  VAIK++    Q        E+ ++  L +++++ L  Y 
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK----NRELLIMKNLNHINIIFLKDYY 128

Query: 542 ------NDDGQMIL--VYDYMARGTLRDHL--YNNDNPPLPWDRRLKICIGAARALHYLH 591
                  ++  + L  V +++ + T+  ++  Y  +N  LP            RAL Y+H
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
              SK I HRD+K  N+L+D           LC FG   +K  ++ Q   S+ Y+   +Y
Sbjct: 188 ---SKFICHRDLKPQNLLID----PNTHTLKLCDFGS--AKNLLAGQ--RSVSYICSRFY 236

Query: 652 RLQLL-------TEKSDVYSFGVVLLEVLCARP 677
           R   L       T   D++S G ++ E++   P
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILGYP 269

Length = 440

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 51/173 (29%), Positives = 78/173 (45%), Gaps = 30/173 (17%)

Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV-KGS 642
           AR + +L   ASK  +HRD+   N+LL +  + K+ DFGL +        H S  V KGS
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR-----DIMHDSNYVSKGS 298

Query: 643 ----IGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECY 698
               + ++ PE     L T  SDV+S+G++L E       I   G      + V +T  Y
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWE-------IFSLGGTPYPGMIVDST-FY 350

Query: 699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPS---MSDVVWGL 748
              K G       +   P     +  ++ + C N +  +RPS   +SD+V  L
Sbjct: 351 NKIKSG------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 57/241 (23%), Positives = 98/241 (40%), Gaps = 43/241 (17%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPV-AIKRLNPG---SQQGALEFQTEIGMLSQLR 530
           +DF +L +IGRG FG V +     D+  V A+K L       ++     + E  +L +  
Sbjct: 1   EDFESLKVIGRGAFGEV-RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD 59

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
            L +V +     D   + L+ +++  G +   L   D   L  +           A+  +
Sbjct: 60  SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETVLAIDSI 117

Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-----------------KFGPNFSKT 633
           H       IHRD+K  N+LLD +   K+SDFGLC                     +F+  
Sbjct: 118 HQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 634 HVSTQVK----------------GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARP 677
           +++++ K                G+  Y+ PE +      +  D +S GV++ E+L   P
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 678 P 678
           P
Sbjct: 235 P 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 54/231 (23%), Positives = 102/231 (44%), Gaps = 51/231 (22%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN--------PGSQQG----ALEFQT--EIGMLSQ 528
           +G G +G V K +       VAIK++            +Q      + F T  E+ ++++
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 529 LRYLHLVSLIG-YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKI------CI 581
           +++ +++ L+  Y   D  + LV D MA   L+  +          DR++++      CI
Sbjct: 77  IKHENIMGLVDVYVEGD-FINLVMDIMA-SDLKKVV----------DRKIRLTESQVKCI 124

Query: 582 --GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFG-PNFSKTHVST 637
                  L+ LH       +HRD+   NI ++ + + K++DFGL  ++G P +S T    
Sbjct: 125 LLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181

Query: 638 QVKGSIGYLDPE----YYR---LQLLTEK----SDVYSFGVVLLEVLCARP 677
           +       +  +    +YR   L +  EK     D++S G +  E+L  +P
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232

Length = 335

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 48.9 bits (117), Expect = 5e-06
 Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 6/96 (6%)

Query: 585 RALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH--VSTQVKGS 642
           R L Y+H   S  +IHRD+K +N+L++E+   ++ DFG+ +   +    H    T+   +
Sbjct: 118 RGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174

Query: 643 IGYLDPE-YYRLQLLTEKSDVYSFGVVLLEVLCARP 677
             Y  PE    L   T   D++S G +  E+L  R 
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 48.9 bits (116), Expect = 5e-06
 Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 25/218 (11%)

Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 12  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 71

Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 72  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 131

Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +        H   ++    GY
Sbjct: 132 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMT---GY 177

Query: 646 LDPEYYRLQLL-------TEKSDVYSFGVVLLEVLCAR 676
           +   +YR   +        +  D++S G ++ E+L  R
Sbjct: 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 48.6 bits (116), Expect = 6e-06
 Identities = 41/153 (26%), Positives = 76/153 (49%), Gaps = 18/153 (11%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRL-----NPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           IG G +G V+K         VA+KR+     + G    AL    EI +L +L++ ++V L
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELKHKNIVRL 64

Query: 538 IGYCNDDGQMILVYDYMARGTLR--DHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
               + D ++ LV++Y  +   +  D    + +P +      ++     + L + H   S
Sbjct: 65  YDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLL----KGLAFCH---S 117

Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG 627
             ++HRD+K  N+L+++    K++DFGL + FG
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFG 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 48.6 bits (116), Expect = 7e-06
 Identities = 62/225 (27%), Positives = 93/225 (41%), Gaps = 41/225 (18%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE---FQTEIGML------ 526
           DF  L +IGRG FG V    +       A+K LN        E   F+ E  +L      
Sbjct: 2   DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR 61

Query: 527 --SQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD-RRLKIC--I 581
             + L Y           D+  + LV DY   G L   L   ++  LP D  R  +   +
Sbjct: 62  WITNLHYAF--------QDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMV 112

Query: 582 GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVK 640
            A  ++H L        +HRD+K  N+LLD+    +++DFG C +   +   T  S    
Sbjct: 113 LAIDSVHQLG------YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD--GTVQSNVAV 164

Query: 641 GSIGYLDPEYYRLQLLTE-------KSDVYSFGVVLLEVLCARPP 678
           G+  Y+ PE   LQ + +       + D +S GV + E+L    P
Sbjct: 165 GTPDYISPEI--LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 48.5 bits (115), Expect = 8e-06
 Identities = 58/240 (24%), Positives = 96/240 (40%), Gaps = 43/240 (17%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYL 532
           DF +L +IGRG FG V            A+K L       ++     + E  +L +    
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61

Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDR-RLKICIGAARALHYLH 591
            +V +     D   + L+ +++  G +   L   D       +  +   + A  A+H L 
Sbjct: 62  WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC---------KFGPN--------FSKTH 634
                  IHRD+K  N+LLD +   K+SDFGLC         +F  N        FS  +
Sbjct: 122 ------FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175

Query: 635 VSTQVK----------------GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           ++++ K                G+  Y+ PE +      +  D +S GV++ E+L   PP
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 48.0 bits (114), Expect = 8e-06
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 24/208 (11%)

Query: 483 IGRGGFGNVYKGFLNGDSTP--VAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           IG G FG V  G +N   TP  V +K L    S Q  ++F  E      L++ +L+  +G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 540 YCNDDGQMILVYDYMARGTLRDHLY-----NNDNPPLPWDRRLKICIGAARALHYLHTGA 594
            C +    +LV ++   G L+ +L          P     +R+   I  A  L +LH   
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI--ALGLLHLHKNN 120

Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGL--CKFGPNFSKTHVSTQVKGSIGYLDPEYY- 651
               IH D+   N LL  +   K+ D+GL   K+  ++  T    Q+   + ++ PE   
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT--PDQLWVPLRWIAPELVD 175

Query: 652 --RLQLL----TEKSDVYSFGVVLLEVL 673
                LL    T++S+V+S GV + E+ 
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 47.5 bits (114), Expect = 1e-05
 Identities = 40/138 (28%), Positives = 57/138 (41%), Gaps = 22/138 (15%)

Query: 547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTT 606
            +L+ DY+  G L D L       L      KI      AL+ LH      IIH D+K  
Sbjct: 84  HVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLE 138

Query: 607 NILLDEEWVAK----VSDFGLCKFGPNFSKTHVSTQVK--GSIGYLDPEYYRLQLLTEKS 660
           N+L D    AK    + D+GLCK         + T     G++ Y  PE  +        
Sbjct: 139 NVLYDR---AKDRIYLCDYGLCK--------IIGTPSCYDGTLDYFSPEKIKGHNYDVSF 187

Query: 661 DVYSFGVVLLEVLCARPP 678
           D ++ GV+  E+L  + P
Sbjct: 188 DWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 42/166 (25%), Positives = 71/166 (42%), Gaps = 17/166 (10%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL-----NPGSQQGALEFQTEIGMLSQLRY 531
           +  L  IG G +G VYK         VA+K+        G    AL   + + MLS+  Y
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62

Query: 532 L-HLVSLIGYCNDDG--QMILVYDYMARGTLR--DHLYNNDNPPLPWDRRLKICIGAARA 586
           +  L+ +      +G   + LV++Y+     +  D        PLP            + 
Sbjct: 63  IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122

Query: 587 LHYLHTGASKVIIHRDVKTTNILLDEE-WVAKVSDFGLCKFGPNFS 631
           + + H      ++HRD+K  N+L+D++  + K++D GL   G  FS
Sbjct: 123 VAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGL---GRAFS 162

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 50/202 (24%), Positives = 93/202 (46%), Gaps = 15/202 (7%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA-LEFQTEIGMLSQLRYLHLV 535
           +  L  +G G +  VYKG    +   VA+K +    ++G       E  +L  L++ ++V
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV 66

Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPP-LPWDRRLKICIGAARALHYLHTGA 594
            L    +    + LV++Y+     +   Y + +P  L  +          R L Y+H   
Sbjct: 67  LLHDIIHTKETLTLVFEYVHTDLCQ---YMDKHPGGLHPENVKLFLFQLLRGLSYIH--- 120

Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
            + I+HRD+K  N+L+ +    K++DFGL +     S T+ +  V  ++ Y  P+   L 
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDV--LL 176

Query: 655 LLTEKS---DVYSFGVVLLEVL 673
             TE S   D++  G + +E++
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 36/103 (34%), Positives = 51/103 (49%), Gaps = 25/103 (24%)

Query: 585 RALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF-GPNFSK--TH-VSTQVK 640
           R L YLH+     I+HRD+K  N+L++   V K+ DFGL +   P+ SK  T  V TQ  
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ-- 168

Query: 641 GSIGYLDPEYYRL-QLL------TEKSDVYSFGVVLLEVLCAR 676
                    YYR  ++L      T   D++S G +  E+L  R
Sbjct: 169 ---------YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 27/212 (12%)

Query: 477 FNNLLIIGRGGFGNVYKGF--LNGDSTPVAIK--RLNPGSQQGALEFQT--EIGMLSQLR 530
           +  L  +G G +  VYKG   L G    VA+K  RL    ++GA  F    E  +L  L+
Sbjct: 7   YKKLDKLGEGSYATVYKGRSKLTGQL--VALKEIRLEH--EEGA-PFTAIREASLLKDLK 61

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + ++V+L    +    + LV++Y+    L+ ++ +        + RL       R L Y 
Sbjct: 62  HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRL-FLFQLLRGLAYC 119

Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
           H    + ++HRD+K  N+L+ E    K++DFGL +     SKT+ +  V  ++ Y  P+ 
Sbjct: 120 H---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDV 174

Query: 651 YRLQLL--TEKS---DVYSFGVVLLEVLCARP 677
               LL  TE S   D++  G +  E+   RP
Sbjct: 175 ----LLGSTEYSTSLDMWGVGCIFYEMATGRP 202

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 18/102 (17%)

Query: 585 RALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL-CKFGPNFSKTHVSTQVKGSI 643
             L Y+H   S  ++HRD+K  N+L++ +   K+ DFGL   F  N        +  G +
Sbjct: 116 CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG------ENAGFM 166

Query: 644 -GYLDPEYYR-------LQLLTEKSDVYSFGVVLLEVLCARP 677
             Y+   +YR        Q  T+  DV+S G +L E+L  +P
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP 208

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 37/122 (30%), Positives = 55/122 (45%), Gaps = 29/122 (23%)

Query: 579 ICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSD----FGLCKFG------- 627
           I  GA R L+YLH       IHR++K ++IL+  + +  +S     + L + G       
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162

Query: 628 --PNFSKTHVSTQVKGSIGYLDPEYYRLQL--LTEKSDVYSFGVVLLEVLCARPP---IL 680
             P FS +         + +L PE  R  L     KSD+YS G+   E+   R P   +L
Sbjct: 163 DFPQFSTS--------VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214

Query: 681 RT 682
           RT
Sbjct: 215 RT 216

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 33/101 (32%), Positives = 49/101 (48%), Gaps = 16/101 (15%)

Query: 585 RALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG 644
           RAL Y+HT     + HRD+K  NIL + +   K+ DFGL +    F+ T   T +  +  
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR--VAFNDT--PTAIFWT-D 165

Query: 645 YLDPEYYRLQLL--------TEKSDVYSFGVVLLEVLCARP 677
           Y+   +YR   L        T   D++S G +  EVL  +P
Sbjct: 166 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 45.6 bits (109), Expect = 5e-05
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 40/213 (18%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--------EIGMLSQL-RYLH 533
           +G G FG+VY          VAIK++         +F +        E+  L +L  + +
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKK-------KFYSWEECMNLREVKSLRKLNEHPN 59

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT- 592
           +V L     ++ ++  V++YM  G L   + +    P        I     + L ++H  
Sbjct: 60  IVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118

Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVKGSIGYLDPE 649
           G      HRD+K  N+L+    V K++DFGL +     P ++  +VST+      Y  PE
Sbjct: 119 G----FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT-DYVSTR-----WYRAPE 168

Query: 650 YYRLQLLTEKS-----DVYSFGVVLLEVLCARP 677
                LL   S     D+++ G ++ E+   RP
Sbjct: 169 I----LLRSTSYSSPVDIWALGCIMAELYTLRP 197

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 45.7 bits (109), Expect = 5e-05
 Identities = 61/245 (24%), Positives = 88/245 (35%), Gaps = 55/245 (22%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL------NPGSQQGALEFQTEIGMLSQ 528
           K F  + ++G+G  G V+   L G     A+K L           +  L   TE  +L+ 
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVL---TEQEILAT 57

Query: 529 LRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR--- 585
           L +  L +L      +  + LV DY   G L   L     P     + L      AR   
Sbjct: 58  LDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLL--QRQP----GKCL--SEEVARFYA 109

Query: 586 -----ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK--------------F 626
                AL YLH      I++RD+K  NILL E     +SDF L K               
Sbjct: 110 AEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRK 166

Query: 627 GPNFSKTH----------VSTQVKGSIG---YLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
           G   S  +           S +    +G   Y+ PE           D ++ G++L E+L
Sbjct: 167 GSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226

Query: 674 CARPP 678
               P
Sbjct: 227 YGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.1 bits (106), Expect = 8e-05
 Identities = 51/212 (24%), Positives = 95/212 (44%), Gaps = 23/212 (10%)

Query: 483 IGRGGFGNVYKGFLNG--DSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHLVSL-- 537
           +GRG +G+VYK       D    A+K++   G    A     EI +L +L++ ++++L  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR---EIALLRELKHPNVIALQK 65

Query: 538 IGYCNDDGQMILVYDYMARG---TLRDHLYNNDN-PPLPWDRRL--KICIGAARALHYLH 591
           +   + D ++ L++DY        ++ H  +  N  P+   R +   +       +HYLH
Sbjct: 66  VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 592 TGASKVIIHRDVKTTNILL----DEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYL 646
              +  ++HRD+K  NIL+     E    K++D G  + F            V  +  Y 
Sbjct: 126 ---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 647 DPEYYR-LQLLTEKSDVYSFGVVLLEVLCARP 677
            PE     +  T+  D+++ G +  E+L + P
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.0 bits (106), Expect = 8e-05
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 23/212 (10%)

Query: 483 IGRGGFGNVYKGFLNG--DSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHLVSL-- 537
           +GRG +G+VYK       D    A+K++   G    A     EI +L +L++ +++SL  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR---EIALLRELKHPNVISLQK 65

Query: 538 IGYCNDDGQMILVYDYMARG---TLRDHLYNNDNPP---LPWDRRLKICIGAARALHYLH 591
           +   + D ++ L++DY        ++ H  +  N     LP      +       +HYLH
Sbjct: 66  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 592 TGASKVIIHRDVKTTNILL----DEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYL 646
              +  ++HRD+K  NIL+     E    K++D G  + F            V  +  Y 
Sbjct: 126 ---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 647 DPEYYR-LQLLTEKSDVYSFGVVLLEVLCARP 677
            PE     +  T+  D+++ G +  E+L + P
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 45.2 bits (107), Expect = 9e-05
 Identities = 32/112 (28%), Positives = 57/112 (50%), Gaps = 12/112 (10%)

Query: 585 RALHYLHTGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKF-GPNFSKTHVSTQVKGS 642
           R L Y+H   S  ++HRD+K  N+ ++ E+ V K+ DFGL +   P++S     ++   +
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181

Query: 643 IGYLDPEYYRLQL----LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL 690
             Y  P   RL L     T+  D+++ G +  E+L  +P      + +Q+ L
Sbjct: 182 KWYRSP---RLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 45.0 bits (106), Expect = 9e-05
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 17/221 (7%)

Query: 463 TQFSISEIKEAT----KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGA 516
             F   EI ++T    K + NL  IG G  G V   +       VAIK+L+    +Q  A
Sbjct: 8   NNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA 67

Query: 517 LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDR 575
                E+ ++  + + +++ L+        +    D Y+    +  +L       L  +R
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER 127

Query: 576 RLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF-GPNFSKT- 633
              +       + +LH+     IIHRD+K +NI++  +   K+ DFGL +  G +F  T 
Sbjct: 128 MSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 184

Query: 634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC 674
           +V T+      Y  PE        E  D++S G ++ E++ 
Sbjct: 185 YVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIK 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 44.6 bits (105), Expect = 9e-05
 Identities = 71/280 (25%), Positives = 120/280 (42%), Gaps = 41/280 (14%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-YLHLVSLIG-Y 540
           IG+G +G V+K     + +  A+K L+P       E + E  +L  L  + ++V   G Y
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE-EIEAEYNILKALSDHPNVVKFYGMY 84

Query: 541 CNDD----GQMILVYDYMARGTLRD----HLYNND--NPPLPWDRRLKICIGAARALHYL 590
              D     Q+ LV +    G++ D     L   +    P+       I   A   L +L
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPII----AYILHEALMGLQHL 140

Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
           H   +   IHRDVK  NILL  E   K+ DFG+     + ++   +T V G+  ++ PE 
Sbjct: 141 HVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTS-TRLRRNTSV-GTPFWMAPEV 195

Query: 651 Y--RLQLLT---EKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD 705
                QL +    + DV+S G+  +E+    PP+      + +       +  RN     
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL------FKIPRN----- 244

Query: 706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
              P    + P +  N+F +    C+  D  +RP++SD++
Sbjct: 245 ---PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 45.1 bits (106), Expect = 1e-04
 Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 13/173 (7%)

Query: 506 KRLNPGSQQGALEFQTEIGMLSQLRY---LHLVSLIGYCNDDGQMILVYDYMARGTLRDH 562
           KR+  GS+  A++ + EI  L +L +   L +  ++    +   +   YD+     + D 
Sbjct: 198 KRVKAGSR-AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDE 256

Query: 563 LYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFG 622
            ++  + PL    R  I      A+ Y+H    K +IHRD+K  NI L+ +    + DFG
Sbjct: 257 AFDWKDRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFG 312

Query: 623 LCKFGPNFSKTHVSTQVK--GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
                  F K   +      G++    PE        E +D++S G++LL++L
Sbjct: 313 TAM---PFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 55/224 (24%), Positives = 99/224 (44%), Gaps = 17/224 (7%)

Query: 459 SDLCTQFSISEIKEAT----KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GS 512
           S+  +QF   ++ ++T    K +  L  IG G  G V   F       VA+K+L+    +
Sbjct: 1   SEEDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN 60

Query: 513 QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPL 571
           Q  A     E+ +L  + + +++SL+        +    D Y+    +  +L    +  L
Sbjct: 61  QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMEL 120

Query: 572 PWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNF 630
             +R   +       + +LH+     IIHRD+K +NI++  +   K+ DFGL +    NF
Sbjct: 121 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF 177

Query: 631 SKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
             T +V T+      Y  PE        E  D++S G ++ E++
Sbjct: 178 MMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 43.6 bits (103), Expect = 3e-04
 Identities = 30/123 (24%), Positives = 45/123 (36%), Gaps = 41/123 (33%)

Query: 599 IHRDVKTTNILLDEEWVAKVSDFGLCK----------FGPN------------------- 629
           IHRD+K  NIL+D +   K++DFGLC           +                      
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 630 -----FSKTHVSTQVK-------GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARP 677
                  +       +       G+  Y+ PE       T+  D +S GV+L E+L  +P
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 678 PIL 680
           P L
Sbjct: 243 PFL 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 43.5 bits (102), Expect = 3e-04
 Identities = 38/146 (26%), Positives = 55/146 (37%), Gaps = 52/146 (35%)

Query: 599 IHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK------------------ 640
           IHRD+K  NIL+D +   K++DFGLC     F  TH S   +                  
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCT---GFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179

Query: 641 ------------------------------GSIGYLDPEYYRLQLLTEKSDVYSFGVVLL 670
                                         G+  Y+ PE       T+  D +S GV+L 
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239

Query: 671 EVLCARPPIL-RTGDKKQVNLAVWAT 695
           E+L  +PP L +T  + Q+ +  W T
Sbjct: 240 EMLVGQPPFLAQTPLETQMKVINWQT 265

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 43.4 bits (102), Expect = 3e-04
 Identities = 31/104 (29%), Positives = 44/104 (42%), Gaps = 10/104 (9%)

Query: 575 RRLKICIGAA------RALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP 628
           R + IC   A      RA+ YLH      IIHRD+K  NI ++      + DFG   F  
Sbjct: 177 RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV 233

Query: 629 NFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEV 672
           + +         G+I    PE           D++S G+VL E+
Sbjct: 234 DINANKYYGWA-GTIATNAPELLARDPYGPAVDIWSAGIVLFEM 276

Length = 391

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 43.1 bits (101), Expect = 5e-04
 Identities = 37/144 (25%), Positives = 54/144 (37%), Gaps = 52/144 (36%)

Query: 599 IHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK------------------ 640
           IHRD+K  NIL+D +   K++DFGLC     F  TH S   +                  
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCT---GFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179

Query: 641 ------------------------------GSIGYLDPEYYRLQLLTEKSDVYSFGVVLL 670
                                         G+  Y+ PE    +  T+  D +S GV+L 
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239

Query: 671 EVLCARPPILR-TGDKKQVNLAVW 693
           E+L  +PP L  T  + Q+ +  W
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 42.7 bits (101), Expect = 5e-04
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 22/102 (21%)

Query: 585 RALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG---PNFSKTHVSTQVKG 641
           R L Y+H   S  ++HRD+K +N+LL+     K+ DFGL +      +F   +V T+   
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR--- 172

Query: 642 SIGYLDPEYYRLQLL------TEKSDVYSFGVVLLEVLCARP 677
                   Y   +LL      T   DV+S G +  E+L  +P
Sbjct: 173 -------WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 43.2 bits (102), Expect = 5e-04
 Identities = 61/259 (23%), Positives = 95/259 (36%), Gaps = 74/259 (28%)

Query: 483 IGRGGFGNVYKGFLNGDST----PVAIKRLNPGSQQGALEFQTEIGMLSQLR-------- 530
           +G G FG VYK  L    +       +K+     + GA+E    I M  ++R        
Sbjct: 140 LGEGAFGVVYKASLVNKQSKKEGKYVLKKAT---EYGAVE----IWMNERVRRACPNSCA 192

Query: 531 -YLHLVSLIGYCNDDGQMILVYDYMARGTL------RDHLYN---------NDNPPLPWD 574
            +++          + +  LV+ Y    TL      ++  YN          D P     
Sbjct: 193 DFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGL-- 250

Query: 575 RRLKICIGAA-----RALHYLH-TGASKVIIHRDVKTTNILLDEEWVA-KVSDFGLC--- 624
            R    I         AL  LH TG    I+HRDVK  NI+  E   + K+ D G     
Sbjct: 251 ERENKIIQTIMRQILFALDGLHSTG----IVHRDVKPQNIIFSEGSGSFKIIDLGAAADL 306

Query: 625 KFGPNFSKTH--------------VSTQVKGS-----IGYLDPEYYRLQLLTEKSDVYSF 665
           + G N+                  +STQ   +        L P  ++L  L ++ D+YS 
Sbjct: 307 RVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN-LPDRFDIYSA 365

Query: 666 GVVLLEVLCARPPILRTGD 684
           G++ L+ +    P LR+  
Sbjct: 366 GLIFLQ-MAF--PNLRSDS 381

Length = 566

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 42.8 bits (100), Expect = 5e-04
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 17/219 (7%)

Query: 464 QFSISEIKEAT----KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGAL 517
           QF   E+ ++T    K + NL  IG G  G V   +       VAIK+L+    +Q  A 
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61

Query: 518 EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRR 576
               E+ ++  + + +++SL+        +    D Y+    +  +L       L  +R 
Sbjct: 62  RAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERM 121

Query: 577 LKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF-GPNFSKT-H 634
             +       + +LH+     IIHRD+K +NI++  +   K+ DFGL +  G +F  T +
Sbjct: 122 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 178

Query: 635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
           V T+      Y  PE        E  D++S G ++ E++
Sbjct: 179 VVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 42.2 bits (99), Expect = 7e-04
 Identities = 54/224 (24%), Positives = 89/224 (39%), Gaps = 48/224 (21%)

Query: 472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRY 531
           E  + + +L  +G G +G+V           VAIK+L       +  FQ+EI      R 
Sbjct: 12  ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL-------SRPFQSEIFAKRAYRE 64

Query: 532 LHLVSLIGYCNDDG---------------QMILVYDYMARGTLRDHLYNNDNPPLPWDRR 576
           L L+  + + N  G                  LV  YM     +  L      PL  D+ 
Sbjct: 65  LTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM-----QTDLQKIMGHPLSEDKV 119

Query: 577 LKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVS 636
             +       L Y+H+     IIHRD+K  N+ ++E+   K+ DFGL +        H  
Sbjct: 120 QYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR--------HAD 168

Query: 637 TQVKGSIGYLDPEYYRLQLL-------TEKSDVYSFGVVLLEVL 673
            ++    GY+   +YR   +        +  D++S G ++ E+L
Sbjct: 169 AEMT---GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML 209

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 42.4 bits (100), Expect = 7e-04
 Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 22/99 (22%)

Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF-GPNFSKT-HVSTQVKGSI 643
            + +LH   S  IIHRD+K +NI++  +   K+ DFGL +  G +F  T +V T+     
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR----- 181

Query: 644 GYLDPEYYR-----LQL-LTEKSDVYSFGVVLLEVLCAR 676
                 YYR     L +   E  D++S G ++ E++   
Sbjct: 182 ------YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.1 bits (99), Expect = 8e-04
 Identities = 36/147 (24%), Positives = 53/147 (36%), Gaps = 57/147 (38%)

Query: 580 CIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH----- 634
           C+ A  A+H L        IHRD+K  NIL+D     K+SDFGL      F K H     
Sbjct: 110 CVLAIEAVHKLG------FIHRDIKPDNILIDRGGHIKLSDFGL---STGFHKQHDSAYY 160

Query: 635 ---------------------------VSTQVK----------------GSIGYLDPEYY 651
                                      +S++ +                G+  Y+ PE +
Sbjct: 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF 220

Query: 652 RLQLLTEKSDVYSFGVVLLEVLCARPP 678
             Q   ++ D +S G ++ E L   PP
Sbjct: 221 LQQGYGQECDWWSLGAIMFECLIGWPP 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 42.0 bits (98), Expect = 8e-04
 Identities = 49/212 (23%), Positives = 95/212 (44%), Gaps = 23/212 (10%)

Query: 472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQL 529
           E  + + NL  +G G +G+V   +       VA+K+L+   Q      +T  E+ +L  +
Sbjct: 12  EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM 71

Query: 530 RYLHLVSLIGY------CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICI-G 582
           ++ +++ L+          +  ++ LV + M        L N        D  ++  I  
Sbjct: 72  KHENVIGLLDVFTPATSIENFNEVYLVTNLMGA-----DLNNIVKCQKLSDEHVQFLIYQ 126

Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS 642
             R L Y+H+     IIHRD+K +N+ ++E+   ++ DFGL +   +    +V+T+    
Sbjct: 127 LLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR---- 179

Query: 643 IGYLDPE-YYRLQLLTEKSDVYSFGVVLLEVL 673
             Y  PE         +  D++S G ++ E+L
Sbjct: 180 -WYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum

 Score = 40.4 bits (95), Expect = 0.001
 Identities = 42/194 (21%), Positives = 66/194 (34%), Gaps = 44/194 (22%)

Query: 195 TLYRINVGGSFISPQMDTGMYRTWIAD--------DGYVTDARPSALPVNTTIVLRFSRI 246
            +  IN GG   +     G   T+ AD        D YV+D   S+    TT        
Sbjct: 1   VVLAINCGGPEHTD--SDG--ITYEADTYFTGGSADYYVSDTNGSSSIAGTTDPE----- 51

Query: 247 LNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRLHFCEFQSEVTEEGDRV 306
                   +Y+T R            + ++         Y V LHF E        G RV
Sbjct: 52  --------LYQTER-YSPS-------SFSYYIPCLENGNYTVILHFAEIYFGEDGLGRRV 95

Query: 307 FKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGSKSDVKKQNLSIALHPAPR----- 361
           F +Y+         D++A +GG G   +++Y         V    L I  + A +     
Sbjct: 96  FDVYVQGKLVLKDFDIVAEAGGKGKTAHKEYIPVT-----VTDGTLEIHFYWAGKGTLLI 150

Query: 362 -WRTKYSDSILNGI 374
            +R  Y +  ++ I
Sbjct: 151 PFRGVYGNPKISAI 164

Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 42/233 (18%)

Query: 483 IGRGGFGNVYKGFLNGDS--TPVAIKRL--NPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           IG G FG V    +  D+    V +K L  N  S++   EF  +      L++ +++  +
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQN-EFLQQGDPYRILQHPNILQCL 61

Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRR-----------LKICIGAARAL 587
           G C +    +LV++Y   G L+ +L         W RR            +I  G    +
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQ-----WHRRNSQLLLLQRMACEIAAGVT-HM 115

Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP-NFSKTHVSTQVK--GSIG 644
           H  +       +H D+   N  L  +   KV D+G+   GP  + + ++ T+      + 
Sbjct: 116 HKHN------FLHSDLALRNCFLTSDLTVKVGDYGI---GPSRYKEDYIETEDDKCVPLR 166

Query: 645 YLDPEY---YRLQLL----TEKSDVYSFGVVLLEVL-CARPPILRTGDKKQVN 689
           +L PE    +   L+    T+ S+V++ GV L E+   A  P     D++ +N
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN 219

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 40.6 bits (95), Expect = 0.003
 Identities = 26/86 (30%), Positives = 41/86 (47%), Gaps = 3/86 (3%)

Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
           A+ Y+H    + IIHRD+KT N+L++      + DFG   F      T     + G++  
Sbjct: 272 AIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDT 328

Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLE 671
             PE       T   D++S G+V+ E
Sbjct: 329 NAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	767
PF12819	347	Malectin_like: Carbohydrate-binding protein of the	100.0
PLN03150	623	hypothetical protein; Provisional	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.98
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.98
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.98
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.98
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.98
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.93
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.9
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.87
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.85
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.8
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.78
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.78
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.77
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.77
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.76
PRK12274	218	serine/threonine protein kinase; Provisional	99.76
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.74
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.73
PRK10345	210	hypothetical protein; Provisional	99.73
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.72
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.71
PRK14879	211	serine/threonine protein kinase; Provisional	99.67
smart00090	237	RIO RIO-like kinase.	99.67
PF11721	174	Malectin: Di-glucose binding within endoplasmic re	99.66
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.65
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.65
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.65
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.63
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.61
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.58
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.51
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.48
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.42
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.41
PF11721	174	Malectin: Di-glucose binding within endoplasmic re	99.37
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.32
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.25
KOG1243	690	consensus Protein kinase [General function predict	99.21
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.19
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.13
PLN03150	623	hypothetical protein; Provisional	99.08
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.05
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.03
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.01
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.0
KOG3087	229	consensus Serine/threonine protein kinase [General	98.9
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.87
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.84
COG4248	637	Uncharacterized protein with protein kinase and he	98.74
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.7
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.57
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.52
PF12819	347	Malectin_like: Carbohydrate-binding protein of the	98.42
PRK09902	216	hypothetical protein; Provisional	98.41
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.32
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.2
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.19
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.15
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.03
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.92
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.87
PF01636	239	APH: Phosphotransferase enzyme family This family	97.85
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.85
PLN02876	822	acyl-CoA dehydrogenase	97.81
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.62
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.59
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.57
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.51
PRK10593	297	hypothetical protein; Provisional	97.45
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.41
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.37
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.36
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.34
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.3
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.29
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.27
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.99
PRK05231	319	homoserine kinase; Provisional	96.81
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.69
PLN02236	344	choline kinase	96.42
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.34
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.15
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	95.89
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.83
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.67
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	95.66
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.6
PLN02756	418	S-methyl-5-thioribose kinase	95.51
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.41
PRK12396	409	5-methylribose kinase; Reviewed	95.24
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	94.94
COG2334	331	Putative homoserine kinase type II (protein kinase	94.94
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.65
PTZ00384	383	choline kinase; Provisional	94.07
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	93.78
PRK11768	325	serine/threonine protein kinase; Provisional	93.66

>PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan []

Probab=100.00  E-value=2.7e-60  Score=511.80  Aligned_cols=323  Identities=38%  Similarity=0.590  Sum_probs=259.6

Q ss_pred             EeeCCCcc-c----ccCCCeeeccCCCCCCCCCcccccc---cCCCCCCCcccceee--ccceeEEEecC--CCceE-EE
Q 042216           15 VACGWLGN-I----SAHGQTWAGDVSSQYSPLGHQQSTI---SKKPREPPYSASRLS--HSQFTYTFNVT--PGQKF-IR   81 (767)
Q Consensus        15 i~cG~~~~-~----~~~~~~w~~D~~~~~~~~~~~~~~~---~~~~~~~~~~t~R~f--~~~~~Y~~~~~--~g~~y-vR   81 (767)
                      ||||++.+ +    +.+||+|++|..|..++..+..+..   ......++|.|||+|  |.|+||+||+.  +|.|| ||
T Consensus         1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~~i~~~~~~~~~~~~~~y~taR~F~~g~r~cY~l~~~~~~~~~yliR   80 (347)
T PF12819_consen    1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSGNISSQPDSSSSDSSPPYQTARIFPEGSRNCYTLPVTPPGGGKYLIR   80 (347)
T ss_pred             CcCCCCCCCcccccCCCCcEEeCCCCcccCCCccccccccCCcCCccccccceEEEcCCCCccEEEeeccCCCCceEEEE
Confidence            79997755 2    3569999999988775554433211   234567889999999  58999999996  57798 99


Q ss_pred             EeeecCCCCCCC-----CCCce-EEEEeCceEEEeccCcccCCCCceEEEEEEeec-CCCceEEEEEecCCCCCCCc-ee
Q 042216           82 LHFYSTSYSGFN-----ISSAF-FSVKANSFTLVNNFSASFAPDDTFFKEFCINVP-EDQRSLSITFTPSPDYQDSY-AF  153 (767)
Q Consensus        82 ~~f~~~~y~~~~-----~~~~~-~~v~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~-~~~~~~~l~~~~~~~~~~~~-pf  153 (767)
                      |||+|||||+++     .++.| ++++.|.|.+|+..+ .  ...++++|+++.+. ++...|||+     +++.++ ||
T Consensus        81 l~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~-~--~~~~~~~E~ii~v~~~~~l~vclv-----~~~~g~~pF  152 (347)
T PF12819_consen   81 LHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSN-S--PSSPVVKEFIINVTWSDTLSVCLV-----PTGSGTFPF  152 (347)
T ss_pred             EEeccccccccccccccCCcceEEEECCceeEEEEecC-C--CcceEEEEEEEEEcCCCcEEEEEE-----eCCCCCCCc
Confidence            999999999874     25779 999999999998876 2  12578999888877 687777777     334466 99


Q ss_pred             eeeeEeEecCCcceeeccCCcccccccCCcccccchhhhheeeeEeecCCcc-cccCCCCccccccccCCCceecCCCCC
Q 042216          154 INGIELVSMPLNLYYTATDDQRLEFVGEGSQFSILNSNALETLYRINVGGSF-ISPQMDTGMYRTWIADDGYVTDARPSA  232 (767)
Q Consensus       154 is~iE~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~al~~~~R~n~G~~~-~~~~~dd~~~R~W~~d~~~~~~~~~~~  232 (767)
                      ||||||||||+++|+..               ....+.||++++|+||||.. .+|||||+|||+|.|.     .....|
T Consensus       153 IsaiEl~~lp~~ly~~~---------------~~~~s~~L~~~~R~n~G~~~~~iryp~D~~dR~W~~~-----~~~~~~  212 (347)
T PF12819_consen  153 ISAIELRPLPDSLYPDT---------------DANSSQALETVYRLNVGGSSSFIRYPDDTYDRIWQPY-----SSSPGW  212 (347)
T ss_pred             eeEEEEEECCccceecc---------------ccCCCceeEEEEeecCCCcccccCCCCCcceeecccc-----ccCccc
Confidence            99999999999999532               12467899999999999984 6899999999999843     124556


Q ss_pred             CCCCcceEEE-eccccCCCCcHHHHHhhhccCCCCCcccccceEEEEecCCCceEEEEEeeeeeecccccCccEEEEEEE
Q 042216          233 LPVNTTIVLR-FSRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRLHFCEFQSEVTEEGDRVFKIYL  311 (767)
Q Consensus       233 ~~~~~~~~~~-~~~~~~~~~P~~v~~ta~~~~~~~~~~~~~~lt~~~~~~~~~~y~v~lhFae~~~~~~~~~~R~F~i~i  311 (767)
                      ..+++..+++ ...++.|.||.+||+||++++++.   ..++|+|.+ +++++.|+|+||||||+......++|+|||||
T Consensus       213 ~~ist~~~i~~~~~~~~~~~P~~V~~TA~~~~~~s---~~~nltw~~-~~~~~~y~v~lHFaEi~~~~~~~~~R~F~Iyi  288 (347)
T PF12819_consen  213 SNISTTSNININSSNNPYDAPSAVYQTARTPSNSS---DPLNLTWSF-VDPGFSYYVRLHFAEIQSLSPNNNQREFDIYI  288 (347)
T ss_pred             cccccceeeecccCCccCcChHHHHHhhhcccccc---cceEEEecc-CCCCccEEEEEEEeecccccCCCCeEEEEEEE
Confidence            7777777776 467789999999999999988874   237899999 99999999999999999864456689999999


Q ss_pred             cccccccccchhh-hcCCCCcceEeeeEEEeccccccccceeEEEecCCCCCCcccccccccceeEEee
Q 042216          312 ANLTAEDVADVIA-WSGGNGVPEYRDYAVAIGSKSDVKKQNLSIALHPAPRWRTKYSDSILNGIEIFKV  379 (767)
Q Consensus       312 n~~~~~~~~di~~-~~~~~~~p~y~~~~v~~~~~~~~~~~~l~i~l~p~~~~~~~~~~~~ln~~~i~~~  379 (767)
                      ||+.+.+  |+.. +.+....|+|.++.+.++..+     .++|+|+|+.++..   +|+|||+|||+|
T Consensus       289 N~~~~~~--~~~~~~~~~~~~~~~~d~~~~~~~~~-----~~~isL~~t~~S~l---ppiLNalEIy~v  347 (347)
T PF12819_consen  289 NGQTAYS--DVSPPYLGADTVPYYSDYVVNVPDSG-----FLNISLGPTPDSTL---PPILNALEIYKV  347 (347)
T ss_pred             CCeEccC--ccCcccccCcceEeecceEEEecCCC-----EEEEEEEeCCCCCc---CceeEeeeeEeC
Confidence            9999987  6655 455677899999998876543     58999999887743   999999999986

This entry represents a malectin-like domain found in a number of plant receptor kinases.

>PLN03150 hypothetical protein; Provisional

Probab=100.00  E-value=7.3e-57  Score=521.76  Aligned_cols=333  Identities=21%  Similarity=0.287  Sum_probs=265.5

Q ss_pred             CCCCCCceEEEeeCCCcc--cccCCCeeeccCCCCCCCCCcccccccCCCCCCCcccceee----ccceeEEEecCCCce
Q 042216            5 PYYTPTEITFVACGWLGN--ISAHGQTWAGDVSSQYSPLGHQQSTISKKPREPPYSASRLS----HSQFTYTFNVTPGQK   78 (767)
Q Consensus         5 ~~~~p~~~~~i~cG~~~~--~~~~~~~w~~D~~~~~~~~~~~~~~~~~~~~~~~~~t~R~f----~~~~~Y~~~~~~g~~   78 (767)
                      .+..++++|+||||++++  +|.+||+|++|..+.++....  .... ....++|.|+|+|    |++|||+||++++.+
T Consensus        18 ~~~~~~~~~~I~CGs~~~~~~d~~~~~w~~D~~~~~~~~~~--~~~~-~~~~~~~~t~R~F~~~~g~~~cY~~~~~~~g~   94 (623)
T PLN03150         18 LASPEPFTMRISCGARVNVRTAPTNTLWYKDFAYTGGIPAN--ATRP-SFIAPPLKTLRYFPLSDGPENCYNINRVPKGH   94 (623)
T ss_pred             cccCCCccEEEeCCCCCCcccCCCCCEEcCCcccccCcccc--ccCc-ccccchhhccccCCcccccccceEeeecCCCc
Confidence            344478889999998876  447999999997663221111  1111 2345779999999    459999999977667


Q ss_pred             E-EEEeeecCCCCCCCCCCce-EEEEeCceEEEec-cCcccCCCCceEEEEEEeecCCCceEEEEEecCCCCCCCceeee
Q 042216           79 F-IRLHFYSTSYSGFNISSAF-FSVKANSFTLVNN-FSASFAPDDTFFKEFCINVPEDQRSLSITFTPSPDYQDSYAFIN  155 (767)
Q Consensus        79 y-vR~~f~~~~y~~~~~~~~~-~~v~~~~~~~~~~-~~~~~~~~~~~~~e~~~~~~~~~~~~~l~~~~~~~~~~~~pfis  155 (767)
                      | ||+||+|||||+.+.++.| ++++++.|.+|.. ++.   +...+++|+++.++++..+|||+     ++++++||||
T Consensus        95 ylVRl~F~~~~y~~~~~~~~Fdv~~~~~~~~tv~~~~~~---~~~~v~~E~i~~~~~~~l~vcf~-----~~~~~~pFIs  166 (623)
T PLN03150         95 YSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSGWSS---HDEQVFAEALVFLTDGSASICFH-----STGHGDPAIL  166 (623)
T ss_pred             EEEEEEeecCCcCCCCCCCceEEEECcEEEEEEecCccc---CCCcEEEEEEEEecCCcEEEEEe-----cCCCCCCcee
Confidence            7 9999999999999988877 8888888998865 222   23478899999999987777776     4457999999


Q ss_pred             eeEeEecCCcceeeccCCcccccccCCcccccchhhhheeeeEeecCCccc---ccCCCCcc--ccccccCCCceecCCC
Q 042216          156 GIELVSMPLNLYYTATDDQRLEFVGEGSQFSILNSNALETLYRINVGGSFI---SPQMDTGM--YRTWIADDGYVTDARP  230 (767)
Q Consensus       156 ~iE~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~al~~~~R~n~G~~~~---~~~~dd~~--~R~W~~d~~~~~~~~~  230 (767)
                      +|||||||+++|.....              +..+.+|+++||+||||+++   .+||||+|  ||+|.+|.+|.   .+
T Consensus       167 ~iEv~~l~~~~y~~~~~--------------~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~---~~  229 (623)
T PLN03150        167 SIEILQVDDKAYNFGPS--------------WGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFG---SG  229 (623)
T ss_pred             EEEEEEcCccccccccc--------------ccCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccC---CC
Confidence            99999999999953210              01256799999999999864   69999999  99999998876   22


Q ss_pred             CCCCCCcceEEEeccccCCCCcHHHHHhhhccCCCCCcccccceEEEEecCCCceEEEEEeeeeeecccccCccEEEEEE
Q 042216          231 SALPVNTTIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRLHFCEFQSEVTEEGDRVFKIY  310 (767)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~P~~v~~ta~~~~~~~~~~~~~~lt~~~~~~~~~~y~v~lhFae~~~~~~~~~~R~F~i~  310 (767)
                      .+...++...++....+++.+|+.|||||+++..+.     .+++|.|+++++..|+|+|||||++......++|+||||
T Consensus       230 ~~~~~st~~~I~~~~~~~~~~P~~VyqTA~~~~~~~-----~~lty~~~v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~  304 (623)
T PLN03150        230 SDQAISTENVIKKASNAPNFYPESLYQSALVSTDTQ-----PDLSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVL  304 (623)
T ss_pred             cccccccccccccccCCCccChHHHhhhhccccCCC-----CceEEEeecCCCCCEEEEEEEEeccCccCCCceEEEEEE
Confidence            345556666666555678899999999999976532     479999999999999999999999864456799999999


Q ss_pred             EcccccccccchhhhcCCCCcceEeeeEEEeccccccccceeEEEecCCCCCCcccccccccceeEEeecC
Q 042216          311 LANLTAEDVADVIAWSGGNGVPEYRDYAVAIGSKSDVKKQNLSIALHPAPRWRTKYSDSILNGIEIFKVDN  381 (767)
Q Consensus       311 in~~~~~~~~di~~~~~~~~~p~y~~~~v~~~~~~~~~~~~l~i~l~p~~~~~~~~~~~~ln~~~i~~~s~  381 (767)
                      |||+.+++++|+..++++...|+|+++.+.+..      ..++|+++|..+     .+|++||+|||++..
T Consensus       305 ing~~~~~~~di~~~~g~~~~~~~~~~~v~~~~------g~l~isl~p~~~-----s~pilNaiEI~~~~~  364 (623)
T PLN03150        305 INGDTAFKDVDIVKMSGERYTALVLNKTVAVSG------RTLTIVLQPKKG-----THAIINAIEVFEIIT  364 (623)
T ss_pred             ECCEEeecccChhhhcCCcccceEEEeEEeecC------CeEEEEEeeCCC-----Ccceeeeeeeeeccc
Confidence            999999999999999888888999999876642      358999999652     269999999999975

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-56  Score=485.34  Aligned_cols=291  Identities=48%  Similarity=0.825  Sum_probs=259.1

Q ss_pred             cccccCHHHHHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeee
Q 042216          461 LCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGY  540 (767)
Q Consensus       461 ~~~~~~~~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~  540 (767)
                      ....|+++||+.||++|+..++||+|+||.||+|.+.++ +.||||++.....+..++|.+|+++|.+++|||+|+|+||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            457799999999999999999999999999999999876 8899999876544325679999999999999999999999


Q ss_pred             eecCC-ceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 042216          541 CNDDG-QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVS  619 (767)
Q Consensus       541 ~~~~~-~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~  619 (767)
                      |.+.+ +.+||||||++|+|.++|+.....+|+|.+|++||.++|+||+|||+.+.+.|||||||++|||||+++++||+
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            99998 49999999999999999987654389999999999999999999999998899999999999999999999999


Q ss_pred             ecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhh
Q 042216          620 DFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR  699 (767)
Q Consensus       620 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~  699 (767)
                      |||+|+..+.. .....+...||.+|+|||++..+..++|+|||||||+|+||+||+.+...........+.+|+...+.
T Consensus       220 DFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  220 DFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             CccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            99999876542 22222211799999999999999999999999999999999999999876655556679999999999


Q ss_pred             cCCcccccccccc-CCCCh-hhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          700 NGKIGDIIDPFLK-GNAPP-VCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       700 ~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                      ++.+.+++|+.+. +.++. .+..++.+++.+|++.+|.+||+|.||+++|+.+..
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            9999999999997 66664 688889999999999999999999999999966553

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-47  Score=405.88  Aligned_cols=254  Identities=34%  Similarity=0.527  Sum_probs=213.6

Q ss_pred             eeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcc--hhHHHHHHHHHhccccceeeeEeeeeecCC-ceEEEEecCCCC
Q 042216          481 LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQG--ALEFQTEIGMLSQLRYLHLVSLIGYCNDDG-QMILVYDYMARG  557 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~--~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~-~~~lV~ey~~~g  557 (767)
                      +.||+|+||+||+|.+.+. ..||||++.......  .++|.+|+.+|.+++|||||+++|+|.+.. .+++|||||++|
T Consensus        47 ~~iG~G~~g~V~~~~~~g~-~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G  125 (362)
T KOG0192|consen   47 EVLGSGSFGTVYKGKWRGT-DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG  125 (362)
T ss_pred             hhcccCCceeEEEEEeCCc-eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence            3599999999999999863 349999997653222  558999999999999999999999999887 799999999999


Q ss_pred             ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCC-eEecCCCCCCeEECCCC-cEEEeecCCcccCCCCCCccc
Q 042216          558 TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV-IIHRDVKTTNILLDEEW-VAKVSDFGLCKFGPNFSKTHV  635 (767)
Q Consensus       558 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-iiH~Dlk~~NILld~~~-~~ki~DfGla~~~~~~~~~~~  635 (767)
                      +|.++|++.....+++..+++++.|||+||.|||   +.+ |||||||++|||++.++ ++||+|||+++......  ..
T Consensus       126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~  200 (362)
T KOG0192|consen  126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TS  200 (362)
T ss_pred             cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--cc
Confidence            9999998755667999999999999999999999   666 99999999999999998 99999999998643211  23


Q ss_pred             cccccCCCcccChhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          636 STQVKGSIGYLDPEYYR--LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       636 ~~~~~gt~~y~aPE~~~--~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      .+...||..|||||++.  ...++.|+||||||++||||+||+.||......   ....   ..         +....+.
T Consensus       201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~---~~~~---~v---------~~~~~Rp  265 (362)
T KOG0192|consen  201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV---QVAS---AV---------VVGGLRP  265 (362)
T ss_pred             ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH---HHHH---HH---------HhcCCCC
Confidence            34468999999999999  669999999999999999999999999665441   1111   11         1122344


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      ..+..++..+..++.+||+.||..||++.+++.+|+.+....
T Consensus       266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence            455668889999999999999999999999999999887644

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-47  Score=406.07  Aligned_cols=253  Identities=32%  Similarity=0.502  Sum_probs=220.7

Q ss_pred             cceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCC
Q 042216          479 NLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGT  558 (767)
Q Consensus       479 ~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gs  558 (767)
                      ..+.||+|-||.||+|.+++. ..||+|.++.. ....+.|.+|+++|++|+|+|||+++|+|..++.++||||||+.|+
T Consensus       210 l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs  287 (468)
T KOG0197|consen  210 LIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS  287 (468)
T ss_pred             HHHHhcCCccceEEEEEEcCC-CcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence            344799999999999999854 68999999865 3445679999999999999999999999999889999999999999


Q ss_pred             hhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcccccc
Q 042216          559 LRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ  638 (767)
Q Consensus       559 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~  638 (767)
                      |.++|+...+..+...+.+.++.|||+||+||+   ++++|||||.++||||+++..+||+||||+|...+ ..-.....
T Consensus       288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d-~~Y~~~~~  363 (468)
T KOG0197|consen  288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD-DEYTASEG  363 (468)
T ss_pred             HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCC-CceeecCC
Confidence            999998866778999999999999999999999   88899999999999999999999999999995433 22334445


Q ss_pred             ccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCCh
Q 042216          639 VKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPP  717 (767)
Q Consensus       639 ~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  717 (767)
                      ..-++.|.|||.+..+.++.|||||||||+||||+| |+.||..+...+..                +.++...+-+.|.
T Consensus       364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~----------------~~le~GyRlp~P~  427 (468)
T KOG0197|consen  364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL----------------ELLERGYRLPRPE  427 (468)
T ss_pred             CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH----------------HHHhccCcCCCCC
Confidence            566789999999999999999999999999999998 99998766543222                2334455667899


Q ss_pred             hhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          718 VCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       718 ~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                      .|+.++.++|..||+.+|++|||++.+.+.|+.+..
T Consensus       428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            999999999999999999999999999999987764

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=9.9e-46  Score=413.32  Aligned_cols=261  Identities=30%  Similarity=0.520  Sum_probs=223.1

Q ss_pred             hccccceeeeccCcEEEEEEEecC-----CCceEEEEEeCCCCCc-chhHHHHHHHHHhccccceeeeEeeeeecCCceE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGSQQ-GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMI  548 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~  548 (767)
                      .+....+.||+|.||+||+|+..+     ..+.||||.+++.... ..++|++|+++|..|+|||||+|+|.|.+++.++
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            344555679999999999998743     3468999999987655 7789999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhccCC------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcE
Q 042216          549 LVYDYMARGTLRDHLYNND------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVA  616 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~  616 (767)
                      ||+|||..|+|.+||+...            ..+|+..+.+.||.|||.||.||-   ++.+|||||..+|+||.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEE
Confidence            9999999999999996421            234899999999999999999999   7889999999999999999999


Q ss_pred             EEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHH
Q 042216          617 KVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWAT  695 (767)
Q Consensus       617 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~  695 (767)
                      ||+||||+|.....+.-.......-+++|||||.+..++||.+||||||||+|||+++ |+.||.+....+..       
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI-------  715 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI-------  715 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH-------
Confidence            9999999996544444443334456789999999999999999999999999999998 99999887765433       


Q ss_pred             HHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 042216          696 ECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL  754 (767)
Q Consensus       696 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~  754 (767)
                      +.++++.+         -..|..|+.++++||..||+.+|.+||+++||-..|+...+.
T Consensus       716 e~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  716 ECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            33344443         346889999999999999999999999999999999877644

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4e-45  Score=373.83  Aligned_cols=251  Identities=25%  Similarity=0.359  Sum_probs=209.0

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCC-ceEEEEecC
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG-QMILVYDYM  554 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~-~~~lV~ey~  554 (767)
                      ++.++.||+|..|+|||+.++.+++.+|+|.+.... ..-.+++.+|++++++.+||+||.++|.|..++ +..++||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            445568999999999999999999999999996543 344567999999999999999999999999888 599999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++|||++++.+.  +.+++...-+|+.+|++||.|||+  .++||||||||+|||++..|++||||||.++...+.    
T Consensus       161 DgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----  232 (364)
T KOG0581|consen  161 DGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----  232 (364)
T ss_pred             CCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence            999999999654  569999999999999999999995  488999999999999999999999999999865331    


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN  714 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  714 (767)
                      ......||..|||||.+.++.|+.++||||||+.++|+++|+.|+....+. .....+..... -.+..         ..
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~~~~~Ll~~I-v~~pp---------P~  301 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YLDIFELLCAI-VDEPP---------PR  301 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CCCHHHHHHHH-hcCCC---------CC
Confidence            445678999999999999999999999999999999999999999664111 11111111111 11111         11


Q ss_pred             CCh-hhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          715 APP-VCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       715 ~~~-~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .|. .+++++..++..||++||.+||++.|+++
T Consensus       302 lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  302 LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            233 38889999999999999999999999984

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=9e-45  Score=396.77  Aligned_cols=273  Identities=26%  Similarity=0.440  Sum_probs=231.1

Q ss_pred             cccCHHHHHHHhhc---------cccceeeeccCcEEEEEEEecCCC---ceEEEEEeCCC-CCcchhHHHHHHHHHhcc
Q 042216          463 TQFSISEIKEATKD---------FNNLLIIGRGGFGNVYKGFLNGDS---TPVAIKRLNPG-SQQGALEFQTEIGMLSQL  529 (767)
Q Consensus       463 ~~~~~~ei~~~t~~---------f~~~~~LG~G~fG~Vy~g~~~~~~---~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l  529 (767)
                      ..++|++-.+|...         ..+.++||.|.||.|++|.++..+   ..||||.++.. .+....+|+.|+.||.++
T Consensus       608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF  687 (996)
T KOG0196|consen  608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF  687 (996)
T ss_pred             CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence            34566665544433         345568999999999999997544   57999999876 455667899999999999


Q ss_pred             ccceeeeEeeeeecCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeE
Q 042216          530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNIL  609 (767)
Q Consensus       530 ~Hpniv~l~g~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIL  609 (767)
                      .||||++|.|+.......++|.|||++|+|+.||+.++++ +++.++..++.+||.||.||.   +.++|||||.++|||
T Consensus       688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNIL  763 (996)
T KOG0196|consen  688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNIL  763 (996)
T ss_pred             CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhhee
Confidence            9999999999999999999999999999999999988754 999999999999999999999   788999999999999


Q ss_pred             ECCCCcEEEeecCCcccCCCCCCcc-ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccc
Q 042216          610 LDEEWVAKVSDFGLCKFGPNFSKTH-VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQ  687 (767)
Q Consensus       610 ld~~~~~ki~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~  687 (767)
                      ++.+..+|++||||+|...+..... .+...+-+++|.|||.+...++|..|||||||+||||+++ |..||..+.+.+.
T Consensus       764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV  843 (996)
T KOG0196|consen  764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV  843 (996)
T ss_pred             eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH
Confidence            9999999999999999765544222 2223345679999999999999999999999999999987 9999977655322


Q ss_pred             hhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          688 VNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       688 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      .                +.++...+-+.|++|+..|.+||+.||++|..+||++.||+..|++++..+
T Consensus       844 I----------------kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  844 I----------------KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             H----------------HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            2                223334566778999999999999999999999999999999999998655

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=364.36  Aligned_cols=203  Identities=32%  Similarity=0.467  Sum_probs=182.0

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ..+|...+.||+|+||+||+|+++..+..||||.+...  .....+.+..|+.+|+.++|||||.|++++...+.++|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            35677777899999999999999999999999999766  4444556889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCC------CcEEEeecCCcc
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEE------WVAKVSDFGLCK  625 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~------~~~ki~DfGla~  625 (767)
                      |||.+|+|.+||++..  .+++.....++.|+|.||++||   +++||||||||+||||+..      -.+||+|||+||
T Consensus        89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            9999999999997654  5999999999999999999999   8889999999999999764      568999999999


Q ss_pred             cCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 042216          626 FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGD  684 (767)
Q Consensus       626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~  684 (767)
                      ....   .......+|++-|||||++..++|+.|+|+||.|++|||+++|++||.....
T Consensus       164 ~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  164 FLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             hCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            7653   3345678999999999999999999999999999999999999999965443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-43  Score=377.39  Aligned_cols=248  Identities=23%  Similarity=0.345  Sum_probs=212.2

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ..|...++||+|||++||.++....+..||+|++.+.   .....+...+||++.+.|+|||||++++++++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688889999999999999999778899999999654   3445567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      |+|++|+|.++++  .++++++.++..++.||+.||.|||   +++|+|||||..|+||++++++||+|||||...... 
T Consensus        98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~-  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD-  171 (592)
T ss_pred             EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCc-
Confidence            9999999999996  4567999999999999999999999   888999999999999999999999999999876432 


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                       .......+||+.|+|||++.....+..+||||+||+||-|++|++||....-.+.      ... +..   .       
T Consensus       172 -~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket------y~~-Ik~---~-------  233 (592)
T KOG0575|consen  172 -GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET------YNK-IKL---N-------  233 (592)
T ss_pred             -ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH------HHH-HHh---c-------
Confidence             2345678999999999999999999999999999999999999999954432211      111 110   0       


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ....|...+.+..+||.++|+.||.+|||+++|+.
T Consensus       234 ~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  234 EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            01234456677889999999999999999999984

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-43  Score=345.81  Aligned_cols=256  Identities=27%  Similarity=0.402  Sum_probs=210.1

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeee-eecCCc-eEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGY-CNDDGQ-MILV  550 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~-~~~~~~-~~lV  550 (767)
                      .+|++++.||+|.||+|||+....++..+|.|.++-.  ..+..+.+..|+.+|++|+|||||+.+++ +.++.+ +++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            3577888999999999999999888999999988743  45566779999999999999999999983 445555 8999


Q ss_pred             EecCCCCChhhhhcc--CCCCCCChHHHHHHHHHHHHHHHHhHhCCCCC--eEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          551 YDYMARGTLRDHLYN--NDNPPLPWDRRLKICIGAARALHYLHTGASKV--IIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      ||||..|+|.+.++.  +..+.+++..+++++.|++.||..+|... +.  |+||||||.||+|+.+|.+||+||||+++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            999999999999853  44567999999999999999999999422 34  99999999999999999999999999998


Q ss_pred             CCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccc
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI  706 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  706 (767)
                      ...  ........+||+.||+||.+....|+.||||||+||++|||+.-++||.+.      ++.. ....+.++.... 
T Consensus       178 l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~-L~~KI~qgd~~~-  247 (375)
T KOG0591|consen  178 LSS--KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLS-LCKKIEQGDYPP-  247 (375)
T ss_pred             hcc--hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHH-HHHHHHcCCCCC-
Confidence            653  233445678999999999999999999999999999999999999999765      1222 223334443222 


Q ss_pred             ccccccCCCC-hhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          707 IDPFLKGNAP-PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       707 ~d~~l~~~~~-~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                              .| ...+.++.+|+..|+..||+.||+...++..+.
T Consensus       248 --------~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  248 --------LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             --------CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence                    23 456888999999999999999998555554443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-42  Score=357.20  Aligned_cols=253  Identities=25%  Similarity=0.335  Sum_probs=205.1

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc-------chhHHHHHHHHHhccccceeeeEeeeeecCCc
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ-------GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQ  546 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~-------~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~  546 (767)
                      .+.|...+.||+|+||.|-+|..+.+++.||||++++....       ......+|+++|++|+|||||++.+++...+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            34567778999999999999999999999999999754211       12235799999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCC---CcEEEeecCC
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEE---WVAKVSDFGL  623 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~---~~~ki~DfGl  623 (767)
                      .|||||||++|.|.+++-.+  +.+.+..-..++.|++.|+.|||   +++|+||||||+|||+..+   ..+||+|||+
T Consensus       251 ~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             eEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence            99999999999999999654  34778888999999999999999   8899999999999999755   8899999999


Q ss_pred             cccCCCCCCccccccccCCCcccChhhhccCCC---CchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhc
Q 042216          624 CKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL---TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRN  700 (767)
Q Consensus       624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~  700 (767)
                      |+...   ....+...+||+.|.|||++.++..   ..|.|+||+||+||-+++|.+||......  ..+.+    .+..
T Consensus       326 AK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~sl~e----QI~~  396 (475)
T KOG0615|consen  326 AKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PSLKE----QILK  396 (475)
T ss_pred             hhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--ccHHH----HHhc
Confidence            99754   3345667899999999999987543   34789999999999999999999654321  11221    1222


Q ss_pred             CCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          701 GKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       701 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      |+...      ........+++.+++|.+||..||++|||+.|++.
T Consensus       397 G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  397 GRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             Ccccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            22110      11123356788999999999999999999999984

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=372.59  Aligned_cols=266  Identities=27%  Similarity=0.473  Sum_probs=214.8

Q ss_pred             HHHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCc
Q 042216          469 EIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQ  546 (767)
Q Consensus       469 ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~  546 (767)
                      +...-.+++.....||+|.||+||+|.+.+   .||||+++..  ..+..+.|.+|+..+++-||.||+-++|||.....
T Consensus       386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             ccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            333344556667789999999999999986   4999999765  34467789999999999999999999999988766


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                       .+|+.+|++-+|..||+... ..++..+.+.|+.|+|+||.|||   .++|||||||+.||||.++++|||+||||+..
T Consensus       463 -AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             -eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceee
Confidence             99999999999999998655 46899999999999999999999   89999999999999999999999999999875


Q ss_pred             CCCCCCccccccccCCCcccChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCc
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYRL---QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKI  703 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~  703 (767)
                      ..............|...|||||+++.   .+|++.|||||||+|+|||+||..||. ....++.   .|+   +..|.+
T Consensus       538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqI---ifm---VGrG~l  610 (678)
T KOG0193|consen  538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQI---IFM---VGRGYL  610 (678)
T ss_pred             eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhhe---EEE---eccccc
Confidence            433333333445568889999999975   479999999999999999999999997 3222211   010   011100


Q ss_pred             cccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 042216          704 GDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL  754 (767)
Q Consensus       704 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~  754 (767)
                        ..|.   ......|+.+|.+|+..||..++++||.+.+|+.+|+.++..
T Consensus       611 --~pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  611 --MPDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             --Cccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence              0111   012346888999999999999999999999999999988763

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3e-41  Score=358.37  Aligned_cols=263  Identities=29%  Similarity=0.452  Sum_probs=219.6

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc-chhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ-GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      .....+.||+|-||.|.++...+ ...||||+++..... ...+|.+|+++|.+|+||||+.|+|.|..++.+++|+|||
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             heehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            45556689999999999999975 589999999987544 4578999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++|+|.+||.++....+.-...++||.|||.||+||.   +..++||||.++|||+|.++++||+|||++|-......-+
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~  694 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR  694 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence            9999999998775555667788899999999999999   7889999999999999999999999999999655545555


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL--CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ell--tg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      +....+-+++|||||.+..+++|.+||||+||++|||++  |...||....++.   ..+-....+..+..      ...
T Consensus       695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~------~~~  765 (807)
T KOG1094|consen  695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGR------QVV  765 (807)
T ss_pred             eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCc------cee
Confidence            555667789999999999999999999999999999985  6889997655432   22222222222211      112


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                      -..|+.|+.++++++++||..|..+||+++++...|+..
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            234778999999999999999999999999999888754

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=346.25  Aligned_cols=243  Identities=29%  Similarity=0.399  Sum_probs=205.2

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      .++|+.+++||+|+||+||.++.++.++.+|+|++++.   ...+.+....|..+|.+++||.||++.-.+++.+.+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            46899999999999999999999999999999999765   233455678999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      +||+.||.|..+|.++.  .+++....-.+..|+.||.|||   +.+||||||||+|||||++|.++|+||||++..-. 
T Consensus       104 ld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~-  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK-  177 (357)
T ss_pred             EeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc-
Confidence            99999999999996554  4888888889999999999999   88999999999999999999999999999986432 


Q ss_pred             CCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                       ....+...+||+.|||||++....++..+|.||+|+++|||++|.+||......      .+.... ..++        
T Consensus       178 -~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~I-~~~k--------  241 (357)
T KOG0598|consen  178 -DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDKI-LKGK--------  241 (357)
T ss_pred             -CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHHH-hcCc--------
Confidence             233455689999999999999999999999999999999999999999655432      222221 1111        


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCC
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRP  739 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RP  739 (767)
                       ....+.-...+..+++...+..||++|.
T Consensus       242 -~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 -LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence             0112223566788999999999999996

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=393.07  Aligned_cols=261  Identities=28%  Similarity=0.476  Sum_probs=217.9

Q ss_pred             ccccceeeeccCcEEEEEEEecCCC-----ceEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDS-----TPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~-----~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      +....+.||+|.||.||.|...+..     ..||||.+... +.++..+|.+|..+|++++|||||+++|+|.+....++
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            3445567999999999999986443     34999999766 55667789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCC-----CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCc
Q 042216          550 VYDYMARGTLRDHLYNND-----NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC  624 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla  624 (767)
                      ++|||++|+|..||++.+     ...|+...++.++.|||+|+.||+   +++.|||||.++|+||++...+||+|||||
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchh
Confidence            999999999999998752     346899999999999999999999   788999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCc
Q 042216          625 KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKI  703 (767)
Q Consensus       625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~  703 (767)
                      +...............-...|||||.+..+.++.|+|||||||+|||++| |..||......+...      .....+  
T Consensus       850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~~~~gg--  921 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------DVLEGG--  921 (1025)
T ss_pred             HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------HHHhCC--
Confidence            95433222222222345679999999999999999999999999999998 899996655432211      111222  


Q ss_pred             cccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          704 GDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       704 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                              +-+.|..|++.++++|.+||+.+|++||++..++++++.+.+..
T Consensus       922 --------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  922 --------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             --------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence                    23457889999999999999999999999999999999887654

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.2e-40  Score=360.53  Aligned_cols=262  Identities=25%  Similarity=0.422  Sum_probs=207.1

Q ss_pred             hhccccceeeeccCcEEEEEEEec-----CCCceEEEEEeCCCC-CcchhHHHHHHHHHhcc-ccceeeeEeeeeecC-C
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLN-----GDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDD-G  545 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~-~  545 (767)
                      .++|...+.||+|+||.||+|.+.     ..+..||||++.... ......+.+|+.++.++ +||||++++++|... +
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            357888889999999999999752     233579999987543 23345789999999999 899999999998764 4


Q ss_pred             ceEEEEecCCCCChhhhhccCC----------------------------------------------------------
Q 042216          546 QMILVYDYMARGTLRDHLYNND----------------------------------------------------------  567 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~~----------------------------------------------------------  567 (767)
                      .++++|||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            6899999999999999986421                                                          


Q ss_pred             --CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccccccCCCcc
Q 042216          568 --NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY  645 (767)
Q Consensus       568 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y  645 (767)
                        ..++++.+++.++.|+++||.|||   +++|+||||||+|||+++++.+||+|||+++...............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              135888999999999999999999   788999999999999999999999999999754322111122234467889


Q ss_pred             cChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHH
Q 042216          646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFV  724 (767)
Q Consensus       646 ~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  724 (767)
                      +|||++.+..++.++|||||||+||||++ |+.||......+  .+    ......+..         ...+..++..+.
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~----~~~~~~~~~---------~~~~~~~~~~l~  307 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EF----CQRLKDGTR---------MRAPENATPEIY  307 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HH----HHHHhcCCC---------CCCCCCCCHHHH
Confidence            99999999999999999999999999997 999996543221  11    111111111         112344567899


Q ss_pred             HHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          725 EVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       725 ~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                      +++.+||+.||.+|||+.||++.|+.+++
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.9e-41  Score=333.96  Aligned_cols=265  Identities=24%  Similarity=0.301  Sum_probs=209.2

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC-cc-hhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ-QG-ALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~-~~-~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      +.|+.+.++|+|+||.|||++.+++++.||||++..... .. .+--++||++|++|+|+|+|.|+.+|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            357777899999999999999999999999999975533 22 3346899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      ||+. ++.+-|.+.. ..++.+...+++.|++.|+.|+|   ++++|||||||+||||+.++.+||||||+|+....  .
T Consensus        82 ~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--p  154 (396)
T KOG0593|consen   82 YCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--P  154 (396)
T ss_pred             ecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcC--C
Confidence            9998 5555554433 35889999999999999999999   88899999999999999999999999999997653  3


Q ss_pred             ccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHH--------Hhh-cCC
Q 042216          633 THVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATE--------CYR-NGK  702 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~--------~~~-~~~  702 (767)
                      ....+..+.|..|.|||.+.+ .+|....||||.||++.||++|.+-|.+..+.++..++.....        .+. ...
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            344566778899999999887 6899999999999999999999999977766555544432111        111 111


Q ss_pred             cccccccccc-----CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          703 IGDIIDPFLK-----GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       703 ~~~~~d~~l~-----~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ...+.-|...     ...-+..+.-+++++..|++.||.+|++-+|++.
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1111111110     0111223456899999999999999999999984

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-41  Score=364.25  Aligned_cols=254  Identities=30%  Similarity=0.445  Sum_probs=212.1

Q ss_pred             eeeeccCcEEEEEEEecCCC---ce-EEEEEeCC---CCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          481 LIIGRGGFGNVYKGFLNGDS---TP-VAIKRLNP---GSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~~~---~~-vAVK~l~~---~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      +.||+|+||.||+|.++..+   .. ||||..+.   .......+|++|++++++++|||||+++|++..+..+++|||+
T Consensus       163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl  242 (474)
T KOG0194|consen  163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL  242 (474)
T ss_pred             ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence            58999999999999986542   23 89999875   2456677899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      |+||+|.++|++... .++..+++.+|.++|+||+|||   +++++||||.++|||++.++.+||+||||++......  
T Consensus       243 ~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~--  316 (474)
T KOG0194|consen  243 CNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV--  316 (474)
T ss_pred             cCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCccee--
Confidence            999999999977654 6999999999999999999999   8889999999999999999999999999998654211  


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      .......-+..|+|||.+..+.++.++|||||||++||+++ |..||.+....   .+..++            +-...+
T Consensus       317 ~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~kI------------~~~~~r  381 (474)
T KOG0194|consen  317 MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKAKI------------VKNGYR  381 (474)
T ss_pred             eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHHHH------------HhcCcc
Confidence            11112246789999999999999999999999999999998 88899665432   111111            111233


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      ...+...+.++..++.+||..+|++||+|.++.+.|+.+....
T Consensus       382 ~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~  424 (474)
T KOG0194|consen  382 MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK  424 (474)
T ss_pred             CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence            3445567888899999999999999999999999999887654

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-40  Score=345.37  Aligned_cols=256  Identities=25%  Similarity=0.362  Sum_probs=206.9

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCC--ceEEEEec
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG--QMILVYDY  553 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~--~~~lV~ey  553 (767)
                      ++...+.||+|+||+||++...+.+...|||..........+.+.+|+.+|.+++|||||+.+|......  .+++.|||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            4566678999999999999998878899999986553333667899999999999999999999855444  68999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC-CCcEEEeecCCcccCCC-CC
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE-EWVAKVSDFGLCKFGPN-FS  631 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~-~~~~ki~DfGla~~~~~-~~  631 (767)
                      +++|+|.+++.+... .|++..+.....|+++||.|||   +++|+||||||+|||++. ++.+||+|||+++.... ..
T Consensus        98 ~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   98 APGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             cCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            999999999987766 7999999999999999999999   899999999999999999 79999999999886442 11


Q ss_pred             CccccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                      .........||+.|||||++..+ ....++|||||||++.||+||++||....+     ...+........         
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~-----~~~~~~~ig~~~---------  239 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE-----EAEALLLIGRED---------  239 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc-----hHHHHHHHhccC---------
Confidence            12223457799999999999953 344599999999999999999999965311     111111111111         


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                      .....|...+.+..+++..|++.+|++|||++++++..-
T Consensus       240 ~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  240 SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence            112456667788999999999999999999999997643

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.7e-39  Score=396.72  Aligned_cols=266  Identities=27%  Similarity=0.450  Sum_probs=221.9

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      ...+...++||+|+||.||+|+...++..||||++......    ...|++++++++||||++++++|.+.+..++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            45677888999999999999999877899999998643322    23568899999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      |++|+|.++++     .++|.++.+|+.|+|+||+|||+.++++|+||||||+||+++.++.+++. ||.......    
T Consensus       765 ~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----  834 (968)
T PLN00113        765 IEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----  834 (968)
T ss_pred             CCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence            99999999994     38999999999999999999998778899999999999999999988876 665443211    


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                        .....++..|||||++.+..++.++|||||||++|||++|+.|+.... .....+..|+............+|+.+..
T Consensus       835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCccccC
Confidence              122357899999999999999999999999999999999999985332 22345777877766666666777777754


Q ss_pred             C--CChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 042216          714 N--APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLR  756 (767)
Q Consensus       714 ~--~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  756 (767)
                      .  .+..+..++.+++.+||+.||++||+|.||+++|+.+.+...
T Consensus       912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  956 (968)
T PLN00113        912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS  956 (968)
T ss_pred             CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence            3  345667788999999999999999999999999999876553

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-41  Score=355.07  Aligned_cols=254  Identities=28%  Similarity=0.477  Sum_probs=213.7

Q ss_pred             cccCHHHHHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeee
Q 042216          463 TQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN  542 (767)
Q Consensus       463 ~~~~~~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~  542 (767)
                      .++.+++|.       +++-||.|+.|-||+|++++  ..||||+++.-       -..+|+.|++|+|+||+.+.|+|.
T Consensus       119 WeiPFe~Is-------ELeWlGSGaQGAVF~Grl~n--etVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCt  182 (904)
T KOG4721|consen  119 WEIPFEEIS-------ELEWLGSGAQGAVFLGRLHN--ETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCT  182 (904)
T ss_pred             ccCCHHHhh-------hhhhhccCcccceeeeeccC--ceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeec
Confidence            445566553       44579999999999999986  68999987522       146799999999999999999999


Q ss_pred             cCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecC
Q 042216          543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFG  622 (767)
Q Consensus       543 ~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfG  622 (767)
                      ....+++|||||..|-|...|+..  .+++-.....+..+||.||.|||   .+.|||||||+-||||..+..+||+|||
T Consensus       183 qsPcyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFG  257 (904)
T KOG4721|consen  183 QSPCYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFG  257 (904)
T ss_pred             CCceeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEecccc
Confidence            999999999999999999999554  46888999999999999999999   7889999999999999999999999999


Q ss_pred             CcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC
Q 042216          623 LCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK  702 (767)
Q Consensus       623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~  702 (767)
                      -++....   .......+||..|||||+++..+.++|.||||||||||||+||..||...+...    +.|         
T Consensus       258 TS~e~~~---~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIw---------  321 (904)
T KOG4721|consen  258 TSKELSD---KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIW---------  321 (904)
T ss_pred             chHhhhh---hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEE---------
Confidence            9886433   223445789999999999999999999999999999999999999996554321    111         


Q ss_pred             ccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       703 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                        .+-...|.-..|..|++-+.-|+++||+..|..||++++++..|+-....+
T Consensus       322 --GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel  372 (904)
T KOG4721|consen  322 --GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL  372 (904)
T ss_pred             --eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence              112234555678899999999999999999999999999999998665443

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=354.14  Aligned_cols=260  Identities=27%  Similarity=0.425  Sum_probs=225.4

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      ..+....++||-|.||.||.|.++.-...||||.++.+ ....++|+.|..+|+.++|||+|+|+|+|..+..+|+|+||
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf  344 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF  344 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence            34556667899999999999999988889999999855 45678999999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      |..|+|.+||++..+..++--.++.++.||+.||.||.   .+.+|||||.++|+|+.++..+||+||||+++......+
T Consensus       345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT  421 (1157)
T KOG4278|consen  345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT  421 (1157)
T ss_pred             ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence            99999999999988888898999999999999999999   788999999999999999999999999999986543222


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      . .....-.+.|.|||-+....++.|+|||+|||+|||+.| |..||-+.+-.       .+..         +++...+
T Consensus       422 A-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-------qVY~---------LLEkgyR  484 (1157)
T KOG4278|consen  422 A-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYG---------LLEKGYR  484 (1157)
T ss_pred             c-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-------HHHH---------HHhcccc
Confidence            1 122345678999999999999999999999999999998 88998654321       1222         3334456


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL  754 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~  754 (767)
                      .+.|..|++++++||+.||+.+|.+||++.|+-+.+|.+++.
T Consensus       485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence            677899999999999999999999999999999999998753

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=337.71  Aligned_cols=263  Identities=24%  Similarity=0.295  Sum_probs=213.7

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      .++|+..++||.|..+.||+|.....+..||||++... .....+++.+|+..++.++||||++.+..+..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            45788888999999999999999888899999999754 34446889999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC-
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS-  631 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~-  631 (767)
                      ||.+||+.+.++..-...+++..+..|.+++++||.|||   .++.||||||+.||||+.+|.+||+|||.+....... 
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            999999999998766667999999999999999999999   7889999999999999999999999999865432211 


Q ss_pred             Ccccc-ccccCCCcccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          632 KTHVS-TQVKGSIGYLDPEYYRL--QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       632 ~~~~~-~~~~gt~~y~aPE~~~~--~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      ..... ....||++|||||++..  ..|+.|+||||||++..||.+|+.||......+...+      . .++......-
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~------t-Lqn~pp~~~t  254 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL------T-LQNDPPTLLT  254 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH------H-hcCCCCCccc
Confidence            11122 45689999999999654  4799999999999999999999999977665432211      1 1122221111


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ..+..+........+.+++..||+.||.+|||++++++
T Consensus       255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            12222223345568999999999999999999999984

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-40  Score=352.87  Aligned_cols=249  Identities=25%  Similarity=0.393  Sum_probs=211.7

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCC
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMA  555 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~  555 (767)
                      .|.....||+|+.|.||.+.....++.||||++....+...+-+.+|+.+|+..+|+|||.++..+..++++|+|||||+
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~  353 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME  353 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence            56666789999999999999988889999999987766666678999999999999999999999988899999999999


Q ss_pred             CCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccc
Q 042216          556 RGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHV  635 (767)
Q Consensus       556 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~  635 (767)
                      +|+|.+.+...   .+++.++..||.++++||+|||   .++|+|||||.+|||++.++.+||+|||+|..+....  ..
T Consensus       354 ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~--~K  425 (550)
T KOG0578|consen  354 GGSLTDVVTKT---RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ--SK  425 (550)
T ss_pred             CCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccccc--Cc
Confidence            99999998543   4899999999999999999999   8999999999999999999999999999998654422  23


Q ss_pred             cccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCC
Q 042216          636 STQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNA  715 (767)
Q Consensus       636 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  715 (767)
                      ....+||+.|||||++....|.+|.||||||++++||+-|++||.......-..++      ...|.        ..-..
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI------a~ng~--------P~lk~  491 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGT--------PKLKN  491 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH------hhcCC--------CCcCC
Confidence            45678999999999999999999999999999999999999999653322111111      11111        11223


Q ss_pred             ChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          716 PPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       716 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      +...+..+.+++.+||+.|+++||++.|+|+
T Consensus       492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  492 PEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             ccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            4566788999999999999999999999995

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-40  Score=345.19  Aligned_cols=266  Identities=21%  Similarity=0.268  Sum_probs=211.6

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecC--CceEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD--GQMILV  550 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~~lV  550 (767)
                      +.|+.+++||+|.||.||+++...+++.||+|++....  .....-..+||.+|++|.||||++|.+...+.  +.+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            45777778999999999999999999999999997654  33344568999999999999999999998766  789999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      +|||++ +|.-++... .-.+++.++..++.|++.||+|+|   +++|+|||||.+|||||.+|.+||+|||||++....
T Consensus       197 FeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             Eecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            999998 888888543 335899999999999999999999   899999999999999999999999999999976543


Q ss_pred             CCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc--ccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG--DII  707 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~--~~~  707 (767)
                       .....+..+-|..|.|||++.+ ..|+...|+||.||||.||++|++.|.+..+.++...+.-......+....  ++.
T Consensus       272 -~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP  350 (560)
T KOG0600|consen  272 -GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP  350 (560)
T ss_pred             -CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence             2333566778999999999876 489999999999999999999999998888777665543322211111111  111


Q ss_pred             cccc-cC--CC-------ChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          708 DPFL-KG--NA-------PPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       708 d~~l-~~--~~-------~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .... +.  .+       -...+...++|+..+|..||.+|.|+.+++.
T Consensus       351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1000 00  01       1123456789999999999999999999874

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=6.6e-39  Score=340.01  Aligned_cols=252  Identities=21%  Similarity=0.316  Sum_probs=203.6

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcc---hhHHHHHHHHHhccccceeeeEeeeeec----CCceE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQG---ALEFQTEIGMLSQLRYLHLVSLIGYCND----DGQMI  548 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~---~~~f~~Ei~~l~~l~Hpniv~l~g~~~~----~~~~~  548 (767)
                      +......||+|++|.||+|.+.  ++.||||+++......   .+.|.+|+.+|.+++||||++++|++.+    ....+
T Consensus        21 ~~~~~~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~   98 (283)
T PHA02988         21 DKYTSVLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLS   98 (283)
T ss_pred             CCCCCeEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceE
Confidence            3444468999999999999985  4789999997653333   4568899999999999999999999876    35789


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      +||||+++|+|.+++.+.  ..++|...+.++.+++.||.|||+  ..+++||||||+|||+++++.+||+|||+++...
T Consensus        99 lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988         99 LILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             EEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            999999999999999654  468999999999999999999994  2468899999999999999999999999987543


Q ss_pred             CCCCccccccccCCCcccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccc
Q 042216          629 NFSKTHVSTQVKGSIGYLDPEYYRL--QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI  706 (767)
Q Consensus       629 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  706 (767)
                      ..     .....++..|+|||++.+  ..++.++|||||||++|||++|+.||......+   +..   .....+     
T Consensus       175 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~---~i~~~~-----  238 (283)
T PHA02988        175 SP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYD---LIINKN-----  238 (283)
T ss_pred             cc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHH---HHHhcC-----
Confidence            21     123457889999999976  689999999999999999999999996543221   111   111111     


Q ss_pred             ccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          707 IDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       707 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                          .+...+..++..+.+++.+||+.||.+|||++||++.|+.+.+
T Consensus       239 ----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        239 ----NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             ----CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence                1112334567889999999999999999999999999987754

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.4e-40  Score=347.73  Aligned_cols=247  Identities=28%  Similarity=0.449  Sum_probs=212.2

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ++|...+.||+|+||+||||+.+.+.+.||+|.+.+.  .+++.+.+.+|++++++|+||||+.++++++...++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            4677778899999999999999999999999998654  34456679999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+.+ +|+.+|..  ...|+++++..|+.+++.||.|||   +++|+|||+||+|||++.++.+|+||||+|+....  .
T Consensus        82 ~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--N  153 (808)
T ss_pred             hhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc--C
Confidence            9987 99999954  446999999999999999999999   88999999999999999999999999999996543  4


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      ..+.+.++||+-|||||.+.++.|+..+|+||+||+|||+++|++||....      +...+.....+        +   
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d--------~---  216 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKD--------P---  216 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcC--------C---
Confidence            556678899999999999999999999999999999999999999995431      11111221111        1   


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      -..|...+..+..++...+.+||.+|.+..+++.
T Consensus       217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            1134567788999999999999999999999983

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.2e-39  Score=339.18  Aligned_cols=251  Identities=35%  Similarity=0.574  Sum_probs=199.8

Q ss_pred             cceeeeccCcEEEEEEEec----CCCceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          479 NLLIIGRGGFGNVYKGFLN----GDSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       479 ~~~~LG~G~fG~Vy~g~~~----~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      ..+.||.|.||.||+|.+.    ..+..|+||.++.... ...++|.+|++.+++++||||++++|+|...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3468999999999999998    3347899999976433 3467899999999999999999999999988889999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++|+|.++|.......+++.+++.|+.|+++||.|||   +.+++|+||+++|||+++++.+||+|||+++........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence            99999999998875667999999999999999999999   678999999999999999999999999999865322222


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      ...........|+|||.+....++.++||||||+++|||++ |+.|+......   .+..   .. .++.         +
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~---~~~~---~~-~~~~---------~  223 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE---EIIE---KL-KQGQ---------R  223 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH---HHHH---HH-HTTE---------E
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccc---cc-cccc---------c
Confidence            33334557789999999999999999999999999999999 78888554221   1111   11 2211         1


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGL  748 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L  748 (767)
                      ...+..++..+.+++.+||+.+|++||++.++++.|
T Consensus       224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            223445678899999999999999999999999887

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.2e-39  Score=356.14  Aligned_cols=259  Identities=25%  Similarity=0.412  Sum_probs=205.5

Q ss_pred             hccccceeeeccCcEEEEEEEe-----cCCCceEEEEEeCCCC-CcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCce
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFL-----NGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQM  547 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~-----~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~  547 (767)
                      ++|+..+.||+|+||.||+|+.     .+.+..||||+++... ....+.+.+|+.+|..+ +||||++++++|.+.+..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4677788999999999999974     2345689999997543 33445688999999999 899999999999999999


Q ss_pred             EEEEecCCCCChhhhhccCC------------------------------------------------------------
Q 042216          548 ILVYDYMARGTLRDHLYNND------------------------------------------------------------  567 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~------------------------------------------------------------  567 (767)
                      ++||||+++|+|.++++...                                                            
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            99999999999999985421                                                            


Q ss_pred             -------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          568 -------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       568 -------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                                   ...++|..+++++.|++.||.|||   +++|+||||||+|||+++++.+||+|||+++.........
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                         125789999999999999999999   7889999999999999999999999999997543322211


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......  ....+    ...+         .+.
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~----~~~~---------~~~  336 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKM----IKEG---------YRM  336 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHH----HHhC---------ccC
Confidence            2223345678999999999999999999999999999998 888886543221  11111    1111         111


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                      ..+...+.++.+++.+||+.||++||++.||+++|++.
T Consensus       337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            12233456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-39  Score=342.32  Aligned_cols=253  Identities=25%  Similarity=0.317  Sum_probs=211.9

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceE
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMI  548 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~  548 (767)
                      ..++|...+.||+|+|++|++|+.+..++.+|||++.+.   .+...+-...|-+.|.+| .||.|++|+..+.++..+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            345788888999999999999999999999999998654   223334467788889999 8999999999999999999


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      +|+||+++|+|.++|++-  ..+++.....++.+|+.||+|||   +++||||||||+|||||++|++||+|||-|+...
T Consensus       151 FvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             EEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            999999999999999665  45899999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCCc---------ccc--ccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHH
Q 042216          629 NFSKT---------HVS--TQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATEC  697 (767)
Q Consensus       629 ~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~  697 (767)
                      .....         ...  ...+||..|.+||++..+..++.+|+|+|||+||+|+.|++||.+..+-    ++-   + 
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney----liF---q-  297 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY----LIF---Q-  297 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH----HHH---H-
Confidence            33221         111  3478999999999999999999999999999999999999999765442    110   0 


Q ss_pred             hhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          698 YRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       698 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                             ++++  +.-.+++..++.+.+|+.+.|..||.+|+|.++|-+.
T Consensus       298 -------kI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  298 -------KIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             -------HHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                   0110  2334566777889999999999999999999888754

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.3e-38  Score=341.30  Aligned_cols=263  Identities=27%  Similarity=0.414  Sum_probs=205.7

Q ss_pred             hccccceeeeccCcEEEEEEEecC----------------CCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNG----------------DSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSL  537 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~----------------~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l  537 (767)
                      ++|...+.||+|+||.||++.+.+                .+..||+|.+.... .....+|.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            467778899999999999998643                23479999987653 2334579999999999999999999


Q ss_pred             eeeeecCCceEEEEecCCCCChhhhhccCC-----------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEe
Q 042216          538 IGYCNDDGQMILVYDYMARGTLRDHLYNND-----------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIH  600 (767)
Q Consensus       538 ~g~~~~~~~~~lV~ey~~~gsL~~~L~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH  600 (767)
                      ++++.+.+..++||||+++|+|.+++....                 ...++|.++++++.|++.||.|||   +.+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence            999999999999999999999999885421                 134788999999999999999999   778999


Q ss_pred             cCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh--CCCC
Q 042216          601 RDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC--ARPP  678 (767)
Q Consensus       601 ~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt--g~~P  678 (767)
                      |||||+|||+++++.+||+|||+++...............++..|+|||++..+.++.++|||||||++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999875433222222233456789999999998899999999999999999986  5667


Q ss_pred             CCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          679 ILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       679 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                      |......   .....+.........      ......++.++..+.+++.+||+.||.+|||+.+|.+.|+
T Consensus       242 ~~~~~~~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTDE---QVIENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCHH---HHHHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            7544322   222222222211110      0111224456778999999999999999999999998886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.9e-39  Score=354.44  Aligned_cols=260  Identities=26%  Similarity=0.409  Sum_probs=206.0

Q ss_pred             hccccceeeeccCcEEEEEEEecC-----CCceEEEEEeCCCC-CcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCce
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGS-QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQM  547 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~  547 (767)
                      ++|+..+.||+|+||.||+|+...     ....||||+++... ......+.+|+++++.+ +|+||++++++|...+..
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            468888899999999999998532     23579999997543 23345688999999999 899999999999999999


Q ss_pred             EEEEecCCCCChhhhhccCC------------------------------------------------------------
Q 042216          548 ILVYDYMARGTLRDHLYNND------------------------------------------------------------  567 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~------------------------------------------------------------  567 (767)
                      ++||||+++|+|.++++...                                                            
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            99999999999999885421                                                            


Q ss_pred             --------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccccc
Q 042216          568 --------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV  639 (767)
Q Consensus       568 --------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~  639 (767)
                              ..++++.++++++.|++.||.|||   +++|+||||||+|||+++++.+||+|||+++..............
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                    124788999999999999999999   788999999999999999999999999998754332211122233


Q ss_pred             cCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChh
Q 042216          640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV  718 (767)
Q Consensus       640 ~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  718 (767)
                      .++..|||||++....++.++|||||||++|||++ |+.||.......  ....    ....+         .....+..
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~----~~~~~---------~~~~~~~~  339 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYK----MVKRG---------YQMSRPDF  339 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHH----HHHcc---------cCccCCCC
Confidence            45678999999998899999999999999999997 999996543221  1111    11111         11112223


Q ss_pred             hHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 042216          719 CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF  752 (767)
Q Consensus       719 ~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~  752 (767)
                      .+.++.+++.+||+.||.+||++.+|+++|++++
T Consensus       340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            4577899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.9e-38  Score=333.24  Aligned_cols=256  Identities=25%  Similarity=0.405  Sum_probs=207.0

Q ss_pred             hccccceeeeccCcEEEEEEEec---CCCceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLN---GDSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~---~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      ++|+..++||+|+||.||+|+++   ..+..||+|.++.... .....|.+|+.++.+++||||+++++++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            56788889999999999999875   3346899999876532 3345689999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.+|++|||.+......
T Consensus        85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999997543 36899999999999999999999   788999999999999999999999999987643211


Q ss_pred             CCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                       .........++..|+|||.+.+..++.++|||||||++||+++ |+.||......+   ....    ...+        
T Consensus       161 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~----~~~~--------  224 (266)
T cd05064         161 -AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKA----VEDG--------  224 (266)
T ss_pred             -chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHH----HHCC--------
Confidence             1111112335678999999999999999999999999999875 999996543321   1111    1111        


Q ss_pred             cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       710 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                       .....+..++..+.+++.+||+.+|.+||++.+|++.|+++
T Consensus       225 -~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 -FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence             11123455677899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.1e-38  Score=338.03  Aligned_cols=257  Identities=30%  Similarity=0.485  Sum_probs=209.6

Q ss_pred             hccccceeeeccCcEEEEEEEecCCC-----ceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecCCceE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDS-----TPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMI  548 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~-----~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~  548 (767)
                      ++|+..+.||+|+||.||+|.....+     ..||+|.+..... ....+|.+|++++.+++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            46778889999999999999876544     5799999875432 33456899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhccCCC--------------CCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC
Q 042216          549 LVYDYMARGTLRDHLYNNDN--------------PPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW  614 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~  614 (767)
                      ++|||+++|+|.+++.....              ..+++.+++.++.|++.||.|||   ..+++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            99999999999999965321              45889999999999999999999   78899999999999999999


Q ss_pred             cEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHH
Q 042216          615 VAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVW  693 (767)
Q Consensus       615 ~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~  693 (767)
                      .+||+|||+++...............++..|+|||.+....++.++|||||||++|||++ |..||......+   +.. 
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~-  237 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIE-  237 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH-
Confidence            999999999875433222222334456788999999998899999999999999999998 999986543321   111 


Q ss_pred             HHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042216          694 ATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF  750 (767)
Q Consensus       694 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~  750 (767)
                         .+..+.         ....+..++.++.+++.+||+.||.+||+++||++.|++
T Consensus       238 ---~i~~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         238 ---MIRSRQ---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ---HHHcCC---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence               111211         112345677889999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.1e-38  Score=311.03  Aligned_cols=265  Identities=22%  Similarity=0.300  Sum_probs=210.9

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcc--hhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQG--ALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~--~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      +|..++.||+|.||.||+|+...+++.||||+++.....+  .....+||+.|+.++|+||+.|++++-..+.+.||+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            5667778999999999999999999999999997653322  34578999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      |+. +|...++.+. ..|+-.++..++.++.+|++|||   .+.|+||||||.|+|++.+|.+||+|||+++....... 
T Consensus        83 m~t-dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~-  156 (318)
T KOG0659|consen   83 MPT-DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR-  156 (318)
T ss_pred             ccc-cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc-
Confidence            987 9998887554 46899999999999999999999   78899999999999999999999999999998654332 


Q ss_pred             cccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc---ccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG---DIIDP  709 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~---~~~d~  709 (767)
                       ..+..+-|..|.|||.+.+ +.|+...||||.||++.||+.|.+-|.+..+-++...+-.+..........   .+.|-
T Consensus       157 -~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  157 -IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             -ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence             2334467889999998875 579999999999999999999988887666554443332221111111111   11111


Q ss_pred             c--------ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          710 F--------LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       710 ~--------l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      .        .....-+.+..+.++++..++..||.+|+|++|++++
T Consensus       236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            0        0111234466778999999999999999999999865

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.4e-38  Score=336.16  Aligned_cols=251  Identities=22%  Similarity=0.324  Sum_probs=205.0

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      |+..+.||+|+||.||++....+++.||+|.+....   ......+.+|++++.+++|+|++++++++.+.+..++|+||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            667789999999999999998888999999986432   22334578999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++|+|.+++.......+++.++..++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||++......   
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~---  155 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---  155 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC---
Confidence            99999998886555556899999999999999999999   788999999999999999999999999998764321   


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      .......|+..|+|||++.+..++.++|||||||++|||++|+.||..........  . ........          ..
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~--~-~~~~~~~~----------~~  222 (285)
T cd05631         156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE--E-VDRRVKED----------QE  222 (285)
T ss_pred             CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH--H-HHHHhhcc----------cc
Confidence            11234568999999999999999999999999999999999999997544321111  0 11111110          11


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPS-----MSDVVW  746 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~  746 (767)
                      ..+...+.++.+|+.+||+.||.+||+     ++++++
T Consensus       223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            223345678899999999999999997     788885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=330.06  Aligned_cols=269  Identities=25%  Similarity=0.354  Sum_probs=203.1

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHh--ccccceeeeEeeeeecCC----ceEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLS--QLRYLHLVSLIGYCNDDG----QMIL  549 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~--~l~Hpniv~l~g~~~~~~----~~~l  549 (767)
                      ..+..++||+|+||.||||++.+  +.||||++.   .++.+.|++|-++.+  .++|+||++++++-+...    +++|
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~~--~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLDN--RLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             chhhHHHhhcCccceeehhhccC--ceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            34445579999999999999976  799999996   455667888877766  468999999999987665    8999


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhC------CCCCeEecCCCCCCeEECCCCcEEEeecCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG------ASKVIIHRDVKTTNILLDEEWVAKVSDFGL  623 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~iiH~Dlk~~NILld~~~~~ki~DfGl  623 (767)
                      |+||.+.|||.+||..+   .++|....+|+..+++||+|||++      .+++|+|||||++||||..|+++.|+||||
T Consensus       286 Vt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             EeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            99999999999999765   489999999999999999999974      356799999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCcccChhhhccCC-CC-----chhhHHHHHHHHHHHHhCCCCCCC--CCC---------cc
Q 042216          624 CKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL-LT-----EKSDVYSFGVVLLEVLCARPPILR--TGD---------KK  686 (767)
Q Consensus       624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~ksDV~SfGvvl~elltg~~P~~~--~~~---------~~  686 (767)
                      |...............+||.+|||||++.+.. +.     .+.||||+|.|||||++...-+..  ..+         +.
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            98765433333334478999999999997642 22     468999999999999986544321  110         00


Q ss_pred             chhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 042216          687 QVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLR  756 (767)
Q Consensus       687 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  756 (767)
                      .-.+.+.-.-.+++..-..+.|.....    ..+..+++.+..||+.||+.|.|+.=|-+++.++....+
T Consensus       443 hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  443 HPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             CCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence            111222111112222222222221111    345678999999999999999999999999988876664

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.7e-38  Score=329.60  Aligned_cols=256  Identities=26%  Similarity=0.405  Sum_probs=210.8

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      .+|...+.||+|+||.||+|..++.++.||+|.+... .....++.+|++++++++|+||++++++|..++..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            4577788999999999999999887889999998744 334567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++++|.+++.......+++..++.++.|+++||+|||   +.+++||||||+|||+++++.+||+|||+++....... .
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~  160 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-T  160 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-e
Confidence            9999999997665567899999999999999999999   78899999999999999999999999999876432211 1


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      ......++..|+|||.+.+..++.++|||||||++|||++ |..|+......+   +.    .....         ....
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~----~~~~~---------~~~~  224 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VY----ELLEK---------GYRM  224 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHC---------CCCC
Confidence            1112234568999999999999999999999999999998 899985432211   11    11111         1122


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                      ..+..++.++.+++.+||+.+|++||++.+++++|+.+
T Consensus       225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            33445677899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=313.47  Aligned_cols=237  Identities=26%  Similarity=0.335  Sum_probs=203.2

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC---cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ---QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      .+|+.+..||.|+||+|.+++.+.++.-+|+|++.....   ...+...+|..+|+.+.||.++++.+.|.+.+.++|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            468888899999999999999999899999999976532   23344678999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|.|..+|++..  ++++....-++.+|+.||+|||   +..|++|||||+|||||.+|.+||+|||+|+....  
T Consensus       124 eyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--  196 (355)
T ss_pred             eccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence            9999999999997654  5899999999999999999999   88899999999999999999999999999986432  


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                         .+-..+||+.|+|||.+..+.+...+|.|||||++|||+.|.+||......       -..+.+.+++         
T Consensus       197 ---rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-------~iY~KI~~~~---------  257 (355)
T KOG0616|consen  197 ---RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-------QIYEKILEGK---------  257 (355)
T ss_pred             ---cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-------HHHHHHHhCc---------
Confidence               355689999999999999999999999999999999999999999765441       1112222221         


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCC
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRR  738 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~R  738 (767)
                       -..|.-...++.+|+...++.|-.+|
T Consensus       258 -v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  258 -VKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             -ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence             12456667788899999999999988

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-39  Score=338.76  Aligned_cols=265  Identities=20%  Similarity=0.257  Sum_probs=210.5

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhH--HHHHHHHHhccc-cceeeeEeeeeecCC-ceE
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE--FQTEIGMLSQLR-YLHLVSLIGYCNDDG-QMI  548 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~--f~~Ei~~l~~l~-Hpniv~l~g~~~~~~-~~~  548 (767)
                      ..++|...+.||.|.||.||+|+....+..||||+++..... .++  -.+|++.|++|. ||||++|...+.+.+ .++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            345677888999999999999999988899999999765332 223  478999999998 999999999998888 999


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      +|||||+. +|.++++.. +..+++..+..|+.||++||+|+|   .+|+.|||+||+|||+..+..+||+||||||...
T Consensus        87 fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccc
Confidence            99999987 999999776 678999999999999999999999   8899999999999999988999999999999653


Q ss_pred             CCCCccccccccCCCcccChhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC-----
Q 042216          629 NFSKTHVSTQVKGSIGYLDPEYY-RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK-----  702 (767)
Q Consensus       629 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~-----  702 (767)
                      .   ....+..+.|..|.|||++ +.+-|+.+.|+||+|||++|+.+-++-|-+..+.++..-+--+.....+..     
T Consensus       162 S---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  162 S---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             c---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            2   2334566788899999986 567899999999999999999999999977665443322111110000000     


Q ss_pred             ---------ccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          703 ---------IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       703 ---------~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                               .....-..+.. .-+.++.++.+++.+|+..||.+|||++|.++.
T Consensus       239 ~La~~mnf~~P~~~~~~l~~-L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKD-LLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHhccCCCcCCCCChHH-hCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                     00000001111 112377889999999999999999999999865

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.8e-38  Score=338.28  Aligned_cols=260  Identities=24%  Similarity=0.427  Sum_probs=208.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCc----eEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDST----PVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~----~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      .+|+..+.||+|+||.||+|++..++.    .||+|.++... ....+++.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            468889999999999999998754443    48999987543 34456789999999999999999999999765 5789


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ++||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++....
T Consensus        86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            999999999999997543 35889999999999999999999   78899999999999999999999999999986543


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      ...........++..|+|||++....++.++|||||||++|||++ |+.||......+   +..    ....+       
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~----~~~~~-------  227 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKG-------  227 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHhCC-------
Confidence            222222222335678999999999999999999999999999997 999986433211   111    11111       


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                        .....+..+..++.+++.+||+.+|.+||++.+++..|..+....
T Consensus       228 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         228 --ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence              111223446678899999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-39  Score=340.86  Aligned_cols=258  Identities=27%  Similarity=0.447  Sum_probs=219.7

Q ss_pred             ccccceeeeccCcEEEEEEEecC----CCceEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNG----DSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~----~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      .....++||+|-||.||+|....    ....||||.-+.+ .....+.|+.|..++++++||||++|+|.|.+. ..|+|
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv  468 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV  468 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence            34445579999999999998743    3346999988765 344567799999999999999999999999765 78999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      ||.++.|.|.+||..+. ..|+......+|.|++.+|.|||   +...|||||..+|||+...-.+||+||||+|.....
T Consensus       469 mEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             EecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            99999999999997664 35899999999999999999999   888999999999999999999999999999987654


Q ss_pred             CCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                      ..-.. +...-++.|||||.+...+++.+||||.|||++||++. |..||.+....+                +...++.
T Consensus       545 ~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------VI~~iEn  607 (974)
T KOG4257|consen  545 AYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------VIGHIEN  607 (974)
T ss_pred             chhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------eEEEecC
Confidence            44333 35567789999999999999999999999999999986 999997765432                2223334


Q ss_pred             cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       710 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      .-+-+.|+.|+..|+.|+.+||..+|.+||.+.++...|+.++++-
T Consensus       608 GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee  653 (974)
T KOG4257|consen  608 GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE  653 (974)
T ss_pred             CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence            4456789999999999999999999999999999999999998844

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-38  Score=339.91  Aligned_cols=249  Identities=27%  Similarity=0.360  Sum_probs=207.9

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC----CC-cchhHHHHHHHHHhccc-cceeeeEeeeeecCCc
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG----SQ-QGALEFQTEIGMLSQLR-YLHLVSLIGYCNDDGQ  546 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~----~~-~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~  546 (767)
                      ....|...+.||+|+||+|++|.+...+..||+|.+...    .. ...+.+.+|+.+++.++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            456788888999999999999999888899999977553    11 22345678999999998 9999999999999999


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCC-CcEEEeecCCcc
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEE-WVAKVSDFGLCK  625 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~-~~~ki~DfGla~  625 (767)
                      .++||||+.+|+|.+++.+  ..++.+.....++.|++.|++|||   +++|+||||||+|||+|.+ +++||+|||++.
T Consensus        95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            9999999999999999976  456899999999999999999999   8899999999999999999 999999999998


Q ss_pred             cCCCCCCccccccccCCCcccChhhhccCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCc
Q 042216          626 FGPNFSKTHVSTQVKGSIGYLDPEYYRLQL-LT-EKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKI  703 (767)
Q Consensus       626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~  703 (767)
                      ...  .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||.....   ..+..    .+..+. 
T Consensus       170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~---~~l~~----ki~~~~-  239 (370)
T KOG0583|consen  170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV---PNLYR----KIRKGE-  239 (370)
T ss_pred             ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH---HHHHH----HHhcCC-
Confidence            753  2233456778999999999999877 76 789999999999999999999965221   11111    111111 


Q ss_pred             cccccccccCCCChhh-HHHHHHHHHHccccCCCCCCCHHHHH
Q 042216          704 GDIIDPFLKGNAPPVC-LNQFVEVAMSCVNDDRIRRPSMSDVV  745 (767)
Q Consensus       704 ~~~~d~~l~~~~~~~~-~~~l~~li~~Cl~~dp~~RPs~~evl  745 (767)
                               -.+|... +.++..++.+|+..||.+|+++.+|+
T Consensus       240 ---------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  240 ---------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             ---------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence                     1234444 78899999999999999999999998

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.7e-38  Score=328.84  Aligned_cols=257  Identities=27%  Similarity=0.437  Sum_probs=214.5

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ...+|...+.||+|+||.||+|...+ +..+++|.+.........++.+|+.+++.++|+||+++++++...+..++|||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            45678888899999999999999987 68899999987665566789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+++|+|.+++.......+++.++..++.|++.||.|||   +++++|+||||+|||+++++.+||+|||++....... 
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~-  158 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-  158 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc-
Confidence            999999999998766667999999999999999999999   7789999999999999999999999999987543211 


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                       .......++..|+|||.+....++.++||||||++++||++ |+.||......+   ......    .         ..
T Consensus       159 -~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~~~----~---------~~  221 (261)
T cd05148         159 -YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQIT----A---------GY  221 (261)
T ss_pred             -ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHH----h---------CC
Confidence             11223346778999999998899999999999999999998 899985543221   111111    1         11


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                      +...+..++..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            1223455677899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-37  Score=326.49  Aligned_cols=258  Identities=29%  Similarity=0.466  Sum_probs=209.4

Q ss_pred             hhccccceeeeccCcEEEEEEEecCC---CceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGD---STPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      .++|...+.||+|+||.||+|.+...   ...||||.+.... .....+|.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            35688889999999999999998643   3579999987543 3334578999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      +|||+++|+|.+++.... ..+++.+++.++.|++.||.|||   +.+|+|+||||+|||+++++.+||+|||+++....
T Consensus        83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          83 ITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            999999999999996644 36899999999999999999999   78899999999999999999999999999986542


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      ...........++..|+|||.+.+..++.++||||||+++|||++ |..||......   .+....    ..+.      
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~----~~~~------  225 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAV----EDGY------  225 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHH----HcCC------
Confidence            222222223345678999999998999999999999999999998 99998544322   111111    1111      


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                         ....+..++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       226 ---~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         226 ---RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               1112334567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=7.4e-38  Score=346.79  Aligned_cols=262  Identities=25%  Similarity=0.382  Sum_probs=207.7

Q ss_pred             hhccccceeeeccCcEEEEEEEecCC-----CceEEEEEeCCCCC-cchhHHHHHHHHHhccc-cceeeeEeeeeecCCc
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGD-----STPVAIKRLNPGSQ-QGALEFQTEIGMLSQLR-YLHLVSLIGYCNDDGQ  546 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~-----~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~  546 (767)
                      .++|...++||+|+||.||+|+....     ...||||++..... ...+.+.+|+++|+++. ||||++++++|.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            45677888999999999999986432     24699999975433 33457899999999996 9999999999999999


Q ss_pred             eEEEEecCCCCChhhhhccCC-----------------------------------------------------------
Q 042216          547 MILVYDYMARGTLRDHLYNND-----------------------------------------------------------  567 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~-----------------------------------------------------------  567 (767)
                      .+||||||++|+|.++|++..                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999999885421                                                           


Q ss_pred             -----------------------------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC
Q 042216          568 -----------------------------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE  612 (767)
Q Consensus       568 -----------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~  612 (767)
                                                         ...+++.+++.++.|+++||.|||   ..+|+||||||+|||+++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence                                               124788999999999999999999   788999999999999999


Q ss_pred             CCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHH
Q 042216          613 EWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLA  691 (767)
Q Consensus       613 ~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~  691 (767)
                      ++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........  + 
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~-  349 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--F-  349 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--H-
Confidence            99999999999875432222112223346788999999998899999999999999999997 9999854322111  1 


Q ss_pred             HHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          692 VWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       692 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                         ......+         .+...+..++.++.+++.+||+.+|++||++.+|+++|+.+++
T Consensus       350 ---~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         350 ---YNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             ---HHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence               1111111         1112234566789999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-39  Score=334.05  Aligned_cols=248  Identities=27%  Similarity=0.380  Sum_probs=209.0

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      .|...+.||+|.||.||||.....++.||+|++... ...+..++++|+.+|.+++++||.+.+|.+..+..++++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            466667899999999999999999999999999754 4455677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      .+|++.+.|..  ...+++..+.-|+.++..||.|||   ..+.+|||||+.|||+.++|.+|++|||.+-.......  
T Consensus        94 ~gGsv~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--  166 (467)
T KOG0201|consen   94 GGGSVLDLLKS--GNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--  166 (467)
T ss_pred             cCcchhhhhcc--CCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence            99999999954  344688888999999999999999   78899999999999999999999999999876543222  


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN  714 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  714 (767)
                      .....+||+-|||||+++...|+.|+||||||++.+||++|.+|+..........++            .+-.-|.+.  
T Consensus       167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI------------pk~~PP~L~--  232 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI------------PKSAPPRLD--  232 (467)
T ss_pred             ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec------------cCCCCCccc--
Confidence            235678999999999999889999999999999999999999999765543222111            111112222  


Q ss_pred             CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       715 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                        ..++..+.+++..||+.||+.||++.++++
T Consensus       233 --~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  233 --GDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             --cccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence              256777999999999999999999999984

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.5e-37  Score=325.07  Aligned_cols=256  Identities=25%  Similarity=0.447  Sum_probs=208.8

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .++|+..+.||+|+||.||+|...+ ++.||+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            3568888999999999999999764 4679999886533 3456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++|+|.+++++.....+++.+++.++.|++.||+|||   ..+++||||||+||+++.++.+||+|||+++....... 
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  158 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-  158 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence            99999999997765667899999999999999999999   67899999999999999999999999999986433211 


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      .......++..|+|||++....++.++|||||||++|||++ |+.||.......   .....    ..+.         .
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~----~~~~---------~  222 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSAL----QRGY---------R  222 (261)
T ss_pred             eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHH----HcCC---------C
Confidence            11223346678999999998899999999999999999998 999986543221   11111    1111         1


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                      ......++.++.+++.+||+.+|++||+++++++.|+++
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         223 MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            112233566789999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=355.52  Aligned_cols=258  Identities=26%  Similarity=0.391  Sum_probs=223.3

Q ss_pred             cccceeeeccCcEEEEEEEecCC----CceEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGD----STPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~----~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      +...++||+|+||+||+|.+--.    +.+||||++... +.+..+++++|+.+|.+|+|||+++|+|+|.... +.||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            34456899999999999987433    358999998654 5566789999999999999999999999998765 88999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      +||+.|+|.+|++.++ ..+.-+..+.|+.|||+||.|||   .+.++||||.++|||+..-..+||+|||+++....+.
T Consensus       777 q~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            9999999999998754 46888999999999999999999   7889999999999999999999999999999887776


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                      ........+-.+.|||-|.+....++.+||||||||++||++| |..|+.+....+..++.                ...
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll----------------e~g  916 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL----------------EKG  916 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH----------------hcc
Confidence            6666666667889999999999999999999999999999998 99999877655443333                223


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      .+-..|+.|..++..++.+||..|+..||+++++...+.++...+
T Consensus       917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence            334568899999999999999999999999999999998877655

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.9e-37  Score=330.21  Aligned_cols=261  Identities=26%  Similarity=0.472  Sum_probs=211.4

Q ss_pred             hccccceeeeccCcEEEEEEEecC-----CCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      .+|...+.||+|+||.||+|+..+     ....+++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            357777899999999999998532     335689999876655556779999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCC--------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCc
Q 042216          550 VYDYMARGTLRDHLYNND--------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV  615 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~  615 (767)
                      ||||+++++|.+++....              ...++|.+++.++.|++.||.|||   +++|+||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            999999999999996432              234899999999999999999999   788999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHH
Q 042216          616 AKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWA  694 (767)
Q Consensus       616 ~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~  694 (767)
                      +||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||......+   ..   
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~---  235 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VI---  235 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---
Confidence            99999999875433222222233456788999999999999999999999999999998 999986544321   11   


Q ss_pred             HHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 042216          695 TECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL  754 (767)
Q Consensus       695 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~  754 (767)
                       +....+...         ..+..++..+.+++.+||+.+|.+||++.+|+++|+.+...
T Consensus       236 -~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         236 -ECITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             -HHHhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence             111222111         11233567799999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.2e-37  Score=329.14  Aligned_cols=261  Identities=26%  Similarity=0.454  Sum_probs=210.8

Q ss_pred             hccccceeeeccCcEEEEEEEec-----CCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLN-----GDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      .+|...+.||+|+||+||++...     .++..+|+|.+..........+.+|++++.+++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            46778889999999999999852     2345699999876665566789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCC-----------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEE
Q 042216          550 VYDYMARGTLRDHLYNND-----------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKV  618 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki  618 (767)
                      ||||+++++|.+++....           ...+++.+++.++.|++.||.|||   +++++||||||+|||+++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence            999999999999986432           235899999999999999999999   788999999999999999999999


Q ss_pred             eecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHH
Q 042216          619 SDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATEC  697 (767)
Q Consensus       619 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~  697 (767)
                      +|||+++...............++..|+|||.+.+..++.++|||||||+++||++ |+.||......+   ..    ..
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~----~~  234 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VI----EC  234 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HH
Confidence            99999875432222122223345778999999999999999999999999999998 899986543221   11    11


Q ss_pred             hhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 042216          698 YRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL  754 (767)
Q Consensus       698 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~  754 (767)
                      ...+...         ..+..++.++.+++.+||+.+|.+|||+.+|++.|+.+.+.
T Consensus       235 i~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         235 ITQGRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            1222111         11223556799999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-38  Score=342.52  Aligned_cols=242  Identities=27%  Similarity=0.413  Sum_probs=208.8

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceE
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMI  548 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~  548 (767)
                      ..++|..+.+||+|.||+|+++.++++++.+|||.+++..   ..+.+..+.|.+++... +||.|++|+.++..+++++
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            4468999999999999999999999999999999998773   44556678898888877 5999999999999999999


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      +||||+.||++..+.+   ...+++....-++..|+.||+|||   .++||+||||.+|||||.+|.+||+||||++..-
T Consensus       446 fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             EEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccC
Confidence            9999999999655543   235899999999999999999999   8899999999999999999999999999999643


Q ss_pred             CCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          629 NFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      .  ....+...+||+.|||||++.+..|+...|.|||||+||||+.|+.||.+.++++.-                   |
T Consensus       520 ~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F-------------------d  578 (694)
T KOG0694|consen  520 G--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF-------------------D  578 (694)
T ss_pred             C--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-------------------H
Confidence            2  334567899999999999999999999999999999999999999999877664322                   2


Q ss_pred             cccc--CCCChhhHHHHHHHHHHccccCCCCCCCH
Q 042216          709 PFLK--GNAPPVCLNQFVEVAMSCVNDDRIRRPSM  741 (767)
Q Consensus       709 ~~l~--~~~~~~~~~~l~~li~~Cl~~dp~~RPs~  741 (767)
                      ..+.  -.+|.-++.+...++.+++..+|++|.-+
T Consensus       579 sI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  579 SIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            2221  23567788899999999999999999866

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3e-37  Score=326.55  Aligned_cols=260  Identities=25%  Similarity=0.399  Sum_probs=205.9

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCc----eEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDST----PVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~----~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      .+|...+.||+|+||.||+|.+..+++    .+++|.+.... .....++..|+.++++++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            467778899999999999999865544    47788875432 233467888899999999999999999986 456789


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ++||+++|+|.+++.... ..++|..+..++.|++.||.|||   +++++||||||+|||+++++.+||+|||+++....
T Consensus        86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            999999999999996543 35899999999999999999999   77899999999999999999999999999986533


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      ...........++..|+|||.+.++.++.++|||||||++|||++ |+.||......+   +.+.    ...+..     
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~----~~~~~~-----  229 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDL----LEKGER-----  229 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHCCCc-----
Confidence            222222334557789999999998899999999999999999998 999986543221   1111    111111     


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                          ...+..+...+.+++.+||..+|.+|||+.|+++.|+.+.+..
T Consensus       230 ----~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         230 ----LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence                1112235567889999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-38  Score=334.55  Aligned_cols=246  Identities=24%  Similarity=0.288  Sum_probs=203.1

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|+..+.||+|+||.||++....+++.||+|++....   ......+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36788889999999999999998888999999986432   233456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....  
T Consensus        81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~--  153 (291)
T cd05612          81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--  153 (291)
T ss_pred             eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccC--
Confidence            999999999999654  35899999999999999999999   78899999999999999999999999999875432  


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                         ......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+   .   ... ...+.         
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~---~~~-i~~~~---------  214 (291)
T cd05612         154 ---RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---I---YEK-ILAGK---------  214 (291)
T ss_pred             ---CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHH-HHhCC---------
Confidence               1223468999999999999899999999999999999999999996543211   1   111 11111         


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPS-----MSDVVWG  747 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~~  747 (767)
                       ...+......+.+++.+||+.||.+||+     ++|+++.
T Consensus       215 -~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         215 -LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence             1123334567889999999999999995     8887744

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.1e-37  Score=336.12  Aligned_cols=263  Identities=23%  Similarity=0.318  Sum_probs=205.8

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      .++|+..+.||+|+||.||+++....+..+|+|.+..... .....+.+|+++|++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            3578899999999999999999998889999999875432 334568999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+++|+|.+++...  ..+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||+++.....  
T Consensus        84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          84 HMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            99999999999654  358999999999999999999994  346999999999999999999999999998754221  


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC---c------
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK---I------  703 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~---~------  703 (767)
                        ......|+..|+|||++.+..++.++|||||||++|||++|+.||......+   +..........+.   .      
T Consensus       158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcc
Confidence              2233468999999999999999999999999999999999999995433211   1111000000000   0      


Q ss_pred             ---------------------cccccccccC---C-CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          704 ---------------------GDIIDPFLKG---N-APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       704 ---------------------~~~~d~~l~~---~-~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                                           .+..+.....   . .....+.++.+++.+||+.||++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                 0000000000   0 011245678999999999999999999999865

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.8e-37  Score=328.01  Aligned_cols=256  Identities=26%  Similarity=0.454  Sum_probs=207.6

Q ss_pred             hccccceeeeccCcEEEEEEEecC-----CCceEEEEEeCCCCCc-chhHHHHHHHHHhccccceeeeEeeeeecCCceE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGSQQ-GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMI  548 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~  548 (767)
                      .+|...+.||+|+||.||+|...+     .+..||||.++..... ..+.+.+|++++++++|+|++++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            457777899999999999998743     2468999998765444 4568999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhccCC------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcE
Q 042216          549 LVYDYMARGTLRDHLYNND------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVA  616 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~  616 (767)
                      +||||+++|+|.+++....            ...+++.++..++.|++.||.|||   +++++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence            9999999999999996432            245889999999999999999999   7889999999999999999999


Q ss_pred             EEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHH
Q 042216          617 KVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWAT  695 (767)
Q Consensus       617 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~  695 (767)
                      ||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||......+   ....  
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~--  236 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIEC--  236 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH--
Confidence            9999999875432221122233346788999999999999999999999999999998 999986543321   1111  


Q ss_pred             HHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          696 ECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       696 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                        ...+..         ...+..++..+.+++.+||+.||.+||++.||++.|+
T Consensus       237 --~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         237 --ITQGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             --HHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence              112111         1123345678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-37  Score=324.63  Aligned_cols=256  Identities=28%  Similarity=0.493  Sum_probs=208.3

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .++|+..+.||+|++|.||+|...++ +.||+|.++... ...+++.+|++++++++|+|++++++++...+..+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCC-eEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            45688888999999999999997654 689999987543 3456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++++|.+++.......+++.++..++.|++.||.|||   +.+++|+||||+||++++++.+||+|||+++....... 
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  158 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-  158 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence            99999999997655557899999999999999999999   77899999999999999999999999999876432111 


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      ........+..|+|||++.+..++.++||||||++++||++ |+.||.......   +..    .....         ..
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~---------~~  222 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQ----QVDQG---------YR  222 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHHcC---------CC
Confidence            11111223467999999999999999999999999999999 999986543211   111    11111         11


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                      ...+..++..+.+++.+|++.+|.+||++.++++.|+.+
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            122344567899999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.7e-37  Score=329.55  Aligned_cols=266  Identities=20%  Similarity=0.253  Sum_probs=203.6

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ++|...+.||+|+||.||+++.+.+++.+|+|++....  ......+.+|+++++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36888899999999999999999888999999986542  2334568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |++++.|..+...  ...+++..+..++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  154 (287)
T cd07848          81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-  154 (287)
T ss_pred             cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-
Confidence            9998777655432  345899999999999999999999   7889999999999999999999999999998643211 


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHH---------HHHhhcCCc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWA---------TECYRNGKI  703 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~---------~~~~~~~~~  703 (767)
                      ........|+..|+|||++.+..++.++|||||||++|||++|++||......+........         .........
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence            11223456899999999999888999999999999999999999999654432211111100         000001001


Q ss_pred             ccccccccc------CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          704 GDIIDPFLK------GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       704 ~~~~d~~l~------~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .....+...      .......+..+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111001000      0111224567999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.1e-37  Score=327.18  Aligned_cols=258  Identities=24%  Similarity=0.449  Sum_probs=205.7

Q ss_pred             HhhccccceeeeccCcEEEEEEEecC-----CCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCc
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQ  546 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~  546 (767)
                      .+++|+..+.||+|+||.||+|...+     .+..||||++.... .....++.+|+.+++.++||||+++++++.+++.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            46779999999999999999998643     23579999986432 2345578999999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhhhccCC--------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEE
Q 042216          547 MILVYDYMARGTLRDHLYNND--------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKV  618 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki  618 (767)
                      .++||||+++|+|.+++.+..        ...+++..+..++.|++.||.|||   +.+++|+||||+|||+++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999986432        234688999999999999999999   778999999999999999999999


Q ss_pred             eecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHH
Q 042216          619 SDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATEC  697 (767)
Q Consensus       619 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~  697 (767)
                      +|||+++...............++..|+|||++..+.++.++|||||||++|||++ |..||......+   ....    
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~~----  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRF----  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----
Confidence            99999875432222111222345778999999998899999999999999999999 788886543321   1111    


Q ss_pred             hhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          698 YRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       698 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                      .......         ..+..++..+.+++.+||+.+|++|||+.|+++.|+
T Consensus       234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         234 VMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            1111111         123345678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.3e-37  Score=351.73  Aligned_cols=252  Identities=20%  Similarity=0.305  Sum_probs=206.4

Q ss_pred             ccccceeeeccCcEEEEEEEecCC-CceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGD-STPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      .|...+.||+|+||.||++....+ +..||+|.+..........+.+|+.+|+.++||||+++++++..++..+|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            388888999999999999988766 6788999876555555556888999999999999999999999999999999999


Q ss_pred             CCCChhhhhccC--CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          555 ARGTLRDHLYNN--DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       555 ~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      ++|+|.++|+..  ...++++.++..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.......
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999988542  3446899999999999999999999   78899999999999999999999999999986543222


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||......      ....... .+..         
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~-~~~~---------  288 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVL-YGKY---------  288 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-hCCC---------
Confidence            22334566999999999999999999999999999999999999999643321      1111111 1111         


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ...+..++.++.+++.+||+.||++||++.+++.
T Consensus       289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            1123345678999999999999999999999874

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.4e-37  Score=338.20  Aligned_cols=261  Identities=26%  Similarity=0.438  Sum_probs=206.0

Q ss_pred             hccccceeeeccCcEEEEEEEecC-----CCceEEEEEeCCCC-CcchhHHHHHHHHHhcc-ccceeeeEeeeeecC-Cc
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGS-QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDD-GQ  546 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~-~~  546 (767)
                      ++|+..+.||+|+||.||+|...+     .++.||+|+++... ....+.+.+|++++.++ +|+||++++++|... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            467888899999999999997543     23689999987543 23345678899999999 899999999988654 57


Q ss_pred             eEEEEecCCCCChhhhhccCC-----------------------------------------------------------
Q 042216          547 MILVYDYMARGTLRDHLYNND-----------------------------------------------------------  567 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~-----------------------------------------------------------  567 (767)
                      +++++||+++|+|.+++....                                                           
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            889999999999999885421                                                           


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccccccCCCcccC
Q 042216          568 NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD  647 (767)
Q Consensus       568 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~a  647 (767)
                      ...++|.++..++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++...............++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            126899999999999999999999   78899999999999999999999999999986433221112223446778999


Q ss_pred             hhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHH
Q 042216          648 PEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEV  726 (767)
Q Consensus       648 PE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  726 (767)
                      ||++.+..++.++|||||||+|+||++ |+.||......+  .+..    ....+.         ....+...+.++.++
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~----~~~~~~---------~~~~~~~~~~~~~~l  308 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCR----RLKEGT---------RMRAPEYATPEIYSI  308 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHH----HHhccC---------CCCCCccCCHHHHHH
Confidence            999999999999999999999999998 999986533221  1111    111111         111233456789999


Q ss_pred             HHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          727 AMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       727 i~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                      +.+||+.+|++||++.||++.|+.+++
T Consensus       309 ~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         309 MLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=9.6e-38  Score=332.56  Aligned_cols=261  Identities=26%  Similarity=0.459  Sum_probs=210.3

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCC-----CceEEEEEeCCC-CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCC
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGD-----STPVAIKRLNPG-SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDG  545 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~-----~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~  545 (767)
                      ..++|+..+.||+|+||.||++...+.     ...+|+|.+... ......++.+|++++.++ +|+||+++++++..++
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            445788888999999999999987543     367999998754 233445688999999999 8999999999999999


Q ss_pred             ceEEEEecCCCCChhhhhccC--------------CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC
Q 042216          546 QMILVYDYMARGTLRDHLYNN--------------DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD  611 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld  611 (767)
                      ..+++|||+++|+|.+++...              ....+++..++.++.|++.||.|||   +.+|+||||||+|||++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEc
Confidence            999999999999999998642              2346899999999999999999999   78899999999999999


Q ss_pred             CCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhH
Q 042216          612 EEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNL  690 (767)
Q Consensus       612 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l  690 (767)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+   .
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~  243 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---L  243 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---H
Confidence            999999999999986543222122223345678999999998899999999999999999997 999985443211   1


Q ss_pred             HHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 042216          691 AVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF  752 (767)
Q Consensus       691 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~  752 (767)
                      .    .....+         .....+..++.++.+++.+||+.+|++|||+.|+++.|+.++
T Consensus       244 ~----~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         244 F----KLLKEG---------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             H----HHHHcC---------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            1    111111         111234456678999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=341.25  Aligned_cols=250  Identities=26%  Similarity=0.389  Sum_probs=213.4

Q ss_pred             cceeeeccCcEEEEEEEecCC---CceEEEEEeCCCCCc-chhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          479 NLLIIGRGGFGNVYKGFLNGD---STPVAIKRLNPGSQQ-GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       479 ~~~~LG~G~fG~Vy~g~~~~~---~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      ..++||+|+||.|++|.++..   ...||||.++..... ...+|.+|+.+|.+|+|||+++|+|...+ ..+.||+|.+
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            344799999999999998643   247999999877654 67789999999999999999999999987 6888999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      +.|||.+.|++.....|-...+..+|.|||.||.||.   ++++|||||.++|+||-..-.+|||||||.+.........
T Consensus       193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y  269 (1039)
T KOG0199|consen  193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY  269 (1039)
T ss_pred             ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence            9999999998866667888999999999999999999   8899999999999999999999999999999765444433


Q ss_pred             ccc-cccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          635 VST-QVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       635 ~~~-~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      ... ...-.+.|+|||.++...++.+||||+|||+||||++ |+.||-+....                .+.+.+|..-+
T Consensus       270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------------qIL~~iD~~er  333 (1039)
T KOG0199|consen  270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------------QILKNIDAGER  333 (1039)
T ss_pred             EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------------HHHHhcccccc
Confidence            333 4456789999999999999999999999999999998 88998554332                12233455555


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGL  748 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L  748 (767)
                      -..|..|+++++++++.||..+|.+|||+..|.+.+
T Consensus       334 LpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            567889999999999999999999999999998554

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-38  Score=339.67  Aligned_cols=254  Identities=26%  Similarity=0.320  Sum_probs=205.6

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|+..+.||+|+||.||+|.....++.||||++....   ......+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888899999999999999998888899999986432   234456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|+|.+++...  ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....  
T Consensus        81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            999999999999543  45899999999999999999999   78899999999999999999999999999875432  


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                         ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....   ..   ...   ..+....
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~---i~---~~~---~~~~~~~  221 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN---LK---YWK---ETLQRPV  221 (333)
T ss_pred             ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH---HH---hcc---ccccCCC
Confidence               22345689999999999999999999999999999999999999965433211110   00   000   0000000


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      ........+.++.+++.+||+.+|.+||++.++++.
T Consensus       222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            000012346778999999999999999999999854

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.3e-38  Score=339.06  Aligned_cols=241  Identities=25%  Similarity=0.323  Sum_probs=199.2

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGT  558 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gs  558 (767)
                      +||+|+||.||+++...+++.||+|++...   .......+.+|++++.+++||||+++++++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   81 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence            699999999999999888899999998753   22334567889999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcccccc
Q 042216          559 LRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ  638 (767)
Q Consensus       559 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~  638 (767)
                      |.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....  .......
T Consensus        82 L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~  154 (323)
T cd05571          82 LFFHLSRE--RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKT  154 (323)
T ss_pred             HHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccc
Confidence            99998653  46899999999999999999999   78899999999999999999999999999874322  1122234


Q ss_pred             ccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChh
Q 042216          639 VKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV  718 (767)
Q Consensus       639 ~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  718 (767)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +...    ...+.          ...+..
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~----~~~~~----------~~~p~~  217 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFEL----ILMEE----------IRFPRT  217 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHHH----HHcCC----------CCCCCC
Confidence            569999999999999999999999999999999999999996543211   1111    11111          122344


Q ss_pred             hHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042216          719 CLNQFVEVAMSCVNDDRIRRP-----SMSDVVW  746 (767)
Q Consensus       719 ~~~~l~~li~~Cl~~dp~~RP-----s~~evl~  746 (767)
                      .+.++.+++.+||+.||++||     ++.++++
T Consensus       218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            567789999999999999999     7888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3e-37  Score=328.42  Aligned_cols=259  Identities=25%  Similarity=0.415  Sum_probs=206.7

Q ss_pred             ccccceeeeccCcEEEEEEEecC-----CCceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      +|+..+.||+|+||.||+|+...     +...+++|.+..... ....++.+|+.+++.++||||+++++.|...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            36677789999999999998743     225688998865432 334678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccC----------------------CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCC
Q 042216          550 VYDYMARGTLRDHLYNN----------------------DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTN  607 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~----------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~N  607 (767)
                      ++||+.+|+|.+++...                      ....+++.+++.++.|++.||.|||   +.+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            99999999999988532                      1235889999999999999999999   7889999999999


Q ss_pred             eEECCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCcc
Q 042216          608 ILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKK  686 (767)
Q Consensus       608 ILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~  686 (767)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||......+
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999875432211111223345678999999988899999999999999999998 999985443221


Q ss_pred             chhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          687 QVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       687 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                         +..    ....         ......+..++.++.+++.+||+.+|.+||++.++++.|++++.
T Consensus       238 ---~~~----~~~~---------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         238 ---LFN----LLKT---------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             ---HHH----HHhC---------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence               111    1111         11222344566789999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.9e-38  Score=339.15  Aligned_cols=245  Identities=26%  Similarity=0.370  Sum_probs=203.2

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      .+|...+.||+|+||.||+|+.+.+++.||+|++...   .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            5688889999999999999999888899999998643   2233456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|+|.+++...  ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        98 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             cCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence            999999999999654  45889999999999999999999   788999999999999999999999999998754321 


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                          .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+   .    ......+..        
T Consensus       172 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~----~~~i~~~~~--------  232 (329)
T PTZ00263        172 ----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---I----YEKILAGRL--------  232 (329)
T ss_pred             ----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---H----HHHHhcCCc--------
Confidence                123568999999999999999999999999999999999999996433211   1    111111111        


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPS-----MSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~  746 (767)
                        ..+.....++.+++.+||+.||.+||+     +++++.
T Consensus       233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence              123334567889999999999999996     677773

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.9e-37  Score=320.45  Aligned_cols=251  Identities=27%  Similarity=0.450  Sum_probs=202.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      ++|+..+.||+|+||.||++.++.. ..+|+|.+... .....++.+|++++++++||||+++++++.+.+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~-~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQ-IKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccC-ceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            4577788999999999999988754 67999988643 233567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++|+|.++++... ..++|..+..++.|++.||.|||   +++++|+||||+||++++++.+||+|||+++....... .
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~  156 (256)
T cd05114          82 ENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-T  156 (256)
T ss_pred             CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-e
Confidence            9999999986543 35899999999999999999999   78899999999999999999999999999875432111 1


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......   ......    ..+.         ..
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~i----~~~~---------~~  220 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEMI----SRGF---------RL  220 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH----HCCC---------CC
Confidence            1122335678999999998899999999999999999999 89998544321   111111    1111         01


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGL  748 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L  748 (767)
                      ..+...+.++.+++.+||+.+|.+||++.++++.|
T Consensus       221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            11223456789999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.5e-37  Score=327.69  Aligned_cols=257  Identities=26%  Similarity=0.425  Sum_probs=205.2

Q ss_pred             hccccceeeeccCcEEEEEEEec----CCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLN----GDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~----~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      .+|+..+.||+|+||.||+|...    ..+..+++|.+.... .+...++.+|++++++++||||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            45777789999999999999852    244789999987543 3334678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCC---------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC
Q 042216          550 VYDYMARGTLRDHLYNND---------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW  614 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~  614 (767)
                      +|||+++|+|.+++....               ...+++.+++.++.|++.||.|||   +++++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            999999999999985321               235889999999999999999999   78899999999999999999


Q ss_pred             cEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHH
Q 042216          615 VAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVW  693 (767)
Q Consensus       615 ~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~  693 (767)
                      .+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......   .... 
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~-  237 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIE-  237 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH-
Confidence            999999999975432222222233446778999999988889999999999999999998 99998654321   1111 


Q ss_pred             HHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042216          694 ATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF  750 (767)
Q Consensus       694 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~  750 (767)
                         .......         ...+..++.++.+++.+||+.||.+||++.+|++.|+.
T Consensus       238 ---~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 ---MVRKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ---HHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence               1111111         11234456789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.1e-37  Score=320.08  Aligned_cols=248  Identities=28%  Similarity=0.443  Sum_probs=200.1

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCChh
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLR  560 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gsL~  560 (767)
                      .||+|+||.||+|+...+++.+|+|...... ......+.+|++++++++||||++++++|...+..++||||+++++|.
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL   81 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence            6899999999999998788899999876443 333456899999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcccccccc
Q 042216          561 DHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK  640 (767)
Q Consensus       561 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~  640 (767)
                      +++.... ..+++.+++.++.|++.||.|||   +.+++|+||||+|||++.++.+||+|||+++...............
T Consensus        82 ~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          82 TFLRTEG-PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            9996543 45899999999999999999999   7889999999999999999999999999987533211111111122


Q ss_pred             CCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhh
Q 042216          641 GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVC  719 (767)
Q Consensus       641 gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  719 (767)
                      .+..|+|||.+.++.++.++|||||||++|||++ |..||.......   .    ......         ......+..+
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---~----~~~~~~---------~~~~~~~~~~  221 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---T----REAIEQ---------GVRLPCPELC  221 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---H----HHHHHc---------CCCCCCcccC
Confidence            3467999999998899999999999999999998 888885433211   1    111111         1112234455


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          720 LNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       720 ~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                      +..+.+++.+||+.+|++||++.+|+++|+
T Consensus       222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.4e-37  Score=327.76  Aligned_cols=265  Identities=20%  Similarity=0.304  Sum_probs=202.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      ++|...+.||+|+||.||+|..+.+++.||+|+++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888899999999999999998888999999986543 23344678999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++ +|.+++.... ..+++..+..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++......  
T Consensus        85 ~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--  157 (288)
T cd07871          85 LDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--  157 (288)
T ss_pred             CCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence            985 9999886443 35789999999999999999999   7889999999999999999999999999987532211  


Q ss_pred             cccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHH-----HHhhc----CCc
Q 042216          634 HVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWAT-----ECYRN----GKI  703 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~-----~~~~~----~~~  703 (767)
                      .......+++.|+|||.+.+ ..++.++||||+||++|||++|++||......+.........     ..+..    ...
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            12233457899999998865 568999999999999999999999996654332221111000     00000    000


Q ss_pred             cccccccccC----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          704 GDIIDPFLKG----NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       704 ~~~~d~~l~~----~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .....+..+.    ...+....++.+++.+|++.||.+|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0011111000    001223567889999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.7e-37  Score=327.56  Aligned_cols=261  Identities=21%  Similarity=0.300  Sum_probs=197.1

Q ss_pred             ccccceeeeccCcEEEEEEEec-CCCceEEEEEeCCCC--CcchhHHHHHHHHHhcc---ccceeeeEeeeee-----cC
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLN-GDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQL---RYLHLVSLIGYCN-----DD  544 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l---~Hpniv~l~g~~~-----~~  544 (767)
                      +|...+.||+|+||.||+|... .+++.||+|++....  ......+.+|+.+++.+   +||||++++++|.     ..
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            6788889999999999999874 345789999886542  22234566777777665   6999999999985     34


Q ss_pred             CceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCc
Q 042216          545 GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC  624 (767)
Q Consensus       545 ~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla  624 (767)
                      ...++||||++ ++|.+++.......+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence            56899999997 59999997665566899999999999999999999   788999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhc---C
Q 042216          625 KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRN---G  701 (767)
Q Consensus       625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~---~  701 (767)
                      +.....   .......|+..|+|||.+....++.++|||||||++|||++|++||......+..  .. .......   .
T Consensus       158 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~--~~-i~~~~~~~~~~  231 (290)
T cd07862         158 RIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL--GK-ILDVIGLPGEE  231 (290)
T ss_pred             EeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH--HH-HHHHhCCCChh
Confidence            754321   2233456899999999999889999999999999999999999999765432211  11 1111000   0


Q ss_pred             Cc-------cccccccccC---CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          702 KI-------GDIIDPFLKG---NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       702 ~~-------~~~~d~~l~~---~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ..       .....+....   ...+.....+.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00       0000000000   011234566789999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.5e-37  Score=329.20  Aligned_cols=260  Identities=23%  Similarity=0.390  Sum_probs=208.2

Q ss_pred             hhccccceeeeccCcEEEEEEEec-----CCCceEEEEEeCCCC-CcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCc
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLN-----GDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQ  546 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~  546 (767)
                      .++|...+.||+|+||.||++...     .....+|||+++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            356888889999999999999752     234579999987543 23345689999999999 79999999999999999


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      .+++|||+++|+|.++++......+++.++..++.|++.||.|||   +++|+|+||||+|||++.++.+||+|||+++.
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence            999999999999999997655455899999999999999999999   78899999999999999999999999999875


Q ss_pred             CCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccc
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGD  705 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  705 (767)
                      ..............++..|+|||.+....++.++|||||||++|||++ |..||......+  .+..    ....+    
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~~----~~~~~----  260 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFYK----LIKEG----  260 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHHH----HHHcC----
Confidence            433221112222345778999999998899999999999999999998 999986543321  1111    11111    


Q ss_pred             cccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       706 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                           .....+...+.++.+++.+||+.+|++||++.||++.|+++
T Consensus       261 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         261 -----YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -----CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                 11112223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=334.79  Aligned_cols=240  Identities=24%  Similarity=0.306  Sum_probs=196.9

Q ss_pred             eeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCCh
Q 042216          483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTL  559 (767)
Q Consensus       483 LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gsL  559 (767)
                      ||+|+||.||++....+++.||+|++...   .......+.+|++++.+++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999999888889999998643   233455688999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccccc
Q 042216          560 RDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV  639 (767)
Q Consensus       560 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~  639 (767)
                      .+++...  ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++....  ........
T Consensus        81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~  153 (312)
T cd05585          81 FHHLQRE--GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTF  153 (312)
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccc
Confidence            9999653  45899999999999999999999   78899999999999999999999999999875322  11223345


Q ss_pred             cCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhh
Q 042216          640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVC  719 (767)
Q Consensus       640 ~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  719 (767)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||......      ........ +.          ...+...
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~-~~----------~~~~~~~  216 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQ-EP----------LRFPDGF  216 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHc-CC----------CCCCCcC
Confidence            6899999999999999999999999999999999999999643221      11111111 11          1123445


Q ss_pred             HHHHHHHHHHccccCCCCCCC---HHHHHH
Q 042216          720 LNQFVEVAMSCVNDDRIRRPS---MSDVVW  746 (767)
Q Consensus       720 ~~~l~~li~~Cl~~dp~~RPs---~~evl~  746 (767)
                      +.++.+++.+||+.||.+||+   +.|++.
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            677899999999999999985   566553

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=5.4e-37  Score=339.77  Aligned_cols=261  Identities=25%  Similarity=0.396  Sum_probs=207.2

Q ss_pred             hhccccceeeeccCcEEEEEEEecC-----CCceEEEEEeCCCCC-cchhHHHHHHHHHhccc-cceeeeEeeeeecCCc
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQLR-YLHLVSLIGYCNDDGQ  546 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~  546 (767)
                      .+++...+.||+|+||.||+|++.+     .++.||||+++.... ...+.+.+|+++|.++. ||||++++++|...+.
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            3456777899999999999998643     345799999975432 23456889999999997 9999999999999999


Q ss_pred             eEEEEecCCCCChhhhhccCC-----------------------------------------------------------
Q 042216          547 MILVYDYMARGTLRDHLYNND-----------------------------------------------------------  567 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~-----------------------------------------------------------  567 (767)
                      .++|+||+++|+|.++|++..                                                           
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            999999999999999996431                                                           


Q ss_pred             -------------------------------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE
Q 042216          568 -------------------------------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL  610 (767)
Q Consensus       568 -------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl  610 (767)
                                                           ...+++..++.++.|++.||.|||   +.+++||||||+|||+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLI  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEE
Confidence                                                 124678889999999999999999   7889999999999999


Q ss_pred             CCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchh
Q 042216          611 DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVN  689 (767)
Q Consensus       611 d~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~  689 (767)
                      ++++.+||+|||+++...............++..|+|||.+....++.++|||||||++|||++ |+.||......+.  
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~--  350 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ--  350 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH--
Confidence            9999999999999875422111111222346788999999998889999999999999999998 8899854432211  


Q ss_pred             HHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 042216          690 LAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF  752 (767)
Q Consensus       690 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~  752 (767)
                          .......+         .+...+..++.++.+++.+||+.+|.+||+++||++.|+.++
T Consensus       351 ----~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         351 ----FYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             ----HHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                11111111         111234456678999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.9e-37  Score=323.39  Aligned_cols=258  Identities=25%  Similarity=0.390  Sum_probs=205.7

Q ss_pred             HhhccccceeeeccCcEEEEEEEecC-----CCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCc
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQ  546 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~  546 (767)
                      .+++|...+.||+|++|.||+|.+..     ....|++|...... ......|..|+.++++++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            34678889999999999999999976     56789999886543 3334568999999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhhhccCC-----CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC---cEEE
Q 042216          547 MILVYDYMARGTLRDHLYNND-----NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW---VAKV  618 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~---~~ki  618 (767)
                      .++||||+++|+|.+++.+..     ...++|.+++.++.|++.||+|||   +.+++|+||||+|||++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence            999999999999999986543     135899999999999999999999   77899999999999998654   6999


Q ss_pred             eecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHH
Q 042216          619 SDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATEC  697 (767)
Q Consensus       619 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~  697 (767)
                      +|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||......+   +..    .
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~----~  233 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VME----F  233 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----H
Confidence            99999986422111111112233568999999998999999999999999999997 999986543321   111    1


Q ss_pred             hhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          698 YRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       698 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                      ...         ..+...+..++..+.+++.+||+.+|++||++.+|++.|+
T Consensus       234 ~~~---------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 VTG---------GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHc---------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            111         1112234456678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.9e-37  Score=335.22  Aligned_cols=241  Identities=24%  Similarity=0.321  Sum_probs=198.4

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGT  558 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gs  558 (767)
                      .||+|+||.||++....+++.||+|++...   .......+.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (323)
T cd05595           2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence            699999999999999888899999998653   22344567889999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcccccc
Q 042216          559 LRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ  638 (767)
Q Consensus       559 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~  638 (767)
                      |..++...  ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.....  ......
T Consensus        82 L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~  154 (323)
T cd05595          82 LFFHLSRE--RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKT  154 (323)
T ss_pred             HHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCcccc
Confidence            99988544  35899999999999999999999   788999999999999999999999999998743221  112234


Q ss_pred             ccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChh
Q 042216          639 VKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV  718 (767)
Q Consensus       639 ~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  718 (767)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.........      .... ...          ...+..
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~------~~~~-~~~----------~~~p~~  217 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF------ELIL-MEE----------IRFPRT  217 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH------HHHh-cCC----------CCCCCC
Confidence            56899999999999999999999999999999999999999654322111      1111 000          112344


Q ss_pred             hHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042216          719 CLNQFVEVAMSCVNDDRIRRP-----SMSDVVW  746 (767)
Q Consensus       719 ~~~~l~~li~~Cl~~dp~~RP-----s~~evl~  746 (767)
                      .+.++.+++.+||+.||.+||     ++.++++
T Consensus       218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            567889999999999999998     8888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=9e-37  Score=322.76  Aligned_cols=261  Identities=24%  Similarity=0.389  Sum_probs=207.8

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCc----eEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDST----PVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMI  548 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~----~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~  548 (767)
                      ..+|+..+.||+|+||+||+|++...+.    .||+|.++... .....++.+|+.++..++|+||++++++|... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            3568888899999999999998765544    48999987543 33456788999999999999999999999754 578


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      +++||+++|+|.++++... ..+++.+++.++.|++.||.|||   +++++||||||+|||+++++.+||+|||+++...
T Consensus        85 l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            9999999999999996543 35899999999999999999999   7889999999999999999999999999998654


Q ss_pred             CCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccc
Q 042216          629 NFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDII  707 (767)
Q Consensus       629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  707 (767)
                      ............++..|+|||.+.+..++.++|||||||++|||++ |..||......   .+..+.    ..+.     
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~----~~~~-----  228 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDLL----EKGE-----  228 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH----HCCC-----
Confidence            3222111222345678999999998899999999999999999998 89998544321   122211    1111     


Q ss_pred             cccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       708 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                          ....+..++.++.+++.+||+.||++||++.++++.|+.+.+..
T Consensus       229 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         229 ----RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             ----cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                11123345678899999999999999999999999998876655

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.6e-37  Score=334.91  Aligned_cols=242  Identities=25%  Similarity=0.317  Sum_probs=199.7

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGT  558 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gs  558 (767)
                      +||+|+||.||++.....++.||+|++...   .......+.+|+++++.++||||+++.+++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            699999999999999888899999998754   23345578899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcccccc
Q 042216          559 LRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ  638 (767)
Q Consensus       559 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~  638 (767)
                      |.+++...  ..+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....  ......
T Consensus        82 L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~  154 (328)
T cd05593          82 LFFHLSRE--RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKT  154 (328)
T ss_pred             HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccccc
Confidence            99988543  45899999999999999999999   788999999999999999999999999998753221  112234


Q ss_pred             ccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChh
Q 042216          639 VKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV  718 (767)
Q Consensus       639 ~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  718 (767)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||......+.      .... ..+          ....+..
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~------~~~~-~~~----------~~~~p~~  217 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELI-LME----------DIKFPRT  217 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH------HHHh-ccC----------CccCCCC
Confidence            5699999999999988999999999999999999999999965432211      1111 000          0122344


Q ss_pred             hHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042216          719 CLNQFVEVAMSCVNDDRIRRP-----SMSDVVWG  747 (767)
Q Consensus       719 ~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~  747 (767)
                      .+.++.+++.+||+.||.+||     ++.|+++.
T Consensus       218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            567789999999999999997     88998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.4e-37  Score=328.71  Aligned_cols=253  Identities=22%  Similarity=0.300  Sum_probs=206.8

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      ..++|+.+..||+|+||.||+++.++++..+|+|++++..   ..+..-...|-.+|....+|.||+|+-.+.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            3568999999999999999999999999999999998763   3344457889999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ||||++||++..+|.+.  ..|++......+.+++.|+.-||   ..++|||||||+|+|||..|++||+||||+.-...
T Consensus       219 iMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             EEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence            99999999999999655  45899999999999999999999   88899999999999999999999999999842100


Q ss_pred             ----------------C------CCc----cc-------------------cccccCCCcccChhhhccCCCCchhhHHH
Q 042216          630 ----------------F------SKT----HV-------------------STQVKGSIGYLDPEYYRLQLLTEKSDVYS  664 (767)
Q Consensus       630 ----------------~------~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~s~ksDV~S  664 (767)
                                      .      ...    ..                   ....+|||.|||||++.+..|+..+|.||
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS  373 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS  373 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence                            0      000    00                   01235999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCccc-hhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCC---
Q 042216          665 FGVVLLEVLCARPPILRTGDKKQ-VNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPS---  740 (767)
Q Consensus       665 fGvvl~elltg~~P~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs---  740 (767)
                      +|||+||||.|-+||......+. ..+..|...              +..+....+..+..+||.+|+. ||++|.-   
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--------------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G  438 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRET--------------LKFPEEVDLSDEAKDLITRLLC-DPENRLGSKG  438 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh--------------ccCCCcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence            99999999999999977665432 334444332              2222233445788999999999 9999975   


Q ss_pred             HHHHH
Q 042216          741 MSDVV  745 (767)
Q Consensus       741 ~~evl  745 (767)
                      ++||-
T Consensus       439 ~~EIK  443 (550)
T KOG0605|consen  439 AEEIK  443 (550)
T ss_pred             HHHHh
Confidence            45543

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.3e-36  Score=319.50  Aligned_cols=258  Identities=28%  Similarity=0.475  Sum_probs=207.2

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCC---ceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDS---TPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~---~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      .++|+..+.||+|+||.||+|.+..++   ..+|+|.+.... ....+++.+|++++.+++|+|++++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            356788889999999999999986543   379999987553 3345678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ||||+++++|.+++..+. ..+++.++..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++.....
T Consensus        84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            999999999999996543 46899999999999999999999   77899999999999999999999999999875432


Q ss_pred             CCCcc-ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccc
Q 042216          630 FSKTH-VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDII  707 (767)
Q Consensus       630 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  707 (767)
                      ..... .......+..|+|||++....++.++|||||||++|||++ |+.||......+      +.... ..+      
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~------~~~~i-~~~------  226 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE------VMKAI-NDG------  226 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHH-hcC------
Confidence            21111 1111223467999999998899999999999999999997 999985443211      11111 111      


Q ss_pred             cccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       708 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                         .....+..++.++.+++.+||+.+|.+||++.+|++.|+++
T Consensus       227 ---~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 ---FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               11122334567889999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.2e-36  Score=320.36  Aligned_cols=255  Identities=27%  Similarity=0.404  Sum_probs=200.4

Q ss_pred             ccceeeeccCcEEEEEEEecCCCc--eEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecC------Cce
Q 042216          478 NNLLIIGRGGFGNVYKGFLNGDST--PVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD------GQM  547 (767)
Q Consensus       478 ~~~~~LG~G~fG~Vy~g~~~~~~~--~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~------~~~  547 (767)
                      ...+.||+|+||.||+|+....+.  .+|+|.++..  .......+.+|+++++.++|+||++++++|...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            345689999999999999876554  5899988654  234456789999999999999999999988532      256


Q ss_pred             EEEEecCCCCChhhhhccC----CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCC
Q 042216          548 ILVYDYMARGTLRDHLYNN----DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL  623 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGl  623 (767)
                      ++++||+++|+|.+++...    ....+++..+..++.|++.||.|||   +++|+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999999987432    2345899999999999999999999   78899999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCC
Q 042216          624 CKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGK  702 (767)
Q Consensus       624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~  702 (767)
                      ++...............++..|+|||++....++.++|||||||++|||++ |+.||......   .+.    .....+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~----~~~~~~~  231 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIY----DYLRQGN  231 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HHHHcCC
Confidence            886433221111223346678999999999999999999999999999999 88888543321   111    1112211


Q ss_pred             ccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       703 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                      ..         ..+..++..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       232 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 RL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11         12334567789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.3e-37  Score=325.12  Aligned_cols=256  Identities=25%  Similarity=0.384  Sum_probs=204.3

Q ss_pred             ccccceeeeccCcEEEEEEEecCC-----CceEEEEEeCCCCCcc-hhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGD-----STPVAIKRLNPGSQQG-ALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~-----~~~vAVK~l~~~~~~~-~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      +|...+.||+|+||.||+|...+.     ++.||+|+++...... ...+.+|+.++..++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            456667899999999999987532     4689999997554332 3568899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccC--------------CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCc
Q 042216          550 VYDYMARGTLRDHLYNN--------------DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV  615 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~  615 (767)
                      ++||+++++|.+++...              ....+++..+..++.|++.||.|||   +.+|+||||||+|||+++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence            99999999999998421              1235889999999999999999999   788999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHH
Q 042216          616 AKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWA  694 (767)
Q Consensus       616 ~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~  694 (767)
                      +||+|||+++...............+++.|+|||.+..+.++.++|||||||++|||++ |..||......   ...   
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~---  236 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVI---  236 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH---
Confidence            99999999875433222222233446788999999988889999999999999999998 88888544321   111   


Q ss_pred             HHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042216          695 TECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF  750 (767)
Q Consensus       695 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~  750 (767)
                      .. ...+.         ....+..++..+.+++..||+.+|.+||++.+|+..|+.
T Consensus       237 ~~-i~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 EM-IRNRQ---------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HH-HHcCC---------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            11 11111         112345577789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-36  Score=320.33  Aligned_cols=256  Identities=26%  Similarity=0.425  Sum_probs=202.9

Q ss_pred             cccceeeeccCcEEEEEEEecCCC---ceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCc-----
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDS---TPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQ-----  546 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~---~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~-----  546 (767)
                      |...+.||+|+||.||+|++..+.   ..||+|+++...  .....++.+|++.++.++|||++++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            455678999999999999986433   679999987542  2334578999999999999999999999876554     


Q ss_pred             -eEEEEecCCCCChhhhhccC----CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 042216          547 -MILVYDYMARGTLRDHLYNN----DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDF  621 (767)
Q Consensus       547 -~~lV~ey~~~gsL~~~L~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~Df  621 (767)
                       .++++||+++|+|..++...    ....+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             79999999999999988542    2346899999999999999999999   778999999999999999999999999


Q ss_pred             CCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhc
Q 042216          622 GLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRN  700 (767)
Q Consensus       622 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~  700 (767)
                      |+++...............++..|+|||.+....++.++|||||||++|||++ |..||......   .+..+.    ..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~----~~  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYL----RH  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----Hc
Confidence            99885433221111222335678999999988899999999999999999999 88888543321   111111    11


Q ss_pred             CCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          701 GKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       701 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                      +.         ....+..++.++.+++.+||+.||.+||++.||++.|+.+
T Consensus       231 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GN---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CC---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11         1122445677899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.4e-37  Score=325.92  Aligned_cols=264  Identities=28%  Similarity=0.418  Sum_probs=204.2

Q ss_pred             hccccceeeeccCcEEEEEEEec----CCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeec--CCceE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLN----GDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCND--DGQMI  548 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~----~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~--~~~~~  548 (767)
                      ++|...+.||+|+||.||++..+    ..+..||+|++........+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46777889999999999999853    3457899999977666666789999999999999999999998754  34689


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      +|+||+++|+|.+++.+.. ..+++..+..++.|++.||.|||   ..+++||||||+||++++++.+||+|||+++...
T Consensus        84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            9999999999999996543 35899999999999999999999   7889999999999999999999999999998653


Q ss_pred             CCCCcc-ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCcc--------c-hhHHHHHHHHh
Q 042216          629 NFSKTH-VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKK--------Q-VNLAVWATECY  698 (767)
Q Consensus       629 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~--------~-~~l~~~~~~~~  698 (767)
                      ...... ......++..|+|||++.+..++.++|||||||+++||++|..++.......        . .......... 
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  238 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL-  238 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH-
Confidence            322111 1112223456999999998899999999999999999999877653221100        0 0000000011 


Q ss_pred             hcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       699 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                              +........+..++.++.+++.+||+.+|++|||+.||++.|+.+
T Consensus       239 --------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         239 --------LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             --------HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence                    111111122345667899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.1e-37  Score=327.31  Aligned_cols=259  Identities=26%  Similarity=0.441  Sum_probs=207.1

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCc--eEEEEEeCCC-CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDST--PVAIKRLNPG-SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~--~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      ++|+..++||+|+||.||+|..++++.  .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            467888899999999999999876543  4788888743 333456789999999999 799999999999999999999


Q ss_pred             EecCCCCChhhhhccCC--------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcE
Q 042216          551 YDYMARGTLRDHLYNND--------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVA  616 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~  616 (767)
                      +||+++|+|.+++.+..              ...+++.++..++.|++.||+|||   +.+++||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999996532              135889999999999999999999   7889999999999999999999


Q ss_pred             EEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHH
Q 042216          617 KVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWAT  695 (767)
Q Consensus       617 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~  695 (767)
                      ||+|||++......   ........+..|+|||++....++.++|||||||++|||++ |+.||......+   +   ..
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~---~~  229 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---L---YE  229 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H---HH
Confidence            99999998642211   11111223567999999998899999999999999999997 999995543211   1   11


Q ss_pred             HHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          696 ECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       696 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      . ...         ......+..++..+.+++.+||+.+|.+||+++++++.|+.+++..
T Consensus       230 ~-~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         230 K-LPQ---------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             H-Hhc---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            1 111         1111223446678999999999999999999999999999888655

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7.2e-37  Score=323.84  Aligned_cols=256  Identities=27%  Similarity=0.463  Sum_probs=206.1

Q ss_pred             hccccceeeeccCcEEEEEEEec-----CCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLN-----GDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      .++...+.||+|+||.||++...     ..+..+|+|.+..........+.+|+++++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            45667778999999999999753     2346799999876666667789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCCC-------------CCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcE
Q 042216          550 VYDYMARGTLRDHLYNNDN-------------PPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVA  616 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~  616 (767)
                      ++||+++|+|.+++.....             ..+++.+++.++.|++.||+|||   +.+++|+||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence            9999999999999865321             35899999999999999999999   7889999999999999999999


Q ss_pred             EEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHH
Q 042216          617 KVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWAT  695 (767)
Q Consensus       617 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~  695 (767)
                      ||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |++||......+.   ..   
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~---  235 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---IE---  235 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---HH---
Confidence            9999999875432211111223335678999999999999999999999999999998 8999854433211   11   


Q ss_pred             HHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          696 ECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       696 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                       ....+.         ....+..++..+.+++.+||+.||.+||++.||++.|+
T Consensus       236 -~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         236 -CITQGR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -HHHcCc---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence             111111         11223345677899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.6e-37  Score=335.11  Aligned_cols=266  Identities=23%  Similarity=0.286  Sum_probs=198.3

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecC-----CceE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD-----GQMI  548 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~-----~~~~  548 (767)
                      +|+..+.||+|+||.||+|....+++.||||++...  .......+.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            467788999999999999999888899999998643  223345688999999999999999999988543     2579


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      +||||+. ++|.+++...  ..+++..+..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            9999996 6899988543  35899999999999999999999   7889999999999999999999999999987532


Q ss_pred             CCCCc-cccccccCCCcccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHH--------HHH
Q 042216          629 NFSKT-HVSTQVKGSIGYLDPEYYRL--QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWA--------TEC  697 (767)
Q Consensus       629 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~--------~~~  697 (767)
                      ..... .......|+..|+|||++..  ..++.++|||||||++|||++|++||...............        ...
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            21111 11234568999999999875  67899999999999999999999999654332111110000        000


Q ss_pred             hhcCCccccccc---cccC---CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          698 YRNGKIGDIIDP---FLKG---NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       698 ~~~~~~~~~~d~---~l~~---~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      +......+.++.   ....   ...+.....+.+++.+||+.||++|||++|+++.
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            000000000000   0000   0011234567899999999999999999999954

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.2e-36  Score=317.60  Aligned_cols=252  Identities=29%  Similarity=0.460  Sum_probs=202.8

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      ++|...+.||+|+||.||+|...+. ..+|+|.+.... ....+|.+|+.++.+++||||+++++++.+.+..+++|||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~-~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCC-CcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            4577778999999999999988653 569999887443 33467999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++|+|.+++..... .+++.+++.++.|++.||.|||   +.+++|+||||+|||+++++.+||+|||+++....... .
T Consensus        82 ~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~  156 (256)
T cd05113          82 SNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T  156 (256)
T ss_pred             CCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence            99999999965433 6899999999999999999999   78899999999999999999999999999875432211 1


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+   ...   . ...+.         +.
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~---~-~~~~~---------~~  220 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVE---K-VSQGL---------RL  220 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH---H-HhcCC---------CC
Confidence            1122335678999999998889999999999999999998 999986443221   111   1 11111         11


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                      ..+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            112234578899999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.5e-37  Score=349.03  Aligned_cols=258  Identities=27%  Similarity=0.375  Sum_probs=208.5

Q ss_pred             HHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCC---
Q 042216          471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG---  545 (767)
Q Consensus       471 ~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~---  545 (767)
                      ....++|...+.||+|+||+||++....+++.||||++...  .......+.+|+..+..++|+|++++...+...+   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            34457899999999999999999999888899999998654  2344556889999999999999999988764332   


Q ss_pred             -----ceEEEEecCCCCChhhhhccC--CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEE
Q 042216          546 -----QMILVYDYMARGTLRDHLYNN--DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKV  618 (767)
Q Consensus       546 -----~~~lV~ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki  618 (767)
                           .+++||||+++|+|.++|...  ....+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEE
Confidence                 368999999999999998643  2356899999999999999999999   788999999999999999999999


Q ss_pred             eecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHh
Q 042216          619 SDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECY  698 (767)
Q Consensus       619 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~  698 (767)
                      +|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||......      ...... 
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~~~-  257 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMHKT-  257 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH-
Confidence            9999998654322223334567999999999999999999999999999999999999999643221      111111 


Q ss_pred             hcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       699 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      ..+.         ....+...+.++.+++.+||+.||.+||++.+++..
T Consensus       258 ~~~~---------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        258 LAGR---------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             hcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1111         112344566789999999999999999999999863

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.7e-37  Score=309.75  Aligned_cols=265  Identities=21%  Similarity=0.268  Sum_probs=208.6

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcc--hhHHHHHHHHHhccccceeeeEeeeeecC--CceEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQG--ALEFQTEIGMLSQLRYLHLVSLIGYCNDD--GQMILV  550 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~--~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~~lV  550 (767)
                      ++|+.++.|++|+||.||+|+.+.++..||+|+++...+..  ...-.+||.+|.+++|||||.+-.+....  +..|||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45788889999999999999999999999999998654322  23458999999999999999998887543  579999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      ||||++ +|...+..-. +++...+...++.|+++|++|||   .+.|+|||||++|+|+...|.+||+||||||.....
T Consensus       156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            999998 9998886544 57889999999999999999999   677999999999999999999999999999976543


Q ss_pred             CCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccc---
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI---  706 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~---  706 (767)
                        ....+..+-|..|.|||.+.+ ..|+...|+||+|||+.||+++++-|.+..+..+.+.+-.......+.....+   
T Consensus       231 --~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  231 --LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             --cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence              223566778999999999875 57999999999999999999999999887776555443322211111111111   


Q ss_pred             --c---------cccccCCCChh-hHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          707 --I---------DPFLKGNAPPV-CLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       707 --~---------d~~l~~~~~~~-~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                        +         -..++..++.. ..+.-.+++...+..||.+|-|++|.++
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence              0         01112222222 3466788999999999999999999874

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.9e-37  Score=322.14  Aligned_cols=257  Identities=26%  Similarity=0.453  Sum_probs=207.4

Q ss_pred             hhccccceeeeccCcEEEEEEEecCC-----CceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCce
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGD-----STPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQM  547 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~-----~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~  547 (767)
                      .++|...+.||+|+||.||+|...+.     +..||+|.+.... .....++.+|+.++..++|+||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            35788888999999999999988643     3689999986543 23345788999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhccCC--------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 042216          548 ILVYDYMARGTLRDHLYNND--------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVS  619 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~  619 (767)
                      ++||||+++|+|.+++....        ...++|..++.++.|++.||.|||   +.+++||||||+|||+++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999986432        234789999999999999999999   7889999999999999999999999


Q ss_pred             ecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHh
Q 042216          620 DFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECY  698 (767)
Q Consensus       620 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~  698 (767)
                      |||+++...............++..|+|||.+..+.++.++|||||||++|||++ |+.||......+   ...+.    
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~----  234 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKFV----  234 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHHH----
Confidence            9999875433222122233446789999999998899999999999999999998 999985443221   11111    


Q ss_pred             hcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       699 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                      ..+.         ....+..++.++.+++.+||+.+|.+|||+.++++.|+
T Consensus       235 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         235 IDGG---------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             hcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            1111         11223445778999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8.3e-37  Score=327.86  Aligned_cols=262  Identities=26%  Similarity=0.436  Sum_probs=209.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCC-------CceEEEEEeCCCC-CcchhHHHHHHHHHhcc-ccceeeeEeeeeecCC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGD-------STPVAIKRLNPGS-QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDG  545 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~-------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~  545 (767)
                      ++|...+.||+|+||.||++...+.       ...+|+|.+.... .....++.+|++++.++ +||||++++++|...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            5688888999999999999986431       2469999987542 33456788999999999 7999999999999999


Q ss_pred             ceEEEEecCCCCChhhhhccCC--------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC
Q 042216          546 QMILVYDYMARGTLRDHLYNND--------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD  611 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld  611 (767)
                      ..++||||+++|+|.+++....              ...++|.++++++.|++.||+|||   +.+++||||||+|||++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence            9999999999999999996532              135899999999999999999999   78899999999999999


Q ss_pred             CCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhH
Q 042216          612 EEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNL  690 (767)
Q Consensus       612 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l  690 (767)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||......     
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~-----  249 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-----  249 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----
Confidence            999999999999875432211111222234568999999998899999999999999999998 88888543321     


Q ss_pred             HHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          691 AVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       691 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                       .... ....+         .....+..++.++.+++.+||+.+|.+||++.+|++.|+.+++..
T Consensus       250 -~~~~-~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         250 -ELFK-LLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             -HHHH-HHHcC---------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence             1111 11111         111234456678999999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.9e-37  Score=332.85  Aligned_cols=261  Identities=23%  Similarity=0.355  Sum_probs=203.5

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      .++|+..+.||+|+||.||++....++..+|+|.+.... .....++.+|++++++++|+||++++++|.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            367888999999999999999999888899999887542 2334568999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+++|+|.+++...  ..+++..+..++.+++.||.|||+  ..+|+|+||||+|||++.++.+||+|||++.....   
T Consensus        84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---  156 (333)
T cd06650          84 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---  156 (333)
T ss_pred             cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh---
Confidence            99999999999653  358899999999999999999994  34799999999999999999999999999875322   


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc--------
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG--------  704 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~--------  704 (767)
                       .......|+..|+|||++.+..++.++|||||||++|||++|+.||........   ..... ....+...        
T Consensus       157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~---~~~~~-~~~~~~~~~~~~~~~~  231 (333)
T cd06650         157 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL---ELMFG-CPVEGDPAESETSPRP  231 (333)
T ss_pred             -hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH---HHHhc-CcccCCccccccCccc
Confidence             112334688999999999988999999999999999999999999864332111   00000 00000000        


Q ss_pred             ---------------------ccccccccCCC---C-hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          705 ---------------------DIIDPFLKGNA---P-PVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       705 ---------------------~~~d~~l~~~~---~-~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                                           .+.+.......   + .....++.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                                 00000000000   0 113467889999999999999999999974

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-37  Score=321.79  Aligned_cols=255  Identities=24%  Similarity=0.331  Sum_probs=203.3

Q ss_pred             HHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--------------cchhHHHHHHHHHhccccceeeeE
Q 042216          472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--------------QGALEFQTEIGMLSQLRYLHLVSL  537 (767)
Q Consensus       472 ~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--------------~~~~~f~~Ei~~l~~l~Hpniv~l  537 (767)
                      ...++|.....||+|.||.|-+|....+++.||||++.+...              ...+...+||.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            345778888899999999999999999999999999865310              122468899999999999999999


Q ss_pred             eeeeecC--CceEEEEecCCCCChhhhhccCCCCC-CChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC
Q 042216          538 IGYCNDD--GQMILVYDYMARGTLRDHLYNNDNPP-LPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW  614 (767)
Q Consensus       538 ~g~~~~~--~~~~lV~ey~~~gsL~~~L~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~  614 (767)
                      +.+..+.  +.+|||+|||..|.+...   ...++ |++.+..+++.+++.||.|||   .++||||||||+|+||++++
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCC
Confidence            9998754  689999999999888654   23344 999999999999999999999   88999999999999999999


Q ss_pred             cEEEeecCCcccCCCC---CCccccccccCCCcccChhhhccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCccc
Q 042216          615 VAKVSDFGLCKFGPNF---SKTHVSTQVKGSIGYLDPEYYRLQL----LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ  687 (767)
Q Consensus       615 ~~ki~DfGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~  687 (767)
                      ++||+|||.+...+..   ..........||+.|||||...++.    .+.+.||||+||+||.|+.|+.||.+....+ 
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~-  326 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE-  326 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH-
Confidence            9999999998754221   1112223467999999999988643    3467899999999999999999996543311 


Q ss_pred             hhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          688 VNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       688 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                        +            ..+++...|.-...++..+++.+|++++|++||++|.+..+|...
T Consensus       327 --l------------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  327 --L------------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             --H------------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence              1            112233333333334567889999999999999999999998643

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.1e-37  Score=335.58  Aligned_cols=248  Identities=21%  Similarity=0.313  Sum_probs=195.5

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      +|+..+.||+|+||.||+|+...+++.||||++..... .....+.+|+++++.++|+||+++++++.+.+..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            34556689999999999999988889999999865432 33456899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++|+|.+..      .+++..+..++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++......  .
T Consensus       155 ~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~  223 (353)
T PLN00034        155 DGGSLEGTH------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--D  223 (353)
T ss_pred             CCCcccccc------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--c
Confidence            999987543      3567788899999999999999   7889999999999999999999999999987643211  1


Q ss_pred             ccccccCCCcccChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          635 VSTQVKGSIGYLDPEYYRL-----QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                      ......||..|+|||++..     ...+.++|||||||++|||++|+.||......+...+.   ... ...        
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~-~~~--------  291 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM---CAI-CMS--------  291 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH---HHH-hcc--------
Confidence            1234568999999998753     23456899999999999999999999633221111111   100 000        


Q ss_pred             cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       710 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                       .....+..+..++.+++.+||+.||++||++.|+++.
T Consensus       292 -~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        292 -QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0112234456789999999999999999999999864

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7e-38  Score=301.29  Aligned_cols=248  Identities=27%  Similarity=0.390  Sum_probs=213.1

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|+..+.||+|-||.||.|..+.+.-.||+|++.+.   ..+-.+++.+|+++-+.|+||||+++++++.+....||++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            4688899999999999999999988899999998654   2334567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||..+|+|...|.......+++.....+..|+|.||.|+|   .+.+|||||||+|+|++..+..||+|||-+-..+   
T Consensus       102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---  175 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---  175 (281)
T ss_pred             EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence            9999999999998777777999999999999999999999   8889999999999999999999999999986532   


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                       .......+||..|+|||...+...+...|+|++|++.||++.|.+||......+  ....     +.+          .
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e--tYkr-----I~k----------~  237 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE--TYKR-----IRK----------V  237 (281)
T ss_pred             -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH--HHHH-----HHH----------c
Confidence             233456789999999999999999999999999999999999999996544221  1110     111          1


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      +-..|...+....++|.+|+..+|.+|.+..|++.
T Consensus       238 ~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  238 DLKFPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             cccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence            22345667778899999999999999999999874

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-37  Score=345.41  Aligned_cols=260  Identities=22%  Similarity=0.276  Sum_probs=214.0

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc-cceeeeEeeee-e---c---CCce
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-YLHLVSLIGYC-N---D---DGQM  547 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~-~---~---~~~~  547 (767)
                      +..+.+.|.+|||+.||+++..+++..+|+|++-...+...+...+||++|++|+ |+|||.+++.+ .   .   .-+.
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            4566778999999999999998887899999998778888889999999999997 99999999932 1   1   1378


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      +|+||||++|+|-+++.......|++.++++|+.|+++|+++||. +.++|||||||-+||||+.+++.||||||.+...
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~  196 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK  196 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence            999999999999999976555569999999999999999999995 4578999999999999999999999999998642


Q ss_pred             CCCCCc-c-c---c--ccccCCCcccChhhh---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHH
Q 042216          628 PNFSKT-H-V---S--TQVKGSIGYLDPEYY---RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATEC  697 (767)
Q Consensus       628 ~~~~~~-~-~---~--~~~~gt~~y~aPE~~---~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~  697 (767)
                      ...... . .   .  -...-|+.|.|||.+   .+...++|+|||+|||+||-|+....||...+..            
T Consensus       197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------------  264 (738)
T KOG1989|consen  197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------------  264 (738)
T ss_pred             cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce------------
Confidence            111100 0 0   0  012368899999986   4678999999999999999999999999654332            


Q ss_pred             hhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          698 YRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       698 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                             .+++....-+..+..+..|.+||..||+.||.+||++-+|++.+-++....
T Consensus       265 -------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  265 -------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             -------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence                   233333444444678999999999999999999999999999998876543

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-36  Score=325.76  Aligned_cols=263  Identities=24%  Similarity=0.441  Sum_probs=210.5

Q ss_pred             hhccccceeeeccCcEEEEEEEecC-------CCceEEEEEeCCCC-CcchhHHHHHHHHHhcc-ccceeeeEeeeeecC
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNG-------DSTPVAIKRLNPGS-QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDD  544 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~-------~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~  544 (767)
                      ..+|...+.||+|+||.||+++...       .+..||+|.+.... .....++.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            4567788899999999999997521       23479999886542 34456789999999999 899999999999999


Q ss_pred             CceEEEEecCCCCChhhhhccCC--------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE
Q 042216          545 GQMILVYDYMARGTLRDHLYNND--------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL  610 (767)
Q Consensus       545 ~~~~lV~ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl  610 (767)
                      ...+++|||+++|+|.+++....              ...+++.++..++.|++.||.|||   +++++||||||+|||+
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence            99999999999999999996532              235789999999999999999999   7889999999999999


Q ss_pred             CCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchh
Q 042216          611 DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVN  689 (767)
Q Consensus       611 d~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~  689 (767)
                      ++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||......    
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----  246 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----  246 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----
Confidence            9999999999999986543222222233446678999999998889999999999999999998 78887543221    


Q ss_pred             HHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          690 LAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       690 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                        .+... ...+.         ....+..++..+.+++.+||+.+|.+||++.||++.|++++...
T Consensus       247 --~~~~~-~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~  300 (304)
T cd05101         247 --ELFKL-LKEGH---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT  300 (304)
T ss_pred             --HHHHH-HHcCC---------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence              11111 11111         11223456778999999999999999999999999999988664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.4e-37  Score=323.32  Aligned_cols=269  Identities=24%  Similarity=0.368  Sum_probs=205.8

Q ss_pred             cccceeeeccCcEEEEEEEe----cCCCceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecC--CceEE
Q 042216          477 FNNLLIIGRGGFGNVYKGFL----NGDSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDD--GQMIL  549 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~----~~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~~l  549 (767)
                      +...+.||+|+||+||++..    ...+..||+|.+..... .....|.+|+++|++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            36778999999999988653    33457899999875432 3456788999999999999999999998654  35889


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      +|||+++|+|.+++...   .+++.++..++.|++.||.|||   +++++||||||+|||+++++.+||+|||+++....
T Consensus        86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            99999999999999643   4899999999999999999999   78899999999999999999999999999886543


Q ss_pred             CCCcc-ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          630 FSKTH-VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       630 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      ..... ......++..|+|||.+....++.++||||||++++||++|+.|+....... ...............+.+.++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhh
Confidence            22111 1122345667999999998889999999999999999999999985432210 001110000001111122222


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF  752 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~  752 (767)
                      .......+..++.++.+++.+||+.+|++||++++|+++|+.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            22333345566788999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=323.52  Aligned_cols=253  Identities=23%  Similarity=0.313  Sum_probs=204.8

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      +|+..++||+|+||+||++....+++.||+|++....   ......+.+|++++++++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3677889999999999999998778899999986432   2223457889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+++|+|.+++.......+++..+..++.|++.||.|||   +.+++||||||+||++++++.++|+|||+++...... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            999999999887655556999999999999999999999   7789999999999999999999999999987643211 


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                        ......|+..|+|||++.+..++.++|||||||++|||++|+.||.........   ..........          .
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~----------~  221 (285)
T cd05605         157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKED----------Q  221 (285)
T ss_pred             --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhc----------c
Confidence              122346899999999999889999999999999999999999999654332111   1111111110          1


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRP-----SMSDVVWG  747 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~  747 (767)
                      ...+...+..+.+++.+||+.||.+||     ++.++++.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            122344567789999999999999999     78888653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.5e-36  Score=316.24  Aligned_cols=251  Identities=27%  Similarity=0.417  Sum_probs=207.4

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      +|...+.||+|++|.||+++...+++.|++|.+...  ......++.+|++++++++|||++++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            467778999999999999999888899999998643  334566789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++++|.+++.......+++.+++.++.+++.||.|||   +.+++|+||||+||++++++.+||+|||+++......  
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~--  155 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--  155 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc--
Confidence            99999999997765567999999999999999999999   7889999999999999999999999999987543321  


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      .......++..|+|||++.+..++.++|+|||||+++||++|+.||.......   ...    ....+..         .
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~----~~~~~~~---------~  219 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LIL----KIIRGVF---------P  219 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHcCCC---------C
Confidence            11233457889999999999999999999999999999999999996543211   111    1111111         1


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      ..+......+.+++.+||+.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1222455678999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.4e-37  Score=335.30  Aligned_cols=246  Identities=24%  Similarity=0.339  Sum_probs=202.0

Q ss_pred             hccccceeeeccCcEEEEEEEecCCC-ceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDS-TPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~-~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      ++|...+.||+|+||.||+|+++..+ ..||+|++...   .......+.+|++++..++||||+++++++.+++..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            46888899999999999999876543 68999998543   223445688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+++|+|.+++.+.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.... 
T Consensus       110 ~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-  183 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-  183 (340)
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence            9999999999999654  35899999999999999999999   78899999999999999999999999999875432 


Q ss_pred             CCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......       .......+.        
T Consensus       184 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------~~~~i~~~~--------  244 (340)
T PTZ00426        184 ----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-------IYQKILEGI--------  244 (340)
T ss_pred             ----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-------HHHHHhcCC--------
Confidence                1234568999999999998889999999999999999999999996543211       011111111        


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRP-----SMSDVVWG  747 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~  747 (767)
                        ...+...+..+.+++.+|++.||.+|+     +++++++.
T Consensus       245 --~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        245 --IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             --CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence              112334456788999999999999995     88888753

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.3e-37  Score=327.69  Aligned_cols=261  Identities=27%  Similarity=0.470  Sum_probs=207.0

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCc--eEEEEEeCCC-CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDST--PVAIKRLNPG-SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~--~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~l  549 (767)
                      .++|+..+.||+|+||.||+|.+..++.  .+++|.+... ......++.+|++++.++ +|+||+++++++.+++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            3567888899999999999999865544  4678877643 233456788999999999 89999999999999999999


Q ss_pred             EEecCCCCChhhhhccCC--------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCc
Q 042216          550 VYDYMARGTLRDHLYNND--------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV  615 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~  615 (767)
                      |+||+++|+|.+++++..              ...+++.+++.++.|++.||+|||   +++++||||||+|||+++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence            999999999999996432              235889999999999999999999   788999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHH
Q 042216          616 AKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWA  694 (767)
Q Consensus       616 ~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~  694 (767)
                      +||+|||+++.....   .......++..|+|||++....++.++|||||||+++||++ |..||......+   ...  
T Consensus       163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~--  234 (303)
T cd05088         163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYE--  234 (303)
T ss_pred             EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HHH--
Confidence            999999998632111   01112234667999999988889999999999999999998 999986443221   111  


Q ss_pred             HHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 042216          695 TECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLR  756 (767)
Q Consensus       695 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  756 (767)
                       . ...+         .....+...+..+.+++.+||+.+|++||++.+++++|+.+++.-.
T Consensus       235 -~-~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         235 -K-LPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             -H-HhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence             1 1111         1111223355678999999999999999999999999998876553

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.3e-36  Score=321.58  Aligned_cols=261  Identities=22%  Similarity=0.353  Sum_probs=209.1

Q ss_pred             hhccccceeeeccCcEEEEEEEecC----CCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeec-CCce
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNG----DSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCND-DGQM  547 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~----~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~-~~~~  547 (767)
                      .++|...++||+|+||.||+|...+    .+..|++|++.... ......+.+|+.++++++|+|++++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678888899999999999999875    24789999887542 3335568899999999999999999999876 4678


Q ss_pred             EEEEecCCCCChhhhhccCCC------CCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 042216          548 ILVYDYMARGTLRDHLYNNDN------PPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDF  621 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~Df  621 (767)
                      ++++||+++|+|.+++.....      ..+++.+++.++.|++.||+|||   +.+++|+||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence            999999999999999865322      46899999999999999999999   788999999999999999999999999


Q ss_pred             CCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhc
Q 042216          622 GLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRN  700 (767)
Q Consensus       622 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~  700 (767)
                      |+++...............++..|+|||++....++.++|||||||++||+++ |+.||......   .+..+..    .
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~----~  234 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAYLK----D  234 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHHHH----c
Confidence            99975432221112223346778999999998899999999999999999998 99999654321   1221111    1


Q ss_pred             CCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          701 GKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       701 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                      +         .....+..++.++.+++.+||+.||++|||+.++++.|+.+.+
T Consensus       235 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         235 G---------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             C---------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1         1111223456788999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.5e-36  Score=323.66  Aligned_cols=263  Identities=27%  Similarity=0.429  Sum_probs=207.9

Q ss_pred             hccccceeeeccCcEEEEEEEecCCC----------------ceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDS----------------TPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSL  537 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~----------------~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l  537 (767)
                      .+|+..+.||+|+||.||+++....+                ..||+|.+.... .....++.+|++++++++|||++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            56788889999999999999875432                468999987553 3345678999999999999999999


Q ss_pred             eeeeecCCceEEEEecCCCCChhhhhccCC---------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCe
Q 042216          538 IGYCNDDGQMILVYDYMARGTLRDHLYNND---------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNI  608 (767)
Q Consensus       538 ~g~~~~~~~~~lV~ey~~~gsL~~~L~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NI  608 (767)
                      ++++..++..++++||+++++|.+++.+..         ...+++..++.++.|++.||.|||   +.+++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhce
Confidence            999999999999999999999999996543         236899999999999999999999   77899999999999


Q ss_pred             EECCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCcc
Q 042216          609 LLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC--ARPPILRTGDKK  686 (767)
Q Consensus       609 Lld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt--g~~P~~~~~~~~  686 (767)
                      +++.++.++|+|||+++...............++..|+|||++....++.++|||||||++|||++  +..|+...... 
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~-  240 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ-  240 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH-
Confidence            999999999999999875433222223334456788999999998899999999999999999998  67787544321 


Q ss_pred             chhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          687 QVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       687 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                        ................      .....+..++.++.+++.+||+.||.+|||+.||++.|+
T Consensus       241 --~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 --QVIENAGHFFRDDGRQ------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             --HHHHHHHhcccccccc------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence              1222222221111111      111123345678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.6e-36  Score=316.39  Aligned_cols=255  Identities=29%  Similarity=0.455  Sum_probs=205.5

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      ++|...+.||+|+||.||+|++.++ ..||+|++.... ....+|.+|++++++++|+||+++++++. .+..++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            4688888999999999999988755 569999987532 23457899999999999999999999875 45689999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++|+|.+++.+.....+++..+..++.|++.||.|||   +.+++|+||||+||++++++.+||+|||+++....... .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~  158 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  158 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc-c
Confidence            9999999997655556899999999999999999999   78899999999999999999999999999875432211 1


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      ......++..|+|||+..+..++.++|||||||++|||++ |+.||......+..       .....+         ...
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~-------~~~~~~---------~~~  222 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------DQVERG---------YRM  222 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH-------HHHhcC---------CCC
Confidence            1123346678999999998899999999999999999999 88888554322111       111111         011


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF  752 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~  752 (767)
                      ..+..++..+.+++.+|++.+|.+||++.++++.|+...
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            123446678899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-37  Score=330.93  Aligned_cols=252  Identities=25%  Similarity=0.380  Sum_probs=217.0

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCc-eEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQ-MILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~-~~lV~  551 (767)
                      ++|..++++|+|+||.+++.+++.+++.+++|++...  +....+...+|+.++++++|||||...+.+.+++. +++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            4677788999999999999999999899999998654  33444567899999999999999999999999988 99999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      +|++||+|.+.|.+..+..++++.+++++.|++.|+.|||   +..|+|||||+.|||++.+..+||+|||+|+......
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999998777677999999999999999999999   7889999999999999999999999999999765422


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                        .......||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+..   .|+.-..             +..
T Consensus       161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~ki~-------------~~~  222 (426)
T KOG0589|consen  161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELILKIN-------------RGL  222 (426)
T ss_pred             --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHHHHh-------------hcc
Confidence              2345678999999999999999999999999999999999999999655432   2222111             112


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      ....+...+.++..++..|++.+|..||++.+++.+
T Consensus       223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            334566788899999999999999999999999987

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-36  Score=315.78  Aligned_cols=251  Identities=29%  Similarity=0.469  Sum_probs=202.2

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      .+|...+.||+|+||.||+|..+. +..+|+|.+.... ....++.+|++++++++|+||+++++++...+..++|+||+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            356777889999999999998864 4679999986432 23457889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++++|.+++.... ..+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++...... ..
T Consensus        82 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~  156 (256)
T cd05059          82 ANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YT  156 (256)
T ss_pred             CCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccc-cc
Confidence            9999999997543 36899999999999999999999   7789999999999999999999999999987543211 11


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+   ...   . ...+         ...
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~---~-~~~~---------~~~  220 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVE---S-VSAG---------YRL  220 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHH---H-HHcC---------CcC
Confidence            1112224567999999998999999999999999999999 899986543321   111   1 1111         111


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGL  748 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L  748 (767)
                      ..+..++.++.+++.+||+.+|++|||+.|+++.|
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            22344677899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-36  Score=324.15  Aligned_cols=263  Identities=25%  Similarity=0.402  Sum_probs=204.0

Q ss_pred             hccccceeeeccCcEEEEEEEecCC--------------CceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEee
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGD--------------STPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIG  539 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~--------------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g  539 (767)
                      ++|+..+.||+|+||.||++...+.              ...||+|.++... ......|.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            4678888999999999999987532              2358999987553 333456899999999999999999999


Q ss_pred             eeecCCceEEEEecCCCCChhhhhccCC----------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeE
Q 042216          540 YCNDDGQMILVYDYMARGTLRDHLYNND----------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNIL  609 (767)
Q Consensus       540 ~~~~~~~~~lV~ey~~~gsL~~~L~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIL  609 (767)
                      ++...+..++||||+++++|.+++....          ...+++..++.++.|++.||+|||   +.+++|+||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence            9999999999999999999999985432          124789999999999999999999   788999999999999


Q ss_pred             ECCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCccc
Q 042216          610 LDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC--ARPPILRTGDKKQ  687 (767)
Q Consensus       610 ld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt--g~~P~~~~~~~~~  687 (767)
                      +++++.+||+|||+++...............++..|+|||++..+.++.++|||||||+++||++  |..||......+ 
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence            99999999999999875432222222223345778999999998899999999999999999988  567775443321 


Q ss_pred             hhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          688 VNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       688 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                        .............      .......+..++..+.+++.+||+.+|++||+|.+|++.|+
T Consensus       241 --~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 --VIENTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             --HHHHHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence              1111111111110      11111223345678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-37  Score=332.31  Aligned_cols=246  Identities=22%  Similarity=0.297  Sum_probs=207.7

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      +...+.||+|+-|.|-+|++..+|+.+|||++....   ......+.+||-+|+.+.|||+++|++.+.++.++|||.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            445567999999999999999999999999997652   22344678999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++|-|+++|.++  ++|++.+..+++.||+.|+.|+|   ..+|+||||||+|+|||.+.++||+|||+|.+...   .
T Consensus        94 v~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~---g  165 (786)
T KOG0588|consen   94 VPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP---G  165 (786)
T ss_pred             cCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccC---C
Confidence            9999999999654  46999999999999999999999   77899999999999999999999999999986433   2


Q ss_pred             cccccccCCCcccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLT-EKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      ......||++.|.|||++.+.+|. .++||||.|||||.|++|+.||++.   ....|..    .++.|..         
T Consensus       166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd---Nir~LLl----KV~~G~f---------  229 (786)
T KOG0588|consen  166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD---NIRVLLL----KVQRGVF---------  229 (786)
T ss_pred             ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc---cHHHHHH----HHHcCcc---------
Confidence            344567899999999999998875 6899999999999999999999622   1222222    2222221         


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                       +.|...+.+..+|+.+|+..||.+|.|++||++.
T Consensus       230 -~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  230 -EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             -cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence             2345667788999999999999999999999864

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3e-36  Score=315.21  Aligned_cols=253  Identities=28%  Similarity=0.470  Sum_probs=203.8

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      ++|+..+.||+|+||.||+|...++ ..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGN-TKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCC-ceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            4677788999999999999988744 6799999875433 3457899999999999999999999885 45689999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++++|.+++++.....+++.++..++.+++.||.|||   +.+++|+||||+||++++++.++|+|||++........ .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-c
Confidence            9999999997655556899999999999999999999   67899999999999999999999999999875432111 1


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      ......++..|+|||++....++.++||||||+++|||++ |+.||......+   ...   . ...+         ...
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~---~-~~~~---------~~~  222 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLE---Q-VERG---------YRM  222 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHH---H-HHcC---------CCC
Confidence            1122335678999999988899999999999999999999 889986543221   111   1 1111         111


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF  750 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~  750 (767)
                      ..+...+..+.+++.+||+.+|.+|||+.++++.|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            2234456789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.1e-36  Score=330.27  Aligned_cols=247  Identities=24%  Similarity=0.338  Sum_probs=199.6

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEEEecCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILVYDYMARG  557 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~ey~~~g  557 (767)
                      +||+|+||.||+++....++.||+|+++..   .......+.+|..++..+ +||||+++++++.+.+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g   81 (329)
T cd05588           2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG   81 (329)
T ss_pred             eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            699999999999999888899999999753   223345678899999988 7999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccc
Q 042216          558 TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST  637 (767)
Q Consensus       558 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~  637 (767)
                      +|.+++.+.  ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++....  ......
T Consensus        82 ~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~~  154 (329)
T cd05588          82 DLMFHMQRQ--RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTTS  154 (329)
T ss_pred             CHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCccc
Confidence            999988544  46999999999999999999999   78899999999999999999999999999874221  112233


Q ss_pred             cccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCcc--chhHHHHHHHHhhcCCccccccccccCCC
Q 042216          638 QVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKK--QVNLAVWATECYRNGKIGDIIDPFLKGNA  715 (767)
Q Consensus       638 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  715 (767)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||......+  ......+.........          ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~  224 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ----------IRI  224 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC----------CCC
Confidence            4578999999999999999999999999999999999999996432211  1122222222222211          112


Q ss_pred             ChhhHHHHHHHHHHccccCCCCCCC------HHHHH
Q 042216          716 PPVCLNQFVEVAMSCVNDDRIRRPS------MSDVV  745 (767)
Q Consensus       716 ~~~~~~~l~~li~~Cl~~dp~~RPs------~~evl  745 (767)
                      +...+.++.+++.+||+.||.+||+      +++++
T Consensus       225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~  260 (329)
T cd05588         225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK  260 (329)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence            3445677899999999999999997      67776

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-37  Score=298.62  Aligned_cols=265  Identities=21%  Similarity=0.296  Sum_probs=212.9

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCC-----ce
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG-----QM  547 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~-----~~  547 (767)
                      ..++|.+.+.||+|||+-||+++.-.++..+|+|++...+.++.++.++|++..++++|||++++++++..+.     ..
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            3467888999999999999999987777899999998888788888999999999999999999999986543     58


Q ss_pred             EEEEecCCCCChhhhhccC--CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcc
Q 042216          548 ILVYDYMARGTLRDHLYNN--DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK  625 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~  625 (767)
                      |++++|...|+|.+.+...  .+..+++.+.+.|+.++++||++||+.. ++++||||||.|||+.+.+.++|.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence            9999999999999999653  3346999999999999999999999432 359999999999999999999999999987


Q ss_pred             cCCCCCCccc-------cccccCCCcccChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHH
Q 042216          626 FGPNFSKTHV-------STQVKGSIGYLDPEYYRL---QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWAT  695 (767)
Q Consensus       626 ~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~---~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~  695 (767)
                      ..+-.-....       -.....|..|.|||.+.-   ...++++|||||||+||+|+.|..||...-+.          
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~----------  247 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ----------  247 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc----------
Confidence            5322111100       012347889999999864   46789999999999999999999999543221          


Q ss_pred             HHhhcCCcc-ccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 042216          696 ECYRNGKIG-DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF  752 (767)
Q Consensus       696 ~~~~~~~~~-~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~  752 (767)
                          .+.+. .+..+.+..+.....++.+.+++.+|++.||.+||++.+++..++.+.
T Consensus       248 ----GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  248 ----GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ----CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                11111 112222333333447889999999999999999999999999998765

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-36  Score=314.16  Aligned_cols=251  Identities=31%  Similarity=0.501  Sum_probs=207.8

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .++|+..+.||+|+||.||+|...+  +.||+|.+..... ..+++.+|+.++++++|+|++++++++..++..++||||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~~--~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYRG--QKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEecC--cEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            3467788899999999999998863  7899999976544 567899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++++|.+++.......+++..+..++.|++.||.|||   ..+++|+||||+||++++++.+||+|||+++.....   
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~---  155 (256)
T cd05039          82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG---  155 (256)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccc---
Confidence            99999999997665557999999999999999999999   788999999999999999999999999998854221   


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                        ......+..|+|||++....++.++||||||++++||++ |+.||......   .+..    ....+         ..
T Consensus       156 --~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~----~~~~~---------~~  217 (256)
T cd05039         156 --QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP----HVEKG---------YR  217 (256)
T ss_pred             --cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHhcC---------CC
Confidence              112335678999999998899999999999999999997 99998544321   1111    11111         11


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                      ...+..++..+.+++.+||..+|++||++.|++++|+.+
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            122344567899999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3e-36  Score=320.39  Aligned_cols=261  Identities=24%  Similarity=0.409  Sum_probs=206.3

Q ss_pred             HhhccccceeeeccCcEEEEEEEecC-----CCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCc
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQ  546 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~  546 (767)
                      ..++|+..+.||+|+||.||+|..++     .+..||+|.+.... .....++.+|+.+++.++||||+++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45678889999999999999997642     23579999886443 2234468899999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhhhccCC--------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEE
Q 042216          547 MILVYDYMARGTLRDHLYNND--------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKV  618 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki  618 (767)
                      .++||||+++|+|.+++.+..        ...+++..+..++.|++.||.|||   +++|+||||||+|||+++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999996421        234678889999999999999999   788999999999999999999999


Q ss_pred             eecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHH
Q 042216          619 SDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATEC  697 (767)
Q Consensus       619 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~  697 (767)
                      +|||+++...............++..|+|||.+..+.++.++|||||||++|||++ |..||......+   ..   .. 
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~---~~-  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VL---KF-  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HH-
Confidence            99999875432222111222345678999999998899999999999999999998 788886543221   11   11 


Q ss_pred             hhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 042216          698 YRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF  752 (767)
Q Consensus       698 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~  752 (767)
                      ...+..         ...+..++..+.+++.+||+.+|++||++.++++.|++.+
T Consensus       234 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         234 VMDGGY---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            111111         1123344678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.2e-36  Score=317.31  Aligned_cols=259  Identities=22%  Similarity=0.330  Sum_probs=208.6

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      .+|...+.||+|+||.||+|+...+++.||||.+...   .......+.+|+++++.++|||++++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4688888999999999999999888899999987542   2233456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcc--CCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          552 DYMARGTLRDHLYN--NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       552 ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ||+++|+|.+++..  .....+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988853  22345889999999999999999999   78899999999999999999999999999876432


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                      ..  .......++..|+|||.+.+..++.++|+||||+++|||++|+.||......    ...+... ......      
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~-~~~~~~------  225 (267)
T cd08228         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQK-IEQCDY------  225 (267)
T ss_pred             hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHH-HhcCCC------
Confidence            11  1122345888999999999888999999999999999999999998543221    1111111 111110      


Q ss_pred             cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       710 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                        ........+..+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus       226 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         226 --PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             --CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence              0111223456789999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.3e-36  Score=321.69  Aligned_cols=264  Identities=19%  Similarity=0.247  Sum_probs=200.4

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      .++|...+.||+|+||.||+|+...+++.||||++..... .....+.+|+++++.++||||+++++++.++...++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            3678889999999999999999988888999999875432 233457889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |++ ++|.+++.... ..+++..+..++.|++.||.|||   +++|+||||||+|||+++++.+||+|||+++.....  
T Consensus        84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--  156 (303)
T cd07869          84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--  156 (303)
T ss_pred             CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC--
Confidence            996 58888886543 45889999999999999999999   788999999999999999999999999998753221  


Q ss_pred             ccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC---cc----
Q 042216          633 THVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK---IG----  704 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~---~~----  704 (767)
                      ........+++.|+|||.+.+ ..++.++|||||||++|||++|+.||....+..  ..............   ..    
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchhh
Confidence            112234568899999999865 468899999999999999999999997543321  11111111110000   00    


Q ss_pred             -ccccc-cccCCCC---------hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          705 -DIIDP-FLKGNAP---------PVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       705 -~~~d~-~l~~~~~---------~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       ...++ ......+         ...+..+.+++.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence             00000 0000000         012356789999999999999999999984

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2e-36  Score=318.59  Aligned_cols=250  Identities=28%  Similarity=0.492  Sum_probs=199.3

Q ss_pred             eeeccCcEEEEEEEecCCCc--eEEEEEeCCCC-CcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEEEecCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGDST--PVAIKRLNPGS-QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILVYDYMARG  557 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~--~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~ey~~~g  557 (767)
                      +||+|+||.||+|++.+++.  .+++|.++... ......+.+|++++.++ +||||++++++|...+..+++|||+++|
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            68999999999999876654  46888887432 34456789999999999 7999999999999999999999999999


Q ss_pred             ChhhhhccCC--------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCC
Q 042216          558 TLRDHLYNND--------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL  623 (767)
Q Consensus       558 sL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGl  623 (767)
                      +|.+++....              ...+++.++..++.|++.||+|||   +.+++|+||||+|||+++++.+||+|||+
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCCC
Confidence            9999986432              134889999999999999999999   78899999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCC
Q 042216          624 CKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGK  702 (767)
Q Consensus       624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~  702 (767)
                      ++....   .........+..|+|||++....++.++|||||||+++||++ |..||......+   .   ... ...+ 
T Consensus       159 ~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~---~~~-~~~~-  227 (270)
T cd05047         159 SRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L---YEK-LPQG-  227 (270)
T ss_pred             ccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---H---HHH-HhCC-
Confidence            863211   111112234567999999998899999999999999999997 999985433211   1   111 1111 


Q ss_pred             ccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       703 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                              .....+..++.++.+++.+||+.+|.+||++.++++.|+.+++
T Consensus       228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~  270 (270)
T cd05047         228 --------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  270 (270)
T ss_pred             --------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence                    1111223455678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.6e-36  Score=315.27  Aligned_cols=248  Identities=25%  Similarity=0.378  Sum_probs=198.4

Q ss_pred             eeeccCcEEEEEEEe--cCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCC
Q 042216          482 IIGRGGFGNVYKGFL--NGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARG  557 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~--~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~g  557 (767)
                      .||+|+||.||+|.+  ..++..+|+|+++...  ....+++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999975  3445789999986443  223567899999999999999999999986 45778999999999


Q ss_pred             ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc-cc
Q 042216          558 TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH-VS  636 (767)
Q Consensus       558 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~-~~  636 (767)
                      +|.+++...  ..+++..+..++.|++.||.|||   +++++||||||+|||+++++.+||+|||+++......... ..
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            999999643  35899999999999999999999   7889999999999999999999999999987543221111 11


Q ss_pred             ccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCC
Q 042216          637 TQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNA  715 (767)
Q Consensus       637 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  715 (767)
                      ....++..|+|||.+....++.++|||||||++|||++ |+.||......+   +..    ...++         .....
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~i~~~---------~~~~~  219 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQ----MIESG---------ERMEC  219 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHCC---------CCCCC
Confidence            22334678999999988889999999999999999998 999996543321   111    11111         11223


Q ss_pred             ChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          716 PPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       716 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                      +..++.++.+++.+||+.||++||++++|++.|++.
T Consensus       220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            445677899999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.3e-36  Score=329.48  Aligned_cols=247  Identities=26%  Similarity=0.354  Sum_probs=198.2

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEEEecCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILVYDYMARG  557 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~ey~~~g  557 (767)
                      +||+|+||.||++....+++.+|+|+++..   .......+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~   81 (329)
T cd05618           2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG   81 (329)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence            699999999999999888899999998754   223345578898888776 8999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccc
Q 042216          558 TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST  637 (767)
Q Consensus       558 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~  637 (767)
                      +|..++...  ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.....  .....
T Consensus        82 ~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~~  154 (329)
T cd05618          82 DLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTS  154 (329)
T ss_pred             CHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCccc
Confidence            999988543  45899999999999999999999   788999999999999999999999999998743221  11223


Q ss_pred             cccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCcc--chhHHHHHHHHhhcCCccccccccccCCC
Q 042216          638 QVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKK--QVNLAVWATECYRNGKIGDIIDPFLKGNA  715 (767)
Q Consensus       638 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  715 (767)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||.......  ......+.........          ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~~  224 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IRI  224 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------CCC
Confidence            4568999999999999999999999999999999999999995322111  1112222222222211          123


Q ss_pred             ChhhHHHHHHHHHHccccCCCCCCC------HHHHH
Q 042216          716 PPVCLNQFVEVAMSCVNDDRIRRPS------MSDVV  745 (767)
Q Consensus       716 ~~~~~~~l~~li~~Cl~~dp~~RPs------~~evl  745 (767)
                      |...+.++.+++.+||+.||.+||+      +.+++
T Consensus       225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~  260 (329)
T cd05618         225 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ  260 (329)
T ss_pred             CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHh
Confidence            4455677889999999999999998      46665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.8e-36  Score=317.18  Aligned_cols=256  Identities=26%  Similarity=0.440  Sum_probs=205.5

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCc---eEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDST---PVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~---~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++...+.||+|+||.||+|.+..++.   .||||.+... ......+|..|+.++++++||||+++++++.+++..++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46778899999999999999875543   6999998754 3334567999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|+|.+++.... ..+++.+++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++......
T Consensus        85 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          85 EFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             ecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999986543 35899999999999999999999   7889999999999999999999999999987543321


Q ss_pred             Cccccc-ccc--CCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccc
Q 042216          632 KTHVST-QVK--GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDII  707 (767)
Q Consensus       632 ~~~~~~-~~~--gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  707 (767)
                      ...... ...  .+..|+|||++....++.++|||||||++|||++ |+.||......   ....+..    ..      
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~----~~------  227 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIE----QD------  227 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHH----cC------
Confidence            111111 111  2457999999999999999999999999999886 99998654322   1222211    10      


Q ss_pred             cccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       708 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                         .....+..++..+.+++.+||+.+|.+||++.+|+.+|+++
T Consensus       228 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 ---YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ---CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence               11122345567789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.6e-36  Score=313.60  Aligned_cols=249  Identities=24%  Similarity=0.388  Sum_probs=198.8

Q ss_pred             eeeccCcEEEEEEEec--CCCceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCC
Q 042216          482 IIGRGGFGNVYKGFLN--GDSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGT  558 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~--~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gs  558 (767)
                      .||+|+||.||+|.+.  +.+..||+|++..... ...+++.+|+.++++++||||++++++|. ....++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999875  3345699999876533 23456899999999999999999999986 457899999999999


Q ss_pred             hhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc-ccc
Q 042216          559 LRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH-VST  637 (767)
Q Consensus       559 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~-~~~  637 (767)
                      |.+++.... ..+++.++++++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++......... ...
T Consensus        81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            999986433 46899999999999999999999   7789999999999999999999999999987543221111 112


Q ss_pred             cccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCC
Q 042216          638 QVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP  716 (767)
Q Consensus       638 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  716 (767)
                      ...++..|+|||.+....++.++|||||||++|||++ |+.||......+   ..    .....+         .....+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~---------~~~~~~  220 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VM----SFIEQG---------KRLDCP  220 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HH----HHHHCC---------CCCCCC
Confidence            2234678999999998889999999999999999996 999996543321   11    111111         112334


Q ss_pred             hhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       717 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                      ..++.++.+++.+||+.+|++||++.+|.+.|+..
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            56678899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.6e-37  Score=332.60  Aligned_cols=243  Identities=24%  Similarity=0.312  Sum_probs=198.0

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGT  558 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gs  558 (767)
                      .||+|+||.||++.....++.||+|++...   ......++.+|++++..++||||+++.+++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (325)
T cd05594           2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (325)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence            699999999999999888899999998653   22334567889999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcccccc
Q 042216          559 LRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ  638 (767)
Q Consensus       559 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~  638 (767)
                      |.+++...  ..+++.++..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||+++.....  ......
T Consensus        82 L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~  155 (325)
T cd05594          82 LFFHLSRE--RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKT  155 (325)
T ss_pred             HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Cccccc
Confidence            99988543  458999999999999999999993  268999999999999999999999999998743221  112234


Q ss_pred             ccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChh
Q 042216          639 VKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV  718 (767)
Q Consensus       639 ~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  718 (767)
                      ..||..|+|||++.+..++.++|||||||++|||++|+.||......+.   ..    ......          ...+..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~---~~----~i~~~~----------~~~p~~  218 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FE----LILMEE----------IRFPRT  218 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH---HH----HHhcCC----------CCCCCC
Confidence            5699999999999999999999999999999999999999965432211   11    011110          112334


Q ss_pred             hHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042216          719 CLNQFVEVAMSCVNDDRIRRP-----SMSDVVWG  747 (767)
Q Consensus       719 ~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~  747 (767)
                      .+.++.+++.+||+.||.+|+     ++.++++.
T Consensus       219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            566789999999999999996     89998743

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.8e-36  Score=318.04  Aligned_cols=260  Identities=23%  Similarity=0.341  Sum_probs=208.9

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      .+|...+.||+|+||.||++....++..+|||.+...   ......++.+|+.+++.++|+||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            3567777899999999999998878889999987643   2233457889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhcc--CCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          552 DYMARGTLRDHLYN--NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       552 ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ||+++++|.+++..  .....+++.+++.++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998863  23356899999999999999999999   78899999999999999999999999999875432


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                      ..  .......++..|+|||.+.+..++.++||||||+++|||++|..||......    ...+... ...     ...+
T Consensus       159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~~-----~~~~  226 (267)
T cd08229         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK-IEQ-----CDYP  226 (267)
T ss_pred             CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhh-hhc-----CCCC
Confidence            11  1122345888999999999889999999999999999999999998643321    1111111 010     0001


Q ss_pred             cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 042216          710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF  752 (767)
Q Consensus       710 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~  752 (767)
                         ...+...+.++.+++.+||+.+|.+||||.+|+++++++.
T Consensus       227 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         227 ---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence               1112235678999999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.8e-36  Score=323.08  Aligned_cols=262  Identities=23%  Similarity=0.448  Sum_probs=207.9

Q ss_pred             hccccceeeeccCcEEEEEEEec-------CCCceEEEEEeCCCC-CcchhHHHHHHHHHhcc-ccceeeeEeeeeecCC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLN-------GDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDG  545 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~  545 (767)
                      .+|...+.||+|+||.||+++..       .....+|+|.++... .....++.+|++++.++ +||||++++++|..++
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            46778889999999999999753       223579999987542 33455788999999999 6999999999999999


Q ss_pred             ceEEEEecCCCCChhhhhccCC--------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC
Q 042216          546 QMILVYDYMARGTLRDHLYNND--------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD  611 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld  611 (767)
                      ..++++||+++|+|.+++....              ...++|.++.+++.|++.||.|||   +++++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence            9999999999999999996532              245899999999999999999999   78899999999999999


Q ss_pred             CCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhH
Q 042216          612 EEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNL  690 (767)
Q Consensus       612 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l  690 (767)
                      +++.+||+|||+++...............++..|+|||.+..+.++.++|||||||++|||++ |+.||......+   +
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~  245 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---L  245 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence            999999999999975432211111122234567999999998899999999999999999999 888885443211   1


Q ss_pred             HHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          691 AVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       691 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      ..    ....+.         ....+..++.++.+++.+||+.+|++||++.|+++.|+++....
T Consensus       246 ~~----~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         246 FK----LLREGH---------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             HH----HHHcCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence            11    111111         11224456678899999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-36  Score=330.65  Aligned_cols=261  Identities=25%  Similarity=0.405  Sum_probs=203.4

Q ss_pred             hccccceeeeccCcEEEEEEEec-----CCCceEEEEEeCCCC-CcchhHHHHHHHHHhcc-ccceeeeEeeeeecC-Cc
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLN-----GDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDD-GQ  546 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~-~~  546 (767)
                      ++|...+.||+|+||.||+|...     ..++.||||+++... ......+.+|+.++.++ +||||++++++|... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            46888889999999999999742     235789999997543 23345688999999999 689999999988654 56


Q ss_pred             eEEEEecCCCCChhhhhccCC-----------------------------------------------------------
Q 042216          547 MILVYDYMARGTLRDHLYNND-----------------------------------------------------------  567 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~-----------------------------------------------------------  567 (767)
                      .+++|||+++|+|.++++...                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            789999999999999986421                                                           


Q ss_pred             ------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccccccC
Q 042216          568 ------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG  641 (767)
Q Consensus       568 ------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~g  641 (767)
                            ...+++.++..++.|+++||.|||   +++|+||||||+|||+++++.+||+|||+++...............+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                  124788999999999999999999   78899999999999999999999999999875432211111222345


Q ss_pred             CCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhH
Q 042216          642 SIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCL  720 (767)
Q Consensus       642 t~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  720 (767)
                      +..|+|||.+.+..++.++||||||+++|||++ |..||.......  .+.    .....+..         ...+....
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~~~~~---------~~~~~~~~  308 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----RRLKEGTR---------MRAPDYTT  308 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHH----HHHhccCC---------CCCCCCCC
Confidence            678999999998899999999999999999997 899985432211  111    11111111         11122234


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          721 NQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       721 ~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                      .++.+++.+||+.+|.+||++.||++.|+.+++
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            578999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.3e-36  Score=327.84  Aligned_cols=240  Identities=26%  Similarity=0.367  Sum_probs=193.8

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEEEecCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILVYDYMARG  557 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~ey~~~g  557 (767)
                      .||+|+||.||+|...+.++.||+|.++...   ....+.+..|..++..+ +||||+++++++..++..++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg   81 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            6999999999999998888899999987532   23344556677777654 8999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccc
Q 042216          558 TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST  637 (767)
Q Consensus       558 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~  637 (767)
                      +|.+++...  ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        82 ~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~  154 (316)
T cd05592          82 DLMFHIQSS--GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS  154 (316)
T ss_pred             cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence            999998654  35899999999999999999999   7889999999999999999999999999987532211  2233


Q ss_pred             cccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCCh
Q 042216          638 QVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPP  717 (767)
Q Consensus       638 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  717 (767)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +   ... ....          ....+.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~---~~~-i~~~----------~~~~~~  217 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---L---FDS-ILND----------RPHFPR  217 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---H---HHH-HHcC----------CCCCCC
Confidence            4568999999999999899999999999999999999999996543321   1   111 1110          112334


Q ss_pred             hhHHHHHHHHHHccccCCCCCCCHH-HHH
Q 042216          718 VCLNQFVEVAMSCVNDDRIRRPSMS-DVV  745 (767)
Q Consensus       718 ~~~~~l~~li~~Cl~~dp~~RPs~~-evl  745 (767)
                      ..+.++.+++.+||+.||.+||++. +++
T Consensus       218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         218 WISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            4567788999999999999999876 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.5e-36  Score=335.84  Aligned_cols=254  Identities=23%  Similarity=0.310  Sum_probs=199.5

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      .|..++.||+|+||+||+|....+++.+|||++....   ......+.+|++++.+++||||+++++++.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788889999999999999998888999999986432   2334568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+++|+|.+++.+.  ..+++..+..++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            99999999999654  35889999999999999999999   78899999999999999999999999999753210000


Q ss_pred             ---------------------------------------------ccccccccCCCcccChhhhccCCCCchhhHHHHHH
Q 042216          633 ---------------------------------------------THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGV  667 (767)
Q Consensus       633 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGv  667 (767)
                                                                   ........||..|+|||.+.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                         00012346999999999999889999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHH--ccccCCCCCCCHHHHH
Q 042216          668 VLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMS--CVNDDRIRRPSMSDVV  745 (767)
Q Consensus       668 vl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--Cl~~dp~~RPs~~evl  745 (767)
                      ++|||++|+.||......+..  .    .....       ...+........+.++.+++.+  |+..++..||++.|++
T Consensus       237 il~elltG~~Pf~~~~~~~~~--~----~i~~~-------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l  303 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQ--L----KVINW-------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK  303 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHH--H----HHHcc-------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence            999999999999654332111  0    00000       0001111112345667788876  6667777799999998


Q ss_pred             HH
Q 042216          746 WG  747 (767)
Q Consensus       746 ~~  747 (767)
                      ..
T Consensus       304 ~h  305 (381)
T cd05626         304 AH  305 (381)
T ss_pred             cC
Confidence            53

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.1e-36  Score=332.51  Aligned_cols=255  Identities=23%  Similarity=0.355  Sum_probs=197.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|+..+.||+|+||+||++.....++.||||++....   ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999998888999999986432   223456788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|+|.+++.+.  ..+++.++..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            999999999999654  46899999999999999999999   7889999999999999999999999999987532110


Q ss_pred             Cc---------------------------------cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 042216          632 KT---------------------------------HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP  678 (767)
Q Consensus       632 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P  678 (767)
                      ..                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            00                                 001234699999999999999999999999999999999999999


Q ss_pred             CCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHcc--ccCCCCCCCHHHHHHH
Q 042216          679 ILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCV--NDDRIRRPSMSDVVWG  747 (767)
Q Consensus       679 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl--~~dp~~RPs~~evl~~  747 (767)
                      |......+..      .. ..... ..+.   +  ......+.++.+++.+++  ..++..||+++||++.
T Consensus       236 f~~~~~~~~~------~~-i~~~~-~~~~---~--p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         236 FCSETPQETY------KK-VMNWK-ETLI---F--PPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCHHHHH------HH-HHcCc-Cccc---C--CCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            9654322111      11 11100 0000   0  001123455667776633  3344567999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.5e-36  Score=328.47  Aligned_cols=242  Identities=26%  Similarity=0.357  Sum_probs=196.8

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccc-eeeeEeeeeecCCceEEEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYL-HLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hp-niv~l~g~~~~~~~~~lV~  551 (767)
                      +|...+.||+|+||.||+|+..+.++.||||++...   .....+.+..|++++..++|+ +|+++.+++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            477888999999999999999888889999998753   233455678899999999764 6888999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|+|.+++...  ..+++.++..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++....  
T Consensus        81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--  153 (324)
T cd05587          81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--  153 (324)
T ss_pred             cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--
Confidence            999999999998654  35899999999999999999999   78899999999999999999999999999874221  


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                      .........||..|+|||++.+..++.++|||||||++|||++|+.||......+   +..   . ....          
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~---~-i~~~----------  216 (324)
T cd05587         154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQ---S-IMEH----------  216 (324)
T ss_pred             CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHH---H-HHcC----------
Confidence            1112234568999999999999999999999999999999999999996543221   111   1 1111          


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSM  741 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~  741 (767)
                      ....+...+.++.+++.+||+.||.+|++.
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         217 NVSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            112233456778999999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.9e-36  Score=314.56  Aligned_cols=249  Identities=34%  Similarity=0.501  Sum_probs=202.6

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeee-cCCceEEEEec
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN-DDGQMILVYDY  553 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~-~~~~~~lV~ey  553 (767)
                      .+|...+.||+|+||.||++...+  ..+|+|.++..  ...+.+.+|+.++++++|+|++++++++. .++..++++||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~--~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEcC--CcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            467888899999999999998764  67999998643  23457899999999999999999999764 45678999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++|+|.+++.......+++..++.++.|++.||+|||   +++++||||||+||++++++.+||+|||+++.....   
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---  155 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  155 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceecccc---
Confidence            99999999997665556899999999999999999999   788999999999999999999999999998753221   


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                        .....++..|+|||++....++.++|||||||++|||++ |+.||.....      ...... ...+         ..
T Consensus       156 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~~~-~~~~---------~~  217 (256)
T cd05082         156 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPR-VEKG---------YK  217 (256)
T ss_pred             --CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHH-HhcC---------CC
Confidence              122335678999999998899999999999999999997 9999854321      111111 1111         11


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                      ...+..++..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            122345667899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.8e-36  Score=327.90  Aligned_cols=245  Identities=26%  Similarity=0.390  Sum_probs=196.7

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHH---hccccceeeeEeeeeecCCceEEE
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGML---SQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l---~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      |...+.||+|+||.||+|....+++.||||+++...   ....+.+.+|++++   ..++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            456789999999999999998888999999986432   23344566676554   567899999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+++|+|..++.+   ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            999999999988854   35899999999999999999999   788999999999999999999999999998743221


Q ss_pred             CCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                        ........|++.|+|||.+.+..++.++|||||||++|||++|+.||......+.      ... ...+.        
T Consensus       155 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~------~~~-i~~~~--------  217 (324)
T cd05589         155 --GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV------FDS-IVNDE--------  217 (324)
T ss_pred             --CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHhCC--------
Confidence              1222345689999999999999999999999999999999999999965432211      111 11111        


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRP-----SMSDVVW  746 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~  746 (767)
                        ...+...+..+.+++.+||+.||.+||     ++.++++
T Consensus       218 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         218 --VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence              112344567789999999999999999     4666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.2e-36  Score=313.45  Aligned_cols=254  Identities=28%  Similarity=0.452  Sum_probs=206.1

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .++|+..++||+|+||.||+|..++ ++.+|+|.+.... ....++.+|+.++++++|+|++++++++. .+..+++|||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            3567888899999999999998765 4789999987543 33567899999999999999999999874 4578999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++|+|.+++.......+++.++..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||++....... .
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~  157 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-Y  157 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-c
Confidence            99999999997766667999999999999999999999   7889999999999999999999999999987543211 1


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      .......++..|+|||++....++.++||||||++++||++ |+.||......+   ....    ...+         ..
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~~~~---------~~  221 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQN----LERG---------YR  221 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHHH----HHcC---------CC
Confidence            11223345678999999998899999999999999999999 999996543221   1111    1111         11


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF  750 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~  750 (767)
                      ...+...+.++.+++.+||+.+|++||+++++++.|+.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            12233456789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-37  Score=334.49  Aligned_cols=254  Identities=24%  Similarity=0.334  Sum_probs=205.6

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|...+.||+|+||.||++....+++.||||++...   .......+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            3688889999999999999999888899999998643   2234557889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|+|.+++.+.  ..+++..+..++.|++.||.|||   .++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            999999999999655  46899999999999999999999   7889999999999999999999999999987543321


Q ss_pred             ---------------------------CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 042216          632 ---------------------------KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGD  684 (767)
Q Consensus       632 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~  684 (767)
                                                 .........||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                       00112345689999999999999999999999999999999999999965442


Q ss_pred             ccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 042216          685 KKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPS-MSDVVWG  747 (767)
Q Consensus       685 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs-~~evl~~  747 (767)
                      .+.      ........       ..+........+.++.+++.+|++ ||.+||+ +.++++.
T Consensus       236 ~~~------~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         236 QET------YNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHH------HHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            111      01111100       001111111246778999999997 9999999 9999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.5e-36  Score=319.78  Aligned_cols=257  Identities=27%  Similarity=0.440  Sum_probs=205.5

Q ss_pred             hhccccceeeeccCcEEEEEEEecC-----CCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCce
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQM  547 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~  547 (767)
                      .++|+....||+|+||.||++...+     ++..+|+|++.... .....++.+|+.++++++|||+++++++|..++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            4578888899999999999998743     45789999987543 23456789999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhccCC--------------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCC
Q 042216          548 ILVYDYMARGTLRDHLYNND--------------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTN  607 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~N  607 (767)
                      ++++||+++|+|.+++....                    ...+++.+++.++.|++.||.|||   ..+++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999996421                    134789999999999999999999   7889999999999


Q ss_pred             eEECCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCcc
Q 042216          608 ILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKK  686 (767)
Q Consensus       608 ILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~  686 (767)
                      ||+++++.+||+|||+++................+..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999875332221111222335678999999998899999999999999999997 888885443221


Q ss_pred             chhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          687 QVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       687 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                            ... ....+...         ..+..++.++.+++.+||+.+|.+|||+.|+++.|+
T Consensus       241 ------~~~-~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         241 ------VIY-YVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             ------HHH-HHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence                  111 11122111         123345678999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=9.9e-36  Score=311.41  Aligned_cols=253  Identities=28%  Similarity=0.441  Sum_probs=203.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      ++|.....||+|++|.||++...++ ..+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            4577778999999999999988765 469999886543 33457889999999999999999999885 45688999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++|+|.++++......+++..+..++.|++.||.|||   +.+++|+||||+||++++++.++|+|||+++....... .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05069          83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-c
Confidence            9999999997665556899999999999999999999   77899999999999999999999999999875432111 1


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      ......++..|+|||...+..++.++||||||+++|||++ |+.||......+   ...+.    ..+         ...
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~---------~~~  222 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQV----ERG---------YRM  222 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcC---------CCC
Confidence            1122345678999999998899999999999999999999 899986543221   11111    111         011


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF  750 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~  750 (767)
                      ..+...+..+.+++.+||+.+|.+||++++|++.|++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            2233456788999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.3e-36  Score=313.56  Aligned_cols=259  Identities=24%  Similarity=0.345  Sum_probs=210.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|...+.||+|+||.||+|....+++.||+|.++..   .......+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            4688888999999999999999877899999988642   2233567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccC--CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          552 DYMARGTLRDHLYNN--DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       552 ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ||+++|+|.+++...  ....+++.+++.++.+++.||.|||   +.+++|+||||+||+++.++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999998642  3345899999999999999999999   78899999999999999999999999999875432


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                      ..  .......++..|+|||.+.+..++.++|||||||++|||++|+.||.....    .+...... ...+.       
T Consensus       159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-~~~~~-------  224 (267)
T cd08224         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKK-IEKCD-------  224 (267)
T ss_pred             CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhh-hhcCC-------
Confidence            11  112234578899999999988899999999999999999999999854321    11111111 11111       


Q ss_pred             cccCCCCh-hhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 042216          710 FLKGNAPP-VCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF  752 (767)
Q Consensus       710 ~l~~~~~~-~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~  752 (767)
                        ....+. ..+..+.+++.+||+.+|.+||++.+|+++|+.+.
T Consensus       225 --~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         225 --YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             --CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence              111122 45667899999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.7e-36  Score=317.53  Aligned_cols=254  Identities=23%  Similarity=0.343  Sum_probs=202.7

Q ss_pred             HHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc-ccceeeeEeeeeecC------
Q 042216          472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDD------  544 (767)
Q Consensus       472 ~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~------  544 (767)
                      .+++.|+..+.||+|+||.||+|...+.++.+|+|++.... ....++.+|+.++.++ +|+|++++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35667888889999999999999998888999999986543 3455788999999998 799999999998653      


Q ss_pred             CceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCc
Q 042216          545 GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC  624 (767)
Q Consensus       545 ~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla  624 (767)
                      ...+++|||+++|+|.+++.......+++..+..++.|++.||.|||   +.+|+|+||||+||++++++.+||+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            45899999999999999997655567899999999999999999999   678999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCcccChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhh
Q 042216          625 KFGPNFSKTHVSTQVKGSIGYLDPEYYR-----LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR  699 (767)
Q Consensus       625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~  699 (767)
                      +.....  ........|+..|+|||++.     ...++.++|||||||++|||++|+.||..........       ...
T Consensus       159 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-------~~~  229 (272)
T cd06637         159 AQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-------LIP  229 (272)
T ss_pred             eecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-------HHh
Confidence            754321  11223456889999999986     3467889999999999999999999995433211110       001


Q ss_pred             cCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       700 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ...        .....+..++.++.+++.+||+.+|.+|||+.++++
T Consensus       230 ~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         230 RNP--------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             cCC--------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            100        011112234567899999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.6e-36  Score=318.54  Aligned_cols=246  Identities=25%  Similarity=0.346  Sum_probs=197.8

Q ss_pred             eeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCCh
Q 042216          483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTL  559 (767)
Q Consensus       483 LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gsL  559 (767)
                      ||+|+||+||++....+++.+|+|++....   ......+..|+++++.++|+||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999998888899999986432   22335678899999999999999999999999999999999999999


Q ss_pred             hhhhcc--CCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccc
Q 042216          560 RDHLYN--NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST  637 (767)
Q Consensus       560 ~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~  637 (767)
                      .+++..  .....+++..++.++.|++.||.|||   +.+|+||||||+||++++++.+||+|||+++......  ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence            988753  23456899999999999999999999   7889999999999999999999999999987543211  1223


Q ss_pred             cccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCCh
Q 042216          638 QVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPP  717 (767)
Q Consensus       638 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  717 (767)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||.........  .......         ...  ....+.
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~---------~~~--~~~~~~  222 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRI---------LND--SVTYPD  222 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHhh---------ccc--CCCCcc
Confidence            456899999999999999999999999999999999999999654332111  1111110         000  012234


Q ss_pred             hhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042216          718 VCLNQFVEVAMSCVNDDRIRRP-----SMSDVVW  746 (767)
Q Consensus       718 ~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~  746 (767)
                      ..+..+.+++.+||+.||++||     +++++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            4667889999999999999999     6777774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.4e-36  Score=326.66  Aligned_cols=242  Identities=25%  Similarity=0.336  Sum_probs=196.8

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      +|...+.||+|+||.||+|....+++.||+|.+....   ......+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778889999999999999998888899999987542   22334567788888777 5899999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|+|.+++...  ..+++.++..++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++....  
T Consensus        81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--  153 (323)
T cd05616          81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--  153 (323)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--
Confidence            999999999998654  35899999999999999999999   78899999999999999999999999999874321  


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                      .........||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+..   . .....         
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~---~-i~~~~---------  217 (323)
T cd05616         154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQ---S-IMEHN---------  217 (323)
T ss_pred             CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHH---H-HHhCC---------
Confidence            111233456899999999999999999999999999999999999999654322   1111   1 11111         


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSM  741 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~  741 (767)
                       ...+...+.++.+++.+|++.||.+|++.
T Consensus       218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence             12234456788999999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.2e-36  Score=319.69  Aligned_cols=247  Identities=22%  Similarity=0.295  Sum_probs=197.5

Q ss_pred             eeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCCh
Q 042216          483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTL  559 (767)
Q Consensus       483 LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gsL  559 (767)
                      ||+|+||.||++..+.+++.+|+|++....   ......+..|++++++++||||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999998888999999986431   12233456799999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccccc
Q 042216          560 RDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV  639 (767)
Q Consensus       560 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~  639 (767)
                      .+++.......+++..+..++.|++.||.|||   +.+++||||||+|||++.++.++|+|||++......   ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeecc
Confidence            99987665567999999999999999999999   788999999999999999999999999998754321   122345


Q ss_pred             cCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhh
Q 042216          640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVC  719 (767)
Q Consensus       640 ~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  719 (767)
                      .|+..|+|||++.+..++.++|||||||++|||++|+.||.......  .......... ...        +. ......
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~-~~~--------~~-~~~~~~  222 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTL-EDE--------VK-FEHQNF  222 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhh-ccc--------cc-cccccC
Confidence            68999999999998889999999999999999999999996443211  1111111111 111        00 011234


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          720 LNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       720 ~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      +.++.+++.+||+.||++||++.|+++.
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccchhh
Confidence            5678999999999999999999776643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-36  Score=311.98  Aligned_cols=249  Identities=33%  Similarity=0.542  Sum_probs=206.1

Q ss_pred             eeeccCcEEEEEEEecCC---CceEEEEEeCCCCCcc-hhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGD---STPVAIKRLNPGSQQG-ALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARG  557 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~---~~~vAVK~l~~~~~~~-~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~g  557 (767)
                      .||+|+||.||++.....   +..+++|.+....... .+.+.+|++++..++|+|++++++++......+++|||++++
T Consensus         2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (262)
T cd00192           2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG   81 (262)
T ss_pred             ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence            699999999999999865   7899999997654333 677899999999999999999999999999999999999999


Q ss_pred             ChhhhhccCC-------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          558 TLRDHLYNND-------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       558 sL~~~L~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      +|.+++....       ...+++.+++.++.|++.||.|||   +++++|+||||+||++++++.+||+|||+++.....
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            9999997642       356999999999999999999999   788999999999999999999999999999865443


Q ss_pred             CCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                      ..........++..|+|||.+....++.++||||+||+++||++ |+.||......   .+..    ....+        
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~----~~~~~--------  223 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLE----YLRKG--------  223 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHHcC--------
Confidence            22222334557889999999998899999999999999999999 69998655321   1111    11111        


Q ss_pred             cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       710 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                       .....+..++.++.+++.+||+.+|.+||++.|+++.|+
T Consensus       224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 -YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             111234455778999999999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-36  Score=312.09  Aligned_cols=249  Identities=27%  Similarity=0.405  Sum_probs=200.1

Q ss_pred             eeeccCcEEEEEEEecCCC---ceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGDS---TPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARG  557 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~---~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~g  557 (767)
                      +||+|+||.||+|.....+   ..+|+|.+..... ...+++.+|+++++.+.|+|++++++++. .+..++||||+++|
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~   80 (257)
T cd05060           2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLG   80 (257)
T ss_pred             ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCC
Confidence            6999999999999875544   6899999876543 24567899999999999999999999886 45789999999999


Q ss_pred             ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc-cc
Q 042216          558 TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH-VS  636 (767)
Q Consensus       558 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~-~~  636 (767)
                      +|.+++....  .+++..++.++.|++.||.|||   ..+++|+||||+|||++.++.+||+|||+++......... ..
T Consensus        81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          81 PLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            9999996543  6899999999999999999999   7789999999999999999999999999987543222111 11


Q ss_pred             ccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCC
Q 042216          637 TQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNA  715 (767)
Q Consensus       637 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  715 (767)
                      ....++..|+|||.+....++.++|||||||++|||++ |+.||......   .+..+.    ....         ....
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~----~~~~---------~~~~  219 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAML----ESGE---------RLPR  219 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH----HcCC---------cCCC
Confidence            12224568999999998899999999999999999998 99998654321   122211    1111         1123


Q ss_pred             ChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 042216          716 PPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF  752 (767)
Q Consensus       716 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~  752 (767)
                      +..++..+.+++.+||+.+|.+||++.+|++.|+++.
T Consensus       220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            4456678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-36  Score=328.10  Aligned_cols=242  Identities=26%  Similarity=0.378  Sum_probs=196.0

Q ss_pred             eeeeccCcEEEEEEEec---CCCceEEEEEeCCC----CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          481 LIIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG----SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~---~~~~~vAVK~l~~~----~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      +.||+|+||.||+++..   ..++.||+|+++..    .......+.+|+++|+.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            47999999999999863   34678999998643    223344578899999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++|+|.+++.+.  ..+.+..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....  ..
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~  154 (323)
T cd05584          82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EG  154 (323)
T ss_pred             CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CC
Confidence            9999999999654  45788899999999999999999   78899999999999999999999999999874321  11


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      .......|++.|+|||++.+..++.++|||||||++|||++|+.||.......      .... ...+.          .
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~~-~~~~~----------~  217 (323)
T cd05584         155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TIDK-ILKGK----------L  217 (323)
T ss_pred             CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHHH-HHcCC----------C
Confidence            12234568999999999998889999999999999999999999996543211      1111 11111          1


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRP-----SMSDVVW  746 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~  746 (767)
                      ..+...+.++.+++.+||+.+|++||     ++.++++
T Consensus       218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            22344567789999999999999999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.6e-36  Score=327.56  Aligned_cols=236  Identities=25%  Similarity=0.366  Sum_probs=193.5

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEEEecCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILVYDYMARG  557 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~ey~~~g  557 (767)
                      +||+|+||.||+++.+.+++.||||++...   .......+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g   81 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG   81 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence            699999999999999888899999998643   233445677888888876 6999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccc
Q 042216          558 TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST  637 (767)
Q Consensus       558 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~  637 (767)
                      +|.+++.+.  ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++....  ......
T Consensus        82 ~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~  154 (320)
T cd05590          82 DLMFHIQKS--RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTS  154 (320)
T ss_pred             hHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccc
Confidence            999998654  35899999999999999999999   78899999999999999999999999999874321  112233


Q ss_pred             cccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCCh
Q 042216          638 QVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPP  717 (767)
Q Consensus       638 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  717 (767)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +.   .. ...+.          ...+.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~---~~-i~~~~----------~~~~~  217 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---LF---EA-ILNDE----------VVYPT  217 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HH---HH-HhcCC----------CCCCC
Confidence            4568999999999999999999999999999999999999996543221   11   11 11111          01233


Q ss_pred             hhHHHHHHHHHHccccCCCCCCCH
Q 042216          718 VCLNQFVEVAMSCVNDDRIRRPSM  741 (767)
Q Consensus       718 ~~~~~l~~li~~Cl~~dp~~RPs~  741 (767)
                      ..+.++.+++.+||+.||.+||++
T Consensus       218 ~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         218 WLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCHHHHHHHHHHcccCHHHCCCC
Confidence            356678999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-36  Score=315.27  Aligned_cols=260  Identities=26%  Similarity=0.427  Sum_probs=208.2

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCc----eEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDST----PVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~----~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      .+|+..+.||+|+||.||+|..+..+.    .+|+|.+..... ....++.+|+.++++++|||+++++++|.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            467777899999999999999765433    689998875533 345678999999999999999999999987 78999


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      |+||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+++|+||||+|||+++++.+||+|||+++....
T Consensus        86 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            999999999999997643 34899999999999999999999   78899999999999999999999999999986543


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      ...........++..|+|||.+....++.++|+||||++++||++ |+.||......+   +..    ....+.      
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~------  228 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPD----LLEKGE------  228 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHH----HHhCCC------
Confidence            222211122234578999999988899999999999999999998 999986543211   111    111111      


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                         ....+..+...+.+++.+||..+|.+||++.++++.|+.+.+..
T Consensus       229 ---~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05057         229 ---RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP  272 (279)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence               11223345677899999999999999999999999999886544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.2e-36  Score=326.23  Aligned_cols=243  Identities=25%  Similarity=0.340  Sum_probs=196.8

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEEEecCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILVYDYMARG  557 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~ey~~~g  557 (767)
                      +||+|+||+||++....+++.+|+|++....   ....+.+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (327)
T cd05617           2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG   81 (327)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence            6999999999999998888999999997542   23345678899999888 6999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccc
Q 042216          558 TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST  637 (767)
Q Consensus       558 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~  637 (767)
                      +|.+++...  ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....  ......
T Consensus        82 ~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~  154 (327)
T cd05617          82 DLMFHMQRQ--RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTS  154 (327)
T ss_pred             cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCcee
Confidence            999988543  35999999999999999999999   78899999999999999999999999999874221  112223


Q ss_pred             cccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCCh
Q 042216          638 QVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPP  717 (767)
Q Consensus       638 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  717 (767)
                      ...||+.|+|||++.+..++.++|||||||+||||++|+.||.............+.........          ...+.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------~~~p~  224 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP----------IRIPR  224 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC----------CCCCC
Confidence            45689999999999999999999999999999999999999965433222222222222222211          11233


Q ss_pred             hhHHHHHHHHHHccccCCCCCCCH
Q 042216          718 VCLNQFVEVAMSCVNDDRIRRPSM  741 (767)
Q Consensus       718 ~~~~~l~~li~~Cl~~dp~~RPs~  741 (767)
                      ..+.++.+++.+||+.||.+||++
T Consensus       225 ~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         225 FLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCHHHHHHHHHHhccCHHHcCCC
Confidence            455678899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.6e-36  Score=327.78  Aligned_cols=242  Identities=24%  Similarity=0.323  Sum_probs=196.9

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEEEecCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILVYDYMARG  557 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~ey~~~g  557 (767)
                      +||+|+||.||+|+..++++.||+|++...   .......+..|.+++..+ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   81 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG   81 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence            699999999999999888889999998753   223345577888888866 7999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccc
Q 042216          558 TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST  637 (767)
Q Consensus       558 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~  637 (767)
                      +|..++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....  .....
T Consensus        82 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~  154 (321)
T cd05591          82 DLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTTT  154 (321)
T ss_pred             cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccC--Ccccc
Confidence            999998654  35899999999999999999999   788999999999999999999999999998753221  12233


Q ss_pred             cccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCCh
Q 042216          638 QVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPP  717 (767)
Q Consensus       638 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  717 (767)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||......+   +.   ... ..+.          ...+.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~---~~i-~~~~----------~~~p~  217 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LF---ESI-LHDD----------VLYPV  217 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HH---HHH-HcCC----------CCCCC
Confidence            4568999999999999999999999999999999999999996543321   11   111 1111          01233


Q ss_pred             hhHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 042216          718 VCLNQFVEVAMSCVNDDRIRRP-------SMSDVVWG  747 (767)
Q Consensus       718 ~~~~~l~~li~~Cl~~dp~~RP-------s~~evl~~  747 (767)
                      ..+.++.+++.+||+.||.+||       ++.++++.
T Consensus       218 ~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         218 WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            3456789999999999999999       77777743

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=7e-36  Score=313.86  Aligned_cols=257  Identities=27%  Similarity=0.444  Sum_probs=205.8

Q ss_pred             hccccceeeeccCcEEEEEEEecCC---CceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGD---STPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      .+|...+.||+|+||.||+|.+...   ...+|+|.++... ......+.+|+.++.+++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            4677888999999999999987533   3479999987543 23345789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+++|+|.+++.... ..+++.+++.++.|++.||.|||   +.+++||||||+|||++.++.++|+|||+++.....
T Consensus        84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999997543 35899999999999999999999   788999999999999999999999999998865332


Q ss_pred             CCcc-ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          631 SKTH-VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       631 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      .... ......++..|+|||++.+..++.++|+|||||+++|+++ |+.||......+   .....    .++       
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~----~~~-------  225 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAI----EEG-------  225 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHH----hCC-------
Confidence            1111 1112234568999999998899999999999999999886 999986543221   11111    111       


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                        .+...+..++..+.+++.+|++.+|.+||+|.++++.|+++
T Consensus       226 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         226 --YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             --CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence              01112334567789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=334.47  Aligned_cols=253  Identities=22%  Similarity=0.316  Sum_probs=201.1

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|+..+.||+|+||+||++....+++.||||++...   .......+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            4688899999999999999999888899999998643   1233456788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            999999999999654  35899999999999999999999   7889999999999999999999999999986432111


Q ss_pred             Cc------------------------------------cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhC
Q 042216          632 KT------------------------------------HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCA  675 (767)
Q Consensus       632 ~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg  675 (767)
                      ..                                    .......||+.|+|||++....++.++|||||||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            00                                    001124589999999999999999999999999999999999


Q ss_pred             CCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 042216          676 RPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPS---MSDVVW  746 (767)
Q Consensus       676 ~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs---~~evl~  746 (767)
                      +.||......+   ..   .......       ..+........++++.+++.+|+. +|.+|++   +.|+++
T Consensus       236 ~~Pf~~~~~~~---~~---~~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         236 YPPFCSDNPQE---TY---RKIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCHHH---HH---HHHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            99996543211   11   1111000       001111112345678899999996 8999997   888875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-35  Score=311.20  Aligned_cols=255  Identities=29%  Similarity=0.495  Sum_probs=208.1

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .++|...+.||+|+||.||++..++ ++.+|||.+.... ....++.+|++++++++|+|++++++++......++||||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            4578888899999999999999864 4789999987543 3456799999999999999999999999988999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++++|.+++.......+++.++..++.+++.||.|||   +.+++|+||||+||++++++.+||+|||+++...... .
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~  158 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-Y  158 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchh-h
Confidence            99999999997766567999999999999999999999   7789999999999999999999999999987543211 1


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      .......++..|+|||.+.+..++.++||||||++++||++ |+.||.......   ....    ...+         ..
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~----~~~~---------~~  222 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQ----VERG---------YR  222 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcC---------CC
Confidence            11122234568999999998899999999999999999998 999996543221   1111    1110         11


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF  750 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~  750 (767)
                      ...+...+.++.+++.+|++.+|.+||++.++++.|+.
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            12233446789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6.2e-36  Score=314.32  Aligned_cols=257  Identities=22%  Similarity=0.381  Sum_probs=206.8

Q ss_pred             HHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       470 i~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      ++.+++++.....||+|+||.||+|....++..|++|.+........+.+.+|++++++++|+||+++++++..++..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            44567778888899999999999999888888999999877666667789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCCCCCC--ChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC-CCcEEEeecCCccc
Q 042216          550 VYDYMARGTLRDHLYNNDNPPL--PWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE-EWVAKVSDFGLCKF  626 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~-~~~~ki~DfGla~~  626 (767)
                      ++||+++++|.+++.... ..+  ++..+..++.|++.||.|||   ..+|+||||||+||+++. ++.+||+|||++..
T Consensus        83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          83 FMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            999999999999997542 234  78889999999999999999   788999999999999986 67999999999875


Q ss_pred             CCCCCCccccccccCCCcccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYRLQ--LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG  704 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  704 (767)
                      .....  .......++..|+|||++...  .++.++||||||+++|||++|+.||.......   ...+.....      
T Consensus       159 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~------  227 (268)
T cd06624         159 LAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMF------  227 (268)
T ss_pred             cccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhh------
Confidence            43211  112234578999999998654  37899999999999999999999986443211   111110000      


Q ss_pred             ccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          705 DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       705 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                           ......+.....++.+++.+||+.+|.+|||+.|++.
T Consensus       228 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         228 -----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             -----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                 0111234455677899999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6e-36  Score=319.45  Aligned_cols=263  Identities=24%  Similarity=0.390  Sum_probs=204.1

Q ss_pred             hccccceeeeccCcEEEEEEEecC----------------CCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNG----------------DSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSL  537 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~----------------~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l  537 (767)
                      ++|+..+.||+|+||.||++...+                ....+|+|++.... .....++.+|++++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            468888899999999999986432                23469999987543 3345679999999999999999999


Q ss_pred             eeeeecCCceEEEEecCCCCChhhhhccCC---------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCe
Q 042216          538 IGYCNDDGQMILVYDYMARGTLRDHLYNND---------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNI  608 (767)
Q Consensus       538 ~g~~~~~~~~~lV~ey~~~gsL~~~L~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NI  608 (767)
                      ++++...+..+++|||+++|+|.+++....         ...+++.++..++.|++.||.|||   +.+++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence            999999999999999999999999986532         124788899999999999999999   77899999999999


Q ss_pred             EECCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCcc
Q 042216          609 LLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC--ARPPILRTGDKK  686 (767)
Q Consensus       609 Lld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt--g~~P~~~~~~~~  686 (767)
                      |+++++.++|+|||+++...............++..|+|||....+.++.++|||||||++|||++  |..||......+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999875432211111222334678999999888889999999999999999998  778885443322


Q ss_pred             chhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          687 QVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       687 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                      .   .............      ......+..++..+.+++.+||+.||.+||++.+|++.|+
T Consensus       242 ~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 V---IENTGEFFRDQGR------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             H---HHHHHHHHhhccc------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1   1111111111100      0111223446678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.3e-36  Score=326.10  Aligned_cols=241  Identities=24%  Similarity=0.344  Sum_probs=197.1

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEEEecCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILVYDYMARG  557 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~ey~~~g  557 (767)
                      .||+|+||+||++....+++.||||++...   .......+..|++++..+ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (318)
T cd05570           2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG   81 (318)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            699999999999999888889999998743   223445677888988887 7999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccc
Q 042216          558 TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST  637 (767)
Q Consensus       558 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~  637 (767)
                      +|.+++.+.  ..+++.++..++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++....  ......
T Consensus        82 ~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~  154 (318)
T cd05570          82 DLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTS  154 (318)
T ss_pred             CHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCccc
Confidence            999988654  35899999999999999999999   78899999999999999999999999999874221  111223


Q ss_pred             cccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCCh
Q 042216          638 QVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPP  717 (767)
Q Consensus       638 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  717 (767)
                      ...|+..|+|||++.+..++.++|||||||++|||++|+.||.......   ..   .. .....          ...+.
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~~---~~-i~~~~----------~~~~~  217 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---LF---QS-ILEDE----------VRYPR  217 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---HH---HH-HHcCC----------CCCCC
Confidence            3568999999999999999999999999999999999999996443211   11   11 11111          11233


Q ss_pred             hhHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 042216          718 VCLNQFVEVAMSCVNDDRIRRPSM-----SDVVW  746 (767)
Q Consensus       718 ~~~~~l~~li~~Cl~~dp~~RPs~-----~evl~  746 (767)
                      ..+..+.+++.+||+.||.+||++     .++++
T Consensus       218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            456778999999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.5e-36  Score=314.46  Aligned_cols=255  Identities=22%  Similarity=0.324  Sum_probs=203.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      .+|+..+.||+|+||.||+|+...+++.||+|++..........+.+|+.++++++||||+++++++..++..++|+||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            46888889999999999999998888899999997655455567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++++|.++++..  .++++.++..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++......  .
T Consensus        89 ~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~  161 (267)
T cd06646          89 GGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--A  161 (267)
T ss_pred             CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc--c
Confidence            999999998643  46899999999999999999999   7889999999999999999999999999987543211  1


Q ss_pred             ccccccCCCcccChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          635 VSTQVKGSIGYLDPEYYR---LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                      ......++..|+|||.+.   ...++.++|||||||++|||++|+.|+......+...  .     ....   ....+..
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~-----~~~~---~~~~~~~  231 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--L-----MSKS---NFQPPKL  231 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--e-----eecC---CCCCCCC
Confidence            122345788999999884   3457889999999999999999999985432211100  0     0000   0000111


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGL  748 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L  748 (767)
                      .  .....+..+.+++.+||+.+|++||+++++++.|
T Consensus       232 ~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 K--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             c--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1  1123456789999999999999999999998643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.2e-36  Score=324.59  Aligned_cols=240  Identities=26%  Similarity=0.343  Sum_probs=193.8

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhc-cccceeeeEeeeeecCCceEEEEecCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQ-LRYLHLVSLIGYCNDDGQMILVYDYMARG  557 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~-l~Hpniv~l~g~~~~~~~~~lV~ey~~~g  557 (767)
                      .||+|+||+||+|...++++.||||+++...   ......+..|..++.. ++||||+++++++.+.+..++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g   81 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence            6999999999999998888899999987541   2334456778888876 48999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccc
Q 042216          558 TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST  637 (767)
Q Consensus       558 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~  637 (767)
                      +|.+++...  ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....  .....
T Consensus        82 ~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~  154 (316)
T cd05619          82 DLMFHIQSC--HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTC  154 (316)
T ss_pred             cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCcee
Confidence            999999653  45899999999999999999999   788999999999999999999999999998742211  11223


Q ss_pred             cccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCCh
Q 042216          638 QVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPP  717 (767)
Q Consensus       638 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  717 (767)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||......+   +...    .....          ...+.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~----i~~~~----------~~~~~  217 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQS----IRMDN----------PCYPR  217 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHH----HHhCC----------CCCCc
Confidence            4568999999999999899999999999999999999999996543211   1111    11110          11223


Q ss_pred             hhHHHHHHHHHHccccCCCCCCCHH-HHH
Q 042216          718 VCLNQFVEVAMSCVNDDRIRRPSMS-DVV  745 (767)
Q Consensus       718 ~~~~~l~~li~~Cl~~dp~~RPs~~-evl  745 (767)
                      ....++.+++.+||+.||.+||++. +++
T Consensus       218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         218 WLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             cCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            3456788999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-36  Score=312.67  Aligned_cols=253  Identities=23%  Similarity=0.349  Sum_probs=205.0

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-----CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-----QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      ++|...+.||+|++|.||++....+++.+|+|.+....     ....+.+.+|++++++++||||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46888889999999999999988788999999886432     1233568899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      |+||+++++|.+++...  ..+++..+..++.|++.||.|||   ..+++|+||||+||++++++.++|+|||+++....
T Consensus        82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            99999999999998654  35889999999999999999999   78899999999999999999999999999875432


Q ss_pred             CCCccc-cccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          630 FSKTHV-STQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       630 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      ...... .....++..|+|||.+.+..++.++||||||+++|||++|+.||........   ..   ....         
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~---~~~~---------  221 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA---IF---KIAT---------  221 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH---HH---HHhc---------
Confidence            211111 1234578899999999998899999999999999999999999864322111   00   0000         


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      .......+......+.+++.+||..+|.+|||+.|+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         222 QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            011122344566788999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.3e-36  Score=326.00  Aligned_cols=252  Identities=24%  Similarity=0.305  Sum_probs=198.9

Q ss_pred             ccccceeeeccCcEEEEEEEec---CCCceEEEEEeCCC----CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCce
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG----SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQM  547 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~---~~~~~vAVK~l~~~----~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~  547 (767)
                      +|+..+.||+|+||.||+++..   ..++.||+|++...    .....+.+..|++++..+ +|+||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4778889999999999998864   34678999998643    122344678899999999 589999999999999999


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      ++||||+++|+|.+++.+.  ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            9999999999999999654  35899999999999999999999   788999999999999999999999999998754


Q ss_pred             CCCCCccccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccc
Q 042216          628 PNFSKTHVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI  706 (767)
Q Consensus       628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  706 (767)
                      ..... .......||..|+|||++.+. .++.++|||||||++|||++|+.||.........  ...... ...      
T Consensus       156 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~-~~~------  225 (332)
T cd05614         156 LSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRR-ILK------  225 (332)
T ss_pred             cccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHH-Hhc------
Confidence            22111 122345699999999999865 4788999999999999999999999644332111  111111 111      


Q ss_pred             ccccccCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042216          707 IDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRP-----SMSDVVW  746 (767)
Q Consensus       707 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~  746 (767)
                          .....+...+..+.+++.+||+.||++||     +++++++
T Consensus       226 ----~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         226 ----CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence                01122334566788999999999999999     7778874

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.3e-36  Score=319.89  Aligned_cols=263  Identities=27%  Similarity=0.416  Sum_probs=207.1

Q ss_pred             hccccceeeeccCcEEEEEEEecC----CCceEEEEEeCCCCCc-chhHHHHHHHHHhccccceeeeEeeeeec--CCce
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNG----DSTPVAIKRLNPGSQQ-GALEFQTEIGMLSQLRYLHLVSLIGYCND--DGQM  547 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~----~~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~--~~~~  547 (767)
                      .+|...+.||+|+||.||++++..    .+..+|||.+...... ...+|.+|+++++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            356667789999999999998753    3578999999765443 46679999999999999999999999977  5578


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      +++|||+++++|.+++.... ..+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++...
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            99999999999999996543 25999999999999999999999   788999999999999999999999999999865


Q ss_pred             CCCCCc-cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccch---------hHHHHHHHH
Q 042216          628 PNFSKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQV---------NLAVWATEC  697 (767)
Q Consensus       628 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~---------~l~~~~~~~  697 (767)
                      ...... .......++..|+|||.+....++.++||||||++++||++|+.|+.........         ....+. ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~  238 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL-EL  238 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH-HH
Confidence            422111 1112234556799999999889999999999999999999999997543221100         011111 11


Q ss_pred             hhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          698 YRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       698 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                      .         ....+...+..++.++.+++.+||+.+|.+||++.||+++|+++
T Consensus       239 ~---------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 L---------KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             H---------HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1         11111222345567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=7.6e-36  Score=348.61  Aligned_cols=264  Identities=23%  Similarity=0.311  Sum_probs=208.2

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC---cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ---QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|+..++||+|+||.||+|.....++.||+|++.....   ...++|.+|++++++++||||+++++++.+++..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            468888999999999999999988889999999875422   23456899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccC---------CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecC
Q 042216          552 DYMARGTLRDHLYNN---------DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFG  622 (767)
Q Consensus       552 ey~~~gsL~~~L~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfG  622 (767)
                      ||+++|+|.+++...         ....+++..++.++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988532         1234678889999999999999999   7889999999999999999999999999


Q ss_pred             CcccCCCCCC----------------ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCcc
Q 042216          623 LCKFGPNFSK----------------THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKK  686 (767)
Q Consensus       623 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~  686 (767)
                      +++.......                ........||+.|||||++.+..++.++|||||||++|||++|+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9975411100                001123468999999999999999999999999999999999999996532211


Q ss_pred             chhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhHhhh
Q 042216          687 QVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRP-SMSDVVWGLEFVFQLL  755 (767)
Q Consensus       687 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RP-s~~evl~~L~~~~~~~  755 (767)
                      ...     ..        .+.++.-. ......+..+.+++.+|++.||++|| +++++++.|+..++..
T Consensus       239 i~~-----~~--------~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~  294 (932)
T PRK13184        239 ISY-----RD--------VILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS  294 (932)
T ss_pred             hhh-----hh--------hccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence            100     00        00010000 00123456788999999999999995 6788888888877643

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.5e-36  Score=330.00  Aligned_cols=259  Identities=20%  Similarity=0.202  Sum_probs=198.2

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      .+|...+.||+|+||.||++.....++.||+|...      ...+.+|+++|++++||||+++++++..+...++|+|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            57999999999999999999998888999999753      235688999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      . ++|.+++...  ..+++.+++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus       166 ~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~  238 (391)
T PHA03212        166 K-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-AN  238 (391)
T ss_pred             C-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cc
Confidence            6 6898888544  35899999999999999999999   7789999999999999999999999999987532211 11


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCcc-----chhHHHHHHHHhh--cC------
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKK-----QVNLAVWATECYR--NG------  701 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~-----~~~l~~~~~~~~~--~~------  701 (767)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.|+.......     ...+.......-.  ..      
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            2234579999999999999999999999999999999999998875432110     0111111000000  00      


Q ss_pred             -Ccccc---------ccccccCC--CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          702 -KIGDI---------IDPFLKGN--APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       702 -~~~~~---------~d~~l~~~--~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       .+...         ..+..+..  .....+.++.+++.+||+.||.+|||++|+++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence             00000         00000000  00123557889999999999999999999985

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.2e-35  Score=308.67  Aligned_cols=246  Identities=28%  Similarity=0.459  Sum_probs=199.0

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCCCCc-chhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCChh
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ-GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLR  560 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gsL~  560 (767)
                      +||+|+||.||+|... +++.+|+|.+...... ....+.+|++++++++||||++++++|...+..++||||+++|+|.
T Consensus         2 ~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             ccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            6899999999999876 4578999998765432 3346889999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcccccccc
Q 042216          561 DHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK  640 (767)
Q Consensus       561 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~  640 (767)
                      +++.... ..+++.+++.++.|++.+|.|||   +++++|+||||+||++++++.+||+|||++....... ........
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~  155 (250)
T cd05085          81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQ  155 (250)
T ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCC
Confidence            9986543 35899999999999999999999   7889999999999999999999999999987432211 11112223


Q ss_pred             CCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhh
Q 042216          641 GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVC  719 (767)
Q Consensus       641 gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  719 (767)
                      ++..|+|||++....++.++||||||+++||+++ |..||.......   ..    .....+         .+...+..+
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~----~~~~~~---------~~~~~~~~~  219 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---AR----EQVEKG---------YRMSCPQKC  219 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HH----HHHHcC---------CCCCCCCCC
Confidence            4678999999998899999999999999999998 999986543211   11    111111         111223445


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          720 LNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       720 ~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                      +.++.+++.+||+.+|++||++.|+++.|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6.3e-36  Score=329.95  Aligned_cols=264  Identities=23%  Similarity=0.243  Sum_probs=200.2

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCC-----ceE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG-----QMI  548 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~-----~~~  548 (767)
                      +|+..+.||+|+||.||++....+++.||||++...  .....+++.+|+++++.++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477888999999999999998878899999998643  2234457889999999999999999999998776     789


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      +|+||+. ++|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            9999997 5888887443  46899999999999999999999   7889999999999999999999999999997543


Q ss_pred             CCCCccccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHH--------------
Q 042216          629 NFSKTHVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVW--------------  693 (767)
Q Consensus       629 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~--------------  693 (767)
                      ... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||..............              
T Consensus       155 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~  233 (372)
T cd07853         155 PDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC  233 (372)
T ss_pred             cCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            211 1122334578899999998764 579999999999999999999999965543221111100              


Q ss_pred             --HHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          694 --ATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       694 --~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                        ....+..... ................+++.+++.+||+.||.+|||+.|+++.
T Consensus       234 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         234 EGARAHILRGPH-KPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHHHhCCC-CCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence              0000000000 0000000001122345678999999999999999999999853

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=7.7e-36  Score=311.09  Aligned_cols=251  Identities=21%  Similarity=0.328  Sum_probs=206.3

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      +|+..+.||+|+||.||+++...+++.+|+|.+... .....+.+.+|+.++++++|+|++++++.+..++..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            467788999999999999999888899999998643 3334567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++|+|.+++.......+++..++.++.|++.||.|||   +++|+|+||||+||++++++.++|+|||+++.....  ..
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GA  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccc--cc
Confidence            9999999987655566899999999999999999999   788999999999999999999999999998754321  11


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN  714 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  714 (767)
                      ......++..|+|||++.+..++.++|+||||+++|+|++|+.||......      ..... ...+...         .
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~---------~  219 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILK-VCQGSYK---------P  219 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHH-HhcCCCC---------C
Confidence            223456888999999999889999999999999999999999999643221      11111 1111111         1


Q ss_pred             CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       715 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      .+...+..+.+++.+||+.||.+||++.+++..
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            233455678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=9.6e-36  Score=323.60  Aligned_cols=262  Identities=25%  Similarity=0.434  Sum_probs=207.8

Q ss_pred             hccccceeeeccCcEEEEEEEecCC-------CceEEEEEeCCCC-CcchhHHHHHHHHHhcc-ccceeeeEeeeeecCC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGD-------STPVAIKRLNPGS-QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDG  545 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~-------~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~  545 (767)
                      .+|...+.||+|+||.||++...+.       ...||+|.+.... ....+++.+|++++.++ +||||++++++|...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            3577888999999999999976321       2368999887542 33456789999999999 7999999999999999


Q ss_pred             ceEEEEecCCCCChhhhhccCC--------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC
Q 042216          546 QMILVYDYMARGTLRDHLYNND--------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD  611 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld  611 (767)
                      ..++++||+++|+|.+++.+..              ...++|.+++.++.|++.||.|||   +++++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence            9999999999999999986432              235889999999999999999999   78899999999999999


Q ss_pred             CCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhH
Q 042216          612 EEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNL  690 (767)
Q Consensus       612 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l  690 (767)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+    
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----  244 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----  244 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----
Confidence            999999999999875433221111222334567999999999999999999999999999998 888885443211    


Q ss_pred             HHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          691 AVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       691 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                        +... ...+         .....+..++.++.+++.+||+.+|.+||++.|+++.|+.+....
T Consensus       245 --~~~~-~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         245 --LFKL-LKEG---------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             --HHHH-HHcC---------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence              1111 1111         111223455678999999999999999999999999999887544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.1e-36  Score=333.10  Aligned_cols=255  Identities=24%  Similarity=0.299  Sum_probs=202.8

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      ..++|+..+.||+|+||.||+++...+++.+|+|++...   .......+.+|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            356799999999999999999999888899999998642   22334457889999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ||||+++|+|.+++...   .+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       121 v~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999999998543   4788889999999999999999   78899999999999999999999999999875432


Q ss_pred             CCCccccccccCCCcccChhhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQ----LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD  705 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  705 (767)
                      ... .......||+.|+|||.+...    .++.++|||||||++|||++|+.||.......      ..........   
T Consensus       195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~---  264 (370)
T cd05596         195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMDHKN---  264 (370)
T ss_pred             CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------HHHHHHcCCC---
Confidence            111 122345699999999998653    47899999999999999999999996543211      1111111100   


Q ss_pred             cccccccCCCChhhHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 042216          706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIR--RPSMSDVVWG  747 (767)
Q Consensus       706 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~--RPs~~evl~~  747 (767)
                          .+........+.++.+++.+|++.+|.+  ||++.|++..
T Consensus       265 ----~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         265 ----SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ----cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                0111112235678899999999999988  9999999743

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.2e-36  Score=316.43  Aligned_cols=249  Identities=27%  Similarity=0.435  Sum_probs=199.2

Q ss_pred             eeeccCcEEEEEEEecCCC------ceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          482 IIGRGGFGNVYKGFLNGDS------TPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~------~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      .||+|+||.||+|+..+..      +.+|+|.+.... .....++.+|+++++.++||||++++++|...+..++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            6899999999999876432      579999886543 234567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccC-----CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC-----cEEEeecCCc
Q 042216          555 ARGTLRDHLYNN-----DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW-----VAKVSDFGLC  624 (767)
Q Consensus       555 ~~gsL~~~L~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~-----~~ki~DfGla  624 (767)
                      ++|+|.+++...     ....+++.+++.++.|++.||.|||   +.+++|+||||+||+++.+.     .++|+|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999653     2234889999999999999999999   77899999999999999877     8999999998


Q ss_pred             ccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCc
Q 042216          625 KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKI  703 (767)
Q Consensus       625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~  703 (767)
                      +...............++..|+|||++.+..++.++|||||||++|||++ |+.||......   .....    ...+  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~----~~~~--  229 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQH----VTAG--  229 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHH----HhcC--
Confidence            75432222122223345678999999999999999999999999999998 99998543321   11111    1111  


Q ss_pred             cccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          704 GDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       704 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                             .....+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       230 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         230 -------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             -------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                   011223345678899999999999999999999999986

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=8.8e-36  Score=316.46  Aligned_cols=251  Identities=22%  Similarity=0.313  Sum_probs=203.4

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC---cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ---QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      |+..++||+|+||.||++.....++.+|+|.+.....   .....+.+|+.++.+++|+|++++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            6677889999999999999998889999999865422   2234577899999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++|+|.+++.......+++.++..++.|++.||.|||   +.+|+||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence            99999999986655556999999999999999999999   7889999999999999999999999999987543211  


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.||............   ......          ...
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---~~~~~~----------~~~  222 (285)
T cd05630         157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKE----------VQE  222 (285)
T ss_pred             -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH---Hhhhhh----------hhh
Confidence             122346899999999999999999999999999999999999999654322111000   000000          011


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPS-----MSDVVW  746 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~  746 (767)
                      ..+......+.+++.+||+.||.+|||     +.|+++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            123345567899999999999999999     888886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.2e-36  Score=330.01  Aligned_cols=253  Identities=23%  Similarity=0.276  Sum_probs=203.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|...+.||+|+||+||++.....++.||+|+++...   ......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36888899999999999999998888999999987532   234456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|+|.+++.+.. ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            9999999999996542 36899999999999999999999   7889999999999999999999999999997643321


Q ss_pred             CccccccccCCCcccChhhhc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYR------LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD  705 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  705 (767)
                      . .......||+.|+|||++.      ...++.++|||||||++|||++|+.||......+      ..........   
T Consensus       157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~---  226 (330)
T cd05601         157 M-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQR---  226 (330)
T ss_pred             c-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCC---
Confidence            1 1223456899999999986      4567899999999999999999999996543221      1111111111   


Q ss_pred             cccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       706 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                          .+........+..+.+++..|++ +|.+||++.+++.
T Consensus       227 ----~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         227 ----FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             ----ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence                01111122356778899999998 9999999999884

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.1e-35  Score=312.57  Aligned_cols=253  Identities=23%  Similarity=0.303  Sum_probs=193.3

Q ss_pred             eeeccCcEEEEEEEecCC--CceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGD--STPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGT  558 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~--~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gs  558 (767)
                      .||+|+||.||+|...++  ...+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            589999999999987543  35799998875532 334578899999999999999999999999999999999999999


Q ss_pred             hhhhhccCC---CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccc
Q 042216          559 LRDHLYNND---NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHV  635 (767)
Q Consensus       559 L~~~L~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~  635 (767)
                      |.++++...   ...+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++..........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999996532   234678888899999999999999   78899999999999999999999999999875332221112


Q ss_pred             cccccCCCcccChhhhccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccc
Q 042216          636 STQVKGSIGYLDPEYYRLQ-------LLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDII  707 (767)
Q Consensus       636 ~~~~~gt~~y~aPE~~~~~-------~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  707 (767)
                      .....++..|+|||++...       .++.++||||||+++|||++ |+.||......+.   ...   .. .+......
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~---~~-~~~~~~~~  231 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTY---TV-REQQLKLP  231 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHH---Hh-hcccCCCC
Confidence            2234577889999998642       35789999999999999996 9999954433211   111   01 11111122


Q ss_pred             cccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       708 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                      ++.+    .....+.+.+++..|| .+|++|||+.||++.|+
T Consensus       232 ~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         232 KPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            2222    1224556788999999 58999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1e-35  Score=315.84  Aligned_cols=251  Identities=24%  Similarity=0.313  Sum_probs=202.2

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      |...+.||+|+||+||++....+++.+|+|.+....   ......+.+|+++++.++|+|++++.+++..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566788999999999999998888999999986542   12234578899999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++|+|.+++.......+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||++......   
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~---  155 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG---  155 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC---
Confidence            99999999987655557999999999999999999999   788999999999999999999999999998754321   


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      .......|+..|+|||++.+..++.++|+|||||++|||++|+.||.........  ..+ ........          .
T Consensus       156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--~~~-~~~~~~~~----------~  222 (285)
T cd05632         156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--EEV-DRRVLETE----------E  222 (285)
T ss_pred             CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HHH-HHhhhccc----------c
Confidence            1122346899999999999889999999999999999999999999654322111  111 11111110          1


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPS-----MSDVVW  746 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~  746 (767)
                      ..+...+..+.+++..||+.||++||+     +.+++.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            123345567889999999999999999     566664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-36  Score=333.22  Aligned_cols=254  Identities=21%  Similarity=0.259  Sum_probs=198.8

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|...+.||+|+||+||++....+++.||||++...   .......+.+|++++.+++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            3688889999999999999999888899999998643   2233456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            999999999999643  45889999999999999999999   7889999999999999999999999999986321100


Q ss_pred             Cc---------------------------------------------cccccccCCCcccChhhhccCCCCchhhHHHHH
Q 042216          632 KT---------------------------------------------HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFG  666 (767)
Q Consensus       632 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfG  666 (767)
                      ..                                             .......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            00                                             000124689999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCC---CCHHH
Q 042216          667 VVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRR---PSMSD  743 (767)
Q Consensus       667 vvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~R---Ps~~e  743 (767)
                      |++|||++|+.||......+.  +    ........       .+.-......+.++.+++.+|++ +|.+|   +++.|
T Consensus       236 vil~elltG~~Pf~~~~~~~~--~----~~i~~~~~-------~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~  301 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHET--Y----RKIINWRE-------TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE  301 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHH--H----HHHHccCC-------ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence            999999999999965432111  0    01000000       01001111245678899999997 66665   69999


Q ss_pred             HHHH
Q 042216          744 VVWG  747 (767)
Q Consensus       744 vl~~  747 (767)
                      +++.
T Consensus       302 ~l~h  305 (377)
T cd05629         302 IKSH  305 (377)
T ss_pred             HhcC
Confidence            8864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.9e-36  Score=323.97  Aligned_cols=240  Identities=24%  Similarity=0.348  Sum_probs=194.1

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEEEecCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILVYDYMARG  557 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~ey~~~g  557 (767)
                      +||+|+||.||+|+.+..++.||+|.++...   ......+..|..++..+ +||||+++++++.+.+..++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g   81 (316)
T cd05620           2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence            6999999999999999888999999987532   23344567788887754 8999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccc
Q 042216          558 TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST  637 (767)
Q Consensus       558 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~  637 (767)
                      +|.+++...  ..+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....  ......
T Consensus        82 ~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~  154 (316)
T cd05620          82 DLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRAS  154 (316)
T ss_pred             cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCcee
Confidence            999998653  45899999999999999999999   78899999999999999999999999999874211  111233


Q ss_pred             cccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCCh
Q 042216          638 QVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPP  717 (767)
Q Consensus       638 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  717 (767)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||......   .+..    .....          ....+.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~----~~~~~----------~~~~~~  217 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFE----SIRVD----------TPHYPR  217 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHH----HHHhC----------CCCCCC
Confidence            456899999999999999999999999999999999999999654321   1111    11111          011233


Q ss_pred             hhHHHHHHHHHHccccCCCCCCCHH-HHH
Q 042216          718 VCLNQFVEVAMSCVNDDRIRRPSMS-DVV  745 (767)
Q Consensus       718 ~~~~~l~~li~~Cl~~dp~~RPs~~-evl  745 (767)
                      ....++.+++.+||+.||.+||++. +++
T Consensus       218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         218 WITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            3566788999999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-35  Score=310.18  Aligned_cols=249  Identities=25%  Similarity=0.399  Sum_probs=201.5

Q ss_pred             eeeccCcEEEEEEEecC-CC--ceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCC
Q 042216          482 IIGRGGFGNVYKGFLNG-DS--TPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARG  557 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~-~~--~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~g  557 (767)
                      .||+|++|.||+|.+.. ++  ..||||.+..... ...+++.+|++++++++||||+++++.+.. ...++|+||+++|
T Consensus         2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~   80 (257)
T cd05040           2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG   80 (257)
T ss_pred             cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence            68999999999998854 22  3699999987655 556789999999999999999999999988 8999999999999


Q ss_pred             ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc-ccc
Q 042216          558 TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT-HVS  636 (767)
Q Consensus       558 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~-~~~  636 (767)
                      +|.+++.+.....++|..++.++.|++.||+|||   +++++|+||||+||+++.++.+||+|||+++........ ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence            9999997654356899999999999999999999   788999999999999999999999999998865332111 111


Q ss_pred             ccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCC
Q 042216          637 TQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNA  715 (767)
Q Consensus       637 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  715 (767)
                      ....++..|+|||++....++.++|||||||++|||++ |+.||......+   ...   .......         ....
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~---~~~~~~~---------~~~~  222 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILK---KIDKEGE---------RLER  222 (257)
T ss_pred             cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHHhcCC---------cCCC
Confidence            23457789999999999999999999999999999998 999985443221   111   1111110         0112


Q ss_pred             ChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          716 PPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       716 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                      +...+..+.+++.+||+.+|.+||++.+|++.|.
T Consensus       223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            2345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.7e-36  Score=334.12  Aligned_cols=252  Identities=22%  Similarity=0.274  Sum_probs=197.0

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      .|..++.||+|+||+||+|.....++.+|+|++....   ......+.+|++++++++|+||+++++.+.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788899999999999999998888999999986432   2334568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC-
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS-  631 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~-  631 (767)
                      |+++|+|.+++.+.  ..+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            99999999999654  35889999999999999999999   7889999999999999999999999999975321000 


Q ss_pred             --------------------------------------------CccccccccCCCcccChhhhccCCCCchhhHHHHHH
Q 042216          632 --------------------------------------------KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGV  667 (767)
Q Consensus       632 --------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGv  667 (767)
                                                                  .........||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                        000012346899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCC---HHHH
Q 042216          668 VLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPS---MSDV  744 (767)
Q Consensus       668 vl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs---~~ev  744 (767)
                      +||||++|+.||......+..      ......       ...+........+.++.+++.+|+ .+|.+|++   +.++
T Consensus       237 il~elltG~~Pf~~~~~~~~~------~~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei  302 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLETQ------MKVINW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI  302 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHHHH------HHHHcc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence            999999999999654332111      000000       001111111233556777777765 48999987   7777


Q ss_pred             HH
Q 042216          745 VW  746 (767)
Q Consensus       745 l~  746 (767)
                      ++
T Consensus       303 ~~  304 (382)
T cd05625         303 KA  304 (382)
T ss_pred             hc
Confidence            64

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.4e-35  Score=317.81  Aligned_cols=260  Identities=26%  Similarity=0.442  Sum_probs=205.1

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCc----eEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDST----PVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~----~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      ++|...+.||+|+||.||+|+...++.    .+|+|.+..... ....++.+|+.+++.++||||++++++|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            467788899999999999998865544    578898865432 2344688999999999999999999999754 5679


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ++||+++|+|.+++.... ..+++..++.++.|++.||.|||   +++|+|+||||+|||+++++.+||+|||+++....
T Consensus        86 v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence            999999999999986543 35899999999999999999999   78899999999999999999999999999986433


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      ...........++..|+|||.+.+..++.++|||||||++|||++ |+.||......   ....+.    ..+.      
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~~~~----~~~~------  228 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIPDLL----EKGE------  228 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HCCC------
Confidence            222111223345678999999998999999999999999999997 89998554321   111111    1111      


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                         ....+..++..+.+++..||..+|++||++.++++.|+.+....
T Consensus       229 ---~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         229 ---RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence               11122345667899999999999999999999999999876443

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-37  Score=312.65  Aligned_cols=268  Identities=22%  Similarity=0.295  Sum_probs=209.8

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCC--CCCcchhHHHHHHHHHhccccceeeeEeeeeec-----CC
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGALEFQTEIGMLSQLRYLHLVSLIGYCND-----DG  545 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~--~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~-----~~  545 (767)
                      ....|...+.||+|+||.|+.+..+.+++.||||++..  ......++-.+|+++|+.++|+||+.+.+....     -+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            34456667789999999999999999999999999873  344556778999999999999999999998865     35


Q ss_pred             ceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcc
Q 042216          546 QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK  625 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~  625 (767)
                      ..|+|+|+|+. +|.+.++.  ++.|+......++.|+++||.|+|   +.+|+||||||+|+|++.+...||||||||+
T Consensus       100 DvYiV~elMet-DL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen  100 DVYLVFELMET-DLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             eeEEehhHHhh-HHHHHHHc--CccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEecccccee
Confidence            78999999955 89998854  345999999999999999999999   7889999999999999999999999999999


Q ss_pred             cCCCCCCccccccccCCCcccChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc
Q 042216          626 FGPNFSKTHVSTQVKGSIGYLDPEYYR-LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG  704 (767)
Q Consensus       626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  704 (767)
                      .........-.+..+.|..|.|||.+. ...|+...||||.||++.||++|++-|.+.+...+..++.-+.....+..+.
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            765432333345667889999999875 5689999999999999999999999998776655554443222111111111


Q ss_pred             ccc--------cc-------cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          705 DII--------DP-------FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       705 ~~~--------d~-------~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      .+-        ..       .+...+ +......++|+.+||..||.+|+|++|.++.
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            111        00       000011 2345668899999999999999999999854

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.3e-36  Score=333.96  Aligned_cols=253  Identities=23%  Similarity=0.267  Sum_probs=199.0

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      +|...+.||+|+||.||+++....++.||||++....   ......+.+|+++|++++|+||+++++.+.+++.+++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6888999999999999999998888999999986431   2234568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC-
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS-  631 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~-  631 (767)
                      |+++|+|.+++.+.  ..+++.....++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          82 YIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            99999999999654  35888999999999999999999   7889999999999999999999999999975221000 


Q ss_pred             ----------------------------------------CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHH
Q 042216          632 ----------------------------------------KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLE  671 (767)
Q Consensus       632 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~e  671 (767)
                                                              .........||+.|||||++.+..++.++|||||||++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                    0000123469999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 042216          672 VLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRP---SMSDVVWG  747 (767)
Q Consensus       672 lltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RP---s~~evl~~  747 (767)
                      |++|+.||......+..      ... ....      ..+........+.++.+++.+|+ .+|.+|+   ++.++++.
T Consensus       237 ll~G~~Pf~~~~~~~~~------~~i-~~~~------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         237 MLVGQPPFLADTPAETQ------LKV-INWE------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hhhCCCCCCCCCHHHHH------HHH-hccC------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            99999999654432111      000 0000      00111111234556778888876 4999999   88988844

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.5e-36  Score=336.12  Aligned_cols=260  Identities=24%  Similarity=0.289  Sum_probs=195.2

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecC--------C
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD--------G  545 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~--------~  545 (767)
                      ..+|...+.||+|+||.||+|.....++.||||++....    ....+|+.+|+.++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            357889999999999999999998888899999885432    2345799999999999999998876321        2


Q ss_pred             ceEEEEecCCCCChhhhhcc--CCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC-cEEEeecC
Q 042216          546 QMILVYDYMARGTLRDHLYN--NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW-VAKVSDFG  622 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~-~~ki~DfG  622 (767)
                      .+++||||+++ +|.+++..  .....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence            46789999985 77777643  23456899999999999999999999   78899999999999999654 79999999


Q ss_pred             CcccCCCCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHH----
Q 042216          623 LCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATEC----  697 (767)
Q Consensus       623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~----  697 (767)
                      +++......   ......||+.|+|||++.+ ..++.++|||||||+||||++|.+||.+....+.  +.......    
T Consensus       217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~~~~~~p~  291 (440)
T PTZ00036        217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRIIQVLGTPT  291 (440)
T ss_pred             cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCC
Confidence            998543211   1223467899999999865 4689999999999999999999999965543221  11111100    


Q ss_pred             ----------hhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          698 ----------YRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       698 ----------~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                                +..-....+....+....+...+.++.+++.+||+.||.+|||+.|+++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                      0000001111111222233345678999999999999999999999983

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.7e-35  Score=316.00  Aligned_cols=250  Identities=25%  Similarity=0.406  Sum_probs=204.8

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      .+|...+.||+|+||.||+|.....++.+++|.+..........+.+|+.+++.++|+|++++++.+......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            47888889999999999999988778899999997665555677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++++|.+++.+   ..+++.++..++.|++.||.|||   +.+|+|+||||+|||++.++.+||+|||+++......  .
T Consensus       100 ~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~  171 (296)
T cd06654         100 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S  171 (296)
T ss_pred             CCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccc--c
Confidence            99999999854   24889999999999999999999   7889999999999999999999999999987532211  1


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN  714 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  714 (767)
                      ......+++.|+|||.+.+..++.++|||||||++|||++|+.||........  +..    ....+.      +  ...
T Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~----~~~~~~------~--~~~  237 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYL----IATNGT------P--ELQ  237 (296)
T ss_pred             ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHH----HhcCCC------C--CCC
Confidence            12234688899999999988899999999999999999999999964432111  110    111110      0  011


Q ss_pred             CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       715 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .+......+.+++.+||..+|++||++.+++.
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            22344567889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.3e-36  Score=325.61  Aligned_cols=237  Identities=29%  Similarity=0.383  Sum_probs=191.2

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHH-HHhccccceeeeEeeeeecCCceEEEEecCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIG-MLSQLRYLHLVSLIGYCNDDGQMILVYDYMARG  557 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~-~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~g  557 (767)
                      +||+|+||+||+|+...+++.||+|++....   .....++..|.. +++.++||||+++++++.+.+..++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g   81 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence            6999999999999998888999999986431   223345556655 567899999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccc
Q 042216          558 TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST  637 (767)
Q Consensus       558 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~  637 (767)
                      +|.+++.+.  ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++....  ......
T Consensus        82 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~  154 (323)
T cd05575          82 ELFFHLQRE--RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTS  154 (323)
T ss_pred             CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccc
Confidence            999998653  46899999999999999999999   78899999999999999999999999999875322  112233


Q ss_pred             cccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCCh
Q 042216          638 QVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPP  717 (767)
Q Consensus       638 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  717 (767)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......      ....... .+.          ...++
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~-~~~----------~~~~~  217 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNIL-NKP----------LRLKP  217 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHH-cCC----------CCCCC
Confidence            456899999999999999999999999999999999999999654321      1111111 111          01123


Q ss_pred             hhHHHHHHHHHHccccCCCCCCCHH
Q 042216          718 VCLNQFVEVAMSCVNDDRIRRPSMS  742 (767)
Q Consensus       718 ~~~~~l~~li~~Cl~~dp~~RPs~~  742 (767)
                      ..+..+.+++.+||+.||.+||++.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         218 NISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            3466789999999999999999885

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.7e-36  Score=330.10  Aligned_cols=255  Identities=24%  Similarity=0.307  Sum_probs=200.8

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      ..++|+..+.||+|+||.||++....+++.+|+|.+...   .......+.+|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            456899999999999999999999988899999998642   22234457899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ||||+++|+|.+++...   .+++..+..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++....
T Consensus       121 v~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            99999999999998543   4788999999999999999999   78899999999999999999999999999986432


Q ss_pred             CCCccccccccCCCcccChhhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQ----LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD  705 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  705 (767)
                      .. ........||+.|+|||++...    .++.++|||||||++|||++|+.||......+.      .........   
T Consensus       195 ~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------~~~i~~~~~---  264 (370)
T cd05621         195 TG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------YSKIMDHKN---  264 (370)
T ss_pred             CC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCc---
Confidence            11 1112345699999999998754    378899999999999999999999965432111      111111100   


Q ss_pred             cccccccCCCChhhHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 042216          706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIR--RPSMSDVVWG  747 (767)
Q Consensus       706 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~--RPs~~evl~~  747 (767)
                          .+........+..+.+++..|++.++.+  ||++.|+++.
T Consensus       265 ----~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         265 ----SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ----ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                0111111234567788999999865544  8899999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.3e-36  Score=314.39  Aligned_cols=239  Identities=25%  Similarity=0.396  Sum_probs=188.9

Q ss_pred             eeeccCcEEEEEEEecCC------------------------CceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeE
Q 042216          482 IIGRGGFGNVYKGFLNGD------------------------STPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSL  537 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~------------------------~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l  537 (767)
                      .||+|+||.||+|.+...                        ...|++|.+.........+|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            599999999999986321                        13589999876544445678899999999999999999


Q ss_pred             eeeeecCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC---
Q 042216          538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW---  614 (767)
Q Consensus       538 ~g~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~---  614 (767)
                      +++|.+....++||||+++|+|..++.+.. ..+++..+..++.|+++||+|||   +++|+||||||+|||++..+   
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCccc
Confidence            999999999999999999999999986543 46899999999999999999999   78899999999999997643   


Q ss_pred             ----cEEEeecCCcccCCCCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCCCccch
Q 042216          615 ----VAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVL-CARPPILRTGDKKQV  688 (767)
Q Consensus       615 ----~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ell-tg~~P~~~~~~~~~~  688 (767)
                          .+|++|||++.....      .....++..|+|||.+.. ..++.++|||||||++|||+ +|+.||......+. 
T Consensus       158 ~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-  230 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-  230 (274)
T ss_pred             CccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence                479999998764221      112346788999998875 56899999999999999995 69999865432211 


Q ss_pred             hHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042216          689 NLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGL  748 (767)
Q Consensus       689 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L  748 (767)
                        ..+.    ...           ...+.....++.+++.+||+.+|.+||++.+|++.|
T Consensus       231 --~~~~----~~~-----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         231 --ERFY----EKK-----------HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             --HHHH----Hhc-----------cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence              1111    100           001122234688999999999999999999999877

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.2e-35  Score=312.26  Aligned_cols=250  Identities=22%  Similarity=0.334  Sum_probs=199.9

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      +|+..++||+|+||.||+|....+++.+|+|.+... ......++.+|++++.+++|||++++++++...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            577788999999999999999888899999998654 2334457899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++|+|..+.      .+++..+..++.|++.||.|||   +.+|+|+||||+|||++.++.+||+|||++......    
T Consensus        82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----  148 (279)
T cd06619          82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----  148 (279)
T ss_pred             CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence            999997653      3678899999999999999999   788999999999999999999999999998753221    


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccch-hHHHHHHHHhhcCCccccccccccC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQV-NLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      ......++..|+|||++.+..++.++|||||||++|||++|+.||......... ....+.. ......     .+.+  
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~--  220 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ-CIVDED-----PPVL--  220 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH-HHhccC-----CCCC--
Confidence            223356889999999999889999999999999999999999999653322111 1111111 111110     0111  


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                       .....+.++.+++.+||+.+|.+||+++|+++.
T Consensus       221 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         221 -PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             -CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence             112234578899999999999999999999854

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.3e-35  Score=310.35  Aligned_cols=258  Identities=27%  Similarity=0.399  Sum_probs=206.1

Q ss_pred             hccccceeeeccCcEEEEEEEecCC---CceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGD---STPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      ++|...+.||+|+||.||+|...+.   ...|+||...... ....+.+.+|+.++++++|||++++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            4577778999999999999987543   3468999887554 3445679999999999999999999999875 467899


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+++|+|.+++.... ..+++.+++.++.+++.||.|||   +.+++|+||||+|||++.++.+||+|||+++.....
T Consensus        85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          85 MELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            99999999999996543 35899999999999999999999   788999999999999999999999999998764332


Q ss_pred             CCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                      . ........++..|+|||.+....++.++||||||++++||++ |+.||......+.   ..+    ...+.       
T Consensus       161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~----~~~~~-------  225 (270)
T cd05056         161 S-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGR----IENGE-------  225 (270)
T ss_pred             c-ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHH----HHcCC-------
Confidence            1 111222334568999999988889999999999999999986 9999965543211   111    11111       


Q ss_pred             cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 042216          710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL  754 (767)
Q Consensus       710 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~  754 (767)
                        ....+..++.++.+++.+|+..+|.+|||+.++++.|+++...
T Consensus       226 --~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         226 --RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             --cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence              1122345667899999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-35  Score=307.59  Aligned_cols=247  Identities=30%  Similarity=0.464  Sum_probs=200.2

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCCCCc-chhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCChh
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ-GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLR  560 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gsL~  560 (767)
                      +||+|+||.||++...+ ++.||+|.+...... ...++.+|++++++++|+||+++++++.+....++|+||+++++|.
T Consensus         2 ~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             ccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            68999999999999877 789999998765433 4567999999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcccccccc
Q 042216          561 DHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK  640 (767)
Q Consensus       561 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~  640 (767)
                      +++.... ..+++..++.++.+++.+|.|||   +++++||||||+|||++.++.+||+|||+++...............
T Consensus        81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            9996543 35889999999999999999999   7889999999999999999999999999987543211111112223


Q ss_pred             CCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhh
Q 042216          641 GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVC  719 (767)
Q Consensus       641 gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  719 (767)
                      .+..|+|||.+.++.++.++|+|||||+++||++ |..||.......   ....    ....         .....+...
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~----~~~~---------~~~~~~~~~  220 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRER----IESG---------YRMPAPQLC  220 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHH----HhcC---------CCCCCCccC
Confidence            4567999999998899999999999999999999 888885543221   1111    1110         111223445


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          720 LNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       720 ~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                      +.++.+++.+||+.+|.+||++.||++.|+
T Consensus       221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.9e-36  Score=316.95  Aligned_cols=263  Identities=24%  Similarity=0.422  Sum_probs=204.7

Q ss_pred             hccccceeeeccCcEEEEEEEe----cCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecC--Cce
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFL----NGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD--GQM  547 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~----~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~  547 (767)
                      +.|...+.||+|+||.||++..    ...+..||+|.++... ......+.+|++++++++|||++++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3467788999999999999985    3346789999987553 33345789999999999999999999998775  568


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      ++||||+++++|.+++.+.. ..++|.+++.++.|++.||+|||   +++++||||||+||++++++.+||+|||+++..
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence            99999999999999986543 35899999999999999999999   788999999999999999999999999998754


Q ss_pred             CCCCCc-cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---------ccchhHHHHHHHH
Q 042216          628 PNFSKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGD---------KKQVNLAVWATEC  697 (767)
Q Consensus       628 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~---------~~~~~l~~~~~~~  697 (767)
                      ...... .......++..|+|||.+.+..++.++|||||||++|||++++.|......         ........+. ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  238 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-RV  238 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-HH
Confidence            322111 112234567789999999888899999999999999999998776422110         0011111111 11


Q ss_pred             hhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          698 YRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       698 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                      ...+.         ....+..++.++.+++.+||+.+|.+||++.++++.|+.+
T Consensus       239 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11111         1122344677899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.7e-35  Score=310.26  Aligned_cols=239  Identities=26%  Similarity=0.394  Sum_probs=189.8

Q ss_pred             eeeccCcEEEEEEEecCC------------CceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          482 IIGRGGFGNVYKGFLNGD------------STPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~------------~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      .||+|+||.||+|+....            ...|++|.+..........|.+|+.++..++||||+++++++..+...++
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l   81 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM   81 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence            589999999999986422            23589998876555555678899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCc-------EEEeecC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV-------AKVSDFG  622 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~-------~ki~DfG  622 (767)
                      +|||+++|+|..++.... ..+++..++.++.|+++||+|||   +++|+||||||+|||++.++.       +|++|||
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          82 VEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999886543 35899999999999999999999   788999999999999987664       8999999


Q ss_pred             CcccCCCCCCccccccccCCCcccChhhhc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCCccchhHHHHHHHHhhc
Q 042216          623 LCKFGPNFSKTHVSTQVKGSIGYLDPEYYR-LQLLTEKSDVYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRN  700 (767)
Q Consensus       623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~SfGvvl~ell-tg~~P~~~~~~~~~~~l~~~~~~~~~~  700 (767)
                      ++.....      .....++..|+|||.+. ...++.++|||||||++|||+ +|+.|+......+..       ... .
T Consensus       158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~~~-~  223 (262)
T cd05077         158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------RFY-E  223 (262)
T ss_pred             CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------HHH-h
Confidence            9864321      12234778899999887 467899999999999999998 588887543221110       000 1


Q ss_pred             CCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042216          701 GKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGL  748 (767)
Q Consensus       701 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L  748 (767)
                      +..        .  .......++.+++.+||+.||.+||++.+|++.|
T Consensus       224 ~~~--------~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         224 GQC--------M--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             cCc--------c--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            100        0  1112346788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=3e-35  Score=299.69  Aligned_cols=267  Identities=20%  Similarity=0.285  Sum_probs=220.8

Q ss_pred             HHHHHHHhhccccceeeeccCcEEEEEEEecCCC-----ceEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeee
Q 042216          467 ISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDS-----TPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGY  540 (767)
Q Consensus       467 ~~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~-----~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~  540 (767)
                      ..++.....+++...++-+|.||+||+|.+.+++     +.|-+|.++.. ++.+...+..|..+|..+.|||+.++.+.
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            3344444566777778999999999999776543     45777877644 55566678999999999999999999999


Q ss_pred             eecC-CceEEEEecCCCCChhhhhcc------CCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCC
Q 042216          541 CNDD-GQMILVYDYMARGTLRDHLYN------NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEE  613 (767)
Q Consensus       541 ~~~~-~~~~lV~ey~~~gsL~~~L~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~  613 (767)
                      |.++ ...+++|.++.-|+|..+|..      +..+.++..+...++.|++.||+|||   +.++||.||.++|++||+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhh
Confidence            8654 577899999999999999972      22345888899999999999999999   8889999999999999999


Q ss_pred             CcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHH
Q 042216          614 WVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAV  692 (767)
Q Consensus       614 ~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~  692 (767)
                      .++||+|=.++|.....+..........+..||+||.+....|+..+|||||||+||||+| |+.|+...+..+....  
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y--  510 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY--  510 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH--
Confidence            9999999999997666566655566667889999999999999999999999999999998 9999987766543322  


Q ss_pred             HHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 042216          693 WATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF  752 (767)
Q Consensus       693 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~  752 (767)
                           +.+|         .+-..|-+|++++..+|.-||...|++||+++|++.-|.+-.
T Consensus       511 -----lkdG---------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  511 -----LKDG---------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             -----Hhcc---------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence                 1222         233457789999999999999999999999999999986653

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1e-35  Score=319.77  Aligned_cols=265  Identities=18%  Similarity=0.288  Sum_probs=201.2

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      ++|...+.||+|+||.||+|+.+..++.||+|+++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            46888889999999999999998888899999987543 22334678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++ +|.+++.... ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++......  
T Consensus        86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  158 (309)
T cd07872          86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--  158 (309)
T ss_pred             CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence            985 8888886543 35889999999999999999999   7889999999999999999999999999987532211  


Q ss_pred             cccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc------cc
Q 042216          634 HVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG------DI  706 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~------~~  706 (767)
                      .......++..|+|||.+.+ ..++.++|||||||++|||++|++||......+..................      +.
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            11223457889999998865 568999999999999999999999996554332211111100000000000      00


Q ss_pred             ccccccC-------CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          707 IDPFLKG-------NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       707 ~d~~l~~-------~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .+.....       ...+..+.++.+++.+|++.||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000000       011234567889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.4e-35  Score=315.07  Aligned_cols=261  Identities=22%  Similarity=0.301  Sum_probs=196.7

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--cchhHHHHHHHHHhcc---ccceeeeEeeeeec-----CC
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--QGALEFQTEIGMLSQL---RYLHLVSLIGYCND-----DG  545 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l---~Hpniv~l~g~~~~-----~~  545 (767)
                      +|+..+.||+|+||.||+|....+++.||+|.+.....  .....+.+|+++++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            46778899999999999999998889999999875422  2233456777777665   69999999998864     24


Q ss_pred             ceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcc
Q 042216          546 QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK  625 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~  625 (767)
                      ..+++|||+++ +|.+++.......+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            57999999985 8999887655556899999999999999999999   7889999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhc---CC
Q 042216          626 FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRN---GK  702 (767)
Q Consensus       626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~---~~  702 (767)
                      .....   .......++..|+|||++.+..++.++|||||||++|||++|++||.......  .+..... ....   ..
T Consensus       157 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~-~~~~~~~~~  230 (288)
T cd07863         157 IYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFD-LIGLPPEDD  230 (288)
T ss_pred             cccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHH-HhCCCChhh
Confidence            54321   12233467899999999998899999999999999999999999986543321  1111111 0000   00


Q ss_pred             cc-------cccccccc---CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          703 IG-------DIIDPFLK---GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       703 ~~-------~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ..       ....+...   ....+....++.+++.+|++.||++|||+.|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00       00000000   0111234567889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=9e-36  Score=322.20  Aligned_cols=242  Identities=24%  Similarity=0.342  Sum_probs=195.9

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccc-cceeeeEeeeeecCCceEEEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLR-YLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      +|+..+.||+|+||.||++....+++.||+|++...   .....+.+..|..++..+. |++|+++.+++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            467788999999999999999888899999998643   2233456788888888885 577888999999899999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|+|.+++.+.  ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~-  154 (323)
T cd05615          81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-  154 (323)
T ss_pred             cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCC-
Confidence            999999999998554  35899999999999999999999   788999999999999999999999999998743211 


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                       ........||..|+|||++.+..++.++|||||||++|||++|+.||......   .+..   ... ...         
T Consensus       155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~---~i~-~~~---------  217 (323)
T cd05615         155 -GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQ---SIM-EHN---------  217 (323)
T ss_pred             -CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHH---HHH-hCC---------
Confidence             11223456899999999999999999999999999999999999999654321   1111   111 111         


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSM  741 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~  741 (767)
                       ...+...+.++.+++.+||+.+|.+|++.
T Consensus       218 -~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 -VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence             12233456678999999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.4e-35  Score=308.51  Aligned_cols=251  Identities=30%  Similarity=0.503  Sum_probs=194.7

Q ss_pred             eeeccCcEEEEEEEecC---CCceEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeee-cCCceEEEEecCCC
Q 042216          482 IIGRGGFGNVYKGFLNG---DSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCN-DDGQMILVYDYMAR  556 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~---~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~-~~~~~~lV~ey~~~  556 (767)
                      .||+|+||.||+|...+   ....+|+|++... .......+.+|+.+++.++|||+++++++|. .++..++++||+.+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~   81 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH   81 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence            68999999999998643   2357999998543 2334567889999999999999999999876 45568999999999


Q ss_pred             CChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc--c
Q 042216          557 GTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT--H  634 (767)
Q Consensus       557 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~--~  634 (767)
                      |+|.+++.+.. ..+++..++.++.|++.||.|||   ..+++||||||+|||+++++.+||+|||+++........  .
T Consensus        82 ~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          82 GDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999996543 34688889999999999999999   778999999999999999999999999998753221110  1


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCA-RPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg-~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      ......++..|+|||.+....++.++|||||||++|||++| .+|+.....   ..+...   . ..+.         ..
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~---~-~~~~---------~~  221 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVY---L-LQGR---------RL  221 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH---H-hcCC---------CC
Confidence            11223456789999999888999999999999999999995 555543221   111111   1 1111         01


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF  752 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~  752 (767)
                      ..+..++..+.+++.+||+.+|++||++.||++.|+.+.
T Consensus       222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            112234567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.6e-35  Score=309.83  Aligned_cols=254  Identities=25%  Similarity=0.437  Sum_probs=205.0

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .++|...+.||+|+||.||++...+. ..+|+|.+.... .....+.+|++++++++|+|++++.+++.+ ...+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~-~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKH-TKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCC-ccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            35678888999999999999987643 679999886542 345678999999999999999999999887 788999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++|+|.+++.+.....+++.++..++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||++....... .
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~  157 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-Y  157 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCC-c
Confidence            99999999997765567899999999999999999999   6789999999999999999999999999987543211 1


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      .......++..|+|||++....++.++|+|||||+++|+++ |+.||......   .+..+    ...+.         .
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~----~~~~~---------~  221 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRA----LERGY---------R  221 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----HhCCC---------C
Confidence            11222345678999999998889999999999999999998 99998654321   11111    11111         1


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF  750 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~  750 (767)
                      ...+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus       222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            11223455678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.9e-36  Score=315.10  Aligned_cols=240  Identities=26%  Similarity=0.386  Sum_probs=191.9

Q ss_pred             eeeccCcEEEEEEEecCCC-------ceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          482 IIGRGGFGNVYKGFLNGDS-------TPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~-------~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      .||+|+||.||+|.....+       ..+++|.+........+++.+|+.+++.++|||++++++++..++..++||||+
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   81 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV   81 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence            6899999999999875433       348888886555555667899999999999999999999999989999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCc--------EEEeecCCccc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV--------AKVSDFGLCKF  626 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~--------~ki~DfGla~~  626 (767)
                      ++|+|.++++... ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.        ++++|||++..
T Consensus        82 ~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          82 KFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999997543 35899999999999999999999   788999999999999987765        69999998764


Q ss_pred             CCCCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCccchhHHHHHHHHhhcCCcc
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCAR-PPILRTGDKKQVNLAVWATECYRNGKIG  704 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~-~P~~~~~~~~~~~l~~~~~~~~~~~~~~  704 (767)
                      ...      .....++..|+|||++.+ ..++.++|||||||++|||++|. .|+.........   .    ....    
T Consensus       158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~---~----~~~~----  220 (258)
T cd05078         158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL---Q----FYED----  220 (258)
T ss_pred             cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH---H----HHHc----
Confidence            321      123457889999999986 45899999999999999999985 555332221110   0    0110    


Q ss_pred             ccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          705 DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       705 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                             ....+.....++.+++.+||+.+|++|||++++++.|+
T Consensus       221 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 -------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                   11223344567899999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.2e-36  Score=326.26  Aligned_cols=239  Identities=25%  Similarity=0.316  Sum_probs=193.4

Q ss_pred             eeeeccCcEEEEEEEec---CCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCC
Q 042216          481 LIIGRGGFGNVYKGFLN---GDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMA  555 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~---~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~  555 (767)
                      +.||+|+||.||++...   ..++.+|+|++....  ......+..|+++|++++||||+++++++..++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            47999999999998763   456899999986532  2234457789999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccc
Q 042216          556 RGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHV  635 (767)
Q Consensus       556 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~  635 (767)
                      +|+|.+++.+.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++.....  ...
T Consensus        82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~  154 (318)
T cd05582          82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKK  154 (318)
T ss_pred             CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CCc
Confidence            99999999543  45899999999999999999999   788999999999999999999999999998754321  112


Q ss_pred             cccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCC
Q 042216          636 STQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNA  715 (767)
Q Consensus       636 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  715 (767)
                      .....|++.|+|||.+....++.++|||||||++|||++|+.||......+   ..   ... ....          ...
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~---~~i-~~~~----------~~~  217 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---TM---TMI-LKAK----------LGM  217 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH---HH---HHH-HcCC----------CCC
Confidence            234568999999999998889999999999999999999999996443211   11   111 1111          112


Q ss_pred             ChhhHHHHHHHHHHccccCCCCCCCHHH
Q 042216          716 PPVCLNQFVEVAMSCVNDDRIRRPSMSD  743 (767)
Q Consensus       716 ~~~~~~~l~~li~~Cl~~dp~~RPs~~e  743 (767)
                      +...+..+.+++.+||+.||.+||++.+
T Consensus       218 p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            3345677889999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.9e-35  Score=317.51  Aligned_cols=262  Identities=24%  Similarity=0.347  Sum_probs=203.4

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      ++|+..+.||+|+||.||++....++..+|+|.+..... ....++.+|++++.+++||||+++++++.+++..++|+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            368888999999999999999988888999999875432 2345688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++++|.+++.+.  ..+++..+..++.|+++||.|||+  ..+++|+||||+|||++.++.+||+|||++......   
T Consensus        81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  153 (308)
T cd06615          81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  153 (308)
T ss_pred             cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence            9999999999654  458999999999999999999994  357999999999999999999999999998753221   


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc---------
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG---------  704 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~---------  704 (767)
                       ......++..|+|||.+.+..++.++|||||||++|||++|+.||.......   ...+...........         
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  229 (308)
T cd06615         154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGH  229 (308)
T ss_pred             -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCC
Confidence             1233568899999999988889999999999999999999999985433211   111110000000000         


Q ss_pred             -----------cccccccc---CCCC-hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          705 -----------DIIDPFLK---GNAP-PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       705 -----------~~~d~~l~---~~~~-~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                                 +..+....   ...+ .....++.+++.+||+.+|++||++.+|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                       00000000   0001 1245578999999999999999999999866

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-35  Score=329.95  Aligned_cols=263  Identities=19%  Similarity=0.181  Sum_probs=199.3

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      ..+|...+.||+|+||.||++.+...++.||||...      ...+.+|+++|++|+|+||+++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            447888899999999999999999888899999642      23467899999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +. ++|.+++.... ..++|.+++.|+.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++........
T Consensus       242 ~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        242 YR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             cC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            95 69998886533 36999999999999999999999   788999999999999999999999999999864332222


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc-c----chhHHHHHHHHhhc-CCccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDK-K----QVNLAVWATECYRN-GKIGDII  707 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~-~----~~~l~~~~~~~~~~-~~~~~~~  707 (767)
                      .......||..|+|||++.+..++.++|||||||+||||++|..|+...... .    ...+...+...... .......
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence            2223456999999999999999999999999999999999988776433211 1    11111111111000 0000000


Q ss_pred             cccc------------cCCCC-------hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          708 DPFL------------KGNAP-------PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       708 d~~l------------~~~~~-------~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      ...+            .....       ......+.+|+.+||+.||.+|||+.|+++.
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0000            00000       0123467899999999999999999999863

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.5e-35  Score=309.89  Aligned_cols=253  Identities=24%  Similarity=0.318  Sum_probs=191.5

Q ss_pred             eeeccCcEEEEEEEecCC--CceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGD--STPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGT  558 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~--~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gs  558 (767)
                      .||+|+||.||+|.....  ...+++|.+.... .....+|.+|++.++.++|+||+++++.|......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            589999999999976432  3468889876443 2334568899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCC---CCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccc
Q 042216          559 LRDHLYNNDN---PPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHV  635 (767)
Q Consensus       559 L~~~L~~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~  635 (767)
                      |.+++.....   ...++.....++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++..........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            9999965432   23578888999999999999999   78899999999999999999999999999864322111111


Q ss_pred             cccccCCCcccChhhhcc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccc
Q 042216          636 STQVKGSIGYLDPEYYRL-------QLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDII  707 (767)
Q Consensus       636 ~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  707 (767)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |+.||....+.+  .+    ...... ....+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~----~~~~~~-~~~~~~  231 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VL----KQVVRE-QDIKLP  231 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HH----HHHhhc-cCccCC
Confidence            223345678999998753       356889999999999999999 788885443221  11    111111 111222


Q ss_pred             cccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       708 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                      ++.    .+...+..+.+++..|| .||.+||++++|++.|.
T Consensus       232 ~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         232 KPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            222    23345567788899998 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-36  Score=310.61  Aligned_cols=261  Identities=24%  Similarity=0.278  Sum_probs=197.7

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecC---C--ceEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD---G--QMIL  549 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~---~--~~~l  549 (767)
                      -.|...+++|.|+||.||+|++......||||+...+.+-    -.+|+++|+++.|||||+|+-++...   +  ...|
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            3577778999999999999999988899999998654332    24689999999999999999887532   2  4568


Q ss_pred             EEecCCCCChhhhhcc--CCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCC-CcEEEeecCCccc
Q 042216          550 VYDYMARGTLRDHLYN--NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEE-WVAKVSDFGLCKF  626 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~-~~~ki~DfGla~~  626 (767)
                      |||||+. +|.+.++.  ..+..++...+.-+..|+.+||.|||   +.+|+||||||+|+|+|.+ |.+||||||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999998 99998864  23456888888899999999999999   7889999999999999965 9999999999997


Q ss_pred             CCCCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc-
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG-  704 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~-  704 (767)
                      ......   ...-..|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+.....+...+.-+.......++. 
T Consensus       176 L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  176 LVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             eccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            543222   233346778999999875 589999999999999999999999997755433322221111110000000 


Q ss_pred             ------ccccccccC-----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          705 ------DIIDPFLKG-----NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       705 ------~~~d~~l~~-----~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                            +.-.+.+..     ........+.++++.++++.+|.+|.++.|++.
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                  111111111     123345678899999999999999999999984

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-36  Score=310.08  Aligned_cols=247  Identities=22%  Similarity=0.355  Sum_probs=207.0

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      .+|+..+.||+|.||+|-++.....++.||||.++++.   ++..-.+.+||++|+.|+||||++++.+++..+...+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            35666678999999999999987788999999997663   344445789999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||..+|.|.+|+.+.  ..|++.+...++.||..|+.|+|   .++++|||||.+|||||+++++||+||||+.++..  
T Consensus       133 EYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~--  205 (668)
T KOG0611|consen  133 EYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD--  205 (668)
T ss_pred             EecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcc--
Confidence            999999999999554  45999999999999999999999   88899999999999999999999999999986543  


Q ss_pred             CccccccccCCCcccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLT-EKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                       ....+..+|++-|.+||++.+.+|. +..|-||+||+||-|+.|..||++.+-.      ..+.+ +..|.        
T Consensus       206 -~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk------~lvrQ-Is~Ga--------  269 (668)
T KOG0611|consen  206 -KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK------RLVRQ-ISRGA--------  269 (668)
T ss_pred             -ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH------HHHHH-hhccc--------
Confidence             3345678999999999999998875 7899999999999999999999765432      11121 11111        


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      .   ..+..+....-||++||..+|++|.|+.||...
T Consensus       270 Y---rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  270 Y---REPETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             c---cCCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence            1   122334456789999999999999999999754

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.3e-35  Score=306.42  Aligned_cols=250  Identities=24%  Similarity=0.380  Sum_probs=203.9

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeec-CCceEEEEe
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCND-DGQMILVYD  552 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~-~~~~~lV~e  552 (767)
                      +|...+.||+|++|.||+++.+.+++.+|+|++....  ....+.+.+|++++++++|+|++++++.+.. +...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4677889999999999999998888899999986432  3345568899999999999999999988764 446789999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+++++|.+++.......+++.++..++.+++.||.+||   +.+++|+||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence            999999999997655567999999999999999999999   7889999999999999999999999999987643221 


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                       .......+++.|+|||.+.+..++.++||||||++++||++|+.||......      .+.... ..+..         
T Consensus       157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~-~~~~~---------  219 (257)
T cd08223         157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRI-IEGKL---------  219 (257)
T ss_pred             -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHH-HhcCC---------
Confidence             1223455889999999999999999999999999999999999998643321      111111 11111         


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ...+...+..+.+++.+||+.+|++||++.++++
T Consensus       220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1123345677999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.6e-35  Score=306.94  Aligned_cols=250  Identities=26%  Similarity=0.381  Sum_probs=204.7

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      ++|+..+.||+|+||.||+|....+++.+++|.+.....  ..++.+|++++++++|+|++++++++......++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            467888899999999999999988778999999865432  668999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++++|.+++.... ..+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.+||+|||++.......  .
T Consensus        81 ~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~  154 (256)
T cd06612          81 GAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--A  154 (256)
T ss_pred             CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCc--c
Confidence            9999999986433 46899999999999999999999   7789999999999999999999999999987543321  1


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN  714 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  714 (767)
                      ......++..|+|||++.+..++.++||||||+++|||++|+.||.........  .     .....     ..+  ...
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--~-----~~~~~-----~~~--~~~  220 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--F-----MIPNK-----PPP--TLS  220 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--h-----hhccC-----CCC--CCC
Confidence            223345788999999999889999999999999999999999998654322111  0     00000     000  111


Q ss_pred             CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       715 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .+.....++.+++.+||+.+|++|||+.||++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            23344567899999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.6e-35  Score=306.15  Aligned_cols=252  Identities=24%  Similarity=0.340  Sum_probs=207.6

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      +|+..+.||+|+||.||.++...+++.+++|.+...  .....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            477888999999999999999888899999987643  344556789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++|+|.+++.+.....+++.++..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||+++....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            99999999997654556899999999999999999999   67899999999999999999999999999876433221 


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                       ......++..|+|||.+.+...+.++||||||+++|||++|+.||......      +..... ..+...         
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~-~~~~~~---------  219 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKI-VQGNYT---------  219 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH-HcCCCC---------
Confidence             223445889999999998888999999999999999999999998543221      111111 111111         


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGL  748 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L  748 (767)
                      ..+...+.++.+++.+||+.+|.+||++.++++.+
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            11234567789999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.3e-35  Score=311.50  Aligned_cols=262  Identities=21%  Similarity=0.264  Sum_probs=199.5

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      +|...+.||+|++|.||+|+...+++.||+|++....  ......+.+|+.++++++|||++++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4677889999999999999998888999999986442  22345688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCC-CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          554 MARGTLRDHLYNND-NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       554 ~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      ++ ++|.+++.... ...+++.++..++.|++.||.|||   +.+++|+||||+|||++.++.+||+|||+++.....  
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  154 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--  154 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--
Confidence            97 68988886533 356899999999999999999999   788999999999999999999999999998753221  


Q ss_pred             ccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHH-------hhc----
Q 042216          633 THVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATEC-------YRN----  700 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~-------~~~----  700 (767)
                      ........++..|+|||.+.+ ..++.++|||||||+++||++|++||....+...  +.......       +..    
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchhh
Confidence            112223356889999998865 4578999999999999999999999965432211  11000000       000    


Q ss_pred             ----CCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          701 ----GKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       701 ----~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                          ..........+. ......+.++.+++.+||+.||.+|||+.+|++
T Consensus       233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         233 PDYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                000000000000 011234567889999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.4e-35  Score=307.75  Aligned_cols=238  Identities=29%  Similarity=0.446  Sum_probs=191.4

Q ss_pred             eeeccCcEEEEEEEecCCC----------ceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          482 IIGRGGFGNVYKGFLNGDS----------TPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~----------~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      .||+|+||.||+|.+.+.+          ..+++|.+...... ...|.+|+.++++++|||+++++++|.. ...++|+
T Consensus         2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            6899999999999997654          35788877654333 6788999999999999999999999988 7889999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC-------cEEEeecCCc
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW-------VAKVSDFGLC  624 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~-------~~ki~DfGla  624 (767)
                      ||+++|+|.+++..... .+++..++.++.|++.||.|||   +++|+||||||+|||++.++       .+||+|||++
T Consensus        80 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          80 EYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999976443 6899999999999999999999   78899999999999999887       7999999998


Q ss_pred             ccCCCCCCccccccccCCCcccChhhhccC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcC
Q 042216          625 KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ--LLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNG  701 (767)
Q Consensus       625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~  701 (767)
                      +....      .....++..|+|||++...  .++.++|||||||++|||++ |..|+......+..   .+    +...
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~---~~----~~~~  222 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE---RF----YQDQ  222 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH---HH----HhcC
Confidence            75322      1223466789999999876  78999999999999999999 57777544321111   11    0100


Q ss_pred             CccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          702 KIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       702 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                      .           ..+......+.+++.+||..+|.+||++.+|++.|+
T Consensus       223 ~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         223 H-----------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             C-----------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0           011111267899999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.2e-36  Score=325.10  Aligned_cols=239  Identities=28%  Similarity=0.371  Sum_probs=192.1

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHH-HHhccccceeeeEeeeeecCCceEEEEecCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIG-MLSQLRYLHLVSLIGYCNDDGQMILVYDYMARG  557 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~-~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~g  557 (767)
                      +||+|+||.||+++...+++.+|+|++...   ......++..|.. +++.++||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05604           2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG   81 (325)
T ss_pred             ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence            699999999999999888899999998643   2233345566654 567789999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccc
Q 042216          558 TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST  637 (767)
Q Consensus       558 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~  637 (767)
                      +|..++...  ..+++.++..++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++....  ......
T Consensus        82 ~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~  154 (325)
T cd05604          82 ELFFHLQRE--RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTT  154 (325)
T ss_pred             CHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcc
Confidence            999988543  46899999999999999999999   78899999999999999999999999999875322  112233


Q ss_pred             cccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCCh
Q 042216          638 QVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPP  717 (767)
Q Consensus       638 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  717 (767)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||......+      ...... .+.        +  ..++
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~~~-~~~--------~--~~~~  217 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MYDNIL-HKP--------L--VLRP  217 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HHHHHH-cCC--------c--cCCC
Confidence            4568999999999999999999999999999999999999996543211      111111 111        0  1122


Q ss_pred             hhHHHHHHHHHHccccCCCCCCCHHHH
Q 042216          718 VCLNQFVEVAMSCVNDDRIRRPSMSDV  744 (767)
Q Consensus       718 ~~~~~l~~li~~Cl~~dp~~RPs~~ev  744 (767)
                      ..+..+.+++.+|++.+|.+||++.+.
T Consensus       218 ~~~~~~~~ll~~ll~~~p~~R~~~~~~  244 (325)
T cd05604         218 GASLTAWSILEELLEKDRQRRLGAKED  244 (325)
T ss_pred             CCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence            345678899999999999999988643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.7e-35  Score=313.40  Aligned_cols=250  Identities=23%  Similarity=0.379  Sum_probs=205.5

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      .+|+..+.||.|++|.||+|....+++.|++|.+..........+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            36888889999999999999988788999999987655555667899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++++|.+++..   ..+++.++..++.+++.||.|||   +.+++|+||||+||+++.++.+||+|||++.......  .
T Consensus        99 ~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--~  170 (296)
T cd06655          99 AGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--S  170 (296)
T ss_pred             CCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccc--c
Confidence            99999998854   25899999999999999999999   7889999999999999999999999999987543211  1


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN  714 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  714 (767)
                      ......++..|+|||.+.+..++.++|||||||++|||++|+.||..........      ..... ....       ..
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~------~~~~~-~~~~-------~~  236 (296)
T cd06655         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATN-GTPE-------LQ  236 (296)
T ss_pred             cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhc-CCcc-------cC
Confidence            1233458889999999998889999999999999999999999996543321110      00000 0000       11


Q ss_pred             CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       715 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .+...+..+.+++.+||+.||.+||++.+++.
T Consensus       237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            23345567889999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.1e-35  Score=327.32  Aligned_cols=261  Identities=23%  Similarity=0.298  Sum_probs=204.2

Q ss_pred             HHHHHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeec
Q 042216          467 ISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCND  543 (767)
Q Consensus       467 ~~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~  543 (767)
                      +.++....++|...+.||+|+||.||++..+.+++.+|+|++...   .......+.+|+.+++.++||||+++++.+.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            344455568999999999999999999999988899999998542   22234457889999999999999999999999


Q ss_pred             CCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCC
Q 042216          544 DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL  623 (767)
Q Consensus       544 ~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGl  623 (767)
                      ++..++||||+++|+|.+++...   .+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            99999999999999999998543   4788889999999999999999   78899999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCcccChhhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhh
Q 042216          624 CKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ----LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR  699 (767)
Q Consensus       624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~  699 (767)
                      ++...... ........||+.|+|||++...    .++.++|||||||++|||++|+.||.......      .......
T Consensus       189 a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~  261 (371)
T cd05622         189 CMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMN  261 (371)
T ss_pred             eeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------HHHHHHc
Confidence            87543211 1122345699999999998754    37899999999999999999999996543211      1111111


Q ss_pred             cCCccccccccccCCCChhhHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 042216          700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIR--RPSMSDVVWG  747 (767)
Q Consensus       700 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~--RPs~~evl~~  747 (767)
                      ....       +........+..+.+++.+|+..++.+  ||++.|+++.
T Consensus       262 ~~~~-------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         262 HKNS-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CCCc-------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            1110       111112345667889999999844443  7899998865

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.8e-35  Score=309.49  Aligned_cols=256  Identities=26%  Similarity=0.440  Sum_probs=204.6

Q ss_pred             hccccceeeeccCcEEEEEEEecC-----CCceEEEEEeCCCCCc-chhHHHHHHHHHhccccceeeeEeeeeecCCceE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGSQQ-GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMI  548 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~  548 (767)
                      ++|+....||+|+||.||+|+.+.     ..+.+++|.+...... ...++.+|++++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            568888899999999999999753     3467999988654433 3567999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhccCCC-------CCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 042216          549 LVYDYMARGTLRDHLYNNDN-------PPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDF  621 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~Df  621 (767)
                      +||||+++|+|.+++.....       ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            99999999999999965431       25899999999999999999999   778999999999999999999999999


Q ss_pred             CCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhc
Q 042216          622 GLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRN  700 (767)
Q Consensus       622 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~  700 (767)
                      |+++...... ........++..|+|||.+.+...+.++||||||++++||++ |..||.......   ...    ....
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~----~~~~  233 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLN----RLQA  233 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHH----HHHc
Confidence            9986432211 111223345778999999988889999999999999999998 788885433211   111    1111


Q ss_pred             CCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          701 GKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       701 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                      +..        ....+..++..+.+++.+||+.+|.+||++.|++..|+
T Consensus       234 ~~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 GKL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            111        11123345678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.4e-35  Score=311.18  Aligned_cols=251  Identities=22%  Similarity=0.338  Sum_probs=201.8

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCC
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMAR  556 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~  556 (767)
                      |+..+.||+|+||.||+|.....+..+++|.+..........+.+|+++++.++|||++++++++..++..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            45566899999999999999888889999999766555667789999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcccc
Q 042216          557 GTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVS  636 (767)
Q Consensus       557 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~  636 (767)
                      |+|..++.+.. .++++..+..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||++......  ....
T Consensus        87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~  160 (282)
T cd06643          87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRR  160 (282)
T ss_pred             CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccc--cccc
Confidence            99999886533 46899999999999999999999   788999999999999999999999999998753221  1122


Q ss_pred             ccccCCCcccChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          637 TQVKGSIGYLDPEYYR-----LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       637 ~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                      ....++..|+|||++.     ...++.++|||||||++|||++|++||......+  .....    .. .....      
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~----~~-~~~~~------  227 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLKI----AK-SEPPT------  227 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHHH----hh-cCCCC------
Confidence            3346889999999984     3457889999999999999999999985443211  11111    01 00000      


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                       ...+...+.++.+++.+||+.+|.+||++.++++.
T Consensus       228 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         228 -LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             01223355678999999999999999999998743

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6.9e-36  Score=323.42  Aligned_cols=240  Identities=27%  Similarity=0.352  Sum_probs=191.6

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHH-HHHhccccceeeeEeeeeecCCceEEEEecCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEI-GMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARG  557 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei-~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~g  557 (767)
                      .||+|+||+||+++...+++.+|+|++....   .....++..|. .+++.++||||+++++++...+..++||||+++|
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG   81 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence            6999999999999998888899999986431   22233445554 4567889999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccc
Q 042216          558 TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST  637 (767)
Q Consensus       558 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~  637 (767)
                      +|.+++...  ..+.+.....++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....  ......
T Consensus        82 ~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~  154 (325)
T cd05602          82 ELFYHLQRE--RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTS  154 (325)
T ss_pred             cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcc
Confidence            999999653  35788888999999999999999   78899999999999999999999999999874322  112233


Q ss_pred             cccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCCh
Q 042216          638 QVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPP  717 (767)
Q Consensus       638 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  717 (767)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+   ..   ..... ..          ...++
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~---~~i~~-~~----------~~~~~  217 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MY---DNILN-KP----------LQLKP  217 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HH---HHHHh-CC----------cCCCC
Confidence            4569999999999999999999999999999999999999996543221   11   11111 10          11223


Q ss_pred             hhHHHHHHHHHHccccCCCCCCCHHHHH
Q 042216          718 VCLNQFVEVAMSCVNDDRIRRPSMSDVV  745 (767)
Q Consensus       718 ~~~~~l~~li~~Cl~~dp~~RPs~~evl  745 (767)
                      ..+..+.+++.+|++.||.+||++.+.+
T Consensus       218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         218 NITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            4566788999999999999999877543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-35  Score=309.91  Aligned_cols=247  Identities=27%  Similarity=0.362  Sum_probs=203.6

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      +|+..+.||.|++|.||+|....+++.+|+|.+.... ......+.+|+++++.++|+|++++++++.++...++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            5677778999999999999998888999999986543 344567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++++|.+++...   ++++..+..++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||+++......  .
T Consensus        82 ~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  153 (274)
T cd06609          82 GGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S  153 (274)
T ss_pred             CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence            999999998653   6899999999999999999999   7889999999999999999999999999987654321  1


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN  714 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  714 (767)
                      ......++..|+|||++.+..++.++|||||||++|||++|+.||........      .. .......     +.+   
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~~-~~~~~~~-----~~~---  218 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------LF-LIPKNNP-----PSL---  218 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------HH-HhhhcCC-----CCC---
Confidence            22334578899999999988899999999999999999999999964432110      00 1111111     111   


Q ss_pred             CChh-hHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          715 APPV-CLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       715 ~~~~-~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       +.. .+..+.+++.+||..+|++||+++++++
T Consensus       219 -~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         219 -EGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             -cccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence             111 4567899999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.9e-35  Score=312.65  Aligned_cols=251  Identities=25%  Similarity=0.387  Sum_probs=205.7

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      ..+|...+.||+|+||.||++.....++.||+|.+..........+.+|+.+++.++|+|++++++++...+..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            36788889999999999999998877889999999766555566788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++++|.+++.+   ..+++.++..++.|++.||.|||   +.+++||||||+|||++.++.++|+|||++.......  
T Consensus        98 ~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--  169 (297)
T cd06656          98 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--  169 (297)
T ss_pred             cCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc--
Confidence            999999999854   34889999999999999999999   7789999999999999999999999999987543211  


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      .......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...........      ....+        ....
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~--------~~~~  235 (297)
T cd06656         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG--------TPEL  235 (297)
T ss_pred             cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC--------CCCC
Confidence            112334588899999999998999999999999999999999999965432211100      00000        0001


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ..+...+..+.+++.+||+.+|.+||++.+|++
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            123344566889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.3e-36  Score=322.66  Aligned_cols=237  Identities=27%  Similarity=0.355  Sum_probs=190.5

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHH-HHhccccceeeeEeeeeecCCceEEEEecCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIG-MLSQLRYLHLVSLIGYCNDDGQMILVYDYMARG  557 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~-~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~g  557 (767)
                      +||+|+||.||+++...+++.||+|++....   .....++..|.. +++.++||||+++++++.+.+..++||||+++|
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG   81 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            6999999999999998888999999986432   222344555654 678899999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccc
Q 042216          558 TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST  637 (767)
Q Consensus       558 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~  637 (767)
                      +|.+++.+.  ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....  .....
T Consensus        82 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~  154 (321)
T cd05603          82 ELFFHLQRE--RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETTS  154 (321)
T ss_pred             CHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCccc
Confidence            999888543  45888999999999999999999   788999999999999999999999999998753221  12233


Q ss_pred             cccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCCh
Q 042216          638 QVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPP  717 (767)
Q Consensus       638 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  717 (767)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||......      ....... ...          ...+.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~-~~~----------~~~~~  217 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMYDNIL-HKP----------LQLPG  217 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHHHHHh-cCC----------CCCCC
Confidence            456899999999999889999999999999999999999999654321      1111111 110          12234


Q ss_pred             hhHHHHHHHHHHccccCCCCCCCHH
Q 042216          718 VCLNQFVEVAMSCVNDDRIRRPSMS  742 (767)
Q Consensus       718 ~~~~~l~~li~~Cl~~dp~~RPs~~  742 (767)
                      .....+.+++.+||+.||.+||+..
T Consensus       218 ~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         218 GKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCHHHHHHHHHHccCCHhhcCCCC
Confidence            4567789999999999999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-36  Score=324.64  Aligned_cols=245  Identities=25%  Similarity=0.424  Sum_probs=209.0

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCChhh
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRD  561 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gsL~~  561 (767)
                      +||+|.||+||.|+...+...+|||.+.....+..+.+.+||.+.+.|+|.|||+.+|.|.+++.+-+.||-++||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            79999999999999998888999999987777778889999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCC--ChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC-CCCcEEEeecCCcccCCCCCCcccccc
Q 042216          562 HLYNNDNPPL--PWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQ  638 (767)
Q Consensus       562 ~L~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld-~~~~~ki~DfGla~~~~~~~~~~~~~~  638 (767)
                      +|+..-+ +|  .+.++--...||++||.|||   .+.|||||||-+|||++ -.|.+||+|||-++...  ....++..
T Consensus       662 LLrskWG-PlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TET  735 (1226)
T KOG4279|consen  662 LLRSKWG-PLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTET  735 (1226)
T ss_pred             HHHhccC-CCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhc--cCCccccc
Confidence            9976654 45  67788888999999999999   78899999999999996 57899999999988643  23445667


Q ss_pred             ccCCCcccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCC
Q 042216          639 VKGSIGYLDPEYYRLQ--LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP  716 (767)
Q Consensus       639 ~~gt~~y~aPE~~~~~--~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  716 (767)
                      ..||.-|||||++..+  .|...+|||||||++.||.||++||...+...   .+.+....+           ....+.|
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---AAMFkVGmy-----------KvHP~iP  801 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---AAMFKVGMY-----------KVHPPIP  801 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---Hhhhhhcce-----------ecCCCCc
Confidence            7899999999999865  58899999999999999999999997665431   111111111           1234567


Q ss_pred             hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       717 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .+.+.+...++++|+.+||.+||++++++.
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            888899999999999999999999999984

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.9e-35  Score=306.49  Aligned_cols=249  Identities=24%  Similarity=0.370  Sum_probs=200.8

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc---------chhHHHHHHHHHhccccceeeeEeeeeecCCce
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ---------GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQM  547 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~---------~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~  547 (767)
                      |.....||+|++|.||+|....+++.+|+|.+......         ..+.+.+|++++++++||||+++++++.+.+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            45567899999999999998877889999988654221         124578999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      ++++||+++++|.+++...  ..+++..+..++.|++.||.|||   +.+++||||+|+||++++++.+||+|||+++..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             EEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            9999999999999999654  45889999999999999999999   778999999999999999999999999998754


Q ss_pred             CCCCC----ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCc
Q 042216          628 PNFSK----THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKI  703 (767)
Q Consensus       628 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~  703 (767)
                      .....    ........|+..|+|||.+.+..++.++|||||||++|||++|+.||........   .   .. ...   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~---~~-~~~---  226 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA---I---FK-IGE---  226 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH---H---HH-Hhc---
Confidence            32111    0111234578899999999988899999999999999999999999965322110   0   00 001   


Q ss_pred             cccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          704 GDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       704 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                            ......+...+..+.+++.+||+.||.+||++.||++
T Consensus       227 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         227 ------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                  1112233455678899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-35  Score=304.06  Aligned_cols=265  Identities=23%  Similarity=0.335  Sum_probs=202.3

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhc--cccceeeeEeeeeecC----Cc
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQ--LRYLHLVSLIGYCNDD----GQ  546 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~--l~Hpniv~l~g~~~~~----~~  546 (767)
                      ...+....+.||+|.||.||+|.+++  ..||||++...   +++.+.+|.++.+.  |||+||+.+++.-..+    .+
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wrG--e~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWRG--EDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hhheeEEEEEecCccccceeeccccC--CceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            34677788899999999999999987  57999999643   34466777777664  6999999999986544    37


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHh-----CCCCCeEecCCCCCCeEECCCCcEEEeec
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT-----GASKVIIHRDVKTTNILLDEEWVAKVSDF  621 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~iiH~Dlk~~NILld~~~~~ki~Df  621 (767)
                      ++||.+|.++|||.|||.+   ..++-+..++++..+|.||++||.     .+.+.|.|||||+.|||+..++.+.|+|+
T Consensus       284 LwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            8999999999999999965   358999999999999999999994     45788999999999999999999999999


Q ss_pred             CCcccCCCCC--CccccccccCCCcccChhhhccCC----CC--chhhHHHHHHHHHHHHhC----------CCCCCCCC
Q 042216          622 GLCKFGPNFS--KTHVSTQVKGSIGYLDPEYYRLQL----LT--EKSDVYSFGVVLLEVLCA----------RPPILRTG  683 (767)
Q Consensus       622 Gla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~----~s--~ksDV~SfGvvl~elltg----------~~P~~~~~  683 (767)
                      |||-......  ........+||.+|||||++....    +.  ..+||||||+|+||++..          +.||....
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            9986433221  112234567999999999997532    21  358999999999999743          36765443


Q ss_pred             CccchhHHHHHHHHhhcCCccccccccccCCC-----ChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          684 DKKQVNLAVWATECYRNGKIGDIIDPFLKGNA-----PPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       684 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      ..+. +..+ +..        -+....++...     ...++..+.++|+.||..+|.-|-|+--+-+.|.++.+..
T Consensus       441 p~DP-s~ee-Mrk--------VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~  507 (513)
T KOG2052|consen  441 PSDP-SFEE-MRK--------VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSD  507 (513)
T ss_pred             CCCC-CHHH-Hhc--------ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcCh
Confidence            2211 1111 111        11222333322     3356788999999999999999999999999998887644

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.7e-35  Score=304.33  Aligned_cols=251  Identities=31%  Similarity=0.496  Sum_probs=203.7

Q ss_pred             ccceeeeccCcEEEEEEEecCCC----ceEEEEEeCCCCCc-chhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          478 NNLLIIGRGGFGNVYKGFLNGDS----TPVAIKRLNPGSQQ-GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       478 ~~~~~LG~G~fG~Vy~g~~~~~~----~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      +..+.||.|+||.||+++....+    ..||+|.+...... ..+.+..|++++..++|+||+++++++.+.+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            44568999999999999998655    78999999765443 56689999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+++++|.+++.......+++.++..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||+++.......
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            999999999997654433899999999999999999999   78899999999999999999999999999976543211


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                      .. .....++..|+|||.+....++.++||||+|++++||++ |++||......   .+..   . ...+.         
T Consensus       159 ~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~---~-~~~~~---------  221 (258)
T smart00219      159 YK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLE---Y-LKKGY---------  221 (258)
T ss_pred             cc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---H-HhcCC---------
Confidence            11 112336789999999988899999999999999999998 78888543221   1111   1 11111         


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGL  748 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L  748 (767)
                      ....+...+.++.+++.+|+..+|++|||+.|+++.|
T Consensus       222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            1112333567899999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.5e-35  Score=306.09  Aligned_cols=247  Identities=30%  Similarity=0.490  Sum_probs=200.4

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      ++|...+.||+|+||.||++...  ++.+|+|.++...  ....+.+|+.++++++|||++++++++..+ ..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~--~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYT--GQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEecccC--CCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            45778889999999999999764  4679999986432  345789999999999999999999998654 579999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++|+|.+++.......+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....    
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----  153 (254)
T cd05083          81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----  153 (254)
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence            9999999997665556899999999999999999999   788999999999999999999999999998753221    


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                       ......+..|+|||.+.+..++.++|+|||||++|||++ |+.||......+   +.    .....+         .+.
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~---------~~~  216 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---VK----ECVEKG---------YRM  216 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH---HH----HHHhCC---------CCC
Confidence             112234567999999998899999999999999999997 999986543221   11    111111         111


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF  750 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~  750 (767)
                      ..+..++..+.+++.+||+.+|.+||++.+|++.|++
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            2233456788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.4e-35  Score=314.37  Aligned_cols=262  Identities=19%  Similarity=0.303  Sum_probs=200.9

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      ++|...+.||+|+||.||+|....+++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++|+||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46888889999999999999998888899999986543 23344678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      ++ ++|.+++.... ..+++..+..++.|+++||.|||   +.+|+|+||||+|||+++++.+||+|||+++......  
T Consensus        86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--  158 (301)
T cd07873          86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--  158 (301)
T ss_pred             cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence            97 59998886543 35889999999999999999999   7889999999999999999999999999987532211  


Q ss_pred             cccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhh---cCCcccccc-
Q 042216          634 HVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR---NGKIGDIID-  708 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~d-  708 (767)
                      .......++..|+|||.+.+ ..++.++|||||||++|||++|++||......+...   .......   ......+.+ 
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH---FIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCChhhchhhhcc
Confidence            11223456889999998865 457889999999999999999999996554322111   1111100   000000000 


Q ss_pred             --------ccccCC----CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          709 --------PFLKGN----APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       709 --------~~l~~~----~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                              +.....    .....+..+.+++.+|++.||.+|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                    000000    11234567889999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.4e-35  Score=311.58  Aligned_cols=248  Identities=26%  Similarity=0.367  Sum_probs=202.3

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      .|+..+.||+|+||.||+|.+...+..||+|.+.... ....+.+.+|++++++++||||+++++++..++..++|+||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3556668999999999999998778899999987443 334557899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++++|.+++..   ..+++..+..++.|+++||.|||   ..+++|+||+|+||++++++.++|+|||++.......  .
T Consensus        85 ~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~  156 (277)
T cd06642          85 GGGSALDLLKP---GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--I  156 (277)
T ss_pred             CCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc--h
Confidence            99999998853   35899999999999999999999   7889999999999999999999999999987543211  1


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN  714 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  714 (767)
                      ......++..|+|||++.+..++.++|||||||++|||++|+.|+.........   .    .....         ....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~----~~~~~---------~~~~  220 (277)
T cd06642         157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---F----LIPKN---------SPPT  220 (277)
T ss_pred             hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---h----hhhcC---------CCCC
Confidence            122345788999999999989999999999999999999999998543322110   0    01111         1111


Q ss_pred             CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       715 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      .+..++..+.+++.+||+.+|.+||++.+|++.
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            223456678999999999999999999999973

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.5e-35  Score=305.39  Aligned_cols=250  Identities=23%  Similarity=0.353  Sum_probs=205.9

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      +|+..+.||+|+||.+|++....+++.+|+|++...  ......++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            477888999999999999999888899999998643  233455789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++++|.+++.......+++.+++.++.|++.||.|||   +.+++|+||+|+|||++.++.++|+|||++.......  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--  155 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--  155 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--
Confidence            99999999997655556899999999999999999999   7889999999999999999999999999987543211  


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      .......|+..|+|||++.+...+.++|+|||||+++||++|+.||......      ..+..... +..         .
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~-~~~---------~  219 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKIIR-GSY---------P  219 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHhc-CCC---------C
Confidence            1122345788999999999889999999999999999999999998543211      11111111 111         1


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ..+.....++.+++.+||+.+|.+||++.+|++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            123345677999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.5e-35  Score=311.56  Aligned_cols=258  Identities=22%  Similarity=0.316  Sum_probs=206.7

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      ++|+..+.||+|+||+||++....+++.+|+|++.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            46777789999999999999998778899999886543 33456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++|+|.+++.+.  ..+++..+..++.+++.+|.|||+  ..+++|+||||+||++++++.++|+|||++......   
T Consensus        85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---  157 (284)
T cd06620          85 MDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---  157 (284)
T ss_pred             CCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence            9999999988653  458999999999999999999994  357999999999999999999999999998643221   


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCcc-----chhHHHHHHHHhhcCCcccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKK-----QVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~-----~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.||......+     ...+..+........      .
T Consensus       158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~  230 (284)
T cd06620         158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------P  230 (284)
T ss_pred             -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------C
Confidence             1223568999999999988899999999999999999999999997544321     111122222211110      0


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                      +.+   ....++.++.+++.+||+.||.+|||+.|++++.-
T Consensus       231 ~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~  268 (284)
T cd06620         231 PRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP  268 (284)
T ss_pred             CCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            001   01125567899999999999999999999998653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.9e-35  Score=301.57  Aligned_cols=268  Identities=21%  Similarity=0.255  Sum_probs=206.2

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc--chhHHHHHHHHHhccccce-eeeEeeeeecCC-----
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLSQLRYLH-LVSLIGYCNDDG-----  545 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~Hpn-iv~l~g~~~~~~-----  545 (767)
                      ...|..+++||+|+||+||+|..+..++.||+|++.....+  ....-.+|+.+|++|+|+| |+.|++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            44567777899999999999999988899999999765442  2344689999999999999 999999998776     


Q ss_pred             -ceEEEEecCCCCChhhhhccCCC--CCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecC
Q 042216          546 -QMILVYDYMARGTLRDHLYNNDN--PPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFG  622 (767)
Q Consensus       546 -~~~lV~ey~~~gsL~~~L~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfG  622 (767)
                       .++||+||++. +|.+++.....  ..++...+..++.|+++||+|||   +++|+||||||+||||+++|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence             88999999987 99999966543  35777899999999999999999   8889999999999999999999999999


Q ss_pred             CcccCCCCCCccccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcC
Q 042216          623 LCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG  701 (767)
Q Consensus       623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~  701 (767)
                      +|+...-..  ...+...+|..|.|||++.+. .|+...||||+||++.||+++++-|.+..+.++...+--......+.
T Consensus       166 lAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  166 LARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             hHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            998643222  224556788999999998876 79999999999999999999999887766533322221111111111


Q ss_pred             Ccccc-----ccccccCCC-Chh-------hHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          702 KIGDI-----IDPFLKGNA-PPV-------CLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       702 ~~~~~-----~d~~l~~~~-~~~-------~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      ....+     .+....... +..       ......+++.+|++.+|.+|.|+..++.+
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            11111     010111110 111       11367899999999999999999999875

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.2e-35  Score=326.16  Aligned_cols=253  Identities=22%  Similarity=0.322  Sum_probs=198.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|+..+.||+|+||.||++..+..++.||+|++...   .......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            3688889999999999999999888899999998643   2233456888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|+|.+++.+.  ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            999999999999654  45899999999999999999999   7889999999999999999999999999986432110


Q ss_pred             C---------------------------------ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 042216          632 K---------------------------------THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP  678 (767)
Q Consensus       632 ~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P  678 (767)
                      .                                 ........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            0                                 0011234699999999999999999999999999999999999999


Q ss_pred             CCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 042216          679 ILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPS---MSDVVW  746 (767)
Q Consensus       679 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs---~~evl~  746 (767)
                      |......+..      .... ...      ..+........+.++.+++.+|+. ||.+|++   +.|+++
T Consensus       236 f~~~~~~~~~------~~i~-~~~------~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~  292 (360)
T cd05627         236 FCSETPQETY------RKVM-NWK------ETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCHHHHH------HHHH-cCC------CceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence            9654332111      1111 000      001000111245667888888764 9999985   666664

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.4e-35  Score=308.40  Aligned_cols=253  Identities=22%  Similarity=0.328  Sum_probs=202.4

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      ++|...+.||+|+||.||+|+...+++.+|+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46777778999999999999998888999999987665555566889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++++|.+++...  ..+++.++..++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||++......  ..
T Consensus        89 ~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~  161 (267)
T cd06645          89 GGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IA  161 (267)
T ss_pred             CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--cc
Confidence            999999998543  35899999999999999999999   778999999999999999999999999998654221  11


Q ss_pred             ccccccCCCcccChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          635 VSTQVKGSIGYLDPEYYR---LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                      ......|+..|+|||++.   ...++.++|||||||++|||++|+.||.........  ..     .....   ...+..
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~--~~-----~~~~~---~~~~~~  231 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FL-----MTKSN---FQPPKL  231 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH--Hh-----hhccC---CCCCcc
Confidence            223446889999999874   456889999999999999999999998654322111  00     00000   000111


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ..  ....+..+.+++.+||+.+|++||++++|++
T Consensus       232 ~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         232 KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            10  1124457889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-35  Score=309.91  Aligned_cols=253  Identities=29%  Similarity=0.448  Sum_probs=201.4

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchh--HHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGAL--EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~--~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      |+..+.||+|+||+||++...++++.+|+|++.........  ...+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            45677999999999999999998889999999766433322  3456999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++++|.+++.  ....+++.+++.++.|+++||.+||   +.+++|+||||+||++++++.++|+|||++....  ....
T Consensus        81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~  153 (260)
T PF00069_consen   81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNE  153 (260)
T ss_dssp             TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTS
T ss_pred             cccccccccc--ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--cccc
Confidence            9999999997  2345899999999999999999999   6789999999999999999999999999987531  1222


Q ss_pred             ccccccCCCcccChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          635 VSTQVKGSIGYLDPEYYR-LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      ......++..|+|||.+. ....+.++||||+|+++++|++|..|+.............   .....    ...   ...
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~~----~~~---~~~  223 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KILKR----PLP---SSS  223 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHHHT----HHH---HHT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hcccc----ccc---ccc
Confidence            344566899999999998 8899999999999999999999999996552111111111   11000    000   000


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ........++.+++.+||+.||++||++.++++
T Consensus       224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            001112378999999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=8.4e-35  Score=303.35  Aligned_cols=251  Identities=29%  Similarity=0.491  Sum_probs=201.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      .+|+..+.||+|+||.||++.+.. +..+|+|.+.... ....+|.+|++++++++|||++++++++......++|+||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            357777899999999999998864 4689999886443 23457899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++++|.+++.... ..+++..+..++.+++.+|.|||   +.+++|+||||+||+++.++.+||+|||+++...... ..
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~  156 (256)
T cd05112          82 EHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YT  156 (256)
T ss_pred             CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc-cc
Confidence            9999999986543 35899999999999999999999   6789999999999999999999999999987543211 11


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      ......++.+|+|||++.++.++.++||||||+++|||++ |+.||......+      .... ...+         ...
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~-~~~~---------~~~  220 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------VVET-INAG---------FRL  220 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHH-HhCC---------CCC
Confidence            1122235678999999998899999999999999999998 999985433221      1111 1111         011


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGL  748 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L  748 (767)
                      ..+...+..+.+++.+||+.+|++||++.+++++|
T Consensus       221 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         221 YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            11223457799999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=8.4e-35  Score=307.42  Aligned_cols=248  Identities=25%  Similarity=0.354  Sum_probs=204.4

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      .|+..+.||+|+||.||+|.....+..||+|.+... .......+.+|++++++++|+|++++++++.++...++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            466677899999999999999877889999998644 2344567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++|+|.+++..   .++++.+...++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.......  .
T Consensus        85 ~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~  156 (277)
T cd06640          85 GGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--I  156 (277)
T ss_pred             CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--c
Confidence            99999999854   35889999999999999999999   7889999999999999999999999999987543211  1


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN  714 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  714 (767)
                      ......++..|+|||++.+..++.++|+|||||++|||++|+.|+.........      . ....         .....
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~-~~~~---------~~~~~  220 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------F-LIPK---------NNPPT  220 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------h-hhhc---------CCCCC
Confidence            223345788999999999888999999999999999999999998654322111      0 0001         11122


Q ss_pred             CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       715 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      .+..++..+.+++.+||+.+|++||++.+++..
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            334567789999999999999999999999865

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.4e-35  Score=324.56  Aligned_cols=262  Identities=24%  Similarity=0.271  Sum_probs=200.0

Q ss_pred             hhccccceeeeccCcEEEEEEEecC--CCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNG--DSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ..+|...+.||+|+||.||++...+  .+..||+|.+...     ..+.+|+++|++++||||+++++++......+++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            3578999999999999999997653  3467999987542     24568999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      |++. ++|.+++..  ...+++.+++.++.|++.||.|||   .++|+||||||+|||++.++.+||+|||+++......
T Consensus       166 e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        166 PKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             hhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            9996 589988833  346999999999999999999999   7889999999999999999999999999987544322


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccch-hHHHHHHHHhhcCCccc-----
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQV-NLAVWATECYRNGKIGD-----  705 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~-~l~~~~~~~~~~~~~~~-----  705 (767)
                      .........||..|+|||++....++.++|||||||++|||++|+.||......... .+.. +..........-     
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~-i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRS-IIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHH-HHHHhccCccccCCccc
Confidence            222233457999999999999999999999999999999999999999665432211 1111 111111000000     


Q ss_pred             --c------ccccccCCCC-------hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          706 --I------IDPFLKGNAP-------PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       706 --~------~d~~l~~~~~-------~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                        +      .....+....       .....++.+++.+||+.||++|||+.|++..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence              0      0000010000       1224567889999999999999999999865

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=5.6e-35  Score=316.61  Aligned_cols=257  Identities=21%  Similarity=0.245  Sum_probs=196.0

Q ss_pred             ceeeecc--CcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCC
Q 042216          480 LLIIGRG--GFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMA  555 (767)
Q Consensus       480 ~~~LG~G--~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~  555 (767)
                      .++||+|  +|++||++..+.+++.||+|++....  ......+.+|+++++.++||||+++++++..++..++|+||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            4579999  78999999999888999999987542  2233457789999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC-c-
Q 042216          556 RGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK-T-  633 (767)
Q Consensus       556 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~-~-  633 (767)
                      +|+|.+++.......+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.++++||+.+........ . 
T Consensus        83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence            999999997655556899999999999999999999   78899999999999999999999999986543211110 0 


Q ss_pred             ---cccccccCCCcccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          634 ---HVSTQVKGSIGYLDPEYYRL--QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       634 ---~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                         .......++..|+|||++..  ..++.++|||||||++|||++|+.||.......  .....     ..+.+...++
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~-----~~~~~~~~~~  232 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEK-----LNGTVPCLLD  232 (327)
T ss_pred             ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHH-----hcCCcccccc
Confidence               01112346778999999876  468999999999999999999999996543211  00000     0011110000


Q ss_pred             -------------------ccc-----------------cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          709 -------------------PFL-----------------KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       709 -------------------~~l-----------------~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                                         ..+                 ...........+.+++.+||+.||.+|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                               000                 00112234567899999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.9e-35  Score=335.73  Aligned_cols=266  Identities=20%  Similarity=0.318  Sum_probs=195.8

Q ss_pred             HHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcccc------ceeeeEeeeeec
Q 042216          470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRY------LHLVSLIGYCND  543 (767)
Q Consensus       470 i~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H------pniv~l~g~~~~  543 (767)
                      +...+++|...++||+|+||+||+|.....++.||||+++... ....++..|++++.+++|      .+++.+++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3445678999999999999999999998888899999986432 223455667777777654      458899998875


Q ss_pred             C-CceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC--------
Q 042216          544 D-GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW--------  614 (767)
Q Consensus       544 ~-~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~--------  614 (767)
                      + +..++|||++ +++|.+++.+.  ..+++..+..|+.|++.||.|||+  ..+|+||||||+|||++.++        
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccc
Confidence            4 5788999988 66899988654  469999999999999999999993  25899999999999998765        


Q ss_pred             --------cEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCcc
Q 042216          615 --------VAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKK  686 (767)
Q Consensus       615 --------~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~  686 (767)
                              .+||+|||++....     .......||..|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~  352 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE  352 (467)
T ss_pred             cccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence                    49999999876321     22345679999999999999999999999999999999999999997654432


Q ss_pred             chhHHHHH---------HH--------Hhhc-CCcccccccc----ccC---CCChhhHHHHHHHHHHccccCCCCCCCH
Q 042216          687 QVNLAVWA---------TE--------CYRN-GKIGDIIDPF----LKG---NAPPVCLNQFVEVAMSCVNDDRIRRPSM  741 (767)
Q Consensus       687 ~~~l~~~~---------~~--------~~~~-~~~~~~~d~~----l~~---~~~~~~~~~l~~li~~Cl~~dp~~RPs~  741 (767)
                      ...+....         ..        .+.. +.+....++.    +..   .........+++|+.+||+.||.+|||+
T Consensus       353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta  432 (467)
T PTZ00284        353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA  432 (467)
T ss_pred             HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence            22221110         00        0000 0000000000    000   0000123567899999999999999999


Q ss_pred             HHHHH
Q 042216          742 SDVVW  746 (767)
Q Consensus       742 ~evl~  746 (767)
                      .|+++
T Consensus       433 ~e~L~  437 (467)
T PTZ00284        433 RQMTT  437 (467)
T ss_pred             HHHhc
Confidence            99985

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-35  Score=304.41  Aligned_cols=254  Identities=24%  Similarity=0.380  Sum_probs=206.9

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      ++|...+.||+|+||.||++....+++.+++|.+........+.+.+|++++++++|||++++++++..++..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            46888889999999999999998777899999997665556778999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++++|.+++.... ..+++.++..++.|++.||.|||   ..+++|+||||+||++++++.+||+|||++......  ..
T Consensus        83 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~  156 (262)
T cd06613          83 GGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--IA  156 (262)
T ss_pred             CCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhh--hh
Confidence            9999999986542 46899999999999999999999   788999999999999999999999999998754321  11


Q ss_pred             ccccccCCCcccChhhhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          635 VSTQVKGSIGYLDPEYYRLQ---LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                      ......++..|+|||.+...   .++.++|||||||++|||++|+.|+......+..  ..     .....   ...+.+
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~--~~-----~~~~~---~~~~~~  226 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL--FL-----ISKSN---FPPPKL  226 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-----HHhcc---CCCccc
Confidence            12334678899999999776   8899999999999999999999999654432111  11     01110   000011


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                        ..+...+.++.+++.+||+.+|.+|||+.+|+.
T Consensus       227 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         227 --KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             --cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              112345677999999999999999999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.4e-35  Score=319.85  Aligned_cols=264  Identities=22%  Similarity=0.238  Sum_probs=199.6

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCC-----
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG-----  545 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~-----  545 (767)
                      ..++|...+.||+|+||.||++.....++.||+|++...  ......++.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            457899999999999999999999888899999998643  2334557889999999999999999999986443     


Q ss_pred             -ceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCc
Q 042216          546 -QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC  624 (767)
Q Consensus       546 -~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla  624 (767)
                       ..++||||+++ +|.+.+..    .+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence             57999999976 67666632    3788999999999999999999   788999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchh------------HHH
Q 042216          625 KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVN------------LAV  692 (767)
Q Consensus       625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~------------l~~  692 (767)
                      +....   ........||..|+|||.+.+..++.++|||||||++|||++|+.||...+......            ...
T Consensus       171 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         171 RTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             ccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence            75322   112234568999999999999999999999999999999999999997553221100            000


Q ss_pred             ----HHHHHhhc-CC-----cccccccccc---CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          693 ----WATECYRN-GK-----IGDIIDPFLK---GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       693 ----~~~~~~~~-~~-----~~~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                          ........ ..     ..+.......   ...+.....++.+++.+||+.||++|||+.|+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                00000000 00     0000000000   00111234668899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1e-34  Score=305.20  Aligned_cols=254  Identities=26%  Similarity=0.404  Sum_probs=201.7

Q ss_pred             ccccceeeeccCcEEEEEEEecC-CCceEEEEEeCCCC----------CcchhHHHHHHHHHhc-cccceeeeEeeeeec
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNG-DSTPVAIKRLNPGS----------QQGALEFQTEIGMLSQ-LRYLHLVSLIGYCND  543 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~-~~~~vAVK~l~~~~----------~~~~~~f~~Ei~~l~~-l~Hpniv~l~g~~~~  543 (767)
                      +|+..+.||+|+||.||+|.... .++.+|+|.+....          .....++.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            36677789999999999999987 56889999875321          1223457788888875 799999999999999


Q ss_pred             CCceEEEEecCCCCChhhhhcc--CCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 042216          544 DGQMILVYDYMARGTLRDHLYN--NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDF  621 (767)
Q Consensus       544 ~~~~~lV~ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~Df  621 (767)
                      ++..+++|||+++++|.+++..  .....+++..++.++.|++.||.|||+  ..+++|+||||+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999998743  233468999999999999999999993  357999999999999999999999999


Q ss_pred             CCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcC
Q 042216          622 GLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG  701 (767)
Q Consensus       622 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~  701 (767)
                      |++.......   ......++..|+|||.+.+..++.++||||||+++|||++|+.||......      ..... ...+
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~~~-~~~~  228 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLATK-IVEA  228 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHHHH-Hhhc
Confidence            9987643321   233456889999999999888999999999999999999999998543221      11111 1111


Q ss_pred             CccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          702 KIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       702 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                      ..        ........+.++.+++.+||+.||.+||++.||.++|+
T Consensus       229 ~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         229 VY--------EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cC--------CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            11        00011134567899999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1e-34  Score=309.30  Aligned_cols=252  Identities=24%  Similarity=0.339  Sum_probs=203.2

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      +.|+..+.||+|+||.||+|+....++.+++|.+........+.+.+|+++++.++|+|++++++.+..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            45777889999999999999998888999999998766666778999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++++|..++.+.. ..+++..+..++.|++.+|.|||   ..+++||||||+||+++.++.+||+|||++......  ..
T Consensus        92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~  165 (292)
T cd06644          92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQ  165 (292)
T ss_pred             CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc--cc
Confidence            9999998875543 45899999999999999999999   788999999999999999999999999998643221  11


Q ss_pred             ccccccCCCcccChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          635 VSTQVKGSIGYLDPEYYR-----LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                      ......++..|+|||++.     ...++.++|||||||++|||++|+.|+......  ...    ... .....     +
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~----~~~-~~~~~-----~  233 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVL----LKI-AKSEP-----P  233 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--HHH----HHH-hcCCC-----c
Confidence            123345788999999884     345788999999999999999999998543321  111    111 11110     0


Q ss_pred             cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       710 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .  ...+...+.++.+++.+||+.+|++||++.++++
T Consensus       234 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         234 T--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             c--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0  0113345567899999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.7e-35  Score=306.20  Aligned_cols=251  Identities=23%  Similarity=0.357  Sum_probs=197.0

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-----CcchhHHHHHHHHHhccccceeeeEeeeeec--CCce
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-----QQGALEFQTEIGMLSQLRYLHLVSLIGYCND--DGQM  547 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~--~~~~  547 (767)
                      .+|...+.||+|+||.||+|.....+..+++|++....     .+....+.+|+.++++++||||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46888889999999999999998878899999886432     1233468899999999999999999998865  3577


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      ++++||+++++|.+++...  ..+++...+.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            8999999999999999653  35899999999999999999999   788999999999999999999999999998754


Q ss_pred             CCCCC-ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccc
Q 042216          628 PNFSK-THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI  706 (767)
Q Consensus       628 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  706 (767)
                      ..... ........++..|+|||++.+..++.++|||||||++|||++|+.||......+.      ........     
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~~~~-----  225 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIATQP-----  225 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHhcCC-----
Confidence            32111 1111234578899999999988899999999999999999999999964422111      11111110     


Q ss_pred             ccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          707 IDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       707 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                          .....+......+.+++ +||..+|++||++.||++
T Consensus       226 ----~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 ----TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ----CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                01122333445566666 788899999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-34  Score=305.46  Aligned_cols=254  Identities=22%  Similarity=0.351  Sum_probs=199.8

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC---c-------chhHHHHHHHHHhccccceeeeEeeeeecCCc
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ---Q-------GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQ  546 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~---~-------~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~  546 (767)
                      |...+.||+|+||.||+|....+++.+|+|.+.....   .       ..+.+.+|+++++.++|+|++++++++...+.
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   82 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY   82 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence            5566789999999999999887788999998753211   1       12357889999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      .++|+||+++|+|.+++.+.  ..+++..+..++.|++.||.|||   +++++|+||+|+||++++++.++|+|||+++.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          83 LSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             eEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            99999999999999999654  46899999999999999999999   77899999999999999999999999999875


Q ss_pred             CCCCCCccccccccCCCcccChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYRLQL--LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG  704 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  704 (767)
                      ..............++..|+|||.+....  ++.++|+||||+++|||++|..||......+     . ....... ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~-~~~~~~~-~~~  230 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-----A-MFKLGNK-RSA  230 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-----H-HHHhhcc-ccC
Confidence            43322222233456889999999987654  8899999999999999999999985332211     1 1111111 111


Q ss_pred             ccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          705 DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       705 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ..+.    .......+..+.+++.+||+.+|.+||++.+|++
T Consensus       231 ~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         231 PPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             CcCC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            1111    1112234678899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=9.5e-35  Score=302.66  Aligned_cols=249  Identities=27%  Similarity=0.404  Sum_probs=204.3

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      +|+..+.||+|+||.||++.....++.+|+|.+...  .......+.+|++++++++|||++++++.+..++..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            477788999999999999999888899999998654  233456789999999999999999999999989999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCC-CcEEEeecCCcccCCCCCC
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEE-WVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~-~~~ki~DfGla~~~~~~~~  632 (767)
                      +++++|.+++.......+++..+..++.+++.+|.|||   +++++|+||||+||+++++ ..+||+|||++....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            99999999997765566899999999999999999999   7889999999999999854 468999999987543321 


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                        ......++..|+|||.+....++.++||||||+++|+|++|+.||......   ..   +..... +.         .
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~---~~~~~~-~~---------~  218 (256)
T cd08220         157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---AL---VLKIMS-GT---------F  218 (256)
T ss_pred             --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HH---HHHHHh-cC---------C
Confidence              122345788999999999888999999999999999999999998544321   11   111111 11         1


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ...+...+.++.+++.+||+.+|.+|||+.|++.
T Consensus       219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            1123345677899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-35  Score=309.36  Aligned_cols=253  Identities=24%  Similarity=0.354  Sum_probs=204.7

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      ++|+..+.||+|+||.||+|....++..+|+|.+..........|.+|++++++++|+|++++++.+..+...++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            46788888999999999999998777899999997665556677999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++++|.+++.+.. ..+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.++|+|||++......  ..
T Consensus        85 ~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~  158 (280)
T cd06611          85 DGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQ  158 (280)
T ss_pred             CCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccc--cc
Confidence            9999999986543 36899999999999999999999   778999999999999999999999999997653221  11


Q ss_pred             ccccccCCCcccChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          635 VSTQVKGSIGYLDPEYYR-----LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                      ......++..|+|||.+.     ...++.++||||||+++|||++|+.||......+  .+..     ...+..     +
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~~-----~~~~~~-----~  226 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLLK-----ILKSEP-----P  226 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHHH-----HhcCCC-----C
Confidence            223345889999999975     3457789999999999999999999996543211  1111     111110     0


Q ss_pred             cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       710 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      .+  ..+..++.++.+++..||+.+|.+||++.+|++.
T Consensus       227 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         227 TL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             Cc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            01  1233456678999999999999999999999854

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=5.1e-35  Score=310.29  Aligned_cols=263  Identities=23%  Similarity=0.340  Sum_probs=205.8

Q ss_pred             cCHHHHHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc-ccceeeeEeeeee-
Q 042216          465 FSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGYCN-  542 (767)
Q Consensus       465 ~~~~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~-  542 (767)
                      +.++.+..+.++|+..+.||+|+||.||++.....++.+|+|.+.... ....++.+|+.++.++ +|||++++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            344566678889999999999999999999998888899999886432 2345688899999999 6999999999884 


Q ss_pred             ----cCCceEEEEecCCCCChhhhhcc--CCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcE
Q 042216          543 ----DDGQMILVYDYMARGTLRDHLYN--NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVA  616 (767)
Q Consensus       543 ----~~~~~~lV~ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~  616 (767)
                          .++..++||||+++|+|.+++..  .....+++..+..++.|++.||.|||   +.+++||||||+||++++++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence                34578999999999999998753  23346899999999999999999999   7889999999999999999999


Q ss_pred             EEeecCCcccCCCCCCccccccccCCCcccChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHH
Q 042216          617 KVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL-----QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLA  691 (767)
Q Consensus       617 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~  691 (767)
                      ||+|||+++.....  ........|+..|+|||++..     ..++.++|||||||++|||++|+.|+........  +.
T Consensus       164 kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~~  239 (286)
T cd06638         164 KLVDFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--LF  239 (286)
T ss_pred             EEccCCceeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--Hh
Confidence            99999998754321  112233468899999998753     4578899999999999999999999865432111  10


Q ss_pred             HHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          692 VWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       692 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      .     .........       ..+..+..++.+++.+||+.||++|||+.||++.
T Consensus       240 ~-----~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         240 K-----IPRNPPPTL-------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             h-----ccccCCCcc-------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            0     001100001       1122345678999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-35  Score=315.76  Aligned_cols=256  Identities=23%  Similarity=0.260  Sum_probs=197.6

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|+..+.||+|+||.||+++....++.||+|++...   .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            3688889999999999999999888899999998642   2233456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|+|.+++.+. ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++.......
T Consensus        81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            999999999999653 235899999999999999999999   7889999999999999999999999999986543211


Q ss_pred             CccccccccCCCcccChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRL-----QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI  706 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  706 (767)
                       ........||+.|+|||++..     +.++.++|||||||++|||++|+.||......      +.............+
T Consensus       157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~  229 (331)
T cd05597         157 -TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQF  229 (331)
T ss_pred             -CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCcccC
Confidence             112223468999999999863     45788999999999999999999999543221      111111111110010


Q ss_pred             ccccccCCCChhhHHHHHHHHHHcccc--CCCCCCCHHHHHHH
Q 042216          707 IDPFLKGNAPPVCLNQFVEVAMSCVND--DRIRRPSMSDVVWG  747 (767)
Q Consensus       707 ~d~~l~~~~~~~~~~~l~~li~~Cl~~--dp~~RPs~~evl~~  747 (767)
                            .......+..+.+++.+|+..  ++..||++.++++.
T Consensus       230 ------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         230 ------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             ------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence                  011122456778888887654  33448899998855

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=9e-35  Score=318.70  Aligned_cols=265  Identities=22%  Similarity=0.229  Sum_probs=200.1

Q ss_pred             HHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecC-----
Q 042216          472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD-----  544 (767)
Q Consensus       472 ~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~-----  544 (767)
                      ...++|...+.||+|+||.||++.....++.||||++....  ......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            34578999999999999999999988778899999987542  23345678999999999999999999988543     


Q ss_pred             -CceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCC
Q 042216          545 -GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL  623 (767)
Q Consensus       545 -~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGl  623 (767)
                       ...++||||+++ +|.+.+..    .+++..+..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcc
Confidence             357999999975 67776632    4889999999999999999999   78899999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHH------------
Q 042216          624 CKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLA------------  691 (767)
Q Consensus       624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~------------  691 (767)
                      ++....   ........||..|+|||++.+..++.++|||||||++|||++|+.||......+.....            
T Consensus       166 ~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         166 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             cccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            975322   12223456899999999999999999999999999999999999999654321111000            


Q ss_pred             ----HHHHHHhhc-CCccccccccc--------cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          692 ----VWATECYRN-GKIGDIIDPFL--------KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       692 ----~~~~~~~~~-~~~~~~~d~~l--------~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                          ......... ........+..        ....+.....++.+++.+||+.||++|||+.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                000000000 00000000000        001112234578899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.3e-35  Score=318.66  Aligned_cols=192  Identities=25%  Similarity=0.352  Sum_probs=166.1

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      ..+|...+.||+|+||.||+|...+.+..||+|.....      ....|+.++++++|+||+++++++...+..++|+||
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  138 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH  138 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence            45799999999999999999999888889999975422      235699999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +. ++|.+++.... ..+++.++..|+.|++.||.|||   ..+|+||||||+|||++.++.+||+|||+++....   .
T Consensus       139 ~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~  210 (357)
T PHA03209        139 YS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---A  210 (357)
T ss_pred             cC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCcccccccc---C
Confidence            95 58988886533 46899999999999999999999   77899999999999999999999999999874321   1


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPI  679 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~  679 (767)
                      .......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            1223456899999999999999999999999999999999866554

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=9.5e-35  Score=309.26  Aligned_cols=262  Identities=26%  Similarity=0.343  Sum_probs=206.2

Q ss_pred             cCHHHHHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc-ccceeeeEeeeeec
Q 042216          465 FSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGYCND  543 (767)
Q Consensus       465 ~~~~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~  543 (767)
                      +++.++..++++|...+.||+|+||.||++....+++.+|+|.+.... ....++.+|+.++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            455666677889999999999999999999998888999999986432 2345678899999998 89999999999865


Q ss_pred             C-----CceEEEEecCCCCChhhhhccC--CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcE
Q 042216          544 D-----GQMILVYDYMARGTLRDHLYNN--DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVA  616 (767)
Q Consensus       544 ~-----~~~~lV~ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~  616 (767)
                      .     +..++|+||+++|+|.++++..  ....+++..+..++.|++.||.|||   ..+++|+||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence            3     3589999999999999988542  3356899999999999999999999   7789999999999999999999


Q ss_pred             EEeecCCcccCCCCCCccccccccCCCcccChhhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHH
Q 042216          617 KVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ-----LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLA  691 (767)
Q Consensus       617 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~  691 (767)
                      ||+|||+++.......  ......++..|+|||.+...     .++.++|||||||++|||++|+.||......+  .+.
T Consensus       168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~~~  243 (291)
T cd06639         168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--TLF  243 (291)
T ss_pred             EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--HHH
Confidence            9999999875432111  12234578899999998643     36889999999999999999999996543211  111


Q ss_pred             HHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          692 VWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       692 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .     ........+       ..+......+.+++.+||+.+|++||++.|+++
T Consensus       244 ~-----~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         244 K-----IPRNPPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             H-----HhcCCCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1     111111111       112234457899999999999999999999975

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.3e-34  Score=306.92  Aligned_cols=265  Identities=24%  Similarity=0.291  Sum_probs=200.6

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ++|+....||+|++|.||+|..+.+++.||+|++....  ....+.+.+|++++++++|+|++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            35778889999999999999998878999999886432  2233567899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |++++.|..++...  ..+++.++..++.|++.||.|||   +++++|+||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            99998888876433  35899999999999999999999   78899999999999999999999999999886533221


Q ss_pred             ccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHH-HHH-------HHhhcCC-
Q 042216          633 THVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAV-WAT-------ECYRNGK-  702 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~-~~~-------~~~~~~~-  702 (767)
                        ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+...... ...       ..+.... 
T Consensus       156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence              1223457788999999876 568899999999999999999999996554322111100 000       0000000 


Q ss_pred             ccccccccccCCC-----ChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          703 IGDIIDPFLKGNA-----PPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       703 ~~~~~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ......+......     .+..+..+.+++.+||+.+|++||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0000000000000     0123567889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-35  Score=309.55  Aligned_cols=265  Identities=25%  Similarity=0.306  Sum_probs=203.1

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      +|+..+.||+|+||.||+|...++++.||+|+++..  .......+.+|++++++++|+||+++++++..++..+++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            578888999999999999999888889999998653  233446789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      ++++.|..++.+  ...+++.++..++.|++.||.|||   ..+++|+||+|+||++++++.+||+|||++........ 
T Consensus        82 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-  155 (288)
T cd07833          82 VERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-  155 (288)
T ss_pred             CCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence            998777665533  245899999999999999999999   77899999999999999999999999999876543222 


Q ss_pred             cccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhh---------cCC-
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR---------NGK-  702 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~---------~~~-  702 (767)
                      .......++..|+|||++... .++.++||||||+++|||++|++||......+.............         ... 
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence            122335578899999999887 889999999999999999999999865433211110000000000         000 


Q ss_pred             ----cccccccc-ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          703 ----IGDIIDPF-LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       703 ----~~~~~d~~-l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                          ..+..++. +....+..++.++.+++.+||+.+|++||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                00000000 001122334778999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.4e-34  Score=304.68  Aligned_cols=256  Identities=26%  Similarity=0.408  Sum_probs=199.0

Q ss_pred             cccceeeeccCcEEEEEEEecC---CCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCC------
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNG---DSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG------  545 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~---~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~------  545 (767)
                      |...++||+|+||.||+|.+..   .++.||||++...  .....+++.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            4456689999999999998753   3578999998754  2334567889999999999999999999886432      


Q ss_pred             ceEEEEecCCCCChhhhhccC----CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 042216          546 QMILVYDYMARGTLRDHLYNN----DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDF  621 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~Df  621 (767)
                      ..++++||+.+|+|.+++...    ....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            247889999999999887432    1235789999999999999999999   778999999999999999999999999


Q ss_pred             CCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhc
Q 042216          622 GLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRN  700 (767)
Q Consensus       622 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~  700 (767)
                      |+++...............++..|++||.+....++.++|||||||++|||++ |++||......   .+..+..    .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~----~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLI----K  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHH----c
Confidence            99885432211111223345678999999998899999999999999999999 88888644321   1111111    1


Q ss_pred             CCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          701 GKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       701 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                      +..         ...+..++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus       231 ~~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GNR---------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            110         011234567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.1e-35  Score=310.91  Aligned_cols=265  Identities=26%  Similarity=0.343  Sum_probs=200.6

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ++|+..+.||+|+||.||+|..+.+++.+|+|++.....  ...+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            367788899999999999999987789999998865422  234568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+++++|.++....  ..++|.+++.++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-  154 (286)
T cd07846          81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-  154 (286)
T ss_pred             cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence            99999998876443  34899999999999999999999   6789999999999999999999999999987543321 


Q ss_pred             ccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchh-HHHHHH-------HHhhcCCc
Q 042216          633 THVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVN-LAVWAT-------ECYRNGKI  703 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~-l~~~~~-------~~~~~~~~  703 (767)
                       .......++..|+|||++.+ ..++.++||||||+++|||++|++||......+... +..+..       .......+
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07846         155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL  233 (286)
T ss_pred             -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence             12233457889999999875 457889999999999999999999985443211110 000000       00000000


Q ss_pred             -ccccccccc-----CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          704 -GDIIDPFLK-----GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       704 -~~~~d~~l~-----~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       .....+...     ....+..+..+.+++.+||+.+|.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence             000000000     0012234677999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2e-34  Score=301.98  Aligned_cols=257  Identities=25%  Similarity=0.350  Sum_probs=206.7

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      ++|+..+.||.|+||+||+|....++..+++|++.... ......+.+|+++++.++|+|++++++.+...+..++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            36888889999999999999988788899999986542 33566799999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCC-CCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          554 MARGTLRDHLYNNDN-PPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      +++++|.+++..... ..+++.....++.|++.||.|||   +.+++|+||||+||++++++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999975432 56899999999999999999999   78899999999999999999999999999875433222


Q ss_pred             c--cccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          633 T--HVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       633 ~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                      .  .......++..|+|||++... .++.++|+|||||++|||++|+.||......+  .+...    ... .     .+
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~----~~~-~-----~~  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLT----LQN-D-----PP  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHH----hcC-C-----CC
Confidence            2  122334688999999998876 78999999999999999999999996543221  11111    111 0     11


Q ss_pred             cccCCC-ChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          710 FLKGNA-PPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       710 ~l~~~~-~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .+.... ....+..+.+++.+||+.||++||++.+|++
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            111111 1245677899999999999999999999975

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=7.5e-35  Score=308.50  Aligned_cols=261  Identities=23%  Similarity=0.355  Sum_probs=206.6

Q ss_pred             cCHHHHHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc-ccceeeeEeeeeec
Q 042216          465 FSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGYCND  543 (767)
Q Consensus       465 ~~~~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~  543 (767)
                      .++.++......|+..+.||+|+||.||+|.....++.+|+|.+.... ....++..|+.++.++ +|+|++++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            355666667788999999999999999999998888899999986442 3345688899999998 69999999999853


Q ss_pred             ------CCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEE
Q 042216          544 ------DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAK  617 (767)
Q Consensus       544 ------~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~k  617 (767)
                            ....+++|||+++|+|.+++.......+++..+..++.|++.||.|||   +.+|+|+||||+||++++++.++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence                  457899999999999999997655566889999999999999999999   78899999999999999999999


Q ss_pred             EeecCCcccCCCCCCccccccccCCCcccChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHH
Q 042216          618 VSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR-----LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAV  692 (767)
Q Consensus       618 i~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~  692 (767)
                      |+|||++.......  .......|+..|+|||.+.     ...++.++|||||||++|||++|+.||......+...   
T Consensus       162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---  236 (282)
T cd06636         162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---  236 (282)
T ss_pred             EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---
Confidence            99999987532211  1123345888999999876     3467889999999999999999999996543211110   


Q ss_pred             HHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          693 WATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       693 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                         . ...        ..........++..+.+++.+||+.||.+||++.|+++
T Consensus       237 ---~-~~~--------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         237 ---L-IPR--------NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ---h-Hhh--------CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence               0 000        00011112235668999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.7e-34  Score=303.61  Aligned_cols=253  Identities=21%  Similarity=0.286  Sum_probs=191.1

Q ss_pred             eeeccCcEEEEEEEecCCC--ceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGDS--TPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGT  558 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~--~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gs  558 (767)
                      .||+|+||+||+|....+.  ..+++|.+.... ......|.+|+.+++.++||||+++++.|.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            5899999999999764332  356677776443 3345679999999999999999999999999999999999999999


Q ss_pred             hhhhhccCC--CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcccc
Q 042216          559 LRDHLYNND--NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVS  636 (767)
Q Consensus       559 L~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~  636 (767)
                      |.+++++..  ...+++..+..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999997542  234677788899999999999999   678999999999999999999999999997642211111122


Q ss_pred             ccccCCCcccChhhhcc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          637 TQVKGSIGYLDPEYYRL-------QLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       637 ~~~~gt~~y~aPE~~~~-------~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      ....++..|+|||++..       ..++.++|||||||++|||++ |..||....+.+      ...... .+....+.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~-~~~~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVI-KDQQVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHH-hhcccccCC
Confidence            34457889999998753       245789999999999999997 567775433211      111111 122223333


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                      +.+.    ......+.+++..|| .+|.+||++++|++.|.
T Consensus       232 ~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            3332    234567888999999 57999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5.7e-35  Score=317.22  Aligned_cols=256  Identities=23%  Similarity=0.245  Sum_probs=198.5

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|...+.||+|+||.||++..+..++.+|+|++...   .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            3688889999999999999999988889999998542   2223345788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|+|.+++.+.. ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-  155 (332)
T cd05623          81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-  155 (332)
T ss_pred             eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccC-
Confidence            9999999999996532 35899999999999999999999   788999999999999999999999999998743221 


Q ss_pred             CccccccccCCCcccChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYR-----LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI  706 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  706 (767)
                      .........||+.|+|||++.     ...++.++|||||||++|||++|+.||......      .............. 
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~-  228 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKERFQ-  228 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHHHhCCCcccc-
Confidence            111223456999999999986     346889999999999999999999999654321      11111111110000 


Q ss_pred             ccccccCCCChhhHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 042216          707 IDPFLKGNAPPVCLNQFVEVAMSCVNDDRI--RRPSMSDVVWG  747 (767)
Q Consensus       707 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~--~RPs~~evl~~  747 (767)
                           .......++.++.+++.+|+..++.  .|+++.|+++.
T Consensus       229 -----~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 -----FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             -----CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                 0011123466788889887755444  47899999765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.1e-34  Score=319.15  Aligned_cols=264  Identities=22%  Similarity=0.248  Sum_probs=199.6

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecC------
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD------  544 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~------  544 (767)
                      ..++|...+.||+|+||.||++.....++.||||++...  ......++.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            457899999999999999999999888889999998753  233445688999999999999999999987543      


Q ss_pred             CceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCc
Q 042216          545 GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC  624 (767)
Q Consensus       545 ~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla  624 (767)
                      ...++||||+++ +|.+++..    .+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            357999999975 77777742    4789999999999999999999   788999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHH---------HH-
Q 042216          625 KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAV---------WA-  694 (767)
Q Consensus       625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~---------~~-  694 (767)
                      +....   ........+|..|+|||++.+..++.++|||||||++|||++|+.||......+......         +. 
T Consensus       174 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         174 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             cccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            75422   112234568999999999999999999999999999999999999996554321111000         00 


Q ss_pred             ------HHHhhc-CCcc-----ccccccc---cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          695 ------TECYRN-GKIG-----DIIDPFL---KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       695 ------~~~~~~-~~~~-----~~~d~~l---~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                            ...... ....     +.....+   ..........++.+++.+|++.||.+|||+.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                  000000 0000     0000000   000111234568899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.7e-34  Score=300.51  Aligned_cols=253  Identities=25%  Similarity=0.408  Sum_probs=208.8

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      ++|+..+.||+|++|.||+++....++.+++|++..... ....++.+|++++.+++|+|++++++++...+..++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            367888899999999999999998889999999876543 4466799999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCC-CCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS-KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      +++++|.+++...  ..+++..++.++.|+++||.|||   + .+++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            9999999999654  56899999999999999999999   7 8899999999999999999999999999875432211


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                        ......++..|+|||.+....++.++|+||||+++|||++|+.||..........+..+..    ....         
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~---------  220 (264)
T cd06623         156 --QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGPP---------  220 (264)
T ss_pred             --cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCCC---------
Confidence              1223457889999999999999999999999999999999999996554312122221111    1110         


Q ss_pred             CCCChh-hHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          713 GNAPPV-CLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       713 ~~~~~~-~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      ...+.. .+..+.+++.+||+.+|++||++.++++.
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            112223 56789999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-34  Score=307.83  Aligned_cols=252  Identities=23%  Similarity=0.345  Sum_probs=201.7

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      +|+..+.||+|+||.||++.....++.+|+|.+... ......++.+|++++.+++|+||+++++.+...+..++|+||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            577788999999999999999878899999988654 2233457899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCC-CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          555 ARGTLRDHLYNND-NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       555 ~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      ++++|.+++.... ...+++..+..++.+++.||.|||+  ..+++|+||||+||+++.++.+||+|||++......   
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  156 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---  156 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence            9999999886532 2368999999999999999999994  358999999999999999999999999998753221   


Q ss_pred             cccccccCCCcccChhhhccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQ------LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDII  707 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~------~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  707 (767)
                       ......++..|+|||.+.+.      .++.++|+|||||++|||++|+.||........   .... .....+.     
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~-~~~~~~~-----  226 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FAQL-SAIVDGD-----  226 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HHHH-HHHhhcC-----
Confidence             22234578899999998654      358899999999999999999999954322111   1100 0111111     


Q ss_pred             cccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       708 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                          ....+..+..++.+++.+||+.+|.+||++.+++.
T Consensus       227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         227 ----PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ----CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                11234446778899999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-34  Score=301.55  Aligned_cols=247  Identities=25%  Similarity=0.407  Sum_probs=201.4

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-----CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-----QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      |...+.||+|++|.||+|....++..|++|.+....     .+..+.+.+|+++++.++|+|++++++++......++++
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            556678999999999999998777899999886432     234567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++++|.+++.+.  ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          82 ELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            999999999999654  35899999999999999999999   7789999999999999999999999999987543222


Q ss_pred             CccccccccCCCcccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQL-LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                         ......++..|+|||.+.... ++.++|+|||||++|||++|+.||.......  ..    ........        
T Consensus       157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~----~~~~~~~~--------  219 (258)
T cd06632         157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AV----FKIGRSKE--------  219 (258)
T ss_pred             ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HH----HHHHhccc--------
Confidence               223455888999999988766 8999999999999999999999985543211  11    11001011        


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       ....+......+.+++.+||+.+|.+||++.+++.
T Consensus       220 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         220 -LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence             11223345677899999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-35  Score=289.58  Aligned_cols=254  Identities=23%  Similarity=0.325  Sum_probs=205.5

Q ss_pred             HHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC----Ccchh----HHHHHHHHHhcc-ccceeeeEeeeee
Q 042216          472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS----QQGAL----EFQTEIGMLSQL-RYLHLVSLIGYCN  542 (767)
Q Consensus       472 ~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~----~~~~~----~f~~Ei~~l~~l-~Hpniv~l~g~~~  542 (767)
                      ..-+.|...++||.|..+.|-+..++.+++..|+|++....    .....    +-.+|+.+|+++ -||+|+.+.++++
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            34567888889999999999999999999999999985431    11122    346789999998 6999999999999


Q ss_pred             cCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecC
Q 042216          543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFG  622 (767)
Q Consensus       543 ~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfG  622 (767)
                      .+..+++|+|.|+.|.|+|+|..  .-.++++...+|+.|+.+|++|||   ...|+||||||+|||+|++.++||+|||
T Consensus        94 s~sF~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccc
Confidence            99999999999999999999954  345999999999999999999999   7889999999999999999999999999


Q ss_pred             CcccCCCCCCccccccccCCCcccChhhhcc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHH
Q 042216          623 LCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL------QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATE  696 (767)
Q Consensus       623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~  696 (767)
                      +++.....   ......+||++|+|||.++.      ..|+...|+|+.||++|.|+.|.+||.....  ...+     .
T Consensus       169 Fa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ--mlML-----R  238 (411)
T KOG0599|consen  169 FACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ--MLML-----R  238 (411)
T ss_pred             eeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH--HHHH-----H
Confidence            99865442   33456899999999998864      4688899999999999999999999953211  1111     1


Q ss_pred             HhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          697 CYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       697 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .+.+|+.      ..+.+--.+.+....+|+.+||+.||.+|.|.+|+++
T Consensus       239 ~ImeGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  239 MIMEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            1112211      1122223345677889999999999999999999985

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-34  Score=311.58  Aligned_cols=254  Identities=23%  Similarity=0.273  Sum_probs=203.9

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC---cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ---QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|+..+.||+|++|.||++...+.++.+|+|.+.....   ...+.+.+|++++..++|+||+++++.+...+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            367888899999999999999988789999999875432   24456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+.+++|.+++.......+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            9999999999997655567999999999999999999999   7889999999999999999999999999986432211


Q ss_pred             Cc---------------------------cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 042216          632 KT---------------------------HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGD  684 (767)
Q Consensus       632 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~  684 (767)
                      ..                           .......|+..|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            00                           011123578899999999988899999999999999999999999965433


Q ss_pred             ccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 042216          685 KKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPS----MSDVVW  746 (767)
Q Consensus       685 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs----~~evl~  746 (767)
                      ..  .+..    ..         +...........+..+.+++.+||+.+|++||+    +.|++.
T Consensus       238 ~~--~~~~----~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 DE--TFSN----IL---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HH--HHHH----Hh---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            21  1111    01         111111111124678999999999999999999    666554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=9.8e-35  Score=311.49  Aligned_cols=257  Identities=22%  Similarity=0.295  Sum_probs=203.6

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|+..+.||+|+||.||++.....++.|++|.+....   ......+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888899999999999999998888899999986543   233456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++......
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            999999999999554  45899999999999999999999   7789999999999999999999999999987421100


Q ss_pred             C-------------ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHh
Q 042216          632 K-------------THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECY  698 (767)
Q Consensus       632 ~-------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~  698 (767)
                      .             ........++..|+|||.+....++.++|+|||||++|||++|+.||......      .+.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~~  229 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVI  229 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH
Confidence            0             00112245788999999998888999999999999999999999999643321      1111111


Q ss_pred             hcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042216          699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF  750 (767)
Q Consensus       699 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~  750 (767)
                      . +.   ...+.    .....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       230 ~-~~---~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         230 S-DD---IEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             h-cc---cCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            1 10   00111    111345678999999999999999997666666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.9e-34  Score=302.38  Aligned_cols=251  Identities=23%  Similarity=0.430  Sum_probs=199.5

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC------cchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ------QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~------~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      +|...+.||+|+||.||+|... +++.+|+|.+.....      .....+.+|++++++++|+||++++++|.+.+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            3566778999999999999875 457899998864321      123458899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ++||+++++|.+++.+.  ..+++..+..++.|++.||.|||   +.+|+|+||+|+||++++++.+||+|||+++....
T Consensus        80 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          80 FMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999999654  35889999999999999999999   77899999999999999999999999999875321


Q ss_pred             CC----CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccc
Q 042216          630 FS----KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD  705 (767)
Q Consensus       630 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  705 (767)
                      ..    .........++..|+|||++.+..++.++|||||||+++||++|+.||......+..  ..   ......    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--~~---~~~~~~----  225 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM--FY---IGAHRG----  225 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH--HH---hhhccC----
Confidence            11    111122345889999999999888999999999999999999999999654322111  00   000000    


Q ss_pred             cccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       706 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                           .....+...+.++.+++.+||+.+|.+||++.++++
T Consensus       226 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         226 -----LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                 111223345677899999999999999999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.2e-34  Score=307.22  Aligned_cols=262  Identities=19%  Similarity=0.250  Sum_probs=200.5

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      +|+..+.||+|++|.||+|+....++.||||++....  ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778889999999999999998888899999986542  22335688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +. ++|.+++.......+++.++..++.|++.||+|||   ..+++|+||+|+||++++++.+||+|||+++......  
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--  154 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--  154 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence            96 68999987665667999999999999999999999   7789999999999999999999999999987543211  


Q ss_pred             cccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhc------------
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRN------------  700 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~------------  700 (767)
                      .......++..|+|||.+.+. .++.++|||||||++|||+||+.||....+.+  .+.......-..            
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHH
Confidence            112233467899999988764 46889999999999999999999996543221  111111100000            


Q ss_pred             ---CCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          701 ---GKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       701 ---~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                         ..........+. ...+....++.+++.+||+.||.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         233 DYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence               000000000000 011223456789999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-34  Score=339.42  Aligned_cols=256  Identities=19%  Similarity=0.283  Sum_probs=200.7

Q ss_pred             HHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeec--CCce
Q 042216          472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCND--DGQM  547 (767)
Q Consensus       472 ~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~--~~~~  547 (767)
                      ....+|...+.||+|+||+||+++....+..+|+|.+...  .......|..|+.+|.+|+||||+++++++..  ...+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            3456899999999999999999999988889999998643  23345578999999999999999999998754  3568


Q ss_pred             EEEEecCCCCChhhhhccC--CCCCCChHHHHHHHHHHHHHHHHhHhCC----CCCeEecCCCCCCeEECC---------
Q 042216          548 ILVYDYMARGTLRDHLYNN--DNPPLPWDRRLKICIGAARALHYLHTGA----SKVIIHRDVKTTNILLDE---------  612 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~iiH~Dlk~~NILld~---------  612 (767)
                      +|||||+++|+|.++|...  ....+++..++.|+.||+.||.|||+..    ..+|+||||||+||||+.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            9999999999999999653  2346999999999999999999999532    146999999999999964         


Q ss_pred             --------CCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 042216          613 --------EWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL--QLLTEKSDVYSFGVVLLEVLCARPPILRT  682 (767)
Q Consensus       613 --------~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SfGvvl~elltg~~P~~~~  682 (767)
                              ...+||+|||+++.....   .......||+.|+|||++..  ..++.++|||||||+||||++|+.||...
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                    345899999999754321   12234568999999999854  45889999999999999999999999644


Q ss_pred             CCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          683 GDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       683 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ....     ..... +..+.       .+   .....+.++.+|+..||+.+|.+||++.|++.
T Consensus       247 ~~~~-----qli~~-lk~~p-------~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        247 NNFS-----QLISE-LKRGP-------DL---PIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CcHH-----HHHHH-HhcCC-------CC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            3211     11111 11110       00   01123567899999999999999999999984

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-35  Score=336.93  Aligned_cols=261  Identities=28%  Similarity=0.453  Sum_probs=211.8

Q ss_pred             hccccceeeeccCcEEEEEEEecC-------CCceEEEEEeCCC-CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNG-------DSTPVAIKRLNPG-SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDG  545 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~-------~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~  545 (767)
                      +++...+.||+|.||.|++|...+       ....||||.++.. ...+.+.+..|+++|+.+ +|+|++.++|+|..++
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            334444489999999999998642       1467999999865 334567799999999998 6999999999999999


Q ss_pred             ceEEEEecCCCCChhhhhccCC------------C--CCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC
Q 042216          546 QMILVYDYMARGTLRDHLYNND------------N--PPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD  611 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~~------------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld  611 (767)
                      ..++|+||+..|+|.++|+.+.            .  ..|+...++.++.|||.||+||+   +.+++||||.++|||+.
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLIT  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEec
Confidence            9999999999999999997654            0  13889999999999999999999   78899999999999999


Q ss_pred             CCCcEEEeecCCcccCCCCCCcccc-ccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchh
Q 042216          612 EEWVAKVSDFGLCKFGPNFSKTHVS-TQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVN  689 (767)
Q Consensus       612 ~~~~~ki~DfGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~  689 (767)
                      ++..+||+|||+++...+....... ....-+..|||||.+....|+.|||||||||+||||++ |..||.+....  ..
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~--~~  530 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT--EE  530 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH--HH
Confidence            9999999999999964432222111 11114567999999999999999999999999999998 88999653211  11


Q ss_pred             HHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          690 LAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       690 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                      +.    +.+++|         .+...|..|..+++++|+.||+.+|++||++.++++.|+.+++
T Consensus       531 l~----~~l~~G---------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  531 LL----EFLKEG---------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             HH----HHHhcC---------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            12    223333         3345577889999999999999999999999999999999654

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.4e-34  Score=302.50  Aligned_cols=254  Identities=26%  Similarity=0.376  Sum_probs=205.3

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeec--CCceEEEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCND--DGQMILVY  551 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~--~~~~~lV~  551 (767)
                      +|+..+.||.|+||.||++....+++.+|+|++...  .....+++.+|++++++++|+|++++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            467778999999999999999888889999998643  23345568899999999999999999998754  45679999


Q ss_pred             ecCCCCChhhhhccC--CCCCCChHHHHHHHHHHHHHHHHhHhCC--CCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          552 DYMARGTLRDHLYNN--DNPPLPWDRRLKICIGAARALHYLHTGA--SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       552 ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      ||+++++|.+++...  ...++++..++.++.+++.||.|||..+  +.+++|+||||+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998653  2456999999999999999999999554  678999999999999999999999999998865


Q ss_pred             CCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccc
Q 042216          628 PNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDII  707 (767)
Q Consensus       628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  707 (767)
                      ....  .......++..|+|||.+....++.++|+||||+++++|++|+.||......   .+.    .....+.     
T Consensus       161 ~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~~~-----  226 (265)
T cd08217         161 GHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLA----SKIKEGK-----  226 (265)
T ss_pred             cCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHH----HHHhcCC-----
Confidence            4322  1123346889999999999888999999999999999999999999654321   111    1111111     


Q ss_pred             cccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       708 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                          ....+...+.++.+++.+|++.+|.+||++.+|++.
T Consensus       227 ----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         227 ----FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                112344556789999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=8e-35  Score=315.88  Aligned_cols=256  Identities=23%  Similarity=0.269  Sum_probs=198.5

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|...+.||+|+||.||+++....++.||+|.+...   .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4688889999999999999999888889999998642   2223445788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|+|.+++.+.. ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            9999999999996532 35899999999999999999999   7889999999999999999999999999987543211


Q ss_pred             CccccccccCCCcccChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRL-----QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI  706 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  706 (767)
                       ........|++.|+|||++..     +.++.++|||||||+||||++|+.||......+      ............. 
T Consensus       157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~-  228 (331)
T cd05624         157 -TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHEERFQ-  228 (331)
T ss_pred             -ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCCCccc-
Confidence             112233569999999999875     567899999999999999999999996443211      1111111100000 


Q ss_pred             ccccccCCCChhhHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 042216          707 IDPFLKGNAPPVCLNQFVEVAMSCVNDDRIR--RPSMSDVVWG  747 (767)
Q Consensus       707 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~--RPs~~evl~~  747 (767)
                          + .......++++.+++.+|++.++.+  |++++++++.
T Consensus       229 ----~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         229 ----F-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ----C-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence                0 0011224567889999988865544  4688888753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.9e-34  Score=305.66  Aligned_cols=262  Identities=20%  Similarity=0.260  Sum_probs=198.1

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      +|+..+.||+|+||.||+|.....++.+|+|++....  ......+.+|++++++++|||++++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            3677789999999999999998888999999986432  22234678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      ++ ++|.+++.... ..+++..+..++.|+++||.|||   ..+++||||||+||+++.++.+||+|||+++......  
T Consensus        81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--  153 (284)
T cd07839          81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--  153 (284)
T ss_pred             CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--
Confidence            97 48888876433 45899999999999999999999   7889999999999999999999999999987532211  


Q ss_pred             cccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcC------Ccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG------KIGDI  706 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~------~~~~~  706 (767)
                      .......++..|+|||.+.+. .++.++|||||||++|||++|+.|+....... ..+. .........      .+...
T Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLK-RIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HHHH-HHHHHhCCCChHHhHHhhhc
Confidence            112234578899999998764 47899999999999999999998864433211 1111 010000000      00000


Q ss_pred             cccc----cc-----CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          707 IDPF----LK-----GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       707 ~d~~----l~-----~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .+..    ..     ....+..+.++.+++.+||+.||.+|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0000    00     0112234677889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.5e-34  Score=300.51  Aligned_cols=251  Identities=22%  Similarity=0.330  Sum_probs=198.5

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-----CcchhHHHHHHHHHhccccceeeeEeeeeecC--Cce
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-----QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD--GQM  547 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~  547 (767)
                      .+|...++||+|+||.||+|...+++..||||.+....     ....+.+.+|++++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888889999999999999998888999999875321     12345688899999999999999999988663  467


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      +++|||+++++|.+++.+.  ..+++...+.++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            8999999999999998654  34788999999999999999999   778999999999999999999999999998754


Q ss_pred             CCCCCc-cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccc
Q 042216          628 PNFSKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI  706 (767)
Q Consensus       628 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  706 (767)
                      ...... .......++..|+|||.+.+..++.++|||||||++|||++|+.||.......     . ........     
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~-~~~~~~~~-----  225 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----A-IFKIATQP-----  225 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----H-HHHHhcCC-----
Confidence            321111 11223458889999999988889999999999999999999999996432211     1 01111000     


Q ss_pred             ccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          707 IDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       707 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                          .....+......+.+++.+|+. +|.+||+++||++
T Consensus       226 ----~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         226 ----TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             ----CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                1122344556678889999995 8999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.1e-34  Score=303.84  Aligned_cols=252  Identities=25%  Similarity=0.341  Sum_probs=204.1

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      +|+..+.||+|++|.||++..+..++.+|+|++.... .....++.+|++++++++||||+++++.+..++..++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5667778999999999999998888999999987653 344567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCC-CCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS-KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      ++++|.+++.... ..+++..+..++.|++.||.|||   + .+++|+||||+||++++++.++|+|||++......   
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~---  154 (265)
T cd06605          82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---  154 (265)
T ss_pred             CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH---
Confidence            9999999996543 56899999999999999999999   6 88999999999999999999999999998643211   


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                       ......++..|+|||.+.+..++.++||||||+++++|++|+.||....... ........... .+..         .
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~-~~~~---------~  222 (265)
T cd06605         155 -LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIV-NEPP---------P  222 (265)
T ss_pred             -HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHh-cCCC---------C
Confidence             1112568889999999999999999999999999999999999996543211 11112111111 1110         0


Q ss_pred             CCChh-hHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          714 NAPPV-CLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       714 ~~~~~-~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ..+.. .+.++.+++.+||..+|++|||+.+++.
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            11112 5667899999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6e-34  Score=302.57  Aligned_cols=258  Identities=24%  Similarity=0.323  Sum_probs=203.0

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecC--CceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDD--GQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~~lV~  551 (767)
                      ++|...+.||.|++|.||++.....++.+|+|.+..... ....++.+|++++++++||||+++++++.+.  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            367888899999999999999988889999999875432 3456789999999999999999999988653  4789999


Q ss_pred             ecCCCCChhhhhcc--CCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          552 DYMARGTLRDHLYN--NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       552 ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ||+++++|.+++..  .....+++..+..++.|++.||.|||   ..+++|+||+|+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999988753  23456899999999999999999999   78899999999999999999999999999865322


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--ccchhHHHHHHHHhhcCCccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGD--KKQVNLAVWATECYRNGKIGDII  707 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~--~~~~~l~~~~~~~~~~~~~~~~~  707 (767)
                      .    ......++..|+|||.+.+..++.++|||||||++|||++|+.||.....  .....+..+...    .....+.
T Consensus       158 ~----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~  229 (287)
T cd06621         158 S----LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPELK  229 (287)
T ss_pred             c----ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhhc
Confidence            1    11234578899999999999999999999999999999999999965432  111222222111    1111111


Q ss_pred             cccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       708 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      +. .  ......++.+.+++.+||+.+|.+|||+.||++
T Consensus       230 ~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         230 DE-P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             cC-C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            00 0  001224567899999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-34  Score=299.07  Aligned_cols=253  Identities=27%  Similarity=0.311  Sum_probs=209.7

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ..|..++.||+|.-|+||++.+++....+|+|++.+..   .+...+.+.|-+||+.+.||.+..|++.++.+...+|+|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            34666778999999999999999988999999997653   344556788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC--
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN--  629 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~--  629 (767)
                      |||+||+|..++++...+.+++..+.-++..++.||+|||   ..|||.|||||+||||-++|.+-|+||.|+.....  
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            9999999999998888888999999999999999999999   89999999999999999999999999999743110  


Q ss_pred             -------------------------------CCCc---------------------cccccccCCCcccChhhhccCCCC
Q 042216          630 -------------------------------FSKT---------------------HVSTQVKGSIGYLDPEYYRLQLLT  657 (767)
Q Consensus       630 -------------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~s  657 (767)
                                                     ....                     ..+...+||-.|+|||++++...+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                           0000                     011234688999999999999999


Q ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCC
Q 042216          658 EKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIR  737 (767)
Q Consensus       658 ~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~  737 (767)
                      .+.|.|+|||+||||+.|..||.+....+.  +.             +++-..+.-...+..+..+.+||++.|.+||.+
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~T--l~-------------NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k  378 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKET--LR-------------NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK  378 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCchhh--HH-------------HHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence            999999999999999999999987765432  22             222222222223355678899999999999999


Q ss_pred             CCC----HHHHH
Q 042216          738 RPS----MSDVV  745 (767)
Q Consensus       738 RPs----~~evl  745 (767)
                      |..    +.||-
T Consensus       379 Rlg~~rGA~eIK  390 (459)
T KOG0610|consen  379 RLGSKRGAAEIK  390 (459)
T ss_pred             hhccccchHHhh
Confidence            997    77775

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.3e-35  Score=318.36  Aligned_cols=261  Identities=21%  Similarity=0.258  Sum_probs=197.5

Q ss_pred             HHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecC----
Q 042216          471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD----  544 (767)
Q Consensus       471 ~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~----  544 (767)
                      ....++|...+.||+|+||.||+|....+++.||||++....  ......+.+|+++|++++||||+++++++...    
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            345678999999999999999999998888899999986532  22345678999999999999999999987533    


Q ss_pred             --CceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecC
Q 042216          545 --GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFG  622 (767)
Q Consensus       545 --~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfG  622 (767)
                        ...++++|++ +++|.+++..   ..+++..+..++.|++.||.|||   +++|+||||||+|||+++++.+||+|||
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCc
Confidence              4578999988 6799887743   35899999999999999999999   7889999999999999999999999999


Q ss_pred             CcccCCCCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcC
Q 042216          623 LCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG  701 (767)
Q Consensus       623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~  701 (767)
                      +++....     ......||..|+|||++.+ ..++.++|||||||++|||++|+.||........  +..+. ......
T Consensus       164 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~-~~~~~~  235 (343)
T cd07878         164 LARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKRIM-EVVGTP  235 (343)
T ss_pred             cceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHH-HHhCCC
Confidence            9875432     1233468899999999876 5789999999999999999999999965432111  11110 000000


Q ss_pred             -----------C-------ccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          702 -----------K-------IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       702 -----------~-------~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                                 .       +.......+.. ........+.+++.+|++.||.+|||+.|++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         236 SPEVLKKISSEHARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CHHHHHhcchhhHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                       0       00000000000 001123457899999999999999999999953

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.6e-34  Score=308.69  Aligned_cols=246  Identities=20%  Similarity=0.312  Sum_probs=199.8

Q ss_pred             ceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCCh
Q 042216          480 LLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTL  559 (767)
Q Consensus       480 ~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gsL  559 (767)
                      ...||+|+||.||++....+++.||+|.+..........+.+|+.++..++|||++++++++..++..++++||+++++|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            34699999999999999877889999998765555566788999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccccc
Q 042216          560 RDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV  639 (767)
Q Consensus       560 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~  639 (767)
                      .+++..   ..+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++.......  ......
T Consensus       106 ~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~  177 (297)
T cd06659         106 TDIVSQ---TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSL  177 (297)
T ss_pred             HHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccccce
Confidence            998743   35899999999999999999999   7889999999999999999999999999987543211  112335


Q ss_pred             cCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhh
Q 042216          640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVC  719 (767)
Q Consensus       640 ~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  719 (767)
                      .++..|+|||++.+..++.++|||||||+++||++|+.||......+.   ...    ......     +..  ......
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~----~~~~~~-----~~~--~~~~~~  243 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKR----LRDSPP-----PKL--KNAHKI  243 (297)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH----HhccCC-----CCc--cccCCC
Confidence            688999999999988999999999999999999999999964432211   111    111100     000  112234


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          720 LNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       720 ~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      ...+.+++.+||+.+|.+||++.++++.
T Consensus       244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         244 SPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            5678899999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.8e-34  Score=304.85  Aligned_cols=262  Identities=21%  Similarity=0.276  Sum_probs=200.4

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc-----chhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ-----GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~-----~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      +|+..+.||+|++|.||+|....+++.||||++......     ....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            366778899999999999999877889999999755322     234567899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+ +|+|.+++.... ..+++..++.++.|+++||.|||   +.+++|+||||+|||++.++.+||+|||+++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            9999 889999996543 36999999999999999999999   788999999999999999999999999998764332


Q ss_pred             CCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhc---------
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRN---------  700 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~---------  700 (767)
                      ..  ......++..|+|||.+.+ ..++.++|||||||+++||++|.+||....+.+.  +... ......         
T Consensus       156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~  230 (298)
T cd07841         156 NR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKI-FEALGTPTEENWPGV  230 (298)
T ss_pred             Cc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHH-HHHcCCCchhhhhhc
Confidence            11  1222346788999998864 4678999999999999999999887754433211  1111 100000         


Q ss_pred             CCccccccccccCC-----CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          701 GKIGDIIDPFLKGN-----APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       701 ~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      ..............     .....+.++.+++.+||+.+|.+|||+.||++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00000000000000     112346778999999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.9e-34  Score=305.37  Aligned_cols=251  Identities=24%  Similarity=0.364  Sum_probs=195.4

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHH-HhccccceeeeEeeeeecCCceEEEEe
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGM-LSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~-l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ++|+..+.||+|+||.||++....+++.||+|++.... .....++..|+.. ++.++|||++++++++..++..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36888899999999999999998888999999987543 2233456667665 556789999999999999999999999


Q ss_pred             cCCCCChhhhhccC--CCCCCChHHHHHHHHHHHHHHHHhHhCCCC-CeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          553 YMARGTLRDHLYNN--DNPPLPWDRRLKICIGAARALHYLHTGASK-VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       553 y~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      |++ |+|.+++...  ....+++..++.++.|++.||.|||   ++ +++||||||+|||++.++.+||+|||+++....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            997 6888877542  2356899999999999999999999   54 899999999999999999999999999875422


Q ss_pred             CCCccccccccCCCcccChhhhcc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRL----QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD  705 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  705 (767)
                         ........++..|+|||.+.+    ..++.++|+|||||++|||++|+.||...... ...+..    ... +..  
T Consensus       157 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~----~~~-~~~--  225 (283)
T cd06617         157 ---SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQ----VVE-EPS--  225 (283)
T ss_pred             ---ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHH----HHh-cCC--
Confidence               112233457889999998864    45688999999999999999999998543221 011111    111 100  


Q ss_pred             cccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       706 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                         +.+   .....+.++.+++.+||..+|.+||++.++++
T Consensus       226 ---~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         226 ---PQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             ---CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               001   01234577899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-34  Score=311.41  Aligned_cols=251  Identities=23%  Similarity=0.290  Sum_probs=211.5

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc---chhHHHHHHHHHhccc-cceeeeEeeeeecCCceEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ---GALEFQTEIGMLSQLR-YLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~---~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~l  549 (767)
                      ...|+..+.||+|.||.||+++.+.+++.+|+|.+.+....   ....+.+|+.+|+++. ||||+.+.+.++.....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            44566667899999999999999998999999999765433   3457899999999998 9999999999999999999


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC----CCcEEEeecCCcc
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE----EWVAKVSDFGLCK  625 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~----~~~~ki~DfGla~  625 (767)
                      |||++.+|.|.+.+...   .+++.....++.|++.++.|||   +.+|+||||||+|+|+..    ++.+|++|||++.
T Consensus       114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            99999999999999766   2899999999999999999999   789999999999999953    3579999999998


Q ss_pred             cCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccc
Q 042216          626 FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD  705 (767)
Q Consensus       626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  705 (767)
                      ....   .......+||+.|+|||++....++..+||||+||++|.|++|.+||....+.+...       ....+..  
T Consensus       188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~--  255 (382)
T KOG0032|consen  188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF--  255 (382)
T ss_pred             EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC--
Confidence            7544   345567889999999999999999999999999999999999999997665432211       1122221  


Q ss_pred             cccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       706 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                          ......-+..+..+.+++..|+..||.+|+|+.++++
T Consensus       256 ----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  256 ----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             ----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence                1222233445778899999999999999999999987

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.6e-34  Score=308.73  Aligned_cols=196  Identities=25%  Similarity=0.378  Sum_probs=159.5

Q ss_pred             eeeeccCcEEEEEEEecC--CCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeec--CCceEEEEecCCC
Q 042216          481 LIIGRGGFGNVYKGFLNG--DSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCND--DGQMILVYDYMAR  556 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~--~~~~~lV~ey~~~  556 (767)
                      .+||+|+||+||+|..++  .++.+|+|.+....  ....+.+|+++|++++||||+++++++..  +...++++||+.+
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH   84 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence            479999999999999753  45789999986432  23457889999999999999999998854  4568899999865


Q ss_pred             CChhhhhccC-------CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE----CCCCcEEEeecCCcc
Q 042216          557 GTLRDHLYNN-------DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL----DEEWVAKVSDFGLCK  625 (767)
Q Consensus       557 gsL~~~L~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl----d~~~~~ki~DfGla~  625 (767)
                       +|.+++...       ....+++..+..++.|++.||.|||   +.+|+||||||+|||+    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence             888877432       1235889999999999999999999   7889999999999999    466799999999998


Q ss_pred             cCCCCCCc-cccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 042216          626 FGPNFSKT-HVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRT  682 (767)
Q Consensus       626 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~  682 (767)
                      ........ .......||+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            64322111 12234568999999999876 46899999999999999999999999644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-34  Score=302.95  Aligned_cols=254  Identities=24%  Similarity=0.349  Sum_probs=202.3

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCC------
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDG------  545 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~------  545 (767)
                      .+++|+..+.||+|++|.||+|..+..++.+++|.+..... ...++.+|+++++++ +|+||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            46789999999999999999999987788999999875433 346789999999999 6999999999997644      


Q ss_pred             ceEEEEecCCCCChhhhhccCC--CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCC
Q 042216          546 QMILVYDYMARGTLRDHLYNND--NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL  623 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGl  623 (767)
                      ..++||||+++++|.+++....  ...+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence            4899999999999999986533  457899999999999999999999   78899999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCcccChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHh
Q 042216          624 CKFGPNFSKTHVSTQVKGSIGYLDPEYYRL-----QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECY  698 (767)
Q Consensus       624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~  698 (767)
                      +......  ........++..|+|||.+..     ..++.++|||||||+++||++|+.||.......  .+..     .
T Consensus       160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~-----~  230 (275)
T cd06608         160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--ALFK-----I  230 (275)
T ss_pred             ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HHHH-----h
Confidence            8754321  112233458889999998753     356789999999999999999999996432211  1111     1


Q ss_pred             hcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       699 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .....     +.+  ..+...+.++.+++.+||..||++|||+.|+++
T Consensus       231 ~~~~~-----~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 PRNPP-----PTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hccCC-----CCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11111     011  112335668899999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.6e-34  Score=304.59  Aligned_cols=262  Identities=21%  Similarity=0.276  Sum_probs=202.4

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      +|...+.||+|++|.||+|....+++.||+|++....  ......+.+|+.++++++|||++++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4677789999999999999998788999999987543  33346789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      + +++|.+++.... ..+++.++..++.|+++||.|||   +.+++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (286)
T cd07832          81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-  154 (286)
T ss_pred             c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence            9 999999986544 56999999999999999999999   78899999999999999999999999999876533221 


Q ss_pred             cccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC----------
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK----------  702 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~----------  702 (767)
                      .......++..|+|||.+.+. .++.++||||+||+++||++|++||....+.+.   ..+.........          
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSL  231 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCc
Confidence            112334688899999988654 468999999999999999999888755433211   111111110000          


Q ss_pred             --cccccccccc----CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          703 --IGDIIDPFLK----GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       703 --~~~~~d~~l~----~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                        ...+..+...    ....+.....+.+++.+|++.+|.+||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence              0000000000    0011234578899999999999999999999975

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.4e-34  Score=300.73  Aligned_cols=254  Identities=22%  Similarity=0.348  Sum_probs=202.5

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC------cchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ------QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~------~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      +|+..+.||+|++|.||++....+++.+|+|.+.....      ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            46777899999999999999887889999999864321      124578999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC-cEEEeecCCcccCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW-VAKVSDFGLCKFGP  628 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~-~~ki~DfGla~~~~  628 (767)
                      |+||+++++|.+++.+.  .++++..+..++.|++.||.|||   +.+++|+||||+||+++.++ .+||+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            99999999999999653  46899999999999999999999   78899999999999998775 69999999987543


Q ss_pred             CCCC--ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccc
Q 042216          629 NFSK--THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI  706 (767)
Q Consensus       629 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  706 (767)
                      ....  ........++..|+|||.+.+..++.++||||+|++++||++|+.||.........   .........      
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~------  226 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFKIASA------  226 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHHHhcc------
Confidence            3211  11122345788999999998888999999999999999999999998543321111   111110000      


Q ss_pred             ccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          707 IDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       707 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                         ......+.....++.+++.+|++.+|.+||++.++++
T Consensus       227 ---~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         227 ---TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ---CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence               1112234455678899999999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.1e-34  Score=301.44  Aligned_cols=247  Identities=26%  Similarity=0.372  Sum_probs=201.9

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCC
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMA  555 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~  555 (767)
                      |+..+.||+|+||.||+|....++..+|+|.+.... ......+.+|++++.+++||||+++++++.++...++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            667778999999999999988778899999886442 3344578899999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccc
Q 042216          556 RGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHV  635 (767)
Q Consensus       556 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~  635 (767)
                      +++|.+++..   ..+++..+..++.+++.++.|||   ..+++|+||||+||+++.++.++|+|||++.......  ..
T Consensus        86 ~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06641          86 GGSALDLLEP---GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hh
Confidence            9999999853   35899999999999999999999   7889999999999999999999999999987543211  11


Q ss_pred             cccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCC
Q 042216          636 STQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNA  715 (767)
Q Consensus       636 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  715 (767)
                      .....++..|+|||.+....++.++|+|||||++|||++|..|+.......      +... .....         ....
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~-~~~~~---------~~~~  221 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFL-IPKNN---------PPTL  221 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHH-HhcCC---------CCCC
Confidence            223457889999999998889999999999999999999999986433211      1111 11111         1112


Q ss_pred             ChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          716 PPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       716 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      +...+.++.+++.+||+.+|.+||++.++++.
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            23456678899999999999999999999974

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-34  Score=304.55  Aligned_cols=263  Identities=20%  Similarity=0.284  Sum_probs=197.8

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc-chhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ-GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      ++|+..+.||+|++|.||+|+.+.+++.||||.+...... ....+.+|++++++++|+||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            5688888999999999999999877889999998654322 234577899999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++ +|.+++.+... .+++.....++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++......  
T Consensus        85 ~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--  157 (291)
T cd07844          85 LDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--  157 (291)
T ss_pred             CCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence            985 99998865433 6899999999999999999999   7889999999999999999999999999987432111  


Q ss_pred             cccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhc---CCccc----
Q 042216          634 HVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRN---GKIGD----  705 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~---~~~~~----  705 (767)
                      .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........  ...........   .....    
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhhhc
Confidence            11122346788999999875 4688999999999999999999999964432111  00000110000   00000    


Q ss_pred             --cc--------cccccCCCC-hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          706 --II--------DPFLKGNAP-PVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       706 --~~--------d~~l~~~~~-~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                        ..        ...+....+ .....++.+++.+||+.+|.+|||+.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence              00        000000000 011256789999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6e-34  Score=298.05  Aligned_cols=253  Identities=25%  Similarity=0.339  Sum_probs=202.3

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      +|+..+.||+|+||.||+|....+++.+++|.+.....  ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            46777899999999999999987788999999876543  2566799999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++++|.+++...  ..+++..+..++.+++.||.|||   +.+++|+||+|+||++++++.+||+|||++.........
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            9999999999654  35889999999999999999999   788999999999999999999999999998764332221


Q ss_pred             cc--cccccCCCcccChhhhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          634 HV--STQVKGSIGYLDPEYYRLQL---LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       634 ~~--~~~~~gt~~y~aPE~~~~~~---~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      ..  .....++..|+|||++....   .+.++||||||++++||++|+.||........  ....    ...+.     .
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~~~----~~~~~-----~  224 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IMFH----VGAGH-----K  224 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HHHH----HhcCC-----C
Confidence            11  11345788999999998766   88999999999999999999999964432111  1110    00010     0


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      +.+.  ........+.+++.+||+.+|.+||++.|++.
T Consensus       225 ~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 PPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0110  11123567889999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.8e-34  Score=299.24  Aligned_cols=250  Identities=22%  Similarity=0.375  Sum_probs=203.8

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      +|...+.||+|+||.||+|..+.++..+|+|.+...  .....+.+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            467788999999999999999888889999998643  223445688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC-cEEEeecCCcccCCCCCC
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW-VAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~-~~ki~DfGla~~~~~~~~  632 (767)
                      +++++|.+++.+.....+++..+..++.|++.||.|||   +.+++|+||||+||++++++ .+||+|||.+......  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--  155 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--  155 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCC--
Confidence            99999999997665556899999999999999999999   77899999999999999875 5699999998754321  


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      ........|+..|+|||++....++.++||||||++++||++|+.||.....      ..+...... +..         
T Consensus       156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~---------  219 (257)
T cd08225         156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQ-GYF---------  219 (257)
T ss_pred             cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhc-ccC---------
Confidence            1122234588899999999888899999999999999999999999854321      122222111 111         


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ...++..+..+.+++.+||+.+|++|||+.|+++
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            1122344567899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.2e-34  Score=308.82  Aligned_cols=246  Identities=20%  Similarity=0.335  Sum_probs=199.2

Q ss_pred             ceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCCh
Q 042216          480 LLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTL  559 (767)
Q Consensus       480 ~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gsL  559 (767)
                      ...||+|+||.||++....++..||||.+..........+.+|+.+++.++|+|++++++.+...+..++||||+++++|
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence            34699999999999999877889999998765555566789999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccccc
Q 042216          560 RDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV  639 (767)
Q Consensus       560 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~  639 (767)
                      .+++..   ..+++.++..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||++.......  ......
T Consensus       107 ~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~  178 (292)
T cd06658         107 TDIVTH---TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSL  178 (292)
T ss_pred             HHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCcee
Confidence            998843   24899999999999999999999   7789999999999999999999999999987543211  112234


Q ss_pred             cCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhh
Q 042216          640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVC  719 (767)
Q Consensus       640 ~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  719 (767)
                      .++..|+|||.+....++.++||||||++++||++|+.||........   ..    ....     ...+.+..  ....
T Consensus       179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~----~~~~-----~~~~~~~~--~~~~  244 (292)
T cd06658         179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---MR----RIRD-----NLPPRVKD--SHKV  244 (292)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH----HHHh-----cCCCcccc--cccc
Confidence            588999999999888899999999999999999999999864332111   11    0111     01111111  1123


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          720 LNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       720 ~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      ...+.+++.+||+.||.+|||+.|+++.
T Consensus       245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         245 SSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            4568899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-35  Score=317.64  Aligned_cols=241  Identities=26%  Similarity=0.311  Sum_probs=188.6

Q ss_pred             eeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhcc---ccceeeeEeeeeecCCceEEEEecCCC
Q 042216          483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQL---RYLHLVSLIGYCNDDGQMILVYDYMAR  556 (767)
Q Consensus       483 LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l---~Hpniv~l~g~~~~~~~~~lV~ey~~~  556 (767)
                      ||+|+||+||+|+....++.||||++....   ......+..|..++..+   +||||+++++++.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999998888999999986431   22233455677776655   699999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcccc
Q 042216          557 GTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVS  636 (767)
Q Consensus       557 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~  636 (767)
                      |+|.+++.+.  ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....  .....
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~  153 (330)
T cd05586          81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTT  153 (330)
T ss_pred             ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCc
Confidence            9999998653  45899999999999999999999   78899999999999999999999999999875322  11223


Q ss_pred             ccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCC
Q 042216          637 TQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNA  715 (767)
Q Consensus       637 ~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  715 (767)
                      ....||..|+|||++.+. .++.++|||||||++|||++|+.||......+      ... ....+..      .+.   
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~------~~~-~i~~~~~------~~~---  217 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ------MYR-NIAFGKV------RFP---  217 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH------HHH-HHHcCCC------CCC---
Confidence            345699999999998754 58999999999999999999999996543211      111 1111110      010   


Q ss_pred             ChhhHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 042216          716 PPVCLNQFVEVAMSCVNDDRIRRP----SMSDVVW  746 (767)
Q Consensus       716 ~~~~~~~l~~li~~Cl~~dp~~RP----s~~evl~  746 (767)
                      ....+.++.+++.+||+.||.+||    ++.++++
T Consensus       218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            112356778999999999999998    4666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=6.1e-34  Score=302.27  Aligned_cols=249  Identities=20%  Similarity=0.341  Sum_probs=202.4

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCC
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMA  555 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~  555 (767)
                      .|...+.||+|++|.||++....+++.+++|++........+.+.+|+.+++.++|+|++++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            34555689999999999999887788999999875555556678999999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccc
Q 042216          556 RGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHV  635 (767)
Q Consensus       556 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~  635 (767)
                      +++|.+++..   ..+++.++..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++......  ...
T Consensus       100 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~  171 (285)
T cd06648         100 GGALTDIVTH---TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPR  171 (285)
T ss_pred             CCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccC--Ccc
Confidence            9999999865   35899999999999999999999   788999999999999999999999999987654321  111


Q ss_pred             cccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCC
Q 042216          636 STQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNA  715 (767)
Q Consensus       636 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  715 (767)
                      .....|+..|+|||.+.+..++.++|||||||+++||++|+.||......      ..... .....     .+.+.  .
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~-~~~~~-----~~~~~--~  237 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKR-IRDNL-----PPKLK--N  237 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHH-HHhcC-----CCCCc--c
Confidence            22345889999999999888999999999999999999999998643221      11111 11111     01111  1


Q ss_pred             ChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          716 PPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       716 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      +...+..+.+++.+||+.+|++||++.++++
T Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            2234567999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-34  Score=300.66  Aligned_cols=248  Identities=24%  Similarity=0.388  Sum_probs=199.8

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC-CCcchhHHHHHHHHHhccc---cceeeeEeeeeecCCceEEEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLR---YLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~---Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      .|+..+.||+|+||.||+|....+++.+|+|.+... ......++.+|+.++++++   |||++++++++.++...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            466677899999999999999878899999998654 3344567889999999997   999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++++|.+++...   .+++...+.++.|++.||.|||   ..+++|+||+|+||++++++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            999999999998543   6899999999999999999999   7789999999999999999999999999987643322


Q ss_pred             CccccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                        .......|+..|+|||.+..+ .++.++|||||||++|||++|+.||.........      . .....     ..+.
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~------~-~~~~~-----~~~~  221 (277)
T cd06917         156 --SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM------M-LIPKS-----KPPR  221 (277)
T ss_pred             --cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh------h-ccccC-----CCCC
Confidence              112334688899999998754 5689999999999999999999999644321110      0 00000     0111


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      +..   ...+.++.+++.+||+.||.+||++.|+++
T Consensus       222 ~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         222 LED---NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            111   124567899999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7e-34  Score=306.34  Aligned_cols=196  Identities=24%  Similarity=0.377  Sum_probs=159.4

Q ss_pred             eeeeccCcEEEEEEEecC--CCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeec--CCceEEEEecCCC
Q 042216          481 LIIGRGGFGNVYKGFLNG--DSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCND--DGQMILVYDYMAR  556 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~--~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~--~~~~~lV~ey~~~  556 (767)
                      ..||+|+||.||+|+..+  .+..+|+|.+....  ....+.+|++++++++||||+++++++..  +...++|+||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            479999999999999754  34689999986432  23467899999999999999999998853  4578999999875


Q ss_pred             CChhhhhccC-------CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE----CCCCcEEEeecCCcc
Q 042216          557 GTLRDHLYNN-------DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL----DEEWVAKVSDFGLCK  625 (767)
Q Consensus       557 gsL~~~L~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl----d~~~~~ki~DfGla~  625 (767)
                       +|.+++...       ....+++..+..++.|++.||.|||   +.+|+||||||+|||+    ++++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             787776421       1235889999999999999999999   7889999999999999    567799999999998


Q ss_pred             cCCCCCCc-cccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 042216          626 FGPNFSKT-HVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRT  682 (767)
Q Consensus       626 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~  682 (767)
                      ........ .......+|..|+|||.+.+ ..++.++|||||||++|||++|++||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            64332111 11234568899999999876 45899999999999999999999999654

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.3e-34  Score=304.16  Aligned_cols=244  Identities=27%  Similarity=0.376  Sum_probs=201.9

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|...+.||+|+||.||++.....++.+|+|.+....   ......+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36788889999999999999998888999999986432   233456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||   +.+++|+||+|+|||+++++.+||+|||+++..... 
T Consensus        81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            999999999999654  46899999999999999999999   788999999999999999999999999998764332 


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                          .....+++.|+|||.+.+...+.++||||||++++||++|+.||......   ...    .....+.         
T Consensus       155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~~~---------  214 (290)
T cd05580         155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIY----EKILEGK---------  214 (290)
T ss_pred             ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHhcCC---------
Confidence                23446889999999998888999999999999999999999998644321   111    1111111         


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRP-----SMSDVV  745 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl  745 (767)
                       ...+......+.+++.+||+.||.+||     +++|++
T Consensus       215 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         215 -VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             -ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence             112334467789999999999999999     677776

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.5e-34  Score=303.90  Aligned_cols=251  Identities=25%  Similarity=0.384  Sum_probs=204.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      .+|...+.||+|+||.||++....+++.+++|.+........+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            57888889999999999999987777899999987555555667899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++++|.+++.+.   .+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++.......  .
T Consensus        99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--~  170 (293)
T cd06647          99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S  170 (293)
T ss_pred             CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc--c
Confidence            999999998543   4789999999999999999999   7889999999999999999999999999986543221  1


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN  714 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  714 (767)
                      ......++..|+|||.+....++.++|||||||++|||++|+.||...........      ....+        .....
T Consensus       171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~--------~~~~~  236 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG--------TPELQ  236 (293)
T ss_pred             ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCC--------CCCCC
Confidence            22334588899999999888899999999999999999999999965432211100      00000        00011


Q ss_pred             CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       715 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      .+......+.+++.+||+.+|++||++.+++..
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            122345678899999999999999999999855

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.2e-33  Score=300.80  Aligned_cols=265  Identities=20%  Similarity=0.239  Sum_probs=198.9

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++++|...+.||+|+||.||+|....++..+|+|++..... .....+.+|+++++.++|+||+++.+++..++..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            35688899999999999999999987788999999865432 23346789999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+. ++|.+++.... ..+.+.++..++.|++.||.|||   ..+|+|+||||+|||++.++.+||+|||+++......
T Consensus        83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            9996 68877775433 35788899999999999999999   7789999999999999999999999999987532211


Q ss_pred             CccccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcC---------
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG---------  701 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~---------  701 (767)
                        .......++..|+|||.+.+. .++.++|||||||++|||++|+.||........ .+... +......         
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~  233 (291)
T cd07870         158 --QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKI-WTVLGVPTEDTWPGVS  233 (291)
T ss_pred             --CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHH-HHHcCCCChhhhhhhh
Confidence              112234468899999998754 578899999999999999999999965433211 11110 0000000         


Q ss_pred             CccccccccccCCC---------ChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          702 KIGDIIDPFLKGNA---------PPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       702 ~~~~~~d~~l~~~~---------~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ..............         .......+.+++.+|++.||.+|||+.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            00000000000000         0012456789999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.2e-33  Score=292.61  Aligned_cols=250  Identities=26%  Similarity=0.417  Sum_probs=205.4

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCC
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMA  555 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~  555 (767)
                      +|...+.||+|++|.||++....+++.+++|++.........++.+|++++++++|+|++++++++...+..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            46677899999999999999987778999999976655566789999999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccc
Q 042216          556 RGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHV  635 (767)
Q Consensus       556 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~  635 (767)
                      +++|.+++.... ..+++..+..++.+++.+|.+||   ..+++|+||+|+||++++++.++|+|||++........   
T Consensus        81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---  153 (253)
T cd05122          81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---  153 (253)
T ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence            999999986543 46899999999999999999999   78899999999999999999999999999876443221   


Q ss_pred             cccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCC
Q 042216          636 STQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNA  715 (767)
Q Consensus       636 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  715 (767)
                      .....++..|+|||.+....++.++||||||+++++|++|+.|+.........   .   .. .........       .
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~---~~-~~~~~~~~~-------~  219 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL---F---KI-ATNGPPGLR-------N  219 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH---H---HH-HhcCCCCcC-------c
Confidence            23456888999999999888999999999999999999999998644321111   0   00 001111110       1


Q ss_pred             ChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          716 PPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       716 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      +...+..+.+++.+||+.||++|||+.|+++
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1123567899999999999999999999975

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.1e-34  Score=304.75  Aligned_cols=255  Identities=26%  Similarity=0.377  Sum_probs=197.9

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccc-cceeeeEeeeeecCCceEEEEec
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLR-YLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      +|...+.||+|+||.||++.....++.+|+|++.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4555668999999999999998888999999987543 234557889999999996 99999999999999999999999


Q ss_pred             CCCCChhhh---hccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          554 MARGTLRDH---LYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       554 ~~~gsL~~~---L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      +.. +|.++   +.......+++..+..++.+++.||+|||+  ..+++||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            874 55443   333334569999999999999999999994  358999999999999999999999999998753221


Q ss_pred             CCccccccccCCCcccChhhhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQ---LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDII  707 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  707 (767)
                         .......|+..|+|||.+...   .++.++|||||||++|||++|+.||.....     .......... +     .
T Consensus       162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-~-----~  227 (288)
T cd06616         162 ---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK-G-----D  227 (288)
T ss_pred             ---CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-C-----C
Confidence               112233578899999998866   689999999999999999999999854321     1111111111 1     1


Q ss_pred             cccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       708 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      .+.+....+..++.++.+++.+||+.+|.+|||+.+|++.
T Consensus       228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1122222233467789999999999999999999999853

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-36  Score=288.85  Aligned_cols=251  Identities=21%  Similarity=0.292  Sum_probs=203.7

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      +++|+..+.||+|.|+.|++..+..+++.+|+|++...  +..+.+++.+|+++.+.|+||||++|.....+.+..|||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            34566667899999999999999888899999987543  4457788999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC---CCCcEEEeecCCcccCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld---~~~~~ki~DfGla~~~~  628 (767)
                      |+|.+|+|..-+-..  ...++...-..+.||+++|.|+|   .++|||||+||.|+|+-   ..--+||+|||++....
T Consensus        90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            999999998766332  34677788889999999999999   88999999999999994   34468999999998654


Q ss_pred             CCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          629 NFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                         .........||++|||||+++..+++..+|||+.||+||-|+.|.+||.+.+..   .+    .+.+..+..     
T Consensus       165 ---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rl----ye~I~~g~y-----  229 (355)
T KOG0033|consen  165 ---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RL----YEQIKAGAY-----  229 (355)
T ss_pred             ---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HH----HHHHhcccc-----
Confidence               233345577999999999999999999999999999999999999999764321   11    111222210     


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHH
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV  745 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl  745 (767)
                       .+.+..-+...++..+|+.+||..||.+|.|+.|.+
T Consensus       230 -d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL  265 (355)
T KOG0033|consen  230 -DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL  265 (355)
T ss_pred             -CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence             011222234567788999999999999999999887

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-35  Score=318.98  Aligned_cols=242  Identities=24%  Similarity=0.390  Sum_probs=193.5

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCC----CCCcchhHHHHHHHHHhccccceeeeEeeeeecCC--ceEEEEecCC
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP----GSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG--QMILVYDYMA  555 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~----~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~--~~~lV~ey~~  555 (767)
                      +||+|+|-+||||....++..||--.++.    .+....+.|..|+.+|+.|+||||++++.++.+..  ...+|+|.|.
T Consensus        47 vLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~T  126 (632)
T KOG0584|consen   47 VLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFT  126 (632)
T ss_pred             hcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeeccc
Confidence            79999999999999988888888543321    23445578999999999999999999999987655  4889999999


Q ss_pred             CCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC-CCCcEEEeecCCcccCCCCCCcc
Q 042216          556 RGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       556 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld-~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      .|+|..|+++..  .++.+.+.+||.||++||.|||+. .++|||||||.+||||+ ..|.|||+|+|||.+...   .+
T Consensus       127 SGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~---s~  200 (632)
T KOG0584|consen  127 SGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK---SH  200 (632)
T ss_pred             CCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc---cc
Confidence            999999997765  488899999999999999999964 58999999999999997 568999999999987532   12


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN  714 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  714 (767)
                       ...+.|||.|||||.+. ..|++..||||||++++||+|+..||..     ..+.+.... .+..|.....+.+     
T Consensus       201 -aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE-----C~n~AQIYK-KV~SGiKP~sl~k-----  267 (632)
T KOG0584|consen  201 -AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE-----CTNPAQIYK-KVTSGIKPAALSK-----  267 (632)
T ss_pred             -cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh-----hCCHHHHHH-HHHcCCCHHHhhc-----
Confidence             23378999999999998 8899999999999999999999999943     222222222 1222221111110     


Q ss_pred             CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       715 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                         -.-.++.++|.+|+.. ..+|||+.|+|.
T Consensus       268 ---V~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  268 ---VKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ---cCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence               0124678999999999 999999999984

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.9e-34  Score=295.25  Aligned_cols=252  Identities=24%  Similarity=0.384  Sum_probs=206.8

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--cchhHHHHHHHHHhccccceeeeEeeeeecC--CceEEEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--QGALEFQTEIGMLSQLRYLHLVSLIGYCNDD--GQMILVY  551 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~~lV~  551 (767)
                      +|...+.||+|++|.||+|....+++.+++|++.....  ...+.+.+|++++++++|+||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            36677899999999999999987788999999875542  4566789999999999999999999999988  8999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++++|.+++.+..  .+++.++..++.+++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            9999999999996543  7999999999999999999999   6889999999999999999999999999987654322


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                      .........++..|+|||.+.....+.++||||||+++++|++|+.||......     .......         .....
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~---------~~~~~  221 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYKI---------GSSGE  221 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHhc---------cccCC
Confidence            111133456888999999999888999999999999999999999999655411     1111111         01111


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ....+...+..+.+++.+|++.+|.+||++.|++.
T Consensus       222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            12234445678999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.8e-34  Score=315.17  Aligned_cols=203  Identities=27%  Similarity=0.349  Sum_probs=175.9

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc-c-----ceeeeEeeeeecCCceEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-Y-----LHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H-----pniv~l~g~~~~~~~~~l  549 (767)
                      +|.++++||+|+||.|-++...++++.||||+++.. ..-..+-..|+.+|..|+ |     -|+|++++++...+++||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            788899999999999999999999999999999754 333455678999999997 4     299999999999999999


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC--CCcEEEeecCCcccC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE--EWVAKVSDFGLCKFG  627 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~--~~~~ki~DfGla~~~  627 (767)
                      |+|.++. +|.++|+.+.-..++...+..|+.||+.||..||   ..+|||+||||+||||.+  ...+||+|||.+...
T Consensus       266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            9999976 9999999888888999999999999999999999   788999999999999964  348999999999864


Q ss_pred             CCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccch
Q 042216          628 PNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQV  688 (767)
Q Consensus       628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~  688 (767)
                      ...-.     ...-+..|.|||++.+.+|+.+.||||||||+.||++|.+-|.+..+.++.
T Consensus       342 ~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl  397 (586)
T KOG0667|consen  342 SQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQL  397 (586)
T ss_pred             CCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHH
Confidence            33221     223456799999999999999999999999999999998888766654443

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5e-34  Score=302.22  Aligned_cols=262  Identities=20%  Similarity=0.240  Sum_probs=199.4

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      |+..+.||+|++|.||+|....+++.||+|++....  ......+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            456778999999999999998788999999986543  223356889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      + ++|.+++.......+++..++.++.|+++||.|||   +++++|+||+|+||+++.++.++|+|||+++......  .
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--R  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--c
Confidence            5 69999987655456899999999999999999999   6789999999999999999999999999987542211  1


Q ss_pred             ccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcC--------Cccc
Q 042216          635 VSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG--------KIGD  705 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~--------~~~~  705 (767)
                      ......++..|+|||++.+. .++.++||||||+++|||++|+.||.......  .+...........        .+.+
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPD  232 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchh
Confidence            11223467899999987654 57899999999999999999999996543211  1111111000000        0000


Q ss_pred             cccc------cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          706 IIDP------FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       706 ~~d~------~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ....      .......+..+.++.+++.+||+.+|.+|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000      0000112234567889999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7.8e-34  Score=304.78  Aligned_cols=246  Identities=28%  Similarity=0.384  Sum_probs=198.1

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC---cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ---QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      +.|+..+.||+|+||.||+|+...+++.||+|++.....   ...+++.+|+++++.++|||++++.++|.+.+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            457778899999999999999987789999999864322   23456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||++ |+|.+++.... ..+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||++...... 
T Consensus        95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            9997 58877775433 35899999999999999999999   788999999999999999999999999998754321 


Q ss_pred             CccccccccCCCcccChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYR---LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                           ....++..|+|||.+.   ...++.++||||||+++|||++|+.||........      .... .....     
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~-~~~~~-----  231 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHI-AQNDS-----  231 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHH-hcCCC-----
Confidence                 2345788999999874   45688999999999999999999999865432111      0110 00000     


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      +   ...+..++..+.+++.+||+.+|++||++.+|+.
T Consensus       232 ~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         232 P---TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             C---CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0   0112235677999999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=8e-34  Score=302.43  Aligned_cols=265  Identities=20%  Similarity=0.280  Sum_probs=200.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc--chhHHHHHHHHHhccccceeeeEeeeeecC--CceEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLSQLRYLHLVSLIGYCNDD--GQMILV  550 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~~lV  550 (767)
                      ++|+..+.||+|+||.||+|+...+++.+++|.++.....  ....+.+|+.++.+++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            4678888999999999999999888889999998754322  233567899999999999999999998777  899999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      +||+++ +|.+++.... ..+++.++..++.|++.||.|||   +.+++|+||||+|||++.++.+||+|||+++.....
T Consensus        85 ~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          85 MEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             ehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            999985 9999886543 36899999999999999999999   778999999999999999999999999998754332


Q ss_pred             CCccccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHH-HH-------HHHHh---
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLA-VW-------ATECY---  698 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~-~~-------~~~~~---  698 (767)
                      .  .......++..|+|||.+.+. .++.++|+||||+++|||++|++||............ ..       .+..+   
T Consensus       160 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         160 L--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             c--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            1  111233467889999998754 4689999999999999999999999654322111000 00       00000   


Q ss_pred             ---hcCCccccccccccCCCChh-hHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          699 ---RNGKIGDIIDPFLKGNAPPV-CLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       699 ---~~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                         ............+....+.. ....+.+++.+||+.+|++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence               00001111111122222222 4667889999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=296.96  Aligned_cols=248  Identities=23%  Similarity=0.360  Sum_probs=208.2

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCC
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMAR  556 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~  556 (767)
                      |+.+.+||+|+||.||++.++..++.+|||++..  ....+++..|+.++++.+.|++|+.+|.+.....+|+|||||.-
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            6677789999999999999999999999998854  34677899999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcccc
Q 042216          557 GTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVS  636 (767)
Q Consensus       557 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~  636 (767)
                      |++.+.++.. +++|++.++..++...++||+|||   ...-||||||+.|||++-+|.+||+|||.+.....  .....
T Consensus       113 GSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKR  186 (502)
T KOG0574|consen  113 GSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKR  186 (502)
T ss_pred             CcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhh
Confidence            9999998654 568999999999999999999999   56679999999999999999999999999864322  12233


Q ss_pred             ccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCC
Q 042216          637 TQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP  716 (767)
Q Consensus       637 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  716 (767)
                      ..+.||+-|||||++..-.|..++||||+|++..||..|++||...-......            .+..-.-|.+  ..|
T Consensus       187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF------------MIPT~PPPTF--~KP  252 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF------------MIPTKPPPTF--KKP  252 (502)
T ss_pred             CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE------------eccCCCCCCC--CCh
Confidence            45779999999999999999999999999999999999999996543321100            0000011111  235


Q ss_pred             hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       717 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ...+.++-+++++||...|++|-|+.++++
T Consensus       253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  253 EEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             HhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            677889999999999999999999998874

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-34  Score=301.00  Aligned_cols=261  Identities=22%  Similarity=0.288  Sum_probs=199.4

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecC--CceEEEEe
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD--GQMILVYD  552 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~~lV~e  552 (767)
                      |+..+.||+|++|.||+|.....++.+|+|++....  ......+.+|++++++++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            456778999999999999998878899999997653  33345688999999999999999999999887  89999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+++ +|.+++.... ..+++.+++.++.|+++||.|||   ..+++|+||||+||++++++.+||+|||++........
T Consensus        81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            9985 8998886543 46899999999999999999999   67899999999999999999999999999875433221


Q ss_pred             ccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhc---CCcc----
Q 042216          633 THVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRN---GKIG----  704 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~---~~~~----  704 (767)
                       .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........   .......   ....    
T Consensus       156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  231 (287)
T cd07840         156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEK---IFELCGSPTDENWPGVSK  231 (287)
T ss_pred             -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCchhhcccccc
Confidence             11233456788999998764 4678999999999999999999999965443211111   1110000   0000    


Q ss_pred             ----------ccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          705 ----------DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       705 ----------~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                                ......+.......++.++.+++.+||+.+|.+||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                      000000111111113677899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1e-33  Score=301.79  Aligned_cols=263  Identities=21%  Similarity=0.273  Sum_probs=196.7

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--cchhHHHHHHHHHhccc-cceeeeEeeeeecCCc-----
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--QGALEFQTEIGMLSQLR-YLHLVSLIGYCNDDGQ-----  546 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~-----  546 (767)
                      ++|+..+.||+|+||.||+|....+++.||+|.+.....  .....+.+|+.+++.++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            367888899999999999999988889999998765422  23456888999999995 6999999999876655     


Q ss_pred             eEEEEecCCCCChhhhhccCC---CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC-CCcEEEeecC
Q 042216          547 MILVYDYMARGTLRDHLYNND---NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE-EWVAKVSDFG  622 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~-~~~~ki~DfG  622 (767)
                      .++||||+++ +|.+++....   ...+++..++.++.|++.||.|||   +++|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 8988885432   346899999999999999999999   788999999999999998 8999999999


Q ss_pred             CcccCCCCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcC
Q 042216          623 LCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG  701 (767)
Q Consensus       623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~  701 (767)
                      +++......  .......+++.|+|||++.+ ..++.++||||||+++|||++|..||....+.+.  +..... .....
T Consensus       157 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~-~~~~~  231 (295)
T cd07837         157 LGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHIFK-LLGTP  231 (295)
T ss_pred             cceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHH-HhCCC
Confidence            987542211  11122346788999998865 4679999999999999999999999965433211  111111 00000


Q ss_pred             C---cccccc-------cccc----CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          702 K---IGDIID-------PFLK----GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       702 ~---~~~~~d-------~~l~----~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .   .....+       +...    ....+....++.+++.+||+.||.+||++.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0   000000       0000    0001234567899999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.9e-34  Score=298.83  Aligned_cols=248  Identities=27%  Similarity=0.313  Sum_probs=204.3

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      +|+..+.||.|+||.||++.....++.+|+|.+....   ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778889999999999999998778899999986542   2345678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+.+++|.+++...  .++++.++..++.|+++||.|||   .++++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            99999999999654  46899999999999999999999   7789999999999999999999999999987543321 


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                        ......++..|+|||.+....++.++|+||||+++|+|++|+.||.......    ..+.......          ..
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~----------~~  218 (258)
T cd05578         155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET----------AD  218 (258)
T ss_pred             --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc----------cc
Confidence              2233557889999999998889999999999999999999999996554321    1111111110          11


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCH--HHHH
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSM--SDVV  745 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~--~evl  745 (767)
                      ...+...+..+.+++.+||+.||.+||++  +|++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            22344456789999999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-35  Score=312.26  Aligned_cols=245  Identities=28%  Similarity=0.379  Sum_probs=204.4

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc---chhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ---GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~---~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      -|+.++.||.|+||-||-+....+...||||++.-..++   ..+++..|+..|.+++|||.+..-||+..+...|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            467777899999999999999888899999999765443   45678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      ||-| |-.|.|.-+ .++|-+..+..|+.+++.||+|||   +.+.||||||+.|||+.+.|.|||+|||.+.+..    
T Consensus       107 YClG-SAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~----  177 (948)
T KOG0577|consen  107 YCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA----  177 (948)
T ss_pred             HHhc-cHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcC----
Confidence            9954 777777443 357999999999999999999999   7889999999999999999999999999987543    


Q ss_pred             ccccccccCCCcccChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYR---LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                        .....+||+.|||||++.   .+.|+-|.||||+|++..||.-.++|+..+....-.  -..+     ..     -.|
T Consensus       178 --PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL--YHIA-----QN-----esP  243 (948)
T KOG0577|consen  178 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIA-----QN-----ESP  243 (948)
T ss_pred             --chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH--HHHH-----hc-----CCC
Confidence              234578999999999875   578999999999999999999999998766543211  1111     11     112


Q ss_pred             cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       710 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .|.   ..+.+..+++++..||+.-|.+|||.+++++
T Consensus       244 tLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  244 TLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            222   3467888999999999999999999998874

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.2e-33  Score=299.89  Aligned_cols=254  Identities=26%  Similarity=0.387  Sum_probs=206.2

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      .++.|+..+.||+|++|.||+|.+...+..+++|++..... ....+.+|+++++.++|+|++++++++...+..++++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            45567777889999999999999987778999999976544 45678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+++++|.+++.... ..+++..+..++.+++.||.|||   +.+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-  170 (286)
T cd06614          96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-  170 (286)
T ss_pred             ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence            999999999997654 36999999999999999999999   7889999999999999999999999999976433211 


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                       .......++..|+|||.+.+..++.++|||||||++|||++|+.||........  ...    . ........      
T Consensus       171 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--~~~----~-~~~~~~~~------  236 (286)
T cd06614         171 -SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--LFL----I-TTKGIPPL------  236 (286)
T ss_pred             -hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--HHH----H-HhcCCCCC------
Confidence             112234578899999999888899999999999999999999999864332111  111    0 11111110      


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                       ..+..++..+.+++.+||+.+|.+||++.+|++.
T Consensus       237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         237 -KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             -cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence             1122255678999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-33  Score=303.02  Aligned_cols=267  Identities=22%  Similarity=0.277  Sum_probs=198.3

Q ss_pred             ccccceeeeccCcEEEEEEEecC--CCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecC--CceE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNG--DSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD--GQMI  548 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~--~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~~  548 (767)
                      .|+..+.||+|+||.||+|+...  .++.||+|.+....   ......+.+|+.++.+++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            36777899999999999999987  67899999997632   33345678899999999999999999999888  7899


Q ss_pred             EEEecCCCCChhhhhccC---CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC----CCcEEEeec
Q 042216          549 LVYDYMARGTLRDHLYNN---DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE----EWVAKVSDF  621 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~----~~~~ki~Df  621 (767)
                      +||||+++ +|.+++...   ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 777766432   2236899999999999999999999   788999999999999999    999999999


Q ss_pred             CCcccCCCCCC-ccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccc-------hhHHH
Q 042216          622 GLCKFGPNFSK-THVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ-------VNLAV  692 (767)
Q Consensus       622 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~-------~~l~~  692 (767)
                      |+++....... ........++..|+|||.+.+ ..++.++|||||||+++||++|++||........       ..+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99886433222 111223457889999998876 4588999999999999999999999965543220       01111


Q ss_pred             HHHHHh-----------hcCCccccccccccCCCC---------h--hhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          693 WATECY-----------RNGKIGDIIDPFLKGNAP---------P--VCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       693 ~~~~~~-----------~~~~~~~~~d~~l~~~~~---------~--~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .....-           .........+.......+         .  ....++.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            111000           000000000000000111         0  33457899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.4e-33  Score=298.52  Aligned_cols=243  Identities=23%  Similarity=0.291  Sum_probs=190.2

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCCCC---cchhHHHHHHHHHh---ccccceeeeEeeeeecCCceEEEEecCC
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ---QGALEFQTEIGMLS---QLRYLHLVSLIGYCNDDGQMILVYDYMA  555 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~---~l~Hpniv~l~g~~~~~~~~~lV~ey~~  555 (767)
                      +||+|+||.||++....+++.+|+|.+.....   .....+.+|..++.   ..+|||++.+.+++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            48999999999999988889999998865421   22223445544443   3479999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccc
Q 042216          556 RGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHV  635 (767)
Q Consensus       556 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~  635 (767)
                      +|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+|+||||+|||+++++.++|+|||++......    .
T Consensus        81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~  151 (279)
T cd05633          81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K  151 (279)
T ss_pred             CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----C
Confidence            99999998643  45999999999999999999999   788999999999999999999999999998643221    1


Q ss_pred             cccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCC
Q 042216          636 STQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN  714 (767)
Q Consensus       636 ~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  714 (767)
                      .....|+..|+|||.+.. ..++.++|||||||+++||++|+.||..........+..    ...          .....
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~~----------~~~~~  217 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTL----------TVNVE  217 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH----Hhh----------cCCcC
Confidence            123468999999999864 568999999999999999999999996543322111111    000          01112


Q ss_pred             CChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042216          715 APPVCLNQFVEVAMSCVNDDRIRRP-----SMSDVVWG  747 (767)
Q Consensus       715 ~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~  747 (767)
                      .+...+.++.+++.+||+.||.+||     +++++++.
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            3445667889999999999999999     59988864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.5e-33  Score=295.01  Aligned_cols=243  Identities=21%  Similarity=0.241  Sum_probs=198.0

Q ss_pred             eeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCCh
Q 042216          483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTL  559 (767)
Q Consensus       483 LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gsL  559 (767)
                      ||.|++|.||+++....++.+|+|++....   ....+.+.+|+++++.++||||+++++.+.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999998778899999986542   23446789999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccccc
Q 042216          560 RDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV  639 (767)
Q Consensus       560 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~  639 (767)
                      .+++.+.  ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||+++......   .....
T Consensus        81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~  152 (262)
T cd05572          81 WTILRDR--GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF  152 (262)
T ss_pred             HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence            9999654  35899999999999999999999   7889999999999999999999999999987653321   12234


Q ss_pred             cCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhh
Q 042216          640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVC  719 (767)
Q Consensus       640 ~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  719 (767)
                      .++..|+|||.+....++.++|+||||+++|||++|+.||.......    ........         +.......+...
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~---------~~~~~~~~~~~~  219 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDIL---------KGNGKLEFPNYI  219 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHh---------ccCCCCCCCccc
Confidence            57889999999988889999999999999999999999996554311    11111111         001122234445


Q ss_pred             HHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042216          720 LNQFVEVAMSCVNDDRIRRPS-----MSDVVW  746 (767)
Q Consensus       720 ~~~l~~li~~Cl~~dp~~RPs-----~~evl~  746 (767)
                      +.++.+++.+||+.+|.+||+     +.|+++
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            678999999999999999999     566554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.4e-33  Score=302.51  Aligned_cols=246  Identities=26%  Similarity=0.378  Sum_probs=197.8

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC---cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ---QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      |...+.||+|+||.||+++...++..+|+|++.....   ....++.+|++++++++|||++++++++.++...++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            6667789999999999999988888999999864422   2345688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +. |+|.+.+... ..+++|.++..++.+++.||.|||   +.+++|+||+|+||+++.++.+||+|||++.....    
T Consensus       107 ~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----  177 (317)
T cd06635         107 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----  177 (317)
T ss_pred             CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence            97 5888877543 346899999999999999999999   78899999999999999999999999999875322    


Q ss_pred             cccccccCCCcccChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYR---LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                        .....++..|+|||++.   .+.++.++|||||||++|||++|+.||........  +..+.    ..+.        
T Consensus       178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~----~~~~--------  241 (317)
T cd06635         178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIA----QNES--------  241 (317)
T ss_pred             --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHH----hccC--------
Confidence              12345788999999974   45789999999999999999999999865432111  11111    1100        


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGL  748 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L  748 (767)
                       ........+..+.+++.+||+.+|.+||++.+|++.+
T Consensus       242 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         242 -PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             -CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence             0111223556789999999999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.7e-33  Score=298.26  Aligned_cols=264  Identities=19%  Similarity=0.262  Sum_probs=200.3

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc-chhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ-GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      +|+..+.||+|++|.||+|+...+++.||||++...... ....+.+|++++++++|+|++++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            477888999999999999999888899999998765332 3456788999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCC-CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          555 ARGTLRDHLYNND-NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       555 ~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      ++ +|.+++.... ...+++.++..++.|++.||.|||   +.+++|+||||+||++++++.++|+|||+++......  
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--  154 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--  154 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence            85 8988886543 346899999999999999999999   7789999999999999999999999999987532211  


Q ss_pred             cccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhH-HHHH-------HHHhhc-CCc
Q 042216          634 HVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL-AVWA-------TECYRN-GKI  703 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l-~~~~-------~~~~~~-~~~  703 (767)
                      .......++..|++||.+.+ ..++.++|||||||++|||++|+.||......+.... ....       .+.+.. ...
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence            11223456889999998865 4578999999999999999999999965443221110 0000       000000 000


Q ss_pred             c----ccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          704 G----DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       704 ~----~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .    ...+... ....+..+..+.+++.+|++.||.+||++.|+++
T Consensus       235 ~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         235 KPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0    0000000 0111234567889999999999999999999974

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.6e-33  Score=301.25  Aligned_cols=265  Identities=23%  Similarity=0.299  Sum_probs=199.9

Q ss_pred             HHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCC----
Q 042216          472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG----  545 (767)
Q Consensus       472 ~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~----  545 (767)
                      ...++|+..+.||+|+||.||+|..+.+++.||+|+++...  ......+.+|++++++++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            35678899999999999999999998888899999987543  223346788999999999999999999987654    


Q ss_pred             ------ceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 042216          546 ------QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVS  619 (767)
Q Consensus       546 ------~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~  619 (767)
                            ..++|+||+++ +|.+.+... ...+++.++..++.|++.||+|||   ..+|+|+||||+||++++++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeC
Confidence                  78999999986 777777544 346899999999999999999999   7789999999999999999999999


Q ss_pred             ecCCcccCCCCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHh
Q 042216          620 DFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECY  698 (767)
Q Consensus       620 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~  698 (767)
                      |||++........ .......++..|+|||.+.+ ..++.++|||||||+++||++|++||......  ..+.. +....
T Consensus       159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~--~~~~~-~~~~~  234 (302)
T cd07864         159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL--AQLEL-ISRLC  234 (302)
T ss_pred             cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHH-HHHHh
Confidence            9999876433221 11122345778999998864 45789999999999999999999999643321  11111 11111


Q ss_pred             hcCC---ccccc--------cc------cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          699 RNGK---IGDII--------DP------FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       699 ~~~~---~~~~~--------d~------~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ....   ..++.        +.      .++. .....+..+.+++.+||+.+|.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CCCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0000   00000        00      0000 01124567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.6e-33  Score=300.31  Aligned_cols=262  Identities=19%  Similarity=0.258  Sum_probs=198.8

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ++|+..+.||+|++|.||+|....+++.||+|++.....  .....+.+|++++++++|+|++++++++...+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            468888899999999999999988888999999864422  234568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC-CCcEEEeecCCcccCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE-EWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~-~~~~ki~DfGla~~~~~~~  631 (767)
                      |++ ++|.+++.......+++..+..++.|++.||+|||   +++++|+||+|+||+++. ++.+||+|||+++..... 
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-  156 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC-
Confidence            996 58888886554445688899999999999999999   778999999999999985 567999999998754221 


Q ss_pred             CccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccc---
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDII---  707 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~---  707 (767)
                       ........++..|+|||++.+ ..++.++|||||||++|||++|++||......+..  .. ........ ..+..   
T Consensus       157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~--~~-~~~~~~~~-~~~~~~~~  231 (294)
T PLN00009        157 -VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL--FK-IFRILGTP-NEETWPGV  231 (294)
T ss_pred             -ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-HHHHhCCC-Chhhcccc
Confidence             111223456889999998865 45789999999999999999999999654332111  11 00000000 00000   


Q ss_pred             ----c-----ccccC----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          708 ----D-----PFLKG----NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       708 ----d-----~~l~~----~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                          +     +....    ...+..+.++.+++.+|++.+|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                0     00000    012234567899999999999999999999985

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.9e-34  Score=310.54  Aligned_cols=268  Identities=23%  Similarity=0.324  Sum_probs=199.9

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecC--Cce
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDD--GQM  547 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~--~~~  547 (767)
                      ..++|...+.||+|+||.||+|....+++.+|+|++...  .......+.+|+.++.++ +||||++++++|...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            456788888999999999999999877789999988543  223345678899999999 999999999998654  368


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      ++||||++ ++|.+++...   .++|..+..++.|++.||.|||   +.+|+|+||||+||++++++.+||+|||+++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            99999997 5999988543   6889999999999999999999   788999999999999999999999999998754


Q ss_pred             CCCCCc---cccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHH--------
Q 042216          628 PNFSKT---HVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWAT--------  695 (767)
Q Consensus       628 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~--------  695 (767)
                      ......   .......|+..|+|||.+.. ..++.++||||||+++|||++|+.||......+.........        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            332211   12233458889999998754 567899999999999999999999996543321110000000        


Q ss_pred             HHhhcCCccccccccc------cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          696 ECYRNGKIGDIIDPFL------KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       696 ~~~~~~~~~~~~d~~l------~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      ..+......++++...      .....+..+.++.+++.+||+.+|.+|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            0000000000111000      001112246778999999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-34  Score=307.67  Aligned_cols=252  Identities=23%  Similarity=0.352  Sum_probs=203.9

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCC--CCCcchhHHHHHHHHHhccc-cceeeeEeeeeecCCceEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGALEFQTEIGMLSQLR-YLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~--~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV  550 (767)
                      ...|+.+++||+||.++||++...+ .+.+|+|++..  ...+...-|.+|+..|.+|+ |.+|++|++|-..++.+|||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            3468888899999999999998764 46788887643  35556677999999999995 89999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||=+. +|.++|.+.......| .+..+..|++.++.++|   ..+|||.||||.|.|+-. |.+||+|||+|......
T Consensus       439 mE~Gd~-DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  439 MECGDI-DLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD  512 (677)
T ss_pred             eecccc-cHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence            997544 9999998776666667 67788999999999999   788999999999999875 59999999999987776


Q ss_pred             CCccccccccCCCcccChhhhccC-----------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhh
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQ-----------LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR  699 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~  699 (767)
                      ...-.....+||+.||+||.+...           +.+.+|||||+||+||+|+.|++||.....       .|.     
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~a-----  580 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIA-----  580 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHH-----
Confidence            666666778899999999998632           256799999999999999999999943211       111     


Q ss_pred             cCCccccccccccCCCChhh-HHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          700 NGKIGDIIDPFLKGNAPPVC-LNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       700 ~~~~~~~~d~~l~~~~~~~~-~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                        ++..+.||.-..++|..- ..+++++++.||..||.+||++.++|+
T Consensus       581 --Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  581 --KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             --HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence              234455664444443322 233999999999999999999999984

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.8e-33  Score=297.25  Aligned_cols=245  Identities=24%  Similarity=0.342  Sum_probs=196.5

Q ss_pred             eeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCCh
Q 042216          483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTL  559 (767)
Q Consensus       483 LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gsL  559 (767)
                      ||+|+||+||++.....++.+|+|.+....   ......+.+|+++++.++|||++++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999988888899999986432   22344577899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccccc
Q 042216          560 RDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV  639 (767)
Q Consensus       560 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~  639 (767)
                      .+++.+.....+++.++..++.|++.||.|||   ..+++|+||+|+||++++++.+||+|||++.....   .......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccc
Confidence            99997665557999999999999999999999   78899999999999999999999999999875432   1112234


Q ss_pred             cCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhh
Q 042216          640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVC  719 (767)
Q Consensus       640 ~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  719 (767)
                      .++..|+|||.+.+..++.++|||||||+++||++|+.||.........  ... ......          .....+...
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~-~~~~~~----------~~~~~~~~~  221 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK--EEL-KRRTLE----------MAVEYPDKF  221 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH--HHH-Hhcccc----------ccccCCccC
Confidence            5778999999998888999999999999999999999999654331111  000 000000          111233445


Q ss_pred             HHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042216          720 LNQFVEVAMSCVNDDRIRRP-----SMSDVVW  746 (767)
Q Consensus       720 ~~~l~~li~~Cl~~dp~~RP-----s~~evl~  746 (767)
                      +..+.+++.+||+.+|.+||     ++.+++.
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            67789999999999999999     6666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-35  Score=311.95  Aligned_cols=250  Identities=22%  Similarity=0.358  Sum_probs=206.4

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCC
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMAR  556 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~  556 (767)
                      +.++..||.|+||+||+++.+..+-..|-|.+...+..+..+|+-||++|..+.||+||+|++.+..++.++++.|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            44455699999999999999987777788988877888888999999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcccc
Q 042216          557 GTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVS  636 (767)
Q Consensus       557 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~  636 (767)
                      |-.+..+..-. .+|++.++.-+|.+++.||.|||   ++.|||||||+.|||++.+|.++|+|||.+....  ......
T Consensus       114 GAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkR  187 (1187)
T KOG0579|consen  114 GAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKR  187 (1187)
T ss_pred             chHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch--hHHhhh
Confidence            99988776543 46999999999999999999999   8899999999999999999999999999975321  222234


Q ss_pred             ccccCCCcccChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          637 TQVKGSIGYLDPEYYR-----LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       637 ~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                      ....||+.|||||+..     ..+|+.++||||||++|.||..+.+|-.......  .+.     .+.......++    
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--Vll-----KiaKSePPTLl----  256 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLL-----KIAKSEPPTLL----  256 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--HHH-----HHhhcCCCccc----
Confidence            4678999999999875     4689999999999999999999999975443221  111     11222222221    


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                         .|......+.+++..||..||..||+++++++
T Consensus       257 ---qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  257 ---QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             ---CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence               25567788999999999999999999999983

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-33  Score=290.13  Aligned_cols=248  Identities=26%  Similarity=0.424  Sum_probs=204.5

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      +|+..+.||+|++|.||+++....++.+++|.+.....  .....+.+|++++++++|+|++++++++.+++..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            46677899999999999999987888999999976643  4556789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++++|.+++...  ..+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (254)
T cd06627          81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-  154 (254)
T ss_pred             CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-
Confidence            9999999998654  46999999999999999999999   78899999999999999999999999999886533221 


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                       ......++..|+|||.......+.++||||+|++++||++|+.|+......    ...+..   ...         ...
T Consensus       155 -~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----~~~~~~---~~~---------~~~  217 (254)
T cd06627         155 -DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----AALFRI---VQD---------DHP  217 (254)
T ss_pred             -cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----HHHHHH---hcc---------CCC
Confidence             123345788999999998888899999999999999999999998643321    111110   011         011


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ..+...+..+.+++.+||..+|++||++.+++.
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            223345677899999999999999999999974

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2e-33  Score=304.67  Aligned_cols=260  Identities=20%  Similarity=0.255  Sum_probs=195.6

Q ss_pred             eeecc--CcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCC
Q 042216          482 IIGRG--GFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARG  557 (767)
Q Consensus       482 ~LG~G--~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~g  557 (767)
                      .||+|  +||+||++++...++.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+|
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46666  99999999998888999999986542  223456889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc-c--
Q 042216          558 TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT-H--  634 (767)
Q Consensus       558 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~-~--  634 (767)
                      +|.+++.+.....+++..+..++.|++.||.|||   +.+++||||||+|||++.++.+|++||+.+......... .  
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            9999997655556899999999999999999999   788999999999999999999999999865322110000 0  


Q ss_pred             --ccccccCCCcccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHH--------------
Q 042216          635 --VSTQVKGSIGYLDPEYYRLQ--LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATE--------------  696 (767)
Q Consensus       635 --~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~--------------  696 (767)
                        ......++..|+|||++.+.  .++.++|||||||+++||++|+.||.......  .+......              
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccchh
Confidence              00112345679999999763  57899999999999999999999996543211  11100000              


Q ss_pred             ------------------HhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          697 ------------------CYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       697 ------------------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                                        .........+.+..++...+..+...+.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                              00000000111122222233456778999999999999999999999984

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.4e-33  Score=300.82  Aligned_cols=268  Identities=21%  Similarity=0.293  Sum_probs=196.7

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCC------
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG------  545 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~------  545 (767)
                      .++|+..+.||+|+||.||++....+++.||||++....  ......+.+|++++++++||||++++++|...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357888999999999999999998888999999886432  222335678999999999999999999987654      


Q ss_pred             --ceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCC
Q 042216          546 --QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL  623 (767)
Q Consensus       546 --~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGl  623 (767)
                        ..++||||+.+ +|.+++.... ..+++.+++.++.|++.||.|||   +++++|+||||+||+++.++.+||+|||+
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence              45999999975 8888875433 35899999999999999999999   77899999999999999999999999999


Q ss_pred             cccCCCCCCc--cccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhc
Q 042216          624 CKFGPNFSKT--HVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRN  700 (767)
Q Consensus       624 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~  700 (767)
                      +.........  .......++..|+|||.+.+. .++.++||||||+++|||++|+.||.....................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            8754322111  112234577889999988664 4788999999999999999999998654432222111111100000


Q ss_pred             CCcc-----cccccc-ccCC---------CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          701 GKIG-----DIIDPF-LKGN---------APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       701 ~~~~-----~~~d~~-l~~~---------~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ....     +..+.. +...         .+......+.+++.+||+.||.+|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            0000     000000 0000         01112356789999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3e-33  Score=291.00  Aligned_cols=250  Identities=25%  Similarity=0.421  Sum_probs=206.8

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      +|...+.||+|+||.||++....+++.+++|++.....  ....++.+|+++++.++|+|++++.+.+..++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            46777899999999999999987788999999875533  4556789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCC--CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          554 MARGTLRDHLYNND--NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       554 ~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      +++++|.+++.+..  ...+++.++..++.+++.||.|||   +.+++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999997643  467999999999999999999999   6789999999999999999999999999987643322


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                        .......++..|+|||.+....++.++||||+|+++++|++|+.||......      ....... ...         
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~-~~~---------  219 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKIL-KGQ---------  219 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHHh-cCC---------
Confidence              1223346888999999999888999999999999999999999998544321      1111111 111         


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ....+......+.+++.+||..+|.+||++.++++
T Consensus       220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11223355678899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3e-33  Score=295.89  Aligned_cols=258  Identities=23%  Similarity=0.277  Sum_probs=194.6

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccc-cceeeeEeeeeecC--CceEEEEe
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLR-YLHLVSLIGYCNDD--GQMILVYD  552 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~--~~~~lV~e  552 (767)
                      |...+.||+|+||.||+|....+++.+|+|+++... ........+|+.++.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            455678999999999999998888999999987542 222234567888898885 99999999999877  89999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |++ |+|.+++.... ..++|.++..++.|++.||.|||   ..+++||||||+||+++. +.+||+|||+++...... 
T Consensus        81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-  153 (282)
T cd07831          81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-  153 (282)
T ss_pred             cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCC-
Confidence            997 58888886533 46899999999999999999999   778999999999999999 999999999987543211 


Q ss_pred             ccccccccCCCcccChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHh-----------hc
Q 042216          633 THVSTQVKGSIGYLDPEYYR-LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECY-----------RN  700 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~-----------~~  700 (767)
                        ......++..|+|||++. .+.++.++|||||||++|||++|+.||......+   ...+.....           ..
T Consensus       154 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         154 --PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             --CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhcc
Confidence              112345788999999765 4567899999999999999999999996543321   111111111           00


Q ss_pred             CCccccccccccC----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          701 GKIGDIIDPFLKG----NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       701 ~~~~~~~d~~l~~----~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ........+....    ......+..+.+++.+||+.+|++||+++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000100000000    011235678999999999999999999999975

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=299.69  Aligned_cols=245  Identities=24%  Similarity=0.357  Sum_probs=207.8

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      +.|..-++||+||||.||-++.+.+++.+|.|++.+.   ..++..--++|-.||++++.+.||.+--.++..+.++||+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            5688888999999999999999999999999988543   3344555688999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ..|.||+|.-||.+..+..+++..+.-.+.+|+.||++||   ...||.|||||+|||||+.|+++|+|+|||...+.  
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~--  339 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE--  339 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCC--
Confidence            9999999999999888888999999999999999999999   78899999999999999999999999999986543  


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                       .......+||.+|||||++.++.|+...|.||+||+||||+.|+.||....+....                +-+|.+.
T Consensus       340 -g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~----------------eEvdrr~  402 (591)
T KOG0986|consen  340 -GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR----------------EEVDRRT  402 (591)
T ss_pred             -CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH----------------HHHHHHH
Confidence             22334458999999999999999999999999999999999999999554332111                0111111


Q ss_pred             ---cCCCChhhHHHHHHHHHHccccCCCCCCCH
Q 042216          712 ---KGNAPPVCLNQFVEVAMSCVNDDRIRRPSM  741 (767)
Q Consensus       712 ---~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~  741 (767)
                         ...++...+++...+....|+.||.+|.-.
T Consensus       403 ~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  403 LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             hcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence               123566778888999999999999999743

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.3e-33  Score=292.07  Aligned_cols=248  Identities=26%  Similarity=0.403  Sum_probs=204.8

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      +|+..+.||+|+||.||+++...+++.+++|.+...  ......++.+|++++++++|+||+++.+++.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            467788999999999999998888889999998654  233455788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccC--CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          554 MARGTLRDHLYNN--DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       554 ~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      +++++|.+++.+.  ....+++..++.++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999998652  2356899999999999999999999   788999999999999999999999999998765432 


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                         ......++..|+|||.+.+..++.++|+||||++++||++|+.||......+   +..    ....+..        
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~----~~~~~~~--------  218 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRY----KVQRGKY--------  218 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHhcCCC--------
Confidence               2223457889999999999999999999999999999999999996543221   111    1111111        


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       ...+.....++.+++.+|++.+|.+||++.++++
T Consensus       219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         219 -PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             -CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             1223355677999999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-34  Score=308.55  Aligned_cols=264  Identities=22%  Similarity=0.283  Sum_probs=198.1

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecC-----Cce
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD-----GQM  547 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~-----~~~  547 (767)
                      +++|...+.||+|+||.||+|....+++.||+|++.... ......+.+|+.++++++|+||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999998888999999986532 23445688899999999999999999987644     357


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      ++++||+.+ +|.+++..   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          84 YIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             EEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            999999975 88887743   35899999999999999999999   788999999999999999999999999998754


Q ss_pred             CCCCC-ccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC---
Q 042216          628 PNFSK-THVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK---  702 (767)
Q Consensus       628 ~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~---  702 (767)
                      ..... ........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.......   ........+....   
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~  233 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQED  233 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHH
Confidence            32111 111223467899999998754 568999999999999999999999995433211   1111111111000   


Q ss_pred             cccccccc-------c--cCC-----CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          703 IGDIIDPF-------L--KGN-----APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       703 ~~~~~d~~-------l--~~~-----~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      ...+.+..       .  ...     ..+..+.++.+++.+||+.+|++|||+.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00000000       0  000     011235668899999999999999999999865

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-33  Score=297.37  Aligned_cols=260  Identities=22%  Similarity=0.261  Sum_probs=200.8

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc--chhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      |...+.||+|++|.||++....+++.+++|++......  ....+..|++++++++|+||+++++++..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            45567899999999999999878899999998754322  3457889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++ +|.+++.... ..+++.++..++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||.+.......  .
T Consensus        81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~  153 (283)
T cd05118          81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R  153 (283)
T ss_pred             CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence            75 8988886543 46899999999999999999999   7889999999999999999999999999987653322  1


Q ss_pred             ccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcC---Ccccccc--
Q 042216          635 VSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG---KIGDIID--  708 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~d--  708 (767)
                      ......++..|+|||.+.+. .++.++|+||||+++++|++|+.||......+....   ........   ......+  
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK---IFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCchHhcccchhhh
Confidence            12234577889999998876 789999999999999999999999865443221111   11110000   0000000  


Q ss_pred             ----ccc-------cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          709 ----PFL-------KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       709 ----~~l-------~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                          ...       .....+..+.++.+++.+||+.||.+||++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                000       00112235678999999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.7e-33  Score=300.82  Aligned_cols=264  Identities=23%  Similarity=0.313  Sum_probs=197.8

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--cchhHHHHHHHHHhccccceeeeEeeeeecC--CceEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--QGALEFQTEIGMLSQLRYLHLVSLIGYCNDD--GQMIL  549 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~~l  549 (767)
                      ..+|+..+.||+|+||.||+|.....++.||+|+++....  .....+.+|+.++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            3578899999999999999999988889999999864422  2233567899999999999999999998654  56899


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ||||+++ +|.+++.... ..+++.++..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++....
T Consensus        86 v~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            9999975 8888886533 46899999999999999999999   78899999999999999999999999999876433


Q ss_pred             CCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcC--Ccc-c
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG--KIG-D  705 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~--~~~-~  705 (767)
                      ..  .......++..|+|||.+.+ ..++.++|||||||++|||++|++||......+....   ........  ... .
T Consensus       161 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~  235 (309)
T cd07845         161 PA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL---IIQLLGTPNESIWPG  235 (309)
T ss_pred             cc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCCChhhchh
Confidence            21  11222345778999999865 5678999999999999999999999965443221111   11110000  000 0


Q ss_pred             c-----ccc-cccCC-------CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          706 I-----IDP-FLKGN-------APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       706 ~-----~d~-~l~~~-------~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      .     ... .+...       .....+.++.+++.+|++.||++|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0     000 00000       001135667899999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-34  Score=296.70  Aligned_cols=247  Identities=22%  Similarity=0.324  Sum_probs=207.9

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc--chhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      -|+..+.||+|.|..|-++++-=.|..||||++.+....  ..-.+.+|++.|+.++|||||+|+.+......+|||.|.
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            455666899999999999998777899999999765332  334588999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC-CCCcEEEeecCCcccCCCCCC
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld-~~~~~ki~DfGla~~~~~~~~  632 (767)
                      =++|+|++||.++.. .+.+....+++.||..|+.|+|   ...+|||||||+||.+- .-|-+||+|||++-.+..   
T Consensus        99 GD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P---  171 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP---  171 (864)
T ss_pred             cCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCC---
Confidence            999999999977653 5899999999999999999999   66799999999998775 567899999999864433   


Q ss_pred             ccccccccCCCcccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLT-EKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                      ....+..+|+..|.|||++.+..|+ ++.||||+||+||.|+||++||....+.+....               ++|  -
T Consensus       172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm---------------ImD--C  234 (864)
T KOG4717|consen  172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM---------------IMD--C  234 (864)
T ss_pred             cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh---------------hhc--c
Confidence            3344567899999999999998886 679999999999999999999977665443322               122  1


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      +...|...+.++.+||..||..||++|.+.++|+.
T Consensus       235 KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  235 KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            22356778889999999999999999999999874

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.1e-33  Score=307.93  Aligned_cols=269  Identities=22%  Similarity=0.275  Sum_probs=202.0

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecC-----Cc
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD-----GQ  546 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~-----~~  546 (767)
                      .++|...+.||+|+||+||++....+++.||||.+...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45788899999999999999999888899999998653  233345678899999999999999999988644     35


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      .++++||+. ++|.+++...  ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            899999996 6899888543  46999999999999999999999   78899999999999999999999999999875


Q ss_pred             CCCCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHH--------HH
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWAT--------EC  697 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~--------~~  697 (767)
                      .....  .......++..|+|||.+.. ..++.++|||||||++|||++|++||......+......-..        ..
T Consensus       158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            43221  12233457889999998865 568899999999999999999999996543211111000000        00


Q ss_pred             hhcCCccc-------cccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHh
Q 042216          698 YRNGKIGD-------IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG--LEFV  751 (767)
Q Consensus       698 ~~~~~~~~-------~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~--L~~~  751 (767)
                      .......+       ..+..+. ...+.++.++.+++.+||+.+|++|||++++++.  ++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            00000000       0000000 0112456778999999999999999999999966  5544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.5e-33  Score=305.91  Aligned_cols=264  Identities=22%  Similarity=0.246  Sum_probs=200.1

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecC------
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD------  544 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~------  544 (767)
                      ..++|+..+.||+|+||.||++....+++.||+|++...  ......++.+|+.++++++|+||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999999888899999998643  233345678899999999999999999988643      


Q ss_pred             CceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCc
Q 042216          545 GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC  624 (767)
Q Consensus       545 ~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla  624 (767)
                      ...++||||+.+ +|.+.+...    +++..+..++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||++
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence            357999999964 888887432    889999999999999999999   778999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHH---------HH--
Q 042216          625 KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLA---------VW--  693 (767)
Q Consensus       625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~---------~~--  693 (767)
                      +.....   .......++..|+|||.+.+..++.++|||||||++++|++|+.||...+........         .+  
T Consensus       166 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         166 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             eeCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            754321   1123345788999999999999999999999999999999999999654321110000         00  


Q ss_pred             -----HHHHhhcCC------ccccccccc----cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          694 -----ATECYRNGK------IGDIIDPFL----KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       694 -----~~~~~~~~~------~~~~~d~~l----~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                           .........      ..++....+    ....+.....++.+++.+||+.||.+|||+.|++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                 000000000      000110000    011122346678899999999999999999999843

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.2e-33  Score=307.19  Aligned_cols=268  Identities=19%  Similarity=0.260  Sum_probs=200.7

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeec----CCce
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCND----DGQM  547 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~----~~~~  547 (767)
                      ..+|+..+.||+|+||.||+|....+++.||+|++....  ......+.+|+.+|++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            367888899999999999999998888999999987542  2345567889999999999999999998753    3468


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      ++|+||+. |+|.+++...  ..+++..+..++.|++.||.|||   .++|+||||||+||++++++.+||+|||+++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            99999996 5899988543  45899999999999999999999   778999999999999999999999999998754


Q ss_pred             CCCCCc--cccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHH--------H
Q 042216          628 PNFSKT--HVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWAT--------E  696 (767)
Q Consensus       628 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~--------~  696 (767)
                      ......  .......++..|+|||.+.. ..++.++|||||||++|||++|+.||.............-..        .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            322111  11223468889999999865 568899999999999999999999996543321111100000        0


Q ss_pred             HhhcCCcccccccc-ccCC-----CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          697 CYRNGKIGDIIDPF-LKGN-----APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       697 ~~~~~~~~~~~d~~-l~~~-----~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      ......+.+.++.. ....     ..+..+.++.+++.+||+.+|.+||++.+++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            00000000000000 0000     112346779999999999999999999998863

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-33  Score=294.63  Aligned_cols=261  Identities=23%  Similarity=0.305  Sum_probs=196.0

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--cchhHHHHHHHHHhcc---ccceeeeEeeeeecCCc-----
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--QGALEFQTEIGMLSQL---RYLHLVSLIGYCNDDGQ-----  546 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l---~Hpniv~l~g~~~~~~~-----  546 (767)
                      |+..+.||+|+||.||+|+.+.+++.+|+|++.....  .....+.+|+.++.++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            4567789999999999999987788999999974422  2234566787777665   59999999999987776     


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      .+++|||+.+ +|.+++.......+++.+++.++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            9999999975 8999887654456999999999999999999999   77899999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCc---
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKI---  703 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~---  703 (767)
                      .....   ......++..|+|||.+.+..++.++|+|||||++|||++|++||......+  .+..+..........   
T Consensus       157 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  231 (287)
T cd07838         157 YSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEWP  231 (287)
T ss_pred             ccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhcC
Confidence            43221   1122347888999999998899999999999999999999999986543321  111111111000000   


Q ss_pred             ------ccccccccc---CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          704 ------GDIIDPFLK---GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       704 ------~~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                            .........   ....+.....+.+++.+||+.||.+||++.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                  000000000   0011223467789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.1e-33  Score=293.54  Aligned_cols=245  Identities=27%  Similarity=0.331  Sum_probs=197.2

Q ss_pred             eeccCcEEEEEEEecCCCceEEEEEeCCCCC---cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCCh
Q 042216          483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ---QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTL  559 (767)
Q Consensus       483 LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gsL  559 (767)
                      ||+|+||.||+++....++.+++|.+.....   .....+.+|++++++++|||++++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999987788999999865433   3456788999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC------c
Q 042216          560 RDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK------T  633 (767)
Q Consensus       560 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~------~  633 (767)
                      .+++.+..  .+++..+..++.|+++||.|||   ..+++|+||+|+||++++++.++|+|||++........      .
T Consensus        81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLENVG--SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            99996543  6899999999999999999999   78899999999999999999999999999875432211      1


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      .......++..|+|||.......+.++||||||++++||++|+.||......+      ..... ..+..          
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~-~~~~~----------  218 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IFQNI-LNGKI----------  218 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-hcCCc----------
Confidence            12233457889999999988889999999999999999999999996443211      11111 11110          


Q ss_pred             CCChh--hHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          714 NAPPV--CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       714 ~~~~~--~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                      ..+..  .+..+.+++.+||+.+|.+|||+.++.+.|+
T Consensus       219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            11112  2677899999999999999999966555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-33  Score=291.18  Aligned_cols=251  Identities=23%  Similarity=0.335  Sum_probs=199.9

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC-----CCcchhHHHHHHHHHhccccceeeeEeeeeecC--Cce
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-----SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD--GQM  547 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~-----~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~  547 (767)
                      .+|...+.||+|+||.||+|.....++.+|+|.+...     ..+....+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688888999999999999999888899999987432     223345788999999999999999999998654  468


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      ++++||+++++|.+++...  ..+++.....++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            8999999999999998643  34889999999999999999999   778999999999999999999999999998754


Q ss_pred             CCCCC-ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccc
Q 042216          628 PNFSK-THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI  706 (767)
Q Consensus       628 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  706 (767)
                      ..... ........++..|+|||++.+..++.++|+|||||+++||++|+.||........  .    ......      
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~~------  224 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--I----FKIATQ------  224 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--H----HHHHcC------
Confidence            32111 1111234588899999999988899999999999999999999999964422111  0    111111      


Q ss_pred             ccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          707 IDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       707 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                         ......+....+.+.+++.+||+ +|.+||+..+++.
T Consensus       225 ---~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         225 ---PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ---CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence               11122355566789999999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5e-33  Score=294.43  Aligned_cols=263  Identities=21%  Similarity=0.305  Sum_probs=198.2

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC-cchhHHHHHHHHHhccc-cceeeeEeeeeecCCceEEEEecC
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQLR-YLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      |...+.||+|++|+||+|+..+.++.|+||++..... .......+|+..+.+++ |+|++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            4566789999999999999987788999999865432 22334567999999999 999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                       +|+|.+++.......+++.++..++.|++.+|.|||   +++++|+||+|+||++++++.++|+|||+++......   
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---  153 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---  153 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence             789999987665457899999999999999999999   7789999999999999999999999999987543211   


Q ss_pred             ccccccCCCcccChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhH----------HHHHHHHhhcCCc
Q 042216          635 VSTQVKGSIGYLDPEYYR-LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL----------AVWATECYRNGKI  703 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l----------~~~~~~~~~~~~~  703 (767)
                      ......++..|+|||.+. ...++.++|+||||++++||++|++||......+...-          ..|..........
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence            122345788999999875 45688999999999999999999999855433211100          0011111000011


Q ss_pred             ccccccccc---CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          704 GDIIDPFLK---GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       704 ~~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ...+.....   ....+....++.+++.+||+.+|.+||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            000000000   0001112467899999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.9e-33  Score=297.20  Aligned_cols=244  Identities=20%  Similarity=0.331  Sum_probs=198.4

Q ss_pred             eeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCChh
Q 042216          481 LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLR  560 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gsL~  560 (767)
                      ..||+|+||.||++.....++.||||++..........+.+|+.+++.++|+|++++++++...+..+++|||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            46999999999999998888999999986555555667899999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcccccccc
Q 042216          561 DHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK  640 (767)
Q Consensus       561 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~  640 (767)
                      +++..   ..+++.....++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++.......  .......
T Consensus       106 ~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~  177 (292)
T cd06657         106 DIVTH---TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV  177 (292)
T ss_pred             HHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence            98743   24899999999999999999999   7789999999999999999999999999986543211  1223345


Q ss_pred             CCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhH
Q 042216          641 GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCL  720 (767)
Q Consensus       641 gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  720 (767)
                      ++..|+|||.+....++.++|+||||+++|||++|..||......+.   .........         +.+.  .....+
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~~~~~~~---------~~~~--~~~~~~  243 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRDNLP---------PKLK--NLHKVS  243 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhhCC---------cccC--CcccCC
Confidence            78999999999888899999999999999999999999864332211   111111100         0110  112345


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          721 NQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       721 ~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ..+.+++.+||+.+|.+||++.++++
T Consensus       244 ~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         244 PSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            56889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.5e-32  Score=288.86  Aligned_cols=251  Identities=21%  Similarity=0.238  Sum_probs=195.4

Q ss_pred             HHHHHHHhhccccceee--eccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc-ccceeeeEeeeeec
Q 042216          467 ISEIKEATKDFNNLLII--GRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGYCND  543 (767)
Q Consensus       467 ~~ei~~~t~~f~~~~~L--G~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~  543 (767)
                      ..++....++|...+.+  |+|+||.||++..+.++..+|+|.+.......     .|+.....+ +|||++++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence            34445555677776666  99999999999998888899999986432211     122222222 69999999999999


Q ss_pred             CCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC-cEEEeecC
Q 042216          544 DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW-VAKVSDFG  622 (767)
Q Consensus       544 ~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~-~~ki~DfG  622 (767)
                      .+..++||||+++|+|.+++....  .+++.++..++.|+++||.|||   +.+++||||||+||+++.++ .++|+|||
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence            999999999999999999996543  7999999999999999999999   77899999999999999988 99999999


Q ss_pred             CcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC
Q 042216          623 LCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK  702 (767)
Q Consensus       623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~  702 (767)
                      +++....      .....++..|+|||++.+..++.++|||||||+++||++|+.||...... ......+....  .. 
T Consensus       156 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~--~~-  225 (267)
T PHA03390        156 LCKIIGT------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ--QK-  225 (267)
T ss_pred             cceecCC------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh--cc-
Confidence            9875322      12235789999999999889999999999999999999999999744322 12222222211  00 


Q ss_pred             ccccccccccCCCChhhHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 042216          703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPS-MSDVVW  746 (767)
Q Consensus       703 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs-~~evl~  746 (767)
                               ....+...+..+.+++.+||+.+|.+||+ ++|+++
T Consensus       226 ---------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        226 ---------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ---------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                     00112245677899999999999999995 688873

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=9.8e-33  Score=294.42  Aligned_cols=257  Identities=16%  Similarity=0.187  Sum_probs=186.7

Q ss_pred             hccccceeeeccCcEEEEEEEecCC---CceEEEEEeCCCCCcchh-----------HHHHHHHHHhccccceeeeEeee
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGD---STPVAIKRLNPGSQQGAL-----------EFQTEIGMLSQLRYLHLVSLIGY  540 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~vAVK~l~~~~~~~~~-----------~f~~Ei~~l~~l~Hpniv~l~g~  540 (767)
                      ++|...++||+|+||.||+|...++   ...+|+|...........           ....+...+..+.|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5788889999999999999998766   556777764332221111           12233445566789999999997


Q ss_pred             eecCC----ceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcE
Q 042216          541 CNDDG----QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVA  616 (767)
Q Consensus       541 ~~~~~----~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~  616 (767)
                      +....    ..++++|++.. ++.+.+...  ...++..+..|+.|++.||.|||   +.+|+||||||+|||++.++.+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcE
Confidence            75443    34677777644 666665432  23578889999999999999999   7889999999999999999999


Q ss_pred             EEeecCCcccCCCCCC-----ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccch-hH
Q 042216          617 KVSDFGLCKFGPNFSK-----THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQV-NL  690 (767)
Q Consensus       617 ki~DfGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~-~l  690 (767)
                      +|+|||+++.......     ........||+.|+|||+..+..++.++|||||||+++||++|+.||......... ..
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            9999999975422111     01122346999999999999999999999999999999999999999765332211 10


Q ss_pred             --HHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          691 --AVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       691 --~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                        .++... ...+.        +   ....++..+.+++..|++.+|++||++.++++.|+
T Consensus       246 ~~~~~~~~-~~~~~--------~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        246 AKCDFIKR-LHEGK--------I---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             hHHHHHHH-hhhhh--------h---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence              111111 11111        0   12335678999999999999999999999998763

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-33  Score=305.72  Aligned_cols=267  Identities=21%  Similarity=0.293  Sum_probs=197.5

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecC------C
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD------G  545 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~------~  545 (767)
                      ..+|...+.||+|+||.||+|+...+++.||||++...  .......+.+|+.+++.++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            37899999999999999999998877889999998643  222345688999999999999999999998654      2


Q ss_pred             ceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcc
Q 042216          546 QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK  625 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~  625 (767)
                      ..++|+||+.. +|.+++    ...+++..+..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++
T Consensus        94 ~~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             eEEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            46999999975 777665    235899999999999999999999   7789999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHH--------HH
Q 042216          626 FGPNFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWA--------TE  696 (767)
Q Consensus       626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~--------~~  696 (767)
                      ....     ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...............        ..
T Consensus       166 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         166 HADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            5322     1123457888999999876 46889999999999999999999999654321111000000        00


Q ss_pred             HhhcCCccccccc---cccCC---CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHhHh
Q 042216          697 CYRNGKIGDIIDP---FLKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG--LEFVFQ  753 (767)
Q Consensus       697 ~~~~~~~~~~~d~---~l~~~---~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~--L~~~~~  753 (767)
                      ...........+.   .....   ..+....++.+++.+||+.||.+||++.+++..  ++...+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            0000000000000   00000   011245668899999999999999999999943  655543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-33  Score=290.58  Aligned_cols=244  Identities=23%  Similarity=0.282  Sum_probs=190.5

Q ss_pred             eeeeccCcEEEEEEEecCCCceEEEEEeCCCCC---cchhHHHHHHHHH-hccccceeeeEeeeeecCCceEEEEecCCC
Q 042216          481 LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ---QGALEFQTEIGML-SQLRYLHLVSLIGYCNDDGQMILVYDYMAR  556 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l-~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~  556 (767)
                      +.||+|+||.||+|.....++.||+|.+.....   .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            368999999999999988788999999865421   2223345555444 455899999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcccc
Q 042216          557 GTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVS  636 (767)
Q Consensus       557 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~  636 (767)
                      ++|.+++...  ..+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||+++....      .
T Consensus        82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~  150 (260)
T cd05611          82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N  150 (260)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence            9999999653  35899999999999999999999   77899999999999999999999999999875322      2


Q ss_pred             ccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCC
Q 042216          637 TQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP  716 (767)
Q Consensus       637 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  716 (767)
                      ....++..|+|||.+.+..++.++||||||++++||++|..||.......   ..    .....+...      ......
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~~~~~------~~~~~~  217 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VF----DNILSRRIN------WPEEVK  217 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HH----HHHHhcccC------CCCccc
Confidence            23457889999999988889999999999999999999999996443221   10    111111100      011122


Q ss_pred             hhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042216          717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGL  748 (767)
Q Consensus       717 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L  748 (767)
                      ..++..+.+++.+||+.+|.+||++.++.+.|
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            24567899999999999999999776554433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=276.53  Aligned_cols=250  Identities=23%  Similarity=0.364  Sum_probs=197.1

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCC-CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEEEecC
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      .+.+..||.|+.|.|++...+..+..+|||.+... +..+.+++++.+.++.+- .+|.||+.+||+..+...++.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            34455799999999999999998999999999765 445566777788776655 4899999999999999999999998


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      .. .+..+|++- .+++++.-+-++...+++||.||.+  .++|+|||+||+|||+|+.|++|+||||++-..-   ...
T Consensus       174 s~-C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv---dSk  246 (391)
T KOG0983|consen  174 ST-CAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV---DSK  246 (391)
T ss_pred             HH-HHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceee---ccc
Confidence            54 566665543 3568999899999999999999997  7899999999999999999999999999986432   233


Q ss_pred             ccccccCCCcccChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          635 VSTQVKGSIGYLDPEYYRL---QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                      ..+...|.+.|||||.+.-   ..|+.++||||||+.|+||.||+.||..-..+ -..+...+    .+ .     -|.|
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-Fe~ltkvl----n~-e-----PP~L  315 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-FEVLTKVL----NE-E-----PPLL  315 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-HHHHHHHH----hc-C-----CCCC
Confidence            4456678999999999863   47889999999999999999999999653321 11111111    11 1     1223


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .+.  ...+..+++++..||++|+.+||...++++
T Consensus       316 ~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  316 PGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             Ccc--cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            221  226778999999999999999999999885

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=9.6e-33  Score=294.69  Aligned_cols=253  Identities=25%  Similarity=0.368  Sum_probs=195.1

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccc-cceeeeEeeeeecCCceEEEEe
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLR-YLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ++|...+.||+|+||.||+|.....++.||||+++... .....++..|+.++.+++ |+||++++++|.+....+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            46778889999999999999998777899999987543 233456777887777765 9999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+.+ +|.+++.... ..+++..+..++.|++.||+|||+  .++|+||||+|+||++++++.+||+|||++......  
T Consensus        95 ~~~~-~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~--  168 (296)
T cd06618          95 LMST-CLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS--  168 (296)
T ss_pred             ccCc-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCC--
Confidence            9854 7777664433 379999999999999999999994  358999999999999999999999999998754321  


Q ss_pred             ccccccccCCCcccChhhhccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQL----LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                       .......++..|+|||.+....    ++.++||||||+++|||++|+.||......     .+........ ....   
T Consensus       169 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~-~~~~---  238 (296)
T cd06618         169 -KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQE-EPPS---  238 (296)
T ss_pred             -CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcC-CCCC---
Confidence             1122335778999999987553    788999999999999999999998542211     0111111111 1000   


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                        +  .....++.++.+++.+||+.||.+||++.++++.
T Consensus       239 --~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         239 --L--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             --C--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              0  1111356779999999999999999999999854

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.6e-32  Score=290.41  Aligned_cols=243  Identities=23%  Similarity=0.289  Sum_probs=189.8

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCCCC---cchhHHHHHHH---HHhccccceeeeEeeeeecCCceEEEEecCC
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ---QGALEFQTEIG---MLSQLRYLHLVSLIGYCNDDGQMILVYDYMA  555 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~---~~~~~f~~Ei~---~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~  555 (767)
                      +||+|+||.||++.....++.||+|.+.....   .....+..|..   +++...|||++.+.+++.+.+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999999987788999999865421   11222444443   3444579999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccc
Q 042216          556 RGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHV  635 (767)
Q Consensus       556 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~  635 (767)
                      +|+|.+++...  ..+++..+..++.|+++||.|||   +.+++||||||+||+++.++.+||+|||+++.....    .
T Consensus        81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~  151 (278)
T cd05606          81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K  151 (278)
T ss_pred             CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----C
Confidence            99999988543  46999999999999999999999   778999999999999999999999999998743221    1


Q ss_pred             cccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCC
Q 042216          636 STQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN  714 (767)
Q Consensus       636 ~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  714 (767)
                      .....|+..|+|||.+..+ .++.++||||+||++|||++|+.||............    .....          ....
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~----------~~~~  217 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLT----------MAVE  217 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHhhc----------cCCC
Confidence            1234689999999998754 6899999999999999999999999654322111110    00000          1112


Q ss_pred             CChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042216          715 APPVCLNQFVEVAMSCVNDDRIRRP-----SMSDVVWG  747 (767)
Q Consensus       715 ~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~  747 (767)
                      .+...+.++.+++.+|+..+|.+||     ++.++++.
T Consensus       218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            2334567899999999999999999     99999853

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1e-32  Score=297.04  Aligned_cols=256  Identities=23%  Similarity=0.224  Sum_probs=190.1

Q ss_pred             CcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCChhhhhc
Q 042216          487 GFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY  564 (767)
Q Consensus       487 ~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gsL~~~L~  564 (767)
                      ++|.||.++...+++.||||++...  .......+.+|+++++.++|+||+++++++.+.+..+++|||+++|+|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            4455555555556689999998754  34455679999999999999999999999999999999999999999999997


Q ss_pred             cCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC-----ccccccc
Q 042216          565 NNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK-----THVSTQV  639 (767)
Q Consensus       565 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~-----~~~~~~~  639 (767)
                      ......+++.....++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||.+........     .......
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~  168 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS  168 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccc
Confidence            665556899999999999999999999   77899999999999999999999999998864322111     1111234


Q ss_pred             cCCCcccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhh-----------cCCccc-
Q 042216          640 KGSIGYLDPEYYRL--QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR-----------NGKIGD-  705 (767)
Q Consensus       640 ~gt~~y~aPE~~~~--~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~-----------~~~~~~-  705 (767)
                      .++..|+|||++..  ..++.++|||||||++|||++|+.||.......  .+.+.......           ...... 
T Consensus       169 ~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
T cd08216         169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQS  246 (314)
T ss_pred             cccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCcc
Confidence            56788999999876  358899999999999999999999996543221  11111000000           000000 


Q ss_pred             ---cccccc----cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          706 ---IIDPFL----KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       706 ---~~d~~l----~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                         ..++..    ..........++.+++.+||+.||++|||+.++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence               000000    011122345678899999999999999999999964

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.3e-32  Score=295.59  Aligned_cols=247  Identities=27%  Similarity=0.356  Sum_probs=196.9

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      .|+..+.||+|+||.||+|....++..+|+|.+...   ......++.+|+++++.++|+|++++.+++......++|+|
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            366667899999999999999888889999998643   22334568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+. |+|.+++.... ..+++.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.....   
T Consensus        96 ~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---  167 (308)
T cd06634          96 YCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  167 (308)
T ss_pred             ccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC---
Confidence            997 68888775433 45899999999999999999999   77899999999999999999999999999875432   


Q ss_pred             ccccccccCCCcccChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYR---LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                         .....++..|+|||.+.   ...++.++|||||||++|||++|+.|+......+..      .. ...+...     
T Consensus       168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~-~~~~~~~-----  232 (308)
T cd06634         168 ---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YH-IAQNESP-----  232 (308)
T ss_pred             ---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH------HH-HhhcCCC-----
Confidence               12345788999999974   356888999999999999999999998554321111      11 1111110     


Q ss_pred             cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042216          710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGL  748 (767)
Q Consensus       710 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L  748 (767)
                         ......+...+.+++.+||+.+|.+||++.++++..
T Consensus       233 ---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         233 ---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             ---CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence               011224556788999999999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-33  Score=302.92  Aligned_cols=272  Identities=22%  Similarity=0.257  Sum_probs=203.6

Q ss_pred             cccCHHHHHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeee
Q 042216          463 TQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGY  540 (767)
Q Consensus       463 ~~~~~~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~  540 (767)
                      ++....++...+++|...+.||+|+||.||+|....+++.||+|++....  ....+.+.+|++++.+++||||++++++
T Consensus         5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~   84 (345)
T cd07877           5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV   84 (345)
T ss_pred             hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence            34556677888899999999999999999999988778899999987532  2234568889999999999999999998


Q ss_pred             eecC------CceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC
Q 042216          541 CNDD------GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW  614 (767)
Q Consensus       541 ~~~~------~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~  614 (767)
                      +...      ...+++++++ +++|.+++..   ..+++..+..++.|+++||+|||   +.+|+||||||+||++++++
T Consensus        85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~  157 (345)
T cd07877          85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             eeecccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCC
Confidence            7533      3467888877 6799888743   24899999999999999999999   78899999999999999999


Q ss_pred             cEEEeecCCcccCCCCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHH
Q 042216          615 VAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVW  693 (767)
Q Consensus       615 ~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~  693 (767)
                      .+||+|||+++....     ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..............
T Consensus       158 ~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (345)
T cd07877         158 ELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  232 (345)
T ss_pred             CEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999875322     1233457889999998866 5688999999999999999999999954432211110000


Q ss_pred             --------HHHHhhcCC-------ccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          694 --------ATECYRNGK-------IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       694 --------~~~~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                              ....+....       +........ .........++.+++.+|++.||.+||++.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HhCCCCHHHHhhcccHhHHHHHHHhcccCCcch-hhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                    000000000       000000000 00011235678899999999999999999999854

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.6e-33  Score=316.43  Aligned_cols=269  Identities=19%  Similarity=0.219  Sum_probs=188.8

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCc-eEEEE------------------EeCCCCCcchhHHHHHHHHHhccccce
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDST-PVAIK------------------RLNPGSQQGALEFQTEIGMLSQLRYLH  533 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~-~vAVK------------------~l~~~~~~~~~~f~~Ei~~l~~l~Hpn  533 (767)
                      ...+|...+.||+|+||+||++..+.... ..++|                  .+. ........+.+|+++|.+++|||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            45789999999999999999987643221 11111                  111 11223456889999999999999


Q ss_pred             eeeEeeeeecCCceEEEEecCCCCChhhhhccCC---CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE
Q 042216          534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNND---NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL  610 (767)
Q Consensus       534 iv~l~g~~~~~~~~~lV~ey~~~gsL~~~L~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl  610 (767)
                      |+++++++...+..++|+|++. ++|.+++....   .......+...++.|++.||.|||   +++|+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence            9999999999999999999985 47877775432   122345667789999999999999   7889999999999999


Q ss_pred             CCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCCccchh
Q 042216          611 DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP-ILRTGDKKQVN  689 (767)
Q Consensus       611 d~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P-~~~~~~~~~~~  689 (767)
                      +.++.+||+|||+++...... ........||..|+|||++.+..++.++|||||||++|||++|..+ +..........
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            999999999999998653321 1122345799999999999999999999999999999999998754 43322221122


Q ss_pred             HHHHHHHHh-hcCCc-------ccccccc-cc---CCC-----ChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          690 LAVWATECY-RNGKI-------GDIIDPF-LK---GNA-----PPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       690 l~~~~~~~~-~~~~~-------~~~~d~~-l~---~~~-----~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      +.......- .....       .+.++.. +.   ...     .......+.+++.+||+.||.+|||+.|++..
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            222111100 00000       0000000 00   000     01123457788999999999999999999853

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=5.9e-33  Score=293.00  Aligned_cols=250  Identities=24%  Similarity=0.317  Sum_probs=203.5

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccc-cceeeeEeeeeecCCceEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLR-YLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV  550 (767)
                      ++|...+.||+|+||.||+++...+++.+|+|++...   .......+.+|++++.+++ |+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            3678888999999999999999888899999998653   2233456889999999998 99999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+++++|.+++.+.  ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            9999999999999654  36999999999999999999999   788999999999999999999999999998754322


Q ss_pred             CCc------------------cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHH
Q 042216          631 SKT------------------HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAV  692 (767)
Q Consensus       631 ~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~  692 (767)
                      ...                  .......++..|+|||......++.++||||||++++|+++|+.||.......   ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~  232 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---TFQ  232 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---HHH
Confidence            210                  11223457889999999988889999999999999999999999996554211   111


Q ss_pred             HHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 042216          693 WATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSM----SDVVW  746 (767)
Q Consensus       693 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~----~evl~  746 (767)
                         ... .          .....+...++.+.+++.+||+.+|.+||++    ++++.
T Consensus       233 ---~~~-~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         233 ---KIL-K----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ---HHH-h----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence               000 0          1122334446778999999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.5e-32  Score=298.65  Aligned_cols=262  Identities=19%  Similarity=0.233  Sum_probs=196.5

Q ss_pred             hcccc-ceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcc--------------hhHHHHHHHHHhccccceeeeEee
Q 042216          475 KDFNN-LLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQG--------------ALEFQTEIGMLSQLRYLHLVSLIG  539 (767)
Q Consensus       475 ~~f~~-~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~--------------~~~f~~Ei~~l~~l~Hpniv~l~g  539 (767)
                      ++|.. .+.||+|+||.||+|.....++.||||++.......              ...+.+|+++++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            34443 356999999999999988788999999986442211              124778999999999999999999


Q ss_pred             eeecCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 042216          540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVS  619 (767)
Q Consensus       540 ~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~  619 (767)
                      ++..++..++||||+. |+|.+++...  ..+++.....++.|++.||.|||   +.+++|+||||+||+++.++.+||+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEEC
Confidence            9999999999999997 5999998543  45899999999999999999999   7889999999999999999999999


Q ss_pred             ecCCcccCCCCC------------CccccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCcc
Q 042216          620 DFGLCKFGPNFS------------KTHVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKK  686 (767)
Q Consensus       620 DfGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~  686 (767)
                      |||+++......            .........++..|+|||.+.+. .++.++|||||||++|||++|++||......+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999987543100            01111223467889999998764 47899999999999999999999996554322


Q ss_pred             chhHHHHHHHHhhcCCcc---cc------------ccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          687 QVNLAVWATECYRNGKIG---DI------------IDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       687 ~~~l~~~~~~~~~~~~~~---~~------------~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .   ..............   ..            ..+... .....++.++.+++.+||+.+|++||+++|++.
T Consensus       242 ~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        242 Q---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             H---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            1   11111111110000   00            000000 011234567899999999999999999999985

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.3e-32  Score=293.04  Aligned_cols=245  Identities=26%  Similarity=0.369  Sum_probs=195.0

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC---cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ---QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      |...+.||+|+||+||+|+...+++.+++|++.....   .....+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            5556679999999999999988889999999864322   2335688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +. |+|.+++.... .++++.++..++.|++.+|.|||   +.+++|+||+|+||++++++.+||+|||++.....    
T Consensus       103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----  173 (313)
T cd06633         103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----  173 (313)
T ss_pred             CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence            96 58888775433 46899999999999999999999   77899999999999999999999999999864221    


Q ss_pred             cccccccCCCcccChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYR---LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                        .....|+..|+|||++.   ...++.++|||||||++|||++|..|+.........      ...... ....     
T Consensus       174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~-~~~~-----  239 (313)
T cd06633         174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQN-DSPT-----  239 (313)
T ss_pred             --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhc-CCCC-----
Confidence              12345788999999984   456889999999999999999999998654321111      111111 1111     


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                         ......+..+.+++.+||+.+|.+||++.+++..
T Consensus       240 ---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         240 ---LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               1112234568899999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.4e-33  Score=301.33  Aligned_cols=268  Identities=23%  Similarity=0.289  Sum_probs=204.4

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCC-----ceE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG-----QMI  548 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~-----~~~  548 (767)
                      +|...+.||+|++|.||+|+....++.+|||++....  ....+.+.+|+++++.++|+||+++.+++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4677789999999999999998778899999987643  344567899999999999999999999987765     789


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      ++|||+++ +|.+++.+.  ..+++..+..++.+++.||.|||   +.+|+|+||||+|||++.++.++|+|||++....
T Consensus        81 lv~e~~~~-~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELMET-DLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchhh-hHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            99999984 899888543  37999999999999999999999   7889999999999999999999999999988643


Q ss_pred             CCCCc-cccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhc------
Q 042216          629 NFSKT-HVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRN------  700 (767)
Q Consensus       629 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~------  700 (767)
                      ..... .......++..|+|||.+.+. .++.++|+||||+++++|++|++||......+....   .......      
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~  231 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL---IVEVLGTPSEEDL  231 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHH---HHHhcCCCChhHh
Confidence            32210 112234578889999999887 899999999999999999999999966543221111   0110000      


Q ss_pred             -----CCcccccccc-c-----cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHhH
Q 042216          701 -----GKIGDIIDPF-L-----KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG--LEFVF  752 (767)
Q Consensus       701 -----~~~~~~~d~~-l-----~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~--L~~~~  752 (767)
                           ....+.+... .     .....+..+..+.+++.+||+.+|.+||++.+++..  ++...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence                 0000000000 0     000112245678999999999999999999999974  44443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.2e-32  Score=296.30  Aligned_cols=265  Identities=22%  Similarity=0.251  Sum_probs=199.9

Q ss_pred             HHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeec-CCc
Q 042216          470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCND-DGQ  546 (767)
Q Consensus       470 i~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~-~~~  546 (767)
                      +...+++|+..+.||+|+||.||++....+++.||+|++...  .....+.+.+|++++.+++|||++++.+++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            345678899999999999999999999888899999988643  22334568899999999999999999998865 567


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      .++++||+. ++|.+++..   .++++.....++.|+++||.|||   +.+|+|+||+|+|||+++++.+||+|||+++.
T Consensus        85 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          85 IYFVTELLG-TDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEEeehhc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence            899999994 589888753   34788889999999999999999   78899999999999999999999999999874


Q ss_pred             CCCCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccch-hHHH--------HHHH
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQV-NLAV--------WATE  696 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~-~l~~--------~~~~  696 (767)
                      ...     ......++..|+|||.+.+ ..++.++|||||||+++||++|+.||......... .+.+        +...
T Consensus       158 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         158 QDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             cCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            322     1123356788999998765 57899999999999999999999999544321100 0000        0000


Q ss_pred             HhhcCCccccccc-cccCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          697 CYRNGKIGDIIDP-FLKGNAP-----PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       697 ~~~~~~~~~~~d~-~l~~~~~-----~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      .. .....+++.. ......+     +....++.+++.+||+.+|++||++.+++..
T Consensus       233 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 IC-SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             cc-chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00 0000000000 0001111     2245788999999999999999999999754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=282.08  Aligned_cols=242  Identities=28%  Similarity=0.353  Sum_probs=203.0

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchh---HHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGAL---EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~---~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      .++|+.+++||+|.||+|-+++-+..++.+|+|++++..-....   --..|-++|+..+||.+..|--.+...+.+++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            46899999999999999999999999999999999876333333   346789999999999999998888999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||..+|.|.-||.+.  ..+++....-.-..|+.||.|||   +++||.||||.+|.|+|.+|.+||+|||||+..-  
T Consensus       247 MeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--  319 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--  319 (516)
T ss_pred             EEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcc--
Confidence            9999999999999654  34777777778889999999999   7889999999999999999999999999998643  


Q ss_pred             CCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                      .........+||+.|+|||++....|....|.|.+||++|||+||+.||...+.+.--.|+.  .+        +     
T Consensus       320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl--~e--------d-----  384 (516)
T KOG0690|consen  320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL--ME--------D-----  384 (516)
T ss_pred             cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH--hh--------h-----
Confidence            33445667899999999999999999999999999999999999999997665432111111  00        0     


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCC
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRP  739 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RP  739 (767)
                        -.+|...+.+...|+...|..||.+|.
T Consensus       385 --~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  385 --LKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             --ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence              124555667788899999999999996

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-32  Score=289.69  Aligned_cols=259  Identities=22%  Similarity=0.290  Sum_probs=199.0

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      |+..+.||+|++|.||+|+....++.+|+|.+....  ......+..|++++++++|+|++++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            345568999999999999998888999999997653  333456889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      + ++|.+++.+.. ..+++.++..++.+++.||.|||   ..+|+|+||+|+||++++++.+||+|||+++.......  
T Consensus        81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--  153 (282)
T cd07829          81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--  153 (282)
T ss_pred             C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence            8 59999997643 35899999999999999999999   67899999999999999999999999999875432211  


Q ss_pred             ccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhh--------------
Q 042216          635 VSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR--------------  699 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~--------------  699 (767)
                      ......++..|+|||.+... .++.++|||||||+++||++|++||......+.   .........              
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhcccc
Confidence            12233456789999998766 889999999999999999999999865432211   111111000              


Q ss_pred             --cCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          700 --NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       700 --~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                        ............... .+.....+.+++.+||+.+|++||++.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         231 DYKPTFPKFPPKDLEKV-LPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccccCccchHHh-cccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence              000000000000001 1122567899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.7e-32  Score=289.87  Aligned_cols=257  Identities=25%  Similarity=0.287  Sum_probs=200.7

Q ss_pred             ccccceeeeccCcEEEEEEEec---CCCceEEEEEeCCCC----CcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCce
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLN---GDSTPVAIKRLNPGS----QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQM  547 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~---~~~~~vAVK~l~~~~----~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~  547 (767)
                      +|+..+.||+|++|.||+++..   ..++.+|||.+....    ......+.+|++++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3667789999999999999864   245789999986432    22345688999999999 599999999999989999


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      ++||||+++|+|.+++...  ..+++..+..++.|+++||.|||   ..+++|+||||+||+++.++.++|+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            9999999999999998643  35889999999999999999999   788999999999999999999999999998754


Q ss_pred             CCCCCccccccccCCCcccChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccc
Q 042216          628 PNFSKTHVSTQVKGSIGYLDPEYYRLQL--LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD  705 (767)
Q Consensus       628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  705 (767)
                      .... ........++..|+|||.+.+..  .+.++||||||++++||++|..||......  .............     
T Consensus       156 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~-----  227 (288)
T cd05583         156 LAEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKS-----  227 (288)
T ss_pred             cccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHcc-----
Confidence            3221 11122345788999999987654  788999999999999999999998543221  1111111111111     


Q ss_pred             cccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       706 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                            ....+......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus       228 ------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         228 ------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             ------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence                  1122334556788999999999999999998887776543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.8e-32  Score=294.16  Aligned_cols=265  Identities=24%  Similarity=0.306  Sum_probs=195.9

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--cchhHHHHHHHHHhccccceeeeEeeeeecC-------
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--QGALEFQTEIGMLSQLRYLHLVSLIGYCNDD-------  544 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~-------  544 (767)
                      .++|...+.||+|+||.||+|+...+++.+|+|++.....  .....+.+|++++++++||||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4689999999999999999999988888999998864422  2234578899999999999999999987543       


Q ss_pred             -CceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCC
Q 042216          545 -GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL  623 (767)
Q Consensus       545 -~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGl  623 (767)
                       ..+++|+||+.. +|...+... ...+++.++..++.|+++||.|||   +.+|+|+||||+|||+++++.+||+|||+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence             346999999975 777776543 346999999999999999999999   78899999999999999999999999999


Q ss_pred             cccCCCCCCc---------cccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHH
Q 042216          624 CKFGPNFSKT---------HVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVW  693 (767)
Q Consensus       624 a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~  693 (767)
                      ++........         ...+...++..|+|||.+.+ ..++.++|||||||++|||++|++||...........   
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~---  238 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL---  238 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---
Confidence            8754322111         11123356788999998765 4588999999999999999999999965433211111   


Q ss_pred             HHHHhhc---------CCccccccccccCCCC-------hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          694 ATECYRN---------GKIGDIIDPFLKGNAP-------PVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       694 ~~~~~~~---------~~~~~~~d~~l~~~~~-------~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .......         ..+....+.......+       ......+.+++.+||+.||.+|||+.|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            1110000         0000000000000011       122356889999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.7e-32  Score=285.17  Aligned_cols=249  Identities=22%  Similarity=0.329  Sum_probs=196.1

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC-----CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-----SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~-----~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      +|...+.||+|+||.||++.....+..+++|.++..     ......++..|+.++++++|||++++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            366677899999999999988766556666665432     222344577899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcc--CCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          551 YDYMARGTLRDHLYN--NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      +||+++++|.+++..  .....+++.+++.++.|++.||.|||   +.+++|+||||+||++++ +.+||+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998864  23456999999999999999999999   788999999999999986 469999999987543


Q ss_pred             CCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          629 NFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      ..  ........++..|+|||.+....++.++|+||||+++|+|++|+.||.....      ....... ..+.      
T Consensus       157 ~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~-~~~~------  221 (260)
T cd08222         157 GS--CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRI-VEGP------  221 (260)
T ss_pred             CC--cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHH-HcCC------
Confidence            21  1122334578899999999888899999999999999999999999853321      1111111 1111      


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                         ....+..++.++.+++.+||+.+|++||++.|+++
T Consensus       222 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         222 ---TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ---CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence               11123455678899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=282.29  Aligned_cols=254  Identities=25%  Similarity=0.318  Sum_probs=198.7

Q ss_pred             ccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC-cchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEEEecCC
Q 042216          478 NNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILVYDYMA  555 (767)
Q Consensus       478 ~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~ey~~  555 (767)
                      +.+..||.|.||+|+|-.++..++.+|||+++.... .+.++++.|.+...+- ++||||+++|.+..++..|+.||.|+
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd  146 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD  146 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence            344579999999999999999999999999986643 5566788898766655 79999999999999999999999997


Q ss_pred             CCChhhhh---ccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          556 RGTLRDHL---YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       556 ~gsL~~~L---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      - ||+.+.   +...+..+++.-+-+|....+.||.||-+  ...|||||+||+|||+|..|.+||||||++-...   .
T Consensus       147 ~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv---~  220 (361)
T KOG1006|consen  147 I-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV---D  220 (361)
T ss_pred             h-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHH---H
Confidence            6 776554   33345568899889999999999999997  6789999999999999999999999999986432   2


Q ss_pred             ccccccccCCCcccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRL--QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                      +...+.-.|...|||||.+..  ..|+.+|||||+|++|+|+.||+.|+..-..     ..+.+.. +..|....+.   
T Consensus       221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~-Vv~gdpp~l~---  291 (361)
T KOG1006|consen  221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQ-VVIGDPPILL---  291 (361)
T ss_pred             HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHH-HHcCCCCeec---
Confidence            333455678889999999863  3589999999999999999999999954322     1111111 1222222111   


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                       ...........++.++..|+.+|..+||+..+++++
T Consensus       292 -~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  292 -FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             -CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence             111123456789999999999999999999998854

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-32  Score=301.87  Aligned_cols=270  Identities=26%  Similarity=0.351  Sum_probs=199.4

Q ss_pred             ccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecC------CceEEE
Q 042216          478 NNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD------GQMILV  550 (767)
Q Consensus       478 ~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~------~~~~lV  550 (767)
                      ...+.||+|+||.||+|+++..|..||||..+... ....+...+|+++|++|+|+|||++++.-++.      ....+|
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv   95 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV   95 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence            33447999999999999999999999999997653 34455678999999999999999999986544      367899


Q ss_pred             EecCCCCChhhhhccCC-CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC--C--CCcEEEeecCCcc
Q 042216          551 YDYMARGTLRDHLYNND-NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD--E--EWVAKVSDFGLCK  625 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld--~--~~~~ki~DfGla~  625 (767)
                      ||||.+|||+..|.+.. ...|++.+.+.+..+++.||.|||   .++|+||||||.||++-  +  ....||+|||.|+
T Consensus        96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            99999999999997643 457999999999999999999999   78899999999999983  3  3356999999999


Q ss_pred             cCCCCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc
Q 042216          626 FGPNFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG  704 (767)
Q Consensus       626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  704 (767)
                      ..+...   ..+...||..|++||.+.. +.|+...|.|||||++||++||..||..........-..|..-.-....+.
T Consensus       173 el~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~  249 (732)
T KOG4250|consen  173 ELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA  249 (732)
T ss_pred             cCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence            765432   4567789999999999984 889999999999999999999999996654432211122222111111111


Q ss_pred             ccccccccCC------CC------hhhHHHHHHHHHHccccCCCCCC--CHHHHHHHHHHhHh
Q 042216          705 DIIDPFLKGN------AP------PVCLNQFVEVAMSCVNDDRIRRP--SMSDVVWGLEFVFQ  753 (767)
Q Consensus       705 ~~~d~~l~~~------~~------~~~~~~l~~li~~Cl~~dp~~RP--s~~evl~~L~~~~~  753 (767)
                      -..++...++      .|      ......+-..+..++..+|++|-  ...+.-..+..++.
T Consensus       250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence            1112211111      11      12233445566666667777776  55555555555543

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.4e-32  Score=299.63  Aligned_cols=265  Identities=19%  Similarity=0.251  Sum_probs=195.7

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecC----------
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD----------  544 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~----------  544 (767)
                      .+|...+.||.|+||.||+|.....++.||+|++........+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            5788889999999999999999888899999998766556667789999999999999999999876543          


Q ss_pred             ----CceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC-CCCcEEEe
Q 042216          545 ----GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD-EEWVAKVS  619 (767)
Q Consensus       545 ----~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld-~~~~~ki~  619 (767)
                          ...++|+||++ ++|.+++..   ..+++.....++.|++.||.|||   +.+|+||||||+||+++ +++.+||+
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence                35789999997 589888743   25889999999999999999999   77899999999999997 56678999


Q ss_pred             ecCCcccCCCCCCc-cccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHH--
Q 042216          620 DFGLCKFGPNFSKT-HVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWAT--  695 (767)
Q Consensus       620 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~--  695 (767)
                      |||+++........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+.........  
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99998754221111 11123357889999998754 568889999999999999999999996543321111100000  


Q ss_pred             ------HHhhcCCccccccccccC-----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          696 ------ECYRNGKIGDIIDPFLKG-----NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       696 ------~~~~~~~~~~~~d~~l~~-----~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                            ..................     ...+....++.+++.+||+.||.+|||+.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                  000000000000000000     001224567889999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=6.7e-32  Score=287.17  Aligned_cols=252  Identities=24%  Similarity=0.286  Sum_probs=196.7

Q ss_pred             ccccceeeeccCcEEEEEEEec---CCCceEEEEEeCCCC----CcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCce
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLN---GDSTPVAIKRLNPGS----QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQM  547 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~---~~~~~vAVK~l~~~~----~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~  547 (767)
                      +|+..+.||+|+||.||++...   .++..||+|++....    ....+.+.+|++++.++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            3667789999999999999874   246789999986532    22345678899999999 589999999999988999


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      ++|+||+++++|.+++...  ..+++..+..++.|++.||.|||   +.+++||||||+|||+++++.+||+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            9999999999999999654  45889999999999999999999   788999999999999999999999999998754


Q ss_pred             CCCCCccccccccCCCcccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccc
Q 042216          628 PNFSKTHVSTQVKGSIGYLDPEYYRLQ--LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD  705 (767)
Q Consensus       628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  705 (767)
                      .... ........|+..|+|||.+...  .++.++||||||+++|||++|+.||......  .....+.......     
T Consensus       156 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~-----  227 (290)
T cd05613         156 HEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKS-----  227 (290)
T ss_pred             cccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhcc-----
Confidence            3211 1112234588899999998753  4678999999999999999999998643221  1112222211111     


Q ss_pred             cccccccCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042216          706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRP-----SMSDVVW  746 (767)
Q Consensus       706 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~  746 (767)
                            ....+......+.+++.+||+.+|.+||     ++.+++.
T Consensus       228 ------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 ------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                  1122344567788999999999999997     6677764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-32  Score=297.36  Aligned_cols=247  Identities=24%  Similarity=0.321  Sum_probs=207.3

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      ....|.....||+|.|++|.++++...+..||||.+.+...  ...+.+.+|+++|..|.|||||+++.+......+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            35678888899999999999999998899999999976632  3345689999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+.+|.+++||.++..  +.......++.|+..+++|||   ++.|+|||||++||||+.+.++||+|||++..+.  
T Consensus       134 ~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--  206 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD--  206 (596)
T ss_pred             EEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec--
Confidence            999999999999976643  666888899999999999999   7889999999999999999999999999998653  


Q ss_pred             CCccccccccCCCcccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQLL-TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                       ........+|++.|.|||++.+..+ .+++|+||+|++||-|++|..||.+..-.                   ++-++
T Consensus       207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-------------------~Lr~r  266 (596)
T KOG0586|consen  207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-------------------ELRPR  266 (596)
T ss_pred             -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-------------------cccch
Confidence             3445667899999999999998765 57899999999999999999999654321                   11122


Q ss_pred             cccCC--CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          710 FLKGN--APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       710 ~l~~~--~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .+++.  .+--...++.+++++++..+|.+|++++++.+
T Consensus       267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             heeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            22222  12223456778999999999999999999974

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.5e-32  Score=293.67  Aligned_cols=263  Identities=22%  Similarity=0.294  Sum_probs=197.9

Q ss_pred             HHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCC---
Q 042216          471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG---  545 (767)
Q Consensus       471 ~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~---  545 (767)
                      ....++|+..+.||+|+||.||++....+++.||||++....  ......+.+|++++++++||||+++++++....   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            345678999999999999999999988888999999986432  223446889999999999999999999986553   


Q ss_pred             ---ceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecC
Q 042216          546 ---QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFG  622 (767)
Q Consensus       546 ---~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfG  622 (767)
                         ..++||||+ +++|.+++..   ..+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence               458999999 6699888753   35899999999999999999999   7889999999999999999999999999


Q ss_pred             CcccCCCCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchh-HH--------H
Q 042216          623 LCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVN-LA--------V  692 (767)
Q Consensus       623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~-l~--------~  692 (767)
                      ++.....     ......++..|+|||.+.+ ..++.++|+|||||++++|++|+.||.......... ..        .
T Consensus       164 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07880         164 LARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE  238 (343)
T ss_pred             ccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            9875422     1123457889999999876 468899999999999999999999996543211100 00        0


Q ss_pred             HHHHHhhcCCcccccc--cccc----CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          693 WATECYRNGKIGDIID--PFLK----GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       693 ~~~~~~~~~~~~~~~d--~~l~----~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      +.... ..........  +...    ......+...+.+++.+|++.||.+|||+.+++.
T Consensus       239 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         239 FVQKL-QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHhh-cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000 0000000000  0000    0011234556889999999999999999999983

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.9e-32  Score=294.25  Aligned_cols=261  Identities=20%  Similarity=0.222  Sum_probs=192.7

Q ss_pred             ccccceeeeccCcEEEEEEEecCC--CceEEEEEeCCC--CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecC----Cc
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGD--STPVAIKRLNPG--SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDD----GQ  546 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~--~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~----~~  546 (767)
                      +|...+.||+|+||.||++.....  ++.+|+|++...  .....+.+.+|+++++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            467778999999999999999876  789999998643  222345678899999999 599999999975432    45


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      .++++||+. ++|.+++..  ...+++..+..++.|++.||.|||   ..+|+||||||+|||+++++.+||+|||+++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            788899886 589998854  346899999999999999999999   78899999999999999999999999999875


Q ss_pred             CCCCCCc--cccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhh----
Q 042216          627 GPNFSKT--HVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR----  699 (767)
Q Consensus       627 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~----  699 (767)
                      .......  .......|+..|+|||++.+ ..++.++|+|||||++++|++|++||........   .........    
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~  231 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ---LNQILQVLGTPDE  231 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH---HHHHHHHhCCCCH
Confidence            4322111  11123468899999998765 4689999999999999999999999865432111   000000000    


Q ss_pred             -------cCCcc-------ccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          700 -------NGKIG-------DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       700 -------~~~~~-------~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                             .....       ......+ ....+.....+.+++.+|++.||.+|||+.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPF-ESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcch-HhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                   00000       0000000 0011223567899999999999999999999873

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.98  E-value=7.6e-32  Score=279.72  Aligned_cols=237  Identities=26%  Similarity=0.327  Sum_probs=194.7

Q ss_pred             eeccCcEEEEEEEecCCCceEEEEEeCCCCC---cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCCh
Q 042216          483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ---QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTL  559 (767)
Q Consensus       483 LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gsL  559 (767)
                      ||+|+||.||++...+.++.+|+|.+.....   .....+..|++++++++|+|++++++.+..++..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6999999999999987788999999875432   2445789999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccccc
Q 042216          560 RDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV  639 (767)
Q Consensus       560 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~  639 (767)
                      .+++...  ..+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++.......  ......
T Consensus        81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~  153 (250)
T cd05123          81 FSHLSKE--GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF  153 (250)
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence            9999654  35899999999999999999999   6889999999999999999999999999987543221  123345


Q ss_pred             cCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhh
Q 042216          640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVC  719 (767)
Q Consensus       640 ~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  719 (767)
                      .++..|+|||...+...+.++|+||||+++|||++|+.||......   ...   ..... .          ....+...
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~---~~~~~-~----------~~~~~~~~  216 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EIY---EKILK-D----------PLRFPEFL  216 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHH---HHHhc-C----------CCCCCCCC
Confidence            6788999999999888999999999999999999999999544321   111   11111 0          11223334


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHH
Q 042216          720 LNQFVEVAMSCVNDDRIRRPSMSD  743 (767)
Q Consensus       720 ~~~l~~li~~Cl~~dp~~RPs~~e  743 (767)
                      +.++.+++.+||..||++||++.+
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCccc
Confidence            677899999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.3e-33  Score=324.74  Aligned_cols=254  Identities=22%  Similarity=0.260  Sum_probs=204.4

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCC--CCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~--~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      +-+++....||.|.||.||-+...++|...|+|.++-  ..........+|..+|..|+|||+|+.+|+-.+.+..++.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            4456667789999999999999999999999997753  23445567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      |||++|+|.+.+....  -+++.....+..|++.|+.|||   +++||||||||.||||+.+|.+|++|||.|.......
T Consensus      1314 EyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             HHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            9999999999995443  3677777778899999999999   7889999999999999999999999999998654432


Q ss_pred             C--ccccccccCCCcccChhhhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccc
Q 042216          632 K--THVSTQVKGSIGYLDPEYYRLQ---LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI  706 (767)
Q Consensus       632 ~--~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  706 (767)
                      .  ........||+.|||||++.+.   ...-+.||||+|||++||+||+.||...+.+-....      .+..|.    
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy------~V~~gh---- 1458 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY------HVAAGH---- 1458 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh------HHhccC----
Confidence            1  1112346799999999999753   355689999999999999999999977665321111      111122    


Q ss_pred             ccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          707 IDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       707 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                           ....|...+.+-.+++..|++.||++|-++.|+++.
T Consensus      1459 -----~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 -----KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -----CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                 233455667778899999999999999888877643

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.98  E-value=1.8e-32  Score=299.07  Aligned_cols=260  Identities=22%  Similarity=0.284  Sum_probs=198.0

Q ss_pred             HHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCc---
Q 042216          472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQ---  546 (767)
Q Consensus       472 ~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~---  546 (767)
                      ...++|.....||+|++|.||+|....+++.||||++...  .......+.+|+.++++++|+|++++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            3567899999999999999999999888899999998643  22334567889999999999999999998766554   


Q ss_pred             ---eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCC
Q 042216          547 ---MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL  623 (767)
Q Consensus       547 ---~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGl  623 (767)
                         .++|+||+ +++|.+++..   ..+++..+..++.|+++||.|||   +.+|+|+||||+||++++++.+||+|||+
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccc
Confidence               89999999 5699998854   35899999999999999999999   78899999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhh---
Q 042216          624 CKFGPNFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR---  699 (767)
Q Consensus       624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~---  699 (767)
                      +......     .....++..|+|||.+.. ..++.++|||||||++|||++|+.||........  +.. ......   
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~--~~~-i~~~~~~~~  236 (343)
T cd07851         165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ--LKR-IMNLVGTPD  236 (343)
T ss_pred             ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHhcCCCC
Confidence            8754321     223457888999999865 3678999999999999999999999964432211  110 000000   


Q ss_pred             --------cCCcccccccccc---C---CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          700 --------NGKIGDIIDPFLK---G---NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       700 --------~~~~~~~~d~~l~---~---~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                              .......+.....   .   ......+.++.+++.+||+.+|.+|||+.+|++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                    0000000000000   0   001123567899999999999999999999975

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.1e-32  Score=282.19  Aligned_cols=243  Identities=26%  Similarity=0.349  Sum_probs=200.5

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcc---hhHHHHHHHHHhcc-ccceeeeEeeeeecCCceE
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQG---ALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMI  548 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~---~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~  548 (767)
                      ...+|..+.+||+|+||+|.++..++....+|||+++++...+   .+--+.|-++|... +-|.+++|..++..-+.+|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            3457888999999999999999999999999999998763222   22235666777665 5789999999999999999


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      +||||+.+|+|.-++++-.  .+.+....-.+..||-||-+||   +++||.||||.+|||||.+|.+||+|||+++..-
T Consensus       427 FVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             eEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccc
Confidence            9999999999999996543  4777888899999999999999   8999999999999999999999999999998522


Q ss_pred             CCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          629 NFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                        -....+...+||+.|+|||++..++|....|.|||||+||||+.|++||.+.++.+.-..+   .            +
T Consensus       502 --~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI---~------------e  564 (683)
T KOG0696|consen  502 --FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI---M------------E  564 (683)
T ss_pred             --cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---H------------H
Confidence              2233455789999999999999999999999999999999999999999876654321111   1            1


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCC
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRP  739 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RP  739 (767)
                      .  .-.+|...+.+...++...+...|.+|.
T Consensus       565 h--nvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  565 H--NVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             c--cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence            0  1135666778888999999999999995

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.98  E-value=3.6e-32  Score=311.51  Aligned_cols=257  Identities=25%  Similarity=0.340  Sum_probs=191.1

Q ss_pred             HHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeeecC-----
Q 042216          471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD-----  544 (767)
Q Consensus       471 ~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~-----  544 (767)
                      .+...+|+++.+||+||||.|||++.+-+++.+|||++... +......+.+|+..|++|+|||||+.+..+.+.     
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            45678999999999999999999999999999999998755 344455688999999999999999966532100     


Q ss_pred             --------------------------------------------------------------------------------
Q 042216          545 --------------------------------------------------------------------------------  544 (767)
Q Consensus       545 --------------------------------------------------------------------------------  544 (767)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------CceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHh
Q 042216          545 ----------------------------------GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL  590 (767)
Q Consensus       545 ----------------------------------~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yL  590 (767)
                                                        -.+|+-||||+.-.|.++++++... -.-...++++.+|++||.|+
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHH
Confidence                                              0157788999987777777554321 14567899999999999999


Q ss_pred             HhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC----------------CCCCccccccccCCCcccChhhhccC
Q 042216          591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP----------------NFSKTHVSTQVKGSIGYLDPEYYRLQ  654 (767)
Q Consensus       591 H~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~  654 (767)
                      |   +.+||||||||.||++|++..+||+|||++....                ........+...||.-|+|||++.+.
T Consensus       714 H---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 H---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             H---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            9   7889999999999999999999999999997611                00111133567799999999999764


Q ss_pred             ---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHcc
Q 042216          655 ---LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCV  731 (767)
Q Consensus       655 ---~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl  731 (767)
                         .|+.|+|+||+|||++||+.   ||...-+  .....    ..++.+.+..-      ..........-.+++.+++
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--Ra~iL----~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll  855 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSME--RASIL----TNLRKGSIPEP------ADFFDPEHPEEASLIRWLL  855 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchHH--HHHHH----HhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence               59999999999999999984   5533221  11111    11223332221      1111222333468999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 042216          732 NDDRIRRPSMSDVVW  746 (767)
Q Consensus       732 ~~dp~~RPs~~evl~  746 (767)
                      +.||.+|||+.|+|.
T Consensus       856 ~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  856 SHDPSKRPTATELLN  870 (1351)
T ss_pred             cCCCccCCCHHHHhh
Confidence            999999999999983

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=2.8e-31  Score=274.00  Aligned_cols=222  Identities=19%  Similarity=0.176  Sum_probs=179.6

Q ss_pred             cCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCChhhhhcc
Q 042216          486 GGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYN  565 (767)
Q Consensus       486 G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gsL~~~L~~  565 (767)
                      |.+|+||++....+++.+|+|++....     ++..|...+....|||++++++++.+.+..+++|||+++|+|.+++.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999999888999999987543     234455555566799999999999999999999999999999999865


Q ss_pred             CCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccccccCCCcc
Q 042216          566 NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY  645 (767)
Q Consensus       566 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y  645 (767)
                      .  ..+++..+..++.|++.||.|||   +++++||||||+||+++.++.++++|||++......     .....++..|
T Consensus        79 ~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y  148 (237)
T cd05576          79 F--LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMY  148 (237)
T ss_pred             h--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccc
Confidence            4  35899999999999999999999   788999999999999999999999999987643221     1223456779


Q ss_pred             cChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHH
Q 042216          646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVE  725 (767)
Q Consensus       646 ~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  725 (767)
                      +|||.+....++.++||||+|++++||++|+.|+.......            .         .......+......+.+
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~---------~~~~~~~~~~~~~~~~~  207 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------N---------THTTLNIPEWVSEEARS  207 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------c---------cccccCCcccCCHHHHH
Confidence            99999988889999999999999999999998864321100            0         00011123345667899


Q ss_pred             HHHHccccCCCCCCCHHH
Q 042216          726 VAMSCVNDDRIRRPSMSD  743 (767)
Q Consensus       726 li~~Cl~~dp~~RPs~~e  743 (767)
                      ++.+|++.||.+||++.+
T Consensus       208 li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         208 LLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             HHHHHccCCHHHhcCCCc
Confidence            999999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-31  Score=295.85  Aligned_cols=258  Identities=24%  Similarity=0.379  Sum_probs=211.2

Q ss_pred             HHHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc-ccceeeeEeeeee-----
Q 042216          469 EIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGYCN-----  542 (767)
Q Consensus       469 ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~-----  542 (767)
                      .+..-+.-|+..++||+|.+|.||+++....++.+|+|++.... ....+...|.++|+.+ .|||++.++|++.     
T Consensus        13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~   91 (953)
T KOG0587|consen   13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG   91 (953)
T ss_pred             hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence            33344567888889999999999999999899999999987653 3445678899999988 6999999999884     


Q ss_pred             cCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecC
Q 042216          543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFG  622 (767)
Q Consensus       543 ~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfG  622 (767)
                      .++++|||||||.+||..|++++-....+.|..+..|+..++.|+.+||   .+.++|||||-.|||+++++.+|++|||
T Consensus        92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFG  168 (953)
T KOG0587|consen   92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFG  168 (953)
T ss_pred             CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeee
Confidence            3479999999999999999998766778999999999999999999999   7889999999999999999999999999


Q ss_pred             CcccCCCCCCccccccccCCCcccChhhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHH
Q 042216          623 LCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ-----LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATEC  697 (767)
Q Consensus       623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~  697 (767)
                      ++.....  .........||+.|||||++...     .|+..+|+||+|++..||.-|.+|+..+-.....         
T Consensus       169 vSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL---------  237 (953)
T KOG0587|consen  169 VSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL---------  237 (953)
T ss_pred             eeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh---------
Confidence            9875432  22334556799999999998753     4677899999999999999999998655332100         


Q ss_pred             hhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          698 YRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       698 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      +   .+.  -.|..+-..+....+++.++|..||..|-++||++.++++
T Consensus       238 F---~Ip--RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  238 F---LIP--RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             c---cCC--CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            0   011  1122222346678899999999999999999999999874

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=9.3e-31  Score=307.98  Aligned_cols=146  Identities=30%  Similarity=0.404  Sum_probs=131.4

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|...+.||+|+||.||+|.....++.||||++....   ......+..|+.++..++||||+++++++...+..+|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888899999999999999998888999999986542   223456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcc
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK  625 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~  625 (767)
                      ||+.+++|.+++...  ..+++..++.++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999653  35889999999999999999999   6789999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=2.2e-31  Score=264.48  Aligned_cols=272  Identities=23%  Similarity=0.289  Sum_probs=199.5

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCC----ceEEEEEeCCCCCc--chhHHHHHHHHHhccccceeeeEeeeeec-CC
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDS----TPVAIKRLNPGSQQ--GALEFQTEIGMLSQLRYLHLVSLIGYCND-DG  545 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~----~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~-~~  545 (767)
                      ....|+....||+|.||.||++..+++.    +.+|||+++.....  -...-.+|+.+++.++|||++.|..++.. +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            3456888889999999999999765442    37899998754221  22356789999999999999999998876 77


Q ss_pred             ceEEEEecCCCCChhhhhccC---CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCC----CcEEE
Q 042216          546 QMILVYDYMARGTLRDHLYNN---DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEE----WVAKV  618 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~----~~~ki  618 (767)
                      ..+|++||.+. +|.+.++-+   ....++-..+.+|+.||+.|+.|||   ++-|+||||||.|||+..+    |.+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEe
Confidence            99999999998 999888543   2346888999999999999999999   5669999999999999877    99999


Q ss_pred             eecCCcccCCCCCCcc-ccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccc------hhH
Q 042216          619 SDFGLCKFGPNFSKTH-VSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ------VNL  690 (767)
Q Consensus       619 ~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~------~~l  690 (767)
                      +|+|++|+..+.-... ....++.|+.|.|||.+.+ ..||++.||||.||+..||+|-++-|.+..+...      .+.
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            9999999876544333 3345678999999999876 5799999999999999999999988865432211      111


Q ss_pred             HHHHHHHhhcC---Ccccc---ccc-----ccc-CCCCh-----------hhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          691 AVWATECYRNG---KIGDI---IDP-----FLK-GNAPP-----------VCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       691 ~~~~~~~~~~~---~~~~~---~d~-----~l~-~~~~~-----------~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      .....+.+.-.   ...++   .+-     .++ .....           .-....++|+..+|..||.+|.|+++.++-
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            11111111100   00000   000     000 00000           011236789999999999999999998864


Q ss_pred             H
Q 042216          748 L  748 (767)
Q Consensus       748 L  748 (767)
                      .
T Consensus       338 ~  338 (438)
T KOG0666|consen  338 P  338 (438)
T ss_pred             c
Confidence            3

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=265.20  Aligned_cols=250  Identities=21%  Similarity=0.284  Sum_probs=198.3

Q ss_pred             Hhhccccc-eeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc-ccceeeeEeeeeec----CCc
Q 042216          473 ATKDFNNL-LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGYCND----DGQ  546 (767)
Q Consensus       473 ~t~~f~~~-~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~----~~~  546 (767)
                      .+++|... .+||-|-.|+|..+.++.+++.+|+|++...     ..-.+|+++.-.. .|||||+++++++.    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            34555543 3699999999999999999999999998643     2346777765544 69999999998753    467


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC---CCCcEEEeecCC
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAKVSDFGL  623 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld---~~~~~ki~DfGl  623 (767)
                      +++|||.|+||.|++.+..+....+++.+.-.|+.||+.|+.|||   +..|.||||||+|+|..   .+..+||+|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccc
Confidence            899999999999999998888888999999999999999999999   88899999999999996   456789999999


Q ss_pred             cccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCc
Q 042216          624 CKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKI  703 (767)
Q Consensus       624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~  703 (767)
                      |+....   .......+-|+.|.|||++...+|+...|+||+||++|-|+||-+||.........  .. +...+..+. 
T Consensus       211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais--pg-Mk~rI~~gq-  283 (400)
T KOG0604|consen  211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PG-MKRRIRTGQ-  283 (400)
T ss_pred             ccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC--hh-HHhHhhccC-
Confidence            985432   23345567899999999999999999999999999999999999999655321100  00 011111111 


Q ss_pred             cccccccccCCCCh----hhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          704 GDIIDPFLKGNAPP----VCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       704 ~~~~d~~l~~~~~~----~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                               -.+|.    ..++...++++.+|..+|.+|.|+.+++.
T Consensus       284 ---------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  284 ---------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             ---------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence                     11222    34677789999999999999999999873

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-31  Score=264.62  Aligned_cols=260  Identities=22%  Similarity=0.299  Sum_probs=202.4

Q ss_pred             HHHHHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc-cceeeeEeeeeecCC
Q 042216          467 ISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-YLHLVSLIGYCNDDG  545 (767)
Q Consensus       467 ~~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~  545 (767)
                      +.++-..|.+     +||+|+++.|--++.-.++..+|||++.+..........+|++++...+ |+||++|+.+++++.
T Consensus        75 F~d~YkLt~e-----~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   75 FEDMYKLTSE-----LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             HHHHHHhHHH-----HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            5566666654     7999999999999887788999999998776667778999999999985 999999999999999


Q ss_pred             ceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC---cEEEeecC
Q 042216          546 QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW---VAKVSDFG  622 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~---~~ki~DfG  622 (767)
                      ..|||||-|.+|+|..+|++..  -+++.+..++..+||.||.+||   .++|.||||||+|||-....   -+|||||.
T Consensus       150 ~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             eEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccc
Confidence            9999999999999999997654  4889999999999999999999   89999999999999986543   57999998


Q ss_pred             CcccCCC-CC----CccccccccCCCcccChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccc-----
Q 042216          623 LCKFGPN-FS----KTHVSTQVKGSIGYLDPEYYR-----LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ-----  687 (767)
Q Consensus       623 la~~~~~-~~----~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~-----  687 (767)
                      |..-... ..    .+......+|+..|||||+..     ...|+.+.|.||+|||||-|++|.+||.+.-....     
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG  304 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG  304 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence            8642111 01    111123457889999999764     34688999999999999999999999976543211     


Q ss_pred             ---hhHHHHHHHHhhcCCccccccccccCCCCh----hhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          688 ---VNLAVWATECYRNGKIGDIIDPFLKGNAPP----VCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       688 ---~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~----~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                         ..-.....+.+++|.          -++|.    ..+.+..+++...+..|+.+|.++.+++.
T Consensus       305 e~Cr~CQ~~LFesIQEGk----------YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  305 EVCRVCQNKLFESIQEGK----------YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CccHHHHHHHHHHHhccC----------CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence               000111122222222          12232    34566778999999999999999998875

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1.9e-30  Score=266.70  Aligned_cols=239  Identities=28%  Similarity=0.326  Sum_probs=194.8

Q ss_pred             CcEEEEEEEecCCCceEEEEEeCCCCCcc-hhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCChhhhhcc
Q 042216          487 GFGNVYKGFLNGDSTPVAIKRLNPGSQQG-ALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYN  565 (767)
Q Consensus       487 ~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~-~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gsL~~~L~~  565 (767)
                      +||.||+|+..++++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999998877899999997665544 67899999999999999999999999999999999999999999999865


Q ss_pred             CCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccccccCCCcc
Q 042216          566 NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY  645 (767)
Q Consensus       566 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y  645 (767)
                      ..  .+++.+++.++.+++.++.+||   ..+++|+||+|+||++++++.++|+|||++.......   ......++..|
T Consensus        81 ~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~  152 (244)
T smart00220       81 RG--RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY  152 (244)
T ss_pred             cc--CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence            43  3899999999999999999999   6789999999999999999999999999988654321   23345578899


Q ss_pred             cChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHH
Q 042216          646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVE  725 (767)
Q Consensus       646 ~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  725 (767)
                      ++||.+....++.++||||||++++||++|..||......  .....+    ...+....       .......+.++.+
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~----~~~~~~~~-------~~~~~~~~~~~~~  219 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKK----IGKPKPPF-------PPPEWKISPEAKD  219 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHH----HhccCCCC-------ccccccCCHHHHH
Confidence            9999999888999999999999999999999998553221  111111    11111000       0000015568999


Q ss_pred             HHHHccccCCCCCCCHHHHHH
Q 042216          726 VAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       726 li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ++.+|+..+|++||++.++++
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHccCCchhccCHHHHhh
Confidence            999999999999999999985

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=6.3e-30  Score=293.76  Aligned_cols=260  Identities=21%  Similarity=0.196  Sum_probs=169.3

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCC----CceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeee------ee
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGD----STPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGY------CN  542 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~----~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~------~~  542 (767)
                      ..++|+..+.||+|+||.||+|++..+    +..||||++......  ..+..|  .+....+.++..++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            457899999999999999999999877    789999988643221  111111  1111122222222111      34


Q ss_pred             cCCceEEEEecCCCCChhhhhccCCCC------------------CCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCC
Q 042216          543 DDGQMILVYDYMARGTLRDHLYNNDNP------------------PLPWDRRLKICIGAARALHYLHTGASKVIIHRDVK  604 (767)
Q Consensus       543 ~~~~~~lV~ey~~~gsL~~~L~~~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk  604 (767)
                      .+...++||||+++++|.+++......                  ...+..+..++.|++.||.|||   +++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            567899999999999999998643210                  1123445679999999999999   7889999999


Q ss_pred             CCCeEECC-CCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccC----------------------CCCchhh
Q 042216          605 TTNILLDE-EWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ----------------------LLTEKSD  661 (767)
Q Consensus       605 ~~NILld~-~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksD  661 (767)
                      |+|||+++ ++.+||+|||+++..... .........+++.|||||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999985 679999999999754321 12233456789999999966422                      2345679


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCCc-------cchhHHHHHHHHhhcCCccccccccccC--CCChhhHHHHHHHHHHccc
Q 042216          662 VYSFGVVLLEVLCARPPILRTGDK-------KQVNLAVWATECYRNGKIGDIIDPFLKG--NAPPVCLNQFVEVAMSCVN  732 (767)
Q Consensus       662 V~SfGvvl~elltg~~P~~~~~~~-------~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~li~~Cl~  732 (767)
                      ||||||+||||+++..+.......       ....+..|.......      ..+.+..  ...........+|+.+||+
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHcc
Confidence            999999999999977664211000       000111121110000      0000000  0000112345689999999


Q ss_pred             cCCCCCCCHHHHHH
Q 042216          733 DDRIRRPSMSDVVW  746 (767)
Q Consensus       733 ~dp~~RPs~~evl~  746 (767)
                      .||++|||+.|+++
T Consensus       436 ~dP~kR~ta~e~L~  449 (566)
T PLN03225        436 FKGRQRISAKAALA  449 (566)
T ss_pred             CCcccCCCHHHHhC
Confidence            99999999999985

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-31  Score=277.30  Aligned_cols=243  Identities=23%  Similarity=0.313  Sum_probs=198.3

Q ss_pred             eeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCC
Q 042216          481 LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGT  558 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gs  558 (767)
                      ++||+|.||+||-|+++..++.||||++.+.  .......+.+|+.+|++++||.||.|...|+..+..++|||-+. |+
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GD  648 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-GD  648 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-ch
Confidence            4899999999999999999999999998654  34455678999999999999999999999999999999999995 47


Q ss_pred             hhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC---CCcEEEeecCCcccCCCCCCccc
Q 042216          559 LRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE---EWVAKVSDFGLCKFGPNFSKTHV  635 (767)
Q Consensus       559 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~---~~~~ki~DfGla~~~~~~~~~~~  635 (767)
                      +.+.+.......|++..-.-++.||+.||.|||   -++|+|+||||+|||+..   --++||||||+||+..+.+   -
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---F  722 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---F  722 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh---h
Confidence            777776666678999999999999999999999   788999999999999954   3489999999999876422   3


Q ss_pred             cccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCC
Q 042216          636 STQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNA  715 (767)
Q Consensus       636 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  715 (767)
                      ...++||+.|+|||++..+.|...-|+||.||++|--+.|..||....+-.+  .+.-+...+.             ...
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd--QIQNAaFMyP-------------p~P  787 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND--QIQNAAFMYP-------------PNP  787 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH--HhhccccccC-------------CCc
Confidence            4567899999999999999999999999999999999999999965433211  1110000000             011


Q ss_pred             ChhhHHHHHHHHHHccccCCCCCCCHHHHH
Q 042216          716 PPVCLNQFVEVAMSCVNDDRIRRPSMSDVV  745 (767)
Q Consensus       716 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl  745 (767)
                      -.+.....+++|...|+..-.+|-|...-+
T Consensus       788 W~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  788 WSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            123456778999999999999998877655

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-31  Score=300.15  Aligned_cols=259  Identities=27%  Similarity=0.305  Sum_probs=206.1

Q ss_pred             HHHHHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeec
Q 042216          467 ISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCND  543 (767)
Q Consensus       467 ~~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~  543 (767)
                      +.+++...++|.++++||+|+||.|..++++..++.+|+|++++.   ......-|..|-.+|..-..+=|+.|+-.+.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            455666678999999999999999999999999999999999763   23334458888889988888999999999999


Q ss_pred             CCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCC
Q 042216          544 DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL  623 (767)
Q Consensus       544 ~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGl  623 (767)
                      +.++|||||||+||+|..+|.+..  +++++...-++..|+.||.-||   +.|+|||||||+|||||..|.+||+|||.
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchh
Confidence            999999999999999999996655  6888888889999999999999   88899999999999999999999999998


Q ss_pred             cccCCCCCCccccccccCCCcccChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHh
Q 042216          624 CKFGPNFSKTHVSTQVKGSIGYLDPEYYRL-----QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECY  698 (767)
Q Consensus       624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~  698 (767)
                      |-..... ..-.+...+|||.|++||++..     +.|.+.+|.||+||++|||+.|..||....      +..-.....
T Consensus       222 Clkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm  294 (1317)
T KOG0612|consen  222 CLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIM  294 (1317)
T ss_pred             HHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHh
Confidence            8654432 2233456779999999999862     578999999999999999999999996542      221111111


Q ss_pred             hcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCC---HHHHH
Q 042216          699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPS---MSDVV  745 (767)
Q Consensus       699 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs---~~evl  745 (767)
                      .-..       .+.-+.....+++..+||.+.+. +|+.|..   ++++-
T Consensus       295 ~hk~-------~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  295 NHKE-------SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK  336 (1317)
T ss_pred             chhh-------hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence            1000       11111123467788889988775 6888877   77765

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-30  Score=282.75  Aligned_cols=240  Identities=20%  Similarity=0.225  Sum_probs=194.9

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEEEe
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ++.|.....+|.|+|+.|-++.+...++..++|++...    ..+-.+|+.++... +|||++++.+.+.+..+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            45566666799999999999999988899999999654    22345677666665 69999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE-CCCCcEEEeecCCcccCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL-DEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl-d~~~~~ki~DfGla~~~~~~~  631 (767)
                      .+.+|-|.+.+....   ....++..|+.+++.++.|||   .++++||||||+|||+ ++.++++|+|||.++..... 
T Consensus       397 ~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             hccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            999998888875543   222677889999999999999   7899999999999999 69999999999999865442 


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                          ....+-|..|.|||++....+++.+|+||||++||||++|+.||......  ..+    ...+..           
T Consensus       470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei----~~~i~~-----------  528 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI----HTRIQM-----------  528 (612)
T ss_pred             ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH----HHhhcC-----------
Confidence                22335678999999999999999999999999999999999999655443  111    111111           


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       +......+....+|+.+||+.||.+||+|.++..
T Consensus       529 -~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  529 -PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             -CccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence             2222456778899999999999999999999873

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-30  Score=236.39  Aligned_cols=264  Identities=19%  Similarity=0.242  Sum_probs=197.3

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      +|...++||+|.||+|++|+..+..+.||+|+++.+.  +.-...-.+|+.+|+.++|+|||++++....++.+-||+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4555668999999999999999888999999886542  22344578999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      |.. +|..+...- +..++......++.|+.+||.++|   ++.+.|||+||.|.||+.+|+.|++|||+++...-.  .
T Consensus        83 cdq-dlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgip--v  155 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--V  155 (292)
T ss_pred             hhH-HHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--e
Confidence            976 787776443 446899999999999999999999   888999999999999999999999999999864321  1


Q ss_pred             cccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCC---cccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGK---IGDIID  708 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~d  708 (767)
                      .+......|..|.+|.++.+ +.|+...|+||-||++.|+.. |++-|.+.+..++...+-|......+..   +.++.|
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence            23344557889999999876 468999999999999999987 6666655544433333333333222221   222233


Q ss_pred             ccccCCCChhh---------HHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          709 PFLKGNAPPVC---------LNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       709 ~~l~~~~~~~~---------~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      -.....++..-         ...=.+++...+.-+|.+|.++++.++
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            22222222211         112245666666678999999887764

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-30  Score=245.51  Aligned_cols=207  Identities=25%  Similarity=0.383  Sum_probs=173.6

Q ss_pred             HHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC-CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCce
Q 042216          470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQM  547 (767)
Q Consensus       470 i~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~  547 (767)
                      ++...+++.....||+|++|.|-+-++...++..|+|++... ..+..++..+|+.+..+- .+|.+|.++|...+++..
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            444556666677899999999999999989999999999755 345556788888877665 799999999999999999


Q ss_pred             EEEEecCCCCChhhhhcc--CCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcc
Q 042216          548 ILVYDYMARGTLRDHLYN--NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK  625 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~  625 (767)
                      ++.||.|.. ||+.+-++  ..+..+++..+-+|+..+..||.|||+  ...+||||+||+||||+.+|++||||||++-
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            999999976 88877643  245568999999999999999999997  6789999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCcccChhhhcc----CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 042216          626 FGPNFSKTHVSTQVKGSIGYLDPEYYRL----QLLTEKSDVYSFGVVLLEVLCARPPILRT  682 (767)
Q Consensus       626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDV~SfGvvl~elltg~~P~~~~  682 (767)
                      ...+   +-..+...|...|||||.+..    ..|+.||||||+|+.+.||.+++.||..-
T Consensus       198 ~L~d---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  198 YLVD---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             eehh---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            5432   223344568889999998753    47899999999999999999999999544

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.9e-29  Score=282.78  Aligned_cols=260  Identities=20%  Similarity=0.228  Sum_probs=181.9

Q ss_pred             HhhccccceeeeccCcEEEEEEEec----------------CCCceEEEEEeCCCCCcchhH--------------HHHH
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLN----------------GDSTPVAIKRLNPGSQQGALE--------------FQTE  522 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~----------------~~~~~vAVK~l~~~~~~~~~~--------------f~~E  522 (767)
                      ..++|+..++||+|+||.||+|.+.                ..++.||||++........++              +..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            3568999999999999999999752                233579999987543332223              3457


Q ss_pred             HHHHhcccccee-----eeEeeeeec--------CCceEEEEecCCCCChhhhhccCC----------------------
Q 042216          523 IGMLSQLRYLHL-----VSLIGYCND--------DGQMILVYDYMARGTLRDHLYNND----------------------  567 (767)
Q Consensus       523 i~~l~~l~Hpni-----v~l~g~~~~--------~~~~~lV~ey~~~gsL~~~L~~~~----------------------  567 (767)
                      +.++.+++|.++     ++++++|..        ++..+|||||+++|+|.++|+...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777788876654     677888753        357899999999999999986421                      


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccccccCCCcccC
Q 042216          568 NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD  647 (767)
Q Consensus       568 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~a  647 (767)
                      ...++|..+..++.|++.+|.|||   ..+|+||||||+|||++.++.+||+|||+++...... ........+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeC
Confidence            123578889999999999999999   6789999999999999999999999999987543211 111112335789999


Q ss_pred             hhhhccCCC----------------------CchhhHHHHHHHHHHHHhCCC-CCCCCCCcc------chhHHHHHHHHh
Q 042216          648 PEYYRLQLL----------------------TEKSDVYSFGVVLLEVLCARP-PILRTGDKK------QVNLAVWATECY  698 (767)
Q Consensus       648 PE~~~~~~~----------------------s~ksDV~SfGvvl~elltg~~-P~~~~~~~~------~~~l~~~~~~~~  698 (767)
                      ||.+.....                      ..+.||||+||+++||++|.. |+.......      ...+..|..  .
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~  456 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--Y  456 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--h
Confidence            998754321                      134799999999999999875 653321100      011112211  1


Q ss_pred             hcCCccccccccccCCCChhhHHHHHHHHHHccccCC---CCCCCHHHHHH
Q 042216          699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDR---IRRPSMSDVVW  746 (767)
Q Consensus       699 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp---~~RPs~~evl~  746 (767)
                      ....        ..-...........+++.+|+..+|   .+|+|++|+++
T Consensus       457 ~~~~--------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        457 KGQK--------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cccC--------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            1111        0011122345677899999998766   68999999975

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.5e-31  Score=258.52  Aligned_cols=265  Identities=22%  Similarity=0.331  Sum_probs=198.5

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC-cc-hhHHHHHHHHHhccccceeeeEeeeeecC--------C
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ-QG-ALEFQTEIGMLSQLRYLHLVSLIGYCNDD--------G  545 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~-~~-~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~--------~  545 (767)
                      .|....+||+|.||.||++..+++++.||+|+.....+ .+ -..-.+|+++|..|+|+|++.++..|...        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            34555689999999999999999989999987644322 22 23468899999999999999999998532        3


Q ss_pred             ceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcc
Q 042216          546 QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK  625 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~  625 (767)
                      .++||+.+|+. +|.-.|... ...++..++.+++.++..||.|+|   ...|+|||+|+.|+||+.++.+||+|||+++
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence            58999999988 888888543 346889999999999999999999   7889999999999999999999999999997


Q ss_pred             cCCCCCC--ccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC
Q 042216          626 FGPNFSK--THVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK  702 (767)
Q Consensus       626 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~  702 (767)
                      .+.....  ....+..+.|..|.+||.+.+ ..++++.|||.-||++.||+|+.+-+.+..+..+..++...........
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            5432221  112344556899999998875 5799999999999999999999998877766555555443322222211


Q ss_pred             cccccccccc-----CCCC-------hh------hHHHHHHHHHHccccCCCCCCCHHHHH
Q 042216          703 IGDIIDPFLK-----GNAP-------PV------CLNQFVEVAMSCVNDDRIRRPSMSDVV  745 (767)
Q Consensus       703 ~~~~~d~~l~-----~~~~-------~~------~~~~l~~li~~Cl~~dp~~RPs~~evl  745 (767)
                      ..++..-.+.     .+.+       .+      ...+.++++..++..||.+|+.+++++
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al  313 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL  313 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence            1111100000     0000       00      123568899999999999999988877

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-29  Score=253.21  Aligned_cols=249  Identities=25%  Similarity=0.364  Sum_probs=202.7

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~l  549 (767)
                      .++|..+.+||+|+|.+|.++.++.+.+.+|+|++++.-   .+...=.+.|-.+..+. +||.+|-|..++..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            468999999999999999999999999999999987642   22233356777777666 79999999999999999999


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      |.||+++|+|.-++++.  .+|+++...-....|..||.|||   +.+||.||||.+|||+|..|.+|++|+|+++..- 
T Consensus       329 vieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l-  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-  402 (593)
T ss_pred             EEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCC-
Confidence            99999999999888554  45899999999999999999999   8999999999999999999999999999998643 


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc-cchhHHHHHHHHhhcCCcccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDK-KQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                       .....+...+||+.|.|||.+++..|....|.|++||+++||+.|+.||.-.+.. ...+..++..+.+.+..      
T Consensus       403 -~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq------  475 (593)
T KOG0695|consen  403 -GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ------  475 (593)
T ss_pred             -CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc------
Confidence             3344567789999999999999999999999999999999999999999644321 22333344444333322      


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCC
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRP  739 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RP  739 (767)
                        ++  .|...+-+...+++.-+.+||.+|.
T Consensus       476 --ir--iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  476 --IR--IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             --cc--ccceeehhhHHHHHHhhcCCcHHhc
Confidence              22  2334445566788999999999985

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=4.1e-30  Score=263.21  Aligned_cols=262  Identities=20%  Similarity=0.293  Sum_probs=201.6

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc-c-c----eeeeEeeeeecCCce
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-Y-L----HLVSLIGYCNDDGQM  547 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H-p----niv~l~g~~~~~~~~  547 (767)
                      +++|....++|+|.||.|-.......+..||||+++... .-.+.-+-|+++|.++. + |    -++++.+|+.-.++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            678899999999999999999998888899999987432 22334567899999993 2 2    578888899999999


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC---------------
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE---------------  612 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~---------------  612 (767)
                      ++|+|.+. -|+.++|..+.-.+.+..++..|+.|+++++++||   +.+++|-||||+|||+.+               
T Consensus       167 CivfellG-~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  167 CIVFELLG-LSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             EEEEeccC-hhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccce
Confidence            99999984 39999998877778999999999999999999999   888999999999999821               


Q ss_pred             -----CCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccc
Q 042216          613 -----EWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ  687 (767)
Q Consensus       613 -----~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~  687 (767)
                           +..+||.|||.|......     ...++.|..|.|||++.+-.++.++||||+||||.||.+|..-|..-++.+.
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH  317 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH  317 (415)
T ss_pred             eccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence                 346899999999864332     2455678899999999999999999999999999999999999977665443


Q ss_pred             hhHHHHHHHH--------------hhcCCccccccccccC----------------CCChhhHHHHHHHHHHccccCCCC
Q 042216          688 VNLAVWATEC--------------YRNGKIGDIIDPFLKG----------------NAPPVCLNQFVEVAMSCVNDDRIR  737 (767)
Q Consensus       688 ~~l~~~~~~~--------------~~~~~~~~~~d~~l~~----------------~~~~~~~~~l~~li~~Cl~~dp~~  737 (767)
                      ..+.+.+...              ...+++. ..+....+                .....+..+|.+|+..||..||.+
T Consensus       318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rld-w~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLD-WPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHhhCCCcHHHhhhhhhHhhhhccccc-CccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            2211111100              0111000 00000000                012234567999999999999999


Q ss_pred             CCCHHHHHH
Q 042216          738 RPSMSDVVW  746 (767)
Q Consensus       738 RPs~~evl~  746 (767)
                      |+|+.|++.
T Consensus       397 RiTl~EAL~  405 (415)
T KOG0671|consen  397 RITLREALS  405 (415)
T ss_pred             cccHHHHhc
Confidence            999999985

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-30  Score=271.90  Aligned_cols=248  Identities=23%  Similarity=0.284  Sum_probs=203.9

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      .++..+..||-||||+|=+++.+.....+|+|++++.   ......-...|-++|.+.+.|.||+|+..+.++...||+|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            4555666899999999999999876556888888654   2233334678999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      |-|-+|.|+..|+..  ..++.....-++..+.+|+.|||   +++||.|||||+|++||.+|-+||.|||+|+......
T Consensus       500 EaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  500 EACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             HhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence            999999999999654  45888888889999999999999   8899999999999999999999999999999765433


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                         .+-..+||+.|.|||++.++..+...|.||+|++++||++|.+||.+.+....-+++.-..            |   
T Consensus       575 ---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi------------d---  636 (732)
T KOG0614|consen  575 ---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI------------D---  636 (732)
T ss_pred             ---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh------------h---
Confidence               3346789999999999999999999999999999999999999998877643333222111            1   


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPS-----MSDVV  745 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs-----~~evl  745 (767)
                      ....|........+++++.+..+|.+|.-     +.||.
T Consensus       637 ~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIk  675 (732)
T KOG0614|consen  637 KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIK  675 (732)
T ss_pred             hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHH
Confidence            11234555667789999999999999985     55554

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-29  Score=260.31  Aligned_cols=257  Identities=25%  Similarity=0.350  Sum_probs=198.2

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--Ccc-----hhHHHHHHHHHhccccceeeeEeeeee-cCCc
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQG-----ALEFQTEIGMLSQLRYLHLVSLIGYCN-DDGQ  546 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~-----~~~f~~Ei~~l~~l~Hpniv~l~g~~~-~~~~  546 (767)
                      ++|-.+++||+|||+.||++..-...+-||||+-..+.  ..+     .+--.+|..+.+.|.||.||++++|+. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            45667778999999999999988777889999864331  111     223578999999999999999999985 5678


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC---CCCcEEEeecCC
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAKVSDFGL  623 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld---~~~~~ki~DfGl  623 (767)
                      +|-|.|||++.+|+-||+.+  +.+++++...|++||+.||.||.+. +.+|||-||||.||||.   .-|.+||+||||
T Consensus       543 FCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             ceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            89999999999999999654  4589999999999999999999854 58899999999999995   457899999999


Q ss_pred             cccCCCCCCcc-----ccccccCCCcccChhhhcc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHH
Q 042216          624 CKFGPNFSKTH-----VSTQVKGSIGYLDPEYYRL----QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWA  694 (767)
Q Consensus       624 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~  694 (767)
                      +++....+...     .+....||..|++||.+.-    .+.+.|.||||.||++|..+.|+.||.....  +.++    
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdI----  693 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDI----  693 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHH----
Confidence            99876654442     3446779999999998753    3578899999999999999999999954422  1111    


Q ss_pred             HHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHH
Q 042216          695 TECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV  745 (767)
Q Consensus       695 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl  745 (767)
                         +.+..+.+.-...+  +.-+..+.+...+|++||+.--++|....++.
T Consensus       694 ---LqeNTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  694 ---LQENTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             ---HhhhchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence               12222222211111  12233456678999999999999997766654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-29  Score=279.67  Aligned_cols=244  Identities=28%  Similarity=0.353  Sum_probs=185.6

Q ss_pred             cccceeeeccCcEE-EEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEEEecC
Q 042216          477 FNNLLIIGRGGFGN-VYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       477 f~~~~~LG~G~fG~-Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      |...+++|.|+-|+ ||+|...+  +.||||++-...   ..-.++|+..|+.- +|||||+.++.-.+...+|+..|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye~--R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYEG--REVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeCC--ceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            55556799999987 89999965  799999986432   22457899999887 6999999998888889999999999


Q ss_pred             CCCChhhhhccC--CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC-----CCcEEEeecCCcccC
Q 042216          555 ARGTLRDHLYNN--DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE-----EWVAKVSDFGLCKFG  627 (767)
Q Consensus       555 ~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~-----~~~~ki~DfGla~~~  627 (767)
                      .. +|.+++...  ......-...+.+..|++.||++||   +.+||||||||.||||+.     ..+++|+|||+++..
T Consensus       586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            76 999999763  1111222445778899999999999   788999999999999975     358999999999876


Q ss_pred             CCCCCcc-ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCccchhHHHHHHHHhhcCCccc
Q 042216          628 PNFSKTH-VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCA-RPPILRTGDKKQVNLAVWATECYRNGKIGD  705 (767)
Q Consensus       628 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg-~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  705 (767)
                      ......- ......||-||+|||++....-+...||||+|||+|+.++| .+||...-+.+ .++..      .+..+..
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NIl~------~~~~L~~  734 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANILT------GNYTLVH  734 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhhhc------Cccceee
Confidence            4432221 23456799999999999998888899999999999999985 89995443211 11110      0000000


Q ss_pred             cccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHH
Q 042216          706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV  745 (767)
Q Consensus       706 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl  745 (767)
                           +.  ...++  +..+||.+|++++|..||++.+|+
T Consensus       735 -----L~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  735 -----LE--PLPDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             -----ec--cCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence                 00  11122  678999999999999999999998

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.6e-28  Score=263.25  Aligned_cols=222  Identities=25%  Similarity=0.351  Sum_probs=179.9

Q ss_pred             HHHHHHHh---hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC---cchhHHHHHHHHHhccccceeeeEeee
Q 042216          467 ISEIKEAT---KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ---QGALEFQTEIGMLSQLRYLHLVSLIGY  540 (767)
Q Consensus       467 ~~ei~~~t---~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~Hpniv~l~g~  540 (767)
                      |-.|+.+.   .-|-.++.||-|+||+|.++...++...+|.|.|.+...   +...-...|-.||..-..+=||+|+-.
T Consensus       618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS  697 (1034)
T KOG0608|consen  618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS  697 (1034)
T ss_pred             HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence            33444443   347777889999999999999888888999999976532   333346789999999999999999999


Q ss_pred             eecCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 042216          541 CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSD  620 (767)
Q Consensus       541 ~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~D  620 (767)
                      +.+++.+|+||+|++||++..+|.+..  -+.+....-.+..+..|+++.|   ..|+|||||||+|||||.+|.+||+|
T Consensus       698 FQDkdnLYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTD  772 (1034)
T KOG0608|consen  698 FQDKDNLYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTD  772 (1034)
T ss_pred             eccCCceEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeee
Confidence            999999999999999999999997654  3677777778889999999999   88899999999999999999999999


Q ss_pred             cCCcccC---------CCCCC---------------c----------------cccccccCCCcccChhhhccCCCCchh
Q 042216          621 FGLCKFG---------PNFSK---------------T----------------HVSTQVKGSIGYLDPEYYRLQLLTEKS  660 (767)
Q Consensus       621 fGla~~~---------~~~~~---------------~----------------~~~~~~~gt~~y~aPE~~~~~~~s~ks  660 (767)
                      ||||.-+         .+...               .                ......+||+.|+|||++....++..+
T Consensus       773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~c  852 (1034)
T KOG0608|consen  773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLC  852 (1034)
T ss_pred             ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccc
Confidence            9998421         10000               0                001124699999999999999999999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCCccc-hhHHHH
Q 042216          661 DVYSFGVVLLEVLCARPPILRTGDKKQ-VNLAVW  693 (767)
Q Consensus       661 DV~SfGvvl~elltg~~P~~~~~~~~~-~~l~~~  693 (767)
                      |.||.||||+||+.|++||......+. ...+.|
T Consensus       853 dwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw  886 (1034)
T KOG0608|consen  853 DWWSVGVILYEMLVGQPPFLADTPGETQYKVINW  886 (1034)
T ss_pred             hhhHhhHHHHHHhhCCCCccCCCCCcceeeeeeh
Confidence            999999999999999999977665443 334444

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-29  Score=247.79  Aligned_cols=265  Identities=22%  Similarity=0.267  Sum_probs=200.2

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecC-----CceEE
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD-----GQMIL  549 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~-----~~~~l  549 (767)
                      .+..+-||-|+||.||.++...+++.||+|++...  +-...+.+.+|+++|..++|.|++..++.....     .++|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            34455799999999999999999999999988543  223456789999999999999999999887543     36789


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ++|.|+. +|...+-.  .+.|+-+.+.-+..||++||.|||   +.+|.||||||.|.|++.+...||||||+++....
T Consensus       135 ~TELmQS-DLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  135 LTELMQS-DLHKIIVS--PQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHHh-hhhheecc--CCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccch
Confidence            9999976 88888743  456888999999999999999999   78899999999999999999999999999996543


Q ss_pred             CCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHH--------hhc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATEC--------YRN  700 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~--------~~~  700 (767)
                       ......+..+-|..|.|||.+++ ..|+...||||.||+..||+..+.-|......++.+++.-....        --+
T Consensus       209 -d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  209 -RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             -hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence             23333455567889999999986 47999999999999999999999888766655544443211100        011


Q ss_pred             CCccccccccccC---------CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042216          701 GKIGDIIDPFLKG---------NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGL  748 (767)
Q Consensus       701 ~~~~~~~d~~l~~---------~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L  748 (767)
                      |.-..++....+.         ..+.....+.+.+...++..||..|.+..+.+..+
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            1111111111111         11122334566788889999999999988887654

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=4.3e-27  Score=235.51  Aligned_cols=211  Identities=34%  Similarity=0.526  Sum_probs=183.8

Q ss_pred             eeccCcEEEEEEEecCCCceEEEEEeCCCCCc-chhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCChhh
Q 042216          483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ-GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRD  561 (767)
Q Consensus       483 LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gsL~~  561 (767)
                      ||+|.+|.||++...++++.+++|++...... ....+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            68999999999999876789999999765432 34678999999999999999999999999899999999999999999


Q ss_pred             hhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC-CCcEEEeecCCcccCCCCCCcccccccc
Q 042216          562 HLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE-EWVAKVSDFGLCKFGPNFSKTHVSTQVK  640 (767)
Q Consensus       562 ~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~-~~~~ki~DfGla~~~~~~~~~~~~~~~~  640 (767)
                      ++.... ..+++..+..++.++++++.+||   ..+++|+||+|.||+++. ++.++|+|||.+........  ......
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~  154 (215)
T cd00180          81 LLKENE-GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV  154 (215)
T ss_pred             HHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence            986542 35899999999999999999999   678999999999999999 89999999999876433211  123345


Q ss_pred             CCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhh
Q 042216          641 GSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVC  719 (767)
Q Consensus       641 gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  719 (767)
                      +...|++||..... ..+.+.|+|++|+++++|                                               
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------  187 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------  187 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence            77889999999877 888999999999999998                                               


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          720 LNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       720 ~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                       ..+.+++..|++.+|.+||++.++++.
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence             457899999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=5e-26  Score=231.46  Aligned_cols=200  Identities=33%  Similarity=0.448  Sum_probs=172.8

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc-chhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCC
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ-GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMA  555 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~  555 (767)
                      |...+.||+|++|.||++...++++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            44567899999999999999887789999999866544 56788999999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccc
Q 042216          556 RGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHV  635 (767)
Q Consensus       556 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~  635 (767)
                      +++|.+++..... .+++..+..++.+++.++.+||   ..+++|+||+++||+++.++.++|+|||++....... ...
T Consensus        81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~~  155 (225)
T smart00221       81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AAL  155 (225)
T ss_pred             CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-ccc
Confidence            9999999865432 1889999999999999999999   6789999999999999999999999999988654322 012


Q ss_pred             cccccCCCcccChhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 042216          636 STQVKGSIGYLDPEYY-RLQLLTEKSDVYSFGVVLLEVLCARPPILR  681 (767)
Q Consensus       636 ~~~~~gt~~y~aPE~~-~~~~~s~ksDV~SfGvvl~elltg~~P~~~  681 (767)
                      .....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            2334577889999998 667888899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=1.9e-27  Score=253.45  Aligned_cols=197  Identities=22%  Similarity=0.360  Sum_probs=170.1

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--------cchhHHHHHHHHHhccc---cceeeeEeeeeec
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--------QGALEFQTEIGMLSQLR---YLHLVSLIGYCND  543 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--------~~~~~f~~Ei~~l~~l~---Hpniv~l~g~~~~  543 (767)
                      .+|.....||+|+||.|+++.++.....|+||.+.+..-        ...-..-.||++|..|+   |+||+++++++++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            368888899999999999999998888999998865411        11123567999999997   9999999999999


Q ss_pred             CCceEEEEecCC-CCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecC
Q 042216          544 DGQMILVYDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFG  622 (767)
Q Consensus       544 ~~~~~lV~ey~~-~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfG  622 (767)
                      ++.+||+||-.. +-+|++++..+  +.+++.+...|+.||+.|+++||   +++|||||||-+||.++.+|.+||+|||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeecc
Confidence            999999999764 45999999554  45999999999999999999999   8999999999999999999999999999


Q ss_pred             CcccCCCCCCccccccccCCCcccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCC
Q 042216          623 LCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLT-EKSDVYSFGVVLLEVLCARPPIL  680 (767)
Q Consensus       623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~SfGvvl~elltg~~P~~  680 (767)
                      .+.+.    +.......+||.+|.|||++.+.+|- ..-|||++|++||.++....||.
T Consensus       716 saa~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  716 SAAYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             chhhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            98753    33345667899999999999988764 56899999999999999988885

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=2.2e-27  Score=257.09  Aligned_cols=253  Identities=23%  Similarity=0.337  Sum_probs=204.8

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      .+|..+..+|.|.+|.|||++.+..++..|+|.++........-.++|+-+++..+||||+.++|-+...+.++++||||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            46777789999999999999999889999999998776666777889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      .+|+|.+.-+.  ..+|++.++...|+...+||+|||   +.+-+|||||-.|||+++.+.+|++|||.+.....  .-.
T Consensus        95 gggslQdiy~~--TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti~  167 (829)
T KOG0576|consen   95 GGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIA  167 (829)
T ss_pred             CCCcccceeee--cccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh--hhh
Confidence            99999997743  457999999999999999999999   78889999999999999999999999999754321  112


Q ss_pred             ccccccCCCcccChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          635 VSTQVKGSIGYLDPEYYR---LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                      ......||+.|||||+..   .+.|..++|||+.|+...|+---++|....-..  ..+......         ..++--
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--r~l~LmTkS---------~~qpp~  236 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--RALFLMTKS---------GFQPPT  236 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--HHHHHhhcc---------CCCCCc
Confidence            234567999999999763   567999999999999999998888886443221  111111111         111111


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       -.......+.+.++++.|+-.+|++||+++.++.
T Consensus       237 -lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  237 -LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             -ccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence             1123456778899999999999999999987763

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.4e-26  Score=224.88  Aligned_cols=258  Identities=17%  Similarity=0.258  Sum_probs=194.4

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc-ccceeeeEeee-eecCCceEEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGY-CNDDGQMILVY  551 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~-~~~~~~~~lV~  551 (767)
                      .+.|.+.+.||+|.||.+-++.+++.++.+++|-+... ....++|.+|...--.| .|.||+.-++. +...+..++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            34678888999999999999999999999999987533 34467899998776666 58899988765 45667888999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC--CCCcEEEeecCCcccCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD--EEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld--~~~~~ki~DfGla~~~~~  629 (767)
                      ||++.|+|.+-+..   ..+-+....+++.|++.||.|+|   +..+||||||.+||||-  +..++||||||+.+... 
T Consensus       102 E~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g-  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG-  174 (378)
T ss_pred             ccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccC-
Confidence            99999999988743   34788889999999999999999   88999999999999993  34589999999987422 


Q ss_pred             CCCccccccccCCCcccChhhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQ-----LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG  704 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  704 (767)
                          .......-+..|.+||.....     ...+.+|+|.||++++.++||++||.....   .+-..|-+..+..+...
T Consensus       175 ----~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~---~d~~Y~~~~~w~~rk~~  247 (378)
T KOG1345|consen  175 ----TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI---MDKPYWEWEQWLKRKNP  247 (378)
T ss_pred             ----ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc---cCchHHHHHHHhcccCc
Confidence                122233456789999977532     356789999999999999999999973322   22233444445444433


Q ss_pred             ccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 042216          705 DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF  752 (767)
Q Consensus       705 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~  752 (767)
                      .+.+.     + ...+++++++.++-+.+++++|=...++.++-....
T Consensus       248 ~~P~~-----F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w  289 (378)
T KOG1345|consen  248 ALPKK-----F-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW  289 (378)
T ss_pred             cCchh-----h-cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence            22211     1 123566788889999999999977777766655544

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=2e-26  Score=231.05  Aligned_cols=255  Identities=22%  Similarity=0.266  Sum_probs=192.8

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecC------Cc
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD------GQ  546 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~------~~  546 (767)
                      .+|..+..+|.|.- .|..+...-.+++||+|++...  .....+.-.+|...+..+.|+|+++++.++...      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45666777888888 6666666556689999987543  334456678999999999999999999998543      47


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      .|+|||+|.. +|.+.++    -.++...+..|..|++.|++|||   +.+|+||||||+||++..++.+||.|||+++.
T Consensus        96 ~y~v~e~m~~-nl~~vi~----~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVIL----MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             HHHHHHhhhh-HHHHHHH----HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcc
Confidence            8999999975 9998886    24788899999999999999999   88999999999999999999999999999985


Q ss_pred             CCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCc---
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKI---  703 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~---  703 (767)
                      ...   .-..+....|..|.|||++.+..+.+..||||.||++.||++|+.-|.+.+.     +..|..-.-..|..   
T Consensus       168 e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~-----idQ~~ki~~~lgtpd~~  239 (369)
T KOG0665|consen  168 EDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH-----IDQWNKIIEQLGTPDPS  239 (369)
T ss_pred             cCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH-----HHHHHHHHHHhcCCCHH
Confidence            322   2345666788899999999988899999999999999999999988864432     22221111110000   


Q ss_pred             ------------------------cc-cccccccC--CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          704 ------------------------GD-IIDPFLKG--NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       704 ------------------------~~-~~d~~l~~--~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                                              .+ +-|.....  +.+......+.+++.+||..+|++|-+++++|+
T Consensus       240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                                    00 00110100  111223445788999999999999999999985

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.93  E-value=3.4e-26  Score=218.66  Aligned_cols=256  Identities=21%  Similarity=0.326  Sum_probs=192.6

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc-cceeeeEeeeeecC--CceEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-YLHLVSLIGYCNDD--GQMILV  550 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~--~~~~lV  550 (767)
                      .++|+..+.+|+|.++.|+.|..-.+.+.++||++++.   ..+.+.+|+.+|..|+ ||||++|++...+.  ....||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            35788888999999999999998777789999999854   3457889999999997 99999999998764  467899


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC-CCcEEEeecCCcccCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE-EWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~-~~~~ki~DfGla~~~~~  629 (767)
                      +||+.+-+...+.     +.|+...+...+.+++.||.|+|   +.||.|||+||.|++||. .-..+|+|+|||.+...
T Consensus       114 FE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             hhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            9999997776654     34677788889999999999999   899999999999999995 55789999999987543


Q ss_pred             CCCccccccccCCCcccChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHH--------hhc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYR-LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATEC--------YRN  700 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~--------~~~  700 (767)
                      ...-   ...+.+..|.-||.+- .+.|+..-|+|||||+|.+|+..+.||....+.. .+++..+.-.        +.+
T Consensus       186 ~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  186 GKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             Ccee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HHHHHHHHHhChHHHHHHHHH
Confidence            2221   2233456678899875 4678899999999999999999999985433221 2222221100        000


Q ss_pred             CCccccccccccC----------------CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          701 GKIGDIIDPFLKG----------------NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       701 ~~~~~~~d~~l~~----------------~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      -.+  .+|+.+.+                .-..-...+.++++...|..|-++|||+.|...
T Consensus       262 Y~i--~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  262 YQI--DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             Hcc--CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            000  02222111                001113467889999999999999999999874

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=6e-25  Score=230.90  Aligned_cols=132  Identities=25%  Similarity=0.372  Sum_probs=114.1

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc-----c---ceeeeEeeeeecC--
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-----Y---LHLVSLIGYCNDD--  544 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-----H---pniv~l~g~~~~~--  544 (767)
                      .+|...++||-|.|++||++....+.+-||+|+.+.. +.-.+.-+.||++|++++     |   .+||+|++++...  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            5788888999999999999999999999999998743 233445688999999884     2   3899999999753  


Q ss_pred             --CceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE
Q 042216          545 --GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL  610 (767)
Q Consensus       545 --~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl  610 (767)
                        .+++||+|++.. +|..+|....-+.++...+.+||.||+.||.|||+.|  +|||-||||+|||+
T Consensus       157 NG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence              589999999954 9999998877778999999999999999999999854  89999999999999

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.2e-25  Score=219.76  Aligned_cols=246  Identities=20%  Similarity=0.331  Sum_probs=196.7

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCCh
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTL  559 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gsL  559 (767)
                      +|.+...|..|+|++.+.  .+++|++...  .....++|..|.-.|+.+.||||++++|.|....++.++..||+.|||
T Consensus       197 kl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl  274 (448)
T KOG0195|consen  197 KLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL  274 (448)
T ss_pred             hhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence            588899999999999865  4666766432  344456799999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccccc
Q 042216          560 RDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV  639 (767)
Q Consensus       560 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~  639 (767)
                      ...|++...-..+..+..+++.++|+||+|||+.. +-|.---|.+..|++|++.+++|+- +-+++.      -.....
T Consensus       275 ynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kfs------fqe~gr  346 (448)
T KOG0195|consen  275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKFS------FQEVGR  346 (448)
T ss_pred             HHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccceee------eecccc
Confidence            99999888778899999999999999999999643 3344556899999999999998851 111110      011112


Q ss_pred             cCCCcccChhhhccCCCC---chhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCC
Q 042216          640 KGSIGYLDPEYYRLQLLT---EKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP  716 (767)
Q Consensus       640 ~gt~~y~aPE~~~~~~~s---~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  716 (767)
                      .-.+.||+||.+..++-+   ..+|+|||.++||||.|...||......+...               ++.-..++-..|
T Consensus       347 ~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm---------------kialeglrv~ip  411 (448)
T KOG0195|consen  347 AYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM---------------KIALEGLRVHIP  411 (448)
T ss_pred             ccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---------------hhhhccccccCC
Confidence            345789999999876543   57899999999999999999997766543221               112234666778


Q ss_pred             hhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 042216          717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF  752 (767)
Q Consensus       717 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~  752 (767)
                      +..+..+.+++.-|+..||.+||.+..|+-.||++.
T Consensus       412 pgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  412 PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            888999999999999999999999999999999864

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.92  E-value=8.7e-26  Score=237.96  Aligned_cols=265  Identities=20%  Similarity=0.225  Sum_probs=199.9

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc------cceeeeEeeeeecCCc
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR------YLHLVSLIGYCNDDGQ  546 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~------Hpniv~l~g~~~~~~~  546 (767)
                      .-..|......|+|-|++|.+|.....++.||||++..+ +.-.+.=+.|+++|.+|.      --|+++|+..+...++
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            345777777899999999999998877789999999754 223344578999999995      2488999999999999


Q ss_pred             eEEEEecCCCCChhhhhccC-CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC-cEEEeecCCc
Q 042216          547 MILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW-VAKVSDFGLC  624 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~-~~ki~DfGla  624 (767)
                      +|||+|-+.. +|.+.|++- .+-.|....+..++.|+.-||..|-   ..+|+|.||||.|||+++.- .+||||||.|
T Consensus       509 LClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  509 LCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             eEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCccc
Confidence            9999998865 999999753 3446888999999999999999999   77899999999999998754 6799999998


Q ss_pred             ccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHh-----h
Q 042216          625 KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECY-----R  699 (767)
Q Consensus       625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~-----~  699 (767)
                      .......   + +....+.-|.|||++.+-.|+...|+||.||+||||.||+.-|.+........+..-+...+     .
T Consensus       585 ~~~~ene---i-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR  660 (752)
T KOG0670|consen  585 SFASENE---I-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR  660 (752)
T ss_pred             ccccccc---c-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence            7543321   1 11223456999999999999999999999999999999999997766544333332221111     1


Q ss_pred             cCC-ccccccccc--------------------------------cC--CC---ChhhHHHHHHHHHHccccCCCCCCCH
Q 042216          700 NGK-IGDIIDPFL--------------------------------KG--NA---PPVCLNQFVEVAMSCVNDDRIRRPSM  741 (767)
Q Consensus       700 ~~~-~~~~~d~~l--------------------------------~~--~~---~~~~~~~l~~li~~Cl~~dp~~RPs~  741 (767)
                      .+. ..+.+|..+                                .+  ..   .+....+|.+|+..|+..||++|.|.
T Consensus       661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~  740 (752)
T KOG0670|consen  661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV  740 (752)
T ss_pred             hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence            111 111122210                                00  01   12345668899999999999999999


Q ss_pred             HHHHH
Q 042216          742 SDVVW  746 (767)
Q Consensus       742 ~evl~  746 (767)
                      .+.|.
T Consensus       741 nqAL~  745 (752)
T KOG0670|consen  741 NQALK  745 (752)
T ss_pred             HHHhc
Confidence            99874

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=4.1e-25  Score=266.44  Aligned_cols=197  Identities=18%  Similarity=0.202  Sum_probs=139.5

Q ss_pred             hcccc-ceeeeEeeee-------ecCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCe
Q 042216          527 SQLRY-LHLVSLIGYC-------NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVI  598 (767)
Q Consensus       527 ~~l~H-pniv~l~g~~-------~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  598 (767)
                      +.++| +||.+++++|       .+...+++++||+ +++|.++|... ...+++.+++.++.||++||.|||   +++|
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~gI  101 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAH---SQGI  101 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            34556 6888888887       2334678888988 45999999643 345999999999999999999999   7889


Q ss_pred             EecCCCCCCeEECCC-------------------CcEEEeecCCcccCCCCCC--------------ccccccccCCCcc
Q 042216          599 IHRDVKTTNILLDEE-------------------WVAKVSDFGLCKFGPNFSK--------------THVSTQVKGSIGY  645 (767)
Q Consensus       599 iH~Dlk~~NILld~~-------------------~~~ki~DfGla~~~~~~~~--------------~~~~~~~~gt~~y  645 (767)
                      +||||||+||||+..                   +.+|++|||+++.......              ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            999999999999654                   4555666666543211000              0001123578889


Q ss_pred             cChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHH
Q 042216          646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVE  725 (767)
Q Consensus       646 ~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  725 (767)
                      ||||++.+..++.++|||||||+||||++|.+|+.....    ....+...         ...+.     ......+...
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~---------~~~~~-----~~~~~~~~~~  243 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHR---------VLPPQ-----ILLNWPKEAS  243 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHh---------hcChh-----hhhcCHHHHH
Confidence            999999999999999999999999999999888632110    11111000         01110     0112334568


Q ss_pred             HHHHccccCCCCCCCHHHHHH
Q 042216          726 VAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       726 li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ++.+||+.+|.+||+|.||++
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhh
Confidence            889999999999999999985

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.90  E-value=1.2e-23  Score=206.40  Aligned_cols=169  Identities=25%  Similarity=0.289  Sum_probs=126.8

Q ss_pred             CChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcccc
Q 042216          557 GTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVS  636 (767)
Q Consensus       557 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~  636 (767)
                      |+|.+++... ...++|.+++.|+.|++.||.|||   +.+      ||+|||++.++.+|+  ||+++.....      
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------   62 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE------   62 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc------
Confidence            7899999653 346999999999999999999999   443      999999999999999  9998764321      


Q ss_pred             ccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCC
Q 042216          637 TQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP  716 (767)
Q Consensus       637 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  716 (767)
                       ...|++.|||||++.+..++.++|||||||++|||++|+.||....... ..+..+.... ...      ++.. ...+
T Consensus        63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~-~~~------~~~~-~~~~  132 (176)
T smart00750       63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGM-PAD------DPRD-RSNL  132 (176)
T ss_pred             -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHh-ccC------Cccc-cccH
Confidence             1258899999999999999999999999999999999999985433211 1111111111 110      0000 0111


Q ss_pred             hhhHH--HHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          717 PVCLN--QFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       717 ~~~~~--~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                      .....  ++.+++.+||+.+|.+||++.|+++.+..+..
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            22233  68999999999999999999999999877654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.90  E-value=6.1e-24  Score=221.04  Aligned_cols=264  Identities=23%  Similarity=0.320  Sum_probs=195.0

Q ss_pred             HHhhccccceeeeccCcEEEEEEEecC---CCceEEEEEeCCCCCcchhHHHHHHHHHhccc-cceeeeEeeeeecCCce
Q 042216          472 EATKDFNNLLIIGRGGFGNVYKGFLNG---DSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-YLHLVSLIGYCNDDGQM  547 (767)
Q Consensus       472 ~~t~~f~~~~~LG~G~fG~Vy~g~~~~---~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~  547 (767)
                      ...+.|..+++||+|.|++||++++..   ....||+|.+...+.  .....+|+++|..+. +.||+++.++...++..
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v  110 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV  110 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence            345678888999999999999998866   567899999875543  346889999999994 89999999999999999


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC-CCCcEEEeecCCccc
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKF  626 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld-~~~~~ki~DfGla~~  626 (767)
                      .+|+||+++-...+++..     ++..++...++.+..||.++|   .++||||||||+|+|.+ ..+.-.|.||||+..
T Consensus       111 ~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             EEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHH
Confidence            999999999999888743     668889999999999999999   89999999999999997 456778999999861


Q ss_pred             CCC--------------CC----------------------------CccccccccCCCcccChhhhc-cCCCCchhhHH
Q 042216          627 GPN--------------FS----------------------------KTHVSTQVKGSIGYLDPEYYR-LQLLTEKSDVY  663 (767)
Q Consensus       627 ~~~--------------~~----------------------------~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~  663 (767)
                      ...              ..                            .........||+||.|||++. ...-++++|||
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw  262 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW  262 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence            000              00                            000011245999999999875 56778999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCCccchhHHHHHH---------HHhhcCC--ccc---------c------cc-ccccC-C-
Q 042216          664 SFGVVLLEVLCARPPILRTGDKKQVNLAVWAT---------ECYRNGK--IGD---------I------ID-PFLKG-N-  714 (767)
Q Consensus       664 SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~---------~~~~~~~--~~~---------~------~d-~~l~~-~-  714 (767)
                      |.||+++-+++++.||....+.- ..+.+.+.         .....|.  +.+         +      ++ ..+.. . 
T Consensus       263 s~GVI~Lslls~~~PFf~a~dd~-~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q  341 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFFKAKDDA-DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ  341 (418)
T ss_pred             eccceeehhhccccccccCcccc-chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence            99999999999999996543321 11111110         0001111  000         0      00 00000 0 


Q ss_pred             -------CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          715 -------APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       715 -------~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                             .....+..+++++.+|+..||.+|.|+++.|+
T Consensus       342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence                   01112346889999999999999999999984

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=4.2e-22  Score=214.58  Aligned_cols=168  Identities=21%  Similarity=0.179  Sum_probs=129.1

Q ss_pred             HHHhhccccceeeeccCcEEEEEEEecC-CCceEEEEEeCCCC-----CcchhHHHHHHHHHhccccceeeeEeeeeecC
Q 042216          471 KEATKDFNNLLIIGRGGFGNVYKGFLNG-DSTPVAIKRLNPGS-----QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD  544 (767)
Q Consensus       471 ~~~t~~f~~~~~LG~G~fG~Vy~g~~~~-~~~~vAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~  544 (767)
                      .....+|...+.||+|+||+||+|.++. +++.+|||++....     ....+.|.+|+++|++++|+|+++.+..   .
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence            3456789999999999999999998865 55778999875331     1224568999999999999999854322   2


Q ss_pred             CceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCC-CCCCeEECCCCcEEEeecCC
Q 042216          545 GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDV-KTTNILLDEEWVAKVSDFGL  623 (767)
Q Consensus       545 ~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dl-k~~NILld~~~~~ki~DfGl  623 (767)
                      +..+|||||+++++|... . ..    .   ...++.+++++|.|||   +++|+|||| ||+|||++.++.+||+|||+
T Consensus        91 ~~~~LVmE~~~G~~L~~~-~-~~----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLA-R-PH----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             CCcEEEEEccCCCCHHHh-C-cc----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            468999999999999632 1 11    1   1467889999999999   789999999 99999999999999999999


Q ss_pred             cccCCCCCCccc------cccccCCCcccChhhhcc
Q 042216          624 CKFGPNFSKTHV------STQVKGSIGYLDPEYYRL  653 (767)
Q Consensus       624 a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~  653 (767)
                      ++..........      .+...+++.|+|||++..
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            986543221111      134568888999998854

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=5.8e-20  Score=198.25  Aligned_cols=262  Identities=21%  Similarity=0.192  Sum_probs=196.8

Q ss_pred             ccccceeeeccCcEEEEEEEecCCC-ceEEEEEeCCCCCcchhHHHHHHHHHhcccc----ceeeeEeeee-ecCCceEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDS-TPVAIKRLNPGSQQGALEFQTEIGMLSQLRY----LHLVSLIGYC-NDDGQMIL  549 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~-~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H----pniv~l~g~~-~~~~~~~l  549 (767)
                      +|.....||+|+||.||++.....+ ..+|+|.-..........+..|+.++..+.+    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            7889999999999999999987653 5788887765433333367888888888863    5888888888 47778899


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCC-----CcEEEeecCCc
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEE-----WVAKVSDFGLC  624 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~-----~~~ki~DfGla  624 (767)
                      ||+.+ +-+|.++........++..+.+.|+.|++.+|.+||   +.+++||||||.|+++...     ..+.|.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99977 559999876555567999999999999999999999   8889999999999999865     46899999999


Q ss_pred             c--cCCCCCCc---cc---cccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccch-hHHHHHH
Q 042216          625 K--FGPNFSKT---HV---STQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQV-NLAVWAT  695 (767)
Q Consensus       625 ~--~~~~~~~~---~~---~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~-~l~~~~~  695 (767)
                      +  ........   ..   .....||..|.++....+...+.+.|+||++.++.|++.|..||......... .+.....
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8  32111110   11   22355999999999999999999999999999999999999999554432211 1111100


Q ss_pred             HHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 042216          696 ECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL  754 (767)
Q Consensus       696 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~  754 (767)
                      .        .....     .....+.++.++...+-..+..++|....+...|+.+...
T Consensus       255 ~--------~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  255 K--------LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             h--------hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            0        00000     1222345566666666668999999999999988777654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.85  E-value=1.4e-19  Score=193.48  Aligned_cols=260  Identities=30%  Similarity=0.419  Sum_probs=195.8

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc---chhHHHHHHHHHhccccc-eeeeEeeeeecCCceEEEEe
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ---GALEFQTEIGMLSQLRYL-HLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~---~~~~f~~Ei~~l~~l~Hp-niv~l~g~~~~~~~~~lV~e  552 (767)
                      |.....||.|+||.||++...   ..+++|.+......   ....+.+|+.++..+.|+ +++++.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            456678999999999999987   67899998765333   366799999999999988 79999999977777899999


Q ss_pred             cCCCCChhhhhccCCC-CCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC-cEEEeecCCcccCCCC
Q 042216          553 YMARGTLRDHLYNNDN-PPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW-VAKVSDFGLCKFGPNF  630 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~-~~ki~DfGla~~~~~~  630 (767)
                      ++.+++|.+++..... ..+.......++.+++.++.|+|   ..+++|||+||+||+++... .++++|||+++.....
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999977654322 26889999999999999999999   67799999999999999988 7999999998754332


Q ss_pred             CCcc----ccccccCCCcccChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc-cchhHHHHHHHHhhcCC
Q 042216          631 SKTH----VSTQVKGSIGYLDPEYYRL---QLLTEKSDVYSFGVVLLEVLCARPPILRTGDK-KQVNLAVWATECYRNGK  702 (767)
Q Consensus       631 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~-~~~~l~~~~~~~~~~~~  702 (767)
                      ....    ......|+..|+|||.+..   ...+...|+||+|++++++++|..|+...... ...............  
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--  233 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--  233 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence            2211    2356679999999999987   57889999999999999999999996444321 011111111111000  


Q ss_pred             ccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       703 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                         .................+.+++..|+..+|..|.++.+....
T Consensus       234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 ---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence               000000000002223567899999999999999998887764

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=1.3e-20  Score=206.25  Aligned_cols=219  Identities=25%  Similarity=0.386  Sum_probs=165.5

Q ss_pred             HhccccceeeeEeeeeecCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCC
Q 042216          526 LSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKT  605 (767)
Q Consensus       526 l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~  605 (767)
                      |+.+.|.|+.+++|.|.++...+.|.+||..|+|.+.+... ...++|.....+..+++.||.|||.  ++-..|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeecc
Confidence            46789999999999999999999999999999999999764 3569999999999999999999995  44449999999


Q ss_pred             CCeEECCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccC-------CCCchhhHHHHHHHHHHHHhCCCC
Q 042216          606 TNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ-------LLTEKSDVYSFGVVLLEVLCARPP  678 (767)
Q Consensus       606 ~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDV~SfGvvl~elltg~~P  678 (767)
                      +|+++|..+.+||+|||+..+..............-..-|.|||.+...       ..+.+.||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999998765321111111222234569999998763       257789999999999999999999


Q ss_pred             CCCCCCccch-hHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 042216          679 ILRTGDKKQV-NLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL  754 (767)
Q Consensus       679 ~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~  754 (767)
                      |......... .+...+..     .....+.|.+....  +..+++..++.+||..+|.+||++.+|-..++.+...
T Consensus       158 ~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             cccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            9654332221 22222211     11122222222111  3444789999999999999999999999888877653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=3.6e-21  Score=220.76  Aligned_cols=254  Identities=19%  Similarity=0.236  Sum_probs=187.8

Q ss_pred             cceeeeccCcEEEEEEEecCCCceEEEEEeC----CC-CCcc-hhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          479 NLLIIGRGGFGNVYKGFLNGDSTPVAIKRLN----PG-SQQG-ALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       479 ~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~----~~-~~~~-~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ..+++|.|.+|.|+..+........+.|...    .. .... ...+..|..+-..++|+|++..+..+.+.....-.||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4457999999988887776555555555432    11 1111 1125667777788899999988888877777777799


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      ||+. +|..++...  ..+.-.++..++.|+..|+.|||   ..+|.|||+|++|+++..++.+||+|||.+.......+
T Consensus       402 ~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             cccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            9999 999998554  35888899999999999999999   78899999999999999999999999999876544333


Q ss_pred             c--cccccccCCCcccChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          633 T--HVSTQVKGSIGYLDPEYYRLQLLTEK-SDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       633 ~--~~~~~~~gt~~y~aPE~~~~~~~s~k-sDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                      .  ......+|+..|+|||.+....|.+. .||||.|+++..|++|+.||......++....      .....-..+...
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~------~~~~~~~~~~~~  549 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT------NNYSDQRNIFEG  549 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh------hccccccccccC
Confidence            3  55667889999999999999998875 89999999999999999999554333222100      000000000000


Q ss_pred             cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       710 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                        ........+.+...++.++|+.||.+|-|+++|++
T Consensus       550 --~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  550 --PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             --hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence              00111234556788999999999999999999974

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.80  E-value=2.6e-20  Score=212.33  Aligned_cols=248  Identities=21%  Similarity=0.252  Sum_probs=180.6

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC-CCcchhHHHHHHHH--HhccccceeeeEeeeeecCCceEEEEe
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-SQQGALEFQTEIGM--LSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~-~~~~~~~f~~Ei~~--l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ++...+.||++.|=+|.+++++++  .|+||++-+. ..-..+.|.++++-  ...++|||.+++..+-..+...|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            566667899999999999999865  3899988544 34445555554433  445589999999988888888899999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc--CCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF--GPNF  630 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~--~~~~  630 (767)
                      |..+ +|.|.|  ..++-|...+...|+.|++.||.-+|   ..+|+|||||.+||||+.-.-+.|+||.--+.  .+++
T Consensus       102 yvkh-nLyDRl--STRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  102 YVKH-NLYDRL--STRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHhh-hhhhhh--ccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            9987 999998  55666888899999999999999999   78899999999999999988999999987542  2221


Q ss_pred             CCc---cccccccCCCcccChhhhccC-----------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHH
Q 042216          631 SKT---HVSTQVKGSIGYLDPEYYRLQ-----------LLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWAT  695 (767)
Q Consensus       631 ~~~---~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~  695 (767)
                      ...   .-......-.+|+|||.+...           .++++.||||+||+++||++ |+++|.-      .+|..   
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~a---  246 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLA---  246 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHh---
Confidence            111   111223344689999977431           27789999999999999998 7888721      11111   


Q ss_pred             HHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          696 ECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       696 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                        ++.+. .......|.. .   +...+.++++.|++.||.+|.++++.|+.
T Consensus       247 --Yr~~~-~~~~e~~Le~-I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  247 --YRSGN-ADDPEQLLEK-I---EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             --HhccC-ccCHHHHHHh-C---cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence              11111 0000000100 0   11246789999999999999999999977

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.78  E-value=6.9e-19  Score=174.45  Aligned_cols=137  Identities=16%  Similarity=0.185  Sum_probs=105.9

Q ss_pred             eeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc--c-------hhHH-----------------HHHHHHHhcccccee
Q 042216          481 LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--G-------ALEF-----------------QTEIGMLSQLRYLHL  534 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~--~-------~~~f-----------------~~Ei~~l~~l~Hpni  534 (767)
                      ..||+|+||.||+|... +++.||||+++.....  .       ...|                 ..|++.+.++.++++
T Consensus         3 ~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           3 GCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            47999999999999987 6789999999754211  1       1122                 349999999987766


Q ss_pred             eeEeeeeecCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHh-HhCCCCCeEecCCCCCCeEECCC
Q 042216          535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL-HTGASKVIIHRDVKTTNILLDEE  613 (767)
Q Consensus       535 v~l~g~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiH~Dlk~~NILld~~  613 (767)
                      .....+.  ....+|||||+++++|...+..  ...+++.+...++.|++.+|.+| |   ..+|+||||||+|||+++ 
T Consensus        82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~~-  153 (190)
T cd05147          82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYHD-  153 (190)
T ss_pred             CCCcEEE--ecCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEEC-
Confidence            4332222  1234899999999877655322  24688999999999999999999 6   678999999999999984 


Q ss_pred             CcEEEeecCCccc
Q 042216          614 WVAKVSDFGLCKF  626 (767)
Q Consensus       614 ~~~ki~DfGla~~  626 (767)
                      +.++|+|||++..
T Consensus       154 ~~v~LiDFG~a~~  166 (190)
T cd05147         154 GKLYIIDVSQSVE  166 (190)
T ss_pred             CcEEEEEcccccc
Confidence            7899999999874

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.78  E-value=5.4e-19  Score=177.38  Aligned_cols=171  Identities=12%  Similarity=0.088  Sum_probs=131.4

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhH---------HHHHHHHHhccccceeeeEeeeeec
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE---------FQTEIGMLSQLRYLHLVSLIGYCND  543 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~---------f~~Ei~~l~~l~Hpniv~l~g~~~~  543 (767)
                      ..++|...++||.|+||.||+....  +..+|||.+.+........         +.+|++.+.+++|++|..+..+...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~~--~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDTD--YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEecC--CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            3578999999999999999997553  4579999997653322222         6789999999999999999887542


Q ss_pred             C--------CceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCc
Q 042216          544 D--------GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV  615 (767)
Q Consensus       544 ~--------~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~  615 (767)
                      .        +..+|+|||++|.+|.++..      ++.    ....+++.+|..||   ..+++|||+||+|++++.++ 
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-
Confidence            2        46899999999999988741      222    34568999999999   78899999999999999988 


Q ss_pred             EEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHH
Q 042216          616 AKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL  673 (767)
Q Consensus       616 ~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ell  673 (767)
                      ++|+|||...........              ..+.....+..++|+|+||+++..+.
T Consensus       173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999999987643211100              11344455667999999999987653

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.77  E-value=2.5e-18  Score=177.74  Aligned_cols=233  Identities=18%  Similarity=0.232  Sum_probs=149.9

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccc----------cceeeeEeeeee
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLR----------YLHLVSLIGYCN  542 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~----------Hpniv~l~g~~~  542 (767)
                      .+.....||.|+++.||.+++.++++.+|||+....   .....+++.+|.-....+.          |-.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            345566899999999999999999999999987433   2334556666665444432          222222222221


Q ss_pred             ---------cC---C-----ceEEEEecCCCCChhhhhc---cC--CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEe
Q 042216          543 ---------DD---G-----QMILVYDYMARGTLRDHLY---NN--DNPPLPWDRRLKICIGAARALHYLHTGASKVIIH  600 (767)
Q Consensus       543 ---------~~---~-----~~~lV~ey~~~gsL~~~L~---~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH  600 (767)
                               ..   .     ..+++|+-+. ++|.+++.   ..  ....+....++.+..|+++.+++||   ..+++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence                     11   1     3467888774 48887753   21  1224556677888899999999999   788999


Q ss_pred             cCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccC--------CCCchhhHHHHHHHHHHH
Q 042216          601 RDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ--------LLTEKSDVYSFGVVLLEV  672 (767)
Q Consensus       601 ~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~s~ksDV~SfGvvl~el  672 (767)
                      +||||+|+|++.+|.++|+||+.......    ... ....+..|.+||.....        .++.+.|.|++|+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~-~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT----RYR-CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTE----EEE-GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCc----eee-ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            99999999999999999999987653221    111 13355789999977542        578899999999999999


Q ss_pred             HhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCC
Q 042216          673 LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRR  738 (767)
Q Consensus       673 ltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~R  738 (767)
                      +||+.||...........                    .-..+. +.++.+..|+..+|+.+|.+|
T Consensus       244 WC~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999965433211100                    112233 667889999999999999988

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.77  E-value=6.3e-18  Score=163.56  Aligned_cols=263  Identities=19%  Similarity=0.208  Sum_probs=192.1

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcccc-ceeeeEeeeeecCCceEEEEe
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRY-LHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H-pniv~l~g~~~~~~~~~lV~e  552 (767)
                      ..+|..++.||+|+||.+|.|..-..+..||||.-+...  ..-++..|.++...|+| ..|..+..|..++..-.|||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            467889999999999999999998888999999865432  23356788888888875 566677778888888999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCC---CcEEEeecCCcccCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEE---WVAKVSDFGLCKFGPN  629 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~---~~~ki~DfGla~~~~~  629 (767)
                      .+ +-||.++..-.. ..++.++.+-++-|++.-++|+|   .++.+||||||+|.|+.-+   ..+.++||||++....
T Consensus        92 LL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             cc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            88 448888764333 35888899999999999999999   7779999999999999743   4688999999985433


Q ss_pred             CCC-cc----ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc
Q 042216          630 FSK-TH----VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG  704 (767)
Q Consensus       630 ~~~-~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  704 (767)
                      ... .+    ......||.+|.+-....+-.-+..-|+=|+|.+|..+-.|..||.+.......+-.+...+.    ++.
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek----K~s  242 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK----KMS  242 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh----hcC
Confidence            211 11    123456999999888777777788899999999999999999999877554333322222221    111


Q ss_pred             ccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 042216          705 DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF  752 (767)
Q Consensus       705 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~  752 (767)
                      -.+. .+    ....+.++...+.-|-..--++-|.-.-+.+.+.-+.
T Consensus       243 ~~ie-~L----C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf  285 (341)
T KOG1163|consen  243 TPIE-VL----CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF  285 (341)
T ss_pred             CCHH-HH----hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence            1111 11    1223556777777787777777787666555544443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.76  E-value=5.9e-18  Score=168.26  Aligned_cols=141  Identities=16%  Similarity=0.096  Sum_probs=108.7

Q ss_pred             ceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcc--------------------------hhHHHHHHHHHhccccce
Q 042216          480 LLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQG--------------------------ALEFQTEIGMLSQLRYLH  533 (767)
Q Consensus       480 ~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~--------------------------~~~f~~Ei~~l~~l~Hpn  533 (767)
                      ...||+|++|.||+|... +++.||||+++......                          ...+..|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            357999999999999987 67899999987652110                          111357889999999988


Q ss_pred             eeeEeeeeecCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCC
Q 042216          534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEE  613 (767)
Q Consensus       534 iv~l~g~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~  613 (767)
                      +.....+...  ..+|||||++++++...+..  ...++..+...++.+++.++.+||+  ..+|+||||||+|||++ +
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~  153 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-C
Confidence            7544333322  34899999998865443222  2357788999999999999999993  27899999999999999 7


Q ss_pred             CcEEEeecCCcccCC
Q 042216          614 WVAKVSDFGLCKFGP  628 (767)
Q Consensus       614 ~~~ki~DfGla~~~~  628 (767)
                      +.++|+|||++....
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            899999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=9.1e-18  Score=164.92  Aligned_cols=190  Identities=17%  Similarity=0.100  Sum_probs=141.6

Q ss_pred             ccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcc----hhHHHHHHHHHhccc-cceeeeEeeeeecCCceEEEEe
Q 042216          478 NNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQG----ALEFQTEIGMLSQLR-YLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       478 ~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~----~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      .....|++|+||+||.+..  .+.+++.+.+.......    ...+.+|+++|++|+ |+++.+++++    +..+++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3456899999999997765  34678877776543211    124789999999995 5788898886    35799999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCC-CCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDV-KTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dl-k~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      |+.+.+|.+.+..         ....++.+++++|.++|   ..+|+|||| ||+|||++.++.++|+|||++.......
T Consensus        79 yI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         79 YLAGAAMYQRPPR---------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             eecCccHHhhhhh---------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            9999898754311         12357789999999999   788999999 7999999999999999999998644322


Q ss_pred             Cc----c---c----cccccCCCcccChhhhccC-CCC-chhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 042216          632 KT----H---V----STQVKGSIGYLDPEYYRLQ-LLT-EKSDVYSFGVVLLEVLCARPPILRTGDK  685 (767)
Q Consensus       632 ~~----~---~----~~~~~gt~~y~aPE~~~~~-~~s-~ksDV~SfGvvl~elltg~~P~~~~~~~  685 (767)
                      ..    .   .    ......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+...+.++
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~  213 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG  213 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence            10    0   0    1123367888888865432 333 5678999999999999999988665543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.74  E-value=5.5e-17  Score=163.89  Aligned_cols=265  Identities=19%  Similarity=0.188  Sum_probs=189.4

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEEEec
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      -+|...++||+|.||..+.|+.--.+++||||.-...  .+.-++..|.+..+.| ..+.|...+-+-.++.+-.||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            3678888999999999999998767799999964322  2334567788777777 468888888888888888999998


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC-----CCcEEEeecCCcccCC
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE-----EWVAKVSDFGLCKFGP  628 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~-----~~~~ki~DfGla~~~~  628 (767)
                      +. -||.|+..-. ...++.+++.-||.|++.-++|+|   .+.+|.|||||+|.||..     ...+.|.|||+|+...
T Consensus       106 LG-PSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  106 LG-PSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             hC-cCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            84 4777765433 345899999999999999999999   788999999999999963     3368999999998754


Q ss_pred             CCCC-ccc----cccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCc
Q 042216          629 NFSK-THV----STQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKI  703 (767)
Q Consensus       629 ~~~~-~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~  703 (767)
                      .... .+.    .....||.+||+-....+..-+..-|+=|+|-+.+..+.|..||.+........--+-+.+..+...+
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i  260 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI  260 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence            3221 111    12356999999999888888899999999999999999999999776432111111111111111111


Q ss_pred             cccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          704 GDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       704 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      .++         ....++++..-+.-.-..+-.+-|..+-+..-+..++...
T Consensus       261 ~~L---------c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~  303 (449)
T KOG1165|consen  261 EVL---------CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL  303 (449)
T ss_pred             HHH---------HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence            111         1123445544444444456667788877777777666554

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.73  E-value=1.1e-17  Score=172.34  Aligned_cols=197  Identities=22%  Similarity=0.299  Sum_probs=139.3

Q ss_pred             ccceeeeEeeeeec---------------------------CCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHH
Q 042216          530 RYLHLVSLIGYCND---------------------------DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG  582 (767)
Q Consensus       530 ~Hpniv~l~g~~~~---------------------------~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~  582 (767)
                      +|||||++.+++.+                           ...+|+||.-.+. +|+++|-...   .+...+.-|+.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence            59999999987632                           2357899988876 9999985432   344556668889


Q ss_pred             HHHHHHHhHhCCCCCeEecCCCCCCeEE--CCCC--cEEEeecCCcccCCCC--CCccc--cccccCCCcccChhhhccC
Q 042216          583 AARALHYLHTGASKVIIHRDVKTTNILL--DEEW--VAKVSDFGLCKFGPNF--SKTHV--STQVKGSIGYLDPEYYRLQ  654 (767)
Q Consensus       583 ia~gL~yLH~~~~~~iiH~Dlk~~NILl--d~~~--~~ki~DfGla~~~~~~--~~~~~--~~~~~gt~~y~aPE~~~~~  654 (767)
                      +++|+.|||   .++|.|||+|++|||+  |++.  ...|+|||++-.....  .-...  .-...|...-||||+....
T Consensus       350 lLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            999999999   7889999999999998  4444  5689999997532210  00111  1123477889999988642


Q ss_pred             C------CCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHH
Q 042216          655 L------LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAM  728 (767)
Q Consensus       655 ~------~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~  728 (767)
                      +      --.|+|.|+.|.+.||+++...||...++.- .+...     +++..+         ...+..++..+.+++.
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~-----Yqe~qL---------Palp~~vpp~~rqlV~  491 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRT-----YQESQL---------PALPSRVPPVARQLVF  491 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echhh-----hhhhhC---------CCCcccCChHHHHHHH
Confidence            1      1258999999999999999999997744321 11111     222221         1235567778899999


Q ss_pred             HccccCCCCCCCHHHHHHHH
Q 042216          729 SCVNDDRIRRPSMSDVVWGL  748 (767)
Q Consensus       729 ~Cl~~dp~~RPs~~evl~~L  748 (767)
                      ..++.||.+|++..-....|
T Consensus       492 ~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHhcCCccccCCccHHHhHH
Confidence            99999999999865544444

>PRK10345 hypothetical protein; Provisional

Probab=99.73  E-value=2.6e-17  Score=164.80  Aligned_cols=136  Identities=20%  Similarity=0.223  Sum_probs=106.7

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc-----ccceeeeEeeeeecCC---c-e
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-----RYLHLVSLIGYCNDDG---Q-M  547 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-----~Hpniv~l~g~~~~~~---~-~  547 (767)
                      +....+||+|+||.||.  +...... +||+.........+++.+|+.++..+     .||||++++|++.++.   . .
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            44566899999999996  5545444 79988765555567899999999999     5799999999998763   3 3


Q ss_pred             EEEEec--CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHH-HHhHhCCCCCeEecCCCCCCeEECC----CCcEEEee
Q 042216          548 ILVYDY--MARGTLRDHLYNNDNPPLPWDRRLKICIGAARAL-HYLHTGASKVIIHRDVKTTNILLDE----EWVAKVSD  620 (767)
Q Consensus       548 ~lV~ey--~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~iiH~Dlk~~NILld~----~~~~ki~D  620 (767)
                      .+|+||  +.+|+|.+++.+.   .+++.  ..++.+++.++ +|||   +++|+||||||+|||++.    +..++|+|
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            378999  5589999999543   25555  35677888777 9999   788999999999999973    34899999


Q ss_pred             cCC
Q 042216          621 FGL  623 (767)
Q Consensus       621 fGl  623 (767)
                      |+-
T Consensus       153 g~G  155 (210)
T PRK10345        153 NIG  155 (210)
T ss_pred             CCC
Confidence            543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=7.3e-17  Score=188.63  Aligned_cols=199  Identities=21%  Similarity=0.193  Sum_probs=157.8

Q ss_pred             HHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc---cceeeeEeeeeecCCc
Q 042216          470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR---YLHLVSLIGYCNDDGQ  546 (767)
Q Consensus       470 i~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~---Hpniv~l~g~~~~~~~  546 (767)
                      ++...+.|.+.+.||+|+||+||+|...+ ++.||+|.-++.+..+   |.--.+++.+|+   -+-|..+...+.-.+.
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            33345678888899999999999999987 7899999988776553   322333444444   2234444444455677


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC-------CCCcEEEe
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD-------EEWVAKVS  619 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld-------~~~~~ki~  619 (767)
                      -+||+||.+.|+|.+++.  ..+.++|...+.+..|+++.+..||   ..+|||+||||+|.||.       +..-++|+
T Consensus       769 S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             ceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEE
Confidence            889999999999999995  5567999999999999999999999   78899999999999993       34468999


Q ss_pred             ecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Q 042216          620 DFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARP  677 (767)
Q Consensus       620 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~  677 (767)
                      |||.+-...-..........++|-.+-.+|...+...+.+.|.|.++.+++-|+.|+.
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            9999864333333334455678889999999999999999999999999999999875

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.71  E-value=3.3e-18  Score=187.15  Aligned_cols=226  Identities=23%  Similarity=0.223  Sum_probs=173.9

Q ss_pred             eeeccCcEEEEEEEe---cCCCceEEEEEeCCCCCcc--hhHHHHHHHHHhccc-cceeeeEeeeeecCCceEEEEecCC
Q 042216          482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQG--ALEFQTEIGMLSQLR-YLHLVSLIGYCNDDGQMILVYDYMA  555 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~---~~~~~~vAVK~l~~~~~~~--~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~ey~~  555 (767)
                      ++|+|+||.|+++.-   .+.++.+|+|.+++.....  ......|..++...+ ||.++++.-.+..+...+++.++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999986532   3345778888886553211  113456778888886 9999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccc
Q 042216          556 RGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHV  635 (767)
Q Consensus       556 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~  635 (767)
                      +|.|...+.+..  ..+..........++-++.++|   +.+|+|||+|++||+++.+|.+++.|||+++..-....   
T Consensus        81 gg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEV--MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---  152 (612)
T ss_pred             cchhhhccccCC--chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence            999999885543  3566666667778899999999   88899999999999999999999999999886432221   


Q ss_pred             cccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCC
Q 042216          636 STQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNA  715 (767)
Q Consensus       636 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  715 (767)
                         .+||..|||||++.  ......|.||||++++||++|..||..    +.      +.....           ..-..
T Consensus       153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~------~~~Il~-----------~~~~~  206 (612)
T KOG0603|consen  153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DT------MKRILK-----------AELEM  206 (612)
T ss_pred             ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HH------HHHHhh-----------hccCC
Confidence               18999999999998  567789999999999999999999965    11      111111           01123


Q ss_pred             ChhhHHHHHHHHHHccccCCCCCCCH
Q 042216          716 PPVCLNQFVEVAMSCVNDDRIRRPSM  741 (767)
Q Consensus       716 ~~~~~~~l~~li~~Cl~~dp~~RPs~  741 (767)
                      |........+++..++..+|..|.-.
T Consensus       207 p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  207 PRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            55556667788888888888888644

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.67  E-value=4.8e-16  Score=157.25  Aligned_cols=134  Identities=28%  Similarity=0.377  Sum_probs=112.2

Q ss_pred             eeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc--------chhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          481 LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--------GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~--------~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      +.||+|++|.||+|...+  ..+++|+.......        ....+.+|++++..++|+++.....++...+..+++||
T Consensus         2 ~~l~~G~~~~vy~~~~~~--~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLG--IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEeeCC--CceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            479999999999998843  57899987643221        12357889999999999998887777777788899999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      |+++++|.+++...     .+ .+..++.+++.+|.+||   ..+++|+|++|.|||++ ++.++|+|||+++.
T Consensus        80 ~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999998532     12 78899999999999999   78899999999999999 78999999999764

>smart00090 RIO RIO-like kinase

Probab=99.67  E-value=5.2e-16  Score=159.16  Aligned_cols=141  Identities=17%  Similarity=0.178  Sum_probs=109.4

Q ss_pred             ccccceeeeccCcEEEEEEE-ecCCCceEEEEEeCCCCCc------------------------chhHHHHHHHHHhccc
Q 042216          476 DFNNLLIIGRGGFGNVYKGF-LNGDSTPVAIKRLNPGSQQ------------------------GALEFQTEIGMLSQLR  530 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~-~~~~~~~vAVK~l~~~~~~------------------------~~~~f~~Ei~~l~~l~  530 (767)
                      .|...+.||+|+||.||+|. ...+++.||||++......                        ....+..|++.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            46677789999999999998 5556789999998754210                        0122568999999997


Q ss_pred             cc--eeeeEeeeeecCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCC-eEecCCCCCC
Q 042216          531 YL--HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV-IIHRDVKTTN  607 (767)
Q Consensus       531 Hp--niv~l~g~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-iiH~Dlk~~N  607 (767)
                      +.  .+.+++++    ...++||||+++++|...+...  ..+...+...++.|++.+|.+||   ..+ ++||||||+|
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~N  179 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYN  179 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhh
Confidence            53  33444443    2358999999998887765322  34566677899999999999999   788 9999999999


Q ss_pred             eEECCCCcEEEeecCCccc
Q 042216          608 ILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       608 ILld~~~~~ki~DfGla~~  626 (767)
                      |+++ ++.++|+|||++..
T Consensus       180 Ili~-~~~i~LiDFg~a~~  197 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             EEEE-CCCEEEEEChhhhc
Confidence            9999 88999999999874

>PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan

Probab=99.66  E-value=4.8e-17  Score=158.17  Aligned_cols=145  Identities=25%  Similarity=0.335  Sum_probs=87.8

Q ss_pred             eeEeecCCcccccCCCCccccccccCCCceecCCCCCCCCCc--ceEEEeccccCCCCcHHHHHhhhccCCCCCcccccc
Q 042216          196 LYRINVGGSFISPQMDTGMYRTWIADDGYVTDARPSALPVNT--TIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYN  273 (767)
Q Consensus       196 ~~R~n~G~~~~~~~~dd~~~R~W~~d~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~P~~v~~ta~~~~~~~~~~~~~~  273 (767)
                      ++|+|+||+..    +|..+..|++|..|....... .....  ..............++.+|||+|....        +
T Consensus         2 ~~~IN~Gg~~~----~~~~g~~w~~D~~~~~g~~~y-~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~--------~   68 (174)
T PF11721_consen    2 VLRINAGGPAY----TDSSGIVWEADQYYTGGSWGY-YVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPS--------S   68 (174)
T ss_dssp             EEEEEETSSSE----EETTTEEE-SSSSSTTSS------------SSTTS--TTS-HHHHHTTT-----SS--------S
T ss_pred             EEEEECCCCcc----cCCCCCEEcCCCCCCCCCccc-ccccccccccccccccccCCCchhhhHhhcCCCC--------c
Confidence            57999999974    555999999998874322200 00000  000011223345678899999999222        4


Q ss_pred             eEEEEe-cCCCceEEEEEeeeeeeccc----ccCccEEEEEEEcccccccccchhhhcCCCCcceEeee-EEEecccccc
Q 042216          274 LTWEFQ-VDSGFIYFVRLHFCEFQSEV----TEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDY-AVAIGSKSDV  347 (767)
Q Consensus       274 lt~~~~-~~~~~~y~v~lhFae~~~~~----~~~~~R~F~i~in~~~~~~~~di~~~~~~~~~p~y~~~-~v~~~~~~~~  347 (767)
                      |+|.+| +.+| .|.|+|||||+....    ...|+|+|||+|||+++.++|||.+.+|+...+.++.+ .+.+.++   
T Consensus        69 f~Y~ip~~~~G-~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg---  144 (174)
T PF11721_consen   69 FSYDIPVVPNG-TYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDG---  144 (174)
T ss_dssp             EEEEEE--S-E-EEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETT---
T ss_pred             eEEEEecCCCc-EEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCC---
Confidence            899999 5556 899999999998732    33899999999999999999999999998887888777 5655433   


Q ss_pred             ccceeEEEecCCC
Q 042216          348 KKQNLSIALHPAP  360 (767)
Q Consensus       348 ~~~~l~i~l~p~~  360 (767)
                         .|.|.+.+..
T Consensus       145 ---~L~i~f~~~~  154 (174)
T PF11721_consen  145 ---TLNIQFVWAG  154 (174)
T ss_dssp             ---EEETTEEEE-
T ss_pred             ---cEEEEEEecC
Confidence               4777776533

It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.65  E-value=4.1e-17  Score=175.45  Aligned_cols=171  Identities=27%  Similarity=0.370  Sum_probs=127.0

Q ss_pred             CceEEEEecCCCCChhhhhcc-CCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCC
Q 042216          545 GQMILVYDYMARGTLRDHLYN-NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL  623 (767)
Q Consensus       545 ~~~~lV~ey~~~gsL~~~L~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGl  623 (767)
                      ..+++.|++|...+|.++|.+ ......+|...+.++.|++.|+.|      ++.+|+|+||.||+...+..+||+|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence            358899999999999999964 344567899999999999999998      5689999999999999999999999999


Q ss_pred             cccCCCCC----CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHh
Q 042216          624 CKFGPNFS----KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECY  698 (767)
Q Consensus       624 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~  698 (767)
                      ........    .....+...||..||+||.+.+..|+.|+||||+|++|+||+. =..++....          ...-+
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t~~d~  472 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------TLTDI  472 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------hhhhh
Confidence            86543322    1223456779999999999999999999999999999999986 222221110          00111


Q ss_pred             hcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCC
Q 042216          699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPS  740 (767)
Q Consensus       699 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs  740 (767)
                      +.+.    +++....++|.     =..++.+++...|.+||+
T Consensus       473 r~g~----ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~  505 (516)
T KOG1033|consen  473 RDGI----IPPEFLQDYPE-----EYTLLQQLLSPSPEERPS  505 (516)
T ss_pred             hcCC----CChHHhhcCcH-----HHHHHHHhcCCCcccCch
Confidence            1211    11111112222     257889999999999993

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.65  E-value=1e-15  Score=176.37  Aligned_cols=137  Identities=23%  Similarity=0.310  Sum_probs=111.8

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CC------cchhHHHHHHHHHhccccceeeeEeeeeecCC
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQ------QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG  545 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~------~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~  545 (767)
                      ...|...+.||+|+||+||+|.+.+.  .+++|+....  ..      .....+.+|++++..++|++++....++....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            34456677899999999999988654  3444432211  11      12345889999999999999998888887777


Q ss_pred             ceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcc
Q 042216          546 QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK  625 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~  625 (767)
                      ..++||||+++++|.+++.          ....++.+++++|.+||   +.+++||||||+|||+ +++.++|+|||+++
T Consensus       410 ~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            8899999999999999884          45789999999999999   7889999999999999 67799999999987


Q ss_pred             c
Q 042216          626 F  626 (767)
Q Consensus       626 ~  626 (767)
                      .
T Consensus       476 ~  476 (535)
T PRK09605        476 Y  476 (535)
T ss_pred             c
Confidence            5

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.65  E-value=9.4e-16  Score=153.62  Aligned_cols=130  Identities=25%  Similarity=0.369  Sum_probs=105.6

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCCCCc--------chhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--------GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~--------~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      +||+|+||.||+|.+.+  ..+++|+.......        ...++.+|++++..++|+++.....++...+..++||||
T Consensus         1 ~ig~G~~~~vy~~~~~~--~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLG--LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeecCC--ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            48999999999998643  67999986543211        124577899999999988766555555666778999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      +++++|.+++.....         .++.+++.+|.+||   ..+++|+|++|.||+++ ++.+++.|||+++.
T Consensus        79 ~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND---------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH---------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999998743210         78999999999999   78899999999999999 78999999999874

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.63  E-value=2.2e-16  Score=180.79  Aligned_cols=210  Identities=25%  Similarity=0.325  Sum_probs=146.1

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      ..+|+.+++|..|++|.||...++...+++|+|+-+.+.     -+.+   +|.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-----ilRn---ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----ILRN---ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccch-----hhhc---cccccCCccee------------------
Confidence            468999999999999999999999888889985322110     0000   22222333333                  


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC---
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF---  630 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~---  630 (767)
                         |+-...++..  ++++..        ++.+++|||   +.+|+|||+||+|.+|..-|.+|++|||+++.+...   
T Consensus       136 ---gDc~tllk~~--g~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 ---GDCATLLKNI--GPLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             ---chhhhhcccC--CCCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence               3433444322  223322        278899999   889999999999999999999999999998753211   


Q ss_pred             --CC--------ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhc
Q 042216          631 --SK--------THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRN  700 (767)
Q Consensus       631 --~~--------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~  700 (767)
                        ..        .-....++||+.|.|||++..+.|....|+|++|+++||.+-|+.||.+...++-..  ..+..    
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg--~visd----  273 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG--QVISD----  273 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh--hhhhh----
Confidence              00        111235689999999999999999999999999999999999999998775543111  10010    


Q ss_pred             CCccccccccccCCCChhhHHHHHHHHHHccccCCCCCC
Q 042216          701 GKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRP  739 (767)
Q Consensus       701 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RP  739 (767)
                              ...-.+.+.....+..+++.+.|+.+|..|-
T Consensus       274 --------~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  274 --------DIEWPEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             --------hccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence                    0001111334456788999999999999995

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.61  E-value=3.4e-15  Score=149.56  Aligned_cols=135  Identities=21%  Similarity=0.169  Sum_probs=105.6

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc----------------------chhHHHHHHHHHhccccce
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ----------------------GALEFQTEIGMLSQLRYLH  533 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~----------------------~~~~f~~Ei~~l~~l~Hpn  533 (767)
                      .+...+.||+|+||.||++... +++.||||++......                      ....+..|+.++..+.|++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            3666678999999999999886 5689999987543200                      0112567888999998874


Q ss_pred             --eeeEeeeeecCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC
Q 042216          534 --LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD  611 (767)
Q Consensus       534 --iv~l~g~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld  611 (767)
                        +...++.    ...++||||+++++|.+....        .....++.+++.++.++|   ..+++|+||||+||+++
T Consensus        95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~  159 (198)
T cd05144          95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVD  159 (198)
T ss_pred             CCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEc
Confidence              4444432    356899999999999776421        245678899999999999   68899999999999999


Q ss_pred             CCCcEEEeecCCccc
Q 042216          612 EEWVAKVSDFGLCKF  626 (767)
Q Consensus       612 ~~~~~ki~DfGla~~  626 (767)
                      +++.++|+|||++..
T Consensus       160 ~~~~~~liDfg~~~~  174 (198)
T cd05144         160 DDEKIYIIDWPQMVS  174 (198)
T ss_pred             CCCcEEEEECCcccc
Confidence            999999999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.58  E-value=2.6e-14  Score=135.42  Aligned_cols=135  Identities=19%  Similarity=0.251  Sum_probs=115.2

Q ss_pred             cceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcccc--ceeeeEeeeeecCCceEEEEecCCC
Q 042216          479 NLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRY--LHLVSLIGYCNDDGQMILVYDYMAR  556 (767)
Q Consensus       479 ~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H--pniv~l~g~~~~~~~~~lV~ey~~~  556 (767)
                      ..+.||+|.++.||++...+  ..+++|.......  ...+..|+..+..++|  .++.+++++....+..++++||+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            34679999999999999865  6799999865433  4578999999999987  5899999998888899999999998


Q ss_pred             CChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          557 GTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       557 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      +.+..+         +......++.+++++|.+||.....+++|+|++|+||++++.+.+++.|||+++.
T Consensus        78 ~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            777654         5567788899999999999965446899999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.51  E-value=8.1e-14  Score=138.06  Aligned_cols=134  Identities=19%  Similarity=0.238  Sum_probs=95.2

Q ss_pred             eeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc--chhHH----------------------HHHHHHHhccccce--e
Q 042216          481 LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEF----------------------QTEIGMLSQLRYLH--L  534 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~--~~~~f----------------------~~Ei~~l~~l~Hpn--i  534 (767)
                      +.||+|+||.||+|... +++.||||++......  ....+                      ..|.+.+..+.+..  +
T Consensus         3 ~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           3 GPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             cccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            47999999999999987 5689999998754211  11111                      34555555554432  3


Q ss_pred             eeEeeeeecCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCC-CCeEecCCCCCCeEECCC
Q 042216          535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS-KVIIHRDVKTTNILLDEE  613 (767)
Q Consensus       535 v~l~g~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~iiH~Dlk~~NILld~~  613 (767)
                      .+.+++    ...++||||++++.+.........  .. .+...++.+++.++.++|   . .+|+|+||||+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence            334432    246899999999654322111110  11 567889999999999999   5 8899999999999999 8


Q ss_pred             CcEEEeecCCccc
Q 042216          614 WVAKVSDFGLCKF  626 (767)
Q Consensus       614 ~~~ki~DfGla~~  626 (767)
                      +.++|+|||.+..
T Consensus       151 ~~~~liDfg~a~~  163 (187)
T cd05119         151 GKVYIIDVPQAVE  163 (187)
T ss_pred             CcEEEEECccccc
Confidence            8999999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.48  E-value=3.1e-13  Score=138.94  Aligned_cols=134  Identities=19%  Similarity=0.191  Sum_probs=104.0

Q ss_pred             eeee-ccCcEEEEEEEecCCCceEEEEEeCCCC-------------CcchhHHHHHHHHHhcccccee--eeEeeeeecC
Q 042216          481 LIIG-RGGFGNVYKGFLNGDSTPVAIKRLNPGS-------------QQGALEFQTEIGMLSQLRYLHL--VSLIGYCNDD  544 (767)
Q Consensus       481 ~~LG-~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-------------~~~~~~f~~Ei~~l~~l~Hpni--v~l~g~~~~~  544 (767)
                      .+|| .||.|+||++...+  ..++||++....             ......+.+|++++.+|+|+++  ...++++...
T Consensus        37 ~~lg~~~g~gtv~~v~~~~--~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTPG--VNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeCC--ceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4688 89999999998863  679999875321             1223457889999999998774  6777765433


Q ss_pred             C----ceEEEEecCCC-CChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 042216          545 G----QMILVYDYMAR-GTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVS  619 (767)
Q Consensus       545 ~----~~~lV~ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~  619 (767)
                      .    ..++|+|++++ .+|.+++...   .++..    .+.+++.+|.+||   ..+|+|+||||.|||++.++.++|+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEE
Confidence            2    23599999997 6899888542   34443    3568999999999   7889999999999999998899999


Q ss_pred             ecCCccc
Q 042216          620 DFGLCKF  626 (767)
Q Consensus       620 DfGla~~  626 (767)
                      |||.++.
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9999874

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.42  E-value=3.3e-13  Score=136.64  Aligned_cols=201  Identities=22%  Similarity=0.304  Sum_probs=140.2

Q ss_pred             HHHhccccceeeeEeeeeecC-----CceEEEEecCCCCChhhhhccC--CCCCCChHHHHHHHHHHHHHHHHhHhCCCC
Q 042216          524 GMLSQLRYLHLVSLIGYCNDD-----GQMILVYDYMARGTLRDHLYNN--DNPPLPWDRRLKICIGAARALHYLHTGASK  596 (767)
Q Consensus       524 ~~l~~l~Hpniv~l~g~~~~~-----~~~~lV~ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~  596 (767)
                      .-|-.+-|-|||+++.|+.+.     .+..++.|||..|+|.++|++.  ....+......+++-||..||.|||. |.+
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence            445566799999999998543     4678999999999999999753  34567888889999999999999995 679


Q ss_pred             CeEecCCCCCCeEECCCCcEEEeecCCcccCCCC--CCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh
Q 042216          597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF--SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC  674 (767)
Q Consensus       597 ~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt  674 (767)
                      +|+|+++..+-|++..++-+||+--.-...-...  ..........+-++|.+||+-.....+-.+|||+||+..+||..
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            9999999999999999999988521111100000  00011122346789999999888888899999999999999987


Q ss_pred             CCCCC-CCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHH
Q 042216          675 ARPPI-LRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV  745 (767)
Q Consensus       675 g~~P~-~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl  745 (767)
                      +..-- ......+..            ..+..++- .+..       ..-..++..|++..|..||+|.+++
T Consensus       278 lEiq~tnseS~~~~e------------e~ia~~i~-~len-------~lqr~~i~kcl~~eP~~rp~ar~ll  329 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVE------------ENIANVII-GLEN-------GLQRGSITKCLEGEPNGRPDARLLL  329 (458)
T ss_pred             heeccCCCcceeehh------------hhhhhhee-eccC-------ccccCcCcccccCCCCCCcchhhhh
Confidence            76532 111110000            00000000 0000       0113578899999999999999987

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.41  E-value=4.1e-14  Score=162.78  Aligned_cols=256  Identities=21%  Similarity=0.262  Sum_probs=186.0

Q ss_pred             ccccceeeeccCcEEEEEEEecCC-CceEEEEEeCCCC--CcchhHHHHHHHHHhccc-cceeeeEeeeeecCCceEEEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGD-STPVAIKRLNPGS--QQGALEFQTEIGMLSQLR-YLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~-~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      .|...+.||+|+|+.|-......+ ...+|+|.+....  .........|..+-..+. |+|++.+++...+.+..++..
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            455555699999999988876433 3456677665443  222233445777777776 999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC-cEEEeecCCcccCCC-
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW-VAKVSDFGLCKFGPN-  629 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~-~~ki~DfGla~~~~~-  629 (767)
                      +|..+|++.+-+........+....-..+.|+..++.|+|.  ..++.|+||||+|.+++..+ ..+++|||+|..... 
T Consensus       101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK  178 (601)
T ss_pred             CcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence            99999999998832222245566677889999999999995  45699999999999999999 999999999986655 


Q ss_pred             CCCccccccccC-CCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccc
Q 042216          630 FSKTHVSTQVKG-SIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDII  707 (767)
Q Consensus       630 ~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  707 (767)
                      ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+....... .....|....   +      
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~---~------  248 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK---G------  248 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc---c------
Confidence            333344445668 9999999998874 55678999999999999999999986544322 1112221111   0      


Q ss_pred             cccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHH
Q 042216          708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV  745 (767)
Q Consensus       708 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl  745 (767)
                        ...............++...++..+|..|.+.+++.
T Consensus       249 --~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  249 --RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             --ccccCccccCChhhhhcccccccCCchhcccccccc
Confidence              000111122334567888889989999999988874

>PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan

Probab=99.37  E-value=8.3e-13  Score=128.46  Aligned_cols=139  Identities=24%  Similarity=0.398  Sum_probs=88.6

Q ss_pred             eEEEeeCCCcccccCCCeeeccCCCCCCCCC------------cccccccCCCCCCCcccceeeccceeEEEec-CCCce
Q 042216           12 ITFVACGWLGNISAHGQTWAGDVSSQYSPLG------------HQQSTISKKPREPPYSASRLSHSQFTYTFNV-TPGQK   78 (767)
Q Consensus        12 ~~~i~cG~~~~~~~~~~~w~~D~~~~~~~~~------------~~~~~~~~~~~~~~~~t~R~f~~~~~Y~~~~-~~g~~   78 (767)
                      .++||||+..+++..|.+|.+|..+..+..+            .....+..+.+..+|+|.|+-...+.|.||+ .+| .
T Consensus         2 ~~~IN~Gg~~~~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~~f~Y~ip~~~~G-~   80 (174)
T PF11721_consen    2 VLRINAGGPAYTDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPSSFSYDIPVVPNG-T   80 (174)
T ss_dssp             EEEEEETSSSEEETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SSSEEEEEE--S-E-E
T ss_pred             EEEEECCCCcccCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCCceEEEEecCCCc-E
Confidence            4899999998889999999999988665551            1222333344556799999833478999995 566 5


Q ss_pred             E-EEEeeecCCCCC---CCCCCce-EEEEeCceEEEeccCcccCCCC---ceEEEEE-EeecCCCceEEEEEe-------
Q 042216           79 F-IRLHFYSTSYSG---FNISSAF-FSVKANSFTLVNNFSASFAPDD---TFFKEFC-INVPEDQRSLSITFT-------  142 (767)
Q Consensus        79 y-vR~~f~~~~y~~---~~~~~~~-~~v~~~~~~~~~~~~~~~~~~~---~~~~e~~-~~~~~~~~~~~l~~~-------  142 (767)
                      | |||||....+..   ...+..+ |+|.+||-.++.++|....++.   +..++++ +.+.  .+.|.|.|.       
T Consensus        81 Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~--dg~L~i~f~~~~~~~~  158 (174)
T PF11721_consen   81 YTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVT--DGTLNIQFVWAGKGTL  158 (174)
T ss_dssp             EEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEE--TTEEETTEEEE--SEE
T ss_pred             EEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEe--CCcEEEEEEecCCCcE
Confidence            7 999999777655   1223445 9999999999999999977764   4666763 3332  346777777       


Q ss_pred             -----cCCCCCCCceeeeee
Q 042216          143 -----PSPDYQDSYAFINGI  157 (767)
Q Consensus       143 -----~~~~~~~~~pfis~i  157 (767)
                           +.    .+.|.||||
T Consensus       159 ~i~~~~~----~~~p~IsaI  174 (174)
T PF11721_consen  159 CIPFIGS----YGNPLISAI  174 (174)
T ss_dssp             EEEEESS----SSSSSEEEE
T ss_pred             Eeecccc----CCCcEEeeC
Confidence                 44    577999887

It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.32  E-value=8.7e-12  Score=139.30  Aligned_cols=143  Identities=20%  Similarity=0.238  Sum_probs=100.5

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcch---------------------------------------
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---------------------------------------  516 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~---------------------------------------  516 (767)
                      .|+. +.||.|++|.||+|++++ ++.||||+.++......                                       
T Consensus       119 ~fd~-~plasaSigQVh~A~l~~-G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~  196 (437)
T TIGR01982       119 EFEE-KPLAAASIAQVHRARLVD-GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR  196 (437)
T ss_pred             hCCC-cceeeeehhheEEEEecC-CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence            3443 479999999999999975 48999999876531110                                       


Q ss_pred             -hHHHHHHHHHhccc----cceeeeEeeee-ecCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHH-HHHH
Q 042216          517 -LEFQTEIGMLSQLR----YLHLVSLIGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR-ALHY  589 (767)
Q Consensus       517 -~~f~~Ei~~l~~l~----Hpniv~l~g~~-~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~-gL~y  589 (767)
                       .+|.+|.+.+.+++    |.+-+.+-..+ ......+|||||+++++|.+.+..... ..   .+..++..++. .+..
T Consensus       197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~q  272 (437)
T TIGR01982       197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQ  272 (437)
T ss_pred             HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHH
Confidence             12455665555553    32333333333 234567999999999999987643211 12   34556666666 4677


Q ss_pred             hHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       590 LH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      +|   ..+++|+|+||.||++++++.++++|||++...
T Consensus       273 l~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       273 VL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             HH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence            88   678999999999999999999999999998754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.25  E-value=1.2e-11  Score=136.15  Aligned_cols=248  Identities=21%  Similarity=0.191  Sum_probs=177.5

Q ss_pred             ccccceeeec--cCcEEEEEEEe--cCCCceEEEEEeCCC--CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceE
Q 042216          476 DFNNLLIIGR--GGFGNVYKGFL--NGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMI  548 (767)
Q Consensus       476 ~f~~~~~LG~--G~fG~Vy~g~~--~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~  548 (767)
                      .|.....+|.  |.+|.||.+..  ......+|+|+-+..  ..+....=.+|+...+++ .|+|.++....+.+.+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3555667999  99999999998  777788999984432  223333335677777777 4999999888899999999


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHH----HHHHhHhCCCCCeEecCCCCCCeEECCC-CcEEEeecCC
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR----ALHYLHTGASKVIIHRDVKTTNILLDEE-WVAKVSDFGL  623 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~iiH~Dlk~~NILld~~-~~~ki~DfGl  623 (767)
                      +-+|++. .+|.++.+.... .++....+.+..+..+    ||.++|   +..++|-|+||.||++..+ ...+++|||+
T Consensus       195 iqtE~~~-~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeecccc-chhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcce
Confidence            9999986 588888765432 3666777777777777    999999   8889999999999999999 8899999999


Q ss_pred             cccCCCCCCccc---cccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhc
Q 042216          624 CKFGPNFSKTHV---STQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRN  700 (767)
Q Consensus       624 a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~  700 (767)
                      ............   .....|...|++||... +.++..+|+|++|.+.+|..++..+....-.      ..|..  .+.
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~~--~r~  340 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN------SSWSQ--LRQ  340 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC------CCccc--ccc
Confidence            876544322211   22235777899999876 5678899999999999999987665422100      01111  011


Q ss_pred             CCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHH
Q 042216          701 GKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV  745 (767)
Q Consensus       701 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl  745 (767)
                      +.        +..++...-..++...+.++++.+|..|++.+.+.
T Consensus       341 ~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  341 GY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             cc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence            00        11111122234455688999999999999876654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.21  E-value=1.5e-10  Score=128.55  Aligned_cols=170  Identities=17%  Similarity=0.212  Sum_probs=128.0

Q ss_pred             EEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCCChhhhhccCCCCCCC
Q 042216          493 KGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLP  572 (767)
Q Consensus       493 ~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~  572 (767)
                      .|..+.++.+|.|+..+..+........+-++.|+.+|||||++++...+.++..|||+|-+.  .|..++.+     +.
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LG  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hH
Confidence            566667778899998876655334446777899999999999999999999999999999874  56666643     33


Q ss_pred             hHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhc
Q 042216          573 WDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR  652 (767)
Q Consensus       573 ~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~  652 (767)
                      .......+.||+.||.+||+  ..+++|++|..+.|++++.|..||++|.++........  ......--..|..|+.+.
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~  178 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEID  178 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcC
Confidence            45666678999999999996  56799999999999999999999999988753222111  011111223466666544


Q ss_pred             cCCCCchhhHHHHHHHHHHHHhC
Q 042216          653 LQLLTEKSDVYSFGVVLLEVLCA  675 (767)
Q Consensus       653 ~~~~s~ksDV~SfGvvl~elltg  675 (767)
                      ...  -..|.|-|||+++|++.|
T Consensus       179 ~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  179 PSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ccc--cchhhhhHHHHHHHHhCc
Confidence            222  346999999999999998

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.19  E-value=1.2e-10  Score=113.18  Aligned_cols=131  Identities=15%  Similarity=0.123  Sum_probs=95.9

Q ss_pred             ceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeee-EeeeeecCCceEEEEecCCCCC
Q 042216          480 LLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVS-LIGYCNDDGQMILVYDYMARGT  558 (767)
Q Consensus       480 ~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~-l~g~~~~~~~~~lV~ey~~~gs  558 (767)
                      .+.|+.|.++.||+++..  +..+++|....... ....+..|++++..+.+.++++ ++.+.  ....++||||+++.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence            346889999999999876  36799998765432 2335688999999987665554 44333  234589999999988


Q ss_pred             hhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCC--CCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          559 LRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA--SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       559 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      +.+..       .   ....++.+++++|..||...  ...++|+|+++.||+++ ++.+++.||+.+..
T Consensus        78 l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          78 LLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            76530       1   11345678999999999432  22369999999999999 56899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.13  E-value=1.7e-10  Score=130.37  Aligned_cols=147  Identities=17%  Similarity=0.138  Sum_probs=94.8

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcc--------------------------------------
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQG--------------------------------------  515 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~--------------------------------------  515 (767)
                      -.+|+. +.||+|++|.||+|+++++++.||||+.++.....                                      
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345766 67999999999999998767899999998652110                                      


Q ss_pred             --hhHHHHHHHHHhccc----cceeeeEeeeeec-CCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHH-H
Q 042216          516 --ALEFQTEIGMLSQLR----YLHLVSLIGYCND-DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARA-L  587 (767)
Q Consensus       516 --~~~f~~Ei~~l~~l~----Hpniv~l~g~~~~-~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~g-L  587 (767)
                        +.+|.+|+..+.+++    +.+.+.+-..+.+ ....+|||||++|+.|.+.-.-.. ...+   +..++...+.. +
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~-~g~d---~~~la~~~v~~~~  273 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA-AGTD---MKLLAERGVEVFF  273 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh-cCCC---HHHHHHHHHHHHH
Confidence              012445555454443    3333333333322 456789999999999987421111 1122   12222222221 2


Q ss_pred             HHhHhCCCCCeEecCCCCCCeEECCCC----cEEEeecCCcccCC
Q 042216          588 HYLHTGASKVIIHRDVKTTNILLDEEW----VAKVSDFGLCKFGP  628 (767)
Q Consensus       588 ~yLH~~~~~~iiH~Dlk~~NILld~~~----~~ki~DfGla~~~~  628 (767)
                      .-++   ..+++|+|+||.||+++.++    .+++.|||++....
T Consensus       274 ~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        274 TQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            2233   56799999999999999888    99999999987543

>PLN03150 hypothetical protein; Provisional

Probab=99.08  E-value=1.1e-09  Score=128.18  Aligned_cols=148  Identities=20%  Similarity=0.287  Sum_probs=101.7

Q ss_pred             eEEEeeCCCcc-------cccC--CCeeeccCCCCCCCCC--cccccccCCCCCC------Ccccceeecc---ceeEEE
Q 042216           12 ITFVACGWLGN-------ISAH--GQTWAGDVSSQYSPLG--HQQSTISKKPREP------PYSASRLSHS---QFTYTF   71 (767)
Q Consensus        12 ~~~i~cG~~~~-------~~~~--~~~w~~D~~~~~~~~~--~~~~~~~~~~~~~------~~~t~R~f~~---~~~Y~~   71 (767)
                      .+|||||+...       +|.-  +|.|.+|..|......  .....+..+...+      .|+|+|.+..   +.+|.+
T Consensus       193 ~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~~~~~st~~~I~~~~~~~~~~P~~VyqTA~~~~~~~~~lty~~  272 (623)
T PLN03150        193 AKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKASNAPNFYPESLYQSALVSTDTQPDLSYTM  272 (623)
T ss_pred             EEEEEecCcccccccCCCCCcccCccccCcCcccCCCcccccccccccccccCCCccChHHHhhhhccccCCCCceEEEe
Confidence            46999997532       2222  7999999865322111  1112222111222      4999999843   689999


Q ss_pred             ecCCCceE-EEEeeecCCCCCCCCCCce-EEEEeCceEEEeccCcccCCC---CceEEEEEEeecCCCceEEEEEecCCC
Q 042216           72 NVTPGQKF-IRLHFYSTSYSGFNISSAF-FSVKANSFTLVNNFSASFAPD---DTFFKEFCINVPEDQRSLSITFTPSPD  146 (767)
Q Consensus        72 ~~~~g~~y-vR~~f~~~~y~~~~~~~~~-~~v~~~~~~~~~~~~~~~~~~---~~~~~e~~~~~~~~~~~~~l~~~~~~~  146 (767)
                      ++.++..| ||+||+.-....... ..+ |+|.+|+...+++++....++   .++++++.+.+.+  +.+.|.|.|.+ 
T Consensus       273 ~v~~~~~Y~VrLhFaEi~~~~~~~-~~R~F~V~ing~~~~~~~di~~~~g~~~~~~~~~~~v~~~~--g~l~isl~p~~-  348 (623)
T PLN03150        273 DVDPNRNYSVWLHFAEIDNSITAE-GKRVFDVLINGDTAFKDVDIVKMSGERYTALVLNKTVAVSG--RTLTIVLQPKK-  348 (623)
T ss_pred             ecCCCCCEEEEEEEEeccCccCCC-ceEEEEEEECCEEeecccChhhhcCCcccceEEEeEEeecC--CeEEEEEeeCC-
Confidence            99776666 999999765322222 335 999999999999988754333   3888888887754  68999999983 


Q ss_pred             CCCCceeeeeeEeEecCCc
Q 042216          147 YQDSYAFINGIELVSMPLN  165 (767)
Q Consensus       147 ~~~~~pfis~iE~~~~~~~  165 (767)
                        ...||||||||+.+...
T Consensus       349 --~s~pilNaiEI~~~~~~  365 (623)
T PLN03150        349 --GTHAIINAIEVFEIITA  365 (623)
T ss_pred             --CCcceeeeeeeeecccc
Confidence              35699999999998863

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.05  E-value=2.5e-09  Score=108.68  Aligned_cols=143  Identities=24%  Similarity=0.360  Sum_probs=111.2

Q ss_pred             eeeeccCcEEEEEEEecCCCceEEEEEeCCCCC-cchhHHHHHHHHHhcccc--ceeeeEeeeeecC---CceEEEEecC
Q 042216          481 LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRY--LHLVSLIGYCNDD---GQMILVYDYM  554 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H--pniv~l~g~~~~~---~~~~lV~ey~  554 (767)
                      +.|+.|..+.||++...+ +..+++|....... ....++..|.+++..+++  .++.+++.++.+.   +..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            468999999999998864 46899998764422 234578899999999975  3456777777654   3668999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCC----------------------------------------
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA----------------------------------------  594 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------  594 (767)
                      ++.+|.+.+..   ..++..++..++.+++++|..||+..                                        
T Consensus        83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            99988876532   24677888888999999999998521                                        


Q ss_pred             -------------CCCeEecCCCCCCeEECC--CCcEEEeecCCcccC
Q 042216          595 -------------SKVIIHRDVKTTNILLDE--EWVAKVSDFGLCKFG  627 (767)
Q Consensus       595 -------------~~~iiH~Dlk~~NILld~--~~~~ki~DfGla~~~  627 (767)
                                   ...++|+|+++.||+++.  ++.+.|.||+.+...
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                         245799999999999998  667899999987753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.03  E-value=2.2e-10  Score=126.36  Aligned_cols=250  Identities=24%  Similarity=0.235  Sum_probs=176.3

Q ss_pred             HHhhccccceeeeccCcEEEEEEEec-CCCceEEEEEeCCCCCcchhH--HHHHHHHHhcc-ccceeeeEeeeeecCCce
Q 042216          472 EATKDFNNLLIIGRGGFGNVYKGFLN-GDSTPVAIKRLNPGSQQGALE--FQTEIGMLSQL-RYLHLVSLIGYCNDDGQM  547 (767)
Q Consensus       472 ~~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~~vAVK~l~~~~~~~~~~--f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~  547 (767)
                      ..+.+|..+..||.|.|+.|++.... .++..+++|.+.........+  -..|+.+...+ .|.+++....-+....+.
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            34568999999999999999988765 567889999886553332222  24566665555 578888877767677788


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCC-CcEEEeecCCccc
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEE-WVAKVSDFGLCKF  626 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~-~~~ki~DfGla~~  626 (767)
                      ++--||++++++...+  .....++...++++..|++.++.++|   ++.++|+|+||+||++..+ +..+++|||+..-
T Consensus       342 ~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             cCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccc
Confidence            8999999999887666  33345788889999999999999999   8889999999999999875 8889999998753


Q ss_pred             CCCCCCccccccccCCCccc--ChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc
Q 042216          627 GPNFSKTHVSTQVKGSIGYL--DPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG  704 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  704 (767)
                      ....     .......-+++  +++......+..+.|++|||.-+.|.+++..-- ....       .|..  +..+.  
T Consensus       417 ~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls-~~~~-------~~~~--i~~~~--  479 (524)
T KOG0601|consen  417 LAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS-ESGV-------QSLT--IRSGD--  479 (524)
T ss_pred             ccee-----cccccccccccccchhhccccccccccccccccccccccccCcccC-cccc-------ccee--eeccc--
Confidence            1110     01111222334  555666678889999999999999998876432 1110       0000  01111  


Q ss_pred             ccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          705 DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       705 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                             ....+ .....+..+...+..+++..||.+.++....+..
T Consensus       480 -------~p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  480 -------TPNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             -------ccCCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence                   01111 2236677888999999999999998887666544

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.01  E-value=3e-09  Score=104.85  Aligned_cols=135  Identities=14%  Similarity=0.109  Sum_probs=96.2

Q ss_pred             eeeeccCcEEEEEEEecC------CCceEEEEEeCCCC------------C----------cchhHHH----HHHHHHhc
Q 042216          481 LIIGRGGFGNVYKGFLNG------DSTPVAIKRLNPGS------------Q----------QGALEFQ----TEIGMLSQ  528 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~------~~~~vAVK~l~~~~------------~----------~~~~~f~----~Ei~~l~~  528 (767)
                      ..||.|--+.||.|...+      .+..+|||+.+...            .          ...+.+.    +|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            368999999999997653      24689999875321            0          0011233    78888988


Q ss_pred             ccc--ceeeeEeeeeecCCceEEEEecCCCCChhh-hhccCCCCCCChHHHHHHHHHHHHHHHHh-HhCCCCCeEecCCC
Q 042216          529 LRY--LHLVSLIGYCNDDGQMILVYDYMARGTLRD-HLYNNDNPPLPWDRRLKICIGAARALHYL-HTGASKVIIHRDVK  604 (767)
Q Consensus       529 l~H--pniv~l~g~~~~~~~~~lV~ey~~~gsL~~-~L~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiH~Dlk  604 (767)
                      +..  -++..++++    ...+|||||+.+..+.. .|+.   ..++..+...+..+++.+|..| |   ..+|+|+||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence            853  345555543    46789999998754432 2221   1345556677889999999999 7   6789999999


Q ss_pred             CCCeEECCCCcEEEeecCCccc
Q 042216          605 TTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       605 ~~NILld~~~~~ki~DfGla~~  626 (767)
                      +.|||+++ +.+.|+|||.+-.
T Consensus       153 ~~NIL~~~-~~v~iIDF~qav~  173 (197)
T cd05146         153 EYNMLWHD-GKVWFIDVSQSVE  173 (197)
T ss_pred             HHHEEEEC-CcEEEEECCCcee
Confidence            99999974 5899999998764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.00  E-value=1.3e-08  Score=110.00  Aligned_cols=169  Identities=21%  Similarity=0.240  Sum_probs=131.0

Q ss_pred             cEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeee----cCCceEEEEecCCC-CChhhh
Q 042216          488 FGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN----DDGQMILVYDYMAR-GTLRDH  562 (767)
Q Consensus       488 fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~----~~~~~~lV~ey~~~-gsL~~~  562 (767)
                      -.+.||+...-+|..+++|+++....+.......-+++++++.|+|+|++..++.    .+..++|||+|.++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3678999998888999999995443333334455688999999999999988775    34578999999986 577775


Q ss_pred             hccC-------------CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          563 LYNN-------------DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       563 L~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      -...             .+...++..+|.++.|++.||.++|   +.|+.-+-|.+++||++.+.+++|+.+|+......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            5321             2345788999999999999999999   67788899999999999999999999988765543


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP  678 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P  678 (767)
                      ...                |-+.   --.+-|.=.||.+++.|.||..-
T Consensus       446 d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT----------------EPLE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC----------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            220                1111   12367999999999999999654

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.90  E-value=1.2e-08  Score=96.44  Aligned_cols=143  Identities=21%  Similarity=0.239  Sum_probs=103.5

Q ss_pred             cceeeeccCcEEEEEEEecCCCceEEEEEeC-CCC-------CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          479 NLLIIGRGGFGNVYKGFLNGDSTPVAIKRLN-PGS-------QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       479 ~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~-~~~-------~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      .+.+|-+|+-++|+++...+  +...||.-. +.-       +...+...+|++.|.+++--.|.-..-++.+...-.++
T Consensus        11 ~l~likQGAEArv~~~~~~G--e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSG--EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccCC--ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            56689999999999999975  556666432 211       12234578899999988754444443344455566789


Q ss_pred             EecCCC-CChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC---cEEEeecCCccc
Q 042216          551 YDYMAR-GTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW---VAKVSDFGLCKF  626 (767)
Q Consensus       551 ~ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~---~~ki~DfGla~~  626 (767)
                      |||+++ -++.+++...............++..+-+.+.-||   ...|||+||..+||+|..++   .+.+.|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999976 47888886654433343444788999999999999   78899999999999996443   458999999764

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.87  E-value=1.7e-08  Score=96.14  Aligned_cols=130  Identities=26%  Similarity=0.353  Sum_probs=99.0

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCC-CCc-------chhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-SQQ-------GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~-~~~-------~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .+++|+-+.+|.+.+.+  ..+++|.-.+. -..       ....-.+|..+|.+++--.|....=+..+.+...++|||
T Consensus         3 ~i~~GAEa~i~~~~~~g--~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           3 LIKQGAEAIIYLTDFLG--LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             hhhCCcceeEEeeeccC--cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            57899999999998764  34666643222 111       122357899999988765555555556677788899999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      +++-.|.+.|...         +..++..+-.-+.-||   ..+|+|+||.++||++..+. +.++||||+..
T Consensus        81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA---------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc---------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888543         3567778888889999   78899999999999998774 89999999874

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.84  E-value=1.3e-09  Score=126.14  Aligned_cols=249  Identities=18%  Similarity=0.204  Sum_probs=166.2

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      .++|...+-+-+|.++.+....-...+...++|......   .+..+....+-.++-..+||-++....-+......+|+
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence            345666666788999999887665555444555443221   11222233333333334566666555444456788999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC--
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP--  628 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~--  628 (767)
                      ++|..+++|...|+...  .++..-.......+...++|||   ...+.|+|++|.|.|+..++..+++|||......  
T Consensus       883 ~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             hHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccc
Confidence            99999999999987643  3454444555666788999999   6668999999999999999999999998432110  


Q ss_pred             -C---C----------------C-------CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 042216          629 -N---F----------------S-------KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILR  681 (767)
Q Consensus       629 -~---~----------------~-------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~  681 (767)
                       .   .                .       .........+|+.|.+||...+.......|.|++|++++|.++|.+||..
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence             0   0                0       00112235689999999999999999999999999999999999999965


Q ss_pred             CCCccchhHHHHHHHHhhcCCcccccccccc-CCCChhhHHHHHHHHHHccccCCCCCCCHH
Q 042216          682 TGDKKQVNLAVWATECYRNGKIGDIIDPFLK-GNAPPVCLNQFVEVAMSCVNDDRIRRPSMS  742 (767)
Q Consensus       682 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~  742 (767)
                      .......               ..++...+. ...+.....+..+++...+..+|.+|-.|.
T Consensus      1038 ~tpq~~f---------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQIF---------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             cchhhhh---------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            4432110               111111111 112344556677888888888999987655

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.74  E-value=5.4e-07  Score=95.20  Aligned_cols=267  Identities=15%  Similarity=0.164  Sum_probs=163.8

Q ss_pred             eeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc-ccceeeeEeee------eec-CCceEEEEe
Q 042216          481 LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGY------CND-DGQMILVYD  552 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~------~~~-~~~~~lV~e  552 (767)
                      ..||+|+-+.+|-.-.-.   ..+-|++.........+   .+.+|.+. .||-+..-+.+      --+ +...-++|.
T Consensus        17 r~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          17 RPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             ccccCCccceeeecchhh---chhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            469999999999643322   23457766443322222   23334443 45533321221      111 223556777


Q ss_pred             cCCCC-Chhhhhc----cCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          553 YMARG-TLRDHLY----NNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       553 y~~~g-sL~~~L~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      .+.+. -+..++.    +..-...+|...++.+..+|.+.+.||   ..+.+-+|+.++|+|+.+++.+.|.|=..-.+.
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceeec
Confidence            66553 2333332    122345789999999999999999999   677889999999999999999999874432221


Q ss_pred             CCCCCccccccccCCCcccChhhhc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCccch--hHHHHHHHHhh
Q 042216          628 PNFSKTHVSTQVKGSIGYLDPEYYR-----LQLLTEKSDVYSFGVVLLEVLCA-RPPILRTGDKKQV--NLAVWATECYR  699 (767)
Q Consensus       628 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~elltg-~~P~~~~~~~~~~--~l~~~~~~~~~  699 (767)
                         .........+|...|.+||.-.     +-.-+...|.|.+||++++|+.| ++||.+.......  -+.    ..+.
T Consensus       168 ---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E----~~Ia  240 (637)
T COG4248         168 ---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE----TDIA  240 (637)
T ss_pred             ---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch----hhhh
Confidence               1122233456888999999765     33456789999999999999875 9999765321110  000    0011


Q ss_pred             cCCccccccccc--c---CCCC-hhhHHHHHHHHHHccccC--CCCCCCHHHHHHHHHHhHhhhhccccccc
Q 042216          700 NGKIGDIIDPFL--K---GNAP-PVCLNQFVEVAMSCVNDD--RIRRPSMSDVVWGLEFVFQLLRESSEKSM  763 (767)
Q Consensus       700 ~~~~~~~~d~~l--~---~~~~-~~~~~~l~~li~~Cl~~d--p~~RPs~~evl~~L~~~~~~~~~~~~~~~  763 (767)
                      .+.....-|.+.  +   ...| ...+..+.-+..+|+...  +.-|||.+-.+..|..+.+.+..|....|
T Consensus       241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~  312 (637)
T COG4248         241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAM  312 (637)
T ss_pred             cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhccc
Confidence            122212112111  0   0111 123445666777887643  56899999999999999988877766654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.70  E-value=1.7e-07  Score=97.59  Aligned_cols=140  Identities=14%  Similarity=0.102  Sum_probs=100.0

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCCCCc-----------chhHHHHHHHHHhccccc--eeeeEeeeeec-----
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ-----------GALEFQTEIGMLSQLRYL--HLVSLIGYCND-----  543 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~-----------~~~~f~~Ei~~l~~l~Hp--niv~l~g~~~~-----  543 (767)
                      .+-+.....|.+..+.+  +.+.||+.......           ....+.+|...+.+|+..  ....++++...     
T Consensus        29 ~v~~~~~rrvvr~~~~g--~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         29 VFRELEGRRTLRFELAG--KSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             EEecCCCceEEEEEECC--EEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            44444445577877743  68999977433211           111377898888888533  33344555543     


Q ss_pred             CCceEEEEecCCCC-ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC-------CCc
Q 042216          544 DGQMILVYDYMARG-TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE-------EWV  615 (767)
Q Consensus       544 ~~~~~lV~ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~-------~~~  615 (767)
                      ....+||+|++++- +|.+++......+.+...+..++.+++..+.-||   ..+|+|+|++++|||++.       +..
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence            23578999999986 8998885322234566777899999999999999   788999999999999975       578


Q ss_pred             EEEeecCCccc
Q 042216          616 AKVSDFGLCKF  626 (767)
Q Consensus       616 ~ki~DfGla~~  626 (767)
                      +.++||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998753

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.57  E-value=2.3e-08  Score=111.97  Aligned_cols=151  Identities=19%  Similarity=0.294  Sum_probs=102.9

Q ss_pred             HHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC-------ccccccccCCCcccChhhhc
Q 042216          580 CIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK-------THVSTQVKGSIGYLDPEYYR  652 (767)
Q Consensus       580 ~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~  652 (767)
                      +.+++.||.|+|.  +.++||++|.|++|.+++++..||+.|+.+........       .....-......|.|||++.
T Consensus       105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            4456699999997  77899999999999999999999999998754322110       11111122456799999999


Q ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHcc
Q 042216          653 LQLLTEKSDVYSFGVVLLEVLCARPP-ILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCV  731 (767)
Q Consensus       653 ~~~~s~ksDV~SfGvvl~elltg~~P-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl  731 (767)
                      ....+.++|+||+||+++.+..|..+ +.......     ......       ...+.. ...+..+.+.++.+=+.+.+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-----~~~~~~-------~~~~~~-~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-----SYSFSR-------NLLNAG-AFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcc-----hhhhhh-------cccccc-cccccccCcHHHHHHHHHHh
Confidence            98999999999999999999854444 33221110     000000       000111 11122455677888899999


Q ss_pred             ccCCCCCCCHHHHH
Q 042216          732 NDDRIRRPSMSDVV  745 (767)
Q Consensus       732 ~~dp~~RPs~~evl  745 (767)
                      ..++..||++.++.
T Consensus       250 ~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLL  263 (700)
T ss_pred             cCCcccCcchhhhh
Confidence            99999999887765

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.52  E-value=8.8e-07  Score=87.09  Aligned_cols=124  Identities=22%  Similarity=0.255  Sum_probs=79.1

Q ss_pred             EEEEEEecCCCceEEEEEeCCCC-------------Cc--------c-----hhHHHHHHHHHhccccc--eeeeEeeee
Q 042216          490 NVYKGFLNGDSTPVAIKRLNPGS-------------QQ--------G-----ALEFQTEIGMLSQLRYL--HLVSLIGYC  541 (767)
Q Consensus       490 ~Vy~g~~~~~~~~vAVK~l~~~~-------------~~--------~-----~~~f~~Ei~~l~~l~Hp--niv~l~g~~  541 (767)
                      .||.|...++ ..+|||..+...             ..        .     .....+|.+.|.++..-  ++.+++.+.
T Consensus         1 ~Vy~~~~~~~-~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDPDG-EEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEECTT-EEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECCCC-CEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4899988644 689999875421             00        0     11256799999998654  455555443


Q ss_pred             ecCCceEEEEecCC--CCChhhhhccCCCCCCChHHHHHHHHHHHHHHHH-hHhCCCCCeEecCCCCCCeEECCCCcEEE
Q 042216          542 NDDGQMILVYDYMA--RGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY-LHTGASKVIIHRDVKTTNILLDEEWVAKV  618 (767)
Q Consensus       542 ~~~~~~~lV~ey~~--~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~iiH~Dlk~~NILld~~~~~ki  618 (767)
                          ..+|||||++  +..+..+. ...   ++......++.+++..+.. +|   ..+|+|+||.+.|||++++ .+.|
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~-~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLK-DVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHH-HCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE
T ss_pred             ----CCEEEEEecCCCccchhhHH-hcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEE
Confidence                4579999998  54444432 211   2244566777888886655 56   7789999999999999988 9999


Q ss_pred             eecCCccc
Q 042216          619 SDFGLCKF  626 (767)
Q Consensus       619 ~DfGla~~  626 (767)
                      +|||.+..
T Consensus       148 IDf~qav~  155 (188)
T PF01163_consen  148 IDFGQAVD  155 (188)
T ss_dssp             --GTTEEE
T ss_pred             EecCccee
Confidence            99998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan []

Probab=98.42  E-value=2e-06  Score=93.46  Aligned_cols=148  Identities=23%  Similarity=0.420  Sum_probs=91.9

Q ss_pred             CCceEEEeeCCCc----c-cccCCCeeeccCCCCCCCCCccc--cccc----CCCCCCC---cccceeec-----cceeE
Q 042216            9 PTEITFVACGWLG----N-ISAHGQTWAGDVSSQYSPLGHQQ--STIS----KKPREPP---YSASRLSH-----SQFTY   69 (767)
Q Consensus         9 p~~~~~i~cG~~~----~-~~~~~~~w~~D~~~~~~~~~~~~--~~~~----~~~~~~~---~~t~R~f~-----~~~~Y   69 (767)
                      -.-.+|++||++.    + .|.-+|.|.+....  .......  ..+.    ...-.+|   |+|||.-+     -...|
T Consensus       177 L~~~~R~n~G~~~~~iryp~D~~dR~W~~~~~~--~~~~~ist~~~i~~~~~~~~~~~P~~V~~TA~~~~~~s~~~nltw  254 (347)
T PF12819_consen  177 LETVYRLNVGGSSSFIRYPDDTYDRIWQPYSSS--PGWSNISTTSNININSSNNPYDAPSAVYQTARTPSNSSDPLNLTW  254 (347)
T ss_pred             eEEEEeecCCCcccccCCCCCcceeeccccccC--ccccccccceeeecccCCccCcChHHHHHhhhcccccccceEEEe
Confidence            4456899999776    3 66679999964111  1111111  1121    1122233   99999862     23456


Q ss_pred             EEecCCCceE-EEEeeecCCCCCCCCCCce-EEEEeCceEEEeccCcccCCC--CceEEEEEEeecCCCceEEEEEecCC
Q 042216           70 TFNVTPGQKF-IRLHFYSTSYSGFNISSAF-FSVKANSFTLVNNFSASFAPD--DTFFKEFCINVPEDQRSLSITFTPSP  145 (767)
Q Consensus        70 ~~~~~~g~~y-vR~~f~~~~y~~~~~~~~~-~~v~~~~~~~~~~~~~~~~~~--~~~~~e~~~~~~~~~~~~~l~~~~~~  145 (767)
                      .+ +.++..| ||+||+.-.....+.. .+ |+|..|+.......+......  .+++..+++.+++.. .+.|.+.|..
T Consensus       255 ~~-~~~~~~y~v~lHFaEi~~~~~~~~-~R~F~IyiN~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~-~~~isL~~t~  331 (347)
T PF12819_consen  255 SF-VDPGFSYYVRLHFAEIQSLSPNNN-QREFDIYINGQTAYSDVSPPYLGADTVPYYSDYVVNVPDSG-FLNISLGPTP  331 (347)
T ss_pred             cc-CCCCccEEEEEEEeecccccCCCC-eEEEEEEECCeEccCccCcccccCcceEeecceEEEecCCC-EEEEEEEeCC
Confidence            67 7888888 9999994443222222 46 999999999887555522222  256778888876543 5666667764


Q ss_pred             CCCCCceeeeeeEeEec
Q 042216          146 DYQDSYAFINGIELVSM  162 (767)
Q Consensus       146 ~~~~~~pfis~iE~~~~  162 (767)
                      +. .--|+|||+||+.+
T Consensus       332 ~S-~lppiLNalEIy~v  347 (347)
T PF12819_consen  332 DS-TLPPILNALEIYKV  347 (347)
T ss_pred             CC-CcCceeEeeeeEeC
Confidence            32 33799999999864

This entry represents a malectin-like domain found in a number of plant receptor kinases.

>PRK09902 hypothetical protein; Provisional

Probab=98.41  E-value=3.8e-06  Score=83.12  Aligned_cols=137  Identities=20%  Similarity=0.202  Sum_probs=104.4

Q ss_pred             eeccCcEEEEEEEecCCCceEEEEEeCCC---C---CcchhHHHHHHHHHhcccc--ceeeeEeeeee-cC----CceEE
Q 042216          483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPG---S---QQGALEFQTEIGMLSQLRY--LHLVSLIGYCN-DD----GQMIL  549 (767)
Q Consensus       483 LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~---~~~~~~f~~Ei~~l~~l~H--pniv~l~g~~~-~~----~~~~l  549 (767)
                      -|+||-+-|++..+.+  +.+-+|+-...   +   +.+...|.+|+..|.+|..  -.+.+++ ++. ..    -..+|
T Consensus        26 ~~rgG~SgV~r~~~~g--~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVERNG--KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEeCC--cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            4679999999988865  36888976421   1   3456789999999999853  2344555 332 21    24689


Q ss_pred             EEecCCC-CChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCc--EEEeecCCcc
Q 042216          550 VYDYMAR-GTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV--AKVSDFGLCK  625 (767)
Q Consensus       550 V~ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~--~ki~DfGla~  625 (767)
                      |+|-+++ -+|.+++.+....+.+..++..+..+++..+.-||   ..++.|+|+.+.|||++.++.  ++++||.-++
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            9997764 48999886654446678888999999999999999   788999999999999986666  9999998765

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.32  E-value=3.8e-06  Score=84.54  Aligned_cols=106  Identities=24%  Similarity=0.280  Sum_probs=83.3

Q ss_pred             hhHHHHHHHHHhcccc--ceeeeEeeeeecCC----ceEEEEecCCCC-ChhhhhccCCCCCCChHHHHHHHHHHHHHHH
Q 042216          516 ALEFQTEIGMLSQLRY--LHLVSLIGYCNDDG----QMILVYDYMARG-TLRDHLYNNDNPPLPWDRRLKICIGAARALH  588 (767)
Q Consensus       516 ~~~f~~Ei~~l~~l~H--pniv~l~g~~~~~~----~~~lV~ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~  588 (767)
                      .....+|...+..|+.  -.....+++.....    ..+||+|++++- +|.+++.....  ++......++.+++..+.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA  132 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence            3457888888877753  34556666665432    458999999874 79999865332  566778899999999999


Q ss_pred             HhHhCCCCCeEecCCCCCCeEECCCC---cEEEeecCCccc
Q 042216          589 YLHTGASKVIIHRDVKTTNILLDEEW---VAKVSDFGLCKF  626 (767)
Q Consensus       589 yLH~~~~~~iiH~Dlk~~NILld~~~---~~ki~DfGla~~  626 (767)
                      -||   ..+|+|+|+++.|||++.+.   .+.++||+-++.
T Consensus       133 ~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999   78899999999999999887   899999998774

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.20  E-value=8.4e-06  Score=82.56  Aligned_cols=130  Identities=22%  Similarity=0.165  Sum_probs=90.1

Q ss_pred             eeeeccCcEEEEEEEecCCCceEEEEEeCCCC----------------------CcchhHHHHHHHHHhccccc--eeee
Q 042216          481 LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS----------------------QQGALEFQTEIGMLSQLRYL--HLVS  536 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~----------------------~~~~~~f~~Ei~~l~~l~Hp--niv~  536 (767)
                      ..||.|--+.||.|....+ .++|||.-+...                      .......++|.+.|.+|.-.  .+.+
T Consensus        97 ~~IGvGKEsdVY~~~~~~g-~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~  175 (304)
T COG0478          97 TKIGVGKESDVYVAIDPKG-RKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPK  175 (304)
T ss_pred             cccccCccceEEEEECCCC-CEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCC
Confidence            4799999999999998744 789999543210                      00112356788888888644  4445


Q ss_pred             EeeeeecCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcE
Q 042216          537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVA  616 (767)
Q Consensus       537 l~g~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~  616 (767)
                      .++    .+...+||||+++-.|...-       ++-...-.|+..|.+-+.-+-   ..+++|+|++.-||+++++|.+
T Consensus       176 P~~----~nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg~~  241 (304)
T COG0478         176 PIA----WNRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDGDI  241 (304)
T ss_pred             ccc----cccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCCCE
Confidence            443    34678999999986655432       223334445555555555444   4669999999999999999999


Q ss_pred             EEeecCCcc
Q 042216          617 KVSDFGLCK  625 (767)
Q Consensus       617 ki~DfGla~  625 (767)
                      .++||--+.
T Consensus       242 ~vIDwPQ~v  250 (304)
T COG0478         242 VVIDWPQAV  250 (304)
T ss_pred             EEEeCcccc
Confidence            999997654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.19  E-value=2.6e-05  Score=79.55  Aligned_cols=140  Identities=16%  Similarity=0.232  Sum_probs=85.4

Q ss_pred             eeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccce--eeeEeeeeecCCceEEEEecCCCCC
Q 042216          481 LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--LVSLIGYCNDDGQMILVYDYMARGT  558 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpn--iv~l~g~~~~~~~~~lV~ey~~~gs  558 (767)
                      ..||+|..+.||+.  . + ..+++|......  ......+|.+++..+..-.  +.+.++++...+...+|||+++|..
T Consensus         7 ~~i~~G~t~~~y~~--~-~-~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH--K-T-GKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe--c-C-CCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            47999999999984  2 2 357788876533  3345688999998886433  4566777777777889999999863


Q ss_pred             -hhhhh---------------------ccCCCCCCChHHHHHHH-H----------HHHH-HHHHhHh-CCCCCeEecCC
Q 042216          559 -LRDHL---------------------YNNDNPPLPWDRRLKIC-I----------GAAR-ALHYLHT-GASKVIIHRDV  603 (767)
Q Consensus       559 -L~~~L---------------------~~~~~~~l~~~~~~~i~-~----------~ia~-gL~yLH~-~~~~~iiH~Dl  603 (767)
                       +...+                     |.-.........+..-. .          .+.. ...+|.. .....++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             22111                     11100011111110000 0          0011 1122221 12345789999


Q ss_pred             CCCCeEECCCCcEEEeecCCcccC
Q 042216          604 KTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       604 k~~NILld~~~~~ki~DfGla~~~  627 (767)
                      .|.||++++++ +.|.||+.+..+
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~~G  183 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFGYG  183 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcCcC
Confidence            99999999888 999999987643

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.15  E-value=1e-05  Score=91.27  Aligned_cols=143  Identities=19%  Similarity=0.211  Sum_probs=93.9

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcc----------------------------------------
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQG----------------------------------------  515 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~----------------------------------------  515 (767)
                      .|+. +-|+.++-|-||+|++++ |+.||||+.+++-...                                        
T Consensus       127 eF~~-~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~  204 (517)
T COG0661         127 EFEP-EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE  204 (517)
T ss_pred             HcCC-CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence            4544 368999999999999986 5899999988753210                                        


Q ss_pred             hhHHHHHHHHHhccc----cceeeeEeeeee-cCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHH-HHH
Q 042216          516 ALEFQTEIGMLSQLR----YLHLVSLIGYCN-DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARA-LHY  589 (767)
Q Consensus       516 ~~~f~~Ei~~l~~l~----Hpniv~l~g~~~-~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~g-L~y  589 (767)
                      .-++.+|..-+.+++    +..-+.+=..+. -.+...|+|||++|-.+.+...-+. ...+.+   .++..++++ +..
T Consensus       205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k---~ia~~~~~~f~~q  280 (517)
T COG0661         205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRK---ELAELLVRAFLRQ  280 (517)
T ss_pred             HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHH---HHHHHHHHHHHHH
Confidence            012444555555442    222233333333 3567899999999999988753222 234433   333333332 222


Q ss_pred             hHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       590 LH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      +-   ..++.|.|..|.||+++.++++.+.|||+....
T Consensus       281 ~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         281 LL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             HH---hcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence            22   356999999999999999999999999998654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.03  E-value=0.0001  Score=72.68  Aligned_cols=103  Identities=22%  Similarity=0.298  Sum_probs=82.4

Q ss_pred             HHHHHHHhcccc-ceeeeEeeeeecCCceEEEEecCCCCChhhhhcc-CCCCCCChHHHHHHHHHHHHHHHHhHhCCCCC
Q 042216          520 QTEIGMLSQLRY-LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYN-NDNPPLPWDRRLKICIGAARALHYLHTGASKV  597 (767)
Q Consensus       520 ~~Ei~~l~~l~H-pniv~l~g~~~~~~~~~lV~ey~~~gsL~~~L~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  597 (767)
                      ..|.-+++.+++ +++.+++|+|    ..+++.||...+++...-.. ..-..-+|..|.+||.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            457888888876 6999999999    44679999998766432000 01123689999999999999999999766566


Q ss_pred             eEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          598 IIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       598 iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      +.-.|++++|+-+++++++|+.|...+..
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            89999999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.92  E-value=1e-06  Score=97.76  Aligned_cols=181  Identities=17%  Similarity=0.132  Sum_probs=128.8

Q ss_pred             eeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccce-eeeEeeeeecCCceEEEEecCCCC-C
Q 042216          481 LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH-LVSLIGYCNDDGQMILVYDYMARG-T  558 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpn-iv~l~g~~~~~~~~~lV~ey~~~g-s  558 (767)
                      +-+++|++++++|.+-..+. ....+.+..     ..+..-++++|.+++||| .+.-++-+..+...+++++++..| +
T Consensus       248 h~fvK~altknpKkRptaek-lL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs  321 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEK-LLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS  321 (829)
T ss_pred             HHHHHHHhcCCCccCCChhh-heeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence            34789999999987554332 222444321     245567899999999999 677777777788899999999887 2


Q ss_pred             hhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcccccc
Q 042216          559 LRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ  638 (767)
Q Consensus       559 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~  638 (767)
                      -..-.. .....+..-+...++..-++++++||+   ..-+|+|    ||+..+ ...|..||+.........   ....
T Consensus       322 ~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t  389 (829)
T KOG0576|consen  322 SALEMT-VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRT  389 (829)
T ss_pred             ccccCC-hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---cccc
Confidence            222111 111124445566677778889999994   3347888    777766 588999999876543322   2345


Q ss_pred             ccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 042216          639 VKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPI  679 (767)
Q Consensus       639 ~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~  679 (767)
                      ..+++.|+|||......+..+.|+|+.|+-..++.-|-+|-
T Consensus       390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            66899999999999999999999999998777777676663

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.87  E-value=0.00019  Score=74.28  Aligned_cols=139  Identities=22%  Similarity=0.236  Sum_probs=84.8

Q ss_pred             eeccCc-EEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc-cceeeeEeeeeecCCceEEEEecCCCCChh
Q 042216          483 IGRGGF-GNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-YLHLVSLIGYCNDDGQMILVYDYMARGTLR  560 (767)
Q Consensus       483 LG~G~f-G~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~ey~~~gsL~  560 (767)
                      |-.|.. ..||+....+  ..+.||+.....   ..++.+|++++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus         6 ~~~g~~~~~v~~~~~~~--~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGKN--PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCCC--CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            445555 7799987653  568888875432   345678999888884 344556777776666789999999988776


Q ss_pred             hhh-------------------ccCC--CCCCC--hHHHHHHHHH--------------------HHHHHHHhHh----C
Q 042216          561 DHL-------------------YNND--NPPLP--WDRRLKICIG--------------------AARALHYLHT----G  593 (767)
Q Consensus       561 ~~L-------------------~~~~--~~~l~--~~~~~~i~~~--------------------ia~gL~yLH~----~  593 (767)
                      +..                   +...  ..+..  ...++..+..                    +...+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            432                   1110  00111  0011100000                    1111122211    1


Q ss_pred             CCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       594 ~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      ....++|+|+.+.|||++++....|.||+.+..
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            135589999999999999987789999998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.85  E-value=0.0001  Score=75.07  Aligned_cols=143  Identities=20%  Similarity=0.226  Sum_probs=84.9

Q ss_pred             ceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccc--eeeeEeeeeec---CCceEEEEecC
Q 042216          480 LLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL--HLVSLIGYCND---DGQMILVYDYM  554 (767)
Q Consensus       480 ~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hp--niv~l~g~~~~---~~~~~lV~ey~  554 (767)
                      ++.|+.|..+.||+....+  ..+++|.....  .....+..|..++..+...  .+.+++.++..   ....+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            3578999999999999876  47999987643  4456778898888888533  34566654432   33568999999


Q ss_pred             CCCChhh----------------hh---ccC--CCCCCChHH---------HHHH------------HHHHHH-HHHHhH
Q 042216          555 ARGTLRD----------------HL---YNN--DNPPLPWDR---------RLKI------------CIGAAR-ALHYLH  591 (767)
Q Consensus       555 ~~gsL~~----------------~L---~~~--~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH  591 (767)
                      ++..+..                .+   +..  ...+..+..         ....            ...+.+ .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9988877                11   111  111111111         0000            011222 233333


Q ss_pred             h----CCCCCeEecCCCCCCeEEC-CCCcEEEeecCCccc
Q 042216          592 T----GASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKF  626 (767)
Q Consensus       592 ~----~~~~~iiH~Dlk~~NILld-~~~~~ki~DfGla~~  626 (767)
                      .    .....++|+|+.+.|||++ +++.+.|.||+.+..
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            2    2356799999999999999 666668999988653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.85  E-value=0.00017  Score=71.79  Aligned_cols=136  Identities=13%  Similarity=0.130  Sum_probs=89.9

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHH---------HHHHHHHhcccc---ceeeeEeeee
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEF---------QTEIGMLSQLRY---LHLVSLIGYC  541 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f---------~~Ei~~l~~l~H---pniv~l~g~~  541 (767)
                      .++|...+++-......|.+-...+  ..+++|..+.......+.|         .+++..+.+++.   -..+.++.++
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei~~--~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEIDG--KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEECC--cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            4677777778777777777776654  6799998765543322222         234444444432   2222322222


Q ss_pred             e-----cCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcE
Q 042216          542 N-----DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVA  616 (767)
Q Consensus       542 ~-----~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~  616 (767)
                      .     -....+|+|||++|..|.++..      ++.    .++..++++|.-||   ..|+.|+|..|.|++++++ .+
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~i  173 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-GI  173 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-cE
Confidence            2     2245679999999988877641      222    24456778899999   7889999999999999966 48


Q ss_pred             EEeecCCcc
Q 042216          617 KVSDFGLCK  625 (767)
Q Consensus       617 ki~DfGla~  625 (767)
                      ++.||+..+
T Consensus       174 ~iID~~~k~  182 (229)
T PF06176_consen  174 RIIDTQGKR  182 (229)
T ss_pred             EEEECcccc
Confidence            999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PLN02876 acyl-CoA dehydrogenase

Probab=97.81  E-value=0.00029  Score=85.71  Aligned_cols=149  Identities=17%  Similarity=0.283  Sum_probs=93.2

Q ss_pred             ceeeeccCcEEEEEEEecCCC--ceEEEEEeCCCC-CcchhHHHHHHHHHhccc-ccee--eeEeeeeecC---CceEEE
Q 042216          480 LLIIGRGGFGNVYKGFLNGDS--TPVAIKRLNPGS-QQGALEFQTEIGMLSQLR-YLHL--VSLIGYCNDD---GQMILV  550 (767)
Q Consensus       480 ~~~LG~G~fG~Vy~g~~~~~~--~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-Hpni--v~l~g~~~~~---~~~~lV  550 (767)
                      ...++.|.+..+|+....+++  ..+++|+..... ......+.+|.++|+.+. |.++  .+++.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            456899999999998876542  367777764432 223456889999999995 6654  7788888764   467899


Q ss_pred             EecCCCCChhhh-----------------------hccCCC---------CCCCh--HHHHHHH---------------H
Q 042216          551 YDYMARGTLRDH-----------------------LYNNDN---------PPLPW--DRRLKIC---------------I  581 (767)
Q Consensus       551 ~ey~~~gsL~~~-----------------------L~~~~~---------~~l~~--~~~~~i~---------------~  581 (767)
                      |||+++..+.+.                       ||.-..         .+..+  .++..+.               -
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            999998654321                       111110         01111  1111111               1


Q ss_pred             HHHHHHHHhHhCC--------CCCeEecCCCCCCeEECC-CC-cEEEeecCCcccCC
Q 042216          582 GAARALHYLHTGA--------SKVIIHRDVKTTNILLDE-EW-VAKVSDFGLCKFGP  628 (767)
Q Consensus       582 ~ia~gL~yLH~~~--------~~~iiH~Dlk~~NILld~-~~-~~ki~DfGla~~~~  628 (767)
                      .+.+.+.+|....        ...+||+|+++.|||++. +. .+-|.||.++..+.
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd  259 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN  259 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence            1233456664321        135999999999999985 33 35789999987653

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.62  E-value=0.00035  Score=78.86  Aligned_cols=144  Identities=18%  Similarity=0.180  Sum_probs=91.0

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc-------------------------------------chhH
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ-------------------------------------GALE  518 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~-------------------------------------~~~~  518 (767)
                      .|+.. .||.-+.|.||+|++++ ++.||||+-++.-+.                                     .+-+
T Consensus       163 ~f~~~-piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELD  240 (538)
T KOG1235|consen  163 EFDEE-PIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELD  240 (538)
T ss_pred             hcCcc-hhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcc
Confidence            44433 59999999999999997 589999998765321                                     1113


Q ss_pred             HHHHHHHHhcc----ccce---eeeEeeeee-cCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHh
Q 042216          519 FQTEIGMLSQL----RYLH---LVSLIGYCN-DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL  590 (767)
Q Consensus       519 f~~Ei~~l~~l----~Hpn---iv~l~g~~~-~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yL  590 (767)
                      |..|.+-..+.    +|-+   -|.+=.++. -.....|+||||+|..+.+.-.-.. ..++-.   .|+..+.++..  
T Consensus       241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~---~i~~~l~~~~~--  314 (538)
T KOG1235|consen  241 FTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK-RGISPH---DILNKLVEAYL--  314 (538)
T ss_pred             hHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH-cCCCHH---HHHHHHHHHHH--
Confidence            55555443333    3544   122222222 2357899999999998877532111 124444   33333333322  


Q ss_pred             HhCCCCCeEecCCCCCCeEECC----CCcEEEeecCCcccC
Q 042216          591 HTGASKVIIHRDVKTTNILLDE----EWVAKVSDFGLCKFG  627 (767)
Q Consensus       591 H~~~~~~iiH~Dlk~~NILld~----~~~~ki~DfGla~~~  627 (767)
                      +.--..|.+|+|=.|.||+++.    ++.+.+-|||+....
T Consensus       315 ~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  315 EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            2112456999999999999983    678999999998754

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.59  E-value=0.00095  Score=67.31  Aligned_cols=153  Identities=16%  Similarity=0.167  Sum_probs=94.9

Q ss_pred             cccCHHHHHHHhhcccccee---eeccCcEEEEEEEecCCCceEEEEEeCCCCCcc-------------------hhH--
Q 042216          463 TQFSISEIKEATKDFNNLLI---IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQG-------------------ALE--  518 (767)
Q Consensus       463 ~~~~~~ei~~~t~~f~~~~~---LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~-------------------~~~--  518 (767)
                      ...+.+.|............   |..|--+.||+|.-. ++..+|||+++......                   .++  
T Consensus        33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv  111 (268)
T COG1718          33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV  111 (268)
T ss_pred             hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence            34556666666665555555   446777789998774 34789999986542111                   001  


Q ss_pred             ---HHHHHHHHhccc--cceeeeEeeeeecCCceEEEEecCCCC-ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHh
Q 042216          519 ---FQTEIGMLSQLR--YLHLVSLIGYCNDDGQMILVYDYMARG-TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT  592 (767)
Q Consensus       519 ---f~~Ei~~l~~l~--Hpniv~l~g~~~~~~~~~lV~ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~  592 (767)
                         -..|..-|.++.  +-.+.+.+++.    .-.|||||+... .-.-.|..   -++...+...+..++++.+.-|-.
T Consensus       112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~  184 (268)
T COG1718         112 FAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYK  184 (268)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHH
Confidence               123555555542  22333333332    446999999653 11112211   122333566677778888887773


Q ss_pred             CCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       593 ~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                        ..++||+||+.-|||+. ++.+.|+|+|-+-.
T Consensus       185 --~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~  215 (268)
T COG1718         185 --EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVT  215 (268)
T ss_pred             --hcCcccccchhhheEEE-CCeEEEEECccccc
Confidence              36799999999999999 77999999998764

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.57  E-value=0.0013  Score=65.27  Aligned_cols=133  Identities=22%  Similarity=0.305  Sum_probs=91.6

Q ss_pred             ccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC----------------CcchhHHHHHHHHHhccc------cceee
Q 042216          478 NNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS----------------QQGALEFQTEIGMLSQLR------YLHLV  535 (767)
Q Consensus       478 ~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~----------------~~~~~~f~~Ei~~l~~l~------Hpniv  535 (767)
                      +....||+|+.=.||.-  .. +...+||+..+..                ....++..+|+.....+.      +.+|.
T Consensus         4 ~~~~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~   80 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP   80 (199)
T ss_pred             CCCcccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence            44557999999999963  32 3567899887655                223456777776666655      78999


Q ss_pred             eEeeeeecCCceEEEEecCCC--C----ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeE
Q 042216          536 SLIGYCNDDGQMILVYDYMAR--G----TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNIL  609 (767)
Q Consensus       536 ~l~g~~~~~~~~~lV~ey~~~--g----sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIL  609 (767)
                      +++|+.+.+-..-+|+|.+.+  |    +|.+++.+.   .++. ...+.+.+..   .||-   ...|+.+|++|.||+
T Consensus        81 r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~~f~---~~l~---~~~Iv~~dl~~~NIv  150 (199)
T PF10707_consen   81 RFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALDEFK---RYLL---DHHIVIRDLNPHNIV  150 (199)
T ss_pred             cEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHHHHH---HHHH---HcCCeecCCCcccEE
Confidence            999999999889999998743  2    577777433   2454 4444444444   4454   455999999999999


Q ss_pred             ECC---CC-cEEEee-cCC
Q 042216          610 LDE---EW-VAKVSD-FGL  623 (767)
Q Consensus       610 ld~---~~-~~ki~D-fGl  623 (767)
                      +..   +. .+.|.| ||-
T Consensus       151 ~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  151 VQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             EEecCCCceEEEEEeCCCC
Confidence            953   22 567776 454

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.51  E-value=0.0009  Score=68.77  Aligned_cols=139  Identities=22%  Similarity=0.238  Sum_probs=76.8

Q ss_pred             eeeeccCcEE-EEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccc---eeeeEeeeeecC---CceEEEEec
Q 042216          481 LIIGRGGFGN-VYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL---HLVSLIGYCNDD---GQMILVYDY  553 (767)
Q Consensus       481 ~~LG~G~fG~-Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hp---niv~l~g~~~~~---~~~~lV~ey  553 (767)
                      +.|+.|+... ||+.   +  ..+++|....  ......+.+|.++|..|...   .+.+.++.+...   ...+++|++
T Consensus         3 ~~~~~gG~~n~vy~~---~--~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL---G--DDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc---C--CceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            4577777764 8875   1  2467776543  22345788999998877532   233344443332   234889999


Q ss_pred             CCCCChhhhh------------------ccCCCC--CC-------------ChHHHH--HHH-------HHHHHH-HHH-
Q 042216          554 MARGTLRDHL------------------YNNDNP--PL-------------PWDRRL--KIC-------IGAARA-LHY-  589 (767)
Q Consensus       554 ~~~gsL~~~L------------------~~~~~~--~l-------------~~~~~~--~i~-------~~ia~g-L~y-  589 (767)
                      ++|.++.+..                  |.-...  +.             .|....  .+.       .+.... ++. 
T Consensus        76 i~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  155 (235)
T cd05155          76 LEGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAA  155 (235)
T ss_pred             ecCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHH
Confidence            9987774321                  111000  00             111110  000       011111 111 


Q ss_pred             hHh--CCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          590 LHT--GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       590 LH~--~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      ++.  .....++|+|+.+.|||++++...-|.||+.+..
T Consensus       156 ~~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         156 LRAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             hcccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            111  1244589999999999999876667999998764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=97.45  E-value=0.003  Score=67.34  Aligned_cols=79  Identities=11%  Similarity=0.079  Sum_probs=56.8

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcccc---ceeeeEeeeeec---CCceEEE
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRY---LHLVSLIGYCND---DGQMILV  550 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H---pniv~l~g~~~~---~~~~~lV  550 (767)
                      ......||.|..+.||+....++  .+.+|..+..  .....|..|.+.|+.|.-   ..+.+++++|..   .+..+||
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~~--~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQG--NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             hheeeecCCccceeEEEEEcCCC--CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            34445799999999999876543  4677775321  123478899999988843   367788888754   3668999


Q ss_pred             EecCCCCCh
Q 042216          551 YDYMARGTL  559 (767)
Q Consensus       551 ~ey~~~gsL  559 (767)
                      ||+++++++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998765

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.41  E-value=0.00038  Score=82.95  Aligned_cols=197  Identities=16%  Similarity=0.164  Sum_probs=134.2

Q ss_pred             HHHHHHHHHhccccceeeeEeeeeecCCc----eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhC
Q 042216          518 EFQTEIGMLSQLRYLHLVSLIGYCNDDGQ----MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG  593 (767)
Q Consensus       518 ~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~----~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~  593 (767)
                      ....|++.+.+++|+|++..+.|..+...    +.+..|++..-++...+...  ..++......++.++.+||.|+|. 
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~-  304 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHS-  304 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHH-
Confidence            34567788889999999999999765532    33456788888888877443  457788888899999999999994 


Q ss_pred             CCCCeEecCCCCC---CeEECCCCcEEEe--ecCCcccCCCCCCccccccccCCCcccChhhhccCCCCc--hhhHHHHH
Q 042216          594 ASKVIIHRDVKTT---NILLDEEWVAKVS--DFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTE--KSDVYSFG  666 (767)
Q Consensus       594 ~~~~iiH~Dlk~~---NILld~~~~~ki~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--ksDV~SfG  666 (767)
                        ....|.-+..+   +.-.+..+...++  ||+.++..+.....   .....+..+.++|......++.  ..|+|.+|
T Consensus       305 --~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  305 --LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG  379 (1351)
T ss_pred             --hccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHH
Confidence              44555555444   4445666677777  88887754432221   1222445678888877665554  47999999


Q ss_pred             HHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          667 VVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       667 vvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ..+..+..|..+-.....                  +..++        +..+...+.+....|+..++++|++..+++.
T Consensus       380 ll~~~~~~~~~i~~~~~~------------------~~~~l--------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~  433 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISEKSAV------------------PVSLL--------DVLSTSELLDALPKCLDEDSEERLSALELLT  433 (1351)
T ss_pred             HHHhhhhhcCcccccccc------------------hhhhh--------ccccchhhhhhhhhhcchhhhhccchhhhhh
Confidence            999999887654311100                  00000        1112225677889999999999999999986


Q ss_pred             HH
Q 042216          747 GL  748 (767)
Q Consensus       747 ~L  748 (767)
                      ..
T Consensus       434 ~~  435 (1351)
T KOG1035|consen  434 HP  435 (1351)
T ss_pred             ch
Confidence            54

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.37  E-value=0.0026  Score=65.25  Aligned_cols=141  Identities=18%  Similarity=0.218  Sum_probs=80.7

Q ss_pred             eeeeccCcEEEEEEEecC-CCceEEEEEeCCCCCcchhHHHHHHHHHhccccceee-eEeeeeecCCceEEEEecCCCCC
Q 042216          481 LIIGRGGFGNVYKGFLNG-DSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV-SLIGYCNDDGQMILVYDYMARGT  558 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~lV~ey~~~gs  558 (767)
                      +.|..|-...+|+....+ .+..+++|+....... .....+|+.++..+....++ ++++.+. +   .++|||+++.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCc
Confidence            457778888999987653 2357888877543222 22345788888888543333 3333332 2   37999999876


Q ss_pred             hhhh-----------------hccCCC---------CCC-ChHHHHHHHH----------------------HHH---HH
Q 042216          559 LRDH-----------------LYNNDN---------PPL-PWDRRLKICI----------------------GAA---RA  586 (767)
Q Consensus       559 L~~~-----------------L~~~~~---------~~l-~~~~~~~i~~----------------------~ia---~g  586 (767)
                      +...                 +|....         ... -|..+..+..                      .+.   ..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            6321                 111110         011 1222111111                      111   11


Q ss_pred             HH-HhHh-CCCCCeEecCCCCCCeEECC-CCcEEEeecCCccc
Q 042216          587 LH-YLHT-GASKVIIHRDVKTTNILLDE-EWVAKVSDFGLCKF  626 (767)
Q Consensus       587 L~-yLH~-~~~~~iiH~Dlk~~NILld~-~~~~ki~DfGla~~  626 (767)
                      |. .+.. .....++|+|+.+.|||+++ +..+.+.||..+..
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            11 1111 12356999999999999998 57899999988764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.36  E-value=0.0012  Score=63.14  Aligned_cols=130  Identities=17%  Similarity=0.156  Sum_probs=86.4

Q ss_pred             ccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCCC
Q 042216          478 NNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARG  557 (767)
Q Consensus       478 ~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~g  557 (767)
                      .....|++|++|.||+|.+.+  ..+|+|.-+.++.  ...+..|+++|..+.--++.+=+-.+.   .-.+.|||+.|-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~--~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRG--GEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeeccC--ceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhhcCc
Confidence            344579999999999999976  4799998765543  446888999999887666654433222   223459999998


Q ss_pred             ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCC-CCCeEECCCCcEEEeecCCccc
Q 042216          558 TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVK-TTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       558 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk-~~NILld~~~~~ki~DfGla~~  626 (767)
                      .|.+.-...     +-++...    +++.-.-|-   ..+|-|+.|. |...+|..+..+.|+||.-|++
T Consensus        98 ~L~~~~~~~-----~rk~l~~----vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIGG-----DRKHLLR----VLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhcc-----cHHHHHH----HHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            887764321     2233333    344423333   5668888883 5555555555999999998774

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.34  E-value=0.0015  Score=68.11  Aligned_cols=137  Identities=15%  Similarity=0.165  Sum_probs=78.2

Q ss_pred             eeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceee-eEeeeeecCCceEEEEecCCCCChhh
Q 042216          483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV-SLIGYCNDDGQMILVYDYMARGTLRD  561 (767)
Q Consensus       483 LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~lV~ey~~~gsL~~  561 (767)
                      +..|-...+|+....  +..+++|........-.....+|.++++.+....++ ++++.+.    -++|+||+++..+..
T Consensus         4 ~~~G~tn~~y~~~~~--~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         4 LSGGLTNRSWRIEHP--GISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             CCCcCcCCeEEEEeC--CccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            456777889988743  357888876543322212457888888888643333 3343332    368999999876643


Q ss_pred             h-----------------hccCC--CCCCChHHHH-HHHHH---------HHHHHHHhHhC-----CCCCeEecCCCCCC
Q 042216          562 H-----------------LYNND--NPPLPWDRRL-KICIG---------AARALHYLHTG-----ASKVIIHRDVKTTN  607 (767)
Q Consensus       562 ~-----------------L~~~~--~~~l~~~~~~-~i~~~---------ia~gL~yLH~~-----~~~~iiH~Dlk~~N  607 (767)
                      .                 ||...  ..+++...+. ....+         +...+..+...     ....++|+|+.+.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 11111  1112222111 11101         11112222111     13468999999999


Q ss_pred             eEECCCCcEEEeecCCccc
Q 042216          608 ILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       608 ILld~~~~~ki~DfGla~~  626 (767)
                      |++++++ +.|.||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999876 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.30  E-value=0.0039  Score=68.63  Aligned_cols=76  Identities=14%  Similarity=0.076  Sum_probs=53.2

Q ss_pred             eeeeccCcEEEEEEEecCCCceEEEEEeCCCC-------CcchhHHHHHHHHHhccc---cceeeeEeeeeecCCceEEE
Q 042216          481 LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-------QQGALEFQTEIGMLSQLR---YLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-------~~~~~~f~~Ei~~l~~l~---Hpniv~l~g~~~~~~~~~lV  550 (767)
                      +.||.|.+..||++...++++.++||.-.+..       ......+..|.+.|..+.   ..++.+++.+.  .+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence            36899999999999997654589999854221       223456777888888763   23456666653  3567899


Q ss_pred             EecCCCCC
Q 042216          551 YDYMARGT  558 (767)
Q Consensus       551 ~ey~~~gs  558 (767)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.29  E-value=0.0042  Score=61.27  Aligned_cols=125  Identities=28%  Similarity=0.334  Sum_probs=87.4

Q ss_pred             hccccceeeeccCc-EEEEEEEecCCCceEEEEEeCC---CCC------------------cchhHHHHHHHHHhccc--
Q 042216          475 KDFNNLLIIGRGGF-GNVYKGFLNGDSTPVAIKRLNP---GSQ------------------QGALEFQTEIGMLSQLR--  530 (767)
Q Consensus       475 ~~f~~~~~LG~G~f-G~Vy~g~~~~~~~~vAVK~l~~---~~~------------------~~~~~f~~Ei~~l~~l~--  530 (767)
                      .+++.++.||.|.- |.||+++..+  +.+|+|....   ...                  .....|..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g--~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDG--RIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECC--eEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            78889999999999 9999999975  6899999321   100                  11235888988888775  


Q ss_pred             -ccee--eeEeeeeecC------------------CceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHH
Q 042216          531 -YLHL--VSLIGYCNDD------------------GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY  589 (767)
Q Consensus       531 -Hpni--v~l~g~~~~~------------------~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~y  589 (767)
                       +.++  ++.+||..=.                  ....+|.||++...           .+.    .+-+.++.+-|..
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~  179 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKI  179 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHH
Confidence             4455  8889887211                  12346666665422           122    2334566677888


Q ss_pred             hHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCc
Q 042216          590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC  624 (767)
Q Consensus       590 LH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla  624 (767)
                      +|   ..+|+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LH---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HH---HCCeeeccCcccccc-----CCEEEecccC
Confidence            99   788999999999986     4579999864

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.27  E-value=0.0019  Score=68.80  Aligned_cols=142  Identities=20%  Similarity=0.161  Sum_probs=85.2

Q ss_pred             ceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccce--eeeEeeee------ecCCceEEEE
Q 042216          480 LLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--LVSLIGYC------NDDGQMILVY  551 (767)
Q Consensus       480 ~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpn--iv~l~g~~------~~~~~~~lV~  551 (767)
                      .+.|..|....+|+....+  ..+++|+...   ....+...|++++..|++..  +.+++...      ...+..++|+
T Consensus        19 i~~i~~G~~n~~y~v~~~~--~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS--GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeCC--CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            4457778778999987654  3688898764   23345667888887775432  34444321      2234668999


Q ss_pred             ecCCCCChhh----h----------hccC----CC-----CCCChHHHHH----------HHHHHHHHHHHhHh----CC
Q 042216          552 DYMARGTLRD----H----------LYNN----DN-----PPLPWDRRLK----------ICIGAARALHYLHT----GA  594 (767)
Q Consensus       552 ey~~~gsL~~----~----------L~~~----~~-----~~l~~~~~~~----------i~~~ia~gL~yLH~----~~  594 (767)
                      +|++|..+..    .          ||..    ..     ....|.....          ....+...+.++..    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9999876532    0          1110    00     1122322211          11112334444442    12


Q ss_pred             CCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       595 ~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      ..+++|+|+.|.|||++++..+.|.||+.+..
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            35699999999999999987788999998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.99  E-value=0.0066  Score=64.88  Aligned_cols=141  Identities=22%  Similarity=0.276  Sum_probs=82.8

Q ss_pred             eeeeccCcEEEEEEEecCC------CceEEEEEeCCCCCcchhHHHHHHHHHhccccceee-eEeeeeecCCceEEEEec
Q 042216          481 LIIGRGGFGNVYKGFLNGD------STPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV-SLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~~------~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~lV~ey  553 (767)
                      +.|..|-...+|+....++      ++.+++|+..... ....+..+|.+++..+....+. ++++++. +   .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence            3466666678999887542      4678899876543 2334567888888888543333 4454443 2   358999


Q ss_pred             CCCCChhhh-----------------hccCCCC---------CCChHHHHHH--------------------------HH
Q 042216          554 MARGTLRDH-----------------LYNNDNP---------PLPWDRRLKI--------------------------CI  581 (767)
Q Consensus       554 ~~~gsL~~~-----------------L~~~~~~---------~l~~~~~~~i--------------------------~~  581 (767)
                      ++|..+...                 ||+....         +.-|..+..+                          ..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            988776431                 1111110         0111111111                          11


Q ss_pred             HHHHHHHHhHh------CCCCCeEecCCCCCCeEECCC----CcEEEeecCCccc
Q 042216          582 GAARALHYLHT------GASKVIIHRDVKTTNILLDEE----WVAKVSDFGLCKF  626 (767)
Q Consensus       582 ~ia~gL~yLH~------~~~~~iiH~Dlk~~NILld~~----~~~ki~DfGla~~  626 (767)
                      .+..-+..|..      .....++|+|+.+.|||++++    +.++++||..+..
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            11222333331      135679999999999999984    7899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=96.81  E-value=0.02  Score=61.69  Aligned_cols=159  Identities=14%  Similarity=0.144  Sum_probs=85.8

Q ss_pred             cccCHHHHHHHhhcccc-----ceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccc--eee
Q 042216          463 TQFSISEIKEATKDFNN-----LLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL--HLV  535 (767)
Q Consensus       463 ~~~~~~ei~~~t~~f~~-----~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hp--niv  535 (767)
                      +..+.+++......|..     .+.|+.|....+|+....++  .+++|+...   ....+...|+.++..|...  .+.
T Consensus         5 t~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g--~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP   79 (319)
T PRK05231          5 TDVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG--EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVP   79 (319)
T ss_pred             ccCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC--cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCC
Confidence            44556666665555543     23466677788999876543  588898752   1223334455555555321  122


Q ss_pred             eEeee------eecCCceEEEEecCCCCChhh-----------h---hccCCC---------CCCCh-HHHHHHH-----
Q 042216          536 SLIGY------CNDDGQMILVYDYMARGTLRD-----------H---LYNNDN---------PPLPW-DRRLKIC-----  580 (767)
Q Consensus       536 ~l~g~------~~~~~~~~lV~ey~~~gsL~~-----------~---L~~~~~---------~~l~~-~~~~~i~-----  580 (767)
                      +.+..      ....+..++++||++|..+..           .   +|....         ..+.| .....-.     
T Consensus        80 ~~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  159 (319)
T PRK05231         80 APVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLA  159 (319)
T ss_pred             cceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccC
Confidence            33321      122456789999999875421           1   111100         01112 2211111     


Q ss_pred             -------HH-HHHHHHHhHhC----CCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          581 -------IG-AARALHYLHTG----ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       581 -------~~-ia~gL~yLH~~----~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                             .+ +...+..+...    ...++||+|+.+.|||++.+...-|.||+.+..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        160 DEQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             hhHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence                   11 11122222211    245799999999999999776668999998764

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.69  E-value=0.036  Score=59.37  Aligned_cols=158  Identities=15%  Similarity=0.133  Sum_probs=89.7

Q ss_pred             cCHHHHHHHhhcccc-----ceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccc--eeeeE
Q 042216          465 FSISEIKEATKDFNN-----LLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL--HLVSL  537 (767)
Q Consensus       465 ~~~~ei~~~t~~f~~-----~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hp--niv~l  537 (767)
                      .+.++|....+.|..     ...++.|-...+|+....+  ..+++|+.....  ...+...|++++..|...  .+.++
T Consensus         7 ~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~--~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~   82 (307)
T TIGR00938         7 VSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDV--GRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKP   82 (307)
T ss_pred             CCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCC--CcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            444556555555533     3346667668899987543  357788775422  233455667777766422  23444


Q ss_pred             eeee------ecCCceEEEEecCCCCChhhh--------------hccCCC---C-------CCChHHHHH---------
Q 042216          538 IGYC------NDDGQMILVYDYMARGTLRDH--------------LYNNDN---P-------PLPWDRRLK---------  578 (767)
Q Consensus       538 ~g~~------~~~~~~~lV~ey~~~gsL~~~--------------L~~~~~---~-------~l~~~~~~~---------  578 (767)
                      +...      ...+..++++||++|..+...              +|....   .       .-.|.....         
T Consensus        83 i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l  162 (307)
T TIGR00938        83 VKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQL  162 (307)
T ss_pred             ccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhccccc
Confidence            4422      223567899999988654211              111000   0       011221111         


Q ss_pred             ---HHHHHHHHHHHhHh----CCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          579 ---ICIGAARALHYLHT----GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       579 ---i~~~ia~gL~yLH~----~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                         ....+.+.+.++..    ....+++|+|+.+.||++++++...|.||+.+..
T Consensus       163 ~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       163 EAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             CHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence               01122334555532    2357899999999999999887778999998754

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PLN02236 choline kinase

Probab=96.42  E-value=0.035  Score=60.49  Aligned_cols=140  Identities=18%  Similarity=0.239  Sum_probs=81.7

Q ss_pred             eeeccCcEEEEEEEecCC----CceEEEEEeCCCCCcchhHHHHHHHHHhccccceee-eEeeeeecCCceEEEEecCCC
Q 042216          482 IIGRGGFGNVYKGFLNGD----STPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV-SLIGYCNDDGQMILVYDYMAR  556 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~----~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~lV~ey~~~  556 (767)
                      .|-.|-.-.+|+....++    ++.+++|+....... ...-.+|..++..+...++. ++++.+. .+   .|+||+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~-~g---~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL-FFDRDDEIRTFECMSRHGQGPRLLGRFP-NG---RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe-eechHHHHHHHHHHHHcCCCCceEEEEC-Cc---eEEEeeCC
Confidence            354566778999876432    357889988665432 22347788888888654444 3445442 22   58999987


Q ss_pred             CChhhh-----------------hccCC----CCCCChHHHHHHHHHH-----------------HHHHHHh----Hh-C
Q 042216          557 GTLRDH-----------------LYNND----NPPLPWDRRLKICIGA-----------------ARALHYL----HT-G  593 (767)
Q Consensus       557 gsL~~~-----------------L~~~~----~~~l~~~~~~~i~~~i-----------------a~gL~yL----H~-~  593 (767)
                      .+|...                 +|...    .....|.++.++..++                 ...+..|    .. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            666421                 11111    0112233333332111                 1112222    11 2


Q ss_pred             CCCCeEecCCCCCCeEECC-CCcEEEeecCCccc
Q 042216          594 ASKVIIHRDVKTTNILLDE-EWVAKVSDFGLCKF  626 (767)
Q Consensus       594 ~~~~iiH~Dlk~~NILld~-~~~~ki~DfGla~~  626 (767)
                      ....++|+|+++.|||+++ +..+.+.||..+..
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            2456899999999999986 46899999988764

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.34  E-value=0.046  Score=58.20  Aligned_cols=123  Identities=15%  Similarity=0.260  Sum_probs=75.2

Q ss_pred             CceEEEEEeC-CCCCcchhHHHHHHHHHhccc--cceeeeEeeeeecCC--ceEEEEecCCCCChhhhhccCCCCCCChH
Q 042216          500 STPVAIKRLN-PGSQQGALEFQTEIGMLSQLR--YLHLVSLIGYCNDDG--QMILVYDYMARGTLRDHLYNNDNPPLPWD  574 (767)
Q Consensus       500 ~~~vAVK~l~-~~~~~~~~~f~~Ei~~l~~l~--Hpniv~l~g~~~~~~--~~~lV~ey~~~gsL~~~L~~~~~~~l~~~  574 (767)
                      ++.+++.+-. ...........+|.++++.+.  ..-+...+++|.++.  ..+.||+|+++..+.+.+.....     .
T Consensus        48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~-----~  122 (321)
T COG3173          48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESL-----G  122 (321)
T ss_pred             CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccc-----h
Confidence            4667777211 122334455677888887763  234455677787665  77999999998544433311110     0


Q ss_pred             HHHHHH-HHHHHHHH--------------------------------------------------HhHhC-----CCCCe
Q 042216          575 RRLKIC-IGAARALH--------------------------------------------------YLHTG-----ASKVI  598 (767)
Q Consensus       575 ~~~~i~-~~ia~gL~--------------------------------------------------yLH~~-----~~~~i  598 (767)
                        .+++ ..+++.|.                                                  ||++.     ....+
T Consensus       123 --~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~l  200 (321)
T COG3173         123 --RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVL  200 (321)
T ss_pred             --HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCcee
Confidence              0111 13333333                                                  33321     23468


Q ss_pred             EecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          599 IHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       599 iH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      +|+|+.+.|++++.+..+-|.||+++.++..
T Consensus       201 vHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         201 VHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             eeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            9999999999999988899999999987544

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.15  E-value=0.03  Score=59.09  Aligned_cols=76  Identities=17%  Similarity=0.285  Sum_probs=47.8

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc---cceeeeEeeeeecCCceEEEEec
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR---YLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~---Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      ....+.++.|....+|+..  .+++.+.||.-.   ......|..|.+-|+.|.   --.+.+.+++....+..+||+||
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~   93 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF   93 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence            3445568889999999987  345789999875   333456888988888883   34677888888777777999999


Q ss_pred             CCCC
Q 042216          554 MARG  557 (767)
Q Consensus       554 ~~~g  557 (767)
                      ++.+
T Consensus        94 l~~~   97 (288)
T PF03881_consen   94 LEMG   97 (288)
T ss_dssp             ----
T ss_pred             ecCC
Confidence            9876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=95.89  E-value=0.006  Score=74.76  Aligned_cols=175  Identities=11%  Similarity=-0.032  Sum_probs=117.4

Q ss_pred             EEEEEeCCCCCcchhH-----HHHHHHHHhccccceeeeEeeeee--cCCceEEEEecCCCCChhhhhccCC--CCCCCh
Q 042216          503 VAIKRLNPGSQQGALE-----FQTEIGMLSQLRYLHLVSLIGYCN--DDGQMILVYDYMARGTLRDHLYNND--NPPLPW  573 (767)
Q Consensus       503 vAVK~l~~~~~~~~~~-----f~~Ei~~l~~l~Hpniv~l~g~~~--~~~~~~lV~ey~~~gsL~~~L~~~~--~~~l~~  573 (767)
                      ..+|+.+...-+...+     ...|...++...|+++.....-..  +..+.+..++|+..|.+.+.|.+..  .+.++.
T Consensus      1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred             eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence            3556655433222222     334444555667888776544332  3456788999999999999986542  233444


Q ss_pred             HHHHHHHHHHHHHHHHhHh--CCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhh
Q 042216          574 DRRLKICIGAARALHYLHT--GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY  651 (767)
Q Consensus       574 ~~~~~i~~~ia~gL~yLH~--~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~  651 (767)
                      ........+......-.|.  ....-.+|+++|+.|.+|..+.++|++++|+.++..+  .........+++-|+.|+..
T Consensus      1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~ 1412 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIK 1412 (2724)
T ss_pred             chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHH
Confidence            4444333333444444442  2234578999999999999999999999999984322  11122344577789999988


Q ss_pred             ccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 042216          652 RLQLLTEKSDVYSFGVVLLEVLCARPPI  679 (767)
Q Consensus       652 ~~~~~s~ksDV~SfGvvl~elltg~~P~  679 (767)
                      ..-.++.++|+|..|+-++++.-|..++
T Consensus      1413 N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1413 NEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            8888899999999999999998887775

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.83  E-value=0.0055  Score=67.47  Aligned_cols=50  Identities=16%  Similarity=0.293  Sum_probs=38.8

Q ss_pred             hhHHHHHHHHHhccccceeeeEeeeeecC-CceEEEEecCCCCChhhhhccC
Q 042216          516 ALEFQTEIGMLSQLRYLHLVSLIGYCNDD-GQMILVYDYMARGTLRDHLYNN  566 (767)
Q Consensus       516 ~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~-~~~~lV~ey~~~gsL~~~L~~~  566 (767)
                      ..++.-...+++.++|+|+...+.+.... ....+|+|++.. ||.+.+...
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~   76 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTG   76 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhc
Confidence            34566678889999999999999887654 357889999865 998887543

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.67  E-value=0.1  Score=56.37  Aligned_cols=81  Identities=19%  Similarity=0.156  Sum_probs=50.1

Q ss_pred             eeeccCcEEEEEEEecCCCceEEEEEeCCC-------CCcchhHHHHHHHHHhccc--cceeeeEeeeeecCCceEEEEe
Q 042216          482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-------SQQGALEFQTEIGMLSQLR--YLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~-------~~~~~~~f~~Ei~~l~~l~--Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      .||.|-..-||++...++++.|+||.-.+.       -+....+..-|.+.|+...  .|..++-+-++ +.+...+|||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-D~e~~~~vME   80 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-DTEMAVTVME   80 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-ccccceehHh
Confidence            478999999999998654467999975321       1223344556777776552  35444433233 3456679999


Q ss_pred             cCCCC-Chhhhh
Q 042216          553 YMARG-TLRDHL  563 (767)
Q Consensus       553 y~~~g-sL~~~L  563 (767)
                      +++.. .|.+.|
T Consensus        81 dL~~~~ilR~~L   92 (370)
T TIGR01767        81 DLSHHKIARKGL   92 (370)
T ss_pred             hCccchHHHHHH
Confidence            99643 344444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=95.66  E-value=0.13  Score=54.23  Aligned_cols=32  Identities=31%  Similarity=0.544  Sum_probs=26.4

Q ss_pred             CCeEecCCCCCCeEECCCCc-EEEeecCCcccC
Q 042216          596 KVIIHRDVKTTNILLDEEWV-AKVSDFGLCKFG  627 (767)
Q Consensus       596 ~~iiH~Dlk~~NILld~~~~-~ki~DfGla~~~  627 (767)
                      ..++|+|+++.|||+++++. .-|.||+.+...
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            45899999999999997554 569999988754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.60  E-value=0.014  Score=60.94  Aligned_cols=143  Identities=17%  Similarity=0.096  Sum_probs=91.1

Q ss_pred             CHHHHHHHhh---ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--C---------------C-----cchhHHH
Q 042216          466 SISEIKEATK---DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--S---------------Q-----QGALEFQ  520 (767)
Q Consensus       466 ~~~ei~~~t~---~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~---------------~-----~~~~~f~  520 (767)
                      .+.-|+...+   -++..+.||-|--+.+|.+-...+ ++.++|.-+..  +               .     .......
T Consensus        80 DyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G-~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~  158 (465)
T KOG2268|consen   80 DYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEG-NPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT  158 (465)
T ss_pred             hHHHHHHHHhcchhhhhccccccccccceEEEecCCC-CchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence            3444444433   245566899999999999988744 67888742211  0               0     0112245


Q ss_pred             HHHHHHhcccc-c-eeeeEeeeeecCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCe
Q 042216          521 TEIGMLSQLRY-L-HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVI  598 (767)
Q Consensus       521 ~Ei~~l~~l~H-p-niv~l~g~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  598 (767)
                      +|...|+.|.. - -+.+.+++    +..++|||++.+-.|.+.-+-     .+..++..-   +..-+.-|.   .+|+
T Consensus       159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~---lm~~Iv~la---~~Gl  223 (465)
T KOG2268|consen  159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-----EDPPTLYDD---LMGLIVRLA---NHGL  223 (465)
T ss_pred             HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec-----CChHHHHHH---HHHHHHHHH---HcCc
Confidence            67777777742 2 23334433    467899999998887764321     222333333   333344454   7889


Q ss_pred             EecCCCCCCeEECCCCcEEEeecCCc
Q 042216          599 IHRDVKTTNILLDEEWVAKVSDFGLC  624 (767)
Q Consensus       599 iH~Dlk~~NILld~~~~~ki~DfGla  624 (767)
                      ||+|..-=||+++++..++++||--+
T Consensus       224 IHgDFNEFNimv~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  224 IHGDFNEFNIMVKDDDKIVVIDFPQM  249 (465)
T ss_pred             eecccchheeEEecCCCEEEeechHh
Confidence            99999999999999999999999654

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.51  E-value=0.22  Score=54.89  Aligned_cols=80  Identities=18%  Similarity=0.148  Sum_probs=51.7

Q ss_pred             ceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC-------cchhHHHHHHHHHhccc---cceeeeEeeeeecCCceEE
Q 042216          480 LLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ-------QGALEFQTEIGMLSQLR---YLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       480 ~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~-------~~~~~f~~Ei~~l~~l~---Hpniv~l~g~~~~~~~~~l  549 (767)
                      .+.||.|....||+....+  ..++||+-.+...       .....-..|.+.|+.+.   ..++.+++.+|.  +..++
T Consensus        37 ~~eiggGn~N~VyrV~~~~--~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSSS--GSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEcCC--ccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence            4468999999999987643  4689998652211       12333344566666553   247778888886  44678


Q ss_pred             EEecCCC--CChhhhh
Q 042216          550 VYDYMAR--GTLRDHL  563 (767)
Q Consensus       550 V~ey~~~--gsL~~~L  563 (767)
                      +||++++  ..|.+.|
T Consensus       113 vME~L~~~~~ilr~~L  128 (418)
T PLN02756        113 GMRYLEPPHIILRKGL  128 (418)
T ss_pred             EEeecCCcceehhhhh
Confidence            8999976  3455444

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.41  E-value=0.16  Score=55.12  Aligned_cols=140  Identities=20%  Similarity=0.311  Sum_probs=80.7

Q ss_pred             eeeccCcEEEEEEEecCC---CceEEEEEeCCCCCcchhHHHHHHHHHhccccceee-eEeeeeecCCceEEEEecCCCC
Q 042216          482 IIGRGGFGNVYKGFLNGD---STPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV-SLIGYCNDDGQMILVYDYMARG  557 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~---~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~lV~ey~~~g  557 (767)
                      .|..|=-..+|+....+.   ...+++|+...... ....-.+|..+++.+..-++. +++++. ..+   +|.+|+++.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~-~~G---~i~~fi~g~   95 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVF-GNG---MIQSFINAR   95 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEe-CCc---EeehhhcCC
Confidence            354466677898876542   23788998865543 233447888888888655554 445554 222   589999776


Q ss_pred             Chhhh-----------------hccCC----CCCCChHHHHHHHHHH----------------------HHHHHHhHh--
Q 042216          558 TLRDH-----------------LYNND----NPPLPWDRRLKICIGA----------------------ARALHYLHT--  592 (767)
Q Consensus       558 sL~~~-----------------L~~~~----~~~l~~~~~~~i~~~i----------------------a~gL~yLH~--  592 (767)
                      .|...                 ||...    ..+--|..+.++..++                      ..-+..+..  
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            55321                 11111    0111233332222221                      111111111  


Q ss_pred             ---CCCCCeEecCCCCCCeEECC-CCcEEEeecCCccc
Q 042216          593 ---GASKVIIHRDVKTTNILLDE-EWVAKVSDFGLCKF  626 (767)
Q Consensus       593 ---~~~~~iiH~Dlk~~NILld~-~~~~ki~DfGla~~  626 (767)
                         .....++|+|+.+.|||+++ ++.++++||..|..
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence               11235899999999999974 57899999998764

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.24  E-value=0.095  Score=57.36  Aligned_cols=83  Identities=18%  Similarity=0.164  Sum_probs=51.1

Q ss_pred             ceeeeccCcEEEEEEEecCCCceEEEEEeCCC------CCcchhHHHHHHHHHhccc--cceeeeEeeeeecCCceEEEE
Q 042216          480 LLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG------SQQGALEFQTEIGMLSQLR--YLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       480 ~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~------~~~~~~~f~~Ei~~l~~l~--Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ...||.|--.-||++....+++.|+||.-.+.      -+....+..-|.+.|+.+.  .|..++-+-++ +.+...+||
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-D~e~~~~vM  112 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF-DSVMNCCVM  112 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-CcHHhhHHH
Confidence            34689999999999998533467999975322      1233445566777777653  35444433333 344667889


Q ss_pred             ecCCCC-Chhhhh
Q 042216          552 DYMARG-TLRDHL  563 (767)
Q Consensus       552 ey~~~g-sL~~~L  563 (767)
                      |+++.. .|++.|
T Consensus       113 EdL~~~~ilR~~L  125 (409)
T PRK12396        113 EDLSDHTILRTAL  125 (409)
T ss_pred             HhCcccHHHHHHH
Confidence            998542 344443

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=94.94  E-value=0.076  Score=53.43  Aligned_cols=121  Identities=22%  Similarity=0.325  Sum_probs=60.0

Q ss_pred             ceEEEEEeCCCCCcchhHHHHHHHHHhccccceee-eEeeeeecCCceEEEEecCCCCChhhh-h---------------
Q 042216          501 TPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV-SLIGYCNDDGQMILVYDYMARGTLRDH-L---------------  563 (767)
Q Consensus       501 ~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~lV~ey~~~gsL~~~-L---------------  563 (767)
                      +.|+||+..... .....-..|..+++.+....+. +++++.. ++   +|+||+++..|..- +               
T Consensus         3 ~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~-~g---~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~   77 (211)
T PF01633_consen    3 EKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFE-NG---RVEEFIEGRTLSPEDFRNPEILKRIAKLLAK   77 (211)
T ss_dssp             SEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEET-TE---EEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred             CEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcC-CC---cEEEEecccccChhhccChHHHHHHHHHHHH
Confidence            568888886553 3345567888888888655554 4444442 32   57799976655321 1               


Q ss_pred             -cc-----CCCCCCChHHHHHH----------------------HHHHHHHHHHhHh-----CCCCCeEecCCCCCCeEE
Q 042216          564 -YN-----NDNPPLPWDRRLKI----------------------CIGAARALHYLHT-----GASKVIIHRDVKTTNILL  610 (767)
Q Consensus       564 -~~-----~~~~~l~~~~~~~i----------------------~~~ia~gL~yLH~-----~~~~~iiH~Dlk~~NILl  610 (767)
                       |.     .....--|..+..+                      ...+..-+..+.+     .....++|+|+.+.|||+
T Consensus        78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~  157 (211)
T PF01633_consen   78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI  157 (211)
T ss_dssp             HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred             HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence             00     00111112222222                      0111111222211     112458999999999999


Q ss_pred             -CCCCcEEEeecCCccc
Q 042216          611 -DEEWVAKVSDFGLCKF  626 (767)
Q Consensus       611 -d~~~~~ki~DfGla~~  626 (767)
                       +.++.++++||..|..
T Consensus       158 ~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  158 NNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             TSSSSCEEE--GTT-EE
T ss_pred             ccCCCeEEEecHHHHhh
Confidence             8899999999998763

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.94  E-value=0.28  Score=52.79  Aligned_cols=136  Identities=21%  Similarity=0.269  Sum_probs=79.1

Q ss_pred             CcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcccc---ceeee---Eeeee--ecCC--ceEEEEecCCC
Q 042216          487 GFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRY---LHLVS---LIGYC--NDDG--QMILVYDYMAR  556 (767)
Q Consensus       487 ~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H---pniv~---l~g~~--~~~~--~~~lV~ey~~~  556 (767)
                      .-..+|+.+..++  .+++|.....  ....++..|+..|..|.-   +-.++   +=|-.  .-.+  ..+-+++|++|
T Consensus        37 ~eN~~f~~~~~~g--~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G  112 (331)
T COG2334          37 EENSNFRVQTEDG--RYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPG  112 (331)
T ss_pred             ccCceEEEEecCC--CeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCC
Confidence            4567898888764  3488888765  344566677777777632   21122   21211  1123  77889999999


Q ss_pred             CChhh-h--------------hcc----------CCCCCCChHH-------------HHHHHHHHHHHHHHhHh----CC
Q 042216          557 GTLRD-H--------------LYN----------NDNPPLPWDR-------------RLKICIGAARALHYLHT----GA  594 (767)
Q Consensus       557 gsL~~-~--------------L~~----------~~~~~l~~~~-------------~~~i~~~ia~gL~yLH~----~~  594 (767)
                      ..+.. .              |+.          .......|..             ......++...+..+.+    ..
T Consensus       113 ~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~l  192 (331)
T COG2334         113 RPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHL  192 (331)
T ss_pred             cCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhC
Confidence            88872 1              110          0011244541             01112233333444332    11


Q ss_pred             CCC---eEecCCCCCCeEECCCCc-EEEeecCCccc
Q 042216          595 SKV---IIHRDVKTTNILLDEEWV-AKVSDFGLCKF  626 (767)
Q Consensus       595 ~~~---iiH~Dlk~~NILld~~~~-~ki~DfGla~~  626 (767)
                      ...   +||+|+.+.|||++.+.. +.+.||+-+..
T Consensus       193 p~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         193 PALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             CcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            223   999999999999998874 89999998763

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.65  E-value=0.32  Score=51.99  Aligned_cols=31  Identities=32%  Similarity=0.469  Sum_probs=26.4

Q ss_pred             CCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       595 ~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      ..+++|+|+.+.||+++. +.+.|.||+.+..
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            367899999999999998 5788999997653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PTZ00384 choline kinase; Provisional

Probab=94.07  E-value=0.58  Score=51.64  Aligned_cols=75  Identities=15%  Similarity=0.128  Sum_probs=45.5

Q ss_pred             eeeccCcEEEEEEEecCCC-c-----eEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCC
Q 042216          482 IIGRGGFGNVYKGFLNGDS-T-----PVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMA  555 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~~~-~-----~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~  555 (767)
                      .|..|--..+|++...++. .     .|.++...... ....+-.+|++++..+...++.+-+-.+..+   .+++||++
T Consensus        57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~---g~l~efIe  132 (383)
T PTZ00384         57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD---FTIQEWVE  132 (383)
T ss_pred             EeCCcccceEEEEEecCCCCCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC---EEEEEEec
Confidence            4555777889998765432 1     24444432222 2222346789999999766665554333332   59999999


Q ss_pred             CCChh
Q 042216          556 RGTLR  560 (767)
Q Consensus       556 ~gsL~  560 (767)
                      +..|.
T Consensus       133 Gr~l~  137 (383)
T PTZ00384        133 GNTMG  137 (383)
T ss_pred             cccCC
Confidence            87764

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=93.78  E-value=0.38  Score=51.59  Aligned_cols=32  Identities=22%  Similarity=0.386  Sum_probs=28.7

Q ss_pred             CCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       595 ~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      ..++||+|+.+.|+|+++++.+.|.||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45799999999999999998999999988764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=93.66  E-value=2.3  Score=45.98  Aligned_cols=96  Identities=13%  Similarity=0.052  Sum_probs=55.0

Q ss_pred             ccccCHHHHHHHhhccccc---e-eeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccc--eee
Q 042216          462 CTQFSISEIKEATKDFNNL---L-IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL--HLV  535 (767)
Q Consensus       462 ~~~~~~~ei~~~t~~f~~~---~-~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hp--niv  535 (767)
                      ...++.+.+..+...+...   . ..-.+.-..||+....++ ..+++|..++. .....+...|++.+..|...  .++
T Consensus         8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~-~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~   85 (325)
T PRK11768          8 FQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDG-RRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVV   85 (325)
T ss_pred             CCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCC-CEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCC
Confidence            3456777777776655331   1 122345577999877543 56888887533 23445667787777766321  122


Q ss_pred             eEe---e--eeecCCceEEEEecCCCCCh
Q 042216          536 SLI---G--YCNDDGQMILVYDYMARGTL  559 (767)
Q Consensus       536 ~l~---g--~~~~~~~~~lV~ey~~~gsL  559 (767)
                      ..+   |  ....++..+.++++++|..+
T Consensus        86 ~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         86 APLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             CCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            211   1  12224567889999987643

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	767
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-77
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-77
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-55
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		9e-54
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-42
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-41
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-41
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-38
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-27
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-26
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-26
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-25
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-25
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-25
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-25
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-25
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-25
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-25
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		7e-25
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		7e-25
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		8e-25
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-24
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-24
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-24
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-24
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-24
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-24
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-24
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-24
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-24
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-24
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-24
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-24
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-24
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-24
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-24
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-24
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-24
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-23
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-23
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-23
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-23
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-22
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-22
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-22
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-22
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-22
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-22
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-20
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-20
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-19
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-19
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-19
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-18
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-18
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-18
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-18
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-18
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-18
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-18
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-18
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-18
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-18
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-18
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		8e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		8e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		8e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		8e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		9e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		9e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		9e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		9e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-17
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-17
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-17
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-17
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-17
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-17
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-17
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-17
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-17
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-17
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-17
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-17
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-17
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-17
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-17
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-17
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-17
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-17
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-17
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-17
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-17
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-17
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-17
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-17
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-17
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-17
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-16
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-16
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-16
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-16
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-16
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-16
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-16
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-16
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-15
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-15
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-15
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-15
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-15
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-15
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-15
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-15
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		8e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-14
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-14
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-14
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		9e-14
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		9e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		9e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-13
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		7e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		8e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		9e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-12
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-12
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-12
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-12
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-12
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-12
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-12
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-12
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-12
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-12
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-12
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-12
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		9e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		9e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		9e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		9e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		7e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		8e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-09
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		9e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		9e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		5e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-08
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		6e-08
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		6e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		7e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-08
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		7e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		7e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		8e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		9e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-07
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-07
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-07
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		5e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		6e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		6e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		6e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		7e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		8e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		8e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		8e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		8e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		8e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		8e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		9e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		9e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		9e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		9e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		9e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		9e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		9e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		9e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		7e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		8e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		9e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		9e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		9e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		6e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		6e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-05
3soa_A	444	Full-Length Human Camkii Length = 444		8e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		8e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		9e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-04
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-04
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-04
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		6e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		6e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		7e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-04
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		7e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-04
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		8e-04
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		8e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-04
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		8e-04
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		8e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-04

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  287 bits (735), Expect = 1e-77,   Method: Compositional matrix adjust.
 Identities = 149/290 (51%), Positives = 198/290 (68%), Gaps = 6/290 (2%)
Query: 467 ISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGML 526
           + +++EAT +F++  +IG G FG VYKG L  D   VA+KR  P S QG  EF+TEI  L
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETL 89
Query: 527 SQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNP--PLPWDRRLKICIGAA 584
           S  R+ HLVSLIG+C++  +MIL+Y YM  G L+ HLY +D P   + W++RL+ICIGAA
Sbjct: 90  SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149
Query: 585 RALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG 644
           R LHYLHT A   IIHRDVK+ NILLDE +V K++DFG+ K G    +TH+   VKG++G
Sbjct: 150 RGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLG 206
Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG 704
           Y+DPEY+    LTEKSDVYSFGVVL EVLCAR  I+++  ++ VNLA WA E + NG++ 
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266
Query: 705 DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
            I+DP L     P  L +F + A+ C+      RPSM DV+W LE+  +L
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  287 bits (735), Expect = 1e-77,   Method: Compositional matrix adjust.
 Identities = 149/290 (51%), Positives = 198/290 (68%), Gaps = 6/290 (2%)
Query: 467 ISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGML 526
           + +++EAT +F++  +IG G FG VYKG L  D   VA+KR  P S QG  EF+TEI  L
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETL 89
Query: 527 SQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNP--PLPWDRRLKICIGAA 584
           S  R+ HLVSLIG+C++  +MIL+Y YM  G L+ HLY +D P   + W++RL+ICIGAA
Sbjct: 90  SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149
Query: 585 RALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG 644
           R LHYLHT A   IIHRDVK+ NILLDE +V K++DFG+ K G    +TH+   VKG++G
Sbjct: 150 RGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLG 206
Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG 704
           Y+DPEY+    LTEKSDVYSFGVVL EVLCAR  I+++  ++ VNLA WA E + NG++ 
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266
Query: 705 DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
            I+DP L     P  L +F + A+ C+      RPSM DV+W LE+  +L
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  212 bits (539), Expect = 6e-55,   Method: Compositional matrix adjust.
 Identities = 119/291 (40%), Positives = 171/291 (58%), Gaps = 7/291 (2%)
Query: 464 QFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA-LEFQTE 522
           +FS+ E++ A+ +F+N  I+GRGGFG VYKG L  D T VA+KRL     QG  L+FQTE
Sbjct: 27  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 523 IGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYN--NDNPPLPWDRRLKIC 580
           + M+S   + +L+ L G+C    + +LVY YMA G++   L       PPL W +R +I 
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 581 IGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK 640
           +G+AR L YLH      IIHRDVK  NILLDEE+ A V DFGL K   ++   HV   V+
Sbjct: 146 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDXHVXXAVR 204
Query: 641 GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP--ILRTGDKKQVNLAVWATECY 698
           G+IG++ PEY      +EK+DV+ +GV+LLE++  +    + R  +   V L  W     
Sbjct: 205 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 264
Query: 699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
           +  K+  ++D  L+GN     + Q ++VA+ C     + RP MS+VV  LE
Sbjct: 265 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  208 bits (529), Expect = 9e-54,   Method: Compositional matrix adjust.
 Identities = 118/291 (40%), Positives = 169/291 (58%), Gaps = 7/291 (2%)
Query: 464 QFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-SQQGALEFQTE 522
           +FS+ E++ A+ +F N  I+GRGGFG VYKG L  D   VA+KRL    +Q G L+FQTE
Sbjct: 19  RFSLRELQVASDNFXNKNILGRGGFGKVYKGRL-ADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 523 IGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYN--NDNPPLPWDRRLKIC 580
           + M+S   + +L+ L G+C    + +LVY YMA G++   L       PPL W +R +I 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 581 IGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK 640
           +G+AR L YLH      IIHRDVK  NILLDEE+ A V DFGL K   ++   HV   V+
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDXHVXXAVR 196
Query: 641 GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP--ILRTGDKKQVNLAVWATECY 698
           G IG++ PEY      +EK+DV+ +GV+LLE++  +    + R  +   V L  W     
Sbjct: 197 GXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
           +  K+  ++D  L+GN     + Q ++VA+ C     + RP MS+VV  LE
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  169 bits (427), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 108/304 (35%), Positives = 169/304 (55%), Gaps = 26/304 (8%)
Query: 465 FSISEIKEATKDFNNLLI------IGRGGFGNVYKGFLNGDSTPVAIKRL----NPGSQQ 514
           FS  E+K  T +F+   I      +G GGFG VYKG++N  +T VA+K+L    +  +++
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEE 72
Query: 515 GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNND-NPPLPW 573
              +F  EI ++++ ++ +LV L+G+ +D   + LVY YM  G+L D L   D  PPL W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 574 DRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT 633
             R KI  GAA  +++LH       IHRD+K+ NILLDE + AK+SDFGL +    F++T
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVW 693
            + +++ G+  Y+ PE  R + +T KSD+YSFGVVLLE++   P +     + Q+ L + 
Sbjct: 190 VMXSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAV-DEHREPQLLLDIK 247
Query: 694 ATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
                    I D ID  +  +A    +     VA  C+++ + +RP +  V        Q
Sbjct: 248 EEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ-------Q 299
Query: 754 LLRE 757
           LL+E
Sbjct: 300 LLQE 303

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  168 bits (425), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 108/304 (35%), Positives = 168/304 (55%), Gaps = 26/304 (8%)
Query: 465 FSISEIKEATKDFNNLLI------IGRGGFGNVYKGFLNGDSTPVAIKRL----NPGSQQ 514
           FS  E+K  T +F+   I      +G GGFG VYKG++N  +T VA+K+L    +  +++
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEE 72
Query: 515 GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNND-NPPLPW 573
              +F  EI ++++ ++ +LV L+G+ +D   + LVY YM  G+L D L   D  PPL W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 574 DRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT 633
             R KI  GAA  +++LH       IHRD+K+ NILLDE + AK+SDFGL +    F++T
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVW 693
            +  ++ G+  Y+ PE  R + +T KSD+YSFGVVLLE++   P +     + Q+ L + 
Sbjct: 190 VMXXRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAV-DEHREPQLLLDIK 247
Query: 694 ATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
                    I D ID  +  +A    +     VA  C+++ + +RP +  V        Q
Sbjct: 248 EEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ-------Q 299
Query: 754 LLRE 757
           LL+E
Sbjct: 300 LLQE 303

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  166 bits (419), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 107/304 (35%), Positives = 167/304 (54%), Gaps = 26/304 (8%)
Query: 465 FSISEIKEATKDFNNLLI------IGRGGFGNVYKGFLNGDSTPVAIKRL----NPGSQQ 514
           FS  E+K  T +F+   I      +G GGFG VYKG++N  +T VA+K+L    +  +++
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEE 66
Query: 515 GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNND-NPPLPW 573
              +F  EI ++++ ++ +LV L+G+ +D   + LVY YM  G+L D L   D  PPL W
Sbjct: 67  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 126
Query: 574 DRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT 633
             R KI  GAA  +++LH       IHRD+K+ NILLDE + AK+SDFGL +    F++ 
Sbjct: 127 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVW 693
            +  ++ G+  Y+ PE  R + +T KSD+YSFGVVLLE++   P +     + Q+ L + 
Sbjct: 184 VMXXRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAV-DEHREPQLLLDIK 241
Query: 694 ATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
                    I D ID  +  +A    +     VA  C+++ + +RP +  V        Q
Sbjct: 242 EEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ-------Q 293
Query: 754 LLRE 757
           LL+E
Sbjct: 294 LLQE 297

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  157 bits (397), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 106/306 (34%), Positives = 163/306 (53%), Gaps = 26/306 (8%)
Query: 465 FSISEIKEATKDFNNLLI------IGRGGFGNVYKGFLNGDSTPVAIKRL----NPGSQQ 514
           FS  E+K  T +F+   I       G GGFG VYKG++N  +T VA+K+L    +  +++
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEE 63
Query: 515 GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNND-NPPLPW 573
              +F  EI + ++ ++ +LV L+G+ +D   + LVY Y   G+L D L   D  PPL W
Sbjct: 64  LKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSW 123
Query: 574 DRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT 633
             R KI  GAA  +++LH       IHRD+K+ NILLDE + AK+SDFGL +    F++ 
Sbjct: 124 HXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVW 693
              +++ G+  Y  PE  R + +T KSD+YSFGVVLLE++   P +     + Q+ L + 
Sbjct: 181 VXXSRIVGTTAYXAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAV-DEHREPQLLLDIK 238
Query: 694 ATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
                    I D ID     +A    +     VA  C+++ + +RP +  V        Q
Sbjct: 239 EEIEDEEKTIEDYIDK-KXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQ-------Q 290
Query: 754 LLRESS 759
           LL+E +
Sbjct: 291 LLQEXT 296

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  119 bits (298), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 142/283 (50%), Gaps = 29/283 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN---PGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           IG G FG VYKG  +GD   VA+K LN   P  QQ    F+ E+G+L + R+++++  +G
Sbjct: 20  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMG 75
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
           Y     Q+ +V  +    +L  HL+ ++       + + I    AR + YLH   +K II
Sbjct: 76  YSTKP-QLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLH---AKSII 130
Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ---LL 656
           HRD+K+ NI L E+   K+ DFGL      +S +H   Q+ GSI ++ PE  R+Q     
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 190
Query: 657 TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP 716
           + +SDVY+FG+VL E++  + P     ++ Q+       E    G +   +   ++ N P
Sbjct: 191 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IEMVGRGSLSPDLSK-VRSNCP 243
Query: 717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESS 759
                +   +   C+   R  RPS   ++  +E   +L RE S
Sbjct: 244 ----KRMKRLMAECLKKKRDERPSFPRILAEIE---ELARELS 279

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  118 bits (296), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 142/283 (50%), Gaps = 29/283 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN---PGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           IG G FG VYKG  +GD   VA+K LN   P  QQ    F+ E+G+L + R+++++  +G
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMG 87
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
           Y     Q+ +V  +    +L  HL+ ++       + + I    AR + YLH   +K II
Sbjct: 88  YSTKP-QLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ---LL 656
           HRD+K+ NI L E+   K+ DFGL      +S +H   Q+ GSI ++ PE  R+Q     
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 657 TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP 716
           + +SDVY+FG+VL E++  + P     ++ Q+       E    G +   +   ++ N P
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IEMVGRGSLSPDLSK-VRSNCP 255
Query: 717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESS 759
                +   +   C+   R  RPS   ++  +E   +L RE S
Sbjct: 256 ----KRMKRLMAECLKKKRDERPSFPRILAEIE---ELARELS 291

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 87/281 (30%), Positives = 141/281 (50%), Gaps = 29/281 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN---PGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           IG G FG VYKG  +GD   VA+K LN   P  QQ    F+ E+G+L + R+++++  +G
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMG 87
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
           Y     Q+ +V  +    +L  HL+ ++       + + I    AR + YLH   +K II
Sbjct: 88  YSTAP-QLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ---LL 656
           HRD+K+ NI L E+   K+ DFGL      +S +H   Q+ GSI ++ PE  R+Q     
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 657 TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP 716
           + +SDVY+FG+VL E++  + P     ++ Q+       E    G +   +   ++ N P
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IEMVGRGSLSPDLSK-VRSNCP 255
Query: 717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRE 757
                +   +   C+   R  RPS   ++  +E   +L RE
Sbjct: 256 ----KRMKRLMAECLKKKRDERPSFPRILAEIE---ELARE 289

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  114 bits (284), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 135/275 (49%), Gaps = 26/275 (9%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN---PGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           IG G FG VYKG  +GD   VA+K LN   P  QQ    F+ E+G+L + R+++++  +G
Sbjct: 18  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMG 73
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
           Y     Q+ +V  +    +L  HL+  +       + + I    A+ + YLH   +K II
Sbjct: 74  YSTKP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSII 128
Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ---LL 656
           HRD+K+ NI L E+   K+ DFGL      +S +H   Q+ GSI ++ PE  R+Q     
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 188
Query: 657 TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP 716
           + +SDVY+FG+VL E++  + P     ++ Q+   V     Y +  +  +     + N P
Sbjct: 189 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--GRGYLSPDLSKV-----RSNCP 241
Query: 717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV 751
                   E    C+   R  RP    ++  +E +
Sbjct: 242 KAMKRLMAE----CLKKKRDERPLFPQILASIELL 272

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  114 bits (284), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 135/275 (49%), Gaps = 26/275 (9%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN---PGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           IG G FG VYKG  +GD   VA+K LN   P  QQ    F+ E+G+L + R+++++  +G
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMG 76
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
           Y     Q+ +V  +    +L  HL+  +       + + I    A+ + YLH   +K II
Sbjct: 77  YSTKP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSII 131
Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ---LL 656
           HRD+K+ NI L E+   K+ DFGL      +S +H   Q+ GSI ++ PE  R+Q     
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 657 TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP 716
           + +SDVY+FG+VL E++  + P     ++ Q+   V     Y +  +  +     + N P
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--GRGYLSPDLSKV-----RSNCP 244
Query: 717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV 751
                   E    C+   R  RP    ++  +E +
Sbjct: 245 KAMKRLMAE----CLKKKRDERPLFPQILASIELL 275

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  114 bits (284), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 135/275 (49%), Gaps = 26/275 (9%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN---PGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           IG G FG VYKG  +GD   VA+K LN   P  QQ    F+ E+G+L + R+++++  +G
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMG 76
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
           Y     Q+ +V  +    +L  HL+  +       + + I    A+ + YLH   +K II
Sbjct: 77  YSTKP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSII 131
Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ---LL 656
           HRD+K+ NI L E+   K+ DFGL      +S +H   Q+ GSI ++ PE  R+Q     
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 657 TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP 716
           + +SDVY+FG+VL E++  + P     ++ Q+   V     Y +  +  +     + N P
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--GRGYLSPDLSKV-----RSNCP 244
Query: 717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV 751
                   E    C+   R  RP    ++  +E +
Sbjct: 245 KAMKRLMAE----CLKKKRDERPLFPQILASIELL 275

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  113 bits (283), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 135/275 (49%), Gaps = 26/275 (9%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN---PGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           IG G FG VYKG  +GD   VA+K LN   P  QQ    F+ E+G+L + R+++++  +G
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMG 71
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
           Y     Q+ +V  +    +L  HL+  +       + + I    A+ + YLH   +K II
Sbjct: 72  YSTKP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSII 126
Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ---LL 656
           HRD+K+ NI L E+   K+ DFGL      +S +H   Q+ GSI ++ PE  R+Q     
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 657 TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP 716
           + +SDVY+FG+VL E++  + P     ++ Q+   V     Y +  +  +     + N P
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--GRGYLSPDLSKV-----RSNCP 239
Query: 717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV 751
                   E    C+   R  RP    ++  +E +
Sbjct: 240 KAMKRLMAE----CLKKKRDERPLFPQILASIELL 270

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 137/279 (49%), Gaps = 26/279 (9%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN---PGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           IG G FG VYKG  +GD   VA+K LN   P  QQ    F+ E+G+L + R+++++  +G
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMG 99
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
           Y     Q+ +V  +    +L  HL+  +       + + I    A+ + YLH   +K II
Sbjct: 100 YSTKP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSII 154
Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ---LL 656
           HRD+K+ NI L E+   K+ DFGL      +S +H   Q+ GSI ++ PE  R+Q     
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 657 TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP 716
           + +SDVY+FG+VL E++  + P     ++ Q+   V     Y +  +  +     + N P
Sbjct: 215 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--GRGYLSPDLSKV-----RSNCP 267
Query: 717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL 755
                   E    C+   R  RP    ++  +E + + L
Sbjct: 268 KAMKRLMAE----CLKKKRDERPLFPQILASIELLARSL 302

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 135/275 (49%), Gaps = 26/275 (9%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN---PGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           IG G FG VYKG  +GD   VA+K LN   P  QQ    F+ E+G+L + R+++++  +G
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMG 71
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
           Y     Q+ +V  +    +L  HL+  +       + + I    A+ + YLH   +K II
Sbjct: 72  YSTAP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSII 126
Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ---LL 656
           HRD+K+ NI L E+   K+ DFGL      +S +H   Q+ GSI ++ PE  R+Q     
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 657 TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP 716
           + +SDVY+FG+VL E++  + P     ++ Q+   V     Y +  +  +     + N P
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--GRGYLSPDLSKV-----RSNCP 239
Query: 717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV 751
                   E    C+   R  RP    ++  +E +
Sbjct: 240 KAMKRLMAE----CLKKKRDERPLFPQILASIELL 270

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  113 bits (282), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 137/279 (49%), Gaps = 26/279 (9%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN---PGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           IG G FG VYKG  +GD   VA+K LN   P  QQ    F+ E+G+L + R+++++  +G
Sbjct: 43  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMG 98
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
           Y     Q+ +V  +    +L  HL+  +       + + I    A+ + YLH   +K II
Sbjct: 99  YSTKP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSII 153
Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ---LL 656
           HRD+K+ NI L E+   K+ DFGL      +S +H   Q+ GSI ++ PE  R+Q     
Sbjct: 154 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 213
Query: 657 TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP 716
           + +SDVY+FG+VL E++  + P     ++ Q+   V     Y +  +  +     + N P
Sbjct: 214 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--GRGYLSPDLSKV-----RSNCP 266
Query: 717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL 755
                   E    C+   R  RP    ++  +E + + L
Sbjct: 267 KAMKRLMAE----CLKKKRDERPLFPQILASIELLARSL 301

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  112 bits (280), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 135/275 (49%), Gaps = 26/275 (9%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN---PGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           IG G FG VYKG  +GD   VA+K LN   P  QQ    F+ E+G+L + R+++++  +G
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMG 71
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
           Y     Q+ +V  +    +L  HL+  +       + + I    A+ + YLH   +K II
Sbjct: 72  YSTKP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSII 126
Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ---LL 656
           HRD+K+ NI L E+   K+ DFGL      +S +H   Q+ GSI ++ PE  R+Q     
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 657 TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP 716
           + +SDVY+FG+VL E++  + P     ++ Q+   V     Y +  +  +     + N P
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--GRGYLSPDLSKV-----RSNCP 239
Query: 717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV 751
                   E    C+   R  RP    ++  +E +
Sbjct: 240 KAMKRLMAE----CLKKKRDERPLFPQILASIELL 270

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  112 bits (280), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 137/279 (49%), Gaps = 26/279 (9%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN---PGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           IG G FG VYKG  +GD   VA+K LN   P  QQ    F+ E+G+L + R+++++  +G
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMG 99
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
           Y     Q+ +V  +    +L  HL+  +       + + I    A+ + YLH   +K II
Sbjct: 100 YSTKP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSII 154
Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ---LL 656
           HRD+K+ NI L E+   K+ DFGL      +S +H   Q+ GSI ++ PE  R+Q     
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 657 TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP 716
           + +SDVY+FG+VL E++  + P     ++ Q+   V     Y +  +  +     + N P
Sbjct: 215 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--GRGYLSPDLSKV-----RSNCP 267
Query: 717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL 755
                   E    C+   R  RP    ++  +E + + L
Sbjct: 268 KAMKRLMAE----CLKKKRDERPLFPQILASIELLARSL 302

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  112 bits (280), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 135/275 (49%), Gaps = 26/275 (9%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN---PGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           IG G FG VYKG  +GD   VA+K LN   P  QQ    F+ E+G+L + R+++++  +G
Sbjct: 36  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMG 91
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
           Y     Q+ +V  +    +L  HL+  +       + + I    A+ + YLH   +K II
Sbjct: 92  YSTKP-QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSII 146
Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ---LL 656
           HRD+K+ NI L E+   K+ DFGL      +S +H   Q+ GSI ++ PE  R+Q     
Sbjct: 147 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 206
Query: 657 TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP 716
           + +SDVY+FG+VL E++  + P     ++ Q+   V     Y +  +  +     + N P
Sbjct: 207 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--GRGYLSPDLSKV-----RSNCP 259
Query: 717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV 751
                   E    C+   R  RP    ++  +E +
Sbjct: 260 KAMKRLMAE----CLKKKRDERPLFPQILASIELL 290

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 135/282 (47%), Gaps = 34/282 (12%)
Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSL 537
           +IGRG FG VY G L   +G     A+K LN  +  G + +F TE  ++    + +++SL
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 538 IGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           +G C   +G  ++V  YM  G LR+ + N  + P   D  +   +  A+ + +L   ASK
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFL---ASK 211
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
             +HRD+   N +LDE++  KV+DFGL +  +   F   H  T  K  + ++  E  + Q
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 655 LLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
             T KSDV+SFGV+L E++    PP                   Y +    DI    L+G
Sbjct: 272 KFTTKSDVWSFGVLLWELMTRGAPP-------------------YPDVNTFDITVYLLQG 312
Query: 714 N---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF 752
                P  C +   EV + C +     RPS S++V  +  +F
Sbjct: 313 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 135/282 (47%), Gaps = 34/282 (12%)
Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSL 537
           +IGRG FG VY G L   +G     A+K LN  +  G + +F TE  ++    + +++SL
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 538 IGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           +G C   +G  ++V  YM  G LR+ + N  + P   D  +   +  A+ + +L   ASK
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFL---ASK 152
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
             +HRD+   N +LDE++  KV+DFGL +  +   F   H  T  K  + ++  E  + Q
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 655 LLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
             T KSDV+SFGV+L E++    PP                   Y +    DI    L+G
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAPP-------------------YPDVNTFDITVYLLQG 253
Query: 714 N---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF 752
                P  C +   EV + C +     RPS S++V  +  +F
Sbjct: 254 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 295

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 135/282 (47%), Gaps = 34/282 (12%)
Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSL 537
           +IGRG FG VY G L   +G     A+K LN  +  G + +F TE  ++    + +++SL
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 538 IGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           +G C   +G  ++V  YM  G LR+ + N  + P   D  +   +  A+ + +L   ASK
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFL---ASK 150
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
             +HRD+   N +LDE++  KV+DFGL +  +   F   H  T  K  + ++  E  + Q
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 210
Query: 655 LLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
             T KSDV+SFGV+L E++    PP                   Y +    DI    L+G
Sbjct: 211 KFTTKSDVWSFGVLLWELMTRGAPP-------------------YPDVNTFDITVYLLQG 251
Query: 714 N---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF 752
                P  C +   EV + C +     RPS S++V  +  +F
Sbjct: 252 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 293

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 135/282 (47%), Gaps = 34/282 (12%)
Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSL 537
           +IGRG FG VY G L   +G     A+K LN  +  G + +F TE  ++    + +++SL
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 538 IGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           +G C   +G  ++V  YM  G LR+ + N  + P   D  +   +  A+ + +L   ASK
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFL---ASK 153
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
             +HRD+   N +LDE++  KV+DFGL +  +   F   H  T  K  + ++  E  + Q
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 655 LLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
             T KSDV+SFGV+L E++    PP                   Y +    DI    L+G
Sbjct: 214 KFTTKSDVWSFGVLLWELMTRGAPP-------------------YPDVNTFDITVYLLQG 254
Query: 714 N---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF 752
                P  C +   EV + C +     RPS S++V  +  +F
Sbjct: 255 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 296

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 135/282 (47%), Gaps = 34/282 (12%)
Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSL 537
           +IGRG FG VY G L   +G     A+K LN  +  G + +F TE  ++    + +++SL
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 538 IGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           +G C   +G  ++V  YM  G LR+ + N  + P   D  +   +  A+ + +L   ASK
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFL---ASK 152
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
             +HRD+   N +LDE++  KV+DFGL +  +   F   H  T  K  + ++  E  + Q
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 655 LLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
             T KSDV+SFGV+L E++    PP                   Y +    DI    L+G
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAPP-------------------YPDVNTFDITVYLLQG 253
Query: 714 N---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF 752
                P  C +   EV + C +     RPS S++V  +  +F
Sbjct: 254 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 295

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 135/282 (47%), Gaps = 34/282 (12%)
Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSL 537
           +IGRG FG VY G L   +G     A+K LN  +  G + +F TE  ++    + +++SL
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 538 IGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           +G C   +G  ++V  YM  G LR+ + N  + P   D  +   +  A+ + +L   ASK
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFL---ASK 157
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
             +HRD+   N +LDE++  KV+DFGL +  +   F   H  T  K  + ++  E  + Q
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 217
Query: 655 LLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
             T KSDV+SFGV+L E++    PP                   Y +    DI    L+G
Sbjct: 218 KFTTKSDVWSFGVLLWELMTRGAPP-------------------YPDVNTFDITVYLLQG 258
Query: 714 N---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF 752
                P  C +   EV + C +     RPS S++V  +  +F
Sbjct: 259 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 300

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  110 bits (276), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 135/282 (47%), Gaps = 34/282 (12%)
Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSL 537
           +IGRG FG VY G L   +G     A+K LN  +  G + +F TE  ++    + +++SL
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 538 IGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           +G C   +G  ++V  YM  G LR+ + N  + P   D  +   +  A+ + YL   ASK
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL---ASK 144
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
             +HRD+   N +LDE++  KV+DFGL +  +   +   H  T  K  + ++  E  + Q
Sbjct: 145 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 204
Query: 655 LLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
             T KSDV+SFGV+L E++    PP                   Y +    DI    L+G
Sbjct: 205 KFTTKSDVWSFGVLLWELMTRGAPP-------------------YPDVNTFDITVYLLQG 245
Query: 714 N---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF 752
                P  C +   EV + C +     RPS S++V  +  +F
Sbjct: 246 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 287

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  110 bits (276), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 135/282 (47%), Gaps = 34/282 (12%)
Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSL 537
           +IGRG FG VY G L   +G     A+K LN  +  G + +F TE  ++    + +++SL
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 538 IGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           +G C   +G  ++V  YM  G LR+ + N  + P   D  +   +  A+ + YL   ASK
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL---ASK 147
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
             +HRD+   N +LDE++  KV+DFGL +  +   +   H  T  K  + ++  E  + Q
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 655 LLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
             T KSDV+SFGV+L E++    PP                   Y +    DI    L+G
Sbjct: 208 KFTTKSDVWSFGVLLWELMTRGAPP-------------------YPDVNTFDITVYLLQG 248
Query: 714 N---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF 752
                P  C +   EV + C +     RPS S++V  +  +F
Sbjct: 249 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 135/282 (47%), Gaps = 34/282 (12%)
Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSL 537
           +IGRG FG VY G L   +G     A+K LN  +  G + +F TE  ++    + +++SL
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 538 IGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           +G C   +G  ++V  YM  G LR+ + N  + P   D  +   +  A+ + YL   ASK
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL---ASK 150
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
             +HRD+   N +LDE++  KV+DFGL +  +   +   H  T  K  + ++  E  + Q
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 210
Query: 655 LLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
             T KSDV+SFGV+L E++    PP                   Y +    DI    L+G
Sbjct: 211 KFTTKSDVWSFGVLLWELMTRGAPP-------------------YPDVNTFDITVYLLQG 251
Query: 714 N---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF 752
                P  C +   EV + C +     RPS S++V  +  +F
Sbjct: 252 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 293

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 135/282 (47%), Gaps = 34/282 (12%)
Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSL 537
           +IGRG FG VY G L   +G     A+K LN  +  G + +F TE  ++    + +++SL
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 538 IGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           +G C   +G  ++V  YM  G LR+ + N  + P   D  +   +  A+ + YL   ASK
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL---ASK 152
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
             +HRD+   N +LDE++  KV+DFGL +  +   +   H  T  K  + ++  E  + Q
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 655 LLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
             T KSDV+SFGV+L E++    PP                   Y +    DI    L+G
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAPP-------------------YPDVNTFDITVYLLQG 253
Query: 714 N---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF 752
                P  C +   EV + C +     RPS S++V  +  +F
Sbjct: 254 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 295

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 135/282 (47%), Gaps = 34/282 (12%)
Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSL 537
           +IGRG FG VY G L   +G     A+K LN  +  G + +F TE  ++    + +++SL
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 538 IGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           +G C   +G  ++V  YM  G LR+ + N  + P   D  +   +  A+ + YL   ASK
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL---ASK 171
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
             +HRD+   N +LDE++  KV+DFGL +  +   +   H  T  K  + ++  E  + Q
Sbjct: 172 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 231
Query: 655 LLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
             T KSDV+SFGV+L E++    PP                   Y +    DI    L+G
Sbjct: 232 KFTTKSDVWSFGVLLWELMTRGAPP-------------------YPDVNTFDITVYLLQG 272
Query: 714 N---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF 752
                P  C +   EV + C +     RPS S++V  +  +F
Sbjct: 273 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 314

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 135/282 (47%), Gaps = 34/282 (12%)
Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSL 537
           +IGRG FG VY G L   +G     A+K LN  +  G + +F TE  ++    + +++SL
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 538 IGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           +G C   +G  ++V  YM  G LR+ + N  + P   D  +   +  A+ + YL   ASK
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL---ASK 152
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
             +HRD+   N +LDE++  KV+DFGL +  +   +   H  T  K  + ++  E  + Q
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 655 LLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
             T KSDV+SFGV+L E++    PP                   Y +    DI    L+G
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAPP-------------------YPDVNTFDITVYLLQG 253
Query: 714 N---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF 752
                P  C +   EV + C +     RPS S++V  +  +F
Sbjct: 254 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 295

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 135/282 (47%), Gaps = 34/282 (12%)
Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSL 537
           +IGRG FG VY G L   +G     A+K LN  +  G + +F TE  ++    + +++SL
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 538 IGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           +G C   +G  ++V  YM  G LR+ + N  + P   D  +   +  A+ + YL   ASK
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL---ASK 170
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
             +HRD+   N +LDE++  KV+DFGL +  +   +   H  T  K  + ++  E  + Q
Sbjct: 171 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 230
Query: 655 LLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
             T KSDV+SFGV+L E++    PP                   Y +    DI    L+G
Sbjct: 231 KFTTKSDVWSFGVLLWELMTRGAPP-------------------YPDVNTFDITVYLLQG 271
Query: 714 N---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF 752
                P  C +   EV + C +     RPS S++V  +  +F
Sbjct: 272 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 313

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 135/282 (47%), Gaps = 34/282 (12%)
Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSL 537
           +IGRG FG VY G L   +G     A+K LN  +  G + +F TE  ++    + +++SL
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 538 IGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           +G C   +G  ++V  YM  G LR+ + N  + P   D  +   +  A+ + YL   ASK
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL---ASK 151
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
             +HRD+   N +LDE++  KV+DFGL +  +   +   H  T  K  + ++  E  + Q
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 211
Query: 655 LLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
             T KSDV+SFGV+L E++    PP                   Y +    DI    L+G
Sbjct: 212 KFTTKSDVWSFGVLLWELMTRGAPP-------------------YPDVNTFDITVYLLQG 252
Query: 714 N---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF 752
                P  C +   EV + C +     RPS S++V  +  +F
Sbjct: 253 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 294

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 135/282 (47%), Gaps = 34/282 (12%)
Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSL 537
           +IGRG FG VY G L   +G     A+K LN  +  G + +F TE  ++    + +++SL
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 538 IGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           +G C   +G  ++V  YM  G LR+ + N  + P   D  +   +  A+ + YL   ASK
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL---ASK 149
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
             +HRD+   N +LDE++  KV+DFGL +  +   +   H  T  K  + ++  E  + Q
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 209
Query: 655 LLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
             T KSDV+SFGV+L E++    PP                   Y +    DI    L+G
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPP-------------------YPDVNTFDITVYLLQG 250
Query: 714 N---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF 752
                P  C +   EV + C +     RPS S++V  +  +F
Sbjct: 251 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 134/282 (47%), Gaps = 34/282 (12%)
Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSL 537
           +IGRG FG VY G L   +G     A+K LN  +  G + +F TE  ++    + +++SL
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 538 IGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           +G C   +G  ++V  YM  G LR+ + N  + P   D  +   +  A+ + +L   ASK
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFL---ASK 153
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
             +HRD+   N +LDE++  KV+DFGL +      F   H  T  K  + ++  E  + Q
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 655 LLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
             T KSDV+SFGV+L E++    PP                   Y +    DI    L+G
Sbjct: 214 KFTTKSDVWSFGVLLWELMTRGAPP-------------------YPDVNTFDITVYLLQG 254
Query: 714 N---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF 752
                P  C +   EV + C +     RPS S++V  +  +F
Sbjct: 255 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 296

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 134/282 (47%), Gaps = 34/282 (12%)
Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSL 537
           +IGRG FG VY G L   +G     A+K LN  +  G + +F TE  ++    + +++SL
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 538 IGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           +G C   +G  ++V  YM  G LR+ + N  + P   D  +   +  A+ + YL   ASK
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL---ASK 151
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
             +HRD+   N +LDE++  KV+DFGL +  +       H  T  K  + ++  E  + Q
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQ 211
Query: 655 LLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
             T KSDV+SFGV+L E++    PP                   Y +    DI    L+G
Sbjct: 212 KFTTKSDVWSFGVLLWELMTRGAPP-------------------YPDVNTFDITVYLLQG 252
Query: 714 N---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF 752
                P  C +   EV + C +     RPS S++V  +  +F
Sbjct: 253 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 294

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 129/270 (47%), Gaps = 25/270 (9%)
Query: 482 IIGRGGFGNVYKGFLNGDS----TPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVS 536
           +IG G FG VYKG L   S     PVAIK L  G +++  ++F  E G++ Q  + +++ 
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           L G  +    M+++ +YM  G L   L   D       + + +  G A  + YL   A+ 
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
             +HRD+   NIL++   V KVSDFGL +    +   T+ ++  K  I +  PE    + 
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226
Query: 656 LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNA 715
            T  SDV+SFG+V+ EV+         G++    L+        N ++   I+   +   
Sbjct: 227 FTSASDVWSFGIVMWEVMT-------YGERPYWELS--------NHEVMKAINDGFRLPT 271
Query: 716 PPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           P  C +   ++ M C   +R RRP  +D+V
Sbjct: 272 PMDCPSAIYQLMMQCWQQERARRPKFADIV 301

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 129/276 (46%), Gaps = 36/276 (13%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--QGALEFQTEIGMLSQLRYLHLVSLIG 539
           IIG GGFG VY+ F  GD   V   R +P     Q     + E  + + L++ ++++L G
Sbjct: 14  IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
            C  +  + LV ++   G L   L     PP   D  +   +  AR ++YLH  A   II
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKRIPP---DILVNWAVQIARGMNYLHDEAIVPII 130
Query: 600 HRDVKTTNILLDEEW--------VAKVSDFGLCKFGPNFSKTHVSTQVK--GSIGYLDPE 649
           HRD+K++NIL+ ++         + K++DFGL +      + H +T++   G+  ++ PE
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAR------EWHRTTKMSAAGAYAWMAPE 184
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
             R  + ++ SDV+S+GV+L E+L    P  R  D   V   V   +             
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVP-FRGIDGLAVAYGVAMNK------------- 230
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
            L    P  C   F ++   C N D   RPS ++++
Sbjct: 231 -LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNIL 265

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 76/269 (28%), Positives = 124/269 (46%), Gaps = 30/269 (11%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV 535
           D N    IG G FG V++   +G    V I        +   EF  E+ ++ +LR+ ++V
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNND-NPPLPWDRRLKICIGAARALHYLHTGA 594
             +G       + +V +Y++RG+L   L+ +     L   RRL +    A+ ++YLH   
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-R 156
Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
           +  I+HRD+K+ N+L+D+++  KV DFGL +     S    S    G+  ++ PE  R +
Sbjct: 157 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 655 LLTEKSDVYSFGVVLLEVL---------------------CARPPILRTGDKKQVNL--A 691
              EKSDVYSFGV+L E+                      C R  I R  + +   +   
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG 274
Query: 692 VWATECYRN---GKIGDIIDPFLKGNAPP 717
            W  E ++      I D++ P +K   PP
Sbjct: 275 CWTNEPWKRPSFATIMDLLRPLIKSAVPP 303

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score =  105 bits (262), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 87/284 (30%), Positives = 132/284 (46%), Gaps = 40/284 (14%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           K+   L  IG+G FG+V  G   G+   V   + +  +Q     F  E  +++QLR+ +L
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNL 76
Query: 535 VSLIGY-CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           V L+G    + G + +V +YMA+G+L D+L +     L  D  LK  +    A+ YL   
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS--IGYLDPEYY 651
                +HRD+   N+L+ E+ VAKVSDFGL       +K   STQ  G   + +  PE  
Sbjct: 137 N---FVHRDLAARNVLVSEDNVAKVSDFGL-------TKEASSTQDTGKLPVKWTAPEAL 186
Query: 652 RLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF 710
           R +  + KSDV+SFG++L E+    R P  R                     + D++   
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-------------------PLKDVVPRV 227
Query: 711 LKG---NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV 751
            KG   +AP  C     EV  +C + D   RPS   +   LE +
Sbjct: 228 EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 87/284 (30%), Positives = 132/284 (46%), Gaps = 40/284 (14%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           K+   L  IG+G FG+V  G   G+   V   + +  +Q     F  E  +++QLR+ +L
Sbjct: 6   KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNL 61
Query: 535 VSLIGY-CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           V L+G    + G + +V +YMA+G+L D+L +     L  D  LK  +    A+ YL   
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 121
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS--IGYLDPEYY 651
                +HRD+   N+L+ E+ VAKVSDFGL       +K   STQ  G   + +  PE  
Sbjct: 122 N---FVHRDLAARNVLVSEDNVAKVSDFGL-------TKEASSTQDTGKLPVKWTAPEAL 171
Query: 652 RLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF 710
           R +  + KSDV+SFG++L E+    R P                   Y    + D++   
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVP-------------------YPRIPLKDVVPRV 212
Query: 711 LKG---NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV 751
            KG   +AP  C     EV  +C + D   RPS   +   LE +
Sbjct: 213 EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 256

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 110/213 (51%), Gaps = 9/213 (4%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           IG G FG VYKG  +GD     +K ++P  +Q    F+ E+ +L + R+++++  +GY  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQ-AFRNEVAVLRKTRHVNILLFMGYMT 102
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            D  + +V  +    +L  HL+  +       + + I    A+ + YLH   +K IIHRD
Sbjct: 103 KDN-LAIVTQWCEGSSLYKHLHVQETK-FQMFQLIDIARQTAQGMDYLH---AKNIIHRD 157
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ---LLTEK 659
           +K+ NI L E    K+ DFGL      +S +    Q  GS+ ++ PE  R+Q     + +
Sbjct: 158 MKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ 217
Query: 660 SDVYSFGVVLLEVLCARPPILRTGDKKQVNLAV 692
           SDVYS+G+VL E++    P     ++ Q+   V
Sbjct: 218 SDVYSYGIVLYELMTGELPYSHINNRDQIIFMV 250

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/284 (30%), Positives = 131/284 (46%), Gaps = 40/284 (14%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           K+   L  IG+G FG+V  G   G+   V   + +  +Q     F  E  +++QLR+ +L
Sbjct: 12  KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNL 67
Query: 535 VSLIGY-CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           V L+G    + G + +V +YMA+G+L D+L +     L  D  LK  +    A+ YL   
Sbjct: 68  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-- 125
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS--IGYLDPEYY 651
                +HRD+   N+L+ E+ VAKVSDFGL       +K   STQ  G   + +  PE  
Sbjct: 126 -GNNFVHRDLAARNVLVSEDNVAKVSDFGL-------TKEASSTQDTGKLPVKWTAPEAL 177
Query: 652 RLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF 710
           R    + KSDV+SFG++L E+    R P                   Y    + D++   
Sbjct: 178 REAAFSTKSDVWSFGILLWEIYSFGRVP-------------------YPRIPLKDVVPRV 218
Query: 711 LKG---NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV 751
            KG   +AP  C     EV  +C + D   RPS   +   LE +
Sbjct: 219 EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 262

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 128/270 (47%), Gaps = 32/270 (11%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV 535
           D N    IG G FG V++   +G    V I        +   EF  E+ ++ +LR+ ++V
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNND-NPPLPWDRRLKICIGAARALHYLHTGA 594
             +G       + +V +Y++RG+L   L+ +     L   RRL +    A+ ++YLH   
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-R 156
Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRL 653
           +  I+HR++K+ N+L+D+++  KV DFGL +     + T +S++   G+  ++ PE  R 
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK---ASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 654 QLLTEKSDVYSFGVVLLEVL---------------------CARPPILRTGDKKQVNL-- 690
           +   EKSDVYSFGV+L E+                      C R  I R  + +   +  
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273
Query: 691 AVWATECYRN---GKIGDIIDPFLKGNAPP 717
             W  E ++      I D++ P +K   PP
Sbjct: 274 GCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 132/284 (46%), Gaps = 40/284 (14%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           K+   L  IG+G FG+V  G   G+   V   + +  +Q     F  E  +++QLR+ +L
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNL 248
Query: 535 VSLIGY-CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           V L+G    + G + +V +YMA+G+L D+L +     L  D  LK  +    A+ YL   
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS--IGYLDPEYY 651
                +HRD+   N+L+ E+ VAKVSDFGL       +K   STQ  G   + +  PE  
Sbjct: 309 N---FVHRDLAARNVLVSEDNVAKVSDFGL-------TKEASSTQDTGKLPVKWTAPEAL 358
Query: 652 RLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF 710
           R +  + KSDV+SFG++L E+    R P  R                     + D++   
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-------------------PLKDVVPRV 399
Query: 711 LKG---NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV 751
            KG   +AP  C     +V  +C + D   RP+   +   LE +
Sbjct: 400 EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 134/271 (49%), Gaps = 37/271 (13%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
           ++GRG FG V K         VAIK++   S++ A  F  E+  LS++ + ++V L G C
Sbjct: 16  VVGRGAFGVVCKAKWRAKD--VAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYGAC 71
Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPW---DRRLKICIGAARALHYLHTGASKVI 598
            +   + LV +Y   G+L + L+  +  PLP+      +  C+  ++ + YLH+   K +
Sbjct: 72  LNP--VCLVMEYAEGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 127
Query: 599 IHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS-KTHVSTQVKGSIGYLDPEYYRLQLLT 657
           IHRD+K  N+LL    VA  +   +C FG     +TH+ T  KGS  ++ PE +     +
Sbjct: 128 IHRDLKPPNLLL----VAGGTVLKICDFGTACDIQTHM-TNNKGSAAWMAPEVFEGSNYS 182
Query: 658 EKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPP 717
           EK DV+S+G++L EV+  R P    G                 G    I+     G  PP
Sbjct: 183 EKCDVFSWGIILWEVITRRKPFDEIG-----------------GPAFRIMWAVHNGTRPP 225
Query: 718 VCLN--QFVEVAMS-CVNDDRIRRPSMSDVV 745
           +  N  + +E  M+ C + D  +RPSM ++V
Sbjct: 226 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIV 256

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 134/271 (49%), Gaps = 37/271 (13%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
           ++GRG FG V K         VAIK++   S++ A  F  E+  LS++ + ++V L G C
Sbjct: 15  VVGRGAFGVVCKAKWRAKD--VAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYGAC 70
Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPW---DRRLKICIGAARALHYLHTGASKVI 598
            +   + LV +Y   G+L + L+  +  PLP+      +  C+  ++ + YLH+   K +
Sbjct: 71  LNP--VCLVMEYAEGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 599 IHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS-KTHVSTQVKGSIGYLDPEYYRLQLLT 657
           IHRD+K  N+LL    VA  +   +C FG     +TH+ T  KGS  ++ PE +     +
Sbjct: 127 IHRDLKPPNLLL----VAGGTVLKICDFGTACDIQTHM-TNNKGSAAWMAPEVFEGSNYS 181
Query: 658 EKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPP 717
           EK DV+S+G++L EV+  R P    G                 G    I+     G  PP
Sbjct: 182 EKCDVFSWGIILWEVITRRKPFDEIG-----------------GPAFRIMWAVHNGTRPP 224
Query: 718 VCLN--QFVEVAMS-CVNDDRIRRPSMSDVV 745
           +  N  + +E  M+ C + D  +RPSM ++V
Sbjct: 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIV 255

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/192 (33%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 483 IGRGGFGNVYKGF-LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
           IG G FG V+ G+ LN D   VAIK +  G+     +F  E  ++ +L +  LV L G C
Sbjct: 15  IGSGQFGLVHLGYWLNKDK--VAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
            +   + LV+++M  G L D+L          +  L +C+     + YL   +   +IHR
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEAS---VIHR 127
Query: 602 DVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSD 661
           D+   N L+ E  V KVSDFG+ +F  +   T  ST  K  + +  PE +     + KSD
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 662 VYSFGVVLLEVL 673
           V+SFGV++ EV 
Sbjct: 187 VWSFGVLMWEVF 198

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/192 (34%), Positives = 97/192 (50%), Gaps = 9/192 (4%)
Query: 483 IGRGGFGNVYKGF-LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
           IG G FG V+ G+ LN D   VAIK +  GS     +F  E  ++ +L +  LV L G C
Sbjct: 35  IGSGQFGLVHLGYWLNKDK--VAIKTIKEGSMSED-DFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
            +   + LV+++M  G L D+L          +  L +C+     + YL       +IHR
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 147
Query: 602 DVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSD 661
           D+   N L+ E  V KVSDFG+ +F  +   T  ST  K  + +  PE +     + KSD
Sbjct: 148 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSD 206
Query: 662 VYSFGVVLLEVL 673
           V+SFGV++ EV 
Sbjct: 207 VWSFGVLMWEVF 218

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/192 (33%), Positives = 97/192 (50%), Gaps = 9/192 (4%)
Query: 483 IGRGGFGNVYKGF-LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
           IG G FG V+ G+ LN D   VAIK +  G+     +F  E  ++ +L +  LV L G C
Sbjct: 13  IGSGQFGLVHLGYWLNKDK--VAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
            +   + LV+++M  G L D+L          +  L +C+     + YL       +IHR
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 125
Query: 602 DVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSD 661
           D+   N L+ E  V KVSDFG+ +F  +   T  ST  K  + +  PE +     + KSD
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSD 184
Query: 662 VYSFGVVLLEVL 673
           V+SFGV++ EV 
Sbjct: 185 VWSFGVLMWEVF 196

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/192 (33%), Positives = 97/192 (50%), Gaps = 9/192 (4%)
Query: 483 IGRGGFGNVYKGF-LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
           IG G FG V+ G+ LN D   VAIK +  G+     +F  E  ++ +L +  LV L G C
Sbjct: 15  IGSGQFGLVHLGYWLNKDK--VAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
            +   + LV+++M  G L D+L          +  L +C+     + YL       +IHR
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 127
Query: 602 DVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSD 661
           D+   N L+ E  V KVSDFG+ +F  +   T  ST  K  + +  PE +     + KSD
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 662 VYSFGVVLLEVL 673
           V+SFGV++ EV 
Sbjct: 187 VWSFGVLMWEVF 198

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/192 (33%), Positives = 97/192 (50%), Gaps = 9/192 (4%)
Query: 483 IGRGGFGNVYKGF-LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
           IG G FG V+ G+ LN D   VAIK +  G+     +F  E  ++ +L +  LV L G C
Sbjct: 18  IGSGQFGLVHLGYWLNKDK--VAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
            +   + LV+++M  G L D+L          +  L +C+     + YL       +IHR
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 130
Query: 602 DVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSD 661
           D+   N L+ E  V KVSDFG+ +F  +   T  ST  K  + +  PE +     + KSD
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSD 189
Query: 662 VYSFGVVLLEVL 673
           V+SFGV++ EV 
Sbjct: 190 VWSFGVLMWEVF 201

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 132/280 (47%), Gaps = 42/280 (15%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGAL-------EFQTEIGMLSQLRYLHLV 535
           IG+GGFG V+KG L  D + VAIK L  G  +G         EFQ E+ ++S L + ++V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
            L G  ++  +M++  +++  G L   L +  + P+ W  +L++ +  A  + Y+    +
Sbjct: 87  KLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQN-QN 142
Query: 596 KVIIHRDVKTTNIL---LDEEW--VAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
             I+HRD+++ NI    LDE     AKV+DFGL +        H  + + G+  ++ PE 
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPET 197
Query: 651 Y--RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK---IGD 705
                +  TEK+D YSF ++L  +L    P                 + Y  GK   I  
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPF----------------DEYSYGKIKFINM 241
Query: 706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           I +  L+   P  C  +   V   C + D  +RP  S +V
Sbjct: 242 IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIV 281

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 125/294 (42%), Gaps = 40/294 (13%)
Query: 483 IGRGGFGNV-----YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G FG V     Y      D   VA+K L   S     +F  E  +L+ L++ H+V  
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 538 IGYCNDDGQMILVYDYMARGT----LRDH-----LYNNDNPP--LPWDRRLKICIGAARA 586
            G C +   +I+V++YM  G     LR H     L    NPP  L   + L I    A  
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 587 LHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL 646
           + YL   AS+  +HRD+ T N L+ E  + K+ DFG+ +   +     V       I ++
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGD 705
            PE    +  T +SDV+S GVVL E+    + P  +  + + +       EC   G++  
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI-------ECITQGRV-- 248
Query: 706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESS 759
                     P  C  +  E+ + C      R P M   + G+  + Q L ++S
Sbjct: 249 -------LQRPRTCPQEVYELMLGCWQ----REPHMRKNIKGIHTLLQNLAKAS 291

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/192 (33%), Positives = 96/192 (50%), Gaps = 9/192 (4%)
Query: 483 IGRGGFGNVYKGF-LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
           IG G FG V+ G+ LN D   VAIK +  G+     +F  E  ++ +L +  LV L G C
Sbjct: 16  IGSGQFGLVHLGYWLNKDK--VAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
            +   + LV ++M  G L D+L          +  L +C+     + YL       +IHR
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 128
Query: 602 DVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSD 661
           D+   N L+ E  V KVSDFG+ +F  +   T  ST  K  + +  PE +     + KSD
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 662 VYSFGVVLLEVL 673
           V+SFGV++ EV 
Sbjct: 188 VWSFGVLMWEVF 199

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 98/191 (51%), Gaps = 6/191 (3%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+ G+ N +ST VA+K L PG+      F  E  ++  L++  LV L     
Sbjct: 21  LGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ +YMA+G+L D L +++   +   + +      A  + Y+     K  IHRD
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 135
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  N+L+ E  + K++DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 136 LRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGCFTIKSDV 194
Query: 663 YSFGVVLLEVL 673
           +SFG++L E++
Sbjct: 195 WSFGILLYEIV 205

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 131/280 (46%), Gaps = 42/280 (15%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGAL-------EFQTEIGMLSQLRYLHLV 535
           IG+GGFG V+KG L  D + VAIK L  G  +G         EFQ E+ ++S L + ++V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
            L G  ++  +M++  +++  G L   L +  + P+ W  +L++ +  A  + Y+    +
Sbjct: 87  KLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQN-QN 142
Query: 596 KVIIHRDVKTTNIL---LDEEW--VAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
             I+HRD+++ NI    LDE     AKV+DFG  +        H  + + G+  ++ PE 
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGLLGNFQWMAPET 197
Query: 651 Y--RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK---IGD 705
                +  TEK+D YSF ++L  +L    P                 + Y  GK   I  
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPF----------------DEYSYGKIKFINM 241
Query: 706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           I +  L+   P  C  +   V   C + D  +RP  S +V
Sbjct: 242 IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIV 281

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 131/280 (46%), Gaps = 42/280 (15%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGAL-------EFQTEIGMLSQLRYLHLV 535
           IG+GGFG V+KG L  D + VAIK L  G  +G         EFQ E+ ++S L + ++V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
            L G  ++  +M++  +++  G L   L +  + P+ W  +L++ +  A  + Y+    +
Sbjct: 87  KLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQN-QN 142
Query: 596 KVIIHRDVKTTNIL---LDEEW--VAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
             I+HRD+++ NI    LDE     AKV+DF L +        H  + + G+  ++ PE 
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGLLGNFQWMAPET 197
Query: 651 Y--RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK---IGD 705
                +  TEK+D YSF ++L  +L    P                 + Y  GK   I  
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPF----------------DEYSYGKIKFINM 241
Query: 706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           I +  L+   P  C  +   V   C + D  +RP  S +V
Sbjct: 242 IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIV 281

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y  RG +   L           R        A AL Y
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK--FDEQRTATYITELANALSY 128
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +T +     G++ YL PE
Sbjct: 129 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPE 181
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 124
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +T +S    G++ YL PE
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----GTLDYLPPE 177
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 131/292 (44%), Gaps = 29/292 (9%)
Query: 482 IIGRGGFGNVYKGFLNG---DSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           +IG G FG V +G L       + VAIK L  G +++   EF +E  ++ Q  + +++ L
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G   +   ++++ ++M  G L   L  ND       + + +  G A  + YL   A   
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQ-FTVIQLVGMLRGIASGMRYL---AEMS 138
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS---IGYLDPEYYRLQ 654
            +HRD+   NIL++   V KVSDFGL +F    S     T   G    I +  PE    +
Sbjct: 139 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFR 198
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             T  SD +S+G+V+ EV+         G++   +++        N  + + I+   +  
Sbjct: 199 KFTSASDAWSYGIVMWEVMS-------FGERPYWDMS--------NQDVINAIEQDYRLP 243
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEKSMIAH 766
            PP C     ++ + C   DR  RP    VV  L+   +++R  +   ++A 
Sbjct: 244 PPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALD---KMIRNPASLKIVAR 292

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 110/233 (47%), Gaps = 15/233 (6%)
Query: 452 GPASSLPSDLCTQFSISEIKE---ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL 508
            P ++   +L ++    E K+   A +DF     +G+G FGNVY          +A+K L
Sbjct: 8   APENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL 67
Query: 509 NPGSQQGA---LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYN 565
                + A    + + E+ + S LR+ +++ L GY +D  ++ L+ +Y   GT+   L  
Sbjct: 68  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 127
Query: 566 NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK 625
                    R        A AL Y H   SK +IHRD+K  N+LL      K++DFG   
Sbjct: 128 LSK--FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV 182
Query: 626 FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
             P+  +T +     G++ YL PE    ++  EK D++S GV+  E L  +PP
Sbjct: 183 HAPSSRRTTLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 123
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +T +     G++ YL PE
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELC----GTLDYLPPE 176
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 122/275 (44%), Gaps = 28/275 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHRD
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTXT-AHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 663 YSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV 718
           ++FGV+L E+    +   P I    D  QV                ++++   +   P  
Sbjct: 194 WAFGVLLWEIATYGMSPYPGI----DPSQVY---------------ELLEKDYRMERPEG 234
Query: 719 CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           C  +  E+  +C   +   RPS +++    E +FQ
Sbjct: 235 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 129/281 (45%), Gaps = 35/281 (12%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+G FG+V    Y    +     VA+K+L   +++   +F+ EI +L  L++ ++V   
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 539 GYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           G C   G+  + L+ +Y+  G+LRD+L  +    +   + L+      + + YL T   K
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGT---K 164
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP-NFSKTHVSTQVKGSIGYLDPEYYRLQL 655
             IHRD+ T NIL++ E   K+ DFGL K  P +     V    +  I +  PE      
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 224
Query: 656 LTEKSDVYSFGVVLLEVLC-----ARPP---ILRTGDKKQVNLAVWATECYRNGKIGDII 707
            +  SDV+SFGVVL E+         PP   +   G+ KQ  + V+             +
Sbjct: 225 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------------L 272
Query: 708 DPFLKGNA----PPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
              LK N     P  C ++   +   C N++  +RPS  D+
Sbjct: 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 313

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 131/292 (44%), Gaps = 29/292 (9%)
Query: 482 IIGRGGFGNVYKGFLNG---DSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           +IG G FG V +G L       + VAIK L  G +++   EF +E  ++ Q  + +++ L
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G   +   ++++ ++M  G L   L  ND       + + +  G A  + YL   A   
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQ-FTVIQLVGMLRGIASGMRYL---AEMS 136
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS---IGYLDPEYYRLQ 654
            +HRD+   NIL++   V KVSDFGL +F    S     T   G    I +  PE    +
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR 196
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             T  SD +S+G+V+ EV+         G++   +++        N  + + I+   +  
Sbjct: 197 KFTSASDAWSYGIVMWEVMS-------FGERPYWDMS--------NQDVINAIEQDYRLP 241
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEKSMIAH 766
            PP C     ++ + C   DR  RP    VV  L+   +++R  +   ++A 
Sbjct: 242 PPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALD---KMIRNPASLKIVAR 290

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 129/281 (45%), Gaps = 35/281 (12%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+G FG+V    Y    +     VA+K+L   +++   +F+ EI +L  L++ ++V   
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 539 GYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           G C   G+  + L+ +Y+  G+LRD+L  +    +   + L+      + + YL T   K
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT---K 138
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP-NFSKTHVSTQVKGSIGYLDPEYYRLQL 655
             IHRD+ T NIL++ E   K+ DFGL K  P +     V    +  I +  PE      
Sbjct: 139 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 198
Query: 656 LTEKSDVYSFGVVLLEVLC-----ARPP---ILRTGDKKQVNLAVWATECYRNGKIGDII 707
            +  SDV+SFGVVL E+         PP   +   G+ KQ  + V+             +
Sbjct: 199 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------------L 246
Query: 708 DPFLKGNA----PPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
              LK N     P  C ++   +   C N++  +RPS  D+
Sbjct: 247 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 287

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 129/281 (45%), Gaps = 35/281 (12%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+G FG+V    Y    +     VA+K+L   +++   +F+ EI +L  L++ ++V   
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 539 GYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           G C   G+  + L+ +Y+  G+LRD+L  +    +   + L+      + + YL T   K
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT---K 140
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP-NFSKTHVSTQVKGSIGYLDPEYYRLQL 655
             IHRD+ T NIL++ E   K+ DFGL K  P +     V    +  I +  PE      
Sbjct: 141 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 200
Query: 656 LTEKSDVYSFGVVLLEVLC-----ARPP---ILRTGDKKQVNLAVWATECYRNGKIGDII 707
            +  SDV+SFGVVL E+         PP   +   G+ KQ  + V+             +
Sbjct: 201 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------------L 248
Query: 708 DPFLKGNA----PPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
              LK N     P  C ++   +   C N++  +RPS  D+
Sbjct: 249 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 289

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 129/281 (45%), Gaps = 35/281 (12%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+G FG+V    Y    +     VA+K+L   +++   +F+ EI +L  L++ ++V   
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 539 GYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           G C   G+  + L+ +Y+  G+LRD+L  +    +   + L+      + + YL T   K
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT---K 139
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP-NFSKTHVSTQVKGSIGYLDPEYYRLQL 655
             IHRD+ T NIL++ E   K+ DFGL K  P +     V    +  I +  PE      
Sbjct: 140 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 199
Query: 656 LTEKSDVYSFGVVLLEVLC-----ARPP---ILRTGDKKQVNLAVWATECYRNGKIGDII 707
            +  SDV+SFGVVL E+         PP   +   G+ KQ  + V+             +
Sbjct: 200 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------------L 247
Query: 708 DPFLKGNA----PPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
              LK N     P  C ++   +   C N++  +RPS  D+
Sbjct: 248 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 288

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 129/281 (45%), Gaps = 35/281 (12%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+G FG+V    Y    +     VA+K+L   +++   +F+ EI +L  L++ ++V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 539 GYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           G C   G+  + L+ +Y+  G+LRD+L  +    +   + L+      + + YL T   K
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT---K 136
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP-NFSKTHVSTQVKGSIGYLDPEYYRLQL 655
             IHRD+ T NIL++ E   K+ DFGL K  P +     V    +  I +  PE      
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 656 LTEKSDVYSFGVVLLEVLC-----ARPP---ILRTGDKKQVNLAVWATECYRNGKIGDII 707
            +  SDV+SFGVVL E+         PP   +   G+ KQ  + V+             +
Sbjct: 197 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------------L 244
Query: 708 DPFLKGNA----PPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
              LK N     P  C ++   +   C N++  +RPS  D+
Sbjct: 245 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 129/281 (45%), Gaps = 35/281 (12%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+G FG+V    Y    +     VA+K+L   +++   +F+ EI +L  L++ ++V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 539 GYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           G C   G+  + L+ +Y+  G+LRD+L  +    +   + L+      + + YL T   K
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT---K 133
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP-NFSKTHVSTQVKGSIGYLDPEYYRLQL 655
             IHRD+ T NIL++ E   K+ DFGL K  P +     V    +  I +  PE      
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 193
Query: 656 LTEKSDVYSFGVVLLEVLC-----ARPP---ILRTGDKKQVNLAVWATECYRNGKIGDII 707
            +  SDV+SFGVVL E+         PP   +   G+ KQ  + V+             +
Sbjct: 194 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------------L 241
Query: 708 DPFLKGNA----PPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
              LK N     P  C ++   +   C N++  +RPS  D+
Sbjct: 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 129/281 (45%), Gaps = 35/281 (12%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+G FG+V    Y    +     VA+K+L   +++   +F+ EI +L  L++ ++V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 539 GYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           G C   G+  + L+ +Y+  G+LRD+L  +    +   + L+      + + YL T   K
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGT---K 133
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP-NFSKTHVSTQVKGSIGYLDPEYYRLQL 655
             IHRD+ T NIL++ E   K+ DFGL K  P +     V    +  I +  PE      
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 193
Query: 656 LTEKSDVYSFGVVLLEVLC-----ARPP---ILRTGDKKQVNLAVWATECYRNGKIGDII 707
            +  SDV+SFGVVL E+         PP   +   G+ KQ  + V+             +
Sbjct: 194 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------------L 241
Query: 708 DPFLKGNA----PPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
              LK N     P  C ++   +   C N++  +RPS  D+
Sbjct: 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 140
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +T +     G++ YL PE
Sbjct: 141 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPE 193
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 194 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 129/281 (45%), Gaps = 35/281 (12%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+G FG+V    Y    +     VA+K+L   +++   +F+ EI +L  L++ ++V   
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 539 GYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           G C   G+  + L+ +Y+  G+LRD+L  +    +   + L+      + + YL T   K
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGT---K 131
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP-NFSKTHVSTQVKGSIGYLDPEYYRLQL 655
             IHRD+ T NIL++ E   K+ DFGL K  P +     V    +  I +  PE      
Sbjct: 132 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 191
Query: 656 LTEKSDVYSFGVVLLEVLC-----ARPP---ILRTGDKKQVNLAVWATECYRNGKIGDII 707
            +  SDV+SFGVVL E+         PP   +   G+ KQ  + V+             +
Sbjct: 192 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------------L 239
Query: 708 DPFLKGNA----PPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
              LK N     P  C ++   +   C N++  +RPS  D+
Sbjct: 240 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 280

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 126
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +T +     G++ YL PE
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPE 179
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 128
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +T +     G++ YL PE
Sbjct: 129 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPE 181
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 129/281 (45%), Gaps = 35/281 (12%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+G FG+V    Y    +     VA+K+L   +++   +F+ EI +L  L++ ++V   
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 539 GYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           G C   G+  + L+ +Y+  G+LRD+L  +    +   + L+      + + YL T   K
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT---K 132
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP-NFSKTHVSTQVKGSIGYLDPEYYRLQL 655
             IHRD+ T NIL++ E   K+ DFGL K  P +     V    +  I +  PE      
Sbjct: 133 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 192
Query: 656 LTEKSDVYSFGVVLLEVLC-----ARPP---ILRTGDKKQVNLAVWATECYRNGKIGDII 707
            +  SDV+SFGVVL E+         PP   +   G+ KQ  + V+             +
Sbjct: 193 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------------L 240
Query: 708 DPFLKGNA----PPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
              LK N     P  C ++   +   C N++  +RPS  D+
Sbjct: 241 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 281

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 129/281 (45%), Gaps = 35/281 (12%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+G FG+V    Y    +     VA+K+L   +++   +F+ EI +L  L++ ++V   
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 539 GYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           G C   G+  + L+ +Y+  G+LRD+L  +    +   + L+      + + YL T   K
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGT---K 137
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP-NFSKTHVSTQVKGSIGYLDPEYYRLQL 655
             IHRD+ T NIL++ E   K+ DFGL K  P +     V    +  I +  PE      
Sbjct: 138 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 197
Query: 656 LTEKSDVYSFGVVLLEVLC-----ARPP---ILRTGDKKQVNLAVWATECYRNGKIGDII 707
            +  SDV+SFGVVL E+         PP   +   G+ KQ  + V+             +
Sbjct: 198 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------------L 245
Query: 708 DPFLKGNA----PPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
              LK N     P  C ++   +   C N++  +RPS  D+
Sbjct: 246 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 286

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 123
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +T +     G++ YL PE
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPE 176
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y  RG +   L           R        A AL Y
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK--FDEQRTATYITELANALSY 128
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +      + G++ YL PE
Sbjct: 129 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLXGTLDYLPPE 181
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 98/191 (51%), Gaps = 6/191 (3%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+ G+ N +ST VA+K L PG+      F  E  ++  L++  LV L     
Sbjct: 20  LGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ ++MA+G+L D L +++   +   + +      A  + Y+     K  IHRD
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 134
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  N+L+ E  + K++DFGL +   +   T      K  I +  PE       T KS+V
Sbjct: 135 LRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGCFTIKSNV 193
Query: 663 YSFGVVLLEVL 673
           +SFG++L E++
Sbjct: 194 WSFGILLYEIV 204

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 124
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +T +     G++ YL PE
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPE 177
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 123
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +T +     G++ YL PE
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPE 176
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 28/275 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHRD
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTXT-AHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 663 YSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV 718
           ++FGV+L E+    +   P I    D  QV                ++++   +   P  
Sbjct: 194 WAFGVLLWEIATYGMSPYPGI----DPSQVY---------------ELLEKDYRMERPEG 234
Query: 719 CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           C  +  E+  +C   +   RPS +++    E +FQ
Sbjct: 235 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 129/281 (45%), Gaps = 35/281 (12%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+G FG+V    Y    +     VA+K+L   +++   +F+ EI +L  L++ ++V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 539 GYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           G C   G+  + L+ +Y+  G+LRD+L  +    +   + L+      + + YL T   K
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGT---K 151
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP-NFSKTHVSTQVKGSIGYLDPEYYRLQL 655
             IHRD+ T NIL++ E   K+ DFGL K  P +     V    +  I +  PE      
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 211
Query: 656 LTEKSDVYSFGVVLLEVLC-----ARPP---ILRTGDKKQVNLAVWATECYRNGKIGDII 707
            +  SDV+SFGVVL E+         PP   +   G+ KQ  + V+             +
Sbjct: 212 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------------L 259
Query: 708 DPFLKGNA----PPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
              LK N     P  C ++   +   C N++  +RPS  D+
Sbjct: 260 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 300

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 129/281 (45%), Gaps = 35/281 (12%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+G FG+V    Y    +     VA+K+L   +++   +F+ EI +L  L++ ++V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 539 GYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           G C   G+  + L+ +Y+  G+LRD+L  +    +   + L+      + + YL T   K
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGT---K 151
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP-NFSKTHVSTQVKGSIGYLDPEYYRLQL 655
             IHRD+ T NIL++ E   K+ DFGL K  P +     V    +  I +  PE      
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 211
Query: 656 LTEKSDVYSFGVVLLEVLC-----ARPP---ILRTGDKKQVNLAVWATECYRNGKIGDII 707
            +  SDV+SFGVVL E+         PP   +   G+ KQ  + V+             +
Sbjct: 212 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------------L 259
Query: 708 DPFLKGNA----PPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
              LK N     P  C ++   +   C N++  +RPS  D+
Sbjct: 260 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 300

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 129/282 (45%), Gaps = 37/282 (13%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+G FG+V    Y    +     VA+K+L   +++   +F+ EI +L  L++ ++V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 539 GYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           G C   G+  + L+ +Y+  G+LRD+L  +    +   + L+      + + YL T   K
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGT---K 133
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS--IGYLDPEYYRLQ 654
             IHRD+ T NIL++ E   K+ DFGL K  P   K     +  G   I +  PE     
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESPIFWYAPESLTES 192
Query: 655 LLTEKSDVYSFGVVLLEVLC-----ARPP---ILRTGDKKQVNLAVWATECYRNGKIGDI 706
             +  SDV+SFGVVL E+         PP   +   G+ KQ  + V+             
Sbjct: 193 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------------ 240
Query: 707 IDPFLKGNA----PPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
           +   LK N     P  C ++   +   C N++  +RPS  D+
Sbjct: 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 128
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +T +     G++ YL PE
Sbjct: 129 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPE 181
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 123
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +T +     G++ YL PE
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLC----GTLDYLPPE 176
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 127
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +T +     G++ YL PE
Sbjct: 128 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPE 180
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 123
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +T +     G++ YL PE
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPE 176
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 123/277 (44%), Gaps = 32/277 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHRD
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 603 VKTTNILLDEEWVAKVSDFGLCKF--GPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKS 660
           +   N L+ E  + KV+DFGL +   G  F+        K  I +  PE       + KS
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTFT---AHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 661 DVYSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP 716
           DV++FGV+L E+    +   P I    D  QV                ++++   +   P
Sbjct: 192 DVWAFGVLLWEIATYGMSPYPGI----DPSQVY---------------ELLEKDYRMERP 232
Query: 717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
             C  +  E+  +C   +   RPS +++    E +FQ
Sbjct: 233 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 122
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +T +     G++ YL PE
Sbjct: 123 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPE 175
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 176 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 129/281 (45%), Gaps = 35/281 (12%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+G FG+V    Y    +     VA+K+L   +++   +F+ EI +L  L++ ++V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 539 GYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           G C   G+  + L+ +Y+  G+LRD+L  +    +   + L+      + + YL T   K
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER-IDHIKLLQYTSQICKGMEYLGT---K 136
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP-NFSKTHVSTQVKGSIGYLDPEYYRLQL 655
             IHRD+ T NIL++ E   K+ DFGL K  P +     V    +  I +  PE      
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 656 LTEKSDVYSFGVVLLEVLC-----ARPP---ILRTGDKKQVNLAVWATECYRNGKIGDII 707
            +  SDV+SFGVVL E+         PP   +   G+ KQ  + V+             +
Sbjct: 197 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------------L 244
Query: 708 DPFLKGNA----PPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
              LK N     P  C ++   +   C N++  +RPS  D+
Sbjct: 245 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 126
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +T +     G++ YL PE
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPE 179
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 28/275 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHRD
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTXT-AHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 663 YSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV 718
           ++FGV+L E+    +   P I    D  QV                ++++   +   P  
Sbjct: 201 WAFGVLLWEIATYGMSPYPGI----DLSQVY---------------ELLEKDYRMERPEG 241
Query: 719 CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           C  +  E+  +C   +   RPS +++    E +FQ
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 28/275 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHRD
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 663 YSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV 718
           ++FGV+L E+    +   P I    D  QV                ++++   +   P  
Sbjct: 201 WAFGVLLWEIATYGMSPYPGI----DLSQVY---------------ELLEKDYRMERPEG 241
Query: 719 CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           C  +  E+  +C   +   RPS +++    E +FQ
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 28/275 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHRD
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 663 YSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV 718
           ++FGV+L E+    +   P I    D  QV                ++++   +   P  
Sbjct: 196 WAFGVLLWEIATYGMSPYPGI----DLSQVY---------------ELLEKDYRMERPEG 236
Query: 719 CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           C  +  E+  +C   +   RPS +++    E +FQ
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 28/275 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHRD
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 663 YSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV 718
           ++FGV+L E+    +   P I    D  QV                ++++   +   P  
Sbjct: 196 WAFGVLLWEIATYGMSPYPGI----DLSQVY---------------ELLEKDYRMERPEG 236
Query: 719 CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           C  +  E+  +C   +   RPS +++    E +FQ
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 28/275 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHRD
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 663 YSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV 718
           ++FGV+L E+    +   P I    D  QV                ++++   +   P  
Sbjct: 196 WAFGVLLWEIATYGMSPYPGI----DLSQVY---------------ELLEKDYRMERPEG 236
Query: 719 CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           C  +  E+  +C   +   RPS +++    E +FQ
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 130/282 (46%), Gaps = 37/282 (13%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+G FG+V    Y    +     VA+K+L   +++   +F+ EI +L  L++ ++V   
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 539 GYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           G C   G+  + L+ +Y+  G+LRD+L  +    +   + L+      + + YL T   K
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGT---K 134
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS--IGYLDPEYYRLQ 654
             IHR++ T NIL++ E   K+ DFGL K  P   K +   +  G   I +  PE     
Sbjct: 135 RYIHRNLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFWYAPESLTES 193
Query: 655 LLTEKSDVYSFGVVLLEVLC-----ARPP---ILRTGDKKQVNLAVWATECYRNGKIGDI 706
             +  SDV+SFGVVL E+         PP   +   G+ KQ  + V+             
Sbjct: 194 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------------ 241
Query: 707 IDPFLKGNA----PPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
           +   LK N     P  C ++   +   C N++  +RPS  D+
Sbjct: 242 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 283

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 28/275 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHRD
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 137
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTGDTXT-AHAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 663 YSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV 718
           ++FGV+L E+    +   P I    D  QV                ++++   +   P  
Sbjct: 197 WAFGVLLWEIATYGMSPYPGI----DLSQVY---------------ELLEKDYRMERPEG 237
Query: 719 CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           C  +  E+  +C   +   RPS +++    E +FQ
Sbjct: 238 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 272

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 115/274 (41%), Gaps = 26/274 (9%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    +V +YM  G L D+L   +   +     L +    + A+ YL     K  IHRD
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIHRD 155
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  V KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 156 LAARNCLVGENHVVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDV 214
Query: 663 YSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG---NAPPVC 719
           ++FGV+L E+                  A +    Y    +  + D   KG     P  C
Sbjct: 215 WAFGVLLWEI------------------ATYGMSPYPGIDLSQVYDLLEKGYRMEQPEGC 256
Query: 720 LNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
             +  E+  +C       RPS ++     E +F 
Sbjct: 257 PPKVYELMRACWKWSPADRPSFAETHQAFETMFH 290

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 28/275 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHRD
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 663 YSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV 718
           ++FGV+L E+    +   P I    D  QV                ++++   +   P  
Sbjct: 201 WAFGVLLWEIATYGMSPYPGI----DLSQVY---------------ELLEKDYRMERPEG 241
Query: 719 CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           C  +  E+  +C   +   RPS +++    E +FQ
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 28/275 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHRD
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 663 YSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV 718
           ++FGV+L E+    +   P I    D  QV                ++++   +   P  
Sbjct: 196 WAFGVLLWEIATYGMSPYPGI----DLSQVY---------------ELLEKDYRMERPEG 236
Query: 719 CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           C  +  E+  +C   +   RPS +++    E +FQ
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 109/233 (46%), Gaps = 15/233 (6%)
Query: 452 GPASSLPSDLCTQFSISEIKE---ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL 508
            P ++   +L ++    E K+   A +DF     +G+G FGNVY          +A+K L
Sbjct: 8   APENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL 67
Query: 509 NPGSQQGA---LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYN 565
                + A    + + E+ + S LR+ +++ L GY +D  ++ L+ +Y   GT+   L  
Sbjct: 68  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 127
Query: 566 NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK 625
                    R        A AL Y H   SK +IHRD+K  N+LL      K++DFG   
Sbjct: 128 LSK--FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV 182
Query: 626 FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
             P+  +  +     G++ YL PE    ++  EK D++S GV+  E L  +PP
Sbjct: 183 HAPSSRRDDLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 137/295 (46%), Gaps = 41/295 (13%)
Query: 483 IGRGGFGNVYKGF---LNGDS----TPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V       L+ D     T VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD-------------RRLKIC 580
           +++L+G C  DG + ++ +Y ++G LR++L   + P L +              + L  C
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   ASK  IHRD+   N+L+ E+ V K++DFGL +   +      +T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV+L E       I   G      + V   E ++
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE-------IFTLGGSPYPGVPV--EELFK 263
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             K G  +D       P  C N+   +   C +    +RP+   +V  L+ +  L
Sbjct: 264 LLKEGHRMD------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 312

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 120
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +T +     G++ YL PE
Sbjct: 121 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPE 173
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 174 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 123
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +  +     G++ YL PE
Sbjct: 124 CH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDYLPPE 176
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 28/275 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHRD
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 663 YSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV 718
           ++FGV+L E+    +   P I    D  QV                ++++   +   P  
Sbjct: 201 WAFGVLLWEIATYGMSPYPGI----DLSQVY---------------ELLEKDYRMERPEG 241
Query: 719 CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           C  +  E+  +C   +   RPS +++    E +FQ
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 28/275 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHRD
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 140
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDV 199
Query: 663 YSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV 718
           ++FGV+L E+    +   P I    D  QV                ++++   +   P  
Sbjct: 200 WAFGVLLWEIATYGMSPYPGI----DLSQVY---------------ELLEKDYRMERPEG 240
Query: 719 CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           C  +  E+  +C   +   RPS +++    E +FQ
Sbjct: 241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 28/275 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHRD
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 663 YSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV 718
           ++FGV+L E+    +   P I    D  QV                ++++   +   P  
Sbjct: 201 WAFGVLLWEIATYGMSPYPGI----DLSQVY---------------ELLEKDYRMERPEG 241
Query: 719 CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           C  +  E+  +C   +   RPS +++    E +FQ
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 128
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +T +     G++ YL PE
Sbjct: 129 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPE 181
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               +   EK D++S GV+  E L  +PP
Sbjct: 182 XIEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 28/275 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHRD
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 149
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 150 LAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDV 208
Query: 663 YSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV 718
           ++FGV+L E+    +   P I    D  QV                ++++   +   P  
Sbjct: 209 WAFGVLLWEIATYGMSPYPGI----DLSQVY---------------ELLEKDYRMERPEG 249
Query: 719 CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           C  +  E+  +C   +   RPS +++    E +FQ
Sbjct: 250 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 284

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 28/275 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHR+
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRN 343
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 663 YSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV 718
           ++FGV+L E+    +   P I    D  QV                ++++   +   P  
Sbjct: 403 WAFGVLLWEIATYGMSPYPGI----DLSQVY---------------ELLEKDYRMERPEG 443
Query: 719 CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           C  +  E+  +C   +   RPS +++    E +FQ
Sbjct: 444 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 28/275 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHRD
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 663 YSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV 718
           ++FGV+L E+    +   P I    D  QV                ++++   +   P  
Sbjct: 196 WAFGVLLWEIATYGMSPYPGI----DLSQVY---------------ELLEKDYRMERPEG 236
Query: 719 CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           C  +  E+  +C   +   RPS +++    E +FQ
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 123/283 (43%), Gaps = 41/283 (14%)
Query: 483 IGRGGFGNVYKGFL-----NGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G FG V+           D   VA+K L   +     +FQ E  +L+ L++ H+V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNN--------DNPPLPWDRRLKICIGAARALHY 589
            G C D   +I+V++YM  G L   L  +        D  P    R+ K  +G ++ LH 
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP----RQAKGELGLSQMLHI 138
Query: 590 LHTGASKVI-------IHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS 642
               AS ++       +HRD+ T N L+    + K+ DFG+ +   +     V       
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 643 IGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNG 701
           I ++ PE    +  T +SDV+SFGV+L E+    + P  +  + + +       EC   G
Sbjct: 199 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI-------ECITQG 251
Query: 702 KIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
           ++ +          P VC  +  +V + C   +  +R ++ ++
Sbjct: 252 RVLE---------RPRVCPKEVYDVMLGCWQREPQQRLNIKEI 285

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 28/275 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHRD
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 663 YSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV 718
           ++FGV+L E+    +   P I    D  QV                ++++   +   P  
Sbjct: 198 WAFGVLLWEIATYGMSPYPGI----DLSQVY---------------ELLEKDYRMERPEG 238
Query: 719 CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           C  +  E+  +C   +   RPS +++    E +FQ
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 125
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +  +     G++ YL PE
Sbjct: 126 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPE 178
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 179 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 126
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +  +     G++ YL PE
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDYLPPE 179
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 28/275 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHRD
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 137
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTGDTYT-APAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 663 YSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV 718
           ++FGV+L E+    +   P I    D  QV                ++++   +   P  
Sbjct: 197 WAFGVLLWEIATYGMSPYPGI----DLSQVY---------------ELLEKDYRMERPEG 237
Query: 719 CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           C  +  E+  +C   +   RPS +++    E +FQ
Sbjct: 238 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 272

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 125
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K+++FG     P+  +T +     G++ YL PE
Sbjct: 126 CH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC----GTLDYLPPE 178
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 179 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 28/275 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHRD
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 663 YSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV 718
           ++FGV+L E+    +   P I    D  QV                ++++   +   P  
Sbjct: 198 WAFGVLLWEIATYGMSPYPGI----DLSQVY---------------ELLEKDYRMERPEG 238
Query: 719 CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           C  +  E+  +C   +   RPS +++    E +FQ
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 28/275 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHRD
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYT-APAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 663 YSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV 718
           ++FGV+L E+    +   P I    D  QV                ++++   +   P  
Sbjct: 198 WAFGVLLWEIATYGMSPYPGI----DLSQVY---------------ELLEKDYRMERPEG 238
Query: 719 CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           C  +  E+  +C   +   RPS +++    E +FQ
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 119/266 (44%), Gaps = 22/266 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           KD   L  +G G FG V  G   G    VAIK +  GS     EF  E  ++  L +  L
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKL 81
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           V L G C     + ++ +YMA G L ++L    +      + L++C     A+ YL    
Sbjct: 82  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE--- 137
Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
           SK  +HRD+   N L++++ V KVSDFGL ++  +  +T  S   K  + +  PE     
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETS-SVGSKFPVRWSPPEVLMYS 196
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             + KSD+++FGV++ E+                +L     E + N +  + I   L+  
Sbjct: 197 KFSSKSDIWAFGVLMWEI---------------YSLGKMPYERFTNSETAEHIAQGLRLY 241
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPS 740
            P +   +   +  SC ++    RP+
Sbjct: 242 RPHLASEKVYTIMYSCWHEKADERPT 267

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 136/295 (46%), Gaps = 41/295 (13%)
Query: 483 IGRGGFGNVYKGF---LNGDS----TPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V       L+ D     T VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD-------------RRLKIC 580
           +++L+G C  DG + ++ +Y ++G LR++L     P L +              + L  C
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   ASK  IHRD+   N+L+ E+ V K++DFGL +   +      +T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV+L E       I   G      + V   E ++
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE-------IFTLGGSPYPGVPV--EELFK 263
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             K G  +D       P  C N+   +   C +    +RP+   +V  L+ +  L
Sbjct: 264 LLKEGHRMD------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 312

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 123
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +  +     G++ YL PE
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDYLPPE 176
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 136/295 (46%), Gaps = 41/295 (13%)
Query: 483 IGRGGFGNVYKGF---LNGDS----TPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V       L+ D     T VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD-------------RRLKIC 580
           +++L+G C  DG + ++ +Y ++G LR++L     P L +              + L  C
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   ASK  IHRD+   N+L+ E+ V K++DFGL +   +      +T  
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV+L E       I   G      + V   E ++
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE-------IFTLGGSPYPGVPV--EELFK 304
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             K G  +D       P  C N+   +   C +    +RP+   +V  L+ +  L
Sbjct: 305 LLKEGHRMD------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 126
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K+++FG     P+  +T +     G++ YL PE
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC----GTLDYLPPE 179
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 123
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +  +     G++ YL PE
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPE 176
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 121/270 (44%), Gaps = 22/270 (8%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G+G FG V+ G  NG +T VAIK L PG+      F  E  ++ +LR+  LV L    +
Sbjct: 275 LGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V +YM++G+L D L       L   + + +    A  + Y+        +HRD
Sbjct: 333 EE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 388
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ E  V KV+DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 663 YSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQ 722
           +SFG++L E        L T  +      V       N ++ D ++   +   PP C   
Sbjct: 448 WSFGILLTE--------LTTKGRVPYPGMV-------NREVLDQVERGYRMPCPPECPES 492
Query: 723 FVEVAMSCVNDDRIRRPSMSDVVWGLEFVF 752
             ++   C   +   RP+   +   LE  F
Sbjct: 493 LHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 28/275 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHR+
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRN 382
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 383 LAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDV 441
Query: 663 YSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV 718
           ++FGV+L E+    +   P I    D  QV                ++++   +   P  
Sbjct: 442 WAFGVLLWEIATYGMSPYPGI----DLSQVY---------------ELLEKDYRMERPEG 482
Query: 719 CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           C  +  E+  +C   +   RPS +++    E +FQ
Sbjct: 483 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 517

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 136/295 (46%), Gaps = 41/295 (13%)
Query: 483 IGRGGFGNVYKGF---LNGDS----TPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V       L+ D     T VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD-------------RRLKIC 580
           +++L+G C  DG + ++ +Y ++G LR++L     P L +              + L  C
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   ASK  IHRD+   N+L+ E+ V K++DFGL +   +      +T  
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV+L E       I   G      + V   E ++
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE-------IFTLGGSPYPGVPV--EELFK 252
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             K G  +D       P  C N+   +   C +    +RP+   +V  L+ +  L
Sbjct: 253 LLKEGHRMD------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 301

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 124
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +  +     G++ YL PE
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC----GTLDYLPPE 177
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 136/295 (46%), Gaps = 41/295 (13%)
Query: 483 IGRGGFGNVYKGF---LNGDS----TPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V       L+ D     T VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD-------------RRLKIC 580
           +++L+G C  DG + ++ +Y ++G LR++L     P L +              + L  C
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   ASK  IHRD+   N+L+ E+ V K++DFGL +   +      +T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV+L E       I   G      + V   E ++
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE-------IFTLGGSPYPGVPV--EELFK 263
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             K G  +D       P  C N+   +   C +    +RP+   +V  L+ +  L
Sbjct: 264 LLKEGHRMD------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 312

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 126
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +  +     G++ YL PE
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPE 179
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 121/274 (44%), Gaps = 34/274 (12%)
Query: 482 IIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           IIG G  G V  G L        PVAIK L  G +++   +F +E  ++ Q  + +++ L
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G        ++V +YM  G+L   L  +D       + + +  G    + YL   +   
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKF---GPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
            +HRD+   N+L+D   V KVSDFGL +     P+ + T  +T  K  I +  PE    +
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXT--TTGGKIPIRWTAPEAIAFR 229
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG- 713
             +  SDV+SFGVV+ EVL                   +    Y N    D+I    +G 
Sbjct: 230 TFSSASDVWSFGVVMWEVLA------------------YGERPYWNMTNRDVISSVEEGY 271
Query: 714 --NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
              AP  C +   ++ + C + DR +RP  S +V
Sbjct: 272 RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIV 305

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 129/281 (45%), Gaps = 35/281 (12%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+G FG+V    Y    +     VA+K+L   +++   +F+ EI +L  L++ ++V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 539 GYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           G C   G+  + L+ +++  G+LR++L  +    +   + L+      + + YL T   K
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER-IDHIKLLQYTSQICKGMEYLGT---K 136
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP-NFSKTHVSTQVKGSIGYLDPEYYRLQL 655
             IHRD+ T NIL++ E   K+ DFGL K  P +     V    +  I +  PE      
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 656 LTEKSDVYSFGVVLLEVLC-----ARPP---ILRTGDKKQVNLAVWATECYRNGKIGDII 707
            +  SDV+SFGVVL E+         PP   +   G+ KQ  + V+             +
Sbjct: 197 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------------L 244
Query: 708 DPFLKGNA----PPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
              LK N     P  C ++   +   C N++  +RPS  D+
Sbjct: 245 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 136/295 (46%), Gaps = 41/295 (13%)
Query: 483 IGRGGFGNVYKGF---LNGDS----TPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V       L+ D     T VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD-------------RRLKIC 580
           +++L+G C  DG + ++ +Y ++G LR++L     P L +              + L  C
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   ASK  IHRD+   N+L+ E+ V K++DFGL +   +      +T  
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV+L E       I   G      + V   E ++
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE-------IFTLGGSPYPGVPV--EELFK 256
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             K G  +D       P  C N+   +   C +    +RP+   +V  L+ +  L
Sbjct: 257 LLKEGHRMD------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 305

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQL 529
           A +DF     +G+G FGNVY          +A+K L     + A    + + E+ + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           R+ +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 126
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H   SK +IHRD+K  N+LL      K++DFG     P+  +  +     G++ YL PE
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLDYLPPE 179
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               ++  EK D++S GV+  E L  +PP
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 117/258 (45%), Gaps = 22/258 (8%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G+G FG V+ G  NG +T VAIK L PG+      F  E  ++ +LR+  LV L    +
Sbjct: 26  LGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V +YM++G+L D L       L   + + +    A  + Y+        +HRD
Sbjct: 84  EE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ E  V KV+DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEXT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 663 YSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQ 722
           +SFG++L E        L T  +      V       N ++ D ++   +   PP C   
Sbjct: 199 WSFGILLTE--------LTTKGRVPYPGMV-------NREVLDQVERGYRMPCPPECPES 243
Query: 723 FVEVAMSCVNDDRIRRPS 740
             ++   C   D   RP+
Sbjct: 244 LHDLMCQCWRKDPEERPT 261

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 97/190 (51%), Gaps = 7/190 (3%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G+G FG V+ G  NG +T VAIK L PG+      F  E  ++ +LR+  LV L    +
Sbjct: 16  LGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V +YM++G+L D L       L   + + +    A  + Y+        +HRD
Sbjct: 74  EE-PIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 129
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ E  V KV+DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIEDNEXT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 188
Query: 663 YSFGVVLLEV 672
           +SFG++L E+
Sbjct: 189 WSFGILLTEL 198

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 136/295 (46%), Gaps = 41/295 (13%)
Query: 483 IGRGGFGNVYKGF---LNGDS----TPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V       L+ D     T VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD-------------RRLKIC 580
           +++L+G C  DG + ++ +Y ++G LR++L     P L +              + L  C
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   ASK  IHRD+   N+L+ E+ V K++DFGL +   +      +T  
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV+L E       I   G      + V   E ++
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE-------IFTLGGSPYPGVPV--EELFK 255
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             K G  +D       P  C N+   +   C +    +RP+   +V  L+ +  L
Sbjct: 256 LLKEGHRMD------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 304

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 119/272 (43%), Gaps = 30/272 (11%)
Query: 482 IIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           IIG G  G V  G L        PVAIK L  G +++   +F +E  ++ Q  + +++ L
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G        ++V +YM  G+L   L  +D       + + +  G    + YL   +   
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
            +HRD+   N+L+D   V KVSDFGL +    +    + +T  K  I +  PE    +  
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF 231
Query: 657 TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG--- 713
           +  SDV+SFGVV+ EVL                   +    Y N    D+I    +G   
Sbjct: 232 SSASDVWSFGVVMWEVLA------------------YGERPYWNMTNRDVISSVEEGYRL 273
Query: 714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
            AP  C +   ++ + C + DR +RP  S +V
Sbjct: 274 PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIV 305

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 117/258 (45%), Gaps = 22/258 (8%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G+G FG V+ G  NG +T VAIK L PG+      F  E  ++ +LR+  LV L    +
Sbjct: 17  LGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V +YM++G+L D L       L   + + +    A  + Y+        +HRD
Sbjct: 75  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 130
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ E  V KV+DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 131 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 663 YSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQ 722
           +SFG++L E        L T  +      V       N ++ D ++   +   PP C   
Sbjct: 190 WSFGILLTE--------LTTKGRVPYPGMV-------NREVLDQVERGYRMPCPPECPES 234
Query: 723 FVEVAMSCVNDDRIRRPS 740
             ++   C   D   RP+
Sbjct: 235 LHDLMCQCWRKDPEERPT 252

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 134/295 (45%), Gaps = 41/295 (13%)
Query: 483 IGRGGFGNVYKGFLNG-------DSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V      G       ++  VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD-------------RRLKIC 580
           +++L+G C  DG + ++ +Y ++G LR++L     P + +              + L  C
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   AS+  IHRD+   N+L+ E  V K++DFGL +   N      +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV++ E       I   G      + V   E ++
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYPGIPV--EELFK 270
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             K G  +D       P  C N+   +   C +    +RP+   +V  L+ +  L
Sbjct: 271 LLKEGHRMD------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 117/258 (45%), Gaps = 22/258 (8%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G+G FG V+ G  NG +T VAIK L PG+      F  E  ++ +LR+  LV L    +
Sbjct: 15  LGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V +YM++G+L D L       L   + + +    A  + Y+        +HRD
Sbjct: 73  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 128
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ E  V KV+DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 129 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 187
Query: 663 YSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQ 722
           +SFG++L E        L T  +      V       N ++ D ++   +   PP C   
Sbjct: 188 WSFGILLTE--------LTTKGRVPYPGMV-------NREVLDQVERGYRMPCPPECPES 232
Query: 723 FVEVAMSCVNDDRIRRPS 740
             ++   C   D   RP+
Sbjct: 233 LHDLMCQCWRKDPEERPT 250

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 136/295 (46%), Gaps = 41/295 (13%)
Query: 483 IGRGGFGNVYKGF---LNGDS----TPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V       L+ D     T VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPW-------------DRRLKIC 580
           +++L+G C  DG + ++ +Y ++G LR++L     P L +              + L  C
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   ASK  IHRD+   N+L+ E+ V K++DFGL +   +      +T  
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV+L E       I   G      + V   E ++
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE-------IFTLGGSPYPGVPV--EELFK 248
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             K G  +D       P  C N+   +   C +    +RP+   +V  L+ +  L
Sbjct: 249 LLKEGHRMD------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 117/258 (45%), Gaps = 22/258 (8%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G+G FG V+ G  NG +T VAIK L PG+      F  E  ++ +LR+  LV L    +
Sbjct: 26  LGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V +YM++G+L D L       L   + + +    A  + Y+        +HRD
Sbjct: 84  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ E  V KV+DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 663 YSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQ 722
           +SFG++L E        L T  +      V       N ++ D ++   +   PP C   
Sbjct: 199 WSFGILLTE--------LTTKGRVPYPGMV-------NREVLDQVERGYRMPCPPECPES 243
Query: 723 FVEVAMSCVNDDRIRRPS 740
             ++   C   D   RP+
Sbjct: 244 LHDLMCQCWRKDPEERPT 261

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 121/270 (44%), Gaps = 22/270 (8%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G+G FG V+ G  NG +T VAIK L PG+      F  E  ++ +LR+  LV L    +
Sbjct: 192 LGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V +YM++G+L D L       L   + + +    A  + Y+        +HRD
Sbjct: 250 EE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ E  V KV+DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 663 YSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQ 722
           +SFG++L E L  +  +   G                N ++ D ++   +   PP C   
Sbjct: 365 WSFGILLTE-LTTKGRVPYPG--------------MVNREVLDQVERGYRMPCPPECPES 409
Query: 723 FVEVAMSCVNDDRIRRPSMSDVVWGLEFVF 752
             ++   C   +   RP+   +   LE  F
Sbjct: 410 LHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 121/270 (44%), Gaps = 22/270 (8%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G+G FG V+ G  NG +T VAIK L PG+      F  E  ++ +LR+  LV L    +
Sbjct: 192 LGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V +YM++G+L D L       L   + + +    A  + Y+        +HRD
Sbjct: 250 EE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ E  V KV+DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 663 YSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQ 722
           +SFG++L E L  +  +   G                N ++ D ++   +   PP C   
Sbjct: 365 WSFGILLTE-LTTKGRVPYPG--------------MVNREVLDQVERGYRMPCPPECPES 409
Query: 723 FVEVAMSCVNDDRIRRPSMSDVVWGLEFVF 752
             ++   C   +   RP+   +   LE  F
Sbjct: 410 LHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 117/258 (45%), Gaps = 22/258 (8%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G+G FG V+ G  NG +T VAIK L PG+      F  E  ++ +LR+  LV L    +
Sbjct: 26  LGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V +YM++G+L D L       L   + + +    A  + Y+        +HRD
Sbjct: 84  EE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ E  V KV+DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 663 YSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQ 722
           +SFG++L E        L T  +      V       N ++ D ++   +   PP C   
Sbjct: 199 WSFGILLTE--------LTTKGRVPYPGMV-------NREVLDQVERGYRMPCPPECPES 243
Query: 723 FVEVAMSCVNDDRIRRPS 740
             ++   C   D   RP+
Sbjct: 244 LHDLMCQCWRKDPEERPT 261

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 136/295 (46%), Gaps = 41/295 (13%)
Query: 483 IGRGGFGNVYKGF---LNGDS----TPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V       L+ D     T VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPW-------------DRRLKIC 580
           +++L+G C  DG + ++ +Y ++G LR++L     P L +              + L  C
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   ASK  IHRD+   N+L+ E+ V K++DFGL +   +      +T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV+L E       I   G      + V   E ++
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE-------IFTLGGSPYPGVPV--EELFK 263
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             K G  +D       P  C N+   +   C +    +RP+   +V  L+ +  L
Sbjct: 264 LLKEGHRMD------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 312

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 118/266 (44%), Gaps = 22/266 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           KD   L  +G G FG V  G   G    VAIK +  GS     EF  E  ++  L +  L
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKL 81
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           V L G C     + ++ +YMA G L ++L    +      + L++C     A+ YL    
Sbjct: 82  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE--- 137
Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
           SK  +HRD+   N L++++ V KVSDFGL ++  +   T  S   K  + +  PE     
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYS 196
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             + KSD+++FGV++ E+                +L     E + N +  + I   L+  
Sbjct: 197 KFSSKSDIWAFGVLMWEI---------------YSLGKMPYERFTNSETAEHIAQGLRLY 241
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPS 740
            P +   +   +  SC ++    RP+
Sbjct: 242 RPHLASEKVYTIMYSCWHEKADERPT 267

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 117/258 (45%), Gaps = 22/258 (8%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G+G FG V+ G  NG +T VAIK L PG+      F  E  ++ +LR+  LV L    +
Sbjct: 26  LGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V +YM++G+L D L       L   + + +    A  + Y+        +HRD
Sbjct: 84  EE-PIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ E  V KV+DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 663 YSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQ 722
           +SFG++L E        L T  +      V       N ++ D ++   +   PP C   
Sbjct: 199 WSFGILLTE--------LTTKGRVPYPGMV-------NREVLDQVERGYRMPCPPECPES 243
Query: 723 FVEVAMSCVNDDRIRRPS 740
             ++   C   D   RP+
Sbjct: 244 LHDLMCQCWRKDPEERPT 261

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 114/252 (45%), Gaps = 25/252 (9%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL-NPGSQQGALEFQ--TEIGMLSQLRY 531
           +DF+    +G+G FGNVY          +A+K L     ++  +E Q   E+ + S LR+
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
            +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y H
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR--FDEQRTATYITELANALSYCH 129
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
              SK +IHRD+K  N+LL      K++DFG     P+  +T +     G++ YL PE  
Sbjct: 130 ---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMI 182
Query: 652 RLQLLTEKSDVYSFGVVLLEVLCARPPI--------LRTGDKKQVNLAVWATECYRNGKI 703
             ++  EK D++S GV+  E L   PP          R   + +     + TE  R    
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGAR---- 238
Query: 704 GDIIDPFLKGNA 715
            D+I   LK NA
Sbjct: 239 -DLISRLLKHNA 249

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 118/266 (44%), Gaps = 22/266 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           KD   L  +G G FG V  G   G    VAIK +  GS     EF  E  ++  L +  L
Sbjct: 8   KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKL 65
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           V L G C     + ++ +YMA G L ++L    +      + L++C     A+ YL    
Sbjct: 66  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE--- 121
Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
           SK  +HRD+   N L++++ V KVSDFGL ++  +   T  S   K  + +  PE     
Sbjct: 122 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYS 180
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             + KSD+++FGV++ E+                +L     E + N +  + I   L+  
Sbjct: 181 KFSSKSDIWAFGVLMWEI---------------YSLGKMPYERFTNSETAEHIAQGLRLY 225
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPS 740
            P +   +   +  SC ++    RP+
Sbjct: 226 RPHLASEKVYTIMYSCWHEKADERPT 251

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 116/258 (44%), Gaps = 22/258 (8%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G+G FG V+ G  NG +T VAIK L PG+      F  E  ++ +LR+  LV L    +
Sbjct: 26  LGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V +YM++G L D L       L   + + +    A  + Y+        +HRD
Sbjct: 84  EE-PIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ E  V KV+DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 663 YSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQ 722
           +SFG++L E        L T  +      V       N ++ D ++   +   PP C   
Sbjct: 199 WSFGILLTE--------LTTKGRVPYPGMV-------NREVLDQVERGYRMPCPPECPES 243
Query: 723 FVEVAMSCVNDDRIRRPS 740
             ++   C   D   RP+
Sbjct: 244 LHDLMCQCWRKDPEERPT 261

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 134/295 (45%), Gaps = 41/295 (13%)
Query: 483 IGRGGFGNVYKGFLNG-------DSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V      G       ++  VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD-------------RRLKIC 580
           +++L+G C  DG + ++ +Y ++G LR++L     P + +              + L  C
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   AS+  IHRD+   N+L+ E  V K++DFGL +   N      +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV++ E       I   G      + V   E ++
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYPGIPV--EELFK 270
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             K G  +D       P  C N+   +   C +    +RP+   +V  L+ +  L
Sbjct: 271 LLKEGHRMD------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 118/266 (44%), Gaps = 22/266 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           KD   L  +G G FG V  G   G    VAIK +  GS     EF  E  ++  L +  L
Sbjct: 15  KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKL 72
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           V L G C     + ++ +YMA G L ++L    +      + L++C     A+ YL    
Sbjct: 73  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE--- 128
Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
           SK  +HRD+   N L++++ V KVSDFGL ++  +   T  S   K  + +  PE     
Sbjct: 129 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYS 187
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             + KSD+++FGV++ E+                +L     E + N +  + I   L+  
Sbjct: 188 KFSSKSDIWAFGVLMWEI---------------YSLGKMPYERFTNSETAEHIAQGLRLY 232
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPS 740
            P +   +   +  SC ++    RP+
Sbjct: 233 RPHLASEKVYTIMYSCWHEKADERPT 258

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 72/258 (27%), Positives = 117/258 (45%), Gaps = 22/258 (8%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G+G FG V+ G  NG +T VAIK L PG+      F  E  ++ +LR+  LV L    +
Sbjct: 192 LGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V +YM++G+L D L       L   + + +    A  + Y+        +HRD
Sbjct: 250 EE-PIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ E  V KV+DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 663 YSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQ 722
           +SFG++L E L  +  +   G                N ++ D ++   +   PP C   
Sbjct: 365 WSFGILLTE-LTTKGRVPYPG--------------MVNREVLDQVERGYRMPCPPECPES 409
Query: 723 FVEVAMSCVNDDRIRRPS 740
             ++   C   +   RP+
Sbjct: 410 LHDLMCQCWRKEPEERPT 427

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 73/258 (28%), Positives = 117/258 (45%), Gaps = 22/258 (8%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G+G FG V+ G  NG +T VAIK L PG+      F  E  ++ +LR+  LV L    +
Sbjct: 193 LGQGCFGEVWMGTWNG-TTRVAIKTLKPGNMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V +YM++G+L D L       L   + + +    A  + Y+        +HRD
Sbjct: 251 EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 306
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ E  V KV+DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 365
Query: 663 YSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQ 722
           +SFG++L E L  +  +   G                N ++ D ++   +   PP C   
Sbjct: 366 WSFGILLTE-LTTKGRVPYPG--------------MVNREVLDQVERGYRMPCPPECPES 410
Query: 723 FVEVAMSCVNDDRIRRPS 740
             ++   C   D   RP+
Sbjct: 411 LHDLMCQCWRKDPEERPT 428

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 73/258 (28%), Positives = 117/258 (45%), Gaps = 22/258 (8%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G+G FG V+ G  NG +T VAIK L PG+      F  E  ++ +LR+  LV L    +
Sbjct: 19  LGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V +YM++G+L D L       L   + + +    A  + Y+        +HRD
Sbjct: 77  EE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 132
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ E  V KV+DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 191
Query: 663 YSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQ 722
           +SFG++L E        L T  +      V       N ++ D ++   +   PP C   
Sbjct: 192 WSFGILLTE--------LTTKGRVPYPGMV-------NREVLDQVERGYRMPCPPECPES 236
Query: 723 FVEVAMSCVNDDRIRRPS 740
             ++   C   +   RP+
Sbjct: 237 LHDLMCQCWRKEPEERPT 254

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 116/258 (44%), Gaps = 22/258 (8%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G+G FG V+ G  NG +T VAIK L PG+      F  E  ++ +LR+  LV L    +
Sbjct: 26  LGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V +YM++G L D L       L   + + +    A  + Y+        +HRD
Sbjct: 84  EE-PIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ E  V KV+DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 663 YSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQ 722
           +SFG++L E        L T  +      V       N ++ D ++   +   PP C   
Sbjct: 199 WSFGILLTE--------LTTKGRVPYPGMV-------NREVLDQVERGYRMPCPPECPES 243
Query: 723 FVEVAMSCVNDDRIRRPS 740
             ++   C   D   RP+
Sbjct: 244 LHDLMCQCWRKDPEERPT 261

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 118/266 (44%), Gaps = 22/266 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           KD   L  +G G FG V  G   G    VAIK +  GS     EF  E  ++  L +  L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKL 61
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           V L G C     + ++ +YMA G L ++L    +      + L++C     A+ YL    
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE--- 117
Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
           SK  +HRD+   N L++++ V KVSDFGL ++  +   T  S   K  + +  PE     
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYS 176
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             + KSD+++FGV++ E+                +L     E + N +  + I   L+  
Sbjct: 177 KFSSKSDIWAFGVLMWEI---------------YSLGKMPYERFTNSETAEHIAQGLRLY 221
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPS 740
            P +   +   +  SC ++    RP+
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPT 247

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 121/274 (44%), Gaps = 28/274 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHRD
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSDV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 663 YSFGVVLLEV----LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV 718
           ++FGV+L E+    +   P I    D  QV                ++++   +   P  
Sbjct: 196 WAFGVLLWEIATYGMSPYPGI----DLSQVY---------------ELLEKDYRMERPEG 236
Query: 719 CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF 752
           C  +  E+  +C   +   RPS +++    E +F
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 118/266 (44%), Gaps = 22/266 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           KD   L  +G G FG V  G   G    VAIK +  GS     EF  E  ++  L +  L
Sbjct: 9   KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKL 66
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           V L G C     + ++ +YMA G L ++L    +      + L++C     A+ YL    
Sbjct: 67  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE--- 122
Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
           SK  +HRD+   N L++++ V KVSDFGL ++  +   T  S   K  + +  PE     
Sbjct: 123 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYS 181
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             + KSD+++FGV++ E+                +L     E + N +  + I   L+  
Sbjct: 182 KFSSKSDIWAFGVLMWEI---------------YSLGKMPYERFTNSETAEHIAQGLRLY 226
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPS 740
            P +   +   +  SC ++    RP+
Sbjct: 227 RPHLASEKVYTIMYSCWHEKADERPT 252

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 38/281 (13%)
Query: 483 IGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G FG V+    +      D   VA+K L   S+    +FQ E  +L+ L++ H+V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNP-------------PLPWDRRLKICIGAA 584
            G C +   +++V++YM  G L   L ++                PL   + L +    A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 585 RALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG 644
             + YL   A    +HRD+ T N L+ +  V K+ DFG+ +   +     V  +    I 
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKI 703
           ++ PE    +  T +SDV+SFGVVL E+    + P  +  + + ++      E  R    
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELER---- 281
Query: 704 GDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
                       P  C  +   +   C   +  +R S+ DV
Sbjct: 282 ------------PRACPPEVYAIMRGCWQREPQQRHSIKDV 310

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 73/258 (28%), Positives = 117/258 (45%), Gaps = 22/258 (8%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G+G FG V+ G  NG +T VAIK L PG+      F  E  ++ ++R+  LV L    +
Sbjct: 26  LGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V +YM++G+L D L       L   + + +    A  + Y+        +HRD
Sbjct: 84  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ E  V KV+DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 663 YSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQ 722
           +SFG++L E        L T  +      V       N ++ D ++   +   PP C   
Sbjct: 199 WSFGILLTE--------LTTKGRVPYPGMV-------NREVLDQVERGYRMPCPPECPES 243
Query: 723 FVEVAMSCVNDDRIRRPS 740
             ++   C   D   RP+
Sbjct: 244 LHDLMCQCWRKDPEERPT 261

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 134/295 (45%), Gaps = 41/295 (13%)
Query: 483 IGRGGFGNVYKGFLNG-------DSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V      G       ++  VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD-------------RRLKIC 580
           +++L+G C  DG + ++ +Y ++G LR++L     P + +              + L  C
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   AS+  IHRD+   N+L+ E  V K++DFGL +   N      +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV++ E       I   G      + V   E ++
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYPGIPV--EELFK 270
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             K G  +D       P  C N+   +   C +    +RP+   +V  L+ +  L
Sbjct: 271 LLKEGHRMD------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 116/258 (44%), Gaps = 22/258 (8%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G+G FG V+ G  NG +T VAIK L PG+      F  E  ++ +LR+  LV L    +
Sbjct: 26  LGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V +YM++G+L D L       L   + + +    A  + Y+        +HRD
Sbjct: 84  EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   NIL+ E  V KV+DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 140 LAAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 663 YSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQ 722
           +SFG++L E        L T  +      V       N ++ D ++   +   PP C   
Sbjct: 199 WSFGILLTE--------LTTKGRVPYPGMV-------NREVLDQVERGYRMPCPPECPES 243
Query: 723 FVEVAMSCVNDDRIRRPS 740
             ++   C   D   RP+
Sbjct: 244 LHDLMCQCWRKDPEERPT 261

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 135/295 (45%), Gaps = 41/295 (13%)
Query: 483 IGRGGFGNVYKGFLNG-------DSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V      G       ++  VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLP--WD-----------RRLKIC 580
           +++L+G C  DG + ++ +Y ++G LR++L     P +   +D           + L  C
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   AS+  IHRD+   N+L+ E  V K++DFGL +   N      +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV++ E       I   G      + V   E ++
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYPGIPV--EELFK 270
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             K G  +D       P  C N+   +   C +    +RP+   +V  L+ +  L
Sbjct: 271 LLKEGHRMD------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 118/266 (44%), Gaps = 22/266 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           KD   L  +G G FG V  G   G    VAIK +  GS     EF  E  ++  L +  L
Sbjct: 9   KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKL 66
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           V L G C     + ++ +YMA G L ++L    +      + L++C     A+ YL    
Sbjct: 67  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE--- 122
Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
           SK  +HRD+   N L++++ V KVSDFGL ++  +   T  S   K  + +  PE     
Sbjct: 123 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SRGSKFPVRWSPPEVLMYS 181
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             + KSD+++FGV++ E+                +L     E + N +  + I   L+  
Sbjct: 182 KFSSKSDIWAFGVLMWEI---------------YSLGKMPYERFTNSETAEHIAQGLRLY 226
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPS 740
            P +   +   +  SC ++    RP+
Sbjct: 227 RPHLASEKVYTIMYSCWHEKADERPT 252

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 134/295 (45%), Gaps = 41/295 (13%)
Query: 483 IGRGGFGNVYKGFLNG-------DSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V      G       ++  VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD-------------RRLKIC 580
           +++L+G C  DG + ++ +Y ++G LR++L     P + +              + L  C
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   AS+  IHRD+   N+L+ E  V K++DFGL +   N      +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV++ E       I   G      + V   E ++
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYPGIPV--EELFK 270
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             K G  +D       P  C N+   +   C +    +RP+   +V  L+ +  L
Sbjct: 271 LLKEGHRMD------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 93/191 (48%), Gaps = 17/191 (8%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+    N   T VA+K + PGS      F  E  ++  L++  LV L     
Sbjct: 190 LGAGQFGEVWMATYN-KHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT 247
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ ++MA+G+L D L +++    P  + +      A  + ++     +  IHRD
Sbjct: 248 KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRD 303
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+    V K++DFGL + G  F            I +  PE       T KSDV
Sbjct: 304 LRAANILVSASLVCKIADFGLARVGAKF-----------PIKWTAPEAINFGSFTIKSDV 352
Query: 663 YSFGVVLLEVL 673
           +SFG++L+E++
Sbjct: 353 WSFGILLMEIV 363

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 133/295 (45%), Gaps = 41/295 (13%)
Query: 483 IGRGGFGNVYKGFLNG-------DSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V      G       ++  VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD-------------RRLKIC 580
           ++ L+G C  DG + ++ +Y ++G LR++L     P + +              + L  C
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   AS+  IHRD+   N+L+ E  V K++DFGL +   N      +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV++ E       I   G      + V   E ++
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYPGIPV--EELFK 270
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             K G  +D       P  C N+   +   C +    +RP+   +V  L+ +  L
Sbjct: 271 LLKEGHRMD------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 134/295 (45%), Gaps = 41/295 (13%)
Query: 483 IGRGGFGNVYKGFLNG-------DSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V      G       ++  VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD-------------RRLKIC 580
           +++L+G C  DG + ++ +Y ++G LR++L     P + +              + L  C
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   AS+  IHRD+   N+L+ E  V K++DFGL +   N      +T  
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV++ E       I   G      + V   E ++
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYPGIPV--EELFK 316
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             K G  +D       P  C N+   +   C +    +RP+   +V  L+ +  L
Sbjct: 317 LLKEGHRMD------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 133/301 (44%), Gaps = 39/301 (12%)
Query: 453 PASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRL 508
           P+ + P+    Q  +  +KE   +   + ++G G FG VYKG     G++   PVAIK L
Sbjct: 22  PSGTAPN----QAQLRILKET--ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL 75
Query: 509 NPGSQQGA-LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NN 566
           N  +   A +EF  E  +++ + + HLV L+G C     + LV   M  G L ++++ + 
Sbjct: 76  NETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLEYVHEHK 134
Query: 567 DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF 626
           DN  +     L  C+  A+ + YL     + ++HRD+   N+L+      K++DFGL + 
Sbjct: 135 DN--IGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARL 189
Query: 627 GPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKK 686
                K + +   K  I ++  E    +  T +SDV+S+GV + E               
Sbjct: 190 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWE--------------- 234
Query: 687 QVNLAVWATECYRNGKIGDIIDPFLKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSD 743
              L  +  + Y      +I D   KG     PP+C      V + C   D   RP   +
Sbjct: 235 ---LMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKE 291
Query: 744 V 744
           +
Sbjct: 292 L 292

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 119/281 (42%), Gaps = 38/281 (13%)
Query: 483 IGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G FG V+    +      D   VA+K L   S+    +FQ E  +L+ L++ H+V  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNP-------------PLPWDRRLKICIGAA 584
            G C +   +++V++YM  G L   L ++                PL   + L +    A
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 585 RALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG 644
             + YL   A    +HRD+ T N L+ +  V K+ DFG+ +   +     V  +    I 
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKI 703
           ++ PE    +  T +SDV+SFGVVL E+    + P  +  + +       A +C   G+ 
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-------AIDCITQGR- 248
Query: 704 GDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
                   +   P  C  +   +   C   +  +R S+ DV
Sbjct: 249 --------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 281

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 119/281 (42%), Gaps = 38/281 (13%)
Query: 483 IGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G FG V+    +      D   VA+K L   S+    +FQ E  +L+ L++ H+V  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNP-------------PLPWDRRLKICIGAA 584
            G C +   +++V++YM  G L   L ++                PL   + L +    A
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 585 RALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG 644
             + YL   A    +HRD+ T N L+ +  V K+ DFG+ +   +     V  +    I 
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKI 703
           ++ PE    +  T +SDV+SFGVVL E+    + P  +  + +       A +C   G+ 
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-------AIDCITQGR- 254
Query: 704 GDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
                   +   P  C  +   +   C   +  +R S+ DV
Sbjct: 255 --------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 287

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 134/295 (45%), Gaps = 41/295 (13%)
Query: 483 IGRGGFGNVYKGFLNG-------DSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V      G       ++  VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD-------------RRLKIC 580
           +++L+G C  DG + ++ +Y ++G LR++L     P + +              + L  C
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   AS+  IHRD+   N+L+ E  V K++DFGL +   N      +T  
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV++ E       I   G      + V   E ++
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYPGIPV--EELFK 259
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             K G  +D       P  C N+   +   C +    +RP+   +V  L+ +  L
Sbjct: 260 LLKEGHRMD------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 308

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 134/295 (45%), Gaps = 41/295 (13%)
Query: 483 IGRGGFGNVYKGFLNG-------DSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V      G       ++  VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD-------------RRLKIC 580
           +++L+G C  DG + ++ +Y ++G LR++L     P + +              + L  C
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   AS+  IHRD+   N+L+ E  V K++DFGL +   N      +T  
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV++ E       I   G      + V   E ++
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYPGIPV--EELFK 257
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             K G  +D       P  C N+   +   C +    +RP+   +V  L+ +  L
Sbjct: 258 LLKEGHRMD------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 306

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 134/295 (45%), Gaps = 41/295 (13%)
Query: 483 IGRGGFGNVYKGFLNG-------DSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V      G       ++  VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD-------------RRLKIC 580
           +++L+G C  DG + ++ +Y ++G LR++L     P + +              + L  C
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   AS+  IHRD+   N+L+ E  V K++DFGL +   N      +T  
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV++ E       I   G      + V   E ++
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYPGIPV--EELFK 262
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             K G  +D       P  C N+   +   C +    +RP+   +V  L+ +  L
Sbjct: 263 LLKEGHRMD------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 311

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 9/199 (4%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRL--NPGSQQGALE-FQTEIGMLSQLRYLHLVSLIG 539
           +G GG   VY       +  VAIK +   P  ++  L+ F+ E+   SQL + ++VS+I 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
              +D    LV +Y+   TL +  Y   + PL  D  +         + + H      I+
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSE--YIESHGPLSVDTAINFTNQILDGIKHAHDMR---IV 133
Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEK 659
           HRD+K  NIL+D     K+ DFG+ K     S T  +  V G++ Y  PE  + +   E 
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGEATDEC 192
Query: 660 SDVYSFGVVLLEVLCARPP 678
           +D+YS G+VL E+L   PP
Sbjct: 193 TDIYSIGIVLYEMLVGEPP 211

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 134/295 (45%), Gaps = 41/295 (13%)
Query: 483 IGRGGFGNVYKGFLNG-------DSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V      G       ++  VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD-------------RRLKIC 580
           +++L+G C  DG + ++ +Y ++G LR++L     P + +              + L  C
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   AS+  IHRD+   N+L+ E  V +++DFGL +   N      +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV++ E       I   G      + V   E ++
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYPGIPV--EELFK 270
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             K G  +D       P  C N+   +   C +    +RP+   +V  L+ +  L
Sbjct: 271 LLKEGHRMD------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 96/190 (50%), Gaps = 7/190 (3%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G+G FG V+ G  NG +T VAIK L PG+      F  E  ++ +LR+  LV L    +
Sbjct: 23  LGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V +YM +G+L D L       L   + + +    A  + Y+        +HRD
Sbjct: 81  EE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRD 136
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ E  V KV+DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 663 YSFGVVLLEV 672
           +SFG++L E+
Sbjct: 196 WSFGILLTEL 205

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 96/190 (50%), Gaps = 7/190 (3%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G+G FG V+ G  NG +T VAIK L PG+      F  E  ++ +LR+  LV L    +
Sbjct: 23  LGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V +YM +G+L D L       L   + + +    A  + Y+        +HRD
Sbjct: 81  EE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRD 136
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ E  V KV+DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEWT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 663 YSFGVVLLEV 672
           +SFG++L E+
Sbjct: 196 WSFGILLTEL 205

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 133/295 (45%), Gaps = 41/295 (13%)
Query: 483 IGRGGFGNVYKGFLNG-------DSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V      G       ++  VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD-------------RRLKIC 580
           +++L+G C  DG + ++  Y ++G LR++L     P + +              + L  C
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   AS+  IHRD+   N+L+ E  V K++DFGL +   N      +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV++ E       I   G      + V   E ++
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYPGIPV--EELFK 270
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             K G  +D       P  C N+   +   C +    +RP+   +V  L+ +  L
Sbjct: 271 LLKEGHRMD------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 133/295 (45%), Gaps = 41/295 (13%)
Query: 483 IGRGGFGNVYKGFLNG-------DSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQL-RYLH 533
           +G G FG V      G       ++  VA+K L   + +  L +  +E+ M+  + ++ +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD-------------RRLKIC 580
           +++L+G C  DG + ++  Y ++G LR++L     P + +              + L  C
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 581 I-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               AR + YL   AS+  IHRD+   N+L+ E  V K++DFGL +   N      +T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV++ E       I   G      + V   E ++
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYPGIPV--EELFK 270
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
             K G  +D       P  C N+   +   C +    +RP+   +V  L+ +  L
Sbjct: 271 LLKEGHRMD------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 128/290 (44%), Gaps = 35/290 (12%)
Query: 464 QFSISEIKEATKDFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LE 518
           Q  +  +KE   +   + ++G G FG VYKG     G++   PVAIK LN  +   A +E
Sbjct: 6   QAQLRILKET--ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE 63
Query: 519 FQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRL 577
           F  E  +++ + + HLV L+G C     + LV   M  G L ++++ + DN  +     L
Sbjct: 64  FMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLEYVHEHKDN--IGSQLLL 120
Query: 578 KICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST 637
             C+  A+ + YL     + ++HRD+   N+L+      K++DFGL +      K + + 
Sbjct: 121 NWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 177
Query: 638 QVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATEC 697
             K  I ++  E    +  T +SDV+S+GV + E                  L  +  + 
Sbjct: 178 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWE------------------LMTFGGKP 219
Query: 698 YRNGKIGDIIDPFLKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
           Y      +I D   KG     PP+C      V + C   D   RP   ++
Sbjct: 220 YDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKEL 269

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 7/191 (3%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+ G+ NG  T VA+K L  GS      F  E  ++ QL++  LV L     
Sbjct: 30  LGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 87
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ +YM  G+L D L       L  ++ L +    A  + ++     +  IHRD
Sbjct: 88  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 143
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ +    K++DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 144 LRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINYGTFTIKSDV 202
Query: 663 YSFGVVLLEVL 673
           +SFG++L E++
Sbjct: 203 WSFGILLTEIV 213

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 7/191 (3%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+ G+ NG  T VA+K L  GS      F  E  ++ QL++  LV L     
Sbjct: 27  LGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ +YM  G+L D L       L  ++ L +    A  + ++     +  IHRD
Sbjct: 85  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 140
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ +    K++DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 663 YSFGVVLLEVL 673
           +SFG++L E++
Sbjct: 200 WSFGILLTEIV 210

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 7/191 (3%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+ G+ NG  T VA+K L  GS      F  E  ++ QL++  LV L     
Sbjct: 29  LGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 86
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ +YM  G+L D L       L  ++ L +    A  + ++     +  IHRD
Sbjct: 87  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 142
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ +    K++DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 143 LRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINYGTFTIKSDV 201
Query: 663 YSFGVVLLEVL 673
           +SFG++L E++
Sbjct: 202 WSFGILLTEIV 212

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 7/191 (3%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+ G+ NG  T VA+K L  GS      F  E  ++ QL++  LV L     
Sbjct: 21  LGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ +YM  G+L D L       L  ++ L +    A  + ++     +  IHRD
Sbjct: 79  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ +    K++DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 663 YSFGVVLLEVL 673
           +SFG++L E++
Sbjct: 194 WSFGILLTEIV 204

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 7/191 (3%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+ G+ NG  T VA+K L  GS      F  E  ++ QL++  LV L     
Sbjct: 23  LGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 80
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ +YM  G+L D L       L  ++ L +    A  + ++     +  IHRD
Sbjct: 81  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 136
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ +    K++DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 137 LRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINYGTFTIKSDV 195
Query: 663 YSFGVVLLEVL 673
           +SFG++L E++
Sbjct: 196 WSFGILLTEIV 206

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 132/301 (43%), Gaps = 35/301 (11%)
Query: 465 FSISEIKEATKDFNNLL---------IIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG- 511
           F+  +  EA ++F   +         +IG G FG V  G L         VAIK L  G 
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 512 SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPL 571
           +++   +F +E  ++ Q  + +++ L G       ++++ ++M  G+L   L  ND    
Sbjct: 74  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-F 132
Query: 572 PWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS 631
              + + +  G A  + YL   A    +HRD+   NIL++   V KVSDFGL +F  + +
Sbjct: 133 TVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 189
Query: 632 KTHVSTQVKGS---IGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQV 688
                T   G    I +  PE  + +  T  SDV+S+G+V+ EV+         G++   
Sbjct: 190 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS-------YGERPYW 242
Query: 689 NLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGL 748
           ++         N  + + I+   +   P  C +   ++ + C   DR  RP    +V  L
Sbjct: 243 DMT--------NQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 294
Query: 749 E 749
           +
Sbjct: 295 D 295

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 7/191 (3%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+ G+ NG  T VA+K L  GS      F  E  ++ QL++  LV L     
Sbjct: 21  LGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ +YM  G+L D L       L  ++ L +    A  + ++     +  IHRD
Sbjct: 79  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ +    K++DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 663 YSFGVVLLEVL 673
           +SFG++L E++
Sbjct: 194 WSFGILLTEIV 204

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 113/252 (44%), Gaps = 25/252 (9%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL-NPGSQQGALEFQ--TEIGMLSQLRY 531
           +DF+    +G+G FGNVY          +A+K L     ++  +E Q   E+ + S LR+
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
            +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y H
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR--FDEQRTATYITELANALSYCH 129
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
              SK +IHRD+K  N+LL      K++DFG     P+  +  +     G++ YL PE  
Sbjct: 130 ---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC----GTLDYLPPEMI 182
Query: 652 RLQLLTEKSDVYSFGVVLLEVLCARPPI--------LRTGDKKQVNLAVWATECYRNGKI 703
             ++  EK D++S GV+  E L   PP          R   + +     + TE  R    
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGAR---- 238
Query: 704 GDIIDPFLKGNA 715
            D+I   LK NA
Sbjct: 239 -DLISRLLKHNA 249

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 7/191 (3%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+ G+ NG  T VA+K L  GS      F  E  ++ QL++  LV L     
Sbjct: 22  LGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 79
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ +YM  G+L D L       L  ++ L +    A  + ++     +  IHRD
Sbjct: 80  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 135
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ +    K++DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 136 LRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAINYGTFTIKSDV 194
Query: 663 YSFGVVLLEVL 673
           +SFG++L E++
Sbjct: 195 WSFGILLTEIV 205

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 97/191 (50%), Gaps = 7/191 (3%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+ G  NG+ T VAIK L PG+      F  E  ++ +L++  LV L    +
Sbjct: 17  LGNGQFGEVWMGTWNGN-TKVAIKTLKPGTMSPE-SFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           ++  + +V +YM +G+L D L + +   L     + +    A  + Y+        IHRD
Sbjct: 75  EE-PIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 130
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +++ NIL+    + K++DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 131 LRSANILVGNGLICKIADFGLARLIEDNEXT-ARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 663 YSFGVVLLEVL 673
           +SFG++L E++
Sbjct: 190 WSFGILLTELV 200

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 7/191 (3%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+ G+ NG  T VA+K L  GS      F  E  ++ QL++  LV L     
Sbjct: 27  LGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ +YM  G+L D L       L  ++ L +    A  + ++     +  IHRD
Sbjct: 85  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 140
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ +    K++DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 663 YSFGVVLLEVL 673
           +SFG++L E++
Sbjct: 200 WSFGILLTEIV 210

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 7/191 (3%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+ G+ NG  T VA+K L  GS      F  E  ++ QL++  LV L     
Sbjct: 26  LGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 83
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ +YM  G+L D L       L  ++ L +    A  + ++     +  IHRD
Sbjct: 84  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 139
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ +    K++DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 140 LRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDV 198
Query: 663 YSFGVVLLEVL 673
           +SFG++L E++
Sbjct: 199 WSFGILLTEIV 209

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 7/191 (3%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+ G+ NG  T VA+K L  GS      F  E  ++ QL++  LV L     
Sbjct: 31  LGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 88
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ +YM  G+L D L       L  ++ L +    A  + ++     +  IHRD
Sbjct: 89  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 144
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ +    K++DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 145 LRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDV 203
Query: 663 YSFGVVLLEVL 673
           +SFG++L E++
Sbjct: 204 WSFGILLTEIV 214

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 7/191 (3%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+ G+ NG  T VA+K L  GS      F  E  ++ QL++  LV L     
Sbjct: 21  LGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ +YM  G+L D L       L  ++ L +    A  + ++     +  IHRD
Sbjct: 79  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ +    K++DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 663 YSFGVVLLEVL 673
           +SFG++L E++
Sbjct: 194 WSFGILLTEIV 204

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 7/191 (3%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+ G+ NG  T VA+K L  GS      F  E  ++ QL++  LV L     
Sbjct: 16  LGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ +YM  G+L D L       L  ++ L +    A  + ++     +  IHRD
Sbjct: 74  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 129
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ +    K++DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 130 LRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDV 188
Query: 663 YSFGVVLLEVL 673
           +SFG++L E++
Sbjct: 189 WSFGILLTEIV 199

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 94/191 (49%), Gaps = 7/191 (3%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+    N   T VA+K + PGS      F  E  ++  L++  LV L     
Sbjct: 23  LGAGQFGEVWMATYN-KHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT 80
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ ++MA+G+L D L +++    P  + +      A  + ++     +  IHRD
Sbjct: 81  KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRD 136
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+    V K++DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 137 LRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDV 195
Query: 663 YSFGVVLLEVL 673
           +SFG++L+E++
Sbjct: 196 WSFGILLMEIV 206

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 122/287 (42%), Gaps = 44/287 (15%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
           ++G+G FG   K         + +K L    ++    F  E+ ++  L + +++  IG  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
             D ++  + +Y+  GTLR  + + D+   PW +R+      A  + YLH   S  IIHR
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLH---SMNIIHR 132
Query: 602 DVKTTNILLDEEWVAKVSDFGLCKF---------------GPNFSKTHVSTQVKGSIGYL 646
           D+ + N L+ E     V+DFGL +                 P+  K +    V G+  ++
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT---VVGNPYWM 189
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLC---ARPPIL-RTGDKKQVNLAVWATECYRNGK 702
            PE    +   EK DV+SFG+VL E++    A P  L RT D                  
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD------------------ 231
Query: 703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
            G  +  FL    PP C   F  + + C + D  +RPS   +   LE
Sbjct: 232 FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQ--TEIGMLSQLRYL 532
           DF+ +  +G+G FGNVY      +   +A+K L     ++  +E Q   EI + S LR+ 
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           +++ +  Y +D  ++ L+ ++  RG L   L  +        R        A ALHY H 
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCH- 131
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
              + +IHRD+K  N+L+  +   K++DFG     P+  +  +     G++ YL PE   
Sbjct: 132 --ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIE 185
Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPP 678
            +   EK D++  GV+  E L   PP
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPP 211

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 94/191 (49%), Gaps = 7/191 (3%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+    N   T VA+K + PGS      F  E  ++  L++  LV L     
Sbjct: 196 LGAGQFGEVWMATYN-KHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ ++MA+G+L D L +++    P  + +      A  + ++     +  IHRD
Sbjct: 254 KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRD 309
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+    V K++DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDV 368
Query: 663 YSFGVVLLEVL 673
           +SFG++L+E++
Sbjct: 369 WSFGILLMEIV 379

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 93/191 (48%), Gaps = 7/191 (3%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V+ G+ NG  T VA+K L  GS      F  E  ++ QL++  LV L     
Sbjct: 17  LGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ +YM  G+L D L       L  ++ L +    A  + ++     +  IHR+
Sbjct: 75  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRN 130
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ +    K++DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 131 LRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDV 189
Query: 663 YSFGVVLLEVL 673
           +SFG++L E++
Sbjct: 190 WSFGILLTEIV 200

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/280 (23%), Positives = 123/280 (43%), Gaps = 38/280 (13%)
Query: 483 IGRGGFGNVYKGFLNG-----DSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G+G FG VY+G   G       T VAIK +N   S +  +EF  E  ++ +    H+V 
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYN-----NDNP---PLPWDRRLKICIGAARALH 588
           L+G  +     +++ + M RG L+ +L +      +NP   P    + +++    A  + 
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           YL+       +HRD+   N ++ E++  K+ DFG+ +            +    + ++ P
Sbjct: 138 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 194
Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID 708
           E  +  + T  SDV+SFGVVL E+                  A  A + Y+      ++ 
Sbjct: 195 ESLKDGVFTTYSDVWSFGVVLWEI------------------ATLAEQPYQGLSNEQVLR 236
Query: 709 PFLKG---NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
             ++G   + P  C +  +E+   C   +   RPS  +++
Sbjct: 237 FVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEII 276

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 92/191 (48%), Gaps = 7/191 (3%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G  G V+ G+ NG  T VA+K L  GS      F  E  ++ QL++  LV L     
Sbjct: 21  LGAGQAGEVWMGYYNG-HTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ +YM  G+L D L       L  ++ L +    A  + ++     +  IHRD
Sbjct: 79  QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           ++  NIL+ +    K++DFGL +   +   T      K  I +  PE       T KSDV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDAEXT-AREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 663 YSFGVVLLEVL 673
           +SFG++L E++
Sbjct: 194 WSFGILLTEIV 204

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPV--AIKRLNP-GSQQGALEFQTEIGMLSQL-RYLHLVSL 537
           +IG G FG V K  +  D   +  AIKR+    S+    +F  E+ +L +L  + ++++L
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLY--------------NNDNPPLPWDRRLKICIGA 583
           +G C   G + L  +Y   G L D L               N+    L   + L      
Sbjct: 82  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 141
Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSI 643
           AR + YL   + K  IHRD+   NIL+ E +VAK++DFGL +    + K    T  +  +
Sbjct: 142 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPV 195
Query: 644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
            ++  E     + T  SDV+S+GV+L E++
Sbjct: 196 RWMAIESLNYSVYTTNSDVWSYGVLLWEIV 225

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPV--AIKRLNP-GSQQGALEFQTEIGMLSQL-RYLHLVSL 537
           +IG G FG V K  +  D   +  AIKR+    S+    +F  E+ +L +L  + ++++L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLY--------------NNDNPPLPWDRRLKICIGA 583
           +G C   G + L  +Y   G L D L               N+    L   + L      
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSI 643
           AR + YL   + K  IHRD+   NIL+ E +VAK++DFGL +    + K    T  +  +
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPV 205
Query: 644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
            ++  E     + T  SDV+S+GV+L E++
Sbjct: 206 RWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 483 IGRGGFGNVYKGFLNG-----DSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G+G FG VY+G   G       T VAIK +N   S +  +EF  E  ++ +    H+V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYN-----NDNP---PLPWDRRLKICIGAARALH 588
           L+G  +     +++ + M RG L+ +L +      +NP   P    + +++    A  + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           YL+       +HRD+   N ++ E++  K+ DFG+ +            +    + ++ P
Sbjct: 147 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 203
Query: 649 EYYRLQLLTEKSDVYSFGVVLLEV 672
           E  +  + T  SDV+SFGVVL E+
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 125/282 (44%), Gaps = 42/282 (14%)
Query: 483 IGRGGFGNVYKGFLNG-----DSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G+G FG VY+G   G       T VAIK +N   S +  +EF  E  ++ +    H+V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYN-----NDNP---PLPWDRRLKICIGAARALH 588
           L+G  +     +++ + M RG L+ +L +      +NP   P    + +++    A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYL 646
           YL+       +HRD+   N ++ E++  K+ DFG+ +    +   +     KG   + ++
Sbjct: 153 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWM 207
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI 706
            PE  +  + T  SDV+SFGVVL E+                  A  A + Y+      +
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEI------------------ATLAEQPYQGLSNEQV 249
Query: 707 IDPFLKG---NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           +   ++G   + P  C +   E+   C   +   RPS  +++
Sbjct: 250 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 125/282 (44%), Gaps = 42/282 (14%)
Query: 483 IGRGGFGNVYKGFLNG-----DSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G+G FG VY+G   G       T VAIK +N   S +  +EF  E  ++ +    H+V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYN-----NDNP---PLPWDRRLKICIGAARALH 588
           L+G  +     +++ + M RG L+ +L +      +NP   P    + +++    A  + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYL 646
           YL+       +HRD+   N ++ E++  K+ DFG+ +    +   +     KG   + ++
Sbjct: 147 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWM 201
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI 706
            PE  +  + T  SDV+SFGVVL E+                  A  A + Y+      +
Sbjct: 202 SPESLKDGVFTTYSDVWSFGVVLWEI------------------ATLAEQPYQGLSNEQV 243
Query: 707 IDPFLKG---NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           +   ++G   + P  C +   E+   C   +   RPS  +++
Sbjct: 244 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 12/206 (5%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQ--TEIGMLSQLRYL 532
           DF+    +G+G FGNVY      +   +A+K L     ++  +E Q   EI + S LR+ 
Sbjct: 16  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 75
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           +++ +  Y +D  ++ L+ ++  RG L   L  +        R        A ALHY H 
Sbjct: 76  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCH- 132
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
              + +IHRD+K  N+L+  +   K++DFG     P+  +  +     G++ YL PE   
Sbjct: 133 --ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIE 186
Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPP 678
            +   EK D++  GV+  E L   PP
Sbjct: 187 GKTHDEKVDLWCAGVLCYEFLVGMPP 212

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 125/282 (44%), Gaps = 42/282 (14%)
Query: 483 IGRGGFGNVYKGFLNG-----DSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G+G FG VY+G   G       T VAIK +N   S +  +EF  E  ++ +    H+V 
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYN-----NDNP---PLPWDRRLKICIGAARALH 588
           L+G  +     +++ + M RG L+ +L +      +NP   P    + +++    A  + 
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYL 646
           YL+       +HRD+   N ++ E++  K+ DFG+ +    +   +     KG   + ++
Sbjct: 144 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWM 198
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI 706
            PE  +  + T  SDV+SFGVVL E+                  A  A + Y+      +
Sbjct: 199 SPESLKDGVFTTYSDVWSFGVVLWEI------------------ATLAEQPYQGLSNEQV 240
Query: 707 IDPFLKG---NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           +   ++G   + P  C +   E+   C   +   RPS  +++
Sbjct: 241 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 282

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 483 IGRGGFGNVYKGFLNG-----DSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G+G FG VY+G   G       T VAIK +N   S +  +EF  E  ++ +    H+V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYN-----NDNP---PLPWDRRLKICIGAARALH 588
           L+G  +     +++ + M RG L+ +L +      +NP   P    + +++    A  + 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYL 646
           YL+       +HRD+   N ++ E++  K+ DFG+ +    +   +     KG   + ++
Sbjct: 146 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWM 200
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEV 672
            PE  +  + T  SDV+SFGVVL E+
Sbjct: 201 SPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 125/282 (44%), Gaps = 42/282 (14%)
Query: 483 IGRGGFGNVYKGFLNG-----DSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G+G FG VY+G   G       T VAIK +N   S +  +EF  E  ++ +    H+V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYN-----NDNP---PLPWDRRLKICIGAARALH 588
           L+G  +     +++ + M RG L+ +L +      +NP   P    + +++    A  + 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYL 646
           YL+       +HRD+   N ++ E++  K+ DFG+ +    +   +     KG   + ++
Sbjct: 140 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWM 194
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI 706
            PE  +  + T  SDV+SFGVVL E+                  A  A + Y+      +
Sbjct: 195 SPESLKDGVFTTYSDVWSFGVVLWEI------------------ATLAEQPYQGLSNEQV 236
Query: 707 IDPFLKG---NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           +   ++G   + P  C +   E+   C   +   RPS  +++
Sbjct: 237 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 278

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 125/282 (44%), Gaps = 42/282 (14%)
Query: 483 IGRGGFGNVYKGFLNG-----DSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G+G FG VY+G   G       T VAIK +N   S +  +EF  E  ++ +    H+V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYN-----NDNP---PLPWDRRLKICIGAARALH 588
           L+G  +     +++ + M RG L+ +L +      +NP   P    + +++    A  + 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYL 646
           YL+       +HRD+   N ++ E++  K+ DFG+ +    +   +     KG   + ++
Sbjct: 146 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWM 200
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI 706
            PE  +  + T  SDV+SFGVVL E+                  A  A + Y+      +
Sbjct: 201 SPESLKDGVFTTYSDVWSFGVVLWEI------------------ATLAEQPYQGLSNEQV 242
Query: 707 IDPFLKG---NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           +   ++G   + P  C +   E+   C   +   RPS  +++
Sbjct: 243 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 127/300 (42%), Gaps = 28/300 (9%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+G FG+V    Y    +     VA+K+L         +FQ EI +L  L    +V   
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 539 GYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           G     G+  + LV +Y+  G LRD L  +    L   R L       + + YL    S+
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYL---GSR 133
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS-IGYLDPEYYRLQL 655
             +HRD+   NIL++ E   K++DFGL K  P     +V  +   S I +  PE     +
Sbjct: 134 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 193
Query: 656 LTEKSDVYSFGVVLLEVL--CAR-----PPILR-TGDKKQVNLAVWATECYRNGKIGDII 707
            + +SDV+SFGVVL E+   C +        LR  G ++ V       E    G+     
Sbjct: 194 FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQ----- 248
Query: 708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEKSMIAHP 767
               +  APP C  +  E+   C       RPS S +   L+ ++   R     +  AHP
Sbjct: 249 ----RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHP 304

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 125/282 (44%), Gaps = 42/282 (14%)
Query: 483 IGRGGFGNVYKGFLNG-----DSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G+G FG VY+G   G       T VAIK +N   S +  +EF  E  ++ +    H+V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYN-----NDNP---PLPWDRRLKICIGAARALH 588
           L+G  +     +++ + M RG L+ +L +      +NP   P    + +++    A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYL 646
           YL+       +HRD+   N ++ E++  K+ DFG+ +    +   +     KG   + ++
Sbjct: 153 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWM 207
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI 706
            PE  +  + T  SDV+SFGVVL E+                  A  A + Y+      +
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEI------------------ATLAEQPYQGLSNEQV 249
Query: 707 IDPFLKG---NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           +   ++G   + P  C +   E+   C   +   RPS  +++
Sbjct: 250 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 125/282 (44%), Gaps = 42/282 (14%)
Query: 483 IGRGGFGNVYKGFLNG-----DSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G+G FG VY+G   G       T VAIK +N   S +  +EF  E  ++ +    H+V 
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYN-----NDNP---PLPWDRRLKICIGAARALH 588
           L+G  +     +++ + M RG L+ +L +      +NP   P    + +++    A  + 
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYL 646
           YL+       +HRD+   N ++ E++  K+ DFG+ +    +   +     KG   + ++
Sbjct: 175 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWM 229
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI 706
            PE  +  + T  SDV+SFGVVL E+                  A  A + Y+      +
Sbjct: 230 SPESLKDGVFTTYSDVWSFGVVLWEI------------------ATLAEQPYQGLSNEQV 271
Query: 707 IDPFLKG---NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           +   ++G   + P  C +   E+   C   +   RPS  +++
Sbjct: 272 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 313

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 126/276 (45%), Gaps = 37/276 (13%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHLV 535
           F  L  IG+G FG V+KG  N     VAIK ++   ++    + Q EI +LSQ    ++ 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
              G    D ++ ++ +Y+  G+  D L   +  PL   +   I     + L YLH   S
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLH---S 137
Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK-----GSIGYLDPEY 650
           +  IHRD+K  N+LL E    K++DFG+       +     TQ+K     G+  ++ PE 
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGV-------AGQLTDTQIKRNXFVGTPFWMAPEV 190
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF 710
            +      K+D++S G+  +E+    PP       K + L            I     P 
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL------------IPKNNPPT 238
Query: 711 LKGN-APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           L+GN + P  L +FVE   +C+N +   RP+  +++
Sbjct: 239 LEGNYSKP--LKEFVE---ACLNKEPSFRPTAKELL 269

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 127/300 (42%), Gaps = 28/300 (9%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+G FG+V    Y    +     VA+K+L         +FQ EI +L  L    +V   
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 539 GYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           G     G+  + LV +Y+  G LRD L  +    L   R L       + + YL    S+
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYL---GSR 134
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS-IGYLDPEYYRLQL 655
             +HRD+   NIL++ E   K++DFGL K  P     +V  +   S I +  PE     +
Sbjct: 135 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 194
Query: 656 LTEKSDVYSFGVVLLEVL--CAR-----PPILR-TGDKKQVNLAVWATECYRNGKIGDII 707
            + +SDV+SFGVVL E+   C +        LR  G ++ V       E    G+     
Sbjct: 195 FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQ----- 249
Query: 708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEKSMIAHP 767
               +  APP C  +  E+   C       RPS S +   L+ ++   R     +  AHP
Sbjct: 250 ----RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHP 305

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 126/276 (45%), Gaps = 37/276 (13%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHLV 535
           F  L  IG+G FG V+KG  N     VAIK ++   ++    + Q EI +LSQ    ++ 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
              G    D ++ ++ +Y+  G+  D L   +  PL   +   I     + L YLH   S
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLH---S 122
Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK-----GSIGYLDPEY 650
           +  IHRD+K  N+LL E    K++DFG+       +     TQ+K     G+  ++ PE 
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGV-------AGQLTDTQIKRNTFVGTPFWMAPEV 175
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF 710
            +      K+D++S G+  +E+    PP       K + L            I     P 
Sbjct: 176 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL------------IPKNNPPT 223
Query: 711 LKGN-APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           L+GN + P  L +FVE   +C+N +   RP+  +++
Sbjct: 224 LEGNYSKP--LKEFVE---ACLNKEPSFRPTAKELL 254

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 127/276 (46%), Gaps = 37/276 (13%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHLV 535
           F  L  IG+G FG V+KG  N     VAIK ++   ++    + Q EI +LSQ    ++ 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
              G    D ++ ++ +Y+  G+  D L   +  PL   +   I     + L YLH   S
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLH---S 142
Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK-----GSIGYLDPEY 650
           +  IHRD+K  N+LL E    K++DFG+       +     TQ+K     G+  ++ PE 
Sbjct: 143 EKKIHRDIKAANVLLSEHGEVKLADFGV-------AGQLTDTQIKRNTFVGTPFWMAPEV 195
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF 710
            +      K+D++S G+  +E+    PP       K + L        +N        P 
Sbjct: 196 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL------IPKNNP------PT 243
Query: 711 LKGN-APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           L+GN + P  L +FVE   +C+N +   RP+  +++
Sbjct: 244 LEGNYSKP--LKEFVE---ACLNKEPSFRPTAKELL 274

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 126/276 (45%), Gaps = 37/276 (13%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHLV 535
           F  L  IG+G FG V+KG  N     VAIK ++   ++    + Q EI +LSQ    ++ 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
              G    D ++ ++ +Y+  G+  D L   +  PL   +   I     + L YLH   S
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLH---S 122
Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK-----GSIGYLDPEY 650
           +  IHRD+K  N+LL E    K++DFG+       +     TQ+K     G+  ++ PE 
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGV-------AGQLTDTQIKRNXFVGTPFWMAPEV 175
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF 710
            +      K+D++S G+  +E+    PP       K + L            I     P 
Sbjct: 176 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL------------IPKNNPPT 223
Query: 711 LKGN-APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           L+GN + P  L +FVE   +C+N +   RP+  +++
Sbjct: 224 LEGNYSKP--LKEFVE---ACLNKEPSFRPTAKELL 254

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 483 IGRGGFGNVYKGFLNG-----DSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G+G FG VY+G   G       T VAIK +N   S +  +EF  E  ++ +    H+V 
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYN-----NDNP---PLPWDRRLKICIGAARALH 588
           L+G  +     +++ + M RG L+ +L +      +NP   P    + +++    A  + 
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYL 646
           YL+       +HRD+   N ++ E++  K+ DFG+ +    +   +     KG   + ++
Sbjct: 143 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWM 197
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEV 672
            PE  +  + T  SDV+SFGVVL E+
Sbjct: 198 SPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 117/271 (43%), Gaps = 28/271 (10%)
Query: 482 IIGRGGFGNVYKGFLNGDSTP---VAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           ++G G FG V  G L   S     VAIK L  G +++   +F  E  ++ Q  + +++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G       +++V +YM  G+L   L  +D       + + +  G A  + YL   +   
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLL 656
            +HRD+   NIL++   V KVSDFGL +   +  +   +T+  K  I +  PE    +  
Sbjct: 168 FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 657 TEKSDVYSFGVVLLEVLC--ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
           T  SDV+S+G+VL EV+    RP               W      N  +   +D   +  
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP--------------YWEMS---NQDVIKAVDEGYRLP 270
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
            P  C     ++ + C   DR  RP    +V
Sbjct: 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 125/282 (44%), Gaps = 42/282 (14%)
Query: 483 IGRGGFGNVYKGFLNG-----DSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G+G FG VY+G   G       T VAIK +N   S +  +EF  E  ++ +    H+V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYN-----NDNP---PLPWDRRLKICIGAARALH 588
           L+G  +     +++ + M RG L+ +L +      +NP   P    + +++    A  + 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYL 646
           YL+       +HRD+   N  + E++  K+ DFG+ +    +   +     KG   + ++
Sbjct: 140 YLNANK---FVHRDLAARNCXVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWM 194
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI 706
            PE  +  + T  SDV+SFGVVL E+                  A  A + Y+      +
Sbjct: 195 SPESLKDGVFTTYSDVWSFGVVLWEI------------------ATLAEQPYQGLSNEQV 236
Query: 707 IDPFLKG---NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           +   ++G   + P  C +  +E+   C   +   RPS  +++
Sbjct: 237 LRFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEII 278

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 120/271 (44%), Gaps = 26/271 (9%)
Query: 482 IIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           +IG G FG V  G L         VAIK L  G +++   +F +E  ++ Q  + +++ L
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G       ++++ ++M  G+L   L  ND       + + +  G A  + YL   A   
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIAAGMKYL---ADMN 129
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS---IGYLDPEYYRLQ 654
            +HR +   NIL++   V KVSDFGL +F  + +     T   G    I +  PE  + +
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             T  SDV+S+G+V+ EV+         G++   ++         N  + + I+   +  
Sbjct: 190 KFTSASDVWSYGIVMWEVMS-------YGERPYWDMT--------NQDVINAIEQDYRLP 234
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
            P  C +   ++ + C   DR  RP    +V
Sbjct: 235 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 265

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 117/271 (43%), Gaps = 28/271 (10%)
Query: 482 IIGRGGFGNVYKGFLNGDSTP---VAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           ++G G FG V  G L   S     VAIK L  G +++   +F  E  ++ Q  + +++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G       +++V +YM  G+L   L  +D       + + +  G A  + YL   +   
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLL 656
            +HRD+   NIL++   V KVSDFGL +   +  +   +T+  K  I +  PE    +  
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 657 TEKSDVYSFGVVLLEVLC--ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
           T  SDV+S+G+VL EV+    RP               W      N  +   +D   +  
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP--------------YWEMS---NQDVIKAVDEGYRLP 270
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
            P  C     ++ + C   DR  RP    +V
Sbjct: 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 120/277 (43%), Gaps = 31/277 (11%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGALEFQTE-IGMLSQLR 530
           +   L ++G G FG V+KG     G+S   PV IK +   S + + +  T+ +  +  L 
Sbjct: 32  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 91
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + H+V L+G C     + LV  Y+  G+L DH+  +     P    L   +  A+ ++YL
Sbjct: 92  HAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGP-QLLLNWGVQIAKGMYYL 149
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
                  ++HR++   N+LL      +V+DFG+    P   K  + ++ K  I ++  E 
Sbjct: 150 EEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 206
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF 710
                 T +SDV+S+GV + E                  L  +  E Y   ++ ++ D  
Sbjct: 207 IHFGKYTHQSDVWSYGVTVWE------------------LMTFGAEPYAGLRLAEVPDLL 248
Query: 711 LKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
            KG     P +C      V + C   D   RP+  ++
Sbjct: 249 EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKEL 285

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 108/245 (44%), Gaps = 35/245 (14%)
Query: 452 GPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG 511
           G   + PS L  ++ + EI            +G GG   V+      D   VA+K L   
Sbjct: 1   GSHMTTPSHLSDRYELGEI------------LGFGGMSEVHLARDLRDHRDVAVKVLRAD 48
Query: 512 SQQGA---LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQM--------ILVYDYMARGTLR 560
             +     L F+ E    + L +  +V++     D G+          +V +Y+   TLR
Sbjct: 49  LARDPSFYLRFRREAQNAAALNHPAIVAVY----DTGEAETPAGPLPYIVMEYVDGVTLR 104
Query: 561 DHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSD 620
           D ++     P+   R +++   A +AL++ H      IIHRDVK  NIL+      KV D
Sbjct: 105 DIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVD 159
Query: 621 FGLCK-FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPI 679
           FG+ +    + +    +  V G+  YL PE  R   +  +SDVYS G VL EVL   PP 
Sbjct: 160 FGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219
Query: 680 LRTGD 684
             TGD
Sbjct: 220 --TGD 222

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPV--AIKRLNP-GSQQGALEFQTEIGMLSQL-RYLHLVSL 537
           +IG G FG V K  +  D   +  AIKR+    S+    +F  E+ +L +L  + ++++L
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLY--------------NNDNPPLPWDRRLKICIGA 583
           +G C   G + L  +Y   G L D L               N+    L   + L      
Sbjct: 89  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 148
Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSI 643
           AR + YL   + K  IHR++   NIL+ E +VAK++DFGL +    + K    T  +  +
Sbjct: 149 ARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPV 202
Query: 644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
            ++  E     + T  SDV+S+GV+L E++
Sbjct: 203 RWMAIESLNYSVYTTNSDVWSYGVLLWEIV 232

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 127/300 (42%), Gaps = 28/300 (9%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+G FG+V    Y    +     VA+K+L         +FQ EI +L  L    +V   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 539 GYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           G     G+  + LV +Y+  G LRD L  +    L   R L       + + YL    S+
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYL---GSR 146
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS-IGYLDPEYYRLQL 655
             +HRD+   NIL++ E   K++DFGL K  P     +V  +   S I +  PE     +
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206
Query: 656 LTEKSDVYSFGVVLLEVL--CAR-----PPILRT-GDKKQVNLAVWATECYRNGKIGDII 707
            + +SDV+SFGVVL E+   C +        LR  G ++ V       E    G+     
Sbjct: 207 FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ----- 261
Query: 708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEKSMIAHP 767
               +  APP C  +  E+   C       RPS S +   L+ ++   R     +  AHP
Sbjct: 262 ----RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHP 317

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 117/271 (43%), Gaps = 28/271 (10%)
Query: 482 IIGRGGFGNVYKGFLNGDSTP---VAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           ++G G FG V  G L   S     VAIK L  G +++   +F  E  ++ Q  + +++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G       +++V +YM  G+L   L  +D       + + +  G A  + YL   +   
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLL 656
            +HRD+   NIL++   V KVSDFGL +   +  +   +T+  K  I +  PE    +  
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 657 TEKSDVYSFGVVLLEVLC--ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
           T  SDV+S+G+VL EV+    RP               W      N  +   +D   +  
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP--------------YWEMS---NQDVIKAVDEGYRLP 270
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
            P  C     ++ + C   DR  RP    +V
Sbjct: 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 117/271 (43%), Gaps = 28/271 (10%)
Query: 482 IIGRGGFGNVYKGFLNGDSTP---VAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           ++G G FG V  G L   S     VAIK L  G +++   +F  E  ++ Q  + +++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G       +++V +YM  G+L   L  +D       + + +  G A  + YL   +   
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLL 656
            +HRD+   NIL++   V KVSDFGL +   +  +   +T+  K  I +  PE    +  
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 657 TEKSDVYSFGVVLLEVLC--ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
           T  SDV+S+G+VL EV+    RP               W      N  +   +D   +  
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP--------------YWEMS---NQDVIKAVDEGYRLP 270
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
            P  C     ++ + C   DR  RP    +V
Sbjct: 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 117/271 (43%), Gaps = 28/271 (10%)
Query: 482 IIGRGGFGNVYKGFLNGDSTP---VAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           ++G G FG V  G L   S     VAIK L  G +++   +F  E  ++ Q  + +++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G       +++V +YM  G+L   L  +D       + + +  G A  + YL   +   
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLL 656
            +HRD+   NIL++   V KVSDFGL +   +  +   +T+  K  I +  PE    +  
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 657 TEKSDVYSFGVVLLEVLC--ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
           T  SDV+S+G+VL EV+    RP               W      N  +   +D   +  
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP--------------YWEMS---NQDVIKAVDEGYRLP 270
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
            P  C     ++ + C   DR  RP    +V
Sbjct: 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 120/277 (43%), Gaps = 31/277 (11%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGALEFQTE-IGMLSQLR 530
           +   L ++G G FG V+KG     G+S   PV IK +   S + + +  T+ +  +  L 
Sbjct: 14  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + H+V L+G C     + LV  Y+  G+L DH+  +     P    L   +  A+ ++YL
Sbjct: 74  HAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGP-QLLLNWGVQIAKGMYYL 131
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
                  ++HR++   N+LL      +V+DFG+    P   K  + ++ K  I ++  E 
Sbjct: 132 EEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF 710
                 T +SDV+S+GV + E                  L  +  E Y   ++ ++ D  
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWE------------------LMTFGAEPYAGLRLAEVPDLL 230
Query: 711 LKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
            KG     P +C      V + C   D   RP+  ++
Sbjct: 231 EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKEL 267

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 117/271 (43%), Gaps = 28/271 (10%)
Query: 482 IIGRGGFGNVYKGFLNGDSTP---VAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           ++G G FG V  G L   S     VAIK L  G +++   +F  E  ++ Q  + +++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G       +++V +YM  G+L   L  +D       + + +  G A  + YL   +   
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLL 656
            +HRD+   NIL++   V KVSDFGL +   +  +   +T+  K  I +  PE    +  
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 657 TEKSDVYSFGVVLLEVLC--ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
           T  SDV+S+G+VL EV+    RP               W      N  +   +D   +  
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP--------------YWEMS---NQDVIKAVDEGYRLP 270
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
            P  C     ++ + C   DR  RP    +V
Sbjct: 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 117/271 (43%), Gaps = 28/271 (10%)
Query: 482 IIGRGGFGNVYKGFLNGDSTP---VAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           ++G G FG V  G L   S     VAIK L  G +++   +F  E  ++ Q  + +++ L
Sbjct: 50  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 109
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G       +++V +YM  G+L   L  +D       + + +  G A  + YL   +   
Sbjct: 110 EGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL---SDMG 165
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLL 656
            +HRD+   NIL++   V KVSDFGL +   +  +   +T+  K  I +  PE    +  
Sbjct: 166 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 225
Query: 657 TEKSDVYSFGVVLLEVLC--ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
           T  SDV+S+G+VL EV+    RP               W      N  +   +D   +  
Sbjct: 226 TSASDVWSYGIVLWEVMSYGERP--------------YWEMS---NQDVIKAVDEGYRLP 268
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
            P  C     ++ + C   DR  RP    +V
Sbjct: 269 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 299

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 117/271 (43%), Gaps = 28/271 (10%)
Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           ++G G FG V  G L   +     VAIK L  G +++   +F  E  ++ Q  + +++ L
Sbjct: 23  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 82
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G       +++V +YM  G+L   L  +D       + + +  G A  + YL   +   
Sbjct: 83  EGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL---SDMG 138
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLL 656
            +HRD+   NIL++   V KVSDFGL +   +  +   +T+  K  I +  PE    +  
Sbjct: 139 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 198
Query: 657 TEKSDVYSFGVVLLEVLC--ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
           T  SDV+S+G+VL EV+    RP               W      N  +   +D   +  
Sbjct: 199 TSASDVWSYGIVLWEVMSYGERP--------------YWEMS---NQDVIKAVDEGYRLP 241
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
            P  C     ++ + C   DR  RP    +V
Sbjct: 242 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 272

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 129/275 (46%), Gaps = 22/275 (8%)
Query: 466 SISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM 525
           SI  + +  K +     IG+G  G VY          VAI+++N   Q        EI +
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 526 LSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR 585
           + + +  ++V+ +       ++ +V +Y+A G+L D +       +   +   +C    +
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQ 127
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIG 644
           AL +LH   S  +IHRD+K+ NILL  +   K++DFG C +  P  SK    +++ G+  
Sbjct: 128 ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSEMVGTPY 181
Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL-AVWATECYRN-GK 702
           ++ PE    +    K D++S G++ +E++   PP L     + + L A   T   +N  K
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241
Query: 703 IGDIIDPFL----------KGNAPPVCLNQFVEVA 727
           +  I   FL          +G+A  +  +QF+++A
Sbjct: 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 35/221 (15%)
Query: 483 IGRGGFGNVYKGFLNG-----DSTPVAIKRLNP-GSQQGALEFQTEIGMLSQLRYLHLVS 536
           IG G FG V++    G       T VA+K L    S     +FQ E  ++++    ++V 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNND----------------------NPPLPWD 574
           L+G C     M L+++YMA G L + L +                         PPL   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 575 RRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSK 632
            +L I    A  + YL   + +  +HRD+ T N L+ E  V K++DFGL +  +  ++ K
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
              +  +   I ++ PE       T +SDV+++GVVL E+ 
Sbjct: 232 ADGNDAIP--IRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 119/271 (43%), Gaps = 28/271 (10%)
Query: 482 IIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           +IG G FG V  G L        PVAIK L  G +++   +F  E  ++ Q  + +++ L
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G       +++V +YM  G+L   L  ND       + + +  G +  + YL   +   
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQ-FTVIQLVGMLRGISAGMKYL---SDMG 144
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLL 656
            +HRD+   NIL++   V KVSDFGL +   +  +   +T+  K  I +  PE    +  
Sbjct: 145 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKF 204
Query: 657 TEKSDVYSFGVVLLEVLC--ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
           T  SDV+S+G+V+ EV+    RP               W      N  +   ++   +  
Sbjct: 205 TSASDVWSYGIVMWEVVSYGERP--------------YWEMT---NQDVIKAVEEGYRLP 247
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           +P  C     ++ + C   +R  RP   ++V
Sbjct: 248 SPMDCPAALYQLMLDCWQKERNSRPKFDEIV 278

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 129/275 (46%), Gaps = 22/275 (8%)
Query: 466 SISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM 525
           SI  + +  K +     IG+G  G VY          VAI+++N   Q        EI +
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 526 LSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR 585
           + + +  ++V+ +       ++ +V +Y+A G+L D +       +   +   +C    +
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQ 127
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIG 644
           AL +LH   S  +IHRD+K+ NILL  +   K++DFG C +  P  SK   ST V G+  
Sbjct: 128 ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMV-GTPY 181
Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL-AVWATECYRN-GK 702
           ++ PE    +    K D++S G++ +E++   PP L     + + L A   T   +N  K
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241
Query: 703 IGDIIDPFL----------KGNAPPVCLNQFVEVA 727
           +  I   FL          +G+A  +  +QF+++A
Sbjct: 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 117/271 (43%), Gaps = 28/271 (10%)
Query: 482 IIGRGGFGNVYKGFLNGDSTP---VAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           ++G G FG V  G L   S     VAIK L  G +++   +F  E  ++ Q  + +++ L
Sbjct: 40  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 99
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G       +++V +YM  G+L   L  +D       + + +  G A  + YL   +   
Sbjct: 100 EGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL---SDMG 155
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLL 656
            +HRD+   NIL++   V KVSDFGL +   +  +   +T+  K  I +  PE    +  
Sbjct: 156 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 215
Query: 657 TEKSDVYSFGVVLLEVLC--ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
           T  SDV+S+G+VL EV+    RP               W      N  +   +D   +  
Sbjct: 216 TSASDVWSYGIVLWEVMSYGERP--------------YWEMS---NQDVIKAVDEGYRLP 258
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
            P  C     ++ + C   DR  RP    +V
Sbjct: 259 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 289

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 108/245 (44%), Gaps = 35/245 (14%)
Query: 452 GPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG 511
           G   + PS L  ++ + EI            +G GG   V+      D   VA+K L   
Sbjct: 1   GSHMTTPSHLSDRYELGEI------------LGFGGMSEVHLARDLRDHRDVAVKVLRAD 48
Query: 512 SQQGA---LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQM--------ILVYDYMARGTLR 560
             +     L F+ E    + L +  +V++     D G+          +V +Y+   TLR
Sbjct: 49  LARDPSFYLRFRREAQNAAALNHPAIVAVY----DTGEAETPAGPLPYIVMEYVDGVTLR 104
Query: 561 DHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSD 620
           D ++     P+   R +++   A +AL++ H      IIHRDVK  NI++      KV D
Sbjct: 105 DIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMD 159
Query: 621 FGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPI 679
           FG+ +   +   +   T  V G+  YL PE  R   +  +SDVYS G VL EVL   PP 
Sbjct: 160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219
Query: 680 LRTGD 684
             TGD
Sbjct: 220 --TGD 222

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 120/280 (42%), Gaps = 45/280 (16%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHLV 535
           F  L  IG+G FG VYKG  N     VAIK ++   ++    + Q EI +LSQ    ++ 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
              G      ++ ++ +Y+  G+  D L      PL       I     + L YLH   S
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLH---S 134
Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK-----GSIGYLDPEY 650
           +  IHRD+K  N+LL E+   K++DFG+       +     TQ+K     G+  ++ PE 
Sbjct: 135 ERKIHRDIKAANVLLSEQGDVKLADFGV-------AGQLTDTQIKRNXFVGTPFWMAPEV 187
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF 710
            +      K+D++S G+  +E+    PP                     N  +  +   F
Sbjct: 188 IKQSAYDFKADIWSLGITAIELAKGEPP---------------------NSDLHPMRVLF 226
Query: 711 L-KGNAPPVCLNQ----FVEVAMSCVNDDRIRRPSMSDVV 745
           L   N+PP    Q    F E   +C+N D   RP+  +++
Sbjct: 227 LIPKNSPPTLEGQHSKPFKEFVEACLNKDPRFRPTAKELL 266

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 108/245 (44%), Gaps = 35/245 (14%)
Query: 452 GPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG 511
           G   + PS L  ++ + EI            +G GG   V+      D   VA+K L   
Sbjct: 1   GSHMTTPSHLSDRYELGEI------------LGFGGMSEVHLARDLRDHRDVAVKVLRAD 48
Query: 512 SQQGA---LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQM--------ILVYDYMARGTLR 560
             +     L F+ E    + L +  +V++     D G+          +V +Y+   TLR
Sbjct: 49  LARDPSFYLRFRREAQNAAALNHPAIVAVY----DTGEAETPAGPLPYIVMEYVDGVTLR 104
Query: 561 DHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSD 620
           D ++     P+   R +++   A +AL++ H      IIHRDVK  NI++      KV D
Sbjct: 105 DIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMD 159
Query: 621 FGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPI 679
           FG+ +   +   +   T  V G+  YL PE  R   +  +SDVYS G VL EVL   PP 
Sbjct: 160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219
Query: 680 LRTGD 684
             TGD
Sbjct: 220 --TGD 222

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 80  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 136
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 137 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 194 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 238
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 239 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 277

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 117/271 (43%), Gaps = 28/271 (10%)
Query: 482 IIGRGGFGNVYKGFLNGDSTP---VAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           ++G G FG V  G L   S     VAIK L  G +++   +F  E  ++ Q  + +++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G       +++V +YM  G+L   L  +D       + + +  G A  + YL   +   
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLL 656
            +HRD+   NIL++   V KVSDFGL +   +  +   +T+  K  I +  PE    +  
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 657 TEKSDVYSFGVVLLEVLC--ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
           T  SDV+S+G+VL EV+    RP               W      N  +   +D   +  
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP--------------YWEMS---NQDVIKAVDEGYRLP 270
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
            P  C     ++ + C   DR  RP    +V
Sbjct: 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 77  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 133
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 134 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 190
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 191 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 235
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 236 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 274

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 77  NPHVCRLLGICLT-STVQLIMQLMPFGXLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 133
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 134 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 190
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E++         G K    +           +I  I++ 
Sbjct: 191 SILHRIYTHQSDVWSYGVTVWELMT-------FGSKPYDGIPA--------SEISSILEK 235
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 236 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 274

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 76  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 132
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 133 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 234
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 235 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 273

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 82  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 138
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 139 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 195
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 196 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 240
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 241 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 279

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 78  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 134
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 135 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 236
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 237 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 275

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 79  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 135
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 136 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 237
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 238 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 276

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 101 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 157
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 158 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 214
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 215 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 259
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 260 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 298

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 78  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 134
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 135 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 236
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 237 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 275

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 483 IGRGGFGNVYKG----FLNGDS-TPVAIKRLNP-GSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G+G FG VY+G     + G++ T VA+K +N   S +  +EF  E  ++      H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLY--------NNDNPPLPWDRRLKICIGAARALH 588
           L+G  +     ++V + MA G L+ +L         N   PP      +++    A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           YL+   +K  +HRD+   N ++  ++  K+ DFG+ +            +    + ++ P
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 649 EYYRLQLLTEKSDVYSFGVVLLEV 672
           E  +  + T  SD++SFGVVL E+
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 483 IGRGGFGNVYKG----FLNGDS-TPVAIKRLNP-GSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G+G FG VY+G     + G++ T VA+K +N   S +  +EF  E  ++      H+V 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLY--------NNDNPPLPWDRRLKICIGAARALH 588
           L+G  +     ++V + MA G L+ +L         N   PP      +++    A  + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           YL+   +K  +HRD+   N ++  ++  K+ DFG+ +            +    + ++ P
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 649 EYYRLQLLTEKSDVYSFGVVLLEV 672
           E  +  + T  SD++SFGVVL E+
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 79  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 135
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 136 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 237
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 238 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 276

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 83  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 139
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 140 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 241
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 242 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 280

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 76  NPHVCRLLGICLT-STVQLITQLMPFGXLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 132
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 133 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E++         G K    +           +I  I++ 
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT-------FGSKPYDGIPA--------SEISSILEK 234
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 235 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 273

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 76  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 132
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 133 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 234
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 235 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 273

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 79  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 135
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 136 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 237
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 238 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 276

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 483 IGRGGFGNVYKG----FLNGDS-TPVAIKRLNP-GSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G+G FG VY+G     + G++ T VA+K +N   S +  +EF  E  ++      H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLY--------NNDNPPLPWDRRLKICIGAARALH 588
           L+G  +     ++V + MA G L+ +L         N   PP      +++    A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           YL+   +K  +HRD+   N ++  ++  K+ DFG+ +            +    + ++ P
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 649 EYYRLQLLTEKSDVYSFGVVLLEV 672
           E  +  + T  SD++SFGVVL E+
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 128/275 (46%), Gaps = 22/275 (8%)
Query: 466 SISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM 525
           SI  + +  K +     IG+G  G VY          VAI+++N   Q        EI +
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 526 LSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR 585
           + + +  ++V+ +       ++ +V +Y+A G+L D +       +   +   +C    +
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQ 127
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIG 644
           AL +LH   S  +IHRD+K+ NILL  +   K++DFG C +  P  SK    + + G+  
Sbjct: 128 ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPY 181
Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL-AVWATECYRN-GK 702
           ++ PE    +    K D++S G++ +E++   PP L     + + L A   T   +N  K
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241
Query: 703 IGDIIDPFL----------KGNAPPVCLNQFVEVA 727
           +  I   FL          +G+A  +  +QF+++A
Sbjct: 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 70  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 126
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 127 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 228
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 267

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 128/275 (46%), Gaps = 22/275 (8%)
Query: 466 SISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM 525
           SI  + +  K +     IG+G  G VY          VAI+++N   Q        EI +
Sbjct: 12  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 71
Query: 526 LSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR 585
           + + +  ++V+ +       ++ +V +Y+A G+L D +       +   +   +C    +
Sbjct: 72  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQ 128
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIG 644
           AL +LH   S  +IHRD+K+ NILL  +   K++DFG C +  P  SK    + + G+  
Sbjct: 129 ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPY 182
Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL-AVWATECYRN-GK 702
           ++ PE    +    K D++S G++ +E++   PP L     + + L A   T   +N  K
Sbjct: 183 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 242
Query: 703 IGDIIDPFL----------KGNAPPVCLNQFVEVA 727
           +  I   FL          +G+A  +  +QF+++A
Sbjct: 243 LSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLKIA 277

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 483 IGRGGFGNVYKG----FLNGDS-TPVAIKRLNP-GSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G+G FG VY+G     + G++ T VA+K +N   S +  +EF  E  ++      H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLY--------NNDNPPLPWDRRLKICIGAARALH 588
           L+G  +     ++V + MA G L+ +L         N   PP      +++    A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYL 646
           YL+   +K  +HRD+   N ++  ++  K+ DFG+ +    +   +     KG   + ++
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETAYYRKGGKGLLPVRWM 199
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEV 672
            PE  +  + T  SD++SFGVVL E+
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 119/269 (44%), Gaps = 24/269 (8%)
Query: 482 IIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           +IG G FG V  G L         VAIK L  G +++   +F  E  ++ Q  + ++V L
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G       +++V ++M  G L   L  +D       + + +  G A  + YL   A   
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFLRKHDGQ-FTVIQLVGMLRGIAAGMRYL---ADMG 165
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
            +HRD+   NIL++   V KVSDFGL +    +    + +T  K  + +  PE  + +  
Sbjct: 166 YVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKF 225
Query: 657 TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP 716
           T  SDV+S+G+V+ EV+         G++   +++        N  +   I+   +  AP
Sbjct: 226 TSASDVWSYGIVMWEVMS-------YGERPYWDMS--------NQDVIKAIEEGYRLPAP 270
Query: 717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
             C     ++ + C   +R  RP    +V
Sbjct: 271 MDCPAGLHQLMLDCWQKERAERPKFEQIV 299

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 138/301 (45%), Gaps = 48/301 (15%)
Query: 479 NLLIIGR----GGFGNVYKGFL---NGDSTPVAIK--RLNPGSQQGALEFQTEIGMLSQL 529
           NLLI+G+    G FG+V +G L   +G S  VA+K  +L+  SQ+   EF +E   +   
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 530 RYLHLVSLIGYCNDDGQM-----ILVYDYMARGTLRDHLYNN--DNPP--LPWDRRLKIC 580
            + +++ L+G C +         +++  +M  G L  +L  +  +  P  +P    LK  
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 581 IGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVST 637
           +  A  + YL   +++  +HRD+   N +L ++    V+DFGL K    G  + +  ++ 
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIA- 209
Query: 638 QVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATEC 697
             K  + ++  E    ++ T KSDV++FGV + E+                  A      
Sbjct: 210 --KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI------------------ATRGMTP 249
Query: 698 YRNGKIGDIIDPFLKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
           Y   +  ++ D  L G+    P  CL++  E+  SC   D + RP+ S +   LE + + 
Sbjct: 250 YPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309
Query: 755 L 755
           L
Sbjct: 310 L 310

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 483 IGRGGFGNVYKG----FLNGDS-TPVAIKRLNP-GSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G+G FG VY+G     + G++ T VA+K +N   S +  +EF  E  ++      H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLY--------NNDNPPLPWDRRLKICIGAARALH 588
           L+G  +     ++V + MA G L+ +L         N   PP      +++    A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYL 646
           YL+   +K  +HRD+   N ++  ++  K+ DFG+ +    +   +     KG   + ++
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWM 199
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEV 672
            PE  +  + T  SD++SFGVVL E+
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 17/213 (7%)
Query: 471 KEATKDFNNLLIIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLS 527
           K + +DF  L  +G G FG V+  +   NG    + + +     +   +E    E  MLS
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDR--RLKICIGAAR 585
            + +  ++ + G   D  Q+ ++ DY+  G L   L  +   P P  +    ++C+    
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL---- 117
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
           AL YLH   SK II+RD+K  NILLD+    K++DFG  K+ P+     V+  + G+  Y
Sbjct: 118 ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGTPDY 169
Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           + PE    +   +  D +SFG+++ E+L    P
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 116/271 (42%), Gaps = 28/271 (10%)
Query: 482 IIGRGGFGNVYKGFLNGDSTP---VAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           ++G G FG V  G L   S     VAIK L  G +++   +F  E  ++ Q  + +++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G       +++V + M  G+L   L  +D       + + +  G A  + YL    +  
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGA-- 168
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLL 656
            +HRD+   NIL++   V KVSDFGL +   +  +   +T+  K  I +  PE    +  
Sbjct: 169 -VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 657 TEKSDVYSFGVVLLEVLC--ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
           T  SDV+S+G+VL EV+    RP               W      N  +   +D   +  
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP--------------YWEMS---NQDVIKAVDEGYRLP 270
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
            P  C     ++ + C   DR  RP    +V
Sbjct: 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 124/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 79  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 135
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 136 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 237
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      +   C   D   RP   +++  +EF
Sbjct: 238 GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI--IEF 276

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 124/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 86  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 142
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 143 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 199
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 200 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 244
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      +   C   D   RP   +++  +EF
Sbjct: 245 GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI--IEF 283

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 483 IGRGGFGNVYKG----FLNGDS-TPVAIKRLNP-GSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G+G FG VY+G     + G++ T VA+K +N   S +  +EF  E  ++      H+V 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLY--------NNDNPPLPWDRRLKICIGAARALH 588
           L+G  +     ++V + MA G L+ +L         N   PP      +++    A  + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYL 646
           YL+   +K  +HRD+   N ++  ++  K+ DFG+ +    +   +     KG   + ++
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWM 198
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEV 672
            PE  +  + T  SD++SFGVVL E+
Sbjct: 199 APESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 124/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A  ++Y
Sbjct: 73  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAEGMNY 129
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 130 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 186
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 187 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 231
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 232 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 270

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKR----LNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           IGRG FG V+ G L  D+T VA+K     L P  +    +F  E  +L Q  + ++V LI
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA---KFLQEARILKQYSHPNIVRLI 178
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVI 598
           G C     + +V + +  G     L   +   L     L++   AA  + YL    SK  
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE---SKCC 234
Query: 599 IHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTE 658
           IHRD+   N L+ E+ V K+SDFG+ +   +          +  + +  PE       + 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 659 KSDVYSFGVVLLE 671
           +SDV+SFG++L E
Sbjct: 295 ESDVWSFGILLWE 307

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 483 IGRGGFGNVYK----GFLNGDST-PVAIKRLNPGSQQGALE-FQTEIGMLSQL-RYLHLV 535
           +G G FG V +    G    D+   VA+K L   +     E   +E+ ++S L ++ ++V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLY--------NNDNPPLPWDRRLKICIGAARAL 587
           +L+G C   G ++++ +Y   G L + L           D  PL     L      A+ +
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
            +L   ASK  IHRDV   N+LL    VAK+ DFGL +   N S   V    +  + ++ 
Sbjct: 166 AFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 222
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVL 673
           PE     + T +SDV+S+G++L E+ 
Sbjct: 223 PESIFDCVYTVQSDVWSYGILLWEIF 248

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 124/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 76  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 132
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 133 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 234
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      +   C   D   RP   +++  +EF
Sbjct: 235 GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI--IEF 273

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 92/198 (46%), Gaps = 11/198 (5%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+G FG+V    Y    +     VA+K+L         +FQ EI +L  L    +V   
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 539 GYCNDDG--QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           G     G  ++ LV +Y+  G LRD L  +    L   R L       + + YL    S+
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYL---GSR 130
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS-IGYLDPEYYRLQL 655
             +HRD+   NIL++ E   K++DFGL K  P      V  +   S I +  PE     +
Sbjct: 131 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNI 190
Query: 656 LTEKSDVYSFGVVLLEVL 673
            + +SDV+SFGVVL E+ 
Sbjct: 191 FSRQSDVWSFGVVLYELF 208

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 108/246 (43%), Gaps = 35/246 (14%)
Query: 451 RGPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP 510
           RG   + PS L  ++ + EI            +G GG   V+          VA+K L  
Sbjct: 17  RGSHMTTPSHLSDRYELGEI------------LGFGGMSEVHLARDLRLHRDVAVKVLRA 64
Query: 511 GSQQGA---LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQM--------ILVYDYMARGTL 559
              +     L F+ E    + L +  +V++     D G+          +V +Y+   TL
Sbjct: 65  DLARDPSFYLRFRREAQNAAALNHPAIVAVY----DTGEAETPAGPLPYIVMEYVDGVTL 120
Query: 560 RDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVS 619
           RD ++     P+   R +++   A +AL++ H      IIHRDVK  NI++      KV 
Sbjct: 121 RDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVM 175
Query: 620 DFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           DFG+ +   +   +   T  V G+  YL PE  R   +  +SDVYS G VL EVL   PP
Sbjct: 176 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235
Query: 679 ILRTGD 684
              TGD
Sbjct: 236 F--TGD 239

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 483 IGRGGFGNVYK----GFLNGDST-PVAIKRLNPGSQQGALE-FQTEIGMLSQL-RYLHLV 535
           +G G FG V +    G    D+   VA+K L   +     E   +E+ ++S L ++ ++V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLY--------NNDNPPLPWDRRLKICIGAARAL 587
           +L+G C   G ++++ +Y   G L + L           D  PL     L      A+ +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
            +L   ASK  IHRDV   N+LL    VAK+ DFGL +   N S   V    +  + ++ 
Sbjct: 174 AFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 230
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVL 673
           PE     + T +SDV+S+G++L E+ 
Sbjct: 231 PESIFDCVYTVQSDVWSYGILLWEIF 256

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/137 (36%), Positives = 71/137 (51%), Gaps = 8/137 (5%)
Query: 549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNI 608
           +V +Y+   TLRD ++     P+   R +++   A +AL++ H      IIHRDVK  NI
Sbjct: 93  IVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 609 LLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLLTEKSDVYSFGV 667
           ++      KV DFG+ +   +   +   T  V G+  YL PE  R   +  +SDVYS G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 668 VLLEVLCARPPILRTGD 684
           VL EVL   PP   TGD
Sbjct: 208 VLYEVLTGEPPF--TGD 222

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/137 (36%), Positives = 71/137 (51%), Gaps = 8/137 (5%)
Query: 549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNI 608
           +V +Y+   TLRD ++     P+   R +++   A +AL++ H      IIHRDVK  NI
Sbjct: 93  IVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 609 LLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLLTEKSDVYSFGV 667
           ++      KV DFG+ +   +   +   T  V G+  YL PE  R   +  +SDVYS G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 668 VLLEVLCARPPILRTGD 684
           VL EVL   PP   TGD
Sbjct: 208 VLYEVLTGEPPF--TGD 222

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 19/228 (8%)
Query: 454 ASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS- 512
           +S  P  L   F+I        DF     +G+G FGNVY          VA+K L     
Sbjct: 9   SSGTPDILTRHFTID-------DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQI 61
Query: 513 QQGALEFQ--TEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPP 570
           ++  +E Q   EI + + L + +++ L  Y  D  ++ L+ +Y  RG L   L  +    
Sbjct: 62  EKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCT-- 119
Query: 571 LPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF 630
               R   I    A AL Y H    K +IHRD+K  N+LL  +   K++DFG     P+ 
Sbjct: 120 FDEQRTATIMEELADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSL 176
Query: 631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            +  +     G++ YL PE    ++  EK D++  GV+  E+L   PP
Sbjct: 177 RRKTMC----GTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPP 220

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKR----LNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           IGRG FG V+ G L  D+T VA+K     L P  +    +F  E  +L Q  + ++V LI
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA---KFLQEARILKQYSHPNIVRLI 178
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVI 598
           G C     + +V + +  G     L   +   L     L++   AA  + YL    SK  
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE---SKCC 234
Query: 599 IHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTE 658
           IHRD+   N L+ E+ V K+SDFG+ +   +          +  + +  PE       + 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 659 KSDVYSFGVVLLE 671
           +SDV+SFG++L E
Sbjct: 295 ESDVWSFGILLWE 307

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 124/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++  G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 83  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 139
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 140 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 241
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 242 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 280

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 116/271 (42%), Gaps = 28/271 (10%)
Query: 482 IIGRGGFGNVYKGFLNGDSTP---VAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           ++G G FG V  G L   S     VAIK L  G +++   +F  E  ++ Q  + +++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G       +++V + M  G+L   L  +D       + + +  G A  + YL   +   
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLL 656
            +HRD+   NIL++   V KVSDFGL +   +  +   +T+  K  I +  PE    +  
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 657 TEKSDVYSFGVVLLEVLC--ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
           T  SDV+S+G+VL EV+    RP               W      N  +   +D   +  
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP--------------YWEMS---NQDVIKAVDEGYRLP 270
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
            P  C     ++ + C   DR  RP    +V
Sbjct: 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 124/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 78  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 134
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFG  K      K + +   K  I ++  E
Sbjct: 135 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 236
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 237 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 275

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 483 IGRGGFGNVYKGFLN--GDST--PVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSL 537
           +G G FG V     +  GD+T   VA+K L P S    + + + EI +L  L + ++V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 538 IGYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
            G C +DG   + L+ +++  G+L+++L  N N  +   ++LK  +   + + YL    S
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYL---GS 144
Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
           +  +HRD+   N+L++ E   K+ DFGL K    +     V       + +  PE     
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 204
Query: 655 LLTEKSDVYSFGVVLLEVL 673
                SDV+SFGV L E+L
Sbjct: 205 KFYIASDVWSFGVTLHELL 223

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNP-----GSQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G FG V   +       VA+K +N         QG +E   EI  L  LR+ H++ L
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 78
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
                   ++I+V +Y A   L D++   D       RR    I    A+ Y H      
Sbjct: 79  YDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQI--ISAVEYCHRHK--- 132
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKF--GPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
           I+HRD+K  N+LLDE    K++DFGL       NF KT       GS  Y  PE    +L
Sbjct: 133 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC-----GSPNYAAPEVISGKL 187
Query: 656 LT-EKSDVYSFGVVLLEVLCARPP 678
               + DV+S GV+L  +LC R P
Sbjct: 188 YAGPEVDVWSCGVILYVMLCRRLP 211

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 124/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 80  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 136
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFG  K      K + +   K  I ++  E
Sbjct: 137 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 194 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 238
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 239 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 277

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 116/271 (42%), Gaps = 28/271 (10%)
Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           ++G G FG V  G L   +     VAIK L  G +++   +F  E  ++ Q  + +++ L
Sbjct: 23  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 82
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G       +++V + M  G+L   L  +D       + + +  G A  + YL   +   
Sbjct: 83  EGVVTKSKPVMIVTEXMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL---SDMG 138
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLL 656
            +HRD+   NIL++   V KVSDFGL +   +  +   +T+  K  I +  PE    +  
Sbjct: 139 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 198
Query: 657 TEKSDVYSFGVVLLEVLC--ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
           T  SDV+S+G+VL EV+    RP               W      N  +   +D   +  
Sbjct: 199 TSASDVWSYGIVLWEVMSYGERP--------------YWEMS---NQDVIKAVDEGYRLP 241
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
            P  C     ++ + C   DR  RP    +V
Sbjct: 242 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 272

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 22/220 (10%)
Query: 477 FNNLLIIGRGGFGNVYK------GFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           F +  ++GRGGFG V+       G L         +       QGA+    E  +L+++ 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVH 243
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYN--NDNPPLPWDRRLKICIGAARALH 588
              +VSL         + LV   M  G +R H+YN   DNP     R +         L 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC---KFGPNFSKTHVSTQVKGSIGY 645
           +LH    + II+RD+K  N+LLD++   ++SD GL    K G   +K +      G+ G+
Sbjct: 304 HLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GTPGF 355
Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDK 685
           + PE    +      D ++ GV L E++ AR P    G+K
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK 395

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNP-----GSQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G FG V   +       VA+K +N         QG +E   EI  L  LR+ H++ L
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 79
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
                   ++I+V +Y A   L D++   D       RR    I    A+ Y H      
Sbjct: 80  YDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQI--ISAVEYCHRHK--- 133
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGP--NFSKTHVSTQVKGSIGYLDPEYYRLQL 655
           I+HRD+K  N+LLDE    K++DFGL       NF KT       GS  Y  PE    +L
Sbjct: 134 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC-----GSPNYAAPEVISGKL 188
Query: 656 LT-EKSDVYSFGVVLLEVLCARPP 678
               + DV+S GV+L  +LC R P
Sbjct: 189 YAGPEVDVWSCGVILYVMLCRRLP 212

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 124/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++  G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 83  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 139
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 140 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 241
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 242 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 280

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 120/267 (44%), Gaps = 22/267 (8%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V  G   G    VA+K +  GS     EF  E   + +L +  LV   G C+
Sbjct: 16  LGSGQFGVVKLGKWKG-QYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + +V +Y++ G L ++L ++     P  + L++C      + +L    S   IHRD
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKGLEP-SQLLEMCYDVCEGMAFL---ESHQFIHRD 129
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDV 662
           +   N L+D +   KVSDFG+ ++  +  +   S   K  + +  PE +     + KSDV
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDV 188
Query: 663 YSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQ 722
           ++FG+++ EV                +L     + Y N ++   +    +   P +  + 
Sbjct: 189 WAFGILMWEVF---------------SLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDT 233
Query: 723 FVEVAMSCVNDDRIRRPSMSDVVWGLE 749
             ++  SC ++   +RP+   ++  +E
Sbjct: 234 IYQIMYSCWHELPEKRPTFQQLLSSIE 260

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 124/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++  G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 76  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 132
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 133 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 234
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 235 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 273

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 124/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 76  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 132
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFG  K      K + +   K  I ++  E
Sbjct: 133 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 234
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 235 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 273

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 22/220 (10%)
Query: 477 FNNLLIIGRGGFGNVYK------GFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           F +  ++GRGGFG V+       G L         +       QGA+    E  +L+++ 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVH 243
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYN--NDNPPLPWDRRLKICIGAARALH 588
              +VSL         + LV   M  G +R H+YN   DNP     R +         L 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC---KFGPNFSKTHVSTQVKGSIGY 645
           +LH    + II+RD+K  N+LLD++   ++SD GL    K G   +K +      G+ G+
Sbjct: 304 HLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GTPGF 355
Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDK 685
           + PE    +      D ++ GV L E++ AR P    G+K
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK 395

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 22/220 (10%)
Query: 477 FNNLLIIGRGGFGNVYK------GFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           F +  ++GRGGFG V+       G L         +       QGA+    E  +L+++ 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVH 243
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYN--NDNPPLPWDRRLKICIGAARALH 588
              +VSL         + LV   M  G +R H+YN   DNP     R +         L 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC---KFGPNFSKTHVSTQVKGSIGY 645
           +LH    + II+RD+K  N+LLD++   ++SD GL    K G   +K +      G+ G+
Sbjct: 304 HLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GTPGF 355
Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDK 685
           + PE    +      D ++ GV L E++ AR P    G+K
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK 395

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 124/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 83  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 139
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFG  K      K + +   K  I ++  E
Sbjct: 140 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 241
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 242 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 280

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 483 IGRGGFGNVYKG----FLNGDS-TPVAIKRLNP-GSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G+G FG VY+G     + G++ T VA+K +N   S +  +EF  E  ++      H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLY--------NNDNPPLPWDRRLKICIGAARALH 588
           L+G  +     ++V + MA G L+ +L         N   PP      +++    A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYL 646
           YL+   +K  +HR++   N ++  ++  K+ DFG+ +    +   +     KG   + ++
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWM 199
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEV 672
            PE  +  + T  SD++SFGVVL E+
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNP-----GSQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G FG V   +       VA+K +N         QG +E   EI  L  LR+ H++ L
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 69
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
                   ++I+V +Y A   L D++   D       RR    I +A  + Y H      
Sbjct: 70  YDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISA--VEYCHRHK--- 123
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGP--NFSKTHVSTQVKGSIGYLDPEYYRLQL 655
           I+HRD+K  N+LLDE    K++DFGL       NF KT       GS  Y  PE    +L
Sbjct: 124 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC-----GSPNYAAPEVISGKL 178
Query: 656 LT-EKSDVYSFGVVLLEVLCARPP 678
               + DV+S GV+L  +LC R P
Sbjct: 179 YAGPEVDVWSCGVILYVMLCRRLP 202

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 118/267 (44%), Gaps = 23/267 (8%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRL---NPGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           IGRG F  VY+     D  PVA+K++   +    +   +   EI +L QL + +++    
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 540 YCNDDGQMILVYDYMARGTLRDHL--YNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
              +D ++ +V +    G L   +  +      +P     K  +    AL ++H   S+ 
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRR 156
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLT 657
           ++HRD+K  N+ +    V K+ D GL +F    SKT  +  + G+  Y+ PE        
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPERIHENGYN 214
Query: 658 EKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPP 717
            KSD++S G +L E+   + P    GDK  +NL           KI     P L  +   
Sbjct: 215 FKSDIWSLGCLLYEMAALQSPFY--GDK--MNLYSLCK------KIEQCDYPPLPSDHYS 264
Query: 718 VCLNQFVEVAMSCVNDDRIRRPSMSDV 744
             L Q V +   C+N D  +RP ++ V
Sbjct: 265 EELRQLVNM---CINPDPEKRPDVTYV 288

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 22/220 (10%)
Query: 477 FNNLLIIGRGGFGNVYK------GFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           F +  ++GRGGFG V+       G L         +       QGA+    E  +L+++ 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVH 243
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYN--NDNPPLPWDRRLKICIGAARALH 588
              +VSL         + LV   M  G +R H+YN   DNP     R +         L 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC---KFGPNFSKTHVSTQVKGSIGY 645
           +LH    + II+RD+K  N+LLD++   ++SD GL    K G   +K +      G+ G+
Sbjct: 304 HLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GTPGF 355
Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDK 685
           + PE    +      D ++ GV L E++ AR P    G+K
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK 395

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 124/281 (44%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAI  L   +   A  E   E  +++ + 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 110 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 166
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E
Sbjct: 167 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 223
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E++         G K    +           +I  I++ 
Sbjct: 224 SILHRIYTHQSDVWSYGVTVWELMT-------FGSKPYDGIPA--------SEISSILEK 268
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      + + C   D   RP   +++  +EF
Sbjct: 269 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI--IEF 307

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 483 IGRGGFGNVYKGFLN--GDST--PVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSL 537
           +G G FG V     +  GD+T   VA+K L P S    + + + EI +L  L + ++V  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 538 IGYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
            G C +DG   + L+ +++  G+L+++L  N N  +   ++LK  +   + + YL    S
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYL---GS 132
Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
           +  +HRD+   N+L++ E   K+ DFGL K    +     V       + +  PE     
Sbjct: 133 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 192
Query: 655 LLTEKSDVYSFGVVLLEVL 673
                SDV+SFGV L E+L
Sbjct: 193 KFYIASDVWSFGVTLHELL 211

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNP-----GSQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G FG V   +       VA+K +N         QG +E   EI  L  LR+ H++ L
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 73
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
                   ++I+V +Y A   L D++   D       RR    I    A+ Y H      
Sbjct: 74  YDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQI--ISAVEYCHRHK--- 127
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGP--NFSKTHVSTQVKGSIGYLDPEYYRLQL 655
           I+HRD+K  N+LLDE    K++DFGL       NF KT       GS  Y  PE    +L
Sbjct: 128 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC-----GSPNYAAPEVISGKL 182
Query: 656 LT-EKSDVYSFGVVLLEVLCARPP 678
               + DV+S GV+L  +LC R P
Sbjct: 183 YAGPEVDVWSCGVILYVMLCRRLP 206

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 483 IGRGGFGNVYKG----FLNGDS-TPVAIKRLNP-GSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G+G FG VY+G     + G++ T VA+K +N   S +  +EF  E  ++      H+V 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLY--------NNDNPPLPWDRRLKICIGAARALH 588
           L+G  +     ++V + MA G L+ +L         N   PP      +++    A  + 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYL 646
           YL+   +K  +HR++   N ++  ++  K+ DFG+ +    +   +     KG   + ++
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWM 200
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEV 672
            PE  +  + T  SD++SFGVVL E+
Sbjct: 201 APESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 118/279 (42%), Gaps = 43/279 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHLV 535
           F  L  IG+G FG V+KG  N     VAIK ++   ++    + Q EI +LSQ    ++ 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
              G      ++ ++ +Y+  G+  D L             LK  +   + L YLH   S
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLH---S 138
Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK-----GSIGYLDPEY 650
           +  IHRD+K  N+LL E+   K++DFG+       +     TQ+K     G+  ++ PE 
Sbjct: 139 EKKIHRDIKAANVLLSEQGDVKLADFGV-------AGQLTDTQIKRNTFVGTPFWMAPEV 191
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF 710
            +      K+D++S G+  +E+    PP     D   + +                    
Sbjct: 192 IQQSAYDSKADIWSLGITAIELAKGEPP---NSDMHPMRVLF-----------------L 231
Query: 711 LKGNAPPVCLNQFV----EVAMSCVNDDRIRRPSMSDVV 745
           +  N PP  +  F     E   +C+N D   RP+  +++
Sbjct: 232 IPKNNPPTLVGDFTKSFKEFIDACLNKDPSFRPTAKELL 270

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 96/209 (45%), Gaps = 34/209 (16%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G FG V    Y    +G    VA+K L  G   Q    +Q EI +L  L + H+V  
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 538 IGYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARAL-------- 587
            G C D G+  + LV +Y+  G+LRD+L  +             C+G A+ L        
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH-------------CVGLAQLLLFAQQICE 122
Query: 588 --HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH-VSTQVKGSIG 644
              YLH   ++  IHR +   N+LLD + + K+ DFGL K  P   + + V       + 
Sbjct: 123 GMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 179
Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
           +  PE  +       SDV+SFGV L E+L
Sbjct: 180 WYAPECLKECKFYYASDVWSFGVTLYELL 208

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 128/274 (46%), Gaps = 22/274 (8%)
Query: 467 ISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGML 526
           I  + +  K +     IG+G  G VY          VAI+++N   Q        EI ++
Sbjct: 13  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 72
Query: 527 SQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARA 586
            + +  ++V+ +       ++ +V +Y+A G+L D +       +   +   +C    +A
Sbjct: 73  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQA 129
Query: 587 LHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGY 645
           L +LH   S  +IHR++K+ NILL  +   K++DFG C +  P  SK   ST V G+  +
Sbjct: 130 LEFLH---SNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMV-GTPYW 183
Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL-AVWATECYRN-GKI 703
           + PE    +    K D++S G++ +E++   PP L     + + L A   T   +N  K+
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 243
Query: 704 GDIIDPFL----------KGNAPPVCLNQFVEVA 727
             I   FL          +G+A  +  +QF+++A
Sbjct: 244 SAIFRDFLNRCLEMDVEKRGSAKELIQHQFLKIA 277

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 96/209 (45%), Gaps = 34/209 (16%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G FG V    Y    +G    VA+K L  G   Q    +Q EI +L  L + H+V  
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 538 IGYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARAL-------- 587
            G C D G+  + LV +Y+  G+LRD+L  +             C+G A+ L        
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH-------------CVGLAQLLLFAQQICE 123
Query: 588 --HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH-VSTQVKGSIG 644
              YLH   ++  IHR +   N+LLD + + K+ DFGL K  P   + + V       + 
Sbjct: 124 GMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 180
Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
           +  PE  +       SDV+SFGV L E+L
Sbjct: 181 WYAPECLKECKFYYASDVWSFGVTLYELL 209

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 123/281 (43%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 78  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 134
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFG  K      K + +   K  I ++  E
Sbjct: 135 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 236
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      +   C   D   RP   +++  +EF
Sbjct: 237 GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI--IEF 275

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 13/204 (6%)
Query: 478 NNLLI----IGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQG-ALEFQTEIGMLSQLR 530
           +NLLI    +G G FG+V +G   +      VAIK L  G+++    E   E  ++ QL 
Sbjct: 9   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 68
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
             ++V LIG C  +  ++LV +    G L   L       +P     ++    +  + YL
Sbjct: 69  NPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYL 126
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDPE 649
                K  +HRD+   N+LL     AK+SDFGL K  G + S     +  K  + +  PE
Sbjct: 127 E---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 183
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVL 673
               +  + +SDV+S+GV + E L
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEAL 207

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 123/281 (43%), Gaps = 29/281 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFL--NGDST--PVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG     G+    PVAIK L   +   A  E   E  +++ + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHY 589
             H+  L+G C     + L+   M  G L D++  + DN  +     L  C+  A+ ++Y
Sbjct: 78  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 134
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L     + ++HRD+   N+L+      K++DFG  K      K + +   K  I ++  E
Sbjct: 135 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP 709
               ++ T +SDV+S+GV + E       ++  G K    +           +I  I++ 
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPA--------SEISSILEK 236
Query: 710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF 750
             +   PP+C      +   C   D   RP   +++  +EF
Sbjct: 237 GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI--IEF 275

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG VYK          A K +   S++   ++  EI +L+   + ++V L+G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK------ICIGAARALHYLHTGASK 596
            DG++ ++ ++   G +       D   L  DR L       +C     AL++LH   SK
Sbjct: 87  HDGKLWIMIEFCPGGAV-------DAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SK 136
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
            IIHRD+K  N+L+  E   +++DFG+     N           G+  ++ PE    + +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 657 TE-----KSDVYSFGVVLLEVLCARPP 678
            +     K+D++S G+ L+E+    PP
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 24/204 (11%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRL--NPGSQQGALEFQTEIGMLSQLRYLHLVS 536
           +G G FG V    Y    +G    VA+K L  + G Q  +  ++ EI +L  L + H++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRS-GWKQEIDILRTLYHEHIIK 97
Query: 537 LIGYCNDDG--QMILVYDYMARGTLRDHLYNNDNPPLPWDRRL----KICIGAARALHYL 590
             G C D G   + LV +Y+  G+LRD+L  +    +   + L    +IC G A    YL
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMA----YL 150
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH-VSTQVKGSIGYLDPE 649
           H   ++  IHRD+   N+LLD + + K+ DFGL K  P   + + V       + +  PE
Sbjct: 151 H---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPE 207
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVL 673
             +       SDV+SFGV L E+L
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELL 231

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLN----PGSQQGALEFQTEIGMLSQLRYLHL 534
           +G G FG V    Y    +G    VA+K L     P  + G   ++ EI +L  L + H+
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG---WKQEIDILRTLYHEHI 78
Query: 535 VSLIGYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRL----KICIGAARALH 588
           +   G C D G+  + LV +Y+  G+LRD+L  +    +   + L    +IC G A    
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMA---- 131
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH-VSTQVKGSIGYLD 647
           YLH   S+  IHR++   N+LLD + + K+ DFGL K  P   + + V       + +  
Sbjct: 132 YLH---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 188
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVL 673
           PE  +       SDV+SFGV L E+L
Sbjct: 189 PECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG VYK          A K +   S++   ++  EI +L+   + ++V L+G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK------ICIGAARALHYLHTGASK 596
            DG++ ++ ++   G +       D   L  DR L       +C     AL++LH   SK
Sbjct: 79  HDGKLWIMIEFCPGGAV-------DAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SK 128
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
            IIHRD+K  N+L+  E   +++DFG+     N           G+  ++ PE    + +
Sbjct: 129 RIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMCETM 186
Query: 657 TE-----KSDVYSFGVVLLEVLCARPP 678
            +     K+D++S G+ L+E+    PP
Sbjct: 187 KDTPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 135/294 (45%), Gaps = 45/294 (15%)
Query: 483 IGRGGFGNVYKGFLNG-DSTP----VAIKRLNPG---SQQGALEFQTEIGMLSQL-RYLH 533
           +GRG FG V +    G D T     VA+K L  G   S+  AL   +E+ +L  +  +L+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 92
Query: 534 LVSLIGYCND-DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK--------IC--IG 582
           +V+L+G C    G ++++ ++   G L  +L +  N  +P+    K        IC    
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQ 152
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQV 639
            A+ + +L   AS+  IHRD+   NILL E+ V K+ DFGL +     P++ +       
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR---KGDA 206
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV+L E       I   G      + +    C R
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------IFSLGASPYPGVKIDEEFCRR 259
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
                  +    +  AP     +  +  + C + +  +RP+ S++V  L  + Q
Sbjct: 260 -------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 478 NNLLI----IGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQG-ALEFQTEIGMLSQLR 530
           +NLLI    +G G FG+V +G   +      VAIK L  G+++    E   E  ++ QL 
Sbjct: 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 394
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG-AARALHY 589
             ++V LIG C  +  ++LV +    G L   L           +R +I +   A  LH 
Sbjct: 395 NPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVG---------KREEIPVSNVAELLHQ 444
Query: 590 LHTG----ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIG 644
           +  G      K  +HR++   N+LL     AK+SDFGL K  G + S     +  K  + 
Sbjct: 445 VSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504
Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
           +  PE    +  + +SDV+S+GV + E L
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEAL 533

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 483 IGRGGFGNV----YKGFLNGDSTPVAIKRLN----PGSQQGALEFQTEIGMLSQLRYLHL 534
           +G G FG V    Y    +G    VA+K L     P  + G   ++ EI +L  L + H+
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG---WKQEIDILRTLYHEHI 78
Query: 535 VSLIGYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRL----KICIGAARALH 588
           +   G C D G+  + LV +Y+  G+LRD+L  +    +   + L    +IC G A    
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMA---- 131
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH-VSTQVKGSIGYLD 647
           YLH   ++  IHR++   N+LLD + + K+ DFGL K  P   + + V       + +  
Sbjct: 132 YLH---AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 188
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVL 673
           PE  +       SDV+SFGV L E+L
Sbjct: 189 PECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 127/293 (43%), Gaps = 34/293 (11%)
Query: 482 IIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           +IG G FG V  G L         VAIK L  G + +   +F +E  ++ Q  + +++ L
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 95
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G       ++++ +YM  G+L   L  ND       + + +  G    + YL   ++  
Sbjct: 96  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGR-FTVIQLVGMLRGIGSGMKYLSDMSA-- 152
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLL 656
            +HRD+   NIL++   V KVSDFG+ +   +  +   +T+  K  I +  PE    +  
Sbjct: 153 -VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 211
Query: 657 TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN-- 714
           T  SDV+S+G+V+ EV+                   +    Y +    D+I    +G   
Sbjct: 212 TSASDVWSYGIVMWEVMS------------------YGERPYWDMSNQDVIKAIEEGYRL 253
Query: 715 APPV-CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ----LLRESSEKS 762
            PP+ C     ++ + C   +R  RP    +V  L+ + +    L R  SE S
Sbjct: 254 PPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRNPNSLKRTGSESS 306

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 122/307 (39%), Gaps = 70/307 (22%)
Query: 483 IGRGGFGNVYKG---FLNGDS--TPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVS 536
           +G G FG V K     L G +  T VA+K L   +    L +  +E  +L Q+ + H++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNN----------------------DNPPLPWD 574
           L G C+ DG ++L+ +Y   G+LR  L  +                      D   L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 575 RRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH 634
             +      ++ + YL   A   ++HRD+   NIL+ E    K+SDFGL +         
Sbjct: 151 DLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-------ARPP-----ILRT 682
             +Q +  + ++  E     + T +SDV+SFGV+L E++          PP     +L+T
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT 267
Query: 683 GDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMS 742
           G + +                            P  C  +   + + C   +  +RP  +
Sbjct: 268 GHRME---------------------------RPDNCSEEMYRLMLQCWKQEPDKRPVFA 300
Query: 743 DVVWGLE 749
           D+   LE
Sbjct: 301 DISKDLE 307

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 139/297 (46%), Gaps = 51/297 (17%)
Query: 483 IGRGGFGNVYKGFLNG-DSTP----VAIKRLNPG---SQQGALEFQTEIGMLSQL-RYLH 533
           +GRG FG V +    G D T     VA+K L  G   S+  AL   +E+ +L  +  +L+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 92
Query: 534 LVSLIGYCND-DGQMILVYDYMARGTLRDHLYNNDNPPLPW----------DRRLKICIG 582
           +V+L+G C    G ++++ ++   G L  +L +  N  +P+          +  +     
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQ 152
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQV 639
            A+ + +L   AS+  IHRD+   NILL E+ V K+ DFGL +     P++ +       
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVR---KGDA 206
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEV--LCARP-PILRTGDKKQVNLAVWATE 696
           +  + ++ PE    ++ T +SDV+SFGV+L E+  L A P P ++  +           E
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----------E 255
Query: 697 CYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
             R  K G       +  AP     +  +  + C + +  +RP+ S++V  L  + Q
Sbjct: 256 FXRRLKEGT------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 102/223 (45%), Gaps = 18/223 (8%)
Query: 466 SISEIKEAT-KDFNNLLIIGRGGFGNVYKGFLNG---DSTP--VAIKRL-NPGSQQGALE 518
           SIS++KE   K+   +  +G G FG VY+G ++G   D +P  VA+K L    S+Q  L+
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 80
Query: 519 FQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPP-----LPW 573
           F  E  ++S+L + ++V  IG         ++ + MA G L+  L      P     L  
Sbjct: 81  FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 140
Query: 574 DRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPNF 630
              L +    A    YL        IHRD+   N LL       VAK+ DFG+ +     
Sbjct: 141 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 197
Query: 631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
           S           + ++ PE +   + T K+D +SFGV+L E+ 
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 122/307 (39%), Gaps = 70/307 (22%)
Query: 483 IGRGGFGNVYKG---FLNGDS--TPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVS 536
           +G G FG V K     L G +  T VA+K L   +    L +  +E  +L Q+ + H++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNN----------------------DNPPLPWD 574
           L G C+ DG ++L+ +Y   G+LR  L  +                      D   L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 575 RRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH 634
             +      ++ + YL   A   ++HRD+   NIL+ E    K+SDFGL +         
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-------ARPP-----ILRT 682
             +Q +  + ++  E     + T +SDV+SFGV+L E++          PP     +L+T
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT 267
Query: 683 GDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMS 742
           G + +                            P  C  +   + + C   +  +RP  +
Sbjct: 268 GHRME---------------------------RPDNCSEEMYRLMLQCWKQEPDKRPVFA 300
Query: 743 DVVWGLE 749
           D+   LE
Sbjct: 301 DISKDLE 307

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 102/223 (45%), Gaps = 18/223 (8%)
Query: 466 SISEIKEAT-KDFNNLLIIGRGGFGNVYKGFLNG---DSTP--VAIKRL-NPGSQQGALE 518
           SIS++KE   K+   +  +G G FG VY+G ++G   D +P  VA+K L    S+Q  L+
Sbjct: 35  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 94
Query: 519 FQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPP-----LPW 573
           F  E  ++S+L + ++V  IG         ++ + MA G L+  L      P     L  
Sbjct: 95  FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 154
Query: 574 DRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPNF 630
              L +    A    YL        IHRD+   N LL       VAK+ DFG+ +     
Sbjct: 155 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
           S           + ++ PE +   + T K+D +SFGV+L E+ 
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 254

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 125/290 (43%), Gaps = 40/290 (13%)
Query: 483 IGRGGFGNVYK----GFLNGDST-PVAIKRLNPGSQQGALE-FQTEIGMLSQL-RYLHLV 535
           +G G FG V +    G +  D+   VA+K L P +     E   +E+ +LS L  ++++V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 536 SLIGYCNDDGQMILVYDYMARGTL-------RDHLYNNDNPP---------LPWDRRLKI 579
           +L+G C   G  +++ +Y   G L       RD    +   P         L  +  L  
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 580 CIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               A+ + +L   ASK  IHRD+   NILL    + K+ DFGL +   N S   V    
Sbjct: 174 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE     + T +SDV+S+G+ L E       +   G      + V       
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWE-------LFSLGSSPYPGMPV------- 276
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
           + K   +I    +  +P     +  ++  +C + D ++RP+   +V  +E
Sbjct: 277 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQ------- 528
           DF+ L +IG+G FG V       +    A+K L    ++  L+ + E  ++S+       
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL---QKKAILKKKEEKHIMSERNVLLKN 95
Query: 529 LRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALH 588
           +++  LV L        ++  V DY+  G L  HL        P  R     I  A AL 
Sbjct: 96  VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI--ASALG 153
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           YLH   S  I++RD+K  NILLD +    ++DFGLCK   N      ++   G+  YL P
Sbjct: 154 YLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAP 208
Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           E    Q      D +  G VL E+L   PP
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 122/307 (39%), Gaps = 70/307 (22%)
Query: 483 IGRGGFGNVYKG---FLNGDS--TPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVS 536
           +G G FG V K     L G +  T VA+K L   +    L +  +E  +L Q+ + H++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNN----------------------DNPPLPWD 574
           L G C+ DG ++L+ +Y   G+LR  L  +                      D   L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 575 RRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH 634
             +      ++ + YL   A   ++HRD+   NIL+ E    K+SDFGL +         
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-------ARPP-----ILRT 682
             +Q +  + ++  E     + T +SDV+SFGV+L E++          PP     +L+T
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT 267
Query: 683 GDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMS 742
           G + +                            P  C  +   + + C   +  +RP  +
Sbjct: 268 GHRME---------------------------RPDNCSEEMYRLMLQCWKQEPDKRPVFA 300
Query: 743 DVVWGLE 749
           D+   LE
Sbjct: 301 DISKDLE 307

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 483 IGRGGFGNVYK----GFLNGDST-PVAIKRLNPGSQQGALE-FQTEIGMLSQL-RYLHLV 535
           +G G FG V +    G    D+   VA+K L   +     E   +E+ ++S L ++ ++V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG-- 593
           +L+G C   G ++++ +Y   G L + L    +  L  D    I    A     LH    
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFL-RRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 594 --------ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
                   ASK  IHRDV   N+LL    VAK+ DFGL +   N S   V    +  + +
Sbjct: 173 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 232
Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
           + PE     + T +SDV+S+G++L E+ 
Sbjct: 233 MAPESIFDCVYTVQSDVWSYGILLWEIF 260

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 483 IGRGGFGNVYK----GFLNGDST-PVAIKRLNPGSQQGALE-FQTEIGMLSQL-RYLHLV 535
           +G G FG V +    G    D+   VA+K L   +     E   +E+ ++S L ++ ++V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRR--------------LKICI 581
           +L+G C   G ++++ +Y   G L + L     P L +                 L    
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 582 GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG 641
             A+ + +L   ASK  IHRDV   N+LL    VAK+ DFGL +   N S   V    + 
Sbjct: 174 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 230
Query: 642 SIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
            + ++ PE     + T +SDV+S+G++L E+ 
Sbjct: 231 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 262

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 109/258 (42%), Gaps = 26/258 (10%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGML 526
           I E  +DF    ++G+G F  VY+         VAIK ++  +   A      Q E+ + 
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 527 SQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARA 586
            QL++  ++ L  Y  D   + LV +    G +  +L N   P                A
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP-----------FSENEA 114
Query: 587 LHYLH---TGA----SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
            H++H   TG     S  I+HRD+  +N+LL      K++DFGL        + H +  +
Sbjct: 115 RHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--L 172
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVN---LAVWATE 696
            G+  Y+ PE         +SDV+S G +   +L  RPP      K  +N   LA +   
Sbjct: 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP 232
Query: 697 CYRNGKIGDIIDPFLKGN 714
            + + +  D+I   L+ N
Sbjct: 233 SFLSIEAKDLIHQLLRRN 250

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 8/208 (3%)
Query: 471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           K+  + F+ L  +G G +G+VYK         VAIK++   S     E   EI ++ Q  
Sbjct: 25  KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCD 82
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
             H+V   G    +  + +V +Y   G++ D +    N  L  D    I     + L YL
Sbjct: 83  SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYL 141
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
           H       IHRD+K  NILL+ E  AK++DFG+   G           V G+  ++ PE 
Sbjct: 142 HFMRK---IHRDIKAGNILLNTEGHAKLADFGVA--GQLTDXMAKRNXVIGTPFWMAPEV 196
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            +       +D++S G+  +E+   +PP
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 125/290 (43%), Gaps = 40/290 (13%)
Query: 483 IGRGGFGNVYK----GFLNGDST-PVAIKRLNPGSQQGALE-FQTEIGMLSQL-RYLHLV 535
           +G G FG V +    G +  D+   VA+K L P +     E   +E+ +LS L  ++++V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 536 SLIGYCNDDGQMILVYDYMARGTL-------RDHLYNNDNPP---------LPWDRRLKI 579
           +L+G C   G  +++ +Y   G L       RD    +   P         L  +  L  
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 580 CIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               A+ + +L   ASK  IHRD+   NILL    + K+ DFGL +   N S   V    
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE     + T +SDV+S+G+ L E       +   G      + V       
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWE-------LFSLGSSPYPGMPV------- 253
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
           + K   +I    +  +P     +  ++  +C + D ++RP+   +V  +E
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 125/290 (43%), Gaps = 40/290 (13%)
Query: 483 IGRGGFGNVYK----GFLNGDST-PVAIKRLNPGSQQGALE-FQTEIGMLSQL-RYLHLV 535
           +G G FG V +    G +  D+   VA+K L P +     E   +E+ +LS L  ++++V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 536 SLIGYCNDDGQMILVYDYMARGTL-------RDHLYNNDNPP---------LPWDRRLKI 579
           +L+G C   G  +++ +Y   G L       RD    +   P         L  +  L  
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 580 CIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               A+ + +L   ASK  IHRD+   NILL    + K+ DFGL +   N S   V    
Sbjct: 169 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE     + T +SDV+S+G+ L E       +   G      + V       
Sbjct: 226 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWE-------LFSLGSSPYPGMPV------- 271
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
           + K   +I    +  +P     +  ++  +C + D ++RP+   +V  +E
Sbjct: 272 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 321

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 125/290 (43%), Gaps = 40/290 (13%)
Query: 483 IGRGGFGNVYK----GFLNGDST-PVAIKRLNPGSQQGALE-FQTEIGMLSQL-RYLHLV 535
           +G G FG V +    G +  D+   VA+K L P +     E   +E+ +LS L  ++++V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 536 SLIGYCNDDGQMILVYDYMARGTL-------RDHLYNNDNPP---------LPWDRRLKI 579
           +L+G C   G  +++ +Y   G L       RD    +   P         L  +  L  
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 580 CIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               A+ + +L   ASK  IHRD+   NILL    + K+ DFGL +   N S   V    
Sbjct: 174 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE     + T +SDV+S+G+ L E       +   G      + V       
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWE-------LFSLGSSPYPGMPV------- 276
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
           + K   +I    +  +P     +  ++  +C + D ++RP+   +V  +E
Sbjct: 277 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 107/246 (43%), Gaps = 32/246 (13%)
Query: 449 KSRGPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIK-- 506
           +S GP   LP         +  KE  + ++   +IGRG    V +          A+K  
Sbjct: 75  QSMGPEDELPD-------WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIM 127
Query: 507 -----RLNPGSQQGALEF-QTEIGMLSQLR-YLHLVSLIGYCNDDGQMILVYDYMARGTL 559
                RL+P   +   E  + E  +L Q+  + H+++LI        M LV+D M +G L
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL 187
Query: 560 RDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVS 619
            D+L   +   L       I      A+ +LH      I+HRD+K  NILLD+    ++S
Sbjct: 188 FDYL--TEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242
Query: 620 DFGL-CKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL------LTEKSDVYSFGVVLLEV 672
           DFG  C   P         ++ G+ GYL PE  +  +        ++ D+++ GV+L  +
Sbjct: 243 DFGFSCHLEPG----EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTL 298
Query: 673 LCARPP 678
           L   PP
Sbjct: 299 LAGSPP 304

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 18/223 (8%)
Query: 466 SISEIKEAT-KDFNNLLIIGRGGFGNVYKGFLNG---DSTP--VAIKRL-NPGSQQGALE 518
           SIS++KE   K+   +  +G G FG VY+G ++G   D +P  VA+K L    S+Q  L+
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 80
Query: 519 FQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPP-----LPW 573
           F  E  ++S+  + ++V  IG         ++ + MA G L+  L      P     L  
Sbjct: 81  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 140
Query: 574 DRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPNF 630
              L +    A    YL        IHRD+   N LL       VAK+ DFG+ +     
Sbjct: 141 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 197
Query: 631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
           S           + ++ PE +   + T K+D +SFGV+L E+ 
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 482 IIGRGGFGNV-----YKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQL-RYLHL 534
           ++G G FG V     Y     G S  VA+K L   +     E   +E+ M++QL  + ++
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHL------YNNDNPPLPWDRRLK---------- 578
           V+L+G C   G + L+++Y   G L ++L      ++ D       +RL+          
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 579 ---ICIG--AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT 633
              +C     A+ + +L     K  +HRD+   N+L+    V K+ DFGL +   + S  
Sbjct: 172 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
            V    +  + ++ PE     + T KSDV+S+G++L E+ 
Sbjct: 229 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 18/223 (8%)
Query: 466 SISEIKEAT-KDFNNLLIIGRGGFGNVYKGFLNG---DSTP--VAIKRL-NPGSQQGALE 518
           SIS++KE   K+   +  +G G FG VY+G ++G   D +P  VA+K L    S+Q  L+
Sbjct: 35  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 94
Query: 519 FQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPP-----LPW 573
           F  E  ++S+  + ++V  IG         ++ + MA G L+  L      P     L  
Sbjct: 95  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 154
Query: 574 DRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPNF 630
              L +    A    YL        IHRD+   N LL       VAK+ DFG+ +     
Sbjct: 155 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
           S           + ++ PE +   + T K+D +SFGV+L E+ 
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 254

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 102/224 (45%), Gaps = 20/224 (8%)
Query: 466 SISEIKEATKDFNNLLI--IGRGGFGNVYKGFLNG---DSTP--VAIKRL-NPGSQQGAL 517
           SIS++KE  +  N  LI  +G G FG VY+G ++G   D +P  VA+K L    S+Q  L
Sbjct: 20  SISDLKEVPRK-NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL 78
Query: 518 EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPP-----LP 572
           +F  E  ++S+  + ++V  IG         ++ + MA G L+  L      P     L 
Sbjct: 79  DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLA 138
Query: 573 WDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPN 629
               L +    A    YL        IHRD+   N LL       VAK+ DFG+ +    
Sbjct: 139 MLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 195
Query: 630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
            S           + ++ PE +   + T K+D +SFGV+L E+ 
Sbjct: 196 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 102/224 (45%), Gaps = 20/224 (8%)
Query: 466 SISEIKEATKDFNNLLI--IGRGGFGNVYKGFLNG---DSTP--VAIKRL-NPGSQQGAL 517
           SIS++KE  +  N  LI  +G G FG VY+G ++G   D +P  VA+K L    S+Q  L
Sbjct: 27  SISDLKEVPRK-NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL 85
Query: 518 EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPP-----LP 572
           +F  E  ++S+  + ++V  IG         ++ + MA G L+  L      P     L 
Sbjct: 86  DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 145
Query: 573 WDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPN 629
               L +    A    YL        IHRD+   N LL       VAK+ DFG+ +    
Sbjct: 146 MLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 202
Query: 630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
            S           + ++ PE +   + T K+D +SFGV+L E+ 
Sbjct: 203 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 246

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 18/223 (8%)
Query: 466 SISEIKEAT-KDFNNLLIIGRGGFGNVYKGFLNG---DSTP--VAIKRL-NPGSQQGALE 518
           SIS++KE   K+   +  +G G FG VY+G ++G   D +P  VA+K L    S+Q  L+
Sbjct: 12  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 71
Query: 519 FQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPP-----LPW 573
           F  E  ++S+  + ++V  IG         ++ + MA G L+  L      P     L  
Sbjct: 72  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 131
Query: 574 DRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPNF 630
              L +    A    YL        IHRD+   N LL       VAK+ DFG+ +     
Sbjct: 132 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 188
Query: 631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
           S           + ++ PE +   + T K+D +SFGV+L E+ 
Sbjct: 189 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 231

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 102/224 (45%), Gaps = 20/224 (8%)
Query: 466 SISEIKEATKDFNNLLI--IGRGGFGNVYKGFLNG---DSTP--VAIKRL-NPGSQQGAL 517
           SIS++KE  +  N  LI  +G G FG VY+G ++G   D +P  VA+K L    S+Q  L
Sbjct: 37  SISDLKEVPRK-NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL 95
Query: 518 EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPP-----LP 572
           +F  E  ++S+  + ++V  IG         ++ + MA G L+  L      P     L 
Sbjct: 96  DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 155
Query: 573 WDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPN 629
               L +    A    YL        IHRD+   N LL       VAK+ DFG+ +    
Sbjct: 156 MLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 212
Query: 630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
            S           + ++ PE +   + T K+D +SFGV+L E+ 
Sbjct: 213 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 256

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 102/224 (45%), Gaps = 20/224 (8%)
Query: 466 SISEIKEATKDFNNLLI--IGRGGFGNVYKGFLNG---DSTP--VAIKRL-NPGSQQGAL 517
           SIS++KE  +  N  LI  +G G FG VY+G ++G   D +P  VA+K L    S+Q  L
Sbjct: 20  SISDLKEVPRK-NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL 78
Query: 518 EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPP-----LP 572
           +F  E  ++S+  + ++V  IG         ++ + MA G L+  L      P     L 
Sbjct: 79  DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 138
Query: 573 WDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPN 629
               L +    A    YL        IHRD+   N LL       VAK+ DFG+ +    
Sbjct: 139 MLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 195
Query: 630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
            S           + ++ PE +   + T K+D +SFGV+L E+ 
Sbjct: 196 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 125/290 (43%), Gaps = 40/290 (13%)
Query: 483 IGRGGFGNVYK----GFLNGDST-PVAIKRLNPGSQQGALE-FQTEIGMLSQL-RYLHLV 535
           +G G FG V +    G +  D+   VA+K L P +     E   +E+ +LS L  ++++V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 536 SLIGYCNDDGQMILVYDYMARGTL-------RDHLYNNDNPP---------LPWDRRLKI 579
           +L+G C   G  +++ +Y   G L       RD    +   P         L  +  L  
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 580 CIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               A+ + +L   ASK  IHRD+   NILL    + K+ DFGL +   N S   V    
Sbjct: 167 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE     + T +SDV+S+G+ L E       +   G      + V       
Sbjct: 224 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWE-------LFSLGSSPYPGMPV------- 269
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
           + K   +I    +  +P     +  ++  +C + D ++RP+   +V  +E
Sbjct: 270 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 319

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 126/293 (43%), Gaps = 34/293 (11%)
Query: 482 IIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           +IG G FG V  G L         VAIK L  G + +   +F +E  ++ Q  + +++ L
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G       ++++ +YM  G+L   L  ND       + + +  G    + YL   +   
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGR-FTVIQLVGMLRGIGSGMKYL---SDMS 130
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLL 656
            +HRD+   NIL++   V KVSDFG+ +   +  +   +T+  K  I +  PE    +  
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 190
Query: 657 TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN-- 714
           T  SDV+S+G+V+ EV+                   +    Y +    D+I    +G   
Sbjct: 191 TSASDVWSYGIVMWEVMS------------------YGERPYWDMSNQDVIKAIEEGYRL 232
Query: 715 APPV-CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ----LLRESSEKS 762
            PP+ C     ++ + C   +R  RP    +V  L+ + +    L R  SE S
Sbjct: 233 PPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRNPNSLKRTGSESS 285

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 483 IGRGGFGNVYK----GFLNGDST-PVAIKRLNPGSQQGALE-FQTEIGMLSQL-RYLHLV 535
           +G G FG V +    G    D+   VA+K L   +     E   +E+ ++S L ++ ++V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNND------------NPPLPWDRRLKICIGA 583
           +L+G C   G ++++ +Y   G L + L                N  L     L      
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQV 173
Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSI 643
           A+ + +L   ASK  IHRDV   N+LL    VAK+ DFGL +   N S   V    +  +
Sbjct: 174 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
            ++ PE     + T +SDV+S+G++L E+ 
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 9/197 (4%)
Query: 482 IIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           +IG G FG V  G L         VAIK L  G + +   +F +E  ++ Q  + +++ L
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G       ++++ +YM  G+L   L  ND       + + +  G    + YL   +   
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGR-FTVIQLVGMLRGIGSGMKYL---SDMS 136
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLL 656
            +HRD+   NIL++   V KVSDFG+ +   +  +   +T+  K  I +  PE    +  
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 196
Query: 657 TEKSDVYSFGVVLLEVL 673
           T  SDV+S+G+V+ EV+
Sbjct: 197 TSASDVWSYGIVMWEVM 213

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 31/219 (14%)
Query: 483 IGRGGFGNVYK----GFLNGDST-PVAIKRLNPGSQQGALE-FQTEIGMLSQL-RYLHLV 535
           +G G FG V +    G    D+   VA+K L   +     E   +E+ ++S L ++ ++V
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLY---------------------NNDNPPLPWD 574
           +L+G C   G ++++ +Y   G L + L                        D  PL   
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 575 RRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH 634
             L      A+ + +L   ASK  IHRDV   N+LL    VAK+ DFGL +   N S   
Sbjct: 159 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 215
Query: 635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
           V    +  + ++ PE     + T +SDV+S+G++L E+ 
Sbjct: 216 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 254

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 18/223 (8%)
Query: 466 SISEIKEAT-KDFNNLLIIGRGGFGNVYKGFLNG---DSTP--VAIKRL-NPGSQQGALE 518
           SIS++KE   K+   +  +G G FG VY+G ++G   D +P  VA+K L    S+Q  L+
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 80
Query: 519 FQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPP-----LPW 573
           F  E  ++S+  + ++V  IG         ++ + MA G L+  L      P     L  
Sbjct: 81  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 140
Query: 574 DRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPNF 630
              L +    A    YL        IHRD+   N LL       VAK+ DFG+ +     
Sbjct: 141 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRA 197
Query: 631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
           S           + ++ PE +   + T K+D +SFGV+L E+ 
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 102/224 (45%), Gaps = 20/224 (8%)
Query: 466 SISEIKEATKDFNNLLI--IGRGGFGNVYKGFLNG---DSTP--VAIKRL-NPGSQQGAL 517
           SIS++KE  +  N  LI  +G G FG VY+G ++G   D +P  VA+K L    S+Q  L
Sbjct: 47  SISDLKEVPRK-NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL 105
Query: 518 EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPP-----LP 572
           +F  E  ++S+  + ++V  IG         ++ + MA G L+  L      P     L 
Sbjct: 106 DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 165
Query: 573 WDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPN 629
               L +    A    YL        IHRD+   N LL       VAK+ DFG+ +    
Sbjct: 166 MLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 222
Query: 630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
            S           + ++ PE +   + T K+D +SFGV+L E+ 
Sbjct: 223 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 266

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 130/293 (44%), Gaps = 41/293 (13%)
Query: 483 IGRGGFGNVYKGFLNG-DSTP----VAIKRLNPG---SQQGALEFQTEIGMLSQL-RYLH 533
           +GRG FG V +    G D T     VA+K L  G   S+  AL   +E+ +L  +  +L+
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 94
Query: 534 LVSLIGYCND-DGQMILVYDYMARGTLRDHLYNNDNPPLPW------------DRRLKIC 580
           +V+L+G C    G ++++ ++   G L  +L +  N  +P+            +  +   
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 581 IGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK 640
              A+ + +L   AS+  IHRD+   NILL E+ V K+ DFGL +              +
Sbjct: 155 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 641 GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRN 700
             + ++ PE    ++ T +SDV+SFGV+L E       I   G      + +    C R 
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------IFSLGASPYPGVKIDEEFCRR- 263
Query: 701 GKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
                 +    +  AP     +  +  + C + +  +RP+ S++V  L  + Q
Sbjct: 264 ------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 117/262 (44%), Gaps = 43/262 (16%)
Query: 477 FNNLLIIGRGGFGNVYK-----GFLNGD--STPVAIKRLNPGSQQGALEFQTEIGMLSQL 529
           F  L ++G+GG+G V++     G   G   +  V  K +   + +     + E  +L ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTL-----RDHLYNNDNPPLPWDRRLKICIGAA 584
           ++  +V LI      G++ L+ +Y++ G L     R+ ++  D            C   A
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA----------CFYLA 128
Query: 585 R---ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG 641
               AL +LH    K II+RD+K  NI+L+ +   K++DFGLCK   +     V+    G
Sbjct: 129 EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCG 183
Query: 642 SIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKK--------QVNLAVW 693
           +I Y+ PE           D +S G ++ ++L   PP      KK        ++NL  +
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY 243
Query: 694 ATECYRNGKIGDIIDPFLKGNA 715
            T+  R     D++   LK NA
Sbjct: 244 LTQEAR-----DLLKKLLKRNA 260

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 117/262 (44%), Gaps = 43/262 (16%)
Query: 477 FNNLLIIGRGGFGNVYK-----GFLNGD--STPVAIKRLNPGSQQGALEFQTEIGMLSQL 529
           F  L ++G+GG+G V++     G   G   +  V  K +   + +     + E  +L ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTL-----RDHLYNNDNPPLPWDRRLKICIGAA 584
           ++  +V LI      G++ L+ +Y++ G L     R+ ++  D            C   A
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA----------CFYLA 128
Query: 585 R---ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG 641
               AL +LH    K II+RD+K  NI+L+ +   K++DFGLCK   +     V+    G
Sbjct: 129 EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCG 183
Query: 642 SIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKK--------QVNLAVW 693
           +I Y+ PE           D +S G ++ ++L   PP      KK        ++NL  +
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY 243
Query: 694 ATECYRNGKIGDIIDPFLKGNA 715
            T+  R     D++   LK NA
Sbjct: 244 LTQEAR-----DLLKKLLKRNA 260

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 116/282 (41%), Gaps = 39/282 (13%)
Query: 483 IGRGGFGNVYKGFLNGDSTP---VAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLI 538
           IG G FG+V++G       P   VAIK     +     E F  E   + Q  + H+V LI
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 539 GYCNDDGQMILVYDYMARGTLRDHL----YNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           G   ++   I++ +    G LR  L    Y+ D   L     +      + AL YL    
Sbjct: 106 GVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAYLE--- 156
Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
           SK  +HRD+   N+L+      K+ DFGL ++  + S  + +++ K  I ++ PE    +
Sbjct: 157 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFR 215
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             T  SDV+ FGV + E+L                  +   + ++  K  D+I     G 
Sbjct: 216 RFTSASDVWMFGVCMWEIL------------------MHGVKPFQGVKNNDVIGRIENGE 257
Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
               PP C      +   C   D  RRP  +++   L  + +
Sbjct: 258 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 299

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 119/290 (41%), Gaps = 39/290 (13%)
Query: 483 IGRGGFGNVYKGFLNGDSTP---VAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLI 538
           IG G FG+V++G       P   VAIK     +     E F  E   + Q  + H+V LI
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 539 GYCNDDGQMILVYDYMARGTLRDHL----YNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           G   ++   I++ +    G LR  L    Y+ D   L     +      + AL YL    
Sbjct: 80  GVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAYLE--- 130
Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
           SK  +HRD+   N+L+      K+ DFGL ++  + S  + +++ K  I ++ PE    +
Sbjct: 131 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFR 189
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             T  SDV+ FGV + E+L                  +   + ++  K  D+I     G 
Sbjct: 190 RFTSASDVWMFGVCMWEIL------------------MHGVKPFQGVKNNDVIGRIENGE 231
Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEK 761
               PP C      +   C   D  RRP  +++   L  + +  +   E+
Sbjct: 232 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQEE 281

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 119/290 (41%), Gaps = 39/290 (13%)
Query: 483 IGRGGFGNVYKGFLNGDSTP---VAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLI 538
           IG G FG+V++G       P   VAIK     +     E F  E   + Q  + H+V LI
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 539 GYCNDDGQMILVYDYMARGTLRDHL----YNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           G   ++   I++ +    G LR  L    Y+ D   L     +      + AL YL    
Sbjct: 81  GVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAYLE--- 131
Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
           SK  +HRD+   N+L+      K+ DFGL ++  + S  + +++ K  I ++ PE    +
Sbjct: 132 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFR 190
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             T  SDV+ FGV + E+L                  +   + ++  K  D+I     G 
Sbjct: 191 RFTSASDVWMFGVCMWEIL------------------MHGVKPFQGVKNNDVIGRIENGE 232
Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEK 761
               PP C      +   C   D  RRP  +++   L  + +  +   E+
Sbjct: 233 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQEE 282

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 135/298 (45%), Gaps = 49/298 (16%)
Query: 483 IGRGGFGNVYKGFLNG-DSTP----VAIKRLNPG---SQQGALEFQTEIGMLSQL-RYLH 533
           +GRG FG V +    G D T     VA+K L  G   S+  AL   +E+ +L  +  +L+
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 94
Query: 534 LVSLIGYCND-DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK------------IC 580
           +V+L+G C    G ++++ ++   G L  +L +  N  +P+    +            IC
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 581 --IGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHV 635
                A+ + +L   AS+  IHRD+   NILL E+ V K+ DFGL +     P++ +   
Sbjct: 155 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR--- 208
Query: 636 STQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWAT 695
               +  + ++ PE    ++ T +SDV+SFGV+L E       I   G      + +   
Sbjct: 209 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------IFSLGASPYPGVKIDEE 261
Query: 696 ECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
            C R       +    +  AP     +  +  + C + +  +RP+ S++V  L  + Q
Sbjct: 262 FCRR-------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 312

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 119/290 (41%), Gaps = 39/290 (13%)
Query: 483 IGRGGFGNVYKGFLNGDSTP---VAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLI 538
           IG G FG+V++G       P   VAIK     +     E F  E   + Q  + H+V LI
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 539 GYCNDDGQMILVYDYMARGTLRDHL----YNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           G   ++   I++ +    G LR  L    Y+ D   L     +      + AL YL    
Sbjct: 75  GVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAYLE--- 125
Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
           SK  +HRD+   N+L+      K+ DFGL ++  + S  + +++ K  I ++ PE    +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFR 184
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             T  SDV+ FGV + E+L                  +   + ++  K  D+I     G 
Sbjct: 185 RFTSASDVWMFGVCMWEIL------------------MHGVKPFQGVKNNDVIGRIENGE 226
Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEK 761
               PP C      +   C   D  RRP  +++   L  + +  +   E+
Sbjct: 227 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQEE 276

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 18/223 (8%)
Query: 466 SISEIKEAT-KDFNNLLIIGRGGFGNVYKGFLNG---DSTP--VAIKRL-NPGSQQGALE 518
           SIS++KE   K+   +  +G G FG VY+G ++G   D +P  VA+K L    S+Q  L+
Sbjct: 35  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELD 94
Query: 519 FQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPP-----LPW 573
           F  E  ++S+  + ++V  IG         ++ + MA G L+  L      P     L  
Sbjct: 95  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 154
Query: 574 DRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPNF 630
              L +    A    YL        IHRD+   N LL       VAK+ DFG+ +     
Sbjct: 155 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
           S           + ++ PE +   + T K+D +SFGV+L E+ 
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 254

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 116/282 (41%), Gaps = 39/282 (13%)
Query: 483 IGRGGFGNVYKGFLNGDSTP---VAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLI 538
           IG G FG+V++G       P   VAIK     +     E F  E   + Q  + H+V LI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 539 GYCNDDGQMILVYDYMARGTLRDHL----YNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           G   ++   I++ +    G LR  L    Y+ D   L     +      + AL YL    
Sbjct: 78  GVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAYLE--- 128
Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
           SK  +HRD+   N+L+      K+ DFGL ++  + S  + +++ K  I ++ PE    +
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFR 187
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             T  SDV+ FGV + E+L                  +   + ++  K  D+I     G 
Sbjct: 188 RFTSASDVWMFGVCMWEIL------------------MHGVKPFQGVKNNDVIGRIENGE 229
Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
               PP C      +   C   D  RRP  +++   L  + +
Sbjct: 230 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 271

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 116/282 (41%), Gaps = 39/282 (13%)
Query: 483 IGRGGFGNVYKGFLNGDSTP---VAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLI 538
           IG G FG+V++G       P   VAIK     +     E F  E   + Q  + H+V LI
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 539 GYCNDDGQMILVYDYMARGTLRDHL----YNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           G   ++   I++ +    G LR  L    Y+ D   L     +      + AL YL    
Sbjct: 83  GVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAYLE--- 133
Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
           SK  +HRD+   N+L+      K+ DFGL ++  + S  + +++ K  I ++ PE    +
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFR 192
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             T  SDV+ FGV + E+L                  +   + ++  K  D+I     G 
Sbjct: 193 RFTSASDVWMFGVCMWEIL------------------MHGVKPFQGVKNNDVIGRIENGE 234
Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
               PP C      +   C   D  RRP  +++   L  + +
Sbjct: 235 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 121/286 (42%), Gaps = 37/286 (12%)
Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSL 537
           I+G G FG VY+G      G+   VA+K           E F +E  ++  L + H+V L
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
           IG   ++   I++  Y   G L  +L  N N  L     +   +   +A+ YL    S  
Sbjct: 91  IGIIEEEPTWIIMELY-PYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYLE---SIN 145
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKF--GPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
            +HRD+   NIL+      K+ DFGL ++    ++ K  V+   +  I ++ PE    + 
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT---RLPIKWMSPESINFRR 202
Query: 656 LTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
            T  SDV+ F V + E+L   + P     +K                   D+I    KG+
Sbjct: 203 FTTASDVWMFAVCMWEILSFGKQPFFWLENK-------------------DVIGVLEKGD 243
Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRE 757
               P +C      +   C + D   RP  +++V  L  V+Q+ ++
Sbjct: 244 RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 289

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 110/224 (49%), Gaps = 14/224 (6%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPV-AIKRLNPGSQQ--GALEFQTEIGMLSQLRY 531
           F  L ++G+G FG V+  K     D+  + A+K L   + +    +  + E  +L ++ +
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGA-ARALHYL 590
             +V L      +G++ L+ D++  G L   L       +  +  +K  +   A AL +L
Sbjct: 86  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHL 142
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
           H+     II+RD+K  NILLDEE   K++DFGL K   +  K   S    G++ Y+ PE 
Sbjct: 143 HSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEV 197
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWA 694
              +  T+ +D +SFGV++ E+L    P      K+ + + + A
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA 241

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 116/282 (41%), Gaps = 39/282 (13%)
Query: 483 IGRGGFGNVYKGFLNGDSTP---VAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLI 538
           IG G FG+V++G       P   VAIK     +     E F  E   + Q  + H+V LI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 539 GYCNDDGQMILVYDYMARGTLRDHL----YNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           G   ++   I++ +    G LR  L    Y+ D   L     +      + AL YL    
Sbjct: 78  GVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAYLE--- 128
Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
           SK  +HRD+   N+L+      K+ DFGL ++  + S  + +++ K  I ++ PE    +
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFR 187
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             T  SDV+ FGV + E+L                  +   + ++  K  D+I     G 
Sbjct: 188 RFTSASDVWMFGVCMWEIL------------------MHGVKPFQGVKNNDVIGRIENGE 229
Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
               PP C      +   C   D  RRP  +++   L  + +
Sbjct: 230 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 271

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 121/286 (42%), Gaps = 37/286 (12%)
Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSL 537
           I+G G FG VY+G      G+   VA+K           E F +E  ++  L + H+V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
           IG   ++   I++  Y   G L  +L  N N  L     +   +   +A+ YL    S  
Sbjct: 79  IGIIEEEPTWIIMELY-PYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYLE---SIN 133
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKF--GPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
            +HRD+   NIL+      K+ DFGL ++    ++ K  V+   +  I ++ PE    + 
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT---RLPIKWMSPESINFRR 190
Query: 656 LTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
            T  SDV+ F V + E+L   + P     +K                   D+I    KG+
Sbjct: 191 FTTASDVWMFAVCMWEILSFGKQPFFWLENK-------------------DVIGVLEKGD 231
Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRE 757
               P +C      +   C + D   RP  +++V  L  V+Q+ ++
Sbjct: 232 RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 121/286 (42%), Gaps = 37/286 (12%)
Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSL 537
           I+G G FG VY+G      G+   VA+K           E F +E  ++  L + H+V L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
           IG   ++   I++  Y   G L  +L  N N  L     +   +   +A+ YL    S  
Sbjct: 75  IGIIEEEPTWIIMELY-PYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYLE---SIN 129
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKF--GPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
            +HRD+   NIL+      K+ DFGL ++    ++ K  V+   +  I ++ PE    + 
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT---RLPIKWMSPESINFRR 186
Query: 656 LTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
            T  SDV+ F V + E+L   + P     +K                   D+I    KG+
Sbjct: 187 FTTASDVWMFAVCMWEILSFGKQPFFWLENK-------------------DVIGVLEKGD 227
Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRE 757
               P +C      +   C + D   RP  +++V  L  V+Q+ ++
Sbjct: 228 RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 273

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV 535
           DF  + +IG GGFG V+K     D     IKR+   +++     + E+  L++L ++++V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIV 67
Query: 536 SLIGYCNDDGQ-----------------MILVYDYMARGTLRDHLYNNDNPPLPWDRRLK 578
              G C D                    + +  ++  +GTL   +       L     L+
Sbjct: 68  HYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 579 ICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ 638
           +     + + Y+H   SK +I+RD+K +NI L +    K+ DFGL     N  K   S  
Sbjct: 127 LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS-- 181
Query: 639 VKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
            KG++ Y+ PE    Q   ++ D+Y+ G++L E+L
Sbjct: 182 -KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 22/225 (9%)
Query: 466 SISEIKEAT-KDFNNLLIIGRGGFGNVYKGFLNG---DSTP--VAIKRL-NPGSQQGALE 518
           SIS++KE   K+   +  +G G FG VY+G ++G   D +P  VA+K L    S+Q  L+
Sbjct: 61  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 120
Query: 519 FQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPP-----LPW 573
           F  E  ++S+  + ++V  IG         ++ + MA G L+  L      P     L  
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 574 DRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAKVSDFGLCK--FGP 628
              L +    A    YL        IHRD+   N LL       VAK+ DFG+ +  +  
Sbjct: 181 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237
Query: 629 NFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
            + +      +   + ++ PE +   + T K+D +SFGV+L E+ 
Sbjct: 238 GYYRKGGCAML--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 100/227 (44%), Gaps = 39/227 (17%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV 535
           DF  + +IG GGFG V+K     D     I+R+   +++     + E+  L++L ++++V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKA----EREVKALAKLDHVNIV 68
Query: 536 SLIG---------YCNDDGQMILVYD--------------------YMARGTLRDHLYNN 566
              G           +DD      YD                    +  +GTL   +   
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 567 DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF 626
               L     L++     + + Y+H   SK +IHRD+K +NI L +    K+ DFGL   
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 627 GPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
             N  K    T+ KG++ Y+ PE    Q   ++ D+Y+ G++L E+L
Sbjct: 186 LKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 135/298 (45%), Gaps = 49/298 (16%)
Query: 483 IGRGGFGNVYKGFLNG-DSTP----VAIKRLNPG---SQQGALEFQTEIGMLSQL-RYLH 533
           +GRG FG V +    G D T     VA+K L  G   S+  AL   +E+ +L  +  +L+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 83
Query: 534 LVSLIGYCND-DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK------------IC 580
           +V+L+G C    G ++++ ++   G L  +L +  N  +P+    +            IC
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 581 --IGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHV 635
                A+ + +L   AS+  IHRD+   NILL E+ V K+ DFGL +     P++ +   
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR--- 197
Query: 636 STQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWAT 695
               +  + ++ PE    ++ T +SDV+SFGV+L E       I   G      + +   
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------IFSLGASPYPGVKIDEE 250
Query: 696 ECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
            C R       +    +  AP     +  +  + C + +  +RP+ S++V  L  + Q
Sbjct: 251 FCRR-------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 130/294 (44%), Gaps = 42/294 (14%)
Query: 483 IGRGGFGNVYKGFLNG-DSTP----VAIKRLNPG---SQQGALEFQTEIGMLSQL-RYLH 533
           +GRG FG V +    G D T     VA+K L  G   S+  AL   +E+ +L  +  +L+
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 93
Query: 534 LVSLIGYCND-DGQMILVYDYMARGTLRDHLYNNDNPPLPWDR-----------RLKIC- 580
           +V+L+G C    G ++++ ++   G L  +L +  N  +P+                IC 
Sbjct: 94  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICY 153
Query: 581 -IGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               A+ + +L   AS+  IHRD+   NILL E+ V K+ DFGL +              
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV+L E       I   G      + +    C R
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------IFSLGASPYPGVKIDEEFCRR 263
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
                  +    +  AP     +  +  + C + +  +RP+ S++V  L  + Q
Sbjct: 264 -------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 22/225 (9%)
Query: 466 SISEIKEAT-KDFNNLLIIGRGGFGNVYKGFLNG---DSTP--VAIKRL-NPGSQQGALE 518
           SIS++KE   K+   +  +G G FG VY+G ++G   D +P  VA+K L    S+Q  L+
Sbjct: 38  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 97
Query: 519 FQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPP-----LPW 573
           F  E  ++S+  + ++V  IG         ++ + MA G L+  L      P     L  
Sbjct: 98  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 157
Query: 574 DRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAKVSDFGLCK--FGP 628
              L +    A    YL        IHRD+   N LL       VAK+ DFG+ +  +  
Sbjct: 158 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 214
Query: 629 NFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
            + +      +   + ++ PE +   + T K+D +SFGV+L E+ 
Sbjct: 215 GYYRKGGCAML--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 257

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 131/295 (44%), Gaps = 43/295 (14%)
Query: 483 IGRGGFGNVYKGFLNG-DSTP----VAIKRLNPG---SQQGALEFQTEIGMLSQL-RYLH 533
           +GRG FG V +    G D T     VA+K L  G   S+  AL   +E+ +L  +  +L+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 83
Query: 534 LVSLIGYCND-DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK------------IC 580
           +V+L+G C    G ++++ ++   G L  +L +  N  +P+    +            IC
Sbjct: 84  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 581 --IGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ 638
                A+ + +L   AS+  IHRD+   NILL E+ V K+ DFGL +             
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 639 VKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECY 698
            +  + ++ PE    ++ T +SDV+SFGV+L E       I   G      + +    C 
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------IFSLGASPYPGVKIDEEFCR 253
Query: 699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           R       +    +  AP     +  +  + C + +  +RP+ S++V  L  + Q
Sbjct: 254 R-------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 131/295 (44%), Gaps = 43/295 (14%)
Query: 483 IGRGGFGNVYKGFLNG-DSTP----VAIKRLNPG---SQQGALEFQTEIGMLSQL-RYLH 533
           +GRG FG V +    G D T     VA+K L  G   S+  AL   +E+ +L  +  +L+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 83
Query: 534 LVSLIGYCND-DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK------------IC 580
           +V+L+G C    G ++++ ++   G L  +L +  N  +P+    +            IC
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 581 --IGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ 638
                A+ + +L   AS+  IHRD+   NILL E+ V K+ DFGL +             
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 639 VKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECY 698
            +  + ++ PE    ++ T +SDV+SFGV+L E       I   G      + +    C 
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------IFSLGASPYPGVKIDEEFCR 253
Query: 699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           R       +    +  AP     +  +  + C + +  +RP+ S++V  L  + Q
Sbjct: 254 R-------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 135/298 (45%), Gaps = 49/298 (16%)
Query: 483 IGRGGFGNVYKGFLNG-DSTP----VAIKRLNPG---SQQGALEFQTEIGMLSQL-RYLH 533
           +GRG FG V +    G D T     VA+K L  G   S+  AL   +E+ +L  +  +L+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 83
Query: 534 LVSLIGYCND-DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK------------IC 580
           +V+L+G C    G ++++ ++   G L  +L +  N  +P+    +            IC
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 581 --IGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHV 635
                A+ + +L   AS+  IHRD+   NILL E+ V K+ DFGL +     P++ +   
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR--- 197
Query: 636 STQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWAT 695
               +  + ++ PE    ++ T +SDV+SFGV+L E       I   G      + +   
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------IFSLGASPYPGVKIDEE 250
Query: 696 ECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
            C R       +    +  AP     +  +  + C + +  +RP+ S++V  L  + Q
Sbjct: 251 FCRR-------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 110/224 (49%), Gaps = 14/224 (6%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPV-AIKRLNPGSQQ--GALEFQTEIGMLSQLRY 531
           F  L ++G+G FG V+  K     D+  + A+K L   + +    +  + E  +L ++ +
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 86
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGA-ARALHYL 590
             +V L      +G++ L+ D++  G L   L       +  +  +K  +   A AL +L
Sbjct: 87  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHL 143
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
           H+     II+RD+K  NILLDEE   K++DFGL K   +  K   S    G++ Y+ PE 
Sbjct: 144 HSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEV 198
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWA 694
              +  T+ +D +SFGV++ E+L    P      K+ + + + A
Sbjct: 199 VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA 242

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 135/298 (45%), Gaps = 49/298 (16%)
Query: 483 IGRGGFGNVYKGFLNG-DSTP----VAIKRLNPG---SQQGALEFQTEIGMLSQL-RYLH 533
           +GRG FG V +    G D T     VA+K L  G   S+  AL   +E+ +L  +  +L+
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 129
Query: 534 LVSLIGYCND-DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK------------IC 580
           +V+L+G C    G ++++ ++   G L  +L +  N  +P+    +            IC
Sbjct: 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 189
Query: 581 --IGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHV 635
                A+ + +L   AS+  IHRD+   NILL E+ V K+ DFGL +     P++ +   
Sbjct: 190 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR--- 243
Query: 636 STQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWAT 695
               +  + ++ PE    ++ T +SDV+SFGV+L E       I   G      + +   
Sbjct: 244 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------IFSLGASPYPGVKIDEE 296
Query: 696 ECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
            C R       +    +  AP     +  +  + C + +  +RP+ S++V  L  + Q
Sbjct: 297 FCRR-------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 110/224 (49%), Gaps = 14/224 (6%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPV-AIKRLNPGSQQ--GALEFQTEIGMLSQLRY 531
           F  L ++G+G FG V+  K     D+  + A+K L   + +    +  + E  +L ++ +
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGA-ARALHYL 590
             +V L      +G++ L+ D++  G L   L       +  +  +K  +   A AL +L
Sbjct: 86  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHL 142
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
           H+     II+RD+K  NILLDEE   K++DFGL K   +  K   S    G++ Y+ PE 
Sbjct: 143 HSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEV 197
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWA 694
              +  T+ +D +SFGV++ E+L    P      K+ + + + A
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA 241

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 121/281 (43%), Gaps = 26/281 (9%)
Query: 482 IIGRGGFGNVYKG-FLNGDSTPV--AIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSL 537
           +IG+G FG VY G +++     +  AIK L+  ++   +E F  E  ++  L + ++++L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 538 IG-YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           IG     +G   ++  YM  G L   + +    P   D  +   +  AR + YL   A +
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-ISFGLQVARGMEYL---AEQ 143
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
             +HRD+   N +LDE +  KV+DFGL +      +         +  + +   E  +  
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY 203
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             T KSDV+SFGV+L E+L    P  R  D   +      T     G+         +  
Sbjct: 204 RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL------THFLAQGR---------RLP 248
Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL 755
            P  C +   +V   C   D   RP+   +V  +E +   L
Sbjct: 249 QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 483 IGRGGFGNVYKGFLNG-DSTP----VAIKRLNPG---SQQGALEFQTEIGMLSQL-RYLH 533
           +GRG FG V +    G D T     VA+K L  G   S+  AL   +E+ +L  +  +L+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 92
Query: 534 LVSLIGYCND-DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK------------IC 580
           +V+L+G C    G ++++ ++   G L  +L +  N  +P+    +            IC
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 581 --IGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ 638
                A+ + +L   AS+  IHRD+   NILL E+ V K+ DFGL +             
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 639 VKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
            +  + ++ PE    ++ T +SDV+SFGV+L E+ 
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 135/298 (45%), Gaps = 49/298 (16%)
Query: 483 IGRGGFGNVYKGFLNG-DSTP----VAIKRLNPG---SQQGALEFQTEIGMLSQL-RYLH 533
           +GRG FG V +    G D T     VA+K L  G   S+  AL   +E+ +L  +  +L+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 92
Query: 534 LVSLIGYCND-DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK------------IC 580
           +V+L+G C    G ++++ ++   G L  +L +  N  +P+    +            IC
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 581 --IGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHV 635
                A+ + +L   AS+  IHRD+   NILL E+ V K+ DFGL +     P++ +   
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR--- 206
Query: 636 STQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWAT 695
               +  + ++ PE    ++ T +SDV+SFGV+L E       I   G      + +   
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------IFSLGASPYPGVKIDEE 259
Query: 696 ECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
            C R       +    +  AP     +  +  + C + +  +RP+ S++V  L  + Q
Sbjct: 260 FCRR-------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 8/223 (3%)
Query: 472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQL 529
           ++ + +  L  IG G FG         D     IK +N    S +   E + E+ +L+ +
Sbjct: 21  QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM 80
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           ++ ++V       ++G + +V DY   G L   +          D+ L   +    AL +
Sbjct: 81  KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           +H    + I+HRD+K+ NI L ++   ++ DFG+ +     S   ++    G+  YL PE
Sbjct: 141 VH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN--STVELARACIGTPYYLSPE 195
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAV 692
               +    KSD+++ G VL E LC        G  K + L +
Sbjct: 196 ICENKPYNNKSDIWALGCVLYE-LCTLKHAFEAGSMKNLVLKI 237

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 105/250 (42%), Gaps = 42/250 (16%)
Query: 454 ASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ 513
           AS  P+    +  +S +++    F  + ++G G +G VYKG         AIK ++    
Sbjct: 3   ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD 62
Query: 514 QGALEFQTEIGMLSQLRYLHLVSLIGYCND---------DGQMILVYDYMARGTLRDHLY 564
           +   E + EI ML   +Y H  ++  Y            D Q+ LV ++   G++ D + 
Sbjct: 63  EEE-EIKQEINMLK--KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 565 NNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC 624
           N     L  +    IC    R L +LH      +IHRD+K  N+LL E    K+ DFG  
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG-- 174
Query: 625 KFGPNFSKTHVSTQVKGSIG----------YLDPEYYRLQLLTE-----KSDVYSFGVVL 669
                     VS Q+  ++G          ++ PE        +     KSD++S G+  
Sbjct: 175 ----------VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA 224
Query: 670 LEVLCARPPI 679
           +E+    PP+
Sbjct: 225 IEMAEGAPPL 234

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 113/278 (40%), Gaps = 31/278 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTP---VAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLI 538
           IG G FG+V++G       P   VAIK     +     E F  E   + Q  + H+V LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVI 598
           G   ++   I++ +    G LR  L       L     +      + AL YL    SK  
Sbjct: 458 GVITENPVWIIM-ELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLE---SKRF 512
Query: 599 IHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTE 658
           +HRD+   N+L+      K+ DFGL ++  + S  + +++ K  I ++ PE    +  T 
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 659 KSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN---A 715
            SDV+ FGV + E+L                  +   + ++  K  D+I     G     
Sbjct: 572 ASDVWMFGVCMWEIL------------------MHGVKPFQGVKNNDVIGRIENGERLPM 613
Query: 716 PPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           PP C      +   C   D  RRP  +++   L  + +
Sbjct: 614 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 113/278 (40%), Gaps = 31/278 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTP---VAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLI 538
           IG G FG+V++G       P   VAIK     +     E F  E   + Q  + H+V LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVI 598
           G   ++   I++ +    G LR  L       L     +      + AL YL    SK  
Sbjct: 458 GVITENPVWIIM-ELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLE---SKRF 512
Query: 599 IHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTE 658
           +HRD+   N+L+      K+ DFGL ++  + S  + +++ K  I ++ PE    +  T 
Sbjct: 513 VHRDIAARNVLVSATDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 659 KSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN---A 715
            SDV+ FGV + E+L                  +   + ++  K  D+I     G     
Sbjct: 572 ASDVWMFGVCMWEIL------------------MHGVKPFQGVKNNDVIGRIENGERLPM 613
Query: 716 PPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           PP C      +   C   D  RRP  +++   L  + +
Sbjct: 614 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 116/282 (41%), Gaps = 39/282 (13%)
Query: 483 IGRGGFGNVYKGFLNGDSTP---VAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLI 538
           IG G FG+V++G       P   VAIK     +     E F  E   + Q  + H+V LI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 539 GYCNDDGQMILVYDYMARGTLRDHL----YNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           G   ++   I++ +    G LR  L    ++ D   L     +      + AL YL    
Sbjct: 78  GVITENPVWIIM-ELCTLGELRSFLQVRKFSLDLASL-----ILYAYQLSTALAYLE--- 128
Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
           SK  +HRD+   N+L+      K+ DFGL ++  + S  + +++ K  I ++ PE    +
Sbjct: 129 SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFR 187
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             T  SDV+ FGV + E+L                  +   + ++  K  D+I     G 
Sbjct: 188 RFTSASDVWMFGVCMWEIL------------------MHGVKPFQGVKNNDVIGRIENGE 229
Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
               PP C      +   C   D  RRP  +++   L  + +
Sbjct: 230 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 271

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 21/219 (9%)
Query: 469 EIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-----FQTEI 523
           ++K   K +  L  +G G F  VYK      +  VAIK++  G +  A +        EI
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 524 GMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKI-CIG 582
            +L +L + +++ L+        + LV+D+M        +   DN  +     +K   + 
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDL---EVIIKDNSLVLTPSHIKAYMLM 120
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH-VSTQV 639
             + L YLH      I+HRD+K  N+LLDE  V K++DFGL K FG PN +  H V T+ 
Sbjct: 121 TLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTR- 176
Query: 640 KGSIGYLDPE-YYRLQLLTEKSDVYSFGVVLLEVLCARP 677
                Y  PE  +  ++     D+++ G +L E+L   P
Sbjct: 177 ----WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 115/282 (40%), Gaps = 39/282 (13%)
Query: 483 IGRGGFGNVYKGFLNGDSTP---VAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLI 538
           IG G FG+V++G       P   VAIK     +     E F  E   + Q  + H+V LI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 539 GYCNDDGQMILVYDYMARGTLRDHL----YNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           G   ++   I++ +    G LR  L    ++ D   L     +      + AL YL    
Sbjct: 78  GVITENPVWIIM-ELCTLGELRSFLQVRKFSLDLASL-----ILYAYQLSTALAYLE--- 128
Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
           SK  +HRD+   N+L+      K+ DFGL ++  + S    +++ K  I ++ PE    +
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STXXKASKGKLPIKWMAPESINFR 187
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             T  SDV+ FGV + E+L                  +   + ++  K  D+I     G 
Sbjct: 188 RFTSASDVWMFGVCMWEIL------------------MHGVKPFQGVKNNDVIGRIENGE 229
Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
               PP C      +   C   D  RRP  +++   L  + +
Sbjct: 230 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 271

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 15/220 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYL 532
            +D++ +  +G G +G V           VA+K ++        E  + EI +   L + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V   G+  +     L  +Y + G L D +  +   P P          A R  H L  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFHQLMA 115
Query: 593 GASKV----IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           G   +    I HRD+K  N+LLDE    K+SDFGL       ++  +  ++ G++ Y+ P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 649 EYY-RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
           E   R +   E  DV+S G+VL  +L    P  +  D  Q
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQ 215

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 483 IGRGGFGNVYKGFLNG-DSTP----VAIKRLNPG---SQQGALEFQTEIGMLSQL-RYLH 533
           +GRG FG V +    G D T     VA+K L  G   S+  AL   +E+ +L  +  +L+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHHLN 92
Query: 534 LVSLIGYCND-DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK------------IC 580
           +V+L+G C    G ++++ ++   G L  +L +  N  +P+    +            IC
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 581 --IGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ 638
                A+ + +L   AS+  IHRD+   NILL E+ V K+ DFGL +             
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 639 VKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
            +  + ++ PE    ++ T +SDV+SFGV+L E+ 
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 11/201 (5%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG VYK      S   A K ++  S++   ++  EI +L+   + ++V L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ ++ A G + D +      PL   +   +C     AL+YLH      IIHRD
Sbjct: 105 YENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRD 160
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTE---- 658
           +K  NIL   +   K++DFG+     N           G+  ++ PE    +   +    
Sbjct: 161 LKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 659 -KSDVYSFGVVLLEVLCARPP 678
            K+DV+S G+ L+E+    PP
Sbjct: 219 YKADVWSLGITLIEMAEIEPP 239

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 11/201 (5%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG VYK      S   A K ++  S++   ++  EI +L+   + ++V L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ ++ A G + D +      PL   +   +C     AL+YLH      IIHRD
Sbjct: 105 YENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRD 160
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTE---- 658
           +K  NIL   +   K++DFG+     N           G+  ++ PE    +   +    
Sbjct: 161 LKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 659 -KSDVYSFGVVLLEVLCARPP 678
            K+DV+S G+ L+E+    PP
Sbjct: 219 YKADVWSLGITLIEMAEIEPP 239

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 11/201 (5%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG VYK      S   A K ++  S++   ++  EI +L+   + ++V L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ ++ A G + D +      PL   +   +C     AL+YLH      IIHRD
Sbjct: 105 YENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRD 160
Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTE---- 658
           +K  NIL   +   K++DFG+     N           G+  ++ PE    +   +    
Sbjct: 161 LKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 659 -KSDVYSFGVVLLEVLCARPP 678
            K+DV+S G+ L+E+    PP
Sbjct: 219 YKADVWSLGITLIEMAEIEPP 239

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 11/208 (5%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP---GSQQGALEFQTEIGMLSQL-R 530
           +DF+ L +IGRG +  V    L       A+K +        +     QTE  +  Q   
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           +  LV L      + ++  V +Y+  G L  H+      P    R     I  + AL+YL
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI--SLALNYL 137
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
           H    + II+RD+K  N+LLD E   K++D+G+CK G     T  ++   G+  Y+ PE 
Sbjct: 138 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEI 192
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            R +      D ++ GV++ E++  R P
Sbjct: 193 LRGEDYGFSVDWWALGVLMFEMMAGRSP 220

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 118/257 (45%), Gaps = 36/257 (14%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLR-YLHLVSLIG 539
           +G+G +G V+K         VA+K++    Q      +T  EI +L++L  + ++V+L+ 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 540 Y--CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
               ++D  + LV+DYM       H     N   P  ++  +     + + YLH+G    
Sbjct: 77  VLRADNDRDVYLVFDYMETDL---HAVIRANILEPVHKQY-VVYQLIKVIKYLHSGG--- 129
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG------------- 644
           ++HRD+K +NILL+ E   KV+DFGL +   N  +  V+  +  SI              
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR--VTNNIPLSINENTENFDDDQPIL 187
Query: 645 --YLDPEYYRL-QLL------TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWAT 695
             Y+   +YR  ++L      T+  D++S G +L E+LC +P    +    Q+   +   
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVI 247
Query: 696 ECYRNGKIGDIIDPFLK 712
           +   N  +  I  PF K
Sbjct: 248 DFPSNEDVESIQSPFAK 264

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 11/208 (5%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP---GSQQGALEFQTEIGMLSQL-R 530
           +DF+ L +IGRG +  V    L       A+K +        +     QTE  +  Q   
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           +  LV L      + ++  V +Y+  G L  H+      P    R     I  + AL+YL
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI--SLALNYL 122
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
           H    + II+RD+K  N+LLD E   K++D+G+CK G     T  ++   G+  Y+ PE 
Sbjct: 123 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEI 177
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            R +      D ++ GV++ E++  R P
Sbjct: 178 LRGEDYGFSVDWWALGVLMFEMMAGRSP 205

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 11/208 (5%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP---GSQQGALEFQTEIGMLSQL-R 530
           +DF+ L +IGRG +  V    L       A+K +        +     QTE  +  Q   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           +  LV L      + ++  V +Y+  G L  H+      P    R     I  + AL+YL
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI--SLALNYL 126
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
           H    + II+RD+K  N+LLD E   K++D+G+CK G     T  ++   G+  Y+ PE 
Sbjct: 127 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEI 181
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            R +      D ++ GV++ E++  R P
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 15/220 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYL 532
            +D++ +  +G G +G V           VA+K ++        E  + EI +   L + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V   G+  +     L  +Y + G L D +  +   P P          A R  H L  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFHQLMA 115
Query: 593 GASKV----IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           G   +    I HRD+K  N+LLDE    K+SDFGL       ++  +  ++ G++ Y+ P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 649 EYY-RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
           E   R +   E  DV+S G+VL  +L    P  +  D  Q
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 215

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 15/220 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYL 532
            +D++ +  +G G +G V           VA+K ++        E  + EI +   L + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V   G+  +     L  +Y + G L D +  +   P P          A R  H L  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFHQLMA 115
Query: 593 GASKV----IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           G   +    I HRD+K  N+LLDE    K+SDFGL       ++  +  ++ G++ Y+ P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 649 EYY-RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
           E   R +   E  DV+S G+VL  +L    P  +  D  Q
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 215

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 15/220 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYL 532
            +D++ +  +G G +G V           VA+K ++        E  + EI +   L + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V   G+  +     L  +Y + G L D +  +   P P          A R  H L  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFHQLMA 116
Query: 593 GASKV----IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           G   +    I HRD+K  N+LLDE    K+SDFGL       ++  +  ++ G++ Y+ P
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 649 EYY-RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
           E   R +   E  DV+S G+VL  +L    P  +  D  Q
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 15/220 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYL 532
            +D++ +  +G G +G V           VA+K ++        E  + EI +   L + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V   G+  +     L  +Y + G L D +  +   P P          A R  H L  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFHQLMA 115
Query: 593 GASKV----IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           G   +    I HRD+K  N+LLDE    K+SDFGL       ++  +  ++ G++ Y+ P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 649 EYY-RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
           E   R +   E  DV+S G+VL  +L    P  +  D  Q
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 215

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 11/208 (5%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVA---IKRLNPGSQQGALEFQTEIGMLSQL-R 530
           +DF+ L +IGRG +  V    L       A   +K+      +     QTE  +  Q   
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           +  LV L      + ++  V +Y+  G L  H+      P    R     I  + AL+YL
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI--SLALNYL 169
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
           H    + II+RD+K  N+LLD E   K++D+G+CK G     T  ++   G+  Y+ PE 
Sbjct: 170 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEI 224
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            R +      D ++ GV++ E++  R P
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 15/220 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYL 532
            +D++ +  +G G +G V           VA+K ++        E  + EI +   L + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V   G+  +     L  +Y + G L D +  +   P P          A R  H L  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFHQLMA 115
Query: 593 GASKV----IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           G   +    I HRD+K  N+LLDE    K+SDFGL       ++  +  ++ G++ Y+ P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 649 EYY-RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
           E   R +   E  DV+S G+VL  +L    P  +  D  Q
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 215

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 15/220 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYL 532
            +D++ +  +G G +G V           VA+K ++        E  + EI +   L + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V   G+  +     L  +Y + G L D +  +   P P          A R  H L  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFHQLMA 116
Query: 593 GASKV----IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           G   +    I HRD+K  N+LLDE    K+SDFGL       ++  +  ++ G++ Y+ P
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176
Query: 649 EYY-RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
           E   R +   E  DV+S G+VL  +L    P  +  D  Q
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 112/278 (40%), Gaps = 31/278 (11%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGD----STPVAIKRLNPGSQQGA-LEFQTEIGMLSQLR 530
           +   + ++G G FG VYKG    D      PVAIK L   +   A  E   E  +++ + 
Sbjct: 18  ELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 77
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
             ++  L+G C     + LV   M  G L DH+  N    L     L  C+  A+ + YL
Sbjct: 78  SPYVSRLLGICLT-STVQLVTQLMPYGCLLDHVRENRGR-LGSQDLLNWCMQIAKGMSYL 135
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
                  ++HRD+   N+L+      K++DFGL +        + +   K  I ++  E 
Sbjct: 136 E---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 192
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF 710
              +  T +SDV+S+GV + E                  L  +  + Y      +I D  
Sbjct: 193 ILRRRFTHQSDVWSYGVTVWE------------------LMTFGAKPYDGIPAREIPDLL 234
Query: 711 LKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
            KG     PP+C      + + C   D   RP   ++V
Sbjct: 235 EKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 272

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 15/220 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYL 532
            +D++ +  +G G +G V           VA+K ++        E  + EI + + L + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V   G+  +     L  +Y + G L D +  +   P P          A R  H L  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFHQLMA 116
Query: 593 GASKV----IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           G   +    I HRD+K  N+LLDE    K+SDFGL       ++  +  ++ G++ Y+ P
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 649 EYY-RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
           E   R +   E  DV+S G+VL  +L    P  +  D  Q
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 15/228 (6%)
Query: 457 LPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQ 514
           +PS+   Q S +  +    DFN L+++G+G FG V      G     AIK L      Q 
Sbjct: 1   MPSEDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQD 60
Query: 515 GALEF-QTEIGMLSQLRYLHLVSLIGYC-NDDGQMILVYDYMARGTLRDHLYN--NDNPP 570
             +E    E  +L+ L     ++ +  C     ++  V +Y+  G L  H+        P
Sbjct: 61  DDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP 120
Query: 571 LPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF 630
                  +I IG    L +LH    + II+RD+K  N++LD E   K++DFG+CK   + 
Sbjct: 121 QAVFYAAEISIG----LFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHM 171
Query: 631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
                + +  G+  Y+ PE    Q   +  D +++GV+L E+L  +PP
Sbjct: 172 MDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 219

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 21/214 (9%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQ---TEIGMLSQLRY 531
           K F++L  IG G FG VY      +S  VAIK+++   +Q   ++Q    E+  L +LR+
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
            + +   G    +    LV +Y   G+  D L      PL       +  GA + L YLH
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEY-CLGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
              S  +IHRDVK  NILL E  + K+ DFG      + S    +    G+  ++ PE  
Sbjct: 172 ---SHNMIHRDVKAGNILLSEPGLVKLGDFG------SASIMAPANXFVGTPYWMAPEV- 221
Query: 652 RLQLLTE-----KSDVYSFGVVLLEVLCARPPIL 680
            +  + E     K DV+S G+  +E+   +PP+ 
Sbjct: 222 -ILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 254

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 96/220 (43%), Gaps = 14/220 (6%)
Query: 466 SISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTE 522
            I  ++   +D++ + +IGRG FG V            A+K L+      +  +  F  E
Sbjct: 66  KIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEE 125
Query: 523 IGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
             +++      +V L     DD  + +V +YM  G L + + N D P   W +     + 
Sbjct: 126 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAKFYTAEV- 183
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS 642
              AL  +H+     +IHRDVK  N+LLD+    K++DFG C         H  T V G+
Sbjct: 184 -VLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GT 238
Query: 643 IGYLDPEYYRLQ----LLTEKSDVYSFGVVLLEVLCARPP 678
             Y+ PE  + Q        + D +S GV L E+L    P
Sbjct: 239 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 15/220 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYL 532
            +D++ +  +G G +G V           VA+K ++        E  + EI +   L + 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V   G+  +     L  +Y + G L D +  +   P P          A R  H L  
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFHQLMA 114
Query: 593 GASKV----IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           G   +    I HRD+K  N+LLDE    K+SDFGL       ++  +  ++ G++ Y+ P
Sbjct: 115 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
Query: 649 EYY-RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
           E   R +   E  DV+S G+VL  +L    P  +  D  Q
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 15/220 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYL 532
            +D++ +  +G G +G V           VA+K ++        E  + EI +   L + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V   G+  +     L  +Y + G L D +  +   P P          A R  H L  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFHQLMA 116
Query: 593 GASKV----IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           G   +    I HRD+K  N+LLDE    K+SDFGL       ++  +  ++ G++ Y+ P
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 649 EYY-RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
           E   R +   E  DV+S G+VL  +L    P  +  D  Q
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 15/220 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYL 532
            +D++ +  +G G +G V           VA+K ++        E  + EI +   L + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V   G+  +     L  +Y + G L D +  +   P P          A R  H L  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFHQLMA 116
Query: 593 GASKV----IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           G   +    I HRD+K  N+LLDE    K+SDFGL       ++  +  ++ G++ Y+ P
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 649 EYY-RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
           E   R +   E  DV+S G+VL  +L    P  +  D  Q
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 15/220 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYL 532
            +D++ +  +G G +G V           VA+K ++        E  + EI +   L + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V   G+  +     L  +Y + G L D +  +   P P          A R  H L  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFHQLMA 115
Query: 593 GASKV----IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           G   +    I HRD+K  N+LLDE    K+SDFGL       ++  +  ++ G++ Y+ P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 649 EYY-RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
           E   R +   E  DV+S G+VL  +L    P  +  D  Q
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 215

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 15/220 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYL 532
            +D++ +  +G G +G V           VA+K ++        E  + EI +   L + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V   G+  +     L  +Y + G L D +  +   P P          A R  H L  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFHQLMA 116
Query: 593 GASKV----IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           G   +    I HRD+K  N+LLDE    K+SDFGL       ++  +  ++ G++ Y+ P
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 649 EYY-RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
           E   R +   E  DV+S G+VL  +L    P  +  D  Q
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 15/220 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYL 532
            +D++ +  +G G +G V           VA+K ++        E  + EI +   L + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V   G+  +     L  +Y + G L D +  +   P P          A R  H L  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFHQLMA 115
Query: 593 GASKV----IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           G   +    I HRD+K  N+LLDE    K+SDFGL       ++  +  ++ G++ Y+ P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 649 EYY-RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
           E   R +   E  DV+S G+VL  +L    P  +  D  Q
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 215

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 76/309 (24%), Positives = 133/309 (43%), Gaps = 45/309 (14%)
Query: 464 QFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGSQQGAL- 517
           Q  + EI  +   F   L  G   FG VYKG L G      +  VAIK L   ++ G L 
Sbjct: 17  QAKLKEISLSAVRFMEEL--GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLR 73
Query: 518 -EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY----NNDNPPLP 572
            EF+ E  + ++L++ ++V L+G    D  + +++ Y + G L + L     ++D     
Sbjct: 74  EEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD 133
Query: 573 WDRRLKICIGAARALHYLHTGA-------SKVIIHRDVKTTNILLDEEWVAKVSDFGLCK 625
            DR +K  +     +H +   A       S  ++H+D+ T N+L+ ++   K+SD GL +
Sbjct: 134 DDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 193
Query: 626 --FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTG 683
             +  ++ K   ++ +   I ++ PE       +  SD++S+GVVL EV           
Sbjct: 194 EVYAADYYKLLGNSLL--PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF---------- 241
Query: 684 DKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSD 743
                +  +     Y N  + ++I        P  C      + + C N+   RRP   D
Sbjct: 242 -----SYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKD 296
Query: 744 V-----VWG 747
           +      WG
Sbjct: 297 IHSRLRAWG 305

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 15/220 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYL 532
            +D++ +  +G G +G V           VA+K ++        E  + EI +   L + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V   G+  +     L  +Y + G L D +  +   P P          A R  H L  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFHQLMA 115
Query: 593 GASKV----IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           G   +    I HRD+K  N+LLDE    K+SDFGL       ++  +  ++ G++ Y+ P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 649 EYY-RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
           E   R +   E  DV+S G+VL  +L    P  +  D  Q
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 215

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 15/220 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYL 532
            +D++ +  +G G +G V           VA+K ++        E  + EI +   L + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V   G+  +     L  +Y + G L D +  +   P P          A R  H L  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFHQLMA 116
Query: 593 GASKV----IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           G   +    I HRD+K  N+LLDE    K+SDFGL       ++  +  ++ G++ Y+ P
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 649 EYY-RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
           E   R +   E  DV+S G+VL  +L    P  +  D  Q
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 21/214 (9%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQ---TEIGMLSQLRY 531
           K F++L  IG G FG VY      +S  VAIK+++   +Q   ++Q    E+  L +LR+
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
            + +   G    +    LV +Y   G+  D L      PL       +  GA + L YLH
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEY-CLGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
              S  +IHRDVK  NILL E  + K+ DFG      + S    +    G+  ++ PE  
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFG------SASIMAPANXFVGTPYWMAPEV- 182
Query: 652 RLQLLTE-----KSDVYSFGVVLLEVLCARPPIL 680
            +  + E     K DV+S G+  +E+   +PP+ 
Sbjct: 183 -ILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 15/220 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYL 532
            +D++ +  +G G +G V           VA+K ++        E  + EI +   L + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V   G+  +     L  +Y + G L D +  +   P P          A R  H L  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFHQLMA 115
Query: 593 GASKV----IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           G   +    I HRD+K  N+LLDE    K+SDFGL       ++  +  ++ G++ Y+ P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 649 EYY-RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
           E   R +   E  DV+S G+VL  +L    P  +  D  Q
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 215

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 15/220 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYL 532
            +D++ +  +G G +G V           VA+K ++        E  + EI +   L + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V   G+  +     L  +Y + G L D +  +   P P          A R  H L  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFHQLMA 115
Query: 593 GASKV----IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           G   +    I HRD+K  N+LLDE    K+SDFGL       ++  +  ++ G++ Y+ P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 649 EYY-RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
           E   R +   E  DV+S G+VL  +L    P  +  D  Q
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 215

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 15/220 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYL 532
            +D++ +  +G G +G V           VA+K ++        E  + EI +   L + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V   G+  +     L  +Y + G L D +  +   P P          A R  H L  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFHQLMA 116
Query: 593 GASKV----IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           G   +    I HRD+K  N+LLDE    K+SDFGL       ++  +  ++ G++ Y+ P
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 649 EYY-RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
           E   R +   E  DV+S G+VL  +L    P  +  D  Q
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 14/224 (6%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPV-AIKRLNPGSQQ--GALEFQTEIGMLSQLRY 531
           F  L ++G+G FG V+  +     DS  + A+K L   + +    +  + E  +L+ + +
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNH 89
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGA-ARALHYL 590
             +V L      +G++ L+ D++  G L   L       +  +  +K  +   A  L +L
Sbjct: 90  PFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALGLDHL 146
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
           H+     II+RD+K  NILLDEE   K++DFGL K   +  K   S    G++ Y+ PE 
Sbjct: 147 HSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTVEYMAPEV 201
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWA 694
              Q  +  +D +S+GV++ E+L    P      K+ + L + A
Sbjct: 202 VNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKA 245

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 15/220 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYL 532
            +D++ +  +G G +G V           VA+K ++        E  + EI +   L + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V   G+  +     L  +Y + G L D +  +   P P          A R  H L  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFHQLMA 115
Query: 593 GASKV----IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           G   +    I HRD+K  N+LLDE    K+SDFGL       ++  +  ++ G++ Y+ P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 649 EYY-RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
           E   R +   E  DV+S G+VL  +L    P  +  D  Q
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 215

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 128/290 (44%), Gaps = 43/290 (14%)
Query: 483 IGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGSQQGAL--EFQTEIGMLSQLRYLHLV 535
           +G   FG VYKG L G      +  VAIK L   ++ G L  EF+ E  + ++L++ ++V
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPNVV 75
Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLY----NNDNPPLPWDRRLKICIGAARALHYLH 591
            L+G    D  + +++ Y + G L + L     ++D      DR +K  +     +H + 
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 592 TGASKV-------IIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGS 642
             A+ +       ++H+D+ T N+L+ ++   K+SD GL +  +  ++ K   ++ +   
Sbjct: 136 QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL--P 193
Query: 643 IGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK 702
           I ++ PE       +  SD++S+GVVL EV                +  +     Y N  
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF---------------SYGLQPYCGYSNQD 238
Query: 703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV-----VWG 747
           + ++I        P  C      + + C N+   RRP   D+      WG
Sbjct: 239 VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 288

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 105/248 (42%), Gaps = 18/248 (7%)
Query: 441 RRAVMKEAKSRGPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDS 500
           + A  +   S  P   L S  C        +    D   ++ +GRG +G V K       
Sbjct: 17  KEAFEQPQTSSTPPRDLDSKACISIGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSG 76
Query: 501 TPVAIKRLNP---GSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARG 557
             +A+KR+       +Q  L    +I M + +     V+  G    +G + +  + M   
Sbjct: 77  QIMAVKRIRATVNSQEQKRLLMDLDISMRT-VDCPFTVTFYGALFREGDVWICMELM--D 133
Query: 558 TLRDHLYN---NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW 614
           T  D  Y    +    +P D   KI +   +AL +LH+  S  +IHRDVK +N+L++   
Sbjct: 134 TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALG 191
Query: 615 VAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL----LTEKSDVYSFGVVLL 670
             K+ DFG+  +      +   T   G   Y+ PE    +L     + KSD++S G+ ++
Sbjct: 192 QVKMCDFGISGY---LVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMI 248
Query: 671 EVLCARPP 678
           E+   R P
Sbjct: 249 ELAILRFP 256

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIG--- 539
           +G+G +G V++G  +G+S  VA+K  +   +Q     +TEI     LR+ +++  I    
Sbjct: 16  VGKGRYGEVWRGLWHGES--VAVKIFSSRDEQSWFR-ETEIYNTVLLRHDNILGFIASDM 72
Query: 540 -YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH-----TG 593
              N   Q+ L+  Y   G+L D L      P      L++ + AA  L +LH     T 
Sbjct: 73  TSRNSSTQLWLITHYHEHGSLYDFLQRQTLEP---HLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF---GPNFSKTHVSTQVKGSIGYLDPEY 650
               I HRD K+ N+L+       ++D GL      G ++     + +V G+  Y+ PE 
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV-GTKRYMAPEV 188
Query: 651 YRLQLLTEK------SDVYSFGVVLLEV 672
              Q+ T+       +D+++FG+VL E+
Sbjct: 189 LDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 10/211 (4%)
Query: 471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLS 527
           K    DF+ L ++G+G FG V            A+K L      ++       TE  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARAL 587
             R+  L +L        ++  V +Y   G L  HL  +       +R          AL
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSAL 118
Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
            YLH   S+ +++RD+K  N++LD++   K++DFGLCK G   S         G+  YL 
Sbjct: 119 EYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKXFCGTPEYLA 173
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           PE           D +  GVV+ E++C R P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 10/211 (4%)
Query: 471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLS 527
           K    DF+ L ++G+G FG V            A+K L      ++       TE  +L 
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 63
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARAL 587
             R+  L +L        ++  V +Y   G L  HL  +       +R          AL
Sbjct: 64  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSAL 121
Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
            YLH   S+ +++RD+K  N++LD++   K++DFGLCK G   S         G+  YL 
Sbjct: 122 EYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEYLA 176
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           PE           D +  GVV+ E++C R P
Sbjct: 177 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 10/211 (4%)
Query: 471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLS 527
           K    DF+ L ++G+G FG V            A+K L      ++       TE  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARAL 587
             R+  L +L        ++  V +Y   G L  HL  +       +R          AL
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSAL 118
Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
            YLH   S+ +++RD+K  N++LD++   K++DFGLCK G   S         G+  YL 
Sbjct: 119 EYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEYLA 173
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           PE           D +  GVV+ E++C R P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT---EIGMLSQLRYLH 533
           F  L  IG+G FG V     N      A+K +N        E +    E+ ++  L +  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           LV+L     D+  M +V D +  G LR HL  N +       +L IC     AL YL   
Sbjct: 77  LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK-EETVKLFIC-ELVMALDYLQ-- 132
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
            ++ IIHRD+K  NILLDE     ++DF +    P   +T ++T + G+  Y+ PE +  
Sbjct: 133 -NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP--RETQITT-MAGTKPYMAPEMFSS 188
Query: 654 QLLTEKS---DVYSFGVVLLEVLCARPP 678
           +     S   D +S GV   E+L  R P
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 10/211 (4%)
Query: 471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLS 527
           K    DF+ L ++G+G FG V            A+K L      ++       TE  +L 
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 65
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARAL 587
             R+  L +L        ++  V +Y   G L  HL  +       +R          AL
Sbjct: 66  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSAL 123
Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
            YLH   S+ +++RD+K  N++LD++   K++DFGLCK G   S         G+  YL 
Sbjct: 124 EYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKXFCGTPEYLA 178
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           PE           D +  GVV+ E++C R P
Sbjct: 179 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 15/217 (6%)
Query: 469 EIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQ 528
           +IK   +DF    ++G+G FG V+       +   AIK L        ++   E  M+ +
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALK--KDVVLMDDDVECTMVEK 69
Query: 529 ----LRYLH--LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
               L + H  L  +         +  V +Y+  G L  H+ +     L   R       
Sbjct: 70  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDL--SRATFYAAE 127
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS 642
               L +LH   SK I++RD+K  NILLD++   K++DFG+CK   N      + +  G+
Sbjct: 128 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNEFCGT 182
Query: 643 IGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPI 679
             Y+ PE    Q      D +SFGV+L E+L  + P 
Sbjct: 183 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 10/211 (4%)
Query: 471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLS 527
           K    DF+ L ++G+G FG V            A+K L      ++       TE  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARAL 587
             R+  L +L        ++  V +Y   G L  HL  +       +R          AL
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSAL 118
Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
            YLH   S+ +++RD+K  N++LD++   K++DFGLCK G   S         G+  YL 
Sbjct: 119 EYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKXFCGTPEYLA 173
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           PE           D +  GVV+ E++C R P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 10/211 (4%)
Query: 471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLS 527
           K    DF+ L ++G+G FG V            A+K L      ++       TE  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARAL 587
             R+  L +L        ++  V +Y   G L  HL  +       +R          AL
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSAL 118
Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
            YLH   S+ +++RD+K  N++LD++   K++DFGLCK G   S         G+  YL 
Sbjct: 119 EYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEYLA 173
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           PE           D +  GVV+ E++C R P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVS 536
            +N + IG G  G V    +      VA+K+++   QQ       E+ ++   ++ ++V 
Sbjct: 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 212
Query: 537 LIGYCNDDGQMILVYDYMARGTLRD---HLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           +        ++ +V +++  G L D   H   N+      ++   +C+   +AL  LH  
Sbjct: 213 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------EQIAAVCLAVLQALSVLH-- 264
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK------GSIGYLD 647
            ++ +IHRD+K+ +ILL  +   K+SDFG C          VS +V       G+  ++ 
Sbjct: 265 -AQGVIHRDIKSDSILLTHDGRVKLSDFGFC--------AQVSKEVPRRKXLVGTPYWMA 315
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           PE         + D++S G++++E++   PP
Sbjct: 316 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 73/312 (23%), Positives = 136/312 (43%), Gaps = 52/312 (16%)
Query: 469 EIKEATKD-------FNNLLIIGRGGFGNVYKGFL---NGDSTPVAIKRLNPG--SQQGA 516
           E+KE  +D       F    ++G+G FG+V +  L   +G    VA+K L     +    
Sbjct: 10  ELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI 69
Query: 517 LEFQTEIGMLSQLRYLHLVSLIGYC---NDDGQM---ILVYDYMARGTLRDHLYNN---D 567
            EF  E   + +  + H+  L+G        G++   +++  +M  G L   L  +   +
Sbjct: 70  EEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE 129
Query: 568 NP-PLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK- 625
           NP  LP    ++  +  A  + YL   +S+  IHRD+   N +L E+    V+DFGL + 
Sbjct: 130 NPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK 186
Query: 626 -FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTG 683
            +  ++ +   ++++   + +L  E     L T  SDV++FGV + E++   + P     
Sbjct: 187 IYSGDYYRQGCASKL--PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP----- 239
Query: 684 DKKQVNLAVWATECYRNGKIGDIIDPFLKGN---APPVCLNQFVEVAMSCVNDDRIRRPS 740
                         Y   +  +I +  + GN    PP C+ +  ++   C + D  +RPS
Sbjct: 240 --------------YAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPS 285
Query: 741 MSDVVWGLEFVF 752
            + +   LE + 
Sbjct: 286 FTCLRMELENIL 297

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 10/211 (4%)
Query: 471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLS 527
           K    DF+ L ++G+G FG V            A+K L      ++       TE  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARAL 587
             R+  L +L        ++  V +Y   G L  HL  +       +R          AL
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSAL 118
Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
            YLH   S+ +++RD+K  N++LD++   K++DFGLCK G   S         G+  YL 
Sbjct: 119 EYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKXFCGTPEYLA 173
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           PE           D +  GVV+ E++C R P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 16/215 (7%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE--FQTEIGMLSQLRYL 532
           +D+  L  IG G +G   K     D   +  K L+ GS   A +    +E+ +L +L++ 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 533 HLVSLIGYCND--DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRR--LKICIGAARALH 588
           ++V       D  +  + +V +Y   G L   +          D    L++      AL 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 589 YLH--TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF---GPNFSKTHVSTQVKGSI 643
             H  +     ++HRD+K  N+ LD +   K+ DFGL +      +F+KT V     G+ 
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-----GTP 180
Query: 644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            Y+ PE        EKSD++S G +L E+    PP
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 15/220 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYL 532
            +D++ +  +G G  G V           VA+K ++        E  + EI +   L + 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V   G+  +     L  +Y + G L D +  +   P P          A R  H L  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---------DAQRFFHQLMA 115
Query: 593 GASKV----IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           G   +    I HRD+K  N+LLDE    K+SDFGL       ++  +  ++ G++ Y+ P
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 649 EYY-RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
           E   R +   E  DV+S G+VL  +L    P  +  D  Q
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 215

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 24/220 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHL 534
           DF ++L  G G F  V           VAIK +   + +G     + EI +L ++++ ++
Sbjct: 21  DFRDVL--GTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHL-----YNNDNPPLPWDRRLKICIGAARALHY 589
           V+L       G + L+   ++ G L D +     Y   +         ++      A+ Y
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-------RLIFQVLDAVKY 131
Query: 590 LHTGASKVIIHRDVKTTNIL---LDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL 646
           LH      I+HRD+K  N+L   LDE+    +SDFGL K     S   V +   G+ GY+
Sbjct: 132 LHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYV 185
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKK 686
            PE    +  ++  D +S GV+   +LC  PP     D K
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK 225

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 24/220 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHL 534
           DF ++L  G G F  V           VAIK +   + +G     + EI +L ++++ ++
Sbjct: 21  DFRDVL--GTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI 78
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHL-----YNNDNPPLPWDRRLKICIGAARALHY 589
           V+L       G + L+   ++ G L D +     Y   +         ++      A+ Y
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-------RLIFQVLDAVKY 131
Query: 590 LHTGASKVIIHRDVKTTNIL---LDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL 646
           LH      I+HRD+K  N+L   LDE+    +SDFGL K     S   V +   G+ GY+
Sbjct: 132 LHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYV 185
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKK 686
            PE    +  ++  D +S GV+   +LC  PP     D K
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK 225

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 12/200 (6%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           +G G FG V  G        VA+K LN     S     + + EI  L   R+ H++ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
             +    + +V +Y++ G L D++  N        RRL   I +   + Y H     +++
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSG--VDYCH---RHMVV 138
Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLT-E 658
           HRD+K  N+LLD    AK++DFGL     +      S    GS  Y  PE    +L    
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GSPNYAAPEVISGRLYAGP 195
Query: 659 KSDVYSFGVVLLEVLCARPP 678
           + D++S GV+L  +LC   P
Sbjct: 196 EVDIWSSGVILYALLCGTLP 215

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 24/220 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHL 534
           DF ++L  G G F  V           VAIK +   + +G     + EI +L ++++ ++
Sbjct: 21  DFRDVL--GTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHL-----YNNDNPPLPWDRRLKICIGAARALHY 589
           V+L       G + L+   ++ G L D +     Y   +         ++      A+ Y
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-------RLIFQVLDAVKY 131
Query: 590 LHTGASKVIIHRDVKTTNIL---LDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL 646
           LH      I+HRD+K  N+L   LDE+    +SDFGL K     S   V +   G+ GY+
Sbjct: 132 LHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYV 185
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKK 686
            PE    +  ++  D +S GV+   +LC  PP     D K
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK 225

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 19/223 (8%)
Query: 471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQT-EIGMLS 527
           K+  +DF    I+G G F  V        S   AIK L      ++  + + T E  ++S
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 64
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARAL 587
           +L +   V L     DD ++     Y   G L  ++    +      R     I    AL
Sbjct: 65  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--VSAL 122
Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
            YLH    K IIHRD+K  NILL+E+   +++DFG  K     SK   +    G+  Y+ 
Sbjct: 123 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 179
Query: 648 PEYYRLQLLTEK-----SDVYSFGVVLLEVLCARPPILRTGDK 685
           PE     LLTEK     SD+++ G ++ +++   PP  R G++
Sbjct: 180 PE-----LLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNE 216

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 93/220 (42%), Gaps = 9/220 (4%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYL 532
           +F  L ++G+G FG V            A+K L      ++       TE  +L   R+ 
Sbjct: 152 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 211
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
            L +L        ++  V +Y   G L  HL  +       DR          AL YLH+
Sbjct: 212 FLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHS 269
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
              K +++RD+K  N++LD++   K++DFGLCK G     T  +    G+  YL PE   
Sbjct: 270 --EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLE 325
Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAV 692
                   D +  GVV+ E++C R P      +K   L +
Sbjct: 326 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 365

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 19/223 (8%)
Query: 471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQT-EIGMLS 527
           K+  +DF    I+G G F  V        S   AIK L      ++  + + T E  ++S
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 65
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARAL 587
           +L +   V L     DD ++     Y   G L  ++    +      R     I    AL
Sbjct: 66  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--VSAL 123
Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
            YLH    K IIHRD+K  NILL+E+   +++DFG  K     SK   +    G+  Y+ 
Sbjct: 124 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 180
Query: 648 PEYYRLQLLTEK-----SDVYSFGVVLLEVLCARPPILRTGDK 685
           PE     LLTEK     SD+++ G ++ +++   PP  R G++
Sbjct: 181 PE-----LLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNE 217

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 93/220 (42%), Gaps = 9/220 (4%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYL 532
           +F  L ++G+G FG V            A+K L      ++       TE  +L   R+ 
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
            L +L        ++  V +Y   G L  HL  +       DR          AL YLH+
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHS 266
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
              K +++RD+K  N++LD++   K++DFGLCK G     T  +    G+  YL PE   
Sbjct: 267 --EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLE 322
Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAV 692
                   D +  GVV+ E++C R P      +K   L +
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 362

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 14/214 (6%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHL 534
           D+    +IG G    V   +       VAIKR+N    Q ++ E   EI  +SQ  + ++
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRD---HLY---NNDNPPLPWDRRLKICIGAARALH 588
           VS         ++ LV   ++ G++ D   H+     + +  L       I       L 
Sbjct: 76  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF---GPNFSKTHVSTQVKGSIGY 645
           YLH       IHRDVK  NILL E+   +++DFG+  F   G + ++  V     G+  +
Sbjct: 136 YLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 646 LDPEYY-RLQLLTEKSDVYSFGVVLLEVLCARPP 678
           + PE   +++    K+D++SFG+  +E+     P
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 19/223 (8%)
Query: 471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQT-EIGMLS 527
           K+  +DF    I+G G F  V        S   AIK L      ++  + + T E  ++S
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARAL 587
           +L +   V L     DD ++     Y   G L  ++    +      R     I    AL
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--VSAL 121
Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
            YLH    K IIHRD+K  NILL+E+   +++DFG  K     SK   +    G+  Y+ 
Sbjct: 122 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 178
Query: 648 PEYYRLQLLTEK-----SDVYSFGVVLLEVLCARPPILRTGDK 685
           PE     LLTEK     SD+++ G ++ +++   PP  R G++
Sbjct: 179 PE-----LLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNE 215

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 19/223 (8%)
Query: 471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQT-EIGMLS 527
           K+  +DF    I+G G F  V        S   AIK L      ++  + + T E  ++S
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 62
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARAL 587
           +L +   V L     DD ++     Y   G L  ++    +      R     I    AL
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--VSAL 120
Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
            YLH    K IIHRD+K  NILL+E+   +++DFG  K     SK   +    G+  Y+ 
Sbjct: 121 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 177
Query: 648 PEYYRLQLLTEK-----SDVYSFGVVLLEVLCARPPILRTGDK 685
           PE     LLTEK     SD+++ G ++ +++   PP  R G++
Sbjct: 178 PE-----LLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNE 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 24/220 (10%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHL 534
           DF ++L  G G F  V           VAIK +   + +G     + EI +L ++++ ++
Sbjct: 21  DFRDVL--GTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHL-----YNNDNPPLPWDRRLKICIGAARALHY 589
           V+L       G + L+   ++ G L D +     Y   +         ++      A+ Y
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-------RLIFQVLDAVKY 131
Query: 590 LHTGASKVIIHRDVKTTNIL---LDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL 646
           LH      I+HRD+K  N+L   LDE+    +SDFGL K     S   V +   G+ GY+
Sbjct: 132 LHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYV 185
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKK 686
            PE    +  ++  D +S GV+   +LC  PP     D K
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK 225

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVS 536
            +N + IG G  G V    +      VA+K+++   QQ       E+ ++   ++ ++V 
Sbjct: 76  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 135
Query: 537 LIGYCNDDGQMILVYDYMARGTLRD---HLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           +        ++ +V +++  G L D   H   N+      ++   +C+   +AL  LH  
Sbjct: 136 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------EQIAAVCLAVLQALSVLH-- 187
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK------GSIGYLD 647
            ++ +IHRD+K+ +ILL  +   K+SDFG C          VS +V       G+  ++ 
Sbjct: 188 -AQGVIHRDIKSDSILLTHDGRVKLSDFGFC--------AQVSKEVPRRKXLVGTPYWMA 238
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           PE         + D++S G++++E++   PP
Sbjct: 239 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 14/214 (6%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHL 534
           D+    +IG G    V   +       VAIKR+N    Q ++ E   EI  +SQ  + ++
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRD---HLY---NNDNPPLPWDRRLKICIGAARALH 588
           VS         ++ LV   ++ G++ D   H+     + +  L       I       L 
Sbjct: 71  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 130
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF---GPNFSKTHVSTQVKGSIGY 645
           YLH       IHRDVK  NILL E+   +++DFG+  F   G + ++  V     G+  +
Sbjct: 131 YLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 187
Query: 646 LDPEYY-RLQLLTEKSDVYSFGVVLLEVLCARPP 678
           + PE   +++    K+D++SFG+  +E+     P
Sbjct: 188 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVS 536
            +N + IG G  G V    +      VA+K+++   QQ       E+ ++   ++ ++V 
Sbjct: 33  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 92
Query: 537 LIGYCNDDGQMILVYDYMARGTLRD---HLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           +        ++ +V +++  G L D   H   N+      ++   +C+   +AL  LH  
Sbjct: 93  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------EQIAAVCLAVLQALSVLHAQ 146
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK------GSIGYLD 647
               +IHRD+K+ +ILL  +   K+SDFG C          VS +V       G+  ++ 
Sbjct: 147 G---VIHRDIKSDSILLTHDGRVKLSDFGFC--------AQVSKEVPRRKXLVGTPYWMA 195
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           PE         + D++S G++++E++   PP
Sbjct: 196 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 92/220 (41%), Gaps = 9/220 (4%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYL 532
           +F  L ++G+G FG V            A+K L      ++       TE  +L   R+ 
Sbjct: 10  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 69
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
            L +L        ++  V +Y   G L  HL  +       DR          AL YLH+
Sbjct: 70  FLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHS 127
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
              K +++RD+K  N++LD++   K++DFGLCK G     T       G+  YL PE   
Sbjct: 128 --EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLAPEVLE 183
Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAV 692
                   D +  GVV+ E++C R P      +K   L +
Sbjct: 184 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 223

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 92/220 (41%), Gaps = 9/220 (4%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYL 532
           +F  L ++G+G FG V            A+K L      ++       TE  +L   R+ 
Sbjct: 9   EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 68
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
            L +L        ++  V +Y   G L  HL  +       DR          AL YLH+
Sbjct: 69  FLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHS 126
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
              K +++RD+K  N++LD++   K++DFGLCK G     T       G+  YL PE   
Sbjct: 127 --EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLAPEVLE 182
Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAV 692
                   D +  GVV+ E++C R P      +K   L +
Sbjct: 183 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 222

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 92/220 (41%), Gaps = 9/220 (4%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYL 532
           +F  L ++G+G FG V            A+K L      ++       TE  +L   R+ 
Sbjct: 11  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 70
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
            L +L        ++  V +Y   G L  HL  +       DR          AL YLH+
Sbjct: 71  FLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHS 128
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
              K +++RD+K  N++LD++   K++DFGLCK G     T       G+  YL PE   
Sbjct: 129 --EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLAPEVLE 184
Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAV 692
                   D +  GVV+ E++C R P      +K   L +
Sbjct: 185 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 224

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVS 536
            +N + IG G  G V    +      VA+K+++   QQ       E+ ++   ++ ++V 
Sbjct: 31  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 90
Query: 537 LIGYCNDDGQMILVYDYMARGTLRD---HLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           +        ++ +V +++  G L D   H   N+      ++   +C+   +AL  LH  
Sbjct: 91  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------EQIAAVCLAVLQALSVLHAQ 144
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK------GSIGYLD 647
               +IHRD+K+ +ILL  +   K+SDFG C          VS +V       G+  ++ 
Sbjct: 145 G---VIHRDIKSDSILLTHDGRVKLSDFGFC--------AQVSKEVPRRKXLVGTPYWMA 193
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           PE         + D++S G++++E++   PP
Sbjct: 194 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 9/214 (4%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQT-EIGMLSQLRY 531
           +DF    I+G G F  V        S   AIK L      ++  + + T E  ++S+L +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              V L     DD ++     Y   G L  ++    +      R     I    AL YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEI--VSALEYLH 149
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               K IIHRD+K  NILL+E+   +++DFG  K     SK   +    G+  Y+ PE  
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 206
Query: 652 RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDK 685
             +  ++ SD+++ G ++ +++   PP  R G++
Sbjct: 207 TEKSASKSSDLWALGCIIYQLVAGLPP-FRAGNE 239

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQT-EIGMLSQLRY 531
           +DF    I+G G F  V        S   AIK L      ++  + + T E  ++S+L +
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              V L     DD ++     Y   G L  ++    +      R     I    AL YLH
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--VSALEYLH 150
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               K IIHRD+K  NILL+E+   +++DFG  K     SK   +    G+  Y+ PE  
Sbjct: 151 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-- 205
Query: 652 RLQLLTEK-----SDVYSFGVVLLEVLCARPPILRTGDK 685
              LLTEK     SD+++ G ++ +++   PP  R G++
Sbjct: 206 ---LLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNE 240

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 26/222 (11%)
Query: 475 KDFNNLLIIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL 532
           K F  + ++G G F  V+  K  L G    +   + +P  +  +LE   EI +L ++++ 
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE--NEIAVLKKIKHE 66
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHL-----YNNDNPPLPWDRRLKICIGAARAL 587
           ++V+L           LV   ++ G L D +     Y   +  L   + L        A+
Sbjct: 67  NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS-------AV 119
Query: 588 HYLHTGASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG 644
            YLH      I+HRD+K  N+L    +E     ++DFGL K   N     + +   G+ G
Sbjct: 120 KYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN----GIMSTACGTPG 172
Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKK 686
           Y+ PE    +  ++  D +S GV+   +LC  PP     + K
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK 214

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVS 536
            +N + IG G  G V    +      VA+K+++   QQ       E+ ++   ++ ++V 
Sbjct: 22  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 537 LIGYCNDDGQMILVYDYMARGTLRD---HLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           +        ++ +V +++  G L D   H   N+      ++   +C+   +AL  LH  
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------EQIAAVCLAVLQALSVLHAQ 135
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK------GSIGYLD 647
               +IHRD+K+ +ILL  +   K+SDFG C          VS +V       G+  ++ 
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFC--------AQVSKEVPRRKXLVGTPYWMA 184
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           PE         + D++S G++++E++   PP
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 17/214 (7%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
           I+G G FG V+K         +A K +     +   E + EI +++QL + +L+ L    
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL---KICIGAARALHYLHTGASKVI 598
                ++LV +Y+  G L D + +        D  L   +IC G  R +H ++      I
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEG-IRHMHQMY------I 208
Query: 599 IHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
           +H D+K  NIL    D + + K+ DFGL +      K  V+    G+  +L PE      
Sbjct: 209 LHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVNF---GTPEFLAPEVVNYDF 264
Query: 656 LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVN 689
           ++  +D++S GV+   +L    P L   D + +N
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN 298

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 479 NLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI 538
           N + IG G  G V           VA+K+++   QQ       E+ ++    + ++V + 
Sbjct: 49  NFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMY 108
Query: 539 GYCNDDGQMILVYDYMARGTLRD---HLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
                  ++ +V +++  G L D   H   N+      ++   +C+   RAL YLH    
Sbjct: 109 SSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------EQIATVCLSVLRALSYLHNQG- 161
Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK------GSIGYLDPE 649
             +IHRD+K+ +ILL  +   K+SDFG C          VS +V       G+  ++ PE
Sbjct: 162 --VIHRDIKSDSILLTSDGRIKLSDFGFC--------AQVSKEVPKRKXLVGTPYWMAPE 211
Query: 650 YY-RLQLLTEKSDVYSFGVVLLEVLCARPP 678
              RL   TE  D++S G++++E++   PP
Sbjct: 212 VISRLPYGTE-VDIWSLGIMVIEMIDGEPP 240

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQT-EIGMLSQLRY 531
           +DF    I+G G F  V        S   AIK L      ++  + + T E  ++S+L +
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              V L     DD ++     Y   G L  ++    +      R     I    AL YLH
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--VSALEYLH 152
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               K IIHRD+K  NILL+E+   +++DFG  K     SK   +    G+  Y+ PE  
Sbjct: 153 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-- 207
Query: 652 RLQLLTEK-----SDVYSFGVVLLEVLCARPPILRTGDK 685
              LLTEK     SD+++ G ++ +++   PP  R G++
Sbjct: 208 ---LLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNE 242

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQT-EIGMLSQLRY 531
           +DF    I+G G F  V        S   AIK L      ++  + + T E  ++S+L +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              V L     DD ++     Y   G L  ++    +      R     I    AL YLH
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--VSALEYLH 147
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               K IIHRD+K  NILL+E+   +++DFG  K     SK   +    G+  Y+ PE  
Sbjct: 148 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPE-- 202
Query: 652 RLQLLTEK-----SDVYSFGVVLLEVLCARPPILRTGDK 685
              LLTEK     SD+++ G ++ +++   PP  R G++
Sbjct: 203 ---LLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNE 237

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 16/215 (7%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE--FQTEIGMLSQLRYL 532
           +D+  L  IG G +G   K     D   +  K L+ GS   A +    +E+ +L +L++ 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 533 HLVSLIGYCND--DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRR--LKICIGAARALH 588
           ++V       D  +  + +V +Y   G L   +          D    L++      AL 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 589 YLH--TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF---GPNFSKTHVSTQVKGSI 643
             H  +     ++HRD+K  N+ LD +   K+ DFGL +      +F+K  V     G+ 
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFV-----GTP 180
Query: 644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            Y+ PE        EKSD++S G +L E+    PP
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQT-EIGMLSQLRY 531
           +DF    I+G G F  V        S   AIK L      ++  + + T E  ++S+L +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              V L     DD ++     Y   G L  ++    +      R     I    AL YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--VSALEYLH 149
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               K IIHRD+K  NILL+E+   +++DFG  K     SK   +    G+  Y+ PE  
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-- 204
Query: 652 RLQLLTEK-----SDVYSFGVVLLEVLCARPPILRTGDK 685
              LLTEK     SD+++ G ++ +++   PP  R G++
Sbjct: 205 ---LLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNE 239

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQT-EIGMLSQLRY 531
           +DF    I+G G F  V        S   AIK L      ++  + + T E  ++S+L +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              V L     DD ++     Y   G L  ++    +      R     I    AL YLH
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--VSALEYLH 147
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               K IIHRD+K  NILL+E+   +++DFG  K     SK   +    G+  Y+ PE  
Sbjct: 148 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-- 202
Query: 652 RLQLLTEK-----SDVYSFGVVLLEVLCARPPILRTGDK 685
              LLTEK     SD+++ G ++ +++   PP  R G++
Sbjct: 203 ---LLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNE 237

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQT-EIGMLSQLRY 531
           +DF    I+G G F  V        S   AIK L      ++  + + T E  ++S+L +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              V L     DD ++     Y   G L  ++    +      R     I    AL YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--VSALEYLH 149
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               K IIHRD+K  NILL+E+   +++DFG  K     SK   +    G+  Y+ PE  
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-- 204
Query: 652 RLQLLTEK-----SDVYSFGVVLLEVLCARPPILRTGDK 685
              LLTEK     SD+++ G ++ +++   PP  R G++
Sbjct: 205 ---LLTEKSAXKSSDLWALGCIIYQLVAGLPP-FRAGNE 239

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQT-EIGMLSQLRY 531
           +DF    I+G G F  V        S   AIK L      ++  + + T E  ++S+L +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              V L     DD ++     Y   G L  ++    +      R     I    AL YLH
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--VSALEYLH 147
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               K IIHRD+K  NILL+E+   +++DFG  K     SK   +    G+  Y+ PE  
Sbjct: 148 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-- 202
Query: 652 RLQLLTEK-----SDVYSFGVVLLEVLCARPPILRTGDK 685
              LLTEK     SD+++ G ++ +++   PP  R G++
Sbjct: 203 ---LLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNE 237

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQT-EIGMLSQLRY 531
           +DF    I+G G F  V        S   AIK L      ++  + + T E  ++S+L +
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              V L     DD ++     Y   G L  ++    +      R     I    AL YLH
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--VSALEYLH 150
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               K IIHRD+K  NILL+E+   +++DFG  K     SK   +    G+  Y+ PE  
Sbjct: 151 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-- 205
Query: 652 RLQLLTEK-----SDVYSFGVVLLEVLCARPPILRTGDK 685
              LLTEK     SD+++ G ++ +++   PP  R G++
Sbjct: 206 ---LLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNE 240

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQT-EIGMLSQLRY 531
           +DF    I+G G F  V        S   AIK L      ++  + + T E  ++S+L +
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              V L     DD ++     Y   G L  ++    +      R     I    AL YLH
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--VSALEYLH 154
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               K IIHRD+K  NILL+E+   +++DFG  K     SK   +    G+  Y+ PE  
Sbjct: 155 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-- 209
Query: 652 RLQLLTEK-----SDVYSFGVVLLEVLCARPPILRTGDK 685
              LLTEK     SD+++ G ++ +++   PP  R G++
Sbjct: 210 ---LLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNE 244

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVS 536
            +N + IG G  G V    +      VA+K+++   QQ       E+ ++   ++ ++V 
Sbjct: 26  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 85
Query: 537 LIGYCNDDGQMILVYDYMARGTLRD---HLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           +        ++ +V +++  G L D   H   N+      ++   +C+   +AL  LH  
Sbjct: 86  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------EQIAAVCLAVLQALSVLH-- 137
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK------GSIGYLD 647
            ++ +IHRD+K+ +ILL  +   K+SDFG C          VS +V       G+  ++ 
Sbjct: 138 -AQGVIHRDIKSDSILLTHDGRVKLSDFGFC--------AQVSKEVPRRKXLVGTPYWMA 188
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           PE         + D++S G++++E++   PP
Sbjct: 189 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           + NL  IG G +G V   + N +   VAIK+++P   Q   +    EI +L + R+ +++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL---KICI---GAARALHY 589
            +     +D       + M    L  HL   D   L   + L    IC       R L Y
Sbjct: 105 GI-----NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 159
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGYLDP 648
           +H+     ++HRD+K +N+LL+     K+ DFGL +   P+   T   T+   +  Y  P
Sbjct: 160 IHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216
Query: 649 E-YYRLQLLTEKSDVYSFGVVLLEVLCARP 677
           E     +  T+  D++S G +L E+L  RP
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNRP 246

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQT-EIGMLSQLRY 531
           +DF    I+G G F  V        S   AIK L      ++  + + T E  ++S+L +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              V L     DD ++     Y   G L  ++    +      R     I    AL YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--VSALEYLH 149
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               K IIHRD+K  NILL+E+   +++DFG  K     SK   +    G+  Y+ PE  
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-- 204
Query: 652 RLQLLTEK-----SDVYSFGVVLLEVLCARPPILRTGDK 685
              LLTEK     SD+++ G ++ +++   PP  R G++
Sbjct: 205 ---LLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNE 239

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQT-EIGMLSQLRY 531
           +DF    I+G G F  V        S   AIK L      ++  + + T E  ++S+L +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              V L     DD ++     Y   G L  ++    +      R     I    AL YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--VSALEYLH 149
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               K IIHRD+K  NILL+E+   +++DFG  K     SK   +    G+  Y+ PE  
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-- 204
Query: 652 RLQLLTEK-----SDVYSFGVVLLEVLCARPPILRTGDK 685
              LLTEK     SD+++ G ++ +++   PP  R G++
Sbjct: 205 ---LLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNE 239

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQT-EIGMLSQLRY 531
           +DF    I+G G F  V        S   AIK L      ++  + + T E  ++S+L +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              V L     DD ++     Y   G L  ++    +      R     I    AL YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--VSALEYLH 149
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               K IIHRD+K  NILL+E+   +++DFG  K     SK   +    G+  Y+ PE  
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-- 204
Query: 652 RLQLLTEK-----SDVYSFGVVLLEVLCARPPILRTGDK 685
              LLTEK     SD+++ G ++ +++   PP  R G++
Sbjct: 205 ---LLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNE 239

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 16/215 (7%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE--FQTEIGMLSQLRYL 532
           +D+  L  IG G +G   K     D   +  K L+ GS   A +    +E+ +L +L++ 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 533 HLVSLIGYCND--DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRR--LKICIGAARALH 588
           ++V       D  +  + +V +Y   G L   +          D    L++      AL 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 589 YLH--TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF---GPNFSKTHVSTQVKGSI 643
             H  +     ++HRD+K  N+ LD +   K+ DFGL +      +F+K  V     G+ 
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-----GTP 180
Query: 644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            Y+ PE        EKSD++S G +L E+    PP
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQT-EIGMLSQLRY 531
           +DF    I+G G F  V        S   AIK L      ++  + + T E  ++S+L +
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              V L     DD ++     Y   G L  ++    +      R     I    AL YLH
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--VSALEYLH 146
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               K IIHRD+K  NILL+E+   +++DFG  K     SK   +    G+  Y+ PE  
Sbjct: 147 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-- 201
Query: 652 RLQLLTEK-----SDVYSFGVVLLEVLCARPPILRTGDK 685
              LLTEK     SD+++ G ++ +++   PP  R G++
Sbjct: 202 ---LLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNE 236

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 11/207 (5%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLN--GDSTPVAIKRLNPGSQQGALEF-QTEIGMLSQLRYL 532
           +F  + ++G+G FG V    +   GD   V + + +   Q   +E   TE  +LS  R  
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 533 HLVSLIGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
             ++ +  C     ++  V +++  G L  H+  +        R          AL +LH
Sbjct: 84  PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEIISALMFLH 141
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               K II+RD+K  N+LLD E   K++DFG+CK G        +    G+  Y+ PE  
Sbjct: 142 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG--ICNGVTTATFCGTPDYIAPEIL 196
Query: 652 RLQLLTEKSDVYSFGVVLLEVLCARPP 678
           +  L     D ++ GV+L E+LC   P
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQT-EIGMLSQLRY 531
           +DF    I+G G F  V        S   AIK L      ++  + + T E  ++S+L +
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              V L     DD ++     Y   G L  ++    +      R     I    AL YLH
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--VSALEYLH 146
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               K IIHRD+K  NILL+E+   +++DFG  K     SK   +    G+  Y+ PE  
Sbjct: 147 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-- 201
Query: 652 RLQLLTEK-----SDVYSFGVVLLEVLCARPPILRTGDK 685
              LLTEK     SD+++ G ++ +++   PP  R G++
Sbjct: 202 ---LLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNE 236

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQT-EIGMLSQLRY 531
           +DF    I+G G F  V        S   AIK L      ++  + + T E  ++S+L +
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              V L     DD ++     Y   G L  ++    +      R     I    AL YLH
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--VSALEYLH 131
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               K IIHRD+K  NILL+E+   +++DFG  K     SK   +    G+  Y+ PE  
Sbjct: 132 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-- 186
Query: 652 RLQLLTEK-----SDVYSFGVVLLEVLCARPPILRTGDK 685
              LLTEK     SD+++ G ++ +++   PP  R G++
Sbjct: 187 ---LLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNE 221

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 15/217 (6%)
Query: 469 EIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQ 528
           +IK   +DF    ++G+G FG V+       +   AIK L        ++   E  M+ +
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK--KDVVLMDDDVECTMVEK 68
Query: 529 ----LRYLH--LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
               L + H  L  +         +  V +Y+  G L  H+ +     L   R       
Sbjct: 69  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDL--SRATFYAAE 126
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS 642
               L +LH   SK I++RD+K  NILLD++   K++DFG+CK   N      +    G+
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNXFCGT 181
Query: 643 IGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPI 679
             Y+ PE    Q      D +SFGV+L E+L  + P 
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           + NL  IG G +G V   + N +   VAIK+++P   Q   +    EI +L + R+ +++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 536 SL--IGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHT 592
            +  I       QM  VY  + +  +   LY       L  D          R L Y+H+
Sbjct: 87  GINDIIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGYLDPE-Y 650
                ++HRD+K +N+LL+     K+ DFGL +   P+   T   T+   +  Y  PE  
Sbjct: 145 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARP 677
              +  T+  D++S G +L E+L  RP
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLSNRP 228

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           + NL  IG G +G V   + N +   VAIK+++P   Q   +    EI +L + R+ +++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 536 SL--IGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHT 592
            +  I       QM  VY  + +  +   LY       L  D          R L Y+H+
Sbjct: 85  GINDIIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGYLDPE-Y 650
                ++HRD+K +N+LL+     K+ DFGL +   P+   T   T+   +  Y  PE  
Sbjct: 143 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARP 677
              +  T+  D++S G +L E+L  RP
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNRP 226

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG--SQQGALE-FQTEIGMLSQ 528
           KD   L  +G G FG V +G  +   G +  VA+K L P   SQ  A++ F  E+  +  
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 529 LRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALH 588
           L + +L+ L G       M +V +    G+L D L  +    L      +  +  A  + 
Sbjct: 72  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMG 129
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLD 647
           YL    SK  IHRD+   N+LL    + K+ DFGL +  P     +V  +  K    +  
Sbjct: 130 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEV 672
           PE  + +  +  SD + FGV L E+
Sbjct: 187 PESLKTRTFSHASDTWMFGVTLWEM 211

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA---LEFQTEIGMLSQLRYLHLVSLIG 539
           +G G FG V           VA+K ++    + +   +  + EI  L  LR+ H++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL---KICIGAARALHYLHTGASK 596
                  +++V +Y A G L D++           RR     IC     A+ Y H     
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIIC-----AIEYCHRHK-- 128
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP--NFSKTHVSTQVKGSIGYLDPEYYRLQ 654
            I+HRD+K  N+LLD+    K++DFGL       NF KT       GS  Y  PE    +
Sbjct: 129 -IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-----GSPNYAAPEVINGK 182
Query: 655 LLT-EKSDVYSFGVVLLEVLCARPP 678
           L    + DV+S G+VL  +L  R P
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLP 207

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           + NL  IG G +G V   + N +   VAIK+++P   Q   +    EI +L + R+ +++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 536 SL--IGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHT 592
            +  I       QM  VY  + +  +   LY       L  D          R L Y+H+
Sbjct: 85  GINDIIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGYLDPE-Y 650
                ++HRD+K +N+LL+     K+ DFGL +   P+   T   T+   +  Y  PE  
Sbjct: 143 AN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARP 677
              +  T+  D++S G +L E+L  RP
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNRP 226

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           + NL  IG G +G V   + N +   VAIK+++P   Q   +    EI +L + R+ +++
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 536 SL--IGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHT 592
            +  I       QM  VY  + +  +   LY       L  D          R L Y+H+
Sbjct: 93  GINDIIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 150
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGYLDPE-Y 650
                ++HRD+K +N+LL+     K+ DFGL +   P+   T   T+   +  Y  PE  
Sbjct: 151 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 207
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARP 677
              +  T+  D++S G +L E+L  RP
Sbjct: 208 LNSKGYTKSIDIWSVGCILAEMLSNRP 234

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           + NL  IG G +G V   + N +   VAIK+++P   Q   +    EI +L + R+ +++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 536 SL--IGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHT 592
            +  I       QM  VY  + +  +   LY       L  D          R L Y+H+
Sbjct: 85  GINDIIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGYLDPE-Y 650
                ++HRD+K +N+LL+     K+ DFGL +   P+   T   T+   +  Y  PE  
Sbjct: 143 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARP 677
              +  T+  D++S G +L E+L  RP
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNRP 226

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           + NL  IG G +G V   + N +   VAIK+++P   Q   +    EI +L + R+ +++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 536 SL--IGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHT 592
            +  I       QM  VY  + +  +   LY       L  D          R L Y+H+
Sbjct: 83  GINDIIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGYLDPE-Y 650
                ++HRD+K +N+LL+     K+ DFGL +   P+   T   T+   +  Y  PE  
Sbjct: 141 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 197
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARP 677
              +  T+  D++S G +L E+L  RP
Sbjct: 198 LNSKGYTKSIDIWSVGCILAEMLSNRP 224

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           + NL  IG G +G V   + N +   VAIK+++P   Q   +    EI +L + R+ +++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 536 SL--IGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHT 592
            +  I       QM  VY  + +  +   LY       L  D          R L Y+H+
Sbjct: 85  GINDIIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGYLDPE-Y 650
                ++HRD+K +N+LL+     K+ DFGL +   P+   T   T+   +  Y  PE  
Sbjct: 143 AN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARP 677
              +  T+  D++S G +L E+L  RP
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNRP 226

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           + NL  IG G +G V   + N +   VAIK+++P   Q   +    EI +L + R+ +++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 536 SL--IGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHT 592
            +  I       QM  VY  + +  +   LY       L  D          R L Y+H+
Sbjct: 90  GINDIIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGYLDPE-Y 650
                ++HRD+K +N+LL+     K+ DFGL +   P+   T   T+   +  Y  PE  
Sbjct: 148 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 204
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARP 677
              +  T+  D++S G +L E+L  RP
Sbjct: 205 LNSKGYTKSIDIWSVGCILAEMLSNRP 231

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           + NL  IG G +G V   + N +   VAIK+++P   Q   +    EI +L + R+ +++
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 536 SL--IGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHT 592
            +  I       QM  VY  + +  +   LY       L  D          R L Y+H+
Sbjct: 91  GINDIIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 148
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGYLDPE-Y 650
                ++HRD+K +N+LL+     K+ DFGL +   P+   T   T+   +  Y  PE  
Sbjct: 149 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 205
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARP 677
              +  T+  D++S G +L E+L  RP
Sbjct: 206 LNSKGYTKSIDIWSVGCILAEMLSNRP 232

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           + NL  IG G +G V   + N +   VAIK+++P   Q   +    EI +L + R+ +++
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 536 SL--IGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHT 592
            +  I       QM  VY  + +  +   LY       L  D          R L Y+H+
Sbjct: 82  GINDIIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 139
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGYLDPE-Y 650
                ++HRD+K +N+LL+     K+ DFGL +   P+   T   T+   +  Y  PE  
Sbjct: 140 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 196
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARP 677
              +  T+  D++S G +L E+L  RP
Sbjct: 197 LNSKGYTKSIDIWSVGCILAEMLSNRP 223

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           + NL  IG G +G V   + N +   VAIK+++P   Q   +    EI +L + R+ +++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 536 SL--IGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHT 592
            +  I       QM  VY  + +  +   LY       L  D          R L Y+H+
Sbjct: 89  GINDIIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGYLDPE-Y 650
                ++HRD+K +N+LL+     K+ DFGL +   P+   T   T+   +  Y  PE  
Sbjct: 147 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARP 677
              +  T+  D++S G +L E+L  RP
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           + NL  IG G +G V   + N +   VAIK+++P   Q   +    EI +L + R+ +++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 536 SL--IGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHT 592
            +  I       QM  VY  + +  +   LY       L  D          R L Y+H+
Sbjct: 83  GINDIIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGYLDPE-Y 650
                ++HRD+K +N+LL+     K+ DFGL +   P+   T   T+   +  Y  PE  
Sbjct: 141 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 197
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARP 677
              +  T+  D++S G +L E+L  RP
Sbjct: 198 LNSKGYTKSIDIWSVGCILAEMLSNRP 224

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           + NL  IG G +G V   + N +   VAIK+++P   Q   +    EI +L + R+ +++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 536 SL--IGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHT 592
            +  I       QM  VY  + +  +   LY       L  D          R L Y+H+
Sbjct: 85  GINDIIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGYLDPE-Y 650
                ++HRD+K +N+LL+     K+ DFGL +   P+   T   T+   +  Y  PE  
Sbjct: 143 AN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARP 677
              +  T+  D++S G +L E+L  RP
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNRP 226

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           + NL  IG G +G V   + N +   VAIK+++P   Q   +    EI +L + R+ +++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 536 SL--IGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHT 592
            +  I       QM  VY  + +  +   LY       L  D          R L Y+H+
Sbjct: 89  GINDIIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGYLDPE-Y 650
                ++HRD+K +N+LL+     K+ DFGL +   P+   T   T+   +  Y  PE  
Sbjct: 147 AN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARP 677
              +  T+  D++S G +L E+L  RP
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           + NL  IG G +G V   + N +   VAIK+++P   Q   +    EI +L + R+ +++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 536 SL--IGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHT 592
            +  I       QM  VY  + +  +   LY       L  D          R L Y+H+
Sbjct: 89  GINDIIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGYLDPE-Y 650
                ++HRD+K +N+LL+     K+ DFGL +   P+   T   T+   +  Y  PE  
Sbjct: 147 AN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARP 677
              +  T+  D++S G +L E+L  RP
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           + NL  IG G +G V   + N +   VAIK+++P   Q   +    EI +L + R+ +++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 536 SL--IGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHT 592
            +  I       QM  VY  + +  +   LY       L  D          R L Y+H+
Sbjct: 105 GINDIIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGYLDPE-Y 650
                ++HRD+K +N+LL+     K+ DFGL +   P+   T   T+   +  Y  PE  
Sbjct: 163 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 219
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARP 677
              +  T+  D++S G +L E+L  RP
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLSNRP 246

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 112/273 (41%), Gaps = 38/273 (13%)
Query: 483 IGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGAL--EFQTEIGMLSQLRYLHLVSLI 538
           +G G FG V KG+  +      VA+K L   +   AL  E   E  ++ QL   ++V +I
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL-KICIGAARALHYLHTGASKV 597
           G C  +  M LV +    G L  +L  N +     D+ + ++    +  + YL       
Sbjct: 437 GICEAESWM-LVMEMAELGPLNKYLQQNRHVK---DKNIIELVHQVSMGMKYLEESN--- 489
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
            +HRD+   N+LL  +  AK+SDFGL K      N+ K    T  K  + +  PE     
Sbjct: 490 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ--THGKWPVKWYAPECINYY 547
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             + KSDV+SFGV++ E                     +  + YR  K  ++     KG 
Sbjct: 548 KFSSKSDVWSFGVLMWEAFS------------------YGQKPYRGMKGSEVTAMLEKGE 589
Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
               P  C  +  ++   C   D   RP  + V
Sbjct: 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 622

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG--SQQGALE-FQTEIGMLSQ 528
           KD   L  +G G FG V +G  +   G +  VA+K L P   SQ  A++ F  E+  +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 529 LRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALH 588
           L + +L+ L G       M +V +    G+L D L  +    L      +  +  A  + 
Sbjct: 78  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMG 135
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLD 647
           YL    SK  IHRD+   N+LL    + K+ DFGL +  P     +V  +  K    +  
Sbjct: 136 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 192
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEV 672
           PE  + +  +  SD + FGV L E+
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEM 217

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 112/273 (41%), Gaps = 38/273 (13%)
Query: 483 IGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGAL--EFQTEIGMLSQLRYLHLVSLI 538
           +G G FG V KG+  +      VA+K L   +   AL  E   E  ++ QL   ++V +I
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL-KICIGAARALHYLHTGASKV 597
           G C  +  M LV +    G L  +L  N +     D+ + ++    +  + YL       
Sbjct: 438 GICEAESWM-LVMEMAELGPLNKYLQQNRHVK---DKNIIELVHQVSMGMKYLEESN--- 490
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
            +HRD+   N+LL  +  AK+SDFGL K      N+ K    T  K  + +  PE     
Sbjct: 491 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ--THGKWPVKWYAPECINYY 548
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             + KSDV+SFGV++ E                     +  + YR  K  ++     KG 
Sbjct: 549 KFSSKSDVWSFGVLMWEAFS------------------YGQKPYRGMKGSEVTAMLEKGE 590
Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
               P  C  +  ++   C   D   RP  + V
Sbjct: 591 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 623

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 92/221 (41%), Gaps = 14/221 (6%)
Query: 466 SISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTE 522
            I +++   +D+  + +IGRG FG V            A+K L+      +  +  F  E
Sbjct: 65  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 124
Query: 523 IGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
             +++      +V L     DD  + +V +YM  G L + + N D P   W R       
Sbjct: 125 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWAR-----FY 178
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS 642
            A  +  L    S   IHRDVK  N+LLD+    K++DFG C            T V G+
Sbjct: 179 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 237
Query: 643 IGYLDPEYYRLQ----LLTEKSDVYSFGVVLLEVLCARPPI 679
             Y+ PE  + Q        + D +S GV L E+L    P 
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 480 LLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           L +  RG FG V+K  L  +   V   ++ P   + + + + E+  L  +++ +++  IG
Sbjct: 29  LEVKARGRFGCVWKAQLLNEYVAV---KIFPIQDKQSWQNEYEVYSLPGMKHENILQFIG 85
Query: 540 Y----CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT--- 592
                 + D  + L+  +  +G+L D L  N    + W+    I    AR L YLH    
Sbjct: 86  AEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIP 142
Query: 593 ----GASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYLD 647
               G    I HRD+K+ N+LL     A ++DFGL  KF    S      QV G+  Y+ 
Sbjct: 143 GLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV-GTRRYMA 201
Query: 648 PEYYRLQLLTEKS-----DVYSFGVVLLEV 672
           PE     +  ++      D+Y+ G+VL E+
Sbjct: 202 PEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 92/221 (41%), Gaps = 14/221 (6%)
Query: 466 SISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTE 522
            I +++   +D+  + +IGRG FG V            A+K L+      +  +  F  E
Sbjct: 60  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119
Query: 523 IGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
             +++      +V L     DD  + +V +YM  G L + + N D P   W R       
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWAR-----FY 173
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS 642
            A  +  L    S   IHRDVK  N+LLD+    K++DFG C            T V G+
Sbjct: 174 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 232
Query: 643 IGYLDPEYYRLQ----LLTEKSDVYSFGVVLLEVLCARPPI 679
             Y+ PE  + Q        + D +S GV L E+L    P 
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           + NL  IG G +G V   + N +   VAIK+++P   Q   +    EI +L   R+ +++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 536 SL--IGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHT 592
            +  I       QM  VY  + +  +   LY       L  D          R L Y+H+
Sbjct: 87  GINDIIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGYLDPE-Y 650
                ++HRD+K +N+LL+     K+ DFGL +   P+   T   T+   +  Y  PE  
Sbjct: 145 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARP 677
              +  T+  D++S G +L E+L  RP
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLSNRP 228

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 480 LLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           L I  RG FG V+K  L  D   V I    P   + + + + EI     +++ +L+  I 
Sbjct: 20  LEIKARGRFGCVWKAQLMNDFVAVKI---FPLQDKQSWQSEREIFSTPGMKHENLLQFIA 76
Query: 540 Y----CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT--- 592
                 N + ++ L+  +  +G+L D+L  N    + W+    +    +R L YLH    
Sbjct: 77  AEKRGSNLEVELWLITAFHDKGSLTDYLKGN---IITWNELCHVAETMSRGLSYLHEDVP 133
Query: 593 -----GASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYL 646
                G    I HRD K+ N+LL  +  A ++DFGL  +F P         QV G+  Y+
Sbjct: 134 WCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV-GTRRYM 192
Query: 647 DPEYYRLQLLTEKS-----DVYSFGVVLLEVL 673
            PE     +  ++      D+Y+ G+VL E++
Sbjct: 193 APEVLEGAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 89/200 (44%), Gaps = 12/200 (6%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           +G G FG V  G        VA+K LN     S     + + EI  L   R+ H++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
             +      +V +Y++ G L D++  +        RRL   I    A+ Y H     +++
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI--LSAVDYCH---RHMVV 133
Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLT-E 658
           HRD+K  N+LLD    AK++DFGL     +      S    GS  Y  PE    +L    
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRLYAGP 190
Query: 659 KSDVYSFGVVLLEVLCARPP 678
           + D++S GV+L  +LC   P
Sbjct: 191 EVDIWSCGVILYALLCGTLP 210

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 92/221 (41%), Gaps = 14/221 (6%)
Query: 466 SISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTE 522
            I +++   +D+  + +IGRG FG V            A+K L+      +  +  F  E
Sbjct: 65  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 124
Query: 523 IGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
             +++      +V L     DD  + +V +YM  G L + + N D P   W R       
Sbjct: 125 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWAR-----FY 178
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS 642
            A  +  L    S   IHRDVK  N+LLD+    K++DFG C            T V G+
Sbjct: 179 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 237
Query: 643 IGYLDPEYYRLQ----LLTEKSDVYSFGVVLLEVLCARPPI 679
             Y+ PE  + Q        + D +S GV L E+L    P 
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 109/232 (46%), Gaps = 36/232 (15%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPV-AIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           DF+   IIGRGGFG VY G    D+  + A+K L+    +     Q E   L++   L L
Sbjct: 189 DFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMK---QGETLALNERIMLSL 244
Query: 535 VSLIGYC----------NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL---KICI 581
           VS  G C          +   ++  + D M  G L  HL +        D R    +I +
Sbjct: 245 VS-TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIIL 302
Query: 582 GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL-CKFGPNFSKTHVSTQVK 640
           G    L ++H   ++ +++RD+K  NILLDE    ++SD GL C F     K H S    
Sbjct: 303 G----LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASV--- 350
Query: 641 GSIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPPIL--RTGDKKQVN 689
           G+ GY+ PE  +  +  + S D +S G +L ++L    P    +T DK +++
Sbjct: 351 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 402

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 91/205 (44%), Gaps = 12/205 (5%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG--SQQGALE-FQTEIGMLSQ 528
           KD   L  +G G FG V +G  +   G +  VA+K L P   SQ  A++ F  E+  +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 529 LRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALH 588
           L + +L+ L G       M +V +    G+L D L  +    L      +  +  A  + 
Sbjct: 78  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMG 135
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP-NFSKTHVSTQVKGSIGYLD 647
           YL    SK  IHRD+   N+LL    + K+ DFGL +  P N     +    K    +  
Sbjct: 136 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCA 192
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEV 672
           PE  + +  +  SD + FGV L E+
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEM 217

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 109/232 (46%), Gaps = 36/232 (15%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPV-AIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           DF+   IIGRGGFG VY G    D+  + A+K L+    +     Q E   L++   L L
Sbjct: 190 DFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMK---QGETLALNERIMLSL 245
Query: 535 VSLIGYC----------NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL---KICI 581
           VS  G C          +   ++  + D M  G L  HL +        D R    +I +
Sbjct: 246 VS-TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIIL 303
Query: 582 GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL-CKFGPNFSKTHVSTQVK 640
           G    L ++H   ++ +++RD+K  NILLDE    ++SD GL C F     K H S    
Sbjct: 304 G----LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASV--- 351
Query: 641 GSIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPPIL--RTGDKKQVN 689
           G+ GY+ PE  +  +  + S D +S G +L ++L    P    +T DK +++
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG--SQQGALE-FQTEIGMLSQ 528
           KD   L  +G G FG V +G  +   G +  VA+K L P   SQ  A++ F  E+  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 529 LRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALH 588
           L + +L+ L G       M +V +    G+L D L  +    L      +  +  A  + 
Sbjct: 68  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMG 125
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLD 647
           YL    SK  IHRD+   N+LL    + K+ DFGL +  P     +V  +  K    +  
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEV 672
           PE  + +  +  SD + FGV L E+
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           + NL  IG G +G V   + N +   VAIK+++P   Q   +    EI +L + R+ +++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 536 SL--IGYCNDDGQMILVY---DYMARGTLR----DHLYNNDNPPLPWDRRLKICIGAARA 586
            +  I       QM  VY   D M     +     HL N        D          R 
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSN--------DHICYFLYQILRG 140
Query: 587 LHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGY 645
           L Y+H+     ++HRD+K +N+LL+     K+ DFGL +   P+   T   T+   +  Y
Sbjct: 141 LKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCARP 677
             PE     +  T+  D++S G +L E+L  RP
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG--SQQGALE-FQTEIGMLSQ 528
           KD   L  +G G FG V +G  +   G +  VA+K L P   SQ  A++ F  E+  +  
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 529 LRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALH 588
           L + +L+ L G       M +V +    G+L D L  +    L      +  +  A  + 
Sbjct: 72  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMG 129
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLD 647
           YL    SK  IHRD+   N+LL    + K+ DFGL +  P     +V  +  K    +  
Sbjct: 130 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEV 672
           PE  + +  +  SD + FGV L E+
Sbjct: 187 PESLKTRTFSHASDTWMFGVTLWEM 211

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 97/219 (44%), Gaps = 19/219 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQT-EIGMLSQLRY 531
           +DF    I+G G F           S   AIK L      ++  + + T E  ++S+L +
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              V L     DD ++     Y   G L  ++    +      R     I    AL YLH
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--VSALEYLH 147
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               K IIHRD+K  NILL+E+   +++DFG  K     SK   +    G+  Y+ PE  
Sbjct: 148 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-- 202
Query: 652 RLQLLTEK-----SDVYSFGVVLLEVLCARPPILRTGDK 685
              LLTEK     SD+++ G ++ +++   PP  R G++
Sbjct: 203 ---LLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNE 237

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 109/232 (46%), Gaps = 36/232 (15%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPV-AIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           DF+   IIGRGGFG VY G    D+  + A+K L+    +     Q E   L++   L L
Sbjct: 190 DFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMK---QGETLALNERIMLSL 245
Query: 535 VSLIGYC----------NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL---KICI 581
           VS  G C          +   ++  + D M  G L  HL +        D R    +I +
Sbjct: 246 VS-TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIIL 303
Query: 582 GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL-CKFGPNFSKTHVSTQVK 640
           G    L ++H   ++ +++RD+K  NILLDE    ++SD GL C F     K H S    
Sbjct: 304 G----LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASV--- 351
Query: 641 GSIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPPIL--RTGDKKQVN 689
           G+ GY+ PE  +  +  + S D +S G +L ++L    P    +T DK +++
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 109/232 (46%), Gaps = 36/232 (15%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPV-AIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           DF+   IIGRGGFG VY G    D+  + A+K L+    +     Q E   L++   L L
Sbjct: 190 DFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMK---QGETLALNERIMLSL 245
Query: 535 VSLIGYC----------NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL---KICI 581
           VS  G C          +   ++  + D M  G L  HL +        D R    +I +
Sbjct: 246 VS-TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIIL 303
Query: 582 GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL-CKFGPNFSKTHVSTQVK 640
           G    L ++H   ++ +++RD+K  NILLDE    ++SD GL C F     K H S    
Sbjct: 304 G----LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASV--- 351
Query: 641 GSIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPPIL--RTGDKKQVN 689
           G+ GY+ PE  +  +  + S D +S G +L ++L    P    +T DK +++
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG--SQQGALE-FQTEIGMLSQ 528
           KD   L  +G G FG V +G  +   G +  VA+K L P   SQ  A++ F  E+  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 529 LRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALH 588
           L + +L+ L G       M +V +    G+L D L  +    L      +  +  A  + 
Sbjct: 68  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMG 125
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLD 647
           YL    SK  IHRD+   N+LL    + K+ DFGL +  P     +V  +  K    +  
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEV 672
           PE  + +  +  SD + FGV L E+
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           + NL  IG G +G V   + N +   VAI++++P   Q   +    EI +L + R+ +++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 536 SL--IGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHT 592
            +  I       QM  VY  + +  +   LY       L  D          R L Y+H+
Sbjct: 89  GINDIIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGYLDPE-Y 650
                ++HRD+K +N+LL+     K+ DFGL +   P+   T   T+   +  Y  PE  
Sbjct: 147 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARP 677
              +  T+  D++S G +L E+L  RP
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 91/205 (44%), Gaps = 12/205 (5%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG--SQQGALE-FQTEIGMLSQ 528
           KD   L  +G G FG V +G  +   G +  VA+K L P   SQ  A++ F  E+  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 529 LRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALH 588
           L + +L+ L G       M +V +    G+L D L  +    L      +  +  A  + 
Sbjct: 68  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMG 125
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP-NFSKTHVSTQVKGSIGYLD 647
           YL    SK  IHRD+   N+LL    + K+ DFGL +  P N     +    K    +  
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCA 182
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEV 672
           PE  + +  +  SD + FGV L E+
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 29/223 (13%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLHL 534
           DF  +  +GRGGFG V++     D    AIKR+  P  +    +   E+  L++L +  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 535 VSLI-GYCNDDGQMIL------VYDYMARGTLR-DHLYNNDNPPLPWDRR-----LKICI 581
           V     +   +    L      VY Y+     R ++L +  N     + R     L I +
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 582 GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-----------FGPNF 630
             A A+ +LH   SK ++HRD+K +NI    + V KV DFGL               P  
Sbjct: 126 QIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
           +    + QV G+  Y+ PE       + K D++S G++L E+L
Sbjct: 183 AYARHTGQV-GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 88/200 (44%), Gaps = 12/200 (6%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           +G G FG V  G        VA+K LN     S     + + EI  L   R+ H++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
             +      +V +Y++ G L D++  +        RRL   I    A+ Y H     +++
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI--LSAVDYCH---RHMVV 133
Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLT-E 658
           HRD+K  N+LLD    AK++DFGL       S         GS  Y  PE    +L    
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRDSCGSPNYAAPEVISGRLYAGP 190
Query: 659 KSDVYSFGVVLLEVLCARPP 678
           + D++S GV+L  +LC   P
Sbjct: 191 EVDIWSCGVILYALLCGTLP 210

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 18/227 (7%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRY 531
           ++  F  L  +G G +  VYKG        VA+K +   S++G       EI ++ +L++
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKIC----IGAARAL 587
            ++V L    + + ++ LV+++M    L+ ++ +      P    L +         + L
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG---PNFSKTHVSTQVKGSI 643
            + H      I+HRD+K  N+L+++    K+ DFGL + FG     FS   V+   +   
Sbjct: 122 AFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL 690
             +    Y   +     D++S G +L E++  +P    T D++Q+ L
Sbjct: 179 VLMGSRTYSTSI-----DIWSCGCILAEMITGKPLFPGTNDEEQLKL 220

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 22/213 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLIGYC 541
           +G G F  V            A+K +   + +G     + EI +L ++++ ++V+L    
Sbjct: 30  LGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIY 89
Query: 542 NDDGQMILVYDYMARGTLRDHL-----YNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
                + LV   ++ G L D +     Y   +      + L        A++YLH     
Sbjct: 90  ESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLD-------AVYYLHRMG-- 140
Query: 597 VIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
            I+HRD+K  N+L    DEE    +SDFGL K      K  V +   G+ GY+ PE    
Sbjct: 141 -IVHRDLKPENLLYYSQDEESKIMISDFGLSKME---GKGDVMSTACGTPGYVAPEVLAQ 196
Query: 654 QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKK 686
           +  ++  D +S GV+   +LC  PP     D K
Sbjct: 197 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDSK 229

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           + NL  IG G +G V   + N +   VAIK+++P   Q   +    EI +L   R+ +++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 536 SL--IGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHT 592
            +  I       QM  VY  + +  +   LY       L  D          R L Y+H+
Sbjct: 87  GINDIIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGYLDPE-Y 650
                ++HRD+K +N+LL+     K+ DFGL +   P+   T   T+   +  Y  PE  
Sbjct: 145 AN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARP 677
              +  T+  D++S G +L E+L  RP
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLSNRP 228

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 101/217 (46%), Gaps = 11/217 (5%)
Query: 481 LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGY 540
           +++G+G +G VY G    +   +AIK +     + +     EI +   L++ ++V  +G 
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 541 CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAA-RALHYLHTGASKVII 599
            +++G + +  + +  G+L   L +   P    ++ +          L YLH      I+
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IV 144
Query: 600 HRDVKTTNILLDE-EWVAKVSDFGLCKFGPNFSKTHVSTQV-KGSIGYLDPEYYRL--QL 655
           HRD+K  N+L++    V K+SDFG  K     +  +  T+   G++ Y+ PE      + 
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSK---RLAGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 656 LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAV 692
             + +D++S G  ++E+   +PP    G+ +     V
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV 238

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 15/210 (7%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEF-QTEIGMLSQLRYL 532
           DFN L+++G+G FG V      G     A+K L      Q   +E    E  +L+     
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 533 HLVSLIGYC-NDDGQMILVYDYMARGTLRDHLYN--NDNPPLPWDRRLKICIGAARALHY 589
             ++ +  C     ++  V +Y+  G L  H+        P       +I IG    L +
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFF 457
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L    SK II+RD+K  N++LD E   K++DFG+CK   N      +    G+  Y+ PE
Sbjct: 458 LQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPE 512
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPI 679
               Q   +  D ++FGV+L E+L  + P 
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 542

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 112/273 (41%), Gaps = 38/273 (13%)
Query: 483 IGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGAL--EFQTEIGMLSQLRYLHLVSLI 538
           +G G FG V KG+  +      VA+K L   +   AL  E   E  ++ QL   ++V +I
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL-KICIGAARALHYLHTGASKV 597
           G C  +  M LV +    G L  +L  N +     D+ + ++    +  + YL       
Sbjct: 93  GICEAESWM-LVMEMAELGPLNKYLQQNRHVK---DKNIIELVHQVSMGMKYLEESN--- 145
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
            +HRD+   N+LL  +  AK+SDFGL K      N+ K    T  K  + +  PE     
Sbjct: 146 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ--THGKWPVKWYAPECINYY 203
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             + KSDV+SFGV++ E                     +  + YR  K  ++     KG 
Sbjct: 204 KFSSKSDVWSFGVLMWEAFS------------------YGQKPYRGMKGSEVTAMLEKGE 245
Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
               P  C  +  ++   C   D   RP  + V
Sbjct: 246 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 278

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 112/273 (41%), Gaps = 38/273 (13%)
Query: 483 IGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGAL--EFQTEIGMLSQLRYLHLVSLI 538
           +G G FG V KG+  +      VA+K L   +   AL  E   E  ++ QL   ++V +I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL-KICIGAARALHYLHTGASKV 597
           G C  +  M LV +    G L  +L  N +     D+ + ++    +  + YL       
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNRHVK---DKNIIELVHQVSMGMKYLEESN--- 147
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
            +HRD+   N+LL  +  AK+SDFGL K      N+ K    T  K  + +  PE     
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ--THGKWPVKWYAPECINYY 205
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             + KSDV+SFGV++ E                     +  + YR  K  ++     KG 
Sbjct: 206 KFSSKSDVWSFGVLMWEAFS------------------YGQKPYRGMKGSEVTAMLEKGE 247
Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
               P  C  +  ++   C   D   RP  + V
Sbjct: 248 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 280

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 112/273 (41%), Gaps = 38/273 (13%)
Query: 483 IGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGAL--EFQTEIGMLSQLRYLHLVSLI 538
           +G G FG V KG+  +      VA+K L   +   AL  E   E  ++ QL   ++V +I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL-KICIGAARALHYLHTGASKV 597
           G C  +  M LV +    G L  +L  N +     D+ + ++    +  + YL       
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNRHVK---DKNIIELVHQVSMGMKYLEESN--- 147
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
            +HRD+   N+LL  +  AK+SDFGL K      N+ K    T  K  + +  PE     
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ--THGKWPVKWYAPECINYY 205
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             + KSDV+SFGV++ E                     +  + YR  K  ++     KG 
Sbjct: 206 KFSSKSDVWSFGVLMWEAFS------------------YGQKPYRGMKGSEVTAMLEKGE 247
Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
               P  C  +  ++   C   D   RP  + V
Sbjct: 248 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 280

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 101/217 (46%), Gaps = 11/217 (5%)
Query: 481 LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGY 540
           +++G+G +G VY G    +   +AIK +     + +     EI +   L++ ++V  +G 
Sbjct: 14  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 73
Query: 541 CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAA-RALHYLHTGASKVII 599
            +++G + +  + +  G+L   L +   P    ++ +          L YLH      I+
Sbjct: 74  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IV 130
Query: 600 HRDVKTTNILLDE-EWVAKVSDFGLCKFGPNFSKTHVSTQV-KGSIGYLDPEYYRL--QL 655
           HRD+K  N+L++    V K+SDFG  K     +  +  T+   G++ Y+ PE      + 
Sbjct: 131 HRDIKGDNVLINTYSGVLKISDFGTSK---RLAGINPCTETFTGTLQYMAPEIIDKGPRG 187
Query: 656 LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAV 692
             + +D++S G  ++E+   +PP    G+ +     V
Sbjct: 188 YGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV 224

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 104/232 (44%), Gaps = 39/232 (16%)
Query: 472 EATKDFNNLLI---IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQ 528
           E + D +NL +   IGRG +G VYKG L  D  PVA+K  +  ++Q  +  +  I  +  
Sbjct: 7   EPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFIN-EKNIYRVPL 63
Query: 529 LRYLHLVSLI---GYCNDDGQM--ILVYDYMARGTLRDHL--YNNDNPPLPWDRRLKICI 581
           + + ++   I        DG+M  +LV +Y   G+L  +L  + +D     W    ++  
Sbjct: 64  MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD-----WVSSCRLAH 118
Query: 582 GAARALHYLHTGASK------VIIHRDVKTTNILLDEEWVAKVSDFGLCK-------FGP 628
              R L YLHT   +       I HRD+ + N+L+  +    +SDFGL           P
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 629 NFSKTHVSTQVKGSIGYLDPEYYR-------LQLLTEKSDVYSFGVVLLEVL 673
                   ++V G+I Y+ PE           +   ++ D+Y+ G++  E+ 
Sbjct: 179 GEEDNAAISEV-GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 18/230 (7%)
Query: 464 QFSISEIKEATKD-FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ---GALEF 519
           Q+   E +  TK+ F    ++G+GGFG V    +       A K+L     +   G    
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 520 QTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL-- 577
             E  +L ++    +VSL         + LV   M  G L+ H+Y+      P  R +  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 578 --KICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHV 635
             +IC G    L  LH    + I++RD+K  NILLD+    ++SD GL    P       
Sbjct: 292 AAEICCG----LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 344
Query: 636 STQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDK 685
                G++GY+ PE  + +  T   D ++ G +L E++  + P  +   K
Sbjct: 345 RV---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 15/209 (7%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEF-QTEIGMLSQLRYL 532
           DFN L+++G+G FG V      G     A+K L      Q   +E    E  +L+     
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 533 HLVSLIGYC-NDDGQMILVYDYMARGTLRDHLYN--NDNPPLPWDRRLKICIGAARALHY 589
             ++ +  C     ++  V +Y+  G L  H+        P       +I IG    L +
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFF 136
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L    SK II+RD+K  N++LD E   K++DFG+CK   N      +    G+  Y+ PE
Sbjct: 137 LQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPE 191
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               Q   +  D ++FGV+L E+L  + P
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 112/273 (41%), Gaps = 38/273 (13%)
Query: 483 IGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGAL--EFQTEIGMLSQLRYLHLVSLI 538
           +G G FG V KG+  +      VA+K L   +   AL  E   E  ++ QL   ++V +I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL-KICIGAARALHYLHTGASKV 597
           G C  +  M LV +    G L  +L  N +     D+ + ++    +  + YL       
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYLQQNRHVK---DKNIIELVHQVSMGMKYLEESN--- 131
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
            +HRD+   N+LL  +  AK+SDFGL K      N+ K    T  K  + +  PE     
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ--THGKWPVKWYAPECINYY 189
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             + KSDV+SFGV++ E                     +  + YR  K  ++     KG 
Sbjct: 190 KFSSKSDVWSFGVLMWEAFS------------------YGQKPYRGMKGSEVTAMLEKGE 231
Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
               P  C  +  ++   C   D   RP  + V
Sbjct: 232 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 264

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 105/235 (44%), Gaps = 36/235 (15%)
Query: 483 IGRGGFGNVYKGFLNG--DSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGY 540
           +G GGF   Y   + G  D    A+KR+    QQ   E Q E  M     + +++ L+ Y
Sbjct: 37  LGEGGFS--YVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 541 C----NDDGQMILVYDYMARGTLRDHL--YNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           C        +  L+  +  RGTL + +    +    L  D+ L + +G  R L  +H   
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--- 151
Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHV--STQV---------KGSI 643
           +K   HRD+K TNILL +E    + D G      N +  HV  S Q          + +I
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLG----SMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 644 GYLDPEYYRLQ---LLTEKSDVYSFGVVLLEVLCARPP---ILRTGDKKQVNLAV 692
            Y  PE + +Q   ++ E++DV+S G VL  ++    P   + + GD   V LAV
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS--VALAV 260

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 111/271 (40%), Gaps = 34/271 (12%)
Query: 483 IGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGAL--EFQTEIGMLSQLRYLHLVSLI 538
           +G G FG V KG+  +      VA+K L   +   AL  E   E  ++ QL   ++V +I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL-KICIGAARALHYLHTGASKV 597
           G C  +  M LV +    G L  +L  N +     D+ + ++    +  + YL       
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYLQQNRHVK---DKNIIELVHQVSMGMKYLEESN--- 131
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
            +HRD+   N+LL  +  AK+SDFGL K    + +     T  K  + +  PE       
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKF 191
Query: 657 TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN-- 714
           + KSDV+SFGV++ E                     +  + YR  K  ++     KG   
Sbjct: 192 SSKSDVWSFGVLMWEAFS------------------YGQKPYRGMKGSEVTAMLEKGERM 233
Query: 715 -APPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
             P  C  +  ++   C   D   RP  + V
Sbjct: 234 GCPAGCPREMYDLMNLCWTYDVENRPGFAAV 264

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 18/230 (7%)
Query: 464 QFSISEIKEATKD-FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ---GALEF 519
           Q+   E +  TK+ F    ++G+GGFG V    +       A K+L     +   G    
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 520 QTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL-- 577
             E  +L ++    +VSL         + LV   M  G L+ H+Y+      P  R +  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 578 --KICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHV 635
             +IC G    L  LH    + I++RD+K  NILLD+    ++SD GL    P       
Sbjct: 292 AAEICCG----LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 344
Query: 636 STQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDK 685
                G++GY+ PE  + +  T   D ++ G +L E++  + P  +   K
Sbjct: 345 RV---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 51/234 (21%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV 535
           DF  + ++G+G FG V K     DS   AIK++    ++ +    +E+ +L+ L + ++V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNHQYVV 65
Query: 536 SL-------------IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
                          +        + +  +Y   GTL D L +++N     D   ++   
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD-LIHSENLNQQRDEYWRLFRQ 124
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK----------------- 625
              AL Y+H   S+ IIHRD+K  NI +DE    K+ DFGL K                 
Sbjct: 125 ILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 626 -FGPNFSKT-----HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
               N +       +V+T+V    G+ +          EK D+YS G++  E++
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYN----------EKIDMYSLGIIFFEMI 225

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 112/273 (41%), Gaps = 38/273 (13%)
Query: 483 IGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGAL--EFQTEIGMLSQLRYLHLVSLI 538
           +G G FG V KG+  +      VA+K L   +   AL  E   E  ++ QL   ++V +I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL-KICIGAARALHYLHTGASKV 597
           G C  +  M LV +    G L  +L  N +     D+ + ++    +  + YL       
Sbjct: 85  GICEAESWM-LVMEMAELGPLNKYLQQNRHVK---DKNIIELVHQVSMGMKYLEESN--- 137
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
            +HRD+   N+LL  +  AK+SDFGL K      N+ K    T  K  + +  PE     
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ--THGKWPVKWYAPECINYY 195
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             + KSDV+SFGV++ E                     +  + YR  K  ++     KG 
Sbjct: 196 KFSSKSDVWSFGVLMWEAFS------------------YGQKPYRGMKGSEVTAMLEKGE 237
Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
               P  C  +  ++   C   D   RP  + V
Sbjct: 238 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 270

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           + NL  IG G +G V   + N +   VAIK+++P   Q   +    EI +L + R+ +++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 536 SL--IGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHT 592
            +  I       QM  VY  + +  +   LY       L  D          R L Y+H+
Sbjct: 89  GINDIIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGYLDPE-Y 650
                ++HRD+K +N+LL+     K+ DFGL +   P+   T    +   +  Y  PE  
Sbjct: 147 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM 203
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARP 677
              +  T+  D++S G +L E+L  RP
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           + NL  IG G +G V   + N +   VAIK+++P   Q   +    EI +L + R+ +++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 536 SL--IGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHT 592
            +  I       QM  VY  + +  +   LY       L  D          R L Y+H+
Sbjct: 90  GINDIIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGYLDPE-Y 650
                ++HRD+K +N+LL+     K+ DFGL +   P+   T    +   +  Y  PE  
Sbjct: 148 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM 204
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARP 677
              +  T+  D++S G +L E+L  RP
Sbjct: 205 LNSKGYTKSIDIWSVGCILAEMLSNRP 231

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 112/273 (41%), Gaps = 38/273 (13%)
Query: 483 IGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGAL--EFQTEIGMLSQLRYLHLVSLI 538
           +G G FG V KG+  +      VA+K L   +   AL  E   E  ++ QL   ++V +I
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL-KICIGAARALHYLHTGASKV 597
           G C  +  M LV +    G L  +L  N +     D+ + ++    +  + YL       
Sbjct: 75  GICEAESWM-LVMEMAELGPLNKYLQQNRHVK---DKNIIELVHQVSMGMKYLEESN--- 127
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
            +HRD+   N+LL  +  AK+SDFGL K      N+ K    T  K  + +  PE     
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ--THGKWPVKWYAPECINYY 185
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             + KSDV+SFGV++ E                     +  + YR  K  ++     KG 
Sbjct: 186 KFSSKSDVWSFGVLMWEAFS------------------YGQKPYRGMKGSEVTAMLEKGE 227
Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
               P  C  +  ++   C   D   RP  + V
Sbjct: 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 260

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 119/289 (41%), Gaps = 40/289 (13%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQL 529
             +D  +L  IGRG +G+V K         +A+KR+       +Q  L    ++ M S  
Sbjct: 20  TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS- 78
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARG--TLRDHLYNNDNPPLPWDRRLKICIGAARAL 587
              ++V   G    +G   +  + M+        ++Y+  +  +P +   KI +   +AL
Sbjct: 79  DCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
           ++L       IIHRD+K +NILLD     K+ DFG+         +   T+  G   Y+ 
Sbjct: 139 NHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGI---SGQLVDSIAKTRDAGCRPYMA 193
Query: 648 PEYY----RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKI 703
           PE        Q    +SDV+S G+ L E+   R P  +           W +       +
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK-----------WNS-------V 235
Query: 704 GDIIDPFLKGNAPPVCLNQ-------FVEVAMSCVNDDRIRRPSMSDVV 745
            D +   +KG+ P +  ++       F+     C+  D  +RP   +++
Sbjct: 236 FDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 112/273 (41%), Gaps = 38/273 (13%)
Query: 483 IGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGAL--EFQTEIGMLSQLRYLHLVSLI 538
           +G G FG V KG+  +      VA+K L   +   AL  E   E  ++ QL   ++V +I
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL-KICIGAARALHYLHTGASKV 597
           G C  +  M LV +    G L  +L  N +     D+ + ++    +  + YL       
Sbjct: 73  GICEAESWM-LVMEMAELGPLNKYLQQNRHVK---DKNIIELVHQVSMGMKYLEESN--- 125
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
            +HRD+   N+LL  +  AK+SDFGL K      N+ K    T  K  + +  PE     
Sbjct: 126 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ--THGKWPVKWYAPECINYY 183
Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             + KSDV+SFGV++ E                     +  + YR  K  ++     KG 
Sbjct: 184 KFSSKSDVWSFGVLMWEAFS------------------YGQKPYRGMKGSEVTAMLEKGE 225
Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
               P  C  +  ++   C   D   RP  + V
Sbjct: 226 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 258

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 7/205 (3%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT-EIGMLSQLRYLHLV 535
           +  L  IG G +G V   + +   T VAIK+++P   Q   +    EI +L + R+ +++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHTGA 594
            +           +   Y+ +  +   LY    +  L  D          R L Y+H+  
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN 164
Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQVKGSIGYLDPE-YYR 652
              ++HRD+K +N+L++     K+ DFGL +   P    T   T+   +  Y  PE    
Sbjct: 165 ---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLN 221
Query: 653 LQLLTEKSDVYSFGVVLLEVLCARP 677
            +  T+  D++S G +L E+L  RP
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNRP 246

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 96/228 (42%), Gaps = 29/228 (12%)
Query: 467 ISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE---FQTEI 523
           + E++   +DF  + +IGRG FG V    +       A+K LN        E   F+ E 
Sbjct: 66  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREER 125
Query: 524 GMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDR------RL 577
            +L       + +L     D+  + LV DY   G L   L   ++  LP D        +
Sbjct: 126 DVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDK-LPEDMARFYIGEM 184
Query: 578 KICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST 637
            + I +   LHY         +HRD+K  N+LLD     +++DFG C    N   T  S+
Sbjct: 185 VLAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSS 234
Query: 638 QVKGSIGYLDPEYYRLQLLTE-------KSDVYSFGVVLLEVLCARPP 678
              G+  Y+ PE   LQ + +       + D +S GV + E+L    P
Sbjct: 235 VAVGTPDYISPEI--LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 461 LCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQ 520
           L  +  + E+K+   DF  +  +G G  G V+K   +  S  V  ++L     + A+  Q
Sbjct: 56  LTQKQKVGELKD--DDFEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHLEIKPAIRNQ 112
Query: 521 T--EIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK 578
              E+ +L +    ++V   G    DG++ +  ++M  G+L   L       +P     K
Sbjct: 113 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGK 170
Query: 579 ICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVST 637
           + I   + L YL       I+HRDVK +NIL++     K+ DFG+  +   + + + V T
Sbjct: 171 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 228
Query: 638 QVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPI 679
           +      Y+ PE  +    + +SD++S G+ L+E+   R PI
Sbjct: 229 R-----SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 91/230 (39%), Gaps = 33/230 (14%)
Query: 467 ISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE---FQTEI 523
           + +++   +DF  L +IGRG FG V    L       A+K LN        E   F+ E 
Sbjct: 66  VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREER 125
Query: 524 GMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYN-NDNPPLPWDR----RLK 578
            +L       + +L     DD  + LV DY   G L   L    D  P    R     + 
Sbjct: 126 DVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMV 185
Query: 579 ICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ 638
           I I +   LHY         +HRD+K  NIL+D     +++DFG C       K      
Sbjct: 186 IAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSC------LKLMEDGT 230
Query: 639 VKGSIGYLDPEYYRLQLLTE----------KSDVYSFGVVLLEVLCARPP 678
           V+ S+    P+Y   ++L            + D +S GV + E+L    P
Sbjct: 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 96/228 (42%), Gaps = 29/228 (12%)
Query: 467 ISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE---FQTEI 523
           + E++   +DF  + +IGRG FG V    +       A+K LN        E   F+ E 
Sbjct: 82  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREER 141
Query: 524 GMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDR------RL 577
            +L       + +L     D+  + LV DY   G L   L   ++  LP D        +
Sbjct: 142 DVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDK-LPEDMARFYIGEM 200
Query: 578 KICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST 637
            + I +   LHY         +HRD+K  N+LLD     +++DFG C    N   T  S+
Sbjct: 201 VLAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSS 250
Query: 638 QVKGSIGYLDPEYYRLQLLTE-------KSDVYSFGVVLLEVLCARPP 678
              G+  Y+ PE   LQ + +       + D +S GV + E+L    P
Sbjct: 251 VAVGTPDYISPEI--LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 107/245 (43%), Gaps = 29/245 (11%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLR 530
           AT  +  +  IG G +G VYK         VA+K +   + +  L   T  E+ +L +L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 531 ---YLHLVSLIGYC-----NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
              + ++V L+  C     + + ++ LV++++ +  LR +L     P LP +    +   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS 642
             R L +LH   +  I+HRD+K  NIL+      K++DFGL +    +S       V  +
Sbjct: 121 FLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALAPVVVT 174
Query: 643 IGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK 702
           + Y  PE           D++S G +  E+   +P            L    +E  + GK
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP------------LFCGNSEADQLGK 222
Query: 703 IGDII 707
           I D+I
Sbjct: 223 IFDLI 227

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 95/218 (43%), Gaps = 35/218 (16%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVS 536
           + +  +IG G FG VY+  L      VAIK++     QG      E+ ++ +L + ++V 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVR 77
Query: 537 L------IGYCNDDGQMILVYDYMARGTLR-DHLYNNDNPPLPWDRRLKICIGAARALHY 589
           L       G   D+  + LV DY+     R    Y+     LP            R+L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 590 LHTGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYL 646
           +H+     I HRD+K  N+LLD +  V K+ DFG  K             V+G  ++ Y+
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSYI 183
Query: 647 DPEYYRLQLL-------TEKSDVYSFGVVLLEVLCARP 677
              YYR   L       T   DV+S G VL E+L  +P
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           IG+G FG V++G   G+   VA+K  +   ++     + EI     LR+ +++  I   N
Sbjct: 12  IGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADN 68
Query: 543 DDG----QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH-----TG 593
            D     Q+ LV DY   G+L D+L   +   +  +  +K+ +  A  L +LH     T 
Sbjct: 69  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT--HVSTQVKGSIGYLDPEYY 651
               I HRD+K+ NIL+ +     ++D GL     + + T         G+  Y+ PE  
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 185
Query: 652 RLQLLT------EKSDVYSFGVVLLEV 672
              +        +++D+Y+ G+V  E+
Sbjct: 186 DDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           IG+G FG V++G   G+   VA+K  +   ++     + EI     LR+ +++  I   N
Sbjct: 50  IGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADN 106
Query: 543 DDG----QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH-----TG 593
            D     Q+ LV DY   G+L D+L   +   +  +  +K+ +  A  L +LH     T 
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT--HVSTQVKGSIGYLDPEYY 651
               I HRD+K+ NIL+ +     ++D GL     + + T         G+  Y+ PE  
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223
Query: 652 RLQLLT------EKSDVYSFGVVLLEV 672
              +        +++D+Y+ G+V  E+
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 95/218 (43%), Gaps = 35/218 (16%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVS 536
           + +  +IG G FG VY+  L      VAIK++     QG      E+ ++ +L + ++V 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVR 77
Query: 537 L------IGYCNDDGQMILVYDYMARGTLR-DHLYNNDNPPLPWDRRLKICIGAARALHY 589
           L       G   D+  + LV DY+     R    Y+     LP            R+L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 590 LHTGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYL 646
           +H+     I HRD+K  N+LLD +  V K+ DFG  K             V+G  ++ Y+
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSYI 183
Query: 647 DPEYYRLQLL-------TEKSDVYSFGVVLLEVLCARP 677
              YYR   L       T   DV+S G VL E+L  +P
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           IG+G FG V++G   G+   VA+K  +   ++     + EI     LR+ +++  I   N
Sbjct: 11  IGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADN 67
Query: 543 DDG----QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH-----TG 593
            D     Q+ LV DY   G+L D+L   +   +  +  +K+ +  A  L +LH     T 
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT--HVSTQVKGSIGYLDPEYY 651
               I HRD+K+ NIL+ +     ++D GL     + + T         G+  Y+ PE  
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 652 RLQLLT------EKSDVYSFGVVLLEV 672
              +        +++D+Y+ G+V  E+
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 18/213 (8%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP---GSQQGALEFQTEIGMLSQLRYL 532
           D   ++ +GRG +G V K         +A+KR+       +Q  L    +I M + +   
Sbjct: 8   DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT-VDCP 66
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYN---NDNPPLPWDRRLKICIGAARALHY 589
             V+  G    +G + +  + M   T  D  Y    +    +P D   KI +   +AL +
Sbjct: 67  FTVTFYGALFREGDVWICMELM--DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           LH+  S  +IHRDVK +N+L++     K+ DFG+  +  +     +     G   Y+ PE
Sbjct: 125 LHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---GCKPYMAPE 179
Query: 650 YYRLQL----LTEKSDVYSFGVVLLEVLCARPP 678
               +L     + KSD++S G+ ++E+   R P
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFP 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           IG+G FG V++G   G+   VA+K  +   ++     + EI     LR+ +++  I   N
Sbjct: 17  IGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADN 73
Query: 543 DDG----QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH-----TG 593
            D     Q+ LV DY   G+L D+L   +   +  +  +K+ +  A  L +LH     T 
Sbjct: 74  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT--HVSTQVKGSIGYLDPEYY 651
               I HRD+K+ NIL+ +     ++D GL     + + T         G+  Y+ PE  
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 190
Query: 652 RLQLLT------EKSDVYSFGVVLLEV 672
              +        +++D+Y+ G+V  E+
Sbjct: 191 DDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           IG+G FG V++G   G+   VA+K  +   ++     + EI     LR+ +++  I   N
Sbjct: 37  IGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADN 93
Query: 543 DDG----QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH-----TG 593
            D     Q+ LV DY   G+L D+L   +   +  +  +K+ +  A  L +LH     T 
Sbjct: 94  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT--HVSTQVKGSIGYLDPEYY 651
               I HRD+K+ NIL+ +     ++D GL     + + T         G+  Y+ PE  
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 210
Query: 652 RLQLLT------EKSDVYSFGVVLLEV 672
              +        +++D+Y+ G+V  E+
Sbjct: 211 DDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 107/245 (43%), Gaps = 29/245 (11%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLR 530
           AT  +  +  IG G +G VYK         VA+K +   + +  L   T  E+ +L +L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 531 ---YLHLVSLIGYC-----NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
              + ++V L+  C     + + ++ LV++++ +  LR +L     P LP +    +   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS 642
             R L +LH   +  I+HRD+K  NIL+      K++DFGL +    +S       V  +
Sbjct: 121 FLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALDPVVVT 174
Query: 643 IGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK 702
           + Y  PE           D++S G +  E+   +P            L    +E  + GK
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP------------LFCGNSEADQLGK 222
Query: 703 IGDII 707
           I D+I
Sbjct: 223 IFDLI 227

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           IG+G FG V++G   G+   VA+K  +   ++     + EI     LR+ +++  I   N
Sbjct: 14  IGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADN 70
Query: 543 DDG----QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH-----TG 593
            D     Q+ LV DY   G+L D+L   +   +  +  +K+ +  A  L +LH     T 
Sbjct: 71  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT--HVSTQVKGSIGYLDPEYY 651
               I HRD+K+ NIL+ +     ++D GL     + + T         G+  Y+ PE  
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 187
Query: 652 RLQLLT------EKSDVYSFGVVLLEV 672
              +        +++D+Y+ G+V  E+
Sbjct: 188 DDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 108/243 (44%), Gaps = 35/243 (14%)
Query: 452 GPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKR---- 507
           G + SLP+  C  +   E+KE          +G GGFG V +         VAIK+    
Sbjct: 4   GRSPSLPTQTCGPW---EMKER---------LGTGGFGYVLRWIHQDTGEQVAIKQCRQE 51
Query: 508 LNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQM------ILVYDYMARGTLRD 561
           L+P +++    +  EI ++ +L + ++VS     +   ++      +L  +Y   G LR 
Sbjct: 52  LSPKNRE---RWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRK 108
Query: 562 HLYNNDNPPLPWDRRLKICIG-AARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAK 617
           +L   +N     +  ++  +   + AL YLH      IIHRD+K  NI+L    +  + K
Sbjct: 109 YLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHK 165
Query: 618 VSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARP 677
           + D G   +     +  + T+  G++ YL PE    +  T   D +SFG +  E +    
Sbjct: 166 IIDLG---YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 222
Query: 678 PIL 680
           P L
Sbjct: 223 PFL 225

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 108/243 (44%), Gaps = 35/243 (14%)
Query: 452 GPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKR---- 507
           G + SLP+  C  +   E+KE          +G GGFG V +         VAIK+    
Sbjct: 3   GRSPSLPTQTCGPW---EMKER---------LGTGGFGYVLRWIHQDTGEQVAIKQCRQE 50
Query: 508 LNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQM------ILVYDYMARGTLRD 561
           L+P +++    +  EI ++ +L + ++VS     +   ++      +L  +Y   G LR 
Sbjct: 51  LSPKNRE---RWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRK 107
Query: 562 HLYNNDNPPLPWDRRLKICIG-AARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAK 617
           +L   +N     +  ++  +   + AL YLH      IIHRD+K  NI+L    +  + K
Sbjct: 108 YLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHK 164
Query: 618 VSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARP 677
           + D G   +     +  + T+  G++ YL PE    +  T   D +SFG +  E +    
Sbjct: 165 IIDLG---YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
Query: 678 PIL 680
           P L
Sbjct: 222 PFL 224

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 91/197 (46%), Gaps = 10/197 (5%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           IG G  G V           VA+K ++   QQ       E+ ++   ++ ++V +     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
              ++ ++ +++  G L D +       L  ++   +C    +AL YLH      +IHRD
Sbjct: 113 VGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRD 166
Query: 603 VKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSD 661
           +K+ +ILL  +   K+SDFG C +   +  K      + G+  ++ PE     L   + D
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RKXLVGTPYWMAPEVISRSLYATEVD 223
Query: 662 VYSFGVVLLEVLCARPP 678
           ++S G++++E++   PP
Sbjct: 224 IWSLGIMVIEMVDGEPP 240

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 461 LCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQ 520
           L  +  + E+K+   DF  +  +G G  G V K   +  S  +  ++L     + A+  Q
Sbjct: 4   LTQKAKVGELKD--DDFERISELGAGNGGVVTK-VQHRPSGLIMARKLIHLEIKPAIRNQ 60
Query: 521 T--EIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK 578
              E+ +L +    ++V   G    DG++ +  ++M  G+L   L       +P +   K
Sbjct: 61  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR--IPEEILGK 118
Query: 579 ICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVST 637
           + I   R L YL       I+HRDVK +NIL++     K+ DFG+  +   + + + V T
Sbjct: 119 VSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 176
Query: 638 QVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPI 679
           +      Y+ PE  +    + +SD++S G+ L+E+   R PI
Sbjct: 177 R-----SYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 106/213 (49%), Gaps = 25/213 (11%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLRYL 532
           + +  L  +G G +G VYK   +     VA+KR+   ++   +      EI +L +L + 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICI-GAARALHYLH 591
           ++VSLI   + +  + LV+++M +  L+  L  ++N     D ++KI +    R + + H
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEK-DLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTHVSTQVKGSIGYLDPE 649
                 I+HRD+K  N+L++ +   K++DFGL + FG P  S TH       ++ Y  P+
Sbjct: 137 QHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRAPD 189
Query: 650 YYRLQLLTEKS-----DVYSFGVVLLEVLCARP 677
                L+  K      D++S G +  E++  +P
Sbjct: 190 V----LMGSKKYSTSVDIWSIGCIFAEMITGKP 218

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 106/213 (49%), Gaps = 25/213 (11%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLRYL 532
           + +  L  +G G +G VYK   +     VA+KR+   ++   +      EI +L +L + 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICI-GAARALHYLH 591
           ++VSLI   + +  + LV+++M +  L+  L  ++N     D ++KI +    R + + H
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEK-DLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTHVSTQVKGSIGYLDPE 649
                 I+HRD+K  N+L++ +   K++DFGL + FG P  S TH       ++ Y  P+
Sbjct: 137 QHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRAPD 189
Query: 650 YYRLQLLTEKS-----DVYSFGVVLLEVLCARP 677
                L+  K      D++S G +  E++  +P
Sbjct: 190 V----LMGSKKYSTSVDIWSIGCIFAEMITGKP 218

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 107/245 (43%), Gaps = 29/245 (11%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLR 530
           AT  +  +  IG G +G VYK         VA+K +   + +  L   T  E+ +L +L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 531 ---YLHLVSLIGYC-----NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
              + ++V L+  C     + + ++ LV++++ +  LR +L     P LP +    +   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS 642
             R L +LH   +  I+HRD+K  NIL+      K++DFGL +    +S       V  +
Sbjct: 121 FLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALFPVVVT 174
Query: 643 IGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK 702
           + Y  PE           D++S G +  E+   +P            L    +E  + GK
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP------------LFCGNSEADQLGK 222
Query: 703 IGDII 707
           I D+I
Sbjct: 223 IFDLI 227

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 92/216 (42%), Gaps = 31/216 (14%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM----LSQLRYL 532
           + +  +IG G FG VY+  L      VAIK++    +    E Q    +    + +LRY 
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 109
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLR-DHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              S  G   D+  + LV DY+     R    Y+     LP            R+L Y+H
Sbjct: 110 FYSS--GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 167
Query: 592 TGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYLDP 648
           +     I HRD+K  N+LLD +  V K+ DFG  K             V+G  ++ Y+  
Sbjct: 168 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSYICS 213
Query: 649 EYYRLQLL-------TEKSDVYSFGVVLLEVLCARP 677
            YYR   L       T   DV+S G VL E+L  +P
Sbjct: 214 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 249

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 106/226 (46%), Gaps = 15/226 (6%)
Query: 457 LPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA 516
           L + L  +  + E+K+   DF  +  +G G  G V+K   +  S  V  ++L     + A
Sbjct: 17  LEAFLTQKQKVGELKD--DDFEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHLEIKPA 73
Query: 517 LEFQT--EIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD 574
           +  Q   E+ +L +    ++V   G    DG++ +  ++M  G+L   L       +P  
Sbjct: 74  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQ 131
Query: 575 RRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKT 633
              K+ I   + L YL       I+HRDVK +NIL++     K+ DFG+  +   + + +
Sbjct: 132 ILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 189
Query: 634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPI 679
            V T+      Y+ PE  +    + +SD++S G+ L+E+   R PI
Sbjct: 190 FVGTR-----SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 107/246 (43%), Gaps = 30/246 (12%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGF-LNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQL 529
           A + +  +  IG G +G V+K   L      VA+KR+   + +  +   T  E+ +L  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 530 R---YLHLVSLIGYC-----NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICI 581
               + ++V L   C     + + ++ LV++++ +  L  +L     P +P +    +  
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMF 127
Query: 582 GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG 641
              R L +LH   S  ++HRD+K  NIL+      K++DFGL +    +S     T V  
Sbjct: 128 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVV 181
Query: 642 SIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG 701
           ++ Y  PE           D++S G +  E+   +P    + D  Q+            G
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL------------G 229
Query: 702 KIGDII 707
           KI D+I
Sbjct: 230 KILDVI 235

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 92/216 (42%), Gaps = 31/216 (14%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM----LSQLRYL 532
           + +  +IG G FG VY+  L      VAIK++    +    E Q    +    + +LRY 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLR-DHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              S  G   D+  + LV DY+     R    Y+     LP            R+L Y+H
Sbjct: 116 FYSS--GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 592 TGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYLDP 648
           +     I HRD+K  N+LLD +  V K+ DFG  K             V+G  ++ Y+  
Sbjct: 174 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSYICS 219
Query: 649 EYYRLQLL-------TEKSDVYSFGVVLLEVLCARP 677
            YYR   L       T   DV+S G VL E+L  +P
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 92/216 (42%), Gaps = 31/216 (14%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM----LSQLRYL 532
           + +  +IG G FG VY+  L      VAIK++    +    E Q    +    + +LRY 
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 119
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLR-DHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              S  G   D+  + LV DY+     R    Y+     LP            R+L Y+H
Sbjct: 120 FYSS--GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 177
Query: 592 TGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYLDP 648
           +     I HRD+K  N+LLD +  V K+ DFG  K             V+G  ++ Y+  
Sbjct: 178 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSYICS 223
Query: 649 EYYRLQLL-------TEKSDVYSFGVVLLEVLCARP 677
            YYR   L       T   DV+S G VL E+L  +P
Sbjct: 224 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 259

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 92/216 (42%), Gaps = 31/216 (14%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM----LSQLRYL 532
           + +  +IG G FG VY+  L      VAIK++    +    E Q    +    + +LRY 
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 117
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLR-DHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              S  G   D+  + LV DY+     R    Y+     LP            R+L Y+H
Sbjct: 118 FYSS--GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 175
Query: 592 TGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYLDP 648
           +     I HRD+K  N+LLD +  V K+ DFG  K             V+G  ++ Y+  
Sbjct: 176 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSYICS 221
Query: 649 EYYRLQLL-------TEKSDVYSFGVVLLEVLCARP 677
            YYR   L       T   DV+S G VL E+L  +P
Sbjct: 222 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 257

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 125/297 (42%), Gaps = 36/297 (12%)
Query: 472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE--FQTEIGMLSQL 529
           ++ + + NL ++G G +G V K         VAIK+         ++     EI +L QL
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRD-HLYNNDNPPLPWDRRLKICIGAARALH 588
           R+ +LV+L+  C    +  LV++++    L D  L+ N    L +    K        + 
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIG 138
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT-----HVSTQVKGSI 643
           + H   S  IIHRD+K  NIL+ +  V K+ DFG       F++T      V      + 
Sbjct: 139 FCH---SHNIIHRDIKPENILVSQSGVVKLCDFG-------FARTLAAPGEVYDDEVATR 188
Query: 644 GYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPPILRTGDKKQV--------NLAVWA 694
            Y  PE     +   K+ DV++ G ++ E+    P      D  Q+        NL    
Sbjct: 189 WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH 248
Query: 695 TECY-RNGKIGDIIDPFLKGNAP-----PVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
            E + +N     +  P +K   P     P      +++A  C++ D  +RP  ++++
Sbjct: 249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 92/216 (42%), Gaps = 31/216 (14%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM----LSQLRYL 532
           + +  +IG G FG VY+  L      VAIK++    +    E Q    +    + +LRY 
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 86
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLR-DHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              S  G   D+  + LV DY+     R    Y+     LP            R+L Y+H
Sbjct: 87  FYSS--GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 144
Query: 592 TGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYLDP 648
           +     I HRD+K  N+LLD +  V K+ DFG  K             V+G  ++ Y+  
Sbjct: 145 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSYICS 190
Query: 649 EYYRLQLL-------TEKSDVYSFGVVLLEVLCARP 677
            YYR   L       T   DV+S G VL E+L  +P
Sbjct: 191 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 226

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 472 EATKDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL 529
           E  ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
            + ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L +
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGY 645
            H   S  ++HRD+K  N+L++ E   K++DFGL + FG P  + TH  V+   +     
Sbjct: 126 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 182
Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           L  +YY     +   D++S G +  E++  R
Sbjct: 183 LGXKYY-----STAVDIWSLGCIFAEMVTRR 208

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 107/246 (43%), Gaps = 30/246 (12%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGF-LNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQL 529
           A + +  +  IG G +G V+K   L      VA+KR+   + +  +   T  E+ +L  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 530 R---YLHLVSLIGYC-----NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICI 581
               + ++V L   C     + + ++ LV++++ +  L  +L     P +P +    +  
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMF 127
Query: 582 GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG 641
              R L +LH   S  ++HRD+K  NIL+      K++DFGL +    +S     T V  
Sbjct: 128 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVV 181
Query: 642 SIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG 701
           ++ Y  PE           D++S G +  E+   +P    + D  Q+            G
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL------------G 229
Query: 702 KIGDII 707
           KI D+I
Sbjct: 230 KILDVI 235

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ----QGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+GGF   Y+   + D+  V   ++ P S         +  TEI +   L   H+V   
Sbjct: 50  LGKGGFAKCYE-ITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVI 598
           G+  DD  + +V +   R +L +          P  R         + + YLH      +
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYF--MRQTIQGVQYLHNNR---V 163
Query: 599 IHRDVKTTNILLDEEWVAKVSDFGLC---KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
           IHRD+K  N+ L+++   K+ DFGL    +F     KT     + G+  Y+ PE    + 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-----LCGTPNYIAPEVLCKKG 218
Query: 656 LTEKSDVYSFGVVLLEVLCARPP 678
            + + D++S G +L  +L  +PP
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPP 241

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 112/242 (46%), Gaps = 36/242 (14%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKR-LNPGSQQG-ALEFQTEIGMLSQLRYLHL 534
           +  L  IG+G FG V+K         VA+K+ L    ++G  +    EI +L  L++ ++
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 535 VSLIGYCNDD--------GQMILVYDYMAR---GTLRDHLYNNDNPPLPWDRRLKICIGA 583
           V+LI  C           G + LV+D+      G L + L       +   R +++ +  
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQMLLNG 137
Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVK 640
              L+Y+H      I+HRD+K  N+L+  + V K++DFGL +      N        +V 
Sbjct: 138 ---LYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV- 190
Query: 641 GSIGYLDPEYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWAT 695
            ++ Y  PE     LL E+      D++  G ++ E +  R PI++ G+ +Q  LA+ + 
Sbjct: 191 VTLWYRPPEL----LLGERDYGPPIDLWGAGCIMAE-MWTRSPIMQ-GNTEQHQLALISQ 244
Query: 696 EC 697
            C
Sbjct: 245 LC 246

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLRYLH 533
           DF  +  +G G  G V+K   +  S  V  ++L     + A+  Q   E+ +L +    +
Sbjct: 7   DFEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           +V   G    DG++ +  ++M  G+L   L       +P     K+ I   + L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREK 123
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
               I+HRDVK +NIL++     K+ DFG+  +   + + + V T+      Y+ PE  +
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQ 176
Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPI 679
               + +SD++S G+ L+E+   R PI
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 92/216 (42%), Gaps = 31/216 (14%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM----LSQLRYL 532
           + +  +IG G FG VY+  L      VAIK++    +    E Q    +    + +LRY 
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 94
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLR-DHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              S  G   D+  + LV DY+     R    Y+     LP            R+L Y+H
Sbjct: 95  FYSS--GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 152
Query: 592 TGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYLDP 648
           +     I HRD+K  N+LLD +  V K+ DFG  K             V+G  ++ Y+  
Sbjct: 153 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSYICS 198
Query: 649 EYYRLQLL-------TEKSDVYSFGVVLLEVLCARP 677
            YYR   L       T   DV+S G VL E+L  +P
Sbjct: 199 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 234

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 92/216 (42%), Gaps = 31/216 (14%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM----LSQLRYL 532
           + +  +IG G FG VY+  L      VAIK++    +    E Q    +    + +LRY 
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 160
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLR-DHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              S  G   D+  + LV DY+     R    Y+     LP            R+L Y+H
Sbjct: 161 FYSS--GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 218
Query: 592 TGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYLDP 648
           +     I HRD+K  N+LLD +  V K+ DFG  K             V+G  ++ Y+  
Sbjct: 219 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSYICS 264
Query: 649 EYYRLQLL-------TEKSDVYSFGVVLLEVLCARP 677
            YYR   L       T   DV+S G VL E+L  +P
Sbjct: 265 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 300

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 106/226 (46%), Gaps = 15/226 (6%)
Query: 457 LPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA 516
           L + L  +  + E+K+   DF  +  +G G  G V+K   +  S  V  ++L     + A
Sbjct: 9   LEAFLTQKQKVGELKD--DDFEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHLEIKPA 65
Query: 517 LEFQT--EIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWD 574
           +  Q   E+ +L +    ++V   G    DG++ +  ++M  G+L   L       +P  
Sbjct: 66  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQ 123
Query: 575 RRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKT 633
              K+ I   + L YL       I+HRDVK +NIL++     K+ DFG+  +   + + +
Sbjct: 124 ILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 181
Query: 634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPI 679
            V T+      Y+ PE  +    + +SD++S G+ L+E+   R PI
Sbjct: 182 FVGTR-----SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 109/248 (43%), Gaps = 32/248 (12%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL---NPGSQQGALEFQT--EIGMLS 527
           AT  +  +  IG G +G VYK         VA+K +   N G   G L   T  E+ +L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 528 QLR---YLHLVSLIGYC-----NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKI 579
           +L    + ++V L+  C     + + ++ LV++++ +  LR +L     P LP +    +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKDL 125
Query: 580 CIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
                R L +LH   +  I+HRD+K  NIL+      K++DFGL +    +S     T V
Sbjct: 126 MRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALTPV 179
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
             ++ Y  PE           D++S G +  E+   +P            L    +E  +
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP------------LFCGNSEADQ 227
Query: 700 NGKIGDII 707
            GKI D+I
Sbjct: 228 LGKIFDLI 235

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 78/179 (43%), Gaps = 24/179 (13%)
Query: 509 NPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDN 568
           N   ++   E   EI +L  L + +++ L     D     LV ++   G L + + N   
Sbjct: 83  NKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-- 140
Query: 569 PPLPWDRRLKICIGA------ARALHYLHTGASKVIIHRDVKTTNILLDEE---WVAKVS 619
                  +   C  A         + YLH      I+HRD+K  NILL+ +      K+ 
Sbjct: 141 ------HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIV 191
Query: 620 DFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           DFGL  F   FSK +      G+  Y+ PE  + +   EK DV+S GV++  +LC  PP
Sbjct: 192 DFGLSSF---FSKDYKLRDRLGTAYYIAPEVLKKKY-NEKCDVWSCGVIMYILLCGYPP 246

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLRYLH 533
           DF  +  +G G  G V+K   +  S  V  ++L     + A+  Q   E+ +L +    +
Sbjct: 7   DFEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           +V   G    DG++ +  ++M  G+L   L       +P     K+ I   + L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLRE- 122
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
               I+HRDVK +NIL++     K+ DFG+  +   + + + V T+      Y+ PE  +
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQ 176
Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPI 679
               + +SD++S G+ L+E+   R PI
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 472 EATKDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL 529
           E  ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
            + ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L +
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGY 645
            H   S  ++HRD+K  N+L++ E   K++DFGL + FG P  + TH  V+   +     
Sbjct: 126 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 182
Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           L  +YY     +   D++S G +  E++  R
Sbjct: 183 LGCKYY-----STAVDIWSLGCIFAEMVTRR 208

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 107/246 (43%), Gaps = 30/246 (12%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGF-LNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQL 529
           A + +  +  IG G +G V+K   L      VA+KR+   + +  +   T  E+ +L  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 530 R---YLHLVSLIGYC-----NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICI 581
               + ++V L   C     + + ++ LV++++ +  L  +L     P +P +    +  
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMF 127
Query: 582 GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG 641
              R L +LH   S  ++HRD+K  NIL+      K++DFGL +    +S     T V  
Sbjct: 128 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVV 181
Query: 642 SIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG 701
           ++ Y  PE           D++S G +  E+   +P    + D  Q+            G
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL------------G 229
Query: 702 KIGDII 707
           KI D+I
Sbjct: 230 KILDVI 235

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           IG+G +G V+ G   G+   VA+K     +++ +   +TEI     +R+ +++  I   +
Sbjct: 45  IGKGRYGEVWMGKWRGEK--VAVKVFFT-TEEASWFRETEIYQTVLMRHENILGFIA-AD 100
Query: 543 DDG-----QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT----- 592
             G     Q+ L+ DY   G+L D+L    +  L     LK+   +   L +LHT     
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVK-GSIGYLDPEY 650
                I HRD+K+ NIL+ +     ++D GL  KF  + ++  +    + G+  Y+ PE 
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 651 YRLQLLTEK------SDVYSFGVVLLEV 672
               L          +D+YSFG++L EV
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLRYLH 533
           DF  +  +G G  G V+K   +  S  V  ++L     + A+  Q   E+ +L +    +
Sbjct: 7   DFEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           +V   G    DG++ +  ++M  G+L   L       +P     K+ I   + L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLRE- 122
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
               I+HRDVK +NIL++     K+ DFG+  +   + + + V T+      Y+ PE  +
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQ 176
Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPI 679
               + +SD++S G+ L+E+   R PI
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 92/216 (42%), Gaps = 31/216 (14%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM----LSQLRYL 532
           + +  +IG G FG VY+  L      VAIK++    +    E Q    +    + +LRY 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLR-DHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              S  G   D+  + LV DY+     R    Y+     LP            R+L Y+H
Sbjct: 82  FYSS--GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 592 TGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYLDP 648
           +     I HRD+K  N+LLD +  V K+ DFG  K             V+G  ++ Y+  
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSYICS 185
Query: 649 EYYRLQLL-------TEKSDVYSFGVVLLEVLCARP 677
            YYR   L       T   DV+S G VL E+L  +P
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 30/215 (13%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHL 534
           +N + ++G+G FG V K          A+K +N  S   +       E+ +L +L + ++
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           + L     D     +V +    G L D +           R+      AAR +  + +G 
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIK---------RKRFSEHDAARIIKQVFSGI 134
Query: 595 SKV----IIHRDVKTTNILLD---EEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIG-- 644
           + +    I+HRD+K  NILL+   ++   K+ DFGL   F  N       T++K  IG  
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-------TKMKDRIGTA 187
Query: 645 -YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            Y+ PE  R     EK DV+S GV+L  +L   PP
Sbjct: 188 YYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           + ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + ++V L+   + + ++ LV+++++   L+D +  +    +P            + L + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMD-LKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYL 646
           H   S  ++HRD+K  N+L++ E   K++DFGL + FG P  +  H  V+   +     L
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 179
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             +YY     +   D++S G +  E++  R
Sbjct: 180 GCKYY-----STAVDIWSLGCIFAEMVTRR 204

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 51/234 (21%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV 535
           DF  + ++G+G FG V K     DS   AIK++    ++ +    +E+ +L+ L + ++V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNHQYVV 65
Query: 536 SL-------------IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
                          +        + +  +Y    TL D L +++N     D   ++   
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYD-LIHSENLNQQRDEYWRLFRQ 124
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK----------------- 625
              AL Y+H   S+ IIHRD+K  NI +DE    K+ DFGL K                 
Sbjct: 125 ILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 626 -FGPNFSKT-----HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
               N +       +V+T+V    G+ +          EK D+YS G++  E++
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYN----------EKIDMYSLGIIFFEMI 225

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           + ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + ++V L+   + + ++ LV+++++   L+D +  +    +P            + L + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMD-LKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYL 646
           H   S  ++HRD+K  N+L++ E   K++DFGL + FG P  +  H  V+   +     L
Sbjct: 122 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 178
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             +YY     +   D++S G +  E++  R
Sbjct: 179 GCKYY-----STAVDIWSLGCIFAEMVTRR 203

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 89/213 (41%), Gaps = 20/213 (9%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM-----LSQLR 530
           D  NL  +G G  G V+K         +A+K++    + G  E    I M     L    
Sbjct: 26  DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR---RSGNKEENKRILMDLDVVLKSHD 82
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
             ++V   G    +  + +  + M  GT  + L      P+P     K+ +   +AL+YL
Sbjct: 83  CPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
                  +IHRDVK +NILLDE    K+ DFG+              +  G   Y+ PE 
Sbjct: 141 KEKHG--VIHRDVKPSNILLDERGQIKLCDFGI---SGRLVDDKAKDRSAGCAAYMAPER 195
Query: 651 YRLQLLTE-----KSDVYSFGVVLLEVLCARPP 678
                 T+     ++DV+S G+ L+E+   + P
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLRYLH 533
           DF  +  +G G  G V+K   +  S  V  ++L     + A+  Q   E+ +L +    +
Sbjct: 7   DFEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           +V   G    DG++ +  ++M  G+L   L       +P     K+ I   + L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLRE- 122
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
               I+HRDVK +NIL++     K+ DFG+  +   + + + V T+      Y+ PE  +
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQ 176
Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPI 679
               + +SD++S G+ L+E+   R PI
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLRYLH 533
           DF  +  +G G  G V+K   +  S  V  ++L     + A+  Q   E+ +L +    +
Sbjct: 7   DFEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           +V   G    DG++ +  ++M  G+L   L       +P     K+ I   + L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLRE- 122
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
               I+HRDVK +NIL++     K+ DFG+  +   + + + V T+      Y+ PE  +
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQ 176
Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPI 679
               + +SD++S G+ L+E+   R PI
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 96/229 (41%), Gaps = 24/229 (10%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-------RYLHL 534
           ++  GGF  VY+    G     A+KRL    ++       E+  + +L       ++   
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 535 VSLIGYCNDDGQM-ILVYDYMARGTLRDHLYNNDNP-PLPWDRRLKICIGAARALHYLHT 592
            S+    +D GQ   L+   + +G L + L   ++  PL  D  LKI     RA+ ++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG-------- 644
                IIHRD+K  N+LL  +   K+ DFG      ++     S Q +  +         
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 645 --YLDPEYYRLQL---LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQV 688
             Y  PE   L     + EK D+++ G +L  +LC R      G K ++
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILY-LLCFRQHPFEDGAKLRI 261

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 112/242 (46%), Gaps = 36/242 (14%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKR-LNPGSQQG-ALEFQTEIGMLSQLRYLHL 534
           +  L  IG+G FG V+K         VA+K+ L    ++G  +    EI +L  L++ ++
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 78
Query: 535 VSLIGYCNDD--------GQMILVYDYMAR---GTLRDHLYNNDNPPLPWDRRLKICIGA 583
           V+LI  C           G + LV+D+      G L + L       +   R +++ +  
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQMLLNG 136
Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVK 640
              L+Y+H      I+HRD+K  N+L+  + V K++DFGL +      N        +V 
Sbjct: 137 ---LYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV- 189
Query: 641 GSIGYLDPEYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWAT 695
            ++ Y  PE     LL E+      D++  G ++ E +  R PI++ G+ +Q  LA+ + 
Sbjct: 190 VTLWYRPPEL----LLGERDYGPPIDLWGAGCIMAE-MWTRSPIMQ-GNTEQHQLALISQ 243
Query: 696 EC 697
            C
Sbjct: 244 LC 245

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           + ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + ++V L+   + + ++ LV++++ +  L+D +  +    +P            + L + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYL 646
           H   S  ++HRD+K  N+L++ E   K++DFGL + FG P  +  H  V+   +     L
Sbjct: 120 H---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 176
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             +YY     +   D++S G +  E++  R
Sbjct: 177 GCKYY-----STAVDIWSLGCIFAEMVTRR 201

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 107/273 (39%), Gaps = 35/273 (12%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAI-----KRLNPGSQQGALEFQTEIGMLSQLRYLHLV-- 535
           IGRG F  VYKG     +  VA      ++L    +Q    F+ E   L  L++ ++V  
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIVRF 90
Query: 536 --SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
             S          ++LV +    GTL+ +L       +   R    C    + L +LHT 
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW--CRQILKGLQFLHT- 147
Query: 594 ASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
            +  IIHRD+K  NI +       K+ D GL        +   +  V G+  +  PE Y 
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGL----ATLKRASFAKAVIGTPEFXAPEXYE 203
Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK 712
            +   E  DVY+FG   LE   +  P     +  Q+         YR    G     F K
Sbjct: 204 -EKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQI---------YRRVTSGVKPASFDK 253
Query: 713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
              P V      E+   C+  ++  R S+ D++
Sbjct: 254 VAIPEV-----KEIIEGCIRQNKDERYSIKDLL 281

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 13/216 (6%)
Query: 465 FSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--E 522
            ++ E+K+   DF  +  +G G  G V+K   +  S  V  ++L     + A+  Q   E
Sbjct: 1   MALGELKD--DDFEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHLEIKPAIRNQIIRE 57
Query: 523 IGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
           + +L +    ++V   G    DG++ +  ++M  G+L   L       +P     K+ I 
Sbjct: 58  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIA 115
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS 642
             + L YL       I+HRDVK +NIL++     K+ DFG+   G    +  ++ +  G+
Sbjct: 116 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDE--MANEFVGT 169
Query: 643 IGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
             Y+ PE  +    + +SD++S G+ L+E+   R P
Sbjct: 170 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ----QGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+GGF   Y+   + D+  V   ++ P S         +  TEI +   L   H+V   
Sbjct: 50  LGKGGFAKCYE-ITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVI 598
           G+  DD  + +V +   R +L +          P  R         + + YLH      +
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYF--MRQTIQGVQYLHNNR---V 163
Query: 599 IHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK----GSIGYLDPEYYRLQ 654
           IHRD+K  N+ L+++   K+ DFGL       +K     + K    G+  Y+ PE    +
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLA------TKIEFDGERKKXLCGTPNYIAPEVLCKK 217
Query: 655 LLTEKSDVYSFGVVLLEVLCARPP 678
             + + D++S G +L  +L  +PP
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 30/215 (13%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQG--ALEFQTEIGMLSQLRYLHL 534
           +N + ++G+G FG V K          A+K +N  S +         E+ +L +L + ++
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           + L     D     +V +    G L D +           R+      AAR +  + +G 
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIK---------RKRFSEHDAARIIKQVFSGI 134
Query: 595 SKV----IIHRDVKTTNILLD---EEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIG-- 644
           + +    I+HRD+K  NILL+   ++   K+ DFGL   F  N       T++K  IG  
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-------TKMKDRIGTA 187
Query: 645 -YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            Y+ PE  R     EK DV+S GV+L  +L   PP
Sbjct: 188 YYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 30/215 (13%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQG--ALEFQTEIGMLSQLRYLHL 534
           +N + ++G+G FG V K          A+K +N  S +         E+ +L +L + ++
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           + L     D     +V +    G L D +           R+      AAR +  + +G 
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIK---------RKRFSEHDAARIIKQVFSGI 134
Query: 595 SKV----IIHRDVKTTNILLD---EEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIG-- 644
           + +    I+HRD+K  NILL+   ++   K+ DFGL   F  N       T++K  IG  
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-------TKMKDRIGTA 187
Query: 645 -YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            Y+ PE  R     EK DV+S GV+L  +L   PP
Sbjct: 188 YYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 475 KDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL 532
           ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L + 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 120
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYLDP 648
             S  ++HRD+K  N+L++ E   K++DFGL + FG P  + TH  V+   +     L  
Sbjct: 121 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGX 178
Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           +YY     +   D++S G +  E++  R
Sbjct: 179 KYY-----STAVDIWSLGCIFAEMVTRR 201

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ----QGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+GGF   Y+   + D+  V   ++ P S         +  TEI +   L   H+V   
Sbjct: 50  LGKGGFAKCYE-ITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVI 598
           G+  DD  + +V +   R +L +          P  R         + + YLH      +
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYF--MRQTIQGVQYLHNNR---V 163
Query: 599 IHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK----GSIGYLDPEYYRLQ 654
           IHRD+K  N+ L+++   K+ DFGL       +K     + K    G+  Y+ PE    +
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLA------TKIEFDGERKKDLCGTPNYIAPEVLCKK 217
Query: 655 LLTEKSDVYSFGVVLLEVLCARPP 678
             + + D++S G +L  +L  +PP
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 107/239 (44%), Gaps = 30/239 (12%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKR-LNPGSQQG-ALEFQTEIGMLSQLRYLHL 534
           +  L  IG+G FG V+K         VA+K+ L    ++G  +    EI +L  L++ ++
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 535 VSLIGYCNDD--------GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARA 586
           V+LI  C           G + LV+D+         L +N           ++       
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA--GLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 587 LHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVKGSI 643
           L+Y+H      I+HRD+K  N+L+  + V K++DFGL +      N        +V  ++
Sbjct: 138 LYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TL 193
Query: 644 GYLDPEYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATEC 697
            Y  PE     LL E+      D++  G ++ E +  R PI++ G+ +Q  LA+ +  C
Sbjct: 194 WYRPPEL----LLGERDYGPPIDLWGAGCIMAE-MWTRSPIMQ-GNTEQHQLALISQLC 246

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 483 IGRGGFGNVY--KGFLNGDSTPVAI---KRLNPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           IG+G F  V   +  L G    V I    +LNP S Q       E+ ++  L + ++V L
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR---EVRIMKILNHPNIVKL 79
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDR-RLKICIGAARALHYLHTGASK 596
                 +  + LV +Y + G + D+L  +        R + +  + A +  H       K
Sbjct: 80  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH------QK 133
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
            I+HRD+K  N+LLD +   K++DFG   F   F+  +      GS  Y  PE ++ +  
Sbjct: 134 YIVHRDLKAENLLLDGDMNIKIADFG---FSNEFTVGNKLDTFCGSPPYAAPELFQGKKY 190
Query: 657 T-EKSDVYSFGVVLLEVLCARPP 678
              + DV+S GV+L  ++    P
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLP 213

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 475 KDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL 532
           ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L + 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH- 120
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYLDP 648
             S  ++HRD+K  N+L++ E   K++DFGL + FG P  + TH  V+   +     L  
Sbjct: 121 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           +YY     +   D++S G +  E++  R
Sbjct: 179 KYY-----STAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           + ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYL 646
           H   S  ++HRD+K  N+L++ E   K++DFGL + FG P  + TH  V+   +     L
Sbjct: 121 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 177
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             +YY     +   D++S G +  E++  R
Sbjct: 178 GCKYY-----STAVDIWSLGCIFAEMVTRR 202

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ----QGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+GGF   Y+   + D+  V   ++ P S         +  TEI +   L   H+V   
Sbjct: 34  LGKGGFAKCYE-ITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 92
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVI 598
           G+  DD  + +V +   R +L +          P  R         + + YLH      +
Sbjct: 93  GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYF--MRQTIQGVQYLHNNR---V 147
Query: 599 IHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK----GSIGYLDPEYYRLQ 654
           IHRD+K  N+ L+++   K+ DFGL       +K     + K    G+  Y+ PE    +
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLA------TKIEFDGERKKDLCGTPNYIAPEVLCKK 201
Query: 655 LLTEKSDVYSFGVVLLEVLCARPP 678
             + + D++S G +L  +L  +PP
Sbjct: 202 GHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 109/245 (44%), Gaps = 35/245 (14%)
Query: 447 EAKSRGPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIK 506
           EA+++GP S   S   +  SI   +  TK       +G G +G VYK      +  VAIK
Sbjct: 13  EAQTQGPGSMSVSAAPSATSIDRYRRITK-------LGEGTYGEVYKAIDTVTNETVAIK 65
Query: 507 RLNPGSQQGALEFQT--EIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY 564
           R+    ++  +      E+ +L +L++ +++ L    + + ++ L+++Y A   L+   Y
Sbjct: 66  RIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY-AENDLKK--Y 122
Query: 565 NNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL-----DEEWVAKVS 619
            + NP +               +++ H   S+  +HRD+K  N+LL      E  V K+ 
Sbjct: 123 MDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIG 179
Query: 620 DFGLCK-FG-PNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKS-----DVYSFGVVLLEV 672
           DFGL + FG P    TH       ++ Y  PE     LL  +      D++S   +  E+
Sbjct: 180 DFGLARAFGIPIRQFTHEII----TLWYRPPEI----LLGSRHYSTSVDIWSIACIWAEM 231
Query: 673 LCARP 677
           L   P
Sbjct: 232 LMKTP 236

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 475 KDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL 532
           ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L + 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 120
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYLDP 648
             S  ++HRD+K  N+L++ E   K++DFGL + FG P  + TH  V+   +     L  
Sbjct: 121 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           +YY     +   D++S G +  E++  R
Sbjct: 179 KYY-----STAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 475 KDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL 532
           ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L + 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYLDP 648
             S  ++HRD+K  N+L++ E   K++DFGL + FG P  + TH  V+   +     L  
Sbjct: 120 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           +YY     +   D++S G +  E++  R
Sbjct: 178 KYY-----STAVDIWSLGCIFAEMVTRR 200

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 475 KDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL 532
           ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L + 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 120
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYLDP 648
             S  ++HRD+K  N+L++ E   K++DFGL + FG P  + TH  V+   +     L  
Sbjct: 121 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           +YY     +   D++S G +  E++  R
Sbjct: 179 KYY-----STAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 475 KDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL 532
           ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L + 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYLDP 648
             S  ++HRD+K  N+L++ E   K++DFGL + FG P  + TH  V+   +     L  
Sbjct: 120 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           +YY     +   D++S G +  E++  R
Sbjct: 178 KYY-----STAVDIWSLGCIFAEMVTRR 200

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA-LEFQTEIGMLSQLRYLHLVSLIGYC 541
           +G G +  VYKG        VA+K +    ++GA      E+ +L  L++ ++V+L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
           + +  + LV++Y+ +  L+ +L +  N     + +L       R L Y H    + ++HR
Sbjct: 70  HTEKSLTLVFEYLDKD-LKQYLDDCGNIINMHNVKL-FLFQLLRGLAYCH---RQKVLHR 124
Query: 602 DVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY------YRLQL 655
           D+K  N+L++E    K++DFGL +     +KT+ +  V  ++ Y  P+       Y  Q+
Sbjct: 125 DLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGSTDYSTQI 182
Query: 656 LTEKSDVYSFGVVLLEVLCARP 677
                D++  G +  E+   RP
Sbjct: 183 -----DMWGVGCIFYEMATGRP 199

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 475 KDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL 532
           ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L + 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYLDP 648
             S  ++HRD+K  N+L++ E   K++DFGL + FG P  + TH  V+   +     L  
Sbjct: 120 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           +YY     +   D++S G +  E++  R
Sbjct: 178 KYY-----STAVDIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 475 KDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL 532
           ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L + 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 120
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYLDP 648
             S  ++HRD+K  N+L++ E   K++DFGL + FG P  + TH  V+   +     L  
Sbjct: 121 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           +YY     +   D++S G +  E++  R
Sbjct: 179 KYY-----STAVDIWSLGCIFAEMVTRR 201

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 475 KDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL 532
           ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L + 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + H 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 124
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYLDP 648
             S  ++HRD+K  N+L++ E   K++DFGL + FG P  + TH  V+   +     L  
Sbjct: 125 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 182
Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           +YY     +   D++S G +  E++  R
Sbjct: 183 KYY-----STAVDIWSLGCIFAEMVTRR 205

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 476 DFNNLLIIGRGGFGNVY--KGFLNGDSTPVAI---KRLNPGSQQGALEFQTEIGMLSQLR 530
           ++  L  IG+G F  V   +  L G    V I    +LN  S Q       E+ ++  L 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR---EVRIMKVLN 71
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDR-RLKICIGAARALHY 589
           + ++V L      +  + LV +Y + G + D+L  +        R + +  + A +  H 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH- 130
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
                 K I+HRD+K  N+LLD +   K++DFG   F   F+  +   +  GS  Y  PE
Sbjct: 131 -----QKFIVHRDLKAENLLLDADMNIKIADFG---FSNEFTFGNKLDEFCGSPPYAAPE 182
Query: 650 YYRLQLLT-EKSDVYSFGVVLLEVLCARPP 678
            ++ +     + DV+S GV+L  ++    P
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 25/224 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGS----QQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+GGF   ++   + D+  V   ++ P S         +   EI +   L + H+V   
Sbjct: 29  LGKGGFAKCFE-ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL--KICIGAARALHYLHTGASK 596
           G+  D+  + +V +   R +L +          P  R    +I +G      YLH     
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC----QYLHRNR-- 141
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK----GSIGYLDPEYYR 652
            +IHRD+K  N+ L+E+   K+ DFGL       +K     + K    G+  Y+ PE   
Sbjct: 142 -VIHRDLKLGNLFLNEDLEVKIGDFGLA------TKVEYDGERKKTLCGTPNYIAPEVLS 194
Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATE 696
            +  + + DV+S G ++  +L  +PP   T   K+  L +   E
Sbjct: 195 KKGHSFEVDVWSIGCIMYTLLVGKPP-FETSCLKETYLRIKKNE 237

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 94/218 (43%), Gaps = 35/218 (16%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVS 536
           + +  +IG G FG VY+  L      VAIK++     QG      E+ ++ +L + ++V 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVR 77
Query: 537 L------IGYCNDDGQMILVYDYMARGTLR-DHLYNNDNPPLPWDRRLKICIGAARALHY 589
           L       G   D+  + LV DY+     R    Y+     LP            R+L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 590 LHTGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYL 646
           +H+     I HRD+K  N+LLD +  V K+ DFG  K             V+G  ++  +
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSXI 183
Query: 647 DPEYYRLQLL-------TEKSDVYSFGVVLLEVLCARP 677
              YYR   L       T   DV+S G VL E+L  +P
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 25/224 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGS----QQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+GGF   ++   + D+  V   ++ P S         +   EI +   L + H+V   
Sbjct: 47  LGKGGFAKCFE-ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL--KICIGAARALHYLHTGASK 596
           G+  D+  + +V +   R +L +          P  R    +I +G      YLH     
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC----QYLHRNR-- 159
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK----GSIGYLDPEYYR 652
            +IHRD+K  N+ L+E+   K+ DFGL       +K     + K    G+  Y+ PE   
Sbjct: 160 -VIHRDLKLGNLFLNEDLEVKIGDFGLA------TKVEYDGERKKVLCGTPNYIAPEVLS 212
Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATE 696
            +  + + DV+S G ++  +L  +PP   T   K+  L +   E
Sbjct: 213 KKGHSFEVDVWSIGCIMYTLLVGKPP-FETSCLKETYLRIKKNE 255

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 25/224 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGS----QQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+GGF   ++   + D+  V   ++ P S         +   EI +   L + H+V   
Sbjct: 49  LGKGGFAKCFE-ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL--KICIGAARALHYLHTGASK 596
           G+  D+  + +V +   R +L +          P  R    +I +G      YLH     
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC----QYLHRNR-- 161
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK----GSIGYLDPEYYR 652
            +IHRD+K  N+ L+E+   K+ DFGL       +K     + K    G+  Y+ PE   
Sbjct: 162 -VIHRDLKLGNLFLNEDLEVKIGDFGLA------TKVEYDGERKKVLCGTPNYIAPEVLS 214
Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATE 696
            +  + + DV+S G ++  +L  +PP   T   K+  L +   E
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPP-FETSCLKETYLRIKKNE 257

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 25/224 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGS----QQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+GGF   ++   + D+  V   ++ P S         +   EI +   L + H+V   
Sbjct: 25  LGKGGFAKCFE-ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL--KICIGAARALHYLHTGASK 596
           G+  D+  + +V +   R +L +          P  R    +I +G      YLH     
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC----QYLHRNR-- 137
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK----GSIGYLDPEYYR 652
            +IHRD+K  N+ L+E+   K+ DFGL       +K     + K    G+  Y+ PE   
Sbjct: 138 -VIHRDLKLGNLFLNEDLEVKIGDFGLA------TKVEYDGERKKTLCGTPNYIAPEVLS 190
Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATE 696
            +  + + DV+S G ++  +L  +PP   T   K+  L +   E
Sbjct: 191 KKGHSFEVDVWSIGCIMYTLLVGKPP-FETSCLKETYLRIKKNE 233

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 101/234 (43%), Gaps = 49/234 (20%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNP-----GSQQGA---LEFQTEIGMLSQLRYLHL 534
           +G G  G V   F       VAIK ++      GS + A   L  +TEI +L +L +  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK--IC----IGAARALH 588
           + +  + + +   I V + M  G L D +  N        +RLK   C         A+ 
Sbjct: 78  IKIKNFFDAEDYYI-VLELMEGGELFDKVVGN--------KRLKEATCKLYFYQMLLAVQ 128
Query: 589 YLHTGASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
           YLH      IIHRD+K  N+LL   +E+ + K++DFG  K      +T +   + G+  Y
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTY 182
Query: 646 LDPE---------YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL 690
           L PE         Y R        D +S GV+L   L   PP   +  + QV+L
Sbjct: 183 LAPEVLVSVGTAGYNR------AVDCWSLGVILFICLSGYPPF--SEHRTQVSL 228

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 25/224 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGS----QQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+GGF   ++   + D+  V   ++ P S         +   EI +   L + H+V   
Sbjct: 25  LGKGGFAKCFE-ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL--KICIGAARALHYLHTGASK 596
           G+  D+  + +V +   R +L +          P  R    +I +G      YLH     
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC----QYLHRNR-- 137
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK----GSIGYLDPEYYR 652
            +IHRD+K  N+ L+E+   K+ DFGL       +K     + K    G+  Y+ PE   
Sbjct: 138 -VIHRDLKLGNLFLNEDLEVKIGDFGLA------TKVEYDGERKKTLCGTPNYIAPEVLS 190
Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATE 696
            +  + + DV+S G ++  +L  +PP   T   K+  L +   E
Sbjct: 191 KKGHSFEVDVWSIGCIMYTLLVGKPP-FETSCLKETYLRIKKNE 233

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 101/234 (43%), Gaps = 49/234 (20%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNP-----GSQQGA---LEFQTEIGMLSQLRYLHL 534
           +G G  G V   F       VAIK ++      GS + A   L  +TEI +L +L +  +
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK--IC----IGAARALH 588
           + +  + + +   I V + M  G L D +  N        +RLK   C         A+ 
Sbjct: 77  IKIKNFFDAEDYYI-VLELMEGGELFDKVVGN--------KRLKEATCKLYFYQMLLAVQ 127
Query: 589 YLHTGASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
           YLH      IIHRD+K  N+LL   +E+ + K++DFG  K      +T +   + G+  Y
Sbjct: 128 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTY 181
Query: 646 LDPE---------YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL 690
           L PE         Y R        D +S GV+L   L   PP   +  + QV+L
Sbjct: 182 LAPEVLVSVGTAGYNR------AVDCWSLGVILFICLSGYPPF--SEHRTQVSL 227

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 101/234 (43%), Gaps = 49/234 (20%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNP-----GSQQGA---LEFQTEIGMLSQLRYLHL 534
           +G G  G V   F       VAIK ++      GS + A   L  +TEI +L +L +  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK--IC----IGAARALH 588
           + +  + + +   I V + M  G L D +  N        +RLK   C         A+ 
Sbjct: 78  IKIKNFFDAEDYYI-VLELMEGGELFDKVVGN--------KRLKEATCKLYFYQMLLAVQ 128
Query: 589 YLHTGASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
           YLH      IIHRD+K  N+LL   +E+ + K++DFG  K      +T +   + G+  Y
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTY 182
Query: 646 LDPE---------YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL 690
           L PE         Y R        D +S GV+L   L   PP   +  + QV+L
Sbjct: 183 LAPEVLVSVGTAGYNR------AVDCWSLGVILFICLSGYPPF--SEHRTQVSL 228

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 25/224 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGS----QQGALEFQTEIGMLSQLRYLHLVSLI 538
           +G+GGF   ++   + D+  V   ++ P S         +   EI +   L + H+V   
Sbjct: 23  LGKGGFAKCFE-ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL--KICIGAARALHYLHTGASK 596
           G+  D+  + +V +   R +L +          P  R    +I +G      YLH     
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC----QYLHRNR-- 135
Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK----GSIGYLDPEYYR 652
            +IHRD+K  N+ L+E+   K+ DFGL       +K     + K    G+  Y+ PE   
Sbjct: 136 -VIHRDLKLGNLFLNEDLEVKIGDFGLA------TKVEYDGERKKVLCGTPNYIAPEVLS 188
Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATE 696
            +  + + DV+S G ++  +L  +PP   T   K+  L +   E
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPP-FETSCLKETYLRIKKNE 231

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 101/234 (43%), Gaps = 49/234 (20%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNP-----GSQQGA---LEFQTEIGMLSQLRYLHL 534
           +G G  G V   F       VAIK ++      GS + A   L  +TEI +L +L +  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK--IC----IGAARALH 588
           + +  + + +   I V + M  G L D +  N        +RLK   C         A+ 
Sbjct: 78  IKIKNFFDAEDYYI-VLELMEGGELFDKVVGN--------KRLKEATCKLYFYQMLLAVQ 128
Query: 589 YLHTGASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
           YLH      IIHRD+K  N+LL   +E+ + K++DFG  K      +T +   + G+  Y
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTY 182
Query: 646 LDPE---------YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL 690
           L PE         Y R        D +S GV+L   L   PP   +  + QV+L
Sbjct: 183 LAPEVLVSVGTAGYNR------AVDCWSLGVILFICLSGYPPF--SEHRTQVSL 228

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 101/234 (43%), Gaps = 49/234 (20%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNP-----GSQQGA---LEFQTEIGMLSQLRYLHL 534
           +G G  G V   F       VAIK ++      GS + A   L  +TEI +L +L +  +
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 83
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK--IC----IGAARALH 588
           + +  + + +   I V + M  G L D +  N        +RLK   C         A+ 
Sbjct: 84  IKIKNFFDAEDYYI-VLELMEGGELFDKVVGN--------KRLKEATCKLYFYQMLLAVQ 134
Query: 589 YLHTGASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
           YLH      IIHRD+K  N+LL   +E+ + K++DFG  K      +T +   + G+  Y
Sbjct: 135 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTY 188
Query: 646 LDPE---------YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL 690
           L PE         Y R        D +S GV+L   L   PP   +  + QV+L
Sbjct: 189 LAPEVLVSVGTAGYNR------AVDCWSLGVILFICLSGYPPF--SEHRTQVSL 234

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +GRG    VY+    G   P A+K L     +  +  +TEIG+L +L + +++ L     
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV--RTEIGVLLRLSHPNIIKLKEIFE 118
Query: 543 DDGQMILVYDYMARGTLRDHL----YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVI 598
              ++ LV + +  G L D +    Y ++       +++        A+ YLH      I
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI------LEAVAYLHENG---I 169
Query: 599 IHRDVKTTNILLDE---EWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
           +HRD+K  N+L      +   K++DFGL K         +   V G+ GY  PE  R   
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKI---VEHQVLMKTVCGTPGYCAPEILRGCA 226
Query: 656 LTEKSDVYSFGVVLLEVLCARPP 678
              + D++S G++   +LC   P
Sbjct: 227 YGPEVDMWSVGIITYILLCGFEP 249

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 18/138 (13%)
Query: 549 LVYDYMARGTLRDHLYNNDNPPLPWDRR-LKICIGAARALHYLHTGASKVIIHRDVKTTN 607
           LV+D M +G L D+L           R+ ++  +    ALH L+      I+HRD+K  N
Sbjct: 88  LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPEN 141
Query: 608 ILLDEEWVAKVSDFGL-CKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL------LTEKS 660
           ILLD++   K++DFG  C+  P         +V G+  YL PE     +        ++ 
Sbjct: 142 ILLDDDMNIKLTDFGFSCQLDPG----EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEV 197
Query: 661 DVYSFGVVLLEVLCARPP 678
           D++S GV++  +L   PP
Sbjct: 198 DMWSTGVIMYTLLAGSPP 215

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 476 DFNNLLIIGRGGFGNVY--KGFLNGDSTPVAI---KRLNPGSQQGALEFQTEIGMLSQLR 530
           ++  L  IG+G F  V   +  L G    V I    +LN  S Q       E+ ++  L 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR---EVRIMKVLN 71
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDR-RLKICIGAARALHY 589
           + ++V L      +  + LV +Y + G + D+L  +        R + +  + A +  H 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH- 130
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
                 K I+HRD+K  N+LLD +   K++DFG   F   F+  +      GS  Y  PE
Sbjct: 131 -----QKFIVHRDLKAENLLLDADMNIKIADFG---FSNEFTFGNKLDTFCGSPPYAAPE 182
Query: 650 YYRLQLLT-EKSDVYSFGVVLLEVLCARPP 678
            ++ +     + DV+S GV+L  ++    P
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 475 KDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL 532
           ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L + 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQD-LKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYLDP 648
             S  ++HRD+K  N+L++ E   K++DFGL + FG P  + TH  V+   +     L  
Sbjct: 120 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           +YY     +   D++S G +  E++  R
Sbjct: 178 KYY-----STAVDIWSLGCIFAEMVTRR 200

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 18/226 (7%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLIGYC 541
           +G G FG+V+            IK +N    Q  +E  + EI +L  L + +++ +    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 542 NDDGQMILVYDYMARGTLRDHLYNND--NPPLPWDRRLKICIGAARALHYLHTGASKVII 599
            D   M +V +    G L + + +       L      ++      AL Y H   S+ ++
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVV 146
Query: 600 HRDVKTTNILLDE---EWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
           H+D+K  NIL  +       K+ DFGL +    F     ST   G+  Y+ PE ++   +
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALYMAPEVFKRD-V 202
Query: 657 TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAV-----WATEC 697
           T K D++S GVV+  +L    P   T  ++    A      +A EC
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC 248

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 476 DFNNLLIIGRGGFGNVY--KGFLNGDSTPVAI---KRLNPGSQQGALEFQTEIGMLSQLR 530
           ++  L  IG+G F  V   +  L G    V I    +LN  S Q       E+ ++  L 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR---EVRIMKVLN 71
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDR-RLKICIGAARALHY 589
           + ++V L      +  + LV +Y + G + D+L  +        R + +  + A +  H 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH- 130
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
                 K I+HRD+K  N+LLD +   K++DFG   F   F+  +      GS  Y  PE
Sbjct: 131 -----QKFIVHRDLKAENLLLDADMNIKIADFG---FSNEFTFGNKLDTFCGSPPYAAPE 182
Query: 650 YYRLQLLT-EKSDVYSFGVVLLEVLCARPP 678
            ++ +     + DV+S GV+L  ++    P
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 18/138 (13%)
Query: 549 LVYDYMARGTLRDHLYNNDNPPLPWDRR-LKICIGAARALHYLHTGASKVIIHRDVKTTN 607
           LV+D M +G L D+L           R+ ++  +    ALH L+      I+HRD+K  N
Sbjct: 101 LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPEN 154
Query: 608 ILLDEEWVAKVSDFGL-CKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL------LTEKS 660
           ILLD++   K++DFG  C+  P         +V G+  YL PE     +        ++ 
Sbjct: 155 ILLDDDMNIKLTDFGFSCQLDPG----EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEV 210
Query: 661 DVYSFGVVLLEVLCARPP 678
           D++S GV++  +L   PP
Sbjct: 211 DMWSTGVIMYTLLAGSPP 228

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM----LSQLRYL 532
           + +  +IG G FG VY+  L      VAIK++    +    E Q    +    + +LRY 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLR-DHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              S  G   D+  + LV DY+     R    Y+     LP            R+L Y+H
Sbjct: 116 FYSS--GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 592 TGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYLDP 648
           +     I HRD+K  N+LLD +  V K+ DFG  K             V+G  ++  +  
Sbjct: 174 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSXICS 219
Query: 649 EYYRLQLL-------TEKSDVYSFGVVLLEVLCARP 677
            YYR   L       T   DV+S G VL E+L  +P
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 476 DFNNLLIIGRGGFGNVY--KGFLNGDSTPVAI---KRLNPGSQQGALEFQTEIGMLSQLR 530
           ++  L  IG+G F  V   +  L G    + I    +LNP S Q       E+ ++  L 
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR---EVRIMKILN 69
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDR-RLKICIGAARALHY 589
           + ++V L      +  + L+ +Y + G + D+L  +        R + +  + A +  H 
Sbjct: 70  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH- 128
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
                 K I+HRD+K  N+LLD +   K++DFG   F   F+         GS  Y  PE
Sbjct: 129 -----QKRIVHRDLKAENLLLDADMNIKIADFG---FSNEFTVGGKLDTFCGSPPYAAPE 180
Query: 650 YYRLQLLT-EKSDVYSFGVVLLEVLCARPP 678
            ++ +     + DV+S GV+L  ++    P
Sbjct: 181 LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 210

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 483 IGRGGFGNVYKGFLN--GD-----STPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV 535
           +G+G F  ++KG     GD      T V +K L+   +  +  F     M+S+L + HLV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNP-PLPWDRRLKICIGAARALHYLHTGA 594
              G C    + ILV +++  G+L  +L  N N   + W  +L++    A A+H+L    
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLE--- 130
Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQV-KGSIGYLDPEYYR 652
              +IH +V   NILL  E   K  +    K   P  S T +   + +  I ++ PE   
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIE 190
Query: 653 ----LQLLTEKSDVYSFGVVLLEV 672
               L L T+K   +SFG  L E+
Sbjct: 191 NPKNLNLATDK---WSFGTTLWEI 211

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILR 136
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGLC+   +    +V+T+      Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATR-----WY 188
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 29/209 (13%)
Query: 483 IGRGGFGNVY--KGFLNGDSTPVAIKR---LNPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G +G V   K  L G    + I +   +   S  GAL    E+ +L QL + +++ L
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGAL--LDEVAVLKQLDHPNIMKL 86
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKIC-IGAARALHYLHTGASK 596
             +  D     LV +    G L D +            R K   + AA  +  + +G + 
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGELFDEII----------LRQKFSEVDAAVIMKQVLSGTTY 136
Query: 597 V----IIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           +    I+HRD+K  N+LL+    + + K+ DFGL     +F       +  G+  Y+ PE
Sbjct: 137 LHKHNIVHRDLKPENLLLESKSRDALIKIVDFGL---SAHFEVGGKMKERLGTAYYIAPE 193
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
             R +   EK DV+S GV+L  +LC  PP
Sbjct: 194 VLRKKY-DEKCDVWSCGVILYILLCGYPP 221

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 476 DFNNLLIIGRGGFGNVY--KGFLNGDSTPVAI---KRLNPGSQQGALEFQTEIGMLSQLR 530
           ++  L  IG+G F  V   +  L G    V I    +LN  S Q       E+ ++  L 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR---EVRIMKVLN 71
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDR-RLKICIGAARALHY 589
           + ++V L      +  + LV +Y + G + D+L  +        R + +  + A +  H 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH- 130
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
                 K I+HRD+K  N+LLD +   K++DFG   F   F+  +      GS  Y  PE
Sbjct: 131 -----QKFIVHRDLKAENLLLDADMNIKIADFG---FSNEFTFGNKLDTFCGSPPYAAPE 182
Query: 650 YYRLQLLT-EKSDVYSFGVVLLEVLCARPP 678
            ++ +     + DV+S GV+L  ++    P
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           + ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYL 646
           H   S  ++HRD+K  N+L++ E   K++DFGL + FG P  +  H  V+   +     L
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 176
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             +YY     +   D++S G +  E++  R
Sbjct: 177 GCKYY-----STAVDIWSLGCIFAEMVTRR 201

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 100/234 (42%), Gaps = 49/234 (20%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIK-----RLNPGSQQGA---LEFQTEIGMLSQLRYLHL 534
           +G G  G V   F       VAI+     +   GS + A   L  +TEI +L +L +  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK--IC----IGAARALH 588
           + +  + + +   I V + M  G L D +  N        +RLK   C         A+ 
Sbjct: 203 IKIKNFFDAEDYYI-VLELMEGGELFDKVVGN--------KRLKEATCKLYFYQMLLAVQ 253
Query: 589 YLHTGASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
           YLH      IIHRD+K  N+LL   +E+ + K++DFG  K      +T +   + G+  Y
Sbjct: 254 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTY 307
Query: 646 LDPE---------YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL 690
           L PE         Y R        D +S GV+L   L   PP   +  + QV+L
Sbjct: 308 LAPEVLVSVGTAGYNR------AVDCWSLGVILFICLSGYPPF--SEHRTQVSL 353

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM----LSQLRYL 532
           + +  +IG G FG VY+  L      VAIK++    +    E Q    +    + +LRY 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 93
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLR-DHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              S  G   D+  + LV DY+     R    Y+     LP            R+L Y+H
Sbjct: 94  FYSS--GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 592 TGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYLDP 648
           +     I HRD+K  N+LLD +  V K+ DFG  K             V+G  ++  +  
Sbjct: 152 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSXICS 197
Query: 649 EYYRLQLL-------TEKSDVYSFGVVLLEVLCARP 677
            YYR   L       T   DV+S G VL E+L  +P
Sbjct: 198 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 233

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 482 IIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLI 538
           ++G+G FG V   K  + G    V +       Q+   E    E+ +L QL + +++ L 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV- 597
            +  D G   LV +    G L D + +         R+    + AAR +  + +G + + 
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIIS---------RKRFSEVDAARIIRQVLSGITYMH 143
Query: 598 ---IIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPNFSKTH--VSTQVKGSIG---YL 646
              I+HRD+K  N+LL+   ++   ++ DFGL         TH   S ++K  IG   Y+
Sbjct: 144 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--------THFEASKKMKDKIGTAYYI 195
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            PE        EK DV+S GV+L  +L   PP
Sbjct: 196 APEVLH-GTYDEKCDVWSTGVILYILLSGCPP 226

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 123/301 (40%), Gaps = 61/301 (20%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLN---PGS--QQGALEFQTEIGMLSQ 528
           T +F+ L  IG G FG+V+K     D    AIKR      GS  +Q AL       +L Q
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 529 LRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPW-DRRLK-ICIGAARA 586
             + H+V       +D  M++  +Y   G+L D +  N      + +  LK + +   R 
Sbjct: 68  --HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 587 LHYLHTGASKVIIHRDVKTTNILL--------------DEEWVAKVSDFGLCKFGPNFSK 632
           L Y+H   S  ++H D+K +NI +              +++W +    F +   G     
Sbjct: 126 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG----- 177
Query: 633 THVSTQVKGSIGYLDPEYYRLQLLTE------KSDVYSFGVVLLEVLCA--RPPILRTGD 684
            HV+      +   D  +   ++L E      K+D+++     L V+CA    P+ R GD
Sbjct: 178 -HVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALA---LTVVCAAGAEPLPRNGD 233
Query: 685 KKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
           +       W     R G++  I         P V   +F E+    ++ D  RRPS   +
Sbjct: 234 Q-------WHE--IRQGRLPRI---------PQVLSQEFTELLKVMIHPDPERRPSAMAL 275
Query: 745 V 745
           V
Sbjct: 276 V 276

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 123/301 (40%), Gaps = 61/301 (20%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLN---PGS--QQGALEFQTEIGMLSQ 528
           T +F+ L  IG G FG+V+K     D    AIKR      GS  +Q AL       +L Q
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 529 LRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPW-DRRLK-ICIGAARA 586
             + H+V       +D  M++  +Y   G+L D +  N      + +  LK + +   R 
Sbjct: 68  --HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 587 LHYLHTGASKVIIHRDVKTTNILL--------------DEEWVAKVSDFGLCKFGPNFSK 632
           L Y+H   S  ++H D+K +NI +              +++W +    F +   G     
Sbjct: 126 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG----- 177
Query: 633 THVSTQVKGSIGYLDPEYYRLQLLTE------KSDVYSFGVVLLEVLCA--RPPILRTGD 684
            HV+      +   D  +   ++L E      K+D+++     L V+CA    P+ R GD
Sbjct: 178 -HVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALA---LTVVCAAGAEPLPRNGD 233
Query: 685 KKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
           +       W     R G++  I         P V   +F E+    ++ D  RRPS   +
Sbjct: 234 Q-------WHE--IRQGRLPRI---------PQVLSQEFTELLKVMIHPDPERRPSAMAL 275
Query: 745 V 745
           V
Sbjct: 276 V 276

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM----LSQLRYL 532
           + +  +IG G FG VY+  L      VAIK++    +    E Q    +    + +LRY 
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 100
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLR-DHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              S  G   D+  + LV DY+     R    Y+     LP            R+L Y+H
Sbjct: 101 FYSS--GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 158
Query: 592 TGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYLDP 648
           +     I HRD+K  N+LLD +  V K+ DFG  K             V+G  ++  +  
Sbjct: 159 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSXICS 204
Query: 649 EYYRLQLL-------TEKSDVYSFGVVLLEVLCARP 677
            YYR   L       T   DV+S G VL E+L  +P
Sbjct: 205 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 240

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           + ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + ++V L+   + + ++ LV+++++   L+  +  +    +P            + L + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYL 646
           H   S  ++HRD+K  N+L++ E   K++DFGL + FG P  +  H  V+   +     L
Sbjct: 123 H---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 179
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             +YY     +   D++S G +  E++  R
Sbjct: 180 GCKYY-----STAVDIWSLGCIFAEMVTRR 204

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           + ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYL 646
           H   S  ++HRD+K  N+L++ E   K++DFGL + FG P  +  H  V+   +     L
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 179
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             +YY     +   D++S G +  E++  R
Sbjct: 180 GCKYY-----STAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           + ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYL 646
           H   S  ++HRD+K  N+L++ E   K++DFGL + FG P  +  H  V+   +     L
Sbjct: 122 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 178
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             +YY     +   D++S G +  E++  R
Sbjct: 179 GCKYY-----STAVDIWSLGCIFAEMVTRR 203

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM----LSQLRYL 532
           + +  +IG G FG VY+  L      VAIK++    +    E Q    +    + +LRY 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 93
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLR-DHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              S  G   D+  + LV DY+     R    Y+     LP            R+L Y+H
Sbjct: 94  FYSS--GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 592 TGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYLDP 648
           +     I HRD+K  N+LLD +  V K+ DFG  K             V+G  ++  +  
Sbjct: 152 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSXICS 197
Query: 649 EYYRLQLL-------TEKSDVYSFGVVLLEVLCARP 677
            YYR   L       T   DV+S G VL E+L  +P
Sbjct: 198 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 233

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           + ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYL 646
           H   S  ++HRD+K  N+L++ E   K++DFGL + FG P  +  H  V+   +     L
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 176
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             +YY     +   D++S G +  E++  R
Sbjct: 177 GCKYY-----STAVDIWSLGCIFAEMVTRR 201

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           + ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYL 646
           H   S  ++HRD+K  N+L++ E   K++DFGL + FG P  +  H  V+   +     L
Sbjct: 122 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 178
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             +YY     +   D++S G +  E++  R
Sbjct: 179 GCKYY-----STAVDIWSLGCIFAEMVTRR 203

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           + ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYL 646
           H   S  ++HRD+K  N+L++ E   K++DFGL + FG P  +  H  V+   +     L
Sbjct: 121 H---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 177
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             +YY     +   D++S G +  E++  R
Sbjct: 178 GCKYY-----STAVDIWSLGCIFAEMVTRR 202

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           + ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYL 646
           H   S  ++HRD+K  N+L++ E   K++DFGL + FG P  +  H  V+   +     L
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 176
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             +YY     +   D++S G +  E++  R
Sbjct: 177 GCKYY-----STAVDIWSLGCIFAEMVTRR 201

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIK----RLNPGSQQGA--LEFQTEIGMLSQLRYLHLVS 536
           +G G F  V K    G     A K    R    S++G    E + E+ +L ++R+ ++++
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           L     +   ++L+ + ++ G L D L   ++  L  D   +        +HYLH   SK
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLH---SK 134
Query: 597 VIIHRDVKTTNILLDEEWV----AKVSDFGLCKFGPNFSKTHVSTQVKGSIG---YLDPE 649
            I H D+K  NI+L ++ V     K+ DFG+        K     + K   G   ++ PE
Sbjct: 135 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA------HKIEAGNEFKNIFGTPEFVAPE 188
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL 690
               + L  ++D++S GV+   +L    P L  G+ KQ  L
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFL--GETKQETL 227

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           + ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYL 646
           H   S  ++HRD+K  N+L++ E   K++DFGL + FG P  +  H  V+   +     L
Sbjct: 122 H---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 178
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             +YY     +   D++S G +  E++  R
Sbjct: 179 GCKYY-----STAVDIWSLGCIFAEMVTRR 203

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           + ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + ++V L+   + + ++ LV+++++   L+  +  +    +P            + L + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYL 646
           H   S  ++HRD+K  N+L++ E   K++DFGL + FG P  +  H  V+   +     L
Sbjct: 121 H---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 177
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             +YY     +   D++S G +  E++  R
Sbjct: 178 GCKYY-----STAVDIWSLGCIFAEMVTRR 202

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           + ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYL 646
           H   S  ++HRD+K  N+L++ E   K++DFGL + FG P  +  H  V+   +     L
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 176
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             +YY     +   D++S G +  E++  R
Sbjct: 177 GCKYY-----STAVDIWSLGCIFAEMVTRR 201

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 482 IIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLI 538
           ++G+G FG V   K  + G    V +       Q+   E    E+ +L QL + +++ L 
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV- 597
            +  D G   LV +    G L D + +         R+    + AAR +  + +G + + 
Sbjct: 116 EFFEDKGYFYLVGEVYTGGELFDEIIS---------RKRFSEVDAARIIRQVLSGITYMH 166
Query: 598 ---IIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPNFSKTH--VSTQVKGSIG---YL 646
              I+HRD+K  N+LL+   ++   ++ DFGL         TH   S ++K  IG   Y+
Sbjct: 167 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--------THFEASKKMKDKIGTAYYI 218
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            PE        EK DV+S GV+L  +L   PP
Sbjct: 219 APEVLH-GTYDEKCDVWSTGVILYILLSGCPP 249

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 100/234 (42%), Gaps = 49/234 (20%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIK-----RLNPGSQQGA---LEFQTEIGMLSQLRYLHL 534
           +G G  G V   F       VAI+     +   GS + A   L  +TEI +L +L +  +
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 216
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK--IC----IGAARALH 588
           + +  + + +   I V + M  G L D +  N        +RLK   C         A+ 
Sbjct: 217 IKIKNFFDAEDYYI-VLELMEGGELFDKVVGN--------KRLKEATCKLYFYQMLLAVQ 267
Query: 589 YLHTGASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
           YLH      IIHRD+K  N+LL   +E+ + K++DFG  K      +T +   + G+  Y
Sbjct: 268 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTY 321
Query: 646 LDPE---------YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL 690
           L PE         Y R        D +S GV+L   L   PP   +  + QV+L
Sbjct: 322 LAPEVLVSVGTAGYNR------AVDCWSLGVILFICLSGYPPF--SEHRTQVSL 367

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 111/242 (45%), Gaps = 36/242 (14%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKR-LNPGSQQG-ALEFQTEIGMLSQLRYLHL 534
           +  L  IG+G FG V+K         VA+K+ L    ++G  +    EI +L  L++ ++
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 535 VSLIGYCNDDGQ--------MILVYDYMAR---GTLRDHLYNNDNPPLPWDRRLKICIGA 583
           V+LI  C             + LV+D+      G L + L       +   R +++ +  
Sbjct: 80  VNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQMLLNG 137
Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVK 640
              L+Y+H      I+HRD+K  N+L+  + V K++DFGL +      N        +V 
Sbjct: 138 ---LYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV- 190
Query: 641 GSIGYLDPEYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWAT 695
            ++ Y  PE     LL E+      D++  G ++ E +  R PI++ G+ +Q  LA+ + 
Sbjct: 191 VTLWYRPPEL----LLGERDYGPPIDLWGAGCIMAE-MWTRSPIMQ-GNTEQHQLALISQ 244
Query: 696 EC 697
            C
Sbjct: 245 LC 246

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM----LSQLRYL 532
           + +  +IG G FG VY+  L      VAIK++    +    E Q    +    + +LRY 
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 89
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLR-DHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              S  G   D+  + LV DY+     R    Y+     LP            R+L Y+H
Sbjct: 90  FYSS--GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 147
Query: 592 TGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYLDP 648
           +     I HRD+K  N+LLD +  V K+ DFG  K             V+G  ++  +  
Sbjct: 148 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSXICS 193
Query: 649 EYYRLQLL-------TEKSDVYSFGVVLLEVLCARP 677
            YYR   L       T   DV+S G VL E+L  +P
Sbjct: 194 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 229

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM----LSQLRYL 532
           + +  +IG G FG VY+  L      VAIK++    +    E Q    +    + +LRY 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLR-DHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              S  G   D+  + LV DY+     R    Y+     LP            R+L Y+H
Sbjct: 82  FYSS--GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 592 TGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYLDP 648
           +     I HRD+K  N+LLD +  V K+ DFG  K             V+G  ++  +  
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSXICS 185
Query: 649 EYYRLQLL-------TEKSDVYSFGVVLLEVLCARP 677
            YYR   L       T   DV+S G VL E+L  +P
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 483 IGRGGFGNVYKGFLN--GD-----STPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV 535
           +G+G F  ++KG     GD      T V +K L+   +  +  F     M+S+L + HLV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNP-PLPWDRRLKICIGAARALHYLHTGA 594
              G C    + ILV +++  G+L  +L  N N   + W  +L++    A A+H+L    
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLE--- 130
Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNFSKTHVSTQV-KGSIGYLDPEYYR 652
              +IH +V   NILL  E   K  +    K   P  S T +   + +  I ++ PE   
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIE 190
Query: 653 ----LQLLTEKSDVYSFGVVLLEV 672
               L L T+K   +SFG  L E+
Sbjct: 191 NPKNLNLATDK---WSFGTTLWEI 211

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           + ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYL 646
           H   S  ++HRD+K  N+L++ E   K++DFGL + FG P  +  H  V+   +     L
Sbjct: 121 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 177
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             +YY     +   D++S G +  E++  R
Sbjct: 178 GCKYY-----STAVDIWSLGCIFAEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           + ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYL 646
           H   S  ++HRD+K  N+L++ E   K++DFGL + FG P  +  H  V+   +     L
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 179
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             +YY     +   D++S G +  E++  R
Sbjct: 180 GCKYY-----STAVDIWSLGCIFAEMVTRR 204

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 123/301 (40%), Gaps = 61/301 (20%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLN---PGS--QQGALEFQTEIGMLSQ 528
           T +F+ L  IG G FG+V+K     D    AIKR      GS  +Q AL       +L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 529 LRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPW-DRRLK-ICIGAARA 586
             + H+V       +D  M++  +Y   G+L D +  N      + +  LK + +   R 
Sbjct: 70  --HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 587 LHYLHTGASKVIIHRDVKTTNILL--------------DEEWVAKVSDFGLCKFGPNFSK 632
           L Y+H   S  ++H D+K +NI +              +++W +    F +   G     
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG----- 179
Query: 633 THVSTQVKGSIGYLDPEYYRLQLLTE------KSDVYSFGVVLLEVLCA--RPPILRTGD 684
            HV+      +   D  +   ++L E      K+D+++     L V+CA    P+ R GD
Sbjct: 180 -HVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALA---LTVVCAAGAEPLPRNGD 235
Query: 685 KKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
           +       W     R G++  I         P V   +F E+    ++ D  RRPS   +
Sbjct: 236 Q-------WHE--IRQGRLPRI---------PQVLSQEFTELLKVMIHPDPERRPSAMAL 277
Query: 745 V 745
           V
Sbjct: 278 V 278

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           + ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYL 646
           H   S  ++HRD+K  N+L++ E   K++DFGL + FG P  +  H  V+   +     L
Sbjct: 124 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 180
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             +YY     +   D++S G +  E++  R
Sbjct: 181 GCKYY-----STAVDIWSLGCIFAEMVTRR 205

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 482 IIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLI 538
           ++G+G FG V   K  + G    V +       Q+   E    E+ +L QL + +++ L 
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV- 597
            +  D G   LV +    G L D + +         R+    + AAR +  + +G + + 
Sbjct: 117 EFFEDKGYFYLVGEVYTGGELFDEIIS---------RKRFSEVDAARIIRQVLSGITYMH 167
Query: 598 ---IIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPNFSKTH--VSTQVKGSIG---YL 646
              I+HRD+K  N+LL+   ++   ++ DFGL         TH   S ++K  IG   Y+
Sbjct: 168 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--------THFEASKKMKDKIGTAYYI 219
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            PE        EK DV+S GV+L  +L   PP
Sbjct: 220 APEVLH-GTYDEKCDVWSTGVILYILLSGCPP 250

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM----LSQLRYL 532
           + +  +IG G FG VY+  L      VAIK++    +    E Q    +    + +LRY 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLR-DHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              S  G   D+  + LV DY+     R    Y+     LP            R+L Y+H
Sbjct: 82  FYSS--GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 592 TGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYLDP 648
           +     I HRD+K  N+LLD +  V K+ DFG  K             V+G  ++  +  
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSXICS 185
Query: 649 EYYRLQLL-------TEKSDVYSFGVVLLEVLCARP 677
            YYR   L       T   DV+S G VL E+L  +P
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIK----RLNPGSQQGA--LEFQTEIGMLSQLRYLHLVS 536
           +G G F  V K    G     A K    R    S++G    E + E+ +L ++R+ ++++
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           L     +   ++L+ + ++ G L D L   ++  L  D   +        +HYLH   SK
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLH---SK 127
Query: 597 VIIHRDVKTTNILLDEEWV----AKVSDFGLCKFGPNFSKTHVSTQVKGSIG---YLDPE 649
            I H D+K  NI+L ++ V     K+ DFG+        K     + K   G   ++ PE
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA------HKIEAGNEFKNIFGTPEFVAPE 181
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL 690
               + L  ++D++S GV+   +L    P L  G+ KQ  L
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSGASPFL--GETKQETL 220

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 482 IIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLI 538
           ++G+G FG V   K  + G    V +       Q+   E    E+ +L QL + +++ L 
Sbjct: 39  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV- 597
            +  D G   LV +    G L D + +         R+    + AAR +  + +G + + 
Sbjct: 99  EFFEDKGYFYLVGEVYTGGELFDEIIS---------RKRFSEVDAARIIRQVLSGITYMH 149
Query: 598 ---IIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPNFSKTH--VSTQVKGSIG---YL 646
              I+HRD+K  N+LL+   ++   ++ DFGL         TH   S ++K  IG   Y+
Sbjct: 150 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--------THFEASKKMKDKIGTAYYI 201
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            PE        EK DV+S GV+L  +L   PP
Sbjct: 202 APEVLH-GTYDEKCDVWSTGVILYILLSGCPP 232

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 24/205 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRL-----NPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           IG G +G V+K         VAIK+      +P  ++ AL    EI ML QL++ +LV+L
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR---EIRMLKQLKHPNLVNL 67
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
           +       ++ LV++Y     L  H  +     +P      I     +A+++ H      
Sbjct: 68  LEVFRRKRRLHLVFEYCDHTVL--HELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC-- 123
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKF--GP-NFSKTHVSTQVKGSIGYL--DPEYYR 652
            IHRDVK  NIL+ +  V K+ DFG  +   GP ++    V+T+   S   L  D +Y  
Sbjct: 124 -IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY-- 180
Query: 653 LQLLTEKSDVYSFGVVLLEVLCARP 677
                   DV++ G V  E+L   P
Sbjct: 181 ----GPPVDVWAIGCVFAELLSGVP 201

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM----LSQLRYL 532
           + +  +IG G FG VY+  L      VAIK++    +    E Q    +    + +LRY 
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 82
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLR-DHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              S  G   D+  + LV DY+     R    Y+     LP            R+L Y+H
Sbjct: 83  FYSS--GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 140
Query: 592 TGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYLDP 648
           +     I HRD+K  N+LLD +  V K+ DFG  K             V+G  ++  +  
Sbjct: 141 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSXICS 186
Query: 649 EYYRLQLL-------TEKSDVYSFGVVLLEVLCARP 677
            YYR   L       T   DV+S G VL E+L  +P
Sbjct: 187 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 222

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 100/219 (45%), Gaps = 23/219 (10%)
Query: 471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           +   +D   L  +G+G +G V++G   G++  VA+K  +   ++     +TE+     LR
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFR-ETELYNTVMLR 60
Query: 531 YLHLVSLIGY----CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARA 586
           + +++  I       +   Q+ L+  Y   G+L D+L       L     L+I +  A  
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASG 117
Query: 587 LHYLH-----TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF-GPNFSKTHVSTQVK 640
           L +LH     T     I HRD+K+ NIL+ +     ++D GL      + ++  V    +
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 641 -GSIGYLDPEYYRLQLLTE------KSDVYSFGVVLLEV 672
            G+  Y+ PE     +  +      + D+++FG+VL EV
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           + ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYL 646
           H   S  ++HRD+K  N+L++ E   K++DFGL + FG P  +  H  V+   +     L
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 179
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             +YY     +   D++S G +  E++  R
Sbjct: 180 GCKYY-----STAVDIWSLGCIFAEMVTRR 204

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 66/138 (47%), Gaps = 18/138 (13%)
Query: 549 LVYDYMARGTLRDHLYNNDNPPLPWDRR-LKICIGAARALHYLHTGASKVIIHRDVKTTN 607
           LV+D M +G L D+L           R+ ++  +    ALH L+      I+HRD+K  N
Sbjct: 101 LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPEN 154
Query: 608 ILLDEEWVAKVSDFGL-CKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL------LTEKS 660
           ILLD++   K++DFG  C+  P      V     G+  YL PE     +        ++ 
Sbjct: 155 ILLDDDMNIKLTDFGFSCQLDPGEKLRSVC----GTPSYLAPEIIECSMNDNHPGYGKEV 210
Query: 661 DVYSFGVVLLEVLCARPP 678
           D++S GV++  +L   PP
Sbjct: 211 DMWSTGVIMYTLLAGSPP 228

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 475 KDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL 532
           ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L + 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYLDP 648
             S  ++HRD+K  N+L++ E   K++DFGL + FG P  +  H  V+   +     L  
Sbjct: 120 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 177
Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           +YY     +   D++S G +  E++  R
Sbjct: 178 KYY-----STAVDIWSLGCIFAEMVTRR 200

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 475 KDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL 532
           ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L + 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYLDP 648
             S  ++HRD+K  N+L++ E   K++DFGL + FG P  +  H  V+   +     L  
Sbjct: 120 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 177
Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           +YY     +   D++S G +  E++  R
Sbjct: 178 KYY-----STAVDIWSLGCIFAEMVTRR 200

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 476 DFNNLLIIGRGGFGNVY--KGFLNGDSTPVAI---KRLNPGSQQGALEFQTEIGMLSQLR 530
           ++  L  IG+G F  V   +  L G    V I    +LN  S Q       E+ ++  L 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR---EVRIMKVLN 71
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDR-RLKICIGAARALHY 589
           + ++V L      +  + LV +Y + G + D+L  +        R + +  + A +  H 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH- 130
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
                 K I+HRD+K  N+LLD +   K++DFG   F   F+  +      G+  Y  PE
Sbjct: 131 -----QKFIVHRDLKAENLLLDADMNIKIADFG---FSNEFTFGNKLDAFCGAPPYAAPE 182
Query: 650 YYRLQLLT-EKSDVYSFGVVLLEVLCARPP 678
            ++ +     + DV+S GV+L  ++    P
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 475 KDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL 532
           ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L + 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 121
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYLDP 648
             S  ++HRD+K  N+L++ E   K++DFGL + FG P  +  H  V+   +     L  
Sbjct: 122 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 179
Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           +YY     +   D++S G +  E++  R
Sbjct: 180 KYY-----STAVDIWSLGCIFAEMVTRR 202

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM----LSQLRYL 532
           + +  +IG G FG VY+  L      VAIK++    +    E Q    +    + +LRY 
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 85
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLR-DHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              S  G   D+  + LV DY+     R    Y+     LP            R+L Y+H
Sbjct: 86  FYSS--GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 143
Query: 592 TGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYLDP 648
           +     I HRD+K  N+LLD +  V K+ DFG  K             V+G  ++  +  
Sbjct: 144 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSXICS 189
Query: 649 EYYRLQLL-------TEKSDVYSFGVVLLEVLCARP 677
            YYR   L       T   DV+S G VL E+L  +P
Sbjct: 190 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 225

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 29/209 (13%)
Query: 483 IGRGGFGNVY--KGFLNGDSTPVAIKR---LNPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G +G V   K  L G    + I +   +   S  GAL    E+ +L QL + +++ L
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGAL--LDEVAVLKQLDHPNIMKL 69
Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKIC-IGAARALHYLHTGASK 596
             +  D     LV +    G L D +            R K   + AA  +  + +G + 
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEII----------LRQKFSEVDAAVIMKQVLSGTTY 119
Query: 597 V----IIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           +    I+HRD+K  N+LL+    + + K+ DFGL     +F       +  G+  Y+ PE
Sbjct: 120 LHKHNIVHRDLKPENLLLESKSRDALIKIVDFGL---SAHFEVGGKMKERLGTAYYIAPE 176
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
             R +   EK DV+S GV+L  +LC  PP
Sbjct: 177 VLRKKY-DEKCDVWSCGVILYILLCGYPP 204

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 476 DFNNLLIIGRGGFGNVY--KGFLNGDSTPVAI---KRLNPGSQQGALEFQTEIGMLSQLR 530
           ++  L  IG+G F  V   +  L G    + I    +LNP S Q       E+ ++  L 
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR---EVRIMKILN 72
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDR-RLKICIGAARALHY 589
           + ++V L      +  + L+ +Y + G + D+L  +        R + +  + A +  H 
Sbjct: 73  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH- 131
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
                 K I+HRD+K  N+LLD +   K++DFG   F   F+         G+  Y  PE
Sbjct: 132 -----QKRIVHRDLKAENLLLDADMNIKIADFG---FSNEFTVGGKLDAFCGAPPYAAPE 183
Query: 650 YYRLQLLT-EKSDVYSFGVVLLEVLCARPP 678
            ++ +     + DV+S GV+L  ++    P
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIK----RLNPGSQQGA--LEFQTEIGMLSQLRYLHLVS 536
           +G G F  V K    G     A K    R    S++G    E + E+ +L ++R+ ++++
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           L     +   ++L+ + ++ G L D L   ++  L  D   +        +HYLH   SK
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLH---SK 148
Query: 597 VIIHRDVKTTNILLDEEWV----AKVSDFGLCKFGPNFSKTHVSTQVKGSIG---YLDPE 649
            I H D+K  NI+L ++ V     K+ DFG+        K     + K   G   ++ PE
Sbjct: 149 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA------HKIEAGNEFKNIFGTPEFVAPE 202
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL 690
               + L  ++D++S GV+   +L    P L  G+ KQ  L
Sbjct: 203 IVNYEPLGLEADMWSIGVITYILLSGASPFL--GETKQETL 241

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 122/299 (40%), Gaps = 57/299 (19%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLN---PGS--QQGALEFQTEIGMLSQ 528
           T +F+ L  IG G FG+V+K     D    AIKR      GS  +Q AL       +L Q
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 65
Query: 529 LRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPW-DRRLK-ICIGAARA 586
             + H+V       +D  M++  +Y   G+L D +  N      + +  LK + +   R 
Sbjct: 66  --HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 123
Query: 587 LHYLHTGASKVIIHRDVKTTNILL--------------DEEWVAKVSDFGLCKFGPNFSK 632
           L Y+H   S  ++H D+K +NI +              +++W +    F +   G     
Sbjct: 124 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG----- 175
Query: 633 THVSTQVKGSIGYLDPEYYRLQLLTE------KSDVYSFGVVLLEVLCARPPILRTGDKK 686
            HV+      +   D  +   ++L E      K+D+++  + ++    A  P+ R GD+ 
Sbjct: 176 -HVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVXAAGAE-PLPRNGDQ- 232
Query: 687 QVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
                 W     R G++  I         P V   +F E+    ++ D  RRPS   +V
Sbjct: 233 ------WHE--IRQGRLPRI---------PQVLSQEFTELLKVMIHPDPERRPSAMALV 274

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 74/163 (45%), Gaps = 18/163 (11%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV 535
           DF  + ++G+G FG V K     DS   AIK++   +++      +E+ +L+ L + ++V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNHQYVV 65
Query: 536 SLIGY-------------CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
                                   + +  +Y    TL D L +++N     D   ++   
Sbjct: 66  RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYD-LIHSENLNQQRDEYWRLFRQ 124
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK 625
              AL Y+H   S+ IIHR++K  NI +DE    K+ DFGL K
Sbjct: 125 ILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 23/207 (11%)
Query: 482 IIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLI 538
           ++G+G FG V   K  + G    V +       Q+   E    E+ +L QL + ++  L 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS--- 595
            +  D G   LV +    G L D + +         R+    + AAR +  + +G +   
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIIS---------RKRFSEVDAARIIRQVLSGITYXH 143
Query: 596 -KVIIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
              I+HRD+K  N+LL+   ++   ++ DFGL     +F  +       G+  Y+ PE  
Sbjct: 144 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKXKDKIGTAYYIAPEVL 200
Query: 652 RLQLLTEKSDVYSFGVVLLEVLCARPP 678
                 EK DV+S GV+L  +L   PP
Sbjct: 201 H-GTYDEKCDVWSTGVILYILLSGCPP 226

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 22/195 (11%)
Query: 506 KRLNPGSQQGA--LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL 563
           KR    S++G    + + E+ +L ++++ ++++L     +   +IL+ + +A G L D L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 564 YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV----AKVS 619
              ++  L  +   +        ++YLH   S  I H D+K  NI+L +  V     K+ 
Sbjct: 106 AEKES--LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII 160
Query: 620 DFGLCK---FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           DFGL     FG  F        + G+  ++ PE    + L  ++D++S GV+   +L   
Sbjct: 161 DFGLAHKIDFGNEFK------NIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214
Query: 677 PPILRTGDKKQVNLA 691
            P L  GD KQ  LA
Sbjct: 215 SPFL--GDTKQETLA 227

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 476 DFNNLLIIGRGGFGNVY--KGFLNGDSTPVAI---KRLNPGSQQGALEFQTEIGMLSQLR 530
           ++  L  IG+G F  V   +  L G    V I    +LN  S Q       E+ ++  L 
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR---EVRIMKVLN 64
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDR-RLKICIGAARALHY 589
           + ++V L      +  + LV +Y + G + D+L  +        R + +  + A +  H 
Sbjct: 65  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCH- 123
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
                 K I+HRD+K  N+LLD +   K++DFG   F   F+  +      GS  Y  PE
Sbjct: 124 -----QKFIVHRDLKAENLLLDADMNIKIADFG---FSNEFTFGNKLDTFCGSPPYAAPE 175
Query: 650 YYRLQLLT-EKSDVYSFGVVLLEVLCARPP 678
            ++ +     + DV+S GV+L  ++    P
Sbjct: 176 LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 205

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 14/215 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ-GALEFQTEIGMLSQLRYL 532
           + DF    ++G G +G V           VAIK++ P  +   AL    EI +L   ++ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICI-GAARALHYLH 591
           +++++      D        Y+ +  ++  L+   +  +  D  ++  I    RA+  LH
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS--KTHVSTQVKGSIGYLDPE 649
            G++  +IHRD+K +N+L++     KV DFGL +     +   +  + Q  G + ++   
Sbjct: 130 -GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 650 YYR---LQLLTEK----SDVYSFGVVLLEVLCARP 677
           +YR   + L + K     DV+S G +L E+   RP
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 473 ATKDFNNLLIIGRGGFGNVYKGF--LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           + ++F  +  IG G +G VYK    L G+   +   RL+  ++        EI +L +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH--VSTQVKGSIGYL 646
           H   S  ++HRD+K  N+L++ E   K++DFGL + FG P  +  H  V+   +     L
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 179
Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             +YY     +   D++S G +  E++  R
Sbjct: 180 GCKYY-----STAVDIWSLGCIFAEMVTRR 204

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ-GALEFQTEIGMLSQLRYL 532
           + DF    ++G G +G V           VAIK++ P  +   AL    EI +L   ++ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICI-GAARALHYLH 591
           +++++      D        Y+ +  ++  L+   +  +  D  ++  I    RA+  LH
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS--KTHVSTQVKGSIGYLDPE 649
            G++  +IHRD+K +N+L++     KV DFGL +     +   +  + Q  G   Y+   
Sbjct: 130 -GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATR 186
Query: 650 YYR---LQLLTEK----SDVYSFGVVLLEVLCARP 677
           +YR   + L + K     DV+S G +L E+   RP
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 22/195 (11%)
Query: 506 KRLNPGSQQGA--LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL 563
           KR    S++G    + + E+ +L ++++ ++++L     +   +IL+ + +A G L D L
Sbjct: 45  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 104
Query: 564 YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV----AKVS 619
              ++  L  +   +        ++YLH   S  I H D+K  NI+L +  V     K+ 
Sbjct: 105 AEKES--LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII 159
Query: 620 DFGLCK---FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           DFGL     FG  F        + G+  ++ PE    + L  ++D++S GV+   +L   
Sbjct: 160 DFGLAHKIDFGNEFK------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213
Query: 677 PPILRTGDKKQVNLA 691
            P L  GD KQ  LA
Sbjct: 214 SPFL--GDTKQETLA 226

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 87/214 (40%), Gaps = 27/214 (12%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQ-TEIGMLSQLRYLH 533
           F  +  IG G FG V   K    G+   + I       +   +E    E  +L  + +  
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           LV L     D+  + +V +YM  G +  HL        P  R     I       YLH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH-- 158
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DPEYY 651
            S  +I+RD+K  N+L+D++   KV+DFG  K            +VKG    L   PEY 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIKVADFGFAK------------RVKGRTWXLCGTPEYL 205
Query: 652 RLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
             +++  K      D ++ GV++ E+    PP  
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 87/214 (40%), Gaps = 27/214 (12%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQ-TEIGMLSQLRYLH 533
           F  +  IG G FG V   K    G+   + I       +   +E    E  +L  + +  
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           LV L     D+  + +V +YM  G +  HL        P  R     I       YLH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH-- 158
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DPEYY 651
            S  +I+RD+K  N+L+D++   KV+DFG  K            +VKG    L   PEY 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIKVADFGFAK------------RVKGRTWXLCGTPEYL 205
Query: 652 RLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
             +++  K      D ++ GV++ E+    PP  
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 22/195 (11%)
Query: 506 KRLNPGSQQGA--LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL 563
           KR    S++G    + + E+ +L ++++ ++++L     +   +IL+ + +A G L D L
Sbjct: 45  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 104
Query: 564 YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV----AKVS 619
              ++  L  +   +        ++YLH   S  I H D+K  NI+L +  V     K+ 
Sbjct: 105 AEKES--LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII 159
Query: 620 DFGLCK---FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           DFGL     FG  F        + G+  ++ PE    + L  ++D++S GV+   +L   
Sbjct: 160 DFGLAHKIDFGNEFK------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213
Query: 677 PPILRTGDKKQVNLA 691
            P L  GD KQ  LA
Sbjct: 214 SPFL--GDTKQETLA 226

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 19/210 (9%)
Query: 476 DFNNLLIIGRGGFGNVY--KGFLNGDSTPVAI---KRLNPGSQQGALEFQTEIGMLSQLR 530
           ++  L  IG+G F  V   +  L G    V I    +LN  S Q       E+ +   L 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR---EVRIXKVLN 71
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDR-RLKICIGAARALHY 589
           + ++V L      +  + LV +Y + G + D+L  +        R + +  + A +  H 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCH- 130
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
                 K I+HRD+K  N+LLD +   K++DFG   F   F+  +      G+  Y  PE
Sbjct: 131 -----QKFIVHRDLKAENLLLDADXNIKIADFG---FSNEFTFGNKLDAFCGAPPYAAPE 182
Query: 650 YYRLQLLT-EKSDVYSFGVVLLEVLCARPP 678
            ++ +     + DV+S GV+L  ++    P
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 22/195 (11%)
Query: 506 KRLNPGSQQGA--LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL 563
           KR    S++G    + + E+ +L ++++ ++++L     +   +IL+ + +A G L D L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 564 YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV----AKVS 619
              ++  L  +   +        ++YLH   S  I H D+K  NI+L +  V     K+ 
Sbjct: 106 AEKES--LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII 160
Query: 620 DFGLCK---FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           DFGL     FG  F        + G+  ++ PE    + L  ++D++S GV+   +L   
Sbjct: 161 DFGLAHKIDFGNEFK------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214
Query: 677 PPILRTGDKKQVNLA 691
            P L  GD KQ  LA
Sbjct: 215 SPFL--GDTKQETLA 227

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 22/195 (11%)
Query: 506 KRLNPGSQQGA--LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL 563
           KR    S++G    + + E+ +L ++++ ++++L     +   +IL+ + +A G L D L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 564 YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV----AKVS 619
              ++  L  +   +        ++YLH   S  I H D+K  NI+L +  V     K+ 
Sbjct: 106 AEKES--LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII 160
Query: 620 DFGLCK---FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           DFGL     FG  F        + G+  ++ PE    + L  ++D++S GV+   +L   
Sbjct: 161 DFGLAHKIDFGNEFK------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214
Query: 677 PPILRTGDKKQVNLA 691
            P L  GD KQ  LA
Sbjct: 215 SPFL--GDTKQETLA 227

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 22/195 (11%)
Query: 506 KRLNPGSQQGA--LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL 563
           KR    S++G    + + E+ +L ++++ ++++L     +   +IL+ + +A G L D L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 564 YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV----AKVS 619
              ++  L  +   +        ++YLH   S  I H D+K  NI+L +  V     K+ 
Sbjct: 106 AEKES--LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII 160
Query: 620 DFGLCK---FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           DFGL     FG  F        + G+  ++ PE    + L  ++D++S GV+   +L   
Sbjct: 161 DFGLAHKIDFGNEFK------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214
Query: 677 PPILRTGDKKQVNLA 691
            P L  GD KQ  LA
Sbjct: 215 SPFL--GDTKQETLA 227

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 22/195 (11%)
Query: 506 KRLNPGSQQGA--LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL 563
           KR    S++G    + + E+ +L ++++ ++++L     +   +IL+ + +A G L D L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 564 YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV----AKVS 619
              ++  L  +   +        ++YLH   S  I H D+K  NI+L +  V     K+ 
Sbjct: 106 AEKES--LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII 160
Query: 620 DFGLCK---FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           DFGL     FG  F        + G+  ++ PE    + L  ++D++S GV+   +L   
Sbjct: 161 DFGLAHKIDFGNEFK------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214
Query: 677 PPILRTGDKKQVNLA 691
            P L  GD KQ  LA
Sbjct: 215 SPFL--GDTKQETLA 227

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 22/195 (11%)
Query: 506 KRLNPGSQQGA--LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL 563
           KR    S++G    + + E+ +L ++++ ++++L     +   +IL+ + +A G L D L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 564 YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV----AKVS 619
              ++  L  +   +        ++YLH   S  I H D+K  NI+L +  V     K+ 
Sbjct: 106 AEKES--LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII 160
Query: 620 DFGLCK---FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           DFGL     FG  F        + G+  ++ PE    + L  ++D++S GV+   +L   
Sbjct: 161 DFGLAHKIDFGNEFK------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214
Query: 677 PPILRTGDKKQVNLA 691
            P L  GD KQ  LA
Sbjct: 215 SPFL--GDTKQETLA 227

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F+ +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 30  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 86
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+A G +  HL        P  R     I       YL
Sbjct: 87  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 144
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+DE+   +V+DFG  K            +VKG    L   P
Sbjct: 145 H---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAK------------RVKGRTWXLCGTP 189
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 190 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 226

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 22/195 (11%)
Query: 506 KRLNPGSQQGA--LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL 563
           KR    S++G    + + E+ +L ++++ ++++L     +   +IL+ + +A G L D L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 564 YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV----AKVS 619
              ++  L  +   +        ++YLH   S  I H D+K  NI+L +  V     K+ 
Sbjct: 106 AEKES--LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII 160
Query: 620 DFGLCK---FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           DFGL     FG  F        + G+  ++ PE    + L  ++D++S GV+   +L   
Sbjct: 161 DFGLAHKIDFGNEFK------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214
Query: 677 PPILRTGDKKQVNLA 691
            P L  GD KQ  LA
Sbjct: 215 SPFL--GDTKQETLA 227

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 22/195 (11%)
Query: 506 KRLNPGSQQGA--LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL 563
           KR    S++G    + + E+ +L ++++ ++++L     +   +IL+ + +A G L D L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 564 YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV----AKVS 619
              ++  L  +   +        ++YLH   S  I H D+K  NI+L +  V     K+ 
Sbjct: 106 AEKES--LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII 160
Query: 620 DFGLCK---FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           DFGL     FG  F        + G+  ++ PE    + L  ++D++S GV+   +L   
Sbjct: 161 DFGLAHKIDFGNEFK------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214
Query: 677 PPILRTGDKKQVNLA 691
            P L  GD KQ  LA
Sbjct: 215 SPFL--GDTKQETLA 227

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 19/210 (9%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F+ +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 120
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+A G +  HL        P  R     I       YL
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 178
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
           H   S  +I+RD+K  N+L+D++   +V+DFG  K     + T     + G+  YL PE 
Sbjct: 179 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT-----LCGTPEYLAPEI 230
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPIL 680
              +   +  D ++ GV++ E+    PP  
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 22/195 (11%)
Query: 506 KRLNPGSQQGA--LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL 563
           KR    S++G    + + E+ +L ++++ ++++L     +   +IL+ + +A G L D L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 564 YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV----AKVS 619
              ++  L  +   +        ++YLH   S  I H D+K  NI+L +  V     K+ 
Sbjct: 106 AEKES--LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII 160
Query: 620 DFGLCK---FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           DFGL     FG  F        + G+  ++ PE    + L  ++D++S GV+   +L   
Sbjct: 161 DFGLAHKIDFGNEFK------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214
Query: 677 PPILRTGDKKQVNLA 691
            P L  GD KQ  LA
Sbjct: 215 SPFL--GDTKQETLA 227

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 89/218 (40%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 534 LVSLIGYCNDDGQMILVYDYM-----------ARGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+ + M            RG L++ L  +      W         
Sbjct: 75  VIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARS----FFWQ-------- 122
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 123 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 175
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 176 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 213

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 22/195 (11%)
Query: 506 KRLNPGSQQGA--LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL 563
           KR    S++G    + + E+ +L ++++ ++++L     +   +IL+ + +A G L D L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 564 YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV----AKVS 619
              ++  L  +   +        ++YLH   S  I H D+K  NI+L +  V     K+ 
Sbjct: 106 AEKES--LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII 160
Query: 620 DFGLCK---FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           DFGL     FG  F        + G+  ++ PE    + L  ++D++S GV+   +L   
Sbjct: 161 DFGLAHKIDFGNEFK------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214
Query: 677 PPILRTGDKKQVNLA 691
            P L  GD KQ  LA
Sbjct: 215 SPFL--GDTKQETLA 227

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 90/216 (41%), Gaps = 31/216 (14%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM----LSQLRYL 532
           + +  +IG G FG VY+  L      VAIK++    +    E Q    +    + +LRY 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLR-DHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              S  G   D   + LV DY+     R    Y+     LP            R+L Y+H
Sbjct: 82  FYSS--GEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 592 TGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKG--SIGYLDP 648
           +     I HRD+K  N+LLD +  V K+ DFG  K             V+G  ++  +  
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGEPNVSXICS 185
Query: 649 EYYRLQLL-------TEKSDVYSFGVVLLEVLCARP 677
            YYR   L       T   DV+S G VL E+L  +P
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 19/210 (9%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F+ +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+A G +  HL        P  R     I       YL
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 157
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
           H   S  +I+RD+K  N+L+D++   +V+DFG  K          +  + G+  YL PE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLXGTPEYLAPEI 209
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPIL 680
              +   +  D ++ GV++ E+    PP  
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 19/210 (9%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F+ +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+A G +  HL        P  R     I       YL
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 157
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
           H   S  +I+RD+K  N+L+D++   +V+DFG  K          +  + G+  YL PE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLAGTPEYLAPEI 209
Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPIL 680
              +   +  D ++ GV++ E+    PP  
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 22/195 (11%)
Query: 506 KRLNPGSQQGA--LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL 563
           KR    S++G    + + E+ +L ++++ ++++L     +   +IL+ + +A G L D L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 564 YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV----AKVS 619
              ++  L  +   +        ++YLH   S  I H D+K  NI+L +  V     K+ 
Sbjct: 106 AEKES--LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII 160
Query: 620 DFGLCK---FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           DFGL     FG  F        + G+  ++ PE    + L  ++D++S GV+   +L   
Sbjct: 161 DFGLAHKIDFGNEFK------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214
Query: 677 PPILRTGDKKQVNLA 691
            P L  GD KQ  LA
Sbjct: 215 SPFL--GDTKQETLA 227

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 22/195 (11%)
Query: 506 KRLNPGSQQGA--LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL 563
           KR    S++G    + + E+ +L ++++ ++++L     +   +IL+ + +A G L D L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL 105
Query: 564 YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV----AKVS 619
              ++  L  +   +        ++YLH   S  I H D+K  NI+L +  V     K+ 
Sbjct: 106 AEKES--LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII 160
Query: 620 DFGLCK---FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           DFGL     FG  F        + G+  ++ PE    + L  ++D++S GV+   +L   
Sbjct: 161 DFGLAHKIDFGNEFK------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214
Query: 677 PPILRTGDKKQVNLA 691
            P L  GD KQ  LA
Sbjct: 215 SPFL--GDTKQETLA 227

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F+ +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+A G +  HL        P  R     I       YL
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 157
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 202
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F+ +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 44  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 100
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+A G +  HL        P  R     I       YL
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 158
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 159 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 203
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F+ +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+A G +  HL        P  R     I       YL
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 157
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 202
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F+ +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+A G +  HL        P  R     I       YL
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 157
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 202
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           +   +    L  +G+G +G V++G   G++  VA+K  +   ++     +TE+     LR
Sbjct: 33  RTVARQITLLECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFR-ETELYNTVMLR 89
Query: 531 YLHLVSLIGY----CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARA 586
           + +++  I       +   Q+ L+  Y   G+L D+L       L     L+I +  A  
Sbjct: 90  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASG 146
Query: 587 LHYLH-----TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF-GPNFSKTHVSTQVK 640
           L +LH     T     I HRD+K+ NIL+ +     ++D GL      + ++  V    +
Sbjct: 147 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 206
Query: 641 -GSIGYLDPEYYRLQLLTE------KSDVYSFGVVLLEV 672
            G+  Y+ PE     +  +      + D+++FG+VL EV
Sbjct: 207 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F+ +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+A G +  HL        P  R     I       YL
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 157
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 202
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F+ +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+A G +  HL        P  R     I       YL
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQI--VLTFEYL 157
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 202
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F+ +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+A G +  HL        P  R     I       YL
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 157
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 202
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F+ +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+A G +  HL        P  R     I       YL
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYL 157
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 202
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F+ +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 120
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+A G +  HL        P  R     I       YL
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYL 178
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 179 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 223
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 224 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 480 LLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           L  +G+G +G V++G   G++  VA+K  +   ++     +TE+     LR+ +++  I 
Sbjct: 13  LECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIA 69
Query: 540 Y----CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH---- 591
                 +   Q+ L+  Y   G+L D+L       L     L+I +  A  L +LH    
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 592 -TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF-GPNFSKTHVSTQVK-GSIGYLDP 648
            T     I HRD+K+ NIL+ +     ++D GL      + ++  V    + G+  Y+ P
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 649 EYYRLQLLTE------KSDVYSFGVVLLEV 672
           E     +  +      + D+++FG+VL EV
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  IG G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 22  IWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 142 GLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 123
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 124 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 176
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 214

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 22/228 (9%)
Query: 471 KEATKDFNNLLIIGRGGFGNVY--KGFLNGDSTPV-AIKRLNPGS----QQGALEFQTEI 523
           K   ++F  L ++G G +G V+  +     D+  + A+K L   +     +     +TE 
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 524 GMLSQLRYLHLVSLIGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
            +L  +R    +  + Y    + ++ L+ DY+  G L  HL   +      +  ++I +G
Sbjct: 110 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT---EHEVQIYVG 166
Query: 583 A-ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF--SKTHVSTQV 639
               AL +LH      II+RD+K  NILLD      ++DFGL K    F   +T  +   
Sbjct: 167 EIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK---EFVADETERAYDF 220
Query: 640 KGSIGYLDPEYYR--LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDK 685
            G+I Y+ P+  R       +  D +S GV++ E+L    P    G+K
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 268

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F+ +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+A G +  HL        P  R     I       YL
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 157
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+++D++   +V+DFG  K            +VKG    L   P
Sbjct: 158 H---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 202
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 203 EYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 123
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 124 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 176
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 214

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLK 88
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 148
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 149 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 200
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F+ +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+A G +  HL        P  R     I       YL
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYL 157
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 202
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 98/230 (42%), Gaps = 13/230 (5%)
Query: 452 GPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG 511
           GP S        Q     I E  + + NL  +G G +G+V   F       VA+K+L+  
Sbjct: 1   GPMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 60
Query: 512 SQQ--GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDN 568
            Q    A     E+ +L  +++ +++ L+        +    D Y+    +   L N   
Sbjct: 61  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 120
Query: 569 PPLPWDRRLKICI-GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG 627
                D  ++  I    R L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +  
Sbjct: 121 CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 177
Query: 628 PNFSKTHVSTQVKGSIGYLDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
            +    +V+T+      Y  PE         +  D++S G ++ E+L  R
Sbjct: 178 DDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLN--PGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           +IG+G FG VY G  +G+   VAI+ ++    ++     F+ E+    Q R+ ++V  +G
Sbjct: 40  LIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
            C     + ++   + +G     +  +    L  ++  +I     + + YLH   +K I+
Sbjct: 97  ACMSPPHLAIITS-LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGIL 152
Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK---GSIGYLDPEYYRLQL- 655
           H+D+K+ N+  D   V  ++DFGL              +++   G + +L PE  R QL 
Sbjct: 153 HKDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR-QLS 210
Query: 656 ---------LTEKSDVYSFGVVLLEVLCARPP 678
                     ++ SDV++ G +  E+     P
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 123
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 124 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 176
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 214

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILR 136
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 144 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WY 195
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 27/214 (12%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQ-TEIGMLSQLRYLH 533
           F  +  IG G FG V   K    G+   + I       +   +E    E  +L  + +  
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           LV L     D+  + +V +Y+  G +  HL        P  R     I       YLH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH-- 158
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DPEYY 651
            S  +I+RD+K  N+L+D++   KV+DFG  K            +VKG    L   PEY 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIKVADFGFAK------------RVKGRTWXLCGTPEYL 205
Query: 652 RLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
             +++  K      D ++ GV++ E+    PP  
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 137
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 138 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 190
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 228

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W       + 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-----VLE 121
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
           A R  H      +  ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 122 AVRHCH------NXGVLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 171
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F+ +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+A G +  HL        P  R     I       YL
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYL 157
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 202
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 27  IWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 86
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 87  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 146
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 147 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 198
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 199 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 75  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 122
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 123 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 175
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 176 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 213

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 137
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 138 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 190
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 228

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILR 136
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 138
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 139 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 191
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 229

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F+ +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 38  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 94
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+A G +  HL        P  R     I       YL
Sbjct: 95  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYL 152
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 153 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 197
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 198 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 234

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIG 644
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+  +    
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEI 193
Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
            L+  +Y      +  D++S G ++ E+L  R
Sbjct: 194 MLNAMHY-----NQTVDIWSVGCIMAELLTGR 220

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 144 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WY 195
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 138
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 139 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 191
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 229

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 27/214 (12%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQ-TEIGMLSQLRYLH 533
           F  +  +G G FG V   K    G+   + I       +   +E    E  +L  + +  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           LV L     D+  + +V +Y+A G +  HL        P  R     I       YLH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH-- 158
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DPEYY 651
            S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   PEY 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTPEYL 205
Query: 652 RLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
             +++  K      D ++ GV++ E+    PP  
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 9/198 (4%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V++          A K +    +      + EI  +S LR+  LV+L     
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           DD +M+++Y++M+ G L + + +  N  +  D  ++      + L ++H       +H D
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN---YVHLD 280
Query: 603 VKTTNILLDEEWV--AKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKS 660
           +K  NI+   +     K+ DFGL           V+T   G+  +  PE    + +   +
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYT 337
Query: 661 DVYSFGVVLLEVLCARPP 678
           D++S GV+   +L    P
Sbjct: 338 DMWSVGVLSYILLSGLSP 355

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 74  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 121
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 122 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 174
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 175 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 212

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 40  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 99
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 100 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 159
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 160 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR-----WY 211
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 150
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 151 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 203
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 148
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 149 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 200
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 139 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 190
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 144 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WY 195
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 148
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 149 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 200
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 151
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 152 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 204
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 15  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 74
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 75  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 134
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 135 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 186
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 139 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 190
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 165
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 166 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 218
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 256

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 151
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 152 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 204
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 150
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 151 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 203
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 151
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 152 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 204
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 138
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 139 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 191
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 229

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILR 132
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 133 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 151
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 152 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 204
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 144 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 195
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 150
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 151 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 203
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 9/198 (4%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V++          A K +    +      + EI  +S LR+  LV+L     
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 118
Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
           DD +M+++Y++M+ G L + + +  N  +  D  ++      + L ++H       +H D
Sbjct: 119 DDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN---YVHLD 174
Query: 603 VKTTNILLDEEWV--AKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKS 660
           +K  NI+   +     K+ DFGL           V+T   G+  +  PE    + +   +
Sbjct: 175 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYT 231
Query: 661 DVYSFGVVLLEVLCARPP 678
           D++S GV+   +L    P
Sbjct: 232 DMWSVGVLSYILLSGLSP 249

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 142 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 16  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 75
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 76  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 135
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 136 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 187
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 188 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 118
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 119 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 171
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 142 GLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 118
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 119 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 171
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 133 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 165
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 166 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 218
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 256

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 36  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 95
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 96  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 155
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 156 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 207
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 74  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 133
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 134 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 185
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 150
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 151 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 203
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 74  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 133
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 134 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 185
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 156
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 157 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 208
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 142 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 87
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 88  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 147
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 148 GLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 199
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 157
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 158 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 210
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 133 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG- 644
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +        H   ++ G +  
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMTGXVAT 185
Query: 645 --YLDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             Y  PE         +  D++S G ++ E+L  R
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 38  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 97
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 98  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 145
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 146 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 198
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 199 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 236

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 87
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 88  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 147
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 148 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 199
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 36  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 95
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 96  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 155
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 156 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 207
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 143 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 194
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F+ +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+A G +  HL        P  R     I       YL
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 157
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 202
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY    ++  K      D ++ GV++ E+    PP  
Sbjct: 203 EYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 27/217 (12%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-YLHLVSLIGY 540
           ++G G +  V       +    A+K +   +         E+  L Q +   +++ LI +
Sbjct: 20  LLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEF 79
Query: 541 CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL--KICIGAARALHYLHTGASKVI 598
             DD +  LV++ +  G++  H+    +    ++ R   ++    A AL +LHT   K I
Sbjct: 80  FEDDTRFYLVFEKLQGGSILAHIQKQKH----FNEREASRVVRDVAAALDFLHT---KGI 132
Query: 599 IHRDVKTTNILLDEEWVAKVSDFGLCKF--GPNFSKTHVSTQVK--------GSIGYLDP 648
            HRD+K  NIL   E   KVS   +C F  G      +  T +         GS  Y+ P
Sbjct: 133 AHRDLKPENILC--ESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAP 190
Query: 649 EYYRL-----QLLTEKSDVYSFGVVLLEVLCARPPIL 680
           E   +         ++ D++S GVVL  +L   PP +
Sbjct: 191 EVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFV 227

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 156
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 157 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 208
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 23/168 (13%)
Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVK 640
           AR + +L   +S+  IHRD+   NILL E  V K+ DFGL +     P++ +       +
Sbjct: 209 ARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVR---KGDTR 262
Query: 641 GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRN 700
             + ++ PE    ++ + KSDV+S+GV+L E       I   G      + +    C R 
Sbjct: 263 LPLKWMAPESIFDKIYSTKSDVWSYGVLLWE-------IFSLGGSPYPGVQMDEDFCSR- 314
Query: 701 GKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGL 748
                 +   ++  AP     +  ++ + C + D   RP  +++V  L
Sbjct: 315 ------LREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 40  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 99
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 100 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 159
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 160 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 211
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 156
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG- 644
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +        H   ++ G +  
Sbjct: 157 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMXGXVAT 205
Query: 645 --YLDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             Y  PE         +  D++S G ++ E+L  R
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 143 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 194
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLR--YLH 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++   +  
Sbjct: 63  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 122
Query: 534 LVSLIGYCNDDGQMILV----------YDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIG 582
           ++ L+ +       +L+          +D++  RG L++ L  +      W         
Sbjct: 123 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFWQ-------- 170
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKG 641
              A+ + H      ++HRD+K  NIL+D        +  L  FG     K  V T   G
Sbjct: 171 VLEAVRHCHNCG---VLHRDIKDENILID----LNRGELKLIDFGSGALLKDTVYTDFDG 223
Query: 642 SIGYLDPEYYRLQLLTEKS-DVYSFGVVLLEVLCARPP 678
           +  Y  PE+ R      +S  V+S G++L +++C   P
Sbjct: 224 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 261

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F+ +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+A G +  HL        P  R     I       YL
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 157
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 202
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ ++    PP  
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFF 239

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 139 GLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WY 190
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 483 IGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGY 540
           +G G +G V   +  +      + I R    S     +   E+ +L  L + +++ L  +
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 541 CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKIC-IGAARALHYLHTGASKV-- 597
             D     LV +    G L D + +          R+K   + AA  +  + +G + +  
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIH----------RMKFNEVDAAVIIKQVLSGVTYLHK 154
Query: 598 --IIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
             I+HRD+K  N+LL+   ++ + K+ DFGL     N  K     +  G+  Y+ PE  R
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM---KERLGTAYYIAPEVLR 211
Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPP 678
            +   EK DV+S GV+L  +L   PP
Sbjct: 212 KKY-DEKCDVWSIGVILFILLAGYPP 236

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/285 (21%), Positives = 118/285 (41%), Gaps = 38/285 (13%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           K  N L  +     G ++KG   G+   V + ++   S + + +F  E   L    + ++
Sbjct: 10  KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 535 VSLIGYCNDDG--QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           + ++G C         L+  +M  G+L + L+   N  +   + +K  +  AR + +LHT
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSI---GYLDPE 649
               +I    + + ++++DE+  A++S           +    S Q  G +    ++ PE
Sbjct: 130 -LEPLIPRHALNSRSVMIDEDMTARIS----------MADVKFSFQSPGRMYAPAWVAPE 178
Query: 650 YYRLQLLTE-----KSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG 704
              LQ   E      +D++SF V+L E++    P     +  ++ + V A E        
Sbjct: 179 A--LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-MEIGMKV-ALEG------- 227
Query: 705 DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
                 L+   PP       ++   C+N+D  +RP    +V  LE
Sbjct: 228 ------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 102/217 (47%), Gaps = 18/217 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL-----NPGSQQGALEFQTEIGMLSQL 529
           + +  L  IG G +G V+K         VA+KR+     + G    AL    EI +L +L
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKEL 58
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           ++ ++V L    + D ++ LV+++  +   +   +++ N  L  +          + L +
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKK--YFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDP 648
            H   S+ ++HRD+K  N+L++     K++DFGL + FG        S +V  ++ Y  P
Sbjct: 117 CH---SRNVLHRDLKPQNLLINRNGELKLADFGLARAFG--IPVRCYSAEVV-TLWYRPP 170
Query: 649 E-YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGD 684
           +  +  +L +   D++S G +  E+  A  P+    D
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGND 207

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 143 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 194
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 14/215 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ-GALEFQTEIGMLSQLRYL 532
           + DF    ++G G +G V           VAIK++ P  +   AL    EI +L   ++ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICI-GAARALHYLH 591
           +++++      D        Y+ +  ++  L+   +  +  D  ++  I    RA+  LH
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS--KTHVSTQVKGSIGYLDPE 649
            G++  +IHRD+K +N+L++     KV DFGL +     +   +  + Q  G    +   
Sbjct: 130 -GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATR 186
Query: 650 YYR---LQLLTEK----SDVYSFGVVLLEVLCARP 677
           +YR   + L + K     DV+S G +L E+   RP
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 87/214 (40%), Gaps = 27/214 (12%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQ-TEIGMLSQLRYLH 533
           F  +  +G G FG V   K    G+   + I       +   +E    E  +L  + +  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           LV L     D+  + +V +Y   G +  HL        P  R     I       YLH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH-- 158
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DPEYY 651
            S  +I+RD+K  N+++D++   KV+DFGL K            +VKG    L   PEY 
Sbjct: 159 -SLDLIYRDLKPENLMIDQQGYIKVTDFGLAK------------RVKGRTWXLCGTPEYL 205
Query: 652 RLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
             +++  K      D ++ GV++ E+    PP  
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVK 640
           A+ + +L   AS+  IHRD+   NILL E+ V K+ DFGL +     P++ +       +
Sbjct: 210 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR---KGDAR 263
Query: 641 GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRN 700
             + ++ PE    ++ T +SDV+SFGV+L E       I   G      + +    C R 
Sbjct: 264 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------IFSLGASPYPGVKIDEEFCRR- 315
Query: 701 GKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
                 +    +  AP     +  +  + C + +  +RP+ S++V  L  + Q
Sbjct: 316 ------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 362

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 23/174 (13%)
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQV 639
            A+ + +L   AS+  IHRD+   NILL E+ V K+ DFGL +     P++ +       
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR---KGDA 260
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV+L E       I   G      + +    C R
Sbjct: 261 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------IFSLGASPYPGVKIDEEFCRR 313
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
                  +    +  AP     +  +  + C + +  +RP+ S++V  L  + Q
Sbjct: 314 -------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 360

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+      Y
Sbjct: 143 GLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WY 194
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 23/174 (13%)
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQV 639
            A+ + +L   AS+  IHRD+   NILL E+ V K+ DFGL +     P++ +       
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR---KGDA 255
Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV+L E       I   G      + +    C R
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------IFSLGASPYPGVKIDEEFCRR 308
Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
                  +    +  AP     +  +  + C + +  +RP+ S++V  L  + Q
Sbjct: 309 -------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK---FGPNFSKTHVSTQVK 640
           A+ + +L   AS+  IHRD+   NILL E+ V K+ DFGL +     P++ +       +
Sbjct: 201 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR---KGDAR 254
Query: 641 GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRN 700
             + ++ PE    ++ T +SDV+SFGV+L E       I   G      + +    C R 
Sbjct: 255 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------IFSLGASPYPGVKIDEEFCRR- 306
Query: 701 GKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
                 +    +  AP     +  +  + C + +  +RP+ S++V  L  + Q
Sbjct: 307 ------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 353

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG- 644
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +        H   ++ G +  
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVAT 185
Query: 645 --YLDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             Y  PE         +  D++S G ++ E+L  R
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG- 644
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +        H   ++ G +  
Sbjct: 133 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVAT 181
Query: 645 --YLDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             Y  PE         +  D++S G ++ E+L  R
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG- 644
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +        H   ++ G +  
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVAT 185
Query: 645 --YLDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             Y  PE         +  D++S G ++ E+L  R
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 13/207 (6%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQ-TEIGMLSQLRYLH 533
           F  +  +G G FG V   K    G+   + I       +   +E    E  +L  + +  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           LV L     D+  + +V +Y+  G +  HL        P  R     I       YLH  
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH-- 159
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
            S  +I+RD+K  N+L+D++   +V+DFG  K     + T     + G+  YL PE    
Sbjct: 160 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEYLAPEIILS 213
Query: 654 QLLTEKSDVYSFGVVLLEVLCARPPIL 680
           +   +  D ++ GV++ E+    PP  
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ D+GL +   +    +V+T+      Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR-----WY 188
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 20/207 (9%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKR-LNP--GSQQGALEFQTEIGMLSQLRY 531
           + F  L  +G G +G V+K     D    A+KR ++P  G +  A +   E+G   ++  
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKL-AEVGSHEKVGQ 115
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
                 +    ++G ++ +   +   +L+ H        LP  +          AL +LH
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCGPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
              S+ ++H DVK  NI L      K+ DFGL           + T   G +   DP Y 
Sbjct: 175 ---SQGLVHLDVKPANIFLGPRGRCKLGDFGLL--------VELGTAGAGEVQEGDPRYM 223
Query: 652 RLQLLT----EKSDVYSFGVVLLEVLC 674
             +LL       +DV+S G+ +LEV C
Sbjct: 224 APELLQGSYGTAADVFSLGLTILEVAC 250

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F  +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+  G +  HL        P  R     I       YL
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 157
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 202
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 27/214 (12%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQ-TEIGMLSQLRYLH 533
           F  +  +G G FG V   K    G+   + I       +   +E    E  +L  + +  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           LV L     D+  + +V +Y+  G +  HL        P  R     I       YLH  
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH-- 159
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DPEYY 651
            S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   PEY 
Sbjct: 160 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTPEYL 206
Query: 652 RLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
             +++  K      D ++ GV++ E+    PP  
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 27/214 (12%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQ-TEIGMLSQLRYLH 533
           F  +  +G G FG V   K    G+   + I       +   +E    E  +L  + +  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           LV L     D+  + +V +Y   G +  HL        P  R     I       YLH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH-- 158
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DPEYY 651
            S  +I+RD+K  N+++D++   +V+DFGL K            +VKG    L   PEY 
Sbjct: 159 -SLDLIYRDLKPENLMIDQQGYIQVTDFGLAK------------RVKGRTWXLCGTPEYL 205
Query: 652 RLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
             +++  K      D ++ GV++ E+    PP  
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 93/195 (47%), Gaps = 22/195 (11%)
Query: 506 KRLNPGSQQGA--LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL 563
           KR +  S++G    E + E+ +L Q+ + ++++L     +   ++L+ + ++ G L D L
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 564 YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV----AKVS 619
              ++  L  +            ++YLHT   K I H D+K  NI+L ++ +     K+ 
Sbjct: 107 AQKES--LSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161
Query: 620 DFGLC---KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           DFGL    + G  F        + G+  ++ PE    + L  ++D++S GV+   +L   
Sbjct: 162 DFGLAHEIEDGVEFK------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215
Query: 677 PPILRTGDKKQVNLA 691
            P L  GD KQ  LA
Sbjct: 216 SPFL--GDTKQETLA 228

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 93/195 (47%), Gaps = 22/195 (11%)
Query: 506 KRLNPGSQQGAL--EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL 563
           KR +  S++G    E + E+ +L Q+ + ++++L     +   ++L+ + ++ G L D L
Sbjct: 47  KRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 564 YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV----AKVS 619
              ++  L  +            ++YLHT   K I H D+K  NI+L ++ +     K+ 
Sbjct: 107 AQKES--LSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161
Query: 620 DFGLC---KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           DFGL    + G  F        + G+  ++ PE    + L  ++D++S GV+   +L   
Sbjct: 162 DFGLAHEIEDGVEFK------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215
Query: 677 PPILRTGDKKQVNLA 691
            P L  GD KQ  LA
Sbjct: 216 SPFL--GDTKQETLA 228

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 27/214 (12%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQ-TEIGMLSQLRYLH 533
           F  +  +G G FG V   K    G+   + I       +   +E    E  +L  + +  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           LV L     D+  + +V +Y+  G +  HL        P  R     I       YLH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH-- 158
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DPEYY 651
            S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   PEY 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTPEYL 205
Query: 652 RLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
             +++  K      D ++ GV++ E+    PP  
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F  +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 100
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+  G +  HL        P  R     I       YL
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 158
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 159 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 203
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 27/214 (12%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQ-TEIGMLSQLRYLH 533
           F  +  +G G FG V   K    G+   + I       +   +E    E  +L  + +  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           LV L     D+  + +V +Y+  G +  HL        P  R     I       YLH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH-- 158
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DPEYY 651
            S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   PEY 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTPEYL 205
Query: 652 RLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
             +++  K      D ++ GV++ E+    PP  
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 27/214 (12%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQ-TEIGMLSQLRYLH 533
           F  +  +G G FG V   K    G+   + I       +   +E    E  +L  + +  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           LV L     D+  + +V +Y   G +  HL        P  R     I       YLH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH-- 158
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DPEYY 651
            S  +I+RD+K  N+++D++   KV+DFG  K            +VKG    L   PEY 
Sbjct: 159 -SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK------------RVKGRTWXLCGTPEYL 205
Query: 652 RLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
             +++  K      D ++ GV++ E+    PP  
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F  +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+  G +  HL        P  R     I       YL
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 157
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 202
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F  +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+  G +  HL        P  R     I       YL
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 157
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 202
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 13/207 (6%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQ-TEIGMLSQLRYLH 533
           F  +  +G G FG V   K    G+   + I       +   +E    E  +L  + +  
Sbjct: 29  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 88
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           LV L     D+  + +V +Y+  G +  HL        P  R     I       YLH  
Sbjct: 89  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH-- 144
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
            S  +I+RD+K  N+L+D++   +V+DFG  K     + T     + G+  YL PE    
Sbjct: 145 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEYLAPEIILS 198
Query: 654 QLLTEKSDVYSFGVVLLEVLCARPPIL 680
           +   +  D ++ GV++ E+    PP  
Sbjct: 199 KGYNKAVDWWALGVLIYEMAAGYPPFF 225

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F  +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 100
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+  G +  HL        P  R     I       YL
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 158
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 159 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 203
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 27/214 (12%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQ-TEIGMLSQLRYLH 533
           F  +  +G G FG V   K    G+   + I       +   +E    E  +L  + +  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           LV L     D+  + +V +Y+  G +  HL        P  R     I       YLH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH-- 158
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DPEYY 651
            S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   PEY 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTPEYL 205
Query: 652 RLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
             +++  K      D ++ GV++ E+    PP  
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 88/217 (40%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F  +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 100
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y   G +  HL        P  R     I       YL
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 158
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+++D++   KV+DFG  K            +VKG    L   P
Sbjct: 159 H---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK------------RVKGRTWXLCGTP 203
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F  +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 100
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+  G +  HL        P  R     I       YL
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 158
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 159 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 203
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 93/195 (47%), Gaps = 22/195 (11%)
Query: 506 KRLNPGSQQGA--LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL 563
           KR +  S++G    E + E+ +L Q+ + ++++L     +   ++L+ + ++ G L D L
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 564 YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV----AKVS 619
              ++  L  +            ++YLHT   K I H D+K  NI+L ++ +     K+ 
Sbjct: 107 AQKES--LSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161
Query: 620 DFGLC---KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           DFGL    + G  F        + G+  ++ PE    + L  ++D++S GV+   +L   
Sbjct: 162 DFGLAHEIEDGVEFK------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215
Query: 677 PPILRTGDKKQVNLA 691
            P L  GD KQ  LA
Sbjct: 216 SPFL--GDTKQETLA 228

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F  +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 64  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 120
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+  G +  HL        P  R     I       YL
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 178
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 179 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 223
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 224 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 27/214 (12%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQ-TEIGMLSQLRYLH 533
           F  +  +G G FG V   K    G+   + I       +   +E    E  +L  + +  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           LV L     D+  + +V +Y   G +  HL        P  R     I       YLH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYLH-- 158
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DPEYY 651
            S  +I+RD+K  N+++D++   KV+DFG  K            +VKG    L   PEY 
Sbjct: 159 -SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK------------RVKGRTWXLCGTPEYL 205
Query: 652 RLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
             +++  K      D ++ GV++ E+    PP  
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 27/214 (12%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQ-TEIGMLSQLRYLH 533
           F  +  +G G FG V   K    G+   + I       +   +E    E  +L  + +  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           LV L     D+  + +V +Y+  G +  HL        P  R     I       YLH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYLH-- 158
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DPEYY 651
            S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   PEY 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTPEYL 205
Query: 652 RLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
             +++  K      D ++ GV++ E+    PP  
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 93/195 (47%), Gaps = 22/195 (11%)
Query: 506 KRLNPGSQQGA--LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL 563
           KR +  S++G    E + E+ +L Q+ + ++++L     +   ++L+ + ++ G L D L
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 564 YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV----AKVS 619
              ++  L  +            ++YLHT   K I H D+K  NI+L ++ +     K+ 
Sbjct: 107 AQKES--LSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161
Query: 620 DFGLC---KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           DFGL    + G  F        + G+  ++ PE    + L  ++D++S GV+   +L   
Sbjct: 162 DFGLAHEIEDGVEFK------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215
Query: 677 PPILRTGDKKQVNLA 691
            P L  GD KQ  LA
Sbjct: 216 SPFL--GDTKQETLA 228

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP---GSQQGALEFQTEIGMLSQLRYL 532
           D   +  +GRG +G V K          A+KR+       +Q  L    +I   + +   
Sbjct: 35  DLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRT-VDCP 93
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYN---NDNPPLPWDRRLKICIGAARALHY 589
             V+  G    +G + +  +     T  D  Y    +    +P D   KI +   +AL +
Sbjct: 94  FTVTFYGALFREGDVWICXELX--DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 151
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           LH+  S  +IHRDVK +N+L++     K  DFG+  +  +     +     G   Y  PE
Sbjct: 152 LHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA---GCKPYXAPE 206
Query: 650 YYRLQL----LTEKSDVYSFGVVLLEVLCARPP 678
               +L     + KSD++S G+  +E+   R P
Sbjct: 207 RINPELNQKGYSVKSDIWSLGITXIELAILRFP 239

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F  +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 92
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+  G +  HL        P  R     I       YL
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 150
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 151 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 195
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 196 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 232

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 54/107 (50%), Gaps = 13/107 (12%)
Query: 577 LKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHV 635
           L I I  A A+ +LH   SK ++HRD+K +NI    + V KV DFGL      +  +  V
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 636 STQV------KGSIG---YLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
            T +       G +G   Y+ PE       + K D++S G++L E+L
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 93/195 (47%), Gaps = 22/195 (11%)
Query: 506 KRLNPGSQQGA--LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL 563
           KR +  S++G    E + E+ +L Q+ + ++++L     +   ++L+ + ++ G L D L
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 564 YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV----AKVS 619
              ++  L  +            ++YLHT   K I H D+K  NI+L ++ +     K+ 
Sbjct: 107 AQKES--LSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161
Query: 620 DFGLC---KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           DFGL    + G  F        + G+  ++ PE    + L  ++D++S GV+   +L   
Sbjct: 162 DFGLAHEIEDGVEFK------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215
Query: 677 PPILRTGDKKQVNLA 691
            P L  GD KQ  LA
Sbjct: 216 SPFL--GDTKQETLA 228

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 93/229 (40%), Gaps = 34/229 (14%)
Query: 462 CTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEF 519
           CT+F        T D+     +G+G F  V +      +   A K +N    S +   + 
Sbjct: 26  CTRF--------TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKL 77
Query: 520 QTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKI 579
           + E  +   L++ ++V L    +++G   LV+D +  G L + +   +            
Sbjct: 78  EREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY----------- 126
Query: 580 CIGAARALHYLHTGASKV-------IIHRDVKTTNILLDEEW---VAKVSDFGLCKFGPN 629
               A A H +H     V       I+HRD+K  N+LL  +      K++DFGL      
Sbjct: 127 -YSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG 185
Query: 630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
             +        G+ GYL PE  R     +  D+++ GV+L  +L   PP
Sbjct: 186 EQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 27/214 (12%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQ-TEIGMLSQLRYLH 533
           F  +  +G G FG V   K    G+   + I       +   +E    E  +L  + +  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           LV L     D+  + +V +Y+  G +  HL        P  R     I       YLH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYLH-- 158
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DPEYY 651
            S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   PEY 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTPEYL 205
Query: 652 RLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
             +++  K      D ++ GV++ E+    PP  
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 93/195 (47%), Gaps = 22/195 (11%)
Query: 506 KRLNPGSQQGA--LEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL 563
           KR +  S++G    E + E+ +L Q+ + ++++L     +   ++L+ + ++ G L D L
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 564 YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV----AKVS 619
              ++  L  +            ++YLHT   K I H D+K  NI+L ++ +     K+ 
Sbjct: 107 AQKES--LSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161
Query: 620 DFGLC---KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           DFGL    + G  F        + G+  ++ PE    + L  ++D++S GV+   +L   
Sbjct: 162 DFGLAHEIEDGVEFK------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215
Query: 677 PPILRTGDKKQVNLA 691
            P L  GD KQ  LA
Sbjct: 216 SPFL--GDTKQETLA 228

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 27/214 (12%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQ-TEIGMLSQLRYLH 533
           F  +  +G G FG V   K    G+   + I       +   +E    E  +L  + +  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           LV L     D+  + +V +Y+  G +  HL        P  R     I       YLH  
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYLH-- 159
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DPEYY 651
            S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   PEY 
Sbjct: 160 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTPEYL 206
Query: 652 RLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
             +++  K      D ++ GV++ E+    PP  
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F+ +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+A G +  HL        P  R     I       YL
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 157
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 202
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           E    +++  K      D ++ GV++ E+    PP  
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--- 533
           F  +  +G G FG V            A+K L+   +Q  ++ +     L++ R L    
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVN 92
Query: 534 ---LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              LV L     D+  + +V +Y+  G +  HL        P  R     I       YL
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYL 150
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   +V+DFG  K            +VKG    L   P
Sbjct: 151 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTP 195
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 196 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 232

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL-NP-GSQQGALEFQTEIGMLSQLRYLHL 534
           + +L  +G G +G V           VAIK+L  P  S+  A     E+ +L  +R+ ++
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 535 VSLIGYCNDDGQM------ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALH 588
           + L+     D  +       LV  +M  GT    L  ++   L  DR   +     + L 
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLR 142
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           Y+H      IIHRD+K  N+ ++E+   K+ DFGL +   +     V T+      Y  P
Sbjct: 143 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTR-----WYRAP 194
Query: 649 EY-YRLQLLTEKSDVYSFGVVLLEVLCAR 676
           E        T+  D++S G ++ E++  +
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 102/217 (47%), Gaps = 18/217 (8%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL-----NPGSQQGALEFQTEIGMLSQL 529
           + +  L  IG G +G V+K         VA+KR+     + G    AL    EI +L +L
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKEL 58
Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           ++ ++V L    + D ++ LV+++  +   +   +++ N  L  +          + L +
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKK--YFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDP 648
            H   S+ ++HRD+K  N+L++     K+++FGL + FG        S +V  ++ Y  P
Sbjct: 117 CH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFG--IPVRCYSAEVV-TLWYRPP 170
Query: 649 E-YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGD 684
           +  +  +L +   D++S G +  E+  A  P+    D
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 78/163 (47%), Gaps = 20/163 (12%)
Query: 518 EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDH------LYNNDNPPL 571
           +F+ E+ +++ ++  + ++  G   +  ++ ++Y+YM   ++         L  N    +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 572 PWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS 631
           P      I      +  Y+H    K I HRDVK +NIL+D+    K+SDFG        S
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGE-------S 199
Query: 632 KTHVSTQVKGSIG---YLDPEYYRLQLLTE--KSDVYSFGVVL 669
           +  V  ++KGS G   ++ PE++  +      K D++S G+ L
Sbjct: 200 EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+  FGL +   +    +V+T+      Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR-----WY 188
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 96/212 (45%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + +  L  +G G +G+V   +       +A+K+L+   Q    A     E+ +L 
Sbjct: 46  IWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLK 105
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 106 HMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 165
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIG 644
            L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T+  +    
Sbjct: 166 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEI 222
Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
            L+  +Y + +     D++S G ++ E+L  R
Sbjct: 223 MLNWMHYNMTV-----DIWSVGCIMAELLTGR 249

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 43/222 (19%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLRYL 532
           + ++ L  IG G +G VYK   N   T  A+K++    +   +   T  EI +L +L++ 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG------AARA 586
           ++V L    +   +++LV++++ +                  + L +C G      A   
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDL---------------KKLLDVCEGGLESVTAKSF 105
Query: 587 LHYLHTGAS----KVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTHVSTQVK 640
           L  L  G +    + ++HRD+K  N+L++ E   K++DFGL + FG P    TH      
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--- 162
Query: 641 GSIGYLDPEYYRLQLLTEKS-----DVYSFGVVLLEVLCARP 677
            ++ Y  P+     L+  K      D++S G +  E++   P
Sbjct: 163 -TLWYRAPDV----LMGSKKYSTTIDIWSVGCIFAEMVNGAP 199

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 43/222 (19%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLRYL 532
           + ++ L  IG G +G VYK   N   T  A+K++    +   +   T  EI +L +L++ 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG------AARA 586
           ++V L    +   +++LV++++ +                  + L +C G      A   
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDL---------------KKLLDVCEGGLESVTAKSF 105
Query: 587 LHYLHTGAS----KVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTHVSTQVK 640
           L  L  G +    + ++HRD+K  N+L++ E   K++DFGL + FG P    TH      
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--- 162
Query: 641 GSIGYLDPEYYRLQLLTEKS-----DVYSFGVVLLEVLCARP 677
            ++ Y  P+     L+  K      D++S G +  E++   P
Sbjct: 163 -TLWYRAPDV----LMGSKKYSTTIDIWSVGCIFAEMVNGTP 199

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 86/214 (40%), Gaps = 27/214 (12%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQ-TEIGMLSQLRYLH 533
           F  +  +G G FG V   K    G+   + I       +   +E    E  +L  + +  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           LV L     D+  + +V +Y   G +  HL        P  R     I       YLH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH-- 158
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DPEYY 651
            S  +I+RD+K  N+++D++   +V+DFG  K            +VKG    L   PEY 
Sbjct: 159 -SLDLIYRDLKPENLMIDQQGYIQVTDFGFAK------------RVKGRTWXLCGTPEYL 205
Query: 652 RLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
             +++  K      D ++ GV++ E+    PP  
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ D GL +   +    +V+T+      Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATR-----WY 188
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 43/222 (19%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLRYL 532
           + ++ L  IG G +G VYK   N   T  A+K++    +   +   T  EI +L +L++ 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG------AARA 586
           ++V L    +   +++LV++++ +                  + L +C G      A   
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDL---------------KKLLDVCEGGLESVTAKSF 105
Query: 587 LHYLHTGAS----KVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTHVSTQVK 640
           L  L  G +    + ++HRD+K  N+L++ E   K++DFGL + FG P    TH      
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--- 162
Query: 641 GSIGYLDPEYYRLQLLTEKS-----DVYSFGVVLLEVLCARP 677
            ++ Y  P+     L+  K      D++S G +  E++   P
Sbjct: 163 -TLWYRAPDV----LMGSKKYSTTIDIWSVGCIFAEMVNGTP 199

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 85/214 (39%), Gaps = 27/214 (12%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQ-TEIGMLSQLRYLH 533
           F  +  +G G FG V   K    G+   + I       +   +E    E  +L  + +  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           L  L     D+  + +V +Y   G +  HL        P  R     I       YLH  
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH-- 159
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DPEYY 651
            S  +I+RD+K  N+++D++   KV+DFG  K            +VKG    L   PEY 
Sbjct: 160 -SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK------------RVKGRTWXLCGTPEYL 206
Query: 652 RLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
             +++  K      D ++ GV++ E+    PP  
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 88/217 (40%), Gaps = 33/217 (15%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR------ 530
           F  +  +G G FG V            A+K L+   +Q  ++ +     L++ R      
Sbjct: 44  FERIRTLGTGSFGRVMLVKHKETGNHYAMKILD---KQKVVKLKQIEHTLNEKRIQQAVN 100
Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           +  LV L     D+  + +V +Y   G +  HL        P  R     I       YL
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYL 158
Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DP 648
           H   S  +I+RD+K  N+L+D++   KV+DFG  K            +VKG    L   P
Sbjct: 159 H---SLDLIYRDLKPENLLIDQQGYIKVADFGFAK------------RVKGRTWXLCGTP 203
Query: 649 EYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           EY   +++  K      D ++ GV++ E+    PP  
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 85/214 (39%), Gaps = 27/214 (12%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQ-TEIGMLSQLRYLH 533
           F  +  +G G FG V   K    G+   + I       +   +E    E  +L  + +  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           L  L     D+  + +V +Y   G +  HL        P  R     I       YLH  
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH-- 159
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DPEYY 651
            S  +I+RD+K  N+++D++   KV+DFG  K            +VKG    L   PEY 
Sbjct: 160 -SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK------------RVKGRTWXLCGTPEYL 206
Query: 652 RLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
             +++  K      D ++ GV++ E+    PP  
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ D GL +   +    +V+T+      Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR-----WY 188
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ DF L +   +    +V+T+      Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR-----WY 188
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 85/214 (39%), Gaps = 27/214 (12%)
Query: 477 FNNLLIIGRGGFGNVY--KGFLNGDSTPVAIKRLNPGSQQGALEFQ-TEIGMLSQLRYLH 533
           F  +  +G G FG V   K    G+   + I       +   +E    E  +L  + +  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           L  L     D+  + +V +Y   G +  HL        P  R     I       YLH  
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYLH-- 159
Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL--DPEYY 651
            S  +I+RD+K  N+++D++   KV+DFG  K            +VKG    L   PEY 
Sbjct: 160 -SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK------------RVKGRTWXLCGTPEYL 206
Query: 652 RLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
             +++  K      D ++ GV++ E+    PP  
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 13/212 (6%)
Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+   Q    A     E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 528 QLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICI-GAAR 585
            +++ +++ L+        +    D Y+    +   L N        D  ++  I    R
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            L Y+H+     IIHRD+K +N+ ++E+   K+ D GL +   +    +V+T+      Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR-----WY 188
Query: 646 LDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             PE         +  D++S G ++ E+L  R
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/244 (23%), Positives = 104/244 (42%), Gaps = 27/244 (11%)
Query: 443 AVMKEAKSRGPASSLPSDLCTQFSIS-EIKEATKDFNNLLIIGRGGFGNVYKGFLNGDST 501
           A M   +  G  S    +  T+FS + ++KE          +G+G F  V +        
Sbjct: 5   ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEE---------LGKGAFSVVRRCVHKTTGL 55
Query: 502 PVAIKRLNPGSQQGALEFQT---EIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGT 558
             A K +N   +  A +FQ    E  +  +L++ ++V L     ++    LV+D +  G 
Sbjct: 56  EFAAKIINT-KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE 114
Query: 559 LRDHLYNNDNPPLPWDRRLKICIGAA-RALHYLHTGASKVIIHRDVKTTNILLDEEW--- 614
           L + +   +      +     CI     ++ Y H+     I+HR++K  N+LL  +    
Sbjct: 115 LFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGA 168
Query: 615 VAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC 674
             K++DFGL       + +       G+ GYL PE  +    ++  D+++ GV+L  +L 
Sbjct: 169 AVKLADFGL---AIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 225
Query: 675 ARPP 678
             PP
Sbjct: 226 GYPP 229

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 40/79 (50%), Gaps = 1/79 (1%)
Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEK 659
           HRDVK  NIL+  +  A + DFG+     +   T +   V G++ Y  PE +     T +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATYR 215
Query: 660 SDVYSFGVVLLEVLCARPP 678
           +D+Y+   VL E L   PP
Sbjct: 216 ADIYALTCVLYECLTGSPP 234

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 17/224 (7%)
Query: 459 SDLCTQFSISEIKEAT----KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GS 512
           S +  QF   E+ ++T    K + NL  IG G  G V   +       VAIK+L+    +
Sbjct: 4   SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 63
Query: 513 QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPL 571
           Q  A     E+ ++  + + +++SL+        +    D Y+    +  +L       L
Sbjct: 64  QTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMEL 123
Query: 572 PWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNF 630
             +R   +       + +LH+     IIHRD+K +NI++  +   K+ DFGL +  G +F
Sbjct: 124 DHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF 180
Query: 631 SKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
             T +V T+      Y  PE        E  D++S G ++ E++
Sbjct: 181 MMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 130/313 (41%), Gaps = 73/313 (23%)
Query: 482 IIGRGGFGN-VYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQ-------LRYLH 533
           ++G G  G  VY+G    D+  VA+KR+ P     A     E+ +L +       +RY  
Sbjct: 31  VLGHGAEGTIVYRGMF--DNRDVAVKRILPECFSFA---DREVQLLRESDEHPNVIRY-- 83
Query: 534 LVSLIGYCND-DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
                 +C + D Q   +   +   TL++++   D   L  +  + +       L +LH 
Sbjct: 84  ------FCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEP-ITLLQQTTSGLAHLH- 135
Query: 593 GASKVIIHRDVKTTNILLDE-----EWVAKVSDFGLCKF----GPNFSKTHVSTQVKGSI 643
             S  I+HRD+K  NIL+       +  A +SDFGLCK       +FS+    + V G+ 
Sbjct: 136 --SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR---RSGVPGTE 190
Query: 644 GYLDPEYYRLQLLTEKS--------DVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWAT 695
           G++ PE     +L+E          D++S G V   V+           ++Q N+ + A 
Sbjct: 191 GWIAPE-----MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC 245
Query: 696 --ECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV-----WGL 748
             +C    K  D+I              + +E  ++    D  +RPS   V+     W L
Sbjct: 246 SLDCLHPEKHEDVI------------ARELIEKMIAM---DPQKRPSAKHVLKHPFFWSL 290
Query: 749 EFVFQLLRESSEK 761
           E   Q  ++ S++
Sbjct: 291 EKQLQFFQDVSDR 303

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 18/211 (8%)
Query: 469 EIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEF--QTEIGML 526
           E +E      + L +GRG FG V++          A+K++        LE     E+   
Sbjct: 87  EYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVR-------LEVFRAEELMAC 139
Query: 527 SQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARA 586
           + L    +V L G   +   + +  + +  G+L   +       LP DR L     A   
Sbjct: 140 AGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGC--LPEDRALYYLGQALEG 197
Query: 587 LHYLHTGASKVIIHRDVKTTNILLDEEWV-AKVSDFG--LCKFGPNFSKTHVSTQ-VKGS 642
           L YLH   S+ I+H DVK  N+LL  +   A + DFG  +C       K+ ++   + G+
Sbjct: 198 LEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGT 254
Query: 643 IGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
             ++ PE    +    K DV+S   ++L +L
Sbjct: 255 ETHMAPEVVLGRSCDAKVDVWSSCCMMLHML 285

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 17/203 (8%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT---EIGMLSQLRYLHLVSLIG 539
           +G+G F  V +          A K +N   +  A +FQ    E  +  +L++ ++V L  
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAA-RALHYLHTGASKVI 598
              ++    LV+D +  G L + +   +      +     CI     ++ Y H+     I
Sbjct: 73  SIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---I 126
Query: 599 IHRDVKTTNILLDEEW---VAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
           +HR++K  N+LL  +      K++DFGL       + +       G+ GYL PE  +   
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGL---AIEVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 656 LTEKSDVYSFGVVLLEVLCARPP 678
            ++  D+++ GV+L  +L   PP
Sbjct: 184 YSKPVDIWACGVILYILLVGYPP 206

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 17/203 (8%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT---EIGMLSQLRYLHLVSLIG 539
           +G+G F  V +          A K +N   +  A +FQ    E  +  +L++ ++V L  
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAA-RALHYLHTGASKVI 598
              ++    LV+D +  G L + +   +      +     CI     ++ Y H+     I
Sbjct: 73  SIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---I 126
Query: 599 IHRDVKTTNILLDEEW---VAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
           +HR++K  N+LL  +      K++DFGL       + +       G+ GYL PE  +   
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGL---AIEVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 656 LTEKSDVYSFGVVLLEVLCARPP 678
            ++  D+++ GV+L  +L   PP
Sbjct: 184 YSKPVDIWACGVILYILLVGYPP 206

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 17/203 (8%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT---EIGMLSQLRYLHLVSLIG 539
           +G+G F  V +          A K +N   +  A +FQ    E  +  +L++ ++V L  
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRLHD 71
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAA-RALHYLHTGASKVI 598
              ++    LV+D +  G L + +   +      +     CI     ++ Y H+     I
Sbjct: 72  SIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---I 125
Query: 599 IHRDVKTTNILLDEEW---VAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
           +HR++K  N+LL  +      K++DFGL       + +       G+ GYL PE  +   
Sbjct: 126 VHRNLKPENLLLASKAKGAAVKLADFGL---AIEVNDSEAWHGFAGTPGYLSPEVLKKDP 182
Query: 656 LTEKSDVYSFGVVLLEVLCARPP 678
            ++  D+++ GV+L  +L   PP
Sbjct: 183 YSKPVDIWACGVILYILLVGYPP 205

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 103/234 (44%), Gaps = 19/234 (8%)
Query: 459 SDLCTQFSISEIKEAT----KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GS 512
           S +  QF   E+ ++T    K + NL  IG G  G V   +       VAIK+L+    +
Sbjct: 4   SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 63
Query: 513 QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPL 571
           Q  A     E+ ++  + + +++SL+        +    D Y+    +  +L       L
Sbjct: 64  QTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMEL 123
Query: 572 PWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNF 630
             +R   +       + +LH+     IIHRD+K +NI++  +   K+ DFGL +  G +F
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF 180
Query: 631 SKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTG 683
             T +V T+      Y  PE        E  D++S G ++ E++  R  IL  G
Sbjct: 181 MMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILFPG 227

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 90/219 (41%), Gaps = 15/219 (6%)
Query: 472 EATKDFNNLLII-----GRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIG 524
           ++ ++FNN  I+     GRG F  V +          A K L      Q    E   EI 
Sbjct: 21  QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIA 80
Query: 525 MLSQLRYL-HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGA 583
           +L   +    +++L     +  ++IL+ +Y A G +           +  +  +++    
Sbjct: 81  VLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQI 140
Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST--QVKG 641
              ++YLH      I+H D+K  NILL    +  + D  +  FG +    H     ++ G
Sbjct: 141 LEGVYYLHQNN---IVHLDLKPQNILLSS--IYPLGDIKIVDFGMSRKIGHACELREIMG 195
Query: 642 SIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPIL 680
           +  YL PE      +T  +D+++ G++   +L    P +
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV 234

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 101/229 (44%), Gaps = 19/229 (8%)
Query: 464 QFSISEIKEAT----KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGAL 517
           QF   E+ ++T    K + NL  IG G  G V   +       VAIK+L+    +Q  A 
Sbjct: 47  QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 106
Query: 518 EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRR 576
               E+ ++  + + +++SL+        +    D Y+    +  +L       L  +R 
Sbjct: 107 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 166
Query: 577 LKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKT-H 634
             +       + +LH+     IIHRD+K +NI++  +   K+ DFGL +  G +F  T +
Sbjct: 167 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 223
Query: 635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTG 683
           V T+      Y  PE        E  D++S G ++ E++  R  IL  G
Sbjct: 224 VVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILFPG 265

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 17/224 (7%)
Query: 459 SDLCTQFSISEIKEAT----KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GS 512
           S +  QF   E+ ++T    K + NL  IG G  G V   +       VAIK+L+    +
Sbjct: 4   SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 63
Query: 513 QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPL 571
           Q  A     E+ ++  + + +++SL+        +    D Y+    +  +L       L
Sbjct: 64  QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMEL 123
Query: 572 PWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNF 630
             +R   +       + +LH+     IIHRD+K +NI++  +   K+ DFGL +  G +F
Sbjct: 124 DHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF 180
Query: 631 SKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
             T +V T+      Y  PE        E  D++S G ++ E++
Sbjct: 181 MMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 91/217 (41%), Gaps = 21/217 (9%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLN-------PGSQQGALEFQTEIGMLSQLRYLHL 534
           +IG+G F  V +          A+K ++       PG     L  + E  +   L++ H+
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDL--KREASICHMLKHPHI 88
Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL--KICIGAARALHYLHT 592
           V L+   + DG + +V+++M    L   +    +    +   +          AL Y H 
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 593 GASKVIIHRDVKTTNILL---DEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYLDP 648
                IIHRDVK  N+LL   +     K+ DFG+  + G +     V+    G+  ++ P
Sbjct: 149 NN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGES---GLVAGGRVGTPHFMAP 202
Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDK 685
           E  + +   +  DV+  GV+L  +L    P   T ++
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER 239

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 99/224 (44%), Gaps = 17/224 (7%)
Query: 459 SDLCTQFSISEIKEAT----KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GS 512
           S + +QF   ++ ++T    K +  L  IG G  G V   F       VA+K+L+    +
Sbjct: 2   SHMDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN 61
Query: 513 QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPL 571
           Q  A     E+ +L  + + +++SL+        +    D Y+    +  +L    +  L
Sbjct: 62  QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMEL 121
Query: 572 PWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP-NF 630
             +R   +       + +LH+     IIHRD+K +NI++  +   K+ DFGL +    NF
Sbjct: 122 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNF 178
Query: 631 SKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
             T +V T+      Y  PE        E  D++S G ++ E++
Sbjct: 179 MMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGELV 217

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 17/219 (7%)
Query: 464 QFSISEIKEAT----KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGAL 517
           QF   E+ ++T    K + NL  IG G  G V   +       VAIK+L+    +Q  A 
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 518 EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRR 576
               E+ ++  + + +++SL+        +    D Y+    +  +L       L  +R 
Sbjct: 62  RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERM 121
Query: 577 LKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKT-H 634
             +       + +LH+     IIHRD+K +NI++  +   K+ DFGL +  G +F  T +
Sbjct: 122 SYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPY 178
Query: 635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
           V T+      Y  PE        E  D++S G ++ E++
Sbjct: 179 VVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 78/168 (46%), Gaps = 20/168 (11%)
Query: 515 GALEFQTEIGMLSQLRYLHLVSLIG--YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLP 572
           G    + EI +L +LR+ +++ L+   Y  +  +M +V +Y   G +++ L   D+ P  
Sbjct: 49  GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEML---DSVP-- 102
Query: 573 WDRRLKICIGAA------RALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF 626
            ++R  +C            L YLH   S+ I+H+D+K  N+LL      K+S  G+ + 
Sbjct: 103 -EKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158
Query: 627 GPNFSKTHVSTQVKGSIGYLDPEYYR-LQLLTE-KSDVYSFGVVLLEV 672
              F+        +GS  +  PE    L   +  K D++S GV L  +
Sbjct: 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNI 206

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 103/234 (44%), Gaps = 19/234 (8%)
Query: 459 SDLCTQFSISEIKEAT----KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GS 512
           S +  QF   E+ ++T    K + NL  IG G  G V   +       VAIK+L+    +
Sbjct: 4   SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 63
Query: 513 QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPL 571
           Q  A     E+ ++  + + +++SL+        +    D Y+    +  +L       L
Sbjct: 64  QTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 123
Query: 572 PWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNF 630
             +R   +       + +LH+     IIHRD+K +NI++  +   K+ DFGL +  G +F
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF 180
Query: 631 SKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTG 683
             T +V T+      Y  PE        E  D++S G ++ E++  R  IL  G
Sbjct: 181 MMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILFPG 227

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 102/235 (43%), Gaps = 18/235 (7%)
Query: 452 GPASSLP-SDLCTQFSISEIKEAT----KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIK 506
           GP  S+  S     F   EI ++T    K + NL  IG G  G V   +       VAIK
Sbjct: 1   GPLGSMSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK 60
Query: 507 RLNP--GSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHL 563
           +L+    +Q  A     E+ ++  + + +++ L+        +    D Y+    +  +L
Sbjct: 61  KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL 120
Query: 564 YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL 623
                  L  +R   +       + +LH+     IIHRD+K +NI++  +   K+ DFGL
Sbjct: 121 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 177
Query: 624 CK-FGPNFSKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
            +  G +F  T +V T+      Y  PE        E  D++S G ++ E++C +
Sbjct: 178 ARTAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 103/234 (44%), Gaps = 19/234 (8%)
Query: 459 SDLCTQFSISEIKEAT----KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GS 512
           S +  QF   E+ ++T    K + NL  IG G  G V   +       VAIK+L+    +
Sbjct: 42  SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 101
Query: 513 QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPL 571
           Q  A     E+ ++  + + +++SL+        +    D Y+    +  +L       L
Sbjct: 102 QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 161
Query: 572 PWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNF 630
             +R   +       + +LH+     IIHRD+K +NI++  +   K+ DFGL +  G +F
Sbjct: 162 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218
Query: 631 SKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTG 683
             T +V T+      Y  PE        E  D++S G ++ E++  R  IL  G
Sbjct: 219 MMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILFPG 265

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 18/211 (8%)
Query: 469 EIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEF--QTEIGML 526
           E +E      + L +GRG FG V++          A+K++        LE     E+   
Sbjct: 68  EYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVR-------LEVFRAEELMAC 120
Query: 527 SQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARA 586
           + L    +V L G   +   + +  + +  G+L   +       LP DR L     A   
Sbjct: 121 AGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGC--LPEDRALYYLGQALEG 178
Query: 587 LHYLHTGASKVIIHRDVKTTNILLDEEWV-AKVSDFG--LCKFGPNFSKTHVSTQ-VKGS 642
           L YLH   S+ I+H DVK  N+LL  +   A + DFG  +C       K  ++   + G+
Sbjct: 179 LEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGT 235
Query: 643 IGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
             ++ PE    +    K DV+S   ++L +L
Sbjct: 236 ETHMAPEVVLGRSCDAKVDVWSSCCMMLHML 266

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 24/205 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           IGRG +G V      G     A K++     +    F+ EI ++  L + +++ L     
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 543 DDGQMILVYDYMARGTL-----RDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
           D+  + LV +    G L        ++   +      R +K  + A    H L+      
Sbjct: 77  DNTDIYLVMELCTGGELFERVVHKRVFRESDAA----RIMKDVLSAVAYCHKLN------ 126
Query: 598 IIHRDVKTTNILL---DEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
           + HRD+K  N L      +   K+ DFGL  +F P      + T+V G+  Y+ P+    
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMRTKV-GTPYYVSPQVLE- 181
Query: 654 QLLTEKSDVYSFGVVLLEVLCARPP 678
            L   + D +S GV++  +LC  PP
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPP 206

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/204 (20%), Positives = 88/204 (43%), Gaps = 24/204 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGALEFQTEIGMLSQLRYLHLVSLIGY 540
           +G G +G+V           VAIK+L+    S+  A     E+ +L  +++ +++ L+  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 541 CNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
                 +   YD Y+    ++  L          ++   +     + L Y+H+     ++
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG---VV 166
Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL--- 656
           HRD+K  N+ ++E+   K+ DFGL +        H   ++    GY+   +YR   +   
Sbjct: 167 HRDLKPGNLAVNEDCELKILDFGLAR--------HADAEM---TGYVVTRWYRAPEVILS 215
Query: 657 ----TEKSDVYSFGVVLLEVLCAR 676
                +  D++S G ++ E+L  +
Sbjct: 216 WMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 24/205 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           IGRG +G V      G     A K++     +    F+ EI ++  L + +++ L     
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 93
Query: 543 DDGQMILVYDYMARGTL-----RDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
           D+  + LV +    G L        ++   +      R +K  + A    H L+      
Sbjct: 94  DNTDIYLVMELCTGGELFERVVHKRVFRESDAA----RIMKDVLSAVAYCHKLN------ 143
Query: 598 IIHRDVKTTNILL---DEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
           + HRD+K  N L      +   K+ DFGL  +F P      + T+V G+  Y+ P+    
Sbjct: 144 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMRTKV-GTPYYVSPQVLE- 198
Query: 654 QLLTEKSDVYSFGVVLLEVLCARPP 678
            L   + D +S GV++  +LC  PP
Sbjct: 199 GLYGPECDEWSAGVMMYVLLCGYPP 223

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 84/203 (41%), Gaps = 16/203 (7%)
Query: 483 IGRGGFGNVYK--GFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGY 540
           IG+G F  V +      G      I      S +   + + E  +   L++ ++V L   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 541 CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGA--ARALHYLHTGASKVI 598
            +++G   LV+D +  G L + +   +      +     CI       LH    G    +
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYS---EADASHCIQQILEAVLHCHQMG----V 124
Query: 599 IHRDVKTTNILLDEEW---VAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
           +HRD+K  N+LL  +      K++DFGL        +        G+ GYL PE  R + 
Sbjct: 125 VHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPEVLRKEA 182
Query: 656 LTEKSDVYSFGVVLLEVLCARPP 678
             +  D+++ GV+L  +L   PP
Sbjct: 183 YGKPVDIWACGVILYILLVGYPP 205

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 17/224 (7%)
Query: 459 SDLCTQFSISEIKEAT----KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GS 512
           S +  QF   E+ ++T    K + NL  IG G  G V   +       VAIK+L+    +
Sbjct: 5   SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 64
Query: 513 QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPL 571
           Q  A     E+ ++  + + +++SL+        +    D Y+    +  +L       L
Sbjct: 65  QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 124
Query: 572 PWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNF 630
             +R   +       + +LH+     IIHRD+K +NI++  +   K+ DFGL +  G +F
Sbjct: 125 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
Query: 631 SKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
             T +V T+      Y  PE        E  D++S G ++ E++
Sbjct: 182 MMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 92/224 (41%), Gaps = 24/224 (10%)
Query: 462 CTQFSISEIKEATKDFNNLLIIGRGGFGNVYK--GFLNGDSTPVAIKRLNPGSQQGALEF 519
           CT+F        T+++     +G+G F  V +    L G      I      S +   + 
Sbjct: 6   CTRF--------TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL 57
Query: 520 QTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKI 579
           + E  +   L++ ++V L    +++G   L++D +  G L + +   +      +     
Sbjct: 58  EREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS---EADASH 114
Query: 580 CIGA--ARALHYLHTGASKVIIHRDVKTTNILLDEEW---VAKVSDFGLCKFGPNFSKTH 634
           CI       LH    G    ++HR++K  N+LL  +      K++DFGL        +  
Sbjct: 115 CIQQILEAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170
Query: 635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
                 G+ GYL PE  R     +  D+++ GV+L  +L   PP
Sbjct: 171 FG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 13/207 (6%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGALEFQTEIGMLSQLRYL 532
           K + NL  IG G  G V   +       VAIK+L+    +Q  A     E+ ++  + + 
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 533 HLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
           +++ L+        +    D Y+    +  +L       L  +R   +       + +LH
Sbjct: 78  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKT-HVSTQVKGSIGYLDPE 649
           +     IIHRD+K +NI++  +   K+ DFGL +  G +F  T +V T+      Y  PE
Sbjct: 138 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPE 189
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
                   E  D++S G ++ E++C +
Sbjct: 190 VILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 61/286 (21%), Positives = 113/286 (39%), Gaps = 40/286 (13%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           K  N L  +     G ++KG   G+   V + ++   S + + +F  E   L    + ++
Sbjct: 10  KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 535 VSLIGYCNDDG--QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           + ++G C         L+  +   G+L + L+   N  +   + +K  +  AR   +LHT
Sbjct: 70  LPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHT 129
Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG---SIGYLDPE 649
               +I    + + ++ +DE+  A++S   + KF         S Q  G   +  ++ PE
Sbjct: 130 -LEPLIPRHALNSRSVXIDEDXTARISXADV-KF---------SFQSPGRXYAPAWVAPE 178
Query: 650 YYRLQLLTE-----KSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG 704
              LQ   E      +D +SF V+L E++    P                     N +IG
Sbjct: 179 A--LQKKPEDTNRRSADXWSFAVLLWELVTREVPFADLS----------------NXEIG 220
Query: 705 -DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
             +    L+   PP       ++   C N+D  +RP    +V  LE
Sbjct: 221 XKVALEGLRPTIPPGISPHVSKLXKICXNEDPAKRPKFDXIVPILE 266

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/204 (20%), Positives = 88/204 (43%), Gaps = 24/204 (11%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGALEFQTEIGMLSQLRYLHLVSLIGY 540
           +G G +G+V           VAIK+L+    S+  A     E+ +L  +++ +++ L+  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 541 CNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
                 +   YD Y+    ++  L          ++   +     + L Y+H+     ++
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG---VV 148
Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL--- 656
           HRD+K  N+ ++E+   K+ DFGL +        H   ++    GY+   +YR   +   
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLAR--------HADAEM---TGYVVTRWYRAPEVILS 197
Query: 657 ----TEKSDVYSFGVVLLEVLCAR 676
                +  D++S G ++ E+L  +
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 17/224 (7%)
Query: 459 SDLCTQFSISEIKEAT----KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GS 512
           S +  QF   E+ ++T    K + NL  IG G  G V   +       VAIK+L+    +
Sbjct: 4   SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 63
Query: 513 QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPL 571
           Q  A     E+ ++  + + +++SL+        +    D Y+    +  +L       L
Sbjct: 64  QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 123
Query: 572 PWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNF 630
             +R   +       + +LH+     IIHRD+K +NI++  +   K+ DFGL +  G +F
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180
Query: 631 SKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
             T +V T+      Y  PE        E  D++S G ++ E++
Sbjct: 181 MMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 31/220 (14%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV 535
           D+  +  +GRG +  V++     ++  V +K L P  +    + + EI +L  LR     
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKN---KIKREIKILENLR----- 89
Query: 536 SLIGYCNDDGQMILVYDYMAR--GTLRDHLYNNDNPPL-----PWDRRLKICIGAARALH 588
              G  N      +V D ++R    + +H+ N D   L      +D R  +     +AL 
Sbjct: 90  ---GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMY-EILKALD 145
Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVA-KVSDFGLCKF---GPNFSKTHVSTQVKGSIG 644
           Y H+     I+HRDVK  N+++D E    ++ D+GL +F   G  ++    S   KG   
Sbjct: 146 YCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 202
Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGD 684
            +D + Y   L     D++S G +L  ++  + P     D
Sbjct: 203 LVDYQMYDYSL-----DMWSLGCMLASMIFRKEPFFHGHD 237

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 17/224 (7%)
Query: 459 SDLCTQFSISEIKEAT----KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GS 512
           S +  QF   E+ ++T    K + NL  IG G  G V   +       VAIK+L+    +
Sbjct: 3   SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 62
Query: 513 QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPL 571
           Q  A     E+ ++  + + +++SL+        +    D Y+    +  +L       L
Sbjct: 63  QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 122
Query: 572 PWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNF 630
             +R   +       + +LH+     IIHRD+K +NI++  +   K+ DFGL +  G +F
Sbjct: 123 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 179
Query: 631 SKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
             T +V T+      Y  PE        E  D++S G ++ E++
Sbjct: 180 MMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 17/224 (7%)
Query: 459 SDLCTQFSISEIKEAT----KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GS 512
           S +  QF   E+ ++T    K + NL  IG G  G V   +       VAIK+L+    +
Sbjct: 4   SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 63
Query: 513 QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPL 571
           Q  A     E+ ++  + + +++SL+        +    D Y+    +  +L       L
Sbjct: 64  QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 123
Query: 572 PWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNF 630
             +R   +       + +LH+     IIHRD+K +NI++  +   K+ DFGL +  G +F
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180
Query: 631 SKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
             T +V T+      Y  PE        E  D++S G ++ E++
Sbjct: 181 MMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 17/224 (7%)
Query: 459 SDLCTQFSISEIKEAT----KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GS 512
           S +  QF   E+ ++T    K + NL  IG G  G V   +       VAIK+L+    +
Sbjct: 5   SKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 64
Query: 513 QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPL 571
           Q  A     E+ ++  + + +++SL+        +    D Y+    +  +L       L
Sbjct: 65  QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 124
Query: 572 PWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNF 630
             +R   +       + +LH+     IIHRD+K +NI++  +   K+ DFGL +  G +F
Sbjct: 125 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
Query: 631 SKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
             T +V T+      Y  PE        E  D++S G ++ E++
Sbjct: 182 MMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 17/219 (7%)
Query: 464 QFSISEIKEAT----KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGAL 517
           QF   E+ ++T    K + NL  IG G  G V   +       VAIK+L+    +Q  A 
Sbjct: 3   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 62
Query: 518 EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRR 576
               E+ ++  + + +++SL+        +    D Y+    +  +L       L  +R 
Sbjct: 63  RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 122
Query: 577 LKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKT-H 634
             +       + +LH+     IIHRD+K +NI++  +   K+ DFGL +  G +F  T +
Sbjct: 123 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 179
Query: 635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
           V T+      Y  PE        E  D++S G ++ E++
Sbjct: 180 VVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 17/219 (7%)
Query: 464 QFSISEIKEAT----KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGAL 517
           QF   E+ ++T    K + NL  IG G  G V   +       VAIK+L+    +Q  A 
Sbjct: 3   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 62
Query: 518 EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRR 576
               E+ ++  + + +++SL+        +    D Y+    +  +L       L  +R 
Sbjct: 63  RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 122
Query: 577 LKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKT-H 634
             +       + +LH+     IIHRD+K +NI++  +   K+ DFGL +  G +F  T +
Sbjct: 123 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 179
Query: 635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
           V T+      Y  PE        E  D++S G ++ E++
Sbjct: 180 VVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 17/219 (7%)
Query: 464 QFSISEIKEAT----KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGAL 517
           QF   E+ ++T    K + NL  IG G  G V   +       VAIK+L+    +Q  A 
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 518 EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRR 576
               E+ ++  + + +++SL+        +    D Y+    +  +L       L  +R 
Sbjct: 62  RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 121
Query: 577 LKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKT-H 634
             +       + +LH+     IIHRD+K +NI++  +   K+ DFGL +  G +F  T +
Sbjct: 122 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 178
Query: 635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
           V T+      Y  PE        E  D++S G ++ E++
Sbjct: 179 VVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 95/222 (42%), Gaps = 22/222 (9%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQG------ALEFQTEIGMLSQLR----Y 531
           ++G+GGFG V+ G    D   VAIK +      G      ++    E+ +L ++     +
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 532 LHLVSLIGYCN-DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
             ++ L+ +    +G M+++   +    L D  Y  +  PL              A+ + 
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFD--YITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 591 HTGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           H   S+ ++HRD+K  NIL+D     AK+ DFG              T   G+  Y  PE
Sbjct: 156 H---SRGVVHRDIKDENILIDLRRGCAKLIDFG----SGALLHDEPYTDFDGTRVYSPPE 208
Query: 650 YY-RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL 690
           +  R Q     + V+S G++L +++C   P  R  +  +  L
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL 250

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 105/238 (44%), Gaps = 34/238 (14%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL---NPGSQQGALEFQTEIGMLSQLRYLH 533
           + +L  +G GG G V+    N     VAIK++   +P S + AL    EI ++ +L + +
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR---EIKIIRRLDHDN 69
Query: 534 LVSLIGYCNDDGQMI---------LVYDYMARGTLRDHLYN--NDNPPLPWDRRLKICIG 582
           +V +       G  +         L   Y+ +  +   L N     P L    RL     
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-FMYQ 128
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCK-FGPNFS-KTHVSTQV 639
             R L Y+H+     ++HRD+K  N+ ++ E+ V K+ DFGL +   P++S K H+S  +
Sbjct: 129 LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 640 -----KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAV 692
                +     L P  Y     T+  D+++ G +  E+L  +       + +Q+ L +
Sbjct: 186 VTKWYRSPRLLLSPNNY-----TKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 6/95 (6%)
Query: 585 RALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH--VSTQVKGS 642
           R L Y+H+     +IHRD+K +N+L++E    K+ DFG+ +        H    T+   +
Sbjct: 170 RGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 643 IGYLDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             Y  PE    L   T+  D++S G +  E+L  R
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 261

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLSQL 529
           E  +    L  +G G +G+V   +       VA+K+L+   Q    A     E+ +L  L
Sbjct: 17  EVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHL 76
Query: 530 RYLHLVSLIGY------CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICI-G 582
           ++ +++ L+          D  ++ LV   M        L N        D  ++  +  
Sbjct: 77  KHENVIGLLDVFTPATSIEDFSEVYLVTTLMGAD-----LNNIVKCQALSDEHVQFLVYQ 131
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS 642
             R L Y+H+     IIHRD+K +N+ ++E+   ++ DFGL +        +V+T+    
Sbjct: 132 LLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR---- 184
Query: 643 IGYLDPE-YYRLQLLTEKSDVYSFGVVLLEVL 673
             Y  PE         +  D++S G ++ E+L
Sbjct: 185 -WYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 215

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 91/215 (42%), Gaps = 23/215 (10%)
Query: 472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLSQL 529
           E  +    L  +G G +G+V   +       VA+K+L+   Q    A     E+ +L  L
Sbjct: 25  EVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHL 84
Query: 530 RYLHLVSLIGY------CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICI-G 582
           ++ +++ L+          D  ++ LV   M        L N        D  ++  +  
Sbjct: 85  KHENVIGLLDVFTPATSIEDFSEVYLVTTLMGAD-----LNNIVKSQALSDEHVQFLVYQ 139
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS 642
             R L Y+H+     IIHRD+K +N+ ++E+   ++ DFGL +        +V+T+    
Sbjct: 140 LLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR---- 192
Query: 643 IGYLDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             Y  PE         +  D++S G ++ E+L  +
Sbjct: 193 -WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 13/204 (6%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGALEFQTEIGMLSQLRYL 532
           K + NL  IG G  G V   +       VAIK+L+    +Q  A     E+ ++  + + 
Sbjct: 24  KRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 533 HLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
           +++ L+        +    D Y+    +  +L       L  +R   +       + +LH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLH 143
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKT-HVSTQVKGSIGYLDPE 649
           +     IIHRD+K +NI++  +   K+ DFGL +  G +F  T +V T+      Y  PE
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPE 195
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVL 673
                   E  D++S GV++ E++
Sbjct: 196 VILGMGYKENVDIWSVGVIMGEMI 219

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 16/203 (7%)
Query: 483 IGRGGFGNVYK--GFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGY 540
           +G+G F  V +    L G      I      S +   + + E  +   L++ ++V L   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 541 CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGA--ARALHYLHTGASKVI 598
            +++G   L++D +  G L + +   +      +     CI       LH    G    +
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVAREYYS---EADASHCIQQILEAVLHCHQMG----V 142
Query: 599 IHRDVKTTNILLDEEW---VAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
           +HRD+K  N+LL  +      K++DFGL        +        G+ GYL PE  R   
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKDP 200
Query: 656 LTEKSDVYSFGVVLLEVLCARPP 678
             +  D+++ GV+L  +L   PP
Sbjct: 201 YGKPVDLWACGVILYILLVGYPP 223

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 13/210 (6%)
Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYL 532
           ++  +  IG G +G V           VAIK++ P +      A     E+ +L   ++ 
Sbjct: 55  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 533 HLVSLIGYCNDD---GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           +++++          G+   VY  +       H   + + PL  +          R L Y
Sbjct: 114 NIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKY 173
Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH--VSTQVKGSIGYLD 647
           +H+     +IHRD+K +N+L++E    K+ DFG+ +        H    T+   +  Y  
Sbjct: 174 MHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 230
Query: 648 PE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           PE    L   T+  D++S G +  E+L  R
Sbjct: 231 PELMLSLHEYTQAIDLWSVGCIFGEMLARR 260

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 63/148 (42%), Gaps = 7/148 (4%)
Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLSQLRYLHLVSLIG 539
           +IGRG +G VY  +       VAIK++N   +          EI +L++L+  +++ L  
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92
Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPP--LPWDRRLKICIGAARALHYLHTGASKV 597
               D  +     Y+        L      P  L  +    I        +++H      
Sbjct: 93  LIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--- 149
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCK 625
           IIHRD+K  N LL+++   KV DFGL +
Sbjct: 150 IIHRDLKPANCLLNQDCSVKVCDFGLAR 177

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 13/207 (6%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGALEFQTEIGMLSQLRYL 532
           K + NL  IG G  G V   +       VAIK+L+    +Q  A     E+ ++  + + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 533 HLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
           +++ L+        +    D Y+    +  +L       L  +R   +       + +LH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNF-SKTHVSTQVKGSIGYLDPE 649
           +     IIHRD+K +NI++  +   K+ DFGL +  G +F  +  V T+      Y  PE
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY-----YRAPE 195
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
                   E  D++S G ++ E++C +
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 32/216 (14%)
Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVS 536
           + N  +IG G FG V++  L  +S  VAIK++    +    E Q    ++  +++ ++V 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKL-VESDEVAIKKVLQDKRFKNRELQ----IMRIVKHPNVVD 96
Query: 537 LIG--YCNDDGQ----MILVYDYMARGTLR-DHLYNNDNPPLPWDRRLKICIGAARALHY 589
           L    Y N D +    + LV +Y+     R    Y      +P            R+L Y
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 590 LHTGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           +H+     I HRD+K  N+LLD    V K+ DFG  K         +    + ++  +  
Sbjct: 157 IHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK---------ILIAGEPNVSXICS 204
Query: 649 EYYRLQLL-------TEKSDVYSFGVVLLEVLCARP 677
            YYR   L       T   D++S G V+ E++  +P
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 91/215 (42%), Gaps = 23/215 (10%)
Query: 472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLSQL 529
           E  +    L  +G G +G+V   +       VA+K+L+   Q    A     E+ +L  L
Sbjct: 25  EVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHL 84
Query: 530 RYLHLVSLIGY------CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICI-G 582
           ++ +++ L+          D  ++ LV   M        L N        D  ++  +  
Sbjct: 85  KHENVIGLLDVFTPATSIEDFSEVYLVTTLMGAD-----LNNIVKCQALSDEHVQFLVYQ 139
Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS 642
             R L Y+H+     IIHRD+K +N+ ++E+   ++ DFGL +        +V+T+    
Sbjct: 140 LLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR---- 192
Query: 643 IGYLDPE-YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
             Y  PE         +  D++S G ++ E+L  +
Sbjct: 193 -WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 13/204 (6%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGALEFQTEIGMLSQLRYL 532
           K + NL  IG G  G V   +       VAIK+L+    +Q  A     E+ ++  + + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 533 HLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
           +++ L+        +    D Y+    +  +L       L  +R   +       + +LH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLH 143
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKT-HVSTQVKGSIGYLDPE 649
           +     IIHRD+K +NI++  +   K+ DFGL +  G +F  T +V T+      Y  PE
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPE 195
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVL 673
                   E  D++S GV++ E++
Sbjct: 196 VILGMGYKENVDIWSVGVIMGEMI 219

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 97/224 (43%), Gaps = 17/224 (7%)
Query: 459 SDLCTQFSISEIKEAT----KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GS 512
           S +  QF   E+ ++T    K +  L  IG G  G V   F       VA+K+L+    +
Sbjct: 4   SKVDNQFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN 63
Query: 513 QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPL 571
           Q  A     E+ +L  + + +++SL+        +    D Y+    +  +L    +  L
Sbjct: 64  QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMEL 123
Query: 572 PWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG-PNF 630
             +R   +       + +LH+     IIHRD+K +NI++  +   K+ DFGL +    NF
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF 180
Query: 631 SKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL 673
             T +V T+      Y  PE           D++S G ++ E++
Sbjct: 181 MMTPYVVTRY-----YRAPEVILGMGYAANVDIWSVGCIMGELV 219

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 64/142 (45%), Gaps = 24/142 (16%)
Query: 547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTT 606
           ++++ + M  G L   +    +         +I      A+ +LH   S  I HRDVK  
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPE 157
Query: 607 NILL---DEEWVAKVSDFGLCKFG-------PNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
           N+L    +++ V K++DFG  K         P ++  +V+ +V G      PE Y     
Sbjct: 158 NLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLG------PEKY----- 206
Query: 657 TEKSDVYSFGVVLLEVLCARPP 678
            +  D++S GV++  +LC  PP
Sbjct: 207 DKSCDMWSLGVIMYILLCGFPP 228

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 18/197 (9%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEF--QTEIGMLSQLRYLHLVSLIGY 540
           +GRG FG V++          A+K++        LE     E+   + L    +V L G 
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVR-------LEVFRVEELVACAGLSSPRIVPLYGA 118
Query: 541 CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIH 600
             +   + +  + +  G+L   +       LP DR L     A   L YLHT   + I+H
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHT---RRILH 173
Query: 601 RDVKTTNILLDEEWV-AKVSDFG--LCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLL 656
            DVK  N+LL  +   A + DFG  LC       K+ ++   + G+  ++ PE    +  
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 657 TEKSDVYSFGVVLLEVL 673
             K D++S   ++L +L
Sbjct: 234 DAKVDIWSSCCMMLHML 250

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 64/142 (45%), Gaps = 24/142 (16%)
Query: 547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTT 606
           ++++ + M  G L   +    +         +I      A+ +LH   S  I HRDVK  
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPE 138
Query: 607 NILL---DEEWVAKVSDFGLCKFG-------PNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
           N+L    +++ V K++DFG  K         P ++  +V+ +V G      PE Y     
Sbjct: 139 NLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLG------PEKY----- 187
Query: 657 TEKSDVYSFGVVLLEVLCARPP 678
            +  D++S GV++  +LC  PP
Sbjct: 188 DKSCDMWSLGVIMYILLCGFPP 209

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 18/197 (9%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEF--QTEIGMLSQLRYLHLVSLIGY 540
           +GRG FG V++          A+K++        LE     E+   + L    +V L G 
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVR-------LEVFRVEELVACAGLSSPRIVPLYGA 134
Query: 541 CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIH 600
             +   + +  + +  G+L   +       LP DR L     A   L YLHT   + I+H
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHT---RRILH 189
Query: 601 RDVKTTNILLDEEWV-AKVSDFG--LCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLL 656
            DVK  N+LL  +   A + DFG  LC       K+ ++   + G+  ++ PE    +  
Sbjct: 190 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 249
Query: 657 TEKSDVYSFGVVLLEVL 673
             K D++S   ++L +L
Sbjct: 250 DAKVDIWSSCCMMLHML 266

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 18/197 (9%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEF--QTEIGMLSQLRYLHLVSLIGY 540
           +GRG FG V++          A+K++        LE     E+   + L    +V L G 
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVR-------LEVFRVEELVACAGLSSPRIVPLYGA 132
Query: 541 CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIH 600
             +   + +  + +  G+L   +       LP DR L     A   L YLHT   + I+H
Sbjct: 133 VREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHT---RRILH 187
Query: 601 RDVKTTNILLDEEWV-AKVSDFG--LCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLL 656
            DVK  N+LL  +   A + DFG  LC       K+ ++   + G+  ++ PE    +  
Sbjct: 188 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 247
Query: 657 TEKSDVYSFGVVLLEVL 673
             K D++S   ++L +L
Sbjct: 248 DAKVDIWSSCCMMLHML 264

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 13/207 (6%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGALEFQTEIGMLSQLRYL 532
           K + NL  IG G  G V   +       VAIK+L+    +Q  A     E+ ++  + + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 533 HLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
           +++ L+        +    D Y+    +  +L       L  +R   +       + +LH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNF-SKTHVSTQVKGSIGYLDPE 649
           +     IIHRD+K +NI++  +   K+ DFGL +  G +F  +  V T+      Y  PE
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY-----YRAPE 195
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCAR 676
                   E  D++S G ++ E++C +
Sbjct: 196 VILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 90/211 (42%), Gaps = 14/211 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRY 531
           T ++     +G+G F  V +          A K +N    S +   + + E  +   L++
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAA-RALHYL 590
            ++V L    +++G   LV+D +  G L + +   +      +     CI     ++++ 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS---EADASHCIQQILESVNHC 119
Query: 591 HTGASKVIIHRDVKTTNILLDEE---WVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
           H      I+HRD+K  N+LL  +      K++DFGL        +        G+ GYL 
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLS 174
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           PE  R     +  D+++ GV+L  +L   PP
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 63/143 (44%), Gaps = 25/143 (17%)
Query: 547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTT 606
           +++V + +  G L   + +  +         +I      A+ YLH   S  I HRDVK  
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPE 160
Query: 607 NILLDEE---WVAKVSDFGLCK--------FGPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
           N+L   +    + K++DFG  K          P ++  +V+ +V G      PE Y    
Sbjct: 161 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG------PEKY---- 210
Query: 656 LTEKSDVYSFGVVLLEVLCARPP 678
             +  D++S GV++  +LC  PP
Sbjct: 211 -DKSCDMWSLGVIMYILLCGYPP 232

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 64/280 (22%), Positives = 118/280 (42%), Gaps = 41/280 (14%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN--PGSQQGALEFQTEIGMLSQLRYL--HLVSLI 538
           IG GG   V++  LN      AIK +N      Q    ++ EI  L++L+     ++ L 
Sbjct: 17  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPL-PWDRRLKICIGAARALHYLHTGASKV 597
            Y   D  + +V   M  G +  + +      + PW+R+         A+H +H      
Sbjct: 76  DYEITDQYIYMV---MECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQHG--- 128
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYLDPEYYR---- 652
           I+H D+K  N L+  + + K+ DFG+  +  P+ +     +QV G++ Y+ PE  +    
Sbjct: 129 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDMSS 186
Query: 653 -------LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD 705
                     ++ KSDV+S G +L  +   + P  +  +              +  K+  
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--------------QISKLHA 232
Query: 706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           IIDP  +   P +      +V   C+  D  +R S+ +++
Sbjct: 233 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 65/280 (23%), Positives = 119/280 (42%), Gaps = 41/280 (14%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN--PGSQQGALEFQTEIGMLSQLRYL--HLVSLI 538
           IG GG   V++  LN      AIK +N      Q    ++ EI  L++L+     ++ L 
Sbjct: 64  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPL-PWDRRLKICIGAARALHYLHTGASKV 597
            Y   D  + +V   M  G +  + +      + PW+R+         A+H +H      
Sbjct: 123 DYEITDQYIYMV---MECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQHG--- 175
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYLDPEYYR---- 652
           I+H D+K  N L+  + + K+ DFG+  +  P+ +     +QV G++ Y+ PE  +    
Sbjct: 176 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDMSS 233
Query: 653 -------LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD 705
                     ++ KSDV+S G +L  +   + P  +      +N         +  K+  
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-----IN---------QISKLHA 279
Query: 706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           IIDP  +   P +      +V   C+  D  +R S+ +++
Sbjct: 280 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 64/280 (22%), Positives = 118/280 (42%), Gaps = 41/280 (14%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN--PGSQQGALEFQTEIGMLSQLRYL--HLVSLI 538
           IG GG   V++  LN      AIK +N      Q    ++ EI  L++L+     ++ L 
Sbjct: 36  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPL-PWDRRLKICIGAARALHYLHTGASKV 597
            Y   D  + +V   M  G +  + +      + PW+R+         A+H +H      
Sbjct: 95  DYEITDQYIYMV---MECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQHG--- 147
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYLDPEYYR---- 652
           I+H D+K  N L+  + + K+ DFG+  +  P+ +     +QV G++ Y+ PE  +    
Sbjct: 148 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDMSS 205
Query: 653 -------LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD 705
                     ++ KSDV+S G +L  +   + P  +  ++                K+  
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--------------SKLHA 251
Query: 706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           IIDP  +   P +      +V   C+  D  +R S+ +++
Sbjct: 252 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 110/287 (38%), Gaps = 56/287 (19%)
Query: 465 FSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-----SQQGALEF 519
           F    + E  K ++    IG+G +G V     N      AIK +N       + +     
Sbjct: 16  FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 520 QTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL--YNNDNP-------- 569
           +TE+ ++ +L + ++  L     D+  + LV +    G L D L  + +D+         
Sbjct: 76  KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 570 -----PLP-------------------WDRRLKICIGAAR----ALHYLHTGASKVIIHR 601
                P P                   + +R K+     R    ALHYLH      I HR
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHR 192
Query: 602 DVKTTNILL--DEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLT 657
           D+K  N L   ++ +  K+ DFGL K  +  N  + +  T   G+  ++ PE   L    
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV--LNTTN 250
Query: 658 E----KSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRN 700
           E    K D +S GV+L  +L    P     D   ++  +    C+ N
Sbjct: 251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN 297

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 65/280 (23%), Positives = 119/280 (42%), Gaps = 41/280 (14%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN--PGSQQGALEFQTEIGMLSQLRYL--HLVSLI 538
           IG GG   V++  LN      AIK +N      Q    ++ EI  L++L+     ++ L 
Sbjct: 64  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPL-PWDRRLKICIGAARALHYLHTGASKV 597
            Y   D  + +V   M  G +  + +      + PW+R+         A+H +H      
Sbjct: 123 DYEITDQYIYMV---MECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQHG--- 175
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYLDPEYYR---- 652
           I+H D+K  N L+  + + K+ DFG+  +  P+ +     +QV G++ Y+ PE  +    
Sbjct: 176 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPPEAIKDMSS 233
Query: 653 -------LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD 705
                     ++ KSDV+S G +L  +   + P  +      +N         +  K+  
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-----IN---------QISKLHA 279
Query: 706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           IIDP  +   P +      +V   C+  D  +R S+ +++
Sbjct: 280 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 13/204 (6%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGALEFQTEIGMLSQLRYL 532
           K + NL  IG G  G V   +       VAIK+L+    +Q  A     E+ ++  + + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 533 HLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
           +++ L+        +    D Y+    +  +L       L  +R   +       + +LH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKT-HVSTQVKGSIGYLDPE 649
           +     IIHRD+K +NI++  +   K+ DFGL +  G +F  T +V T+      Y  PE
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPE 195
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVL 673
                   E  D++S G ++ E++
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMI 219

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 13/204 (6%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGALEFQTEIGMLSQLRYL 532
           K + NL  IG G  G V   +       VAIK+L+    +Q  A     E+ ++  + + 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 533 HLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
           +++ L+        +    D Y+    +  +L       L  +R   +       + +LH
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKT-HVSTQVKGSIGYLDPE 649
           +     IIHRD+K +NI++  +   K+ DFGL +  G +F  T +V T+      Y  PE
Sbjct: 145 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPE 196
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVL 673
                   E  D++S G ++ E++
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMI 220

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 65/280 (23%), Positives = 119/280 (42%), Gaps = 41/280 (14%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN--PGSQQGALEFQTEIGMLSQLRYL--HLVSLI 538
           IG GG   V++  LN      AIK +N      Q    ++ EI  L++L+     ++ L 
Sbjct: 64  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPL-PWDRRLKICIGAARALHYLHTGASKV 597
            Y   D  + +V   M  G +  + +      + PW+R+         A+H +H      
Sbjct: 123 DYEITDQYIYMV---MECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQHG--- 175
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYLDPEYYR---- 652
           I+H D+K  N L+  + + K+ DFG+  +  P+ +     +QV G++ Y+ PE  +    
Sbjct: 176 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDMSS 233
Query: 653 -------LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD 705
                     ++ KSDV+S G +L  +   + P  +      +N         +  K+  
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-----IN---------QISKLHA 279
Query: 706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           IIDP  +   P +      +V   C+  D  +R S+ +++
Sbjct: 280 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 90/211 (42%), Gaps = 14/211 (6%)
Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRY 531
           T ++     +G+G F  V +          A K +N    S +   + + E  +   L++
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAA-RALHYL 590
            ++V L    +++G   LV+D +  G L + +   +      +     CI     ++++ 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS---EADASHCIQQILESVNHC 119
Query: 591 HTGASKVIIHRDVKTTNILLDEE---WVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
           H      I+HRD+K  N+LL  +      K++DFGL        +        G+ GYL 
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLS 174
Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           PE  R     +  D+++ GV+L  +L   PP
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 44/189 (23%), Positives = 81/189 (42%), Gaps = 21/189 (11%)
Query: 472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-----------FQ 520
           E ++ ++ +  +G G FG V+       +  V +K +    ++  LE             
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIK---KEKVLEDCWIEDPKLGKVT 77
Query: 521 TEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKIC 580
            EI +LS++ + +++ ++    + G   LV +    G L    + + +P L       I 
Sbjct: 78  LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIF 136
Query: 581 IGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK 640
                A+ YL     K IIHRD+K  NI++ E++  K+ DFG   +     +  +     
Sbjct: 137 RQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAY---LERGKLFYTFC 190
Query: 641 GSIGYLDPE 649
           G+I Y  PE
Sbjct: 191 GTIEYCAPE 199

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 13/204 (6%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGALEFQTEIGMLSQLRYL 532
           K + NL  IG G  G V   +       VAIK+L+    +Q  A     E+ ++  + + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 533 HLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
           +++ L+        +    D Y+    +  +L       L  +R   +       + +LH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLH 143
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKT-HVSTQVKGSIGYLDPE 649
           +     IIHRD+K +NI++  +   K+ DFGL +  G +F  T +V T+      Y  PE
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPE 195
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVL 673
                   E  D++S G ++ E++
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 13/204 (6%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGALEFQTEIGMLSQLRYL 532
           K + NL  IG G  G V   +       VAIK+L+    +Q  A     E+ ++  + + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 533 HLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
           +++ L+        +    D Y+    +  +L       L  +R   +       + +LH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKT-HVSTQVKGSIGYLDPE 649
           +     IIHRD+K +NI++  +   K+ DFGL +  G +F  T +V T+      Y  PE
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPE 195
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVL 673
                   E  D++S G ++ E++
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 13/204 (6%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGALEFQTEIGMLSQLRYL 532
           K + NL  IG G  G V   +       VAIK+L+    +Q  A     E+ ++  + + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 533 HLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
           +++ L+        +    D Y+    +  +L       L  +R   +       + +LH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKT-HVSTQVKGSIGYLDPE 649
           +     IIHRD+K +NI++  +   K+ DFGL +  G +F  T +V T+      Y  PE
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPE 195
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVL 673
                   E  D++S G ++ E++
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMI 219

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 63/143 (44%), Gaps = 25/143 (17%)
Query: 547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTT 606
           +++V + +  G L   + +  +         +I      A+ YLH   S  I HRDVK  
Sbjct: 96  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPE 152
Query: 607 NILLDEEW---VAKVSDFGLCK--------FGPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
           N+L   +    + K++DFG  K          P ++  +V+ +V G      PE Y    
Sbjct: 153 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG------PEKY---- 202
Query: 656 LTEKSDVYSFGVVLLEVLCARPP 678
             +  D++S GV++  +LC  PP
Sbjct: 203 -DKSCDMWSLGVIMYILLCGYPP 224

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 64/280 (22%), Positives = 117/280 (41%), Gaps = 41/280 (14%)
Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN--PGSQQGALEFQTEIGMLSQLRYL--HLVSLI 538
           IG GG   V++  LN      AIK +N      Q    ++ EI  L++L+     ++ L 
Sbjct: 36  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPL-PWDRRLKICIGAARALHYLHTGASKV 597
            Y   D  + +V   M  G +  + +      + PW+R+         A+H +H      
Sbjct: 95  DYEITDQYIYMV---MECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQHG--- 147
Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYLDPEYYR---- 652
           I+H D+K  N L+  + + K+ DFG+  +  P+       +QV G++ Y+ PE  +    
Sbjct: 148 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQV-GTVNYMPPEAIKDMSS 205
Query: 653 -------LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD 705
                     ++ KSDV+S G +L  +   + P  +  ++                K+  
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--------------SKLHA 251
Query: 706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           IIDP  +   P +      +V   C+  D  +R S+ +++
Sbjct: 252 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 63/143 (44%), Gaps = 25/143 (17%)
Query: 547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTT 606
           +++V + +  G L   + +  +         +I      A+ YLH   S  I HRDVK  
Sbjct: 94  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPE 150
Query: 607 NILLDEEW---VAKVSDFGLCK--------FGPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
           N+L   +    + K++DFG  K          P ++  +V+ +V G      PE Y    
Sbjct: 151 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG------PEKY---- 200
Query: 656 LTEKSDVYSFGVVLLEVLCARPP 678
             +  D++S GV++  +LC  PP
Sbjct: 201 -DKSCDMWSLGVIMYILLCGYPP 222

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 63/143 (44%), Gaps = 25/143 (17%)
Query: 547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTT 606
           +++V + +  G L   + +  +         +I      A+ YLH   S  I HRDVK  
Sbjct: 95  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPE 151
Query: 607 NILLDEEW---VAKVSDFGLCK--------FGPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
           N+L   +    + K++DFG  K          P ++  +V+ +V G      PE Y    
Sbjct: 152 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG------PEKY---- 201
Query: 656 LTEKSDVYSFGVVLLEVLCARPP 678
             +  D++S GV++  +LC  PP
Sbjct: 202 -DKSCDMWSLGVIMYILLCGYPP 223

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGALEFQTEIGMLSQLRYL 532
           K + NL  IG G  G V   +       VAIK+L+    +Q  A     E+ ++  + + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 533 HLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
           +++ L+        +    D Y+    +  +L       L  +R   +       + +LH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKT-HVSTQVKGSIGYLDPE 649
           +     IIHRD+K +NI++  +   K+ DFGL +  G +F  T  V T+      Y  PE
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRY-----YRAPE 195
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVL 673
                   E  D++S G ++ E++
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMI 219

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 79/174 (45%), Gaps = 33/174 (18%)
Query: 522 EIGMLSQLRYLHLVSLIGYCND--DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKI 579
           EI +L +L + ++V L+   +D  +  + +V++ + +G + +        PL  D+    
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME---VPTLKPLSEDQARFY 142
Query: 580 CIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
                + + YLH    + IIHRD+K +N+L+ E+   K++DFG            VS + 
Sbjct: 143 FQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFG------------VSNEF 187
Query: 640 KGSIGYLD-----PEYYRLQLLTEKS--------DVYSFGVVLLEVLCARPPIL 680
           KGS   L      P +   + L+E          DV++ GV L   +  + P +
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 63/143 (44%), Gaps = 25/143 (17%)
Query: 547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTT 606
           +++V + +  G L   + +  +         +I      A+ YLH   S  I HRDVK  
Sbjct: 89  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPE 145
Query: 607 NILLDEEW---VAKVSDFGLCK--------FGPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
           N+L   +    + K++DFG  K          P ++  +V+ +V G      PE Y    
Sbjct: 146 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG------PEKY---- 195
Query: 656 LTEKSDVYSFGVVLLEVLCARPP 678
             +  D++S GV++  +LC  PP
Sbjct: 196 -DKSCDMWSLGVIMYILLCGYPP 217

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 13/204 (6%)
Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP--GSQQGALEFQTEIGMLSQLRYL 532
           K + NL  IG G  G V   +       VAIK+L+    +Q  A     E+ ++  + + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 533 HLVSLIGYCNDDGQMILVYD-YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
           +++ L+        +    D Y+    +  +L       L  +R   +       + +LH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKT-HVSTQVKGSIGYLDPE 649
           +     IIHRD+K +NI++  +   K+ DFGL +  G +F  T +V T+      Y  PE
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPE 195
Query: 650 YYRLQLLTEKSDVYSFGVVLLEVL 673
                   E  D++S G ++ E++
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMI 219

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	767
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-179
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-130
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-126
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-79
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-66
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-65
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-64
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-64
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-63
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-62
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-62
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	8e-62
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-61
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-60
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-52
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-51
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-51
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-49
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-44
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-42
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-41
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-40
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-40
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-40
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-40
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-39
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-39
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-39
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-39
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-39
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-38
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-38
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-38
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-37
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-37
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-37
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-37
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-37
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-37
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-36
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-36
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-36
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-36
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-36
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-36
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-36
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-36
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-36
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-36
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-35
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-35
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-35
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-35
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-35
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-35
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-35
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-34
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-34
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-34
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-34
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-34
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-34
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-34
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-33
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-33
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-32
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-32
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-32
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-32
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-31
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-30
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-30
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-30
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-29
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-29
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-29
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-29
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-28
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-28
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-28
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	9e-28
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-27
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-27
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-27
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	1e-27
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	6e-11
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-27
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-27
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	7e-27
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-27
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	8e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-26
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-25
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-25
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-25
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-25
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-25
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-24
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-24
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-24
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-24
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-24
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-24
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-23
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-23
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-22
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-21
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-20
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-20
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-20
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-20
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-20
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-20
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-20
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-20
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-19
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-19
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-19
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-19
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-19
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-19
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-19
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-19
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-19
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-18
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-18
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-18
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-18
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-17
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-17
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	8e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-16
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-16
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-16
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-11
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-16
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-16
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-15
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-15
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-15
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-15
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-15
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-14
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-14
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-14
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-14
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-14
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-14
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-14
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-14
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-13
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-13
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-13
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-13
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-13
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	8e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	9e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	9e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-06
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-12
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-12
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	9e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-11
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	8e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	8e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-08
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-05

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  513 bits (1323), Expect = e-179
 Identities = 153/308 (49%), Positives = 204/308 (66%), Gaps = 6/308 (1%)

Query: 449 KSRGPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL 508
                +S L      +  + +++EAT +F++  +IG G FG VYKG L  D   VA+KR 
Sbjct: 13  NDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRR 71

Query: 509 NPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDN 568
            P S QG  EF+TEI  LS  R+ HLVSLIG+C++  +MIL+Y YM  G L+ HLY +D 
Sbjct: 72  TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131

Query: 569 P--PLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF 626
           P   + W++RL+ICIGAAR LHYLHT A   IIHRDVK+ NILLDE +V K++DFG+ K 
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK 188

Query: 627 GPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKK 686
           G    +TH+ST VKG++GY+DPEY+    LTEKSDVYSFGVVL EVLCAR  I+++  ++
Sbjct: 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248

Query: 687 QVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW 746
            VNLA WA E + NG++  I+DP L     P  L +F + A+ C+      RPSM DV+W
Sbjct: 249 MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308

Query: 747 GLEFVFQL 754
            LE+  +L
Sbjct: 309 KLEYALRL 316

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  388 bits (998), Expect = e-130
 Identities = 103/299 (34%), Positives = 165/299 (55%), Gaps = 21/299 (7%)

Query: 465 FSISEIKEATKDFNNLL------IIGRGGFGNVYKGFLNGDSTPVAIKRL----NPGSQQ 514
           FS  E+K  T +F+          +G GGFG VYKG++N   T VA+K+L    +  +++
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVAVKKLAAMVDITTEE 72

Query: 515 GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYN-NDNPPLPW 573
              +F  EI ++++ ++ +LV L+G+ +D   + LVY YM  G+L D L   +  PPL W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132

Query: 574 DRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT 633
             R KI  GAA  +++LH       IHRD+K+ NILLDE + AK+SDFGL +    F++T
Sbjct: 133 HMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189

Query: 634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVW 693
            +++++ G+  Y+ PE  R + +T KSD+YSFGVVLLE++   P +     ++   L   
Sbjct: 190 VMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEH--REPQLLLDI 246

Query: 694 ATECYRN-GKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV 751
             E       I D ID  +  +A    +     VA  C+++ + +RP +  V   L+ +
Sbjct: 247 KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  377 bits (971), Expect = e-126
 Identities = 121/290 (41%), Positives = 170/290 (58%), Gaps = 7/290 (2%)

Query: 465 FSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGA-LEFQTEI 523
           FS+ E++ A+ +F+N  I+GRGGFG VYKG L  D T VA+KRL     QG  L+FQTE+
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEV 78

Query: 524 GMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY--NNDNPPLPWDRRLKICI 581
            M+S   + +L+ L G+C    + +LVY YMA G++   L       PPL W +R +I +
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138

Query: 582 GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG 641
           G+AR L YLH      IIHRDVK  NILLDEE+ A V DFGL K       THV+T V+G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KDTHVTTAVRG 197

Query: 642 SIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPI--LRTGDKKQVNLAVWATECYR 699
           +IG++ PEY      +EK+DV+ +GV+LLE++  +      R  +   V L  W     +
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257

Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
             K+  ++D  L+GN     + Q ++VA+ C     + RP MS+VV  LE
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  255 bits (653), Expect = 6e-79
 Identities = 64/308 (20%), Positives = 112/308 (36%), Gaps = 28/308 (9%)

Query: 464 QFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEI 523
                 +   +     L +  RG FG V+K  L      VA+K      +Q   + + E+
Sbjct: 13  DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQS-WQNEYEV 69

Query: 524 GMLSQLRYLHLVSLIGYC----NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKI 579
             L  +++ +++  IG      + D  + L+  +  +G+L D L  N    + W+    I
Sbjct: 70  YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHI 126

Query: 580 CIGAARALHYLHT------GASK-VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK 632
               AR L YLH          K  I HRD+K+ N+LL     A ++DFGL         
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 633 THVSTQVKGSIGYLDPEYYRLQLL-----TEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
              +    G+  Y+ PE     +        + D+Y+ G+VL E+           D+  
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

Query: 688 VNLAVWATECYRNGKIGDII-----DPFLKGNAPP-VCLNQFVEVAMSCVNDDRIRRPSM 741
           +       +      + +++      P L+        +    E    C + D   R S 
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306

Query: 742 SDVVWGLE 749
             V   + 
Sbjct: 307 GCVGERIT 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  221 bits (566), Expect = 2e-66
 Identities = 78/330 (23%), Positives = 139/330 (42%), Gaps = 40/330 (12%)

Query: 445 MKEAKSRGPASSLPSDLCTQFSISEIKEATK---DFNNLLI---IGRGGFGNVYKGFLNG 498
           MK      P S                +       + +L I   IG G FG V++   +G
Sbjct: 1   MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG 60

Query: 499 DSTPVAIKRLNPGSQQGAL--EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMAR 556
             + VA+K L           EF  E+ ++ +LR+ ++V  +G       + +V +Y++R
Sbjct: 61  --SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118

Query: 557 GTLRDHLYNNDN-PPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV 615
           G+L   L+ +     L   RRL +    A+ ++YLH   +  I+HR++K+ N+L+D+++ 
Sbjct: 119 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYT 177

Query: 616 AKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCA 675
            KV DFGL +   +   +  S    G+  ++ PE  R +   EKSDVYSFGV+L E+   
Sbjct: 178 VKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATL 235

Query: 676 RPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNA----PPVCLNQFVEVAMSCV 731
           + P                   + N     ++            P     Q   +   C 
Sbjct: 236 QQP-------------------WGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCW 276

Query: 732 NDDRIRRPSMSDVVWGLEFVFQLLRESSEK 761
            ++  +RPS + ++  L     L++ +   
Sbjct: 277 TNEPWKRPSFATIMDLLR---PLIKSAVPP 303

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  217 bits (556), Expect = 5e-65
 Identities = 67/335 (20%), Positives = 125/335 (37%), Gaps = 56/335 (16%)

Query: 447 EAKSRGPASSLPSDLCTQFSISEIKEATKDFNNLLI---IGRGGFGNVYKGFLNGDSTPV 503
            A+S    +S  S    ++ I         F  L I   IG+G FG VY G  +G+   V
Sbjct: 10  SARSFPRKASQTSIFLQEWDI--------PFEQLEIGELIGKGRFGQVYHGRWHGE---V 58

Query: 504 AIKRLNPGSQQGAL--EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRD 561
           AI+ ++           F+ E+    Q R+ ++V  +G C     + ++       TL  
Sbjct: 59  AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118

Query: 562 HLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDF 621
            + +     L  ++  +I     + + YLH   +K I+H+D+K+ N+  D      ++DF
Sbjct: 119 VVRDA-KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDF 173

Query: 622 GLCKF---GPNFSKTHVSTQVKGSIGYLDPEYYRLQLL---------TEKSDVYSFGVVL 669
           GL           +        G + +L PE  R             ++ SDV++ G + 
Sbjct: 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIW 233

Query: 670 LEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV----CLNQFVE 725
            E+     P                   ++      II     G  P +       +  +
Sbjct: 234 YELHAREWP-------------------FKTQPAEAIIWQMGTGMKPNLSQIGMGKEISD 274

Query: 726 VAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSE 760
           + + C   ++  RP+ + ++  LE + +  R  S 
Sbjct: 275 ILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSH 309

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  216 bits (552), Expect = 2e-64
 Identities = 76/292 (26%), Positives = 127/292 (43%), Gaps = 41/292 (14%)

Query: 466 SISEIKEATKDFNNLLI---IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTE 522
           S+  I     D+  + +   +GRG FG V K         VAIK++   S++    F  E
Sbjct: 1   SLHMI-----DYKEIEVEEVVGRGAFGVVCKAKWRA--KDVAIKQIESESERK--AFIVE 51

Query: 523 IGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPP-LPWDRRLKICI 581
           +  LS++ + ++V L G C +   + LV +Y   G+L + L+  +  P       +  C+
Sbjct: 52  LRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 109

Query: 582 GAARALHYLHTGASKVIIHRDVKTTNILLDEEW-VAKVSDFGLCKFGPNFSKTHVSTQVK 640
             ++ + YLH+   K +IHRD+K  N+LL     V K+ DFG              T  K
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNK 164

Query: 641 GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRN 700
           GS  ++ PE +     +EK DV+S+G++L EV+  R P              +       
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP--------------FDEIGGPA 210

Query: 701 GKIGDIIDPFLKGNAPPV---CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
            +I   +     G  PP+          +   C + D  +RPSM ++V  + 
Sbjct: 211 FRIMWAV---HNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  214 bits (546), Expect = 7e-64
 Identities = 82/290 (28%), Positives = 136/290 (46%), Gaps = 30/290 (10%)

Query: 476 DFNNLLI---IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGAL--EFQTEIGMLSQLR 530
               + +   IG G FG VYKG  +GD   VA+K LN  +        F+ E+G+L + R
Sbjct: 22  PDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           +++++  +GY     Q+ +V  +    +L  HL+ ++       + + I    AR + YL
Sbjct: 79  HVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYL 136

Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
           H   +K IIHRD+K+ NI L E+   K+ DFGL      +S +H   Q+ GSI ++ PE 
Sbjct: 137 H---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193

Query: 651 YRLQLL---TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDII 707
            R+Q     + +SDVY+FG+VL E++  + P     +    +  +      R     D+ 
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY---SNINNRDQIIEMVG--RGSLSPDLS 248

Query: 708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRE 757
                      C  +   +   C+   R  RPS   ++  +E   +L RE
Sbjct: 249 ------KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE---ELARE 289

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  208 bits (532), Expect = 4e-62
 Identities = 78/289 (26%), Positives = 130/289 (44%), Gaps = 39/289 (13%)

Query: 476 DFNNLLI---IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGAL----EFQTEIGMLSQ 528
           DF  L +   IG GGFG VY+ F  G    VA+K       +         + E  + + 
Sbjct: 5   DFAELTLEEIIGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62

Query: 529 LRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALH 588
           L++ ++++L G C  +  + LV ++   G L   L       +P D  +   +  AR ++
Sbjct: 63  LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMN 119

Query: 589 YLHTGASKVIIHRDVKTTNILLDEE--------WVAKVSDFGLCKFGPNFSKTHVSTQVK 640
           YLH  A   IIHRD+K++NIL+ ++         + K++DFGL +    + +T   +   
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTTKMSAA- 175

Query: 641 GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRN 700
           G+  ++ PE  R  + ++ SDV+S+GV+L E+L    P  R  D   V   V A      
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP-FRGIDGLAVAYGV-AMNKLA- 232

Query: 701 GKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
                     +    P  C   F ++   C N D   RPS ++++  L 
Sbjct: 233 --------LPI----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  207 bits (530), Expect = 7e-62
 Identities = 57/284 (20%), Positives = 114/284 (40%), Gaps = 35/284 (12%)

Query: 476 DFNNLLI---IGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLR 530
           DF  L     +     G ++KG   G    + +K L     S + + +F  E   L    
Sbjct: 8   DFKQLNFLTKLNENHSGELWKGRWQG--NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65

Query: 531 YLHLVSLIGYCND--DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALH 588
           + +++ ++G C         L+  +M  G+L + L+   N  +   + +K  +  AR + 
Sbjct: 66  HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125

Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           +LHT    +I    + + ++++DE+  A++S   +         +  S     +  ++ P
Sbjct: 126 FLHT-LEPLIPRHALNSRSVMIDEDMTARISMADV-------KFSFQSPGRMYAPAWVAP 177

Query: 649 EYYR---LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD 705
           E  +          +D++SF V+L E++    P        ++ + V A E  R      
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVP-FADLSNMEIGMKV-ALEGLR------ 229

Query: 706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
              P +    PP       ++   C+N+D  +RP    +V  LE
Sbjct: 230 ---PTI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  209 bits (534), Expect = 8e-62
 Identities = 65/279 (23%), Positives = 111/279 (39%), Gaps = 30/279 (10%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G+G FG   K         + +K L    ++    F  E+ ++  L + +++  IG   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            D ++  + +Y+  GTLR  + + D+   PW +R+      A  + YLH   S  IIHRD
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLH---SMNIIHRD 133

Query: 603 VKTTNILLDEEWVAKVSDFGL------------CKFGPNFSKTHVSTQVKGSIGYLDPEY 650
           + + N L+ E     V+DFGL                           V G+  ++ PE 
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193

Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF 710
              +   EK DV+SFG+VL E++            + ++  +                 +
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNAD-PDYLPRTMDFGLNVRGFLD---------RY 243

Query: 711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
                PP C   F  + + C + D  +RPS   +   LE
Sbjct: 244 ----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  206 bits (526), Expect = 4e-61
 Identities = 83/307 (27%), Positives = 136/307 (44%), Gaps = 47/307 (15%)

Query: 463 TQFSISEIKEATKDFNNLLI---IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGAL-- 517
           ++F  S +       N +     IG+GGFG V+KG L  D + VAIK L  G  +G    
Sbjct: 6   SEFPKSRLPTL--ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEM 63

Query: 518 -----EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLP 572
                EFQ E+ ++S L + ++V L G  ++     +V +++  G L   L +  + P+ 
Sbjct: 64  IEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAH-PIK 120

Query: 573 WDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW-----VAKVSDFGLCKFG 627
           W  +L++ +  A  + Y+    +  I+HRD+++ NI L          AKV+DFGL +  
Sbjct: 121 WSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ- 178

Query: 628 PNFSKTHVSTQVKGSIGYLDPE--YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDK 685
                 H  + + G+  ++ PE      +  TEK+D YSF ++L  +L    P       
Sbjct: 179 ----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP------- 227

Query: 686 KQVNLAVWATECYRNGKIGDIIDPFLKGNAPPV---CLNQFVEVAMSCVNDDRIRRPSMS 742
                  +    Y  GKI  I     +G  P +   C  +   V   C + D  +RP  S
Sbjct: 228 -------FDE--YSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFS 278

Query: 743 DVVWGLE 749
            +V  L 
Sbjct: 279 YIVKELS 285

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  207 bits (528), Expect = 1e-60
 Identities = 64/318 (20%), Positives = 120/318 (37%), Gaps = 45/318 (14%)

Query: 464 QFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTE- 522
           + + SE      +   L +IGRG +G VYKG L+    PVA+K  +  ++Q    F  E 
Sbjct: 2   EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSFANRQ---NFINEK 56

Query: 523 -IGMLSQLRYLHLVSLIGYC-----NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRR 576
            I  +  + + ++   I        +   + +LV +Y   G+L  +L  +      W   
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSS 113

Query: 577 LKICIGAARALHYLHTGASK------VIIHRDVKTTNILLDEEWVAKVSDFGL------C 624
            ++     R L YLHT   +       I HRD+ + N+L+  +    +SDFGL       
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 625 KFGPNFSKTHVSTQVKGSIGYLDPEYYR-------LQLLTEKSDVYSFGVVLLEVLCARP 677
           +      + + +    G+I Y+ PE           +   ++ D+Y+ G++  E+     
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 678 PILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPP----------VCLNQFVEVA 727
            +       +  +A + TE   +    D+     +    P          + +    E  
Sbjct: 234 DLFPGESVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292

Query: 728 MSCVNDDRIRRPSMSDVV 745
             C + D   R +     
Sbjct: 293 EDCWDQDAEARLTAQXAE 310

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  183 bits (465), Expect = 6e-52
 Identities = 68/330 (20%), Positives = 121/330 (36%), Gaps = 44/330 (13%)

Query: 442 RAVMKEAKSRGPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDST 501
           R ++++++S G  S LP        +       K    +  IG+G +G V+ G   G   
Sbjct: 12  RDLIEQSQSSGSGSGLP------LLVQRTI--AKQIQMVKQIGKGRYGEVWMGKWRG--E 61

Query: 502 PVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG----QMILVYDYMARG 557
            VA+K      +  +   +TEI     +R+ +++  I           Q+ L+ DY   G
Sbjct: 62  KVAVKVFFTTEEA-SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENG 120

Query: 558 TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT-----GASKVIIHRDVKTTNILLDE 612
           +L D+L +     L     LK+   +   L +LHT          I HRD+K+ NIL+ +
Sbjct: 121 SLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177

Query: 613 EWVAKVSDFGLCKFGPNFSKTH--VSTQVKGSIGYLDPE------YYRLQLLTEKSDVYS 664
                ++D GL     + +           G+  Y+ PE                +D+YS
Sbjct: 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYS 237

Query: 665 FGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID---------PFLKGNA 715
           FG++L EV           + +      +      +    D+ +          F    +
Sbjct: 238 FGLILWEVARRCVSGGIVEEYQL----PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWS 293

Query: 716 PPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
              CL Q  ++   C   +   R +   V 
Sbjct: 294 SDECLRQMGKLMTECWAHNPASRLTALRVK 323

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  179 bits (455), Expect = 8e-51
 Identities = 57/290 (19%), Positives = 106/290 (36%), Gaps = 36/290 (12%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
            +G+G +G V++G   G    VA+K  +   ++     +TE+     LR+ +++  I   
Sbjct: 15  CVGKGRYGEVWRGSWQG--ENVAVKIFSSRDEKSWF-RETELYNTVMLRHENILGFIASD 71

Query: 542 ----NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK- 596
               +   Q+ L+  Y   G+L D+L       L     L+I +  A  L +LH      
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGT 128

Query: 597 ----VIIHRDVKTTNILLDEEWVAKVSDFGL-CKFGPNFSKTHV-STQVKGSIGYLDPE- 649
                I HRD+K+ NIL+ +     ++D GL      + ++  V +    G+  Y+ PE 
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188

Query: 650 -----YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG 704
                        ++ D+++FG+VL EV           D K      +      +    
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP----PFYDVVPNDPSFE 244

Query: 705 DIID---------PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           D+                      L    ++   C   +   R +   + 
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  176 bits (448), Expect = 2e-49
 Identities = 60/290 (20%), Positives = 112/290 (38%), Gaps = 36/290 (12%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
            IG+G FG V++G   G    VA+K  +   ++     + EI     LR+ +++  I   
Sbjct: 49  SIGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAAD 105

Query: 542 NDDG----QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK- 596
           N D     Q+ LV DY   G+L D+L       +  +  +K+ +  A  L +LH      
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGT 162

Query: 597 ----VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH--VSTQVKGSIGYLDPEY 650
                I HRD+K+ NIL+ +     ++D GL     + + T         G+  Y+ PE 
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222

Query: 651 YRLQLL------TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG 704
               +        +++D+Y+ G+V  E+   R  I    +  Q+    +      +  + 
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQL---PYYDLVPSDPSVE 278

Query: 705 DIIDPFLKGNAPPV---------CLNQFVEVAMSCVNDDRIRRPSMSDVV 745
           ++     +    P           L    ++   C   +   R +   + 
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  163 bits (416), Expect = 1e-44
 Identities = 71/279 (25%), Positives = 111/279 (39%), Gaps = 28/279 (10%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
           IGRG FG V+ G L  D+T VA+K            +F  E  +L Q  + ++V LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
                + +V + +  G     L       L     L++   AA  + YL    SK  IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHR 237

Query: 602 DVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSD 661
           D+   N L+ E+ V K+SDFG+ +   +          +  + +  PE       + +SD
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESD 297

Query: 662 VYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG---NAPP 717
           V+SFG++L E       P                   Y N       +   KG     P 
Sbjct: 298 VWSFGILLWETFSLGASP-------------------YPNLSNQQTREFVEKGGRLPCPE 338

Query: 718 VCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLR 756
           +C +    +   C   +  +RPS S +   L+ + +  R
Sbjct: 339 LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  160 bits (406), Expect = 3e-42
 Identities = 68/282 (24%), Positives = 117/282 (41%), Gaps = 31/282 (10%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
            +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 285

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
             +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHR
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHR 342

Query: 602 DVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSD 661
           ++   N L+ E  + KV+DFGL +              K  I +  PE       + KSD
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401

Query: 662 VYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN---APP 717
           V++FGV+L E+      P                   Y    +  + +   K      P 
Sbjct: 402 VWAFGVLLWEIATYGMSP-------------------YPGIDLSQVYELLEKDYRMERPE 442

Query: 718 VCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESS 759
            C  +  E+  +C   +   RPS +++    E    + +ESS
Sbjct: 443 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFE---TMFQESS 481

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  156 bits (396), Expect = 2e-41
 Identities = 76/276 (27%), Positives = 120/276 (43%), Gaps = 30/276 (10%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
            +G+G FG V+ G  NG +T VAIK L PG+      F  E  ++ +LR+  LV L    
Sbjct: 191 KLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
           +++   I V +YM++G+L D L       L   + + +    A  + Y+        +HR
Sbjct: 249 SEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHR 304

Query: 602 DVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSD 661
           D++  NIL+ E  V KV+DFGL +   + ++       K  I +  PE       T KSD
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363

Query: 662 VYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG---NAPP 717
           V+SFG++L E+    R P                   Y      +++D   +G     PP
Sbjct: 364 VWSFGILLTELTTKGRVP-------------------YPGMVNREVLDQVERGYRMPCPP 404

Query: 718 VCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
            C     ++   C   +   RP+   +   LE  F 
Sbjct: 405 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  151 bits (383), Expect = 1e-40
 Identities = 66/289 (22%), Positives = 116/289 (40%), Gaps = 38/289 (13%)

Query: 482 IIGRGGFGNVYKGFLNGDS----TPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVS 536
           ++G G FG VYKG    +      PVAIK L   +   A  E   E  +++ +   H+  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           L+G C      + +   M  G L D++  +    +     L  C+  A+ ++YL     +
Sbjct: 82  LLGICLTSTVQL-ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYL---EDR 136

Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
            ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E    ++ 
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196

Query: 657 TEKSDVYSFGVVLLEV--LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
           T +SDV+S+GV + E+    ++P                    Y      +I     KG 
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKP--------------------YDGIPASEISSILEKGE 236

Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSE 760
               PP+C      +   C   D   RP   +++       ++ R+   
Sbjct: 237 RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFS---KMARDPQR 282

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  155 bits (393), Expect = 2e-40
 Identities = 76/276 (27%), Positives = 120/276 (43%), Gaps = 30/276 (10%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
            +G+G FG V+ G  NG +T VAIK L PG+      F  E  ++ +LR+  LV L    
Sbjct: 274 KLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
           +++   I V +YM++G+L D L       L   + + +    A  + Y+        +HR
Sbjct: 332 SEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHR 387

Query: 602 DVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSD 661
           D++  NIL+ E  V KV+DFGL +   + ++       K  I +  PE       T KSD
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446

Query: 662 VYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG---NAPP 717
           V+SFG++L E+    R P                   Y      +++D   +G     PP
Sbjct: 447 VWSFGILLTELTTKGRVP-------------------YPGMVNREVLDQVERGYRMPCPP 487

Query: 718 VCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
            C     ++   C   +   RP+   +   LE  F 
Sbjct: 488 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  148 bits (377), Expect = 4e-40
 Identities = 87/318 (27%), Positives = 140/318 (44%), Gaps = 46/318 (14%)

Query: 455 SSLPSDLCTQFSISEIKEATKDFNNLLI-----IGRGGFGNVYKGFL---NGDSTPVAIK 506
           S+L  +L     +  ++      ++L++     IGRG FG VY G L   +G     A+K
Sbjct: 5   SALNPEL-----VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 59

Query: 507 RLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYC-NDDGQMILVYDYMARGTLRDHLY 564
            LN         +F TE  ++    + +++SL+G C   +G  ++V  YM  G LR+ + 
Sbjct: 60  SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 119

Query: 565 NNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC 624
           N           +   +  A+ + YL   ASK  +HRD+   N +LDE++  KV+DFGL 
Sbjct: 120 NET-HNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175

Query: 625 K--FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEV--LCARPPIL 680
           +  +   +   H  T  K  + ++  E  + Q  T KSDV+SFGV+L E+    A P   
Sbjct: 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--- 232

Query: 681 RTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN---APPVCLNQFVEVAMSCVNDDRIR 737
                            Y +    DI    L+G     P  C +   EV + C +     
Sbjct: 233 -----------------YPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEM 275

Query: 738 RPSMSDVVWGLEFVFQLL 755
           RPS S++V  +  +F   
Sbjct: 276 RPSFSELVSRISAIFSTF 293

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  147 bits (374), Expect = 8e-40
 Identities = 69/276 (25%), Positives = 117/276 (42%), Gaps = 28/276 (10%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
            +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +LV L+G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 78

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
             +    ++ ++M  G L D+L   +   +     L +    + A+ YL     K  IHR
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHR 135

Query: 602 DVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSD 661
           D+   N L+ E  + KV+DFGL +     + T      K  I +  PE       + KSD
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSD 194

Query: 662 VYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN---APP 717
           V++FGV+L E+      P                   Y    +  + +   K      P 
Sbjct: 195 VWAFGVLLWEIATYGMSP-------------------YPGIDLSQVYELLEKDYRMERPE 235

Query: 718 VCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
            C  +  E+  +C   +   RPS +++    E +FQ
Sbjct: 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  149 bits (377), Expect = 2e-39
 Identities = 91/381 (23%), Positives = 146/381 (38%), Gaps = 49/381 (12%)

Query: 404 SPQQSTKAKNNRPRMLGIVGVVASGLVVLFIVFLLISRRAVMKEAKSRGPASSLPSDLCT 463
            P       + R R     G++             I   +     K+             
Sbjct: 5   DPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTV 64

Query: 464 QFSISEI--------KEATKDFNNLLI-----IGRGGFGNVYKGFL---NGDSTPVAIKR 507
              +S +        +      ++L++     IGRG FG VY G L   +G     A+K 
Sbjct: 65  HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 124

Query: 508 LNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCND-DGQMILVYDYMARGTLRDHLYN 565
           LN         +F TE  ++    + +++SL+G C   +G  ++V  YM  G LR+ + N
Sbjct: 125 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 184

Query: 566 NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK 625
                      +   +  A+ + +L   ASK  +HRD+   N +LDE++  KV+DFGL +
Sbjct: 185 ET-HNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

Query: 626 F--GPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEV--LCARPPILR 681
                 F   H  T  K  + ++  E  + Q  T KSDV+SFGV+L E+    A P    
Sbjct: 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP---- 296

Query: 682 TGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN---APPVCLNQFVEVAMSCVNDDRIRR 738
                           Y +    DI    L+G     P  C +   EV + C +     R
Sbjct: 297 ----------------YPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 340

Query: 739 PSMSDVVWGLEFVFQLLRESS 759
           PS S++V  +  +F       
Sbjct: 341 PSFSELVSRISAIFSTFIGEH 361

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  147 bits (373), Expect = 2e-39
 Identities = 67/296 (22%), Positives = 119/296 (40%), Gaps = 38/296 (12%)

Query: 482 IIGRGGFGNVYKGFLNGDS----TPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVS 536
           ++G G FG VYKG    +      PVAIK L   +   A  E   E  +++ +   H+  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           L+G C      + +   M  G L D++  +    +     L  C+  A+ ++YL     +
Sbjct: 82  LLGICLTSTVQL-ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYL---EDR 136

Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
            ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E    ++ 
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196

Query: 657 TEKSDVYSFGVVLLEV--LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
           T +SDV+S+GV + E+    ++P                    Y      +I     KG 
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKP--------------------YDGIPASEISSILEKGE 236

Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEKSMIAHP 767
               PP+C      + + C   D   RP   +++       ++ R+     +I   
Sbjct: 237 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS---KMARDPQRYLVIQGD 289

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  150 bits (381), Expect = 3e-39
 Identities = 66/277 (23%), Positives = 114/277 (41%), Gaps = 32/277 (11%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
            +G G FG V+    N   T VA+K + PGS      F  E  ++  L++  LV L    
Sbjct: 195 KLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVV 252

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
             +   I + ++MA+G+L D L +++    P  + +      A  + ++     +  IHR
Sbjct: 253 TKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHR 308

Query: 602 DVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSD 661
           D++  NIL+    V K++DFGL +   + ++       K  I +  PE       T KSD
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367

Query: 662 VYSFGVVLLEV--LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG---NAP 716
           V+SFG++L+E+      P                    Y      ++I    +G     P
Sbjct: 368 VWSFGILLMEIVTYGRIP--------------------YPGMSNPEVIRALERGYRMPRP 407

Query: 717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
             C  +   + M C  +    RP+   +   L+  + 
Sbjct: 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  147 bits (372), Expect = 3e-39
 Identities = 78/298 (26%), Positives = 129/298 (43%), Gaps = 22/298 (7%)

Query: 482 IIGRGGFGNVYKGFLNGD----STPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
            +G+G FG+V     +         VA+K+L         +FQ EI +L  L    +V  
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89

Query: 538 IGYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
            G     G+  + LV +Y+  G LRD L  +    L   R L       + + YL    S
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLG---S 145

Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS-IGYLDPEYYRLQ 654
           +  +HRD+   NIL++ E   K++DFGL K  P     +V  +   S I +  PE     
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205

Query: 655 LLTEKSDVYSFGVVLLEV--LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK 712
           + + +SDV+SFGVVL E+   C +     +   + + +     +     ++ ++++   +
Sbjct: 206 IFSRQSDVWSFGVVLYELFTYCDKS---CSPSAEFLRMMGCERDVPALSRLLELLE---E 259

Query: 713 GN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEKSMIAHP 767
           G    APP C  +  E+   C       RPS S +   L+ ++   R     +  AHP
Sbjct: 260 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHP 317

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  145 bits (367), Expect = 7e-39
 Identities = 70/286 (24%), Positives = 126/286 (44%), Gaps = 25/286 (8%)

Query: 482 IIGRGGFGNVYKGFLNG----DSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
            +G+G FG+V     +         VA+K+L   +++   +F+ EI +L  L++ ++V  
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76

Query: 538 IGYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
            G C   G+  + L+ +Y+  G+LRD+L  +    +   + L+      + + YL    +
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG---T 132

Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS-IGYLDPEYYRLQ 654
           K  IHRD+ T NIL++ E   K+ DFGL K  P   +     +   S I +  PE     
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192

Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATEC----YRNGKIGDIIDPF 710
             +  SDV+SFGVVL E       +    +K +   A +             +  +I+  
Sbjct: 193 KFSVASDVWSFGVVLYE-------LFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245

Query: 711 LKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
                   P  C ++   +   C N++  +RPS  D+   ++ +  
Sbjct: 246 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  144 bits (365), Expect = 2e-38
 Identities = 66/286 (23%), Positives = 123/286 (43%), Gaps = 25/286 (8%)

Query: 482 IIGRGGFGNVYKGFLNGD----STPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVS 536
            +G G FG V     + +       VA+K L P S    + + + EI +L  L + ++V 
Sbjct: 28  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87

Query: 537 LIGYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
             G C +DG   + L+ +++  G+L+++L  N    +   ++LK  +   + + YL    
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYL---G 143

Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT-HVSTQVKGSIGYLDPEYYRL 653
           S+  +HRD+   N+L++ E   K+ DFGL K      +   V       + +  PE    
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203

Query: 654 QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATEC---YRNGKIGDIIDPF 710
                 SDV+SFGV L E       +L   D     +A++       +    +  +++  
Sbjct: 204 SKFYIASDVWSFGVTLHE-------LLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256

Query: 711 LKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
            +G     PP C ++  ++   C       R S  +++ G E + +
Sbjct: 257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  144 bits (366), Expect = 2e-38
 Identities = 70/286 (24%), Positives = 126/286 (44%), Gaps = 25/286 (8%)

Query: 482 IIGRGGFGNVYKGFLNG----DSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
            +G+G FG+V     +         VA+K+L   +++   +F+ EI +L  L++ ++V  
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107

Query: 538 IGYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
            G C   G+  + L+ +Y+  G+LRD+L  +    +   + L+      + + YL    +
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYL---GT 163

Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT-HVSTQVKGSIGYLDPEYYRLQ 654
           K  IHRD+ T NIL++ E   K+ DFGL K  P   +   V    +  I +  PE     
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 223

Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATEC----YRNGKIGDIIDPF 710
             +  SDV+SFGVVL E       +    +K +   A +             +  +I+  
Sbjct: 224 KFSVASDVWSFGVVLYE-------LFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276

Query: 711 LKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
                   P  C ++   +   C N++  +RPS  D+   ++ +  
Sbjct: 277 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  146 bits (370), Expect = 8e-38
 Identities = 81/280 (28%), Positives = 125/280 (44%), Gaps = 42/280 (15%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
            IG+G FG+V  G   G    VA+K +   +      F  E  +++QLR+ +LV L+G  
Sbjct: 200 TIGKGEFGDVMLGDYRG--NKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVI 255

Query: 542 -NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIH 600
             + G + +V +YMA+G+L D+L +     L  D  LK  +    A+ YL        +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVH 312

Query: 601 RDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS---IGYLDPEYYRLQLLT 657
           RD+   N+L+ E+ VAKVSDFGL K          S+        + +  PE  R +  +
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTAPEALREKKFS 364

Query: 658 EKSDVYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN-- 714
            KSDV+SFG++L E+    R P                   Y    + D++    KG   
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVP-------------------YPRIPLKDVVPRVEKGYKM 405

Query: 715 -APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
            AP  C     +V  +C + D   RP+   +   LE +  
Sbjct: 406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  140 bits (355), Expect = 2e-37
 Identities = 72/276 (26%), Positives = 114/276 (41%), Gaps = 30/276 (10%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
            +G G FG V+ G+ NG  T VA+K L  GS      F  E  ++ QL++  LV L    
Sbjct: 20  RLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVV 77

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
             +   I + +YM  G+L D L       L  ++ L +    A  + ++     +  IHR
Sbjct: 78  TQEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHR 133

Query: 602 DVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSD 661
           D++  NIL+ +    K++DFGL +   +   T      K  I +  PE       T KSD
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSD 192

Query: 662 VYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG---NAPP 717
           V+SFG++L E++   R P                   Y      ++I    +G     P 
Sbjct: 193 VWSFGILLTEIVTHGRIP-------------------YPGMTNPEVIQNLERGYRMVRPD 233

Query: 718 VCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
            C  +  ++   C  +    RP+   +   LE  F 
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  140 bits (356), Expect = 2e-37
 Identities = 71/293 (24%), Positives = 115/293 (39%), Gaps = 34/293 (11%)

Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           +IG+G FG VY G       +    AIK L+     Q    F  E  ++  L + ++++L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87

Query: 538 IGYCND-DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           IG     +G   ++  YM  G L   + +           +   +  AR + YL   A +
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYL---AEQ 143

Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCK--FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
             +HRD+   N +LDE +  KV+DFGL +      +         +  + +   E  +  
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY 203

Query: 655 LLTEKSDVYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
             T KSDV+SFGV+L E+L    PP                   YR+    D+     +G
Sbjct: 204 RFTTKSDVWSFGVLLWELLTRGAPP-------------------YRHIDPFDLTHFLAQG 244

Query: 714 N---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEKSM 763
                P  C +   +V   C   D   RP+   +V  +E +   L       +
Sbjct: 245 RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQL 297

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  139 bits (352), Expect = 3e-37
 Identities = 72/276 (26%), Positives = 117/276 (42%), Gaps = 30/276 (10%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
            IG G FG V+ G+       VAIK +  G+     +F  E  ++ +L +  LV L G C
Sbjct: 15  EIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
            +   + LV ++M  G L D+L          +  L +C+     + YL       +IHR
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYL---EEACVIHR 128

Query: 602 DVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSD 661
           D+   N L+ E  V KVSDFG+ +F  +   T  ST  K  + +  PE +     + KSD
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSD 187

Query: 662 VYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN---APP 717
           V+SFGV++ EV    + P                   Y N    ++++    G     P 
Sbjct: 188 VWSFGVLMWEVFSEGKIP-------------------YENRSNSEVVEDISTGFRLYKPR 228

Query: 718 VCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           +      ++   C  +    RP+ S ++  L  + +
Sbjct: 229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  140 bits (354), Expect = 4e-37
 Identities = 67/288 (23%), Positives = 107/288 (37%), Gaps = 34/288 (11%)

Query: 482 IIGRGGFGNVYKGFLNGDS--TPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSL 537
            +G G FG V KG+         VA+K L           E   E  ++ QL   ++V +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
           IG C  +  M+ V +    G L  +L  N +        +++    +  + YL       
Sbjct: 84  IGICEAESWML-VMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYL---EESN 137

Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLL 656
            +HRD+   N+LL  +  AK+SDFGL K        + +    K  + +  PE       
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197

Query: 657 TEKSDVYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN- 714
           + KSDV+SFGV++ E     + P                   YR  K  ++     KG  
Sbjct: 198 SSKSDVWSFGVLMWEAFSYGQKP-------------------YRGMKGSEVTAMLEKGER 238

Query: 715 --APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSE 760
              P  C  +  ++   C   D   RP  + V   L   +  +     
Sbjct: 239 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 286

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  140 bits (356), Expect = 4e-37
 Identities = 66/296 (22%), Positives = 118/296 (39%), Gaps = 38/296 (12%)

Query: 482 IIGRGGFGNVYKGFLNGDS----TPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVS 536
           ++G G FG V+KG    +      PV IK +   S + +       +  +  L + H+V 
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           L+G C      + V  Y+  G+L DH+  +    L     L   +  A+ ++YL      
Sbjct: 80  LLGLCPGSSLQL-VTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYL---EEH 134

Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
            ++HR++   N+LL      +V+DFG+    P   K  + ++ K  I ++  E       
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194

Query: 657 TEKSDVYSFGVVLLEV--LCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
           T +SDV+S+GV + E+    A P                    Y   ++ ++ D   KG 
Sbjct: 195 THQSDVWSYGVTVWELMTFGAEP--------------------YAGLRLAEVPDLLEKGE 234

Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEKSMIAHP 767
               P +C      V + C   D   RP+  ++        ++ R+     +I   
Sbjct: 235 RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFT---RMARDPPRYLVIKRE 287

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  139 bits (353), Expect = 4e-37
 Identities = 68/290 (23%), Positives = 110/290 (37%), Gaps = 34/290 (11%)

Query: 483 IGRGGFGNVYKGFLN--GDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSLIG 539
           +G G FG+V +G          VAIK L  G+++    E   E  ++ QL   ++V LIG
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
            C  +  M+ V +    G L   L       +P     ++    +  + YL     K  +
Sbjct: 78  VCQAEALML-VMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL---EEKNFV 132

Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLLTE 658
           HRD+   N+LL     AK+SDFGL K        + +    K  + +  PE    +  + 
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192

Query: 659 KSDVYSFGVVLLEVLC--ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN-- 714
           +SDV+S+GV + E L    +P                    Y+  K  +++    +G   
Sbjct: 193 RSDVWSYGVTMWEALSYGQKP--------------------YKKMKGPEVMAFIEQGKRM 232

Query: 715 -APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEKSM 763
             PP C  +   +   C       RP    V   +   +  L    E   
Sbjct: 233 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 282

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  139 bits (353), Expect = 5e-37
 Identities = 52/220 (23%), Positives = 85/220 (38%), Gaps = 50/220 (22%)

Query: 482 IIGRGGFGNVYKGFLNG-------DSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
            +G+G F  ++KG             T V +K L+   +  +  F     M+S+L + HL
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           V   G C    + ILV +++  G+L  +L  N    +    +L++    A A+H+L    
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFL---E 130

Query: 595 SKVIIHRDVKTTNILLDEEW--------VAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL 646
              +IH +V   NILL  E           K+SD G+                  SI  L
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI------------------SITVL 172

Query: 647 DPEYYRL-------------QLLTEKSDVYSFGVVLLEVL 673
             +  +              + L   +D +SFG  L E+ 
Sbjct: 173 PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  138 bits (349), Expect = 1e-36
 Identities = 64/276 (23%), Positives = 121/276 (43%), Gaps = 30/276 (10%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
            +G G FG V  G   G    VA+K +  GS     EF  E   + +L +  LV   G C
Sbjct: 15  ELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
           + +  + +V +Y++ G L ++L ++    L   + L++C      + +L    S   IHR
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFL---ESHQFIHR 128

Query: 602 DVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSD 661
           D+   N L+D +   KVSDFG+ ++  +  +   S   K  + +  PE +     + KSD
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187

Query: 662 VYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG---NAPP 717
           V++FG+++ EV    + P                   Y      +++    +G     P 
Sbjct: 188 VWAFGILMWEVFSLGKMP-------------------YDLYTNSEVVLKVSQGHRLYRPH 228

Query: 718 VCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           +  +   ++  SC ++   +RP+   ++  +E + +
Sbjct: 229 LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  139 bits (353), Expect = 1e-36
 Identities = 78/309 (25%), Positives = 125/309 (40%), Gaps = 66/309 (21%)

Query: 482 IIGRGGFGNVYKGFLNGD--STPVAIKRLNPG-SQQGALEFQTEIGMLSQL-RYLHLVSL 537
           +IG G FG V K  +  D      AIKR+    S+    +F  E+ +L +L  + ++++L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHL--------------YNNDNPPLPWDRRLKICIGA 583
           +G C   G + L  +Y   G L D L               N+    L   + L      
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151

Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSI 643
           AR + YL   + K  IHRD+   NIL+ E +VAK++DFGL +             VK ++
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--------EVYVKKTM 200

Query: 644 GYL-----DPE--YYRLQLLTEKSDVYSFGVVLLEV--LCARPPILRTGDKKQVNLAVWA 694
           G L       E   Y   + T  SDV+S+GV+L E+  L   P                 
Sbjct: 201 GRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTP----------------- 241

Query: 695 TECYRNGKIGDIIDPFLKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV 751
              Y      ++ +   +G     P  C ++  ++   C  +    RPS + ++  L   
Sbjct: 242 ---YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN-- 296

Query: 752 FQLLRESSE 760
            ++L E   
Sbjct: 297 -RMLEERKT 304

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  138 bits (349), Expect = 1e-36
 Identities = 67/289 (23%), Positives = 114/289 (39%), Gaps = 37/289 (12%)

Query: 482 IIGRGGFGNVYKGFLN---GDSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSL 537
           I+G G FG VY+G      G+   VA+K            +F +E  ++  L + H+V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
           IG   ++   I + +    G L  +L  N    L     +   +   +A+ YL    S  
Sbjct: 79  IGIIEEEPTWI-IMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYL---ESIN 133

Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS--IGYLDPEYYRLQL 655
            +HRD+   NIL+      K+ DFGL ++                  I ++ PE    + 
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRY---IEDEDYYKASVTRLPIKWMSPESINFRR 190

Query: 656 LTEKSDVYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
            T  SDV+ F V + E+L   + P                   +   +  D+I    KG+
Sbjct: 191 FTTASDVWMFAVCMWEILSFGKQP-------------------FFWLENKDVIGVLEKGD 231

Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSE 760
               P +C      +   C + D   RP  +++V  L  V+Q+ ++ + 
Sbjct: 232 RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAM 280

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  138 bits (349), Expect = 1e-36
 Identities = 87/279 (31%), Positives = 129/279 (46%), Gaps = 40/279 (14%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
            IG+G FG+V  G   G    VA+K +   +   A  F  E  +++QLR+ +LV L+G  
Sbjct: 28  TIGKGEFGDVMLGDYRG--NKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 542 -NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIH 600
             + G + +V +YMA+G+L D+L +     L  D  LK  +    A+ YL        +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVH 140

Query: 601 RDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS--IGYLDPEYYRLQLLTE 658
           RD+   N+L+ E+ VAKVSDFGL       +K   STQ  G   + +  PE  R +  + 
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGL-------TKEASSTQDTGKLPVKWTAPEALREKKFST 193

Query: 659 KSDVYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN--- 714
           KSDV+SFG++L E+    R P                   Y    + D++    KG    
Sbjct: 194 KSDVWSFGILLWEIYSFGRVP-------------------YPRIPLKDVVPRVEKGYKMD 234

Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           AP  C     EV  +C + D   RPS   +   LE +  
Sbjct: 235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  139 bits (352), Expect = 1e-36
 Identities = 77/281 (27%), Positives = 123/281 (43%), Gaps = 32/281 (11%)

Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           IIG G  G V  G L        PVAIK L  G +++   +F +E  ++ Q  + +++ L
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G        ++V +YM  G+L   L  +D       + + +  G    + YL   +   
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYL---SDLG 171

Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKF-GPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
            +HRD+   N+L+D   V KVSDFGL +    +    + +T  K  I +  PE    +  
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF 231

Query: 657 TEKSDVYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN- 714
           +  SDV+SFGVV+ EVL     P                   Y N    D+I    +G  
Sbjct: 232 SSASDVWSFGVVMWEVLAYGERP-------------------YWNMTNRDVISSVEEGYR 272

Query: 715 --APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
             AP  C +   ++ + C + DR +RP  S +V  L+ + +
Sbjct: 273 LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  137 bits (348), Expect = 2e-36
 Identities = 68/284 (23%), Positives = 117/284 (41%), Gaps = 37/284 (13%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
            +G G FG V  G   G    VAIK +  GS     EF  E  ++  L +  LV L G C
Sbjct: 31  ELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
                + ++ +YMA G L ++L           + L++C     A+ YL    SK  +HR
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYL---ESKQFLHR 144

Query: 602 DVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS--IGYLDPEYYRLQLLTEK 659
           D+   N L++++ V KVSDFGL ++         ++ V     + +  PE       + K
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRY---VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201

Query: 660 SDVYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG---NA 715
           SD+++FGV++ E+    + P                   Y      +  +   +G     
Sbjct: 202 SDIWAFGVLMWEIYSLGKMP-------------------YERFTNSETAEHIAQGLRLYR 242

Query: 716 PPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESS 759
           P +   +   +  SC ++    RP+   ++  +     ++ E S
Sbjct: 243 PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL---DVMDEES 283

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  139 bits (352), Expect = 2e-36
 Identities = 79/282 (28%), Positives = 128/282 (45%), Gaps = 33/282 (11%)

Query: 482 IIGRGGFGNVYKGFLNGDS----TPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVS 536
           +IG G FG VYKG L   S     PVAIK L  G +++  ++F  E G++ Q  + +++ 
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           L G  +    M+++ +YM  G L   L   D       + + +  G A  + YL   A+ 
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYL---ANM 166

Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKF-GPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
             +HRD+   NIL++   V KVSDFGL +    +   T+ ++  K  I +  PE    + 
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226

Query: 656 LTEKSDVYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
            T  SDV+SFG+V+ EV+     P                   Y      +++     G 
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGERP-------------------YWELSNHEVMKAINDGF 267

Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
               P  C +   ++ M C   +R RRP  +D+V  L+ + +
Sbjct: 268 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  138 bits (350), Expect = 2e-36
 Identities = 68/286 (23%), Positives = 115/286 (40%), Gaps = 27/286 (9%)

Query: 482 IIGRGGFGNVYKGFLNGD----STPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVS 536
            +G G FG V     +         VA+K L   +       ++ EI +L  L + H++ 
Sbjct: 38  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97

Query: 537 LIGYCNDDGQ--MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
             G C D G   + LV +Y+  G+LRD+L  +    +   + L         + YLH   
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLH--- 151

Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT-HVSTQVKGSIGYLDPEYYRL 653
           ++  IHRD+   N+LLD + + K+ DFGL K  P   +   V       + +  PE  + 
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211

Query: 654 QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATEC---YRNGKIGDIIDPF 710
                 SDV+SFGV L E       +L   D  Q     +            +  + +  
Sbjct: 212 YKFYYASDVWSFGVTLYE-------LLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264

Query: 711 LKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
            +G     P  C  +   +  +C   +   RP+  +++  L+ V +
Sbjct: 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  137 bits (347), Expect = 3e-36
 Identities = 67/293 (22%), Positives = 105/293 (35%), Gaps = 38/293 (12%)

Query: 469 EIKEATKDFNNLLIIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG---SQQGALEFQTE 522
            I E  KD   L  +G G FG V +G  +   G +  VA+K L P      +   +F  E
Sbjct: 14  LIGE--KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71

Query: 523 IGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
           +  +  L + +L+ L G        + V +    G+L D L  +           +  + 
Sbjct: 72  VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQ 129

Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKG 641
            A  + YL    SK  IHRD+   N+LL    + K+ DFGL +  P     +V  +  K 
Sbjct: 130 VAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186

Query: 642 SIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRN 700
              +  PE  + +  +  SD + FGV L E+    + P                   +  
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-------------------WIG 227

Query: 701 GKIGDIIDPFLKGN----APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
                I+    K       P  C      V + C       RP+   +   L 
Sbjct: 228 LNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  139 bits (353), Expect = 3e-36
 Identities = 71/281 (25%), Positives = 117/281 (41%), Gaps = 32/281 (11%)

Query: 482 IIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
           ++G G FG V  G L         VAIK L  G +++   +F  E  ++ Q  + +++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
            G       +++V +YM  G+L   L  +D       + + +  G A  + YL   +   
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL---SDMG 167

Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKF-GPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
            +HRD+   NIL++   V KVSDFGL +    +    + +   K  I +  PE    +  
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227

Query: 657 TEKSDVYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN- 714
           T  SDV+S+G+VL EV+     P                   Y      D+I    +G  
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP-------------------YWEMSNQDVIKAVDEGYR 268

Query: 715 --APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
              P  C     ++ + C   DR  RP    +V  L+ + +
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  137 bits (347), Expect = 6e-36
 Identities = 70/294 (23%), Positives = 122/294 (41%), Gaps = 56/294 (19%)

Query: 482 IIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLV 535
            +G+G FG VY+G   G       T VAIK +N   S +  +EF  E  ++ +    H+V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91

Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHL--------YNNDNPPLPWDRRLKICIGAARAL 587
            L+G  +     +++ + M RG L+ +L         N    P    + +++    A  +
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151

Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ--VKGSIGY 645
            YL    +   +HRD+   N ++ E++  K+ DFG+       ++    T    KG  G 
Sbjct: 152 AYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGM-------TRDIYETDYYRKGGKGL 201

Query: 646 L-----DPEYYRLQLLTEKSDVYSFGVVLLEV--LCARPPILRTGDKKQVNLAVWATECY 698
           L      PE  +  + T  SDV+SFGVVL E+  L  +P                    Y
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--------------------Y 241

Query: 699 RNGKIGDIIDPFLKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
           +      ++   ++G     P  C +   E+   C   +   RPS  +++  ++
Sbjct: 242 QGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  137 bits (347), Expect = 8e-36
 Identities = 72/301 (23%), Positives = 119/301 (39%), Gaps = 49/301 (16%)

Query: 483 IGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G FG V+    +      D   VA+K L   S+    +FQ E  +L+ L++ H+V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHL-------------YNNDNPPLPWDRRLKICIGAA 584
            G C +   +++V++YM  G L   L              +    PL   + L +    A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 585 RALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG 644
             + YL   A    +HRD+ T N L+ +  V K+ DFG+ +   +     V  +    I 
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225

Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEV--LCARPPILRTGDKKQVNLAVWATECYRNGK 702
           ++ PE    +  T +SDV+SFGVVL E+     +P                    +    
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--------------------WYQLS 265

Query: 703 IGDIIDPFLKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESS 759
             + ID   +G     P  C  +   +   C   +  +R S+ DV   L+    L +   
Sbjct: 266 NTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ---ALAQAPP 322

Query: 760 E 760
            
Sbjct: 323 V 323

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  135 bits (343), Expect = 8e-36
 Identities = 70/282 (24%), Positives = 107/282 (37%), Gaps = 37/282 (13%)

Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
            IG G FG+V++G        +  VAIK      S     +F  E   + Q  + H+V L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
           IG   ++   I + +    G LR  L       L     +      + AL YL    SK 
Sbjct: 82  IGVITENPVWI-IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYL---ESKR 136

Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS--IGYLDPEYYRLQL 655
            +HRD+   N+L+      K+ DFGL ++      +      KG   I ++ PE    + 
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMAPESINFRR 193

Query: 656 LTEKSDVYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
            T  SDV+ FGV + E+L     P                   ++  K  D+I     G 
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVKP-------------------FQGVKNNDVIGRIENGE 234

Query: 715 ---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
               PP C      +   C   D  RRP  +++   L  + +
Sbjct: 235 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  136 bits (345), Expect = 1e-35
 Identities = 71/294 (24%), Positives = 124/294 (42%), Gaps = 40/294 (13%)

Query: 482 IIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVS 536
           I+G G FG+V +G L    G S  VA+K +     SQ+   EF +E   +    + +++ 
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100

Query: 537 LIGYCNDDGQMI-----LVYDYMARGTLRDHL----YNNDNPPLPWDRRLKICIGAARAL 587
           L+G C +          ++  +M  G L  +L           +P    LK  +  A  +
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160

Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
            YL   +++  +HRD+   N +L ++    V+DFGL K   +          K  + ++ 
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217

Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRNGKIGDI 706
            E    ++ T KSDV++FGV + E+      P                   Y   +  ++
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEIATRGMTP-------------------YPGVQNHEM 258

Query: 707 IDPFLKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRE 757
            D  L G+    P  CL++  E+  SC   D + RP+ S +   LE + + L +
Sbjct: 259 YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  135 bits (341), Expect = 2e-35
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIK--RLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
            IGRG F  VYKG     +  VA    +    ++     F+ E  ML  L++ ++V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 540 Y----CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
                      ++LV + M  GTL+ +L       +        C    + L +LHT  +
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHT-RT 149

Query: 596 KVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
             IIHRD+K  NI +       K+ D GL        +   +  V G+  ++ PE Y  +
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPEMYE-E 204

Query: 655 LLTEKSDVYSFGVVLLEVLCARPP 678
              E  DVY+FG+ +LE+  +  P
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYP 228

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  135 bits (343), Expect = 2e-35
 Identities = 67/291 (23%), Positives = 111/291 (38%), Gaps = 42/291 (14%)

Query: 482 IIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLV 535
            +G G FG VY+G ++G         VA+K L    S+Q  L+F  E  ++S+  + ++V
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96

Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHL-----YNNDNPPLPWDRRLKICIGAARALHYL 590
             IG         ++ + MA G L+  L       +    L     L +    A    YL
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156

Query: 591 HTGASKVIIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
                   IHRD+   N LL       VAK+ DFG+ +     S           + ++ 
Sbjct: 157 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213

Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEV--LCARPPILRTGDKKQVNLAVWATECYRNGKIGD 705
           PE +   + T K+D +SFGV+L E+  L   P                    Y +    +
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--------------------YPSKSNQE 253

Query: 706 IIDPFLKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           +++    G     P  C      +   C       RP+ + ++  +E+  Q
Sbjct: 254 VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  141 bits (358), Expect = 3e-35
 Identities = 70/280 (25%), Positives = 111/280 (39%), Gaps = 33/280 (11%)

Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSL 537
            IG G FG+V++G        +  VAIK      S     +F  E   + Q  + H+V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
           IG   ++   I + +    G LR  L       L     +      + AL YL    SK 
Sbjct: 457 IGVITENPVWI-IMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYL---ESKR 511

Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLT 657
            +HRD+   N+L+      K+ DFGL ++  + S  + +++ K  I ++ PE    +  T
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRRFT 570

Query: 658 EKSDVYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN-- 714
             SDV+ FGV + E+L     P                   ++  K  D+I     G   
Sbjct: 571 SASDVWMFGVCMWEILMHGVKP-------------------FQGVKNNDVIGRIENGERL 611

Query: 715 -APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
             PP C      +   C   D  RRP  +++   L  + +
Sbjct: 612 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  135 bits (342), Expect = 3e-35
 Identities = 68/298 (22%), Positives = 118/298 (39%), Gaps = 41/298 (13%)

Query: 482 IIGRGGFGNVYKGFLN---GDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVS 536
           ++G+G FG+V +  L    G    VA+K L     +     EF  E   + +  + H+  
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89

Query: 537 LIGYCNDDG------QMILVYDYMARGTLRDHL----YNNDNPPLPWDRRLKICIGAARA 586
           L+G              +++  +M  G L   L       +   LP    ++  +  A  
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 587 LHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL 646
           + YL   +S+  IHRD+   N +L E+    V+DFGL +   +          K  + +L
Sbjct: 150 MEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206

Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRNGKIGD 705
             E     L T  SDV++FGV + E++   + P                   Y   +  +
Sbjct: 207 ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP-------------------YAGIENAE 247

Query: 706 IIDPFLKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSE 760
           I +  + GN    PP C+ +  ++   C + D  +RPS + +   LE +   L   S 
Sbjct: 248 IYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  135 bits (341), Expect = 4e-35
 Identities = 62/250 (24%), Positives = 101/250 (40%), Gaps = 21/250 (8%)

Query: 445 MKEAKSRGPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVA 504
           M  +      SS   +    F    +    K +  +  +G GGF  V       D    A
Sbjct: 1   MGSSHHHHHHSSGREN--LYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYA 58

Query: 505 IKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC----NDDGQMILVYDYMARGTLR 560
           +KR+    QQ   E Q E  M     + +++ L+ YC        +  L+  +  RGTL 
Sbjct: 59  LKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118

Query: 561 DHLYN--NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKV 618
           + +    +    L  D+ L + +G  R L  +H   +K   HRD+K TNILL +E    +
Sbjct: 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVL 175

Query: 619 SDFGLCK---FGPNFSKTHVSTQ----VKGSIGYLDPE---YYRLQLLTEKSDVYSFGVV 668
            D G           S+  ++ Q     + +I Y  PE        ++ E++DV+S G V
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235

Query: 669 LLEVLCARPP 678
           L  ++    P
Sbjct: 236 LYAMMFGEGP 245

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  134 bits (339), Expect = 5e-35
 Identities = 71/313 (22%), Positives = 118/313 (37%), Gaps = 83/313 (26%)

Query: 483 IGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G FG V+           D   VA+K L   +     +FQ E  +L+ L++ H+V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHL--------------YNNDNPPLPWDRRLKICIGA 583
            G C D   +I+V++YM  G L   L                     L   + L I    
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSI 643
           A  + YL   AS+  +HRD+ T N L+    + K+ DFG+            S  V    
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGM------------SRDV---- 183

Query: 644 GYLDPEYYRLQ---LL---------------TEKSDVYSFGVVLLEV--LCARPPILRTG 683
                +YYR+    +L               T +SDV+SFGV+L E+     +P      
Sbjct: 184 --YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP------ 235

Query: 684 DKKQVNLAVWATECYRNGKIGDIIDPFLKGN---APPVCLNQFVEVAMSCVNDDRIRRPS 740
                         +      ++I+   +G     P VC  +  +V + C   +  +R +
Sbjct: 236 --------------WFQLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLN 281

Query: 741 MSDVVWGLEFVFQ 753
           + ++   L  + +
Sbjct: 282 IKEIYKILHALGK 294

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  132 bits (335), Expect = 2e-34
 Identities = 57/278 (20%), Positives = 92/278 (33%), Gaps = 40/278 (14%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNP---GSQQGALEFQTEIGMLSQLRY 531
           + F  L  +G G +G V+K     D    A+KR      G +  A +           ++
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
              V L     + G + L  +     +L+ H        LP  +          AL +LH
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL-CGPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLH 174

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
              S+ ++H DVK  NI L      K+ DFGL                +G   Y+ PE  
Sbjct: 175 ---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPE-- 226

Query: 652 RLQLL----TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK-IGDI 706
              LL       +DV+S G+ +LEV C                          G+    +
Sbjct: 227 ---LLQGSYGTAADVFSLGLTILEVACNMEL-------------------PHGGEGWQQL 264

Query: 707 IDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
              +L         ++   V +  +  D   R +   +
Sbjct: 265 RQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEAL 302

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  134 bits (338), Expect = 3e-34
 Identities = 66/291 (22%), Positives = 110/291 (37%), Gaps = 42/291 (14%)

Query: 482 IIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLV 535
            +G G FG VY+G ++G         VA+K L    S+Q  L+F  E  ++S+  + ++V
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137

Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHL-----YNNDNPPLPWDRRLKICIGAARALHYL 590
             IG         ++ + MA G L+  L       +    L     L +    A    YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197

Query: 591 HTGASKVIIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
                   IHRD+   N LL       VAK+ DFG+ +                 + ++ 
Sbjct: 198 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 254

Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEV--LCARPPILRTGDKKQVNLAVWATECYRNGKIGD 705
           PE +   + T K+D +SFGV+L E+  L   P                    Y +    +
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--------------------YPSKSNQE 294

Query: 706 IIDPFLKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           +++    G     P  C      +   C       RP+ + ++  +E+  Q
Sbjct: 295 VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  131 bits (332), Expect = 3e-34
 Identities = 67/303 (22%), Positives = 124/303 (40%), Gaps = 48/303 (15%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
            DF  + +IG GGFG V+K     D     IKR+   ++    + + E+  L++L ++++
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNI 66

Query: 535 VSLIGY----------------CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK 578
           V   G                  +    + +  ++  +GTL   +       L     L+
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 579 ICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ 638
           +     + + Y+H   SK +I+RD+K +NI L +    K+ DFGL             T+
Sbjct: 127 LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS---LKNDGKRTR 180

Query: 639 VKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECY 698
            KG++ Y+ PE    Q   ++ D+Y+ G++L E+L        T                
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD---------L 231

Query: 699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRES 758
           R+G I DI D   K           ++     ++     RP+ S+++     V++   E 
Sbjct: 232 RDGIISDIFDKKEK---------TLLQ---KLLSKKPEDRPNTSEIL-RTLTVWKKSPEK 278

Query: 759 SEK 761
           +E+
Sbjct: 279 NER 281

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  138 bits (348), Expect = 3e-34
 Identities = 67/292 (22%), Positives = 110/292 (37%), Gaps = 32/292 (10%)

Query: 483 IGRGGFGNVYKGFLNGDS--TPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRYLHLVSLIG 539
           +G G FG+V +G          VAIK L  G+++    E   E  ++ QL   ++V LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
            C  +  M+ V +    G L   L       +P     ++    +  + YL     K  +
Sbjct: 404 VCQAEALML-VMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL---EEKNFV 458

Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ-VKGSIGYLDPEYYRLQLLTE 658
           HR++   N+LL     AK+SDFGL K        + +    K  + +  PE    +  + 
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518

Query: 659 KSDVYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN--- 714
           +SDV+S+GV + E L   + P                   Y+  K  +++    +G    
Sbjct: 519 RSDVWSYGVTMWEALSYGQKP-------------------YKKMKGPEVMAFIEQGKRME 559

Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEKSMIAH 766
            PP C  +   +   C       RP    V   +   +  L    E      
Sbjct: 560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSALE 611

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  133 bits (337), Expect = 3e-34
 Identities = 66/305 (21%), Positives = 126/305 (41%), Gaps = 61/305 (20%)

Query: 482 IIGRGGFGNVYKGFLNG-------DSTPVAIKRLNPG-SQQGALEFQTEIGMLSQL-RYL 532
            +G G FG V      G       ++  VA+K L    +++   +  +E+ M+  + ++ 
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147

Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHL--------------YNNDNPPLPWDRRLK 578
           ++++L+G C  DG + ++ +Y ++G LR++L                     + +   + 
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207

Query: 579 ICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVS-T 637
                AR + YL   AS+  IHRD+   N+L+ E  V K++DFGL +        +    
Sbjct: 208 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR------DINNIDY 258

Query: 638 QVKGSIGYL-----DPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLA 691
             K + G L      PE    ++ T +SDV+SFGV++ E+      P             
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP------------- 305

Query: 692 VWATECYRNGKIGDIIDPFLKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGL 748
                 Y    + ++     +G+    P  C N+   +   C +    +RP+   +V  L
Sbjct: 306 ------YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359

Query: 749 EFVFQ 753
           + +  
Sbjct: 360 DRILT 364

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  132 bits (333), Expect = 3e-34
 Identities = 69/310 (22%), Positives = 123/310 (39%), Gaps = 32/310 (10%)

Query: 445 MKEAKSRGPASSLPSDLCTQFSISEIKEAT-KDFNNLLIIGRGGFGNVYKGFLNGDSTPV 503
           M E         +P     +    ++   T  +F     IGRG F  VY+     D  PV
Sbjct: 1   MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPV 60

Query: 504 AIKRLNPGSQQGALE---FQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLR 560
           A+K++       A        EI +L QL + +++       +D ++ +V +    G L 
Sbjct: 61  ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLS 120

Query: 561 DHL--YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKV 618
             +  +      +P     K  +    AL ++H   S+ ++HRD+K  N+ +    V K+
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKL 177

Query: 619 SDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            D GL +F  +   T   + V G+  Y+ PE         KSD++S G +L E+   + P
Sbjct: 178 GDLGLGRFFSS-KTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

Query: 679 ILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQF----VEVAMSCVNDD 734
                     +L           KI        + + PP+  + +     ++   C+N D
Sbjct: 236 -FYGDKMNLYSLCK---------KI-------EQCDYPPLPSDHYSEELRQLVNMCINPD 278

Query: 735 RIRRPSMSDV 744
             +RP ++ V
Sbjct: 279 PEKRPDVTYV 288

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  131 bits (331), Expect = 4e-34
 Identities = 68/310 (21%), Positives = 114/310 (36%), Gaps = 84/310 (27%)

Query: 483 IGRGGFGNVYKGFLNG-----DSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVS 536
           +G   FG VYKG L G      +  VAIK L          EF+ E  + ++L++ ++V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNN--------------DNPPLPWDRRLKICIG 582
           L+G    D  + +++ Y + G L + L                     L     + +   
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136

Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS 642
            A  + YL   +S  ++H+D+ T N+L+ ++   K+SD GL              +V  +
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGL------------FREVYAA 181

Query: 643 IGYLDPEYYRLQ---LL---------------TEKSDVYSFGVVLLEV--LCARPPILRT 682
                 +YY+L    LL               +  SD++S+GVVL EV     +P     
Sbjct: 182 ------DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP----- 230

Query: 683 GDKKQVNLAVWATECYRNGKIGDIIDPFLKGN---APPVCLNQFVEVAMSCVNDDRIRRP 739
                          Y      D+++          P  C      + + C N+   RRP
Sbjct: 231 ---------------YCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRP 275

Query: 740 SMSDVVWGLE 749
              D+   L 
Sbjct: 276 RFKDIHSRLR 285

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  132 bits (335), Expect = 4e-34
 Identities = 47/212 (22%), Positives = 91/212 (42%), Gaps = 19/212 (8%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIK-----RLNPGSQQGALEFQTEIGMLSQL 529
           + +  L  IG G FG         D     IK     R++   ++ +     E+ +L+ +
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR---EVAVLANM 80

Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           ++ ++V       ++G + +V DY   G L   +          D+ L   +    AL +
Sbjct: 81  KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF---GPNFSKTHVSTQVKGSIGYL 646
           +H    + I+HRD+K+ NI L ++   ++ DFG+ +        ++  +     G+  YL
Sbjct: 141 VH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-----GTPYYL 192

Query: 647 DPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            PE    +    KSD+++ G VL E+   +  
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLKHA 224

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  131 bits (331), Expect = 1e-33
 Identities = 67/305 (21%), Positives = 127/305 (41%), Gaps = 63/305 (20%)

Query: 483 IGRGGFGNVYKGFLNG-------DSTPVAIKRLNPG-SQQGALEFQTEIGMLSQL-RYLH 533
           +G G FG V      G       ++  VA+K L    +++   +  +E+ M+  + ++ +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHL--------------YNNDNPPLPWDRRLKI 579
           +++L+G C  DG + ++ +Y ++G LR++L                     + +   +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 580 CIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVS-TQ 638
               AR + YL   AS+  IHRD+   N+L+ E  V K++DFGL +        +     
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR------DINNIDYY 213

Query: 639 VKGSIGYL-----DPEYYRLQLLTEKSDVYSFGVVLLEV--LCARPPILRTGDKKQVNLA 691
            K + G L      PE    ++ T +SDV+SFGV++ E+  L   P              
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-------------- 259

Query: 692 VWATECYRNGKIGDIIDPFLKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGL 748
                 Y    + ++     +G+    P  C N+   +   C +    +RP+   +V  L
Sbjct: 260 ------YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

Query: 749 EFVFQ 753
           + +  
Sbjct: 314 DRILT 318

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  130 bits (328), Expect = 1e-33
 Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 15/202 (7%)

Query: 483 IGRGGFGNVYKGF---LNGDSTPVAIKRLNP--GSQQGALE-FQTEIGMLSQLRYLHLVS 536
           +G GG   VY      LN     VAIK +      ++  L+ F+ E+   SQL + ++VS
Sbjct: 19  LGGGGMSTVYLAEDTILN---IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           +I    +D    LV +Y+   TL +++    + PL  D  +         + + H     
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAH---DM 130

Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
            I+HRD+K  NIL+D     K+ DFG+ K     S T  +  V G++ Y  PE  + +  
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAKGEAT 189

Query: 657 TEKSDVYSFGVVLLEVLCARPP 678
            E +D+YS G+VL E+L   PP
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPP 211

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  129 bits (327), Expect = 5e-33
 Identities = 74/318 (23%), Positives = 117/318 (36%), Gaps = 73/318 (22%)

Query: 483 IGRGGFGNVYKGFLNG-----DSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVS 536
           IG G FG V++    G       T VA+K L    S     +FQ E  ++++    ++V 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHL----------------------YNNDNPPLPWD 574
           L+G C     M L+++YMA G L + L                       +   PPL   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 575 RRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH 634
            +L I    A  + YL   + +  +HRD+ T N L+ E  V K++DFGL       S+  
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGL-------SRNI 224

Query: 635 VSTQ--VKGSIGYL-----DPEYYRLQLLTEKSDVYSFGVVLLEV--LCARPPILRTGDK 685
            S           +      PE       T +SDV+++GVVL E+     +P        
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP-------- 276

Query: 686 KQVNLAVWATECYRNGKIGDIIDPFLKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMS 742
                       Y      ++I     GN    P  C  +   +   C +     RPS  
Sbjct: 277 ------------YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFC 324

Query: 743 DVVWGLEFVFQLLRESSE 760
            +   L+   ++   +  
Sbjct: 325 SIHRILQ---RMCERAEG 339

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  127 bits (322), Expect = 1e-32
 Identities = 72/302 (23%), Positives = 126/302 (41%), Gaps = 55/302 (18%)

Query: 482 IIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPG-SQQGALEFQTEIGMLSQL-RYLHL 534
            +GRG FG V +    G         VA+K L  G +        +E+ +L  +  +L++
Sbjct: 34  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93

Query: 535 VSLIGYCNDDGQ-MILVYDYMARGTLRDHL--------------YNNDNPPLPWDRRLKI 579
           V+L+G C   G  ++++ ++   G L  +L               +     L  +  +  
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153

Query: 580 CIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               A+ + +L   AS+  IHRD+   NILL E+ V K+ DFGL +   +  K      V
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPD--YV 205

Query: 640 KGSIGYL-----DPEYYRLQLLTEKSDVYSFGVVLLEV--LCARP-PILRTGDKKQVNLA 691
           +     L      PE    ++ T +SDV+SFGV+L E+  L A P P ++    ++    
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRR 263

Query: 692 VWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV 751
           +   E  R                P     +  +  + C + +  +RP+ S++V  L  +
Sbjct: 264 L--KEGTRMRA-------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

Query: 752 FQ 753
            Q
Sbjct: 309 LQ 310

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  126 bits (318), Expect = 2e-32
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 12/213 (5%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYL 532
           +D+  L  IG G +G   K     D   +  K L+ G  ++       +E+ +L +L++ 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 533 HLVSLIG--YCNDDGQMILVYDYMARGTLRDHL--YNNDNPPLPWDRRLKICIGAARALH 588
           ++V          +  + +V +Y   G L   +     +   L  +  L++      AL 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 589 YLHT--GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGY 645
             H        ++HRD+K  N+ LD +   K+ DFGL +    + S     T V G+  Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--TFV-GTPYY 182

Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           + PE        EKSD++S G +L E+    PP
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  126 bits (320), Expect = 2e-32
 Identities = 61/227 (26%), Positives = 94/227 (41%), Gaps = 47/227 (20%)

Query: 482 IIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLV 535
            +G G FG V K            T VA+K L    S     +  +E  +L Q+ + H++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89

Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHL----------------------YNNDNPPLPW 573
            L G C+ DG ++L+ +Y   G+LR  L                       + D   L  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149

Query: 574 DRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT 633
              +      ++ + YL   A   ++HRD+   NIL+ E    K+SDFGL +        
Sbjct: 150 GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR-------- 198

Query: 634 HVSTQ---VKGSIGYL-----DPEYYRLQLLTEKSDVYSFGVVLLEV 672
            V  +   VK S G +       E     + T +SDV+SFGV+L E+
Sbjct: 199 DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  126 bits (320), Expect = 2e-32
 Identities = 56/202 (27%), Positives = 87/202 (43%), Gaps = 15/202 (7%)

Query: 483 IGRGGFGNVYKGFLNGDST---PVAIKRLNP--GSQQGALE-FQTEIGMLSQLRYLHLVS 536
           +GRGG G+VY+     D+     VA+K ++    S        Q E     +L+  H+V 
Sbjct: 42  VGRGGMGDVYEAE---DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           +  +   DGQ+ +    +    L   L      PL   R + I      AL   H   + 
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAH---AA 153

Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
              HRDVK  NIL+  +  A + DFG+     +   T +   V G++ Y+ PE +     
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESHA 212

Query: 657 TEKSDVYSFGVVLLEVLCARPP 678
           T ++D+Y+   VL E L   PP
Sbjct: 213 TYRADIYALTCVLYECLTGSPP 234

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  125 bits (316), Expect = 7e-32
 Identities = 74/307 (24%), Positives = 128/307 (41%), Gaps = 53/307 (17%)

Query: 482 IIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPG-SQQGALEFQTEIGMLSQL-RYLHL 534
            +G G FG V +    G      +  VA+K L P           +E+ +LS L  ++++
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHL----------------YNNDNPPLPWDRRLK 578
           V+L+G C   G  +++ +Y   G L + L                  +D   L  +  L 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 579 ICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ 638
                A+ + +L   ASK  IHRD+   NILL    + K+ DFGL +   N S   V   
Sbjct: 150 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 639 VKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEV--LCARP-PILRTGDK--KQVNLAVW 693
            +  + ++ PE     + T +SDV+S+G+ L E+  L + P P +    K  K +     
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI----- 261

Query: 694 ATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
             E +R                P     +  ++  +C + D ++RP+   +V  +E   +
Sbjct: 262 -KEGFRMLS-------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE---K 304

Query: 754 LLRESSE 760
            + ES+ 
Sbjct: 305 QISESTN 311

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  126 bits (318), Expect = 8e-32
 Identities = 67/310 (21%), Positives = 113/310 (36%), Gaps = 65/310 (20%)

Query: 482 IIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPG-SQQGALEFQTEIGMLSQL-RYLHL 534
           ++G G FG V      G      S  VA+K L             +E+ M++QL  + ++
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHL---------------------YNNDNPPLPW 573
           V+L+G C   G + L+++Y   G L ++L                        D   L +
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171

Query: 574 DRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT 633
           +  L      A+ + +L     K  +HRD+   N+L+    V K+ DFGL +   +    
Sbjct: 172 EDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR---DIMSD 225

Query: 634 HVSTQVKGSIGYL-----DPEYYRLQLLTEKSDVYSFGVVLLEV--LCARP-PILRTGDK 685
                V      L      PE     + T KSDV+S+G++L E+  L   P P +     
Sbjct: 226 SN--YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 283

Query: 686 --KQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSD 743
             K +         ++  +             P     +   +  SC   D  +RPS  +
Sbjct: 284 FYKLI------QNGFKMDQ-------------PFYATEEIYIIMQSCWAFDSRKRPSFPN 324

Query: 744 VVWGLEFVFQ 753
           +   L     
Sbjct: 325 LTSFLGCQLA 334

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  125 bits (316), Expect = 1e-31
 Identities = 70/296 (23%), Positives = 117/296 (39%), Gaps = 46/296 (15%)

Query: 482 IIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPG-SQQGALEFQTEIGMLSQL-RYLHL 534
            +G G FG V +    G         VA+K L             +E+ ++S L ++ ++
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHL------------YNNDNPPLPWDRRLKICIG 582
           V+L+G C   G ++++ +Y   G L + L            +   N        L     
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172

Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS 642
            A+ + +L   ASK  IHRDV   N+LL    VAK+ DFGL +   N S   V    +  
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229

Query: 643 IGYLDPEYYRLQLLTEKSDVYSFGVVLLEV--LCARP-PILRTGDK--KQVNLAVWATEC 697
           + ++ PE     + T +SDV+S+G++L E+  L   P P +    K  K V       + 
Sbjct: 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV------KDG 283

Query: 698 YRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           Y+  +             P         +  +C   +   RP+   +   L+   Q
Sbjct: 284 YQMAQ-------------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  126 bits (318), Expect = 1e-31
 Identities = 72/304 (23%), Positives = 127/304 (41%), Gaps = 61/304 (20%)

Query: 483 IGRGGFGNVYKGFLNG-------DSTPVAIKRLNPG-SQQGALEFQTEIGMLSQL-RYLH 533
           +G G FG V      G         T VA+K L    +++   +  +E+ M+  + ++ +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHL--------------YNNDNPPLPWDRRLKI 579
           +++L+G C  DG + ++ +Y ++G LR++L               +N    L     +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 580 CIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVS-TQ 638
               AR + YL   ASK  IHRD+   N+L+ E+ V K++DFGL +        H     
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHIDYY 247

Query: 639 VKGSIGYL-----DPEYYRLQLLTEKSDVYSFGVVLLEVL-CARPPILRTGDKKQVNLAV 692
            K + G L      PE    ++ T +SDV+SFGV+L E+      P              
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-------------- 293

Query: 693 WATECYRNGKIGDIIDPFLKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
                Y    + ++     +G+    P  C N+   +   C +    +RP+   +V  L+
Sbjct: 294 -----YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348

Query: 750 FVFQ 753
            +  
Sbjct: 349 RIVA 352

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  123 bits (311), Expect = 4e-31
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 21/208 (10%)

Query: 483 IGRGGFGNVYKGFLNGDST---PVAIKRLNP--GSQQGALE-FQTEIGMLSQLRYLHLVS 536
           +G GG   V+      D      VA+K L             F+ E    + L +  +V+
Sbjct: 20  LGFGGMSEVHLAR---DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 537 LIGYCNDDGQMILVYDYMA----RG-TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
           +      +     +  Y+      G TLRD +  +   P+   R +++   A +AL++ H
Sbjct: 77  VYDTGEAETPAGPLP-YIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSH 133

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST-QVKGSIGYLDPEY 650
                 IIHRDVK  NI++      KV DFG+ +   +   +   T  V G+  YL PE 
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190

Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            R   +  +SDVYS G VL EVL   PP
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  121 bits (306), Expect = 1e-30
 Identities = 62/294 (21%), Positives = 107/294 (36%), Gaps = 45/294 (15%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLN-PGSQQGALEFQTEIGMLSQLRYLH 533
            DF  +  +GRGGFG V++     D    AIKR+  P  +    +   E+  L++L +  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 534 LVSLIGYCNDDGQMI------------LVYDYMARGTLRDHL-YNNDNPPLPWDRRLKIC 580
           +V       +                 +      +  L+D +              L I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 581 IGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-------FGPNFSKT 633
           +  A A+ +LH   SK ++HRD+K +NI    + V KV DFGL              +  
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 634 HVSTQVKGSIG---YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL 690
               +  G +G   Y+ PE       + K D++S G++L E+L    P     ++ +   
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238

Query: 691 AVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
            V      RN K   +                 V+     ++   + RP   ++
Sbjct: 239 DV------RNLKFPPLFTQKYPC------EYVMVQ---DMLSPSPMERPEAINI 277

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  121 bits (306), Expect = 5e-30
 Identities = 67/324 (20%), Positives = 121/324 (37%), Gaps = 40/324 (12%)

Query: 439 ISRRAVMKEAKSRGPASSLPSDLCTQFSISE---IKEATKDFNNLLIIGRGGFGNVYKGF 495
           +   A  K  +    +  L +D   + S S    I    + ++ L  IG GG   V++  
Sbjct: 17  MKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV- 75

Query: 496 LNGDSTPVAIKR--LNPGSQQGALEFQTEIGMLSQLR--YLHLVSLIGYCNDDGQMILVY 551
           LN      AIK   L     Q    ++ EI  L++L+     ++ L  Y   D  + +V 
Sbjct: 76  LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135

Query: 552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD 611
           +      L   L    +      +     +    A+H +H      I+H D+K  N L+ 
Sbjct: 136 EC-GNIDLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIH---QHGIVHSDLKPANFLIV 189

Query: 612 EEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE-----------YYRLQLLTEKS 660
           +  + K+ DFG+       + + V     G++ Y+ PE                 ++ KS
Sbjct: 190 DGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248

Query: 661 DVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCL 720
           DV+S G +L  +   + P              +     +  K+  IIDP  +   P +  
Sbjct: 249 DVWSLGCILYYMTYGKTP--------------FQQIINQISKLHAIIDPNHEIEFPDIPE 294

Query: 721 NQFVEVAMSCVNDDRIRRPSMSDV 744
               +V   C+  D  +R S+ ++
Sbjct: 295 KDLQDVLKCCLKRDPKQRISIPEL 318

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  119 bits (301), Expect = 6e-30
 Identities = 58/236 (24%), Positives = 97/236 (41%), Gaps = 43/236 (18%)

Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH 533
             DF  + ++G+G FG V K     DS   AIK++   +++      +E+ +L+ L + +
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63

Query: 534 LVSLIGYCNDDGQMI-------------LVYDYMARGTLRDHLYNNDNPPLPWDRRLKIC 580
           +V       +    +             +  +Y   GTL D + +++N     D   ++ 
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-HSENLNQQRDEYWRLF 122

Query: 581 IGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVS---- 636
                AL Y+H   S+ IIHRD+K  NI +DE    K+ DFGL K               
Sbjct: 123 RQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 637 --------TQVKGSIGYLDPE------YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
                   T   G+  Y+  E      +Y      EK D+YS G++  E++   P 
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFEMIY--PF 228

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  119 bits (300), Expect = 1e-29
 Identities = 60/287 (20%), Positives = 109/287 (37%), Gaps = 41/287 (14%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKR--LNPGSQQGALEFQTEIGMLSQLR-- 530
           + ++ L  IG GG   V++  LN      AIK   L     Q    ++ EI  L++L+  
Sbjct: 28  RIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL--KICIGAARALH 588
              ++ L  Y   D  + +V +      L   L    +      +     +      A+H
Sbjct: 87  SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNML----EAVH 141

Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
            +H      I+H D+K  N L+ +  + K+ DFG+       + + V     G++ Y+ P
Sbjct: 142 TIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197

Query: 649 E-----------YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATEC 697
           E                 ++ KSDV+S G +L  +   + P              +    
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--------------FQQII 243

Query: 698 YRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
            +  K+  IIDP  +   P +      +V   C+  D  +R S+ ++
Sbjct: 244 NQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  119 bits (300), Expect = 1e-29
 Identities = 61/285 (21%), Positives = 109/285 (38%), Gaps = 37/285 (12%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLN--PGSQQGALEFQTEIGMLSQLR-- 530
           + ++ L  IG GG   V++  LN      AIK +N      Q    ++ EI  L++L+  
Sbjct: 9   RIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
              ++ L  Y   D  + +V +      L   L       +    R         A+H +
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTI 124

Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE- 649
           H      I+H D+K  N L+ +  + K+ DFG+       + + V     G++ Y+ PE 
Sbjct: 125 H---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180

Query: 650 ----------YYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
                           ++ KSDV+S G +L  +   + P              +     +
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--------------FQQIINQ 226

Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
             K+  IIDP  +   P +      +V   C+  D  +R S+ ++
Sbjct: 227 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  123 bits (310), Expect = 2e-29
 Identities = 47/205 (22%), Positives = 77/205 (37%), Gaps = 26/205 (12%)

Query: 483 IGRGGFGNVYKGF---LNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLI 538
           I  GG G +Y      +NG   PV +K L       A      E   L+++ +  +V + 
Sbjct: 88  IAHGGLGWIYLALDRNVNGR--PVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 539 GYCNDDGQMILVYDYMA----RG-TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
            +     +      Y+      G +L+          LP    +   +    AL YLH  
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLH-- 199

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
            S  +++ D+K  NI+L EE + K+ D G                + G+ G+  PE  R 
Sbjct: 200 -SIGLVYNDLKPENIMLTEEQL-KLIDLGAVS-----RINSFGY-LYGTPGFQAPEIVR- 250

Query: 654 QLLTEKSDVYSFGVVLLEVLCARPP 678
              T  +D+Y+ G  L  +    P 
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPT 275

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  117 bits (294), Expect = 4e-29
 Identities = 53/214 (24%), Positives = 97/214 (45%), Gaps = 19/214 (8%)

Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH 533
            + +  +  +G G FG VYK          A K +   S++   ++  EI +L+   + +
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           +V L+G    DG++ ++ ++   G +   +    +  L   +   +C     AL++LH  
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLH-- 134

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSK--THVST------QVKGSIG 644
            SK IIHRD+K  N+L+  E   +++DFG+  K      K  + + T      +V     
Sbjct: 135 -SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCET 193

Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
             D  Y        K+D++S G+ L+E+    PP
Sbjct: 194 MKDTPY------DYKADIWSLGITLIEMAQIEPP 221

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  116 bits (293), Expect = 4e-29
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 12/206 (5%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQT--EIGMLSQLRYL 532
           DF+    +G+G FGNVY      +   +A+K L     ++  +E Q   EI + S LR+ 
Sbjct: 15  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74

Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           +++ +  Y +D  ++ L+ ++  RG L   L  +        R        A ALHY H 
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCH- 131

Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
              + +IHRD+K  N+L+  +   K++DFG     P+  +        G++ YL PE   
Sbjct: 132 --ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-LRRRTMC---GTLDYLPPEMIE 185

Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPP 678
            +   EK D++  GV+  E L   PP
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPP 211

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  117 bits (295), Expect = 5e-29
 Identities = 51/218 (23%), Positives = 85/218 (38%), Gaps = 23/218 (10%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL-HLVSLIGYC 541
           +  GGF  VY+    G     A+KRL    ++       E+  + +L    ++V      
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95

Query: 542 -------NDDGQMILVYDYMARGTLRDHLYN-NDNPPLPWDRRLKICIGAARALHYLHTG 593
                  +      L+   + +G L + L       PL  D  LKI     RA+ ++H  
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR- 154

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF---GPNFSKTHVSTQVK-------GSI 643
               IIHRD+K  N+LL  +   K+ DFG        P++S +     +         + 
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214

Query: 644 GYLDPE---YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            Y  PE    Y    + EK D+++ G +L  +   + P
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  115 bits (290), Expect = 2e-28
 Identities = 48/213 (22%), Positives = 83/213 (38%), Gaps = 22/213 (10%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLIGY 540
           I+G+G   NV++G         AIK  N  S    ++    E  +L +L + ++V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 541 CNDDG--QMILVYDYMARGTLRDHLYNNDNP-PLPWDRRLKICIGAARALHYLHTGASKV 597
             +      +L+ ++   G+L   L    N   LP    L +       +++L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132

Query: 598 IIHRDVKTTNILL----DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
           I+HR++K  NI+     D + V K++DFG  +             + G+  YL P+ Y  
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEYLHPDMYER 189

Query: 654 QLL--------TEKSDVYSFGVVLLEVLCARPP 678
            +L            D++S GV          P
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  120 bits (302), Expect = 2e-28
 Identities = 56/210 (26%), Positives = 87/210 (41%), Gaps = 17/210 (8%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLI-- 538
            +G GGFG V +         VAIK+          E +  EI ++ +L + ++VS    
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 539 ----GYCNDDGQMILVYDYMARGTLRDHLYNNDNP-PLPWDRRLKICIGAARALHYLHTG 593
                    +   +L  +Y   G LR +L   +N   L       +    + AL YLH  
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH-- 138

Query: 594 ASKVIIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
               IIHRD+K  NI+L    +  + K+ D G  K      +  + T+  G++ YL PE 
Sbjct: 139 -ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE---LDQGELCTEFVGTLQYLAPEL 194

Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPIL 680
              +  T   D +SFG +  E +    P L
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFL 224

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  114 bits (287), Expect = 3e-28
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 14/208 (6%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQT--EIGMLSQLRY 531
           +DF     +G+G FGNVY          +A+K L     ++  +E Q   E+ + S LR+
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
            +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y H
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCH 126

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-FSKTHVSTQVKGSIGYLDPEY 650
              SK +IHRD+K  N+LL      K++DFG     P+            G++ YL PE 
Sbjct: 127 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-----GTLDYLPPEM 178

Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPP 678
              ++  EK D++S GV+  E L  +PP
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  113 bits (286), Expect = 4e-28
 Identities = 50/206 (24%), Positives = 96/206 (46%), Gaps = 19/206 (9%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
           ++G+G +G VY G    +   +AIK +     + +     EI +   L++ ++V  +G  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL------KICIGAARALHYLHTGAS 595
           +++G + +  + +  G+L   L  +   PL  + +       +I  G    L YLH    
Sbjct: 89  SENGFIKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIGFYTKQILEG----LKYLH---D 140

Query: 596 KVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
             I+HRD+K  N+L++    V K+SDFG  K     +    +    G++ Y+ PE     
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKG 198

Query: 655 LL--TEKSDVYSFGVVLLEVLCARPP 678
                + +D++S G  ++E+   +PP
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPP 224

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  116 bits (291), Expect = 9e-28
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 22/209 (10%)

Query: 482 IIGRGGFGN-VYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIG 539
           ++G G  G  VY+G  +     VA+KR+ P     A     E+ +L +   + +++    
Sbjct: 31  VLGHGAEGTIVYRGMFDNR--DVAVKRILPECFSFA---DREVQLLRESDEHPNVIRYFC 85

Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
              D     +  +  A  TL++++   D   L  +    +       L +LH   S  I+
Sbjct: 86  TEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLH---SLNIV 140

Query: 600 HRDVKTTNILLDE-----EWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
           HRD+K  NIL+       +  A +SDFGLCK            + V G+ G++ PE    
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200

Query: 654 QL---LTEKSDVYSFGVVLLEVLCA-RPP 678
                 T   D++S G V   V+     P
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHP 229

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  115 bits (289), Expect = 1e-27
 Identities = 48/213 (22%), Positives = 83/213 (38%), Gaps = 22/213 (10%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLIGY 540
           I+G+G   NV++G         AIK  N  S    ++    E  +L +L + ++V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 541 CNDDG--QMILVYDYMARGTLRDHLYNNDNP-PLPWDRRLKICIGAARALHYLHTGASKV 597
             +      +L+ ++   G+L   L    N   LP    L +       +++L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132

Query: 598 IIHRDVKTTNILL----DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
           I+HR++K  NI+     D + V K++DFG  +             + G+  YL P+ Y  
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEYLHPDMYER 189

Query: 654 QLL--------TEKSDVYSFGVVLLEVLCARPP 678
            +L            D++S GV          P
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  112 bits (282), Expect = 1e-27
 Identities = 50/238 (21%), Positives = 87/238 (36%), Gaps = 50/238 (21%)

Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLN-----PGSQQGALEFQTEIGMLSQ 528
           T +F+ L  IG G FG+V+K     D    AIKR          +Q AL    E+   + 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR---EVYAHAV 66

Query: 529 L-RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL--YNNDNPPLPWDRRLKICIGAAR 585
           L ++ H+V       +D  M++  +Y   G+L D +                 + +   R
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEE-------------------WVAKVSDFGLCKF 626
            L Y+H   S  ++H D+K +NI +                       + K+ D G    
Sbjct: 127 GLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT- 182

Query: 627 GPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTE------KSDVYSFGVVLLEVLCARPP 678
                 +    +  G   +L  E     +L E      K+D+++  + ++    A P 
Sbjct: 183 ----RISSPQVEE-GDSRFLANE-----VLQENYTHLPKADIFALALTVVCAAGAEPL 230

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  114 bits (286), Expect = 1e-27
 Identities = 34/231 (14%), Positives = 68/231 (29%), Gaps = 22/231 (9%)

Query: 467 ISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTP-----VAIKRLNPGSQQGALEFQT 521
            +E +  +K      ++G G F  VY+      +         +K   P +         
Sbjct: 57  KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ 116

Query: 522 EIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL---YNNDNPPLPWDRRLK 578
            +  L        +            +LV +  + GTL + +    N     +P    + 
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176

Query: 579 ICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVA-----------KVSDFGLCKFG 627
             +     +  +H      IIH D+K  N +L   ++             + D G     
Sbjct: 177 FAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233

Query: 628 PNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
             F K  + T    + G+   E    +    + D +     +  +L     
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174

 Score =  108 bits (272), Expect = 1e-27
 Identities = 25/193 (12%), Positives = 57/193 (29%), Gaps = 31/193 (16%)

Query: 192 ALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDARPSALPVNTTIVLRFSRILNFSA 251
           A + ++ +N GG              +  D       R S   +   I      + +   
Sbjct: 3   ADKVIWAVNAGGESHVDVHG----IHYRKDPLEGRVGRASDYGMKLPI------LRSNPE 52

Query: 252 PLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRLHFCEFQSEVTEEGDRVFKIYL 311
              +Y+T R          + +  ++  +     Y + L F E      +   +VF + +
Sbjct: 53  DQVLYQTERYN--------EDSFGYDIPIKEEGEYVLVLKFAEVYF--AQSQQKVFDVRV 102

Query: 312 ANLTAEDVADVIAWSGGNGVPE------YRDYAVAIGSKSDVKKQNLSIALHPAPRWRTK 365
              T     D+    G +   +       +   +++  +       LS+           
Sbjct: 103 NGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVK-----GY 157

Query: 366 YSDSILNGIEIFK 378
           Y +  +  + I K
Sbjct: 158 YDNPKVCALFIMK 170

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174

 Score = 60.7 bits (147), Expect = 6e-11
 Identities = 22/165 (13%), Positives = 45/165 (27%), Gaps = 18/165 (10%)

Query: 17  CGWLGNISAHGQTWAGD-----VSSQYSPLGHQQSTISKKPREPPYSASRLSHSQFTYTF 71
            G   ++  HG  +  D     V              S    +  Y   R +   F Y  
Sbjct: 12  AGGESHVDVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNEDSFGYDI 71

Query: 72  NV-TPGQKFIRLHFYSTSYSGFNISSAFFSVKANSFTLVNNFSASFAPDDTFFKEFCINV 130
            +   G+  + L F    ++        F V+ N  T+V +         +   +  I +
Sbjct: 72  PIKEEGEYVLVLKFAEVYFAQSQ--QKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPI 129

Query: 131 PEDQRSLSITFTPS----------PDYQDSYAFINGIELVSMPLN 165
              +  LS+    S                   +  + ++    +
Sbjct: 130 SIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIMKGTAD 174

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  112 bits (281), Expect = 2e-27
 Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 26/214 (12%)

Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH 533
            K +     IG+G  G VY          VAI+++N   Q        EI ++ + +  +
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           +V+ +       ++ +V +Y+A G+L D +       +   +   +C    +AL +LH  
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH-- 133

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSK--THVST------QVKGSIG 644
            S  +IHRD+K+ NILL  +   K++DFG C +  P  SK  T V T      +V     
Sbjct: 134 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192

Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           Y             K D++S G++ +E++   PP
Sbjct: 193 Y-----------GPKVDIWSLGIMAIEMIEGEPP 215

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  112 bits (281), Expect = 3e-27
 Identities = 63/235 (26%), Positives = 105/235 (44%), Gaps = 13/235 (5%)

Query: 445 MKEAKSRGPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVA 504
           ++  + R P       L      S  K+  + F+ L  +G G +G+VYK         VA
Sbjct: 2   LETVQLRNPPRRQLKKLD---EDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVA 58

Query: 505 IKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY 564
           IK++   S     E   EI ++ Q    H+V   G    +  + +V +Y   G++ D + 
Sbjct: 59  IKQVPVESDLQ--EIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-II 115

Query: 565 NNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC 624
              N  L  D    I     + L YLH       IHRD+K  NILL+ E  AK++DFG+ 
Sbjct: 116 RLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVA 172

Query: 625 -KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            +     +K +  T + G+  ++ PE  +       +D++S G+  +E+   +PP
Sbjct: 173 GQLTDTMAKRN--TVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  113 bits (284), Expect = 4e-27
 Identities = 46/245 (18%), Positives = 87/245 (35%), Gaps = 20/245 (8%)

Query: 445 MKEAKSRGPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRG--GFGNVYKGFLNGDSTP 502
           M         +     + +             +  L +IG+G      V           
Sbjct: 1   MAHHHHHHMENLYFQGMSS------FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEY 54

Query: 503 VAIKRLNPGSQQGAL--EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLR 560
           V ++R+N  +    +    Q E+ +     + ++V        D ++ +V  +MA G+ +
Sbjct: 55  VTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 114

Query: 561 DHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSD 620
           D +  +    +       I  G  +AL Y+H       +HR VK ++IL+  +    +S 
Sbjct: 115 DLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSG 171

Query: 621 FGLC-KFGPNFSKTH-VSTQVKGSIG---YLDPEYYRLQLL--TEKSDVYSFGVVLLEVL 673
                    +  +   V    K S+    +L PE  +  L     KSD+YS G+   E+ 
Sbjct: 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231

Query: 674 CARPP 678
               P
Sbjct: 232 NGHVP 236

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  112 bits (282), Expect = 4e-27
 Identities = 65/287 (22%), Positives = 111/287 (38%), Gaps = 27/287 (9%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKR----LNPGSQQGALEFQTEIGMLSQLR 530
            DF  +  +G G  G V+K         +A K     + P  +    +   E+ +L +  
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN---QIIRELQVLHECN 89

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
             ++V   G    DG++ +  ++M  G+L D +       +P     K+ I   + L YL
Sbjct: 90  SPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGR-IPEQILGKVSIAVIKGLTYL 147

Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG---YLD 647
                  I+HRDVK +NIL++     K+ DFG        S   + +     +G   Y+ 
Sbjct: 148 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFG-------VSGQLIDSMANSFVGTRSYMS 198

Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDII 707
           PE  +    + +SD++S G+ L+E+   R PI     K+   +     E           
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258

Query: 708 DPFLKGNAPPVCLNQ---FVEVAMSCVNDDRIRRPSMSDVVWGLEFV 751
            P    N   +         E+    VN+     P +   V+ LEF 
Sbjct: 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEP---PPKLPSGVFSLEFQ 302

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  113 bits (283), Expect = 5e-27
 Identities = 31/264 (11%), Positives = 75/264 (28%), Gaps = 44/264 (16%)

Query: 454 ASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ 513
            S   +    +   SE+ E  +      ++G+       +           +       +
Sbjct: 58  TSLWNTGQPFRV-ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER 116

Query: 514 QGA---LEFQTEIGMLSQLR----------YLHLVSLIGYCNDDGQ-------------- 546
             +    + + E+  L  LR          +L  +       D  +              
Sbjct: 117 PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMW 176

Query: 547 --MILVYDYMARGTLRDHL-----YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
                      +  L+        +++ +  L    RL++ +   R L  LH      ++
Sbjct: 177 VLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV 233

Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ----- 654
           H  ++  +I+LD+     ++ F         + + +                        
Sbjct: 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGF-APPETTAERMLPFGQHHPT 292

Query: 655 LLTEKSDVYSFGVVLLEVLCARPP 678
           L+T   D ++ G+ +  + CA  P
Sbjct: 293 LMTFAFDTWTLGLAIYWIWCADLP 316

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  111 bits (280), Expect = 7e-27
 Identities = 48/265 (18%), Positives = 99/265 (37%), Gaps = 52/265 (19%)

Query: 452 GPASSLPSDLCTQFSISEIKEATKDFNNLLI--------IGRGGFGNVYKGFLNGDSTPV 503
           GP  S+  D+ + +S            +  I        + +G F  +     +      
Sbjct: 1   GPLGSM-KDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDN--KFY 57

Query: 504 AIKRLN----------------PGSQQGALE-FQTEIGMLSQLRYLHLVSLIGYCNDDGQ 546
           A+K+                    S +   + F+ E+ +++ ++  + ++  G   +  +
Sbjct: 58  ALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDE 117

Query: 547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGA------ARALHYLHTGASKVIIH 600
           + ++Y+YM   ++             +   + I +          +  Y+H    K I H
Sbjct: 118 VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICH 175

Query: 601 RDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE-------YYRL 653
           RDVK +NIL+D+    K+SDFG  ++  +  K   S   +G+  ++ PE       Y   
Sbjct: 176 RDVKPSNILMDKNGRVKLSDFGESEYMVD-KKIKGS---RGTYEFMPPEFFSNESSYN-- 229

Query: 654 QLLTEKSDVYSFGVVLLEVLCARPP 678
                K D++S G+ L  +     P
Sbjct: 230 ---GAKVDIWSLGICLYVMFYNVVP 251

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  110 bits (278), Expect = 8e-27
 Identities = 48/206 (23%), Positives = 97/206 (47%), Gaps = 10/206 (4%)

Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH 533
               ++ + IG G  G V           VA+K ++   QQ       E+ ++   ++ +
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           +V +        ++ ++ +++  G L D +       L  ++   +C    +AL YLH  
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLH-- 158

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
            ++ +IHRD+K+ +ILL  +   K+SDFG C +   +  K    + V G+  ++ PE   
Sbjct: 159 -AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--SLV-GTPYWMAPEVIS 214

Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPP 678
             L   + D++S G++++E++   PP
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDGEPP 240

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  111 bits (279), Expect = 8e-27
 Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 18/217 (8%)

Query: 468 SEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIK--RLNPGSQQGALEFQTEIGM 525
            E +E      +   +GRG FG V++          A+K  RL     +       E+  
Sbjct: 51  YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVA 103

Query: 526 LSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR 585
            + L    +V L G   +   + +  + +  G+L   +       LP DR L     A  
Sbjct: 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALE 161

Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEE-WVAKVSDFGLCK--FGPNFSKTHVSTQ-VKG 641
            L YLH   ++ I+H DVK  N+LL  +   A + DFG           K+ ++   + G
Sbjct: 162 GLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218

Query: 642 SIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           +  ++ PE    +    K D++S   ++L +L    P
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  110 bits (275), Expect = 4e-26
 Identities = 35/256 (13%), Positives = 77/256 (30%), Gaps = 54/256 (21%)

Query: 468 SEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL------------------- 508
           SE+ E  +      ++G+       +           +                      
Sbjct: 66  SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 125

Query: 509 ---------NPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM-ARGT 558
                    N    +  L F     ++   +   ++ +     D   +   + Y   +  
Sbjct: 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 185

Query: 559 LRDHL-----YNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEE 613
           L+        +++ +  L    RL++ +   R L  LH      ++H  ++  +I+LD+ 
Sbjct: 186 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQR 242

Query: 614 WVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY-----------YRLQLLTEKSDV 662
               ++ F          +         S G+  PE             R  L+T   D 
Sbjct: 243 GGVFLTGFEHLV------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDA 296

Query: 663 YSFGVVLLEVLCARPP 678
           ++ G+V+  + CA  P
Sbjct: 297 WALGLVIYWIWCADLP 312

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  109 bits (273), Expect = 5e-26
 Identities = 61/241 (25%), Positives = 102/241 (42%), Gaps = 26/241 (10%)

Query: 454 ASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ 513
           AS  P+    +  +S +++    F  + ++G G +G VYKG         AIK ++    
Sbjct: 3   ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD 62

Query: 514 QGALEFQTEIGMLSQL-RYLHLVSLIG------YCNDDGQMILVYDYMARGTLRDHLYNN 566
           +   E + EI ML +   + ++ +  G          D Q+ LV ++   G++ D + N 
Sbjct: 63  EEE-EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT 121

Query: 567 DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-K 625
               L  +    IC    R L +LH      +IHRD+K  N+LL E    K+ DFG+  +
Sbjct: 122 KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178

Query: 626 FGPNFSK--THVST------QVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARP 677
                 +  T + T      +V       D  Y        KSD++S G+  +E+    P
Sbjct: 179 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATY------DFKSDLWSLGITAIEMAEGAP 232

Query: 678 P 678
           P
Sbjct: 233 P 233

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  107 bits (270), Expect = 7e-26
 Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 27/215 (12%)

Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYL 532
            + F  L  IG+G FG V+KG  N     VAIK ++    +  +E  Q EI +LSQ    
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++    G    D ++ ++ +Y+  G+  D L      PL   +   I     + L YLH 
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLH- 136

Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSK--THVST------QVKGSI 643
             S+  IHRD+K  N+LL E    K++DFG+  +      K  T V T      +V    
Sbjct: 137 --SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 194

Query: 644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            Y             K+D++S G+  +E+    PP
Sbjct: 195 AY-----------DSKADIWSLGITAIELARGEPP 218

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  106 bits (267), Expect = 1e-25
 Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 14/215 (6%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLH 533
            D+    +IG G    V   +       VAIKR+N    Q +++    EI  +SQ  + +
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLK------ICIGAARAL 587
           +VS         ++ LV   ++ G++ D + +           L       I       L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG--- 644
            YLH       IHRDVK  NILL E+   +++DFG+  F         +   K  +G   
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 645 YLDPE-YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           ++ PE   +++    K+D++SFG+  +E+     P
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  107 bits (269), Expect = 2e-25
 Identities = 29/261 (11%), Positives = 58/261 (22%), Gaps = 46/261 (17%)

Query: 454 ASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ 513
           A+  P +  T    S + +  +    +  +  G    V+           A+K    G++
Sbjct: 42  ATVWPQNAETTVD-SLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE 100

Query: 514 QGALE---FQTEIGMLSQLR---------YLHLVSLIGYCNDDGQMI------------- 548
               E           ++L             L+          Q               
Sbjct: 101 NSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAV 160

Query: 549 ----LVYDYMARGTLRD-----HLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
               L+    +   L                        +     R    L    SK ++
Sbjct: 161 ANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV 216

Query: 600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ--LLT 657
           H      N+ +  +    + D                      + Y   E+        T
Sbjct: 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASS-----VPVTYAPREFLNASTATFT 271

Query: 658 EKSDVYSFGVVLLEVLCARPP 678
              + +  G+ +  V C   P
Sbjct: 272 HALNAWQLGLSIYRVWCLFLP 292

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  105 bits (264), Expect = 3e-25
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 15/217 (6%)

Query: 468 SEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQ--TEIG 524
           + I E  +DF    ++G+G F  VY+         VAIK ++  +  +  +  +   E+ 
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63

Query: 525 MLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAA 584
           +  QL++  ++ L  Y  D   + LV +    G +  +L N   P    +          
Sbjct: 64  IHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP-FSENEARHFMHQII 122

Query: 585 RALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL---CKFGPNFSKTHVSTQVKG 641
             + YLH   S  I+HRD+  +N+LL      K++DFGL    K       T     + G
Sbjct: 123 TGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-----LCG 174

Query: 642 SIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           +  Y+ PE         +SDV+S G +   +L  RPP
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  108 bits (271), Expect = 3e-25
 Identities = 57/246 (23%), Positives = 94/246 (38%), Gaps = 43/246 (17%)

Query: 467 ISEIKEATKDFNNLL----IIGRGGFGNV-YKGFLNGDSTPVAIKRLNPGSQQGALEFQT 521
           I+ I    +   NL+    I+G G  G V ++G   G   PVA+KR+       A     
Sbjct: 3   IANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGR--PVAVKRMLIDFCDIA---LM 57

Query: 522 EIGMLSQL-RYLHLVSLIGYCNDDGQMILVYDYMARGTLRD-----HLYNNDNPPLPWDR 575
           EI +L++   + +++        D  + +  +      L+D     ++ + +        
Sbjct: 58  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYN 116

Query: 576 RLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD-------------EEWVAKVSDFG 622
            + +    A  + +LH   S  IIHRD+K  NIL+              E     +SDFG
Sbjct: 117 PISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173

Query: 623 LCKF--GPNFSKTHVSTQVKGSIGYLDPE-------YYRLQLLTEKSDVYSFGVVLLEVL 673
           LCK       S         G+ G+  PE           + LT   D++S G V   +L
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233

Query: 674 CA-RPP 678
              + P
Sbjct: 234 SKGKHP 239

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  106 bits (266), Expect = 5e-25
 Identities = 65/216 (30%), Positives = 96/216 (44%), Gaps = 27/216 (12%)

Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEF---QTEIGMLSQLR 530
            K F++L  IG G FG VY      +S  VAIK+++   +Q   ++     E+  L +LR
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + + +   G    +    LV +Y   G+  D L      PL       +  GA + L YL
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYL 170

Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK--THVST------QVKGS 642
           H   S  +IHRDVK  NILL E  + K+ DFG        +   + V T      +V   
Sbjct: 171 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS---IMAPANSFVGTPYWMAPEV--- 221

Query: 643 IGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           I  +D   Y       K DV+S G+  +E+   +PP
Sbjct: 222 ILAMDEGQY-----DGKVDVWSLGITCIELAERKPP 252

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  104 bits (262), Expect = 7e-25
 Identities = 46/202 (22%), Positives = 81/202 (40%), Gaps = 16/202 (7%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALE-FQTEIGMLSQLRYLHLVSLIG 539
           +G+GGF   ++          A K +      +    E    EI +   L + H+V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
           +  D+  + +V +   R +L +         L                 YLH      +I
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLH---RNRVI 137

Query: 600 HRDVKTTNILLDEEWVAKVSDFGLC---KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
           HRD+K  N+ L+E+   K+ DFGL    ++     K      + G+  Y+ PE    +  
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-----LCGTPNYIAPEVLSKKGH 192

Query: 657 TEKSDVYSFGVVLLEVLCARPP 678
           + + DV+S G ++  +L  +PP
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPP 214

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  105 bits (263), Expect = 9e-25
 Identities = 61/246 (24%), Positives = 105/246 (42%), Gaps = 42/246 (17%)

Query: 456 SLPSDLCTQFSISEIKEAT-KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ 514
           S+ S    + S  +  + T +D  +L  IGRG +G+V K         +A+KR+     +
Sbjct: 2   SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61

Query: 515 GALEFQTEIGM-----LSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLR--DHLYNND 567
              + Q ++ M     +      ++V   G    +G   +  + M+    +   ++Y+  
Sbjct: 62  ---KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVL 118

Query: 568 NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG 627
           +  +P +   KI +   +AL++L       IIHRD+K +NILLD     K+ DFG     
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFG----- 171

Query: 628 PNFSKTHVSTQVKGSIG---------YLDPEYYRLQLL------TEKSDVYSFGVVLLEV 672
                  +S Q+  SI          Y+ PE  R+           +SDV+S G+ L E+
Sbjct: 172 -------ISGQLVDSIAKTRDAGCRPYMAPE--RIDPSASRQGYDVRSDVWSLGITLYEL 222

Query: 673 LCARPP 678
              R P
Sbjct: 223 ATGRFP 228

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  104 bits (262), Expect = 1e-24
 Identities = 53/243 (21%), Positives = 91/243 (37%), Gaps = 22/243 (9%)

Query: 448 AKSRGPASSLPSDLCTQFSISEIKEATKDFNNLL------IIGRGGFGNVYKGFLNGDST 501
            K+  P  + P          EI E   D  +         +G+GGF   ++        
Sbjct: 8   GKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKE 67

Query: 502 PVAIKRLNPGS--QQGALE-FQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGT 558
             A K +      +    E    EI +   L + H+V   G+  D+  + +V +   R +
Sbjct: 68  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 127

Query: 559 LRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKV 618
           L +         L                 YLH      +IHRD+K  N+ L+E+   K+
Sbjct: 128 LLELHKRRK--ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKI 182

Query: 619 SDFGLC---KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCA 675
            DFGL    ++     K      + G+  Y+ PE    +  + + DV+S G ++  +L  
Sbjct: 183 GDFGLATKVEYDGERKKV-----LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 237

Query: 676 RPP 678
           +PP
Sbjct: 238 KPP 240

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  107 bits (269), Expect = 1e-24
 Identities = 53/234 (22%), Positives = 93/234 (39%), Gaps = 22/234 (9%)

Query: 458 PSDLCTQFSISE---IKEATKDFNNLL----IIGRGGFGNVYKGFLNGDSTPVAIKRLN- 509
           P  +      +    ++ +T  F++      ++G+G FG V            A+K ++ 
Sbjct: 2   PGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK 61

Query: 510 --PGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNND 567
                +        E+ +L QL + +++ L  +  D G   LV +    G L D + +  
Sbjct: 62  RQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK 121

Query: 568 NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL---DEEWVAKVSDFGLC 624
                     +I       + Y+H      I+HRD+K  N+LL    ++   ++ DFGL 
Sbjct: 122 R--FSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176

Query: 625 KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
                F  +       G+  Y+ PE        EK DV+S GV+L  +L   PP
Sbjct: 177 TH---FEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 226

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  102 bits (257), Expect = 5e-24
 Identities = 49/222 (22%), Positives = 88/222 (39%), Gaps = 36/222 (16%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGML-SQLRYL 532
            D  NL  +G G  G V+K         +A+K++     +   +    ++ ++       
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V   G    +  + +  + M      + L      P+P     K+ +   +AL+YL  
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCA--EKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142

Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG-------- 644
                +IHRDVK +NILLDE    K+ DFG            +S ++             
Sbjct: 143 --KHGVIHRDVKPSNILLDERGQIKLCDFG------------ISGRLVDDKAKDRSAGCA 188

Query: 645 -YLDPEYYRLQLL-------TEKSDVYSFGVVLLEVLCARPP 678
            Y+ PE  R+            ++DV+S G+ L+E+   + P
Sbjct: 189 AYMAPE--RIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  105 bits (263), Expect = 7e-24
 Identities = 53/218 (24%), Positives = 85/218 (38%), Gaps = 18/218 (8%)

Query: 470 IKEATKDFNNLL----IIGRGGFGNVYKGFLNGDSTPVAIKRLN--PGSQQGALEFQTEI 523
           I       + +      +G G +G V            AIK +     S     +   E+
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87

Query: 524 GMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGA 583
            +L  L + +++ L  +  D     LV +    G L D + +             I    
Sbjct: 88  AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQV 145

Query: 584 ARALHYLHTGASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVK 640
              + YLH      I+HRD+K  N+LL   +++ + K+ DFGL      F       +  
Sbjct: 146 LSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV---FENQKKMKERL 199

Query: 641 GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           G+  Y+ PE  R +   EK DV+S GV+L  +L   PP
Sbjct: 200 GTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPP 236

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  104 bits (262), Expect = 8e-24
 Identities = 57/255 (22%), Positives = 90/255 (35%), Gaps = 29/255 (11%)

Query: 444 VMKEAKSRGPASSLPSDLCTQFSISEIKEATKDFNNLLII----GRGGFGNVYKGFLNGD 499
           +           +L            +++               G G +G V        
Sbjct: 1   MHHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNG 60

Query: 500 STPVAIKRLN-------------PGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQ 546
            +  AIK +                 ++   E   EI +L  L + +++ L     D   
Sbjct: 61  HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120

Query: 547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTT 606
             LV ++   G L + + N             I       + YLH      I+HRD+K  
Sbjct: 121 FYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICYLH---KHNIVHRDIKPE 175

Query: 607 NILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVY 663
           NILL   +     K+ DFGL  F   FSK +      G+  Y+ PE  + +   EK DV+
Sbjct: 176 NILLENKNSLLNIKIVDFGLSSF---FSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVW 231

Query: 664 SFGVVLLEVLCARPP 678
           S GV++  +LC  PP
Sbjct: 232 SCGVIMYILLCGYPP 246

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  104 bits (260), Expect = 2e-23
 Identities = 63/242 (26%), Positives = 102/242 (42%), Gaps = 18/242 (7%)

Query: 445 MKEAKSRGPASSLPSDLCTQFSISEIKEATK-DFNNLLIIGRGGFGNVYKGFLNGDSTPV 503
           +  A       S+  +   Q+   E +  TK  F    ++G+GGFG V    +       
Sbjct: 153 LSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMY 212

Query: 504 AIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYC-NDDGQMILVYDYMARGTL 559
           A K+L       ++G      E  +L ++    +VSL  Y       + LV   M  G L
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDL 271

Query: 560 RDHLYNNDNPPLPWDRRLKICIGAAR---ALHYLHTGASKVIIHRDVKTTNILLDEEWVA 616
           + H+Y+      P  R       AA     L  LH    + I++RD+K  NILLD+    
Sbjct: 272 KFHIYHMGQAGFPEAR---AVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHI 325

Query: 617 KVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           ++SD GL    P         +V G++GY+ PE  + +  T   D ++ G +L E++  +
Sbjct: 326 RISDLGLAVHVPEGQTIK--GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

Query: 677 PP 678
            P
Sbjct: 383 SP 384

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 99.2 bits (248), Expect = 4e-23
 Identities = 53/226 (23%), Positives = 94/226 (41%), Gaps = 44/226 (19%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM-----LSQLR 530
           D   ++ +GRG +G V K         +A+KR+         + Q  + M     +  + 
Sbjct: 8   DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS---QEQKRLLMDLDISMRTVD 64

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLY---NNDNPPLPWDRRLKICIGAARAL 587
               V+  G    +G + +  + M   +L D  Y    +    +P D   KI +   +AL
Sbjct: 65  CPFTVTFYGALFREGDVWICMELMD-TSL-DKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122

Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG--- 644
            +LH+  S  +IHRDVK +N+L++     K+ DFG            +S  +   +    
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFG------------ISGYLVDDVAKDI 168

Query: 645 ------YLDPEYYRLQLL------TEKSDVYSFGVVLLEVLCARPP 678
                 Y+ PE  R+         + KSD++S G+ ++E+   R P
Sbjct: 169 DAGCKPYMAPE--RINPELNQKGYSVKSDIWSLGITMIELAILRFP 212

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  100 bits (251), Expect = 2e-22
 Identities = 64/239 (26%), Positives = 99/239 (41%), Gaps = 29/239 (12%)

Query: 455 SSLPSDLCTQFSISEIKEAT-KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-- 511
            SL      Q+   E +      F +  ++GRGGFG V+   +       A K+LN    
Sbjct: 164 DSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL 223

Query: 512 -SQQGALEFQTEIGMLSQLRYLHLVSLIGYC-NDDGQMILVYDYMARGTLRDHLYNND-- 567
             ++G      E  +L+++    +VSL  Y       + LV   M  G +R H+YN D  
Sbjct: 224 KKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDED 282

Query: 568 NPPLPWDRRLKICIGAAR--------ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVS 619
           NP     R        A          L +LH    + II+RD+K  N+LLD++   ++S
Sbjct: 283 NPGFQEPR--------AIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRIS 331

Query: 620 DFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           D GL                 G+ G++ PE    +      D ++ GV L E++ AR P
Sbjct: 332 DLGLAVELKAGQTK-TKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  100 bits (250), Expect = 2e-22
 Identities = 52/202 (25%), Positives = 83/202 (41%), Gaps = 14/202 (6%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLN--PGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           ++G+G FG V K          A+K +N      +       E+ +L +L + +++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVII 599
              D     +V +    G L D +              +I       + Y+H      I+
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMH---KHNIV 143

Query: 600 HRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
           HRD+K  NILL   +++   K+ DFGL      F +        G+  Y+ PE  R    
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVLR-GTY 199

Query: 657 TEKSDVYSFGVVLLEVLCARPP 678
            EK DV+S GV+L  +L   PP
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 98.5 bits (246), Expect = 3e-22
 Identities = 58/217 (26%), Positives = 89/217 (41%), Gaps = 30/217 (13%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEF-QTEIGMLSQLRYL 532
            F  L  IG+G FG V     N      A+K +N     ++  +     E+ ++  L + 
Sbjct: 16  HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHP 75

Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR------- 585
            LV+L     D+  M +V D +  G LR HL           + +       +       
Sbjct: 76  FLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ----------QNVHFKEETVKLFICELV 125

Query: 586 -ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG 644
            AL YL    ++ IIHRD+K  NILLDE     ++DF +        +    T + G+  
Sbjct: 126 MALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAGTKP 179

Query: 645 YLDPEYYRLQLLTEKS---DVYSFGVVLLEVLCARPP 678
           Y+ PE +  +     S   D +S GV   E+L  R P
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 97.6 bits (243), Expect = 3e-22
 Identities = 52/245 (21%), Positives = 88/245 (35%), Gaps = 52/245 (21%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIK-----RLNPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           IG+G +G V     N      AIK     ++   + +     +TE+ ++ +L + ++  L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG--------------- 582
                D+  + LV +    G L D L    +          +                  
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 583 ----------------AAR-------ALHYLHTGASKVIIHRDVKTTNILL--DEEWVAK 617
                            +        ALHYLH   ++ I HRD+K  N L   ++ +  K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210

Query: 618 VSDFGLCKF--GPNFSKTHVSTQVKGSIGYLDPE--YYRLQLLTEKSDVYSFGVVLLEVL 673
           + DFGL K     N  + +  T   G+  ++ PE      +    K D +S GV+L  +L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270

Query: 674 CARPP 678
               P
Sbjct: 271 MGAVP 275

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 96.9 bits (241), Expect = 6e-22
 Identities = 65/342 (19%), Positives = 111/342 (32%), Gaps = 96/342 (28%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLH 533
            DF  +  +GRGGFG V++     D    AIKR+   +++ A E    E+  L++L +  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 534 LVSLIGYCNDDGQMILVYD----------------------------------------- 552
           +V       +        +                                         
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 553 YMARGTLRDHLY-----------------NNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
            +   + + +LY                             L I I  A A+ +LH   S
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---S 182

Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN-------FSKTHVSTQVKGSIG---Y 645
           K ++HRD+K +NI    + V KV DFGL              +         G +G   Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD 705
           + PE       + K D++S G++L E+L +                   T+  R   I D
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFS-----------------TQMERVRIITD 285

Query: 706 IIDPFLKGNAPPVCLNQFVEVAM---SCVNDDRIRRPSMSDV 744
           +         P +   ++ +  M     ++     RP  +D+
Sbjct: 286 VR----NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 97.5 bits (243), Expect = 1e-21
 Identities = 62/259 (23%), Positives = 98/259 (37%), Gaps = 35/259 (13%)

Query: 434 IVFLLISRRAVMKEAKSRGPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYK 493
           I   L   +  +    +    S  P  L  ++ +S+             +G G  G V  
Sbjct: 106 IALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKT------------LGSGACGEVKL 153

Query: 494 GFLNGDSTPVAIKRLN--------PGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG 545
            F       VAI+ ++              AL  +TEI +L +L +  ++ +  +  D  
Sbjct: 154 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAE 212

Query: 546 QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKT 605
              +V + M  G L D +  N    L              A+ YLH      IIHRD+K 
Sbjct: 213 DYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKP 267

Query: 606 TNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE---YYRLQLLTEK 659
            N+LL   +E+ + K++DFG  K      +T +   + G+  YL PE             
Sbjct: 268 ENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 324

Query: 660 SDVYSFGVVLLEVLCARPP 678
            D +S GV+L   L   PP
Sbjct: 325 VDCWSLGVILFICLSGYPP 343

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 99.2 bits (247), Expect = 1e-21
 Identities = 66/251 (26%), Positives = 102/251 (40%), Gaps = 23/251 (9%)

Query: 441 RRAVMKEAKSRGPASSLPSDLCTQFSISEIKEATK-----DFNNLLIIGRGGFGNVYKGF 495
              + +  +       + SD  T+F   +  E        DF+   IIGRGGFG VY   
Sbjct: 150 IEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCR 209

Query: 496 LNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLH---LVSLIGYCN-DDGQMI 548
                   A+K L+      +QG      E  MLS +       +V +  Y      ++ 
Sbjct: 210 KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLS 268

Query: 549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNI 608
            + D M  G L  HL  +        R     I     L ++H   ++ +++RD+K  NI
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI--ILGLEHMH---NRFVVYRDLKPANI 323

Query: 609 LLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKS-DVYSFGV 667
           LLDE    ++SD GL        K H    V G+ GY+ PE  +  +  + S D +S G 
Sbjct: 324 LLDEHGHVRISDLGLACDFSK-KKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGC 379

Query: 668 VLLEVLCARPP 678
           +L ++L    P
Sbjct: 380 MLFKLLRGHSP 390

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 13/202 (6%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLIGYC 541
           +G G FG+V+            IK +N    Q  +E  + EI +L  L + +++ +    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRR--LKICIGAARALHYLHTGASKVII 599
            D   M +V +    G L + + +              ++      AL Y H   S+ ++
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVV 146

Query: 600 HRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL 656
           H+D+K  NIL          K+ DFGL +    F     ST   G+  Y+ PE ++ + +
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALYMAPEVFK-RDV 202

Query: 657 TEKSDVYSFGVVLLEVLCARPP 678
           T K D++S GVV+  +L    P
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLP 224

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 94.2 bits (235), Expect = 3e-21
 Identities = 64/248 (25%), Positives = 99/248 (39%), Gaps = 34/248 (13%)

Query: 447 EAKSRGPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIK 506
           +  +  P     S    Q      K+  +DF    I+G G F  V        S   AIK
Sbjct: 2   DGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIK 61

Query: 507 RLNPGS--QQGALEF-QTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHL 563
            L      ++  + +   E  ++S+L +   V L     DD ++     Y   G L  ++
Sbjct: 62  ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI 121

Query: 564 YNNDNPPLPWDRRLKICIGAAR--------ALHYLHTGASKVIIHRDVKTTNILLDEEWV 615
                      +         R        AL YLH    K IIHRD+K  NILL+E+  
Sbjct: 122 R----------KIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMH 168

Query: 616 AKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEK-----SDVYSFGVVLL 670
            +++DFG  K     SK   +    G+  Y+ PE     LLTEK     SD+++ G ++ 
Sbjct: 169 IQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-----LLTEKSACKSSDLWALGCIIY 223

Query: 671 EVLCARPP 678
           +++   PP
Sbjct: 224 QLVAGLPP 231

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 93.7 bits (233), Expect = 3e-21
 Identities = 37/266 (13%), Positives = 78/266 (29%), Gaps = 59/266 (22%)

Query: 483 IGRGGFGNVYKGFLNGDST---PVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVS 536
            G       ++     D+     VA+  ++P          E  +    LS++    +  
Sbjct: 39  HGGVPPLQFWQAL---DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH-TGAS 595
           ++   +     ++V +++  G+L++     D  P P    ++     A A    H  G  
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSP-VGAIRAMQSLAAAADAAHRAG-- 149

Query: 596 KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL 655
             +       + + +  +    ++                          +         
Sbjct: 150 --VALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA------ 179

Query: 656 LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF-LKGN 714
              + D+   G  L  +L  R P+   G +  +  A   T        G  I+P  +  +
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA-------GQPIEPADIDRD 231

Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPS 740
            P     Q   VA   V  D   R +
Sbjct: 232 IPF----QISAVAARSVQGDGGIRSA 253

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 92.2 bits (230), Expect = 1e-20
 Identities = 49/213 (23%), Positives = 83/213 (38%), Gaps = 38/213 (17%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
           ++G G F  V+           A+K +           + EI +L ++++ ++V+L    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 542 NDDGQMILVYDYMARGTL------RDHLYNNDNPPLPWDRRLKICIGAAR-------ALH 588
                  LV   ++ G L      R      D               A+        A+ 
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGVYTEKD---------------ASLVIQQVLSAVK 120

Query: 589 YLHTGASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
           YLH      I+HRD+K  N+L    +E     ++DFGL K   N     + +   G+ GY
Sbjct: 121 YLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN----GIMSTACGTPGY 173

Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           + PE    +  ++  D +S GV+   +LC  PP
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 50/218 (22%), Positives = 80/218 (36%), Gaps = 48/218 (22%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
            IGRG +G V      G     A K++     +    F+ EI ++  L + +++ L    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75

Query: 542 NDDGQMILVYDYMARGTL------RDHLYNNDNPPLPWDRRLKICIGAAR-------ALH 588
            D+  + LV +    G L      +     +D               AAR       A+ 
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKRVFRESD---------------AARIMKDVLSAVA 120

Query: 589 YLHTGASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
           Y H      + HRD+K  N L      +   K+ DFGL      F    +     G+  Y
Sbjct: 121 YCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKVGTPYY 174

Query: 646 LDPE-----YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           + P+     Y        + D +S GV++  +LC  PP
Sbjct: 175 VSPQVLEGLY------GPECDEWSAGVMMYVLLCGYPP 206

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 48/215 (22%), Positives = 87/215 (40%), Gaps = 39/215 (18%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLN--PGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
            +G+G F  V +          A K +N    S +   + + E  +  +L++ ++V L  
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72

Query: 540 YCNDDGQMILVYDYMARGTL------RDHLYNNDNPPLPWDRRLKICIGAAR-------A 586
              ++    LV+D +  G L      R+     D               A+        +
Sbjct: 73  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD---------------ASHCIQQILES 117

Query: 587 LHYLHTGASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSI 643
           + Y H   S  I+HR++K  N+LL    +    K++DFGL       + +       G+ 
Sbjct: 118 IAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTP 171

Query: 644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           GYL PE  +    ++  D+++ GV+L  +L   PP
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 53/213 (24%), Positives = 84/213 (39%), Gaps = 36/213 (16%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLN--PGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           ++G+G FG V K          A+K +N      +       E+ +L +L + +++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 540 YCNDDGQMILVYDYMARGTL------RDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
              D     +V +    G L      R     +D          +I       + Y+H  
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA--------ARIIKQVFSGITYMH-- 138

Query: 594 ASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE- 649
               I+HRD+K  NILL   +++   K+ DFGL      F +        G+  Y+ PE 
Sbjct: 139 -KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEV 194

Query: 650 ----YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               Y       EK DV+S GV+L  +L   PP
Sbjct: 195 LRGTY------DEKCDVWSAGVILYILLSGTPP 221

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 92.9 bits (231), Expect = 2e-20
 Identities = 41/208 (19%), Positives = 80/208 (38%), Gaps = 29/208 (13%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG V++            K +N          + EI +++QL +  L++L     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118

Query: 543 DDGQMILVYDYMARGTL------RDHLYNNDNPPLPWDRRLKICIGAAR----ALHYLHT 592
           D  +M+L+ ++++ G L       D+  +               I   R     L ++H 
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSE-----------AEVINYMRQACEGLKHMH- 166

Query: 593 GASKVIIHRDVKTTNILL--DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
                I+H D+K  NI+    +    K+ DFGL       +   +      +  +  PE 
Sbjct: 167 --EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATAEFAAPEI 221

Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPP 678
              + +   +D+++ GV+   +L    P
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 94.1 bits (234), Expect = 3e-20
 Identities = 49/251 (19%), Positives = 93/251 (37%), Gaps = 25/251 (9%)

Query: 440 SRRAVMKEAKSRGPASSLPSDLCTQFSISEIKEATKDFNNLLII----GRGGFGNVYKGF 495
             + V  +        +   D+  Q+    ++       +   I    G G FG V++  
Sbjct: 118 QGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVT 177

Query: 496 LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMA 555
                   A K +    +      + EI  +S LR+  LV+L     DD +M+++Y++M+
Sbjct: 178 ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237

Query: 556 RGTLRDHLYNNDNPPLPWDRRL--KICIGAAR----ALHYLHTGASKVIIHRDVKTTNIL 609
            G L + + +  N       ++     +   R     L ++H       +H D+K  NI+
Sbjct: 238 GGELFEKVADEHN-------KMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIM 287

Query: 610 L--DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGV 667
                    K+ DFGL                 G+  +  PE    + +   +D++S GV
Sbjct: 288 FTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344

Query: 668 VLLEVLCARPP 678
           +   +L    P
Sbjct: 345 LSYILLSGLSP 355

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 93.3 bits (232), Expect = 3e-20
 Identities = 59/229 (25%), Positives = 91/229 (39%), Gaps = 29/229 (12%)

Query: 466 SISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALE-FQTE 522
            + +++   +DF  L +IGRG FG V    L       A+K LN     ++     F+ E
Sbjct: 65  KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124

Query: 523 IGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
             +L       + +L     DD  + LV DY   G L   L   ++  LP +        
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEM------- 176

Query: 583 AAR--------ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH 634
            AR        A+  +H       +HRD+K  NIL+D     +++DFG C          
Sbjct: 177 -ARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232

Query: 635 VSTQVKGSIGYLDPEYYRLQLLTEKS-----DVYSFGVVLLEVLCARPP 678
            S  V G+  Y+ PE  +     +       D +S GV + E+L    P
Sbjct: 233 SSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 91.6 bits (228), Expect = 5e-20
 Identities = 53/250 (21%), Positives = 98/250 (39%), Gaps = 44/250 (17%)

Query: 452 GP-ASSLPSDLCTQFSISEIKEATKDFNNLL----IIGRGGFGNVYKGFLNGDSTPVAIK 506
           GP  +S+            +  A+  F++       +G+G F  V +          A K
Sbjct: 1   GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60

Query: 507 RLN--PGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTL----- 559
            +N    S +   + + E  +  +L++ ++V L     ++    LV+D +  G L     
Sbjct: 61  IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120

Query: 560 -RDHLYNNDNPPLPWDRRLKICIGAAR-------ALHYLHTGASKVIIHRDVKTTNILL- 610
            R+     D               A+        ++ Y H   S  I+HR++K  N+LL 
Sbjct: 121 AREFYSEAD---------------ASHCIQQILESIAYCH---SNGIVHRNLKPENLLLA 162

Query: 611 --DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVV 668
              +    K++DFGL       + +       G+ GYL PE  +    ++  D+++ GV+
Sbjct: 163 SKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 219

Query: 669 LLEVLCARPP 678
           L  +L   PP
Sbjct: 220 LYILLVGYPP 229

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 92.1 bits (229), Expect = 6e-20
 Identities = 54/232 (23%), Positives = 86/232 (37%), Gaps = 33/232 (14%)

Query: 466 SISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALE-FQTE 522
            + E++    DF  L +IGRG F  V    +       A+K +N     ++G +  F+ E
Sbjct: 52  RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE 111

Query: 523 IGMLSQLRYLHLVSLIGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICI 581
             +L       +  L  +   D+  + LV +Y   G L   L       +P +       
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEM------ 163

Query: 582 GAAR--------ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT 633
             AR        A+  +H       +HRD+K  NILLD     +++DFG C         
Sbjct: 164 --ARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218

Query: 634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVY-------SFGVVLLEVLCARPP 678
                V G+  YL PE  +       +  Y       + GV   E+   + P
Sbjct: 219 RSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 89.6 bits (223), Expect = 9e-20
 Identities = 47/226 (20%), Positives = 82/226 (36%), Gaps = 50/226 (22%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLN---------PGSQQGALEFQTEIGMLSQLRY- 531
           I+GRG    V +          A+K ++            Q+       E+ +L ++   
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTL------RDHLYNNDNPPLPWDRRLKICIGAAR 585
            +++ L      +    LV+D M +G L      +  L   +                 +
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE---------------TRK 128

Query: 586 -------ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ 638
                   +  LH      I+HRD+K  NILLD++   K++DFG               +
Sbjct: 129 IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLRE 182

Query: 639 VKGSIGYLDPE------YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           V G+  YL PE              ++ D++S GV++  +L   PP
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 59/251 (23%), Positives = 90/251 (35%), Gaps = 61/251 (24%)

Query: 455 SSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLN----- 509
           S  P  L  ++ +S+             +G G  G V   F       VAIK ++     
Sbjct: 2   SVYPKALRDEYIMSKT------------LGSGACGEVKLAFERKTCKKVAIKIISKRKFA 49

Query: 510 ---PGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTL------R 560
                    AL  +TEI +L +L +  ++ +  +  D     +V + M  G L       
Sbjct: 50  IGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN 108

Query: 561 DHLYNNDNPPLPWDRRLKICIGAAR-------ALHYLHTGASKVIIHRDVKTTNILL--- 610
             L                             A+ YLH      IIHRD+K  N+LL   
Sbjct: 109 KRLKEAT---------------CKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQ 150

Query: 611 DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE---YYRLQLLTEKSDVYSFGV 667
           +E+ + K++DFG  K      +T +   + G+  YL PE              D +S GV
Sbjct: 151 EEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207

Query: 668 VLLEVLCARPP 678
           +L   L   PP
Sbjct: 208 ILFICLSGYPP 218

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 90.5 bits (225), Expect = 1e-19
 Identities = 52/259 (20%), Positives = 98/259 (37%), Gaps = 38/259 (14%)

Query: 439 ISRRAVMKEAKSRGPASSLPSDLCTQFSISEIKEATKDFNNL------LIIGRGGFGNVY 492
           ++ R  +K  ++   A  +P+     F    +       N+        I+G G FG V+
Sbjct: 48  LTERMPVKSKRTSALAVDIPAPP-APFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVH 106

Query: 493 KGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD 552
           K         +A K +     +   E + EI +++QL + +L+ L         ++LV +
Sbjct: 107 KCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166

Query: 553 YMARGTL------RDHLYNNDNPPLPWDRRLKICIGAAR----ALHYLHTGASKVIIHRD 602
           Y+  G L        +                  I   +     + ++H      I+H D
Sbjct: 167 YVDGGELFDRIIDESYNLTE-----------LDTILFMKQICEGIRHMH---QMYILHLD 212

Query: 603 VKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEK 659
           +K  NIL    D + + K+ DFGL +    +          G+  +L PE      ++  
Sbjct: 213 LKPENILCVNRDAKQI-KIIDFGLARR---YKPREKLKVNFGTPEFLAPEVVNYDFVSFP 268

Query: 660 SDVYSFGVVLLEVLCARPP 678
           +D++S GV+   +L    P
Sbjct: 269 TDMWSVGVIAYMLLSGLSP 287

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 44/208 (21%), Positives = 82/208 (39%), Gaps = 17/208 (8%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIK-----RLNPGSQQGALEFQTEIGMLSQLRYLHLVS 536
           +IG+G F  V +          A+K     +          + + E  +   L++ H+V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL--KICIGAARALHYLHTGA 594
           L+   + DG + +V+++M    L   +    +    +   +          AL Y H   
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH--- 147

Query: 595 SKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTH-VSTQVKGSIGYLDPEY 650
              IIHRDVK   +LL   +     K+  FG+        ++  V+    G+  ++ PE 
Sbjct: 148 DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ---LGESGLVAGGRVGTPHFMAPEV 204

Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            + +   +  DV+  GV+L  +L    P
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLP 232

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 55/213 (25%), Positives = 86/213 (40%), Gaps = 39/213 (18%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC 541
            +GRG    VY+    G   P A+K L     +  +   TEIG+L +L + +++ L    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR--TEIGVLLRLSHPNIIKLKEIF 117

Query: 542 NDDGQMILVYDYMARGTLRD------HLYNNDNPPLPWDRRLKICIGAAR-------ALH 588
               ++ LV + +  G L D      +    D               AA        A+ 
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSERD---------------AADAVKQILEAVA 162

Query: 589 YLHTGASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
           YLH      I+HRD+K  N+L      +   K++DFGL K         +   V G+ GY
Sbjct: 163 YLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI---VEHQVLMKTVCGTPGY 216

Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
             PE  R      + D++S G++   +LC   P
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 88.6 bits (220), Expect = 4e-19
 Identities = 51/225 (22%), Positives = 86/225 (38%), Gaps = 49/225 (21%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLN--------PGSQQGALEFQTEIGMLSQLR-YL 532
           +IGRG    V +          A+K +            ++     + E  +L Q+  + 
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160

Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTL------RDHLYNNDNPPLPWDRRLKICIGAAR- 585
           H+++LI        M LV+D M +G L      +  L   +                   
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKE---------------TRSI 205

Query: 586 ------ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
                 A+ +LH   +  I+HRD+K  NILLD+    ++SDFG               ++
Sbjct: 206 MRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCH---LEPGEKLREL 259

Query: 640 KGSIGYLDPE------YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            G+ GYL PE              ++ D+++ GV+L  +L   PP
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 46/209 (22%), Positives = 83/209 (39%), Gaps = 22/209 (10%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN------PGSQQGALEFQTEIGMLSQLRYL---- 532
           +G+GGFG V+ G    D   VAIK +             ++    E+ +L ++       
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 533 HLVSLIGYCNDDGQMILVYDYMARGT-LRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
            ++ L+ +       +LV +       L D++       L              A+ + H
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCH 156

Query: 592 TGASKVIIHRDVKTTNILLDEEW-VAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
              S+ ++HRD+K  NIL+D     AK+ DFG      +      +    G+  Y  PE+
Sbjct: 157 ---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD---EPYTDFD-GTRVYSPPEW 209

Query: 651 YRLQLLT-EKSDVYSFGVVLLEVLCARPP 678
                     + V+S G++L +++C   P
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIP 238

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 88.2 bits (219), Expect = 6e-19
 Identities = 42/216 (19%), Positives = 82/216 (37%), Gaps = 38/216 (17%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIK-----RLNPGSQQGALE-FQTEIGMLSQLRYLHLVS 536
           +G G F  V K          A K     +     +    E  + E+ +L Q+ + ++++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 537 LIGYCNDDGQMILVYDYMARGTL------RDHLYNNDNPPLPWDRRLKICIGAAR----A 586
           L     +   ++L+ + ++ G L      ++ L   +                 +     
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE------------ATSFIKQILDG 127

Query: 587 LHYLHTGASKVIIHRDVKTTNILL----DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS 642
           ++YLH   +K I H D+K  NI+L          K+ DFGL               + G+
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGT 181

Query: 643 IGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
             ++ PE    + L  ++D++S GV+   +L    P
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 87.3 bits (217), Expect = 8e-19
 Identities = 44/216 (20%), Positives = 85/216 (39%), Gaps = 38/216 (17%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIK-----RLNPGSQQGALE-FQTEIGMLSQLRYLHLVS 536
           +G G F  V K          A K     R     +  + E  + E+ +L ++++ ++++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 537 LIGYCNDDGQMILVYDYMARGTL------RDHLYNNDNPPLPWDRRLKICIGAAR----A 586
           L     +   +IL+ + +A G L      ++ L   +                 +     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE------------ATEFLKQILNG 126

Query: 587 LHYLHTGASKVIIHRDVKTTNILL----DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS 642
           ++YLH   S  I H D+K  NI+L      +   K+ DFGL          +    + G+
Sbjct: 127 VYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGT 180

Query: 643 IGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
             ++ PE    + L  ++D++S GV+   +L    P
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 87.0 bits (216), Expect = 9e-19
 Identities = 48/207 (23%), Positives = 83/207 (40%), Gaps = 20/207 (9%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN------PGSQQGALEFQTEIGMLSQLRYL--HL 534
           +G GGFG+VY G    D+ PVAIK +        G          E+ +L ++      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 535 VSLIGYCNDDGQMILVYDYMA-RGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           + L+ +       +L+ +       L D +       L  +           A+ + H  
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCH-- 166

Query: 594 ASKVIIHRDVKTTNILLDEE-WVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
            +  ++HRD+K  NIL+D      K+ DFG          T  +    G+  Y  PE+ R
Sbjct: 167 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL---LKDTVYTDFD-GTRVYSPPEWIR 221

Query: 653 LQLLT-EKSDVYSFGVVLLEVLCARPP 678
                   + V+S G++L +++C   P
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIP 248

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 42/217 (19%), Positives = 83/217 (38%), Gaps = 38/217 (17%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIK-----RLNPGSQQGALE-FQTEIGMLSQLRYLHLV 535
            +G G F  V K          A K     +     +  + E  + E+ +L Q+ + +++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 536 SLIGYCNDDGQMILVYDYMARGTL------RDHLYNNDNPPLPWDRRLKICIGAAR---- 585
           +L     +   ++L+ + ++ G L      ++ L   +                 +    
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE------------ATSFIKQILD 126

Query: 586 ALHYLHTGASKVIIHRDVKTTNILL----DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG 641
            ++YLH   +K I H D+K  NI+L          K+ DFGL               + G
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFG 180

Query: 642 SIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           +  ++ PE    + L  ++D++S GV+   +L    P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 47/219 (21%), Positives = 90/219 (41%), Gaps = 44/219 (20%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIK-----RLNPGSQQGALE-FQTEIGMLSQLRYLHLVS 536
           +G G F  V K    G     A K     RL+   +  + E  + E+ +L ++R+ ++++
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 537 LIGYCNDDGQMILVYDYMARGTL------RDHLYNNDNPPLPWDRRLKICIGAAR----- 585
           L     +   ++L+ + ++ G L      ++ L  ++               A +     
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDE---------------ATQFLKQI 117

Query: 586 --ALHYLHTGASKVIIHRDVKTTNILL----DEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
              +HYLH   SK I H D+K  NI+L          K+ DFG+          +    +
Sbjct: 118 LDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAGNEFKNI 171

Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            G+  ++ PE    + L  ++D++S GV+   +L    P
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 87.8 bits (218), Expect = 1e-18
 Identities = 59/228 (25%), Positives = 90/228 (39%), Gaps = 30/228 (13%)

Query: 466 SISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALE-FQTE 522
            I +++   +D+  + +IGRG FG V            A+K L+     ++     F  E
Sbjct: 60  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119

Query: 523 IGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
             +++      +V L     DD  + +V +YM  G L + +               +   
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-----------SNYDVPEK 168

Query: 583 AAR--------ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH 634
            AR        AL  +H   S   IHRDVK  N+LLD+    K++DFG C          
Sbjct: 169 WARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225

Query: 635 VSTQVKGSIGYLDPEYYRLQLLTEK----SDVYSFGVVLLEVLCARPP 678
             T V G+  Y+ PE  + Q          D +S GV L E+L    P
Sbjct: 226 CDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 85.9 bits (213), Expect = 3e-18
 Identities = 45/213 (21%), Positives = 83/213 (38%), Gaps = 32/213 (15%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN--------PGSQQGALEFQTEIGMLSQLRYLHL 534
           +G G FG V+       +  V +K +                 +   EI +LS++ + ++
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 535 VSLIGYCNDDGQMILVYDYMARGT-LRDHLYNNDNPPLPWDRRL--KICIGAARALHYLH 591
           + ++    + G   LV +    G  L   +  +     P    +  ++      A+ YL 
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV----SAVGYLR 147

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               K IIHRD+K  NI++ E++  K+ DFG   +       +      G+I Y  PE  
Sbjct: 148 ---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPE-- 199

Query: 652 RLQLLTEKS------DVYSFGVVLLEVLCARPP 678
              +L          +++S GV L  ++    P
Sbjct: 200 ---VLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 86.7 bits (215), Expect = 5e-18
 Identities = 61/238 (25%), Positives = 96/238 (40%), Gaps = 11/238 (4%)

Query: 445 MKEAKSRGPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVA 504
           M         +S   ++    +  + +    +F  L ++G+G FG V            A
Sbjct: 118 MDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYA 177

Query: 505 IKRLNPGS--QQGALEF-QTEIGMLSQLRYLHLVSLIGYC-NDDGQMILVYDYMARGTLR 560
           +K L       +  +    TE  +L   R+  L +L  Y      ++  V +Y   G L 
Sbjct: 178 MKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELF 236

Query: 561 DHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSD 620
            HL           R     I    AL YLH  + K +++RD+K  N++LD++   K++D
Sbjct: 237 FHLSRERVFSEDRARFYGAEI--VSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITD 292

Query: 621 FGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           FGLCK G     T       G+  YL PE           D +  GVV+ E++C R P
Sbjct: 293 FGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 84.7 bits (210), Expect = 6e-18
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 37/212 (17%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIK-----RLNPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           IG+G F  V           VAIK     +LNP S Q   +   E+ ++  L + ++V L
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ---KLFREVRIMKILNHPNIVKL 79

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR--------ALHY 589
                 +  + L+ +Y + G + D+L  +         R+K     AR        A+ Y
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVAHG--------RMKE--KEARSKFRQIVSAVQY 129

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGP-NFSKTHVSTQVKGSIGYLD 647
            H    K I+HRD+K  N+LLD +   K++DFG   +F               G+  Y  
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-----GAPPYAA 181

Query: 648 PEYYRLQLLT-EKSDVYSFGVVLLEVLCARPP 678
           PE ++ +     + DV+S GV+L  ++    P
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 86.2 bits (214), Expect = 7e-18
 Identities = 46/215 (21%), Positives = 85/215 (39%), Gaps = 38/215 (17%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLN--PGSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
            +G+G F  V +          A   +N    S +   + + E  +   L++ ++V L  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77

Query: 540 YCNDDGQMILVYDYMARGTL------RDHLYNNDNPPLPWDRRLKICIGAAR-------A 586
             +++G   L++D +  G L      R++    D               A+        A
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD---------------ASHCIQQILEA 122

Query: 587 LHYLHTGASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSI 643
           + + H      ++HR++K  N+LL    +    K++DFGL        +        G+ 
Sbjct: 123 VLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG--EQQAWFGFAGTP 177

Query: 644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           GYL PE  R     +  D+++ GV+L  +L   PP
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 84.2 bits (209), Expect = 8e-18
 Identities = 34/208 (16%), Positives = 79/208 (37%), Gaps = 30/208 (14%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +GRG FG V++            K +        +  + EI +L+  R+ +++ L     
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 543 DDGQMILVYDYMARGTL------RDHLYNNDNPPLPWDRRLKICIGAAR----ALHYLHT 592
              ++++++++++   +           N            +  +        AL +LH 
Sbjct: 72  SMEELVMIFEFISGLDIFERINTSAFELNE-----------REIVSYVHQVCEALQFLH- 119

Query: 593 GASKVIIHRDVKTTNILL--DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
             S  I H D++  NI+         K+ +FG  +             +  +  Y  PE 
Sbjct: 120 --SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLFTAPEYYAPEV 174

Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           ++  +++  +D++S G ++  +L    P
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINP 202

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 23/211 (10%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALE-FQTEIGMLSQLRYL 532
            F+ +  +G G FG V            A+K L+     +   +E    E  +L  + + 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
            LV L     D+  + +V +Y+A G +  HL        P  R     I       YLH 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH- 158

Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
             S  +I+RD+K  N+L+D++   +V+DFG  K     + T       G+   L PE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEALAPE--- 208

Query: 653 LQLLTEKS-----DVYSFGVVLLEVLCARPP 678
             ++  K      D ++ GV++ E+    PP
Sbjct: 209 --IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 82.6 bits (205), Expect = 1e-17
 Identities = 53/207 (25%), Positives = 86/207 (41%), Gaps = 25/207 (12%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLIGYC 541
           +G G +G V           VA+K ++        E  + EI +   L + ++V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR--------ALHYLHTG 593
            +     L  +Y + G L D +  +          +      A+         + YLH  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDI--------GMPE--PDAQRFFHQLMAGVVYLH-- 122

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDPEYYR 652
               I HRD+K  N+LLDE    K+SDFGL   F  N  +  ++    G++ Y+ PE  +
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180

Query: 653 LQLLT-EKSDVYSFGVVLLEVLCARPP 678
            +    E  DV+S G+VL  +L    P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 44/209 (21%), Positives = 78/209 (37%), Gaps = 26/209 (12%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIK-----RLNPGSQQGALEFQTEIGMLSQLRYL-HLVS 536
           +GRG F  V +          A K     R     +    E   EI +L   +    +++
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRA---EILHEIAVLELAKSCPRVIN 93

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR----ALHYLHT 592
           L     +  ++IL+ +Y A G +           +         I   +     ++YLH 
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSE----NDVIRLIKQILEGVYYLH- 148

Query: 593 GASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
                I+H D+K  NILL         K+ DFG+ +            ++ G+  YL PE
Sbjct: 149 --QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK---IGHACELREIMGTPEYLAPE 203

Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
                 +T  +D+++ G++   +L    P
Sbjct: 204 ILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 22/212 (10%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEF-QTEIGMLSQLRYL 532
           DF+ L ++G+G FG V            A+K L       +  +    TE  +L   R+ 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 533 HLVSLIGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
            L +L  Y      ++  V +Y   G L  HL           R     I    AL YLH
Sbjct: 66  FLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI--VSALEYLH 122

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
              S+ +++RD+K  N++LD++   K++DFGLCK G +   T       G+  YL PE  
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPE-- 175

Query: 652 RLQLLTEKS-----DVYSFGVVLLEVLCARPP 678
              +L +       D +  GVV+ E++C R P
Sbjct: 176 ---VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 82.4 bits (204), Expect = 4e-17
 Identities = 53/207 (25%), Positives = 86/207 (41%), Gaps = 25/207 (12%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSLIGYC 541
           +G G +G V           VA+K ++        E  + EI +   L + ++V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR--------ALHYLHTG 593
            +     L  +Y + G L D +  +          +      A+         + YLH  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDI--------GMPE--PDAQRFFHQLMAGVVYLH-- 122

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDPEYYR 652
               I HRD+K  N+LLDE    K+SDFGL   F  N  +  ++    G++ Y+ PE  +
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180

Query: 653 LQLLT-EKSDVYSFGVVLLEVLCARPP 678
            +    E  DV+S G+VL  +L    P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 81.2 bits (201), Expect = 8e-17
 Identities = 53/218 (24%), Positives = 87/218 (39%), Gaps = 33/218 (15%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-YLHLVSLIGY 540
           ++G G    V        S   A+K +             E+ ML Q + + +++ LI +
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 541 CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL-------KICIGAARALHYLHTG 593
             ++ +  LV++ M  G++  H++          RR         +    A AL +LH  
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIH---------KRRHFNELEASVVVQDVASALDFLH-- 128

Query: 594 ASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCK-FGPNFSKTHVSTQVK----GSIGY 645
            +K I HRD+K  NIL    ++    K+ DF L      N   + +ST       GS  Y
Sbjct: 129 -NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187

Query: 646 LDPEYYRLQLLTEKS-----DVYSFGVVLLEVLCARPP 678
           + PE                D++S GV+L  +L   PP
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 80.7 bits (200), Expect = 1e-16
 Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 45/222 (20%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALE-FQTEIGMLSQLRYL 532
           DF  L  +G G FG V+      +    A+K L      +   +E    E  MLS + + 
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66

Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNN---DNPPLPWDRRLKICIGAAR---- 585
            ++ + G   D  Q+ ++ DY+  G L   L  +    NP              A+    
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP-------------VAKFYAA 113

Query: 586 ----ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG 641
               AL YLH   SK II+RD+K  NILLD+    K++DFG  K+ P+ + T       G
Sbjct: 114 EVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----G 165

Query: 642 SIGYLDPEYYRLQLLTEKS-----DVYSFGVVLLEVLCARPP 678
           +  Y+ PE     +++ K      D +SFG+++ E+L    P
Sbjct: 166 TPDYIAPE-----VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 82.8 bits (204), Expect = 2e-16
 Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 15/209 (7%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEF-QTEIGMLSQLRYL 532
           DFN L+++G+G FG V      G     A+K L      Q   +E    E  +L+     
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK- 400

Query: 533 H--LVSLIGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
              L  L   C     ++  V +Y+  G L  H+        P        I  A  L +
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI--AIGLFF 457

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L    SK II+RD+K  N++LD E   K++DFG+CK       T  +    G+  Y+ PE
Sbjct: 458 LQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAPE 512

Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               Q   +  D ++FGV+L E+L  + P
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 50/214 (23%), Positives = 85/214 (39%), Gaps = 32/214 (14%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQ--TEIGMLSQLRYLHLVSL- 537
           +G G +G V +   +      A+K L      +    E     EI +L +LR+ +++ L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 538 -IGYCNDDGQMILVYDYMARGT--LRDHLYNNDNPPLPWDRRLKICIGAAR--------A 586
            + Y  +  +M +V +Y   G   + D +           +R  +C   A          
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE---------KRFPVC--QAHGYFCQLIDG 121

Query: 587 LHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL 646
           L YLH   S+ I+H+D+K  N+LL      K+S  G+ +    F+        +GS  + 
Sbjct: 122 LEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 647 DPEYYRLQLLTE--KSDVYSFGVVLLEVLCARPP 678
            PE           K D++S GV L  +     P
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 38/155 (24%), Positives = 71/155 (45%), Gaps = 13/155 (8%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQG----ALEFQTEIGMLSQLRY 531
            F  L  +G G +  VYKG        VA+K +   S++G    A+    EI ++ +L++
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR---EISLMKELKH 62

Query: 532 LHLVSLIGYCNDDGQMILVYDYMA---RGTLRDHLYNNDNPPLPWDRRLKICIGAARALH 588
            ++V L    + + ++ LV+++M    +  +      N    L  +          + L 
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122

Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL 623
           + H      I+HRD+K  N+L+++    K+ DFGL
Sbjct: 123 FCH---ENKILHRDLKPQNLLINKRGQLKLGDFGL 154

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)

Query: 476 DFNNLLIIGRGGFGNVY---KGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLR 530
            F  L ++G+G FG V+   K   +      A+K L   +   +  +  + E  +L ++ 
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84

Query: 531 YLHLVSLIGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           +  +V L  Y    +G++ L+ D++  G L   L           +     +  A AL +
Sbjct: 85  HPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL--ALALDH 141

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           LH   S  II+RD+K  NILLDEE   K++DFGL K   +      +    G++ Y+ PE
Sbjct: 142 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPE 196

Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               +  T+ +D +SFGV++ E+L    P
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 80.0 bits (198), Expect = 3e-16
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 7/150 (4%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLRYLH 533
            + NL ++G G +G V K         VAIK+         ++     EI +L QLR+ +
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           LV+L+  C    +  LV++++   T+ D L    N  L +    K        + + H  
Sbjct: 86  LVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNG-LDYQVVQKYLFQIINGIGFCH-- 141

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGL 623
            S  IIHRD+K  NIL+ +  V K+ DFG 
Sbjct: 142 -SHNIIHRDIKPENILVSQSGVVKLCDFGF 170

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 32/210 (15%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIK-----RLNPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G FG V  G        VA+K     ++      G ++   EI  L   R+ H++ L
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHIIKL 76

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR--------ALHY 589
               +      +V +Y++ G L D++  +         R++     AR        A+ Y
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHG--------RVEE--MEARRLFQQILSAVDY 126

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H     +++HRD+K  N+LLD    AK++DFGL     +      S    GS  Y  PE
Sbjct: 127 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE 180

Query: 650 YYRLQLLT-EKSDVYSFGVVLLEVLCARPP 678
               +L    + D++S GV+L  +LC   P
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 79.6 bits (196), Expect = 4e-16
 Identities = 54/249 (21%), Positives = 99/249 (39%), Gaps = 32/249 (12%)

Query: 518 EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL 577
           + +  +G +       L S+    +      +    ++     +   +     L  +  +
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLI 196

Query: 578 KICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVST 637
                 A+ + +L   AS+  IHRD+   NILL E+ V K+ DFGL +            
Sbjct: 197 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253

Query: 638 QVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEV--LCARPPILRTGDKKQVNLAVWAT 695
             +  + ++ PE    ++ T +SDV+SFGV+L E+  L A P                  
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP------------------ 295

Query: 696 ECYRNGKIGDIIDPFLK-GN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV 751
             Y   KI +     LK G    AP     +  +  + C + +  +RP+ S++V  L   
Sbjct: 296 --YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG-- 351

Query: 752 FQLLRESSE 760
             LL+ +++
Sbjct: 352 -NLLQANAQ 359

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 30/152 (19%), Positives = 57/152 (37%), Gaps = 17/152 (11%)

Query: 482 IIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGSQQGAL-EFQTEIGMLSQLRY-LHL 534
            +GRG FG V +    G         VA+K L  G+         +E+ +L  + + L++
Sbjct: 29  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88

Query: 535 VSLIGYCND-DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           V+L+G C    G ++++ ++   G L  +L           +R +      +   +    
Sbjct: 89  VNLLGACTKPGGPLMVIVEFCKFGNLSTYL---------RSKRNEFVPYKTKGARFRQGK 139

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK 625
                I  D+K     +     +  S F   K
Sbjct: 140 DYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 78.4 bits (194), Expect = 7e-16
 Identities = 47/170 (27%), Positives = 76/170 (44%), Gaps = 16/170 (9%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL-----NPGSQQGALEFQTEIGMLSQLR 530
            +  +  IG G +G V+K         VAIK+      +P  ++ AL    EI ML QL+
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR---EIRMLKQLK 60

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + +LV+L+       ++ LV++Y    T+   L            +  I     +A+++ 
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK-SITWQTLQAVNFC 118

Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH-VST 637
           H       IHRDVK  NIL+ +  V K+ DFG  +    P+      V+T
Sbjct: 119 H---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT 165

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 78.5 bits (194), Expect = 8e-16
 Identities = 58/210 (27%), Positives = 86/210 (40%), Gaps = 33/210 (15%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIK-----RLNPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G FG V           VA+K      L        +E   EI  L  LR+ H++ L
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIKL 74

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR--------ALHY 589
                    +++V +Y A G L D++           +R+       R        A+ Y
Sbjct: 75  YDVITTPTDIVMVIEY-AGGELFDYIVEK--------KRMTE--DEGRRFFQQIICAIEY 123

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H      I+HRD+K  N+LLD+    K++DFGL     + +    S    GS  Y  PE
Sbjct: 124 CH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE 177

Query: 650 YYRLQLLT-EKSDVYSFGVVLLEVLCARPP 678
               +L    + DV+S G+VL  +L  R P
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 54/244 (22%), Positives = 95/244 (38%), Gaps = 73/244 (29%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLN------------------------PGSQQGALE 518
           IG+G +G V   +   D+T  A+K L+                           Q     
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 519 FQT--EIGMLSQLRYLHLVSL---IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPW 573
            Q   EI +L +L + ++V L   +   N+D  + +V++ + +G + +         +P 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVME---------VPT 130

Query: 574 DRRLKICIGAAR--------ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK 625
            + L      AR         + YLH    + IIHRD+K +N+L+ E+   K++DFG+  
Sbjct: 131 LKPLS--EDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185

Query: 626 F---GPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTE--------KSDVYSFGVVLLEVLC 674
                       V     G+  ++ PE      L+E          DV++ GV L   + 
Sbjct: 186 EFKGSDALLSNTV-----GTPAFMAPE-----SLSETRKIFSGKALDVWAMGVTLYCFVF 235

Query: 675 ARPP 678
            + P
Sbjct: 236 GQCP 239

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 77.6 bits (192), Expect = 1e-15
 Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 42/224 (18%)

Query: 476 DFNNLLIIGRGGFGNVY---KGFLNGDSTPVAIKRLNPGS---QQGALEF-QTEIGMLSQ 528
            F  L ++G+GG+G V+   K          A+K L               + E  +L +
Sbjct: 18  CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77

Query: 529 LRYLHLVSLIGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR-- 585
           +++  +V LI Y     G++ L+ +Y++ G L   L          +         A   
Sbjct: 78  VKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLER--------EGIFME--DTACFY 126

Query: 586 ------ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
                 AL +LH    K II+RD+K  NI+L+ +   K++DFGLCK   +     V+   
Sbjct: 127 LAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTF 181

Query: 640 KGSIGYLDPEYYRLQLLTEKS-----DVYSFGVVLLEVLCARPP 678
            G+I Y+ PE     +L         D +S G ++ ++L   PP
Sbjct: 182 CGTIEYMAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 78.0 bits (193), Expect = 1e-15
 Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 15/209 (7%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEF-QTEIGMLSQLRYL 532
           DFN L+++G+G FG V      G     A+K L      Q   +E    E  +L+     
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK- 79

Query: 533 H--LVSLIGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
              L  L   C     ++  V +Y+  G L  H+        P        I  A  L +
Sbjct: 80  PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI--AIGLFF 136

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           L    SK II+RD+K  N++LD E   K++DFG+CK       T  +    G+  Y+ PE
Sbjct: 137 LQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAPE 191

Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               Q   +  D ++FGV+L E+L  + P
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 59/209 (28%), Positives = 88/209 (42%), Gaps = 15/209 (7%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALE-FQTEIGMLSQLRYL 532
           DF    ++G+G FG V+       +   AIK L          +E    E  +LS     
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE- 76

Query: 533 H--LVSLIGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           H  L  +          +  V +Y+  G L  H+ +     L         I     L +
Sbjct: 77  HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI--ILGLQF 133

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           LH   SK I++RD+K  NILLD++   K++DFG+CK          +T   G+  Y+ PE
Sbjct: 134 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFC-GTPDYIAPE 188

Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               Q      D +SFGV+L E+L  + P
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 76.4 bits (189), Expect = 2e-15
 Identities = 41/164 (25%), Positives = 82/164 (50%), Gaps = 8/164 (4%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLRYL 532
           ++F  +  IG G +G VYK         VA+K++   ++   +      EI +L +L + 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62

Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V L+   + + ++ LV++++ +  L+  +  +    +P            + L + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 120

Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH 634
             S  ++HRD+K  N+L++ E   K++DFGL + FG P  + TH
Sbjct: 121 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 162

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 42/208 (20%), Positives = 75/208 (36%), Gaps = 28/208 (13%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRY-LHLVSLIGY 540
            +G G F    K      +   A+K ++   +      Q EI  L       ++V L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT---QKEITALKLCEGHPNIVKLHEV 74

Query: 541 CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL-------KICIGAARALHYLHTG 593
            +D     LV + +  G L + +           ++         I      A+ ++H  
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIK---------KKKHFSETEASYIMRKLVSAVSHMH-- 123

Query: 594 ASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
               ++HRD+K  N+L    ++    K+ DFG  +  P             ++ Y  PE 
Sbjct: 124 -DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP--PDNQPLKTPCFTLHYAAPEL 180

Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPP 678
                  E  D++S GV+L  +L  + P
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSGQVP 208

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 76.0 bits (188), Expect = 3e-15
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 28/218 (12%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLRYL 532
           + +  L  IG G +G V+K         VA+KR+        +      EI +L +L++ 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL--KICIGAARALHYL 590
           ++V L    + D ++ LV+++  +  L+ +    D+     D  +         + L + 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFC 117

Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH-VSTQVKGSIGYLD 647
           H   S+ ++HRD+K  N+L++     K+++FGL + FG P    +  V T     + Y  
Sbjct: 118 H---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVT-----LWYRP 169

Query: 648 PEYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           P+     L   K      D++S G +  E+  A  P+ 
Sbjct: 170 PDV----LFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 76.5 bits (189), Expect = 4e-15
 Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 15/209 (7%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEF-QTEIGMLSQLRYL 532
           +F  + ++G+G FG V    +       A+K L      Q   +E   TE  +LS  R  
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN- 82

Query: 533 H--LVSLIGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           H  L  L   C     ++  V +++  G L  H+  +        R     I    AL +
Sbjct: 83  HPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEI--ISALMF 139

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           LH    K II+RD+K  N+LLD E   K++DFG+CK G     T  +T   G+  Y+ PE
Sbjct: 140 LH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT-TATFC-GTPDYIAPE 194

Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
             +  L     D ++ GV+L E+LC   P
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 76.5 bits (189), Expect = 4e-15
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 15/209 (7%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEF-QTEIGMLSQLRYL 532
           DF+ L +IGRG +  V    L       A+K +          +++ QTE  +  Q    
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN- 68

Query: 533 H--LVSLIGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           H  LV L   C   + ++  V +Y+  G L  H+      P    R     I  + AL+Y
Sbjct: 69  HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI--SLALNY 125

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           LH    + II+RD+K  N+LLD E   K++D+G+CK G     T  ++   G+  Y+ PE
Sbjct: 126 LH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPE 180

Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
             R +      D ++ GV++ E++  R P
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 76.2 bits (188), Expect = 5e-15
 Identities = 46/205 (22%), Positives = 84/205 (40%), Gaps = 20/205 (9%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGY 540
           ++G G  G V + F        A+K L       + + + E+    Q     H+V ++  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCILDV 90

Query: 541 CNDDGQMI----LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
             +         ++ + M  G L   +    +         +I      A+ +LH   S 
Sbjct: 91  YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SH 147

Query: 597 VIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
            I HRDVK  N+L    +++ V K++DFG  K     ++  + T    +  Y+ PE    
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE---TTQNALQTPC-YTPYYVAPEVLGP 203

Query: 654 QLLTEKSDVYSFGVVLLEVLCARPP 678
           +   +  D++S GV++  +LC  PP
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGFPP 228

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 77.1 bits (190), Expect = 5e-15
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 32/210 (15%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIK-----RLNPGSQQGALEFQTEIGMLSQLRYLHLVSL 537
           +G G FG V  G        VA+K     ++      G +    EI  L   R+ H++ L
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKLFRHPHIIKL 81

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR--------ALHY 589
               +    + +V +Y++ G L D++  N         RL      +R         + Y
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNG--------RLDE--KESRRLFQQILSGVDY 131

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
            H     +++HRD+K  N+LLD    AK++DFGL     +      S    GS  Y  PE
Sbjct: 132 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE 185

Query: 650 YYRLQLLT-EKSDVYSFGVVLLEVLCARPP 678
               +L    + D++S GV+L  +LC   P
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCGTLP 215

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 75.4 bits (186), Expect = 1e-14
 Identities = 42/217 (19%), Positives = 81/217 (37%), Gaps = 46/217 (21%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL---HLVSLI 538
            IG G +    +      +   A+K ++    +   +   EI +L  LRY    ++++L 
Sbjct: 29  DIGVGSYSVCKRCIHKATNMEFAVKIID----KSKRDPTEEIEIL--LRYGQHPNIITLK 82

Query: 539 GYCNDDGQMILVYDYMARGTL------RDHLYNNDNPPLPWDRRLKICIGAAR------- 585
              +D   + +V + M  G L      +      +               A+        
Sbjct: 83  DVYDDGKYVYVVTELMKGGELLDKILRQKFFSERE---------------ASAVLFTITK 127

Query: 586 ALHYLHTGASKVIIHRDVKTTNILL----DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG 641
            + YLH   ++ ++HRD+K +NIL           ++ DFG  K     ++  +      
Sbjct: 128 TVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR--AENGLLMTPCY 182

Query: 642 SIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           +  ++ PE    Q      D++S GV+L  +L    P
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 75.8 bits (187), Expect = 1e-14
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 15/209 (7%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEF-QTEIGMLSQLRYL 532
           DF+ L +IGRG +  V    L       A++ +          +++ QTE  +  Q    
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN- 111

Query: 533 H--LVSLIGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           H  LV L   C   + ++  V +Y+  G L  H+      P    R     I  + AL+Y
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI--SLALNY 168

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           LH    + II+RD+K  N+LLD E   K++D+G+CK G     T  ++   G+  Y+ PE
Sbjct: 169 LH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPE 223

Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
             R +      D ++ GV++ E++  R P
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 74.9 bits (185), Expect = 1e-14
 Identities = 53/175 (30%), Positives = 82/175 (46%), Gaps = 16/175 (9%)

Query: 469 EIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE---FQT--EI 523
           ++K   K +  L  +G G F  VYK      +  VAIK++  G +  A +        EI
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 524 GMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL--KICI 581
            +L +L + +++ L+        + LV+D+M    L   +    +  L           +
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVII---KDNSLVLTPSHIKAYML 119

Query: 582 GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH 634
              + L YLH      I+HRD+K  N+LLDE  V K++DFGL K FG PN + TH
Sbjct: 120 MTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 171

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 40/168 (23%), Positives = 79/168 (47%), Gaps = 18/168 (10%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQG----ALEFQTEIGMLSQLR 530
           + +  L  +G G +  VYKG        VA+K +    ++G    A+    E+ +L  L+
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLK 58

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL--KICIGAARALH 588
           + ++V+L    + +  + LV++Y+ +  L+ +L   D+     +            R L 
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL---DDCGNIINMHNVKLFLFQLLRGLA 114

Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH 634
           Y H    + ++HRD+K  N+L++E    K++DFGL +    P  +  +
Sbjct: 115 YCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 73.9 bits (182), Expect = 3e-14
 Identities = 54/207 (26%), Positives = 78/207 (37%), Gaps = 28/207 (13%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           IG G FG             VA+K +  G+       Q EI     LR+ ++V       
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE-NVQREIINHRSLRHPNIVRFKEVIL 86

Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR--------ALHYLHTGA 594
               + ++ +Y + G L + + N          R       AR         + Y H   
Sbjct: 87  TPTHLAIIMEYASGGELYERICNA--------GRFSE--DEARFFFQQLLSGVSYCH--- 133

Query: 595 SKVIIHRDVKTTNILLDEEWVA--KVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
           S  I HRD+K  N LLD       K+ DFG  K     S+    + V G+  Y+ PE   
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIAPEVLL 190

Query: 653 LQLLT-EKSDVYSFGVVLLEVLCARPP 678
            Q    + +DV+S GV L  +L    P
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYP 217

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 73.4 bits (181), Expect = 3e-14
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 33/217 (15%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDST--PVAIKRLNPGSQQGALEFQT--EIGMLSQLR 530
           + +  L  +G G +G VYK     DS    VA+KR+   ++   +      EI +L +L 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAK---DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH 77

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL--KICIGAARALH 588
           + ++VSLI   + +  + LV+++M +  L+  L   D                   R + 
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL---DENKTGLQDSQIKIYLYQLLRGVA 133

Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH-VSTQVKGSIGY 645
           + H      I+HRD+K  N+L++ +   K++DFGL + FG P  S TH V T     + Y
Sbjct: 134 HCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVT-----LWY 185

Query: 646 LDPEYYRLQLLTEKS-----DVYSFGVVLLEVLCARP 677
             P+     L+  K      D++S G +  E++  +P
Sbjct: 186 RAPDV----LMGSKKYSTSVDIWSIGCIFAEMITGKP 218

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 73.4 bits (181), Expect = 3e-14
 Identities = 42/173 (24%), Positives = 77/173 (44%), Gaps = 18/173 (10%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEF--QT---EIGMLSQLR 530
            +  +  IG G +G VYK         VA+K +   +  G       +   E+ +L +L 
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69

Query: 531 YL---HLVSLI-----GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
                ++V L+        + + ++ LV++++ +  LR +L     P LP +    +   
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 128

Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTH 634
             R L +LH   +  I+HRD+K  NIL+      K++DFGL + +    + T 
Sbjct: 129 FLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 73.9 bits (182), Expect = 3e-14
 Identities = 56/229 (24%), Positives = 91/229 (39%), Gaps = 48/229 (20%)

Query: 476 DFNNLLIIGRGGFGNVY---KGFLNGDSTPVAIKRLNPGSQQGALEF----QTEIGMLSQ 528
           +F  L ++G G +G V+   K   +      A+K L   +     +     +TE  +L  
Sbjct: 55  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114

Query: 529 LRYLH---LVSLIGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAA 584
           +R      LV+L  Y    + ++ L+ DY+  G L  HL           +R +      
Sbjct: 115 IR--QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLS----------QRERFTEHEV 161

Query: 585 R--------ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVS 636
           +        AL +LH      II+RD+K  NILLD      ++DFGL K           
Sbjct: 162 QIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 218

Query: 637 TQVKGSIGYLDPEYYRLQLLTEKS-------DVYSFGVVLLEVLCARPP 678
               G+I Y+ P+     ++           D +S GV++ E+L    P
Sbjct: 219 DFC-GTIEYMAPD-----IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 73.8 bits (182), Expect = 3e-14
 Identities = 65/209 (31%), Positives = 92/209 (44%), Gaps = 15/209 (7%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEF-QTEIGMLSQLRYL 532
           DF+ L +IG+G FG V       +    A+K L   +  ++   +   +E  +L +    
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK- 97

Query: 533 H--LVSLIGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
           H  LV L  +      ++  V DY+  G L  HL        P  R     I  A AL Y
Sbjct: 98  HPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI--ASALGY 154

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           LH   S  I++RD+K  NILLD +    ++DFGLCK   N      ++   G+  YL PE
Sbjct: 155 LH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPE 209

Query: 650 YYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
               Q      D +  G VL E+L   PP
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 72.5 bits (179), Expect = 5e-14
 Identities = 41/168 (24%), Positives = 81/168 (48%), Gaps = 18/168 (10%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDST--PVAIKRLNPGSQQGALEFQT--EIGMLSQLR 530
           + ++ L  IG G +G VYK     ++     A+K++    +   +   T  EI +L +L+
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQ---NNYGETFALKKIRLEKEDEGIPSTTIREISILKELK 58

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRL--KICIGAARALH 588
           + ++V L    +   +++LV++++ +  L+  L   D      +        +     + 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLL---DVCEGGLESVTAKSFLLQLLNGIA 114

Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FG-PNFSKTH 634
           Y H    + ++HRD+K  N+L++ E   K++DFGL + FG P    TH
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 73.6 bits (181), Expect = 6e-14
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 47/230 (20%)

Query: 471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           +     + +  +IG G FG VY+  L      VAIK++     Q       E+ ++ +L 
Sbjct: 50  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLD 105

Query: 531 YLHLVSLIGY------CNDDGQMILVYDYMARGTLRDHL--YNNDNPPLPWDRRLK---- 578
           + ++V L  +        D+  + LV DY+   T+      Y+     LP    +K    
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMY 163

Query: 579 -ICIGAARALHYLHTGASKVIIHRDVKTTNILLDEE-WVAKVSDFGLCK-FGPNFSKTH- 634
            +     R+L Y+H   S  I HRD+K  N+LLD +  V K+ DFG  K           
Sbjct: 164 QLF----RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 216

Query: 635 VSTQVKGSIGYLDPEYYR-------LQLLTEKSDVYSFGVVLLEVLCARP 677
           + ++           YYR           T   DV+S G VL E+L  +P
Sbjct: 217 ICSR-----------YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 38/189 (20%), Positives = 77/189 (40%), Gaps = 21/189 (11%)

Query: 447 EAKSRGPASSLPSDLCTQFSISEIKEATK--DFNNLLIIGRGGFGNVYKGFLNGDSTPVA 504
                       +      S+S    AT    +  +  +G G +G VYK      +  VA
Sbjct: 4   HHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVA 63

Query: 505 IKRLNPGSQQGALEFQT--EIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDH 562
           IKR+    ++  +      E+ +L +L++ +++ L    + + ++ L+++Y       ++
Sbjct: 64  IKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA------EN 117

Query: 563 ---LYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVA--- 616
               Y + NP +               +++ H   S+  +HRD+K  N+LL     +   
Sbjct: 118 DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETP 174

Query: 617 --KVSDFGL 623
             K+ DFGL
Sbjct: 175 VLKIGDFGL 183

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 53/233 (22%), Positives = 89/233 (38%), Gaps = 47/233 (20%)

Query: 471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKR--LNPGSQQGALEFQTEIGMLSQ 528
           ++    F    + G+G FG V  G        VAIK+   +P  +   L+    +  L+ 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IMQDLAV 75

Query: 529 LRYLHLVSLIGY-------CNDDGQMILVYDYMARGTLRDHL--YNNDNPPLPWDRRLK- 578
           L + ++V L  Y          D  + +V +Y+   TL      Y       P    +K 
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP-PILIKV 133

Query: 579 ----ICIGAARALHYLHTGASKVIIHRDVKTTNILLDEE-WVAKVSDFGLCK-FGPNFSK 632
               +     R++  LH   S  + HRD+K  N+L++E     K+ DFG  K   P+   
Sbjct: 134 FLFQLI----RSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188

Query: 633 TH-VSTQVKGSIGYLDPEYYR-------LQLLTEKSDVYSFGVVLLEVLCARP 677
              + ++           YYR        Q  T   D++S G +  E++   P
Sbjct: 189 VAYICSR-----------YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 71.2 bits (175), Expect = 3e-13
 Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 48/224 (21%)

Query: 477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVS 536
           + N  +IG G FG V++  L  +S  VAIK++     Q       E+ ++  +++ ++V 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLV-ESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVD 96

Query: 537 LI------GYCNDDGQMILVYDYMARGTLRDHL--YNNDNPPLPWDRRLK-----ICIGA 583
           L       G   D+  + LV +Y+   T+      Y      +P    +K     +    
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP-MLLIKLYMYQLL--- 151

Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEE-WVAKVSDFGLCK-FGPNFSKTH-VSTQVK 640
            R+L Y+H   S  I HRD+K  N+LLD    V K+ DFG  K           + ++  
Sbjct: 152 -RSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR-- 205

Query: 641 GSIGYLDPEYYRL-QLL------TEKSDVYSFGVVLLEVLCARP 677
                    YYR  +L+      T   D++S G V+ E++  +P
Sbjct: 206 ---------YYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 45/205 (21%), Positives = 82/205 (40%), Gaps = 19/205 (9%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGY 540
           ++G G  G V + F        A+K L         + + E+ +  +  +  H+V ++  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 123

Query: 541 CNDDGQMI----LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
             +         +V + +  G L   + +  +         +I      A+ YLH   S 
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 180

Query: 597 VIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
            I HRDVK  N+L        + K++DFG  K     +  +  T    +  Y+ PE    
Sbjct: 181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPCYTPYYVAPEVLGP 237

Query: 654 QLLTEKSDVYSFGVVLLEVLCARPP 678
           +   +  D++S GV++  +LC  PP
Sbjct: 238 EKYDKSCDMWSLGVIMYILLCGYPP 262

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 70.0 bits (172), Expect = 5e-13
 Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 51/234 (21%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT--EIGMLSQLRYLH 533
            +  L  IG+G FG V+K         VA+K++   +++         EI +L  L++ +
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 77

Query: 534 LVSLIG--------YCNDDGQMILVYDYMARGTLRDH-----LYNNDNPPLPWDRRLKIC 580
           +V+LI         Y    G + LV+D+       +H     L    N  + +       
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFC------EHDLAGLL---SNVLVKFTLSEIKR 128

Query: 581 IGA--ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSK----- 632
           +       L+Y+H      I+HRD+K  N+L+  + V K++DFGL   F    +      
Sbjct: 129 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185

Query: 633 TH-VSTQVKGSIGYLDPEYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPIL 680
           T+ V T     + Y  PE     LL E+      D++  G ++ E +  R PI+
Sbjct: 186 TNRVVT-----LWYRPPEL----LLGERDYGPPIDLWGAGCIMAE-MWTRSPIM 229

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 69.2 bits (170), Expect = 8e-13
 Identities = 41/173 (23%), Positives = 78/173 (45%), Gaps = 18/173 (10%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDST--PVAIKRLNPGSQQGALEFQT--EIGMLSQLRY 531
            +  +  IG G +G V+K   +  +    VA+KR+   + +  +   T  E+ +L  L  
Sbjct: 12  QYECVAEIGEGAYGKVFKA-RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70

Query: 532 --------LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGA 583
                   L  V  +   + + ++ LV++++ +  L  +L     P +P +    +    
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQL 129

Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHV 635
            R L +LH   S  ++HRD+K  NIL+      K++DFGL + +    + T V
Sbjct: 130 LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 179

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 69.2 bits (170), Expect = 9e-13
 Identities = 44/234 (18%), Positives = 92/234 (39%), Gaps = 41/234 (17%)

Query: 463 TQFSISEIK-EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL-----NPGSQQGA 516
            +  +++   E  K + +   +G G +G+V           VAIK+L     +    + A
Sbjct: 11  YKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA 70

Query: 517 LEFQTEIGMLSQLRYLHLVSLI------GYCNDDGQMILVYDYMARGTLRDHLYNNDNPP 570
                E+ +L  +++ +++ L+          +     LV  +M   T  D L       
Sbjct: 71  YR---ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM--QT--D-LQKIMGLK 122

Query: 571 LPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF 630
              ++   +     + L Y+H+     ++HRD+K  N+ ++E+   K+ DFGL +     
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179

Query: 631 SKTHVSTQVKGSIGYLDPEYYR-------LQLLTEKSDVYSFGVVLLEVLCARP 677
              +V T+           +YR            +  D++S G ++ E+L  + 
Sbjct: 180 MTGYVVTR-----------WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 49/225 (21%), Positives = 92/225 (40%), Gaps = 43/225 (19%)

Query: 472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRY 531
               D+  +  +GRG +  V++     ++  V +K L P  ++       EI +L  LR 
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK---REIKILENLRG 89

Query: 532 LH--LVSLIGYCNDDGQM--ILVYDYMARGTLRDHLYNNDNPPLPWDRRLK-----ICIG 582
               +++L     D       LV++++     +          L  D  ++     I   
Sbjct: 90  -GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLT-DYDIRFYMYEIL-- 140

Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVA-KVSDFGLCKFG-PNFSKTH-VSTQV 639
             +AL Y H   S  I+HRDVK  N+++D E    ++ D+GL +F  P       V+++ 
Sbjct: 141 --KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 195

Query: 640 KGSIGYLDPEYYRLQLLTEKS-----DVYSFGVVLLEVLCARPPI 679
                +  PE     L+  +      D++S G +L  ++  + P 
Sbjct: 196 -----FKGPEL----LVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 70.7 bits (172), Expect = 1e-12
 Identities = 79/514 (15%), Positives = 155/514 (30%), Gaps = 139/514 (27%)

Query: 291 HFCEFQSEVTEEGDR-VFKIYLANLTAE-DVADVIAWSGGNGVPEYRDYAVAIGSKSDVK 348
           H  +F++   +   + +  ++        D  DV            +D   +I SK ++ 
Sbjct: 5   HHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDV------------QDMPKSILSKEEID 52

Query: 349 KQNLSIALHPAPRWRTKYSDSIL-----NGIEIFKVDNNGSLAGPNPYPTVSQASSFGTR 403
                I +       T      L       ++ F  +    L   N Y  +        R
Sbjct: 53  H----IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEE---VLR-IN-YKFLMSPIKTEQR 103

Query: 404 SPQQSTKAKNN-RPRMLGIVGVVASGLVVLFIVFLLISRRAVMKEAKSRGPASSLPSDLC 462
            P   T+     R R+     V A   V         SR     + +             
Sbjct: 104 QPSMMTRMYIEQRDRLYNDNQVFAKYNV---------SRLQPYLKLRQ------------ 142

Query: 463 TQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTE 522
              ++ E++ A     N+LI G  G G   K       T VA+        Q  ++F+  
Sbjct: 143 ---ALLELRPA----KNVLIDGVLGSG---K-------TWVALDVCLSYKVQCKMDFK-- 183

Query: 523 IGMLSQLRYLHLVSLIGYCNDDGQMI-----LVYDYMARGTLRDHLYNNDNPPLPWDRRL 577
                    +  ++L   CN    ++     L+Y      T R    ++ N  L      
Sbjct: 184 ---------IFWLNL-KNCNSPETVLEMLQKLLYQIDPNWTSRSD--HSSNIKLR----- 226

Query: 578 KICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSD-FGL-CKFGPNFSKTHV 635
                    +H +     +++  +  +   ++L     AK  + F L C       K  +
Sbjct: 227 ---------IHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC-------KILL 270

Query: 636 STQVKGSIGYLDPEYYRLQLLTEKSDVYS-------FGVVL------L-EVLCARPPILR 681
           +T+ K    +L         L   S   +           L      L   +    P   
Sbjct: 271 TTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRL 330

Query: 682 T--GDKKQVNLAVWATECYRN---GKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDD-R 735
           +   +  +  LA W  + +++    K+  II+  L    P      F  +++        
Sbjct: 331 SIIAESIRDGLATW--DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV--FPPSAH 386

Query: 736 IRRPSMS-DVVWG---LEFVFQLLRESSEKSMIA 765
           I  P++   ++W       V  ++ +  + S++ 
Sbjct: 387 I--PTILLSLIWFDVIKSDVMVVVNKLHKYSLVE 418

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 64.5 bits (156), Expect = 9e-11
 Identities = 82/622 (13%), Positives = 164/622 (26%), Gaps = 192/622 (30%)

Query: 120 DTFFKEF-CINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMPLNLYYTATDDQRLEF 178
           D F   F C +V +  +S+    +   +            ++                  
Sbjct: 27  DAFVDNFDCKDVQDMPKSI---LS-KEEIDH---------IIMSK-------DAVSGTLR 66

Query: 179 VGEGSQFSILNSNALETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDARPSALPVNTT 238
           +     F  L S   E + +      F+   +    Y+ ++      T+ R  ++     
Sbjct: 67  L-----FWTLLSKQEEMVQK------FVEEVLRIN-YK-FLMS-PIKTEQRQPSMMTRMY 112

Query: 239 IVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQVDSGFIYFVRLHFCEFQSE 298
           I  R  R+ N +   A Y  +R     +   +                 +R    E +  
Sbjct: 113 IEQR-DRLYNDNQVFAKYNVSRL----QPYLK-----------------LRQALLELRPA 150

Query: 299 --VTEEGDRVF-KIYLANLTAEDVA------DVIAWSGGNGVPEYRDYAVAIGSKSDVKK 349
             V  +G     K ++A                I W             + + + +  + 
Sbjct: 151 KNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFW-------------LNLKNCNSPET 197

Query: 350 -----QNLSIALHPAPRWRTKYSDSILNGIEIFKVDNNGSLAGPNPYPT-------VSQA 397
                Q L   + P    R+ +S +I   I   + +    L    PY         V  A
Sbjct: 198 VLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK-PYENCLLVLLNVQNA 256

Query: 398 SSFGTRSPQQSTKAKNNRPRMLGI---VGVVASGLVVLFIVFLLISRRAVMKEAKSRG-- 452
            ++          A N   ++L       V             L      +   + +   
Sbjct: 257 KAW---------NAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL 307

Query: 453 ------PASSLPSDLCTQ--FSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVA 504
                     LP ++ T     +S I E+ +D             + +K  +N D     
Sbjct: 308 LKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW--------DNWK-HVNCDKLTTI 358

Query: 505 IKR----LNPGSQQ------------------------GALEFQTEIGMLSQLR------ 530
           I+     L P   +                          +     + ++++L       
Sbjct: 359 IESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVE 418

Query: 531 --------YLH--LVSLIGYCNDDGQM--ILVYDYMARGTLRDHLYNNDNPPLPWDRRLK 578
                    +    + L     ++  +   +V  Y     +     ++D  P   D+   
Sbjct: 419 KQPKESTISIPSIYLELKVKLENEYALHRSIVDHY----NIPKTFDSDDLIPPYLDQYF- 473

Query: 579 ICIGAARALHYLHTG---ASKVIIHRDVKTTNILLDEEWV-AKVSDFGLCKFGPNFSKTH 634
                     Y H G    +     R      + LD  ++  K+            S  +
Sbjct: 474 ----------YSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASG-SILN 522

Query: 635 VSTQVKGSIGYL---DPEYYRL 653
              Q+K    Y+   DP+Y RL
Sbjct: 523 TLQQLKFYKPYICDNDPKYERL 544

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.4 bits (122), Expect = 1e-06
 Identities = 65/411 (15%), Positives = 127/411 (30%), Gaps = 102/411 (24%)

Query: 30  WA--GDVSSQYSPLGHQQSTISKKPREPPYSASRLSHSQFTYTFNVTPGQKFIRLHFYST 87
           W    + +S  + L   Q  + +   +P ++ SR  HS       +   Q  +R    S 
Sbjct: 186 WLNLKNCNSPETVLEMLQKLLYQI--DPNWT-SRSDHSS-NIKLRIHSIQAELRRLLKSK 241

Query: 88  SY----------------SGFNIS----------SAFFSVKANSFT--LVNNFSASFAPD 119
            Y                + FN+S               + A + T   +++ S +  PD
Sbjct: 242 PYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD 301

Query: 120 DT---FFKEFCINV-PEDQRSLSITFTPSPDYQDSYAFINGI-ELVSMPLNL--YYTATD 172
           +      K   ++  P+D     +T  P          ++ I E +   L     +   +
Sbjct: 302 EVKSLLLK--YLDCRPQDLPREVLTTNP--------RRLSIIAESIRDGLATWDNWKHVN 351

Query: 173 DQRLEFVGEGSQFSILNSNALETLYR---INVGGSFISPQMDTGMYRTWIADDGYVTD-- 227
             +L  + E S  ++L       ++    +    + I   +   +   W           
Sbjct: 352 CDKLTTIIESS-LNVLEPAEYRKMFDRLSVFPPSAHIPTIL---LSLIWFDVIKSDVMVV 407

Query: 228 ----ARPSAL---PVNTTIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYNLTWEFQV 280
                + S +   P  +TI +  S  L     L          L ++I + YN+   F  
Sbjct: 408 VNKLHKYSLVEKQPKESTISI-PSIYLELKVKLENEYA-----LHRSIVDHYNIPKTFDS 461

Query: 281 DS-------GFIY-FVRLHFCEFQSEVTEEGDRVFKIYLAN---LTAEDVADVIAWSGGN 329
           D         + Y  +  H      E  E       ++L +   L  +   D  AW+   
Sbjct: 462 DDLIPPYLDQYFYSHIGHHL--KNIEHPERMTLFRMVFL-DFRFLEQKIRHDSTAWNASG 518

Query: 330 GVPE-------YRDYAVAIGSKSDVKKQNLSIALHPAPR-----WRTKYSD 368
            +         Y+ Y   I       ++ ++  L   P+       +KY+D
Sbjct: 519 SILNTLQQLKFYKPY---ICDNDPKYERLVNAILDFLPKIEENLICSKYTD 566

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 44/174 (25%), Positives = 71/174 (40%), Gaps = 23/174 (13%)

Query: 483 IGRGGFGNVYKG--FLNGDSTPVAIKRLNP-GSQQGALEFQTEIGMLSQLRYLHLVSLIG 539
           +GRG +G+VYK       D    A+K++   G    A     EI +L +L++ +++SL  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR---EIALLRELKHPNVISLQK 85

Query: 540 YCND--DGQMILVYDYMAR------GTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
                 D ++ L++DY            R    N     LP      +       +HYLH
Sbjct: 86  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 592 TGASKVIIHRDVKTTNILLDEEW----VAKVSDFGL-CKFG-PNFSKTHVSTQV 639
              +  ++HRD+K  NIL+  E       K++D G    F  P      +   V
Sbjct: 146 ---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 68.9 bits (169), Expect = 2e-12
 Identities = 45/231 (19%), Positives = 83/231 (35%), Gaps = 42/231 (18%)

Query: 472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE--FQT-------- 521
                +     I  G +G V  G ++ +  PVAIKR+      G                
Sbjct: 19  AMQSPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77

Query: 522 -EIGMLSQLRYLHLVSLI-----GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDR 575
            EI +L+   + +++ L             ++ LV + M   T    + ++    +    
Sbjct: 78  REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVISPQH 135

Query: 576 RLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC-KFGPNFSKT- 633
                      LH LH      ++HRD+   NILL +     + DF L  +   + +KT 
Sbjct: 136 IQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH 192

Query: 634 HVSTQVKGSIGYLDPEYYR-------LQLLTEKSDVYSFGVVLLEVLCARP 677
           +V+ +           +YR        +  T+  D++S G V+ E+   + 
Sbjct: 193 YVTHR-----------WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 45/229 (19%)

Query: 472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT---------E 522
           +    + NL  IG G +G V   + N +   VAIK+++P        F+          E
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLRE 75

Query: 523 IGMLSQLRYLHLVSLI-----GYCNDDGQMILVYDYMARGT-LRDHLYNNDNPPLPWDRR 576
           I +L + R+ +++ +              + +V D M   T L   L       L  D  
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQ---HLSNDHI 130

Query: 577 LKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHV 635
                   R L Y+H+     ++HRD+K +N+LL+     K+ DFGL +   P+   T  
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187

Query: 636 STQVKGSIGYLDPEYYR-------LQLLTEKSDVYSFGVVLLEVLCARP 677
            T       Y+   +YR        +  T+  D++S G +L E+L  RP
Sbjct: 188 LT------EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 67.7 bits (166), Expect = 4e-12
 Identities = 51/235 (21%), Positives = 96/235 (40%), Gaps = 42/235 (17%)

Query: 463 TQFSISEIK-EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL-----NPGSQQGA 516
            +  +++   E    + +L  +G G +G V           VAIK+L     +    + A
Sbjct: 12  YRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA 71

Query: 517 LEFQTEIGMLSQLRYLHLVSLI------GYCNDDGQMILVYDYMARGT-LRDHLYNNDNP 569
                E+ +L  +R+ +++ L+         +D     LV  +M  GT L   + +    
Sbjct: 72  YR---ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE--- 123

Query: 570 PLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN 629
            L  DR   +     + L Y+H      IIHRD+K  N+ ++E+   K+ DFGL +   +
Sbjct: 124 KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS 180

Query: 630 FSKTHVSTQVKGSIGYLDPEYYR-------LQLLTEKSDVYSFGVVLLEVLCARP 677
               +V T+           +YR           T+  D++S G ++ E++  + 
Sbjct: 181 EMTGYVVTR-----------WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 67.9 bits (166), Expect = 5e-12
 Identities = 52/228 (22%), Positives = 92/228 (40%), Gaps = 30/228 (13%)

Query: 464 QFSISEIK-EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL-----NPGSQQGAL 517
              + +      K + NL  IG G  G V   +       VAIK+L     N    + A 
Sbjct: 50  SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY 109

Query: 518 EFQTEIGMLSQLRYLHLVSLI------GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPL 571
               E+ ++  + + +++SL+          +   + LV + M       +L       L
Sbjct: 110 R---ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DA---NLCQVIQMEL 161

Query: 572 PWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL-CKFGPNF 630
             +R   +       + +LH+     IIHRD+K +NI++  +   K+ DFGL    G +F
Sbjct: 162 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218

Query: 631 SKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARP 677
             T +V T+      Y  PE        E  D++S G ++ E++  + 
Sbjct: 219 MMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 66.5 bits (163), Expect = 7e-12
 Identities = 48/242 (19%), Positives = 88/242 (36%), Gaps = 64/242 (26%)

Query: 472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQT---------E 522
             + DF    ++G G +G V           VAIK++ P        F           E
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLRE 59

Query: 523 IGMLSQLRYLHLVSLI-----GYCNDDGQMILVYDYM--------ARGTLRD-H----LY 564
           I +L   ++ +++++          +  ++ ++ + M        +   L D H    +Y
Sbjct: 60  IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY 119

Query: 565 NNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC 624
                               RA+  LH      +IHRD+K +N+L++     KV DFGL 
Sbjct: 120 Q-------------TL----RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA 159

Query: 625 KFGPNFSKTHVSTQVKGSI--GYLDPEYYR-------LQLLTEKSDVYSFGVVLLEVLCA 675
           +     +  +     + S    ++   +YR           +   DV+S G +L E+   
Sbjct: 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219

Query: 676 RP 677
           RP
Sbjct: 220 RP 221

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 66.6 bits (163), Expect = 9e-12
 Identities = 52/228 (22%), Positives = 92/228 (40%), Gaps = 30/228 (13%)

Query: 464 QFSISEIK-EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL-----NPGSQQGAL 517
              I +      K + NL  IG G  G V   +       VAIK+L     N    + A 
Sbjct: 13  SVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY 72

Query: 518 EFQTEIGMLSQLRYLHLVSLI-----GYCNDDGQMI-LVYDYMARGTLRDHLYNNDNPPL 571
               E+ ++  + + +++ L+         ++ Q + +V + M      + L       L
Sbjct: 73  R---ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM--DA--N-LCQVIQMEL 124

Query: 572 PWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL-CKFGPNF 630
             +R   +       + +LH+     IIHRD+K +NI++  +   K+ DFGL    G +F
Sbjct: 125 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181

Query: 631 SKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARP 677
             T +V T+      Y  PE        E  D++S G ++ E++    
Sbjct: 182 MMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 66.2 bits (162), Expect = 9e-12
 Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 42/235 (17%)

Query: 463 TQFSISEIK-EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL-----NPGSQQGA 516
            +  +++   E  + + NL  +G G +G+V   F       VA+K+L     +    +  
Sbjct: 16  YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT 75

Query: 517 LEFQTEIGMLSQLRYLHLVSLI------GYCNDDGQMILVYDYMARGT-LRDHLYNNDNP 569
                E+ +L  +++ +++ L+          +   + LV   M  G  L + +      
Sbjct: 76  YR---ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQ--- 127

Query: 570 PLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN 629
            L  D    +     R L Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   +
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184

Query: 630 FSKTHVSTQVKGSIGYLDPEYYR-------LQLLTEKSDVYSFGVVLLEVLCARP 677
               +V+T+           +YR            +  D++S G ++ E+L  R 
Sbjct: 185 EMTGYVATR-----------WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 40/225 (17%), Positives = 84/225 (37%), Gaps = 46/225 (20%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIK--RLNPGSQQGALEFQTEIGMLSQLR--------- 530
            +G G F  V+      ++T VA+K  R +    + A +   EI +L ++          
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKEDS 82

Query: 531 --YLHLVSLIG---YCNDDGQ-MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAA 584
               H++ L+    +   +G  +++V++ +    L   +   ++  +P     +I     
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLL 141

Query: 585 RALHYLHTGASKVIIHRDVKTTNILLDEEWVA------KVSDFGLCKFGPNFSKTHVSTQ 638
             L Y+H      IIH D+K  N+L++           K++D G   +       H +  
Sbjct: 142 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE----HYTN- 194

Query: 639 VKGSIGYLDPEYYR-----LQLL-TEKSDVYSFGVVLLEVLCARP 677
                  +    YR     L       +D++S   ++ E++    
Sbjct: 195 ------SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 45/253 (17%), Positives = 87/253 (34%), Gaps = 67/253 (26%)

Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL------------------------- 508
           +K ++    +G G FG V + F        A+K++                         
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKL 65

Query: 509 ---------NPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTL 559
                             +   ++G  +     H  S+I   + +  + ++ +Y+   TL
Sbjct: 66  VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTL 124

Query: 560 RDHL--YNNDNPPLPWDRRLK-----ICIGAARALHYLHTGASKVIIHRDVKTTNILLDE 612
              L  +      +P    +      +     RA+ ++H   S  I HRD+K  N+L++ 
Sbjct: 125 HKVLKSFIRSGRSIP-MNLISIYIYQLF----RAVGFIH---SLGICHRDIKPQNLLVNS 176

Query: 613 E-WVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR-------LQLLTEKSDVYS 664
           +    K+ DFG  K              + S+ Y+   +YR           T   D++S
Sbjct: 177 KDNTLKLCDFGSAK---------KLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWS 227

Query: 665 FGVVLLEVLCARP 677
            G V  E++  +P
Sbjct: 228 IGCVFGELILGKP 240

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.4 bits (153), Expect = 7e-11
 Identities = 36/213 (16%), Positives = 55/213 (25%), Gaps = 56/213 (26%)

Query: 460 DLCTQFSISEIKE--ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL--------N 509
             C+Q           T+       IG G FG V++   +   TPVAIK +        N
Sbjct: 3   GECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADH--TPVAIKIIAIEGPDLVN 60

Query: 510 PGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN--------------------------- 542
              Q+   E   EI +  +L  L                                     
Sbjct: 61  GSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNS 120

Query: 543 ------------DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
                        D Q+ +V ++   G     L               I      +L   
Sbjct: 121 TKGSANDRPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVA 177

Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL 623
                    HRD+   N+LL +  + K+     
Sbjct: 178 EASLR--FEHRDLHWGNVLLKKTSLKKLHYTLN 208

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 64.0 bits (156), Expect = 8e-11
 Identities = 48/206 (23%), Positives = 79/206 (38%), Gaps = 34/206 (16%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIK--RLNPGSQQGALEFQTEIGMLSQLRYL------H 533
           +IG+G FG V K + +     VA+K  R      + A     EI +L  LR        +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA---EEIRILEHLRKQDKDNTMN 160

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           ++ ++        + + ++ ++   L + +  N           K      + L  LH  
Sbjct: 161 VIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH-- 217

Query: 594 ASKVIIHRDVKTTNILLDEEWVA--KVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               IIH D+K  NILL ++  +  KV DFG   +        V T       Y+   +Y
Sbjct: 218 -KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ----RVYT-------YIQSRFY 265

Query: 652 R-----LQLL-TEKSDVYSFGVVLLE 671
           R     L        D++S G +L E
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAE 291

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 42/211 (19%), Positives = 79/211 (37%), Gaps = 47/211 (22%)

Query: 472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL-----NPGSQQGALEFQTEIGML 526
               ++    +IGRG +G VY  +       VAIK++     +    +  L    EI +L
Sbjct: 23  HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR---EITIL 79

Query: 527 SQLRYLHLVSLI-----GYCNDDGQMILVYDYM---------ARGTLRD-H----LYNND 567
           ++L+  +++ L             ++ +V +               L + H    LYN  
Sbjct: 80  NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYN-- 137

Query: 568 NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG 627
                      +        +++H      IIHRD+K  N LL+++   KV DFGL +  
Sbjct: 138 -----------LL----LGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTI 179

Query: 628 PNFSKTHVSTQVKGSIGYLDPEYYRLQLLTE 658
            +   T++   ++ +           + LT 
Sbjct: 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 40/216 (18%), Positives = 78/216 (36%), Gaps = 52/216 (24%)

Query: 472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL-----NPGSQQGALEFQTEIGML 526
           +    +    +IG G +G+V + +   +   VAIK++     +    +  L    EI +L
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR---EIAIL 106

Query: 527 SQLRYLHLVSLI-----GYCNDDGQMILVYDYM---------ARGTLRD-H----LYNND 567
           ++L + H+V ++            ++ +V +               L + H    LYN  
Sbjct: 107 NRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYN-- 164

Query: 568 NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL---- 623
                      +       + Y+H+     I+HRD+K  N L++++   KV DFGL    
Sbjct: 165 -----------LL----VGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206

Query: 624 -CKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTE 658
                 N        +   ++          + LT 
Sbjct: 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTG 242

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 60.9 bits (148), Expect = 6e-10
 Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 32/212 (15%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIK--RLNPGSQQGALEFQTEIGMLSQLRYL------H 533
           +IG+G FG V K +   +   VAIK  +        A     E+ +L  +         +
Sbjct: 61  LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ---IEVRLLELMNKHDTEMKYY 117

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           +V L  +      + LV++ ++   L D L N +   +  +   K       AL +L T 
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP 176

Query: 594 ASKVIIHRDVKTTNILLDEEWVA--KVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
               IIH D+K  NILL     +  K+ DFG        S   +  ++     Y+   +Y
Sbjct: 177 ELS-IIHCDLKPENILLCNPKRSAIKIVDFG--------SSCQLGQRI---YQYIQSRFY 224

Query: 652 R-----LQLL-TEKSDVYSFGVVLLEVLCARP 677
           R     L +      D++S G +L+E+    P
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 60.0 bits (146), Expect = 8e-10
 Identities = 51/230 (22%), Positives = 93/230 (40%), Gaps = 38/230 (16%)

Query: 472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRY 531
           +    + +L  +G GG G V+    N     VAIK++     Q       EI ++ +L +
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDH 67

Query: 532 LHLVSLI--------------GYCNDDGQMILVYDYMARGT-LRDHLYNNDNPPLPWDRR 576
            ++V +               G   +   + +V +YM   T L + L      PL  +  
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQG---PLLEEHA 122

Query: 577 LKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW-VAKVSDFGLCK-FGPNFSKTH 634
                   R L Y+H+     ++HRD+K  N+ ++ E  V K+ DFGL +   P++S   
Sbjct: 123 RLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179

Query: 635 VSTQVKGSIGYLDPEYYR-------LQLLTEKSDVYSFGVVLLEVLCARP 677
             +        L  ++YR           T+  D+++ G +  E+L  + 
Sbjct: 180 HLS------EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 57/253 (22%), Positives = 103/253 (40%), Gaps = 76/253 (30%)

Query: 472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRL-NPGSQQGALEFQT--------- 521
              + +  +  +G+G +G V+K         VA+K++ +         FQ          
Sbjct: 6   HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA--------FQNSTDAQRTFR 57

Query: 522 EIGMLSQLRYLH--LVSL--IGYCNDDGQMILVYDYM--------ARGTLRD-H----LY 564
           EI +L++L   H  +V+L  +   ++D  + LV+DYM            L   H    +Y
Sbjct: 58  EIMILTELSG-HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY 116

Query: 565 NNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC 624
                         +     + + YLH+G    ++HRD+K +NILL+ E   KV+DFGL 
Sbjct: 117 Q-------------LI----KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS 156

Query: 625 KFGPNFSKTHVSTQVKGSIGYLDPE-------------YYR-------LQLLTEKSDVYS 664
           +   N  +   +  +  +    + +             +YR           T+  D++S
Sbjct: 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWS 216

Query: 665 FGVVLLEVLCARP 677
            G +L E+LC +P
Sbjct: 217 LGCILGEILCGKP 229

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 56.9 bits (138), Expect = 6e-09
 Identities = 43/205 (20%), Positives = 76/205 (37%), Gaps = 40/205 (19%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGY 540
           ++G G  G V + F        A+K L         + + E+ +  +  +  H+V ++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 79

Query: 541 CNDDGQMI----LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
             +         +V + +  G L   + +  +         +I      A+ YLH   S 
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 136

Query: 597 VIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
            I HRDVK  N+L        + K++DFG  K            +  G   Y        
Sbjct: 137 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK------------ETTGE-KY-------- 175

Query: 654 QLLTEKSDVYSFGVVLLEVLCARPP 678
               +  D++S GV++  +LC  PP
Sbjct: 176 ---DKSCDMWSLGVIMYILLCGYPP 197

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 36/158 (22%), Positives = 63/158 (39%), Gaps = 12/158 (7%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-YLHLVSLIGYC 541
           IG G FG++Y G        VAIK     ++   L    E  +   ++  + + ++    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWCG 74

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
            +    ++V + +  G   + L+N  +        L +       + Y+H   SK  IHR
Sbjct: 75  AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHR 129

Query: 602 DVKTTNILLDEEWVAK---VSDFGLCK-FGPNFSKTHV 635
           DVK  N L+          + DFGL K +    +  H+
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 167

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 13/168 (7%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-YLHLVSLIGYC 541
           IG G FG +Y G     +  VAIK  N  ++   L +  E  +   L+    + ++  + 
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWFG 72

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
            +    +LV D +   +L D L+N  +  L     L +       + ++H   SK  +HR
Sbjct: 73  VEGDYNVLVMDLLGP-SLED-LFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHR 127

Query: 602 DVKTTNILLDEEWVAK---VSDFGLCK-FGPNFSKTHVS-TQVKGSIG 644
           D+K  N L+     A    + DFGL K +    +  H+   + K   G
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 55.5 bits (134), Expect = 3e-08
 Identities = 28/165 (16%), Positives = 56/165 (33%), Gaps = 27/165 (16%)

Query: 483 IGRGGFGNVYKGF--------LNGDSTPVAIKRLNPGSQQGALEF--------QTEIGML 526
             R   G +Y+                  ++K L+    +   E           ++   
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKW 108

Query: 527 SQLRYLHLV---SLIGYCNDDGQM-ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
            +L    L+   + +G+     +   LV   + R +L+  L  +    L     L++   
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACR 167

Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKV--SDFGLCK 625
              AL +LH       +H +V   NI +D E  ++V  + +G   
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 55.0 bits (133), Expect = 4e-08
 Identities = 44/217 (20%), Positives = 84/217 (38%), Gaps = 38/217 (17%)

Query: 482 IIGRGGFGNVYKGF-LNGDSTPVAIK--RLNPGSQQGALEFQTEIGMLSQLRYL------ 532
            +G G FG V +          VA+K  +      + A   ++EI +L  L         
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA---RSEIQVLEHLNTTDPNSTF 77

Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
             V ++ +    G + +V++ +   +  D +  N   P   D   K+     +++++LH 
Sbjct: 78  RCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH- 135

Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK----GS------ 642
             S  + H D+K  NIL  +    +  +           +T ++  +K    GS      
Sbjct: 136 --SNKLTHTDLKPENILFVQSDYTEAYN----PKIKRDERTLINPDIKVVDFGSATYDDE 189

Query: 643 --IGYLDPEYYR-----LQLL-TEKSDVYSFGVVLLE 671
                +   +YR     L L  ++  DV+S G +L+E
Sbjct: 190 HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 226

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 54.6 bits (132), Expect = 5e-08
 Identities = 48/217 (22%), Positives = 80/217 (36%), Gaps = 34/217 (15%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIK--RLNPGSQQGALEFQTEIGMLSQLRYL-----HL 534
            +G G FG V       +    A+K  R      + A   + E  +L +++       ++
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA---KIEADILKKIQNDDINNNNI 98

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           V   G       M L+++ +   +L + +  N+      +     CI   +AL+YL    
Sbjct: 99  VKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR--- 154

Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHV--STQVK----GSIGYLDP 648
              + H D+K  NILLD+ +  K              + +   ST +K    G   +   
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214

Query: 649 E--------YYR-----LQLL-TEKSDVYSFGVVLLE 671
                     YR     L L     SD++SFG VL E
Sbjct: 215 YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 54.3 bits (131), Expect = 6e-08
 Identities = 45/217 (20%), Positives = 81/217 (37%), Gaps = 38/217 (17%)

Query: 482 IIGRGGFGNVYKGF-LNGDSTPVAIK--RLNPGSQQGALEFQTEIGMLSQLRYL------ 532
            +G G FG V +        + VA+K  R     ++ A   + EI +L +++        
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA---RLEINVLKKIKEKDKENKF 82

Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
             V +  + N  G M + ++ + +    + L  N+  P P      +      AL +LH 
Sbjct: 83  LCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH- 140

Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK----GSIGYLDP 648
                + H D+K  NIL        + +           K+  +T ++    GS  +   
Sbjct: 141 --ENQLTHTDLKPENILFVNSEFETLYNEH----KSCEEKSVKNTSIRVADFGSATFDHE 194

Query: 649 E--------YYR-----LQLL-TEKSDVYSFGVVLLE 671
                    +YR     L+L   +  DV+S G +L E
Sbjct: 195 HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 53.9 bits (130), Expect = 8e-08
 Identities = 35/166 (21%), Positives = 60/166 (36%), Gaps = 26/166 (15%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-YLHLVSLIGYC 541
           IG G FG +++G    ++  VAIK     S    L    E      L     + ++  + 
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIPNVYYFG 75

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRR------LKICIGAARALHYLHTGAS 595
            +    +LV D +   +L D L           R+                +  +H    
Sbjct: 76  QEGLHNVLVIDLLGP-SLEDLLDLC-------GRKFSVKTVAMAAKQMLARVQSIH---E 124

Query: 596 KVIIHRDVKTTNILLDEEWVAK-----VSDFGLCK-FGPNFSKTHV 635
           K +++RD+K  N L+            V DFG+ K +    +K H+
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 170

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 51.2 bits (123), Expect = 6e-07
 Identities = 36/149 (24%), Positives = 54/149 (36%), Gaps = 13/149 (8%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-YLHLVSLIGYC 541
           IG G FG +  G     +  VAIK     S+   L    E     QL     +  +  + 
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVYYFG 74

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
                  +V + +  G   + L++  +        L I I     + Y+H   SK +I+R
Sbjct: 75  PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYR 129

Query: 602 DVKTTNILLDEEWVAKVS-----DFGLCK 625
           DVK  N L+              DF L K
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 36/142 (25%), Positives = 57/142 (40%), Gaps = 20/142 (14%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIK--RLNPGSQQGALEFQTEIGMLSQLR--------YL 532
           +G G F  V+  +       VA+K  +      + AL+   EI +L  +R          
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD---EIRLLKSVRNSDPNDPNRE 101

Query: 533 HLVSLIGYCNDDGQ----MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALH 588
            +V L+      G     + +V++ +    L   +  ++   LP     KI     + L 
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLD 160

Query: 589 YLHTGASKVIIHRDVKTTNILL 610
           YLHT     IIH D+K  NILL
Sbjct: 161 YLHTKCR--IIHTDIKPENILL 180

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 35/175 (20%), Positives = 62/175 (35%), Gaps = 28/175 (16%)

Query: 483 IGRGGFGNVYKGFLN-----GDSTPVAIKRLNPGSQQGALEFQ--------TEIGMLSQL 529
           IG+GGFG +Y   +N     G   P  +K     +     E +         +I    + 
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 530 RYLHLV---SLIGYCNDDGQM----ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
           R L  +      G    D        ++ D    G+    +Y  +         L++ + 
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSLR 160

Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKV--SDFGLCK-FGPNFSKTH 634
               L Y+H       +H D+K +N+LL+ +   +V   D+GL   + P      
Sbjct: 161 ILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 35/172 (20%), Positives = 57/172 (33%), Gaps = 25/172 (14%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ-GALEFQTEIGMLSQLR-YLHLVSLIGY 540
           IG GGFG +Y  F        A   +    Q+ G L    E+    ++     +   I  
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS--ELKFYQRVAKKDCIKKWIER 102

Query: 541 CNDDGQMILVYDYMARGTLRDHLYN---------------NDNPPLPWDRRLKICIGAAR 585
              D   I ++        +   Y                  N        L++ I    
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLD 162

Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKV--SDFGLCK-FGPNFSKTH 634
            L Y+H       +H D+K  N+LL  +   +V  +D+GL   + PN +   
Sbjct: 163 VLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	767
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	99.91
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	99.81
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.72
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.54
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.2
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.99
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.9
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.74
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.41
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.3
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.3
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.18
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.09
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.07
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.92
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.62
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.38
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.2
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.19
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.09
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.0
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.62
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.62
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.59
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.56
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.49
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.4
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	95.97
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.37
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	94.97
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.06
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	88.9
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	82.21

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.4e-54  Score=460.77  Aligned_cols=262  Identities=27%  Similarity=0.444  Sum_probs=214.1

Q ss_pred             hccccceeeeccCcEEEEEEEecC-----CCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      ++|...+.||+|+||+||+|++.+     +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+.+.++|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            467777899999999999998753     457899999987777777889999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCC-------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcE
Q 042216          550 VYDYMARGTLRDHLYNND-------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVA  616 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~  616 (767)
                      |||||++|+|.++|+...             ..+++|.+++.|+.|+|+||+|||   +++|+||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence            999999999999997532             246999999999999999999999   6789999999999999999999


Q ss_pred             EEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHH
Q 042216          617 KVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWAT  695 (767)
Q Consensus       617 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~  695 (767)
                      ||+|||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.||......+   +...  
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~--  272 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---AIDC--  272 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---HHHH--
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---HHHH--
Confidence            9999999986544333334456679999999999999999999999999999999999 899997654321   1111  


Q ss_pred             HHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          696 ECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       696 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                        +..+.         +...|..+++++.+|+.+||+.||++||||+||++.|+.+.+.+
T Consensus       273 --i~~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p  321 (329)
T 4aoj_A          273 --ITQGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP  321 (329)
T ss_dssp             --HHHTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred             --HHcCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence              11221         22345677889999999999999999999999999999987654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.3e-54  Score=456.74  Aligned_cols=261  Identities=26%  Similarity=0.441  Sum_probs=218.7

Q ss_pred             hccccceeeeccCcEEEEEEEecC-----CCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      ++|...+.||+|+||+||+|++.+     +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+++.++|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            467778899999999999998753     357899999987777777889999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccC-----------CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEE
Q 042216          550 VYDYMARGTLRDHLYNN-----------DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKV  618 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki  618 (767)
                      |||||++|+|.++|++.           ....++|.+++.|+.|+|+||.|||   +++|+||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence            99999999999999753           2356999999999999999999999   678999999999999999999999


Q ss_pred             eecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHH
Q 042216          619 SDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATEC  697 (767)
Q Consensus       619 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~  697 (767)
                      +|||+++...............||+.|||||++.++.++.++|||||||+||||+| |+.||......+   +..    .
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~----~  242 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIE----C  242 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHH----H
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----H
Confidence            99999986443233333344569999999999999999999999999999999998 899997654321   111    1


Q ss_pred             hhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 042216          698 YRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL  754 (767)
Q Consensus       698 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~  754 (767)
                      +..+.         +...|..+++++.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus       243 i~~~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          243 ITQGR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            22221         1234567888999999999999999999999999999987643

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2e-53  Score=452.73  Aligned_cols=257  Identities=25%  Similarity=0.386  Sum_probs=213.5

Q ss_pred             ccccceeeeccCcEEEEEEEecC-----CCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      ++...+.||+|+||+||+|++.+     .++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++.++|
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            45556789999999999999742     34789999997653 3345689999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCC--------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCc
Q 042216          550 VYDYMARGTLRDHLYNND--------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV  615 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~  615 (767)
                      |||||++|+|.++|+...              ...++|.+++.|+.|||+||+|||   +++||||||||+||||++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCC
Confidence            999999999999996432              245999999999999999999999   678999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHH
Q 042216          616 AKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWA  694 (767)
Q Consensus       616 ~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~  694 (767)
                      +||+|||+++...............||+.|||||++.++.++.++|||||||+||||+| |+.||.+....   .+..  
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~~~--  258 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVVE--  258 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HHHH--
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HHHH--
Confidence            99999999986543333334455679999999999999999999999999999999998 89999665432   1222  


Q ss_pred             HHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          695 TECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       695 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                        .+..+.         +.+.|..++.++.+|+.+||+.||.+||||+||++.|+..
T Consensus       259 --~i~~~~---------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          259 --MIRNRQ---------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             --HHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             --HHHcCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence              122221         2234667888999999999999999999999999999854

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-52  Score=444.20  Aligned_cols=262  Identities=28%  Similarity=0.487  Sum_probs=208.2

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      +++...+.||+|+||+||+|++++   .||||+++..  +.+..++|.+|+++|++++|||||+++|+|.+ +.++||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            466777899999999999998864   5999998744  33445679999999999999999999999865 57899999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      ||++|+|.++|+... .+++|.+++.|+.|+|+||+|||   +++||||||||+||||++++.+||+|||+|+.......
T Consensus       112 y~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          112 WCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             CCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             cCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            999999999997543 46999999999999999999999   67899999999999999999999999999987554333


Q ss_pred             ccccccccCCCcccChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRL---QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                      .......+||+.|||||++.+   +.++.++|||||||+||||+||+.||........  +    ......+.    ..+
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~--~----~~~~~~~~----~~p  257 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ--I----IFMVGRGY----ASP  257 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--H----HHHHHTTC----CCC
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH--H----HHHHhcCC----CCC
Confidence            344456789999999999964   4689999999999999999999999965543211  1    11112211    111


Q ss_pred             cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       710 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      .+ ...+..++.++.+|+.+||+.||++||||.||++.|+.+...+
T Consensus       258 ~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          258 DL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             CS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             Cc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence            11 1234567888999999999999999999999999998776544

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.6e-51  Score=444.09  Aligned_cols=267  Identities=24%  Similarity=0.385  Sum_probs=220.5

Q ss_pred             HHHhhccccceeeeccCcEEEEEEEecCCC-----ceEEEEEeCCCCC-cchhHHHHHHHHHhcccc-ceeeeEeeeeec
Q 042216          471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDS-----TPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRY-LHLVSLIGYCND  543 (767)
Q Consensus       471 ~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~-----~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H-pniv~l~g~~~~  543 (767)
                      +...++|...+.||+|+||+||+|.+.+.+     +.||||++..... ...++|.+|+++|.+++| ||||+++|+|.+
T Consensus        60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~  139 (353)
T 4ase_A           60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK  139 (353)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence            334578899999999999999999986532     5799999976543 345679999999999965 899999999976


Q ss_pred             C-CceEEEEecCCCCChhhhhccCC--------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCe
Q 042216          544 D-GQMILVYDYMARGTLRDHLYNND--------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNI  608 (767)
Q Consensus       544 ~-~~~~lV~ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NI  608 (767)
                      . +.+++|||||++|+|.++|+...              ...++|.+++.++.|||+||+|||   +++||||||||+||
T Consensus       140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NI  216 (353)
T 4ase_A          140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNI  216 (353)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred             cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccce
Confidence            4 57899999999999999997532              245899999999999999999999   78899999999999


Q ss_pred             EECCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccc
Q 042216          609 LLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQ  687 (767)
Q Consensus       609 Lld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~  687 (767)
                      |+++++.+||+|||+|+...............||+.|||||++.++.++.++|||||||+||||+| |+.||......+ 
T Consensus       217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-  295 (353)
T 4ase_A          217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-  295 (353)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred             eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence            999999999999999987654333334456679999999999999999999999999999999998 999996654321 


Q ss_pred             hhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          688 VNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       688 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                       .+..    .+.++         .+...|..++.++.+++.+||+.||.+|||++||++.|+.+++.-
T Consensus       296 -~~~~----~i~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          296 -EFCR----RLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             -HHHH----HHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             -HHHH----HHHcC---------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence             1111    12222         122345667888999999999999999999999999999988654

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.2e-50  Score=435.84  Aligned_cols=251  Identities=22%  Similarity=0.342  Sum_probs=207.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ++|..++.||+|+||+||+|+...+++.||||++....  ....+.|.+|+++|++|+|||||++++++.+++.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            57999999999999999999999888999999997542  3345679999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      ||++|+|.++|.......+++.++..++.||+.||.|||   +++|+||||||+||||++++.+||+|||+|+....  .
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--T  178 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH--H
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecC--C
Confidence            999999999998766667899999999999999999999   78899999999999999999999999999986432  1


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      .......+||+.|||||++.+..|+.++|||||||+||||++|+.||......+   +   .... ..+..         
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~---~~~i-~~~~~---------  242 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN---L---VLKI-ISGSF---------  242 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H---HHHH-HHTCC---------
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---H---HHHH-HcCCC---------
Confidence            122345679999999999999999999999999999999999999996543221   1   1111 11111         


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ...+..++.++.+|+.+||+.||.+|||++|+++
T Consensus       243 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1223456778999999999999999999999985

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.3e-50  Score=430.09  Aligned_cols=250  Identities=20%  Similarity=0.322  Sum_probs=212.1

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      ..|+..+.||+|+||+||+|+++.+++.||||++........+.+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            45889999999999999999999888999999997665556677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++|+|.+++.+   ..+++.++..++.|++.||+|||   +++|+||||||+||||+.++.+||+|||+|+.....  ..
T Consensus       154 ~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~  225 (346)
T 4fih_A          154 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VP  225 (346)
T ss_dssp             TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SC
T ss_pred             CCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCC--CC
Confidence            99999999965   35999999999999999999999   788999999999999999999999999999865432  22


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN  714 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  714 (767)
                      .....+||+.|||||++.+..|+.++|||||||+||||++|++||......+   ....    +....     .+.  ..
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~----i~~~~-----~~~--~~  291 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKM----IRDNL-----PPR--LK  291 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHH----HHHSS-----CCC--CS
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHH----HHcCC-----CCC--CC
Confidence            3456789999999999999999999999999999999999999996543321   1111    11111     011  11


Q ss_pred             CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       715 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .+...+.++.+|+.+||+.||++|||++|+++
T Consensus       292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            23456778999999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=9.1e-50  Score=427.03  Aligned_cols=257  Identities=20%  Similarity=0.217  Sum_probs=212.6

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      +.|...+.||+|+||+||+|+++.+++.||||+++....     +.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            467888899999999999999998889999999975322     247999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC-cEEEeecCCcccCCCCCCc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW-VAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~-~~ki~DfGla~~~~~~~~~  633 (767)
                      ++|+|.++|++.  ..+++.++..++.|++.||+|||   +++|+||||||+||||+.++ .+||+|||+|+........
T Consensus       133 ~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          133 EGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             TTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            999999999654  35999999999999999999999   78899999999999999887 6999999999875432211


Q ss_pred             ---cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          634 ---HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       634 ---~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                         ......+||+.|||||++.+..++.++|||||||+||||++|++||......+...  . +.   ....        
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--~-i~---~~~~--------  273 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL--K-IA---SEPP--------  273 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH--H-HH---HSCC--------
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH--H-HH---cCCC--------
Confidence               12234679999999999999999999999999999999999999997654432211  1 11   1100        


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      -....++.++..+.+++.+||+.||.+|||+.|+++.|...++..
T Consensus       274 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~  318 (336)
T 4g3f_A          274 PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV  318 (336)
T ss_dssp             GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence            001235567788999999999999999999999999999888765

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.2e-49  Score=422.09  Aligned_cols=269  Identities=22%  Similarity=0.282  Sum_probs=200.6

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCC----ceEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG----QMILV  550 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~----~~~lV  550 (767)
                      +++...+.||+|+||+||+|++.  ++.||||+++.... ....+..|+..+.+++|||||+++|+|.+++    .++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            45667789999999999999985  47899999964321 1122345666677899999999999998654    57999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhC-----CCCCeEecCCCCCCeEECCCCcEEEeecCCcc
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG-----ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK  625 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~  625 (767)
                      ||||++|+|.++|+..   +++|..+++++.|+++||+|||+.     +.++|+||||||+||||+.++++||+|||+++
T Consensus        80 ~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            9999999999999753   589999999999999999999953     13489999999999999999999999999998


Q ss_pred             cCCCCCCc--cccccccCCCcccChhhhccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccc---------h
Q 042216          626 FGPNFSKT--HVSTQVKGSIGYLDPEYYRLQ------LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ---------V  688 (767)
Q Consensus       626 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~---------~  688 (767)
                      ........  ......+||+.|||||++.+.      .++.++|||||||+||||+||++|+........         .
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            64332221  122345799999999999754      467899999999999999999887744322111         0


Q ss_pred             hHHHHHHHHhhcCCccccccccccCC-CChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 042216          689 NLAVWATECYRNGKIGDIIDPFLKGN-APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL  754 (767)
Q Consensus       689 ~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~  754 (767)
                      .... .......+    ..++.+... .+..++..+.+|+.+||+.||.+||||.||++.|+.+.+.
T Consensus       237 ~~~~-~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          237 SVEE-MRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CHHH-HHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hHHH-HHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            1111 11111111    111111111 1234677899999999999999999999999999987653

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7.3e-50  Score=422.77  Aligned_cols=249  Identities=23%  Similarity=0.291  Sum_probs=212.2

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|+..++||+|+||+||+|+.+.+++.||||++.+.   .....+.+.+|+++|++|+|||||++++++.+++.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4799999999999999999999988999999999643   2334567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      |||++|+|.++|.+.  ..+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+......
T Consensus       112 Ey~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          112 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            999999999999654  35999999999999999999999   7889999999999999999999999999998765433


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                      ........+||+.|||||++.+..++.++||||+||+||||++|++||......+   +..   . ...+.         
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~---~-i~~~~---------  250 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---IFA---K-IIKLE---------  250 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---H-HHHTC---------
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---H-HHcCC---------
Confidence            3344556789999999999999999999999999999999999999996543221   111   1 11111         


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV  745 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl  745 (767)
                       ...|...+.++.+|+.+||+.||.+|||++|++
T Consensus       251 -~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          251 -YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             -CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             -CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence             123445667889999999999999999999864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.2e-49  Score=416.91  Aligned_cols=245  Identities=25%  Similarity=0.408  Sum_probs=198.5

Q ss_pred             ccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeec----CCceEEEE
Q 042216          478 NNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCND----DGQMILVY  551 (767)
Q Consensus       478 ~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~----~~~~~lV~  551 (767)
                      ...+.||+|+||+||+|.+..++..||+|++...  .....+.|.+|+++|++|+|||||++++++.+    ++.++|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            4445799999999999999988899999998643  33345679999999999999999999999864    35689999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCC--eEecCCCCCCeEEC-CCCcEEEeecCCcccCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV--IIHRDVKTTNILLD-EEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiH~Dlk~~NILld-~~~~~ki~DfGla~~~~  628 (767)
                      |||++|+|.++|.+.  ..+++..+..++.|++.||+|||   +++  |+||||||+||||+ +++.+||+|||+|+...
T Consensus       109 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            999999999999654  46999999999999999999999   565  99999999999998 48999999999998643


Q ss_pred             CCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          629 NFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      .    ......+||+.|||||++.+ .++.++|||||||+||||+||+.||.......  .+    ......+....   
T Consensus       184 ~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~----~~~i~~~~~~~---  249 (290)
T 3fpq_A          184 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QI----YRRVTSGVKPA---  249 (290)
T ss_dssp             T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HH----HHHHTTTCCCG---
T ss_pred             C----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HH----HHHHHcCCCCC---
Confidence            2    23345689999999998875 69999999999999999999999996543321  11    11112211110   


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                           ..+..+++++.+|+.+||+.||.+|||++|+++
T Consensus       250 -----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          250 -----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 112234567899999999999999999999974

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=8.5e-49  Score=430.94  Aligned_cols=250  Identities=20%  Similarity=0.334  Sum_probs=212.7

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      +.|+..+.||+|+||.||+|+++.+++.||||++........+.+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            46899999999999999999999888999999998766666778999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++|+|.+++...   .+++.++..++.|++.||+|||   +++|+||||||+||||+.++.+||+|||+|+.....  ..
T Consensus       231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--~~  302 (423)
T 4fie_A          231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VP  302 (423)
T ss_dssp             TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS--CC
T ss_pred             CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCC--Cc
Confidence            999999999643   4999999999999999999999   788999999999999999999999999999865432  22


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN  714 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  714 (767)
                      .....+||+.|||||++.+..|+.++|||||||+||||++|++||......+   +...    +....     .+.+  .
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~----i~~~~-----~~~~--~  368 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKM----IRDNL-----PPRL--K  368 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHH----HHHSC-----CCCC--S
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHH----HHcCC-----CCCC--c
Confidence            3456789999999999999999999999999999999999999996543321   1111    11111     1111  1


Q ss_pred             CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       715 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .+...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            23345678999999999999999999999985

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.5e-48  Score=404.32  Aligned_cols=246  Identities=25%  Similarity=0.365  Sum_probs=194.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|+..+.||+|+||+||+|+...+++.||||++....   ......+.+|+++|++++||||+++++++.+++.+++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            58999999999999999999998888999999996542   233456899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+ +|+|.+++.+.  ..+++.++..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+|+....  
T Consensus        93 Ey~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--  164 (275)
T 3hyh_A           93 EYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--  164 (275)
T ss_dssp             ECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             eCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCC--
Confidence            999 67999999654  45999999999999999999999   78899999999999999999999999999986432  


Q ss_pred             CccccccccCCCcccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLL-TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                       .......+||+.|||||++.+..+ +.++||||+||+||||++|+.||......   .+.   .. ...+.        
T Consensus       165 -~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~~---~~-i~~~~--------  228 (275)
T 3hyh_A          165 -GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VLF---KN-ISNGV--------  228 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HH-HHHTC--------
T ss_pred             -CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HHH---HH-HHcCC--------
Confidence             222345679999999999998876 58999999999999999999999653221   111   11 11111        


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                        ...+...+.++.+++.+||+.||++|||++|+++
T Consensus       229 --~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          229 --YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              1123445678899999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.9e-48  Score=411.84  Aligned_cols=248  Identities=25%  Similarity=0.315  Sum_probs=199.4

Q ss_pred             hccccceeeeccCcEEEEEEEec---CCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLN---GDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~---~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      ++|+..+.||+|+||+||+|+..   ..++.||||+++...  ......+.+|+++|++++|||||++++++.+++.+||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999873   345789999997542  2334468899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      |||||++|+|.++|.+.  ..+++.++..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+|+....
T Consensus       104 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            99999999999999654  35999999999999999999999   78899999999999999999999999999985432


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                      .  .......+||+.|||||++.+..++.++|||||||+||||+||+.||......+   +..   . ...+.       
T Consensus       179 ~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~---~-i~~~~-------  242 (304)
T 3ubd_A          179 H--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TMT---M-ILKAK-------  242 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---H-HHHCC-------
T ss_pred             C--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---HHH---H-HHcCC-------
Confidence            1  122345689999999999999999999999999999999999999996543321   111   1 11111       


Q ss_pred             cccCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042216          710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPS-----MSDVVW  746 (767)
Q Consensus       710 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~  746 (767)
                         ...|...+.++.+|+.+||+.||++|||     ++|+++
T Consensus       243 ---~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          243 ---LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             ---CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence               1234556778999999999999999998     466663

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.1e-46  Score=396.16  Aligned_cols=252  Identities=24%  Similarity=0.323  Sum_probs=190.6

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecCC-------
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG-------  545 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~-------  545 (767)
                      .++|+.++.||+|+||+||+|+.+.+++.||||+++.... ...+.+.+|+++|++|+|||||++++++.+.+       
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            3579999999999999999999998889999999865433 34467899999999999999999999986544       


Q ss_pred             -----ceEEEEecCCCCChhhhhccCCC-CCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 042216          546 -----QMILVYDYMARGTLRDHLYNNDN-PPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVS  619 (767)
Q Consensus       546 -----~~~lV~ey~~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~  619 (767)
                           .+|+|||||++|+|.+++..... ...++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEc
Confidence                 37999999999999999975432 23567778999999999999999   7889999999999999999999999


Q ss_pred             ecCCcccCCCCCCcc----------ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchh
Q 042216          620 DFGLCKFGPNFSKTH----------VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVN  689 (767)
Q Consensus       620 DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~  689 (767)
                      |||+|+.........          ..+..+||+.|||||++.+..++.++|||||||+||||++   ||....+     
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-----  232 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-----  232 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-----
Confidence            999998654322111          1234579999999999999999999999999999999996   7642111     


Q ss_pred             HHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          690 LAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       690 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ....... ........         ......+.+.+++.+||+.||.+|||+.|+++
T Consensus       233 ~~~~~~~-~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          233 RVRTLTD-VRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHHH-HHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHH-HhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1111111 11111100         01223345678999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.2e-45  Score=397.41  Aligned_cols=288  Identities=51%  Similarity=0.920  Sum_probs=253.3

Q ss_pred             ccCHHHHHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeec
Q 042216          464 QFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCND  543 (767)
Q Consensus       464 ~~~~~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~  543 (767)
                      ++.+.++..++++|+..+.||+|+||.||+|++. +++.||||++........+++.+|++++++++||||+++++++.+
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            3444455667889999999999999999999976 458899999987776777889999999999999999999999999


Q ss_pred             CCceEEEEecCCCCChhhhhccCC--CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 042216          544 DGQMILVYDYMARGTLRDHLYNND--NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDF  621 (767)
Q Consensus       544 ~~~~~lV~ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~Df  621 (767)
                      .+..++||||+++|+|.+++....  ...++|.+++.++.|++.||.|||   +++|+||||||+|||++.++.+||+||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeec
Confidence            999999999999999999996543  235899999999999999999999   678999999999999999999999999


Q ss_pred             CCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcC
Q 042216          622 GLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG  701 (767)
Q Consensus       622 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~  701 (767)
                      |+++...............||+.|+|||.+.+..++.++|||||||++|||++|+.||......+......|.......+
T Consensus       184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
T 2qkw_B          184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG  263 (321)
T ss_dssp             TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred             ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence            99986543333333445568999999999999999999999999999999999999998776666677788887777788


Q ss_pred             CccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          702 KIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       702 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      .+...+++.+....+..++..+.+++.+||+.||++|||+.||++.|+.+++..
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            888888888888888899999999999999999999999999999999998765

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.6e-45  Score=400.12  Aligned_cols=262  Identities=21%  Similarity=0.254  Sum_probs=203.7

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeec------CCc
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCND------DGQ  546 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~------~~~  546 (767)
                      ++|+..+.||+|+||+||+|.++.+++.||||+++...  ....+.+.+|+++|+.|+|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999999888999999997543  2334568899999999999999999998753      367


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      +|||||||+ |+|.+++.+  ...+++.++..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus       134 ~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence            899999996 689999955  356999999999999999999999   78899999999999999999999999999986


Q ss_pred             CCCCC--CccccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCc
Q 042216          627 GPNFS--KTHVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKI  703 (767)
Q Consensus       627 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~  703 (767)
                      .....  ........+||+.|||||++.+. .++.++||||+||++|||++|++||.+....+....+.   ....... 
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~---~~~g~p~-  283 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIM---MVLGTPS-  283 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH---HHHCCCC-
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHH---HhcCCCC-
Confidence            53221  12233457899999999998765 57999999999999999999999997654432222111   1110000 


Q ss_pred             cccccc-----------cccC--CC-----ChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          704 GDIIDP-----------FLKG--NA-----PPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       704 ~~~~d~-----------~l~~--~~-----~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ......           .+..  ..     .+..+.++.+|+.+||+.||.+|||+.|+++
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000000           0000  00     1123567899999999999999999999985

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.8e-44  Score=385.47  Aligned_cols=288  Identities=41%  Similarity=0.684  Sum_probs=248.0

Q ss_pred             ccccCHHHHHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeee
Q 042216          462 CTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGY  540 (767)
Q Consensus       462 ~~~~~~~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~  540 (767)
                      ...+++.++....++|...+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            467899999999999999999999999999999865 458899999976532 334478999999999999999999999


Q ss_pred             eecCCceEEEEecCCCCChhhhhccCC--CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEE
Q 042216          541 CNDDGQMILVYDYMARGTLRDHLYNND--NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKV  618 (767)
Q Consensus       541 ~~~~~~~~lV~ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki  618 (767)
                      |...+..++||||+++|+|.+++....  ...++|..+..++.|++.||.|||+.+..+|+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            999999999999999999999997643  345999999999999999999999544448999999999999999999999


Q ss_pred             eecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CCccchhHHHHHHH
Q 042216          619 SDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRT--GDKKQVNLAVWATE  696 (767)
Q Consensus       619 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~--~~~~~~~l~~~~~~  696 (767)
                      +|||+++..... .........||+.|+|||.+.+..++.++|||||||++|||++|+.||...  .......+..|...
T Consensus       176 ~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          176 GDFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             CCCSSCEECCSS-SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             ccCccccccCcc-cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            999999865432 223344556999999999999889999999999999999999999999522  22334566777777


Q ss_pred             HhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          697 CYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       697 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                      ......+..+.+..+....+..++..+.+++.+||+.||.+|||+.||+++|+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            7777888888888888888899999999999999999999999999999999864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.2e-43  Score=382.13  Aligned_cols=201  Identities=23%  Similarity=0.353  Sum_probs=170.7

Q ss_pred             HhhccccceeeeccCcEEEEEEEec---CCCceEEEEEeCCCCCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceE
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLN---GDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMI  548 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~---~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~  548 (767)
                      ..++|+..+.||+|+||+||+|+.+   ..++.||||++....  ...++.+|+++|..+ +||||+++++++.+.+.++
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            4567999999999999999999864   345789999986543  345688999999998 6999999999999999999


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCC-CcEEEeecCCcccC
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEE-WVAKVSDFGLCKFG  627 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~-~~~ki~DfGla~~~  627 (767)
                      +|||||++|+|.+++.     .+++.++..++.|++.||+|||   +++|+||||||+|||++.+ +.+||+|||+|+..
T Consensus        97 lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             EEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            9999999999999983     4899999999999999999999   7889999999999999876 79999999999754


Q ss_pred             CCCCC--------------------------ccccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCC
Q 042216          628 PNFSK--------------------------THVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPIL  680 (767)
Q Consensus       628 ~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~  680 (767)
                      .....                          ....+..+||+.|||||++.+. .++.++||||+||++|||++|+.||.
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            32211                          0112345799999999999765 58999999999999999999999996


Q ss_pred             CCC
Q 042216          681 RTG  683 (767)
Q Consensus       681 ~~~  683 (767)
                      ...
T Consensus       249 ~~~  251 (361)
T 4f9c_A          249 KAS  251 (361)
T ss_dssp             CCS
T ss_pred             CCC
Confidence            543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.2e-43  Score=407.13  Aligned_cols=253  Identities=19%  Similarity=0.242  Sum_probs=211.6

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .++|+..+.||+|+||.||+|..+.+++.||+|++........+.+.+|+++|+.|+|||||++++++.+.+.++|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            36899999999999999999999988999999999776655667789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCC--CcEEEeecCCcccCCCCC
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEE--WVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~--~~~ki~DfGla~~~~~~~  631 (767)
                      |++|+|.++|.... ..+++.++..++.||+.||.|||   +++|+||||||+|||++.+  +.+||+|||+++..... 
T Consensus       236 ~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-  310 (573)
T 3uto_A          236 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-  310 (573)
T ss_dssp             CCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred             cCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence            99999999996443 46999999999999999999999   7889999999999999854  89999999999875432 


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                        ......+||+.|||||++.+..++.++||||+||+||||++|++||.+....+..   .    .+.....      .+
T Consensus       311 --~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~---~----~i~~~~~------~~  375 (573)
T 3uto_A          311 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL---R----NVKSCDW------NM  375 (573)
T ss_dssp             --SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---H----HHHTTCC------CC
T ss_pred             --CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---H----HHHhCCC------CC
Confidence              2334567999999999999999999999999999999999999999654432111   1    1111110      01


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ........+.++.+|+.+||+.||.+|||+.|+++
T Consensus       376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11112335677899999999999999999999985

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.9e-43  Score=400.12  Aligned_cols=249  Identities=23%  Similarity=0.296  Sum_probs=202.9

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHH---HHHHHHHhccccceeeeEeeeeecCCceE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEF---QTEIGMLSQLRYLHLVSLIGYCNDDGQMI  548 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f---~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~  548 (767)
                      ++|+..++||+|+||+||+|+.+.+++.||||++.+..   .......   ..++.+++.++|||||++++++.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            57999999999999999999999999999999986421   1222223   34466777889999999999999999999


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      ||||||++|+|.++|.+.  ..+++..+..++.||+.||.|||   +++||||||||+||||+.+|.+||+|||+|+...
T Consensus       269 lVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            999999999999999754  45999999999999999999999   8899999999999999999999999999998653


Q ss_pred             CCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccc
Q 042216          629 NFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDII  707 (767)
Q Consensus       629 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  707 (767)
                      ..    .....+||+.|||||++.. ..|+.++||||+||+||||++|++||..........+..   ... ..      
T Consensus       344 ~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~---~i~-~~------  409 (689)
T 3v5w_A          344 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTL-TM------  409 (689)
T ss_dssp             SC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH---HHH-HC------
T ss_pred             CC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hhc-CC------
Confidence            31    2334689999999999964 579999999999999999999999996543322111111   111 11      


Q ss_pred             cccccCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042216          708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPS-----MSDVVW  746 (767)
Q Consensus       708 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~  746 (767)
                          ....+...+.++.+|+.+||+.||.+|++     ++||++
T Consensus       410 ----~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          410 ----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ----CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                11234556778999999999999999998     677763

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2e-42  Score=370.21  Aligned_cols=263  Identities=26%  Similarity=0.389  Sum_probs=217.6

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      ++|...+.||+|+||+||+|....+++.||+|++........+.|.+|++++++++||||+++++++.+++..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            57888899999999999999998888999999997766667778999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.........
T Consensus        90 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           90 KGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             TTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             CCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            9999999997643 45999999999999999999999   6789999999999999999999999999998643321111


Q ss_pred             ------------ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC
Q 042216          635 ------------VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK  702 (767)
Q Consensus       635 ------------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~  702 (767)
                                  ......||+.|+|||++.+..++.++|||||||++|||++|..|+...........            
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~------------  233 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG------------  233 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS------------
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh------------
Confidence                        11145699999999999999999999999999999999999999855432211100            


Q ss_pred             ccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       703 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                        ......+....+..++..+.+++.+||+.||.+|||+.++++.|+.+...+
T Consensus       234 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          234 --LNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             --BCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --hhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence              000001111224455667899999999999999999999999999987655

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.6e-42  Score=378.89  Aligned_cols=264  Identities=25%  Similarity=0.442  Sum_probs=218.8

Q ss_pred             hhccccceeeeccCcEEEEEEEecC-------CCceEEEEEeCCCCC-cchhHHHHHHHHHhcc-ccceeeeEeeeeecC
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNG-------DSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQL-RYLHLVSLIGYCNDD  544 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~-------~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~  544 (767)
                      .++|...+.||+|+||.||+|.+.+       .+..||||+++.... ....++.+|+++++++ +||||++++++|.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            3678889999999999999998742       335799999976533 3456799999999999 899999999999999


Q ss_pred             CceEEEEecCCCCChhhhhccCC--------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE
Q 042216          545 GQMILVYDYMARGTLRDHLYNND--------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL  610 (767)
Q Consensus       545 ~~~~lV~ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl  610 (767)
                      +..++||||+++|+|.+++....              ...+++.+++.++.|++.||.|||   +++|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            99999999999999999997543              235899999999999999999999   6789999999999999


Q ss_pred             CCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchh
Q 042216          611 DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVN  689 (767)
Q Consensus       611 d~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~  689 (767)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+   
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---  313 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  313 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence            9999999999999986544332233344567889999999999999999999999999999999 999996554322   


Q ss_pred             HHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 042216          690 LAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLR  756 (767)
Q Consensus       690 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  756 (767)
                      +..    ....+         .....+..++.++.+++.+||+.||.+||++.|+++.|+.+++...
T Consensus       314 ~~~----~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          314 LFK----LLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             HHH----HHHTT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHH----HHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            111    11111         1223455677889999999999999999999999999999988763

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.8e-41  Score=360.53  Aligned_cols=282  Identities=37%  Similarity=0.626  Sum_probs=230.8

Q ss_pred             ccccCHHHHHHHhhccccc------eeeeccCcEEEEEEEecCCCceEEEEEeCCCC----CcchhHHHHHHHHHhcccc
Q 042216          462 CTQFSISEIKEATKDFNNL------LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS----QQGALEFQTEIGMLSQLRY  531 (767)
Q Consensus       462 ~~~~~~~ei~~~t~~f~~~------~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~----~~~~~~f~~Ei~~l~~l~H  531 (767)
                      ...|++.++..++++|...      +.||+|+||.||+|...  ++.||||++....    ....+.+.+|++++++++|
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS--SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC--CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            4679999999999999988      88999999999999874  4789999986532    2335678999999999999


Q ss_pred             ceeeeEeeeeecCCceEEEEecCCCCChhhhhccC-CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE
Q 042216          532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNN-DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL  610 (767)
Q Consensus       532 pniv~l~g~~~~~~~~~lV~ey~~~gsL~~~L~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl  610 (767)
                      |||+++++++.+.+..++||||+++|+|.+++... ....+++..++.++.|++.||.|||   +.+|+||||||+|||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEE
Confidence            99999999999999999999999999999998643 2356999999999999999999999   6789999999999999


Q ss_pred             CCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhH
Q 042216          611 DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL  690 (767)
Q Consensus       611 d~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l  690 (767)
                      ++++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.||........  +
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~  243 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--L  243 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--T
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--H
Confidence            9999999999999986544333333445679999999998875 588999999999999999999999965543321  1


Q ss_pred             HHHHHHHhh-cCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 042216          691 AVWATECYR-NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF  752 (767)
Q Consensus       691 ~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~  752 (767)
                      ..+...... ...+.+.+++.+ ...+..++..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            122222111 122333344433 2346678889999999999999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.7e-42  Score=381.53  Aligned_cols=261  Identities=26%  Similarity=0.393  Sum_probs=215.4

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      .++|...+.||+|+||.||+|.+..+++.||||+++.... ....+|.+|++++++++||||++++++|...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            4578888999999999999999987789999999875432 334578999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus       193 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             CCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            999999999996532 35899999999999999999999   67899999999999999999999999999985432211


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                      ........++..|+|||.+..+.++.++|||||||++|||++ |+.||......+   ..    .....+         .
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~~----~~~~~~---------~  332 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---TR----EFVEKG---------G  332 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---HH----HHHHTT---------C
T ss_pred             eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcC---------C
Confidence            111122335778999999999999999999999999999998 999996543321   11    111111         1


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL  754 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~  754 (767)
                      +...+..++.++.+++.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       333 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            2234556778899999999999999999999999999988654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=367.22  Aligned_cols=261  Identities=28%  Similarity=0.451  Sum_probs=213.9

Q ss_pred             hccccceeeeccCcEEEEEEEecCCC---ceEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDS---TPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~---~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      ++|...+.||+|+||.||+|.+...+   ..||||+++.. .....++|.+|++++++++||||+++++++.+.+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            46788889999999999999986443   45999999765 334456799999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+++|+|.+++.... ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       129 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             eeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            99999999999996543 46999999999999999999999   678999999999999999999999999999865432


Q ss_pred             CC-ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          631 SK-THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       631 ~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      .. ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+   +..    ....+       
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~----~~~~~-------  270 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---VIS----SVEEG-------  270 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHH----HHHTT-------
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---HHH----HHHcC-------
Confidence            21 112233456788999999999999999999999999999999 999996544321   111    11111       


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                        .....+..++..+.+++.+||+.||.+|||+.+|++.|+.+++..
T Consensus       271 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          271 --YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             --CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence              122334567788999999999999999999999999999998766

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.2e-41  Score=364.18  Aligned_cols=262  Identities=27%  Similarity=0.416  Sum_probs=206.9

Q ss_pred             HHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--cchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       472 ~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      ....+|+..+.||+|+||+||+|+..  ++.||||++.....  ...+++.+|++++++++||||+++++++.+.+..++
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            34568899999999999999999885  37899999875532  334578999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCC-CCCCChHHHHHHHHHHHHHHHHhHhCCCCC--eEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          550 VYDYMARGTLRDHLYNND-NPPLPWDRRLKICIGAARALHYLHTGASKV--IIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      ||||+++|+|.+++.... ...+++..++.++.|++.||.|||   +.+  |+||||||+|||++.++.+||+|||+++.
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            999999999999997543 124899999999999999999999   777  99999999999999999999999999975


Q ss_pred             CCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccc
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI  706 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  706 (767)
                      ....  ........||+.|+|||.+.+..++.++|||||||++|||++|+.||......+   ......   ...     
T Consensus       189 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~~~~---~~~-----  255 (309)
T 3p86_A          189 KAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VVAAVG---FKC-----  255 (309)
T ss_dssp             ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHHHHH---HSC-----
T ss_pred             cccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH---hcC-----
Confidence            3321  112334569999999999999999999999999999999999999996543321   111111   011     


Q ss_pred             ccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          707 IDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       707 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                          .....+..++.++.+++.+||+.||.+|||+.+|++.|+.+++..
T Consensus       256 ----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          256 ----KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             ----CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence                112334556778999999999999999999999999999988654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.7e-41  Score=365.14  Aligned_cols=269  Identities=23%  Similarity=0.293  Sum_probs=210.1

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCC----ceEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG----QMIL  549 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~----~~~l  549 (767)
                      .++|+..++||+|+||+||+|+..  ++.||||++.... .....+..|+.++.+++||||+++++++....    .+++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            357899999999999999999986  3789999996432 23345667899999999999999999998754    3699


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCC----------CeEecCCCCCCeEECCCCcEEEe
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK----------VIIHRDVKTTNILLDEEWVAKVS  619 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~----------~iiH~Dlk~~NILld~~~~~ki~  619 (767)
                      ||||+++|+|.+++...   .++|..++.++.|++.||.|||   +.          +|+||||||+|||++.++.+||+
T Consensus       100 v~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence            99999999999999653   4899999999999999999999   66          99999999999999999999999


Q ss_pred             ecCCcccCCCCCCccccccccCCCcccChhhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhH----
Q 042216          620 DFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ-----LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL----  690 (767)
Q Consensus       620 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l----  690 (767)
                      |||+++...............||+.|+|||++.+.     .++.++|||||||++|||++|+.||....+......    
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            99999765433333233446799999999999863     456789999999999999999999976543322211    


Q ss_pred             ------HHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          691 ------AVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       691 ------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                            ..+.... ........+....   ....++.++.+++.+||+.||.+|||+.||++.|+.+.+..
T Consensus       254 ~~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          254 GQHPSLEDMQEVV-VHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             CSSCCHHHHHHHH-TTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ccCCchhhhhhhh-hcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                  1111111 1111111111111   12346678999999999999999999999999999887643

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.6e-41  Score=359.57  Aligned_cols=251  Identities=24%  Similarity=0.382  Sum_probs=211.0

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .++|...+.||+|+||+||+|....+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            35799999999999999999999888899999999766555667789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++|+|.+++.+.   .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......  
T Consensus        99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  170 (297)
T 3fxz_A           99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--  170 (297)
T ss_dssp             CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred             CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--
Confidence            9999999999654   4899999999999999999999   6789999999999999999999999999987654322  


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........  .    .....+.        ...
T Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~----~~~~~~~--------~~~  236 (297)
T 3fxz_A          171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--Y----LIATNGT--------PEL  236 (297)
T ss_dssp             CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--H----HHHHHCS--------CCC
T ss_pred             cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--H----HHHhCCC--------CCC
Confidence            2234457999999999999999999999999999999999999999654332111  1    1111111        011


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ..+...+..+.+++.+||+.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            224456778999999999999999999999985

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=8.6e-42  Score=372.85  Aligned_cols=273  Identities=24%  Similarity=0.392  Sum_probs=220.5

Q ss_pred             cCHHHHHHHhhccccceeeeccCcEEEEEEEe-----cCCCceEEEEEeCCCCC-cchhHHHHHHHHHhcc-ccceeeeE
Q 042216          465 FSISEIKEATKDFNNLLIIGRGGFGNVYKGFL-----NGDSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQL-RYLHLVSL  537 (767)
Q Consensus       465 ~~~~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~-----~~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~Hpniv~l  537 (767)
                      +...+.....++|...+.||+|+||.||+|.+     ...++.||||++..... ...+.+.+|++++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            44555555678999999999999999999984     44557899999976533 3446799999999999 79999999


Q ss_pred             eeeeecCC-ceEEEEecCCCCChhhhhccCCC------------------------------------------------
Q 042216          538 IGYCNDDG-QMILVYDYMARGTLRDHLYNNDN------------------------------------------------  568 (767)
Q Consensus       538 ~g~~~~~~-~~~lV~ey~~~gsL~~~L~~~~~------------------------------------------------  568 (767)
                      +++|.+.+ ..++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99998765 48999999999999999975432                                                


Q ss_pred             ----------------CCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          569 ----------------PPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       569 ----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                                      ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                            12899999999999999999999   67899999999999999999999999999986544333


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                      ........||+.|+|||++.+..++.++|||||||++|||++ |+.||......+.  +..    ....+         .
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~----~~~~~---------~  313 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR----RLKEG---------T  313 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHH----HHHHT---------C
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHH----HHHcC---------C
Confidence            333445668899999999999999999999999999999998 9999965543221  111    11111         1


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      ....+..++.++.+++.+||+.||.+|||+.||++.|+.+++..
T Consensus       314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence            12234456678999999999999999999999999999988654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.4e-41  Score=366.65  Aligned_cols=260  Identities=24%  Similarity=0.407  Sum_probs=207.7

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCc----eEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDST----PVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~----~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      ++|...+.||+|+||+||+|++..+++    .||+|.+... .....++|.+|+.++++++||||++++++|.+. ..++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence            578899999999999999999865544    3688888644 344567899999999999999999999999875 4789


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      |+||+.+|+|.+++.... ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        94 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            999999999999997643 46999999999999999999999   67899999999999999999999999999986543


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      ...........+|..|+|||++.+..++.++|||||||++|||++ |+.||......+.   ...    ...        
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~----~~~--------  234 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSI----LEK--------  234 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHH----HHT--------
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH---HHH----HHc--------
Confidence            333333344557889999999999999999999999999999999 9999965543321   111    111        


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                       ......+..++.++.+++.+||+.||.+||++.||++.|+.+.+..
T Consensus       235 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~  280 (327)
T 3poz_A          235 -GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             -TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred             -CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence             1122335567788999999999999999999999999999887644

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.6e-41  Score=372.94  Aligned_cols=261  Identities=26%  Similarity=0.419  Sum_probs=204.4

Q ss_pred             hccccceeeeccCcEEEEEEEec---CCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLN---GDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~---~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      .+|...+.||+|+||.||+|++.   ..+..||||+++... ....++|.+|++++++++||||++++++|.+.+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57888999999999999999886   345789999997653 33456799999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+++|+|.++++... ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       125 ~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            99999999999997543 46999999999999999999999   678999999999999999999999999999865432


Q ss_pred             CCcc-ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          631 SKTH-VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       631 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      .... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+   +..    ...         
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~~----~i~---------  264 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VIK----AVD---------  264 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HHH----HHH---------
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHH---------
Confidence            2111 1122345778999999999999999999999999999998 999996543221   111    111         


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      ...+...+..++..+.+++.+||+.||.+||++.+|+++|+.+++..
T Consensus       265 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            11222334567788999999999999999999999999999997654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.9e-42  Score=367.55  Aligned_cols=269  Identities=25%  Similarity=0.394  Sum_probs=212.6

Q ss_pred             hhccccceeeeccCcEEEEEEEe----cCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeec--CCce
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFL----NGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCND--DGQM  547 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~----~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~--~~~~  547 (767)
                      .++|+..+.||+|+||+||++++    ...++.||||++........+.+.+|++++++++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            35788899999999999999984    45668999999987766667789999999999999999999999854  3568


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      ++||||+++|+|.+++.... ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             EEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            99999999999999997653 35899999999999999999999   678999999999999999999999999999865


Q ss_pred             CCCCCc-cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc---------cchhHHHHHHHH
Q 042216          628 PNFSKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDK---------KQVNLAVWATEC  697 (767)
Q Consensus       628 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~---------~~~~l~~~~~~~  697 (767)
                      ...... .......++..|+|||.+.+..++.++||||||+++|||++|..|+......         ............
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (295)
T 3ugc_A          165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  244 (295)
T ss_dssp             -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence            332211 1223345778899999999999999999999999999999999998532110         000011111111


Q ss_pred             hhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          698 YRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       698 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      ..         ...+...+..++.++.+++.+||+.||.+|||+.||++.|+.+.+.+
T Consensus       245 ~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          245 LK---------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HH---------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             Hh---------ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            11         11223345667888999999999999999999999999999987654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=8.6e-41  Score=359.59  Aligned_cols=262  Identities=20%  Similarity=0.316  Sum_probs=217.7

Q ss_pred             cccCHHHHHHHhhc----------cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccc
Q 042216          463 TQFSISEIKEATKD----------FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL  532 (767)
Q Consensus       463 ~~~~~~ei~~~t~~----------f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hp  532 (767)
                      ..++.++++.+++.          |+..+.||+|+||.||+|+...+++.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45788899888864          67777999999999999999877899999999877666677899999999999999


Q ss_pred             eeeeEeeeeecCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC
Q 042216          533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE  612 (767)
Q Consensus       533 niv~l~g~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~  612 (767)
                      ||+++++++...+..++||||+++|+|.+++.+   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~  176 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTL  176 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECC
Confidence            999999999999999999999999999999854   35999999999999999999999   678999999999999999


Q ss_pred             CCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHH
Q 042216          613 EWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAV  692 (767)
Q Consensus       613 ~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~  692 (767)
                      ++.+||+|||+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ...
T Consensus       177 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---~~~  251 (321)
T 2c30_A          177 DGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMK  251 (321)
T ss_dssp             TCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH
T ss_pred             CCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH
Confidence            9999999999987654321  12344579999999999999999999999999999999999999996543211   111


Q ss_pred             HHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          693 WATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       693 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .    ......     +.+  ..+...+..+.+++.+||+.||.+|||+.|+++
T Consensus       252 ~----~~~~~~-----~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          252 R----LRDSPP-----PKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             H----HHHSSC-----CCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             H----HhcCCC-----CCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1    111111     111  112345667899999999999999999999985

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.2e-41  Score=388.01  Aligned_cols=260  Identities=25%  Similarity=0.403  Sum_probs=219.8

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      ..+|...+.||+|+||.||+|.++..+..||||+++... ...++|.+|+++|++++||||++++++|.+.+..++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            356888889999999999999998777899999997543 3467899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      |++|+|.++|.......+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++...... .
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  373 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-Y  373 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-E
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-e
Confidence            99999999998766667999999999999999999999   6789999999999999999999999999998653321 1


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      .......++..|+|||.+....++.++|||||||+||||++ |+.||......+   +...    +.         ...+
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~----~~---------~~~~  437 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL----LE---------KDYR  437 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH----HH---------TTCC
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HH---------cCCC
Confidence            12233456789999999999999999999999999999999 999996654322   1111    11         1122


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL  754 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~  754 (767)
                      ...+..++.++.+++.+||+.||.+|||+.+|++.|+.+++.
T Consensus       438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence            344566788899999999999999999999999999987643

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-41  Score=370.67  Aligned_cols=264  Identities=26%  Similarity=0.439  Sum_probs=218.5

Q ss_pred             hhccccceeeeccCcEEEEEEEecC-------CCceEEEEEeCCCC-CcchhHHHHHHHHHhcc-ccceeeeEeeeeecC
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNG-------DSTPVAIKRLNPGS-QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDD  544 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~-------~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~  544 (767)
                      .++|...+.||+|+||+||+|+..+       .++.||||++.... .....++.+|+++++++ +||||++++++|...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            3578888999999999999998743       23579999997653 33456789999999999 999999999999999


Q ss_pred             CceEEEEecCCCCChhhhhccCC--------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE
Q 042216          545 GQMILVYDYMARGTLRDHLYNND--------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL  610 (767)
Q Consensus       545 ~~~~lV~ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl  610 (767)
                      +..++||||+++|+|.+++....              ...+++.+++.++.|++.||.|||   +.+|+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence            99999999999999999997643              245999999999999999999999   6789999999999999


Q ss_pred             CCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchh
Q 042216          611 DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVN  689 (767)
Q Consensus       611 d~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~  689 (767)
                      ++++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+   
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~---  301 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  301 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence            9999999999999986544333233444567889999999999999999999999999999999 999996543221   


Q ss_pred             HHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 042216          690 LAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLR  756 (767)
Q Consensus       690 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  756 (767)
                      +.    .....+         .....+..++.++.+++.+||+.||.+|||+.||++.|+.++....
T Consensus       302 ~~----~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          302 LF----KLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             HH----HHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             HH----HHHHcC---------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            11    111111         1222345567789999999999999999999999999999987764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.7e-41  Score=360.50  Aligned_cols=262  Identities=25%  Similarity=0.412  Sum_probs=216.9

Q ss_pred             hhccccceeeeccCcEEEEEEEec-----CCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCce
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLN-----GDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQM  547 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~  547 (767)
                      .++|...+.||+|+||.||+|...     .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            467888899999999999999873     344789999997543 34456789999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhccCCC----------------------CCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCC
Q 042216          548 ILVYDYMARGTLRDHLYNNDN----------------------PPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKT  605 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~  605 (767)
                      ++||||+++|+|.+++.....                      ..+++.+++.++.|++.||.|||   +++|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence            999999999999999976432                      34899999999999999999999   67899999999


Q ss_pred             CCeEECCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 042216          606 TNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGD  684 (767)
Q Consensus       606 ~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~  684 (767)
                      +|||+++++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999986544332223334557889999999999999999999999999999999 9999965543


Q ss_pred             ccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 042216          685 KKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL  754 (767)
Q Consensus       685 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~  754 (767)
                      ..   +..    ....+.         ....+..++..+.+++.+||+.||.+||++.|+++.|+.+++.
T Consensus       259 ~~---~~~----~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          259 ER---LFN----LLKTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             GG---HHH----HHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HH---HHH----HhhcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            22   111    111111         1223445677899999999999999999999999999998764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=6.5e-41  Score=377.45  Aligned_cols=252  Identities=33%  Similarity=0.494  Sum_probs=211.7

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCC-ceEEEEe
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG-QMILVYD  552 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~-~~~lV~e  552 (767)
                      .++|...+.||+|+||.||+|.+.+  +.||||+++...  ..++|.+|+++|++++||||++++++|.+.+ ..++|||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~~--~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT--EEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEecC--CeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3568888899999999999999863  689999997543  4568999999999999999999999987665 7999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+++|+|.+++.......+++..++.++.|++.||.|||   +++|+||||||+|||+++++.+||+|||+++.....  
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence            999999999998765556899999999999999999999   678999999999999999999999999999853221  


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                         .....++..|+|||.+.+..++.++|||||||+||||++ |+.||......+..   .    .+..+         .
T Consensus       343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~----~i~~~---------~  403 (450)
T 1k9a_A          343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---P----RVEKG---------Y  403 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH---H----HHHTT---------C
T ss_pred             ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H----HHHcC---------C
Confidence               122357889999999999999999999999999999998 99999765433211   1    11111         1


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                      +...+..++.++.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            223456678899999999999999999999999999998764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.9e-41  Score=362.85  Aligned_cols=260  Identities=24%  Similarity=0.376  Sum_probs=211.0

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCce----EEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTP----VAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~----vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      ++|...+.||+|+||+||+|.+..+++.    ||+|.+.... .....++.+|+.++.+++||||++++++|. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            4688889999999999999998766554    8888875443 344567889999999999999999999986 567899


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ||||+.+|+|.+++... ...+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            99999999999999754 346899999999999999999999   67899999999999999999999999999987654


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      ...........++..|+|||.+.+..++.++|||||||++|||++ |+.||......+..   .    ....+       
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~----~~~~~-------  233 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP---D----LLEKG-------  233 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH---H----HHHTT-------
T ss_pred             ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH---H----HHHcC-------
Confidence            443334455668889999999999999999999999999999999 99999765433211   1    11111       


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                        .....+..++.++.+++.+||+.||.+||++.++++.|+.+....
T Consensus       234 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          234 --ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             --CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             --CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence              111223345567889999999999999999999999999887544

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-41  Score=366.04  Aligned_cols=267  Identities=25%  Similarity=0.386  Sum_probs=213.0

Q ss_pred             hhccccceeeeccCcEEEEEEEec-----CCCceEEEEEeCCC-CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCc
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLN-----GDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQ  546 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~  546 (767)
                      .++|...+.||+|+||.||+|...     +.+..||||++... .......+.+|+.++.++ +||||+++++++...+.
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  123 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  123 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence            468889999999999999999973     34568999999754 334456799999999999 89999999999999999


Q ss_pred             eEEEEecCCCCChhhhhccCCC---------------------CCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCC
Q 042216          547 MILVYDYMARGTLRDHLYNNDN---------------------PPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKT  605 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~  605 (767)
                      .++||||+++|+|.+++.....                     ..+++..++.++.|++.||.|||   +.+|+||||||
T Consensus       124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp  200 (344)
T 1rjb_A          124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA  200 (344)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred             cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCh
Confidence            9999999999999999975432                     24899999999999999999999   67899999999


Q ss_pred             CCeEECCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 042216          606 TNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGD  684 (767)
Q Consensus       606 ~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~  684 (767)
                      +|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  280 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  280 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence            999999999999999999975433222223344567889999999999999999999999999999998 9999966543


Q ss_pred             ccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhcc
Q 042216          685 KKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRES  758 (767)
Q Consensus       685 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~~  758 (767)
                      ..  ....    ....+         .....+..++.++.+++.+||+.||.+|||+.||++.|+.++....+.
T Consensus       281 ~~--~~~~----~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~  339 (344)
T 1rjb_A          281 DA--NFYK----LIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA  339 (344)
T ss_dssp             SH--HHHH----HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred             HH--HHHH----HHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHH
Confidence            21  1111    11111         122334456778999999999999999999999999999988766443

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-41  Score=366.28  Aligned_cols=264  Identities=27%  Similarity=0.433  Sum_probs=215.4

Q ss_pred             HhhccccceeeeccCcEEEEEEEecC-----CCceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecCCc
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQ  546 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~  546 (767)
                      ..++|...+.||+|+||.||+|+..+     .++.||||+++.... .....+.+|++++++++||||+++++++.+.+.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            45789999999999999999999863     347899999976533 335679999999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhhhccCC----------------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCC
Q 042216          547 MILVYDYMARGTLRDHLYNND----------------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVK  604 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk  604 (767)
                      .++||||+++|+|.+++....                      ...+++.+++.++.|++.||.|||   +++|+|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence            999999999999999997642                      156999999999999999999999   6789999999


Q ss_pred             CCCeEECCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 042216          605 TTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTG  683 (767)
Q Consensus       605 ~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~  683 (767)
                      |+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            9999999999999999999875432222222334568899999999999999999999999999999999 999996543


Q ss_pred             CccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          684 DKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       684 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      ..+   +.    .....+..         ...+..++.++.+++.+||+.||.+||++.+|++.|+.+.+..
T Consensus       282 ~~~---~~----~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          282 HEE---VI----YYVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             HHH---HH----HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             hHH---HH----HHHhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            221   11    11222211         1234456778999999999999999999999999999987655

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.9e-41  Score=382.35  Aligned_cols=259  Identities=25%  Similarity=0.436  Sum_probs=214.4

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .++|...+.||+|+||.||+|.+.+ +..||||+++... ...++|.+|+++|++++||||+++++++. .+..++||||
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             hHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            4678888999999999999999975 4789999997643 45678999999999999999999999986 5678999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++|+|.++|+......+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++..... ..
T Consensus       264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~-~~  339 (454)
T 1qcf_A          264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN-EY  339 (454)
T ss_dssp             CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH-HH
T ss_pred             cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC-ce
Confidence            99999999997654446899999999999999999999   678999999999999999999999999999864321 11


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      .......++..|+|||.+....++.++|||||||+||||++ |+.||......+   +...    +..+         .+
T Consensus       340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~~~----i~~~---------~~  403 (454)
T 1qcf_A          340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRA----LERG---------YR  403 (454)
T ss_dssp             HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHH----HHHT---------CC
T ss_pred             eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcC---------CC
Confidence            11223446788999999999999999999999999999999 999996543321   1111    1111         12


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      ...+..++.++.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus       404 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence            2335567788999999999999999999999999999886544

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=372.86  Aligned_cols=262  Identities=24%  Similarity=0.375  Sum_probs=212.6

Q ss_pred             hccccceeeeccCcEEEEEEEec-----CCCceEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLN-----GDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMI  548 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~  548 (767)
                      ++|...+.||+|+||+||+|++.     ..++.||||++... ......++.+|+.++++++||||+++++++.+.+..+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            57888899999999999999954     34568999999654 3344557899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhccCC-----CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC---cEEEee
Q 042216          549 LVYDYMARGTLRDHLYNND-----NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW---VAKVSD  620 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~---~~ki~D  620 (767)
                      +||||+++|+|.+++....     ...+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999996532     245899999999999999999999   77899999999999999544   599999


Q ss_pred             cCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhh
Q 042216          621 FGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYR  699 (767)
Q Consensus       621 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~  699 (767)
                      ||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+   +..    ...
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~~----~i~  300 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLE----FVT  300 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHH----HHH
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHH
Confidence            999974322112222334567899999999999999999999999999999998 999996543221   111    111


Q ss_pred             cCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       700 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      .+.         ....+..++..+.+++.+||+.||.+||++.+|++.|+.+.+..
T Consensus       301 ~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          301 SGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             cCC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            111         12234456778999999999999999999999999999988755

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=7.3e-41  Score=358.02  Aligned_cols=264  Identities=24%  Similarity=0.396  Sum_probs=217.8

Q ss_pred             hhccccceeeeccCcEEEEEEEe-----cCCCceEEEEEeCCCCC-cchhHHHHHHHHHhcc-ccceeeeEeeeeecCCc
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFL-----NGDSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQ  546 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~-----~~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~  546 (767)
                      .++|...+.||+|+||.||+|+.     ...++.||||++..... ...+.+.+|++++.++ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            45788899999999999999985     34557899999976543 3456789999999999 99999999999999999


Q ss_pred             eEEEEecCCCCChhhhhccCCC----------------CCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE
Q 042216          547 MILVYDYMARGTLRDHLYNNDN----------------PPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL  610 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl  610 (767)
                      .++||||+++|+|.+++.....                ..+++.+++.++.|++.||.|||   +.+|+||||||+|||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence            9999999999999999976432                25899999999999999999999   6789999999999999


Q ss_pred             CCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchh
Q 042216          611 DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVN  689 (767)
Q Consensus       611 d~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~  689 (767)
                      +.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......  .
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~  256 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--K  256 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--H
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--H
Confidence            9999999999999986544333333344567889999999999999999999999999999999 999996554321  1


Q ss_pred             HHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          690 LAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       690 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      ......    .+         .....+..++..+.+++.+||+.||.+|||+.|+++.|+++++..
T Consensus       257 ~~~~~~----~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          257 FYKMIK----EG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             HHHHHH----HT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHHhc----cC---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            111111    11         112223456678999999999999999999999999999988754

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.6e-41  Score=366.92  Aligned_cols=267  Identities=24%  Similarity=0.360  Sum_probs=217.6

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCC-----ceEEEEEeCCCCC-cchhHHHHHHHHHhcc-ccceeeeEeeeeecCC
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDS-----TPVAIKRLNPGSQ-QGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDG  545 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~-----~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~  545 (767)
                      ..++|...+.||+|+||.||+|.....+     +.||+|.+..... .....+.+|+++++++ +||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            4568899999999999999999986544     3799999976533 3456789999999999 8999999999999999


Q ss_pred             ceEEEEecCCCCChhhhhccCC------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCC
Q 042216          546 QMILVYDYMARGTLRDHLYNND------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEE  613 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~  613 (767)
                      ..++||||+++|+|.+++....            ...+++..++.++.|++.||.|||   +.+|+||||||+|||++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCC
Confidence            9999999999999999996431            346899999999999999999999   6789999999999999999


Q ss_pred             CcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHH
Q 042216          614 WVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAV  692 (767)
Q Consensus       614 ~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~  692 (767)
                      +.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |..||.......  ....
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~  278 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KFYK  278 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HHHH
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HHHH
Confidence            9999999999975433222222334557889999999999999999999999999999998 999996544321  1111


Q ss_pred             HHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhc
Q 042216          693 WATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRE  757 (767)
Q Consensus       693 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~  757 (767)
                      ....    +         .....+..++..+.+++.+||+.||.+|||+.||++.|+.+.+..++
T Consensus       279 ~~~~----~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~  330 (333)
T 2i1m_A          279 LVKD----G---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR  330 (333)
T ss_dssp             HHHH----T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHhc----C---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhc
Confidence            1111    1         11122344567899999999999999999999999999999877644

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4e-40  Score=349.71  Aligned_cols=269  Identities=17%  Similarity=0.151  Sum_probs=217.7

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEEEe
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      .++|...+.||+|+||.||+|....+++.||||++....  ....+.+|++++..+ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            357899999999999999999988888999999986432  334688999999999 79999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCc-----EEEeecCCcccC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV-----AKVSDFGLCKFG  627 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~-----~ki~DfGla~~~  627 (767)
                      |+ +++|.+++.... ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.     +||+|||+++..
T Consensus        87 ~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           87 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             ec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            99 899999997643 35999999999999999999999   788999999999999987776     999999999865


Q ss_pred             CCCCCc-----cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC
Q 042216          628 PNFSKT-----HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK  702 (767)
Q Consensus       628 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~  702 (767)
                      ......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......................
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  241 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence            332211     123455699999999999999999999999999999999999999976544332222222211111111


Q ss_pred             ccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhcc
Q 042216          703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRES  758 (767)
Q Consensus       703 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~~  758 (767)
                      ..+         ....++.++.+++.+||+.||.+||++++|++.|+.+.+.....
T Consensus       242 ~~~---------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~  288 (298)
T 1csn_A          242 LRE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT  288 (298)
T ss_dssp             HHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             HHH---------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence            100         11235678999999999999999999999999999998776443

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-40  Score=348.98  Aligned_cols=256  Identities=27%  Similarity=0.476  Sum_probs=212.1

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      ++|...+.||+|+||.||+|...+ ++.||+|++.... ...+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhceeeheecCCCccEEEEEEecC-CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            578888999999999999999875 4679999997543 34567999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++|+|.+++.... ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        88 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~  162 (269)
T 4hcu_A           88 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYT  162 (269)
T ss_dssp             TTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH-HHH
T ss_pred             CCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccc-ccc
Confidence            9999999996543 46899999999999999999999   678999999999999999999999999999754321 111


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      ......+++.|+|||.+....++.++||||||+++|||++ |+.||......+   .   ... ...+         ...
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~---~---~~~-~~~~---------~~~  226 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---V---VED-ISTG---------FRL  226 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H---HHH-HHTT---------CCC
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH---H---HHH-HhcC---------ccC
Confidence            2233456788999999999999999999999999999999 999996543221   1   111 1111         112


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                      ..+...+..+.+++.+||+.||.+||++.|+++.|+.+.+
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            2334456789999999999999999999999999998875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.8e-41  Score=361.28  Aligned_cols=248  Identities=22%  Similarity=0.300  Sum_probs=207.7

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      .++|...+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+++|+.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            45799999999999999999999888899999998654  2334567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|+|.+++...  ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....  
T Consensus        94 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--  166 (328)
T 3fe3_A           94 EYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV--  166 (328)
T ss_dssp             CCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS--
T ss_pred             ECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC--
Confidence            999999999999654  35899999999999999999999   67899999999999999999999999999975432  


Q ss_pred             CccccccccCCCcccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLT-EKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                       ........||+.|+|||++.+..+. .++|||||||++|||++|+.||......+   +.   .. ...+.        
T Consensus       167 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~---~~-i~~~~--------  230 (328)
T 3fe3_A          167 -GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LR---ER-VLRGK--------  230 (328)
T ss_dssp             -SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HH-HHHCC--------
T ss_pred             -CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH---HH---HH-HHhCC--------
Confidence             1233456799999999999888765 79999999999999999999996543211   11   11 11111        


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                        ...|...+.++.+++.+||+.||.+|||++|+++
T Consensus       231 --~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          231 --YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             --CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             --CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              1223445677899999999999999999999985

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=9.1e-41  Score=359.33  Aligned_cols=264  Identities=24%  Similarity=0.408  Sum_probs=199.4

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCc---eEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCce
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDST---PVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQM  547 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~---~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~  547 (767)
                      ..++|...+.||+|+||.||+|....++.   .||||++...  .....+++.+|++++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            34679999999999999999999876553   7999999754  344567899999999999999999999999877655


Q ss_pred             ------EEEEecCCCCChhhhhccC----CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEE
Q 042216          548 ------ILVYDYMARGTLRDHLYNN----DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAK  617 (767)
Q Consensus       548 ------~lV~ey~~~gsL~~~L~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~k  617 (767)
                            ++||||+++|+|.+++...    ....+++.+++.++.|++.||.|||   +.+|+||||||+|||+++++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence                  9999999999999998542    2235899999999999999999999   67899999999999999999999


Q ss_pred             EeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHH
Q 042216          618 VSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATE  696 (767)
Q Consensus       618 i~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~  696 (767)
                      |+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+..   ..   
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~~---  251 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY---NY---  251 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HH---
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH---HH---
Confidence            999999986543222223334457889999999999999999999999999999999 99999665433211   11   


Q ss_pred             HhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          697 CYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       697 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                       ...+.         ....+..++.++.+++.+||+.||.+|||+.++++.|+.+++.+
T Consensus       252 -~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          252 -LIGGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             -HHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             -HhcCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence             11111         11234456778999999999999999999999999999998655

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8.5e-41  Score=353.24  Aligned_cols=263  Identities=25%  Similarity=0.399  Sum_probs=222.3

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ..++|...+.||+|+||.||+|.....+..||+|++... ....+++.+|++++++++||||+++++++.+.+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            456788999999999999999999987889999999754 3446679999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+++|+|.+++.......+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  165 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-  165 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-
Confidence            999999999998766677999999999999999999999   6789999999999999999999999999998654322 


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                      ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......   ....    ...         ..
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~----~~~---------~~  229 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL----LEK---------DY  229 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH----HHT---------TC
T ss_pred             cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----Hhc---------cC
Confidence            222334457889999999999999999999999999999999 999986544322   1111    111         12


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLR  756 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  756 (767)
                      ....+..++.++.+++.+||+.||.+|||+.++++.|+.+.+...
T Consensus       230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~  274 (288)
T 3kfa_A          230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS  274 (288)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            223345667889999999999999999999999999999987654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9.9e-41  Score=354.49  Aligned_cols=264  Identities=24%  Similarity=0.339  Sum_probs=210.8

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC---cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ---QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      .++|...+.||+|+||.||++.....++.||+|++.....   ...+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            3578899999999999999999988889999999854422   3345789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+++|+|.+++...  .++++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        90 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            9999999999999654  35999999999999999999999   678999999999999999999999999999865332


Q ss_pred             CCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                      . ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.......      ........ ...     .
T Consensus       165 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~-~~~-----~  231 (294)
T 4eqm_A          165 S-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQD-SVP-----N  231 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSS-CCC-----C
T ss_pred             c-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhc-cCC-----C
Confidence            1 122334569999999999999999999999999999999999999996543211      11111111 110     1


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhHhhh
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRP-SMSDVVWGLEFVFQLL  755 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RP-s~~evl~~L~~~~~~~  755 (767)
                      .....+...+..+.+++.+||+.||.+|| +++++.+.|+.+++..
T Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence            11112334567899999999999999998 9999999998876554

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8.8e-41  Score=359.85  Aligned_cols=255  Identities=22%  Similarity=0.305  Sum_probs=206.6

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      .++|+..+.||+|+||+||+|....+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            357899999999999999999998888999999986443 2334568999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+++|+|.+++...  ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus        86 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            99999999999543  45999999999999999999999   78899999999999999999999999999976533222


Q ss_pred             ccccccccCCCcccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLL-TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                      ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... .....+..    ..         .
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~----~~---------~  226 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKE----KK---------T  226 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHHHT----TC---------T
T ss_pred             ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhc----cc---------c
Confidence            333345679999999999987765 789999999999999999999996554321 11111111    10         0


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      ........+..+.+++.+||+.||.+|||+.|+++.
T Consensus       227 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            011123456778899999999999999999999753

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.3e-40  Score=356.38  Aligned_cols=265  Identities=18%  Similarity=0.133  Sum_probs=213.9

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEEEe
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      .++|...+.||+|+||+||+|+...+++.||||++....  ....+.+|+++++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            357889999999999999999998888999999986543  234688999999999 99999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCc-----EEEeecCCcccC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV-----AKVSDFGLCKFG  627 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~-----~ki~DfGla~~~  627 (767)
                      |+ +|+|.+++... ...+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.     +||+|||+++..
T Consensus        86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            99 89999999764 346999999999999999999999   678999999999999999887     999999999864


Q ss_pred             CCCCCcc-----ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC
Q 042216          628 PNFSKTH-----VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK  702 (767)
Q Consensus       628 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~  702 (767)
                      .......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......................
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~  240 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP  240 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence            3322111     12356799999999999999999999999999999999999999976543322222221111111000


Q ss_pred             ccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       703 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      .     ..+    ...++ ++.+++..||+.||.+||++.+|++.|+.+.+..
T Consensus       241 ~-----~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          241 I-----EVL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             H-----HHH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             H-----HHH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            0     000    11234 8999999999999999999999999999887765

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.8e-41  Score=377.51  Aligned_cols=259  Identities=28%  Similarity=0.448  Sum_probs=210.3

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .++|...+.||+|+||.||+|.+.++ ..||||+++... ...++|.+|+++|++++||||+++++++.+ +..++||||
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            35688888999999999999999754 679999997653 345689999999999999999999999976 678999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++|+|.++|.......+++.+++.++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++...... .
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  335 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-e
Confidence            99999999997544456899999999999999999999   6789999999999999999999999999998653321 1


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      .......++..|+|||.+....++.++|||||||+||||++ |+.||......+   ..    .....+         .+
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~----~~i~~~---------~~  399 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VL----DQVERG---------YR  399 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HH----HHHHTT---------CC
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcC---------CC
Confidence            12233457789999999999999999999999999999999 999996543321   11    111111         12


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      ...+..++..+.+++.+||+.||.+|||+++|++.|+.+....
T Consensus       400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence            2345667888999999999999999999999999999887554

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-40  Score=356.43  Aligned_cols=260  Identities=24%  Similarity=0.392  Sum_probs=207.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCce----EEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTP----VAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~----vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      ++|...+.||+|+||.||+|.+..+++.    ||+|.+... .....+++.+|+.++++++||||++++++|... ..++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceE
Confidence            5789999999999999999998766554    577877544 344567899999999999999999999999876 4889


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      |+||+.+|+|.+++.... ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        94 v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            999999999999997653 45899999999999999999999   67899999999999999999999999999986543


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      ...........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+.   ...    ...        
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~~----~~~--------  234 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSI----LEK--------  234 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHH----HHT--------
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HHH----HHc--------
Confidence            333333334557889999999999999999999999999999999 9999966544321   111    111        


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                       ......+..++.++.+++.+||+.||.+||++.|+++.|+.+.+..
T Consensus       235 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          235 -GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             -TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             -CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence             1122334556778999999999999999999999999999987554

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.8e-40  Score=357.50  Aligned_cols=264  Identities=24%  Similarity=0.439  Sum_probs=216.2

Q ss_pred             hhccccceeeeccCcEEEEEEEec-------CCCceEEEEEeCCCC-CcchhHHHHHHHHHhcc-ccceeeeEeeeeecC
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLN-------GDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDD  544 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~-------~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~  544 (767)
                      .++|...+.||+|+||.||+|...       .++..||||++.... .....++.+|+++++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            467889999999999999999975       244689999997553 33456789999999999 899999999999999


Q ss_pred             CceEEEEecCCCCChhhhhccCCC--------------CCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE
Q 042216          545 GQMILVYDYMARGTLRDHLYNNDN--------------PPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL  610 (767)
Q Consensus       545 ~~~~lV~ey~~~gsL~~~L~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl  610 (767)
                      +..++||||+++|+|.+++.....              ..+++.+++.++.|++.||.|||   +.+|+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence            999999999999999999975432              34899999999999999999999   6789999999999999


Q ss_pred             CCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchh
Q 042216          611 DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVN  689 (767)
Q Consensus       611 d~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~  689 (767)
                      +.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+   
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---  267 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  267 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---
Confidence            9999999999999986544332223344557889999999998899999999999999999999 999996543221   


Q ss_pred             HHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 042216          690 LAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLR  756 (767)
Q Consensus       690 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  756 (767)
                      +...    ...+.         ....+..++.++.+++.+||+.||.+||++.|+++.|+.+++...
T Consensus       268 ~~~~----~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          268 LFKL----LKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             HHHH----HHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHH----HhcCC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            1111    11111         122344567789999999999999999999999999999987764

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.5e-40  Score=358.06  Aligned_cols=249  Identities=25%  Similarity=0.341  Sum_probs=208.6

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      .++|+..+.||+|+||+||+++.+.+++.||+|+++..   .......+.+|+++|+.++||||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            35789999999999999999999888899999998643   233456788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+++|+|.+++.+.  ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.... 
T Consensus        84 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-  157 (337)
T ss_dssp             EECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhccc-
Confidence            9999999999999654  35899999999999999999999   67899999999999999999999999999985322 


Q ss_pred             CCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                       ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +.   .... .+.        
T Consensus       158 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~---~~i~-~~~--------  221 (337)
T 1o6l_A          158 -DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LF---ELIL-MEE--------  221 (337)
T ss_dssp             -TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHH-HCC--------
T ss_pred             -CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---HH---HHHH-cCC--------
Confidence             1223345679999999999999999999999999999999999999996543211   11   1111 111        


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRP-----SMSDVVW  746 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~  746 (767)
                        ...+...+.++.+++.+||+.||.+||     +++||++
T Consensus       222 --~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence              113445667889999999999999999     8999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.2e-40  Score=347.85  Aligned_cols=253  Identities=30%  Similarity=0.473  Sum_probs=207.0

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcc-------hhHHHHHHHHHhccccceeeeEeeeeecCCce
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQG-------ALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQM  547 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~-------~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~  547 (767)
                      ++|...+.||+|+||+||+|++..+++.||||++.......       .+++.+|++++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            57888899999999999999998888999999986543221       167899999999999999999999997654  


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCC--eEecCCCCCCeEECCCCc-----EEEee
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV--IIHRDVKTTNILLDEEWV-----AKVSD  620 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiH~Dlk~~NILld~~~~-----~ki~D  620 (767)
                      ++||||+++|+|.+++.... ..+++..++.++.|++.||.|||   +.+  |+||||||+|||++.++.     +||+|
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            69999999999999886543 46999999999999999999999   777  999999999999988776     99999


Q ss_pred             cCCcccCCCCCCccccccccCCCcccChhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHh
Q 042216          621 FGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR--LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECY  698 (767)
Q Consensus       621 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~  698 (767)
                      ||+++....     ......||+.|+|||.+.  ...++.++|||||||++|||++|+.||......... ....   ..
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~---~~  243 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-FINM---IR  243 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-HHHH---HH
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-HHHH---Hh
Confidence            999974322     234457899999999984  456789999999999999999999999655433211 1111   11


Q ss_pred             hcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       699 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                      ..         ......+..++.++.+++.+||+.||.+|||++|+++.|+++
T Consensus       244 ~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          244 EE---------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HS---------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             cc---------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            11         122234456678899999999999999999999999999853

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.9e-40  Score=348.33  Aligned_cols=258  Identities=28%  Similarity=0.446  Sum_probs=210.3

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .++|...+.||+|+||.||++...+ +..||||++.... ...+++.+|++++.+++||||+++++++.+.+..++||||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcC-CCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            4578889999999999999998874 4689999997543 3456799999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++|+|.+++.... ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..... ..
T Consensus       101 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~  175 (283)
T 3gen_A          101 MANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EY  175 (283)
T ss_dssp             CTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH-HH
T ss_pred             cCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccc-cc
Confidence            99999999996532 35999999999999999999999   678999999999999999999999999999754321 11


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.   .   .. ...+         ..
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~---~---~~-~~~~---------~~  239 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET---A---EH-IAQG---------LR  239 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---H---HH-HHTT---------CC
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH---H---HH-Hhcc---------cC
Confidence            12233456788999999999999999999999999999998 9999965443211   1   11 1111         11


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL  754 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~  754 (767)
                      ...+...+..+.+++.+||+.||.+|||+.|+++.|+.++..
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            223344567899999999999999999999999999988754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.6e-40  Score=345.88  Aligned_cols=257  Identities=25%  Similarity=0.422  Sum_probs=211.6

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .++|...+.||+|+||.||+|...+ +..||+|++.... ...+++.+|++++.+++||||+++++++.+.+..++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            4578889999999999999998875 4679999997543 3456799999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++|+|.+++.... ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus        85 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~  159 (268)
T 3sxs_A           85 ISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-Y  159 (268)
T ss_dssp             CTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-E
T ss_pred             cCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh-h
Confidence            99999999996542 35899999999999999999999   6789999999999999999999999999998654322 1


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.      ... ...+.         .
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~-~~~~~---------~  223 (268)
T 3sxs_A          160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV------VLK-VSQGH---------R  223 (268)
T ss_dssp             EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------HHH-HHTTC---------C
T ss_pred             hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH------HHH-HHcCC---------C
Confidence            22233456778999999999899999999999999999999 9999965433211      111 11111         1


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                      ...+...+..+.+++.+||+.||.+|||+.|+++.|+.+.+
T Consensus       224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            12233456779999999999999999999999999987754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.2e-40  Score=347.88  Aligned_cols=260  Identities=25%  Similarity=0.384  Sum_probs=202.7

Q ss_pred             hhccccceeeeccCcEEEEEEEecCC---CceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGD---STPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      .++|...+.||+|+||.||+|....+   +..||+|++.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            45788899999999999999998643   3569999987543 333557899999999999999999999985 567899


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ||||+++|+|.+++.... ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        93 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            999999999999997543 46899999999999999999999   67899999999999999999999999999986533


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      .. ........+++.|+|||.+....++.++|||||||++|||++ |+.||......+   ....    ...+.      
T Consensus       169 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~----i~~~~------  234 (281)
T 1mp8_A          169 ST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGR----IENGE------  234 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HHTTC------
T ss_pred             cc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHH----HHcCC------
Confidence            21 112233456789999999999999999999999999999996 999996554332   1111    11111      


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                         ....+..++..+.+++.+||+.||.+|||+.|+++.|+.+++..
T Consensus       235 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          235 ---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence               11234556778999999999999999999999999999998654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4e-40  Score=344.34  Aligned_cols=252  Identities=20%  Similarity=0.319  Sum_probs=208.5

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecC--CceEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD--GQMILV  550 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~~lV  550 (767)
                      ++|...+.||+|+||.||+|++.  ++.||||++....  ....++|.+|+.++++++||||+++++++.+.  +..++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            57888899999999999999986  4789999997553  33456799999999999999999999999877  788999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCC--eEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV--IIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      |||+++|+|.+++.......+++.+++.++.|++.||.|||   +.+  |+||||||+|||++.++.++|+|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            99999999999998766667999999999999999999999   677  9999999999999999999999998865321


Q ss_pred             CCCCccccccccCCCcccChhhhccCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccc
Q 042216          629 NFSKTHVSTQVKGSIGYLDPEYYRLQLLTE---KSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD  705 (767)
Q Consensus       629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  705 (767)
                             .....||+.|+|||.+.+...+.   ++|||||||++|||++|+.||.......      ........+    
T Consensus       165 -------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~----  227 (271)
T 3kmu_A          165 -------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMKVALEG----  227 (271)
T ss_dssp             -------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHHHHHSC----
T ss_pred             -------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHHHHhcC----
Confidence                   12346899999999998765444   8999999999999999999996543221      111111111    


Q ss_pred             cccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       706 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                           .....+..++.++.+++.+||+.||.+|||++|+++.|+.+.+
T Consensus       228 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          228 -----LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                 1223345567789999999999999999999999999998753

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.3e-41  Score=363.63  Aligned_cols=279  Identities=27%  Similarity=0.387  Sum_probs=214.7

Q ss_pred             hccccceeeeccCcEEEEEEEe----cCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeee--cCCceE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFL----NGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN--DDGQMI  548 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~----~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~--~~~~~~  548 (767)
                      ++|...+.||+|+||.||++.+    ...++.||||++........+.+.+|++++++++||||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5788899999999999999984    4566899999998776666677999999999999999999999886  456789


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      +||||+++|+|.+++.... ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            9999999999999996533 35899999999999999999999   6789999999999999999999999999998654


Q ss_pred             CCCCc-cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCcc--------chhHHHHHHHHhh
Q 042216          629 NFSKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKK--------QVNLAVWATECYR  699 (767)
Q Consensus       629 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~--------~~~l~~~~~~~~~  699 (767)
                      ..... .......+|..|+|||.+.+..++.++|||||||++|||++|+.||.......        ..........   
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  255 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE---  255 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH---
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH---
Confidence            32221 12234568888999999999999999999999999999999999985432110        0000011111   


Q ss_pred             cCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhcccccccccC
Q 042216          700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEKSMIAH  766 (767)
Q Consensus       700 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~  766 (767)
                            .+........+..++..+.+++.+||+.||.+|||+.|+++.|+.+..............+
T Consensus       256 ------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~  316 (327)
T 3lxl_A          256 ------LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAH  316 (327)
T ss_dssp             ------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------------
T ss_pred             ------HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccccccccC
Confidence                  1112223344566788899999999999999999999999999999877655554444333

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.6e-40  Score=358.58  Aligned_cols=252  Identities=19%  Similarity=0.234  Sum_probs=207.0

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc------chhHHHHHHHHHhccccceeeeEeeeeecCCce
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ------GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQM  547 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~------~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~  547 (767)
                      .++|...+.||+|+||.||++..+.+++.||+|.+......      ..+.+.+|+.+|.+++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            45788999999999999999999988899999998654321      246789999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC----cEEEeecCC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW----VAKVSDFGL  623 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~----~~ki~DfGl  623 (767)
                      ++||||+++|+|.+++..  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++    .+||+|||+
T Consensus        91 ~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            999999999999999954  346999999999999999999999   67899999999999998877    799999999


Q ss_pred             cccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCc
Q 042216          624 CKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKI  703 (767)
Q Consensus       624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~  703 (767)
                      ++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +.   .. +..+..
T Consensus       166 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~---~~---~~-i~~~~~  235 (361)
T 2yab_A          166 AHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TL---AN-ITAVSY  235 (361)
T ss_dssp             CEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH---HH-HHTTCC
T ss_pred             ceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HH-HHhcCC
Confidence            9865432   12344579999999999999999999999999999999999999996543221   11   11 111110


Q ss_pred             cccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          704 GDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       704 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .  .++.    .....+..+.+++.+||+.||.+|||+.|+++
T Consensus       236 ~--~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          236 D--FDEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             C--CCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             C--CCch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0  0000    11234567899999999999999999999984

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.5e-41  Score=376.62  Aligned_cols=263  Identities=22%  Similarity=0.264  Sum_probs=210.7

Q ss_pred             HHHHHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeec
Q 042216          467 ISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCND  543 (767)
Q Consensus       467 ~~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~  543 (767)
                      +.+++...++|+..++||+|+||+||+|+++.+++.||+|++...   .......+.+|+.++..++||||++++++|.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            445555678999999999999999999999988899999998642   12223458899999999999999999999999


Q ss_pred             CCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCC
Q 042216          544 DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL  623 (767)
Q Consensus       544 ~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGl  623 (767)
                      .+.++||||||++|+|.++|.+. ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhh
Confidence            99999999999999999999753 246999999999999999999999   67899999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCcccChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHh
Q 042216          624 CKFGPNFSKTHVSTQVKGSIGYLDPEYYR-----LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECY  698 (767)
Q Consensus       624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~  698 (767)
                      ++..... ........+||+.|+|||++.     ...++.++|||||||++|||++|+.||......+..  ....... 
T Consensus       222 a~~~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~--~~i~~~~-  297 (437)
T 4aw2_A          222 CLKLMED-GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY--GKIMNHK-  297 (437)
T ss_dssp             CEECCTT-SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHHHTHH-
T ss_pred             hhhcccC-CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH--Hhhhhcc-
Confidence            9765332 222334467999999999987     567899999999999999999999999654332211  1111000 


Q ss_pred             hcCCccccccccccCCCChhhHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 042216          699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIR--RPSMSDVVW  746 (767)
Q Consensus       699 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~--RPs~~evl~  746 (767)
                      .....         .......+.++.+++.+||+.+|++  ||+++|+++
T Consensus       298 ~~~~~---------p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          298 ERFQF---------PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHCCC---------CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ccccC---------CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            00000         0111235677899999999888888  999999985

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.1e-40  Score=353.77  Aligned_cols=252  Identities=20%  Similarity=0.254  Sum_probs=206.6

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC------cchhHHHHHHHHHhccccceeeeEeeeeecCCce
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ------QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQM  547 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~------~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~  547 (767)
                      .++|...+.||+|+||.||++....+++.||+|.+.....      .....+.+|+.+|++++||||+++++++.+.+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            4578899999999999999999988889999999865422      1356789999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC----cEEEeecCC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW----VAKVSDFGL  623 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~----~~ki~DfGl  623 (767)
                      ++||||+++|+|.+++..  ...+++.++..++.|++.||.|||   +.+|+||||||+|||++.++    .+||+|||+
T Consensus        90 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            999999999999999954  346999999999999999999999   67899999999999999887    899999999


Q ss_pred             cccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCc
Q 042216          624 CKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKI  703 (767)
Q Consensus       624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~  703 (767)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.  +.    .. .....
T Consensus       165 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~----~~-~~~~~  234 (326)
T 2y0a_A          165 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LA----NV-SAVNY  234 (326)
T ss_dssp             CEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HH----HH-HHTCC
T ss_pred             CeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HH----HH-HhcCC
Confidence            98653221   22345699999999999999999999999999999999999999965432211  11    11 11000


Q ss_pred             cccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          704 GDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       704 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       .     .........+..+.+++.+||+.||.+|||+.|+++
T Consensus       235 -~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          235 -E-----FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             -C-----CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -C-----cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             0     000011234567889999999999999999999985

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.5e-40  Score=349.15  Aligned_cols=257  Identities=28%  Similarity=0.456  Sum_probs=203.7

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      ++|...+.||+|+||.||+|+..+  +.||||++...  ...+.|.+|++++++++||||+++++++.  +..++||||+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~   81 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWRA--KDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA   81 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETT--EEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred             hHeeeeeEeecCCCceEEEEEECC--eeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence            568888999999999999999863  78999998643  34567999999999999999999999987  4589999999


Q ss_pred             CCCChhhhhccCCC-CCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCc-EEEeecCCcccCCCCCC
Q 042216          555 ARGTLRDHLYNNDN-PPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV-AKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       555 ~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~-~ki~DfGla~~~~~~~~  632 (767)
                      ++|+|.+++..... ..+++..++.++.|+++||.|||+.+.++|+||||||+|||++.++. +||+|||+++....   
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~---  158 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---  158 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc---
Confidence            99999999975432 24789999999999999999999533378999999999999988876 79999999875322   


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                        ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........  ...+  . ...+.         .
T Consensus       159 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~--~-~~~~~---------~  222 (307)
T 2eva_A          159 --HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMW--A-VHNGT---------R  222 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHH--H-HHTTC---------C
T ss_pred             --ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--HHHH--H-HhcCC---------C
Confidence              12234689999999999999999999999999999999999999965433211  1111  1 11111         1


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLR  756 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  756 (767)
                      ...+..++..+.+++.+||+.||.+|||+.++++.|+.+.+...
T Consensus       223 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  266 (307)
T 2eva_A          223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP  266 (307)
T ss_dssp             CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred             CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence            12233456778999999999999999999999999999987663

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=347.46  Aligned_cols=272  Identities=18%  Similarity=0.212  Sum_probs=213.5

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCC--ceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG--QMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~--~~~lV~  551 (767)
                      ++|...++||+|+||+||+|....+++.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            56888899999999999999999888999999997543 334567889999999999999999999987655  789999


Q ss_pred             ecCCCCChhhhhccCC-CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE----CCCCcEEEeecCCccc
Q 042216          552 DYMARGTLRDHLYNND-NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL----DEEWVAKVSDFGLCKF  626 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl----d~~~~~ki~DfGla~~  626 (767)
                      ||+++|+|.+++.... ...+++.+++.++.|++.||.|||   +.+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            9999999999997543 234999999999999999999999   6789999999999999    8888999999999986


Q ss_pred             CCCCCCccccccccCCCcccChhhhc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccc-hhHHHHHHHH
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYR--------LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ-VNLAVWATEC  697 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~-~~l~~~~~~~  697 (767)
                      .....   ......||..|+|||++.        ...++.++|||||||++|||++|+.||........ ..........
T Consensus       166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             cCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            54322   223456999999999986        57889999999999999999999999965443221 1111111111


Q ss_pred             hhcCCcccccc---------c--cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 042216          698 YRNGKIGDIID---------P--FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF  752 (767)
Q Consensus       698 ~~~~~~~~~~d---------~--~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~  752 (767)
                      .....+..+.+         .  .............+.+++.+||+.||++|||++|+++...+..
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            11111111100         0  0111334567788999999999999999999999998887553

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-39  Score=352.74  Aligned_cols=261  Identities=30%  Similarity=0.508  Sum_probs=206.4

Q ss_pred             hccccceeeeccCcEEEEEEEecCCC----ceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDS----TPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~----~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      .+|...+.||+|+||.||+|.....+    ..||||++.... .....++.+|++++.+++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            35666789999999999999886442    359999997653 3344578999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ||||+++|+|.+++.... ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       124 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            999999999999997543 46999999999999999999999   67899999999999999999999999999986433


Q ss_pred             CCC-ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccc
Q 042216          630 FSK-THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDII  707 (767)
Q Consensus       630 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  707 (767)
                      ... ........+|..|+|||.+.+..++.++|||||||++|||++ |+.||......+   +.    .....+      
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~----~~~~~~------  266 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VM----KAINDG------  266 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH----HHHHTT------
T ss_pred             ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HH----HHHHCC------
Confidence            211 111223346788999999999999999999999999999999 999996543221   11    111111      


Q ss_pred             cccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       708 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                         .+...+..++..+.+++.+||+.||.+||++.++++.|+.+++..
T Consensus       267 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          267 ---FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             ---CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             ---CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence               112234456778999999999999999999999999999988765

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.1e-40  Score=344.20  Aligned_cols=259  Identities=26%  Similarity=0.439  Sum_probs=212.6

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .++|...+.||+|+||.||+|...+ +..||||++.... ...+.+.+|++++++++||||+++++++. .+..++||||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   88 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY   88 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence            3578889999999999999999874 4689999997543 34567999999999999999999999986 4568999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++++|.+++.......+++.+++.++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++...... .
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  164 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-Y  164 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-E
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-c
Confidence            99999999996543346999999999999999999999   6789999999999999999999999999998654321 1


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      .......++..|+|||.+.+..++.++||||||++++||++ |+.||......+   +..    ....+         ..
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~----~~~~~---------~~  228 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQ----NLERG---------YR  228 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH----HHHTT---------CC
T ss_pred             ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---HHH----HHhcc---------cC
Confidence            12233457789999999998899999999999999999999 999986543221   111    11111         11


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      ...+..++.++.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence            1234456678999999999999999999999999999998765

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.3e-39  Score=359.26  Aligned_cols=251  Identities=25%  Similarity=0.357  Sum_probs=204.0

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~l  549 (767)
                      .++|+..++||+|+||+||+++.+.+++.||+|+++..   .......+.+|..+|.++ +||||+++++++.+.+.+++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            35799999999999999999999988899999998754   233345688999999887 89999999999999999999


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ||||+++|+|.+++.+.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       131 V~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            99999999999999654  35999999999999999999999   67899999999999999999999999999985322


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCcc--chhHHHHHHHHhhcCCccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKK--QVNLAVWATECYRNGKIGDII  707 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~  707 (767)
                        ........+||+.|+|||++.+..++.++|||||||++|||++|+.||......+  ................     
T Consensus       206 --~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-----  278 (396)
T 4dc2_A          206 --PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-----  278 (396)
T ss_dssp             --TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-----
T ss_pred             --CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-----
Confidence              1223445679999999999999999999999999999999999999996443211  1111111222222111     


Q ss_pred             cccccCCCChhhHHHHHHHHHHccccCCCCCCCH
Q 042216          708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSM  741 (767)
Q Consensus       708 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~  741 (767)
                           ...+...+.++.+++.+||+.||.+||++
T Consensus       279 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          279 -----IRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             -----cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                 12344567789999999999999999985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.8e-40  Score=381.64  Aligned_cols=259  Identities=28%  Similarity=0.449  Sum_probs=214.3

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .++|...+.||+|+||.||+|.+.++ ..||||+++... ...++|.+|+++|++++||||++++++|.+ +..++||||
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            45688888999999999999999754 679999997654 345689999999999999999999999976 678999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      |++|+|.++|.......+++.+++.++.|++.||.|||   +++|+||||||+|||+++++.+||+|||+++..... ..
T Consensus       343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~  418 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EY  418 (535)
T ss_dssp             CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH-HH
T ss_pred             hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC-ce
Confidence            99999999997544456899999999999999999999   678999999999999999999999999999864321 11


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      .......++..|+|||.+....++.++|||||||+||||++ |+.||......+   +.    ..+..+         .+
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---~~----~~i~~~---------~~  482 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VL----DQVERG---------YR  482 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---HH----HHHHTT---------CC
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcC---------CC
Confidence            11223456789999999999999999999999999999999 999996543321   11    111111         12


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      ...+..++..+.+|+.+||+.||++|||+.+|+++|+.+....
T Consensus       483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence            2345567788999999999999999999999999999887544

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.9e-39  Score=344.97  Aligned_cols=265  Identities=22%  Similarity=0.310  Sum_probs=202.2

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhc--cccceeeeEeeeeec----CCce
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQ--LRYLHLVSLIGYCND----DGQM  547 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~--l~Hpniv~l~g~~~~----~~~~  547 (767)
                      .++|...+.||+|+||+||+|+..  ++.||||++..   .....+..|.+++..  ++||||+++++++..    ....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEET--TEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEEC--CEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            468999999999999999999984  47899999863   234556667777666  799999999998754    3468


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhC-----CCCCeEecCCCCCCeEECCCCcEEEeecC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG-----ASKVIIHRDVKTTNILLDEEWVAKVSDFG  622 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiH~Dlk~~NILld~~~~~ki~DfG  622 (767)
                      ++||||+++|+|.++++.   ..+++..++.++.|++.||.|||..     ++++|+||||||+|||++.++.+||+|||
T Consensus        82 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  158 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG  158 (301)
T ss_dssp             EEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence            999999999999999943   3599999999999999999999942     25789999999999999999999999999


Q ss_pred             CcccCCCCCCc--cccccccCCCcccChhhhccC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCCCC
Q 042216          623 LCKFGPNFSKT--HVSTQVKGSIGYLDPEYYRLQ------LLTEKSDVYSFGVVLLEVLCA----------RPPILRTGD  684 (767)
Q Consensus       623 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~ksDV~SfGvvl~elltg----------~~P~~~~~~  684 (767)
                      +++........  .......||+.|+|||.+.+.      .++.++|||||||++|||++|          +.||.....
T Consensus       159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~  238 (301)
T 3q4u_A          159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP  238 (301)
T ss_dssp             TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence            99754322111  112334799999999999876      455799999999999999999          888855433


Q ss_pred             ccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          685 KKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       685 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                      .... ..................    ....+..++.++.+++.+||+.||.+|||+.||++.|+++
T Consensus       239 ~~~~-~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          239 NDPS-FEDMRKVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             SSCC-HHHHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcc-hhhhhHHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            2211 111111111111111110    0112235678899999999999999999999999999875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=8.5e-40  Score=346.20  Aligned_cols=261  Identities=30%  Similarity=0.519  Sum_probs=199.2

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      .++|...+.||+|+||+||+|+..+   .||||+++...  ....+.|.+|++++++++||||+++++++. .+..++||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~   98 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT   98 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEE
Confidence            4578889999999999999998754   59999997543  334567999999999999999999999764 55789999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++++|.+++.... ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        99 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A           99 QWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             EecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence            9999999999996543 46999999999999999999999   6789999999999999999999999999997544322


Q ss_pred             CccccccccCCCcccChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYR---LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      .........||+.|+|||.+.   ...++.++||||||+++|||++|+.||......+  .+...    ...+.....  
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~----~~~~~~~~~--  246 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEM----VGRGSLSPD--  246 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHH----HHHTSCCCC--
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHH----hcccccCcc--
Confidence            233334567999999999986   5678899999999999999999999996654322  11221    111111111  


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                        + ......++.++.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus       247 --~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          247 --L-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             --T-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             --h-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence              1 11234566789999999999999999999999999998764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.2e-39  Score=349.11  Aligned_cols=267  Identities=25%  Similarity=0.402  Sum_probs=205.4

Q ss_pred             HHHHhhccccceeeeccCcEEEEEEEecC---CCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecC
Q 042216          470 IKEATKDFNNLLIIGRGGFGNVYKGFLNG---DSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD  544 (767)
Q Consensus       470 i~~~t~~f~~~~~LG~G~fG~Vy~g~~~~---~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~  544 (767)
                      +....++|...+.||+|+||.||+|....   .+..||+|++....  ....+.+.+|+.++++++||||+++++++.+.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            33445688888999999999999998764   33579999987542  33456789999999999999999999999775


Q ss_pred             C-----ceEEEEecCCCCChhhhhcc----CCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCc
Q 042216          545 G-----QMILVYDYMARGTLRDHLYN----NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV  615 (767)
Q Consensus       545 ~-----~~~lV~ey~~~gsL~~~L~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~  615 (767)
                      +     ..++||||+++|+|.+++..    .....+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCc
Confidence            4     35999999999999999843    23456999999999999999999999   788999999999999999999


Q ss_pred             EEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHH
Q 042216          616 AKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWA  694 (767)
Q Consensus       616 ~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~  694 (767)
                      +||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+   .... 
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~-  261 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYDY-  261 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH-
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHH-
Confidence            99999999976533222222334557889999999999999999999999999999999 889986544322   1111 


Q ss_pred             HHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          695 TECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       695 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                         ...+.         ....+..++.++.+++.+||+.||.+|||+.++++.|+.+++.+
T Consensus       262 ---~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          262 ---LLHGH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             ---HHTTC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ---HHcCC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence               11111         11234456678999999999999999999999999999998765

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.5e-40  Score=352.40  Aligned_cols=273  Identities=24%  Similarity=0.389  Sum_probs=219.2

Q ss_pred             cCHHHHHHHhhccccceeeeccCcEEEEEEEec-----CCCceEEEEEeCCCCC-cchhHHHHHHHHHhcc-ccceeeeE
Q 042216          465 FSISEIKEATKDFNNLLIIGRGGFGNVYKGFLN-----GDSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQL-RYLHLVSL  537 (767)
Q Consensus       465 ~~~~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~Hpniv~l  537 (767)
                      +...+.....++|...+.||+|+||.||+|...     ..++.||||++..... ...+.+.+|++++.++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            344444455678999999999999999999853     3457899999976533 3445789999999999 79999999


Q ss_pred             eeeeecCC-ceEEEEecCCCCChhhhhccCCC--------------CCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecC
Q 042216          538 IGYCNDDG-QMILVYDYMARGTLRDHLYNNDN--------------PPLPWDRRLKICIGAARALHYLHTGASKVIIHRD  602 (767)
Q Consensus       538 ~g~~~~~~-~~~lV~ey~~~gsL~~~L~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~D  602 (767)
                      ++++...+ ..++||||+++|+|.+++.....              ..+++..++.++.|++.||.|||   +.+|+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence            99987654 58999999999999999976432              23899999999999999999999   67899999


Q ss_pred             CCCCCeEECCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 042216          603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILR  681 (767)
Q Consensus       603 lk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~  681 (767)
                      |||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999986543333233344567889999999999999999999999999999998 9999965


Q ss_pred             CCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          682 TGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       682 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      .....  .+..    ....+.         ....+..++.++.+++.+||+.||.+|||+.||++.|+.+++..
T Consensus       254 ~~~~~--~~~~----~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          254 VKIDE--EFCR----RLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             CCCSH--HHHH----HHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cchhH--HHHH----HhccCc---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            44321  1111    111111         11223445678999999999999999999999999999998754

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.3e-39  Score=346.56  Aligned_cols=265  Identities=23%  Similarity=0.394  Sum_probs=210.5

Q ss_pred             hccccceeeeccCcEEEEEEEe----cCCCceEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeeecC--Cce
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFL----NGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD--GQM  547 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~----~~~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~  547 (767)
                      +.|+..+.||+|+||.||++.+    ...++.||||++... .......+.+|++++++++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4588889999999999999983    456789999999754 334456799999999999999999999999876  678


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      ++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence            99999999999999996543 35899999999999999999999   678999999999999999999999999999865


Q ss_pred             CCCCCc-cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---------ccchhHHHHHHHH
Q 042216          628 PNFSKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGD---------KKQVNLAVWATEC  697 (767)
Q Consensus       628 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~---------~~~~~l~~~~~~~  697 (767)
                      ...... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.....         ......... ...
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~  255 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL-VNT  255 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH-HHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH-HHH
Confidence            432221 223345688889999999999999999999999999999999998632210         001111111 111


Q ss_pred             hhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          698 YRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       698 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                      ...         ......+..++.++.+++.+||+.||.+|||+.|+++.|+.+++
T Consensus       256 ~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          256 LKE---------GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             HHT---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             Hhc---------cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            111         11223455677889999999999999999999999999998763

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=8e-40  Score=342.58  Aligned_cols=253  Identities=29%  Similarity=0.472  Sum_probs=197.1

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC----CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS----QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~----~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      ++|...+.||+|+||.||+|.+.  ++.||||++....    ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            57888899999999999999986  4789999986542    23346789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC--------CCcEEEeecC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE--------EWVAKVSDFG  622 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~--------~~~~ki~DfG  622 (767)
                      |||+++++|.+++..   ..+++..++.++.|++.||.|||+.+..+|+||||||+|||++.        ++.+||+|||
T Consensus        85 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           85 MEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            999999999999853   36899999999999999999999433223999999999999986        7789999999


Q ss_pred             CcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC
Q 042216          623 LCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK  702 (767)
Q Consensus       623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~  702 (767)
                      +++.....    ......||+.|+|||.+.+..++.++||||||++++||++|+.||........      .......  
T Consensus       162 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~--  229 (271)
T 3dtc_A          162 LAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------AYGVAMN--  229 (271)
T ss_dssp             C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHHHHTS--
T ss_pred             cccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHhhhcC--
Confidence            99754321    12245689999999999999999999999999999999999999965432211      1111111  


Q ss_pred             ccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       703 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                             ......+..++..+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus       230 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          230 -------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             -------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             -------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                   122233456678899999999999999999999999999753

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-39  Score=359.03  Aligned_cols=253  Identities=18%  Similarity=0.255  Sum_probs=209.7

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .++|...+.||+|+||.||+|....+++.||+|++..........+.+|+++|.+++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            46799999999999999999999888899999999766555566799999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC--CCcEEEeecCCcccCCCCC
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE--EWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~--~~~~ki~DfGla~~~~~~~  631 (767)
                      +++|+|.+++.... ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.  ++.+||+|||+++..... 
T Consensus       130 ~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-  204 (387)
T 1kob_A          130 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-  204 (387)
T ss_dssp             CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred             CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence            99999999996542 36899999999999999999999   678999999999999974  578999999999865432 


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   ...   .. .....      ..
T Consensus       205 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~---~i-~~~~~------~~  269 (387)
T 1kob_A          205 --EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQ---NV-KRCDW------EF  269 (387)
T ss_dssp             --SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHH---HH-HHCCC------CC
T ss_pred             --cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH---HHH---HH-HhCCC------CC
Confidence              12234569999999999999999999999999999999999999996543221   111   11 11110      01


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ........+.++.+++.+||+.||.+|||+.|+++
T Consensus       270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            11122345678999999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-39  Score=340.14  Aligned_cols=256  Identities=27%  Similarity=0.467  Sum_probs=211.6

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      ++|...+.||+|+||.||++...+ ++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hheeeeeEecCCCceeEEEEEecC-CCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            578888999999999999999874 47899999976533 3467999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++|+|.+++.... ..+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++..... ...
T Consensus        86 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~  160 (267)
T 3t9t_A           86 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYT  160 (267)
T ss_dssp             TTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHH
T ss_pred             CCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccc-ccc
Confidence            9999999997543 46899999999999999999999   678999999999999999999999999998754321 111


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      ......++..|+|||.+....++.++||||||+++|||++ |+.||......+   .   ... ...+         ...
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~---~~~-i~~~---------~~~  224 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---V---VED-ISTG---------FRL  224 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H---HHH-HHTT---------CCC
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---H---HHH-HhcC---------CcC
Confidence            2233457788999999999999999999999999999999 899986543211   1   111 1111         111


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                      ..+...+..+.+++.+||+.||.+||++.++++.|+.+.+
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            2234456789999999999999999999999999998865

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=346.00  Aligned_cols=249  Identities=20%  Similarity=0.314  Sum_probs=198.5

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--------------------------cchhHHHHHHHHHhc
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--------------------------QGALEFQTEIGMLSQ  528 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--------------------------~~~~~f~~Ei~~l~~  528 (767)
                      ++|...+.||+|+||.||+|+...+++.||||++.....                          ...+++.+|++++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            578899999999999999999988889999999865421                          123568999999999


Q ss_pred             cccceeeeEeeeeec--CCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCC
Q 042216          529 LRYLHLVSLIGYCND--DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTT  606 (767)
Q Consensus       529 l~Hpniv~l~g~~~~--~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~  606 (767)
                      ++||||+++++++.+  .+..++||||+++|+|.+++..   ..+++.++..++.|++.||.|||   +.+|+||||||+
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~  166 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS  166 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence            999999999999986  5688999999999999987632   46999999999999999999999   678999999999


Q ss_pred             CeEECCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 042216          607 NILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL---LTEKSDVYSFGVVLLEVLCARPPILRTG  683 (767)
Q Consensus       607 NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDV~SfGvvl~elltg~~P~~~~~  683 (767)
                      |||++.++.+||+|||+++.....  ........||+.|+|||.+.+..   .+.++|||||||++|||++|+.||....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            999999999999999999865332  12234457999999999998655   4788999999999999999999996432


Q ss_pred             CccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          684 DKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       684 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ..      .+... .....        +........+.++.+++.+||+.||.+|||+.|+++
T Consensus       245 ~~------~~~~~-~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          245 IM------CLHSK-IKSQA--------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HH------HHHHH-HHHCC--------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HH------HHHHH-Hhccc--------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            21      11111 11111        111112345677999999999999999999999874

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-39  Score=378.66  Aligned_cols=261  Identities=25%  Similarity=0.398  Sum_probs=209.3

Q ss_pred             ccccce-eeeccCcEEEEEEEec--CCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          476 DFNNLL-IIGRGGFGNVYKGFLN--GDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       476 ~f~~~~-~LG~G~fG~Vy~g~~~--~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++.... .||+|+||.||+|.+.  +++..||||+++... ....++|.+|+++|++++||||++++++|.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            333333 6999999999999875  344679999998653 3456789999999999999999999999976 5799999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|+|.++|... ...+++.+++.++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++......
T Consensus       415 E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             ECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred             EeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence            999999999999654 346999999999999999999999   6789999999999999999999999999998653322


Q ss_pred             Cc-cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          632 KT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       632 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                      .. .......+++.|+|||++....++.++|||||||+||||++ |+.||......+   +.    ..+..+        
T Consensus       491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~----~~i~~~--------  555 (613)
T 2ozo_A          491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM----AFIEQG--------  555 (613)
T ss_dssp             -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HH----HHHHTT--------
T ss_pred             ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcC--------
Confidence            11 11223346789999999999999999999999999999998 999997654432   11    111222        


Q ss_pred             cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhc
Q 042216          710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRE  757 (767)
Q Consensus       710 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~  757 (767)
                       .+...+..++.++.+++.+||+.||.+||++.+|++.|+.+......
T Consensus       556 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~  602 (613)
T 2ozo_A          556 -KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  602 (613)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred             -CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence             12234566788999999999999999999999999999998876643

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.1e-40  Score=359.30  Aligned_cols=273  Identities=17%  Similarity=0.200  Sum_probs=210.9

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCC-----CceEEEEEeCCCCCcc-----------hhHHHHHHHHHhccccceeee
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGD-----STPVAIKRLNPGSQQG-----------ALEFQTEIGMLSQLRYLHLVS  536 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~-----~~~vAVK~l~~~~~~~-----------~~~f~~Ei~~l~~l~Hpniv~  536 (767)
                      ..++|...+.||+|+||.||+|.+..+     ++.||||++.......           ...+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            346899999999999999999998764     4789999987553211           112345566677788999999


Q ss_pred             EeeeeecC----CceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC-
Q 042216          537 LIGYCNDD----GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD-  611 (767)
Q Consensus       537 l~g~~~~~----~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld-  611 (767)
                      +++++...    ...+|||||+ +|+|.+++... ...+++.+++.++.|++.||.|||   +.+|+||||||+|||++ 
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEES
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEec
Confidence            99998764    4589999999 99999999764 346999999999999999999999   67899999999999999 


Q ss_pred             -CCCcEEEeecCCcccCCCCCCc-----cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc
Q 042216          612 -EEWVAKVSDFGLCKFGPNFSKT-----HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDK  685 (767)
Q Consensus       612 -~~~~~ki~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~  685 (767)
                       .++.+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             8999999999999764321111     1123445999999999999999999999999999999999999999753322


Q ss_pred             cchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 042216          686 KQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLR  756 (767)
Q Consensus       686 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  756 (767)
                      .  ....+...... ..+.+++++.+.   ...++.++.+++..||+.||.+||++.+|++.|+.+++...
T Consensus       268 ~--~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  332 (364)
T 3op5_A          268 P--KYVRDSKIRYR-ENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG  332 (364)
T ss_dssp             H--HHHHHHHHHHH-HCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             H--HHHHHHHHHhh-hhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            1  11221221111 123333333332   13446788999999999999999999999999999987664

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-39  Score=349.18  Aligned_cols=245  Identities=27%  Similarity=0.372  Sum_probs=207.0

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|+..+.||+|+||+||+++...+++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            5789999999999999999999888899999998643   1234556789999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....  
T Consensus        86 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--  158 (318)
T 1fot_A           86 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--  158 (318)
T ss_dssp             CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred             eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence            999999999999754  35899999999999999999999   78899999999999999999999999999986432  


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                         .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+      ....... +.         
T Consensus       159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~i~~-~~---------  219 (318)
T 1fot_A          159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKILN-AE---------  219 (318)
T ss_dssp             ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHH-CC---------
T ss_pred             ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-CC---------
Confidence               2234579999999999999999999999999999999999999996543211      1111111 11         


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRP-----SMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~  746 (767)
                       ...+...+.++.+++.+||+.||.+||     +++|+++
T Consensus       220 -~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          220 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence             113445567899999999999999999     8888873

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.5e-40  Score=357.41  Aligned_cols=268  Identities=24%  Similarity=0.416  Sum_probs=216.3

Q ss_pred             HHHHHHHhhccccceeeeccCcEEEEEEEecC-----CCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeee
Q 042216          467 ISEIKEATKDFNNLLIIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGY  540 (767)
Q Consensus       467 ~~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~  540 (767)
                      .++.....++|...+.||+|+||.||+|...+     .++.||||++.... .....++.+|++++++++||||++++++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            34444566789999999999999999998762     35789999997543 2344568999999999999999999999


Q ss_pred             eecCCceEEEEecCCCCChhhhhccCC--------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC
Q 042216          541 CNDDGQMILVYDYMARGTLRDHLYNND--------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE  612 (767)
Q Consensus       541 ~~~~~~~~lV~ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~  612 (767)
                      +.+.+..++||||+++|+|.+++....        ...+++..++.++.|++.||.|||   +.+|+||||||+|||++.
T Consensus        97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~  173 (322)
T 1p4o_A           97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAE  173 (322)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECT
T ss_pred             EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcC
Confidence            999999999999999999999996421        245799999999999999999999   678999999999999999


Q ss_pred             CCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHH
Q 042216          613 EWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLA  691 (767)
Q Consensus       613 ~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~  691 (767)
                      ++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......   ..
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~  250 (322)
T 1p4o_A          174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VL  250 (322)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---HH
T ss_pred             CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH---HH
Confidence            99999999999875432222222233457889999999999999999999999999999999 889986543221   11


Q ss_pred             HHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          692 VWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       692 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                      .    ....+..         ...+..++..+.+++.+||+.||.+|||+.|+++.|+.+++
T Consensus       251 ~----~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          251 R----FVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             H----HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             H----HHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            1    1111111         12244567789999999999999999999999999987754

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.5e-39  Score=355.77  Aligned_cols=254  Identities=19%  Similarity=0.269  Sum_probs=207.8

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      ..++|...+.||+|+||.||++..+.+++.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4578999999999999999999998888999999997543  23446789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCC---CcEEEeecCCcccC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEE---WVAKVSDFGLCKFG  627 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~---~~~ki~DfGla~~~  627 (767)
                      |||+++|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.+   +.+||+|||+++..
T Consensus       107 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             ECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            9999999999999543  46899999999999999999999   6789999999999999865   45999999999865


Q ss_pred             CCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccc
Q 042216          628 PNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDII  707 (767)
Q Consensus       628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  707 (767)
                      ...   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+..    ....+...   
T Consensus       182 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~----~i~~~~~~---  248 (362)
T 2bdw_A          182 NDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYA----QIKAGAYD---  248 (362)
T ss_dssp             TTC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHTCCC---
T ss_pred             cCC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHH----HHHhCCCC---
Confidence            422   1223467999999999999999999999999999999999999999654321   1111    11111110   


Q ss_pred             cccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       708 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                         .........+.++.+++.+||+.||.+||++.|+++.
T Consensus       249 ---~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          249 ---YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ---CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ---CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               0001112456778999999999999999999999853

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-39  Score=358.03  Aligned_cols=262  Identities=29%  Similarity=0.463  Sum_probs=202.0

Q ss_pred             ccccceeeeccCcEEEEEEEecCC---CceEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeeec-CCceEEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGD---STPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCND-DGQMILV  550 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~---~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~-~~~~~lV  550 (767)
                      .|...+.||+|+||+||+|++...   ...||||.+... .....++|.+|+.++++++||||++++++|.+ ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            456677899999999999987533   246899998654 33455679999999999999999999999754 5688999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+++|+|.+++.... ..+++.+++.++.|+++||.|||   +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus       170 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            99999999999996543 45899999999999999999999   678999999999999999999999999999854322


Q ss_pred             CC--ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccc
Q 042216          631 SK--THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDII  707 (767)
Q Consensus       631 ~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  707 (767)
                      ..  ........+|+.|+|||.+.+..++.++|||||||++|||++ |.+||......+   ....    ...+.     
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~----~~~~~-----  313 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY----LLQGR-----  313 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHH----HHTTC-----
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHH----HHcCC-----
Confidence            11  112233457889999999999999999999999999999999 677775544322   1111    11111     


Q ss_pred             cccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhc
Q 042216          708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRE  757 (767)
Q Consensus       708 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~  757 (767)
                          ....+..++..+.+++.+||+.||.+|||+.|+++.|+.++..+..
T Consensus       314 ----~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~  359 (373)
T 3c1x_A          314 ----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  359 (373)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence                1122445677899999999999999999999999999999877643

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.2e-40  Score=350.28  Aligned_cols=253  Identities=25%  Similarity=0.348  Sum_probs=205.8

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCC-------ceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCc
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDS-------TPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQ  546 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~-------~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~  546 (767)
                      .++|...+.||+|+||+||+|.....+       ..||+|++........+.+.+|++++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            357888899999999999999987654       4699999976666667789999999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCc--------EEE
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV--------AKV  618 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~--------~ki  618 (767)
                      .++||||+++|+|.+++.... ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.        +||
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeee
Confidence            999999999999999997643 34899999999999999999999   678999999999999998887        999


Q ss_pred             eecCCcccCCCCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHH
Q 042216          619 SDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATEC  697 (767)
Q Consensus       619 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~  697 (767)
                      +|||+++....      .....++..|+|||.+.+ ..++.++|||||||++|||++|..|+.......  ....    .
T Consensus       163 ~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~--~~~~----~  230 (289)
T 4fvq_A          163 SDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--RKLQ----F  230 (289)
T ss_dssp             CCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHH----H
T ss_pred             ccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH--HHHH----H
Confidence            99999874321      123457889999999987 779999999999999999999655443322211  1111    0


Q ss_pred             hhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          698 YRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       698 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                      ...           ....+...+.++.+++.+||+.||.+|||+.|+++.|+.++.
T Consensus       231 ~~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          231 YED-----------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HHT-----------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             hhc-----------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            111           011122334568899999999999999999999999998764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-40  Score=352.17  Aligned_cols=252  Identities=16%  Similarity=0.227  Sum_probs=207.3

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .++|...+.||+|+||.||++....+++.+|+|.+... ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            46788999999999999999999988899999998744 33455688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC--CCcEEEeecCCcccCCCCC
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE--EWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~--~~~~ki~DfGla~~~~~~~  631 (767)
                      +++|+|.+++.... ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.  ++.+||+|||+++..... 
T Consensus        83 ~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-  157 (321)
T 1tki_A           83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-  157 (321)
T ss_dssp             CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred             CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence            99999999996532 36999999999999999999999   678999999999999987  789999999999865432 


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   ..   ..... +...  .+.  
T Consensus       158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---~~i~~-~~~~--~~~--  224 (321)
T 1tki_A          158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---II---ENIMN-AEYT--FDE--  224 (321)
T ss_dssp             --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHHH-TCCC--CCH--
T ss_pred             --CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---HH---HHHHc-CCCC--CCh--
Confidence              22344568999999999998889999999999999999999999996543321   11   11111 1100  000  


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                        ......+.++.+++.+||+.||.+|||+.|+++
T Consensus       225 --~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          225 --EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             --HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              001234567899999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.6e-39  Score=340.52  Aligned_cols=271  Identities=19%  Similarity=0.181  Sum_probs=214.2

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeee-ecCCceEEEEe
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC-NDDGQMILVYD  552 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~-~~~~~~~lV~e  552 (767)
                      .++|...+.||+|+||.||+|+...+++.||||++....  ...++.+|++++..++|++++..+.++ .+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            467899999999999999999998888999999986543  234689999999999998877766666 55677899999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE---CCCCcEEEeecCCcccCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl---d~~~~~ki~DfGla~~~~~  629 (767)
                      |+ +++|.+++.... ..+++.+++.++.|++.||.|||   +++|+||||||+|||+   +.++.+||+|||+++....
T Consensus        86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             ec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            99 899999996443 46999999999999999999999   6789999999999999   4888999999999986543


Q ss_pred             CCCc-----cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc
Q 042216          630 FSKT-----HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG  704 (767)
Q Consensus       630 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  704 (767)
                      ....     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........................
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  240 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred             cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence            2221     11234579999999999999999999999999999999999999997654332222222111111110000


Q ss_pred             ccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhcccc
Q 042216          705 DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSE  760 (767)
Q Consensus       705 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~  760 (767)
                           .    ....++.++.+++.+||+.||.+|||+++|++.|+.+.+......+
T Consensus       241 -----~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~  287 (296)
T 3uzp_A          241 -----V----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD  287 (296)
T ss_dssp             -----H----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSS
T ss_pred             -----H----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccc
Confidence                 0    1123456799999999999999999999999999999887754333

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.6e-39  Score=341.79  Aligned_cols=269  Identities=19%  Similarity=0.179  Sum_probs=210.4

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeee-ecCCceEEEE
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYC-NDDGQMILVY  551 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~-~~~~~~~lV~  551 (767)
                      ..++|...+.||+|+||+||+|+....++.||||++....  ...++.+|++++..++|++++..+.++ .+.+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            4578999999999999999999998888999999875432  234688999999999988877777766 5667889999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE---CCCCcEEEeecCCcccCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl---d~~~~~ki~DfGla~~~~  628 (767)
                      ||+ +|+|.+++.... ..+++.+++.++.|++.||.|||   +.+|+||||||+|||+   ++++.+||+|||+++...
T Consensus        85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             ECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             Ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            999 899999997543 35999999999999999999999   6789999999999999   789999999999998654


Q ss_pred             CCCCc-----cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCc
Q 042216          629 NFSKT-----HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKI  703 (767)
Q Consensus       629 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~  703 (767)
                      .....     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........................
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence            32221     1223457899999999999999999999999999999999999999765443322222211111111000


Q ss_pred             cccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhc
Q 042216          704 GDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRE  757 (767)
Q Consensus       704 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~  757 (767)
                      .     .    ....++.++.+++.+||+.||.+|||+++|++.|+.+.+....
T Consensus       240 ~-----~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~  284 (296)
T 4hgt_A          240 E-----V----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             H-----H----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             h-----h----hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence            0     0    0123456799999999999999999999999999999877643

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.7e-40  Score=359.03  Aligned_cols=250  Identities=24%  Similarity=0.345  Sum_probs=202.9

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceE
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMI  548 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~  548 (767)
                      ..++|+..++||+|+||+||+++.+.+++.||||+++..   .......+.+|.+++..+ +||||+++++++.+.+.++
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            346899999999999999999999988899999998643   223345678999999988 6999999999999999999


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      +||||+++|+|.+++.+.  ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       101 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            999999999999999654  35899999999999999999999   6789999999999999999999999999998532


Q ss_pred             CCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          629 NFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      .  ........+||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +.   ... ..+.      
T Consensus       176 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~---~~i-~~~~------  240 (353)
T 3txo_A          176 C--NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---LF---EAI-LNDE------  240 (353)
T ss_dssp             C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHH-HHCC------
T ss_pred             c--CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH---HH---HHH-HcCC------
Confidence            2  1223345679999999999999899999999999999999999999996543321   11   111 1111      


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSM------SDVVW  746 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~------~evl~  746 (767)
                          ...+...+..+.+++.+||+.||.+||++      .|+++
T Consensus       241 ----~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          241 ----VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             ----CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                12344456778999999999999999998      67763

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=357.64  Aligned_cols=250  Identities=26%  Similarity=0.328  Sum_probs=207.6

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|...+.||+|+||.||++....+++.||+|++...   .....+.+.+|+++|+.++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            5799999999999999999999988899999998643   2334567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+.+|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        95 e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-  168 (384)
T ss_dssp             CCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred             ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence            999999999999653  45999999999999999999999   778999999999999999999999999999865332 


Q ss_pred             CccccccccCCCcccChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRL---QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                        .......||+.|+|||++..   ..++.++|||||||++|||++|+.||..........+.....    ..       
T Consensus       169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~----~~-------  235 (384)
T 4fr4_A          169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE----TT-------  235 (384)
T ss_dssp             --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH----HC-------
T ss_pred             --CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----hc-------
Confidence              23345679999999999874   458999999999999999999999996544332222211111    10       


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPS-MSDVVW  746 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs-~~evl~  746 (767)
                         ....+...+..+.+++.+||+.||.+||+ +++|++
T Consensus       236 ---~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 ---VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ---ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence               11234556778999999999999999998 677653

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.6e-39  Score=342.39  Aligned_cols=261  Identities=25%  Similarity=0.397  Sum_probs=210.0

Q ss_pred             hhccccceeeeccCcEEEEEEEecCC---CceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGD---STPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      .++|...+.||+|+||.||+|.....   +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            46788999999999999999987543   3469999997653 3345679999999999999999999999865 46789


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ||||+++++|.+++.... ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        90 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             EEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             EEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            999999999999996543 45899999999999999999999   67899999999999999999999999999986433


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      .. ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.   ....    ..+.      
T Consensus       166 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~~~----~~~~------  231 (281)
T 3cc6_A          166 ED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IGVL----EKGD------  231 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HHHH----HHTC------
T ss_pred             cc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HHHH----hcCC------
Confidence            21 112234457889999999999999999999999999999998 9999965443321   1111    1111      


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLR  756 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  756 (767)
                         ....+..++..+.+++.+||+.||.+||++.|+++.|+.+.+...
T Consensus       232 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  276 (281)
T 3cc6_A          232 ---RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK  276 (281)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence               112234456789999999999999999999999999999987653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=355.74  Aligned_cols=246  Identities=23%  Similarity=0.295  Sum_probs=196.0

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--cchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--QGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      .++|+..++||+|+||+||+|....+++.||||++.....  ....++..|+..+.++ +||||++++++|.+++..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            3679999999999999999999998889999999865432  2333456666666555 899999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+ +++|.+++.... ..++|..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       136 ~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             EECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             Eecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            9999 669999886543 46999999999999999999999   678999999999999999999999999998764322


Q ss_pred             CCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                         .......||+.|+|||++.+ .++.++|||||||++|||++|..|+.....        |  ..+..+..    .+ 
T Consensus       211 ---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--------~--~~~~~~~~----~~-  271 (311)
T 3p1a_A          211 ---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--------W--QQLRQGYL----PP-  271 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--------H--HHHTTTCC----CH-
T ss_pred             ---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------H--HHHhccCC----Cc-
Confidence               22344569999999999875 789999999999999999999776633211        1  11111111    01 


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                         ..+...+.++.+++.+||+.||.+|||+.|+++
T Consensus       272 ---~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          272 ---EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence               112234677999999999999999999999985

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.7e-39  Score=362.51  Aligned_cols=254  Identities=18%  Similarity=0.255  Sum_probs=207.4

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      ..++|...+.||+|+||.||++....+++.+|+|++....  ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            4678999999999999999999998888999999987543  23345689999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC---CCCcEEEeecCCcccC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAKVSDFGLCKFG  627 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld---~~~~~ki~DfGla~~~  627 (767)
                      |||+++|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++   +++.+||+|||+++..
T Consensus        89 ~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           89 FDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             ECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            9999999999999664  35999999999999999999999   67899999999999998   5678999999999765


Q ss_pred             CCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccc
Q 042216          628 PNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDII  707 (767)
Q Consensus       628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  707 (767)
                      ...  ........||+.|+|||++.+..++.++|||||||++|||++|++||......+   +..    ....+...   
T Consensus       164 ~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~---~~~----~i~~~~~~---  231 (444)
T 3soa_A          164 EGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR---LYQ----QIKAGAYD---  231 (444)
T ss_dssp             CTT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH----HHHHTCCC---
T ss_pred             cCC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH---HHH----HHHhCCCC---
Confidence            432  122344679999999999999999999999999999999999999996543221   111    11111110   


Q ss_pred             cccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       708 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                         .........+.++.+++.+||+.||.+|||+.|+++
T Consensus       232 ---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          232 ---FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             ---CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence               011112345678899999999999999999999985

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.2e-40  Score=364.34  Aligned_cols=260  Identities=23%  Similarity=0.283  Sum_probs=209.8

Q ss_pred             HHHHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecC
Q 042216          468 SEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD  544 (767)
Q Consensus       468 ~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~  544 (767)
                      .+++...++|...++||+|+||+||+|+.+.+++.||+|++...   .......+.+|+.++..++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            34445567999999999999999999999988899999998642   122344588999999999999999999999999


Q ss_pred             CceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCc
Q 042216          545 GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC  624 (767)
Q Consensus       545 ~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla  624 (767)
                      +.+++||||+++|+|.+++.+.   .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEecccee
Confidence            9999999999999999999653   4899999999999999999999   678999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCCcccChhhhccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhc
Q 042216          625 KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQL----LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRN  700 (767)
Q Consensus       625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~  700 (767)
                      +...... .......+||+.|+|||++....    ++.++|||||||+||||++|+.||......+.  .........  
T Consensus       216 ~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~~~i~~~~~--  290 (410)
T 3v8s_A          216 MKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT--YSKIMNHKN--  290 (410)
T ss_dssp             EECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHTHHH--
T ss_pred             EeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH--HHHHHhccc--
Confidence            8654321 12233567999999999998765    78999999999999999999999965433211  111111000  


Q ss_pred             CCccccccccccCCCChhhHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 042216          701 GKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIR--RPSMSDVVWG  747 (767)
Q Consensus       701 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~--RPs~~evl~~  747 (767)
                               .+........+.++.+++.+||+.+|.+  ||+++||++.
T Consensus       291 ---------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          291 ---------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             ---------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             ---------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence                     0111112245677899999999999988  9999999853

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-39  Score=341.79  Aligned_cols=262  Identities=26%  Similarity=0.386  Sum_probs=208.8

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCc---eEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecCCce-EEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDST---PVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQM-ILV  550 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~---~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~-~lV  550 (767)
                      .|...++||+|+||+||+|.+.+++.   .+|+|.+..... ...+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45556789999999999999754433   799999975433 3456789999999999999999999999876655 999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      +||+.+|+|.+++... ...+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       102 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             ECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             EecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            9999999999999653 346899999999999999999999   678999999999999999999999999999754322


Q ss_pred             C--CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          631 S--KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       631 ~--~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      .  .........++..|+|||.+.+..++.++|||||||++|||++|..|+......  ..+....    ..+.      
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~~----~~~~------  245 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHFL----AQGR------  245 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHHH----HTTC------
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHHh----hcCC------
Confidence            1  111223456788999999999999999999999999999999966554332221  1111111    1111      


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLR  756 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  756 (767)
                         ....+..++..+.+++.+||+.||.+|||+.++++.|+.+++.+.
T Consensus       246 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          246 ---RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             ---CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence               112344566789999999999999999999999999999987663

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.1e-39  Score=351.72  Aligned_cols=260  Identities=27%  Similarity=0.465  Sum_probs=211.0

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceE--EEEEeCCC-CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPV--AIKRLNPG-SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~v--AVK~l~~~-~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      ++|...+.||+|+||.||+|....++..+  |+|++... .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57888999999999999999987766644  99988753 334556799999999999 899999999999999999999


Q ss_pred             EecCCCCChhhhhccCC--------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcE
Q 042216          551 YDYMARGTLRDHLYNND--------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVA  616 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~  616 (767)
                      |||+++|+|.+++....              ...+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence            99999999999997543              346999999999999999999999   7889999999999999999999


Q ss_pred             EEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHH
Q 042216          617 KVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWAT  695 (767)
Q Consensus       617 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~  695 (767)
                      ||+|||+++....   ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+      .. 
T Consensus       182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~-  251 (327)
T 1fvr_A          182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LY-  251 (327)
T ss_dssp             EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HH-
T ss_pred             EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH------HH-
Confidence            9999999874221   112233457889999999998899999999999999999998 999996543211      11 


Q ss_pred             HHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 042216          696 ECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLR  756 (767)
Q Consensus       696 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  756 (767)
                      .....+         .....+..++.++.+++.+||+.||.+|||+.|+++.|+.+++...
T Consensus       252 ~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          252 EKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             HHGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             HHhhcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence            111111         1222344567789999999999999999999999999999887653

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-39  Score=341.56  Aligned_cols=261  Identities=25%  Similarity=0.409  Sum_probs=212.4

Q ss_pred             hccccce-eeeccCcEEEEEEEec--CCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          475 KDFNNLL-IIGRGGFGNVYKGFLN--GDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       475 ~~f~~~~-~LG~G~fG~Vy~g~~~--~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      ++|.... .||+|+||.||+|...  +.+..||||++.... ....+++.+|++++++++||||+++++++ +.+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4566665 8999999999999864  345789999997653 33456799999999999999999999999 45679999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+++|+|.+++... ...+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            9999999999999643 346999999999999999999999   678999999999999999999999999999865432


Q ss_pred             CCc-cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          631 SKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       631 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      ... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+   +..    ....+.      
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~----~i~~~~------  230 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMA----FIEQGK------  230 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHH----HHHTTC------
T ss_pred             cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHH----HHhcCC------
Confidence            221 11233456889999999998899999999999999999998 999996554321   111    111111      


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLR  756 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  756 (767)
                         ....+..++.++.+++.+||+.||.+||++.++++.|+.+.....
T Consensus       231 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  275 (287)
T 1u59_A          231 ---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  275 (287)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ---cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence               123345677889999999999999999999999999999987664

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.5e-39  Score=346.52  Aligned_cols=262  Identities=21%  Similarity=0.279  Sum_probs=202.4

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      .++|+..+.||+|+||+||+|+... ++.||+|++.....  .....+.+|++++++++||||+++++++.+++..++||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            4689999999999999999999864 68999999975432  23457889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++ +|.+++.... ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        99 e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-  172 (311)
T 3niz_A           99 EFMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP-  172 (311)
T ss_dssp             ECCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC-
T ss_pred             cCCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCC-
Confidence            99985 8888886543 45999999999999999999999   678999999999999999999999999999864321 


Q ss_pred             CccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccc-----
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD-----  705 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~-----  705 (767)
                       ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+..  .. ............     
T Consensus       173 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~-i~~~~~~~~~~~~~~~~  248 (311)
T 3niz_A          173 -VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL--PK-IFSILGTPNPREWPQVQ  248 (311)
T ss_dssp             -CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH--HH-HHHHHCCCCTTTSGGGT
T ss_pred             -cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH--HH-HHHHHCCCChHHhhhhh
Confidence             122334568999999999876 56899999999999999999999999765543322  11 111111110000     


Q ss_pred             -----------cccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          706 -----------IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       706 -----------~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                                 ..+........+..+.++.+++.+||+.||.+|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                       00000000011234567899999999999999999999985

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5.1e-40  Score=346.22  Aligned_cols=254  Identities=24%  Similarity=0.374  Sum_probs=209.5

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeec---------
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCND---------  543 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~---------  543 (767)
                      ...+|...+.||+|+||.||+|....+++.||+|++....    ..+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4567999999999999999999998778999999997543    357889999999999999999998854         


Q ss_pred             -------CCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcE
Q 042216          544 -------DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVA  616 (767)
Q Consensus       544 -------~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~  616 (767)
                             ....++||||+++|+|.+++.......+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCE
Confidence                   445899999999999999997655567999999999999999999999   6789999999999999999999


Q ss_pred             EEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHH
Q 042216          617 KVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATE  696 (767)
Q Consensus       617 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~  696 (767)
                      ||+|||+++......   ......|++.|+|||.+.+..++.++||||||+++|||++|..|+...        ... ..
T Consensus       162 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~-~~  229 (284)
T 2a19_B          162 KIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKF-FT  229 (284)
T ss_dssp             EECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHH-HH
T ss_pred             EECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHH-HH
Confidence            999999988654321   223456899999999999999999999999999999999999886321        111 11


Q ss_pred             HhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhc
Q 042216          697 CYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRE  757 (767)
Q Consensus       697 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~  757 (767)
                      ....+.            .+...+..+.+++.+||+.||.+|||+.|+++.|+.+....+.
T Consensus       230 ~~~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~  278 (284)
T 2a19_B          230 DLRDGI------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK  278 (284)
T ss_dssp             HHHTTC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred             Hhhccc------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence            111111            2233456788999999999999999999999999988776644

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-40  Score=356.54  Aligned_cols=268  Identities=27%  Similarity=0.420  Sum_probs=214.8

Q ss_pred             hccccceeeeccCcEEEEEEEe----cCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCC--ceE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFL----NGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG--QMI  548 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~----~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~--~~~  548 (767)
                      ++|...+.||+|+||.||++..    ...++.||||++........+.+.+|++++++++||||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            5688889999999999999984    4467899999998776666778999999999999999999999987654  789


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      +||||+++|+|.+++.... ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       121 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            9999999999999997653 35899999999999999999999   6789999999999999999999999999998654


Q ss_pred             CCCCc-cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCc--------cc-hhHHHHHHHHh
Q 042216          629 NFSKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDK--------KQ-VNLAVWATECY  698 (767)
Q Consensus       629 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~--------~~-~~l~~~~~~~~  698 (767)
                      ..... .......++..|+|||.+.+..++.++|||||||++|||++|+.|+......        .. ...........
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL  276 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence            32221 1123345778899999999888999999999999999999999987432100        00 00111111111


Q ss_pred             hcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       699 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      ..         ......+..++.++.+++.+||+.||.+|||+.||++.|+.+.+.+
T Consensus       277 ~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          277 KN---------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             HT---------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hc---------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            11         1122335567788999999999999999999999999999987655

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.8e-39  Score=343.90  Aligned_cols=261  Identities=25%  Similarity=0.368  Sum_probs=210.2

Q ss_pred             hhccccce-eeeccCcEEEEEEEe--cCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceE
Q 042216          474 TKDFNNLL-IIGRGGFGNVYKGFL--NGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMI  548 (767)
Q Consensus       474 t~~f~~~~-~LG~G~fG~Vy~g~~--~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~  548 (767)
                      .++|...+ .||+|+||.||+|..  ...++.||||++....  ....+++.+|+++++.++||||+++++++ +.+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            35677777 899999999999954  4456789999997543  22356799999999999999999999999 567889


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      +||||+++++|.+++...  ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        94 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            999999999999999764  35899999999999999999999   6789999999999999999999999999998654


Q ss_pred             CCCCc-cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccc
Q 042216          629 NFSKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDI  706 (767)
Q Consensus       629 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  706 (767)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+   +.    .....+.    
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~----~~~~~~~----  237 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VT----AMLEKGE----  237 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HH----HHHHTTC----
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH----HHHHcCC----
Confidence            32221 11223446788999999998889999999999999999999 999996543321   11    1111111    


Q ss_pred             ccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 042216          707 IDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLR  756 (767)
Q Consensus       707 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  756 (767)
                           ....+..++..+.+++.+||+.||.+||++.+|++.|+.++....
T Consensus       238 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          238 -----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence                 122345667889999999999999999999999999999987664

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.3e-39  Score=349.78  Aligned_cols=264  Identities=19%  Similarity=0.294  Sum_probs=193.0

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      .++|...+.||+|+||.||+|....+++.||+|++.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            457888899999999999999998888999999987543 3344678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccC----CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          553 YMARGTLRDHLYNN----DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       553 y~~~gsL~~~L~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      |++ |+|.+++...    ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 5999988542    2245899999999999999999999   6789999999999999999999999999998643


Q ss_pred             CCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcC---Ccc
Q 042216          629 NFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG---KIG  704 (767)
Q Consensus       629 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~---~~~  704 (767)
                      ...  .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+...   .........   ...
T Consensus       160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLK---LIFDIMGTPNESLWP  234 (317)
T ss_dssp             SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCSCCTTTCG
T ss_pred             CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCChhHhh
Confidence            211  12234568999999999976 468999999999999999999999997654332211   111111100   000


Q ss_pred             cc-----cccc------------ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          705 DI-----IDPF------------LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       705 ~~-----~d~~------------l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .+     ..+.            +....+...+.++.+++.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            00     0000            011111234567899999999999999999999975

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.5e-39  Score=343.11  Aligned_cols=263  Identities=19%  Similarity=0.248  Sum_probs=203.8

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ++|+..+.||+|+||+||+|....+++.||||++....  ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46888999999999999999998888999999987543  2334678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+++ +|.+++... ...+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus        82 ~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--  154 (292)
T ss_dssp             CCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC--
T ss_pred             cCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc--
Confidence            9986 666666443 346999999999999999999999   678999999999999999999999999999865321  


Q ss_pred             ccccccccCCCcccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc------c
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQL-LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG------D  705 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~------~  705 (767)
                      ........||+.|+|||.+.+.. ++.++|||||||++|||++|..|+....... ..+.. ...........      +
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~-~~~~~-i~~~~~~~~~~~~~~~~~  232 (292)
T 3o0g_A          155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKR-IFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-HHHHH-HHHHHCCCCTTTCTTGGG
T ss_pred             cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH-HHHHH-HHHHhCCCChhhhhhhcc
Confidence            22234456899999999997765 8999999999999999999888864433221 11111 11111110000      0


Q ss_pred             ccc---------ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          706 IID---------PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       706 ~~d---------~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ..+         ........+..+.++.+++.+||+.||.+|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            000         00011122345678899999999999999999999975

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.6e-39  Score=351.38  Aligned_cols=250  Identities=26%  Similarity=0.353  Sum_probs=203.5

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      ++|...+.||+|+||.||+++.+.+++.||+|++....   ......+.+|..++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            57899999999999999999999888999999997542   22345688999999988 899999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+++|+|.+++.+.  ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        89 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            9999999999999654  35899999999999999999999   678999999999999999999999999999853221


Q ss_pred             CCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccc--hhHHHHHHHHhhcCCcccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ--VNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~d  708 (767)
                        .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........  ...............      
T Consensus       164 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------  235 (345)
T 3a8x_A          164 --GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------  235 (345)
T ss_dssp             --TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC------
T ss_pred             --CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC------
Confidence              1233456799999999999999999999999999999999999999965322111  011111111111111      


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCH
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSM  741 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~  741 (767)
                          ...+...+.++.+++.+||+.||.+||++
T Consensus       236 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          236 ----IRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             ----CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                12344566789999999999999999995

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.4e-39  Score=355.70  Aligned_cols=274  Identities=21%  Similarity=0.246  Sum_probs=213.4

Q ss_pred             ccccCHHHHHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc-----cceeee
Q 042216          462 CTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-----YLHLVS  536 (767)
Q Consensus       462 ~~~~~~~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-----Hpniv~  536 (767)
                      ...+++.+.....++|...+.||+|+||+||+|+...+++.||||++... ......+..|++++..++     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            34556666556678999999999999999999999888899999999642 334556788999999886     999999


Q ss_pred             EeeeeecCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC----
Q 042216          537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE----  612 (767)
Q Consensus       537 l~g~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~----  612 (767)
                      +++++...+..++||||+ +++|.+++.......+++.++..++.|++.||.|||   +.+|+||||||+|||++.    
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccc
Confidence            999999999999999999 889999998776667999999999999999999999   788999999999999986    


Q ss_pred             ---------------------CCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHH
Q 042216          613 ---------------------EWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLE  671 (767)
Q Consensus       613 ---------------------~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~e  671 (767)
                                           ++.+||+|||+++....     ......||+.|+|||++.+..++.++|||||||++||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  251 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence                                 78999999999986432     1234568999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCCccchhHHHH---------HHHHhhcCCcccccc-ccccCCCC--------------------hhhHH
Q 042216          672 VLCARPPILRTGDKKQVNLAVW---------ATECYRNGKIGDIID-PFLKGNAP--------------------PVCLN  721 (767)
Q Consensus       672 lltg~~P~~~~~~~~~~~l~~~---------~~~~~~~~~~~~~~d-~~l~~~~~--------------------~~~~~  721 (767)
                      |++|+.||......+.......         ........ ....++ ..+....+                    ....+
T Consensus       252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  330 (360)
T 3llt_A          252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTN-GSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE  330 (360)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSG-GGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred             HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhcc-CccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence            9999999976543221111110         00000000 000000 00000000                    01125


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHH
Q 042216          722 QFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       722 ~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .+.+++.+||+.||.+|||++|+++
T Consensus       331 ~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          331 LFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHhc
Confidence            6789999999999999999999974

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.9e-39  Score=358.68  Aligned_cols=269  Identities=19%  Similarity=0.205  Sum_probs=206.9

Q ss_pred             hhccccceeeecc--CcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          474 TKDFNNLLIIGRG--GFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       474 t~~f~~~~~LG~G--~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      .++|+..+.||+|  +||+||+++...+++.||||++....  ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4579999999999  99999999999888999999996542  2334568889999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      |||||++|+|.+++.......+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            999999999999998766567999999999999999999999   67899999999999999999999999998764321


Q ss_pred             CC-----CccccccccCCCcccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhh---
Q 042216          630 FS-----KTHVSTQVKGSIGYLDPEYYRL--QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR---  699 (767)
Q Consensus       630 ~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~---  699 (767)
                      ..     .........||+.|+|||++.+  ..++.++|||||||++|||++|+.||.........  .........   
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~  258 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLL  258 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC---------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCCCCccc
Confidence            11     0111223468899999999987  67999999999999999999999999665433211  100000000   


Q ss_pred             ------cC-------------Ccccccc---c------cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          700 ------NG-------------KIGDIID---P------FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       700 ------~~-------------~~~~~~d---~------~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                            ..             ...+.+.   +      ......+...+.++.+|+.+||+.||.+|||++|+++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                  00             0000000   0      00001233456779999999999999999999999843

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-39  Score=346.73  Aligned_cols=264  Identities=22%  Similarity=0.297  Sum_probs=203.8

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-----CcchhHHHHHHHHHhccc---cceeeeEeeeeecC
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-----QQGALEFQTEIGMLSQLR---YLHLVSLIGYCNDD  544 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~---Hpniv~l~g~~~~~  544 (767)
                      ..++|...+.||+|+||+||+|+...+++.||||++....     ......+.+|++++++++   ||||++++++|...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4678999999999999999999998888999999986322     122346778888877775   99999999999765


Q ss_pred             C-----ceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 042216          545 G-----QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVS  619 (767)
Q Consensus       545 ~-----~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~  619 (767)
                      .     ..++||||+. |+|.+++.......+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence            4     4799999997 59999998776666999999999999999999999   6789999999999999999999999


Q ss_pred             ecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhh
Q 042216          620 DFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR  699 (767)
Q Consensus       620 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~  699 (767)
                      |||+++....   ........||+.|+|||.+.+..++.++|||||||++|||++|++||......+..  .. ......
T Consensus       163 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~-i~~~~~  236 (308)
T 3g33_A          163 DFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL--GK-IFDLIG  236 (308)
T ss_dssp             SCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH--HH-HHHHHC
T ss_pred             eCccccccCC---CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-HHHHhC
Confidence            9999986432   22234567899999999999999999999999999999999999999665432211  11 111111


Q ss_pred             cCCcccc------ccccccC-------CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          700 NGKIGDI------IDPFLKG-------NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       700 ~~~~~~~------~d~~l~~-------~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .......      ....+..       ...+..+.++.+++.+||+.||.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            1000000      0000000       011235577899999999999999999999975

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=354.26  Aligned_cols=273  Identities=16%  Similarity=0.145  Sum_probs=213.3

Q ss_pred             hccccceeeeccCcEEEEEEEecC--------CCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeee----------
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNG--------DSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVS----------  536 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~--------~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~----------  536 (767)
                      ++|...+.||+|+||.||+|+...        .++.||||++...     ..+.+|++++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            578999999999999999999976        3689999998643     46889999999999999998          


Q ss_pred             -----Eeeeeec-CCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE
Q 042216          537 -----LIGYCND-DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL  610 (767)
Q Consensus       537 -----l~g~~~~-~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl  610 (767)
                           +++++.. ++..++||||+ +|+|.+++.......+++.+++.++.|++.||.|||   +.+|+||||||+|||+
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFV  192 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEE
Confidence                 5677765 67889999999 999999998664467999999999999999999999   6789999999999999


Q ss_pred             CCCC--cEEEeecCCcccCCCCCC-----ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 042216          611 DEEW--VAKVSDFGLCKFGPNFSK-----THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTG  683 (767)
Q Consensus       611 d~~~--~~ki~DfGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~  683 (767)
                      +.++  .+||+|||+++.......     ........||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9998  999999999975432111     111234479999999999999999999999999999999999999996654


Q ss_pred             CccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhcccccc
Q 042216          684 DKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEKS  762 (767)
Q Consensus       684 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~~~  762 (767)
                      ... ..+.........  ....+.+...   .....+.++.+++.+||+.||.+||++++|++.|+.+++.........
T Consensus       273 ~~~-~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~  345 (352)
T 2jii_A          273 PNT-EDIMKQKQKFVD--KPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDP  345 (352)
T ss_dssp             TCH-HHHHHHHHHHHH--SCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSC
T ss_pred             cCH-HHHHHHHHhccC--Chhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCcc
Confidence            221 112221111111  1111111111   012345779999999999999999999999999999998775444433

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=357.60  Aligned_cols=250  Identities=22%  Similarity=0.282  Sum_probs=200.9

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCC
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMAR  556 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~  556 (767)
                      +...+.||+|+||.||+|....+++.||+|+++.......+++.+|+++|++++||||+++++++.+.+..++||||+++
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~  170 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG  170 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            34456899999999999999888899999999876656677899999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE--CCCCcEEEeecCCcccCCCCCCcc
Q 042216          557 GTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL--DEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       557 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl--d~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      |+|.+++.... ..+++..++.++.|++.||.|||   +.+|+||||||+|||+  +.++.+||+|||+++......   
T Consensus       171 ~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---  243 (373)
T 2x4f_A          171 GELFDRIIDES-YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---  243 (373)
T ss_dssp             CEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---
T ss_pred             CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---
Confidence            99999986543 35899999999999999999999   6789999999999999  677899999999998654322   


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN  714 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  714 (767)
                      ......||+.|+|||++....++.++|||||||++|||++|+.||......+  .+..    ......  .     +...
T Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~----i~~~~~--~-----~~~~  310 (373)
T 2x4f_A          244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE--TLNN----ILACRW--D-----LEDE  310 (373)
T ss_dssp             BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHH----HHHTCC--C-----SCSG
T ss_pred             ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH----HHhccC--C-----CChh
Confidence            2234469999999999999999999999999999999999999996554321  1111    111100  0     0001


Q ss_pred             CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       715 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .....+.++.+++.+||+.||.+|||+.|+++
T Consensus       311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          311 EFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11234677899999999999999999999986

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.5e-40  Score=355.83  Aligned_cols=251  Identities=24%  Similarity=0.323  Sum_probs=206.6

Q ss_pred             HHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCc
Q 042216          471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQ  546 (767)
Q Consensus       471 ~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~  546 (767)
                      ....++|...+.||+|+||+||+|+.+.+++.||||+++...   ......+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345678999999999999999999999888999999996431   23445678899999887 89999999999999999


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      .++||||+++|+|.+++.+.  ..+++.++..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            99999999999999999654  35899999999999999999999   67899999999999999999999999999985


Q ss_pred             CCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccc
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI  706 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  706 (767)
                      ....  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +..   . ...+.    
T Consensus       168 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~---~-i~~~~----  234 (345)
T 1xjd_A          168 NMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFH---S-IRMDN----  234 (345)
T ss_dssp             CCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---H-HHHCC----
T ss_pred             cccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---HHH---H-HHhCC----
Confidence            3221  122345679999999999999999999999999999999999999996543221   111   1 11111    


Q ss_pred             ccccccCCCChhhHHHHHHHHHHccccCCCCCCCHH-HHH
Q 042216          707 IDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMS-DVV  745 (767)
Q Consensus       707 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~-evl  745 (767)
                            ...+...+.++.+++.+||+.||.+||++. ||+
T Consensus       235 ------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          235 ------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                  122344567889999999999999999997 664

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.3e-40  Score=354.51  Aligned_cols=273  Identities=25%  Similarity=0.388  Sum_probs=212.2

Q ss_pred             cccceeeeccCcEEEEEEEec----CCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecC--CceEE
Q 042216          477 FNNLLIIGRGGFGNVYKGFLN----GDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD--GQMIL  549 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~----~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~~l  549 (767)
                      |...+.||+|+||+||++.+.    ..++.||||++.... ....+.+.+|++++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488889999999999888653    356789999997653 23456789999999999999999999999874  57899


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ||||+++|+|.+++...   .+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            99999999999999654   3899999999999999999999   67899999999999999999999999999986543


Q ss_pred             CCCc-cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          630 FSKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       630 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      .... .......+|..|+|||.+.+..++.++|||||||++|||++|+.||....... .....+.........+.+.++
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHHHHH
T ss_pred             cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHHHHh
Confidence            2221 22334567888999999999999999999999999999999999985432110 000000000000001111222


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLR  756 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  756 (767)
                      .......+..++.++.+++.+||+.||.+|||+.|+++.|+.+.+...
T Consensus       266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            223334456677889999999999999999999999999999987764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.6e-39  Score=351.41  Aligned_cols=247  Identities=23%  Similarity=0.304  Sum_probs=204.8

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|...+.||+|+||.||+|.+..+++.||||++...   .......+.+|+++++.++||||+++++++...+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5788899999999999999999888899999998643   1223457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+ +|+|.+++...  ..+++.++..++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++..... 
T Consensus        89 E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-  161 (336)
T 3h4j_B           89 EYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-  161 (336)
T ss_dssp             CCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred             ECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence            999 68999998654  35999999999999999999999   678999999999999999999999999999864332 


Q ss_pred             CccccccccCCCcccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLL-TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                        .......||+.|+|||.+.+..+ ++++|||||||++|||++|+.||........                ...+.. 
T Consensus       162 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~~-  222 (336)
T 3h4j_B          162 --NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVNS-  222 (336)
T ss_dssp             --BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCCS-
T ss_pred             --cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHHc-
Confidence              22344579999999999988765 7899999999999999999999965432110                000100 


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      .....+...+..+.+++.+||+.||.+|||++|+++.
T Consensus       223 ~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          223 CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            0112344567788999999999999999999999853

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.6e-39  Score=341.85  Aligned_cols=261  Identities=30%  Similarity=0.476  Sum_probs=206.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCC---CceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeee-cCCceEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGD---STPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCN-DDGQMIL  549 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~-~~~~~~l  549 (767)
                      .+|...+.||+|+||+||+|++..+   ...+|+|.+..... ...+.+.+|+.++++++||||++++++|. .++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            4677788999999999999987543   23589999875433 34567899999999999999999999865 4568899


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ||||+++|+|.+++... ...+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       105 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            99999999999999654 346899999999999999999999   67899999999999999999999999999986433


Q ss_pred             CCC--ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccc
Q 042216          630 FSK--THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDI  706 (767)
Q Consensus       630 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  706 (767)
                      ...  ........+|+.|+|||.+.+..++.++||||||+++|||++ |.+||......+   .....    ..+.    
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~~----~~~~----  249 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL----LQGR----  249 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHHH----HTTC----
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHHH----hcCC----
Confidence            221  112234457889999999999999999999999999999999 555664433321   11111    1111    


Q ss_pred             ccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          707 IDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       707 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                           ....+..++..+.+++.+||+.||.+|||+.|+++.|+.++...
T Consensus       250 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          250 -----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             -----CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                 11223445678999999999999999999999999999998765

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.1e-39  Score=351.53  Aligned_cols=252  Identities=22%  Similarity=0.269  Sum_probs=192.8

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ..++|...+.||+|+||.||+|+..++++.||||++....  ..+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            3467899999999999999999999888899999997543  34568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC---CCcEEEeecCCcccCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE---EWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~---~~~~ki~DfGla~~~~~  629 (767)
                      |+++|+|.+++...  ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.   ++.+||+|||+++....
T Consensus       129 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          129 LVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             CCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             eCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            99999999999653  45899999999999999999999   678999999999999975   88999999999986432


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                      .   .......||+.|+|||++.+..++.++|||||||++|||++|+.||........  +    ..........     
T Consensus       204 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~----~~~i~~~~~~-----  269 (349)
T 2w4o_A          204 Q---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--M----FRRILNCEYY-----  269 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--H----HHHHHTTCCC-----
T ss_pred             c---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--H----HHHHHhCCCc-----
Confidence            1   223345689999999999999999999999999999999999999965433211  1    1111111110     


Q ss_pred             cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       710 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       .........+.++.+++.+||+.||++|||+.|+++
T Consensus       270 -~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          270 -FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             -CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             111122345678899999999999999999999985

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2e-39  Score=352.91  Aligned_cols=245  Identities=22%  Similarity=0.300  Sum_probs=207.0

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|...+.||+|+||.||+++...+++.||||++...   .......+.+|+++|+.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            5799999999999999999999888899999998643   2234567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|+|.+++.+.  ..+++.++..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++....  
T Consensus       121 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~--  193 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--  193 (350)
T ss_dssp             ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred             cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccC--
Confidence            999999999999754  35899999999999999999999   78899999999999999999999999999986432  


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                         ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +   ... +..+.         
T Consensus       194 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~---~~~-i~~~~---------  254 (350)
T 1rdq_E          194 ---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---I---YEK-IVSGK---------  254 (350)
T ss_dssp             ---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHH-HHHCC---------
T ss_pred             ---CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH---H---HHH-HHcCC---------
Confidence               1234579999999999999999999999999999999999999996543211   1   111 11111         


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPS-----MSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~  746 (767)
                       ...+...+.++.+++.+||+.||.+||+     ++||++
T Consensus       255 -~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence             1234456678999999999999999998     888874

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.3e-39  Score=344.16  Aligned_cols=267  Identities=22%  Similarity=0.325  Sum_probs=205.2

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      ..+|...+.||+|+||.||+|....+++.||||++....   .....++.+|++++++++||||+++++++.+.+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            357899999999999999999998788999999997532   23455789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhcc--CCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          551 YDYMARGTLRDHLYN--NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      |||+++|+|.+++..  .....+++..++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999864  23456899999999999999999999   6789999999999999999999999999987543


Q ss_pred             CCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          629 NFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      ..  ........|+..|+|||.+....++.++||||||+++|||++|+.||......    ....... ........   
T Consensus       188 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~~~~~~~---  257 (310)
T 2wqm_A          188 SK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK-IEQCDYPP---  257 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHH-HHTTCSCC---
T ss_pred             CC--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHH-hhcccCCC---
Confidence            21  11223456899999999999999999999999999999999999999644321    1111111 11111111   


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhcc
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRES  758 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~~  758 (767)
                           .....++.++.+++.+||+.||.+|||+.+|++.|+.+.....+.
T Consensus       258 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~  302 (310)
T 2wqm_A          258 -----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS  302 (310)
T ss_dssp             -----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             -----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence                 112345678999999999999999999999999999998776543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.7e-39  Score=345.93  Aligned_cols=253  Identities=24%  Similarity=0.307  Sum_probs=199.5

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCC------
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG------  545 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~------  545 (767)
                      ..++|+..+.||+|+||.||+|+...+++.||||++.... ....+.+.+|+++|++++||||+++++++.+.+      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            3467999999999999999999998888999999997543 334567999999999999999999999986543      


Q ss_pred             ---------------------------------------------------ceEEEEecCCCCChhhhhccCCC-CCCCh
Q 042216          546 ---------------------------------------------------QMILVYDYMARGTLRDHLYNNDN-PPLPW  573 (767)
Q Consensus       546 ---------------------------------------------------~~~lV~ey~~~gsL~~~L~~~~~-~~l~~  573 (767)
                                                                         ..++||||+++|+|.+++..... ...++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               27999999999999999976432 34567


Q ss_pred             HHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc----------cccccccCCC
Q 042216          574 DRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT----------HVSTQVKGSI  643 (767)
Q Consensus       574 ~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~----------~~~~~~~gt~  643 (767)
                      ..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++........          .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            789999999999999999   678999999999999999999999999999865432211          1223456999


Q ss_pred             cccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHH
Q 042216          644 GYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQF  723 (767)
Q Consensus       644 ~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  723 (767)
                      .|+|||.+.+..++.++|||||||++|||++|..|+..        ..... .........         ........++
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~~~-~~~~~~~~~---------~~~~~~~~~~  302 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVRII-TDVRNLKFP---------LLFTQKYPQE  302 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHHHH-HHHHTTCCC---------HHHHHHCHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHHHH-HHhhccCCC---------cccccCChhH
Confidence            99999999999999999999999999999998776411        11111 111111110         0112345667


Q ss_pred             HHHHHHccccCCCCCCCHHHHHH
Q 042216          724 VEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       724 ~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .+++.+||+.||.+|||+.|+++
T Consensus       303 ~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          303 HMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCCCCcCCCHHHHhh
Confidence            89999999999999999999985

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5.1e-39  Score=350.16  Aligned_cols=254  Identities=20%  Similarity=0.255  Sum_probs=205.3

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC-----CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-----SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMI  548 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~-----~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~  548 (767)
                      .++|...+.||+|+||+||++....+++.||||++...     .....+.+.+|+++++.++||||+++++++.+++..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45789999999999999999999888899999998532     2224567999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhccC--CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCc---EEEeecCC
Q 042216          549 LVYDYMARGTLRDHLYNN--DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV---AKVSDFGL  623 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~---~ki~DfGl  623 (767)
                      +||||+++|+|.+++...  ....+++..+..++.|++.||.|||   +++|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999999888543  2345899999999999999999999   678999999999999986554   99999999


Q ss_pred             cccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCc
Q 042216          624 CKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKI  703 (767)
Q Consensus       624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~  703 (767)
                      ++.....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....    .+..    ....+..
T Consensus       180 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~----~i~~~~~  249 (351)
T 3c0i_A          180 AIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFE----GIIKGKY  249 (351)
T ss_dssp             CEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHH----HHHHTCC
T ss_pred             eeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHH----HHHcCCC
Confidence            9865432  1223445799999999999999999999999999999999999999965321    1111    1111110


Q ss_pred             cccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          704 GDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       704 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .  ..+..    ....+.++.+++.+||+.||.+|||+.|+++
T Consensus       250 ~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          250 K--MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             C--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             C--CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0  00000    0134567899999999999999999999984

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=350.95  Aligned_cols=260  Identities=21%  Similarity=0.307  Sum_probs=194.2

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc-cceeeeEeeeee--------cC
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-YLHLVSLIGYCN--------DD  544 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~--------~~  544 (767)
                      ..+|...++||+|+||.||+|+....++.||||++........+.+.+|+.++.+++ ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            457889999999999999999998888999999987665556677899999999996 999999999983        34


Q ss_pred             CceEEEEecCCCCChhhhhcc-CCCCCCChHHHHHHHHHHHHHHHHhHhCCCCC--eEecCCCCCCeEECCCCcEEEeec
Q 042216          545 GQMILVYDYMARGTLRDHLYN-NDNPPLPWDRRLKICIGAARALHYLHTGASKV--IIHRDVKTTNILLDEEWVAKVSDF  621 (767)
Q Consensus       545 ~~~~lV~ey~~~gsL~~~L~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiH~Dlk~~NILld~~~~~ki~Df  621 (767)
                      ...++|+||+. |+|.+++.. .....+++.+++.++.|++.||.|||   +.+  |+||||||+|||++.++.+||+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecC
Confidence            45899999996 699998864 23346999999999999999999999   677  999999999999999999999999


Q ss_pred             CCcccCCCCCCcc----------ccccccCCCcccChhhh---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccch
Q 042216          622 GLCKFGPNFSKTH----------VSTQVKGSIGYLDPEYY---RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQV  688 (767)
Q Consensus       622 Gla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~  688 (767)
                      |+++.........          ......||+.|+|||.+   .+..++.++|||||||++|||++|+.||.......  
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--  260 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--  260 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence            9998654321110          11134589999999998   56678999999999999999999999995432211  


Q ss_pred             hHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 042216          689 NLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLR  756 (767)
Q Consensus       689 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  756 (767)
                                       +.+.......+......+.+++.+||+.||.+|||+.|+++.|+.+.+...
T Consensus       261 -----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          261 -----------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             -----------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence                             111111112223334557899999999999999999999999998876543

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.2e-39  Score=342.84  Aligned_cols=252  Identities=34%  Similarity=0.496  Sum_probs=202.7

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecC-CceEEEEe
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD-GQMILVYD  552 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~-~~~~lV~e  552 (767)
                      .++|...+.||+|+||.||++...  ++.||||++....  ..+.+.+|++++++++||||+++++++.+. +..++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            467899999999999999999886  4789999997543  456789999999999999999999997654 57899999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+++|+|.+++.......+++..++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++.....  
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence            999999999997654344889999999999999999999   678999999999999999999999999998753321  


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                         .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+   ...    ....+         .
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~----~~~~~---------~  231 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP----RVEKG---------Y  231 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHH----HHTTT---------C
T ss_pred             ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHhcC---------C
Confidence               223357889999999999999999999999999999998 999996543321   111    11111         1


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                      ....+..++..+.+++.+||+.||.+||++.|+++.|+.+..
T Consensus       232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence            123345567789999999999999999999999999998864

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.3e-39  Score=351.15  Aligned_cols=263  Identities=25%  Similarity=0.382  Sum_probs=208.6

Q ss_pred             hhccccceeeeccCcEEEEEEEe-----cCCCceEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeeecCCce
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFL-----NGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQM  547 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~-----~~~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~  547 (767)
                      .++|...+.||+|+||.||+|+.     ...++.||||++... ......++.+|+.++++++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46789999999999999999984     345578999999644 334456789999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhccCCC-----CCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC---CCCcEEEe
Q 042216          548 ILVYDYMARGTLRDHLYNNDN-----PPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAKVS  619 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld---~~~~~ki~  619 (767)
                      ++||||+++|+|.+++.....     ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++   .+..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999976432     45899999999999999999999   67899999999999998   45569999


Q ss_pred             ecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHh
Q 042216          620 DFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECY  698 (767)
Q Consensus       620 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~  698 (767)
                      |||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......   ....    ..
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~----~~  258 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLE----FV  258 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH----HH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHH----HH
Confidence            9999874322222222334567899999999999999999999999999999998 99998654321   1111    11


Q ss_pred             hcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       699 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      ..+.         ....+..++..+.+++.+||+.||.+||++.+|++.|+.+.+..
T Consensus       259 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          259 TSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             hcCC---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            1111         11234456678999999999999999999999999999887655

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.6e-39  Score=352.19  Aligned_cols=250  Identities=24%  Similarity=0.328  Sum_probs=206.5

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceE
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMI  548 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~  548 (767)
                      ..++|...+.||+|+||+||+++.+.+++.||||+++..   .......+..|..+|..+ +||||+++++++.+.+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            346899999999999999999999888889999998643   223455688999999988 8999999999999999999


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      +||||+++|+|.+++.+.  ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        98 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            999999999999999654  35899999999999999999999   6789999999999999999999999999998532


Q ss_pred             CCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          629 NFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      .  ........+||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +.   .... .+.      
T Consensus       173 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~---~~i~-~~~------  237 (353)
T 2i0e_A          173 W--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LF---QSIM-EHN------  237 (353)
T ss_dssp             C--TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHH-HCC------
T ss_pred             c--CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---HH---HHHH-hCC------
Confidence            2  1223345679999999999999999999999999999999999999996543221   11   1111 111      


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPS-----MSDVVW  746 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~  746 (767)
                          ...+...+.++.+++.+||+.||.+||+     ++|+++
T Consensus       238 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          238 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             ----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                1234456678999999999999999995     466663

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-38  Score=341.46  Aligned_cols=269  Identities=23%  Similarity=0.294  Sum_probs=204.4

Q ss_pred             HHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc--ccceeeeEeeeeecC----
Q 042216          471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL--RYLHLVSLIGYCNDD----  544 (767)
Q Consensus       471 ~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l--~Hpniv~l~g~~~~~----  544 (767)
                      ....++|...+.||+|+||.||+|+..  ++.||||++...   ....+..|.+++..+  +||||+++++++...    
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            345678999999999999999999986  478999998532   334455666666554  899999999999877    


Q ss_pred             CceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCC--------CeEecCCCCCCeEECCCCcE
Q 042216          545 GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK--------VIIHRDVKTTNILLDEEWVA  616 (767)
Q Consensus       545 ~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~--------~iiH~Dlk~~NILld~~~~~  616 (767)
                      ...++||||+++|+|.+++...   .+++.+++.++.|++.||.|||   +.        +|+||||||+|||++.++.+
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCE
Confidence            6889999999999999999653   5899999999999999999999   55        89999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcc--ccccccCCCcccChhhhccCCCCch------hhHHHHHHHHHHHHhC----------CCC
Q 042216          617 KVSDFGLCKFGPNFSKTH--VSTQVKGSIGYLDPEYYRLQLLTEK------SDVYSFGVVLLEVLCA----------RPP  678 (767)
Q Consensus       617 ki~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k------sDV~SfGvvl~elltg----------~~P  678 (767)
                      ||+|||+++.........  ......||+.|+|||++.+...+.+      +|||||||++|||++|          +.|
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            999999997543322111  1124569999999999987766654      9999999999999999          666


Q ss_pred             CCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          679 ILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       679 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      |........ ..... ...............   ...+..++.++.+++.+||+.||.+|||+.||++.|+.+.+..
T Consensus       262 ~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          262 YHDLVPSDP-SYEDM-REIVCIKKLRPSFPN---RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             TTTTSCSSC-CHHHH-HHHHTTSCCCCCCCG---GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             HhhhcCCCC-chhhh-HHHHhhhccCccccc---cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            644322211 11111 111111111111100   0112367889999999999999999999999999999988654

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.6e-39  Score=378.46  Aligned_cols=253  Identities=26%  Similarity=0.385  Sum_probs=204.2

Q ss_pred             eeeeccCcEEEEEEEe--cCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCC
Q 042216          481 LIIGRGGFGNVYKGFL--NGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMAR  556 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~--~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~  556 (767)
                      +.||+|+||.||+|.+  +..++.||||+++...  ....++|.+|+++|.+++||||++++++|.. +..++|||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999965  3445789999997542  2335689999999999999999999999964 568999999999


Q ss_pred             CChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC-ccc
Q 042216          557 GTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK-THV  635 (767)
Q Consensus       557 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~-~~~  635 (767)
                      |+|.+++...  ..+++.+++.|+.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus       454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            9999999654  45899999999999999999999   67899999999999999999999999999986543221 122


Q ss_pred             cccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCC
Q 042216          636 STQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN  714 (767)
Q Consensus       636 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  714 (767)
                      .....+|+.|+|||++....++.++|||||||+||||++ |+.||......+   +    ...+..+         .+..
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~----~~~i~~~---------~~~~  592 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---V----TAMLEKG---------ERMG  592 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H----HHHHHTT---------CCCC
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcC---------CCCC
Confidence            234457889999999999999999999999999999998 999996554321   1    1111221         1223


Q ss_pred             CChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       715 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      .+..++.++.+++.+||+.||++||++.+|++.|+.+...+
T Consensus       593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            45567888999999999999999999999999999887654

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=6.5e-39  Score=346.70  Aligned_cols=273  Identities=20%  Similarity=0.327  Sum_probs=200.4

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHH--HhccccceeeeEeeeee-----cCCc
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM--LSQLRYLHLVSLIGYCN-----DDGQ  546 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~--l~~l~Hpniv~l~g~~~-----~~~~  546 (767)
                      .++|...+.||+|+||.||+|+..  ++.||||++...   ....+..|.++  +..++||||+++++.+.     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEEC--CeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            357889999999999999999874  489999998633   23345555544  45689999999998553     2336


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCC---------CeEecCCCCCCeEECCCCcEE
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK---------VIIHRDVKTTNILLDEEWVAK  617 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~---------~iiH~Dlk~~NILld~~~~~k  617 (767)
                      .++||||+++|+|.+++...   .+++..++.++.|++.||.|||   +.         +|+||||||+|||++.++.+|
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             EEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEE
Confidence            78999999999999999654   3589999999999999999999   56         899999999999999999999


Q ss_pred             EeecCCcccCCCCCC------ccccccccCCCcccChhhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 042216          618 VSDFGLCKFGPNFSK------THVSTQVKGSIGYLDPEYYRL-------QLLTEKSDVYSFGVVLLEVLCARPPILRTGD  684 (767)
Q Consensus       618 i~DfGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~SfGvvl~elltg~~P~~~~~~  684 (767)
                      |+|||+++.......      ........||+.|+|||++.+       ..++.++|||||||++|||++|+.|+.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            999999976532211      112234569999999999986       4566799999999999999999877644322


Q ss_pred             ccch------------hHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 042216          685 KKQV------------NLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF  752 (767)
Q Consensus       685 ~~~~------------~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~  752 (767)
                      ....            ....+ ............+...  ......++.++.+++.+||+.||.+|||+.|+++.|+.++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDM-QVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHH-HHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHH-HhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            1110            00111 1111111100000000  0112346778999999999999999999999999999999


Q ss_pred             hhhhcccc
Q 042216          753 QLLRESSE  760 (767)
Q Consensus       753 ~~~~~~~~  760 (767)
                      ..+.+.+.
T Consensus       318 ~~~~~~~~  325 (336)
T 3g2f_A          318 MIWERNKS  325 (336)
T ss_dssp             HCCCC---
T ss_pred             HHHHhccc
Confidence            88854443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.1e-39  Score=338.97  Aligned_cols=248  Identities=27%  Similarity=0.405  Sum_probs=204.8

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      .++|...+.||+|+||.||+|....+++.||||++....   ......+.+|++++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467999999999999999999999888899999985431   22345688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+++|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++..... 
T Consensus        88 ~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~-  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-  161 (279)
T ss_dssp             ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCc-
Confidence            9999999999999654  35899999999999999999999   78899999999999999999999999999864322 


Q ss_pred             CCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                         .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+.   .   .. ...          
T Consensus       162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~---~~-~~~----------  221 (279)
T 3fdn_A          162 ---SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---Y---KR-ISR----------  221 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H---HH-HHH----------
T ss_pred             ---ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH---H---HH-HHh----------
Confidence               122345689999999999999999999999999999999999999964432111   1   11 111          


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      .....+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus       222 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          222 VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            1112344456788999999999999999999999964

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.3e-39  Score=351.57  Aligned_cols=262  Identities=23%  Similarity=0.236  Sum_probs=204.6

Q ss_pred             HHHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC-----CCcchhHHHHHHHHHhccccceeeeEeeeeec
Q 042216          469 EIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-----SQQGALEFQTEIGMLSQLRYLHLVSLIGYCND  543 (767)
Q Consensus       469 ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~-----~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~  543 (767)
                      ++....++|...+.||+|+||.||+|....+++.||+|++...     .....+.+.+|++++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            3456778999999999999999999999888899999998543     33455679999999999999999999999999


Q ss_pred             CCceEEEEecCCCCChhhhhccC--------------------------------------CCCCCChHHHHHHHHHHHH
Q 042216          544 DGQMILVYDYMARGTLRDHLYNN--------------------------------------DNPPLPWDRRLKICIGAAR  585 (767)
Q Consensus       544 ~~~~~lV~ey~~~gsL~~~L~~~--------------------------------------~~~~l~~~~~~~i~~~ia~  585 (767)
                      .+..++||||+++|+|.+++...                                      ....+++..+..++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            99999999999999999998521                                      0112467788899999999


Q ss_pred             HHHHhHhCCCCCeEecCCCCCCeEECCCC--cEEEeecCCcccCCCCCC--ccccccccCCCcccChhhhcc--CCCCch
Q 042216          586 ALHYLHTGASKVIIHRDVKTTNILLDEEW--VAKVSDFGLCKFGPNFSK--THVSTQVKGSIGYLDPEYYRL--QLLTEK  659 (767)
Q Consensus       586 gL~yLH~~~~~~iiH~Dlk~~NILld~~~--~~ki~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~s~k  659 (767)
                      ||.|||   +.+|+||||||+|||++.++  .+||+|||+++.......  ........||+.|+|||.+..  ..++.+
T Consensus       180 ~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            999999   67899999999999998766  899999999975322111  112344569999999999975  678999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCC
Q 042216          660 SDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRP  739 (767)
Q Consensus       660 sDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RP  739 (767)
                      +|||||||++|||++|+.||......+.      ..........       .........+..+.+++.+||+.||.+||
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  323 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADT------ISQVLNKKLC-------FENPNYNVLSPLARDLLSNLLNRNVDERF  323 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCC-------TTSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcccc-------cCCcccccCCHHHHHHHHHHcCCChhHCC
Confidence            9999999999999999999965543211      1111111100       00111123567889999999999999999


Q ss_pred             CHHHHHH
Q 042216          740 SMSDVVW  746 (767)
Q Consensus       740 s~~evl~  746 (767)
                      ++.|+++
T Consensus       324 s~~~~l~  330 (345)
T 3hko_A          324 DAMRALQ  330 (345)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHhc
Confidence            9999986

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=352.60  Aligned_cols=252  Identities=23%  Similarity=0.325  Sum_probs=198.4

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhcccc--ceeeeEeeeeecCCceEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRY--LHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H--pniv~l~g~~~~~~~~~l  549 (767)
                      .++|...+.||+|+||.||++.... ++.||||++...  .....+.+.+|+++|.+++|  +||+++++++...+..++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTT-SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCC-CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            3568899999999999999998864 688999998654  23344678999999999976  999999999999999999


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ||| +.+|+|.+++...  ..+++.++..++.|++.||.|||   +.+|+||||||+|||++ ++.+||+|||+++....
T Consensus        87 v~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EEC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             EEe-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            999 5678999999764  46899999999999999999999   67899999999999997 57899999999986544


Q ss_pred             CCCccccccccCCCcccChhhhcc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHh
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRL-----------QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECY  698 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~  698 (767)
                      ...........||+.|+|||++.+           ..++.++|||||||++|||++|+.||......     .....   
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~---  231 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLH---  231 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHH---
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHH---
Confidence            333323345679999999999865           67899999999999999999999999654321     11111   


Q ss_pred             hcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       699 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                            .++++......+...+.++.+++.+||+.||.+|||+.|+++.
T Consensus       232 ------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          232 ------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             ------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ------HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence                  1122223333444556788999999999999999999999854

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.8e-39  Score=357.31  Aligned_cols=251  Identities=23%  Similarity=0.328  Sum_probs=198.9

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccc--cceeeeEeeeeecCCceEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLR--YLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~--Hpniv~l~g~~~~~~~~~lV  550 (767)
                      .+|...+.||+|+||.||++.... ++.||||++....  ......+.+|+++|.+++  ||||+++++++...+..++|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            458999999999999999999875 6889999986542  334567999999999996  59999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      || +.+++|.+++....  .+++.++..++.|++.||.|||   +.+|+||||||+|||++ ++.+||+|||+++.....
T Consensus       135 ~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             Ee-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            99 56789999997643  6899999999999999999999   78899999999999996 579999999999865433


Q ss_pred             CCccccccccCCCcccChhhhcc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhh
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRL-----------QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR  699 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~  699 (767)
                      ..........||+.|+|||++.+           ..++.++|||||||+||||++|+.||......     ......   
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~~---  279 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHA---  279 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHH---
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHHH---
Confidence            22223345679999999999865           46899999999999999999999999654321     111111   


Q ss_pred             cCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       700 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                            ++++......+...+.++.+++.+||+.||.+|||+.|+++.
T Consensus       280 ------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          280 ------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             ------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ------HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence                  122222223344446678999999999999999999999853

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.6e-39  Score=365.78  Aligned_cols=250  Identities=25%  Similarity=0.334  Sum_probs=198.7

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      .++|+..+.||+|+||.||++....+++.||||++...   .......+.+|+++++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            36799999999999999999999888899999998643   334455688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+++|+|.+++...  ..+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||+++.... 
T Consensus       227 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-  301 (446)
T 4ejn_A          227 MEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-  301 (446)
T ss_dssp             ECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccC-
Confidence            9999999999999654  358999999999999999999993  27899999999999999999999999999985332 


Q ss_pred             CCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                       .........||+.|+|||++.+..++.++|||||||+||||++|+.||.......   +..   ..... .        
T Consensus       302 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~---~i~~~-~--------  365 (446)
T 4ejn_A          302 -DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFE---LILME-E--------  365 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHC-C--------
T ss_pred             -CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHH---HHHhC-C--------
Confidence             1222345679999999999999999999999999999999999999996543221   111   11111 1        


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRP-----SMSDVVW  746 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~  746 (767)
                        ...+...+.++.+++.+||+.||.+||     +++|+++
T Consensus       366 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 --IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence              113445567899999999999999999     9999985

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=361.97  Aligned_cols=263  Identities=21%  Similarity=0.218  Sum_probs=208.6

Q ss_pred             CHHHHHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeee
Q 042216          466 SISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCN  542 (767)
Q Consensus       466 ~~~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~  542 (767)
                      .+++++...++|+..++||+|+||+||+++.+.+++.||||+++...   ......+.+|..++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            34455556789999999999999999999998888999999986421   223345889999999999999999999999


Q ss_pred             cCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecC
Q 042216          543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFG  622 (767)
Q Consensus       543 ~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfG  622 (767)
                      +.+.+++||||+++|+|.+++.+.. ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeech
Confidence            9999999999999999999997542 35899999999999999999999   6789999999999999999999999999


Q ss_pred             CcccCCCCCCccccccccCCCcccChhhhc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHH
Q 042216          623 LCKFGPNFSKTHVSTQVKGSIGYLDPEYYR-------LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWAT  695 (767)
Q Consensus       623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~  695 (767)
                      +++...... .......+||+.|+|||++.       ...++.++|||||||++|||++|+.||......+..  .....
T Consensus       208 la~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~--~~i~~  284 (412)
T 2vd5_A          208 SCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY--GKIVH  284 (412)
T ss_dssp             TCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHHHT
T ss_pred             hheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH--HHHHh
Confidence            998654321 12233467999999999987       357899999999999999999999999654332111  11110


Q ss_pred             HHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCC---CCHHHHHH
Q 042216          696 ECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRR---PSMSDVVW  746 (767)
Q Consensus       696 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~R---Ps~~evl~  746 (767)
                      .. .....         ...+...+.++.+++.+||+ +|.+|   |+++|+++
T Consensus       285 ~~-~~~~~---------p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          285 YK-EHLSL---------PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HH-HHCCC---------C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             cc-cCcCC---------CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            00 00000         01123456788999999999 99998   58999874

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.9e-39  Score=345.64  Aligned_cols=249  Identities=25%  Similarity=0.355  Sum_probs=196.6

Q ss_pred             hhccccceeeeccCcEEEEEEEec---CCCceEEEEEeCCCC----CcchhHHHHHHHHHhccccceeeeEeeeeecCCc
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLN---GDSTPVAIKRLNPGS----QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQ  546 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~---~~~~~vAVK~l~~~~----~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~  546 (767)
                      .++|...+.||+|+||.||+++..   ..++.||+|+++...    ......+.+|+++|++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            357999999999999999999984   456899999997542    2334567899999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      .++||||+++|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            99999999999999999654  35899999999999999999999   67899999999999999999999999999875


Q ss_pred             CCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccc
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI  706 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  706 (767)
                      ....  ........||+.|+|||.+.+..++.++|||||||++|||++|+.||......+   ..   ..... ..    
T Consensus       171 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~---~~i~~-~~----  237 (327)
T 3a62_A          171 SIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK---TI---DKILK-CK----  237 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH---HHHHH-TC----
T ss_pred             cccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH---HH---HHHHh-CC----
Confidence            3221  122344579999999999999999999999999999999999999996543221   11   11111 11    


Q ss_pred             ccccccCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042216          707 IDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRP-----SMSDVVW  746 (767)
Q Consensus       707 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~  746 (767)
                            ...+...+.++.+++.+||+.||.+||     ++.|+++
T Consensus       238 ------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 ------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                  123445567899999999999999999     7778774

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=9.5e-39  Score=349.93  Aligned_cols=256  Identities=17%  Similarity=0.177  Sum_probs=207.3

Q ss_pred             HhhccccceeeeccCcEEEEEEE-----ecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc---cceeeeEeeeeecC
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGF-----LNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR---YLHLVSLIGYCNDD  544 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~-----~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~---Hpniv~l~g~~~~~  544 (767)
                      ..++|...+.||+|+||+||+|.     ....++.||||++...   ...++..|++++..++   |+|++++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            35679999999999999999994     4456689999999754   3456777888777776   99999999999999


Q ss_pred             CceEEEEecCCCCChhhhhccC---CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC---------
Q 042216          545 GQMILVYDYMARGTLRDHLYNN---DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE---------  612 (767)
Q Consensus       545 ~~~~lV~ey~~~gsL~~~L~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~---------  612 (767)
                      +..++||||+++|+|.+++...   ....++|.+++.|+.|++.||+|||   +.+|+||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccc
Confidence            9999999999999999999642   3456999999999999999999999   788999999999999998         


Q ss_pred             --CCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhH
Q 042216          613 --EWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL  690 (767)
Q Consensus       613 --~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l  690 (767)
                        ++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||........   
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---  293 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---  293 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence              899999999999754322333344566799999999999999999999999999999999999999854322110   


Q ss_pred             HHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCC-CCHHHHHHHHHHhHhhh
Q 042216          691 AVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRR-PSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       691 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~R-Ps~~evl~~L~~~~~~~  755 (767)
                                     .++..+...   ...+.+.+++..|++.+|.+| |+++++.+.|+..++..
T Consensus       294 ---------------~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          294 ---------------KPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             ---------------EECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ---------------eechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence                           011111111   135567789999999999998 68899999998877653

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.8e-39  Score=352.46  Aligned_cols=254  Identities=21%  Similarity=0.212  Sum_probs=197.3

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .++|...+.||+|+||+||+++...+++.||||++.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            457999999999999999999999888999999997543 2345688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCc--EEEeecCCcccCCCCC
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV--AKVSDFGLCKFGPNFS  631 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~--~ki~DfGla~~~~~~~  631 (767)
                      +++|+|.+++...  ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.  +||+|||+++....  
T Consensus        98 ~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~--  170 (361)
T 3uc3_A           98 ASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--  170 (361)
T ss_dssp             CCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence            9999999999653  35999999999999999999999   788999999999999987765  99999999874321  


Q ss_pred             CccccccccCCCcccChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEK-SDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k-sDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                       ........||+.|+|||++.+..++.+ +|||||||++|||++|+.||........  ...........         .
T Consensus       171 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~---------~  238 (361)
T 3uc3_A          171 -HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSV---------K  238 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTT---------C
T ss_pred             -cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcC---------C
Confidence             112234569999999999988877665 8999999999999999999965443221  11111211111         1


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      .........+.++.+++.+||+.||.+|||+.|+++.
T Consensus       239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            1111122346778999999999999999999999853

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.4e-39  Score=337.75  Aligned_cols=255  Identities=22%  Similarity=0.309  Sum_probs=208.1

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ..++|+..+.||+|+||.||+|....+++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            346799999999999999999999888899999998643 2334567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++++|.+++...  ..+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++.......
T Consensus        85 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           85 EYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             ECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            999999999999543  45899999999999999999999   6789999999999999999999999999987543222


Q ss_pred             CccccccccCCCcccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLL-TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                      .........|+..|+|||.+.+..+ +.++||||||+++|||++|+.||....... .....|.     ....       
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~-----~~~~-------  226 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWK-----EKKT-------  226 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHH-----TTCT-------
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhh-----hccc-------
Confidence            2222345668999999999987665 789999999999999999999996554321 1111111     1100       


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       ........+..+.+++.+||+.||.+|||+.|+++
T Consensus       227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          227 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence             00112345677899999999999999999999975

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.9e-39  Score=340.21  Aligned_cols=261  Identities=19%  Similarity=0.248  Sum_probs=199.8

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ++|...+.||+|+||+||+|+.. .++.||+|++.....  .....+.+|++++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcC-CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            46888999999999999999984 568899999865432  234678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+++ +|.+++.... ..+++.++..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.....  
T Consensus        81 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  153 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--  153 (288)
T ss_dssp             CCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--
Confidence            9986 9999886543 46899999999999999999999   678999999999999999999999999998753221  


Q ss_pred             ccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC---cc----
Q 042216          633 THVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK---IG----  704 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~---~~----  704 (767)
                      ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.  +.. .........   ..    
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMR-IFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCCCTTTSTTGGG
T ss_pred             ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHHCCCChhhchhhhc
Confidence            112234468999999999976 4689999999999999999999999965443221  111 111111100   00    


Q ss_pred             -ccccccccC-------CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          705 -DIIDPFLKG-------NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       705 -~~~d~~l~~-------~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       ...++.+..       ......+.++.+++.+||+.||.+|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             001111110       112235677899999999999999999999975

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.1e-39  Score=344.39  Aligned_cols=265  Identities=23%  Similarity=0.297  Sum_probs=201.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc--chhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ++|...+.||+|+||+||+|....+++.||||++......  ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            5788999999999999999999888899999998654332  24568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        83 ~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  156 (311)
T 4agu_A           83 YCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-  156 (311)
T ss_dssp             CCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             eCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-
Confidence            99999999988543  45899999999999999999999   6789999999999999999999999999998643221 


Q ss_pred             ccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHH--------HHHhhcCC-
Q 042216          633 THVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWA--------TECYRNGK-  702 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~--------~~~~~~~~-  702 (767)
                       .......||..|+|||.+.+ ..++.++|||||||++|||++|+.||......+........        ...+.... 
T Consensus       157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          157 -DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             -cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence             12234568999999999876 67899999999999999999999999665443222111100        00000000 


Q ss_pred             cc--ccccccccCC---CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          703 IG--DIIDPFLKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       703 ~~--~~~d~~l~~~---~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ..  .+.++.-...   ..+..+..+.+++.+||+.||.+|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00  0000000000   01235667899999999999999999999984

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1e-38  Score=335.43  Aligned_cols=248  Identities=21%  Similarity=0.273  Sum_probs=207.4

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ..++|...+.||+|+||.||+|....++..+|+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            35679999999999999999999998888999999976655667789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE---CCCCcEEEeecCCcccCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl---d~~~~~ki~DfGla~~~~~  629 (767)
                      |+++++|.+++...  ..+++.++..++.|++.||.|||   +.+|+||||||+|||+   +.++.+||+|||++.....
T Consensus        87 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           87 LCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             ccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            99999999998654  35899999999999999999999   6789999999999999   8889999999999976433


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                      .   .......||+.|+|||.+.+. ++.++||||||+++|||++|+.||......+.   .   . ....+..      
T Consensus       162 ~---~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~---~-~~~~~~~------  224 (277)
T 3f3z_A          162 G---KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV---M---L-KIREGTF------  224 (277)
T ss_dssp             T---SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---H-HHHHCCC------
T ss_pred             c---cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH---H---H-HHHhCCC------
Confidence            2   223345689999999998754 89999999999999999999999965433211   1   1 1111110      


Q ss_pred             cccCCCCh----hhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          710 FLKGNAPP----VCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       710 ~l~~~~~~----~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                          ..+.    ..+..+.+++.+||+.||.+|||+.|+++
T Consensus       225 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          225 ----TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             ----CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ----CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                1111    34567899999999999999999999985

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=346.84  Aligned_cols=264  Identities=26%  Similarity=0.305  Sum_probs=208.4

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeee----cCCceEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN----DDGQMIL  549 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~----~~~~~~l  549 (767)
                      .++|...+.||+|+||.||++.....++.||||++........+.+.+|++++++++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            457999999999999999999998888999999987665566778999999999999999999999986    3457899


Q ss_pred             EEecCCCCChhhhhccC--CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          550 VYDYMARGTLRDHLYNN--DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      ||||+++|+|.+++...  ....+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999998652  3456999999999999999999999   678999999999999999999999999998753


Q ss_pred             CCCCCcc-------ccccccCCCcccChhhhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHH
Q 042216          628 PNFSKTH-------VSTQVKGSIGYLDPEYYRLQL---LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATEC  697 (767)
Q Consensus       628 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~  697 (767)
                      .......       ......||+.|+|||.+....   ++.++|||||||++|||++|+.||........ .....    
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~----  259 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALA----  259 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHH----
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHH----
Confidence            2111100       012235799999999987554   68999999999999999999999843211100 01110    


Q ss_pred             hhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 042216          698 YRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL  754 (767)
Q Consensus       698 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~  754 (767)
                      ...         ......+..++..+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus       260 ~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          260 VQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             HHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             hhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence            011         111122345567899999999999999999999999999987543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.4e-39  Score=354.76  Aligned_cols=272  Identities=18%  Similarity=0.203  Sum_probs=214.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCC--ceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG--QMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~--~~~lV~  551 (767)
                      ++|...++||+|+||+||+|....+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            46888899999999999999999888999999997543 234567889999999999999999999998655  789999


Q ss_pred             ecCCCCChhhhhccCC-CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE----CCCCcEEEeecCCccc
Q 042216          552 DYMARGTLRDHLYNND-NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL----DEEWVAKVSDFGLCKF  626 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl----d~~~~~ki~DfGla~~  626 (767)
                      ||+++|+|.+++.... ...+++..++.++.|++.||.|||   +.+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            9999999999996543 234999999999999999999999   6789999999999999    8888899999999986


Q ss_pred             CCCCCCccccccccCCCcccChhhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHh
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYRL--------QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECY  698 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~  698 (767)
                      ....   .......||..|+|||++..        ..++.++|||||||++|||++|+.||.........  ........
T Consensus       166 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~  240 (396)
T 4eut_A          166 LEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKII  240 (396)
T ss_dssp             CCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHH
T ss_pred             ccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHh
Confidence            5332   22234569999999999865        56788999999999999999999999654332211  11111111


Q ss_pred             hcC---Cccccc---c------c--cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 042216          699 RNG---KIGDII---D------P--FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL  754 (767)
Q Consensus       699 ~~~---~~~~~~---d------~--~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~  754 (767)
                      ...   .+..+.   +      .  .............+.+++.+||+.||++||++.|+++.|+.+++.
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            111   111000   0      0  011123456778899999999999999999999999999988764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.1e-39  Score=349.41  Aligned_cols=249  Identities=21%  Similarity=0.270  Sum_probs=181.4

Q ss_pred             eeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc-cceeeeEeeeeecCCceEEEEecCCCCCh
Q 042216          481 LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-YLHLVSLIGYCNDDGQMILVYDYMARGTL  559 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~ey~~~gsL  559 (767)
                      +.||+|+||.||++....+++.||||++..   .....+.+|+.++..++ ||||+++++++.+++..++||||+++|+|
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L   93 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL   93 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence            679999999999999998889999999853   34456889999999997 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC---cEEEeecCCcccCCCCCCcccc
Q 042216          560 RDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW---VAKVSDFGLCKFGPNFSKTHVS  636 (767)
Q Consensus       560 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~---~~ki~DfGla~~~~~~~~~~~~  636 (767)
                      .+++...  ..+++.++..++.|++.||.|||   +++|+||||||+|||++.++   .+||+|||+++.....  ....
T Consensus        94 ~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~~  166 (325)
T 3kn6_A           94 FERIKKK--KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPL  166 (325)
T ss_dssp             HHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC--CCcc
Confidence            9999764  46999999999999999999999   67899999999999997655   8999999999864332  2223


Q ss_pred             ccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCC
Q 042216          637 TQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP  716 (767)
Q Consensus       637 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  716 (767)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....................+...      ......
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~~~  240 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGEAW  240 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSHHH
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCcccc
Confidence            34568999999999999999999999999999999999999996544321111111112222222110      000011


Q ss_pred             hhhHHHHHHHHHHccccCCCCCCCHHHHH
Q 042216          717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVV  745 (767)
Q Consensus       717 ~~~~~~l~~li~~Cl~~dp~~RPs~~evl  745 (767)
                      ...+.++.+++.+||+.||.+|||++|++
T Consensus       241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell  269 (325)
T 3kn6_A          241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLR  269 (325)
T ss_dssp             HTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred             cCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence            23567899999999999999999999987

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=6.1e-39  Score=367.28  Aligned_cols=254  Identities=23%  Similarity=0.326  Sum_probs=211.2

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      .++|...++||+|+||.||+|+...+++.||||++...   .......+.+|+++|.+++||||+++++++.+.+.+++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            45789999999999999999999888899999998643   223445688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+++|+|.+++.......+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999997766566999999999999999999999   678999999999999999999999999999865432


Q ss_pred             CCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                         .......||+.|+|||++.+..++.++|||||||++|||++|+.||............   .......         
T Consensus       340 ---~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i---~~~i~~~---------  404 (576)
T 2acx_A          340 ---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKEV---------  404 (576)
T ss_dssp             ---CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH---HHHHHHC---------
T ss_pred             ---ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH---HHHhhcc---------
Confidence               1233457999999999999989999999999999999999999999765432211111   1111111         


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRP-----SMSDVVW  746 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~  746 (767)
                       ....+...+.++.+++.+||+.||.+||     +++||++
T Consensus       405 -~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          405 -PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             -cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence             1123445667899999999999999999     7888874

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=7.7e-39  Score=344.25  Aligned_cols=253  Identities=19%  Similarity=0.239  Sum_probs=207.1

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc------chhHHHHHHHHHhccccceeeeEeeeeecCCc
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ------GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQ  546 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~------~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~  546 (767)
                      ..++|...+.||+|+||.||++....+++.||||.+......      ...++.+|+.++.+++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            346789999999999999999999888899999998654221      35679999999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC----cEEEeecC
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW----VAKVSDFG  622 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~----~~ki~DfG  622 (767)
                      .++||||+++++|.+++...  ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++    .+||+|||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            99999999999999999653  46899999999999999999999   67899999999999999888    79999999


Q ss_pred             CcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC
Q 042216          623 LCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK  702 (767)
Q Consensus       623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~  702 (767)
                      +++.....   .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.      ... .....
T Consensus       165 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~-i~~~~  234 (321)
T 2a2a_A          165 LAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LAN-ITSVS  234 (321)
T ss_dssp             TCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHH-HHTTC
T ss_pred             cceecCcc---ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH------HHH-HHhcc
Confidence            99865432   122345689999999999999999999999999999999999999965432211      111 11111


Q ss_pred             ccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       703 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .  ..++..    ....+..+.+++.+||+.||.+|||+.|+++
T Consensus       235 ~--~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          235 Y--DFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             C--CCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             c--ccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0  000001    1234567899999999999999999999985

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.1e-38  Score=353.59  Aligned_cols=252  Identities=19%  Similarity=0.311  Sum_probs=195.0

Q ss_pred             hccccc-eeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhc-cccceeeeEeeeeec----CCceE
Q 042216          475 KDFNNL-LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQ-LRYLHLVSLIGYCND----DGQMI  548 (767)
Q Consensus       475 ~~f~~~-~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~-l~Hpniv~l~g~~~~----~~~~~  548 (767)
                      ++|... ++||+|+||+||++....+++.||||++..     ...+.+|++++.+ .+||||+++++++..    .+.++
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456665 689999999999999998889999999853     2457788888754 489999999998865    56789


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC---CCcEEEeecCCcc
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE---EWVAKVSDFGLCK  625 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~---~~~~ki~DfGla~  625 (767)
                      +||||+++|+|.+++.......+++.++..++.|++.||.|||   +.+|+||||||+|||++.   ++.+||+|||+++
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            9999999999999998765567999999999999999999999   678999999999999997   7899999999998


Q ss_pred             cCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccch-hHHHHHHHHhhcCCcc
Q 042216          626 FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQV-NLAVWATECYRNGKIG  704 (767)
Q Consensus       626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~-~l~~~~~~~~~~~~~~  704 (767)
                      .....   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......    ..+...
T Consensus       213 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~~~  285 (400)
T 1nxk_A          213 ETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYE  285 (400)
T ss_dssp             ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTCCC
T ss_pred             ccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCccc
Confidence            64321   2234567899999999999999999999999999999999999999655432211 111111    111100


Q ss_pred             ccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          705 DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       705 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                            +.......++.++.+++.+||+.||.+|||+.|+++.
T Consensus       286 ------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          286 ------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             ------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                  0011123456789999999999999999999999863

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.4e-39  Score=350.09  Aligned_cols=247  Identities=28%  Similarity=0.372  Sum_probs=202.5

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc---chhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ---GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~---~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      .+.|...+.||+|+||+||+|....+++.||||++......   ..+++.+|++++++++||||+++++++..++..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            34588889999999999999999888899999999754322   235689999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+. |+|.+++.... ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.... 
T Consensus       133 ~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  206 (348)
T ss_dssp             EECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence            99997 68888885432 46999999999999999999999   67899999999999999999999999999975432 


Q ss_pred             CCccccccccCCCcccChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYR---LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDII  707 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  707 (767)
                           .....||+.|+|||++.   .+.++.++|||||||++|||++|+.||.......      ..........     
T Consensus       207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~~~~~~~~-----  270 (348)
T 1u5q_A          207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNES-----  270 (348)
T ss_dssp             -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCC-----
T ss_pred             -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhcCC-----
Confidence                 23456899999999984   5678999999999999999999999996543221      1111111111     


Q ss_pred             cccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       708 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       +   ...+..++..+.+++.+||+.||.+|||+.++++
T Consensus       271 -~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          271 -P---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             -C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -C---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence             1   1112345677899999999999999999999984

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.5e-39  Score=349.74  Aligned_cols=267  Identities=17%  Similarity=0.171  Sum_probs=201.7

Q ss_pred             hhccccceeeeccCcEEEEEEEecC---CCceEEEEEeCCCCCc-----------chhHHHHHHHHHhccccceeeeEee
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNG---DSTPVAIKRLNPGSQQ-----------GALEFQTEIGMLSQLRYLHLVSLIG  539 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~---~~~~vAVK~l~~~~~~-----------~~~~f~~Ei~~l~~l~Hpniv~l~g  539 (767)
                      .++|...+.||+|+||.||+|....   .+..+|||+.......           ....+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3578999999999999999999976   5678999998755322           1234677888999999999999999


Q ss_pred             eeec----CCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC-
Q 042216          540 YCND----DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW-  614 (767)
Q Consensus       540 ~~~~----~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~-  614 (767)
                      ++..    ....++||||+ +++|.+++....  .+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++ 
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSST
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCC
Confidence            9987    67899999999 999999996543  6999999999999999999999   67899999999999998877 


Q ss_pred             -cEEEeecCCcccCCCCCC-----ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccch
Q 042216          615 -VAKVSDFGLCKFGPNFSK-----THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQV  688 (767)
Q Consensus       615 -~~ki~DfGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~  688 (767)
                       .+||+|||+++.......     ........||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence             999999999976432111     11123457999999999999999999999999999999999999999543222111


Q ss_pred             hHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 042216          689 NLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF  752 (767)
Q Consensus       689 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~  752 (767)
                       . .......... +...+....   ....++.++.+++.+||+.||.+||++.+|++.|+.+.
T Consensus       270 -~-~~~~~~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          270 -V-QTAKTNLLDE-LPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             -H-HHHHHHHHHT-TTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             -H-HHHHHhhccc-ccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence             1 1111111110 000000000   01145668999999999999999999999999998764

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4e-39  Score=348.66  Aligned_cols=244  Identities=20%  Similarity=0.324  Sum_probs=205.5

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--------cchhHHHHHHHHHhccccceeeeEeeeeecC
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--------QGALEFQTEIGMLSQLRYLHLVSLIGYCNDD  544 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--------~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~  544 (767)
                      ..++|...+.||+|+||+||+|....+++.||||++.....        .....+.+|++++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            45789999999999999999999988889999999875431        1334678899999999999999999999999


Q ss_pred             CceEEEEecCCCC-ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCC
Q 042216          545 GQMILVYDYMARG-TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL  623 (767)
Q Consensus       545 ~~~~lV~ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGl  623 (767)
                      +..++||||+..| +|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence            9999999999777 999999654  35999999999999999999999   67899999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCcccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC
Q 042216          624 CKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL-TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK  702 (767)
Q Consensus       624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~  702 (767)
                      ++.....   .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......                 
T Consensus       177 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------------  236 (335)
T 3dls_A          177 AAYLERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------------  236 (335)
T ss_dssp             CEECCTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------
T ss_pred             ceECCCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------
Confidence            9865432   12234569999999999988776 88999999999999999999999542210                 


Q ss_pred             ccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       703 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                          ....  ...+...+.++.+++.+||+.||.+|||+.|+++.
T Consensus       237 ----~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 ----VEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ----TTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ----Hhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                0000  11233356779999999999999999999999864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.7e-39  Score=344.83  Aligned_cols=264  Identities=22%  Similarity=0.250  Sum_probs=203.6

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC---cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ---QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      .++|...+.||+|+||.||++....+++.||||++.....   ...+.+.+|+.++.+++||||+++++++..++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            4689999999999999999999988889999999875422   2246789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+++++|.+++...  ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++......
T Consensus       113 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            9999999999999654  35899999999999999999999   678999999999999999999999999998754332


Q ss_pred             CCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                      . ........|++.|+|||.+.+..++.++||||||+++|||++|+.||......       .......... .   .  
T Consensus       188 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~-~---~--  253 (309)
T 2h34_A          188 K-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAI-P---R--  253 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCC-C---C--
T ss_pred             c-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCC-C---C--
Confidence            1 11223456899999999999999999999999999999999999999643211       1111111111 0   0  


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhHhhhhc
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRP-SMSDVVWGLEFVFQLLRE  757 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RP-s~~evl~~L~~~~~~~~~  757 (767)
                       ....+..++.++.+++.+||+.||.+|| +++++++.|+.+++....
T Consensus       254 -~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~  300 (309)
T 2h34_A          254 -PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ  300 (309)
T ss_dssp             -GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred             -ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence             0112334566789999999999999999 999999999988766643

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.3e-38  Score=335.85  Aligned_cols=253  Identities=19%  Similarity=0.282  Sum_probs=206.8

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      .++|...+.||+|+||.||+|....+++.||+|++...  .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            46789999999999999999999888899999998643  2334567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCc---EEEeecCCcccCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV---AKVSDFGLCKFGP  628 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~---~ki~DfGla~~~~  628 (767)
                      ||+++|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.   +||+|||++....
T Consensus        85 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            999999999988654  35899999999999999999999   678999999999999986655   9999999997643


Q ss_pred             CCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          629 NFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      ..   .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......   ...   . ...+...    
T Consensus       160 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~---~-~~~~~~~----  225 (284)
T 3kk8_A          160 DS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYA---Q-IKAGAYD----  225 (284)
T ss_dssp             SS---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---H-HHHTCCC----
T ss_pred             cC---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH---HHH---H-HHhcccc----
Confidence            32   22234568999999999999999999999999999999999999996543221   111   1 1111110    


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                        .........+.++.+++.+||+.||.+|||+.|+++.
T Consensus       226 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          226 --YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             --CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             --CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence              0111123456778999999999999999999999863

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=337.02  Aligned_cols=252  Identities=21%  Similarity=0.366  Sum_probs=203.2

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCC
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMA  555 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~  555 (767)
                      ++....+||+|+||.||+|....+++.||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            35555689999999999999988889999999987666667789999999999999999999999999999999999999


Q ss_pred             CCChhhhhccCC-CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC-CCcEEEeecCCcccCCCCCCc
Q 042216          556 RGTLRDHLYNND-NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE-EWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       556 ~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~-~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++|.+++.... ...+++..+..++.|++.||.|||   +.+|+|+||||+|||++. ++.+||+|||+++.....  .
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--~  177 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--N  177 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCC--C
Confidence            999999997653 335779999999999999999999   678999999999999987 899999999999764321  1


Q ss_pred             cccccccCCCcccChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQL--LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                      .......|+..|+|||.+....  ++.++||||||+++|||++|+.||.........   .+.... .          ..
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~-~----------~~  243 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA---MFKVGM-F----------KV  243 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH---HHHHHH-H----------CC
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH---HHhhcc-c----------cc
Confidence            1223456899999999987643  889999999999999999999999654332111   110000 0          01


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ....+..++.++.+++.+||+.||.+||++.|+++
T Consensus       244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            12234456778999999999999999999999974

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-38  Score=336.91  Aligned_cols=251  Identities=24%  Similarity=0.297  Sum_probs=199.9

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      ++|...+.||+|+||.||++....++..+|+|++... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            5789999999999999999999888899999998654 334457799999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccC--CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE---CCCCcEEEeecCCcccCC
Q 042216          554 MARGTLRDHLYNN--DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       554 ~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl---d~~~~~ki~DfGla~~~~  628 (767)
                      +++|+|.+++...  ....+++..++.++.|++.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++...
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999998543  2356999999999999999999999   6789999999999999   556889999999997543


Q ss_pred             CCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          629 NFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      ..   .......||+.|+|||.+. +.++.++|||||||++|||++|+.||......+.   ..   .......      
T Consensus       179 ~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~---~~---~~~~~~~------  242 (285)
T 3is5_A          179 SD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV---QQ---KATYKEP------  242 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---HHHHCCC------
T ss_pred             Cc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH---Hh---hhccCCc------
Confidence            21   2234456899999999986 5689999999999999999999999965432211   11   1111100      


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       .... .....+.++.+++.+||+.||.+|||+.|+++
T Consensus       243 -~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          243 -NYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             -CCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             -cccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0000 01123567889999999999999999999974

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.7e-39  Score=346.23  Aligned_cols=261  Identities=26%  Similarity=0.330  Sum_probs=199.4

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC---cchhHHHHHHHHHhccccceeeeEeeeeecCCc----
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ---QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQ----  546 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~----  546 (767)
                      .++|...+.||+|+||.||+++...+++.||||++.....   .....+.+|++++.+++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            3578899999999999999999988889999999976532   224568999999999999999999999876544    


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      .++||||+++|+|.+++...  ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             cEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence            39999999999999999654  35899999999999999999999   67899999999999999999999999999976


Q ss_pred             CCCCCCc-cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccc
Q 042216          627 GPNFSKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD  705 (767)
Q Consensus       627 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  705 (767)
                      ....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+      ............ 
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~-  238 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIP-  238 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCC-
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCCC-
Confidence            4332211 12234568999999999999999999999999999999999999996543221      111111111100 


Q ss_pred             cccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHH-HHHHHHhH
Q 042216          706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV-VWGLEFVF  752 (767)
Q Consensus       706 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~ev-l~~L~~~~  752 (767)
                         +.   ......+.++.+++.+||+.||.+||+..++ .+.|..+.
T Consensus       239 ---~~---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          239 ---PS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             ---HH---HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ---cc---cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence               00   0112356778999999999999999965554 45555544

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-38  Score=359.23  Aligned_cols=247  Identities=24%  Similarity=0.335  Sum_probs=206.5

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|...+.||+|+||.||+|++..+++.||||++....   ......+.+|+++++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57888899999999999999998888999999986431   223457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|+|.+++.+.  ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        96 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-  169 (476)
T 2y94_A           96 EYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-  169 (476)
T ss_dssp             ECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence            999999999999643  46999999999999999999999   788999999999999999999999999999865332 


Q ss_pred             CccccccccCCCcccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLL-TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                        ......+||+.|+|||.+.+..+ +.++|||||||++|||++|+.||.......   +.   . ....+.        
T Consensus       170 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~---~-~i~~~~--------  232 (476)
T 2y94_A          170 --EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---LF---K-KICDGI--------  232 (476)
T ss_dssp             --CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---HH---H-HHHTTC--------
T ss_pred             --ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---HH---H-HHhcCC--------
Confidence              22344579999999999988765 689999999999999999999996543221   11   1 111111        


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                        ...+...+.++.+++.+||+.||.+|||+.|+++
T Consensus       233 --~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          233 --FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence              1123345667899999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.7e-39  Score=347.77  Aligned_cols=253  Identities=19%  Similarity=0.276  Sum_probs=204.3

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEEE
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ..++|...+.||+|+||.||++..+.+++.||||++.....    ...+|++++.++ +||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            45689999999999999999999998889999999975432    345788888888 7999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCC----CcEEEeecCCcccC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEE----WVAKVSDFGLCKFG  627 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~----~~~ki~DfGla~~~  627 (767)
                      ||+++|+|.+++.+.  ..+++.++..++.|++.||.|||   +.+|+||||||+|||+.++    +.+||+|||+++..
T Consensus        96 E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           96 ELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            999999999999654  45899999999999999999999   6789999999999998533    35999999999864


Q ss_pred             CCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccc
Q 042216          628 PNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDII  707 (767)
Q Consensus       628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  707 (767)
                      ....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+..    .+..+..    
T Consensus       171 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~----~i~~~~~----  240 (342)
T 2qr7_A          171 RAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA----RIGSGKF----  240 (342)
T ss_dssp             BCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH----HHHHCCC----
T ss_pred             cCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH----HHccCCc----
Confidence            3321  22344578999999999988888999999999999999999999997543222221211    1112211    


Q ss_pred             cccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       708 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                        .+........+.++.+++.+||+.||.+||++.|+++
T Consensus       241 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          241 --SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             --CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              1111223456678999999999999999999999985

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.2e-38  Score=343.75  Aligned_cols=258  Identities=18%  Similarity=0.243  Sum_probs=207.4

Q ss_pred             HHHHhhccccc-eeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCC
Q 042216          470 IKEATKDFNNL-LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDG  545 (767)
Q Consensus       470 i~~~t~~f~~~-~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~  545 (767)
                      .....+.|... +.||+|+||.||+|....+++.||||++...  ......++.+|+.++.++ +||||+++++++.+.+
T Consensus        23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~  102 (327)
T 3lm5_A           23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS  102 (327)
T ss_dssp             HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence            34455667776 7899999999999999988899999998754  233456789999999999 4699999999999999


Q ss_pred             ceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC---CCcEEEeecC
Q 042216          546 QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE---EWVAKVSDFG  622 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~---~~~~ki~DfG  622 (767)
                      ..++||||+++|+|.+++.......+++.+++.++.|++.||.|||   +.+|+||||||+|||++.   ++.+||+|||
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg  179 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFG  179 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred             eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence            9999999999999999997666667999999999999999999999   678999999999999998   7899999999


Q ss_pred             CcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC
Q 042216          623 LCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK  702 (767)
Q Consensus       623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~  702 (767)
                      +++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..  ..     .....
T Consensus       180 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~-----i~~~~  249 (327)
T 3lm5_A          180 MSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY--LN-----ISQVN  249 (327)
T ss_dssp             GCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HH-----HHHTC
T ss_pred             cccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH--HH-----HHhcc
Confidence            99865322   1223456999999999999999999999999999999999999999654332111  10     01100


Q ss_pred             ccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       703 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                            ..........++..+.+++.+||+.||.+|||++|+++
T Consensus       250 ------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          250 ------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             ------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence                  01111223345678899999999999999999999985

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.7e-39  Score=353.53  Aligned_cols=248  Identities=27%  Similarity=0.362  Sum_probs=195.8

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHH-HhccccceeeeEeeeeecCCceEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGM-LSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~-l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      .++|...+.||+|+||+||+++.+.+++.||||++....   ......+.+|..+ ++.++||||+++++++.+.+.+++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            357999999999999999999999888999999996542   2234456777776 567899999999999999999999


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ||||+++|+|.+++.+.  ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       117 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            99999999999999654  35889999999999999999999   77899999999999999999999999999985322


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                        ........+||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +   ...... +.       
T Consensus       192 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~---~~~i~~-~~-------  255 (373)
T 2r5t_A          192 --HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---M---YDNILN-KP-------  255 (373)
T ss_dssp             --CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH---H---HHHHHH-SC-------
T ss_pred             --CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---H---HHHHHh-cc-------
Confidence              1123345679999999999999999999999999999999999999996543211   1   111111 11       


Q ss_pred             cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHH
Q 042216          710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV  745 (767)
Q Consensus       710 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl  745 (767)
                         ...+...+..+.+++.+||+.||.+||++.+.+
T Consensus       256 ---~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          256 ---LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             ---CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             ---cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence               112344567789999999999999999985433

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.4e-39  Score=354.31  Aligned_cols=266  Identities=24%  Similarity=0.340  Sum_probs=195.8

Q ss_pred             HHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccc-cceeeeEeeeeecCC--c
Q 042216          472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLR-YLHLVSLIGYCNDDG--Q  546 (767)
Q Consensus       472 ~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~--~  546 (767)
                      ...++|...+.||+|+||.||+|....+++.||||++...  .....+.+.+|+.++.+++ ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3567899999999999999999999888899999998654  2334556889999999997 999999999997543  7


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      .++|||||+ |+|.+++...   .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            899999998 5999998653   5899999999999999999999   67899999999999999999999999999975


Q ss_pred             CCCCC-------------------CccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCcc
Q 042216          627 GPNFS-------------------KTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKK  686 (767)
Q Consensus       627 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~  686 (767)
                      .....                   .....+...||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            43211                   1112234579999999999976 679999999999999999999999997654332


Q ss_pred             chhHHHHHHHHhhcCCccc---cc------------------ccccc------------CCCChhhHHHHHHHHHHcccc
Q 042216          687 QVNLAVWATECYRNGKIGD---II------------------DPFLK------------GNAPPVCLNQFVEVAMSCVND  733 (767)
Q Consensus       687 ~~~l~~~~~~~~~~~~~~~---~~------------------d~~l~------------~~~~~~~~~~l~~li~~Cl~~  733 (767)
                      +....  . ..........   +.                  .....            ......++.++.+|+.+||+.
T Consensus       239 ~~~~i--~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          239 QLERI--I-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             HHHHH--H-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             HHHHH--H-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            21111  1 1110000000   00                  00000            001113456789999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 042216          734 DRIRRPSMSDVVWG  747 (767)
Q Consensus       734 dp~~RPs~~evl~~  747 (767)
                      ||.+|||++|+++.
T Consensus       316 dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          316 NPNKRISANDALKH  329 (388)
T ss_dssp             SGGGSCCHHHHTTS
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999854

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.8e-39  Score=345.42  Aligned_cols=261  Identities=22%  Similarity=0.248  Sum_probs=199.6

Q ss_pred             hccccc-eeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEEEe
Q 042216          475 KDFNNL-LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       475 ~~f~~~-~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      +.|... ++||+|+||+||+|....+++.||||++..........+.+|++++.++ +||||+++++++.+++..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            356653 5799999999999998888899999999776666677899999999985 79999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCc---EEEeecCCcccCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV---AKVSDFGLCKFGPN  629 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~---~ki~DfGla~~~~~  629 (767)
                      |+++|+|.+++...  ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.   +||+|||+++....
T Consensus        92 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           92 KMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             cCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            99999999999654  35899999999999999999999   678999999999999998776   99999999875432


Q ss_pred             CCC-----ccccccccCCCcccChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchh--------HH
Q 042216          630 FSK-----THVSTQVKGSIGYLDPEYYRL-----QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVN--------LA  691 (767)
Q Consensus       630 ~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~--------l~  691 (767)
                      ...     ........||+.|+|||.+..     ..++.++|||||||++|||++|+.||..........        ..
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            111     111223459999999999875     568899999999999999999999996654321000        00


Q ss_pred             HHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          692 VWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       692 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .........+.. ...+.     .....+.++.+++.+||+.||.+|||+.|+++
T Consensus       247 ~~~~~~i~~~~~-~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          247 NMLFESIQEGKY-EFPDK-----DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHCCC-CCCHH-----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhccCc-ccCch-----hcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            001111111110 00000     00124567899999999999999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8.8e-39  Score=337.01  Aligned_cols=246  Identities=24%  Similarity=0.336  Sum_probs=202.7

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEE
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~l  549 (767)
                      ..++|...+.||+|+||.||+|....+++.||||++...  ......++.+|+..+..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            457899999999999999999999888899999998754  334456788999999999 99999999999999999999


Q ss_pred             EEecCCCCChhhhhccCC--CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC---------------
Q 042216          550 VYDYMARGTLRDHLYNND--NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE---------------  612 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~---------------  612 (767)
                      ||||+++|+|.+++....  ...+++.+++.++.|++.||.|||   +++|+||||||+|||++.               
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999996532  256899999999999999999999   678999999999999984               


Q ss_pred             ----CCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccc
Q 042216          613 ----EWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ  687 (767)
Q Consensus       613 ----~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~  687 (767)
                          ...+||+|||++......      ....||..|+|||.+.+. .++.++|||||||+++||++|.+++....    
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----  235 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----  235 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred             ccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence                448999999998864331      223589999999999865 66789999999999999999998763221    


Q ss_pred             hhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          688 VNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       688 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       ..     .....+..         ...+..++.++.+++.+||+.||.+|||+.|+++
T Consensus       236 -~~-----~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          236 -QW-----HEIRQGRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -HH-----HHHHTTCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HH-----HHHHcCCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence             11     11122211         1233455678999999999999999999999975

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2e-38  Score=334.56  Aligned_cols=246  Identities=25%  Similarity=0.378  Sum_probs=206.6

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|...+.||+|+||.||+|....+++.||||++...   .......+.+|++++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            5789999999999999999999888889999998543   1223457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++...... 
T Consensus        94 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            999999999999654  35899999999999999999999   788999999999999999999999999998754321 


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                         ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+      .... ....          
T Consensus       168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~-~~~~----------  227 (284)
T 2vgo_A          168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------THRR-IVNV----------  227 (284)
T ss_dssp             ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHH-HHTT----------
T ss_pred             ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HHHH-Hhcc----------
Confidence               1234568999999999999999999999999999999999999996543211      1111 1111          


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ....+...+..+.+++.+||+.||.+||++.|+++
T Consensus       228 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          228 DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            11233455678899999999999999999999985

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.6e-38  Score=354.88  Aligned_cols=266  Identities=20%  Similarity=0.181  Sum_probs=212.1

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcccc-ceeeeEeeeeecCCceEEEEe
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRY-LHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H-pniv~l~g~~~~~~~~~lV~e  552 (767)
                      .++|...++||+|+||.||+|+...+++.||||++.....  ..++..|++++..|+| +++..+..++.+.+..+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            3678899999999999999999988889999998865432  3468899999999987 556666666777888999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE---CCCCcEEEeecCCcccCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl---d~~~~~ki~DfGla~~~~~  629 (767)
                      |+ +++|.+++.... ..+++.+++.|+.||+.||.|||   +.+|+||||||+||||   +.++.+||+|||+++....
T Consensus        84 ~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             CC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            99 899999997543 46999999999999999999999   6789999999999999   6889999999999986543


Q ss_pred             CCCc-----cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc
Q 042216          630 FSKT-----HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG  704 (767)
Q Consensus       630 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  704 (767)
                      ....     .......||..|+|||.+.+..++.++|||||||+||||++|+.||.......................+.
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE  238 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred             CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence            2211     11225679999999999999999999999999999999999999997765443332222222211111111


Q ss_pred             ccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          705 DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       705 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      .+         ...++.++.+++..||+.+|.+||++.+|++.|+.++...
T Consensus       239 ~l---------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          239 AL---------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HH---------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HH---------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            10         1234567999999999999999999999999999997654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.9e-38  Score=336.71  Aligned_cols=253  Identities=21%  Similarity=0.273  Sum_probs=204.6

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC----CcchhHHHHHHHHHhccccceeeeEeeee--ecCCce
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS----QQGALEFQTEIGMLSQLRYLHLVSLIGYC--NDDGQM  547 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~----~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~--~~~~~~  547 (767)
                      .++|...+.||+|+||.||++....+++.||+|++....    ......+.+|++++++++||||+++++++  .+.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            467999999999999999999998888999999986432    23456799999999999999999999998  445689


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      ++||||++++ |.+++.......+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999986 888887665667999999999999999999999   678999999999999999999999999999865


Q ss_pred             CCCCCccccccccCCCcccChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccc
Q 042216          628 PNFSKTHVSTQVKGSIGYLDPEYYRLQL--LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD  705 (767)
Q Consensus       628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  705 (767)
                      .............|+..|+|||.+.+..  .+.++||||||+++|||++|+.||......      .... ....+.   
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~-~i~~~~---  229 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------KLFE-NIGKGS---  229 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHH-HHHHCC---
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------HHHH-HHhcCC---
Confidence            4333333334566899999999998644  378999999999999999999999654321      1111 111111   


Q ss_pred             cccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       706 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                             ...+..++..+.+++.+||+.||.+|||+.|+++.
T Consensus       230 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 -------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             -------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                   12234566788999999999999999999999864

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=335.70  Aligned_cols=250  Identities=24%  Similarity=0.336  Sum_probs=186.5

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      .++|...+.||+|+||.||+|+...+++.||||++....   ....+.+.+|++++.+++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            357899999999999999999998778999999986431   22346789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+++++|.+++... ...+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++......
T Consensus        90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            9999999999999654 246899999999999999999999   678999999999999999999999999999864321


Q ss_pred             CCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                      .  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........          .     .+... 
T Consensus       166 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----------~-----~~~~~-  227 (278)
T 3cok_A          166 H--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL----------N-----KVVLA-  227 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSS-
T ss_pred             C--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH----------H-----HHhhc-
Confidence            1  1123456899999999999889999999999999999999999999654322110          0     00000 


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       ....+...+.++.+++.+||+.||.+|||++++++
T Consensus       228 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          228 -DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence             01223445678899999999999999999999985

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.9e-38  Score=334.25  Aligned_cols=252  Identities=21%  Similarity=0.279  Sum_probs=203.3

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC------cchhHHHHHHHHHhccccceeeeEeeeeecCCce
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ------QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQM  547 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~------~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~  547 (767)
                      .++|...+.||+|+||.||++....+++.||+|.+.....      ...+.+.+|++++++++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            3578899999999999999999988889999999864421      1356799999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC----cEEEeecCC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW----VAKVSDFGL  623 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~----~~ki~DfGl  623 (767)
                      ++||||+++++|.+++...  ..+++.+++.++.|++.||.|||   +.+|+||||||+||+++.++    .+||+|||+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            9999999999999999653  35899999999999999999999   67899999999999998877    899999999


Q ss_pred             cccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCc
Q 042216          624 CKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKI  703 (767)
Q Consensus       624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~  703 (767)
                      ++......   ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+.  +    .. ......
T Consensus       159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~-~~~~~~  228 (283)
T 3bhy_A          159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET--L----TN-ISAVNY  228 (283)
T ss_dssp             CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--H----HH-HHTTCC
T ss_pred             ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH--H----HH-hHhccc
Confidence            97643211   22345689999999999999999999999999999999999999965432211  1    11 111110


Q ss_pred             cccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          704 GDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       704 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                        ..+.    ......+..+.+++.+||+.||.+||++.|+++
T Consensus       229 --~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          229 --DFDE----EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             --CCCH----HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --CCcc----hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence              0000    011234567899999999999999999999996

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.1e-39  Score=356.71  Aligned_cols=250  Identities=14%  Similarity=0.130  Sum_probs=194.3

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHH---HHHhccccceeeeEe-------ee
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEI---GMLSQLRYLHLVSLI-------GY  540 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei---~~l~~l~Hpniv~l~-------g~  540 (767)
                      .++|...+.||+|+||.||+|+...+++.||||++...   .....+.+.+|+   ++|++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            35688888999999999999998877899999998633   334456789999   555566899999998       55


Q ss_pred             eecCC-----------------ceEEEEecCCCCChhhhhccCC-----CCCCChHHHHHHHHHHHHHHHHhHhCCCCCe
Q 042216          541 CNDDG-----------------QMILVYDYMARGTLRDHLYNND-----NPPLPWDRRLKICIGAARALHYLHTGASKVI  598 (767)
Q Consensus       541 ~~~~~-----------------~~~lV~ey~~~gsL~~~L~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  598 (767)
                      +...+                 ..++||||+ +|+|.+++....     ...+++..++.|+.|++.||+|||   +.+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            55443                 388999999 579999996532     123456899999999999999999   6789


Q ss_pred             EecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccC-----------CCCchhhHHHHHH
Q 042216          599 IHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ-----------LLTEKSDVYSFGV  667 (767)
Q Consensus       599 iH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDV~SfGv  667 (767)
                      +||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999985321     2334567 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH-
Q 042216          668 VLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW-  746 (767)
Q Consensus       668 vl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~-  746 (767)
                      ++|||++|+.||.........               ..+    ..  ....++.++.+++.+||+.||.+|||+.|+++ 
T Consensus       302 il~elltg~~Pf~~~~~~~~~---------------~~~----~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGS---------------EWI----FR--SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HHHHHHHSSCCC------CCS---------------GGG----GS--SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             HHHHHHHCCCCCcccccccch---------------hhh----hh--hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            999999999999544322111               011    10  11244577899999999999999999999995 


Q ss_pred             -HHHHhHhh
Q 042216          747 -GLEFVFQL  754 (767)
Q Consensus       747 -~L~~~~~~  754 (767)
                       .++.+.+.
T Consensus       361 p~f~~~~~~  369 (377)
T 3byv_A          361 PEYEQLRTE  369 (377)
T ss_dssp             HHHHHHHHH
T ss_pred             hHHHHHHHH
Confidence             44444433

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.3e-38  Score=337.72  Aligned_cols=252  Identities=21%  Similarity=0.316  Sum_probs=206.0

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ..++|...+.||+|+||.||+++...+++.||+|++..........+.+|++++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            35678999999999999999999988889999999986655455678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE---CCCCcEEEeecCCcccCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl---d~~~~~ki~DfGla~~~~~  629 (767)
                      |+++|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||+   ++++.+||+|||+++....
T Consensus        87 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           87 LVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             cCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            99999999998654  35899999999999999999999   6789999999999999   7889999999999875332


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                          .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......   .+..    .+..+..      
T Consensus       162 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~----~i~~~~~------  224 (304)
T 2jam_A          162 ----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFE----KIKEGYY------  224 (304)
T ss_dssp             ----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH----HHHHCCC------
T ss_pred             ----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHH----HHHcCCC------
Confidence                1223346899999999999999999999999999999999999999654322   1111    1111111      


Q ss_pred             cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       710 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ..........+.++.+++.+||+.||.+|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          225 EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0111223345678999999999999999999999985

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5e-39  Score=346.26  Aligned_cols=262  Identities=19%  Similarity=0.281  Sum_probs=198.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc-chhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ-GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      ++|...+.||+|+||+||+|....+++.||||++...... ....+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            4688899999999999999999888899999999754322 223456799999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      ++ |+|.+++.... ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....  .
T Consensus        82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--T  154 (324)
T ss_dssp             CS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC--c
Confidence            98 59999887653 46899999999999999999999   678999999999999999999999999998754321  1


Q ss_pred             cccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcC---Cccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG---KIGDIIDP  709 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~d~  709 (767)
                      .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+..   ..........   ........
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGC
T ss_pred             cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHhchhhhcc
Confidence            22234568999999999876 57899999999999999999999999765433221   1111111110   01111000


Q ss_pred             ---------cccC----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          710 ---------FLKG----NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       710 ---------~l~~----~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                               ....    ...+..+.++.+++.+||+.||.+|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                     0000    011234567899999999999999999999985

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=9.3e-38  Score=338.36  Aligned_cols=273  Identities=22%  Similarity=0.294  Sum_probs=210.6

Q ss_pred             HHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhc--cccceeeeEeeeeecCC--
Q 042216          470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQ--LRYLHLVSLIGYCNDDG--  545 (767)
Q Consensus       470 i~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~--l~Hpniv~l~g~~~~~~--  545 (767)
                      -....++|...+.||+|+||.||+|+..  ++.||||++..   .....+.+|++++..  ++||||+++++++...+  
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            3455678999999999999999999985  48899999863   345567889888887  78999999999998775  


Q ss_pred             --ceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCC-----CCCeEecCCCCCCeEECCCCcEEE
Q 042216          546 --QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA-----SKVIIHRDVKTTNILLDEEWVAKV  618 (767)
Q Consensus       546 --~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiH~Dlk~~NILld~~~~~ki  618 (767)
                        ..++||||+++|+|.+++.+.   .+++.+++.++.|++.||.|||...     +.+|+||||||+|||++.++.+||
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL  188 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  188 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred             cceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence              789999999999999999653   5899999999999999999999321     468999999999999999999999


Q ss_pred             eecCCcccCCCCCCcc--ccccccCCCcccChhhhccCC------CCchhhHHHHHHHHHHHHhC----------CCCCC
Q 042216          619 SDFGLCKFGPNFSKTH--VSTQVKGSIGYLDPEYYRLQL------LTEKSDVYSFGVVLLEVLCA----------RPPIL  680 (767)
Q Consensus       619 ~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~s~ksDV~SfGvvl~elltg----------~~P~~  680 (767)
                      +|||+++.........  ......||+.|+|||.+.+..      ++.++|||||||++|||++|          +.||.
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~  268 (342)
T 1b6c_B          189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  268 (342)
T ss_dssp             CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence            9999997543222111  223456999999999998652      33789999999999999999          77875


Q ss_pred             CCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          681 RTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       681 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      ...... .....+.... ........+...   .....++..+.+++.+||+.||.+|||+.||++.|+.+.+..
T Consensus       269 ~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          269 DLVPSD-PSVEEMRKVV-CEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             TTSCSS-CCHHHHHHHH-TTSCCCCCCCGG---GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             ccCcCc-ccHHHHHHHH-HHHHhCCCCccc---ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence            543221 1122222211 111111111000   012357788999999999999999999999999999887543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.3e-38  Score=336.17  Aligned_cols=249  Identities=26%  Similarity=0.378  Sum_probs=208.0

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      +.|...+.||+|+||.||+|....+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            46888999999999999999998888999999997553 34567799999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++++|.+++..   ..+++..+..++.|++.||.|||   +.+|+|+||||+|||++.++.+||+|||++.......  
T Consensus       102 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--  173 (303)
T 3a7i_A          102 LGGGSALDLLEP---GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--  173 (303)
T ss_dssp             CTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--
T ss_pred             CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc--
Confidence            999999999854   35899999999999999999999   6789999999999999999999999999997643321  


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......   ....    .....         ..
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~----~~~~~---------~~  237 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VLFL----IPKNN---------PP  237 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHH----HHHSC---------CC
T ss_pred             cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HHHH----hhcCC---------CC
Confidence            12234568999999999999999999999999999999999999996543221   1111    11111         11


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      ..+..++..+.+++.+||+.||.+|||+.|+++.
T Consensus       238 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          238 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            1233456678999999999999999999999864

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.2e-39  Score=339.53  Aligned_cols=255  Identities=25%  Similarity=0.379  Sum_probs=206.2

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeee--cCCceEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCN--DDGQMIL  549 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~--~~~~~~l  549 (767)
                      .++|...+.||+|+||.||++....+++.||+|++....  ....+.+.+|++++++++||||+++++++.  ..+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467899999999999999999998888999999997543  334567899999999999999999999874  4678999


Q ss_pred             EEecCCCCChhhhhccC--CCCCCChHHHHHHHHHHHHHHHHhHhCCCCC-----eEecCCCCCCeEECCCCcEEEeecC
Q 042216          550 VYDYMARGTLRDHLYNN--DNPPLPWDRRLKICIGAARALHYLHTGASKV-----IIHRDVKTTNILLDEEWVAKVSDFG  622 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----iiH~Dlk~~NILld~~~~~ki~DfG  622 (767)
                      ||||+++|+|.+++...  ....+++..++.++.|++.||.|||   +.+     |+||||||+|||++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999999653  2345999999999999999999999   555     9999999999999999999999999


Q ss_pred             CcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC
Q 042216          623 LCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK  702 (767)
Q Consensus       623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~  702 (767)
                      +++.....  ........|+..|+|||.+.+..++.++||||||+++|||++|+.||......   .+..    ....+.
T Consensus       162 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~----~i~~~~  232 (279)
T 2w5a_A          162 LARILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAG----KIREGK  232 (279)
T ss_dssp             HHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHTC
T ss_pred             hheeeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHHH----HHhhcc
Confidence            98764321  11223356899999999999999999999999999999999999999654321   1111    112222


Q ss_pred             ccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       703 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                      .         ...+..++.++.+++.+||+.||.+||++.||++.+.
T Consensus       233 ~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          233 F---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             C---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             c---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            1         1223456678999999999999999999999987653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.2e-38  Score=360.46  Aligned_cols=253  Identities=25%  Similarity=0.352  Sum_probs=208.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|...++||+|+||.||+++.+.+++.||+|++...   .......+.+|+++|++++||||+++++++...+.+++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            5788889999999999999999888899999998643   1234457889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCC--CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          552 DYMARGTLRDHLYNND--NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ||+++|+|.+++....  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999999996543  456999999999999999999999   67899999999999999999999999999986533


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                      ..  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........  ........... .       
T Consensus       342 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~~-~-------  409 (543)
T 3c4z_A          342 GQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLEQ-A-------  409 (543)
T ss_dssp             TC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHHC-C-------
T ss_pred             CC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhhc-c-------
Confidence            21  122345799999999999999999999999999999999999999976543211  11111111111 1       


Q ss_pred             cccCCCChhhHHHHHHHHHHccccCCCCCCCH-----HHHH
Q 042216          710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSM-----SDVV  745 (767)
Q Consensus       710 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~-----~evl  745 (767)
                         ...+...+..+.+++.+||+.||.+||++     ++|+
T Consensus       410 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~  447 (543)
T 3c4z_A          410 ---VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR  447 (543)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred             ---cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence               12345567789999999999999999975     5665

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-38  Score=343.05  Aligned_cols=268  Identities=24%  Similarity=0.287  Sum_probs=200.6

Q ss_pred             HHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc-----chhHHHHHHHHHhccccceeeeEeeeeecC
Q 042216          470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ-----GALEFQTEIGMLSQLRYLHLVSLIGYCNDD  544 (767)
Q Consensus       470 i~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~-----~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~  544 (767)
                      +....++|...+.||+|+||.||+|....+++.||||++......     ..+.+.+|++++++++||||+++++++.+.
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (346)
T 1ua2_A            5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK   84 (346)
T ss_dssp             --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence            344567899999999999999999999888899999998753221     234688999999999999999999999999


Q ss_pred             CceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCc
Q 042216          545 GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC  624 (767)
Q Consensus       545 ~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla  624 (767)
                      +..++||||+++ +|.+++.... ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        85 ~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           85 SNISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             TCCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             CceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence            999999999986 8988886543 46899999999999999999999   678999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC-
Q 042216          625 KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK-  702 (767)
Q Consensus       625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~-  702 (767)
                      +.....  ........||+.|+|||.+.+. .++.++|||||||++|||++|.+||......+  .+.... ....... 
T Consensus       160 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~~~~i~-~~~~~~~~  234 (346)
T 1ua2_A          160 KSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIF-ETLGTPTE  234 (346)
T ss_dssp             STTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH-HHHCCCCT
T ss_pred             eeccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHH-HHcCCCCh
Confidence            864322  1223445789999999999754 58999999999999999999999986543321  111111 1111100 


Q ss_pred             --ccc---cccccccCC---C-----ChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          703 --IGD---IIDPFLKGN---A-----PPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       703 --~~~---~~d~~l~~~---~-----~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                        ..+   ..+......   .     ....+.++.+++.+||+.||.+|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence              000   000000000   1     13345789999999999999999999999864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.2e-38  Score=344.16  Aligned_cols=263  Identities=19%  Similarity=0.251  Sum_probs=196.1

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      ..++|...+.||+|+||+||+|....+++.||||++.....  .....+.+|++++++++||||+++++++.+++..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            45689999999999999999999988889999999975432  2245678999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE-----CCCCcEEEeecCCcc
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL-----DEEWVAKVSDFGLCK  625 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl-----d~~~~~ki~DfGla~  625 (767)
                      |||+++ +|.+++....  .+++.++..++.|++.||.|||   +.+|+||||||+|||+     ++++.+||+|||+++
T Consensus       112 ~e~~~~-~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          112 FEYAEN-DLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EECCSE-EHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EecCCC-CHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            999985 9999996543  5899999999999999999999   6789999999999999     556679999999997


Q ss_pred             cCCCCCCccccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC--
Q 042216          626 FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK--  702 (767)
Q Consensus       626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~--  702 (767)
                      .....  ........||..|+|||++.+. .++.++|||||||++|||++|+.||......+  .+..... ......  
T Consensus       186 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~-~~~~~~~~  260 (329)
T 3gbz_A          186 AFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIFE-VLGLPDDT  260 (329)
T ss_dssp             HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-HHCCCCTT
T ss_pred             ccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHHH-HhCCCchh
Confidence            54321  1122345689999999999874 58999999999999999999999996544322  1111111 111000  


Q ss_pred             -cc-------------ccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          703 -IG-------------DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       703 -~~-------------~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       ..             +.....+....+.....++.+++.+||+.||.+|||+.|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence             00             000000000011124567899999999999999999999975

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.3e-38  Score=335.90  Aligned_cols=250  Identities=20%  Similarity=0.285  Sum_probs=207.7

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      .++|...+.||+|+||.||++....+++.+|+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            357888999999999999999999888999999986432   23455688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+++++|.+++...  ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        94 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           94 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            9999999999988653  35899999999999999999999   678999999999999999999999999999864322


Q ss_pred             CCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                      .  .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+      .... .....        
T Consensus       169 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~-~~~~~--------  231 (294)
T 2rku_A          169 G--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLR-IKKNE--------  231 (294)
T ss_dssp             T--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHH-HHTTC--------
T ss_pred             c--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-Hhhcc--------
Confidence            1  12334568999999999999899999999999999999999999996543221      1111 11111        


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                        ...+...+..+.+++.+||+.||.+|||++|+++.
T Consensus       232 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          232 --YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             --CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence              11233455678999999999999999999999864

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.5e-38  Score=334.89  Aligned_cols=247  Identities=25%  Similarity=0.397  Sum_probs=199.1

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeec----CCceEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCND----DGQMIL  549 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~----~~~~~l  549 (767)
                      .|...+.||+|+||.||+|....++..||+|++...  .....+.+.+|+.++++++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            366677899999999999999888899999998643  33345678999999999999999999998864    356899


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCC--eEecCCCCCCeEEC-CCCcEEEeecCCccc
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV--IIHRDVKTTNILLD-EEWVAKVSDFGLCKF  626 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiH~Dlk~~NILld-~~~~~ki~DfGla~~  626 (767)
                      ||||+++|+|.+++...  ..+++..++.++.|++.||.|||   +.+  |+||||||+|||++ +++.+||+|||++..
T Consensus       107 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            99999999999999653  45899999999999999999999   666  99999999999998 889999999999975


Q ss_pred             CCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccc
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI  706 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  706 (767)
                      ....    ......||+.|+|||.+. +.++.++|||||||++|||++|+.||.......     ..... ...+.... 
T Consensus       182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~-~~~~~~~~-  249 (290)
T 1t4h_A          182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRR-VTSGVKPA-  249 (290)
T ss_dssp             CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHH-HTTTCCCG-
T ss_pred             cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-----HHHHH-HhccCCcc-
Confidence            4321    223456899999999887 458999999999999999999999996543321     11111 11111110 


Q ss_pred             ccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          707 IDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       707 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                             ..+...+.++.+++.+||+.||.+|||++|+++
T Consensus       250 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          250 -------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                   112233467899999999999999999999985

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6.9e-39  Score=346.14  Aligned_cols=266  Identities=24%  Similarity=0.343  Sum_probs=202.7

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc--chhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~--~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      .++|...+.||+|+||.||+|....+++.||||++......  ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            35788999999999999999999988899999998654322  2445789999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus       104 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  177 (331)
T 4aaa_A          104 EFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-  177 (331)
T ss_dssp             ECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC-
Confidence            999999998887543  35999999999999999999999   678999999999999999999999999999754321 


Q ss_pred             CccccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHH--------HHHHhh-cC
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVW--------ATECYR-NG  701 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~--------~~~~~~-~~  701 (767)
                       ........|+..|+|||.+.+. .++.++|||||||++|||++|+.||......+.......        ....+. ..
T Consensus       178 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          178 -GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             -ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence             1223345689999999999875 789999999999999999999999966543221111100        000000 00


Q ss_pred             CccccccccccCC-----CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          702 KIGDIIDPFLKGN-----APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       702 ~~~~~~d~~l~~~-----~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .......+.+...     ..+.++..+.+++.+||+.||.+|||+.|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0111111111111     11245678999999999999999999999985

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=9.4e-39  Score=339.82  Aligned_cols=263  Identities=23%  Similarity=0.316  Sum_probs=188.5

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      .++|...+.||+|+||.||+|....+++.||||++.... .....++.+|++++.+++||||+++++++...+..++|||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            468999999999999999999988777899999986542 3345678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhcc------CCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          553 YMARGTLRDHLYN------NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       553 y~~~gsL~~~L~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      |+++|+|.+++..      .....+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  170 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAF  170 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence            9999999999863      12456899999999999999999999   67899999999999999999999999999875


Q ss_pred             CCCCCC---ccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC
Q 042216          627 GPNFSK---THVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK  702 (767)
Q Consensus       627 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~  702 (767)
                      ......   ........||+.|+|||.+.. ..++.++|||||||++|||++|+.||.........   .   .... ..
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~---~~~~-~~  243 (303)
T 2vwi_A          171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---M---LTLQ-ND  243 (303)
T ss_dssp             CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---H---HHHT-SS
T ss_pred             eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH---H---HHhc-cC
Confidence            432211   112234568999999999875 57899999999999999999999999665433211   1   1111 11


Q ss_pred             ccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       703 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .................+.++.+++.+||+.||.+||++.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            11111111111222345567899999999999999999999985

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.3e-38  Score=342.77  Aligned_cols=250  Identities=20%  Similarity=0.288  Sum_probs=207.6

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      .++|...+.||+|+||.||++....+++.+|+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            35788899999999999999999988899999998643   223455689999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+++++|.+++...  ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            9999999999998653  35899999999999999999999   678999999999999999999999999999864322


Q ss_pred             CCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                      .  .......|+..|+|||.+.+..++.++|||||||++|||++|+.||......+      .... .....        
T Consensus       195 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~-~~~~~--------  257 (335)
T 2owb_A          195 G--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLR-IKKNE--------  257 (335)
T ss_dssp             T--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHH-HHHTC--------
T ss_pred             c--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH------HHHH-HhcCC--------
Confidence            1  22334568999999999999999999999999999999999999996543211      1111 11111        


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                        ...+......+.+++.+||+.||.+|||+.|+++.
T Consensus       258 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          258 --YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             --CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              11233455678999999999999999999999863

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.4e-38  Score=353.10  Aligned_cols=254  Identities=24%  Similarity=0.334  Sum_probs=195.0

Q ss_pred             HHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--------CcchhHHHHHHHHHhccccceeeeEeeeeec
Q 042216          472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--------QQGALEFQTEIGMLSQLRYLHLVSLIGYCND  543 (767)
Q Consensus       472 ~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--------~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~  543 (767)
                      ...++|...+.||+|+||+||+|....+++.||||++....        ......+.+|+++|++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            35678999999999999999999999888999999986421        1223458899999999999999999999854


Q ss_pred             CCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCC---CcEEEee
Q 042216          544 DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEE---WVAKVSD  620 (767)
Q Consensus       544 ~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~---~~~ki~D  620 (767)
                       +..++||||+++|+|.+++...  ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.+   +.+||+|
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             -CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEee
Confidence             4689999999999999998543  46999999999999999999999   6789999999999999654   4599999


Q ss_pred             cCCcccCCCCCCccccccccCCCcccChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHH
Q 042216          621 FGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR---LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATEC  697 (767)
Q Consensus       621 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~  697 (767)
                      ||+++....   ........||+.|+|||++.   ...++.++|||||||++|||++|+.||.......  .+...    
T Consensus       286 FG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~----  356 (419)
T 3i6u_A          286 FGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ----  356 (419)
T ss_dssp             SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHH----
T ss_pred             cccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHH----
Confidence            999986532   22234567999999999985   3678899999999999999999999996543321  11111    


Q ss_pred             hhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          698 YRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       698 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ...+.....  +    ......+.++.+++.+||+.||.+|||+.|+++
T Consensus       357 i~~~~~~~~--~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          357 ITSGKYNFI--P----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHTTCCCCC--H----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhcCCCCCC--c----hhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            111111000  0    001234567899999999999999999999985

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=343.35  Aligned_cols=262  Identities=24%  Similarity=0.356  Sum_probs=204.0

Q ss_pred             ccCHHHHHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc-ccceeeeEeeeee
Q 042216          464 QFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGYCN  542 (767)
Q Consensus       464 ~~~~~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~  542 (767)
                      .+++.++....++|...+.||+|+||.||+|....+++.||||++.... ....++.+|+.++.++ +||||+++++++.
T Consensus        13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            3444455556788999999999999999999998788999999986543 3456789999999999 8999999999987


Q ss_pred             c------CCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcE
Q 042216          543 D------DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVA  616 (767)
Q Consensus       543 ~------~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~  616 (767)
                      .      .+..++||||+++|+|.+++.......+++..+..++.|++.||.|||   +.+|+|+||||+|||++.++.+
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCE
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCE
Confidence            6      468899999999999999997765567999999999999999999999   6789999999999999999999


Q ss_pred             EEeecCCcccCCCCCCccccccccCCCcccChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHH
Q 042216          617 KVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR-----LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLA  691 (767)
Q Consensus       617 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~  691 (767)
                      ||+|||++......  ........|+..|+|||.+.     ...++.++|||||||++|||++|+.||........   .
T Consensus       169 kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~  243 (326)
T 2x7f_A          169 KLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---L  243 (326)
T ss_dssp             EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H
T ss_pred             EEeeCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---H
Confidence            99999998754321  11223456899999999987     56789999999999999999999999965432211   1


Q ss_pred             HHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          692 VWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       692 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                         ...... ...        ...+..++..+.+++.+||+.||.+||++.++++
T Consensus       244 ---~~~~~~-~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          244 ---FLIPRN-PAP--------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             ---HHHHHS-CCC--------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ---HHhhcC-ccc--------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence               111111 110        1112345678899999999999999999999985

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.2e-38  Score=356.37  Aligned_cols=260  Identities=23%  Similarity=0.236  Sum_probs=196.6

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecC------C
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD------G  545 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~------~  545 (767)
                      .++|+..+.||+|+||+||+|.....++.||||++...  .....+++.+|+.+|+.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46799999999999999999999888899999999754  333456788999999999999999999999654      3


Q ss_pred             ceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcc
Q 042216          546 QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK  625 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~  625 (767)
                      ..++||||+++ +|.+.+..    .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            56999999986 57666632    3899999999999999999999   6789999999999999999999999999998


Q ss_pred             cCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHH---------
Q 042216          626 FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATE---------  696 (767)
Q Consensus       626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~---------  696 (767)
                      ....   ....+...||+.|+|||++.+..++.++|||||||++|||++|+.||.+....++..  .....         
T Consensus       213 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~--~i~~~lg~p~~~~~  287 (464)
T 3ttj_A          213 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN--KVIEQLGTPCPEFM  287 (464)
T ss_dssp             -------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCSCCHHHH
T ss_pred             ecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcCCCCHHHH
Confidence            6432   222345679999999999999999999999999999999999999996654322111  11110         


Q ss_pred             ---------HhhcC-Ccc-----ccccccccCCC---ChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          697 ---------CYRNG-KIG-----DIIDPFLKGNA---PPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       697 ---------~~~~~-~~~-----~~~d~~l~~~~---~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                               ..... ...     ..+...+....   ......++.+|+.+||+.||.+|||++|+++
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                     00000 000     00000000000   0112567899999999999999999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.9e-38  Score=341.61  Aligned_cols=268  Identities=22%  Similarity=0.283  Sum_probs=202.1

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeec--------
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCND--------  543 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~--------  543 (767)
                      .++|...+.||+|+||.||+|....+++.||||++....  ......+.+|+++++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            367999999999999999999998888999999986543  2334578899999999999999999999876        


Q ss_pred             CCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCC
Q 042216          544 DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL  623 (767)
Q Consensus       544 ~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGl  623 (767)
                      .+..++||||+++ +|.+.+.... ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence            4468999999985 7877775443 35999999999999999999999   67899999999999999999999999999


Q ss_pred             cccCCCCCC--ccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhc
Q 042216          624 CKFGPNFSK--THVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRN  700 (767)
Q Consensus       624 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~  700 (767)
                      ++.......  ........||+.|+|||++.+ ..++.++|||||||++|||++|++||.....................
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            986532221  122244568999999999876 46899999999999999999999999765433222111111100000


Q ss_pred             CCccccccccc-------cCC-CCh-------hhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          701 GKIGDIIDPFL-------KGN-APP-------VCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       701 ~~~~~~~d~~l-------~~~-~~~-------~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ......-+..+       ... ...       .....+.+++.+||+.||.+|||++|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            00000000000       000 000       01345889999999999999999999985

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.2e-38  Score=348.35  Aligned_cols=264  Identities=22%  Similarity=0.316  Sum_probs=204.5

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      ++|...+.||+|+||.||++....+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            57899999999999999999999888999999997653 33356789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++|+|.+++...  ..+++..+..++.+++.||.|||+  ..+|+||||||+|||++.++.+||+|||+++....    
T Consensus       113 ~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----  184 (360)
T 3eqc_A          113 MDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----  184 (360)
T ss_dssp             CTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----
T ss_pred             CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCccccc----
Confidence            9999999999654  358999999999999999999994  23799999999999999999999999999864211    


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHH---------------------
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAV---------------------  692 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~---------------------  692 (767)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+......                     
T Consensus       185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (360)
T 3eqc_A          185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  264 (360)
T ss_dssp             HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred             ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence            12234568999999999999999999999999999999999999996543221110000                     


Q ss_pred             --HHHHHhhcCCcccccccccc----CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          693 --WATECYRNGKIGDIIDPFLK----GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       693 --~~~~~~~~~~~~~~~d~~l~----~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                        +...........+.++....    .......+.++.+++.+||+.||.+|||++|+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence              00000000000000110000    0111234667999999999999999999999985

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.5e-37  Score=343.61  Aligned_cols=263  Identities=18%  Similarity=0.204  Sum_probs=205.5

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc--------cceeeeEeeeee---
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR--------YLHLVSLIGYCN---  542 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~--------Hpniv~l~g~~~---  542 (767)
                      .++|...+.||+|+||+||+|+...+++.||||++... ......+.+|+++++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            36799999999999999999999888899999999743 334567889999999986        788999999987   


Q ss_pred             -cCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCC-CeEecCCCCCCeEECCCC------
Q 042216          543 -DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK-VIIHRDVKTTNILLDEEW------  614 (767)
Q Consensus       543 -~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~iiH~Dlk~~NILld~~~------  614 (767)
                       .....++||||+ +++|.+++.......+++..+..++.|++.||.|||   ++ +|+||||||+|||++.++      
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhh
Confidence             556899999999 567777776665567999999999999999999999   55 899999999999999775      


Q ss_pred             -------------------------------------------cEEEeecCCcccCCCCCCccccccccCCCcccChhhh
Q 042216          615 -------------------------------------------VAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY  651 (767)
Q Consensus       615 -------------------------------------------~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~  651 (767)
                                                                 .+||+|||+++....     ......||..|+|||++
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCChhh
Confidence                                                       899999999986432     12345689999999999


Q ss_pred             ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchh---HHHHHHHHhhc--------C-----------Cccccccc
Q 042216          652 RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVN---LAVWATECYRN--------G-----------KIGDIIDP  709 (767)
Q Consensus       652 ~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~---l~~~~~~~~~~--------~-----------~~~~~~d~  709 (767)
                      .+..++.++|||||||+||||++|+.||......+...   ...........        +           ....+.+.
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            99999999999999999999999999997654332111   11111111100        0           00000000


Q ss_pred             c---------ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          710 F---------LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       710 ~---------l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .         -....+...+..+.+|+.+||+.||.+|||++|+++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            0         001235567788999999999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.9e-37  Score=332.90  Aligned_cols=257  Identities=20%  Similarity=0.272  Sum_probs=202.9

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc-cceeeeEeeeeec--CCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-YLHLVSLIGYCND--DGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~--~~~~~lV~  551 (767)
                      ++|+..+.||+|+||+||+|....+++.||||++...   ..+.+.+|++++++++ ||||+++++++.+  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            5788999999999999999999888899999999743   3567899999999997 9999999999987  66789999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC-cEEEeecCCcccCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW-VAKVSDFGLCKFGPNF  630 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~-~~ki~DfGla~~~~~~  630 (767)
                      ||+++++|.+++.     .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++ .+||+|||+++.....
T Consensus       113 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             ECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             eccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            9999999999984     3889999999999999999999   67899999999999999766 8999999999865332


Q ss_pred             CCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHH--------HhhcC
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATE--------CYRNG  701 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~--------~~~~~  701 (767)
                      .   ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ..+......        .....
T Consensus       185 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          185 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHHHHHHHCHHHHHHHHHHT
T ss_pred             C---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHHHHHhcCCchhhhHHHHh
Confidence            2   2234568999999999877 679999999999999999999999995443321 111111100        00000


Q ss_pred             --------------CccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          702 --------------KIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       702 --------------~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                                    ......+.......+...+.++.+++.+||+.||.+|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                          000111111222223345778999999999999999999999985

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-38  Score=344.60  Aligned_cols=255  Identities=24%  Similarity=0.289  Sum_probs=204.8

Q ss_pred             hccccceeeeccCcEEEEEEEec---CCCceEEEEEeCCCC----CcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCc
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLN---GDSTPVAIKRLNPGS----QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQ  546 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~---~~~~~vAVK~l~~~~----~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~  546 (767)
                      ++|...+.||+|+||.||+++..   ..++.||||+++...    ......+.+|+++|.++ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            57999999999999999999984   356899999986432    22345678899999999 69999999999999999


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      .++||||+++|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             EEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            99999999999999999654  35899999999999999999999   67899999999999999999999999999975


Q ss_pred             CCCCCCccccccccCCCcccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYRL--QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG  704 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  704 (767)
                      .... .........||+.|+|||++.+  ..++.++|||||||+||||++|+.||.........  ..........    
T Consensus       209 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~----  281 (355)
T 1vzo_A          209 FVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS----  281 (355)
T ss_dssp             CCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHC----
T ss_pred             cccC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhcc----
Confidence            4321 1222334579999999999985  35789999999999999999999999655433221  1111211111    


Q ss_pred             ccccccccCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 042216          705 DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRP-----SMSDVVWGL  748 (767)
Q Consensus       705 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~~L  748 (767)
                             ....+...+..+.+++.+||+.||.+||     ++.|+++..
T Consensus       282 -------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          282 -------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             -------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                   1123445667889999999999999999     999998653

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.8e-38  Score=348.54  Aligned_cols=255  Identities=11%  Similarity=0.024  Sum_probs=186.2

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC---cchhHHHHHHHHHhcc--ccceeeeEe-------eee
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ---QGALEFQTEIGMLSQL--RYLHLVSLI-------GYC  541 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l--~Hpniv~l~-------g~~  541 (767)
                      ..+|...+.||+|+||.||+|++..+++.||||++.....   .....+.+|++++..|  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            3458888999999999999999988889999999986543   2344577885555544  699988754       343


Q ss_pred             ecC-----------------CceEEEEecCCCCChhhhhccCCCCCCChHHH------HHHHHHHHHHHHHhHhCCCCCe
Q 042216          542 NDD-----------------GQMILVYDYMARGTLRDHLYNNDNPPLPWDRR------LKICIGAARALHYLHTGASKVI  598 (767)
Q Consensus       542 ~~~-----------------~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~i  598 (767)
                      ...                 ...++||||++ |+|.+++.... ..+.+..+      +.++.|++.||+|||   +++|
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~i  215 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQ---SKGL  215 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCC
Confidence            322                 23799999999 89999997542 23566677      888899999999999   7789


Q ss_pred             EecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhcc--CCCCchhhHHHHHHHHHHHHhCC
Q 042216          599 IHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL--QLLTEKSDVYSFGVVLLEVLCAR  676 (767)
Q Consensus       599 iH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SfGvvl~elltg~  676 (767)
                      +||||||+|||++.++.+||+|||+++....     ......+|+.|+|||++.+  ..++.++|||||||+||||++|+
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999986432     1223456799999999987  68999999999999999999999


Q ss_pred             CCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          677 PPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       677 ~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .||..........        +............+.......++..+.+++.+||+.||++|||+.|+++
T Consensus       291 ~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          291 LPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             CSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9996653321110        0000001111111222223456788999999999999999999999984

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.8e-38  Score=335.63  Aligned_cols=252  Identities=23%  Similarity=0.334  Sum_probs=189.7

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC-cchh-HHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ-QGAL-EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~-~~~~-~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      .++|+..+.||+|+||+||++....+++.||||++..... .... .+.++...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            4678999999999999999999988889999999975532 2222 3445555688889999999999999999999999


Q ss_pred             ecCCCCChhhhhcc--CCCCCCChHHHHHHHHHHHHHHHHhHhCCCC-CeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          552 DYMARGTLRDHLYN--NDNPPLPWDRRLKICIGAARALHYLHTGASK-VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       552 ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      ||++ |+|.+++..  .....+++..++.++.|++.||.|||   +. +|+||||||+|||++.++.+||+|||+++...
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9998 488887754  23456999999999999999999999   55 89999999999999999999999999997543


Q ss_pred             CCCCccccccccCCCcccChhhh----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc
Q 042216          629 NFSKTHVSTQVKGSIGYLDPEYY----RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG  704 (767)
Q Consensus       629 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  704 (767)
                      ..   .......||+.|+|||.+    ....++.++|||||||++|||++|+.||....... ..+    ........  
T Consensus       162 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~----~~~~~~~~--  231 (290)
T 3fme_A          162 DD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-QQL----KQVVEEPS--  231 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-HHH----HHHHHSCC--
T ss_pred             cc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-HHH----HHHhccCC--
Confidence            21   122334689999999996    55678999999999999999999999996433221 111    11111111  


Q ss_pred             ccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          705 DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       705 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                             ....+...+.++.+++.+||+.||.+|||+.|+++
T Consensus       232 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          232 -------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                   11112345677999999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4e-38  Score=347.37  Aligned_cols=263  Identities=19%  Similarity=0.219  Sum_probs=199.6

Q ss_pred             HHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeec-------
Q 042216          471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCND-------  543 (767)
Q Consensus       471 ~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~-------  543 (767)
                      ....++|...+.||+|+||.||+|....+++.||||++.....    ...+|+++++.++||||+++++++..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            4456789999999999999999999988889999999864422    23479999999999999999999843       


Q ss_pred             -------------------------------CCceEEEEecCCCCChhhhhcc--CCCCCCChHHHHHHHHHHHHHHHHh
Q 042216          544 -------------------------------DGQMILVYDYMARGTLRDHLYN--NDNPPLPWDRRLKICIGAARALHYL  590 (767)
Q Consensus       544 -------------------------------~~~~~lV~ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yL  590 (767)
                                                     ....++||||++ |+|.+.+..  .....+++..+..++.|++.||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           234889999998 588877753  2345699999999999999999999


Q ss_pred             HhCCCCCeEecCCCCCCeEEC-CCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccC-CCCchhhHHHHHHH
Q 042216          591 HTGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVV  668 (767)
Q Consensus       591 H~~~~~~iiH~Dlk~~NILld-~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvv  668 (767)
                      |   +.+|+||||||+|||++ .++.+||+|||+++......   ......+|..|+|||.+.+. .++.++|||||||+
T Consensus       158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9   78899999999999997 68899999999998643321   23345689999999998765 58999999999999


Q ss_pred             HHHHHhCCCCCCCCCCccchhHHHHHHHHh--------------hcCCccccccccccCCCChhhHHHHHHHHHHccccC
Q 042216          669 LLEVLCARPPILRTGDKKQVNLAVWATECY--------------RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDD  734 (767)
Q Consensus       669 l~elltg~~P~~~~~~~~~~~l~~~~~~~~--------------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~d  734 (767)
                      +|||++|+.||......+.  +.......-              ............+....+...+.++.+++.+||+.|
T Consensus       232 l~ell~g~~pf~~~~~~~~--~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQ--LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            9999999999976543221  111111000              000011111111111234446677999999999999


Q ss_pred             CCCCCCHHHHHH
Q 042216          735 RIRRPSMSDVVW  746 (767)
Q Consensus       735 p~~RPs~~evl~  746 (767)
                      |.+|||+.|+++
T Consensus       310 P~~R~t~~e~l~  321 (383)
T 3eb0_A          310 PDLRINPYEAMA  321 (383)
T ss_dssp             GGGSCCHHHHHT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999984

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.8e-38  Score=335.84  Aligned_cols=260  Identities=24%  Similarity=0.365  Sum_probs=200.0

Q ss_pred             hhccccceeeeccCcEEEEEEEecCC-C--ceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCce
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGD-S--TPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQM  547 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~-~--~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~  547 (767)
                      .++|...+.||+|+||.||+|++... +  ..||||+++..   .....+++.+|++++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            35789999999999999999986432 2  36899998754   2334567899999999999999999999998764 8


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      ++|+||+++|+|.+++.... ..+++.++..++.|++.||.|||   +.+|+|+||||+|||++.++.+||+|||+++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            99999999999999996542 35899999999999999999999   678999999999999999999999999999865


Q ss_pred             CCCCCcc-ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccc
Q 042216          628 PNFSKTH-VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGD  705 (767)
Q Consensus       628 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  705 (767)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+      .........    
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~----  241 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEG----  241 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSC----
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH------HHHHHHccC----
Confidence            4322211 2234457889999999998889999999999999999999 999996543221      111111111    


Q ss_pred             cccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       706 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                           .....+..++.++.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       242 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          242 -----ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             -----CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                 1112234567789999999999999999999999999987754

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-38  Score=346.21  Aligned_cols=257  Identities=20%  Similarity=0.253  Sum_probs=197.2

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCC------
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG------  545 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~------  545 (767)
                      .++|...+.||+|+||.||+|....+++.||||++....  ....+.+.+|+++|+.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467899999999999999999998888999999996542  223457889999999999999999999997653      


Q ss_pred             ceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcc
Q 042216          546 QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK  625 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~  625 (767)
                      ..++||||+ +++|.+++..   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            469999999 7799999865   35899999999999999999999   6789999999999999999999999999998


Q ss_pred             cCCCCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcC---
Q 042216          626 FGPNFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG---  701 (767)
Q Consensus       626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~---  701 (767)
                      ....     ......+|..|+|||++.+ ..++.++||||+||+++||++|+.||......+.....  .. .....   
T Consensus       177 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i--~~-~~g~~~~~  248 (367)
T 1cm8_A          177 QADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI--MK-VTGTPPAE  248 (367)
T ss_dssp             ECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HH-HHCCCCHH
T ss_pred             cccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HH-hcCCCCHH
Confidence            6432     1234568999999999887 68999999999999999999999999765432211111  10 00000   


Q ss_pred             ---------------CccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          702 ---------------KIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       702 ---------------~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                                     .+.......+. ......+..+.+++.+||+.||.+|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          249 FVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence                           00000000010 112345677899999999999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.1e-38  Score=353.27  Aligned_cols=201  Identities=23%  Similarity=0.307  Sum_probs=175.7

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc------ccceeeeEeeeeecCCce
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL------RYLHLVSLIGYCNDDGQM  547 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l------~Hpniv~l~g~~~~~~~~  547 (767)
                      ..+|...+.||+|+||.||+|....+++.||||++... .....++.+|++++..+      .|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            45689999999999999999999888899999999743 23345678888888877      467999999999999999


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCc--EEEeecCCcc
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV--AKVSDFGLCK  625 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~--~ki~DfGla~  625 (767)
                      ++||||+. ++|.+++.......+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.  +||+|||+++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999996 69999998776667999999999999999999999   678999999999999999887  9999999997


Q ss_pred             cCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 042216          626 FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGD  684 (767)
Q Consensus       626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~  684 (767)
                      ....     ......||+.|+|||++.+..++.++|||||||+||||++|++||....+
T Consensus       251 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          251 YEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             ETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            5432     12345689999999999999999999999999999999999999966543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.1e-37  Score=336.76  Aligned_cols=263  Identities=18%  Similarity=0.280  Sum_probs=206.3

Q ss_pred             hhccccceeeeccCcEEEEEEEe-cCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccce------eeeEeeeeecCCc
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFL-NGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH------LVSLIGYCNDDGQ  546 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpn------iv~l~g~~~~~~~  546 (767)
                      .++|...+.||+|+||.||+|.. ..+++.||||++... ......+.+|++++..++|++      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            35789999999999999999988 456789999999643 234567889999999998875      9999999999999


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC--------------
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE--------------  612 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~--------------  612 (767)
                      .++||||+ +++|.+++......++++.++..++.|++.||.|||   +++|+||||||+|||++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 889999998776667999999999999999999999   678999999999999987              


Q ss_pred             -----CCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccc
Q 042216          613 -----EWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ  687 (767)
Q Consensus       613 -----~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~  687 (767)
                           ++.+||+|||+++....     ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             cccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                 67899999999986432     12345689999999999999999999999999999999999999976543322


Q ss_pred             hhHHHHHHHH-----hhcCCcccc---------------------cccc-ccCCCChhhHHHHHHHHHHccccCCCCCCC
Q 042216          688 VNLAVWATEC-----YRNGKIGDI---------------------IDPF-LKGNAPPVCLNQFVEVAMSCVNDDRIRRPS  740 (767)
Q Consensus       688 ~~l~~~~~~~-----~~~~~~~~~---------------------~d~~-l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs  740 (767)
                      ..........     .........                     ..+. -....+..++.++.+++.+||+.||.+|||
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  322 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT  322 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence            1111100000     000000000                     0000 001123456788999999999999999999


Q ss_pred             HHHHHH
Q 042216          741 MSDVVW  746 (767)
Q Consensus       741 ~~evl~  746 (767)
                      +.|+++
T Consensus       323 ~~ell~  328 (339)
T 1z57_A          323 LREALK  328 (339)
T ss_dssp             HHHHTT
T ss_pred             HHHHhc
Confidence            999975

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.3e-37  Score=348.80  Aligned_cols=200  Identities=25%  Similarity=0.314  Sum_probs=168.2

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecC-----Cc
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD-----GQ  546 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~-----~~  546 (767)
                      .++|...+.||+|+||.||+|....+++.||||++....  ....+.+.+|+++|++++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999999888999999997542  23456789999999999999999999999766     57


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      .++||||++ |+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            899999997 5999999653  45999999999999999999999   67899999999999999999999999999986


Q ss_pred             CCCCCCc--------------------cccccccCCCcccChhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 042216          627 GPNFSKT--------------------HVSTQVKGSIGYLDPEYY-RLQLLTEKSDVYSFGVVLLEVLCARPPI  679 (767)
Q Consensus       627 ~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDV~SfGvvl~elltg~~P~  679 (767)
                      .......                    ...+...||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            5332211                    123456799999999986 5667999999999999999999865544

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.8e-38  Score=336.34  Aligned_cols=253  Identities=22%  Similarity=0.335  Sum_probs=201.9

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .++|+..+.||+|+||.||+|....+++.||+|++..........+.+|++++..++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            46789999999999999999999888899999999877666778899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++++|.+++.... ..+++..+..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||++.....  ..
T Consensus        98 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~  171 (302)
T 2j7t_A           98 CPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--TL  171 (302)
T ss_dssp             CTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--HH
T ss_pred             CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccc--cc
Confidence            99999999986532 35899999999999999999999   67899999999999999999999999998753110  01


Q ss_pred             cccccccCCCcccChhhh-----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          634 HVSTQVKGSIGYLDPEYY-----RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~-----~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      .......|+..|+|||.+     ....++.++||||||+++|||++|+.||.......      ........ ....   
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~-~~~~---  241 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKS-DPPT---  241 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHS-CCCC---
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHhcc-CCcc---
Confidence            112234689999999998     36678999999999999999999999996543221      11111111 1100   


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                          ...+..++..+.+++.+||+.||.+|||+.++++
T Consensus       242 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          242 ----LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             ----CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ----cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                1123445678999999999999999999999984

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6e-38  Score=329.22  Aligned_cols=248  Identities=25%  Similarity=0.333  Sum_probs=197.5

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|...+.||+|+||.||+|+...+++.||||++...   .......+.+|+++++.++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            5788899999999999999999877899999998643   2233457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++++|.+++...  ..+++.++..++.|++.||.|||   +.+|+|+||||+|||++.++.+||+|||++...... 
T Consensus        91 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-  164 (276)
T 2h6d_A           91 EYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-  164 (276)
T ss_dssp             ECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             eccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCC-
Confidence            999999999999654  35899999999999999999999   678999999999999999999999999999864332 


Q ss_pred             CccccccccCCCcccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLL-TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                        .......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||......   .+..    ....+.        
T Consensus       165 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~----~~~~~~--------  227 (276)
T 2h6d_A          165 --EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLFK----KIRGGV--------  227 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCC--------
T ss_pred             --cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHH----HhhcCc--------
Confidence              12234568999999999987765 68999999999999999999999543221   1111    111111        


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                        ...+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus       228 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          228 --FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              11233456778999999999999999999999863

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1e-37  Score=352.43  Aligned_cols=265  Identities=18%  Similarity=0.198  Sum_probs=186.5

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeec-----CCce
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCND-----DGQM  547 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~-----~~~~  547 (767)
                      ++|...+.||+|+||+||+|....+++.||||++....  ....+.+.+|+++|++++||||+++++++..     ...+
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            57899999999999999999998888999999996542  2345678999999999999999999999843     3578


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      ++||||+. |+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       133 ~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          133 YVVLEIAD-SDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEECCCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEeccc-cchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            99999985 6999998653  45999999999999999999999   678999999999999999999999999999865


Q ss_pred             CCCCCc-------------------------cccccccCCCcccChhhh-ccCCCCchhhHHHHHHHHHHHHh-------
Q 042216          628 PNFSKT-------------------------HVSTQVKGSIGYLDPEYY-RLQLLTEKSDVYSFGVVLLEVLC-------  674 (767)
Q Consensus       628 ~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDV~SfGvvl~ellt-------  674 (767)
                      ......                         ...+..+||+.|+|||++ ....++.++|||||||+||||++       
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~  286 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA  286 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence            322110                         122345689999999986 56679999999999999999999       


Q ss_pred             ----CCCCCCCCCCcc-----------------chhHHHHHHHHhhcCC------------------ccccccccccCCC
Q 042216          675 ----ARPPILRTGDKK-----------------QVNLAVWATECYRNGK------------------IGDIIDPFLKGNA  715 (767)
Q Consensus       675 ----g~~P~~~~~~~~-----------------~~~l~~~~~~~~~~~~------------------~~~~~d~~l~~~~  715 (767)
                          |+++|.+.....                 ...........+....                  ........+. ..
T Consensus       287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  365 (458)
T 3rp9_A          287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA-ER  365 (458)
T ss_dssp             SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG-GG
T ss_pred             ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH-HH
Confidence                555554332100                 0000111111110000                  0000000000 01


Q ss_pred             ChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          716 PPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       716 ~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .+..+.++.+|+.+||+.||.+|||++|+++
T Consensus       366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~  396 (458)
T 3rp9_A          366 FPASSADAIHLLKRMLVFNPNKRITINECLA  396 (458)
T ss_dssp             STTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            1234677899999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.3e-37  Score=354.81  Aligned_cols=252  Identities=23%  Similarity=0.316  Sum_probs=201.2

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      ..++|...+.||+|+||+||+|....++..||||++....  ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3457999999999999999999998888999999987542  33456789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC---CCcEEEeecCCcccC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE---EWVAKVSDFGLCKFG  627 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~---~~~~ki~DfGla~~~  627 (767)
                      |||+++|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.   ++.+||+|||+++..
T Consensus       115 ~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          115 MECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            9999999999988654  35899999999999999999999   678999999999999976   455999999999865


Q ss_pred             CCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccc
Q 042216          628 PNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDII  707 (767)
Q Consensus       628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  707 (767)
                      ...   .......||+.|+|||++. +.++.++|||||||++|||++|++||......+   +..   . ...+... ..
T Consensus       190 ~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~---~-i~~~~~~-~~  257 (494)
T 3lij_A          190 ENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE---ILR---K-VEKGKYT-FD  257 (494)
T ss_dssp             BTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---H-HHHTCCC-CC
T ss_pred             CCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---H-HHhCCCC-CC
Confidence            332   2234457999999999986 568999999999999999999999996544321   111   1 1111110 00


Q ss_pred             cccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       708 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .     ......+..+.+++.+||+.||.+|||+.|+++
T Consensus       258 ~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          258 S-----PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             S-----GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             c-----hhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            0     011234567899999999999999999999984

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=332.74  Aligned_cols=252  Identities=24%  Similarity=0.351  Sum_probs=202.6

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ..++|...+.||+|+||.||+|....+++.||||++....  ...++.+|++++.+++||||+++++++...+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4567999999999999999999998888999999997542  45678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+++|+|.+++... ...+++..++.++.|++.||.|||   +.+++|+||||+|||++.++.+||+|||++......  
T Consensus       105 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (314)
T 3com_A          105 YCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT--  178 (314)
T ss_dssp             CCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--
T ss_pred             cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--
Confidence            99999999998632 346899999999999999999999   678999999999999999999999999999754321  


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      ........|+..|+|||.+.+..++.++||||||+++|||++|+.||........   .   .. .......       .
T Consensus       179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~---~~-~~~~~~~-------~  244 (314)
T 3com_A          179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA---I---FM-IPTNPPP-------T  244 (314)
T ss_dssp             BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H---HH-HHHSCCC-------C
T ss_pred             ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH---H---HH-HhcCCCc-------c
Confidence            1122345689999999999999999999999999999999999999965432211   1   11 1111100       0


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ...+...+..+.+++.+||+.||.+|||+.++++
T Consensus       245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          245 FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            1123345678999999999999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.3e-37  Score=334.82  Aligned_cols=253  Identities=25%  Similarity=0.317  Sum_probs=199.5

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--------CcchhHHHHHHHHHhccccceeeeEeeeeecC
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--------QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD  544 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--------~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~  544 (767)
                      ..++|...+.||+|+||.||+|....+++.||||++....        ......+.+|++++++++||||+++++++..+
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4568999999999999999999998888999999986532        12234588999999999999999999998765


Q ss_pred             CceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCc---EEEeec
Q 042216          545 GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV---AKVSDF  621 (767)
Q Consensus       545 ~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~---~ki~Df  621 (767)
                      + .++||||+++|+|.+++..  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.   +||+||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             c-eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence            4 8999999999999999854  346999999999999999999999   678999999999999987654   999999


Q ss_pred             CCcccCCCCCCccccccccCCCcccChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHh
Q 042216          622 GLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR---LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECY  698 (767)
Q Consensus       622 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~  698 (767)
                      |+++....   ........||+.|+|||++.   ...++.++|||||||++|||++|+.||.......  .+.....   
T Consensus       162 g~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~---  233 (322)
T 2ycf_A          162 GHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT---  233 (322)
T ss_dssp             TTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHH---
T ss_pred             ccceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHH---
Confidence            99986532   12223456899999999974   5678999999999999999999999996544321  1211111   


Q ss_pred             hcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       699 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       .+....  .+.    .....+.++.+++.+||+.||.+||++.|+++
T Consensus       234 -~~~~~~--~~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          234 -SGKYNF--IPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -HTCCCC--CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -hCcccc--Cch----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence             111100  000    01234567899999999999999999999983

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.8e-37  Score=329.46  Aligned_cols=253  Identities=21%  Similarity=0.259  Sum_probs=205.7

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC---------cchhHHHHHHHHHhccc-cceeeeEeeeee
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ---------QGALEFQTEIGMLSQLR-YLHLVSLIGYCN  542 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~---------~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~  542 (767)
                      ..++|...+.||+|+||.||+|....+++.||||++.....         ...+.+.+|++++.+++ ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            35689999999999999999999988889999999865431         12345789999999996 999999999999


Q ss_pred             cCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecC
Q 042216          543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFG  622 (767)
Q Consensus       543 ~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfG  622 (767)
                      ..+..++||||+++|+|.+++...  ..+++.+++.++.|++.||.|||   +.+++|+||||+|||++.++.+||+|||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEeccc
Confidence            999999999999999999999653  45899999999999999999999   6789999999999999999999999999


Q ss_pred             CcccCCCCCCccccccccCCCcccChhhhc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHH
Q 042216          623 LCKFGPNFSKTHVSTQVKGSIGYLDPEYYR------LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATE  696 (767)
Q Consensus       623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~  696 (767)
                      ++......   .......|++.|+|||.+.      ...++.++||||||+++|||++|+.||.......   ...   .
T Consensus       170 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~---~  240 (298)
T 1phk_A          170 FSCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---MLR---M  240 (298)
T ss_dssp             TCEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---H
T ss_pred             chhhcCCC---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---HHH---H
Confidence            99764332   1223456899999999985      4568899999999999999999999996543211   111   1


Q ss_pred             HhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          697 CYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       697 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       ...+...      .........+..+.+++.+||+.||.+|||+.|+++
T Consensus       241 -~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          241 -IMSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             -HHHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -HhcCCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence             1111100      011112345678999999999999999999999975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=9.5e-38  Score=367.69  Aligned_cols=249  Identities=24%  Similarity=0.328  Sum_probs=207.9

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceE
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMI  548 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~  548 (767)
                      ..++|...++||+|+||+||+|+.+.+++.||||+++..   .......+..|..+|..+ +||+|+++++++.+.+.++
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            356899999999999999999999988899999998643   233455688899999988 7999999999999999999


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      |||||+++|+|.++|...  ..+++..+..++.|++.||.|||   +.+|+||||||+||||+.++.+||+|||+++...
T Consensus       419 lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            999999999999999754  35999999999999999999999   7789999999999999999999999999998532


Q ss_pred             CCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          629 NFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      ..  ........||+.|+|||++.+..++.++|||||||+||||++|+.||......+   +   ... +..+.      
T Consensus       494 ~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~---~---~~~-i~~~~------  558 (674)
T 3pfq_A          494 WD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---L---FQS-IMEHN------  558 (674)
T ss_dssp             CT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHH-HHSSC------
T ss_pred             cC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH---H---HHH-HHhCC------
Confidence            21  223445679999999999999999999999999999999999999996543321   1   111 11111      


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCH-----HHHH
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSM-----SDVV  745 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~-----~evl  745 (767)
                          ...+...+.++.+|+.+||+.||.+||++     +||+
T Consensus       559 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~  596 (674)
T 3pfq_A          559 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK  596 (674)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred             ----CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence                12345567789999999999999999997     6665

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.2e-37  Score=365.69  Aligned_cols=260  Identities=25%  Similarity=0.383  Sum_probs=209.1

Q ss_pred             hhccccceeeeccCcEEEEEEEecCC---CceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGD---STPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      .++|...+.||+|+||.||+|.+...   +..||||++..... ...+.|.+|+.++++++||||+++++++. ++..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence            46788889999999999999998543   35799999875433 33467999999999999999999999985 457899


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ||||+++|+|.+++.... ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       468 v~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             EEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             EEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            999999999999997543 45899999999999999999999   67899999999999999999999999999986533


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      .. ........+|+.|+|||.+....++.++|||||||++|||++ |..||......+   ....    ...+.      
T Consensus       544 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~~----i~~~~------  609 (656)
T 2j0j_A          544 ST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGR----IENGE------  609 (656)
T ss_dssp             -----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHH----HHHTC------
T ss_pred             Cc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHH----HHcCC------
Confidence            21 112233457789999999999999999999999999999997 999996543321   1111    11111      


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                         ....+..++..+.+++.+||+.||.+|||+.+|++.|+.+++..
T Consensus       610 ---~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          610 ---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence               11234566788999999999999999999999999999987654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.7e-37  Score=336.47  Aligned_cols=258  Identities=23%  Similarity=0.317  Sum_probs=206.7

Q ss_pred             HHHHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc--------chhHHHHHHHHHhcc-ccceeeeEe
Q 042216          468 SEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--------GALEFQTEIGMLSQL-RYLHLVSLI  538 (767)
Q Consensus       468 ~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~--------~~~~f~~Ei~~l~~l-~Hpniv~l~  538 (767)
                      .......++|...+.||+|+||.||+|.+..+++.||||++......        ..+.+.+|+.++.++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            33445567899999999999999999999877899999998755321        134578999999999 799999999


Q ss_pred             eeeecCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEE
Q 042216          539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKV  618 (767)
Q Consensus       539 g~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki  618 (767)
                      +++...+..++||||+++|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+|+||||+|||++.++.+||
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEE
Confidence            9999999999999999999999999653  45899999999999999999999   678999999999999999999999


Q ss_pred             eecCCcccCCCCCCccccccccCCCcccChhhhcc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHH
Q 042216          619 SDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL------QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAV  692 (767)
Q Consensus       619 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~  692 (767)
                      +|||++.......   ......||+.|+|||++.+      ..++.++|||||||++|||++|+.||......   ....
T Consensus       242 ~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~  315 (365)
T 2y7j_A          242 SDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LMLR  315 (365)
T ss_dssp             CCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH
T ss_pred             EecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HHHH
Confidence            9999987654321   2334679999999999863      35889999999999999999999999654321   1111


Q ss_pred             HHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          693 WATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       693 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .    ...+... ...+.     ....+..+.+++.+||+.||.+|||+.|+++
T Consensus       316 ~----i~~~~~~-~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          316 M----IMEGQYQ-FSSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             H----HHHTCCC-CCHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             H----HHhCCCC-CCCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1    1111100 00000     0123567899999999999999999999985

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.2e-37  Score=354.48  Aligned_cols=252  Identities=22%  Similarity=0.317  Sum_probs=204.5

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      ..++|...+.||+|+||+||++....+++.||||++...  .......+.+|+++|++++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            456799999999999999999999888899999998543  233456789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC---CCCcEEEeecCCcccC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAKVSDFGLCKFG  627 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld---~~~~~ki~DfGla~~~  627 (767)
                      |||+.+|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++   .++.+||+|||+++..
T Consensus       100 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          100 GELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            9999999999998654  35899999999999999999999   67899999999999995   5668999999999754


Q ss_pred             CCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccc
Q 042216          628 PNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDII  707 (767)
Q Consensus       628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  707 (767)
                      ...   .......||+.|+|||++.+ .++.++|||||||++|||++|++||......+   +..   . +..+...   
T Consensus       175 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~---~-i~~~~~~---  240 (486)
T 3mwu_A          175 QQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILK---R-VETGKYA---  240 (486)
T ss_dssp             CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---H-HHHTCCC---
T ss_pred             CCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---H-HHhCCCC---
Confidence            322   22334569999999999875 58999999999999999999999996543321   111   1 1111110   


Q ss_pred             cccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       708 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                         .........+.++.+++.+||+.||.+|||+.|+++
T Consensus       241 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          241 ---FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             ---SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence               000112345678899999999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=8.1e-38  Score=355.77  Aligned_cols=252  Identities=21%  Similarity=0.287  Sum_probs=206.8

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      ..++|...+.||+|+||.||++....+++.||||++....   ......+.+|++++++++||||+++++++.+.+..++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3467999999999999999999998888999999986542   3445679999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE---CCCCcEEEeecCCccc
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKF  626 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl---d~~~~~ki~DfGla~~  626 (767)
                      ||||+.+|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++.
T Consensus       104 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             EECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            99999999999999654  45999999999999999999999   6789999999999999   5678999999999975


Q ss_pred             CCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccc
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI  706 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  706 (767)
                      ....   .......||+.|+|||++.+ .++.++|||||||++|||++|++||......+   +..    .+..+...  
T Consensus       179 ~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~----~i~~~~~~--  245 (484)
T 3nyv_A          179 FEAS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---ILK----KVEKGKYT--  245 (484)
T ss_dssp             BCCC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCCCC--
T ss_pred             cccc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---HHH----HHHcCCCC--
Confidence            4332   12334569999999999876 68999999999999999999999996544321   111    11111110  


Q ss_pred             ccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          707 IDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       707 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                          .........+.++.+++.+||+.||.+|||+.|+++
T Consensus       246 ----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          246 ----FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             ----CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence                000112345678899999999999999999999985

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2e-37  Score=333.50  Aligned_cols=264  Identities=22%  Similarity=0.305  Sum_probs=204.9

Q ss_pred             HhhccccceeeeccCcEEEEEEEec-CCCceEEEEEeCCCC--CcchhHHHHHHHHHhcc---ccceeeeEeeeee----
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLN-GDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQL---RYLHLVSLIGYCN----  542 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l---~Hpniv~l~g~~~----  542 (767)
                      +.++|...+.||+|+||.||+|... .+++.||+|++....  ......+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999984 566889999986432  22334677888877776   7999999999987    


Q ss_pred             -cCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 042216          543 -DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDF  621 (767)
Q Consensus       543 -~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~Df  621 (767)
                       .....++||||++ |+|.+++.......+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence             5568899999998 69999998766667999999999999999999999   678999999999999999999999999


Q ss_pred             CCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcC
Q 042216          622 GLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG  701 (767)
Q Consensus       622 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~  701 (767)
                      |+++....   ........||..|+|||.+.+..++.++|||||||++|||++|+.||........  +.. ........
T Consensus       165 g~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~-i~~~~~~~  238 (326)
T 1blx_A          165 GLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGK-ILDVIGLP  238 (326)
T ss_dssp             CSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCC
T ss_pred             cccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHH-HHHHcCCC
Confidence            99975432   2223446689999999999999999999999999999999999999965543221  111 11111100


Q ss_pred             Ccccc------ccccc-------cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          702 KIGDI------IDPFL-------KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       702 ~~~~~------~d~~l-------~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .....      ....+       ........+..+.+++.+||+.||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000      00000       01122345677899999999999999999999984

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6.9e-38  Score=342.49  Aligned_cols=270  Identities=20%  Similarity=0.224  Sum_probs=200.9

Q ss_pred             cCHHHHHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc-----------chhHHHHHHHHHhccccce
Q 042216          465 FSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ-----------GALEFQTEIGMLSQLRYLH  533 (767)
Q Consensus       465 ~~~~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~-----------~~~~f~~Ei~~l~~l~Hpn  533 (767)
                      ....++....++|...+.||+|+||.||+|.... ++.||||++......           ..+.+.+|++++++++|||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   90 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN   90 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence            4467788889999999999999999999999875 689999998643221           1267899999999999999


Q ss_pred             eeeEeeeeec-----CCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCe
Q 042216          534 LVSLIGYCND-----DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNI  608 (767)
Q Consensus       534 iv~l~g~~~~-----~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NI  608 (767)
                      |+++++++..     ....++||||++ |+|.+++... ...+++..+..++.|++.||.|||   +.+|+||||||+||
T Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NI  165 (362)
T 3pg1_A           91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNI  165 (362)
T ss_dssp             BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGE
T ss_pred             ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHE
Confidence            9999999843     346899999998 6888888644 346999999999999999999999   67899999999999


Q ss_pred             EECCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccc
Q 042216          609 LLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ  687 (767)
Q Consensus       609 Lld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~  687 (767)
                      |++.++.+||+|||+++....   ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~  242 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ  242 (362)
T ss_dssp             EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             EEcCCCCEEEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999999999999999974322   122334568999999999876 6799999999999999999999999965543221


Q ss_pred             hhHHHHHHHHhhcCCcc-----------ccccccccC-------CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          688 VNLAVWATECYRNGKIG-----------DIIDPFLKG-------NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       688 ~~l~~~~~~~~~~~~~~-----------~~~d~~l~~-------~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .  .. ...........           +.+...+..       ...+.....+.+++.+||+.||.+|||+.|+++
T Consensus       243 ~--~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          243 L--NK-IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             H--HH-HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H--HH-HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            1  11 11111000000           000000000       112234567899999999999999999999985

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.8e-37  Score=339.08  Aligned_cols=263  Identities=22%  Similarity=0.229  Sum_probs=194.0

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCC------
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG------  545 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~------  545 (767)
                      .++|...+.||+|+||.||+|.....++.||||++....  ....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            357899999999999999999998888999999997542  233456889999999999999999999997654      


Q ss_pred             ceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcc
Q 042216          546 QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK  625 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~  625 (767)
                      ..++||||+++ +|.+++..    .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             ceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            68999999985 78888842    4899999999999999999999   6789999999999999999999999999997


Q ss_pred             cCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHH-------------
Q 042216          626 FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAV-------------  692 (767)
Q Consensus       626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~-------------  692 (767)
                      ....   ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+......             
T Consensus       176 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          176 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred             cccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            5432   112334578999999999999999999999999999999999999996654321110000             


Q ss_pred             ---HHHHHhhcC-C-----ccccccccccCCC---ChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          693 ---WATECYRNG-K-----IGDIIDPFLKGNA---PPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       693 ---~~~~~~~~~-~-----~~~~~d~~l~~~~---~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                         ......... .     ..+.....+....   +...+.++.+++.+||+.||.+|||++|+++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence               000000000 0     0000000000000   11236778999999999999999999999863

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.9e-38  Score=337.91  Aligned_cols=261  Identities=21%  Similarity=0.337  Sum_probs=201.1

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      .++|...+.||+|+||.||+|...+   .+|+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            4678888999999999999998864   4999998754  2334456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++++|.+++.... ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++ ++.+||+|||+++......
T Consensus       109 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             BCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred             ecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence            9999999999996543 46899999999999999999999   67899999999999998 6799999999987542211


Q ss_pred             ---CccccccccCCCcccChhhhcc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhh
Q 042216          632 ---KTHVSTQVKGSIGYLDPEYYRL---------QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR  699 (767)
Q Consensus       632 ---~~~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~  699 (767)
                         .........|++.|+|||.+..         ..++.++|||||||++|||++|+.||.......   .   ... ..
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~---~~~-~~  256 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA---I---IWQ-MG  256 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH---H---HHH-HH
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHH-hc
Confidence               1112233458999999999874         457899999999999999999999996543221   1   111 11


Q ss_pred             cCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhc
Q 042216          700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRE  757 (767)
Q Consensus       700 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~  757 (767)
                      .+....     +   .+..++.++.+++.+||+.||.+|||+.+++++|+.+.+..+.
T Consensus       257 ~~~~~~-----~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~  306 (319)
T 2y4i_B          257 TGMKPN-----L---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR  306 (319)
T ss_dssp             TTCCCC-----C---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred             cCCCCC-----C---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            111111     1   1123445688999999999999999999999999988766543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=9.1e-38  Score=339.44  Aligned_cols=259  Identities=20%  Similarity=0.319  Sum_probs=204.7

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc---c--------------hhHHHHHHHHHhccccceeee
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ---G--------------ALEFQTEIGMLSQLRYLHLVS  536 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~---~--------------~~~f~~Ei~~l~~l~Hpniv~  536 (767)
                      .++|...+.||+|+||.||+|..  +++.||||++......   .              ...+.+|++++.+++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            35799999999999999999999  5589999998643111   1              178999999999999999999


Q ss_pred             EeeeeecCCceEEEEecCCCCChhhh------hccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE
Q 042216          537 LIGYCNDDGQMILVYDYMARGTLRDH------LYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL  610 (767)
Q Consensus       537 l~g~~~~~~~~~lV~ey~~~gsL~~~------L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl  610 (767)
                      +++++.+.+..++||||+++|+|.++      +.......+++..++.++.|++.||.|||+  ..+|+||||||+|||+
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILM  185 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEE
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEE
Confidence            99999999999999999999999999      655446679999999999999999999993  2889999999999999


Q ss_pred             CCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCccch
Q 042216          611 DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ-LLTE-KSDVYSFGVVLLEVLCARPPILRTGDKKQV  688 (767)
Q Consensus       611 d~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDV~SfGvvl~elltg~~P~~~~~~~~~~  688 (767)
                      +.++.+||+|||+++.....    ......|+..|+|||.+.+. .++. ++|||||||++|||++|+.||......  .
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~  259 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--V  259 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--H
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--H
Confidence            99999999999999864321    23455689999999999877 6666 999999999999999999999655431  1


Q ss_pred             hHHHHHHHHhhcCCcccccc--ccc-------cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          689 NLAVWATECYRNGKIGDIID--PFL-------KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       689 ~l~~~~~~~~~~~~~~~~~d--~~l-------~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .+..    ....+....-.+  ...       ........+.++.+++.+||+.||.+|||+.|+++
T Consensus       260 ~~~~----~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          260 ELFN----NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHH----HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHH----HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111    111111110000  000       00011345678999999999999999999999985

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.2e-37  Score=341.04  Aligned_cols=263  Identities=24%  Similarity=0.299  Sum_probs=203.2

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecC-----Cce
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDD-----GQM  547 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~-----~~~  547 (767)
                      ..+|...+.||+|+||.||+|....+++.||||++..... ...+.+.+|++++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            4679999999999999999999988889999999975433 3346789999999999999999999998654     468


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      ++|+||++ |+|.+++...   .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            99999998 4999998653   4899999999999999999999   678999999999999999999999999999865


Q ss_pred             CCCCC-ccccccccCCCcccChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCc--
Q 042216          628 PNFSK-THVSTQVKGSIGYLDPEYYR-LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKI--  703 (767)
Q Consensus       628 ~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~--  703 (767)
                      ..... ........||+.|+|||++. ...++.++|||||||++|||++|+.||......+.....   .........  
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~  255 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGSPSQED  255 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH---HHHHCSCCHHH
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH---HHHhCCCCHHH
Confidence            33211 11123457999999999865 455899999999999999999999999665443222111   111000000  


Q ss_pred             -ccccc--------ccc-cCC-----CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          704 -GDIID--------PFL-KGN-----APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       704 -~~~~d--------~~l-~~~-----~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       ....+        ... ...     ..+..+.++.+++.+||+.||.+|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             00000        000 000     11234567899999999999999999999985

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.3e-37  Score=351.49  Aligned_cols=252  Identities=24%  Similarity=0.324  Sum_probs=202.7

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC-------------cchhHHHHHHHHHhccccceeeeEee
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ-------------QGALEFQTEIGMLSQLRYLHLVSLIG  539 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~-------------~~~~~f~~Ei~~l~~l~Hpniv~l~g  539 (767)
                      ..++|...+.||+|+||+||+|....+++.||||++.....             ...+++.+|+.+|++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            35689999999999999999999998889999999865421             23467899999999999999999999


Q ss_pred             eeecCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC---cE
Q 042216          540 YCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW---VA  616 (767)
Q Consensus       540 ~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~---~~  616 (767)
                      ++.+.+..++||||+++|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++   .+
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccE
Confidence            999999999999999999999998654  35999999999999999999999   67899999999999998775   69


Q ss_pred             EEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHH
Q 042216          617 KVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATE  696 (767)
Q Consensus       617 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~  696 (767)
                      ||+|||+++.....   .......||+.|+|||++. +.++.++|||||||++|||++|+.||......+   +..    
T Consensus       189 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~----  257 (504)
T 3q5i_A          189 KIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD---IIK----  257 (504)
T ss_dssp             EECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----
T ss_pred             EEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----
Confidence            99999999865432   2234456999999999987 468999999999999999999999996544321   111    


Q ss_pred             HhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          697 CYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       697 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ....+....  +.    ......+.++.+++.+||+.||.+|||++|+++
T Consensus       258 ~i~~~~~~~--~~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          258 KVEKGKYYF--DF----NDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHCCCCC--CH----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHcCCCCC--Cc----cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            111111100  00    001234567899999999999999999999984

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.2e-37  Score=347.63  Aligned_cols=259  Identities=25%  Similarity=0.251  Sum_probs=195.6

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecC------CceE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD------GQMI  548 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~------~~~~  548 (767)
                      .+|...+.||+|+||.||+|++...++.||||++....    ..+.+|+++|++++||||+++++++...      ..++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            35888889999999999999998888999999986432    2234799999999999999999988532      2367


Q ss_pred             EEEecCCCCChhhhhcc--CCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCC-CcEEEeecCCcc
Q 042216          549 LVYDYMARGTLRDHLYN--NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEE-WVAKVSDFGLCK  625 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~-~~~ki~DfGla~  625 (767)
                      +||||+++ +|.+.+..  .....+++..+..++.|+++||.|||   +.+|+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999986 66666542  23456999999999999999999999   7889999999999999954 678999999998


Q ss_pred             cCCCCCCccccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHH-------
Q 042216          626 FGPNFSKTHVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATEC-------  697 (767)
Q Consensus       626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~-------  697 (767)
                      ......   ......||+.|+|||++.+. .++.++|||||||+||||++|+.||......+  .+.......       
T Consensus       206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHH
T ss_pred             hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHH
Confidence            643221   22345689999999998764 79999999999999999999999997654322  222221110       


Q ss_pred             hh--cCCccccccccccC-----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          698 YR--NGKIGDIIDPFLKG-----NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       698 ~~--~~~~~~~~d~~l~~-----~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      +.  .....+..-+.+..     ..+...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            00  00001111111110     122345678999999999999999999999985

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.7e-37  Score=332.33  Aligned_cols=254  Identities=23%  Similarity=0.318  Sum_probs=198.3

Q ss_pred             HHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhcccc--ceeeeEeeeeecCCce
Q 042216          472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRY--LHLVSLIGYCNDDGQM  547 (767)
Q Consensus       472 ~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H--pniv~l~g~~~~~~~~  547 (767)
                      ...++|...+.||+|+||.||++.... ++.||||++...  .......+.+|++++.+++|  +||+++++++...+..
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~  103 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  103 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence            345679999999999999999999865 678999998654  23345678999999999974  9999999999999999


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      ++||| +.+++|.+++...  ..+++.++..++.|++.||.|||   +.+|+||||||+|||+++ +.+||+|||+++..
T Consensus       104 ~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          104 YMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQM  176 (313)
T ss_dssp             EEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred             EEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccc
Confidence            99999 6678999999754  36899999999999999999999   678999999999999975 79999999999865


Q ss_pred             CCCCCccccccccCCCcccChhhhcc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHH
Q 042216          628 PNFSKTHVSTQVKGSIGYLDPEYYRL-----------QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATE  696 (767)
Q Consensus       628 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~  696 (767)
                      .............|++.|+|||.+..           ..++.++|||||||++|||++|+.||.......     .....
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~~  251 (313)
T 3cek_A          177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHA  251 (313)
T ss_dssp             -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHH
T ss_pred             cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----HHHHH
Confidence            43222222334568999999999875           478899999999999999999999996543211     11111


Q ss_pred             HhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          697 CYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       697 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                               ++++......+...+.++.+++.+||+.||.+||++.|+++.
T Consensus       252 ---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          252 ---------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             ---------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---------HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence                     112222223344456788999999999999999999999864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.9e-38  Score=345.13  Aligned_cols=258  Identities=22%  Similarity=0.277  Sum_probs=185.6

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecC------C
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD------G  545 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~------~  545 (767)
                      .++|...+.||+|+||.||+|....+++.||||++....  ....+.+.+|+++|+.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            468999999999999999999998888999999996542  23456788999999999999999999998654      5


Q ss_pred             ceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcc
Q 042216          546 QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK  625 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~  625 (767)
                      ..++|+|++ +++|.+++..   ..+++..+..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            689999999 6799998854   45999999999999999999999   6789999999999999999999999999998


Q ss_pred             cCCCCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC--
Q 042216          626 FGPNFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK--  702 (767)
Q Consensus       626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~--  702 (767)
                      ....     ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||............   ........  
T Consensus       181 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i---~~~~g~p~~~  252 (367)
T 2fst_X          181 HTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LRLVGTPGAE  252 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCCHH
T ss_pred             cccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCCHH
Confidence            5432     1234568999999999876 68999999999999999999999999665432221111   11110000  


Q ss_pred             -ccccccc-------cccC--C-----CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          703 -IGDIIDP-------FLKG--N-----APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       703 -~~~~~d~-------~l~~--~-----~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       +..+...       .+..  .     .....+..+.+|+.+||+.||.+|||+.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence             0000000       0000  0     01123567899999999999999999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.1e-37  Score=333.90  Aligned_cols=263  Identities=18%  Similarity=0.240  Sum_probs=204.5

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCC-ceEEEEEeCCCCCcchhHHHHHHHHHhccccce------eeeEeeeeecCCc
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDS-TPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH------LVSLIGYCNDDGQ  546 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~-~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpn------iv~l~g~~~~~~~  546 (767)
                      .++|...+.||+|+||.||+|.....+ +.||||+++.. ......+.+|++++++++|++      ++.+.+++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            367999999999999999999987655 68999999643 234567889999999998877      9999999999999


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE----------------
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL----------------  610 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl----------------  610 (767)
                      .++||||+ +++|.+++.......+++.++..++.|++.||.|||   +.+|+||||||+|||+                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 668888887666567999999999999999999999   7889999999999999                


Q ss_pred             ---CCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccc
Q 042216          611 ---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ  687 (767)
Q Consensus       611 ---d~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~  687 (767)
                         +.++.+||+|||+++....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence               5688999999999986432     12345689999999999999999999999999999999999999976543321


Q ss_pred             hhHHHHHHHH-----hhcCCcccc-cccc---------------------ccCCCChhhHHHHHHHHHHccccCCCCCCC
Q 042216          688 VNLAVWATEC-----YRNGKIGDI-IDPF---------------------LKGNAPPVCLNQFVEVAMSCVNDDRIRRPS  740 (767)
Q Consensus       688 ~~l~~~~~~~-----~~~~~~~~~-~d~~---------------------l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs  740 (767)
                      ..........     ......... ....                     ........+..++.+++.+||+.||.+|||
T Consensus       248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  327 (355)
T 2eu9_A          248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT  327 (355)
T ss_dssp             HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence            1111100000     000000000 0000                     001122345678999999999999999999


Q ss_pred             HHHHHH
Q 042216          741 MSDVVW  746 (767)
Q Consensus       741 ~~evl~  746 (767)
                      +.|+++
T Consensus       328 ~~e~l~  333 (355)
T 2eu9_A          328 LAEALL  333 (355)
T ss_dssp             HHHHTT
T ss_pred             HHHHhc
Confidence            999984

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.7e-36  Score=334.19  Aligned_cols=204  Identities=25%  Similarity=0.248  Sum_probs=175.1

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc-cc-----eeeeEeeeeecCCc
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-YL-----HLVSLIGYCNDDGQ  546 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-Hp-----niv~l~g~~~~~~~  546 (767)
                      ..++|...+.||+|+||+||+|....+++.||||++... .....++..|++++..++ |+     +++++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            457899999999999999999999888899999999743 233456788888888875 44     49999999999999


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC--CCCcEEEeecCCc
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD--EEWVAKVSDFGLC  624 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld--~~~~~ki~DfGla  624 (767)
                      .++||||++ |+|.+++.......+++..+..++.|++.||.|||.. ..+|+||||||+|||++  .++.+||+|||++
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            999999996 5999999876656799999999999999999999932 36899999999999994  5788999999999


Q ss_pred             ccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 042216          625 KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGD  684 (767)
Q Consensus       625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~  684 (767)
                      +....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       209 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          209 CQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             EETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             eeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            86432     12345689999999999999999999999999999999999999976543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.6e-38  Score=336.34  Aligned_cols=262  Identities=21%  Similarity=0.266  Sum_probs=196.4

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeee------------
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN------------  542 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~------------  542 (767)
                      ++|...+.||+|+||.||+|.....++.||||++........+++.+|++++++++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            57888999999999999999999888999999998766666778999999999999999999999873            


Q ss_pred             --cCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC-CCCcEEEe
Q 042216          543 --DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD-EEWVAKVS  619 (767)
Q Consensus       543 --~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld-~~~~~ki~  619 (767)
                        +.+..++||||++ |+|.+++..   .++++..+..++.|++.||.|||   +.+|+||||||+|||++ +++.+||+
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             ccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence              3467899999998 699999853   35899999999999999999999   67899999999999997 67799999


Q ss_pred             ecCCcccCCCCCC-ccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHH
Q 042216          620 DFGLCKFGPNFSK-THVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATEC  697 (767)
Q Consensus       620 DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~  697 (767)
                      |||+++....... ........++..|+|||.+.. ..++.++|||||||++|||++|+.||......+..  .... ..
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~~~~-~~  240 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM--QLIL-ES  240 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHH-HH
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH--HHHH-Hh
Confidence            9999986432111 112233457899999998865 68899999999999999999999999765432211  1111 00


Q ss_pred             hhc----------CCccccccccccCC------CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          698 YRN----------GKIGDIIDPFLKGN------APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       698 ~~~----------~~~~~~~d~~l~~~------~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ...          ..+...+.......      .....+.++.+++.+||+.||.+|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            000          00000000000000      11235678999999999999999999999985

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.6e-37  Score=336.51  Aligned_cols=263  Identities=21%  Similarity=0.284  Sum_probs=201.3

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC-cchhHHHHHHHHHhccccceeeeEeeeeecC-----Cce
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQLRYLHLVSLIGYCNDD-----GQM  547 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~-----~~~  547 (767)
                      .++|...+.||+|+||.||+|....+++.||||++..... .....+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            4678999999999999999999988889999999975432 3345688999999999999999999998754     678


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      ++||||++ |+|.+++..   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        90 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            99999998 599999865   35899999999999999999999   678999999999999999999999999999865


Q ss_pred             CCCCCcc--------ccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHh
Q 042216          628 PNFSKTH--------VSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECY  698 (767)
Q Consensus       628 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~  698 (767)
                      .......        ......||+.|+|||.+.. ..++.++|||||||++|||++|+.||.........  .. .....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~-~~~~~  239 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL--LL-IFGII  239 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HH-HHHHH
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH--HH-HHHHh
Confidence            3221110        1123468999999998764 78999999999999999999999999665432111  11 11111


Q ss_pred             hcCC----cccccccc-------cc--C-----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          699 RNGK----IGDIIDPF-------LK--G-----NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       699 ~~~~----~~~~~d~~-------l~--~-----~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ....    ...+....       +.  .     ...+..+.++.+++.+||+.||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0000    00000000       00  0     011245677899999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=8.1e-37  Score=335.10  Aligned_cols=261  Identities=18%  Similarity=0.203  Sum_probs=202.1

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc-----------cceeeeEeeeeec
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-----------YLHLVSLIGYCND  543 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-----------Hpniv~l~g~~~~  543 (767)
                      .+|...+.||+|+||.||+|+...+++.||||++... ......+.+|++++.+++           ||||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            5789999999999999999999888899999999743 234456889999999886           8999999999876


Q ss_pred             CC----ceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCC-CeEecCCCCCCeEE------CC
Q 042216          544 DG----QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK-VIIHRDVKTTNILL------DE  612 (767)
Q Consensus       544 ~~----~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~iiH~Dlk~~NILl------d~  612 (767)
                      .+    ..++||||+ +++|.+++.......+++..+..++.|++.||.|||   ++ +|+||||||+|||+      +.
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcC
Confidence            54    789999999 889999998766667999999999999999999999   55 89999999999999      44


Q ss_pred             CCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccc----h
Q 042216          613 EWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ----V  688 (767)
Q Consensus       613 ~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~----~  688 (767)
                      .+.+||+|||+++....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||........    .
T Consensus       174 ~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             EEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             cceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence            55899999999976432     12345689999999999999999999999999999999999999965442211    1


Q ss_pred             hHHHHHHHHhh------------------cC-Cccccccc---------cccCCCChhhHHHHHHHHHHccccCCCCCCC
Q 042216          689 NLAVWATECYR------------------NG-KIGDIIDP---------FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPS  740 (767)
Q Consensus       689 ~l~~~~~~~~~------------------~~-~~~~~~d~---------~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs  740 (767)
                      .+.... ....                  .. ....+...         .-....+..++.++.+++.+||+.||.+|||
T Consensus       249 ~~~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          249 HIAQII-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHH-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHH-HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            111111 1000                  00 00000000         0011345677889999999999999999999


Q ss_pred             HHHHHH
Q 042216          741 MSDVVW  746 (767)
Q Consensus       741 ~~evl~  746 (767)
                      +.|+++
T Consensus       328 ~~ell~  333 (373)
T 1q8y_A          328 AGGLVN  333 (373)
T ss_dssp             HHHHHT
T ss_pred             HHHHhh
Confidence            999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2e-37  Score=340.26  Aligned_cols=258  Identities=19%  Similarity=0.235  Sum_probs=198.3

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--cchhHHHHHHHHHhccccceeeeEeeeeecCCce----
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQM----  547 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~----  547 (767)
                      .++|...+.||+|+||.||+|....+++.||||++.....  ...+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            4578889999999999999999988889999999975432  2346788999999999999999999999877654    


Q ss_pred             --EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcc
Q 042216          548 --ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK  625 (767)
Q Consensus       548 --~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~  625 (767)
                        ++||||+. |+|.+++.    ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence              99999998 58888873    24899999999999999999999   6789999999999999999999999999997


Q ss_pred             cCCCCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC--
Q 042216          626 FGPNFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK--  702 (767)
Q Consensus       626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~--  702 (767)
                      ....     ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+..  ..... ......  
T Consensus       193 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~i~~-~~~~~~~~  264 (371)
T 4exu_A          193 HADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL--TQILK-VTGVPGTE  264 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHH-HHCCCCHH
T ss_pred             cccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHH-HhCCCcHH
Confidence            5432     2234568999999999987 68999999999999999999999999654432111  11110 000000  


Q ss_pred             -ccccc-----------cccccC---CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          703 -IGDII-----------DPFLKG---NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       703 -~~~~~-----------d~~l~~---~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                       ...+.           ......   ...+.++..+.+++.+||+.||.+|||+.|+++.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence             00000           000000   0112346789999999999999999999999853

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5.6e-37  Score=334.23  Aligned_cols=256  Identities=19%  Similarity=0.235  Sum_probs=198.4

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--cchhHHHHHHHHHhccccceeeeEeeeeecCCc-----
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQ-----  546 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~-----  546 (767)
                      .++|...+.||+|+||.||+|....+++.||||++.....  ...+.+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            3578888999999999999999988889999999975432  234578899999999999999999999987654     


Q ss_pred             -eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcc
Q 042216          547 -MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK  625 (767)
Q Consensus       547 -~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~  625 (767)
                       .++||||++ |+|.+++..    .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence             499999998 599888732    4899999999999999999999   6789999999999999999999999999997


Q ss_pred             cCCCCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcC---
Q 042216          626 FGPNFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG---  701 (767)
Q Consensus       626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~---  701 (767)
                      ....     ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.  +..... .....   
T Consensus       175 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~i~~-~~~~~~~~  246 (353)
T 3coi_A          175 HADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILK-VTGVPGTE  246 (353)
T ss_dssp             C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH--HHHHHH-HHCBCCHH
T ss_pred             CCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH-HhCCCCHH
Confidence            5332     1234568999999999886 6889999999999999999999999976543211  111110 00000   


Q ss_pred             ---------------CccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          702 ---------------KIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       702 ---------------~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                                     .+.....+.+ .......+.++.+++.+||+.||.+|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          247 FVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                           0000000000 1122345778999999999999999999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5.2e-37  Score=330.71  Aligned_cols=254  Identities=23%  Similarity=0.334  Sum_probs=181.9

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC-cchhHHHHHHH-HHhccccceeeeEeeeeecCCceEEEEe
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ-QGALEFQTEIG-MLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~-~~~~~f~~Ei~-~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ++|...+.||+|+||.||+|....+++.||||++..... ....++..|+. +++.++||||+++++++...+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            578888899999999999999988889999999976532 33445666665 7778899999999999999999999999


Q ss_pred             cCCCCChhhhhcc---CCCCCCChHHHHHHHHHHHHHHHHhHhCCCC-CeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          553 YMARGTLRDHLYN---NDNPPLPWDRRLKICIGAARALHYLHTGASK-VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       553 y~~~gsL~~~L~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      |+++ +|.+++..   .....+++..+..++.|++.||.|||   .. +|+||||||+|||++.++.+||+|||+++...
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            9985 88877742   23456999999999999999999999   55 89999999999999999999999999997543


Q ss_pred             CCCCccccccccCCCcccChhhh----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc
Q 042216          629 NFSKTHVSTQVKGSIGYLDPEYY----RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG  704 (767)
Q Consensus       629 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  704 (767)
                      ..   .......||..|+|||.+    .+..++.++|||||||++|||++|+.||........         ...  .+.
T Consensus       178 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------~~~--~~~  243 (327)
T 3aln_A          178 DS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---------QLT--QVV  243 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------C--CCC
T ss_pred             cc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------HHH--HHh
Confidence            21   122334689999999998    456789999999999999999999999964322100         000  000


Q ss_pred             ccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          705 DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       705 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ....+.+.......++..+.+++.+||+.||.+|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            111111222222346678999999999999999999999985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.7e-37  Score=326.29  Aligned_cols=254  Identities=24%  Similarity=0.327  Sum_probs=195.7

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeec---------
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCND---------  543 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~---------  543 (767)
                      ..++|+..+.||+|+||.||+|+...+++.||||++... ......+.+|++++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            456899999999999999999999888899999998532 3345678999999999999999999998754         


Q ss_pred             ----CCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 042216          544 ----DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVS  619 (767)
Q Consensus       544 ----~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~  619 (767)
                          .+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEe
Confidence                357899999999999999997543 35788999999999999999999   6789999999999999999999999


Q ss_pred             ecCCcccCCCCCC------------ccccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCcc
Q 042216          620 DFGLCKFGPNFSK------------THVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKK  686 (767)
Q Consensus       620 DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~  686 (767)
                      |||+++.......            ........|+..|+|||.+.+. .++.++|||||||++|||++   |+....   
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~---  232 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM---  232 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH---
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch---
Confidence            9999976432110            1122345689999999999864 78999999999999999998   442211   


Q ss_pred             chhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          687 QVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       687 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                        ........ ....      ...+....+...+..+.+++.+||+.||.+|||+.++++
T Consensus       233 --~~~~~~~~-~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          233 --ERVNILKK-LRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             --HHHHHHHH-HHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --hHHHHHHh-cccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence              11111111 1111      111222334556677899999999999999999999985

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.7e-37  Score=334.73  Aligned_cols=271  Identities=20%  Similarity=0.183  Sum_probs=194.6

Q ss_pred             HHHHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCc-
Q 042216          468 SEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQ-  546 (767)
Q Consensus       468 ~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~-  546 (767)
                      .+.....++|...+.||+|+||.||+|+...+++.||||++.... .....+.+|++.+..++||||+++++++...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            455677889999999999999999999998888999999986543 333456788889999999999999999865433 


Q ss_pred             ------eEEEEecCCCCChhhhhcc--CCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC-CCcEE
Q 042216          547 ------MILVYDYMARGTLRDHLYN--NDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE-EWVAK  617 (767)
Q Consensus       547 ------~~lV~ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~-~~~~k  617 (767)
                            .++||||+++ +|.+.+..  .....+++..+..++.|++.||.|||. ++.+|+||||||+|||++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEE
Confidence                  7899999986 55544432  334568999999999999999999993 2467999999999999996 89999


Q ss_pred             EeecCCcccCCCCCCccccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHH
Q 042216          618 VSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATE  696 (767)
Q Consensus       618 i~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~  696 (767)
                      |+|||+++.....   .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........  +......
T Consensus       173 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~~~~  247 (360)
T 3e3p_A          173 LCDFGSAKKLSPS---EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHEIVRV  247 (360)
T ss_dssp             ECCCTTCBCCCTT---SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHH
T ss_pred             EeeCCCceecCCC---CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--HHHHHHH
Confidence            9999999865432   122345689999999998654 489999999999999999999999976543221  1111111


Q ss_pred             H----------h-hcCCcccccc------ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          697 C----------Y-RNGKIGDIID------PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       697 ~----------~-~~~~~~~~~d------~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .          . .........+      .......+...+.++.+++.+||+.||.+|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            0          0 0000000000      00111223346788999999999999999999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5e-37  Score=332.42  Aligned_cols=252  Identities=20%  Similarity=0.287  Sum_probs=176.5

Q ss_pred             hhccccce-eeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHH-HHHhccccceeeeEeeeeec----CCce
Q 042216          474 TKDFNNLL-IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEI-GMLSQLRYLHLVSLIGYCND----DGQM  547 (767)
Q Consensus       474 t~~f~~~~-~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei-~~l~~l~Hpniv~l~g~~~~----~~~~  547 (767)
                      .++|...+ +||+|+||+||+|....+++.||||++...    . ...+|+ ..+..++||||+++++++..    +...
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~-~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----P-KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----H-HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----H-HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            46788854 699999999999999988899999998642    1 223333 44566799999999999875    4458


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC---CCcEEEeecCCc
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE---EWVAKVSDFGLC  624 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~---~~~~ki~DfGla  624 (767)
                      ++||||+++|+|.+++.......+++.+++.++.|++.||.|||   +.+|+||||||+|||++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            99999999999999998766667999999999999999999999   678999999999999976   456999999999


Q ss_pred             ccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc
Q 042216          625 KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG  704 (767)
Q Consensus       625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  704 (767)
                      +....    .......||+.|+|||++....++.++|||||||++|||++|+.||...........   .......+   
T Consensus       179 ~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~---  248 (336)
T 3fhr_A          179 KETTQ----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKRRIRLG---  248 (336)
T ss_dssp             EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             eeccc----cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHHhhhcc---
Confidence            75432    122345689999999999888899999999999999999999999965433211000   00000000   


Q ss_pred             ccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          705 DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       705 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                         ...+.......++.++.+++.+||+.||.+|||+.|+++
T Consensus       249 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          249 ---QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               001111122345678999999999999999999999996

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9e-37  Score=322.53  Aligned_cols=253  Identities=22%  Similarity=0.303  Sum_probs=204.1

Q ss_pred             HHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       472 ~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      ...++|...+.||+|+||.||+|+...+++.||||++...  .......+.+|++++++++||||+++++++.+.+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            3457899999999999999999999878899999998643  23446678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCC---CcEEEeecCCccc
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEE---WVAKVSDFGLCKF  626 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~---~~~ki~DfGla~~  626 (767)
                      |+||+++++|.+++...  ..+++.+++.++.|++.||.|||   +.+++||||||+|||++.+   +.+||+|||+++.
T Consensus        99 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A           99 VGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            99999999999988654  35899999999999999999999   6789999999999999754   4799999999875


Q ss_pred             CCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccc
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDI  706 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  706 (767)
                      .....   ......++..|+|||.+.+ .++.++||||||+++|||++|+.||......+   ...    .+..+.... 
T Consensus       174 ~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~----~~~~~~~~~-  241 (287)
T 2wei_A          174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILK----RVETGKYAF-  241 (287)
T ss_dssp             BCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCCCCC-
T ss_pred             ecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHcCCCCC-
Confidence            43221   1223458899999999875 48999999999999999999999996543221   111    111111100 


Q ss_pred             ccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          707 IDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       707 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                           ........+.++.+++.+||+.||.+|||+.|+++
T Consensus       242 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          242 -----DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             -----CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence                 00001234567899999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=6.1e-37  Score=339.08  Aligned_cols=259  Identities=23%  Similarity=0.258  Sum_probs=192.7

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCC------ceE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG------QMI  548 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~------~~~  548 (767)
                      .+|...++||+|+||.||+|+...++ .+|+|++.....    ...+|+++++.++||||+++++++...+      ..+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~-~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTE-EEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCC-eEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            46888999999999999999997665 488888754322    2236999999999999999999985443      378


Q ss_pred             EEEecCCCCChhhhhc-cCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC-CCCcEEEeecCCccc
Q 042216          549 LVYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD-EEWVAKVSDFGLCKF  626 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld-~~~~~ki~DfGla~~  626 (767)
                      +||||++++.+..... ......+++..+..++.|+++||.|||   +.+|+||||||+|||++ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            9999998754433321 122456999999999999999999999   67899999999999999 799999999999986


Q ss_pred             CCCCCCccccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHH--------
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATEC--------  697 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~--------  697 (767)
                      .....   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.  +.......        
T Consensus       192 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          192 LIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIKVLGTPSREQI  266 (394)
T ss_dssp             CCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHH
T ss_pred             ccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHH
Confidence            53221   22345689999999998764 589999999999999999999999976543221  11111100        


Q ss_pred             ------hhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          698 ------YRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       698 ------~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                            +............+....+...+.++.+++.+||+.||.+|||+.|+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence                  0000000000000111122335678999999999999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6e-37  Score=327.85  Aligned_cols=245  Identities=22%  Similarity=0.362  Sum_probs=193.7

Q ss_pred             HHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC------cchhHHHHHHHHHhcc----ccceeeeEee
Q 042216          470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ------QGALEFQTEIGMLSQL----RYLHLVSLIG  539 (767)
Q Consensus       470 i~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~------~~~~~f~~Ei~~l~~l----~Hpniv~l~g  539 (767)
                      .....++|...+.||+|+||.||+|....+++.||||++.....      .....+.+|+.++.++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            34456789999999999999999999988889999999965432      1233467899999988    8999999999


Q ss_pred             eeecCCceEEEEec-CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC-CCCcEE
Q 042216          540 YCNDDGQMILVYDY-MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD-EEWVAK  617 (767)
Q Consensus       540 ~~~~~~~~~lV~ey-~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld-~~~~~k  617 (767)
                      ++...+..++|+|| +.+++|.+++...  ..+++..++.++.|++.||.|||   +.+|+||||||+|||++ +++.+|
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEE
Confidence            99999999999999 7899999999653  35899999999999999999999   67899999999999999 899999


Q ss_pred             EeecCCcccCCCCCCccccccccCCCcccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHH
Q 042216          618 VSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLT-EKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATE  696 (767)
Q Consensus       618 i~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~  696 (767)
                      |+|||+++.....    ......|+..|+|||++.+..+. .++|||||||++|||++|+.||.....            
T Consensus       181 l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------  244 (312)
T 2iwi_A          181 LIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------------  244 (312)
T ss_dssp             ECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------
T ss_pred             EEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------------
Confidence            9999999865432    22345689999999999876664 589999999999999999999953210            


Q ss_pred             HhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          697 CYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       697 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ... .          ....+...+.++.+++.+||+.||.+|||+.|+++
T Consensus       245 ~~~-~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          245 ILE-A----------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             HHH-T----------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             Hhh-h----------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000 0          01123445677899999999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=338.30  Aligned_cols=265  Identities=21%  Similarity=0.258  Sum_probs=182.2

Q ss_pred             cccc-ceeeeccCcEEEEEEEec--CCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeee--cCCceEEE
Q 042216          476 DFNN-LLIIGRGGFGNVYKGFLN--GDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN--DDGQMILV  550 (767)
Q Consensus       476 ~f~~-~~~LG~G~fG~Vy~g~~~--~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~--~~~~~~lV  550 (767)
                      .|.. .++||+|+||+||+|.++  ..++.||||++....  ....+.+|+++|++++||||+++++++.  .....++|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            4554 347999999999999976  346789999997432  3346889999999999999999999994  46789999


Q ss_pred             EecCCCCChhhhhccC-------CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE----CCCCcEEEe
Q 042216          551 YDYMARGTLRDHLYNN-------DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL----DEEWVAKVS  619 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl----d~~~~~ki~  619 (767)
                      |||+++ +|.+++...       ....+++..+..++.|++.||.|||   +.+|+||||||+|||+    +.++.+||+
T Consensus        99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            999975 888877521       2235999999999999999999999   6789999999999999    778999999


Q ss_pred             ecCCcccCCCCCC-ccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCcc------chhHH
Q 042216          620 DFGLCKFGPNFSK-THVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKK------QVNLA  691 (767)
Q Consensus       620 DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~------~~~l~  691 (767)
                      |||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||....+..      .....
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            9999986533211 122334678999999999987 458999999999999999999999996543311      00111


Q ss_pred             HHHHHHhhcCC---ccccc-------------cccccC--------CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          692 VWATECYRNGK---IGDII-------------DPFLKG--------NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       692 ~~~~~~~~~~~---~~~~~-------------d~~l~~--------~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ......+....   ...+.             ......        ........++.+|+.+||+.||.+|||++|+++
T Consensus       255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11111111000   00000             000000        000111456889999999999999999999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5e-37  Score=330.06  Aligned_cols=242  Identities=22%  Similarity=0.373  Sum_probs=200.8

Q ss_pred             HhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc------chhHHHHHHHHHhccc--cceeeeEeeeeecC
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ------GALEFQTEIGMLSQLR--YLHLVSLIGYCNDD  544 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~------~~~~f~~Ei~~l~~l~--Hpniv~l~g~~~~~  544 (767)
                      ..++|...+.||+|+||.||+|....+++.||||++......      ....+.+|+.++++++  |+||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            456799999999999999999999888899999998654221      2345778999999996  59999999999999


Q ss_pred             CceEEEEecCCC-CChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC-CCCcEEEeecC
Q 042216          545 GQMILVYDYMAR-GTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD-EEWVAKVSDFG  622 (767)
Q Consensus       545 ~~~~lV~ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld-~~~~~ki~DfG  622 (767)
                      +..++|+|++.+ ++|.+++...  ..+++..++.++.|++.||.|||   +.+|+||||||+|||++ +++.+||+|||
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             CcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            999999999986 8999999653  45899999999999999999999   67899999999999999 78999999999


Q ss_pred             CcccCCCCCCccccccccCCCcccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcC
Q 042216          623 LCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL-TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG  701 (767)
Q Consensus       623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~  701 (767)
                      +++.....    ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....            ... +
T Consensus       196 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------~~~-~  258 (320)
T 3a99_A          196 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIR-G  258 (320)
T ss_dssp             TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHH-C
T ss_pred             cccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------------hhc-c
Confidence            99865431    2234568999999999987665 6889999999999999999999943210            001 1


Q ss_pred             CccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          702 KIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       702 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .          ...+...+.++.+++.+||+.||.+|||++||++
T Consensus       259 ~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          259 Q----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             C----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             c----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0          0122345667899999999999999999999986

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.2e-36  Score=324.04  Aligned_cols=252  Identities=22%  Similarity=0.288  Sum_probs=181.3

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc-chh-HHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ-GAL-EFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~-~~~-~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      .++|...+.||+|+||.||+|....+++.||||++...... ... .+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            45788899999999999999999888899999999755322 222 3444556788889999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCC-CCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS-KVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      ||+ ++.+..++. .....+++..+..++.|++.||.|||   + .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       104 e~~-~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          104 ELM-GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             CCC-SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecc-CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            999 444444443 32456899999999999999999999   5 38999999999999999999999999998754321


Q ss_pred             CCccccccccCCCcccChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYR-----LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD  705 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  705 (767)
                         .......|++.|+|||.+.     ...++.++|||||||++|||++|+.||.......     ........... ..
T Consensus       179 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~-~~  249 (318)
T 2dyl_A          179 ---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-----EVLTKVLQEEP-PL  249 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHHHSCC-CC
T ss_pred             ---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-----HHHHHHhccCC-CC
Confidence               1223456899999999994     5678899999999999999999999996533211     11111111110 00


Q ss_pred             cccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       706 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                           +  .....++.++.+++.+||+.||.+||++.|+++
T Consensus       250 -----~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          250 -----L--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             -----C--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -----C--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                 0  111235677899999999999999999999985

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.3e-35  Score=332.70  Aligned_cols=250  Identities=21%  Similarity=0.244  Sum_probs=185.3

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEEEecCC
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILVYDYMA  555 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~ey~~  555 (767)
                      |...++||+|+||+||.+... +++.||||++...   ....+.+|+++|.++ +||||+++++++.+++..++||||+.
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~~-~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEES-SSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeccCeEeeCCCeEEEEEEEE-CCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            445578999999999765444 4589999998632   344678999999886 89999999999999999999999996


Q ss_pred             CCChhhhhccCCCCC-----CChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC-------------CCcEE
Q 042216          556 RGTLRDHLYNNDNPP-----LPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE-------------EWVAK  617 (767)
Q Consensus       556 ~gsL~~~L~~~~~~~-----l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~-------------~~~~k  617 (767)
                       |+|.+++.......     .++..++.++.|++.||+|||   +.+|+||||||+|||++.             ++.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             69999997543211     244466889999999999999   678999999999999965             45899


Q ss_pred             EeecCCcccCCCCCCcc--ccccccCCCcccChhhhcc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccc
Q 042216          618 VSDFGLCKFGPNFSKTH--VSTQVKGSIGYLDPEYYRL-------QLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQ  687 (767)
Q Consensus       618 i~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~  687 (767)
                      |+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||....... 
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-  247 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-  247 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence            99999998654322111  1234579999999999975       678999999999999999999 999995443221 


Q ss_pred             hhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          688 VNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       688 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                         .......   ...     +.+....+...+.++.+++.+||+.||.+|||+.||++
T Consensus       248 ---~~i~~~~---~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 ---SNIIRGI---FSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             ---HHHHHTC---CCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---HHHhcCC---CCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence               1111110   000     11112224566788999999999999999999999984

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.8e-36  Score=345.43  Aligned_cols=269  Identities=22%  Similarity=0.281  Sum_probs=205.1

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeeec------CCc
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCND------DGQ  546 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~------~~~  546 (767)
                      .++|...+.||+|+||.||+|....+++.||||++... .......+.+|++++.+++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            36799999999999999999999888899999998754 33345678999999999999999999999765      678


Q ss_pred             eEEEEecCCCCChhhhhccCC-CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCc---EEEeecC
Q 042216          547 MILVYDYMARGTLRDHLYNND-NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV---AKVSDFG  622 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~---~ki~DfG  622 (767)
                      .++||||+++|+|.+++.... ...+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            899999999999999997643 346999999999999999999999   678999999999999986664   9999999


Q ss_pred             CcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC
Q 042216          623 LCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK  702 (767)
Q Consensus       623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~  702 (767)
                      +++.....   .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......     ..|.........
T Consensus       170 ~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~  241 (676)
T 3qa8_A          170 YAKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSN  241 (676)
T ss_dssp             CCCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC----
T ss_pred             cccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccc
Confidence            99865332   2234467999999999999999999999999999999999999999653211     111100000000


Q ss_pred             ----cccccccc--------ccCCCChhhHHHHHHHHHHccccCCCCCCCHHH-----HHHHHHHhHh
Q 042216          703 ----IGDIIDPF--------LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSD-----VVWGLEFVFQ  753 (767)
Q Consensus       703 ----~~~~~d~~--------l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~e-----vl~~L~~~~~  753 (767)
                          ..+.....        .........+..+.+++.+||+.||.+|||+.|     ..+.++.+++
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence                00000000        011234557889999999999999999999988     4466665554

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.5e-35  Score=310.46  Aligned_cols=232  Identities=13%  Similarity=0.063  Sum_probs=186.4

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC---cchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ---QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|...+.||+|+||.||+|.....++.||||++.....   ...+++.+|+.++.+++||||+++++++.+.+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            568899999999999999999988789999999976533   22467899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++++|.+++.+.    ....++.+++.|++.||.|||   +++|+||||||+|||++.++.+||++++         
T Consensus       111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~---------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA---------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred             EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence            999999999999432    355578899999999999999   6789999999999999999999997443         


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                                   |++|       ++.++|||||||++|||++|+.||......+....            ....+....
T Consensus       175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~------------~~~~~~~~~  222 (286)
T 3uqc_A          175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP------------AERDTAGQP  222 (286)
T ss_dssp             -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE------------CCBCTTSCB
T ss_pred             -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH------------HHHHhccCC
Confidence                         3333       68899999999999999999999976543211100            000000000


Q ss_pred             c--CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          712 K--GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       712 ~--~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      .  ......++.++.+++.+||+.||.+| |+.|+++.|+.+....
T Consensus       223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          223 IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            0  01123456779999999999999999 9999999999887544

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.2e-35  Score=349.31  Aligned_cols=242  Identities=20%  Similarity=0.286  Sum_probs=195.9

Q ss_pred             hccccceeeeccCcEEEEEEEecC-CCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCc-----e
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNG-DSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQ-----M  547 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~-----~  547 (767)
                      ++|...+.||+|+||.||+|.+.. +++.||||++.... ......+.+|++++.+++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            679999999999999999999875 56899999986543 2344568999999999999999999999987665     7


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      ++||||+++++|.+++..    .++|.+++.++.|++.||.|||   +++|+||||||+|||++.+ .+||+|||+++..
T Consensus       160 ~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             EEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            999999999999988743    5999999999999999999999   6789999999999999986 9999999999865


Q ss_pred             CCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccc
Q 042216          628 PNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDII  707 (767)
Q Consensus       628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  707 (767)
                      ...      ....||+.|+|||++.++. +.++|||||||+|+||++|.+|+.......                   +.
T Consensus       232 ~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------------------~~  285 (681)
T 2pzi_A          232 NSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-------------------LP  285 (681)
T ss_dssp             TCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------CC
T ss_pred             ccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-------------------cc
Confidence            332      3456999999999998654 899999999999999999998875321100                   00


Q ss_pred             cccccCCCChhhHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhHhh
Q 042216          708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRP-SMSDVVWGLEFVFQL  754 (767)
Q Consensus       708 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RP-s~~evl~~L~~~~~~  754 (767)
                          ...........+.+++.+||+.||.+|| +++++.+.|..++..
T Consensus       286 ----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  329 (681)
T 2pzi_A          286 ----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE  329 (681)
T ss_dssp             ----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred             ----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence                0000112346788999999999999999 577777778776543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-35  Score=328.86  Aligned_cols=249  Identities=23%  Similarity=0.259  Sum_probs=186.3

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEEEe
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ..+|...++||+|+||+|+..... +++.||||++.....   ..+.+|+++|+++ +||||+++++++.+.+..++|||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEES-SSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEEe-CCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            346888899999999996543333 457899999965432   3467899999999 89999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC-----CCCcEEEeecCCcccC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD-----EEWVAKVSDFGLCKFG  627 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld-----~~~~~ki~DfGla~~~  627 (767)
                      |+. |+|.+++..... .+.+..++.++.|++.||.|||   +.+|+||||||+|||++     ....+||+|||+++..
T Consensus        99 ~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           99 LCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            997 599999976542 3556677899999999999999   67899999999999994     3346889999999865


Q ss_pred             CCCCCc-cccccccCCCcccChhhhc---cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCC
Q 042216          628 PNFSKT-HVSTQVKGSIGYLDPEYYR---LQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGK  702 (767)
Q Consensus       628 ~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~  702 (767)
                      ...... .......||+.|+|||++.   ...++.++|||||||++|||++ |..||.......    .   ........
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----~---~~~~~~~~  246 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----A---NILLGACS  246 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----H---HHHTTCCC
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----H---HHHhccCC
Confidence            432111 2234467999999999997   4677889999999999999999 899985433211    0   11111110


Q ss_pred             ccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHH
Q 042216          703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV  745 (767)
Q Consensus       703 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl  745 (767)
                      . ..      ...+......+.+++.+||+.||.+|||+.||+
T Consensus       247 ~-~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl  282 (432)
T 3p23_A          247 L-DC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL  282 (432)
T ss_dssp             C-TT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             c-cc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence            0 00      011234556688999999999999999999998

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=9.5e-35  Score=309.06  Aligned_cols=228  Identities=20%  Similarity=0.324  Sum_probs=182.3

Q ss_pred             hhccccc-eeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHH-hccccceeeeEeeeeec----CCce
Q 042216          474 TKDFNNL-LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGML-SQLRYLHLVSLIGYCND----DGQM  547 (767)
Q Consensus       474 t~~f~~~-~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l-~~l~Hpniv~l~g~~~~----~~~~  547 (767)
                      .++|... ++||+|+||.||++....+++.||+|++..     ...+.+|++++ +.++||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            3567776 679999999999999988889999999853     34677899888 55689999999999876    6788


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC---CCcEEEeecCCc
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE---EWVAKVSDFGLC  624 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~---~~~~ki~DfGla  624 (767)
                      ++||||+++|+|.+++.......+++.+++.++.|++.||.|||   +.+|+||||||+|||++.   ++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999998776667999999999999999999999   678999999999999998   789999999998


Q ss_pred             ccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc
Q 042216          625 KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG  704 (767)
Q Consensus       625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  704 (767)
                      +...                        +..++.++|||||||++|||++|+.||........           ......
T Consensus       168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~  212 (299)
T 3m2w_A          168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKT  212 (299)
T ss_dssp             EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCC
T ss_pred             cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHH
Confidence            6432                        13467899999999999999999999965432110           000000


Q ss_pred             ccccccccCCCC----hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          705 DIIDPFLKGNAP----PVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       705 ~~~d~~l~~~~~----~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .+....  ...+    ..++.++.+++.+||+.||.+|||+.|+++
T Consensus       213 ~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          213 RIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             SSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            000000  0111    235678999999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=8.7e-35  Score=323.76  Aligned_cols=241  Identities=15%  Similarity=0.122  Sum_probs=182.2

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHHHHHHHhcccc-cee---------------e
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRY-LHL---------------V  535 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H-pni---------------v  535 (767)
                      .+|...++||+|+||+||+|++..+++.||||++....   ....+.|.+|+.++..++| +|.               +
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            45777789999999999999998888999999987432   2335679999999999976 211               1


Q ss_pred             eE------eeeeec-----CCceEEEEecCCCCChhhhhc-----cCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeE
Q 042216          536 SL------IGYCND-----DGQMILVYDYMARGTLRDHLY-----NNDNPPLPWDRRLKICIGAARALHYLHTGASKVII  599 (767)
Q Consensus       536 ~l------~g~~~~-----~~~~~lV~ey~~~gsL~~~L~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ii  599 (767)
                      .+      ..+...     ....+++|+++ +++|.+++.     ......+++..++.++.|+++||.|||   +++|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence            11      111111     12456777765 579999884     233456889999999999999999999   78899


Q ss_pred             ecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhh----------ccCCCCchhhHHHHHHHH
Q 042216          600 HRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY----------RLQLLTEKSDVYSFGVVL  669 (767)
Q Consensus       600 H~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDV~SfGvvl  669 (767)
                      ||||||+|||++.++.+||+|||+++....     ......| +.|+|||++          ....++.++|||||||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            999999999999999999999999875332     1344567 999999999          555688999999999999


Q ss_pred             HHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          670 LEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       670 ~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      |||++|+.||......+.                   .+..+..  ....+.++.+++.+||+.||.+||++.++++
T Consensus       308 ~elltg~~Pf~~~~~~~~-------------------~~~~~~~--~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGG-------------------SEWIFRS--CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSC-------------------SGGGGSS--CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHCCCCCCCcchhhh-------------------HHHHHhh--cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            999999999965432211                   1111111  1134567999999999999999999888753

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.5e-34  Score=309.03  Aligned_cols=243  Identities=19%  Similarity=0.177  Sum_probs=181.6

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--------CcchhHHHHHHHHHhccc---------cceeee
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--------QQGALEFQTEIGMLSQLR---------YLHLVS  536 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--------~~~~~~f~~Ei~~l~~l~---------Hpniv~  536 (767)
                      .++|...+.||+|+||+||+|+..  ++.||||++....        ....+.+.+|+.++++++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEET--TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEeC--CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            467888999999999999999984  4899999987542        223367899999999886         666666


Q ss_pred             Eeeee-----------------ec-------------CCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHH
Q 042216          537 LIGYC-----------------ND-------------DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARA  586 (767)
Q Consensus       537 l~g~~-----------------~~-------------~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~g  586 (767)
                      +.+.+                 .+             .+..++||||+++|+|.+.+.+   ..+++.++..++.|++.|
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence            66543                 32             6789999999999987777743   458999999999999999


Q ss_pred             HHHhHhCCCCCeEecCCCCCCeEECCCC--------------------cEEEeecCCcccCCCCCCccccccccCCCccc
Q 042216          587 LHYLHTGASKVIIHRDVKTTNILLDEEW--------------------VAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL  646 (767)
Q Consensus       587 L~yLH~~~~~~iiH~Dlk~~NILld~~~--------------------~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~  646 (767)
                      |.|||+  +.+|+||||||+|||++.++                    .+||+|||+++....       ....||+.|+
T Consensus       174 L~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~  244 (336)
T 2vuw_A          174 LAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSM  244 (336)
T ss_dssp             HHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTT
T ss_pred             HHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeeccc
Confidence            999993  35699999999999999887                    999999999985432       2346999999


Q ss_pred             ChhhhccCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHH
Q 042216          647 DPEYYRLQLLTEKSDVYSFGVV-LLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVE  725 (767)
Q Consensus       647 aPE~~~~~~~s~ksDV~SfGvv-l~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  725 (767)
                      |||++.+.. +.++||||+|++ .+++++|..||...     ..+..............    .......+...+.++.+
T Consensus       245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----~~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~~~d  314 (336)
T 2vuw_A          245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----LWLHYLTDKMLKQMTFK----TKCNTPAMKQIKRKIQE  314 (336)
T ss_dssp             CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----HHHHHHHHHHHHTCCCS----SCCCSHHHHHHHHHHHH
T ss_pred             ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----hhhhHHHHhhhhhhccC----cccchhhhhhcCHHHHH
Confidence            999998766 899999998777 67788899987211     00000011111110000    00111123457788999


Q ss_pred             HHHHccccCCCCCCCHHHHH
Q 042216          726 VAMSCVNDDRIRRPSMSDVV  745 (767)
Q Consensus       726 li~~Cl~~dp~~RPs~~evl  745 (767)
                      |+.+||+.|     |++|++
T Consensus       315 li~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          315 FHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHGGGSS-----SHHHHH
T ss_pred             HHHHHhccC-----CHHHHH
Confidence            999999976     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=3.9e-28  Score=279.92  Aligned_cols=185  Identities=18%  Similarity=0.067  Sum_probs=128.7

Q ss_pred             eeccCcEEEEEEEecCCCceEEEEEeCCCC----------CcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEEE
Q 042216          483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGS----------QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       483 LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~----------~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      .+.|+.|.+..+...--++.+++|.+....          +...++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            455666655554443345789999986542          12345799999999999 7999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||++||+|.++|.+.  .+++..   +|+.||+.||+|||   +++||||||||+||||++++.+||+|||+++..... 
T Consensus       322 Eyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~-  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD-  392 (569)
T ss_dssp             ECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             ecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC-
Confidence            999999999999654  346654   58899999999999   788999999999999999999999999999865432 


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP  678 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P  678 (767)
                       .......+||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       393 -~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 -CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             -CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence             122345679999999999875 467789999999998877655433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=2.9e-25  Score=254.55  Aligned_cols=185  Identities=17%  Similarity=0.160  Sum_probs=145.4

Q ss_pred             ccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc--------chhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          478 NNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ--------GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       478 ~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~--------~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      ...++||+|+||.||+|...+  +.+++|+.......        ..+.+.+|+++|++++||||+++..++...+..++
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLD--FDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEECSS--CEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEEECC--CeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            345689999999999996643  67899987543211        12348999999999999999977777777888899


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ||||+++|+|.+++..          +..++.|+++||.|||   +++|+||||||+|||+++  .+||+|||+++....
T Consensus       417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            9999999999999954          5689999999999999   778999999999999999  999999999987543


Q ss_pred             CCCcc-----ccccccCCCcccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 042216          630 FSKTH-----VSTQVKGSIGYLDPEYYRL--QLLTEKSDVYSFGVVLLEVLCARPPI  679 (767)
Q Consensus       630 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SfGvvl~elltg~~P~  679 (767)
                      .....     ......||+.|||||++..  ..|+.++|+|+..+-.++.+.++.+|
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            21111     1235679999999999986  66888899999999999988887776

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A*

Probab=99.91  E-value=2.3e-24  Score=208.93  Aligned_cols=160  Identities=16%  Similarity=0.180  Sum_probs=120.5

Q ss_pred             eeeeEeecCCcccccCCCCccccccccCCCceecCCCCCCCCCcceEEEeccccCCCCcHHHHHhhhccCCCCCcccccc
Q 042216          194 ETLYRINVGGSFISPQMDTGMYRTWIADDGYVTDARPSALPVNTTIVLRFSRILNFSAPLAVYRTARTMGLDKNINEQYN  273 (767)
Q Consensus       194 ~~~~R~n~G~~~~~~~~dd~~~R~W~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~v~~ta~~~~~~~~~~~~~~  273 (767)
                      +++||+||||+.++   | ..+|.|++|..+.........  .....    ....+.+|+.||||||.+..        +
T Consensus         5 ~~~~~INcGg~~~~---d-~~gr~w~~D~~~~~~g~~~~~--~~~~~----~~~~~~~~~~lY~TaR~~~~--------~   66 (174)
T 2jwp_A            5 KVIWAVNAGGESHV---D-VHGIHYRKDPLEGRVGRASDY--GMKLP----ILRSNPEDQVLYQTERYNED--------S   66 (174)
T ss_dssp             HEEEEEEETSSSEE---E-TTTEEECSSCSSTTCCCCCCC--CTTSC----CSSSCHHHHHTTTCCCCCCS--------C
T ss_pred             cEEEEEECCCCCcc---C-CCCCEEcCCcCcccCCccccc--ccceE----ecccCCCCchhhhhhccCCC--------C
Confidence            67899999999865   3 488999999766321111100  11111    11235689999999999553        4


Q ss_pred             eEEEEecCCCceEEEEEeeeeeecccccCccEEEEEEEcccccccccchhhhcCCCCcceEeeeEEEecccc-------c
Q 042216          274 LTWEFQVDSGFIYFVRLHFCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGSKS-------D  346 (767)
Q Consensus       274 lt~~~~~~~~~~y~v~lhFae~~~~~~~~~~R~F~i~in~~~~~~~~di~~~~~~~~~p~y~~~~v~~~~~~-------~  346 (767)
                      ++|.+|++++..|+|||||||+..  ++.++|+|||||||++++++|||.+++|+ ..|++++|.+.+....       .
T Consensus        67 ~tY~f~v~~~G~Y~VrLhF~ei~~--~~~~~rvFdV~ing~~~l~~fdi~~~ag~-~~~~~~~~~~~v~~~~l~i~~~~~  143 (174)
T 2jwp_A           67 FGYDIPIKEEGEYVLVLKFAEVYF--AQSQQKVFDVRVNGHTVVKDLDIFDRVGH-STAHDEIIPISIKKGKLSVQGEVS  143 (174)
T ss_dssp             EEEEEECCSCEEEEEEEEEECCSC--CCSSSSCEEEEETTEEEEEEECHHHHHSS-SSCEEEEEEEEEETTEEEETTEEE
T ss_pred             eEEEEEeCCCeEEEEEEEEecccc--CCCCCeEeEEEECCEEeecCcCHHHhhCC-CeeEEEEEEEEEecCceeeeeeec
Confidence            999999998679999999999987  46899999999999999999999999987 6899999887653211       0


Q ss_pred             cccceeEEEecCCCCCCcccccccccceeEEee
Q 042216          347 VKKQNLSIALHPAPRWRTKYSDSILNGIEIFKV  379 (767)
Q Consensus       347 ~~~~~l~i~l~p~~~~~~~~~~~~ln~~~i~~~  379 (767)
                      ...+.|+|+++|..     ...|++||+||++-
T Consensus       144 ~~~g~L~I~f~p~~-----~~~a~inaIEI~~~  171 (174)
T 2jwp_A          144 TFTGKLSVEFVKGY-----YDNPKVCALFIMKG  171 (174)
T ss_dssp             ECCSEEEEEEECSS-----SCSSSEEEEEEESS
T ss_pred             ccCCeEEEEEeccC-----CCCcEEEEEEEEeC
Confidence            13456999998742     34899999999873

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=5.8e-22  Score=208.33  Aligned_cols=146  Identities=13%  Similarity=0.036  Sum_probs=117.8

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC------------------cchhHHHHHHHHHhccccceee
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ------------------QGALEFQTEIGMLSQLRYLHLV  535 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~------------------~~~~~f~~Ei~~l~~l~Hpniv  535 (767)
                      ...|...+.||+|+||.||+|.. .+++.||||.++....                  .....+.+|++++++++  | +
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~  164 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L  164 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred             CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence            34555668999999999999999 5678999999964321                  12456899999999998  4 6


Q ss_pred             eEeeeeecCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCc
Q 042216          536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWV  615 (767)
Q Consensus       536 ~l~g~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~  615 (767)
                      ++.+++. .+..++||||+++|+|.+ +..        .....++.|++.||.|||   +.+|+||||||+|||++ ++.
T Consensus       165 ~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~  230 (282)
T 1zar_A          165 AVPKVYA-WEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEG  230 (282)
T ss_dssp             SSCCEEE-EETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTE
T ss_pred             CcCeEEe-ccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCc
Confidence            6666554 356799999999999998 521        234579999999999999   78899999999999999 999


Q ss_pred             EEEeecCCcccCCCCCCccccccccCCCcccChhhhc
Q 042216          616 AKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR  652 (767)
Q Consensus       616 ~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~  652 (767)
                      +||+|||+++.               +..++|||++.
T Consensus       231 vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          231 IWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             EEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             EEEEECCCCeE---------------CCCCCHHHHHH
Confidence            99999999873               23478999875

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A*

Probab=99.81  E-value=9e-20  Score=176.62  Aligned_cols=148  Identities=15%  Similarity=0.184  Sum_probs=109.8

Q ss_pred             ceEEEeeCCCcccccCCCeeeccCCCCCCCCCc--c-ccccc--CCCCCCCcccceeeccceeEEEecCCCceE-EEEee
Q 042216           11 EITFVACGWLGNISAHGQTWAGDVSSQYSPLGH--Q-QSTIS--KKPREPPYSASRLSHSQFTYTFNVTPGQKF-IRLHF   84 (767)
Q Consensus        11 ~~~~i~cG~~~~~~~~~~~w~~D~~~~~~~~~~--~-~~~~~--~~~~~~~~~t~R~f~~~~~Y~~~~~~g~~y-vR~~f   84 (767)
                      ..|+||||++..+|.+||+|.+|..+...+...  . ...+.  ......+|+|+|+|..+.+|.||+.++..| |||||
T Consensus         6 ~~~~INcGg~~~~d~~gr~w~~D~~~~~~g~~~~~~~~~~~~~~~~~~~~lY~TaR~~~~~~tY~f~v~~~G~Y~VrLhF   85 (174)
T 2jwp_A            6 VIWAVNAGGESHVDVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNEDSFGYDIPIKEEGEYVLVLKF   85 (174)
T ss_dssp             EEEEEEETSSSEEETTTEEECSSCSSTTCCCCCCCCTTSCCSSSCHHHHHTTTCCCCCCSCEEEEEECCSCEEEEEEEEE
T ss_pred             EEEEEECCCCCccCCCCCEEcCCcCcccCCcccccccceEecccCCCCchhhhhhccCCCCeEEEEEeCCCeEEEEEEEE
Confidence            579999999877778999999998653111110  0 00111  111234699999998899999999764466 99999


Q ss_pred             ecCCCCCCCCCCceEEEEeCceEEEeccCcccCCCC--ceEEEEEEeec-----------CCCceEEEEEecCCCCCCCc
Q 042216           85 YSTSYSGFNISSAFFSVKANSFTLVNNFSASFAPDD--TFFKEFCINVP-----------EDQRSLSITFTPSPDYQDSY  151 (767)
Q Consensus        85 ~~~~y~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~--~~~~e~~~~~~-----------~~~~~~~l~~~~~~~~~~~~  151 (767)
                      ++-.|..  .....|+|.+|+..++++||.+..++.  ++++++.+.+.           ...+.++|.|.|..   ...
T Consensus        86 ~ei~~~~--~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~---~~~  160 (174)
T 2jwp_A           86 AEVYFAQ--SQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGY---YDN  160 (174)
T ss_dssp             ECCSCCC--SSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECSS---SCS
T ss_pred             eccccCC--CCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEEEeccC---CCC
Confidence            9988754  334449999999999999998765543  78888887642           13468999999862   578


Q ss_pred             eeeeeeEeEecC
Q 042216          152 AFINGIELVSMP  163 (767)
Q Consensus       152 pfis~iE~~~~~  163 (767)
                      ||||||||++.+
T Consensus       161 a~inaIEI~~~~  172 (174)
T 2jwp_A          161 PKVCALFIMKGT  172 (174)
T ss_dssp             SSEEEEEEESSC
T ss_pred             cEEEEEEEEeCc
Confidence            999999999864

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.72  E-value=1.6e-17  Score=172.23  Aligned_cols=137  Identities=17%  Similarity=0.109  Sum_probs=105.2

Q ss_pred             cccceeeeccCcEEEEEEEecCCCce--EEEEEeCCCCCc------------------------chhHHHHHHHHHhccc
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTP--VAIKRLNPGSQQ------------------------GALEFQTEIGMLSQLR  530 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~--vAVK~l~~~~~~------------------------~~~~f~~Ei~~l~~l~  530 (767)
                      +...+.||+|+||.||+|....+++.  ||||+++.....                        ....+.+|+.+|.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            45667899999999999998545678  999987543111                        0125789999999998


Q ss_pred             ccee--eeEeeeeecCCceEEEEecCCC-C----ChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCC
Q 042216          531 YLHL--VSLIGYCNDDGQMILVYDYMAR-G----TLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDV  603 (767)
Q Consensus       531 Hpni--v~l~g~~~~~~~~~lV~ey~~~-g----sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dl  603 (767)
                      |+++  ..++.+    +..+|||||+.+ |    +|.+++..     .++..+..++.|++.+|.|||.  ..+|+||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl  197 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQ--EAELVHADL  197 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence            8754  334432    367899999942 4    56655422     2356788999999999999994  457999999


Q ss_pred             CCCCeEECCCCcEEEeecCCccc
Q 042216          604 KTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       604 k~~NILld~~~~~ki~DfGla~~  626 (767)
                      ||+|||+++  .++|+|||++..
T Consensus       198 kp~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEE
T ss_pred             CHHHEEEcC--cEEEEECccccc
Confidence            999999998  999999999875

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.54  E-value=5.1e-15  Score=159.91  Aligned_cols=136  Identities=14%  Similarity=0.075  Sum_probs=94.6

Q ss_pred             cccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC-----c---------chhHHH--------HHHHHHhcccccee
Q 042216          477 FNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ-----Q---------GALEFQ--------TEIGMLSQLRYLHL  534 (767)
Q Consensus       477 f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~-----~---------~~~~f~--------~Ei~~l~~l~Hpni  534 (767)
                      |.....||+|++|.||+|.... ++.||||+++....     .         ......        .|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~-G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEK-GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTT-CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECCC-CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            7788899999999999999864 58899998764310     0         011122        34444444433322


Q ss_pred             eeEeeeeecCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC
Q 042216          535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW  614 (767)
Q Consensus       535 v~l~g~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~  614 (767)
                      .-..-+.  ....+|||||+++++|.++...        .....++.|++.+|.+||   ..+||||||||.|||+++++
T Consensus       176 ~vp~p~~--~~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          176 PVPEPIA--QSRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEK  242 (397)
T ss_dssp             SCCCEEE--EETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEE
T ss_pred             CCCeeee--ccCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCC
Confidence            1111111  1234799999999888766421        234568899999999999   67899999999999998776


Q ss_pred             ----------cEEEeecCCccc
Q 042216          615 ----------VAKVSDFGLCKF  626 (767)
Q Consensus       615 ----------~~ki~DfGla~~  626 (767)
                                .+.|+||+-+-.
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEE
T ss_pred             CcccccccccceEEEEeCCccc
Confidence                      389999997653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.20  E-value=5e-11  Score=123.18  Aligned_cols=147  Identities=16%  Similarity=0.143  Sum_probs=115.0

Q ss_pred             HHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc-cceeeeEeeeeecCCceE
Q 042216          470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-YLHLVSLIGYCNDDGQMI  548 (767)
Q Consensus       470 i~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~  548 (767)
                      +......|.....++.|+.+.||+....  +..+++|+...........+.+|+++++.+. +..+.++++++...+..+
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            4455567877778888889999999764  3689999986432233446889999999884 677888999998888999


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhC-----------------------------------
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG-----------------------------------  593 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----------------------------------  593 (767)
                      +||||++|.+|.+.+.       +......++.+++++|..||+.                                   
T Consensus        87 lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            9999999999987642       1223457889999999999971                                   


Q ss_pred             ---------------------CCCCeEecCCCCCCeEECCCCcEEEeecCCcc
Q 042216          594 ---------------------ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK  625 (767)
Q Consensus       594 ---------------------~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~  625 (767)
                                           ....++|+|+++.|||++++..+.|.||+.+.
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                 01458999999999999876666799999865

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.99  E-value=8.9e-10  Score=113.20  Aligned_cols=138  Identities=18%  Similarity=0.114  Sum_probs=100.0

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccce--eeeEeeeeecCCceEEEEe
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--LVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpn--iv~l~g~~~~~~~~~lV~e  552 (767)
                      .++....+.+.|..+.||++... ++..+++|.....   ....+..|+.+++.+++.+  +.+++++....+..++|||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e   95 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   95 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             CCCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence            34444333345566999999764 3467999997643   2346789999999986544  4558888888788999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCC--------------------------------------
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA--------------------------------------  594 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------  594 (767)
                      |+++.+|.  ...     .   ....++.++++.|..||...                                      
T Consensus        96 ~i~G~~l~--~~~-----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           96 EVPGQDLL--SSH-----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             CCSSEETT--TSC-----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             ecCCcccC--cCc-----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            99998884  211     1   12366778888888888532                                      


Q ss_pred             -----------------CCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          595 -----------------SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       595 -----------------~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                                       ...++|+|++|.|||++++..+.|.||+.+..
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                             12399999999999998876677999998763

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.90  E-value=4.2e-09  Score=114.04  Aligned_cols=143  Identities=17%  Similarity=0.286  Sum_probs=107.9

Q ss_pred             cceeeeccCcEEEEEEEecCCCceEEEEEeC--CCC-CcchhHHHHHHHHHhccc--cceeeeEeeeeecC---CceEEE
Q 042216          479 NLLIIGRGGFGNVYKGFLNGDSTPVAIKRLN--PGS-QQGALEFQTEIGMLSQLR--YLHLVSLIGYCNDD---GQMILV  550 (767)
Q Consensus       479 ~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~--~~~-~~~~~~f~~Ei~~l~~l~--Hpniv~l~g~~~~~---~~~~lV  550 (767)
                      ..+.|+.|.++.||+....+  ..+++|+..  ... ......+.+|..+++.|+  +..+.+++.++.+.   +..++|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~--~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG--QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS--CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEECC--ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            34578999999999998754  578888775  332 123456889999999986  45688889988776   458999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCC------------------------------------
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA------------------------------------  594 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------  594 (767)
                      |||+++..|.+..    -..++..++..++.++++.|..||...                                    
T Consensus       120 me~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          120 MEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            9999998875422    123778889999999999999999621                                    


Q ss_pred             -------------------CCCeEecCCCCCCeEECCCCc--EEEeecCCcccC
Q 042216          595 -------------------SKVIIHRDVKTTNILLDEEWV--AKVSDFGLCKFG  627 (767)
Q Consensus       595 -------------------~~~iiH~Dlk~~NILld~~~~--~ki~DfGla~~~  627 (767)
                                         ...++|+|+++.|||++.++.  +.|.||+.+...
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                               257999999999999997653  689999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.74  E-value=6.8e-09  Score=109.65  Aligned_cols=187  Identities=17%  Similarity=0.152  Sum_probs=122.1

Q ss_pred             ceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc-cc--eeeeEeeeeecCC---ceEEEEec
Q 042216          480 LLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-YL--HLVSLIGYCNDDG---QMILVYDY  553 (767)
Q Consensus       480 ~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-Hp--niv~l~g~~~~~~---~~~lV~ey  553 (767)
                      .+.++.|....||+..     ..+++|+....  .....+.+|.++|+.+. +.  .+.+++..+...+   ..++|||+
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            3468999999999862     46889986432  33557889999998873 32  2334555543333   34889999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhC----------------------------------------
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG----------------------------------------  593 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------  593 (767)
                      ++|.+|.+...    ..++..++..++.++++.|..||..                                        
T Consensus        98 i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           98 IKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             cCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            99988875432    2366777888888888888888851                                        


Q ss_pred             ---------------CCCCeEecCCCCCCeEECC--CCcEEEeecCCcccCCCCCCccccccc------------cCCCc
Q 042216          594 ---------------ASKVIIHRDVKTTNILLDE--EWVAKVSDFGLCKFGPNFSKTHVSTQV------------KGSIG  644 (767)
Q Consensus       594 ---------------~~~~iiH~Dlk~~NILld~--~~~~ki~DfGla~~~~~~~~~~~~~~~------------~gt~~  644 (767)
                                     ....++|+|+++.||++++  +..+.|.||+.+........-......            ....+
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                           1145899999999999998  556789999998764331110000000            00001


Q ss_pred             ccC-hhhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 042216          645 YLD-PEYYRLQLLTEKSDVYSFGVVLLEVLCARPPI  679 (767)
Q Consensus       645 y~a-PE~~~~~~~s~ksDV~SfGvvl~elltg~~P~  679 (767)
                      ... |+....  .....+.|+++.++|++.+|..++
T Consensus       254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            112 222211  112368999999999999998776

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.30  E-value=3e-06  Score=87.35  Aligned_cols=136  Identities=19%  Similarity=0.187  Sum_probs=99.0

Q ss_pred             eeeccCcE-EEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc-cceeeeEeeeeecCCceEEEEecCCCCCh
Q 042216          482 IIGRGGFG-NVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-YLHLVSLIGYCNDDGQMILVYDYMARGTL  559 (767)
Q Consensus       482 ~LG~G~fG-~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~ey~~~gsL  559 (767)
                      .+..|..| .||+.....++..+++|+-...   ...++.+|...|+.|. +-.+-++++++.+.+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45556655 6999887767778999986532   3456888999998874 33466788889888899999999999887


Q ss_pred             hhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhC----------------------------------------------
Q 042216          560 RDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG----------------------------------------------  593 (767)
Q Consensus       560 ~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------------  593 (767)
                      .+.....      ......++.+++..|.-||..                                              
T Consensus       108 ~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          108 FQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            7654221      123345566666666666641                                              


Q ss_pred             ---------CCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          594 ---------ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       594 ---------~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                               ....++|+|+.+.|||+++++.+-|.||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                     012379999999999999887778999998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.18  E-value=1e-05  Score=85.21  Aligned_cols=137  Identities=20%  Similarity=0.205  Sum_probs=93.8

Q ss_pred             ceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccc---eeeeEeeeee-cCCceEEEEecCC
Q 042216          480 LLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL---HLVSLIGYCN-DDGQMILVYDYMA  555 (767)
Q Consensus       480 ~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hp---niv~l~g~~~-~~~~~~lV~ey~~  555 (767)
                      ...++.|....||+.     +..+++|+..  .......+.+|.++|..|++.   .+.+.+.++. ..+..++|||+++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            446888999999988     2568888853  223345788999999998642   3556666664 4556789999999


Q ss_pred             CCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhC------------------------------------------
Q 042216          556 RGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG------------------------------------------  593 (767)
Q Consensus       556 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------  593 (767)
                      |..|.+....    .++..++..++.++++.|..||..                                          
T Consensus        97 G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           97 GQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             SEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             CeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            9888653211    134444555555555555555531                                          


Q ss_pred             ---------------CCCCeEecCCCCCCeEECC---CCc-EEEeecCCcccC
Q 042216          594 ---------------ASKVIIHRDVKTTNILLDE---EWV-AKVSDFGLCKFG  627 (767)
Q Consensus       594 ---------------~~~~iiH~Dlk~~NILld~---~~~-~ki~DfGla~~~  627 (767)
                                     ....++|+|+++.|||++.   ++. +.|.||+.+...
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                           2345799999999999987   345 589999987653

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.09  E-value=1.3e-05  Score=86.33  Aligned_cols=82  Identities=6%  Similarity=-0.017  Sum_probs=57.0

Q ss_pred             ceee-eccCcEEEEEEEec---C---CCceEEEEEeCCCC---CcchhHHHHHHHHHhcccc---ceeeeEeeeeecC--
Q 042216          480 LLII-GRGGFGNVYKGFLN---G---DSTPVAIKRLNPGS---QQGALEFQTEIGMLSQLRY---LHLVSLIGYCNDD--  544 (767)
Q Consensus       480 ~~~L-G~G~fG~Vy~g~~~---~---~~~~vAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H---pniv~l~g~~~~~--  544 (767)
                      .+.| +.|....+|+....   +   ++..+++|+.....   ......+.+|+.+++.|+.   ..+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3467 78888999998764   1   13578888765432   1123567889999988853   3566788887665  


Q ss_pred             -CceEEEEecCCCCChhh
Q 042216          545 -GQMILVYDYMARGTLRD  561 (767)
Q Consensus       545 -~~~~lV~ey~~~gsL~~  561 (767)
                       +..++||||+++..|.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             45789999999877654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.92  E-value=4.2e-05  Score=83.64  Aligned_cols=76  Identities=17%  Similarity=0.134  Sum_probs=49.7

Q ss_pred             ceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC-------cchhHHHHHHHHHhcccc--ceee-eEeeeeecCCceEE
Q 042216          480 LLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ-------QGALEFQTEIGMLSQLRY--LHLV-SLIGYCNDDGQMIL  549 (767)
Q Consensus       480 ~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~-------~~~~~f~~Ei~~l~~l~H--pniv-~l~g~~~~~~~~~l  549 (767)
                      .+.||.|..+.||++....+++.++||...+...       .....+..|.++|..+..  +..+ +++.+.  .+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            4578999999999997765557899998654321       223456789888887742  3333 455443  445689


Q ss_pred             EEecCCCC
Q 042216          550 VYDYMARG  557 (767)
Q Consensus       550 V~ey~~~g  557 (767)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.62  E-value=0.00029  Score=74.83  Aligned_cols=140  Identities=19%  Similarity=0.197  Sum_probs=80.5

Q ss_pred             eeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccc--eeeeEee------eeecCCceEEEEe
Q 042216          481 LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL--HLVSLIG------YCNDDGQMILVYD  552 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hp--niv~l~g------~~~~~~~~~lV~e  552 (767)
                      ..|+.|..+.||+....+  ..+++|+....    ..++..|..++..|+..  .+.+++.      +....+..+++||
T Consensus        38 ~~l~gG~~n~~~~v~~~~--~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDS--GAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEETT--EEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeCC--CCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            346667788999998754  35899998642    23444566666655321  2233332      1123567889999


Q ss_pred             cCCCCChh--------------hhhcc--C-C--C-------CCCChHHHH-----------------------------
Q 042216          553 YMARGTLR--------------DHLYN--N-D--N-------PPLPWDRRL-----------------------------  577 (767)
Q Consensus       553 y~~~gsL~--------------~~L~~--~-~--~-------~~l~~~~~~-----------------------------  577 (767)
                      |+++..+.              ..||.  . .  .       ..-.|...+                             
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986553              01111  0 0  0       011332211                             


Q ss_pred             --HHHHHHHHHHHHhHh----------CCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          578 --KICIGAARALHYLHT----------GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       578 --~i~~~ia~gL~yLH~----------~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                        .+...+..++.+|+.          .....++|+|+++.|||++.++.+.|.||+.+..
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence              011123345666653          1257799999999999998888999999998754

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.38  E-value=0.00078  Score=70.81  Aligned_cols=139  Identities=14%  Similarity=0.162  Sum_probs=92.0

Q ss_pred             ccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc---cceeeeEeeeeecCCceEEEEecC
Q 042216          478 NNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR---YLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       478 ~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~---Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      ...+.|+.|....+|+....  +..+++|+....   ....+..|...|+.|.   ...+.++++++...+..++||||+
T Consensus        39 ~~~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLINDE--VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             CEEEEECCSSSSEEEEEESS--SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eeeEEeCCccceeeeEEEEC--CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            34457899999999998763  367889987532   3456889999998884   256778888888888899999999


Q ss_pred             CCCChhh-----------hhccCCC-C-------------------CCChHHHHH---HH--H--------------HHH
Q 042216          555 ARGTLRD-----------HLYNNDN-P-------------------PLPWDRRLK---IC--I--------------GAA  584 (767)
Q Consensus       555 ~~gsL~~-----------~L~~~~~-~-------------------~l~~~~~~~---i~--~--------------~ia  584 (767)
                      ++..+..           .|+.... .                   .-+|.....   +.  .              .++
T Consensus       114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~  193 (312)
T 3jr1_A          114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV  193 (312)
T ss_dssp             CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred             cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence            9876531           1222211 0                   114543221   11  1              111


Q ss_pred             HH-HHHhH-hCCCCCeEecCCCCCCeEECCCCcEEEeecC
Q 042216          585 RA-LHYLH-TGASKVIIHRDVKTTNILLDEEWVAKVSDFG  622 (767)
Q Consensus       585 ~g-L~yLH-~~~~~~iiH~Dlk~~NILld~~~~~ki~DfG  622 (767)
                      .- ...|. ....+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            11 12332 12356799999999999999887 8888874

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.20  E-value=0.0012  Score=72.54  Aligned_cols=78  Identities=13%  Similarity=0.137  Sum_probs=48.6

Q ss_pred             CCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCccccccc-cCCCcccChhhhccC---CCCchhhHHHHHHHHH
Q 042216          595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV-KGSIGYLDPEYYRLQ---LLTEKSDVYSFGVVLL  670 (767)
Q Consensus       595 ~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~s~ksDV~SfGvvl~  670 (767)
                      ...++|+|+++.|||++.++ ++|.||+.+...+....-  .... .-...|++|+.....   ......++......+|
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl--a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI--GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH--HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH--HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            67899999999999999876 999999998764321110  0000 011345666554311   1122355667888888


Q ss_pred             HHHhC
Q 042216          671 EVLCA  675 (767)
Q Consensus       671 elltg  675 (767)
                      +.+++
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            87665

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.19  E-value=0.00095  Score=69.26  Aligned_cols=79  Identities=16%  Similarity=0.145  Sum_probs=56.8

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcccc---ceeeeEeeeeecCCceEEEEe
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRY---LHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H---pniv~l~g~~~~~~~~~lV~e  552 (767)
                      .......+|.|..+.||+.++.++ +.+++|+...........|..|...|+.|.-   -.+.+++++.    .-++|||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG-~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e   90 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADG-TPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME   90 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTS-CEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCC-CEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence            456667899999999999998754 7899998765544444568899999888742   1334445443    3478999


Q ss_pred             cCCCCCh
Q 042216          553 YMARGTL  559 (767)
Q Consensus       553 y~~~gsL  559 (767)
                      |++.+..
T Consensus        91 ~l~~~~~   97 (288)
T 3f7w_A           91 WVDERPP   97 (288)
T ss_dssp             CCCCCCC
T ss_pred             eecccCC
Confidence            9987654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.09  E-value=0.0028  Score=66.64  Aligned_cols=159  Identities=13%  Similarity=0.121  Sum_probs=90.9

Q ss_pred             cccCHHHHHHHhhcccc-----ceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccce--ee
Q 042216          463 TQFSISEIKEATKDFNN-----LLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH--LV  535 (767)
Q Consensus       463 ~~~~~~ei~~~t~~f~~-----~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpn--iv  535 (767)
                      +.++.+++......|..     .+.|+.|....+|+....++  .+++|.....  ....++..|+.++..|+...  +.
T Consensus         5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g--~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP   80 (322)
T 2ppq_A            5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD--PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCP   80 (322)
T ss_dssp             CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC--CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCC
T ss_pred             ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc--cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCC
Confidence            34667777777776654     23466788899999987543  6889988652  12335667777777774322  22


Q ss_pred             eEeeee------ecCCceEEEEecCCCCChhh--------------hhccC--C--CC---C---CChHHHHHH------
Q 042216          536 SLIGYC------NDDGQMILVYDYMARGTLRD--------------HLYNN--D--NP---P---LPWDRRLKI------  579 (767)
Q Consensus       536 ~l~g~~------~~~~~~~lV~ey~~~gsL~~--------------~L~~~--~--~~---~---l~~~~~~~i------  579 (767)
                      +++...      ...+..+++++|+++..+..              .++..  .  ..   .   ..|...+.-      
T Consensus        81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~  160 (322)
T 2ppq_A           81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  160 (322)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence            333211      12356789999999865421              01111  0  00   0   123321110      


Q ss_pred             ------HHHHHHHHHHhHhC----CCCCeEecCCCCCCeEECCCCcEEEeecCCcc
Q 042216          580 ------CIGAARALHYLHTG----ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK  625 (767)
Q Consensus       580 ------~~~ia~gL~yLH~~----~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~  625 (767)
                            ...+.+.+..|++.    ....++|+|+.+.|||++++..+.|.||+.+.
T Consensus       161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                  01133445555431    23579999999999999987666899998765

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.00  E-value=0.003  Score=65.86  Aligned_cols=138  Identities=12%  Similarity=0.066  Sum_probs=76.3

Q ss_pred             ceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcccccee-eeEeeeeecCCceEEEEecC-CCC
Q 042216          480 LLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL-VSLIGYCNDDGQMILVYDYM-ARG  557 (767)
Q Consensus       480 ~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpni-v~l~g~~~~~~~~~lV~ey~-~~g  557 (767)
                      .+.|+.|....+|+.      ..+++|+....... .....+|..+++.+....+ .++++++  .+.-++++||+ ++.
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence            567999999999998      35889988654222 2234678888877753333 3455443  33457899999 554


Q ss_pred             Chhhh------------------hccCCC---CCCC-hHHHHHHHH--------------HHHHHH----HHhH-hCCCC
Q 042216          558 TLRDH------------------LYNNDN---PPLP-WDRRLKICI--------------GAARAL----HYLH-TGASK  596 (767)
Q Consensus       558 sL~~~------------------L~~~~~---~~l~-~~~~~~i~~--------------~ia~gL----~yLH-~~~~~  596 (767)
                      +|...                  ||....   ...+ +........              .+...+    ..|. .....
T Consensus        94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~  173 (301)
T 3dxq_A           94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL  173 (301)
T ss_dssp             ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred             cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence            44310                  111110   0001 111111100              011111    1111 12245


Q ss_pred             CeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       597 ~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      .++|+|+.+.||+ ..++.+.|.||..+...
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            6899999999999 55667899999987653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.62  E-value=0.005  Score=67.76  Aligned_cols=74  Identities=16%  Similarity=0.153  Sum_probs=49.7

Q ss_pred             ceeeeccCcEEEEEEEecC-------CCceEEEEEeCCCCCcchhHHHHHHHHHhcccccee-eeEeeeeecCCceEEEE
Q 042216          480 LLIIGRGGFGNVYKGFLNG-------DSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL-VSLIGYCNDDGQMILVY  551 (767)
Q Consensus       480 ~~~LG~G~fG~Vy~g~~~~-------~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpni-v~l~g~~~~~~~~~lV~  551 (767)
                      .+.|+.|-...+|+....+       ++..+++|+....  .....+.+|..++..|...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3468888889999998753       2367889988432  112456689999888854444 456665542    2899


Q ss_pred             ecCCCCCh
Q 042216          552 DYMARGTL  559 (767)
Q Consensus       552 ey~~~gsL  559 (767)
                      ||+++.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986444

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.62  E-value=0.0069  Score=65.31  Aligned_cols=140  Identities=16%  Similarity=0.157  Sum_probs=82.5

Q ss_pred             eeeccCcEEEEEEEecC-------CCceEEEEEeCCCCCcchhHHHHHHHHHhccccce-eeeEeeeeecCCceEEEEec
Q 042216          482 IIGRGGFGNVYKGFLNG-------DSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLH-LVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       482 ~LG~G~fG~Vy~g~~~~-------~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpn-iv~l~g~~~~~~~~~lV~ey  553 (767)
                      .|..|-...+|+....+       ++..+++|+.... ......+.+|.++++.|.-.. ..++++++.+    .+||||
T Consensus        57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~  131 (379)
T 3feg_A           57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY  131 (379)
T ss_dssp             EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred             EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence            56667778899988742       2367889886432 234556778999998885322 3456666643    289999


Q ss_pred             CCCCChhhh-----------------hccCC---CCCC--ChHHHHHHHHHHHH-------------------HHHHhH-
Q 042216          554 MARGTLRDH-----------------LYNND---NPPL--PWDRRLKICIGAAR-------------------ALHYLH-  591 (767)
Q Consensus       554 ~~~gsL~~~-----------------L~~~~---~~~l--~~~~~~~i~~~ia~-------------------gL~yLH-  591 (767)
                      +++..|..-                 ||...   ....  -|.++.++..++..                   .+..|. 
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            998665421                 11111   1112  24555555443321                   223332 


Q ss_pred             ---h-CCCCCeEecCCCCCCeEECCC----CcEEEeecCCccc
Q 042216          592 ---T-GASKVIIHRDVKTTNILLDEE----WVAKVSDFGLCKF  626 (767)
Q Consensus       592 ---~-~~~~~iiH~Dlk~~NILld~~----~~~ki~DfGla~~  626 (767)
                         . .....++|+|+.+.|||++.+    +.+.|.||..+..
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               1 123569999999999999876    7899999988753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.59  E-value=0.017  Score=60.65  Aligned_cols=160  Identities=14%  Similarity=0.137  Sum_probs=91.0

Q ss_pred             cccCHHHHHHHhhccc-----cceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccc--eee
Q 042216          463 TQFSISEIKEATKDFN-----NLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL--HLV  535 (767)
Q Consensus       463 ~~~~~~ei~~~t~~f~-----~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hp--niv  535 (767)
                      ...+.+++......|.     ....|+ |....||+....+ ++.+++|...+.. .....+..|..++..|+..  .+.
T Consensus         9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~-g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp   85 (328)
T 1zyl_A            9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDED-RRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVA   85 (328)
T ss_dssp             CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTT-CCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBC
T ss_pred             CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCC-CCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeec
Confidence            4456666766665553     233566 8888999887653 3579999986432 2344667788888777432  233


Q ss_pred             eEeee-----eecCCceEEEEecCCCCChhh-----------h---hcc--C--C---CCCCChHHH----HHH------
Q 042216          536 SLIGY-----CNDDGQMILVYDYMARGTLRD-----------H---LYN--N--D---NPPLPWDRR----LKI------  579 (767)
Q Consensus       536 ~l~g~-----~~~~~~~~lV~ey~~~gsL~~-----------~---L~~--~--~---~~~l~~~~~----~~i------  579 (767)
                      +++..     ....+..++++|++++..+..           .   +|.  .  .   ....++...    ..+      
T Consensus        86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  165 (328)
T 1zyl_A           86 APVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL  165 (328)
T ss_dssp             CCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred             ceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCc
Confidence            44433     112345678999998754421           0   111  0  0   111222211    001      


Q ss_pred             ---------HHHHHHHHHHhHh----CCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          580 ---------CIGAARALHYLHT----GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       580 ---------~~~ia~gL~yLH~----~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                               ...+...+..+..    .....++|+|+++.|||++ + .+.|.||+.+...
T Consensus       166 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          166 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence                     0011112222221    1245689999999999999 4 8999999987653

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.56  E-value=0.0071  Score=59.04  Aligned_cols=101  Identities=14%  Similarity=0.122  Sum_probs=65.4

Q ss_pred             CChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcccc
Q 042216          557 GTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVS  636 (767)
Q Consensus       557 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~~~  636 (767)
                      -||.+.|... +.+++++++|.+|.|.+.+|.-+-... .. ..+=+.+..|++..+|.+.+.+ ..+.           
T Consensus        33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence            3788888644 458999999999999999987762111 11 1233456889999999988763 1110           


Q ss_pred             ccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCC
Q 042216          637 TQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR  676 (767)
Q Consensus       637 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~  676 (767)
                         .....+.|||... ...+.+.-|||+|++||..+--.
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence               0122456788653 45678999999999999988633

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.49  E-value=0.011  Score=62.32  Aligned_cols=142  Identities=15%  Similarity=0.143  Sum_probs=73.1

Q ss_pred             eeeccCcEE-EEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcccc--ceeeeEeeeeecCCceEEEEecCCCCC
Q 042216          482 IIGRGGFGN-VYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRY--LHLVSLIGYCNDDGQMILVYDYMARGT  558 (767)
Q Consensus       482 ~LG~G~fG~-Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H--pniv~l~g~~~~~~~~~lV~ey~~~gs  558 (767)
                      .|+.|.... +|+....+ +..+++|...+...   .++..|+.++..+..  -.+.+++.++.+.+  +++||++.+..
T Consensus        25 ~l~gg~s~~~~~r~~~~~-~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPT-GAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             C--------CCEEEECTT-CCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             ECCCCCCCceEEEEEcCC-CCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            455555444 66775532 35677776543221   334567777776643  23455666654433  78999997766


Q ss_pred             hhhhhcc---------------------CCCCC---CChHHHH-------H-------------HHHHHHHHHHHhH---
Q 042216          559 LRDHLYN---------------------NDNPP---LPWDRRL-------K-------------ICIGAARALHYLH---  591 (767)
Q Consensus       559 L~~~L~~---------------------~~~~~---l~~~~~~-------~-------------i~~~ia~gL~yLH---  591 (767)
                      +.+++..                     .....   .+.....       .             ....+...+..|.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            6543321                     10001   1111000       0             0001111222221   


Q ss_pred             hCCCCCeEecCCCCCCeEECCC----CcEEEeecCCcccCCC
Q 042216          592 TGASKVIIHRDVKTTNILLDEE----WVAKVSDFGLCKFGPN  629 (767)
Q Consensus       592 ~~~~~~iiH~Dlk~~NILld~~----~~~ki~DfGla~~~~~  629 (767)
                      ......++|+|+.+.|||++.+    ..+.|.||+.+..++.
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~  220 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR  220 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence            1124679999999999999874    6899999999876543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.40  E-value=0.02  Score=63.35  Aligned_cols=75  Identities=13%  Similarity=0.095  Sum_probs=48.1

Q ss_pred             ceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcccccee-eeEeeeeecCCceEEEEecCCCCC
Q 042216          480 LLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL-VSLIGYCNDDGQMILVYDYMARGT  558 (767)
Q Consensus       480 ~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpni-v~l~g~~~~~~~~~lV~ey~~~gs  558 (767)
                      .+.|+.|-...+|+....+++..+++|+...... ...+..+|..++..|...++ .++++.+. +   .+|+||+++.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCcc
Confidence            3468888889999998865346788998754322 12223678888888864444 45666663 2   25999998755


Q ss_pred             h
Q 042216          559 L  559 (767)
Q Consensus       559 L  559 (767)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=95.97  E-value=0.023  Score=60.91  Aligned_cols=74  Identities=11%  Similarity=0.090  Sum_probs=44.1

Q ss_pred             eeeeccCcEEEEEEEecCC--------CceEEEEEeCCCCCcchhHHHHHHHHHhccccceee-eEeeeeecCCceEEEE
Q 042216          481 LIIGRGGFGNVYKGFLNGD--------STPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV-SLIGYCNDDGQMILVY  551 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~~--------~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~lV~  551 (767)
                      ..|+.|....+|+....++        +..+++|+..... ....+...|.+++..|...+++ ++++..  .  -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            3577788889999987531        2568888775432 2222346788888887543433 555443  2  36899


Q ss_pred             ecCCCCCh
Q 042216          552 DYMARGTL  559 (767)
Q Consensus       552 ey~~~gsL  559 (767)
                      ||+++..|
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=94.97  E-value=0.1  Score=55.12  Aligned_cols=33  Identities=21%  Similarity=0.313  Sum_probs=28.7

Q ss_pred             CCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       595 ~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                      ...++|+|+.+.||++++++.+.|.||+.+...
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            356999999999999998888999999887653

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.06  E-value=0.49  Score=51.50  Aligned_cols=140  Identities=14%  Similarity=0.170  Sum_probs=83.8

Q ss_pred             eeeeccCcEEEEEEEecCC-------CceEEEEEeCCCCCcchhHHHHHHHHHhcccccee-eeEeeeeecCCceEEEEe
Q 042216          481 LIIGRGGFGNVYKGFLNGD-------STPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL-VSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~~-------~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpni-v~l~g~~~~~~~~~lV~e  552 (767)
                      +.|..|-...+|+....++       +..+++|+..... ....+..+|..+++.+.-.++ .++++.+.    -++|+|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            3576777888999987631       3678888865433 223344678888888853333 34454332    278999


Q ss_pred             cCCCCChhhh-----------------hcc----C-------CCCCCChHHHHHHHHHH-------------------HH
Q 042216          553 YMARGTLRDH-----------------LYN----N-------DNPPLPWDRRLKICIGA-------------------AR  585 (767)
Q Consensus       553 y~~~gsL~~~-----------------L~~----~-------~~~~l~~~~~~~i~~~i-------------------a~  585 (767)
                      |+++..|..-                 ||.    .       ...+.-|.++.++..++                   ..
T Consensus       151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  230 (424)
T 3mes_A          151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE  230 (424)
T ss_dssp             CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred             EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence            9998664310                 010    0       11122344444443222                   12


Q ss_pred             HHHHhHh---------------------CCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          586 ALHYLHT---------------------GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       586 gL~yLH~---------------------~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      .+.+|.+                     .....++|+|+.+.||+ +.++.+.|.||..+..
T Consensus       231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            2333321                     11346899999999999 7788999999998764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=88.90  E-value=1.4  Score=47.43  Aligned_cols=30  Identities=33%  Similarity=0.500  Sum_probs=25.5

Q ss_pred             CeEecCCCCCCeEE------CCCCcEEEeecCCccc
Q 042216          597 VIIHRDVKTTNILL------DEEWVAKVSDFGLCKF  626 (767)
Q Consensus       597 ~iiH~Dlk~~NILl------d~~~~~ki~DfGla~~  626 (767)
                      .++|+|+.+.|||+      +++..+++.||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46899999999999      4567899999998764

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=82.21  E-value=3.8  Score=39.78  Aligned_cols=115  Identities=9%  Similarity=0.121  Sum_probs=78.7

Q ss_pred             ccceeeeEeeeeecCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeE
Q 042216          530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNIL  609 (767)
Q Consensus       530 ~Hpniv~l~g~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIL  609 (767)
                      .||+.++. .+-.+++.+.+.|+.-+.+.=+..+     ..++...+++++.+++....+++   .  -+|--|.|+|++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~~---~--r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVNR---T--RYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGGG---S--SEECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHhc---C--ceEEEEecceEE
Confidence            57888866 4555666766666654432222223     23678899999999988776655   2  378899999999


Q ss_pred             ECCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 042216          610 LDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPI  679 (767)
Q Consensus       610 ld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~  679 (767)
                      ++.++.+++.-.|+-..                   ++|.     ..++..=.-.+=|++..+++++..|
T Consensus       112 f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             ECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             EcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence            99999999987776332                   1222     1223333447888999999999887

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	767
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-71
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-65
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-64
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-63
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-63
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-63
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-62
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-61
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-61
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-61
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-60
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-60
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-60
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-59
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-59
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-58
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-57
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-57
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-57
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	7e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-57
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-56
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-56
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-56
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-55
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-53
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-52
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-51
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-50
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-49
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-48
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-47
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-45
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-45
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-43
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-42
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-42
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-42
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	9e-42
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-41
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-41
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-40
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-39
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-38
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	9e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	8e-31
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-18

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (593), Expect = 3e-71
 Identities = 83/294 (28%), Positives = 134/294 (45%), Gaps = 31/294 (10%)

Query: 476 DFNNLLI---IGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLR 530
               + +   IG G FG VYKG  +GD   VA+K LN    + Q    F+ E+G+L + R
Sbjct: 6   PDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           +++++  +GY     Q+ +V  +    +L  HL+  +       + + I    A+ + YL
Sbjct: 63  HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYL 120

Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
           H    K IIHRD+K+ NI L E+   K+ DFGL      +S +H   Q+ GSI ++ PE 
Sbjct: 121 HA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177

Query: 651 YRLQ---LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDII 707
            R+Q     + +SDVY+FG+VL E++  + P     ++ Q+   V              +
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG----------RGYL 227

Query: 708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEK 761
            P L       C      +   C+   R  RP    ++  +E     L  S  K
Sbjct: 228 SPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL----LARSLPK 276

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  216 bits (552), Expect = 2e-65
 Identities = 70/285 (24%), Positives = 120/285 (42%), Gaps = 23/285 (8%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
            D      +G G +G VY+G     S  VA+K L   + +   EF  E  ++ ++++ +L
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 75

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           V L+G C  +    ++ ++M  G L D+L   +   +     L +    + A+ YL    
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 132

Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
            K  IHRD+   N L+ E  + KV+DFGL +              K  I +  PE     
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN 191

Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             + KSDV++FGV+L E+           D  QV                ++++   +  
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---------------ELLEKDYRME 236

Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESS 759
            P  C  +  E+  +C   +   RPS +++    E    + +ESS
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE---TMFQESS 278

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (547), Expect = 2e-64
 Identities = 64/301 (21%), Positives = 117/301 (38%), Gaps = 31/301 (10%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           IG+G FG V++G   G    VA+K  +   ++     + EI     LR+ +++  I   N
Sbjct: 11  IGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADN 67

Query: 543 DDG----QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA---- 594
            D     Q+ LV DY   G+L D+L   +   +  +  +K+ +  A  L +LH       
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124

Query: 595 -SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT--HVSTQVKGSIGYLDPEYY 651
               I HRD+K+ NIL+ +     ++D GL     + + T         G+  Y+ PE  
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184

Query: 652 RLQL------LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ----VNLAVWATECYRNG 701
              +        +++D+Y+ G+V  E+           D +     +  +  + E  R  
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244

Query: 702 KIGDIIDPFLKGNAPPV-CLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSE 760
                + P +         L    ++   C   +   R +   +   L    QL ++   
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS---QLSQQEGI 301

Query: 761 K 761
           K
Sbjct: 302 K 302

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 2e-63
 Identities = 65/275 (23%), Positives = 112/275 (40%), Gaps = 22/275 (8%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           +    +  +G G FG V+ G+ N   T VA+K L  GS      F  E  ++ QL++  L
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRL 70

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           V L      +   I + +YM  G+L D L       L  ++ L +    A  + ++    
Sbjct: 71  VRLYAVVTQEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--- 126

Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
            +  IHRD++  NIL+ +    K++DFGL +   + ++       K  I +  PE     
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYG 185

Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             T KSDV+SFG++L E++             +V                  ++   +  
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---------------QNLERGYRMV 230

Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
            P  C  +  ++   C  +    RP+   +   LE
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 8e-63
 Identities = 84/276 (30%), Positives = 123/276 (44%), Gaps = 28/276 (10%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           K+   L  IG+G FG+V  G   G    VA+K +   +      F  E  +++QLR+ +L
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNL 62

Query: 535 VSLIGYC-NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           V L+G    + G + +V +YMA+G+L D+L +     L  D  LK  +    A+ YL   
Sbjct: 63  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-- 120

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
                +HRD+   N+L+ E+ VAKVSDFGL K   +   T      K  + +  PE  R 
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALRE 174

Query: 654 QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
           +  + KSDV+SFG++L E+             K V   V        G   D        
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV------EKGYKMDA------- 221

Query: 714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
             P  C     EV  +C + D   RPS   +   LE
Sbjct: 222 --PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  210 bits (535), Expect = 9e-63
 Identities = 73/313 (23%), Positives = 132/313 (42%), Gaps = 40/313 (12%)

Query: 465 FSISEIKEATKDFNNLL---------IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPG- 511
           F+  +  EA ++F   +         +IG G FG V  G L         VAIK L  G 
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 512 SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPL 571
           +++   +F +E  ++ Q  + +++ L G       ++++ ++M  G+L D     ++   
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQF 125

Query: 572 PWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS 631
              + + +  G A  + YL        +HRD+   NIL++   V KVSDFGL +F  + +
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 632 KTHVSTQV---KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVL-CARPPILRTGDKKQ 687
                T     K  I +  PE  + +  T  SDV+S+G+V+ EV+     P         
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY-------- 234

Query: 688 VNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG 747
                       N  + + I+   +   P  C +   ++ + C   DR  RP    +V  
Sbjct: 235 --------WDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 748 LEFVFQLLRESSE 760
           L+   +++R  + 
Sbjct: 287 LD---KMIRNPNS 296

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 2e-62
 Identities = 70/275 (25%), Positives = 117/275 (42%), Gaps = 22/275 (8%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
            +   +  IG G FG V+ G+   +   VAIK +  G+     +F  E  ++ +L +  L
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKL 62

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           V L G C +   + LV+++M  G L D+L          +  L +C+     + YL    
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMAYLE--- 118

Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
              +IHRD+   N L+ E  V KVSDFG+ +F  +  +   ST  K  + +  PE +   
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFS 177

Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             + KSDV+SFGV++ EV                       E   N ++ + I    +  
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIP---------------YENRSNSEVVEDISTGFRLY 222

Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
            P +      ++   C  +    RP+ S ++  L 
Sbjct: 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 1e-61
 Identities = 71/276 (25%), Positives = 120/276 (43%), Gaps = 24/276 (8%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           KD   L  +G G FG V  G   G    VAIK +  GS     EF  E  ++  L +  L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKL 61

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           V L G C     + ++ +YMA G L ++L           + L++C     A+ YL +  
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES-- 118

Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
            K  +HRD+   N L++++ V KVSDFGL ++  +  +   S   K  + +  PE     
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 655 LLTEKSDVYSFGVVLLEVL-CARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
             + KSD+++FGV++ E+    + P                 E + N +  + I   L+ 
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPY----------------ERFTNSETAEHIAQGLRL 220

Query: 714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
             P +   +   +  SC ++    RP+   ++  + 
Sbjct: 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 3e-61
 Identities = 83/306 (27%), Positives = 138/306 (45%), Gaps = 26/306 (8%)

Query: 455 SSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFL---NGDSTPVAIKRLNPG 511
           S+L  +L        I  ++   +   +IGRG FG VY G L   +G     A+K LN  
Sbjct: 7   SALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI 66

Query: 512 SQQGALE-FQTEIGMLSQLRYLHLVSLIGYC-NDDGQMILVYDYMARGTLRDHLYNNDNP 569
           +  G +  F TE  ++    + +++SL+G C   +G  ++V  YM  G LR+    N+  
Sbjct: 67  TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF-IRNETH 125

Query: 570 PLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF--G 627
                  +   +  A+ + +L +   K  +HRD+   N +LDE++  KV+DFGL +    
Sbjct: 126 NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182

Query: 628 PNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
             F   H  T  K  + ++  E  + Q  T KSDV+SFGV+L E++    P     D   
Sbjct: 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--YPDVNT 240

Query: 688 VNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG 747
            ++ V+  +  R  +             P  C +   EV + C +     RPS S++V  
Sbjct: 241 FDITVYLLQGRRLLQ-------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

Query: 748 LEFVFQ 753
           +  +F 
Sbjct: 288 ISAIFS 293

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 6e-61
 Identities = 74/298 (24%), Positives = 117/298 (39%), Gaps = 28/298 (9%)

Query: 471 KEATKDFNNLLI----IGRGGFGNVYKGFL--NGDSTPVAIKRLNPGSQQGALE-FQTEI 523
           K+     +NLLI    +G G FG+V +G          VAIK L  G+++   E    E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 524 GMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGA 583
            ++ QL   ++V LIG C  +  ++LV +    G L   L       +P     ++    
Sbjct: 61  QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQV 118

Query: 584 ARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF-GPNFSKTHVSTQVKGS 642
           +  + YL     K  +HRD+   N+LL     AK+SDFGL K  G + S     +  K  
Sbjct: 119 SMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175

Query: 643 IGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK 702
           + +  PE    +  + +SDV+S+GV + E L       +     +V   +        GK
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI------EQGK 229

Query: 703 IGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSE 760
             +          PP C  +   +   C       RP    V   +   +  L    E
Sbjct: 230 RMEC---------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 3e-60
 Identities = 80/304 (26%), Positives = 133/304 (43%), Gaps = 30/304 (9%)

Query: 468 SEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDS----TPVAIKRLNPG-SQQGALEFQTE 522
           +EI           +IG G FG VYKG L   S     PVAIK L  G +++  ++F  E
Sbjct: 2   TEIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 59

Query: 523 IGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
            G++ Q  + +++ L G  +    M+++ +YM  G L        +      + + +  G
Sbjct: 60  AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLRG 118

Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKG 641
            A  + YL    +   +HRD+   NIL++   V KVSDFGL +    +   T+ ++  K 
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175

Query: 642 SIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG 701
            I +  PE    +  T  SDV+SFG+V+ EV+                          N 
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP---------------YWELSNH 220

Query: 702 KIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEK 761
           ++   I+   +   P  C +   ++ M C   +R RRP  +D+V  L+   +L+R     
Sbjct: 221 EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD---KLIRAPDSL 277

Query: 762 SMIA 765
             +A
Sbjct: 278 KTLA 281

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 4e-60
 Identities = 71/286 (24%), Positives = 121/286 (42%), Gaps = 22/286 (7%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL 534
           +     + +G+G FG V+ G  N  +T VAIK L PG+      F  E  ++ +LR+  L
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKL 74

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGA 594
           V L    +++  + +V +YM++G+L D L       L   + + +    A  + Y+    
Sbjct: 75  VQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-- 131

Query: 595 SKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
               +HRD++  NIL+ E  V KV+DFGL +   + ++       K  I +  PE     
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG 189

Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             T KSDV+SFG++L E+                           N ++ D ++   +  
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPY---------------PGMVNREVLDQVERGYRMP 234

Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSE 760
            PP C     ++   C   +   RP+   +   LE  F       +
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 6e-60
 Identities = 64/297 (21%), Positives = 117/297 (39%), Gaps = 14/297 (4%)

Query: 469 EIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLS 527
           E+K+   DF  +  +G G  G V+K         +A K ++   +         E+ +L 
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59

Query: 528 QLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARAL 587
           +    ++V   G    DG++ +  ++M  G+L   L       +P     K+ I   + L
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGL 117

Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
            YL       I+HRDVK +NIL++     K+ DFG+     +     ++    G+  Y+ 
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMS 171

Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDII 707
           PE  +    + +SD++S G+ L+E+   R PI     K+   +     E           
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231

Query: 708 DP---FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEK 761
            P                  E+    VN+   + PS    +   +FV + L ++  +
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 288

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  201 bits (511), Expect = 3e-59
 Identities = 73/302 (24%), Positives = 116/302 (38%), Gaps = 46/302 (15%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNG-----DSTPVAIKRLNP-GSQQGALEFQTEIGMLSQL 529
           +   +  IG G FG V++    G       T VA+K L    S     +FQ E  ++++ 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73

Query: 530 RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNND---------------------- 567
              ++V L+G C     M L+++YMA G L + L +                        
Sbjct: 74  DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 568 NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG 627
            PPL    +L I    A  + YL     +  +HRD+ T N L+ E  V K++DFGL +  
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190

Query: 628 PNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
            +             I ++ PE       T +SDV+++GVVL E+             ++
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 688 VNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG 747
           V   V      R+G I            P  C  +   +   C +     RPS   +   
Sbjct: 251 VIYYV------RDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295

Query: 748 LE 749
           L+
Sbjct: 296 LQ 297

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 7e-59
 Identities = 69/301 (22%), Positives = 124/301 (41%), Gaps = 43/301 (14%)

Query: 482 IIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGSQQGALE-FQTEIGMLSQL-RYLHL 534
            +G G FG V +    G      +  VA+K L P +     E   +E+ +LS L  ++++
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 535 VSLIGYCNDDGQMILVYDYMARGTLRDHLYN----------------NDNPPLPWDRRLK 578
           V+L+G C   G  +++ +Y   G L + L                  +D   L  +  L 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 579 ICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ 638
                A+ + +L    SK  IHRD+   NILL    + K+ DFGL +   N S   V   
Sbjct: 150 FSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 639 VKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECY 698
            +  + ++ PE     + T +SDV+S+G+ L E+                          
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------PYPGMP 252

Query: 699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRES 758
            + K   +I    +  +P     +  ++  +C + D ++RP+   +V  +E   + + ES
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE---KQISES 309

Query: 759 S 759
           +
Sbjct: 310 T 310

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 4e-58
 Identities = 69/281 (24%), Positives = 111/281 (39%), Gaps = 27/281 (9%)

Query: 483 IGRGGFGNVYKGFLNGDST--PVAIKRLNPGSQQGAL--EFQTEIGMLSQLRYLHLVSLI 538
           +G G FG V KG+         VA+K L   +   AL  E   E  ++ QL   ++V +I
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 539 GYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVI 598
           G C  +   +LV +    G L  +L  N    +     +++    +  + YL        
Sbjct: 75  GICEAES-WMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNF 128

Query: 599 IHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLT 657
           +HRD+   N+LL  +  AK+SDFGL K    + +     T  K  + +  PE       +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188

Query: 658 EKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPP 717
            KSDV+SFGV++ E         R     +V      T     G+             P 
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------TAMLEKGERMGC---------PA 233

Query: 718 VCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE-FVFQLLRE 757
            C  +  ++   C   D   RP  + V   L  + + ++ E
Sbjct: 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 3e-57
 Identities = 60/267 (22%), Positives = 109/267 (40%), Gaps = 25/267 (9%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           +G G FG VYK      S   A K ++  S++   ++  EI +L+   + ++V L+    
Sbjct: 20  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79

Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +  + ++ ++ A G +   +   +  PL   +   +C     AL+YLH      IIHRD
Sbjct: 80  YENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLH---DNKIIHRD 135

Query: 603 VKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY-----YRLQLLT 657
           +K  NIL   +   K++DFG+        +        G+  ++ PE       + +   
Sbjct: 136 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRPYD 193

Query: 658 EKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPP 717
            K+DV+S G+ L+E+    PP       + +             KI     P L    P 
Sbjct: 194 YKADVWSLGITLIEMAEIEPPHHELNPMRVLL------------KIAKSEPPTLA--QPS 239

Query: 718 VCLNQFVEVAMSCVNDDRIRRPSMSDV 744
              + F +    C+  +   R + S +
Sbjct: 240 RWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 3e-57
 Identities = 68/274 (24%), Positives = 114/274 (41%), Gaps = 29/274 (10%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRY 531
           +DF     +G+G FGNVY          +A+K L            + + E+ + S LR+
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
            +++ L GY +D  ++ L+ +Y   GT+   L           R        A AL Y H
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCH 123

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
              SK +IHRD+K  N+LL      K++DFG     P+       T + G++ YL PE  
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTTLCGTLDYLPPEMI 176

Query: 652 RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL 711
             ++  EK D++S GV+  E L  +PP      ++               +I  +   F 
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK------------RISRVEFTF- 223

Query: 712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
               P        ++    +  +  +RP + +V+
Sbjct: 224 ----PDFVTEGARDLISRLLKHNPSQRPMLREVL 253

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 6e-57
 Identities = 62/271 (22%), Positives = 106/271 (39%), Gaps = 29/271 (10%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIG 539
            IGRG F  VYKG     +  VA   L     ++     F+ E  ML  L++ ++V    
Sbjct: 16  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75

Query: 540 YC----NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
                      ++LV + M  GTL+ +L       +        C    + L +LHT  +
Sbjct: 76  SWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHT-RT 132

Query: 596 KVIIHRDVKTTNILL-DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
             IIHRD+K  NI +       K+ D GL        +   +  V G+  ++ PE Y  +
Sbjct: 133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPEMYE-E 187

Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
              E  DVY+FG+ +LE+  +  P              ++           +       +
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYP--------------YSECQNAAQIYRRVTSGVKPAS 233

Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
              V + +  E+   C+  ++  R S+ D++
Sbjct: 234 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (495), Expect = 7e-57
 Identities = 66/297 (22%), Positives = 123/297 (41%), Gaps = 28/297 (9%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDST----PVAIKRLNPG-SQQGALEFQTEIGMLSQLR 530
           +F  + ++G G FG VYKG    +      PVAIK L    S +   E   E  +++ + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
             H+  L+G C     + L+   M  G L D++  + +        L  C+  A+ ++YL
Sbjct: 70  NPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYL 127

Query: 591 HTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEY 650
                + ++HRD+   N+L+      K++DFGL K      K + +   K  I ++  E 
Sbjct: 128 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 651 YRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF 710
              ++ T +SDV+S+GV + E++                      +     +I  I++  
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISSILEKG 229

Query: 711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESSEKSMIAHP 767
            +   PP+C      + + C   D   RP   +++       ++ R+     +I   
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS---KMARDPQRYLVIQGD 283

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 8e-57
 Identities = 65/278 (23%), Positives = 110/278 (39%), Gaps = 26/278 (9%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGAL--EFQTEIGMLSQLRYLH 533
           D+  L  IG G +G   K     D   +  K L+ GS   A      +E+ +L +L++ +
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 534 LVSLIGYCND--DGQMILVYDYMARGTLRDHLYNN--DNPPLPWDRRLKICIGAARALHY 589
           +V       D  +  + +V +Y   G L   +     +   L  +  L++      AL  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 590 LH--TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
            H  +     ++HRD+K  N+ LD +   K+ DFGL +       T  +    G+  Y+ 
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKAFVGTPYYMS 182

Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDII 707
           PE        EKSD++S G +L E+    PP      K+            R GK   I 
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-------GKIREGKFRRI- 234

Query: 708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
                   P    ++  E+    +N     RPS+ +++
Sbjct: 235 --------PYRYSDELNEIITRMLNLKDYHRPSVEEIL 264

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 1e-56
 Identities = 65/298 (21%), Positives = 115/298 (38%), Gaps = 45/298 (15%)

Query: 476 DFNNLLIIGRGGFGNVYKGFL-----NGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQL 529
           +     ++G G FG V           G S  VA+K L   +     E   +E+ M++QL
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 530 -RYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNN---------------------D 567
             + ++V+L+G C   G + L+++Y   G L ++L +                      D
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 568 NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG 627
              L ++  L      A+ + +L     K  +HRD+   N+L+    V K+ DFGL +  
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214

Query: 628 PNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ 687
            + S   V    +  + ++ PE     + T KSDV+S+G++L E+               
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 688 VNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
                             +I    K + P     +   +  SC   D  +RPS  ++ 
Sbjct: 275 N--------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 1e-56
 Identities = 69/308 (22%), Positives = 124/308 (40%), Gaps = 39/308 (12%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFL--NGDSTPVAIKRLNP-GSQQGALEFQTEIGMLSQL-R 530
            D     +IG G FG V K  +  +G     AIKR+    S+    +F  E+ +L +L  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNP--------------PLPWDRR 576
           + ++++L+G C   G + L  +Y   G L D L  +                  L   + 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 577 LKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVS 636
           L      AR + YL     K  IHRD+   NIL+ E +VAK++DFGL +    + K    
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--- 183

Query: 637 TQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATE 696
           T  +  + ++  E     + T  SDV+S+GV+L E++             ++        
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------- 236

Query: 697 CYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLR 756
                   + +    +   P  C ++  ++   C  +    RPS + ++  L  + +  +
Sbjct: 237 --------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288

Query: 757 ESSEKSMI 764
                ++ 
Sbjct: 289 TYVNTTLY 296

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  191 bits (487), Expect = 7e-56
 Identities = 68/289 (23%), Positives = 109/289 (37%), Gaps = 35/289 (12%)

Query: 466 SISEI---KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQG---ALEF 519
            ++E+    +  K F++L  IG G FG VY      +S  VAIK+++   +Q      + 
Sbjct: 3   DVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI 62

Query: 520 QTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKI 579
             E+  L +LR+ + +   G    +    LV +Y           +    PL       +
Sbjct: 63  IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAV 120

Query: 580 CIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
             GA + L YLH   S  +IHRDVK  NILL E  + K+ DFG             +   
Sbjct: 121 THGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANSF 171

Query: 640 KGSIGYLDPEYYRLQ---LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATE 696
            G+  ++ PE            K DV+S G+  +E+   +PP+        +        
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------- 224

Query: 697 CYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
                 I     P L+          F     SC+      RP+   ++
Sbjct: 225 -----HIAQNESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 2e-55
 Identities = 58/272 (21%), Positives = 109/272 (40%), Gaps = 21/272 (7%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLH 533
           +D++ +  +G G +G V           VA+K ++        E  + EI +   L + +
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           +V   G+  +     L  +Y + G L D +  +    +P     +        + YLH  
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH-- 120

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR- 652
               I HRD+K  N+LLDE    K+SDFGL       ++  +  ++ G++ Y+ PE  + 
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179

Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK 712
            +   E  DV+S G+VL  +L    P  +  D  Q              +  D  +    
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--------------EYSDWKEKKTY 225

Query: 713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
            N      +  + +    + ++   R ++ D+
Sbjct: 226 LNPWKKIDSAPLALLHKILVENPSARITIPDI 257

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 2e-55
 Identities = 63/279 (22%), Positives = 118/279 (42%), Gaps = 22/279 (7%)

Query: 466 SISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGM 525
           SI  + +  K +     IG+G  G VY          VAI+++N   Q        EI +
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70

Query: 526 LSQLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR 585
           + + +  ++V+ +       ++ +V +Y+A G+L D +       +   +   +C    +
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQ 127

Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
           AL +LH   S  +IHRD+K+ NILL  +   K++DFG C            + + G+  +
Sbjct: 128 ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYW 182

Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD 705
           + PE    +    K D++S G++ +E++   PP L     + +              I  
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------------LIAT 230

Query: 706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
              P L+   P      F +    C++ D  +R S  ++
Sbjct: 231 NGTPELQ--NPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 6e-55
 Identities = 63/278 (22%), Positives = 100/278 (35%), Gaps = 26/278 (9%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFL---NGDSTPVAIKRLNP---GSQQGALEFQTEIGMLSQ 528
           KD   L  +G G FG V +G     +G +  VA+K L P      +   +F  E+  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 529 LRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALH 588
           L + +L+ L G       M +V +    G+L D                +  +  A  + 
Sbjct: 68  LDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMG 125

Query: 589 YLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHV-STQVKGSIGYLD 647
           YL    SK  IHRD+   N+LL    + K+ DFGL +  P     +V     K    +  
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182

Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDII 707
           PE  + +  +  SD + FGV L E+           +  Q+              +  I 
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--------------LHKID 228

Query: 708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV 745
               +   P  C      V + C       RP+   + 
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 1e-53
 Identities = 65/277 (23%), Positives = 109/277 (39%), Gaps = 27/277 (9%)

Query: 482 IIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLRYLHLVSL 537
            IG G FG+V++G        +  VAIK     +     E F  E   + Q  + H+V L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 538 IGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV 597
           IG    +  + ++ +    G LR          L     +      + AL YL    SK 
Sbjct: 74  IGVI-TENPVWIIMELCTLGELRSF-LQVRKYSLDLASLILYAYQLSTALAYLE---SKR 128

Query: 598 IIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLT 657
            +HRD+   N+L+      K+ DFGL ++  + S  + +++ K  I ++ PE    +  T
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRRFT 187

Query: 658 EKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGNAP 716
             SDV+ FGV + E+L     P     +   +             +I +     +    P
Sbjct: 188 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG------------RIENGERLPM----P 231

Query: 717 PVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
           P C      +   C   D  RRP  +++   L  + +
Sbjct: 232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 2e-52
 Identities = 65/289 (22%), Positives = 120/289 (41%), Gaps = 32/289 (11%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPG-SQQGALEFQTEIGMLSQ 528
           +       +G+G FG VY+G   G       T VAIK +N   S +  +EF  E  ++ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 529 LRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDN--------PPLPWDRRLKIC 580
               H+V L+G  +     +++ + M RG L+ +L +            P    + +++ 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 581 IGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVK 640
              A  + YL+   +   +HRD+   N ++ E++  K+ DFG+ +            +  
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 641 GSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRN 700
             + ++ PE  +  + T  SDV+SFGVVL E+        +    +QV   V        
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV------ME 250

Query: 701 GKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE 749
           G + D          P  C +   E+   C   +   RPS  +++  ++
Sbjct: 251 GGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 1e-51
 Identities = 62/279 (22%), Positives = 102/279 (36%), Gaps = 29/279 (10%)

Query: 471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLS 527
           K+  +DF    I+G G F  V        S   AIK L       +        E  ++S
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 528 QLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARAL 587
           +L +   V L     DD ++     Y   G L  ++                      AL
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSAL 121

Query: 588 HYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
            YLH    K IIHRD+K  NILL+E+   +++DFG  K     SK   +    G+  Y+ 
Sbjct: 122 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178

Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDII 707
           PE    +   + SD+++ G ++ +++   PP                   +R G    I 
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPP-------------------FRAGNEYLIF 219

Query: 708 DPFLKGNA--PPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
              +K     P     +  ++    +  D  +R    ++
Sbjct: 220 QKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  177 bits (451), Expect = 2e-50
 Identities = 53/271 (19%), Positives = 99/271 (36%), Gaps = 22/271 (8%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV 535
            ++    +G G FG V++          A K +    +      + EI  +S LR+  LV
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86

Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
           +L     DD +M+++Y++M+ G L + + +  N  +  D  ++      + L ++H    
Sbjct: 87  NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMH---E 142

Query: 596 KVIIHRDVKTTNILL--DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
              +H D+K  NI+         K+ DFGL                 G+  +  PE    
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVAEG 199

Query: 654 QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
           + +   +D++S GV+   +L    P     D +            RN K  D        
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET----------LRNVKSCDWNMDD--- 246

Query: 714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
           +A         +     +  D   R ++   
Sbjct: 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 4e-50
 Identities = 68/296 (22%), Positives = 127/296 (42%), Gaps = 41/296 (13%)

Query: 482 IIGRGGFGNVYKGFLNG-------DSTPVAIKRLNPG-SQQGALEFQTEIGMLSQL-RYL 532
            +G G FG V      G         T VA+K L    +++   +  +E+ M+  + ++ 
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPP--------------LPWDRRLK 578
           ++++L+G C  DG + ++ +Y ++G LR++L     P               L     + 
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 579 ICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQ 638
                AR + YL    SK  IHRD+   N+L+ E+ V K++DFGL +   +      +T 
Sbjct: 140 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196

Query: 639 VKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECY 698
            +  + ++ PE    ++ T +SDV+SFGV+L E+             +++       +  
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL------FKLL 250

Query: 699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL 754
           + G   D          P  C N+   +   C +    +RP+   +V  L+ +  L
Sbjct: 251 KEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  174 bits (442), Expect = 5e-49
 Identities = 46/271 (16%), Positives = 103/271 (38%), Gaps = 22/271 (8%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV 535
            ++ L  +G G FG V++            K +N          + EI +++QL +  L+
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89

Query: 536 SLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGAS 595
           +L     D  +M+L+ ++++ G L D +    +  +     +     A   L ++H    
Sbjct: 90  NLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH---E 145

Query: 596 KVIIHRDVKTTNILLD--EEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
             I+H D+K  NI+ +  +    K+ DFGL       +   +      +  +  PE    
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATAEFAAPEIVDR 202

Query: 654 QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
           + +   +D+++ GV+   +L    P     D + +              +      F + 
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ------------NVKRCDWEFDE- 249

Query: 714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
           +A      +  +   + +  +  +R ++ D 
Sbjct: 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 1e-48
 Identities = 64/300 (21%), Positives = 116/300 (38%), Gaps = 42/300 (14%)

Query: 482 IIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGSQQGALE--FQTEIGMLSQLRYLHL 534
            +GRG FG V +    G         VA+K L  G+              ++    +L++
Sbjct: 20  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79

Query: 535 VSLIGYCNDDGQMI-LVYDYMARGTLRDHLYNNDNP--------------PLPWDRRLKI 579
           V+L+G C   G  + ++ ++   G L  +L +  N                L  +  +  
Sbjct: 80  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139

Query: 580 CIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQV 639
               A+ + +L    S+  IHRD+   NILL E+ V K+ DFGL +              
Sbjct: 140 SFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196

Query: 640 KGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           +  + ++ PE    ++ T +SDV+SFGV+L E+               V +        +
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----YPGVKIDEEFCRRLK 251

Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRESS 759
            G              P     +  +  + C + +  +RP+ S++V  L     LL+ ++
Sbjct: 252 EGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG---NLLQANA 299

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 9e-47
 Identities = 44/276 (15%), Positives = 104/276 (37%), Gaps = 23/276 (8%)

Query: 471 KEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR 530
           KE  + +     +GRG FG V++            K +        L  + EI +L+  R
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIAR 59

Query: 531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYL 590
           + +++ L        ++++++++++   + + + N     L     +        AL +L
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFL 118

Query: 591 HTGASKVIIHRDVKTTNILLD--EEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDP 648
           H   S  I H D++  NI+         K+ +FG  +             +  +  Y  P
Sbjct: 119 H---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLFTAPEYYAP 172

Query: 649 EYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID 708
           E ++  +++  +D++S G ++  +L    P L   +++ +   + A             +
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA-------------E 219

Query: 709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
                 A      + ++     +  +R  R + S+ 
Sbjct: 220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  163 bits (413), Expect = 6e-46
 Identities = 68/291 (23%), Positives = 107/291 (36%), Gaps = 31/291 (10%)

Query: 474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLR 530
           +  +    I+G GG   V+          VA+K L           L F+ E    + L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 531 YLHLVSLIGYCNDD----GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARA 586
           +  +V++      +        +V +Y+   TLRD ++     P+   R +++   A +A
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQA 123

Query: 587 LHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGY 645
           L++ H      IIHRDVK  NI++      KV DFG+ +    + +    +  V G+  Y
Sbjct: 124 LNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180

Query: 646 LDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD 705
           L PE  R   +  +SDVYS G VL EVL   PP             V             
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE----------- 229

Query: 706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLR 756
             DP                V +  +  +   R   +      E    L+R
Sbjct: 230 --DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAA-----EMRADLVR 273

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  163 bits (414), Expect = 1e-45
 Identities = 57/280 (20%), Positives = 105/280 (37%), Gaps = 25/280 (8%)

Query: 469 EIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLS 527
           + ++    ++   ++G G F  V           VAIK +   + +G     + EI +L 
Sbjct: 3   QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH 62

Query: 528 QLRYLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARAL 587
           ++++ ++V+L       G + L+   ++ G L D +              ++      A+
Sbjct: 63  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAV 120

Query: 588 HYLHTGASKVIIHRDVKTTNILL---DEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIG 644
            YLH      I+HRD+K  N+L    DE+    +SDFGL K         V +   G+ G
Sbjct: 121 KYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPG 174

Query: 645 YLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG 704
           Y+ PE    +  ++  D +S GV+   +LC  PP     D K     + A          
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA---------- 224

Query: 705 DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
              +            +   +     +  D  +R +    
Sbjct: 225 ---EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  160 bits (406), Expect = 7e-45
 Identities = 52/285 (18%), Positives = 101/285 (35%), Gaps = 37/285 (12%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---------QQGALEFQTEIGML 526
           ++    I+GRG    V +          A+K ++            Q+       E+ +L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 527 SQLR-YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR 585
            ++  + +++ L      +    LV+D M +G L D+L   +   L      KI      
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLE 121

Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGY 645
            +  LH      I+HRD+K  NILLD++   K++DFG               +V G+  Y
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTPSY 175

Query: 646 LDPEYYRLQLL------TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYR 699
           L PE     +        ++ D++S GV++  +L   PP         + + +       
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG----- 230

Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
                   +            +   ++    +     +R +  + 
Sbjct: 231 --------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 4e-43
 Identities = 59/293 (20%), Positives = 111/293 (37%), Gaps = 28/293 (9%)

Query: 473 ATKDFNNLLIIGRGGFGNVYKGF-LNGDSTPVAIKRLNP--GSQQGALEFQTEIGMLSQL 529
           A + +  +  IG G +G V+K   L      VA+KR+    G +   L    E+ +L  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 530 RYL---HLVSLIGYC-----NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICI 581
                 ++V L   C     + + ++ LV++++ +     +L     P +P +    +  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMMF 123

Query: 582 GAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKG 641
              R L +LH   S  ++HRD+K  NIL+      K++DFGL +    +S     T V  
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVV 177

Query: 642 SIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAV--------- 692
           ++ Y  PE           D++S G +  E+   +P    + D  Q+   +         
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237

Query: 693 -WATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
            W  +     +                      ++ + C+  +  +R S    
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  155 bits (392), Expect = 1e-42
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 13/207 (6%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRY 531
           +DF  L  +G G FG V+      +    A+K L        +       E  MLS + +
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
             ++ + G   D  Q+ ++ DY+  G L   L  +   P P  +     +    AL YLH
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV--CLALEYLH 121

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
              SK II+RD+K  NILLD+    K++DFG  K+ P+ + T       G+  Y+ PE  
Sbjct: 122 ---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIAPEVV 173

Query: 652 RLQLLTEKSDVYSFGVVLLEVLCARPP 678
             +   +  D +SFG+++ E+L    P
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTP 200

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 3e-42
 Identities = 59/280 (21%), Positives = 109/280 (38%), Gaps = 24/280 (8%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-----FQTEIGMLSQLRYLHLVS 536
            +G G F  VYK      +  VAIK++  G +  A +        EI +L +L + +++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           L+        + LV+D+M           +++  L         +   + L YLH     
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVII--KDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 597 VIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR-LQL 655
            I+HRD+K  N+LLDE  V K++DFGL K   + ++ +  T    +  Y  PE     ++
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGARM 177

Query: 656 LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL----------AVWATECYRNGKIGD 705
                D+++ G +L E+L   P +    D  Q+              W   C     +  
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237

Query: 706 IIDPFLK-GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
              P +   +      +  +++       +   R + +  
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  154 bits (389), Expect = 9e-42
 Identities = 63/273 (23%), Positives = 103/273 (37%), Gaps = 30/273 (10%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYL 532
           DF+   IIGRGGFG VY           A+K L+      +QG      E  MLS +   
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 533 ---HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHY 589
               +V +    +   ++  + D M  G L  HL  + +                  L +
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEH 122

Query: 590 LHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPE 649
           +H   ++ +++RD+K  NILLDE    ++SD GL      FSK        G+ GY+ PE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD---FSKKK-PHASVGTHGYMAPE 175

Query: 650 YYRLQL-LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID 708
             +  +     +D +S G +L ++L    P  +   K +  +              D + 
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--------------DRMT 221

Query: 709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSM 741
             +    P     +   +    +  D  RR   
Sbjct: 222 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGC 254

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  152 bits (384), Expect = 9e-42
 Identities = 51/279 (18%), Positives = 93/279 (33%), Gaps = 23/279 (8%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCN 542
           IG G FG++Y G        VAIK     ++    +   E  +   ++    +  I +C 
Sbjct: 15  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQGGVGIPTIRWCG 72

Query: 543 DDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRD 602
            +G   ++   +   +L + L+N  +        L +       + Y+H   SK  IHRD
Sbjct: 73  AEGDYNVMVMELLGPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 128

Query: 603 VKTTNIL---LDEEWVAKVSDFGLCKF-----GPNFSKTHVSTQVKGSIGYLDPEYYRLQ 654
           VK  N L     +  +  + DFGL K               +  + G+  Y     +   
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188

Query: 655 LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN 714
             + + D+ S G VL+       P        +       +E   +  I  +        
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL-------- 240

Query: 715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
                 ++F      C +     +P  S +      +F 
Sbjct: 241 -CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 1e-41
 Identities = 55/207 (26%), Positives = 82/207 (39%), Gaps = 11/207 (5%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLS-QLRY 531
           DF    ++G+G FG V+       +   AIK L                E  +LS    +
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
             L  +         +  V +Y+  G L  H+           R           L +LH
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
              SK I++RD+K  NILLD++   K++DFG+CK               G+  Y+ PE  
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEIL 175

Query: 652 RLQLLTEKSDVYSFGVVLLEVLCARPP 678
             Q      D +SFGV+L E+L  + P
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSP 202

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-41
 Identities = 61/320 (19%), Positives = 119/320 (37%), Gaps = 35/320 (10%)

Query: 472 EATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALE-FQTEIGMLSQLR 530
           +    + NL  IG G +G V   + N +   VAIK+++P   Q   +    EI +L + R
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64

Query: 531 YLHLVSLIGYCND----DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARA 586
           + +++ +            + + +  ++    L   L       L  D          R 
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRG 121

Query: 587 LHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF-GPNFSKTHVSTQVKGSIGY 645
           L Y+H   S  ++HRD+K +N+LL+     K+ DFGL +   P+   T   T+   +  Y
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 646 LDPEYYRLQLL-TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAV----------WA 694
             PE        T+  D++S G +L E+L  RP         Q+N  +            
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238

Query: 695 TECYRNGKIGDIIDPFLKG----NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVV---WG 747
                  +   +  P           P   ++ +++    +  +  +R  +   +   + 
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY- 297

Query: 748 LEFVFQLLRESSEKSMIAHP 767
                +   + S++ +   P
Sbjct: 298 ----LEQYYDPSDEPIAEAP 313

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 1e-41
 Identities = 52/284 (18%), Positives = 106/284 (37%), Gaps = 21/284 (7%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLH 533
           +F  +  IG G +G VYK         VA+K++     ++        EI +L +L + +
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           +V L+   + + ++ LV++++ +  L+  +  +    +P            + L + H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
            S  ++HRD+K  N+L++ E   K++DFGL +          + +V              
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARA-FGVPVRTYTHEVVTLWYRAPEILLGC 177

Query: 654 QLLTEKSDVYSFGVVLLEVLCARPP------------ILRT-GDKKQVNLAVWATECYRN 700
           +  +   D++S G +  E++  R              I RT G   +V      +     
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

Query: 701 GKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
                          PP+       +    ++ D  +R S    
Sbjct: 238 PSFPKWARQDFSKVVPPLD-EDGRSLLSQMLHYDPNKRISAKAA 280

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-41
 Identities = 47/271 (17%), Positives = 100/271 (36%), Gaps = 28/271 (10%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGY 540
           ++G G  G V + F        A+K L    +      + E+ +  +  +  H+V ++  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73

Query: 541 CND----DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
             +       +++V + +  G L   + +  +         +I      A+ YLH   S 
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130

Query: 597 VIIHRDVKTTNILLDEEW---VAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
            I HRDVK  N+L   +    + K++DFG  K   + +          +  Y+ PE    
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLGP 187

Query: 654 QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG 713
           +   +  D++S GV++  +LC  PP                       ++G    P  + 
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------GMKTRIRMGQYEFPNPE- 240

Query: 714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
                   +   +  + +  +  +R ++++ 
Sbjct: 241 --WSEVSEEVKMLIRNLLKTEPTQRMTITEF 269

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  149 bits (376), Expect = 1e-40
 Identities = 48/282 (17%), Positives = 90/282 (31%), Gaps = 27/282 (9%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYL-HLVSLIGYC 541
           IG G FG +++G    ++  VAIK      +  A + + E      L     + ++  + 
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70

Query: 542 NDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHR 601
            +    +LV D +  G   + L +                     +  +H    K +++R
Sbjct: 71  QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYR 125

Query: 602 DVKTTNILLDEEWV-----AKVSDFGLCKF-----GPNFSKTHVSTQVKGSIGYLDPEYY 651
           D+K  N L+            V DFG+ KF                 + G+  Y+    +
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185

Query: 652 RLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL 711
             +  + + D+ + G V +  L    P    G K        AT   +  +IG+      
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLP--WQGLK-------AATNKQKYERIGEKKQSTP 236

Query: 712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ 753
                     +F +      N      P    +      V +
Sbjct: 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 2e-40
 Identities = 61/289 (21%), Positives = 100/289 (34%), Gaps = 29/289 (10%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV 535
            + +  +IG G FG VY+  L      VAIK++    +        E+ ++ +L + ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIV 76

Query: 536 SLIGYCNDDGQ------MILVYDYMARGTLRDHL-YNNDNPPLPWDRRLKICIGAARALH 588
            L  +    G+      + LV DY+     R    Y+     LP            R+L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 589 YLHTGASKVIIHRDVKTTNILLDEE-WVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
           Y+H   S  I HRD+K  N+LLD +  V K+ DFG  K           + +        
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRYYRAP 191

Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPP------------ILRTGDKKQVNLAVWAT 695
              +     T   DV+S G VL E+L  +P             I++              
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251

Query: 696 ECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
             Y   K   I          P    + + +    +      R +  + 
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 1e-39
 Identities = 53/273 (19%), Positives = 98/273 (35%), Gaps = 41/273 (15%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNP------GSQQGALEFQTEIGMLSQLRYLH-- 533
           ++G GGFG+VY G    D+ PVAIK +        G          E+ +L ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           ++ L+ +       +L+ +                  L  +           A+ + H  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH-- 127

Query: 594 ASKVIIHRDVKTTNILLDEE-WVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
            +  ++HRD+K  NIL+D      K+ DFG         K  V T   G+  Y  PE+ R
Sbjct: 128 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGA----LLKDTVYTDFDGTRVYSPPEWIR 182

Query: 653 L-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL 711
             +     + V+S G++L +++C   P     D++ +                     F 
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIP--FEHDEEIIRG-----------------QVFF 223

Query: 712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
           +         +   +   C+      RP+  ++
Sbjct: 224 RQRVSS----ECQHLIRWCLALRPSDRPTFEEI 252

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 9e-39
 Identities = 55/272 (20%), Positives = 104/272 (38%), Gaps = 31/272 (11%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGAL------EFQTEIGMLSQLRYLHLVS 536
           +G G F  V K          A K +     + +       + + E+ +L ++++ ++++
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77

Query: 537 LIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASK 596
           L     +   +IL+ + +A G L D     +   L  +   +        ++YLH   S 
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDF--LAEKESLTEEEATEFLKQILNGVYYLH---SL 132

Query: 597 VIIHRDVKTTNILLDEEWVA----KVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
            I H D+K  NI+L +  V     K+ DFGL          +    + G+  ++ PE   
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFVAPEIVN 189

Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK 712
            + L  ++D++S GV+   +L    P L  GD KQ  LA  +   Y             +
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETLANVSAVNYE-----------FE 236

Query: 713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
                       +     +  D  +R ++ D 
Sbjct: 237 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  143 bits (360), Expect = 1e-38
 Identities = 46/283 (16%), Positives = 101/283 (35%), Gaps = 21/283 (7%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLH 533
            ++ L  IG G +G VYK   N      A+K++      +        EI +L +L++ +
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 534 LVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG 593
           +V L    +   +++LV++++ +   +          L         +     + Y H  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCH-- 117

Query: 594 ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRL 653
             + ++HRD+K  N+L++ E   K++DFGL +          + ++              
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIVTLWYRAPDVLMGS 175

Query: 654 QLLTEKSDVYSFGVVLLEVLCARPP------------ILRTGDKKQVNLAVWATECYRNG 701
           +  +   D++S G +  E++   P             I R             TE  +  
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 702 KIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
               + +P    +         +++    +  D  +R +    
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 1e-37
 Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 10/207 (4%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRY 531
            DF+ L ++G+G FG V            A+K L      ++       TE  +L   R+
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
             L +L        ++  V +Y   G L  HL          +R          AL YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH 122

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
              S+ +++RD+K  N++LD++   K++DFGLCK G +   T       G+  YL PE  
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVL 177

Query: 652 RLQLLTEKSDVYSFGVVLLEVLCARPP 678
                    D +  GVV+ E++C R P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  140 bits (354), Expect = 3e-37
 Identities = 52/242 (21%), Positives = 94/242 (38%), Gaps = 13/242 (5%)

Query: 440 SRRAVMKEAKSRGPASSLPSDLCTQFSISEIKEATKDFNNLLIIGRGGFGNVYKGFLNGD 499
           +++   +E+     A +    L    + S+       F+ +  +G G FG V        
Sbjct: 6   AKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKES 65

Query: 500 STPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMAR 556
               A+K L+       +       E  +L  + +  LV L     D+  + +V +Y+A 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125

Query: 557 GTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVA 616
           G +  HL                         YLH   S  +I+RD+K  N+L+D++   
Sbjct: 126 GEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180

Query: 617 KVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR 676
           +V+DFG  K     + T     + G+   L PE    +   +  D ++ GV++ E+    
Sbjct: 181 QVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

Query: 677 PP 678
           PP
Sbjct: 236 PP 237

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 9e-37
 Identities = 57/297 (19%), Positives = 110/297 (37%), Gaps = 33/297 (11%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGAL--EFQTEIGMLSQLRYLH 533
            +  L  IG+G FG V+K         VA+K++   +++         EI +L  L++ +
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70

Query: 534 LVSLIGYCND--------DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAAR 585
           +V+LI  C           G + LV+D+            N           ++      
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLN 128

Query: 586 ALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVS--TQVKGSI 643
            L+Y+H      I+HRD+K  N+L+  + V K++DFGL +       +  +  T    ++
Sbjct: 129 GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 644 GYLDPEYYR-LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNL------------ 690
            Y  PE     +      D++  G ++ E+    P +    ++ Q+ L            
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245

Query: 691 --AVWATECYRNGKIGDIIDPFLKGNAPPVCLN-QFVEVAMSCVNDDRIRRPSMSDV 744
              V   E Y   ++       +K        +   +++    +  D  +R    D 
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (344), Expect = 2e-36
 Identities = 48/285 (16%), Positives = 105/285 (36%), Gaps = 21/285 (7%)

Query: 475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYL 532
           + +  L  IG G +G V+K         VA+KR+      +        EI +L +L++ 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 533 HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++V L    + D ++ LV+++  +   +     N +     +          + L + H+
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD--PEIVKSFLFQLLKGLGFCHS 119

Query: 593 GASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYR 652
              + ++HRD+K  N+L++     K+++FGL +          S +V           + 
Sbjct: 120 ---RNVLHRDLKPQNLLINRNGELKLANFGLARA-FGIPVRCYSAEVVTLWYRPPDVLFG 175

Query: 653 LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWA-------------TECYR 699
            +L +   D++S G +  E+  A  P+    D       ++              T+   
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235

Query: 700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV 744
                         N  P       ++  + +  + ++R S  + 
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 1e-34
 Identities = 57/306 (18%), Positives = 110/306 (35%), Gaps = 37/306 (12%)

Query: 465 FSISEIKEATKDFNN----LLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALE 518
           F   E+ +   +       L  +G G +G V           VAIK+L     S+  A  
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 519 FQTEIGMLSQLRYLHLVSLIGYCNDDGQM------ILVYDYMARGTLRDHLYNNDNPPLP 572
              E+ +L  +R+ +++ L+     D  +       LV  +M  GT    L    +  L 
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLM--KHEKLG 119

Query: 573 WDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK 632
            DR   +     + L Y+H   +  IIHRD+K  N+ ++E+   K+ DFGL +     + 
Sbjct: 120 EDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QAD 172

Query: 633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ----V 688
           + ++  V                 T+  D++S G ++ E++  +     +    Q    +
Sbjct: 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232

Query: 689 NLAVWATECYRNGKIGDIIDPFLKG----------NAPPVCLNQFVEVAMSCVNDDRIRR 738
            +       +      D    ++KG          +         V +    +  D  +R
Sbjct: 233 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 292

Query: 739 PSMSDV 744
            +  + 
Sbjct: 293 VTAGEA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 7e-31
 Identities = 51/227 (22%), Positives = 93/227 (40%), Gaps = 23/227 (10%)

Query: 464 QFSISEIKEAT----KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGAL 517
           QF   E+ ++T    K + NL  IG G  G V   +       VAIK+L+    +Q  A 
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61

Query: 518 EFQTEIGMLSQLRYLHLVSLIGYC------NDDGQMILVYDYMARGTLRDHLYNNDNPPL 571
               E+ ++  + + +++SL+          +   + LV + M     +           
Sbjct: 62  RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----- 116

Query: 572 PWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS 631
             +R   +       + +LH   S  IIHRD+K +NI++  +   K+ DFGL +      
Sbjct: 117 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AG 170

Query: 632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
            + + T    +  Y  PE        E  D++S G ++ E++  +  
Sbjct: 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  121 bits (304), Expect = 8e-31
 Identities = 46/209 (22%), Positives = 87/209 (41%), Gaps = 19/209 (9%)

Query: 476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRY-LHL 534
           D+  +  +GRG +  V++     ++  V +K L P  ++   + + EI +L  LR   ++
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNI 92

Query: 535 VSLIGYCND--DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHT 592
           ++L     D       LV++++     +          L             +AL Y H 
Sbjct: 93  ITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH- 146

Query: 593 GASKVIIHRDVKTTNILLDEE-WVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYY 651
             S  I+HRDVK  N+++D E    ++ D+GL +F   +           S  +  PE  
Sbjct: 147 --SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELL 201

Query: 652 R-LQLLTEKSDVYSFGVVLLEVLCARPPI 679
              Q+     D++S G +L  ++  + P 
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPF 230

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 1e-30
 Identities = 59/278 (21%), Positives = 101/278 (36%), Gaps = 29/278 (10%)

Query: 475 KDFNNLLIIGRGGFGNVYKG---FLNGDSTPVAIKRLNPGS----QQGALEFQTEIGMLS 527
           ++F  L ++G G +G V+       +      A+K L   +     +     +TE  +L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 528 QLRYL-HLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARA 586
            +R    LV+L      + ++ L+ DY+  G L  HL   +           + I     
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEI 138

Query: 587 LHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYL 646
           +  L       II+RD+K  NILLD      ++DFGL K          +    G+I Y+
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYM 197

Query: 647 DPEYYRLQL--LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG 704
            P+  R       +  D +S GV++ E+L    P    G+K                +I 
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA------------EIS 245

Query: 705 DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMS 742
             I    +   P        ++    +  D  +R    
Sbjct: 246 RRILKS-EPPYPQEMSALAKDLIQRLLMKDPKKRLGCG 282

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 5e-29
 Identities = 47/216 (21%), Positives = 88/216 (40%), Gaps = 17/216 (7%)

Query: 470 IKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLS 527
           I E  + + NL  +G G +G+V   F       VA+K+L+    S   A     E+ +L 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 72

Query: 528 QLRYLHLVSLIGYCND-----DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIG 582
            +++ +++ L+          +   + +  ++      D         L  D    +   
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA---DLNNIVKCQKLTDDHVQFLIYQ 129

Query: 583 AARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGS 642
             R L Y+H   S  IIHRD+K +N+ ++E+   K+ DFGL +   +    +V+T     
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT----R 182

Query: 643 IGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
                          +  D++S G ++ E+L  R  
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  110 bits (276), Expect = 6e-27
 Identities = 36/211 (17%), Positives = 76/211 (36%), Gaps = 18/211 (8%)

Query: 483 IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-----------Y 531
           +G G F  V+      ++T VA+K +    +      + EI +L ++             
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 532 LHLVSLIGYCND---DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALH 588
            H++ L+ + N    +G  +++   +    L   +   ++  +P     +I       L 
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 589 YLHTGASKVIIHRDVKTTNILLDEE-WVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLD 647
           Y+H      IIH D+K  N+L++       +    +   G         T    +  Y  
Sbjct: 140 YMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 648 PEYYRLQLLTEKSDVYSFGVVLLEVLCARPP 678
           PE          +D++S   ++ E++     
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFL 228

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.0 bits (199), Expect = 4e-18
 Identities = 31/201 (15%), Positives = 64/201 (31%), Gaps = 27/201 (13%)

Query: 482 IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS----------QQGALEFQTEIGMLSQLRY 531
           ++G G    V+    +       +K    G             G L F       ++  +
Sbjct: 7   LMGEGKESAVFNC-YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 532 LHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLH 591
             L  L G       +  VY +     L + +   +   +  +   ++       +   +
Sbjct: 66  RALQKLQGLA-----VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 592 TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK-FGPNFSKTHVSTQVKGSIGYLDPEY 650
               + I+H D+   N+L+ EE +  + DF      G    +  +   V+  I Y    Y
Sbjct: 121 ---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIITYFSRTY 176

Query: 651 YRLQLLTEKSDVYSFGVVLLE 671
                   + D+ S    +L+
Sbjct: 177 ------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	767
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.82
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.4
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.71
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.43
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.03
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.96
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.68
d2o14a1	146	Hypothetical protein YxiM {Bacillus subtilis [TaxI	94.56
d2o14a1	146	Hypothetical protein YxiM {Bacillus subtilis [TaxI	82.86

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-50  Score=428.78  Aligned_cols=272  Identities=26%  Similarity=0.451  Sum_probs=210.7

Q ss_pred             ccCHHHHHHHhhcc---------ccceeeeccCcEEEEEEEecCCCc---eEEEEEeCCC-CCcchhHHHHHHHHHhccc
Q 042216          464 QFSISEIKEATKDF---------NNLLIIGRGGFGNVYKGFLNGDST---PVAIKRLNPG-SQQGALEFQTEIGMLSQLR  530 (767)
Q Consensus       464 ~~~~~ei~~~t~~f---------~~~~~LG~G~fG~Vy~g~~~~~~~---~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~  530 (767)
                      .++++++.+++.+|         +..++||+|+||+||+|.++.+++   .||||++... .....++|.+|+++|++++
T Consensus         6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~   85 (299)
T d1jpaa_           6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD   85 (299)
T ss_dssp             GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred             CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence            35566666666554         345789999999999999865443   5899998654 3444567999999999999


Q ss_pred             cceeeeEeeeeecCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEE
Q 042216          531 YLHLVSLIGYCNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILL  610 (767)
Q Consensus       531 Hpniv~l~g~~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILl  610 (767)
                      |||||+++|+|.+++..++|||||++|+|.+++.... ..++|.+++.++.|+|+||.|||   +++|+||||||+||||
T Consensus        86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl  161 (299)
T d1jpaa_          86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILV  161 (299)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEE
Confidence            9999999999999999999999999999999886543 46999999999999999999999   6889999999999999


Q ss_pred             CCCCcEEEeecCCcccCCCCCCccc---cccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCcc
Q 042216          611 DEEWVAKVSDFGLCKFGPNFSKTHV---STQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKK  686 (767)
Q Consensus       611 d~~~~~ki~DfGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~  686 (767)
                      +.++.+||+|||+++..........   .....||+.|||||.+.++.++.++|||||||+||||+| |+.||...... 
T Consensus       162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-  240 (299)
T d1jpaa_         162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-  240 (299)
T ss_dssp             CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-
T ss_pred             CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999986543222111   123457899999999999999999999999999999998 89999654332 


Q ss_pred             chhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          687 QVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       687 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                        .+...    +..+         .+...+..++.++.+++.+||+.||.+||||.||++.|+.+++.+
T Consensus       241 --~~~~~----i~~~---------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         241 --DVINA----IEQD---------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             --HHHHH----HHTT---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             --HHHHH----HHcC---------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence              11111    1111         222345667888999999999999999999999999999987654

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=421.24  Aligned_cols=262  Identities=30%  Similarity=0.533  Sum_probs=208.1

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ++|...+.||+|+||+||+|++++   .||||+++..  .....++|.+|+++|++++||||+++++++.+ +.+++|||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             ccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            567888899999999999998753   5999998654  34556789999999999999999999999865 57899999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      ||++|+|.++|+... ..++|.+++.|+.|+|+||+|||   +++|+||||||+|||++.++.+||+|||+++.......
T Consensus        84 y~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          84 WCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             CCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             cCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            999999999997543 46999999999999999999999   67899999999999999999999999999987654333


Q ss_pred             ccccccccCCCcccChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRL---QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                      ........||+.|||||++.+   ..++.++|||||||+||||+||+.||........  +...    ...+..    .+
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~~~~----~~~~~~----~p  229 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIFM----VGRGYL----SP  229 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHH----HHHTSC----CC
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--HHHH----HhcCCC----CC
Confidence            344456789999999999864   3589999999999999999999999976543321  1111    111111    11


Q ss_pred             cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       710 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      .+ ...+..+++++.+++.+||+.||.+|||++||++.|+.+.+.+
T Consensus       230 ~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         230 DL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             CG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             cc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence            11 1234456788999999999999999999999999999887643

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.1e-51  Score=428.18  Aligned_cols=261  Identities=26%  Similarity=0.397  Sum_probs=220.7

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .++|...+.||+|+||+||+|+++.+++.||||+++... ...++|.+|+++|++++|||||+++++|.+++..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            467888899999999999999998888999999997543 4566899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      |++|+|.++|.+.....++|..++.|+.|+|.||+|||   +++|+||||||+||||++++.+||+|||+++..... ..
T Consensus        95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-~~  170 (287)
T d1opja_          95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TY  170 (287)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-SS
T ss_pred             ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCC-Cc
Confidence            99999999998776778999999999999999999999   678999999999999999999999999999875432 22


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      .......|++.|||||++.++.++.++|||||||++|||++|..|+.......  .+.    .....         ..+.
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--~~~----~~i~~---------~~~~  235 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVY----ELLEK---------DYRM  235 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH----HHHHT---------TCCC
T ss_pred             eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH--HHH----HHHhc---------CCCC
Confidence            23344568899999999999999999999999999999999777764332211  111    11111         2233


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL  754 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~  754 (767)
                      ..+..+++++.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus       236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            44566788899999999999999999999999999987653

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-50  Score=416.73  Aligned_cols=256  Identities=27%  Similarity=0.460  Sum_probs=203.4

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      ++|+..+.||+|+||+||+|.+.+ ++.||||+++.. ....++|.+|++++++++||||++++|+|.+++..++||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            467888899999999999999875 468999999754 344578999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++|+|.+++.... ..++|..++.++.|+|.||.|||   +++|+||||||+|||+++++.+||+|||+++...... ..
T Consensus        83 ~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~  157 (263)
T d1sm2a_          83 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT  157 (263)
T ss_dssp             TTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCC-ce
Confidence            9999999986543 46899999999999999999999   6789999999999999999999999999998654322 22


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCA-RPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg-~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      ......||+.|||||++.+..++.++|||||||++|||+|+ ++|+.....   ..+...+.    .+         .+.
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~~i~----~~---------~~~  221 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDIS----TG---------FRL  221 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHHHHH----HT---------CCC
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHHHHH----hc---------CCC
Confidence            23345689999999999999999999999999999999995 555533221   11111111    11         122


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                      ..|..+++++.+++.+||+.||++||||+||++.|+++.+
T Consensus       222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            3355667889999999999999999999999999998865

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=415.20  Aligned_cols=258  Identities=26%  Similarity=0.419  Sum_probs=212.6

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .++|+..+.||+|+||+||+|.+++ ++.||||+++... ...++|.+|+++|++++|||||+++|+|.+ +..++||||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECC-CCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            3578888899999999999999874 4789999997543 445689999999999999999999998865 567999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++|+|.+++......+++|.++++|+.|+++||+|||   +++|+||||||+||||++++.+||+|||+++..... ..
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~  164 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EY  164 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CE
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCC-cc
Confidence            99999999886655556999999999999999999999   678999999999999999999999999999876432 22


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      .......||+.|||||++..+.++.++|||||||+||||+||..|+......  ..+..    .+..+         .+.
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~~----~i~~~---------~~~  229 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQ----NLERG---------YRM  229 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHH----HHHTT---------CCC
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHHH----HHHhc---------CCC
Confidence            2334567899999999999999999999999999999999966555333221  11111    11111         122


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                      ..+..+++++.+++.+||+.||++||||+||+++|+....
T Consensus       230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            3355677889999999999999999999999999998764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=414.02  Aligned_cols=253  Identities=23%  Similarity=0.318  Sum_probs=207.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      ++|+..+.||+|+||+||+|+++.+++.||||++.... .+..+++.+|+++|++++||||+++++++.+++..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57899999999999999999998888999999986543 33445799999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++|+|.++|...  ..+++.++..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+|+........
T Consensus        85 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          85 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            9999999999643  46999999999999999999999   778999999999999999999999999999875433333


Q ss_pred             cccccccCCCcccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLL-TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                      ......+||+.|||||++.+..+ +.++|||||||+||||++|+.||....+.... ...+     ....        ..
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~-----~~~~--------~~  225 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW-----KEKK--------TY  225 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHH-----HTTC--------TT
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHH-----hcCC--------CC
Confidence            34456789999999999988776 57899999999999999999999655432211 1111     1110        01


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .......+.++.+++.+||+.||++|||++|+++
T Consensus       226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1112345677889999999999999999999864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-49  Score=411.96  Aligned_cols=262  Identities=26%  Similarity=0.412  Sum_probs=214.1

Q ss_pred             hcccccee-eeccCcEEEEEEEecC--CCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          475 KDFNNLLI-IGRGGFGNVYKGFLNG--DSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       475 ~~f~~~~~-LG~G~fG~Vy~g~~~~--~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      +++...+. ||+|+||+||+|.++.  ++..||||+++... ....++|.+|+++|++++|||||+++|+|.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            45566664 9999999999998753  34579999997653 3345679999999999999999999999965 568999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      ||||++|+|.+++.... ..+++.+++.++.|+|.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        87 mE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            99999999999985443 46999999999999999999999   688999999999999999999999999999875443


Q ss_pred             CCc-cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          631 SKT-HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       631 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      ... .......||+.|||||++..+.++.++|||||||++|||+| |+.||......+   +.    ..+..+.      
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~----~~i~~~~------  229 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM----AFIEQGK------  229 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HH----HHHHTTC------
T ss_pred             ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCC------
Confidence            221 22334568999999999999999999999999999999998 999997654322   11    1122221      


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhc
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLRE  757 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~  757 (767)
                         +...|..++.++.+|+.+||+.||++||||.+|++.|+.+...+..
T Consensus       230 ---~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~  275 (285)
T d1u59a_         230 ---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  275 (285)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             ---CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence               2234566788899999999999999999999999999988765533

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-49  Score=413.55  Aligned_cols=262  Identities=29%  Similarity=0.458  Sum_probs=207.8

Q ss_pred             hccccceeeeccCcEEEEEEEecCCC----ceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDS----TPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~----~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      ..|+..++||+|+||+||+|.++.++    ..||||++.... .....+|.+|+++|++++|||||+++|+|.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            45788889999999999999987543    469999997553 3345579999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      |||||.+|+|.+++.... ..++|.+++.++.|++.||+|||   +++|+||||||+||||+.++.+||+|||+++....
T Consensus        87 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          87 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            999999999999886543 46999999999999999999999   78899999999999999999999999999986543


Q ss_pred             CCC-ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          630 FSK-THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       630 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      ... ........||+.|||||++.++.++.++|||||||+||||++|..|+......  ..+..    .+..        
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~----~i~~--------  228 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMK----AIND--------  228 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHH----HHHT--------
T ss_pred             CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHH----HHhc--------
Confidence            222 22233456899999999999999999999999999999999976665433221  11111    1111        


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                       ..+...+..++.++.+|+.+||+.||++||||.||+++|+.+++..
T Consensus       229 -~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         229 -GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             -TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             -cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence             2233455667788999999999999999999999999999988754

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-49  Score=419.81  Aligned_cols=257  Identities=26%  Similarity=0.386  Sum_probs=211.4

Q ss_pred             hccccceeeeccCcEEEEEEEecCCC-----ceEEEEEeCCC-CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCce
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDS-----TPVAIKRLNPG-SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQM  547 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~-----~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~  547 (767)
                      ++|+..++||+|+||+||+|++.+.+     ..||||++... .......|.+|+.+|.++ +|||||+++++|.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            57888899999999999999986543     36999998654 344456799999999998 899999999999999999


Q ss_pred             EEEEecCCCCChhhhhccCCC---------------------CCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCC
Q 042216          548 ILVYDYMARGTLRDHLYNNDN---------------------PPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTT  606 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~  606 (767)
                      ++|||||++|+|.++|+....                     ..++|..++.++.|+++||+|||   +++|+||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchh
Confidence            999999999999999965431                     35899999999999999999999   678999999999


Q ss_pred             CeEECCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCc
Q 042216          607 NILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDK  685 (767)
Q Consensus       607 NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~  685 (767)
                      |||++.++.+||+|||+|+...............||+.|||||.+.++.++.++|||||||+||||+| |+.||......
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999986544333333345668999999999999999999999999999999997 89999655432


Q ss_pred             cchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042216          686 KQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLE  749 (767)
Q Consensus       686 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~  749 (767)
                      .  .+..    ....         ..+...|..+++++.+|+.+||+.||++|||++||++.|.
T Consensus       274 ~--~~~~----~~~~---------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         274 A--NFYK----LIQN---------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             H--HHHH----HHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             H--HHHH----HHhc---------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            2  1111    1111         1223445667888999999999999999999999999985

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=407.60  Aligned_cols=252  Identities=25%  Similarity=0.383  Sum_probs=204.8

Q ss_pred             eeeeccCcEEEEEEEecCC--CceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecCCC
Q 042216          481 LIIGRGGFGNVYKGFLNGD--STPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYMAR  556 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~~~  556 (767)
                      +.||+|+||+||+|.+...  ++.||||+++...  ....++|.+|+++|++++||||++++|+|.. +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            4699999999999987543  4679999996542  3335679999999999999999999999965 467899999999


Q ss_pred             CChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc-cc
Q 042216          557 GTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT-HV  635 (767)
Q Consensus       557 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~-~~  635 (767)
                      |+|.+++++.  ..++|.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++........ ..
T Consensus        92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            9999999754  45999999999999999999999   678999999999999999999999999999865433222 22


Q ss_pred             cccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCC
Q 042216          636 STQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN  714 (767)
Q Consensus       636 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  714 (767)
                      .....||+.|||||.+.+..++.++|||||||++|||+| |+.||......+   +.    ..+..+         .+..
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~----~~i~~~---------~~~~  230 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VT----AMLEKG---------ERMG  230 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HH----HHHHTT---------CCCC
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---HH----HHHHcC---------CCCC
Confidence            334568999999999999999999999999999999998 899996543321   11    112222         1223


Q ss_pred             CChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 042216          715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL  754 (767)
Q Consensus       715 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~  754 (767)
                      .|..++.++.+|+.+||+.||.+|||+++|+++|+.....
T Consensus       231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            4566788899999999999999999999999999887543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=405.05  Aligned_cols=246  Identities=27%  Similarity=0.397  Sum_probs=208.9

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|+..+.||+|+||+||+|+.+.+++.||+|++...   .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            4689999999999999999999988899999998643   2334567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      |||++|+|.+++.+.  ..+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        86 Ey~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  159 (263)
T ss_dssp             ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred             eecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence            999999999999654  35999999999999999999999   788999999999999999999999999999864332 


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                         ......||+.|||||++.+..++.++|||||||+||||++|+.||......+   +.    .....+.         
T Consensus       160 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~----~~i~~~~---------  220 (263)
T d2j4za1         160 ---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TY----KRISRVE---------  220 (263)
T ss_dssp             ---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH----HHHHTTC---------
T ss_pred             ---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---HH----HHHHcCC---------
Confidence               2334679999999999999999999999999999999999999996543211   11    1111111         


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       ...|...++++.+++.+||+.||.+|||++|+++
T Consensus       221 -~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         221 -FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence             1234456778999999999999999999999985

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-48  Score=401.62  Aligned_cols=253  Identities=28%  Similarity=0.443  Sum_probs=213.5

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      ++|+..+.||+|+||+||+|+++ +++.||||+++... ...++|.+|++++++++||||++++|+|.+++..++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            57888889999999999999986 45789999997643 34578999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++|+|.+++.... ..+++..+.+++.|+++||.|||   +.+|+||||||+|||+++++.+||+|||+++...... ..
T Consensus        82 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~  156 (258)
T d1k2pa_          82 ANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YT  156 (258)
T ss_dssp             TTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CC
T ss_pred             CCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC-ce
Confidence            9999999976543 35899999999999999999999   6789999999999999999999999999998654322 22


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKG  713 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  713 (767)
                      ......||+.|+|||.+....++.++|||||||++|||+| |+.||......+.   .    ..+.++         .+.
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~---~----~~i~~~---------~~~  220 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET---A----EHIAQG---------LRL  220 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH---H----HHHHTT---------CCC
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH---H----HHHHhC---------CCC
Confidence            3344668999999999999999999999999999999998 8999965543221   1    111221         222


Q ss_pred             CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042216          714 NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEF  750 (767)
Q Consensus       714 ~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~  750 (767)
                      ..|..+++++.+++.+||+.||++|||+++|++.|..
T Consensus       221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            3455677889999999999999999999999998854

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-48  Score=407.44  Aligned_cols=250  Identities=24%  Similarity=0.387  Sum_probs=211.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      ++|+..+.||+|+||+||+|....+++.||||++........+.+.+|+++|++++||||+++++++.+++..++|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            36899999999999999999998888999999997655556677999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++|+|.+++.+.   .+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....  ..
T Consensus       100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~--~~  171 (293)
T d1yhwa1         100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QS  171 (293)
T ss_dssp             TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--TC
T ss_pred             CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccc--cc
Confidence            999999988653   5899999999999999999999   788999999999999999999999999999865332  22


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN  714 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  714 (767)
                      ......||+.|||||++.++.++.++|||||||++|||++|+.||........  +.    .....+.        ....
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~----~~~~~~~--------~~~~  237 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LY----LIATNGT--------PELQ  237 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH----HHHHHCS--------CCCS
T ss_pred             cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH--HH----HHHhCCC--------CCCC
Confidence            33456799999999999999999999999999999999999999965433211  11    1111111        0112


Q ss_pred             CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       715 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .+...+.++.+++.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            34456778999999999999999999999974

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=407.00  Aligned_cols=255  Identities=25%  Similarity=0.393  Sum_probs=198.5

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeec--CCceEE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCND--DGQMIL  549 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~--~~~~~l  549 (767)
                      .++|+..+.||+|+||+||+|+.+.+++.||||++....  ....+.+.+|+++|++++||||+++++++.+  .+.+++
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            367999999999999999999998888999999997653  3334568999999999999999999999864  457899


Q ss_pred             EEecCCCCChhhhhccC--CCCCCChHHHHHHHHHHHHHHHHhHhCC--CCCeEecCCCCCCeEECCCCcEEEeecCCcc
Q 042216          550 VYDYMARGTLRDHLYNN--DNPPLPWDRRLKICIGAARALHYLHTGA--SKVIIHRDVKTTNILLDEEWVAKVSDFGLCK  625 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~Dlk~~NILld~~~~~ki~DfGla~  625 (767)
                      |||||++|+|.+++.+.  .+..+++.+++.++.|++.||.|||+.+  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999998642  3457999999999999999999999532  2459999999999999999999999999998


Q ss_pred             cCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccc
Q 042216          626 FGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD  705 (767)
Q Consensus       626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  705 (767)
                      .....  ........||+.|||||++.+..++.++|||||||++|||++|+.||......   .+.    ..+..+... 
T Consensus       163 ~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~----~~i~~~~~~-  232 (269)
T d2java1         163 ILNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELA----GKIREGKFR-  232 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH----HHHHHTCCC-
T ss_pred             ecccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHH----HHHHcCCCC-
Confidence            75432  22234567999999999999999999999999999999999999999654322   111    112222211 


Q ss_pred             cccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       706 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                              ..+..+++++.+++.+||+.||.+|||++|+++
T Consensus       233 --------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 --------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                    234456778999999999999999999999874

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-48  Score=406.81  Aligned_cols=252  Identities=22%  Similarity=0.336  Sum_probs=210.8

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      +.|+..+.||+|+||+||+|+...+++.||||++........+.|.+|+++|++++||||+++++++.+++..++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            35788899999999999999999888999999998777777788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++|+|.+++.+.. .++++.++..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++....  ...
T Consensus        92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~  165 (288)
T d2jfla1          92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQ  165 (288)
T ss_dssp             TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHH
T ss_pred             CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCC--Ccc
Confidence            9999999986533 46999999999999999999999   77899999999999999999999999999875321  112


Q ss_pred             ccccccCCCcccChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          635 VSTQVKGSIGYLDPEYYR-----LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                      ......||+.|||||++.     ...++.++|||||||++|||++|+.||......+..  ..    .. .+...     
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~--~~----i~-~~~~~-----  233 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL--LK----IA-KSEPP-----  233 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--HH----HH-HSCCC-----
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH--HH----HH-cCCCC-----
Confidence            234567999999999984     456899999999999999999999999665433211  11    11 11111     


Q ss_pred             cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       710 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                        ....+..++.++.+++.+||+.||.+|||++|+++
T Consensus       234 --~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         234 --TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             --CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              11224456788999999999999999999999975

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-48  Score=406.07  Aligned_cols=259  Identities=27%  Similarity=0.395  Sum_probs=209.1

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      ++|+..+.||+|+||.||+|+++++ +.||||+++.. ....++|.+|+.++++++|||||+++|+|.+ +..++||||+
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            5789999999999999999999765 57999999754 3456789999999999999999999999954 5689999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCcc
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKTH  634 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~~  634 (767)
                      ++|+|.+++.......++|.+++.++.|++.||+|||   +++|+||||||+||||+.++.+||+|||+++..... ...
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~-~~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYT  169 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCC-Cce
Confidence            9999999997665567999999999999999999999   678999999999999999999999999999865332 222


Q ss_pred             ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccccCC
Q 042216          635 VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLKGN  714 (767)
Q Consensus       635 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  714 (767)
                      ......||+.|+|||++..+.++.++|||||||+||||++|..|+......  ..+...+    ..         ..+..
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i----~~---------~~~~~  234 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQV----ER---------GYRMP  234 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHH----HT---------TCCCC
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHH----Hh---------cCCCC
Confidence            334467899999999999999999999999999999999976665443221  1111111    11         12233


Q ss_pred             CChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          715 APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       715 ~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      .+..+++++.+++.+||+.||++||+|++|+++|+......
T Consensus       235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            45667788999999999999999999999999999876544

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=409.21  Aligned_cols=260  Identities=25%  Similarity=0.426  Sum_probs=210.4

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCc----eEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDST----PVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMIL  549 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~----~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l  549 (767)
                      .+|+..++||+|+||+||+|.+..+++    .||+|+++.. ..+..++|.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            468999999999999999999876554    5899998754 445567899999999999999999999999865 6778


Q ss_pred             EEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCC
Q 042216          550 VYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       550 V~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~  629 (767)
                      ++||+.+|+|.+++.... ..+++..++.++.|+|.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        88 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            899999999999887653 46999999999999999999999   67899999999999999999999999999987654


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      ...........||+.|||||++.++.++.++|||||||+||||+| |++||......+   +...+    ..+       
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i----~~~-------  229 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL----EKG-------  229 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHH----HHT-------
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HcC-------
Confidence            333333445678999999999999999999999999999999998 788886554332   11111    111       


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                        .+...+..++.++.+++.+||+.||.+|||+.||++.|+.+.+.+
T Consensus       230 --~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~  274 (317)
T d1xkka_         230 --ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  274 (317)
T ss_dssp             --CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred             --CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence              222345677888999999999999999999999999999886543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-48  Score=410.82  Aligned_cols=261  Identities=27%  Similarity=0.439  Sum_probs=214.6

Q ss_pred             HhhccccceeeeccCcEEEEEEEecC-----CCceEEEEEeCCCCCc-chhHHHHHHHHHhccccceeeeEeeeeecCCc
Q 042216          473 ATKDFNNLLIIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGSQQ-GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQ  546 (767)
Q Consensus       473 ~t~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~  546 (767)
                      ..++|+..+.||+|+||+||+|++++     +++.||||+++..... ..++|.+|+++|++++||||++++++|...+.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            45689999999999999999999763     3468999999765433 35679999999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhhhccCC----------------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCC
Q 042216          547 MILVYDYMARGTLRDHLYNND----------------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVK  604 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk  604 (767)
                      .+++|||+++|+|.++|+...                      ...++|.+++.|+.|++.||+|||   +++|+|||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEc
Confidence            999999999999999996421                      235899999999999999999999   7889999999


Q ss_pred             CCCeEECCCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCC
Q 042216          605 TTNILLDEEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR-PPILRTG  683 (767)
Q Consensus       605 ~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~-~P~~~~~  683 (767)
                      |+|||+|.++.+||+|||+++...........+...|++.|+|||.+.+..++.++|||||||++|||++|. +||....
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~  247 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  247 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence            999999999999999999998543333333344567899999999999999999999999999999999986 5675543


Q ss_pred             CccchhHHHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 042216          684 DKKQVNLAVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF  752 (767)
Q Consensus       684 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~  752 (767)
                      ..+   +..    .+.++..         ...+..++.++.+|+.+||+.||.+||||.||+++|+++.
T Consensus       248 ~~e---~~~----~v~~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         248 HEE---VIY----YVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             HHH---HHH----HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHH---HHH----HHHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            322   111    1222221         2235566778999999999999999999999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-48  Score=405.68  Aligned_cols=250  Identities=23%  Similarity=0.280  Sum_probs=207.1

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|+..+.||+|+||+||+|+.+.+++.||||++...   .....+.+.+|+++|++++||||+++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5799999999999999999999888899999998643   2334567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+++|+|.+++...  ..+++.++..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++......
T Consensus        88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence            999999999998654  35999999999999999999999   7889999999999999999999999999998765433


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                      .........||+.|||||++.+..++.++|||||||+||||++|+.||......+   +.    .....+.         
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~----~~i~~~~---------  226 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---IF----QKIIKLE---------  226 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HHHHTTC---------
T ss_pred             cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---HH----HHHHcCC---------
Confidence            3334445679999999999999999999999999999999999999996543221   11    1111111         


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       ...+...++++.+|+.+||+.||.+|||++|++.
T Consensus       227 -~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         227 -YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             -CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence             1234456678999999999999999999999754

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-48  Score=399.05  Aligned_cols=250  Identities=34%  Similarity=0.496  Sum_probs=202.7

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeec-CCceEEEEec
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCND-DGQMILVYDY  553 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~-~~~~~lV~ey  553 (767)
                      ++|+..+.||+|+||.||+|.+++  +.||||+++..  ...++|.+|++++++++||||++++|+|.+ .+.+++||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~--~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT--EEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEECC--eEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            467788899999999999999964  68999999643  345679999999999999999999999865 4678999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +++|+|.++|.......++|..+++|+.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++....    
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----  155 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----  155 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCC----
Confidence            99999999997654456899999999999999999999   67899999999999999999999999999985432    


Q ss_pred             cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          634 HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                       ......++..|+|||++.++.++.++|||||||++|||+| |++|+......   .+..++    .+         ..+
T Consensus       156 -~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i----~~---------~~~  218 (262)
T d1byga_         156 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----EK---------GYK  218 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH----TT---------TCC
T ss_pred             -CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHH----Hc---------CCC
Confidence             2233467899999999999999999999999999999998 68887554332   222221    11         123


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVF  752 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~  752 (767)
                      ...+..++.++.+++.+||+.||.+||||.||+++|+.+.
T Consensus       219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            3445667788999999999999999999999999999875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-47  Score=396.36  Aligned_cols=245  Identities=26%  Similarity=0.410  Sum_probs=197.4

Q ss_pred             ccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeec----CCceEEEE
Q 042216          478 NNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCND----DGQMILVY  551 (767)
Q Consensus       478 ~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~----~~~~~lV~  551 (767)
                      ...+.||+|+||+||+|.+..+++.||+|++...  .....+.|.+|+++|++++||||+++++++.+    +..+++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            3445799999999999999988899999998643  33345678999999999999999999999864    34689999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCC--eEecCCCCCCeEEC-CCCcEEEeecCCcccCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKV--IIHRDVKTTNILLD-EEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiH~Dlk~~NILld-~~~~~ki~DfGla~~~~  628 (767)
                      ||+++|+|.+++.+.  ..+++.++..++.|+++||+|||   +++  |+||||||+|||++ +++.+||+|||+++...
T Consensus        92 E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            999999999999654  45899999999999999999999   566  99999999999996 58899999999998643


Q ss_pred             CCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          629 NFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                      .    .......||+.|||||++.+ .++.++|||||||++|||++|+.||........  +    ......+....   
T Consensus       167 ~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~----~~~i~~~~~~~---  232 (270)
T d1t4ha_         167 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--I----YRRVTSGVKPA---  232 (270)
T ss_dssp             T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--H----HHHHTTTCCCG---
T ss_pred             C----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--H----HHHHHcCCCCc---
Confidence            2    22345679999999999875 699999999999999999999999965433211  1    11111111110   


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                           ..+..+++++.+++.+||+.||++|||++|+++
T Consensus       233 -----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         233 -----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                 112234567899999999999999999999975

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=409.52  Aligned_cols=265  Identities=22%  Similarity=0.313  Sum_probs=206.9

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      .++|+..+.||+|+||+||+|+...+++.||+|+++... .....++.+|+.+|++++|||||+++++|.+++.+++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            468999999999999999999998888999999997553 3345678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      ||++|+|.+++.+.  ..+++..+..++.|++.||.|||+  .++|+||||||+|||+++++.+||+|||+|+....   
T Consensus        85 y~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---  157 (322)
T d1s9ja_          85 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---  157 (322)
T ss_dssp             CCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---
T ss_pred             cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCC---
Confidence            99999999999654  359999999999999999999994  24799999999999999999999999999985321   


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHH-HHHHhh------------
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVW-ATECYR------------  699 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~-~~~~~~------------  699 (767)
                       ......+||+.|||||++.+..++.++||||+||++|||++|+.||......+....... ......            
T Consensus       158 -~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         158 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             -HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             -CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence             223346799999999999999999999999999999999999999966443221100000 000000            


Q ss_pred             ----------cCCccccccccccC---CCC-hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          700 ----------NGKIGDIIDPFLKG---NAP-PVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       700 ----------~~~~~~~~d~~l~~---~~~-~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                                .....+..+.....   ..+ ...+.++.+++.+||+.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                      00000000000000   001 123567899999999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-47  Score=394.58  Aligned_cols=259  Identities=25%  Similarity=0.384  Sum_probs=203.8

Q ss_pred             hccccceeeeccCcEEEEEEEecCC---CceEEEEEeCCCCCc-chhHHHHHHHHHhccccceeeeEeeeeecCCceEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGD---STPVAIKRLNPGSQQ-GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~vAVK~l~~~~~~-~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      ++|+..+.||+|+||.||+|++...   ...||||+++..... ..+.|.+|+++|++++||||++++++|. ++..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            5788889999999999999988643   346899998754333 3457999999999999999999999996 4688999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      |||+++|+|.+++.... ..+++.+++.++.|+++||.|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        86 ~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            99999999999876543 46899999999999999999999   788999999999999999999999999999865432


Q ss_pred             CCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                       .........||+.|+|||.+..+.++.++|||||||++|||++ |.+||......+   +...    +..+.       
T Consensus       162 -~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~----i~~~~-------  226 (273)
T d1mp8a_         162 -TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGR----IENGE-------  226 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HHTTC-------
T ss_pred             -cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHH----HHcCC-------
Confidence             2223345668999999999999999999999999999999998 899986554432   1111    12221       


Q ss_pred             cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       710 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                        +...+..+++++.+|+.+||+.||.+|||++||++.|+.+++..
T Consensus       227 --~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  270 (273)
T d1mp8a_         227 --RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  270 (273)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence              12345567788999999999999999999999999999987654

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-47  Score=400.89  Aligned_cols=262  Identities=25%  Similarity=0.406  Sum_probs=204.4

Q ss_pred             hhccccceeeeccCcEEEEEEEecCC-----CceEEEEEeCCCC-CcchhHHHHHHHHHhcc-ccceeeeEeeeeecC-C
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGD-----STPVAIKRLNPGS-QQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDD-G  545 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~-----~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~-~  545 (767)
                      .++|+..+.||+|+||.||+|.+...     ++.||||+++... ....+++.+|..++.++ +|+||+.+++++.+. +
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            36788999999999999999997543     3579999997543 34456788888888887 689999999998764 4


Q ss_pred             ceEEEEecCCCCChhhhhccCC--------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC
Q 042216          546 QMILVYDYMARGTLRDHLYNND--------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD  611 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld  611 (767)
                      .+++|||||++|+|.++|+...              ...++|.+++.++.|+++||+|||   +++|+||||||+||||+
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeEC
Confidence            6899999999999999996532              235899999999999999999999   78899999999999999


Q ss_pred             CCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCccchhH
Q 042216          612 EEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR-PPILRTGDKKQVNL  690 (767)
Q Consensus       612 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~-~P~~~~~~~~~~~l  690 (767)
                      +++.+||+|||+++...............||+.|||||.+.++.++.++|||||||++|||++|. +||......+  .+
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~--~~  246 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EF  246 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--HH
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH--HH
Confidence            99999999999998755444444445667999999999999999999999999999999999865 5675443221  11


Q ss_pred             HHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 042216          691 AVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQ  753 (767)
Q Consensus       691 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~  753 (767)
                      .    ..+..+.         +...+..+++++.+++.+||+.||.+|||++||++.|+.++|
T Consensus       247 ~----~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         247 C----RRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             H----HHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H----HHHhcCC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            1    1112221         223345567789999999999999999999999999999875

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7e-47  Score=400.61  Aligned_cols=252  Identities=22%  Similarity=0.307  Sum_probs=194.2

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      .+.|+..+.||+|+||+||+|+.+.+++.||||++.... ......+.+|+++|++++||||+++++++.+++.+++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            356889999999999999999998888999999987543 2334568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC---CCCcEEEeecCCcccCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPN  629 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld---~~~~~ki~DfGla~~~~~  629 (767)
                      ||++|+|.++|.+.  ..+++.++..++.|++.||+|||   +++|+||||||+|||+.   +++.+||+|||+++....
T Consensus        88 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          88 LVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             ccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            99999999999653  46999999999999999999999   78899999999999994   578999999999986432


Q ss_pred             CCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccc
Q 042216          630 FSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP  709 (767)
Q Consensus       630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  709 (767)
                         ........||+.|||||++.+..++.++|||||||+||||++|+.||......+   +..    ....+.      .
T Consensus       163 ---~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~----~i~~~~------~  226 (307)
T d1a06a_         163 ---GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFE----QILKAE------Y  226 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH----HHHTTC------C
T ss_pred             ---CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HHH----HHhccC------C
Confidence               222345679999999999999999999999999999999999999996543221   111    111111      1


Q ss_pred             cccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          710 FLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       710 ~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ......+...++++.+++.+||+.||.+|||++|+++
T Consensus       227 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1112233456678999999999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.9e-47  Score=399.96  Aligned_cols=246  Identities=26%  Similarity=0.340  Sum_probs=203.9

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc---chhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ---GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~---~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      +.|+.++.||+|+||+||+|+...+++.||||++......   ..+++.+|+++|++++|||||++++++.+++..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            3589999999999999999999888899999999765432   3356899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      |||.+|+|..++...  .++++.++..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++....  
T Consensus        95 E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  167 (309)
T ss_dssp             ECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             EecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence            999999998776443  46999999999999999999999   78899999999999999999999999999985432  


Q ss_pred             CccccccccCCCcccChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRL---QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIID  708 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  708 (767)
                          .....||+.|||||++.+   +.++.++|||||||++|||++|+.||......+.      ....... ...    
T Consensus       168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~------~~~i~~~-~~~----  232 (309)
T d1u5ra_         168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQN-ESP----  232 (309)
T ss_dssp             ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHS-CCC----
T ss_pred             ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhC-CCC----
Confidence                234579999999999864   4689999999999999999999999965432211      1111111 111    


Q ss_pred             ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          709 PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       709 ~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                          ...+..+++++.+++.+||+.||.+|||++|+++
T Consensus       233 ----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         233 ----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ----CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ----CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                1122345678999999999999999999999974

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-47  Score=399.98  Aligned_cols=262  Identities=26%  Similarity=0.438  Sum_probs=212.6

Q ss_pred             hccccceeeeccCcEEEEEEEecCCC-------ceEEEEEeCCCCC-cchhHHHHHHHHHhcc-ccceeeeEeeeeecCC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDS-------TPVAIKRLNPGSQ-QGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDG  545 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~-------~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~  545 (767)
                      ++|...+.||+|+||.||+|+..+.+       ..||||+++.... ....++.+|...+.++ +||||++++++|.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            47888889999999999999875432       4799999976543 4457789999999888 8999999999999999


Q ss_pred             ceEEEEecCCCCChhhhhccCC--------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC
Q 042216          546 QMILVYDYMARGTLRDHLYNND--------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD  611 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld  611 (767)
                      ..++||||+++|+|.++|....              ...+++.+++.++.|++.||+|||   +++|+||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeec
Confidence            9999999999999999996543              246899999999999999999999   78899999999999999


Q ss_pred             CCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhH
Q 042216          612 EEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNL  690 (767)
Q Consensus       612 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l  690 (767)
                      .++.+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |++||......   .+
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~~  246 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---EL  246 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HH
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---HH
Confidence            999999999999986544333334455678999999999999999999999999999999998 68888544321   11


Q ss_pred             HHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          691 AVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       691 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                          ...+..+         .+...+..++.++.+|+.+||+.||.+|||+.||+++|++++++.
T Consensus       247 ----~~~i~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~  298 (299)
T d1fgka_         247 ----FKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  298 (299)
T ss_dssp             ----HHHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ----HHHHHcC---------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhcC
Confidence                1222222         222344556778999999999999999999999999999998653

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.7e-46  Score=404.53  Aligned_cols=253  Identities=19%  Similarity=0.243  Sum_probs=211.0

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .++|+..+.||+|+||.||+|+...+++.||||++........+.+.+|+++|++++||||+++++++.+++.+++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            35899999999999999999999888899999999876666667799999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC--CCCcEEEeecCCcccCCCCC
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD--EEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld--~~~~~ki~DfGla~~~~~~~  631 (767)
                      |++|+|.+++.+.. ..+++.++..++.||+.||.|||   +++|+||||||+|||++  .++.+||+|||+++..... 
T Consensus       105 ~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-  179 (350)
T d1koaa2         105 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-  179 (350)
T ss_dssp             CCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred             CCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence            99999999986543 35999999999999999999999   78899999999999995  4678999999999865432 


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                        .......||+.|||||++.+..++.++|||||||++|||++|+.||.+....+   +.   ... ..+..      .+
T Consensus       180 --~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~---~~i-~~~~~------~~  244 (350)
T d1koaa2         180 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TL---RNV-KSCDW------NM  244 (350)
T ss_dssp             --SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHH-HHTCC------CS
T ss_pred             --cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH---HH---HHH-HhCCC------CC
Confidence              22345679999999999999999999999999999999999999996543221   11   111 11110      01


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ........++++.+++.+||+.||.+|||++|+++
T Consensus       245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11112345678899999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-46  Score=400.68  Aligned_cols=259  Identities=28%  Similarity=0.463  Sum_probs=210.4

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCc--eEEEEEeCCC-CCcchhHHHHHHHHHhcc-ccceeeeEeeeeecCCceEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDST--PVAIKRLNPG-SQQGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~--~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      ++|+..++||+|+||+||+|++++++.  .||||+++.. .....++|.+|+++|+++ +||||++++|+|.+++.+++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            578888899999999999999977654  5788888644 444566899999999999 799999999999999999999


Q ss_pred             EecCCCCChhhhhccC--------------CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcE
Q 042216          551 YDYMARGTLRDHLYNN--------------DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVA  616 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~  616 (767)
                      |||+++|+|.++|+..              ....++|.+++.++.|+|.||.|||   +++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            9999999999999654              2357999999999999999999999   7789999999999999999999


Q ss_pred             EEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCCccchhHHHHHH
Q 042216          617 KVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARP-PILRTGDKKQVNLAVWAT  695 (767)
Q Consensus       617 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~-P~~~~~~~~~~~l~~~~~  695 (767)
                      ||+|||+++....   ........||..|+|||.+..+.++.++|||||||++|||++|.. ||......   .+.    
T Consensus       167 kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~---~~~----  236 (309)
T d1fvra_         167 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELY----  236 (309)
T ss_dssp             EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH----
T ss_pred             EEccccccccccc---cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH---HHH----
Confidence            9999999985322   122234568999999999999999999999999999999999764 56433221   111    


Q ss_pred             HHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          696 ECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       696 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      ..+.++         .+...+..+++++.+|+.+||+.||++||||+||++.|+++++..
T Consensus       237 ~~i~~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         237 EKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             HHGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHHHhc---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            111221         123345567789999999999999999999999999999998654

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.7e-46  Score=402.23  Aligned_cols=252  Identities=18%  Similarity=0.251  Sum_probs=211.4

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDYM  554 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey~  554 (767)
                      ++|+..+.||+|+||+||+|....+++.||||+++.........+.+|+++|++++||||+++++++.+++.+++|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999998888999999997665555667899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC--CCCcEEEeecCCcccCCCCCC
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD--EEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld--~~~~~ki~DfGla~~~~~~~~  632 (767)
                      ++|+|.+++... ..++++.++..|+.||+.||.|||   +++|+||||||+|||++  .++.+||+|||+++.....  
T Consensus       109 ~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~--  182 (352)
T d1koba_         109 SGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--  182 (352)
T ss_dssp             CCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred             CCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence            999999987543 346999999999999999999999   78899999999999998  6789999999999865432  


Q ss_pred             ccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                       .......||+.|||||++.+..++.++|||||||+||||+||+.||.+....+   +..   . ...+.      ....
T Consensus       183 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~---~-i~~~~------~~~~  248 (352)
T d1koba_         183 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQ---N-VKRCD------WEFD  248 (352)
T ss_dssp             -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHH---H-HHHCC------CCCC
T ss_pred             -CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHH---H-HHhCC------CCCC
Confidence             23345679999999999999999999999999999999999999996543321   111   1 11111      1111


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .......+.++.+|+.+||+.||.+|||+.|+++
T Consensus       249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2223456678899999999999999999999985

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-46  Score=397.46  Aligned_cols=262  Identities=24%  Similarity=0.382  Sum_probs=216.4

Q ss_pred             hccccceeeeccCcEEEEEEEec-----CCCceEEEEEeCCCCC-cchhHHHHHHHHHhcc-ccceeeeEeeeeecCCce
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLN-----GDSTPVAIKRLNPGSQ-QGALEFQTEIGMLSQL-RYLHLVSLIGYCNDDGQM  547 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~  547 (767)
                      ++|+..+.||+|+||.||+|++.     ..++.||||+++.... ....+|.+|+.+++++ +|||||+++++|.+.+..
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            57888889999999999999874     3446899999976543 3455789999999999 699999999999999999


Q ss_pred             EEEEecCCCCChhhhhccCC----------------CCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC
Q 042216          548 ILVYDYMARGTLRDHLYNND----------------NPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD  611 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld  611 (767)
                      ++|||||++|+|.++|++..                ...+++..+..++.|++.||+|||   +++++||||||+|||++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccccc
Confidence            99999999999999997542                236899999999999999999999   78899999999999999


Q ss_pred             CCCcEEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhH
Q 042216          612 EEWVAKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNL  690 (767)
Q Consensus       612 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l  690 (767)
                      .++.+||+|||+++...............||+.|+|||.+..+.++.++|||||||++|||+| |++|+......+.  +
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~--~  257 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--F  257 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--H
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--H
Confidence            999999999999987655444445556789999999999999999999999999999999999 5555543332211  1


Q ss_pred             HHHHHHHhhcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 042216          691 AVWATECYRNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL  754 (767)
Q Consensus       691 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~  754 (767)
                      ...+.             ...+...+..++.++.+|+.+||+.||.+||||+||+++|+++++.
T Consensus       258 ~~~i~-------------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         258 YKMIK-------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHHH-------------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHh-------------cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            11111             1122334455678899999999999999999999999999988654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-46  Score=393.93  Aligned_cols=257  Identities=30%  Similarity=0.475  Sum_probs=207.0

Q ss_pred             ceeeeccCcEEEEEEEecCCC---ceEEEEEeCCC-CCcchhHHHHHHHHHhccccceeeeEeeeeec-CCceEEEEecC
Q 042216          480 LLIIGRGGFGNVYKGFLNGDS---TPVAIKRLNPG-SQQGALEFQTEIGMLSQLRYLHLVSLIGYCND-DGQMILVYDYM  554 (767)
Q Consensus       480 ~~~LG~G~fG~Vy~g~~~~~~---~~vAVK~l~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~-~~~~~lV~ey~  554 (767)
                      .++||+|+||+||+|++..++   ..||||+++.. ......+|.+|+++|++++||||++++|+|.+ ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            357999999999999986542   36899999754 44455779999999999999999999999875 56899999999


Q ss_pred             CCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc-
Q 042216          555 ARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT-  633 (767)
Q Consensus       555 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~-  633 (767)
                      ++|+|.+++.... ..+++..++.++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++........ 
T Consensus       112 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         112 KHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             TTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             ecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            9999999986543 46889999999999999999999   788999999999999999999999999999865432221 


Q ss_pred             -cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccccc
Q 042216          634 -HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFLK  712 (767)
Q Consensus       634 -~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  712 (767)
                       .......||+.|+|||.+..+.++.++||||||+++|||+||+.|+......  ..+..++    ..+.         +
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i----~~g~---------~  252 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYL----LQGR---------R  252 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----HTTC---------C
T ss_pred             ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHH----HcCC---------C
Confidence             2233456899999999999999999999999999999999988877543221  1112211    1111         1


Q ss_pred             CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          713 GNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       713 ~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                      ...+..+++++.+++.+||+.||++||+|.||++.|+.+++..
T Consensus       253 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~  295 (311)
T d1r0pa_         253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  295 (311)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence            2234556788999999999999999999999999999998654

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=391.57  Aligned_cols=257  Identities=25%  Similarity=0.381  Sum_probs=200.8

Q ss_pred             hccccceeeeccCcEEEEEEEecCC---CceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGD---STPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMI  548 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~  548 (767)
                      ++|+..+.||+|+||.||+|++...   ...||||+++..   ..+..++|.+|+++|++++||||++++|+|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            5788899999999999999987533   236899998754   23345679999999999999999999999975 4778


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      +||||+++|+|.+++.... ..+++..++.++.|+|.||.|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            9999999999999886543 35999999999999999999999   6789999999999999999999999999998754


Q ss_pred             CCCCcc-ccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCccchhHHHHHHHHhhcCCcccc
Q 042216          629 NFSKTH-VSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLC-ARPPILRTGDKKQVNLAVWATECYRNGKIGDI  706 (767)
Q Consensus       629 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ellt-g~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  706 (767)
                      ...... ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||......+   ..   ......+     
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~---~~i~~~~-----  231 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---IL---HKIDKEG-----  231 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---HHHHTSC-----
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HH---HHHHhCC-----
Confidence            433222 2334568889999999999999999999999999999998 899996543321   11   1111221     


Q ss_pred             ccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 042216          707 IDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFV  751 (767)
Q Consensus       707 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~  751 (767)
                          .+.+.+..++.++.+++.+||+.||++||||+||++.|+++
T Consensus       232 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         232 ----ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                22233456677899999999999999999999999988764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-46  Score=392.37  Aligned_cols=251  Identities=19%  Similarity=0.239  Sum_probs=206.9

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC------CcchhHHHHHHHHHhccccceeeeEeeeeecCCceE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS------QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMI  548 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~------~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~  548 (767)
                      +.|+..+.||+|+||+||+|+.+.+++.||||++....      ....+.|.+|+++|++++||||+++++++.+.+.++
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            56899999999999999999998888999999986432      123567999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC----cEEEeecCCc
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW----VAKVSDFGLC  624 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~----~~ki~DfGla  624 (767)
                      +|||||++|+|.++|.+.  ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++    .+||+|||++
T Consensus        90 iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          90 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence            999999999999999654  35999999999999999999999   78899999999999998776    5999999999


Q ss_pred             ccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc
Q 042216          625 KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG  704 (767)
Q Consensus       625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  704 (767)
                      +.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+..      .. ...+.. 
T Consensus       165 ~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~------~~-i~~~~~-  233 (293)
T d1jksa_         165 HKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------AN-VSAVNY-  233 (293)
T ss_dssp             EECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HH-HHTTCC-
T ss_pred             hhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH------HH-HHhcCC-
Confidence            865332   2234557899999999999999999999999999999999999999654332111      11 111110 


Q ss_pred             ccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          705 DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       705 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                           ......+...+.++.+++.+||+.||.+|||++|+++
T Consensus       234 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         234 -----EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             -----CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0000112235667899999999999999999999975

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-46  Score=395.96  Aligned_cols=261  Identities=23%  Similarity=0.403  Sum_probs=214.3

Q ss_pred             hccccceeeeccCcEEEEEEEecC-----CCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCCceE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNG-----DSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMI  548 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~  548 (767)
                      ++|...+.||+|+||+||+|.+.+     .++.||||+++... .+....|.+|++++++++||||++++++|..++..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            578888999999999999998753     23689999997543 334456899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhccC--------CCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 042216          549 LVYDYMARGTLRDHLYNN--------DNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSD  620 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~D  620 (767)
                      +|||||++|+|.+++...        ....+++..+.+++.|+|+||.|||   +++|+||||||+|||+++++++||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEee
Confidence            999999999999998542        2245799999999999999999999   67899999999999999999999999


Q ss_pred             cCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCccchhHHHHHHHHhh
Q 042216          621 FGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCAR-PPILRTGDKKQVNLAVWATECYR  699 (767)
Q Consensus       621 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~-~P~~~~~~~~~~~l~~~~~~~~~  699 (767)
                      ||+++...............||+.|+|||.+.++.++.++|||||||++|||+||. +||......+      +.. ...
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~------~~~-~i~  249 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------VLR-FVM  249 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH------HHH-HHH
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH------HHH-HHH
Confidence            99998654433333444556899999999999999999999999999999999985 6664433221      111 112


Q ss_pred             cCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 042216          700 NGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL  754 (767)
Q Consensus       700 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~  754 (767)
                      ++.         +...+..++..+.+++.+||+.||.+||||++|+++|++.++-
T Consensus       250 ~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~  295 (308)
T d1p4oa_         250 EGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  295 (308)
T ss_dssp             TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             hCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            221         1223456678899999999999999999999999999877653

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2e-45  Score=390.99  Aligned_cols=245  Identities=27%  Similarity=0.379  Sum_probs=208.1

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|+..+.||+|+||+||+|+.+.+++.||||+++..   .....+.+.+|+.+|++++||||+++++++.+.+.+++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5789999999999999999999888899999998643   2334567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      |||++|+|.+++....  .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....  
T Consensus        84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~--  156 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--  156 (316)
T ss_dssp             CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred             eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecc--
Confidence            9999999999986543  5789999999999999999999   88999999999999999999999999999986543  


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                         .....+||+.|||||++.+..++.++|||||||+||||++|+.||......+   +   ... ...+.         
T Consensus       157 ---~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~---~~~-i~~~~---------  217 (316)
T d1fota_         157 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---T---YEK-ILNAE---------  217 (316)
T ss_dssp             ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHH-HHHCC---------
T ss_pred             ---ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH---H---HHH-HHcCC---------
Confidence               2335679999999999999999999999999999999999999996543221   1   111 11111         


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRP-----SMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~  746 (767)
                       ...++..+.++.+++.+||+.||.+||     |++|+++
T Consensus       218 -~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         218 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence             123445667899999999999999996     8999975

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-45  Score=393.44  Aligned_cols=248  Identities=25%  Similarity=0.334  Sum_probs=210.0

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|+..++||+|+||+||+|+.+.+++.||||+++..   .....+.+.+|+.+|++++||||+++++++.+++.+++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5799999999999999999999888899999998643   2334567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      |||++|+|.+++.+..  .+++..+..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++..... 
T Consensus        85 ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-  158 (337)
T d1o6la_          85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-  158 (337)
T ss_dssp             ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred             eccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccC-
Confidence            9999999999996643  5899999999999999999999   788999999999999999999999999999864332 


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                       .......+||+.|||||++.+..++.++||||+||++|||++|++||......+   +..    ....+.         
T Consensus       159 -~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~----~i~~~~---------  221 (337)
T d1o6la_         159 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFE----LILMEE---------  221 (337)
T ss_dssp             -TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCC---------
T ss_pred             -CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HHH----HHhcCC---------
Confidence             223345679999999999999999999999999999999999999996554321   111    111111         


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPS-----MSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~  746 (767)
                       ...|...+.++.+|+.+||+.||.+||+     ++|+++
T Consensus       222 -~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         222 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence             1234556778899999999999999995     788875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-45  Score=386.59  Aligned_cols=268  Identities=22%  Similarity=0.286  Sum_probs=200.8

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHH--HHHHHHhccccceeeeEeeeeecCC----ceE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQ--TEIGMLSQLRYLHLVSLIGYCNDDG----QMI  548 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~--~Ei~~l~~l~Hpniv~l~g~~~~~~----~~~  548 (767)
                      +++...+.||+|+||.||+|++.  ++.||||+++..   ..+++.  .|+..+.+++||||++++++|.+.+    .++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            45667788999999999999985  378999999643   233443  4555566789999999999997654    589


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhC-----CCCCeEecCCCCCCeEECCCCcEEEeecCC
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG-----ASKVIIHRDVKTTNILLDEEWVAKVSDFGL  623 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiH~Dlk~~NILld~~~~~ki~DfGl  623 (767)
                      +|||||++|+|.++|++.   .++|.++++++.|+|.||+|||+.     ..++|+||||||+||||+.++.+||+|||+
T Consensus        78 lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            999999999999999764   589999999999999999999953     247999999999999999999999999999


Q ss_pred             cccCCCCCCc--cccccccCCCcccChhhhccCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCCccc--------
Q 042216          624 CKFGPNFSKT--HVSTQVKGSIGYLDPEYYRLQL------LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQ--------  687 (767)
Q Consensus       624 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~--------  687 (767)
                      ++........  .......||+.|||||++....      ++.++|||||||+||||+||..|+........        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~  234 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence            9865332221  1233567999999999987643      57799999999999999999988744322111        


Q ss_pred             hhHHHHHHHHhhcCCccccccccccCC-CChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 042216          688 VNLAVWATECYRNGKIGDIIDPFLKGN-APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQL  754 (767)
Q Consensus       688 ~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~  754 (767)
                      .............+.    .++.+... .+..+...+.+++.+||+.||.+|||+.||++.|+.+.+.
T Consensus       235 ~~~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         235 DPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             SCCHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            001111122211111    11111111 1234567799999999999999999999999999987653

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.7e-45  Score=382.60  Aligned_cols=261  Identities=26%  Similarity=0.317  Sum_probs=204.6

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC---cchhHHHHHHHHHhccccceeeeEeeeeecCC----c
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ---QGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG----Q  546 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~---~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~----~  546 (767)
                      .++|+..+.||+|+||+||+|+...+++.||||+++....   .....|.+|+++|+.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            3568999999999999999999988889999999976532   23456899999999999999999999987654    3


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      .++||||+++|+|.+++...  ..+++.++..++.|++.||+|||   +++|+||||||+|||++.++..+|+|||+++.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhh
Confidence            78999999999999988654  35999999999999999999999   78899999999999999999999999999875


Q ss_pred             CCCCC-CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccc
Q 042216          627 GPNFS-KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD  705 (767)
Q Consensus       627 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  705 (767)
                      ..... .........||+.|||||++.+..++.++|||||||++|||+||++||......+      ...........  
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~~~--  232 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPI--  232 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCC--
T ss_pred             hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhcCCC--
Confidence            43222 1223345679999999999999999999999999999999999999996543221      11122222111  


Q ss_pred             cccccccCCCChhhHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhH
Q 042216          706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRP-SMSDVVWGLEFVF  752 (767)
Q Consensus       706 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RP-s~~evl~~L~~~~  752 (767)
                           .........++++.+++.+||+.||.+|| |++++++.|.++.
T Consensus       233 -----~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         233 -----PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             -----CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -----CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence                 01112234567899999999999999999 8999998887653

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.3e-44  Score=377.48  Aligned_cols=251  Identities=21%  Similarity=0.266  Sum_probs=206.8

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc---------chhHHHHHHHHHhccc-cceeeeEeeeeecC
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ---------GALEFQTEIGMLSQLR-YLHLVSLIGYCNDD  544 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~---------~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~  544 (767)
                      ++|+..+.||+|+||+||+|+...+++.||||++......         ..+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5788999999999999999999888899999998654321         1235889999999997 99999999999999


Q ss_pred             CceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCc
Q 042216          545 GQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLC  624 (767)
Q Consensus       545 ~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla  624 (767)
                      +..+||||||++|+|.++|...  .++++.++..++.|+++||+|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             cceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhe
Confidence            9999999999999999999654  46999999999999999999999   678999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCCcccChhhhcc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHh
Q 042216          625 KFGPNFSKTHVSTQVKGSIGYLDPEYYRL------QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECY  698 (767)
Q Consensus       625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~  698 (767)
                      +.....   .......||..|+|||.+.+      ..++.++||||+||++|||++|+.||.......   ..    ...
T Consensus       158 ~~~~~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~---~~----~~i  227 (277)
T d1phka_         158 CQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---ML----RMI  227 (277)
T ss_dssp             EECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HHH
T ss_pred             eEccCC---CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH---HH----HHH
Confidence            865432   22345679999999999863      357889999999999999999999997554321   11    111


Q ss_pred             hcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          699 RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       699 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ..+..      ..........++++.+++.+||+.||.+|||++||++
T Consensus       228 ~~~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         228 MSGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HhCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            11111      1112223456788999999999999999999999864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-44  Score=389.48  Aligned_cols=245  Identities=22%  Similarity=0.299  Sum_probs=207.5

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~  551 (767)
                      ++|+.++.||+|+||+||+|+++.+++.||||++...   .....+.+.+|+++|+.++||||+++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            4799999999999999999999888899999998642   2234557899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~  631 (767)
                      ||+.+|+|.+++.+..  .+++.++..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++....  
T Consensus       121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--  193 (350)
T ss_dssp             ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred             ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--
Confidence            9999999999996543  5999999999999999999999   78899999999999999999999999999986532  


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                         ......||+.|||||++.+..++.++|||||||+||||++|+.||......   .+..   . ...+.         
T Consensus       194 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~---~-i~~~~---------  254 (350)
T d1rdqe_         194 ---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYE---K-IVSGK---------  254 (350)
T ss_dssp             ---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---H-HHHCC---------
T ss_pred             ---ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH---HHHH---H-HhcCC---------
Confidence               223467999999999999999999999999999999999999999654321   1111   1 11111         


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRP-----SMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RP-----s~~evl~  746 (767)
                       ...+...+.++.+++.+||+.||.+|+     |++|+++
T Consensus       255 -~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence             122445667899999999999999994     8999985

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-44  Score=380.23  Aligned_cols=258  Identities=23%  Similarity=0.259  Sum_probs=197.7

Q ss_pred             cceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc-----chhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          479 NLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ-----GALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       479 ~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~-----~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .+++||+|+||+||+|+.+.+++.||||+++.....     ..+.+.+|+++|++++||||+++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            457899999999999999888899999998654221     234689999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCCc
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSKT  633 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~~  633 (767)
                      +.++++..++.  ....+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......  
T Consensus        82 ~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--  154 (299)
T d1ua2a_          82 METDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--  154 (299)
T ss_dssp             CSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--
T ss_pred             hcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc--
Confidence            99987776663  3346899999999999999999999   7889999999999999999999999999997643321  


Q ss_pred             cccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccc---
Q 042216          634 HVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDP---  709 (767)
Q Consensus       634 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~---  709 (767)
                      .......||+.|+|||++.. ..++.++|||||||++|||++|++||....+.+..  .. ..............+.   
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l--~~-i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL--TR-IFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HH-HHHHHCCCCTTTSSSTTSS
T ss_pred             ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHH--HH-HHHhcCCCChhhccchhcc
Confidence            22334579999999999865 46799999999999999999999999655433221  11 1111111000000000   


Q ss_pred             ----ccc--CCC-----ChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          710 ----FLK--GNA-----PPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       710 ----~l~--~~~-----~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                          ...  ...     ....++++.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence                000  001     1234567899999999999999999999975

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3e-44  Score=389.26  Aligned_cols=249  Identities=23%  Similarity=0.302  Sum_probs=201.9

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC---CcchhHHHH---HHHHHhccccceeeeEeeeeecCCceE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS---QQGALEFQT---EIGMLSQLRYLHLVSLIGYCNDDGQMI  548 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~---~~~~~~f~~---Ei~~l~~l~Hpniv~l~g~~~~~~~~~  548 (767)
                      ++|+..++||+|+||.||+|+...+++.||||++....   ......+.+   |+++++.++||||+++++++.+.+.++
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57899999999999999999999888999999985321   122223344   467777888999999999999999999


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      +|||||++|+|.++|.+.  ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            999999999999999654  45889999999999999999999   7889999999999999999999999999998653


Q ss_pred             CCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccc
Q 042216          629 NFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDII  707 (767)
Q Consensus       629 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  707 (767)
                      ..    ......||+.|||||++.. ..++.++|||||||+||||++|+.||..........+.    .....       
T Consensus       159 ~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~~~~-------  223 (364)
T d1omwa3         159 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLT-------  223 (364)
T ss_dssp             SS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH----HHSSS-------
T ss_pred             CC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH----Hhccc-------
Confidence            32    2334579999999999975 56899999999999999999999999765433221111    11100       


Q ss_pred             cccccCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042216          708 DPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPS-----MSDVVW  746 (767)
Q Consensus       708 d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~  746 (767)
                         .....+...+.++.+++.+||+.||.+|||     ++|+++
T Consensus       224 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         224 ---MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ---CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence               111234456778999999999999999999     588874

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-44  Score=385.98  Aligned_cols=253  Identities=19%  Similarity=0.292  Sum_probs=201.4

Q ss_pred             hhccccce-eeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcc-ccceeeeEeeeeec----CCce
Q 042216          474 TKDFNNLL-IIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQL-RYLHLVSLIGYCND----DGQM  547 (767)
Q Consensus       474 t~~f~~~~-~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~----~~~~  547 (767)
                      .++|.... +||+|+||+||+|++..+++.||||+++.     ...+.+|++++.++ +||||+++++++.+    +..+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            35788765 59999999999999988889999999853     34678899987655 89999999998864    4678


Q ss_pred             EEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC---CCcEEEeecCCc
Q 042216          548 ILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE---EWVAKVSDFGLC  624 (767)
Q Consensus       548 ~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~---~~~~ki~DfGla  624 (767)
                      |+|||||++|+|.++|.+.....+++.++..++.|++.||.|||   +++|+||||||+|||++.   ++.+||+|||++
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence            99999999999999998765567999999999999999999999   788999999999999985   567999999999


Q ss_pred             ccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc
Q 042216          625 KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG  704 (767)
Q Consensus       625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  704 (767)
                      +.....   .......||+.|||||++.+..++.++|||||||+||||+||+.||.+.........   .......+.  
T Consensus       162 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~~~~i~~~~--  233 (335)
T d2ozaa1         162 KETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQ--  233 (335)
T ss_dssp             EECCCC---CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS--
T ss_pred             eeccCC---CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---HHHHHhcCC--
Confidence            865432   223456799999999999999999999999999999999999999965443221100   000000000  


Q ss_pred             ccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          705 DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       705 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                          ..+........++++.+|+.+||+.||.+|||+.|+++
T Consensus       234 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         234 ----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             ----SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ----CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                00111111345678999999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=385.23  Aligned_cols=247  Identities=24%  Similarity=0.334  Sum_probs=205.5

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC---CCcchhHHHHHHHHHh-ccccceeeeEeeeeecCCceEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG---SQQGALEFQTEIGMLS-QLRYLHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~---~~~~~~~f~~Ei~~l~-~l~Hpniv~l~g~~~~~~~~~lV  550 (767)
                      ++|...+.||+|+||+||+|+.+.+++.||||+++..   .....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5788899999999999999999988999999999643   2334456777777765 68999999999999999999999


Q ss_pred             EecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCC
Q 042216          551 YDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       551 ~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~  630 (767)
                      ||||++|+|.+++...  ..+++.++..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++.....
T Consensus        82 mEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            9999999999999654  35899999999999999999999   678999999999999999999999999999854322


Q ss_pred             CCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF  710 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  710 (767)
                        ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+   +.    .....+.        
T Consensus       157 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~----~~i~~~~--------  219 (320)
T d1xjda_         157 --DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LF----HSIRMDN--------  219 (320)
T ss_dssp             --TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HHHHHCC--------
T ss_pred             --cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---HH----HHHHcCC--------
Confidence              223345679999999999999999999999999999999999999996543321   11    1111111        


Q ss_pred             ccCCCChhhHHHHHHHHHHccccCCCCCCCHH-HHH
Q 042216          711 LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMS-DVV  745 (767)
Q Consensus       711 l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~-evl  745 (767)
                        ...|..++.++.+|+.+||+.||.+||++. |++
T Consensus       220 --~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         220 --PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             --CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             --CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence              123445677899999999999999999995 675

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-44  Score=381.19  Aligned_cols=252  Identities=16%  Similarity=0.237  Sum_probs=206.4

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEec
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ey  553 (767)
                      .++|...+.||+|+||+||+|.++.+++.||||+++... .....+.+|+++|+.++||||+++++++.+++.+||||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            357889999999999999999999888999999997543 3345688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC--CCcEEEeecCCcccCCCCC
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE--EWVAKVSDFGLCKFGPNFS  631 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~--~~~~ki~DfGla~~~~~~~  631 (767)
                      |++|+|.++|.... ..+++.++..++.|++.||.|||   +++|+||||||+|||++.  ...+||+|||+++....  
T Consensus        83 ~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~--  156 (321)
T d1tkia_          83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--  156 (321)
T ss_dssp             CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred             CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhcccc--
Confidence            99999999996542 36999999999999999999999   788999999999999984  45899999999986533  


Q ss_pred             CccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccccccccc
Q 042216          632 KTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPFL  711 (767)
Q Consensus       632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  711 (767)
                       ........+|+.|+|||.+.+..++.++||||+||++|||++|+.||......+   +.   .. ...+...  ++   
T Consensus       157 -~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~~---~~-i~~~~~~--~~---  223 (321)
T d1tkia_         157 -GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---II---EN-IMNAEYT--FD---  223 (321)
T ss_dssp             -TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HH-HHHTCCC--CC---
T ss_pred             -CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---HH---HH-HHhCCCC--CC---
Confidence             222344568999999999999999999999999999999999999996543321   11   11 1111100  00   


Q ss_pred             cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          712 KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       712 ~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       .......+.++.+++.+||+.||.+|||+.|+++
T Consensus       224 -~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         224 -EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0001134567899999999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-43  Score=374.13  Aligned_cols=261  Identities=21%  Similarity=0.285  Sum_probs=203.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ++|+.++.||+|+||+||+|++..+++.||||+++...  .....++.+|+++|++++||||+++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            57899999999999999999998888999999996543  2345679999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+.+ ++.+++.......+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....  
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--  155 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--  155 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCC--
Confidence            9975 5556665555667999999999999999999999   788999999999999999999999999999764321  


Q ss_pred             ccccccccCCCcccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcccccccc-
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQL-LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGDIIDPF-  710 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~-  710 (767)
                      ........||+.|+|||.+.... .+.++|||||||++|||++|+.||......+.  +.......   +...+..-+. 
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~~~---~~~~~~~~~~~  230 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTL---GTPDEVVWPGV  230 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHH---CCCCTTTSTTG
T ss_pred             cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHHHHHhc---CCCchhhcccc
Confidence            22334557999999999877654 58899999999999999999999965433221  11111110   0111110000 


Q ss_pred             -----ccCC-----------CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          711 -----LKGN-----------APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       711 -----l~~~-----------~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                           ....           .....+.++.+++.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                 0000           01234567899999999999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-44  Score=371.11  Aligned_cols=240  Identities=22%  Similarity=0.366  Sum_probs=198.3

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC------cchhHHHHHHHHHhccc--cceeeeEeeeeecCCc
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ------QGALEFQTEIGMLSQLR--YLHLVSLIGYCNDDGQ  546 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~------~~~~~f~~Ei~~l~~l~--Hpniv~l~g~~~~~~~  546 (767)
                      ++|+..++||+|+||+||+|+...+++.||||++.....      ....++.+|+.+|++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            578889999999999999999988889999999864311      12234778999999996  8999999999999999


Q ss_pred             eEEEEecCCC-CChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC-CCcEEEeecCCc
Q 042216          547 MILVYDYMAR-GTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE-EWVAKVSDFGLC  624 (767)
Q Consensus       547 ~~lV~ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~-~~~~ki~DfGla  624 (767)
                      .++||||+.+ ++|.+++...  ..+++.++..++.|++.||+|||   +++|+||||||+|||++. ++.+||+|||++
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccc
Confidence            9999999976 5788887543  45999999999999999999999   788999999999999985 579999999999


Q ss_pred             ccCCCCCCccccccccCCCcccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCc
Q 042216          625 KFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLL-TEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKI  703 (767)
Q Consensus       625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~  703 (767)
                      +....    ...+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....            . ..+. 
T Consensus       159 ~~~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------i-~~~~-  220 (273)
T d1xwsa_         159 ALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------I-IRGQ-  220 (273)
T ss_dssp             EECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------H-HHCC-
T ss_pred             eeccc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------------H-hhcc-
Confidence            86432    22345679999999999987765 5779999999999999999999953210            0 1111 


Q ss_pred             cccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          704 GDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       704 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                               ...+...+.++.+++.+||+.||++|||++|+++
T Consensus       221 ---------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 ---------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             ---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                     1123345678899999999999999999999985

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.3e-42  Score=365.06  Aligned_cols=261  Identities=18%  Similarity=0.232  Sum_probs=199.7

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ++|+.++.||+|+||+||+|+.+ +++.||||+++...  ....+.+.+|+.+|++++||||+++++++..++..++++|
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            57889999999999999999987 45899999996543  2335679999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      |+.++.+..+...  ...+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++......  
T Consensus        81 ~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--  153 (286)
T d1ob3a_          81 HLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--  153 (286)
T ss_dssp             CCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             eehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccC--
Confidence            9988777666533  356999999999999999999999   678999999999999999999999999998764322  


Q ss_pred             ccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcC---Ccccc--
Q 042216          633 THVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG---KIGDI--  706 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~---~~~~~--  706 (767)
                      ........+++.|+|||.+.. ..++.++|||||||++|||++|+.||....+.+..  .. ........   .....  
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~--~~-i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL--MR-IFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HH-HHHHHCCCCTTTSTTGGG
T ss_pred             ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHH--HH-HHHhhCCCChhhccchhh
Confidence            122234468899999999875 45799999999999999999999999655432211  11 11111100   00000  


Q ss_pred             ---ccccc-------cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          707 ---IDPFL-------KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       707 ---~d~~l-------~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                         .+...       ........+..+.+++.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               00000       01112334567899999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-42  Score=367.00  Aligned_cols=264  Identities=20%  Similarity=0.275  Sum_probs=199.7

Q ss_pred             hhccccceeeeccCcEEEEEEEecC-CCceEEEEEeCCC--CCcchhHHHHHHHHHhcc---ccceeeeEeeeeec----
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNG-DSTPVAIKRLNPG--SQQGALEFQTEIGMLSQL---RYLHLVSLIGYCND----  543 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~-~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l---~Hpniv~l~g~~~~----  543 (767)
                      .++|+.++.||+|+||+||+|++.. +++.||||+++..  .......+.+|+.+|+.|   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            4689999999999999999999854 4567999998643  223344567888877766   79999999999852    


Q ss_pred             -CCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecC
Q 042216          544 -DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFG  622 (767)
Q Consensus       544 -~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfG  622 (767)
                       ....+++|||+.+|.+..... .....+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             cCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchh
Confidence             357899999999877654443 34456899999999999999999999   7889999999999999999999999999


Q ss_pred             CcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcC-
Q 042216          623 LCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG-  701 (767)
Q Consensus       623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~-  701 (767)
                      +++....   ........||+.|+|||++.+..++.++||||+||++|||++|++||......+..  ........... 
T Consensus       162 ~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~--~~i~~~~~~~~~  236 (305)
T d1blxa_         162 LARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL--GKILDVIGLPGE  236 (305)
T ss_dssp             SCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCCCCG
T ss_pred             hhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHH--HHHHHhhCCCch
Confidence            9875432   23345667999999999999999999999999999999999999999755432221  11111110000 


Q ss_pred             -Ccc---ccccccc-------cCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          702 -KIG---DIIDPFL-------KGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       702 -~~~---~~~d~~l-------~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                       ...   .......       ........++.+.+|+.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence             000   0000000       01122334667889999999999999999999875

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4e-41  Score=354.51  Aligned_cols=266  Identities=18%  Similarity=0.159  Sum_probs=212.6

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcccc-ceeeeEeeeeecCCceEEEEec
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRY-LHLVSLIGYCNDDGQMILVYDY  553 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H-pniv~l~g~~~~~~~~~lV~ey  553 (767)
                      ++|...+.||+|+||+||+|++..+++.||||++....  ...++.+|++.+..|+| +|++.+++++.++...++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            57889999999999999999998888999999886432  23457889999999965 8999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECC-----CCcEEEeecCCcccCC
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDE-----EWVAKVSDFGLCKFGP  628 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~-----~~~~ki~DfGla~~~~  628 (767)
                      + +|+|.+++.... ..+++.++..++.|++.||+|||   +++|+||||||+|||++.     ++.+||+|||+++...
T Consensus        83 ~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          83 L-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             c-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            9 679999886543 46899999999999999999999   889999999999999974     5789999999998653


Q ss_pred             CCCCc-----cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCc
Q 042216          629 NFSKT-----HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKI  703 (767)
Q Consensus       629 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~  703 (767)
                      .....     .......||+.|||||.+.+..++.++|||||||++|||++|+.||........................
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  237 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence            32111     1223457999999999999999999999999999999999999999765543322222212111111111


Q ss_pred             cccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 042216          704 GDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLLR  756 (767)
Q Consensus       704 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  756 (767)
                      .+     +    ...+++++.+++..|+..+|++||+++.+.+.|+.+++...
T Consensus       238 ~~-----l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~  281 (293)
T d1csna_         238 RE-----L----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  281 (293)
T ss_dssp             HH-----H----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HH-----h----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence            11     1    22345678999999999999999999999999998876553

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-41  Score=363.32  Aligned_cols=268  Identities=21%  Similarity=0.250  Sum_probs=198.4

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCC--CCcchhHHHHHHHHHhccccceeeeEeeeeec--------
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG--SQQGALEFQTEIGMLSQLRYLHLVSLIGYCND--------  543 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~--------  543 (767)
                      .++|+.++.||+|+||+||+|+...+++.||||++...  .......+.+|+++|++++|||++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            36899999999999999999999888899999998544  33445678999999999999999999998854        


Q ss_pred             CCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCC
Q 042216          544 DGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGL  623 (767)
Q Consensus       544 ~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGl  623 (767)
                      ++..++||||++++.+..+.  .....++...+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecce
Confidence            34689999999987776554  33346889999999999999999999   78899999999999999999999999999


Q ss_pred             cccCCCCCCc--cccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhc
Q 042216          624 CKFGPNFSKT--HVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRN  700 (767)
Q Consensus       624 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~  700 (767)
                      ++........  .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||....+.+..............
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9765432221  122335699999999998765 6899999999999999999999999655433222211111100000


Q ss_pred             CCcccccccccc--------CCCCh-------hhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          701 GKIGDIIDPFLK--------GNAPP-------VCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       701 ~~~~~~~d~~l~--------~~~~~-------~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ............        ...+.       .....+.+|+.+||+.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            000000000000        00000       12345778999999999999999999984

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.1e-41  Score=355.83  Aligned_cols=265  Identities=19%  Similarity=0.171  Sum_probs=202.4

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEe-eeeecCCceEEEEec
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLI-GYCNDDGQMILVYDY  553 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~-g~~~~~~~~~lV~ey  553 (767)
                      ++|+..+.||+|+||+||+|++..+++.||||++....  ...++..|+++++.++|+|++..+ .+..+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            46889999999999999999998888999999986543  234688999999999877655554 455677788999999


Q ss_pred             CCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEEC---CCCcEEEeecCCcccCCCC
Q 042216          554 MARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLD---EEWVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       554 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld---~~~~~ki~DfGla~~~~~~  630 (767)
                      +. |+|.+.+.... ..+++..+..++.|++.||+|||   +++|+||||||+|||++   .+..+||+|||+++.....
T Consensus        85 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          85 LG-PSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CC-CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             cC-Cchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            95 56766665433 46999999999999999999999   78899999999999986   4567999999999865332


Q ss_pred             CCc-----cccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccc
Q 042216          631 SKT-----HVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD  705 (767)
Q Consensus       631 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  705 (767)
                      ...     .......||+.|||||.+.+..++.++|||||||++|||++|+.||........................  
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--  237 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI--  237 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH--
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh--
Confidence            211     1223457999999999999999999999999999999999999999765443222211111111000000  


Q ss_pred             cccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 042216          706 IIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWGLEFVFQLL  755 (767)
Q Consensus       706 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~L~~~~~~~  755 (767)
                         +.+    ...++.++.+++..||+.+|.+||+++++.+.|+.+....
T Consensus       238 ---~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         238 ---EVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             ---HHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ---hHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence               001    2245677899999999999999999999999998876544

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-41  Score=366.03  Aligned_cols=259  Identities=25%  Similarity=0.239  Sum_probs=195.5

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccccceeeeEeeeeecC------CceEE
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLVSLIGYCNDD------GQMIL  549 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~------~~~~l  549 (767)
                      +|...++||+|+||+||+|++..+++.||||++.....    .+.+|+++|++++||||+++++++...      ..++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            58888899999999999999998889999999975432    234799999999999999999998532      34789


Q ss_pred             EEecCCCCChhhhhc-cCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC-cEEEeecCCcccC
Q 042216          550 VYDYMARGTLRDHLY-NNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW-VAKVSDFGLCKFG  627 (767)
Q Consensus       550 V~ey~~~gsL~~~L~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~-~~ki~DfGla~~~  627 (767)
                      |||||++|.+....+ ......+++.++..++.|++.||+|||   +++|+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999998764443332 123456999999999999999999999   78999999999999999765 8999999999865


Q ss_pred             CCCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHH-----------
Q 042216          628 PNFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWAT-----------  695 (767)
Q Consensus       628 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~-----------  695 (767)
                      ...   .......||..|+|||.+.+ ..++.++||||+||++|||++|++||......+.  +.....           
T Consensus       174 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         174 VRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             CTT---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCHHHHH
T ss_pred             cCC---cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHHHHhCCChHHhhh
Confidence            332   22334579999999998765 5789999999999999999999999965543221  111111           


Q ss_pred             HHh---hcCCccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          696 ECY---RNGKIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       696 ~~~---~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ...   .....................+.++.+|+.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000   000011110001111122345677899999999999999999999985

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-41  Score=351.57  Aligned_cols=263  Identities=19%  Similarity=0.223  Sum_probs=205.8

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCCceEEEEe
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDGQMILVYD  552 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~e  552 (767)
                      ++|+.++.||+|+||+||+|+...+++.||||+++...  .....++.+|+.+|+.++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            47899999999999999999998888999999986443  3345678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCCCCCC
Q 042216          553 YMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGPNFSK  632 (767)
Q Consensus       553 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~~~~~  632 (767)
                      ++.+++|..++...  ..+++..+..++.|++.||+|||   .++|+||||||+|||++.++.+||+|||.++...... 
T Consensus        82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-  155 (292)
T d1unla_          82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-  155 (292)
T ss_dssp             CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-
T ss_pred             eccccccccccccc--cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCC-
Confidence            99999998887543  46899999999999999999999   6789999999999999999999999999998654322 


Q ss_pred             ccccccccCCCcccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCC---c---cc
Q 042216          633 THVSTQVKGSIGYLDPEYYRLQL-LTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGK---I---GD  705 (767)
Q Consensus       633 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~---~---~~  705 (767)
                       .......++..|+|||.+.... ++.++|||||||++|||++|+.||........  ....+........   .   ..
T Consensus       156 -~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             -SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGG
T ss_pred             -ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCChhhhhhhhh
Confidence             2233445778899999987654 69999999999999999999999754333211  1111111111100   0   00


Q ss_pred             ccc---------ccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          706 IID---------PFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       706 ~~d---------~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      ..+         ..-...........+.+|+.+||+.||.+|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000         00011123345667899999999999999999999874

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-41  Score=364.11  Aligned_cols=261  Identities=20%  Similarity=0.249  Sum_probs=195.2

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeecCC------
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG------  545 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~------  545 (767)
                      .++|+.++.||+|+||+||+|....+++.||||+++...  ....+.+.+|+++|++++||||++++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            357999999999999999999998888999999997542  233557899999999999999999999997654      


Q ss_pred             ceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcc
Q 042216          546 QMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK  625 (767)
Q Consensus       546 ~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~  625 (767)
                      .+++||||+ +.+|..+++.   ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccccee
Confidence            579999999 4577776643   35999999999999999999999   7889999999999999999999999999998


Q ss_pred             cCCCCCCccccccccCCCcccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHH-----Hhh
Q 042216          626 FGPNFSKTHVSTQVKGSIGYLDPEYYRL-QLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATE-----CYR  699 (767)
Q Consensus       626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~-----~~~  699 (767)
                      ....     ..+...||+.|+|||.+.+ ..++.++||||+||++|||++|++||.................     ...
T Consensus       170 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         170 QADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             ECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence            6432     2344679999999999876 4678999999999999999999999966543221111110000     000


Q ss_pred             cC----------CccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          700 NG----------KIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       700 ~~----------~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                      ..          ...+.....+ .......+..+.+|+.+||+.||.+|||+.|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00          0000000000 01123345678899999999999999999999863

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-41  Score=364.37  Aligned_cols=265  Identities=22%  Similarity=0.277  Sum_probs=198.2

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC-CcchhHHHHHHHHHhccccceeeeEeeeeecCC----ceE
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS-QQGALEFQTEIGMLSQLRYLHLVSLIGYCNDDG----QMI  548 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~----~~~  548 (767)
                      +.+|+.++.||+|+||+||+|+...+++.||||++.... ....+.+++|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            356899999999999999999998888999999997543 333557899999999999999999999997543    335


Q ss_pred             EEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccCC
Q 042216          549 LVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFGP  628 (767)
Q Consensus       549 lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~~  628 (767)
                      ++++|+.+|+|.+++...   .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            556677799999999643   5899999999999999999999   7889999999999999999999999999998643


Q ss_pred             CCCC-ccccccccCCCcccChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCccc-
Q 042216          629 NFSK-THVSTQVKGSIGYLDPEYYR-LQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIGD-  705 (767)
Q Consensus       629 ~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~-  705 (767)
                      .... ........||+.|+|||.+. ...++.++||||+||+++||++|+.||......+.......   ......... 
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~  237 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG---ILGSPSQEDL  237 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---HHCSCCHHHH
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhh---hccCCChhhh
Confidence            3221 11234566999999999985 45678999999999999999999999965543222111110   000000000 


Q ss_pred             ----------cc--cccccC----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          706 ----------II--DPFLKG----NAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       706 ----------~~--d~~l~~----~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                                ..  .+....    ...+..+.++.+++.+||+.||.+|||++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                      00  000000    0011234578899999999999999999999863

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.6e-40  Score=352.42  Aligned_cols=257  Identities=20%  Similarity=0.291  Sum_probs=199.6

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc-cceeeeEeeeeec--CCceEEEE
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-YLHLVSLIGYCND--DGQMILVY  551 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~--~~~~~lV~  551 (767)
                      ++|+.+++||+|+||+||+|+...+++.||||+++..   ..+++.+|+++|++++ ||||+++++++..  ...+++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999999888899999999643   3567899999999995 9999999999874  45799999


Q ss_pred             ecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCC-CcEEEeecCCcccCCCC
Q 042216          552 DYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEE-WVAKVSDFGLCKFGPNF  630 (767)
Q Consensus       552 ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~-~~~ki~DfGla~~~~~~  630 (767)
                      ||+.+|+|.++.     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.+ ..+||+|||+++.....
T Consensus       112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            999999998764     35899999999999999999999   7889999999999999864 46999999999865432


Q ss_pred             CCccccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHH-----------HHHHHHh
Q 042216          631 SKTHVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLA-----------VWATECY  698 (767)
Q Consensus       631 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~-----------~~~~~~~  698 (767)
                         .......+|+.|+|||.+.+. .++.++||||+||+++||++|+.||............           .+... .
T Consensus       184 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~-~  259 (328)
T d3bqca1         184 ---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK-Y  259 (328)
T ss_dssp             ---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH-T
T ss_pred             ---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh-c
Confidence               223455689999999998765 5799999999999999999999999655432211100           00000 0


Q ss_pred             hcCCc---ccc--------ccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          699 RNGKI---GDI--------IDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       699 ~~~~~---~~~--------~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                      .....   ...        .............+.++.+|+.+||+.||.+|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000   000        0001111122345677899999999999999999999975

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-41  Score=356.11  Aligned_cols=253  Identities=24%  Similarity=0.295  Sum_probs=203.6

Q ss_pred             hccccceeeeccCcEEEEEEEe---cCCCceEEEEEeCCCC----CcchhHHHHHHHHHhcccc-ceeeeEeeeeecCCc
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFL---NGDSTPVAIKRLNPGS----QQGALEFQTEIGMLSQLRY-LHLVSLIGYCNDDGQ  546 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~---~~~~~~vAVK~l~~~~----~~~~~~f~~Ei~~l~~l~H-pniv~l~g~~~~~~~  546 (767)
                      ++|+..+.||+|+||+||+|+.   +.+++.||||+++...    ....+.+.+|+++|++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5799999999999999999987   3356899999986432    2234568899999999977 899999999999999


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      .+++|||+.+|+|.+++....  .+.......++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            999999999999999996554  4678899999999999999999   78899999999999999999999999999986


Q ss_pred             CCCCCCccccccccCCCcccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcCCcc
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYRLQ--LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNGKIG  704 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  704 (767)
                      ..... ........|++.|+|||.+...  .++.++|||||||+||||++|+.||............  ...... .   
T Consensus       179 ~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i--~~~~~~-~---  251 (322)
T d1vzoa_         179 FVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILK-S---  251 (322)
T ss_dssp             CCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHH-C---
T ss_pred             hcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhccc-C---
Confidence            53322 2223446799999999999754  4788999999999999999999999766543322111  111111 1   


Q ss_pred             ccccccccCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042216          705 DIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPS-----MSDVVW  746 (767)
Q Consensus       705 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs-----~~evl~  746 (767)
                             ....+..++.++.+++.+||+.||.+|||     ++|+++
T Consensus       252 -------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 -------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                   11234567788999999999999999994     788875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-40  Score=354.03  Aligned_cols=262  Identities=23%  Similarity=0.221  Sum_probs=191.2

Q ss_pred             hccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCC--CcchhHHHHHHHHHhccccceeeeEeeeeec------CCc
Q 042216          475 KDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGS--QQGALEFQTEIGMLSQLRYLHLVSLIGYCND------DGQ  546 (767)
Q Consensus       475 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~------~~~  546 (767)
                      ++|+.+++||+|+||+||+|.+..+++.||||++....  .....++.+|+.+|++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999998888999999997543  3334568999999999999999999999853      367


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      +|+||||+.++ |.+.+.    ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+|++|||+++.
T Consensus        97 ~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhc
Confidence            89999999765 444442    34899999999999999999999   78899999999999999999999999999875


Q ss_pred             CCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHH--------------
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAV--------------  692 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~--------------  692 (767)
                      ...   ........+|+.|+|||.+.+..+++++||||+||+++||++|+.||.............              
T Consensus       169 ~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         169 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             ccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            432   223345678999999999999999999999999999999999999996543221110000              


Q ss_pred             --HHHHHhhcC-Cc-----cccccccccCC---CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042216          693 --WATECYRNG-KI-----GDIIDPFLKGN---APPVCLNQFVEVAMSCVNDDRIRRPSMSDVVWG  747 (767)
Q Consensus       693 --~~~~~~~~~-~~-----~~~~d~~l~~~---~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~~  747 (767)
                        ......... ..     ...........   .....+.++.+|+.+||+.||++|||++|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence              000000000 00     00000011111   122356778999999999999999999999843

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-40  Score=355.07  Aligned_cols=258  Identities=21%  Similarity=0.258  Sum_probs=196.3

Q ss_pred             hhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCC--cchhHHHHHHHHHhccccceeeeEeeeeec-----CCc
Q 042216          474 TKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQ--QGALEFQTEIGMLSQLRYLHLVSLIGYCND-----DGQ  546 (767)
Q Consensus       474 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~-----~~~  546 (767)
                      .++|+..+.||+|+||+||+|+...+++.||||++.....  ...+++.+|+++|++++|||++++++++..     ...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            4579999999999999999999988889999999975532  334568899999999999999999999853     334


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                      .+++++|+.+|+|.+++..   ..+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+|++|||++..
T Consensus        97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcc
Confidence            5677788889999999854   35999999999999999999999   78899999999999999999999999999874


Q ss_pred             CCCCCCccccccccCCCcccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCccchhHHHHHHHHhhcC----
Q 042216          627 GPNFSKTHVSTQVKGSIGYLDPEYYRLQ-LLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQVNLAVWATECYRNG----  701 (767)
Q Consensus       627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~~l~~~~~~~~~~~----  701 (767)
                      ..     .......|+..|+|||.+.+. .++.++|||||||++|||++|++||.+..........   .......    
T Consensus       171 ~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i---~~~~~~~~~~~  242 (348)
T d2gfsa1         171 TD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LRLVGTPGAEL  242 (348)
T ss_dssp             CT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCHHH
T ss_pred             cC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCChHH
Confidence            32     223445689999999987665 5689999999999999999999999655432211111   1100000    


Q ss_pred             --------------CccccccccccCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042216          702 --------------KIGDIIDPFLKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDVVW  746 (767)
Q Consensus       702 --------------~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~evl~  746 (767)
                                    .........+. ......+.++.+|+.+||+.||.+|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         243 LKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HTTCCCHHHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhccchhhhhhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                          00000000000 001234567889999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.4e-35  Score=315.57  Aligned_cols=263  Identities=17%  Similarity=0.166  Sum_probs=191.3

Q ss_pred             ccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc-----------cceeeeEeeeeecC
Q 042216          476 DFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-----------YLHLVSLIGYCNDD  544 (767)
Q Consensus       476 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-----------Hpniv~l~g~~~~~  544 (767)
                      +|...++||+|+||+||+|+...+++.||||+++... ...+.+.+|+++++.++           |+||+++++++...
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            4888999999999999999998888999999997542 23456788999888775           57899999888643


Q ss_pred             --CceEEEEecCCCCC-hhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCC------c
Q 042216          545 --GQMILVYDYMARGT-LRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEW------V  615 (767)
Q Consensus       545 --~~~~lV~ey~~~gs-L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~------~  615 (767)
                        ...+++++++..+. ............+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++      .
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence              45666666665543 3334444555678999999999999999999995  47899999999999998654      4


Q ss_pred             EEEeecCCcccCCCCCCccccccccCCCcccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCccch----hHH
Q 042216          616 AKVSDFGLCKFGPNFSKTHVSTQVKGSIGYLDPEYYRLQLLTEKSDVYSFGVVLLEVLCARPPILRTGDKKQV----NLA  691 (767)
Q Consensus       616 ~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~elltg~~P~~~~~~~~~~----~l~  691 (767)
                      +|++|||.+.....     ......||+.|+|||.+....++.++||||+||+++||++|+.||.........    .+.
T Consensus       171 ~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         171 IKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             eeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence            99999999875322     224456999999999999999999999999999999999999999654322111    111


Q ss_pred             HHHHHH-----------------hhcCCcccccccc----------ccCCCChhhHHHHHHHHHHccccCCCCCCCHHHH
Q 042216          692 VWATEC-----------------YRNGKIGDIIDPF----------LKGNAPPVCLNQFVEVAMSCVNDDRIRRPSMSDV  744 (767)
Q Consensus       692 ~~~~~~-----------------~~~~~~~~~~d~~----------l~~~~~~~~~~~l~~li~~Cl~~dp~~RPs~~ev  744 (767)
                      ......                 .........+...          .........+.++.+|+.+||+.||.+|||++|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            111100                 0000000000000          0122345667889999999999999999999999


Q ss_pred             HH
Q 042216          745 VW  746 (767)
Q Consensus       745 l~  746 (767)
                      ++
T Consensus       326 L~  327 (362)
T d1q8ya_         326 VN  327 (362)
T ss_dssp             HT
T ss_pred             hc
Confidence            85

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.82  E-value=1.3e-20  Score=183.93  Aligned_cols=162  Identities=14%  Similarity=0.122  Sum_probs=117.0

Q ss_pred             cceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCc------------------chhHHHHHHHHHhccccceeeeEeee
Q 042216          479 NLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQ------------------GALEFQTEIGMLSQLRYLHLVSLIGY  540 (767)
Q Consensus       479 ~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~------------------~~~~f~~Ei~~l~~l~Hpniv~l~g~  540 (767)
                      ..+.||+|+||+||+|...+ ++.||||+++.....                  .......|...+.++.|.+++..+++
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~-g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETT-TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hCCEeeeCcceEEEEEECCC-CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            35689999999999999864 578999987642110                  01234568888999999999888766


Q ss_pred             eecCCceEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 042216          541 CNDDGQMILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTGASKVIIHRDVKTTNILLDEEWVAKVSD  620 (767)
Q Consensus       541 ~~~~~~~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NILld~~~~~ki~D  620 (767)
                      .    ..+++|||++++.+.+         +++.....++.|++++|+|||   ..+|+||||||+|||++++ .++|+|
T Consensus        83 ~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECC
T ss_pred             c----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEE
Confidence            4    2379999998865543         344556789999999999999   6789999999999999976 589999


Q ss_pred             cCCcccCCCCCCccccccccCCCcccC------hhhhccCCCCchhhHHHHHHHH
Q 042216          621 FGLCKFGPNFSKTHVSTQVKGSIGYLD------PEYYRLQLLTEKSDVYSFGVVL  669 (767)
Q Consensus       621 fGla~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~s~ksDV~SfGvvl  669 (767)
                      ||++....+...          ..|+.      .|.+ .+.++.++|+||..--+
T Consensus       146 FG~a~~~~~~~~----------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         146 FPQSVEVGEEGW----------REILERDVRNIITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CTTCEETTSTTH----------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             CCCcccCCCCCc----------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence            999875432111          01111      1111 35678889999975433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.40  E-value=6.1e-07  Score=89.69  Aligned_cols=150  Identities=17%  Similarity=0.160  Sum_probs=102.6

Q ss_pred             HHHHHHhhccccceeeeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhccc-cceeeeEeeeeecCCc
Q 042216          468 SEIKEATKDFNNLLIIGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLR-YLHLVSLIGYCNDDGQ  546 (767)
Q Consensus       468 ~ei~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~  546 (767)
                      .+++.....+...+..+-++...||+....  ++.+++|+...........+.+|..++..+. +--+.+++.++.+++.
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~--~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEeC--CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            356666677776554443444689988653  3568889886554445556788988887774 4345677788888888


Q ss_pred             eEEEEecCCCCChhhhhccCCCCCCChHHHHHHHHHHHHHHHHhHhC---------------------------------
Q 042216          547 MILVYDYMARGTLRDHLYNNDNPPLPWDRRLKICIGAARALHYLHTG---------------------------------  593 (767)
Q Consensus       547 ~~lV~ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------  593 (767)
                      .++||+++++.++.+.....       .....++.++++.+..||+.                                 
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             eEEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            99999999998886554211       12333455555556666631                                 


Q ss_pred             -----------------------CCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          594 -----------------------ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       594 -----------------------~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                                             ....++|+|+.+.|||++++...-|.||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                   012379999999999999877677999998763

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.71  E-value=6.9e-05  Score=73.74  Aligned_cols=131  Identities=20%  Similarity=0.184  Sum_probs=84.0

Q ss_pred             eeeccCc-EEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcccc--ceeeeEeeeeecCCceEEEEecCCCCC
Q 042216          482 IIGRGGF-GNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRY--LHLVSLIGYCNDDGQMILVYDYMARGT  558 (767)
Q Consensus       482 ~LG~G~f-G~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~H--pniv~l~g~~~~~~~~~lV~ey~~~gs  558 (767)
                      .+..|.. +.||+....+ +..+++|......   ...+..|...|+.+..  -.+.++++++.+.+..++||+++++.+
T Consensus        17 ~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQG-RPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             ECSCTTSSCEEEEEECTT-SCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EcCCcccCCeEEEEEeCC-CCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            3445553 6789988764 4568889865443   3356778888877743  345667888888889999999998866


Q ss_pred             hhhhhccCCCCCCChHHHHHHHHHHHHHHHHhH-----------------------------------------------
Q 042216          559 LRDHLYNNDNPPLPWDRRLKICIGAARALHYLH-----------------------------------------------  591 (767)
Q Consensus       559 L~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH-----------------------------------------------  591 (767)
                      +.+..       +.   ...++.++++.|.-||                                               
T Consensus        93 ~~~~~-------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          93 LLSSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTTSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             ccccc-------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            64321       00   0111122222222222                                               


Q ss_pred             ----hC----CCCCeEecCCCCCCeEECCCCcEEEeecCCccc
Q 042216          592 ----TG----ASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKF  626 (767)
Q Consensus       592 ----~~----~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~  626 (767)
                          ..    ....++|+|+.+.|||++++..+-|.||+.+..
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                11    123479999999999999886778999988653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.43  E-value=0.00026  Score=74.57  Aligned_cols=76  Identities=13%  Similarity=0.051  Sum_probs=48.3

Q ss_pred             eeeeccCcEEEEEEEecCCCceEEEEEeCCC-------CCcchhHHHHHHHHHhccc-c--ceeeeEeeeeecCCceEEE
Q 042216          481 LIIGRGGFGNVYKGFLNGDSTPVAIKRLNPG-------SQQGALEFQTEIGMLSQLR-Y--LHLVSLIGYCNDDGQMILV  550 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~-------~~~~~~~f~~Ei~~l~~l~-H--pniv~l~g~~~~~~~~~lV  550 (767)
                      +.||.|....||+.....+++.++||.-.+.       -.........|.+.|..+. +  ..+.+++.++  .+..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence            3689999999999998777788999975432       1122334556888777663 2  3455555543  4456899


Q ss_pred             EecCCCCC
Q 042216          551 YDYMARGT  558 (767)
Q Consensus       551 ~ey~~~gs  558 (767)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.03  E-value=0.012  Score=59.59  Aligned_cols=160  Identities=13%  Similarity=0.123  Sum_probs=86.7

Q ss_pred             ccCHHHHHHHhhcccc---ceeee-ccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcccccee--eeE
Q 042216          464 QFSISEIKEATKDFNN---LLIIG-RGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL--VSL  537 (767)
Q Consensus       464 ~~~~~ei~~~t~~f~~---~~~LG-~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpni--v~l  537 (767)
                      .++.+.|..+...+..   ..++- .+.--.||++..++ ++.+++|..++. .....++..|...+..|....+  +..
T Consensus         7 ~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~d-g~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p   84 (325)
T d1zyla1           7 TLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDED-RRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAP   84 (325)
T ss_dssp             CCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCTT-CCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred             ccCHHHHHHHHHHcCCCCCcCccccccccceeEEEEcCC-CCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCc
Confidence            4556666555544321   11111 12235799998865 478999998754 2345667888888887753221  111


Q ss_pred             ee-----eeecCCceEEEEecCCCCChhh----h----------hcc----C---CCCCCChH-----------------
Q 042216          538 IG-----YCNDDGQMILVYDYMARGTLRD----H----------LYN----N---DNPPLPWD-----------------  574 (767)
Q Consensus       538 ~g-----~~~~~~~~~lV~ey~~~gsL~~----~----------L~~----~---~~~~l~~~-----------------  574 (767)
                      +.     ....++..+.++++++|..+..    .          ++.    .   ....+++.                 
T Consensus        85 ~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~  164 (325)
T d1zyla1          85 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP  164 (325)
T ss_dssp             CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred             eecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCC
Confidence            11     1233456788999988643321    0          010    0   01112211                 


Q ss_pred             --HHHHHHHHHHHHHHHhH----hCCCCCeEecCCCCCCeEECCCCcEEEeecCCcccC
Q 042216          575 --RRLKICIGAARALHYLH----TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCKFG  627 (767)
Q Consensus       575 --~~~~i~~~ia~gL~yLH----~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~~~  627 (767)
                        .+..+...+.+.+..+.    .....++||+|+.+.|||++++  ..+.||+-+...
T Consensus       165 ~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~g  221 (325)
T d1zyla1         165 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARNG  221 (325)
T ss_dssp             TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred             HHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhcccC
Confidence              11111112222233332    2234578999999999999854  458899988753

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.96  E-value=0.013  Score=58.92  Aligned_cols=158  Identities=12%  Similarity=0.066  Sum_probs=84.6

Q ss_pred             ccCHHHHHHHhhcccccee-----eeccCcEEEEEEEecCCCceEEEEEeCCCCCcchhHHHHHHHHHhcccccee--ee
Q 042216          464 QFSISEIKEATKDFNNLLI-----IGRGGFGNVYKGFLNGDSTPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHL--VS  536 (767)
Q Consensus       464 ~~~~~ei~~~t~~f~~~~~-----LG~G~fG~Vy~g~~~~~~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpni--v~  536 (767)
                      ..+.+|++....+|...++     |..|---+.|+.+..++  .+++|+.....  ...++..|++++..|...++  ..
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g--~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~   77 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD--PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL   77 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC--CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC--cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccc
Confidence            4677888888888876443     33555577899987653  58999886432  23345556667766643221  11


Q ss_pred             Eeee------eecCCceEEEEecCCCCChhhhh--------------cc----CC----CCCC-----------------
Q 042216          537 LIGY------CNDDGQMILVYDYMARGTLRDHL--------------YN----ND----NPPL-----------------  571 (767)
Q Consensus       537 l~g~------~~~~~~~~lV~ey~~~gsL~~~L--------------~~----~~----~~~l-----------------  571 (767)
                      .+..      ....+....++.++.+......-              +.    ..    ....                 
T Consensus        78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (316)
T d2ppqa1          78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  157 (316)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence            1111      11234456667766654332110              00    00    0000                 


Q ss_pred             ChHHHHHHHHHHHHHHHHhH-hCCCCCeEecCCCCCCeEECCCCcEEEeecCCcc
Q 042216          572 PWDRRLKICIGAARALHYLH-TGASKVIIHRDVKTTNILLDEEWVAKVSDFGLCK  625 (767)
Q Consensus       572 ~~~~~~~i~~~ia~gL~yLH-~~~~~~iiH~Dlk~~NILld~~~~~ki~DfGla~  625 (767)
                      ........+......+.-.+ .....++||+|+.+.||+++.+...-|.||+.+.
T Consensus       158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            00011112222222222222 1235679999999999999998777899999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.68  E-value=0.017  Score=60.01  Aligned_cols=74  Identities=16%  Similarity=0.120  Sum_probs=49.2

Q ss_pred             eeeeccCcEEEEEEEecCC-------CceEEEEEeCCCCCcchhHHHHHHHHHhccccceee-eEeeeeecCCceEEEEe
Q 042216          481 LIIGRGGFGNVYKGFLNGD-------STPVAIKRLNPGSQQGALEFQTEIGMLSQLRYLHLV-SLIGYCNDDGQMILVYD  552 (767)
Q Consensus       481 ~~LG~G~fG~Vy~g~~~~~-------~~~vAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~lV~e  552 (767)
                      +.|+.|---.+|+....+.       .+.|.+++.. . ........+|..+++.+.-.++. ++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            4677788888999987542       2456666654 2 22344567899888888544444 66777643    58999


Q ss_pred             cCCCCChh
Q 042216          553 YMARGTLR  560 (767)
Q Consensus       553 y~~~gsL~  560 (767)
                      |+++..|.
T Consensus       122 fi~g~~l~  129 (395)
T d1nw1a_         122 YIPSRPLS  129 (395)
T ss_dssp             CCCEEECC
T ss_pred             EeccccCC
Confidence            99875543

>d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]}

class: All beta proteins
fold: Galactose-binding domain-like
superfamily: Galactose-binding domain-like
family: YxiM N-terminal domain-like
domain: Hypothetical protein YxiM
species: Bacillus subtilis [TaxId: 1423]

Probab=94.56  E-value=0.19  Score=43.78  Aligned_cols=133  Identities=14%  Similarity=0.135  Sum_probs=77.8

Q ss_pred             EEEeeCC----Cccc-ccCCCeeeccCCCCCCCCCcccccccCCCCCCCccccee--e--ccceeEEEecCCCceEEEEe
Q 042216           13 TFVACGW----LGNI-SAHGQTWAGDVSSQYSPLGHQQSTISKKPREPPYSASRL--S--HSQFTYTFNVTPGQKFIRLH   83 (767)
Q Consensus        13 ~~i~cG~----~~~~-~~~~~~w~~D~~~~~~~~~~~~~~~~~~~~~~~~~t~R~--f--~~~~~Y~~~~~~g~~yvR~~   83 (767)
                      |++|-|+    .+++ +..+..|.++.+|......+ ............-..+..  |  +..+.|.+++..|.+-|+++
T Consensus         3 ~~fDfg~g~~~~Gy~~v~~~~~ys~~~GYG~~~~~~-~~~r~~~~~~~~~d~~~~~~~~~~~~~~f~v~vPnG~Y~Vtv~   81 (146)
T d2o14a1           3 YQFDFGSGSMEPGYIGVRASDRYDRSKGYGFQTPEN-MRDVAASGAGVKSDAVEFLAYGTKSNNTFNVDLPNGLYEVKVT   81 (146)
T ss_dssp             EEEEESSSCCCTTSEEECTTCBCBTTTTEEESCGGG-EEEEECSSSGGGGEEEEESSCSTTCSCCEEEECCSEEEEEEEE
T ss_pred             eEECCCCCCCccceEeeccCceecCCCccceecCCc-cccccccCcccccchhhhcccccCCCceEEEECCCCeEEEEEE
Confidence            6778883    3333 33477788888772221111 111111111111111111  1  34567999988884449999


Q ss_pred             eecCCCCCCCCCCceEEEEeCceEEEeccCcccCCCCceEEEEEEeecCCCceEEEEEecCCCCCCCceeeeeeEeEecC
Q 042216           84 FYSTSYSGFNISSAFFSVKANSFTLVNNFSASFAPDDTFFKEFCINVPEDQRSLSITFTPSPDYQDSYAFINGIELVSMP  163 (767)
Q Consensus        84 f~~~~y~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~l~~~~~~~~~~~~pfis~iE~~~~~  163 (767)
                      |--         .....+.+.+-..+..+..     ....+.|.+.+.  .+.|.|.|+...  +...|-||+|||.+.+
T Consensus        82 ~Gd---------~~~~~~~~eg~~~~~~~~g-----~~~~~~~~V~Vt--DG~L~l~ft~~~--~G~~~~in~l~I~~~~  143 (146)
T d2o14a1          82 LGN---------TARASVAAEGVFQVINMTG-----DGAEDTFQIPVT--DGQLNLLVTEGK--AGTAFTLSALKIKKLS  143 (146)
T ss_dssp             ESS---------CSEEEEEETTEEEEEEEES-----TTCEEEEEEEEC--SSEEEEEEEESS--TTSCCEEEEEEEEEEE
T ss_pred             Eec---------CCCccEEEeeEEeccccCC-----ccEEEEEEEEEE--CCeEEEEEecCC--CCCccEEEEEEEEecc
Confidence            872         1135677787777766543     344556666664  468999887553  2578999999999876


Q ss_pred             C
Q 042216          164 L  164 (767)
Q Consensus       164 ~  164 (767)
                      +
T Consensus       144 d  144 (146)
T d2o14a1         144 D  144 (146)
T ss_dssp             S
T ss_pred             c
Confidence            5

>d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]}

class: All beta proteins
fold: Galactose-binding domain-like
superfamily: Galactose-binding domain-like
family: YxiM N-terminal domain-like
domain: Hypothetical protein YxiM
species: Bacillus subtilis [TaxId: 1423]

Probab=82.86  E-value=1.6  Score=37.58  Aligned_cols=80  Identities=11%  Similarity=0.185  Sum_probs=51.1

Q ss_pred             eEEEEecCCCceEEEEEeeeeeecccccCccEEEEEEEcccccccccchhhhcCCCCcceEeeeEEEeccccccccceeE
Q 042216          274 LTWEFQVDSGFIYFVRLHFCEFQSEVTEEGDRVFKIYLANLTAEDVADVIAWSGGNGVPEYRDYAVAIGSKSDVKKQNLS  353 (767)
Q Consensus       274 lt~~~~~~~~~~y~v~lhFae~~~~~~~~~~R~F~i~in~~~~~~~~di~~~~~~~~~p~y~~~~v~~~~~~~~~~~~l~  353 (767)
                      ..|..++.+| .|.|.++|.|...         .++.+.|+.....     ..+   ...-+.+.|.+.+.      .|+
T Consensus        65 ~~f~v~vPnG-~Y~Vtv~~Gd~~~---------~~~~~eg~~~~~~-----~~g---~~~~~~~~V~VtDG------~L~  120 (146)
T d2o14a1          65 NTFNVDLPNG-LYEVKVTLGNTAR---------ASVAAEGVFQVIN-----MTG---DGAEDTFQIPVTDG------QLN  120 (146)
T ss_dssp             CCEEEECCSE-EEEEEEEESSCSE---------EEEEETTEEEEEE-----EES---TTCEEEEEEEECSS------EEE
T ss_pred             ceEEEECCCC-eEEEEEEEecCCC---------ccEEEeeEEeccc-----cCC---ccEEEEEEEEEECC------eEE
Confidence            4689999989 9999999999532         2566666543322     222   23345566666543      588


Q ss_pred             EEecCCCCCCcccccccccceeEEeecC
Q 042216          354 IALHPAPRWRTKYSDSILNGIEIFKVDN  381 (767)
Q Consensus       354 i~l~p~~~~~~~~~~~~ln~~~i~~~s~  381 (767)
                      |.++...+.    ..+.||.++|-+++.
T Consensus       121 l~ft~~~~G----~~~~in~l~I~~~~d  144 (146)
T d2o14a1         121 LLVTEGKAG----TAFTLSALKIKKLSD  144 (146)
T ss_dssp             EEEEESSTT----SCCEEEEEEEEEEES
T ss_pred             EEEecCCCC----CccEEEEEEEEeccc
Confidence            877532211    267899999988753